Citrus Sinensis ID: 007006

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-
Protein Sequence
MLFCNISSHLIFKDTFDHHIQLTMELNRAFISEVKSYRRTMPTAANLASQAIRWLHLLSIVSSVMSQYFAEEDMVLSCAVSNNTASNTFTSNLNILFNQKLHSEAGKSLYYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHSSSIMDTSAPLCMKIFQNTYNVTKSLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGALAPSSAPGGKRGRAISIAIGTTLSALIVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLSLSLSLF
Secondary Structure (PSIPRED)
ccEEcccccEEEcccccEEEEEEEEcccHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEccccccccccHHHHHHHHHHHHcccccccccccEEEcccccccEEEEEEEccccccHHcHHHHHHHHHHHHHHccccccEEEEEEEcccEEEEEccccccccccccccccccccccccHHHHHHHHHHHHHHcccccccccEEEEEcccccccccEEEEccccccHHHHHHHHHHHHHHHHHHccccccccEEEEcccccEEEEEEcccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHcccHHHHHHHccHHHHHHHHcccccccccccccccccccccccccccccHHHHHHHHccccccccccccccccccEEEcccccEEEEEEcccccccHHHHHHHHHHHHHHccccccccEEcccccccEEEEEEEEcccccccEEcccccccccccHHHHHHHHHHHHHHHHHHcccccccEEEccccccccccccccccccccccccccccccccccccccEEEEcccccHHHHcccccccccccccHHEEEEEEEccccccccccccccccHHHHHHHccccccccc
Secondary Structure Prediction (SSPRO)
ccEEEcccHHEEccccccHHEEHHHHHHcccccccccHcHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccHHHHHHHHHHHHcccccccccccEcccccccccEEEEEEEEcccccHHHHHHHHHHHHHHHHHHcccccEEEEEEcccEEEEEEEcccHcccccccccccEEEcccccccHHHHHHHHHHHHHHcccccHHcccccccccccEEEEEEEEcccccHHHHHHHHHHHHHHccHHcccccccccEEEEccEEEEEEEEcccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccHEEEEEccccccccccccccccccccccccEEcHHHHHHHHccccHHccccccccccEEccEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHHHEEcccccEEEEEEEcccccccEEEEcHHHcccccHHHHHHHHHHHHHHHHHHHHccHccEEcccccHHHEEEcccccEEEccccccEEcccccEEccccEEEEEccHccHHHHHHccccHHHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHHcccccc
Coil and Loop (DISEMBL)
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
Flexible Loop (DISEMBL)
MLFCNISSHLIFKDTFDHHIQLTMELNRAFISEVKSYRRTMPTAANLASQAIRWLHLLSIVSSVMSQYFAEEDMVLSCAVSNNTASNTFTSNLNILFNQKLHSEAGKSLYYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHSSSIMDTSAPLCMKIFQNTYNVTKSLAQSFNDVIAMpslssfrnaTKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGALapssapggkRGRAISIAIGTTLSALIVVLFGSFLWYRRRRHardqeekrnsqevqflhwegrIRNHYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLSLSLSLF
Low Complexity Region (SEG)
MLFCNISSHLIFKDTFDHHIQLTMELNRAFISEVKSYRRTMPTAANLASQAIRWLHLLSIVSSVMSQYFAEEDMVLSCAVsnntasntftsnlnILFNQKLHSEAGKSLYYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHSSSIMDTSAPLCMKIFQNTYNVTKSLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGALAPSSAPGGKRGRAISIAIGTTLSALIVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRllgcclegqelllIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLSLSLSLF
Disordered region (IsUnstruct)
*LFCNISSHLIFKDTFDHHIQLTMELNRAFISEVKSYRRTMPTAANLASQAIRWLHLLSIVSSVMSQYFAEEDMVLSCAVSNNTASNTFTSNLNILFNQKLHSEAGKSLYYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHSSSIMDTSAPLCMKIFQNTYNVTKSLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGALA********RGRAISIAIGTTLSALIVVLFGSFLWYRRR**************VQFLHWEGRIRNHYAYNILRGGKQQ***QEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLSL*****
Disordered Region (DISOPRED)
MLF****SHLIFKDTFDHHIQLTMELNRAFISEVKSYRRTMPTAANLASQAIRWLHLLSIVSSVMSQYFAEEDMVLSCAVSNNTASNTFTSNLNILFNQKLHSEAGKSLYYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHSSSIMDTSAPLCMKIFQNTYNVTKSLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKV**********************AIGTTLSALIVVLFGSFLWYRRRRH*****************WEG********************QEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLSLSLSLF
Disordered Region (DISEMBL)
MLFCNISSHLIFKDTFDHHIQLTMELNRAFISEVKSYRRTMPTAANLASQAIRWLHLLSIVSSVMSQYFAEEDMVLSCAVSNNTASNTFTSNLNILFNQKLHSEAGKSLYYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHSSSIMDTSAPLCMKIFQNTYNVTKSLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGAL*********RGRAISIAIGTTLSALIVVLFGSFLWYRRRR************EVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLSLSLSLF
Disordered Region (DISPRO)
MLFCNISSHLIFKDTFDHHIQLTMELNRAFISEVKSYRRTMPTAANLASQAIRWLHLLSIVSSVMSQYFAEEDMVLSCAVSNNTASNTFTSNLNILFNQKLHSEAGKSLYYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHSSSIMDTSAPLCMKIFQNTYNVTKSLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGAL*********RGRAISIAIGTTLSALIVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIR*************QAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLSLSL***
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLFCNISSHLIFKDTFDHHIQLTMELNRAFISEVKSYRRTMPTAANLASQAIRWLHLLSIVSSVMSQYFAEEDMVLSCAVSNNTASNTFTSNLNILFNQKLHSEAGKSLYYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHSSSIMDTSAPLCMKIFQNTYNVTKSLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGALAPSSAPGGKRGRAISIAIGTTLSALIVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLSLSLSLF
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	621	2.2.26 [Sep-21-2011]
Q9M0X5	675	Cysteine-rich receptor-li	yes	no	0.768	0.706	0.453	1e-116
Q8GYA4	669	Cysteine-rich receptor-li	no	no	0.795	0.738	0.422	1e-109
O65479	666	Putative cysteine-rich re	no	no	0.800	0.746	0.435	1e-109
Q8GWJ7	645	Cysteine-rich receptor-li	no	no	0.832	0.801	0.424	1e-109
O65468	676	Cysteine-rich receptor-li	no	no	0.800	0.735	0.429	1e-106
Q8W4G6	627	Cysteine-rich receptor-li	no	no	0.785	0.778	0.413	1e-106
Q9C5S8	659	Cysteine-rich receptor-li	no	no	0.761	0.717	0.432	1e-103
Q9C5S9	674	Cysteine-rich receptor-li	no	no	0.747	0.688	0.418	1e-103
Q9ZP16	667	Cysteine-rich receptor-li	no	no	0.753	0.701	0.400	1e-101
Q8L7G3	659	Cysteine-rich receptor-li	no	no	0.780	0.735	0.401	1e-100

>sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1

 Score =  419 bits (1076), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 241/531 (45%), Positives = 314/531 (59%), Gaps = 54/531 (10%)

Query: 105 AGKSLYYNASEGEFPDS--VYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWY 162
           A  SL+ NA+ GE  DS  VYG++LC+ +VS + C++C+  A N  LQ+C   K A IWY
Sbjct: 63  AYASLFDNAAAGEENDSNRVYGVFLCRGDVSAEICRDCVAFAANETLQRCPREKVAVIWY 122

Query: 163 QVQECMVRFSDHSSSIMDTSAPLCMKIFQNTYNVTKSLAQSFN--------DVIAMPSLS 214
              ECMVR+S+ S  I+            N  N+T++    FN        DV    +LS
Sbjct: 123 D--ECMVRYSNQS--IVGQMRIRPGVFLTNKQNITENQVSRFNESLPALLIDVAVKAALS 178

Query: 215 SFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFP 274
           S + AT++ N +    + +  QC P L+  DC  CL   I ++ RC D   +G GR++ P
Sbjct: 179 SRKFATEKANFTVFQTIYSLVQCTPDLTNQDCESCLRQVINYLPRCCDR-SVG-GRVIAP 236

Query: 275 SCIMGFELYRY---------------SKVPAVGALAPSSAPGGKRGRAISIAIGTTLSAL 319
           SC   +ELY +               S V A     PS    GK    I  AI   +S +
Sbjct: 237 SCSFRYELYPFYNETIAAAPMAPPPSSTVTAPPLNIPSEKGKGKNLTVIVTAIAVPVS-V 295

Query: 320 IVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFP 379
            V+L G+  W   RR        + S E + L  +G                   S E  
Sbjct: 296 CVLLLGAMCWLLARRR-----NNKLSAETEDLDEDG-----------------ITSTETL 333

Query: 380 LFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVN 439
            F       ATN FS+ NKLG GGFG VYKG L  G+ +A+KRLS+ S QG +EFKNEV+
Sbjct: 334 QFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGETVAIKRLSQGSTQGAEEFKNEVD 393

Query: 440 LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 499
           ++AKLQH+NL +LLG CL+G+E +L+YE++PNKSLD  LFD  +   LDW+RR  II GI
Sbjct: 394 VVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEKRRVLDWQRRYKIIEGI 453

Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTY 559
           ARGILYLH DSRL IIHRDLKASNILLD DM+PKISDFG+ARIFG +Q QANT  I GTY
Sbjct: 454 ARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIFGVDQTQANTKRIVGTY 513

Query: 560 GYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYV 610
           GYM+PEYA+ G +S+KSDV+SFGVL+LE+I+G+KN+ FY  +    L+TYV
Sbjct: 514 GYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKNSSFYEEDGLGDLVTYV 564

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3

 Score =  397 bits (1021), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 234/554 (42%), Positives = 320/554 (57%), Gaps = 60/554 (10%)

Query: 80  VSNNTASNTFTSNLNILFNQKLHSEAGKSL-YYNASEGEFPDSVYGLYLCKFNVSFQSCQ 138
            +N T+++T+ +NL  L        A  S  + NA+ G+ PD V GL+ C+ +VS + C+
Sbjct: 47  TANYTSNSTYNNNLKTLLASLSSRNASYSTGFQNATVGQAPDRVTGLFNCRGDVSTEVCR 106

Query: 139 NCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHSSSIMDTSAPLCMKIFQNTYNVTK 198
            C+  AVN  L +C   KEA ++Y   EC++R+S+ +  I+ T       I  NT NVT 
Sbjct: 107 RCVSFAVNDTLTRCPNQKEATLYYD--ECVLRYSNQN--ILSTLITTGGVILVNTRNVTS 162

Query: 199 SLAQSFNDVIAMPSL---------SSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDC 249
           +     +D++ +P+L         SS +  T++ N + +       QC P L+  DC  C
Sbjct: 163 NQLDLLSDLV-LPTLNQAATVALNSSKKFGTRKNNFTALQSFYGLVQCTPDLTRQDCSRC 221

Query: 250 LNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGAL-------------AP 296
           L   I  I     P      RI+ PSC   +E+Y +    AV                 P
Sbjct: 222 LQLVINQI-----PTDRIGARIINPSCTSRYEIYAFYTESAVPPPPPPPSISTPPVSAPP 276

Query: 297 SSAPGGKRGRAISIAIGTTLSALIVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGR 356
            S   G     +   +   + A+++ + G     RR R                      
Sbjct: 277 RSGKDGNSKVLVIAIVVPIIVAVLLFIAGYCFLTRRAR---------------------- 314

Query: 357 IRNHYAYNILRGGK-QQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADG 415
            +++Y  +   G     A+S +      R    AT+ F + NK+GQGGFG VYKGTL+DG
Sbjct: 315 -KSYYTPSAFAGDDITTADSLQLDY---RTIQTATDDFVESNKIGQGGFGEVYKGTLSDG 370

Query: 416 KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLD 475
             +AVKRLS++SGQG  EFKNEV L+AKLQH+NLVRLLG CL+G+E +L+YEY+PNKSLD
Sbjct: 371 TEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLD 430

Query: 476 VHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS 535
             LFD  +  QLDW RR  II G+ARGILYLH+DSRL IIHRDLKASNILLD DMNPKI+
Sbjct: 431 YFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIA 490

Query: 536 DFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNN 595
           DFG+ARIFG +Q + NT+ I GTYGYM+PEYAM G +S+KSDV+SFGVL+LEIISG+KN+
Sbjct: 491 DFGMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNS 550

Query: 596 GFYFSEHGQTLLTY 609
            FY ++    L++Y
Sbjct: 551 SFYQTDGAHDLVSY 564

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65479|CRK20_ARATH Putative cysteine-rich receptor-like protein kinase 20 OS=Arabidopsis thaliana GN=CRK20 PE=2 SV=2

 Score =  396 bits (1017), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 234/537 (43%), Positives = 317/537 (59%), Gaps = 40/537 (7%)

Query: 77  SCAVSNNTASN-TFTSNLNILFNQKLHSEAGKSL-YYNASEGEFPDSVYGLYLCKFNVSF 134
           +C+++   +SN T+++NL  L +      A  S  + NA+ G+ PD V GL+LC+ NVS 
Sbjct: 32  NCSITTTYSSNSTYSTNLKTLLSSLSSRNASYSTGFQNATAGQAPDMVTGLFLCRGNVSP 91

Query: 135 QSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHSS-SIMDTSAPLCMKIFQNT 193
           + C++CI  +VN  L +C   +EA  +Y+  +CM+R+S+ +  S ++T   + M   QN 
Sbjct: 92  EVCRSCIALSVNESLSRCPNEREAVFYYE--QCMLRYSNRNILSTLNTDGGVFM---QNA 146

Query: 194 YNVTKSLAQSFNDVIAMP--------SLSSFRNATKRTNISNIIRLETFGQCIPVLSVDD 245
            N        F D++  P        + S  R A  + +++ +  L    QC P L+  D
Sbjct: 147 RNPISVKQDRFRDLVLNPMNLAAIEAARSIKRFAVTKFDLNALQSLYGMVQCTPDLTEQD 206

Query: 246 CRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGALAPSSAPGGKRG 305
           C DCL  +I   Q  +D  G   GR   PSC   ++ Y +     VG    SS   GK G
Sbjct: 207 CLDCLQQSIN--QVTYDKIG---GRTFLPSCTSRYDNYEFYNEFNVGTPQDSSPRPGKGG 261

Query: 306 RA-ISIAIGTTLSALIVVLFGSFLWYRRRRHARDQ------EEKRNSQEVQFLHWEGRIR 358
            + + +        ++ +LF +F   RR +  +        + KR   EV     E    
Sbjct: 262 NSSVIVIAVVVPITVLFLLFVAFFSVRRAKRKKTIGAIPLFKVKRKETEVT----EPPAE 317

Query: 359 NHYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAI 418
                +I   G  Q        F  +  + AT+ F   NKLGQGGFG VYKGT   G  +
Sbjct: 318 TTDGDDITTAGSLQ--------FDFKAIVAATDIFLPINKLGQGGFGEVYKGTFPSGVQV 369

Query: 419 AVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL 478
           AVKRLS+ SGQG +EF+NEV ++AKLQH+NLV+LLG CLEG+E +L+YE++PNKSLD  L
Sbjct: 370 AVKRLSKNSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDYFL 429

Query: 479 FDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538
           FD T   QLDW RR  II GIARGILYLH+DSRL IIHRDLKA NILLD DMNPK++DFG
Sbjct: 430 FDPTMQGQLDWSRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFG 489

Query: 539 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNN 595
           +ARIFG +Q +ANT  + GTYGYMAPEYAM G FS+KSDV+SFGVL+LEI+SG KN+
Sbjct: 490 MARIFGMDQTEANTRRVVGTYGYMAPEYAMYGKFSMKSDVYSFGVLVLEIVSGMKNS 546

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8GWJ7|CRK19_ARATH Cysteine-rich receptor-like protein kinase 19 OS=Arabidopsis thaliana GN=CRK19 PE=2 SV=2

 Score =  394 bits (1013), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 240/565 (42%), Positives = 334/565 (59%), Gaps = 48/565 (8%)

Query: 59  SIVSSVMSQYFAEEDMVLSCAVSNNTASN-TFTSNLNILFNQKLHSEAGKSL--YYNASE 115
           SI +S  + ++    +  +C+V+   +SN T+++NL  L +      A      +  A+ 
Sbjct: 15  SITASAQNTFY----LYHNCSVTTTFSSNSTYSTNLKTLLSSLSSLNASSYSTGFQTATA 70

Query: 116 GEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHS 175
           G+ PD V GL+LC+ +VS + C++C+  AVN  L +C   KE   +Y+  +C++R+S+ +
Sbjct: 71  GQAPDRVTGLFLCRVDVSSEVCRSCVTFAVNETLTRCPKDKEGVFYYE--QCLLRYSNRN 128

Query: 176 -SSIMDTSAPLCMKIFQNTYNVTKSLAQSFNDVIAMP-------SLSSFRN-ATKRTNIS 226
             + ++T   + M+  +N  +V +     F D++  P       +  SF+  A ++ +++
Sbjct: 129 IVATLNTDGGMFMQSARNPLSVKQ---DQFRDLVLTPMNLAAVEAARSFKKWAVRKIDLN 185

Query: 227 NIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYS 286
               L    +C P L   DC DCL   I   Q  +D  G   GRIL PSC   ++ Y + 
Sbjct: 186 ASQSLYGMVRCTPDLREQDCLDCLKIGIN--QVTYDKIG---GRILLPSCASRYDNYAFY 240

Query: 287 KVPAVGALAPSSAPGGKRGRAISIAIGTTLSALIVVLFGSFLWYRRRRHARDQEEKRNSQ 346
               VG    SS   GK G +  I I   +   ++ L    ++  R ++ R   EK    
Sbjct: 241 NESNVGTPQDSSPRPGKGGNSSVIIIAVVVPITVLFLLLVAVFSVRAKNKRTLNEKEPVA 300

Query: 347 EVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGP 406
           E      +G        +I   G  Q        F  +    ATN F   NKLGQGGFG 
Sbjct: 301 E------DGN-------DITTAGSLQ--------FDFKAIEAATNCFLPINKLGQGGFGE 339

Query: 407 VYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY 466
           VYKGTL+ G  +AVKRLS+TSGQG +EF+NEV ++AKLQH+NLV+LLG CLEG+E +L+Y
Sbjct: 340 VYKGTLSSGLQVAVKRLSKTSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVY 399

Query: 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 526
           E++PNKSLD  LFD+T  ++LDW RR  II GIARGILYLH+DSRL IIHRDLKA NILL
Sbjct: 400 EFVPNKSLDHFLFDSTMKMKLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILL 459

Query: 527 DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLL 586
           DDDMNPKI+DFG+ARIFG +Q +A T  + GTYGYM+PEYAM G FS+KSDV+SFGVL+L
Sbjct: 460 DDDMNPKIADFGMARIFGMDQTEAMTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVL 519

Query: 587 EIISGRKNNGFY-FSEHGQTLLTYV 610
           EIISG KN+  Y   E    L+TY 
Sbjct: 520 EIISGMKNSSLYQMDESVGNLVTYT 544

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2

 Score =  387 bits (995), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 236/550 (42%), Positives = 322/550 (58%), Gaps = 53/550 (9%)

Query: 84  TASNTFTSNLNILFNQKLHSEAGKSL-YYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIV 142
           ++++T+++NL  L +      A  S  + N   G+ PD V GL+LC+ ++S + C NC+ 
Sbjct: 51  SSNSTYSTNLKTLLSSFASRNASYSTGFQNIRAGQTPDRVTGLFLCRGDLSPEVCSNCVA 110

Query: 143 AAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHS-SSIMDTSAPLCMK------IFQNTYN 195
            +VN  L +C   +EA  +Y+  EC++R+S  +  S +     L M+        QN  +
Sbjct: 111 FSVNESLTRCPNQREAVFYYE--ECILRYSHKNFLSTVTYEGELIMRNPNNISSIQNQRD 168

Query: 196 VTKSLAQS-FNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTI 254
               L QS  N      + SS + +T +T ++++  L    QC P L+  DC  CL ++I
Sbjct: 169 QFIDLVQSNMNQAANEAANSSRKFSTIKTELTSLQTLYGLVQCTPDLARQDCFSCLTSSI 228

Query: 255 RWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGA-----LAPSSAPG-------G 302
             +   F    +G  R  +PSC   +ELY +    A+G      L P S P        G
Sbjct: 229 NRMMPLFR---IG-ARQFWPSCNSRYELYAFYNETAIGTPSPPPLFPGSTPPLTSPSIPG 284

Query: 303 KRGRAISIAIGTTLSAL--IVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNH 360
           K G +  + +   + A+   + L G     +R +   D     ++ EV            
Sbjct: 285 KSGNSTVLVVAIVVLAVLLFIALVGYCFLAQRTKKTFDTA---SASEV------------ 329

Query: 361 YAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAV 420
                   G   A +    L   R    ATN F++ NK+G+GGFG VYKGT ++GK +AV
Sbjct: 330 --------GDDMATADSLQL-DYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAV 380

Query: 421 KRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD 480
           KRLS+ S QG  EFK EV ++AKLQH+NLVRLLG  L+G+E +L+YEYMPNKSLD  LFD
Sbjct: 381 KRLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFD 440

Query: 481 ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
            T+  QLDW +R +II GIARGILYLH+DSRL IIHRDLKASNILLD D+NPKI+DFG+A
Sbjct: 441 PTKQTQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMA 500

Query: 541 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFS 600
           RIFG +Q Q NT+ I GTYGYMAPEYAM G FS+KSDV+SFGVL+LEIISGRKN+ F  S
Sbjct: 501 RIFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDES 560

Query: 601 EHGQTLLTYV 610
           +  Q LLT+ 
Sbjct: 561 DGAQDLLTHT 570

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2

 Score =  385 bits (989), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 225/544 (41%), Positives = 311/544 (57%), Gaps = 56/544 (10%)

Query: 89  FTSNLNILFNQKLHSEAGKSL-YYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNS 147
           + +NL  L +      A  S  + +A  G+ PD V GL+LC+ +VS   C+NC+  ++N 
Sbjct: 43  YLTNLRTLLSSLSAPNASYSTGFQSARAGQAPDRVTGLFLCRGDVSPAVCRNCVAFSIND 102

Query: 148 VLQKCSGTKEAFIWYQVQECMVRFSDHS--SSIMDTSAPLCM----KIFQNTYNVTKSLA 201
            L +C   +++  +Y   ECM+R+SD +  S++    A + M     I QN  N  K   
Sbjct: 103 TLVQCPSERKSVFYY--DECMLRYSDQNILSTLAYDGAWIRMNGNISIDQNQMNRFKDFV 160

Query: 202 QSFNDVIAMPSLSSFRN-ATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRC 260
            S  +  A+ + SS R   T +   + +  L    QC P L+  DC  CL ++I+ +   
Sbjct: 161 SSTMNQAAVKAASSPRKFYTVKATWTALQTLYGLVQCTPDLTRQDCFSCLESSIKLM--- 217

Query: 261 FDPPGMGFGRILFPSCIMGFELYRYSKVPAV--------------GALAPSSAPGGK-RG 305
             P     GR L+ SC   +EL+ +     V                +   S PG     
Sbjct: 218 --PLYKTGGRTLYSSCNSRYELFAFYNETTVRTQQAPPPLPPSSTPLVTSPSLPGKSWNS 275

Query: 306 RAISIAIGTTLSALIVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNI 365
             + +AI  T+    ++L   + + +R +++ D     +  ++                 
Sbjct: 276 NVLVVAIVLTILVAALLLIAGYCFAKRVKNSSDNAPAFDGDDI----------------- 318

Query: 366 LRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSR 425
                    + E      R+   ATN FS+ NK+GQGGFG VYKGT ++G  +AVKRLS+
Sbjct: 319 ---------TTESLQLDYRMIRAATNKFSENNKIGQGGFGEVYKGTFSNGTEVAVKRLSK 369

Query: 426 TSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSV 485
           +SGQG  EFKNEV ++AKLQH+NLVRLLG  + G E +L+YEYMPNKSLD  LFD  +  
Sbjct: 370 SSGQGDTEFKNEVVVVAKLQHRNLVRLLGFSIGGGERILVYEYMPNKSLDYFLFDPAKQN 429

Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           QLDW RR  +I GIARGILYLH+DSRL IIHRDLKASNILLD DMNPK++DFGLARIFG 
Sbjct: 430 QLDWTRRYKVIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKLADFGLARIFGM 489

Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQT 605
           +Q Q NT+ I GT+GYMAPEYA+ G FS+KSDV+SFGVL+LEIISG+KNN FY ++    
Sbjct: 490 DQTQENTSRIVGTFGYMAPEYAIHGQFSVKSDVYSFGVLVLEIISGKKNNSFYETDGAHD 549

Query: 606 LLTY 609
           L+T+
Sbjct: 550 LVTH 553

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9C5S8|CRK5_ARATH Cysteine-rich receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=CRK5 PE=1 SV=1

 Score =  377 bits (967), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 232/537 (43%), Positives = 307/537 (57%), Gaps = 64/537 (11%)

Query: 89  FTSNLNILFNQKLHSEAGKSL-YYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNS 147
           + SNL  L      + A  SL  ++ ++G+  D V+GLYLCK ++S +SC+ C++ A   
Sbjct: 46  YFSNLQTLLTSLSSNNAYFSLGSHSLTKGQNSDMVFGLYLCKGDLSPESCRECVIFAAKD 105

Query: 148 VLQKCSGTKEAFIWYQVQECMVRFSDHSSSIMDTSAPLCMKIFQNTYNVTKSLAQSFNDV 207
              +C G KE  I Y   ECM+ +SD +   MDT     +  + NT  VT   +  FND 
Sbjct: 106 TRSRCPGGKEFLIQYD--ECMLGYSDRNI-FMDTVTTTTIITW-NTQKVTADQSDRFNDA 161

Query: 208 I---------AMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQ 258
           +            + +S + A K+++ S+   L    QCIP L+ +DC  CL  +I+ + 
Sbjct: 162 VLSLMKKSAEEAANSTSKKFAVKKSDFSSSQSLYASVQCIPDLTSEDCVMCLQQSIKELY 221

Query: 259 RCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGAL--------------APSSAPGGKR 304
             F+  G   GR L PSC   +E+Y + K    G +               PS  PG  +
Sbjct: 222 --FNKVG---GRFLVPSCNSRYEVYPFYKETIEGTVLPPPVSAPPLPLVSTPSFPPGKGK 276

Query: 305 GRAISIAIGTTL---SALIVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHY 361
              + I         S LI V   SF   +R +   D  E+ +                 
Sbjct: 277 NSTVIIIAIVVPVAISVLICVAVFSFHASKRAKKTYDTPEEDD----------------- 319

Query: 362 AYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVK 421
              I   G  Q        F  ++   AT+ FS  NKLGQGGFG VYKGTL +G  +AVK
Sbjct: 320 ---ITTAGSLQ--------FDFKVIEAATDKFSMCNKLGQGGFGQVYKGTLPNGVQVAVK 368

Query: 422 RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA 481
           RLS+TSGQG +EFKNEV ++AKLQH+NLV+LLG CLE +E +L+YE++ NKSLD  LFD+
Sbjct: 369 RLSKTSGQGEKEFKNEVVVVAKLQHRNLVKLLGFCLEREEKILVYEFVSNKSLDYFLFDS 428

Query: 482 TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
               QLDW  R  II GIARGILYLH+DSRL IIHRDLKA NILLD DMNPK++DFG+AR
Sbjct: 429 RMQSQLDWTTRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMAR 488

Query: 542 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY 598
           IF  +Q +A+T  + GTYGYM+PEYAM G FS+KSDV+SFGVL+LEIISGRKN+  Y
Sbjct: 489 IFEIDQTEAHTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGRKNSSLY 545

Involved in multiple distinct defense responses. May function as a disease resistance (R) protein.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9C5S9|CRK6_ARATH Cysteine-rich receptor-like protein kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1

 Score =  375 bits (964), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 225/538 (41%), Positives = 307/538 (57%), Gaps = 74/538 (13%)

Query: 110 YYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMV 169
           + NA+ G+ PD V GL+LC+ +VS + C+NC+  +VN  L  C   +EA  +Y+  +C++
Sbjct: 68  FQNATAGKAPDRVTGLFLCRGDVSPEVCRNCVAFSVNQTLNLCPKVREAVFYYE--QCIL 125

Query: 170 RFSDHSSSIMDTSAPLCMKIFQNTYNVTKSLAQ----------SFNDVIAMPSLSSFRNA 219
           R+S H + +          I  NT  ++ +  Q          + ++     + SS +  
Sbjct: 126 RYS-HKNILSTAITNEGEFILSNTNTISPNQKQIDGFTSFVSSTMSEAAGKAANSSRKLY 184

Query: 220 TKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRI----LFPS 275
           T  T ++    L    QC P L+  DC  CL ++I          GM   RI     +PS
Sbjct: 185 TVNTELTAYQNLYGLLQCTPDLTRADCLSCLQSSIN---------GMALSRIGARLYWPS 235

Query: 276 CIMGFELYRYSKVPAV---------------------GALAPSSAPGGKRGRAISIAIGT 314
           C   +ELY +    A+                       ++ SS PG K G +  + +  
Sbjct: 236 CTARYELYPFYNESAIETPPLPPPPPPPPPRESLVSTPPISSSSLPG-KSGNSTVLVVAV 294

Query: 315 TLSAL--IVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQ 372
            + A+   + L G     ++++   D     ++ EV                    G   
Sbjct: 295 VVLAVLLFIALVGYCFLAKKKKKTFDTA---SASEV--------------------GDDM 331

Query: 373 AESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQ 432
           A +    L   R    ATN F++ NK+G+GGFG VYKGT ++GK +AVKRLS+ S QG  
Sbjct: 332 ATADSLQL-DYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQGEA 390

Query: 433 EFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR 492
           EFK EV ++AKLQH+NLVRLLG  L+G+E +L+YEYMPNKSLD  LFD T+ +QLDW +R
Sbjct: 391 EFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQIQLDWMQR 450

Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
            +II GIARGILYLH+DSRL IIHRDLKASNILLD D+NPKI+DFG+ARIFG +Q Q NT
Sbjct: 451 YNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQDNT 510

Query: 553 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYV 610
           + I GTYGYMAPEYAM G FS+KSDV+SFGVL+LEIISGRKN+ F  S+  Q LLT+ 
Sbjct: 511 SRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFGESDGAQDLLTHA 568

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9ZP16|CRK11_ARATH Cysteine-rich receptor-like protein kinase 11 OS=Arabidopsis thaliana GN=CRK11 PE=2 SV=2

 Score =  369 bits (947), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 218/544 (40%), Positives = 297/544 (54%), Gaps = 76/544 (13%)

Query: 109 LYYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWY-QVQEC 167
           LYYN S G+ P+ VY + +C    + + C +CI       L+ C    EA+ W  +   C
Sbjct: 61  LYYNGSIGQQPNRVYAIGMCIPGSTSEDCSDCIKKESEFFLKNCPNQTEAYSWPGEPTLC 120

Query: 168 MVRFSDHS---------------SSIMDTSAPLCMKIFQNTYNVTKSLAQSFNDVIAMPS 212
            VR+S+ S               +  +D++     KI++       S A +     + PS
Sbjct: 121 YVRYSNTSFSGSADLNPRNWLTNTGDLDSNLTEFTKIWEGLMGRMISAASTAK---STPS 177

Query: 213 LSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRIL 272
            S    +     ++ ++ +    QC P LS  DC +CL  +    Q C      G   ++
Sbjct: 178 SSDNHYSADSAVLTPLLNIYALMQCTPDLSSGDCENCLRQSAIDYQSCCSQKRGGV--VM 235

Query: 273 FPSCIMGFELYRYSKVPAVGALAPSS-----------------------APGGKRGRAIS 309
            PSC + ++LY YS   A   L  +S                       + G   G  ++
Sbjct: 236 RPSCFLRWDLYTYSN--AFDNLTVASPPPEPPVTVPQPAGDQDNPTNNDSKGISAGVVVA 293

Query: 310 IAIGTTLSALIVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGG 369
           I + T ++ LI+++ G  L+ RR+ + R + E                            
Sbjct: 294 ITVPTVIAILILLVLGFVLFRRRKSYQRTKTES--------------------------- 326

Query: 370 KQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ 429
           +    + +  ++  +    ATN FS  NKLG+GGFG VYKG L++G  +AVKRLS+ SGQ
Sbjct: 327 ESDISTTDSLVYDFKTIEAATNKFSTSNKLGEGGFGAVYKGKLSNGTDVAVKRLSKKSGQ 386

Query: 430 GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDW 489
           G +EF+NE  L+ KLQH+NLVRLLG CLE +E +LIYE++ NKSLD  LFD  +  QLDW
Sbjct: 387 GTREFRNEAVLVTKLQHRNLVRLLGFCLEREEQILIYEFVHNKSLDYFLFDPEKQSQLDW 446

Query: 490 KRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549
            RR  II GIARGILYLH+DSRLKIIHRDLKASNILLD DMNPKI+DFGLA IFG  Q Q
Sbjct: 447 TRRYKIIGGIARGILYLHQDSRLKIIHRDLKASNILLDADMNPKIADFGLATIFGVEQTQ 506

Query: 550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQT---L 606
            NTN IAGTY YM+PEYAM G +S+KSD++SFGVL+LEIISG+KN+G Y  +   T   L
Sbjct: 507 GNTNRIAGTYAYMSPEYAMHGQYSMKSDIYSFGVLVLEIISGKKNSGVYQMDETSTAGNL 566

Query: 607 LTYV 610
           +TY 
Sbjct: 567 VTYA 570

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8L7G3|CRK7_ARATH Cysteine-rich receptor-like protein kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=2 SV=1

 Score =  364 bits (935), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 223/556 (40%), Positives = 316/556 (56%), Gaps = 71/556 (12%)

Query: 84  TASNTFTSNLNILFNQKLHSEAGKSL-YYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIV 142
           ++++T+ +NL  L +      A  S  + NA+ G+  D V GL+LC+ +VS + C+NC+ 
Sbjct: 40  SSNSTYLTNLKTLLSSLSSRNASYSTGFQNATVGQALDRVTGLFLCRGDVSPEVCRNCVT 99

Query: 143 AAVNSVLQKCSGTKEAFIWYQVQECMVRFSDH---SSSIMDTSA-----PLCMKIFQNTY 194
            AVN+   +C   +EA  +Y+  EC++R+S     S++I +        P  +   QN  
Sbjct: 100 FAVNNTFSRCPNQREAVFYYE--ECILRYSHKNILSTAITNEGEFILRNPNHISPIQNQI 157

Query: 195 NVTKSLAQSFNDVIAMPSLSSFRN-ATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNT 253
           N   +L  S  + IA+ +  + R  +T +T ++ +       QC P LS  +C +CL ++
Sbjct: 158 NQFTNLVLSNMNQIAIEAADNPRKFSTIKTELTALQTFYGLVQCTPDLSRQNCMNCLTSS 217

Query: 254 IRWIQRCFDPPGMGFGRI----LFPSCIMGFELYRYSKVPAVGALAPSSA---------P 300
           I           M F RI     +PSC   +ELY +    A+G   P             
Sbjct: 218 INR---------MPFSRIGARQFWPSCNSRYELYDFYNETAIGTPPPPLPPLASPSLSDK 268

Query: 301 GGKRGRAISIAIGTTLSALIVVLFGSFLWYRRRRH------ARDQEEKRNSQEVQFLHWE 354
            G     +   +   + A+++ + G   + +R +       A D+++K   + +Q  +  
Sbjct: 269 SGNSNVVVVAVVVPIIVAVLIFIAGYCFFAKRAKKTYGTTPALDEDDKTTIESLQLDY-- 326

Query: 355 GRIRNHYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLAD 414
                                        R    ATN FS+ NK+G+GGFG VYKGT ++
Sbjct: 327 -----------------------------RAIQAATNDFSENNKIGRGGFGDVYKGTFSN 357

Query: 415 GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 474
           G  +AVKRLS+TS QG  EFKNEV ++A L+HKNLVR+LG  +E +E +L+YEY+ NKSL
Sbjct: 358 GTEVAVKRLSKTSEQGDTEFKNEVVVVANLRHKNLVRILGFSIEREERILVYEYVENKSL 417

Query: 475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 534
           D  LFD  +  QL W +R  II GIARGILYLH+DSRL IIHRDLKASNILLD DMNPKI
Sbjct: 418 DNFLFDPAKKGQLYWTQRYHIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKI 477

Query: 535 SDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKN 594
           +DFG+ARIFG +Q Q NT+ I GTYGYM+PEYAM G FS+KSDV+SFGVL+LEIISGRKN
Sbjct: 478 ADFGMARIFGMDQTQQNTSRIVGTYGYMSPEYAMRGQFSMKSDVYSFGVLVLEIISGRKN 537

Query: 595 NGFYFSEHGQTLLTYV 610
           N F  ++  Q L+T+ 
Sbjct: 538 NSFIETDDAQDLVTHA 553

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	621
359477817	670	PREDICTED: cysteine-rich receptor-like p	0.848	0.786	0.534	1e-145
147776074	815	hypothetical protein VITISV_005300 [Viti	0.885	0.674	0.512	1e-144
224076400	666	predicted protein [Populus trichocarpa]	0.793	0.740	0.496	1e-131
255555021	686	ATP binding protein, putative [Ricinus c	0.811	0.734	0.463	1e-130
356575777	671	PREDICTED: cysteine-rich receptor-like p	0.814	0.754	0.458	1e-119
359474717	663	PREDICTED: cysteine-rich receptor-like p	0.792	0.742	0.458	1e-118
359496705	1453	PREDICTED: uncharacterized protein LOC10	0.866	0.370	0.428	1e-118
356575779	666	PREDICTED: cysteine-rich receptor-like p	0.813	0.758	0.463	1e-117
356575781	659	PREDICTED: cysteine-rich receptor-like p	0.809	0.763	0.445	1e-116
351721533	667	cysteine-rich protein precursor [Glycine	0.805	0.749	0.448	1e-116

>gi|359477817|ref|XP_003632027.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like [Vitis vinifera]

 Score =  522 bits (1344), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 290/543 (53%), Positives = 364/543 (67%), Gaps = 16/543 (2%)

Query: 78  CAVSNNTASNTFTSNLNILFNQKLHSEAGKSLYYNASEGEFPDSVYGLYLCKFNVSFQSC 137
           C  +++  S  F SNL  L ++ L++E G S +    EGE PD VYGL+LC+ +VS   C
Sbjct: 35  CNNNSHAGSTKFQSNLGALLSRSLNNEGGISSFSMVYEGEDPDKVYGLFLCRPDVSKHIC 94

Query: 138 QNCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHSS-SIMDTSAPLCMKIFQNTYNV 196
           Q+CI AA   ++Q C   KEA IWY   EC +R+S+ S  S ++    L M   QN    
Sbjct: 95  QSCIDAATLKIVQVCQHKKEAIIWYN--ECFLRYSNRSFFSNLEMKPTLYMWNTQNASAP 152

Query: 197 TK---SLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNT 253
            K    L + F ++ A  + S    A  +  +SN + L    QC   L +  CR CL+  
Sbjct: 153 DKFDQKLGEMFQNLTAQATSSDDMYAIGQVEVSNFLNLYGIVQCTRDLRMSYCRRCLDEV 212

Query: 254 IRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKV--PAVGALAPSS-APGGKRGRAIS- 309
           + +I    +  G   GR+L PSC + +E+Y ++ V  P V A  PSS +P G++GR    
Sbjct: 213 VGYIPNFME--GKQGGRVLAPSCYIRYEVYPFAAVEDPVVEAQVPSSISPRGRKGRKTKW 270

Query: 310 IAIGTTLSALIVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEG-RIR-NHYAYNILR 367
           IA GT+LS ++VV F  +   RRR+ A D EEK +  ++  L   G R+    Y+   L+
Sbjct: 271 IATGTSLSGIVVVAFCVYYVIRRRKGA-DPEEKESKGDLCLLDLGGGRLDAEDYSSETLQ 329

Query: 368 GGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS 427
           G    A+S+EFP+    +  EAT HFS++NKLG+GGFGPVYKGTL+DGK IAVKRLS TS
Sbjct: 330 G-DMLAKSKEFPVIGFDIVYEATQHFSNDNKLGEGGFGPVYKGTLSDGKEIAVKRLSSTS 388

Query: 428 GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQL 487
           GQGLQEFKNEV LIAKLQH+NLVRLLGCCLEG ELLLIYEYMPNKSLD  LFD+TR ++L
Sbjct: 389 GQGLQEFKNEVILIAKLQHRNLVRLLGCCLEGNELLLIYEYMPNKSLDFFLFDSTRGLEL 448

Query: 488 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
           DWK R SIINGIARGI YLHEDSRL+IIHRDLK SNILLD DMNPKISDFGLARIF G++
Sbjct: 449 DWKTRFSIINGIARGISYLHEDSRLRIIHRDLKPSNILLDGDMNPKISDFGLARIFAGSE 508

Query: 548 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLL 607
           N  NT  I G+YGYMAPEYAM G++S KSDVFSFGV+LLEII+GRKN GF+ S  G +LL
Sbjct: 509 NGTNTAKIVGSYGYMAPEYAMEGLYSNKSDVFSFGVVLLEIITGRKNAGFHLSGMGLSLL 568

Query: 608 TYV 610
           +Y 
Sbjct: 569 SYA 571

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147776074|emb|CAN65425.1| hypothetical protein VITISV_005300 [Vitis vinifera]

 Score =  519 bits (1336), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 294/574 (51%), Positives = 374/574 (65%), Gaps = 24/574 (4%)

Query: 55  LHLLSIVSSVMSQYFAEEDMVLSCAVSNNTA--------SNTFTSNLNILFNQKLHSEAG 106
           + L+ I    ++ +F   +  +   + N+T          N   SNL  L ++ L++E G
Sbjct: 149 IGLVDIAFGWLAYWFEGTEEAVGTKLLNSTTFPRLHAWIQNFKQSNLGALLSRSLNNEGG 208

Query: 107 KSLYYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQE 166
            S +    EGE PD VYGL+LC+ +VS   CQ+CI AA   ++Q C   KEA IWY   E
Sbjct: 209 ISSFSMVYEGEDPDKVYGLFLCRPDVSKHICQSCIDAATLKIVQVCQHKKEAIIWYN--E 266

Query: 167 CMVRFSDHSS-SIMDTSAPLCMKIFQNTYNVTK---SLAQSFNDVIAMPSLSSFRNATKR 222
           C +R+S+ S  S ++    L M   QN     K    L + F ++ A  + S    A  +
Sbjct: 267 CFLRYSNRSFFSNLEMKPTLYMWNRQNASAPDKFDQKLGEMFQNLTAKATSSDGMYAIGQ 326

Query: 223 TNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFEL 282
             +SN + L    QC   L +  CR CL+  + +I    +  G   GR+L PSC + +E+
Sbjct: 327 VEVSNFLNLYGIVQCTRDLRMSYCRQCLDEVVGYIPNFME--GKEGGRVLAPSCYIRYEI 384

Query: 283 YRYSKV--PAVGALAPSS-APGGKRGRAIS-IAIGTTLSALIVVLFGSFLWYRRRRHARD 338
           Y ++ V  P V A  PSS +P G++GR    IA GT+LS ++VV F  +   RRR+ A D
Sbjct: 385 YPFAAVEDPIVEAQVPSSISPRGRKGRKTKWIATGTSLSGIVVVAFCVYYVIRRRKGA-D 443

Query: 339 QEEKRNSQEVQFLHWEG-RIR-NHYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDE 396
            EEK +  ++  L   G R+    Y+   L+G    A+S+EFP+    +  EAT HFS++
Sbjct: 444 PEEKESKGDLCLLDLGGGRLDAEDYSSETLQG-DMLAKSKEFPVIGFDIVYEATQHFSND 502

Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
           NKLG+GGFGPVYKGTL+DGK IAVKRLSRTSGQGLQEFKNEV LIAKLQH+NLVRLLGCC
Sbjct: 503 NKLGEGGFGPVYKGTLSDGKEIAVKRLSRTSGQGLQEFKNEVILIAKLQHRNLVRLLGCC 562

Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
           LEG ELLLIYEYMPNKSLD  LFD+TR ++LDWK R SIINGIARGI YLHEDSRL+IIH
Sbjct: 563 LEGNELLLIYEYMPNKSLDFFLFDSTRGLELDWKTRFSIINGIARGISYLHEDSRLRIIH 622

Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDLK SNILLD DMNPKISDFGLARIF G++N  NT  I G+YGYMAPEYAM G++S KS
Sbjct: 623 RDLKPSNILLDGDMNPKISDFGLARIFAGSENGTNTAKIVGSYGYMAPEYAMEGLYSNKS 682

Query: 577 DVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYV 610
           DVFSFGV+LLEII+GRKN GF+ S  G +LL+Y 
Sbjct: 683 DVFSFGVVLLEIITGRKNAGFHLSGMGLSLLSYA 716

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224076400|ref|XP_002304937.1| predicted protein [Populus trichocarpa] gi|222847901|gb|EEE85448.1| predicted protein [Populus trichocarpa]

 Score =  474 bits (1220), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 270/544 (49%), Positives = 341/544 (62%), Gaps = 51/544 (9%)

Query: 89  FTSNLNILFNQKLHSEAGKSL-YYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNS 147
           +  NLN L +    +    S+ ++NAS G  PD VYGL+ C+ ++S   CQNC+  A   
Sbjct: 52  YKDNLNTLLSSLASNATSNSIGFFNASAGLEPDDVYGLFFCRGDLSTDVCQNCVANATKD 111

Query: 148 VLQK-CSGTKEAFIWYQVQECMVRFSDHSS-SIMDTSAPLCMKIFQNTY-------NVTK 198
           ++Q+ C   K AFIWY   EC +R+S+    S M+      +   +N          +  
Sbjct: 112 IVQRRCPTQKVAFIWYD--ECFLRYSNKIMFSTMERDPNYTLWNPENVAVHADFNRELLN 169

Query: 199 SLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQ 258
           ++  + N    MP+ +    ATK  N +    L    QC P LS  DC  CL      ++
Sbjct: 170 TIFTAVNRAANMPAGAKKFRATK-ANYTTEHYLYVLVQCTPDLSSGDCEQCLLAAYSGLE 228

Query: 259 RCFDPPGMGFGRILFPSCIMGFELY-RYSKV-PAVGALAPSSAP-------GGKRG--RA 307
            C +    G  RILFPSCI+ FE Y  Y++      ALAPS  P        G +G  + 
Sbjct: 229 ICCNEKRGG--RILFPSCIVNFETYINYNETYVESAALAPSPVPQEKHFCYAGDKGSSKK 286

Query: 308 ISIAIGTTLSALI-VVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNIL 366
             I IG TLS ++ V+L  SF +   RR  RD      S E+ +                
Sbjct: 287 TWIIIGATLSTIVGVLLLSSFAYTMWRRKKRDD----CSNEIMY---------------- 326

Query: 367 RGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT 426
                + +SQ+  L  L + L+ATN +S+ENKLGQGGFGPVYKG + DGK IAVKRLSRT
Sbjct: 327 ----GEVKSQDSFLIQLDIVLKATNQYSNENKLGQGGFGPVYKGVMEDGKEIAVKRLSRT 382

Query: 427 SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ 486
           SGQGL+EF NEVNLIA+LQH+NLV+LLGCCLE  E LL+YEYMPNKSLDV LFD+   VQ
Sbjct: 383 SGQGLREFMNEVNLIARLQHRNLVKLLGCCLEKNEKLLVYEYMPNKSLDVFLFDSAMRVQ 442

Query: 487 LDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546
           LDW+RR SIINGIARG+LYLHEDSRL+IIHRDLKASNILLD +MNPKISDFG+ARIFGGN
Sbjct: 443 LDWQRRLSIINGIARGLLYLHEDSRLRIIHRDLKASNILLDYEMNPKISDFGMARIFGGN 502

Query: 547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTL 606
            ++ANTN I GTYGYMAPEYAM G+ S+KSDVFSFGVL+LEIISG++N GF+ SE G++L
Sbjct: 503 HSEANTNRIVGTYGYMAPEYAMEGLSSVKSDVFSFGVLMLEIISGKRNGGFHLSEEGKSL 562

Query: 607 LTYV 610
           L + 
Sbjct: 563 LNFT 566

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255555021|ref|XP_002518548.1| ATP binding protein, putative [Ricinus communis] gi|223542393|gb|EEF43935.1| ATP binding protein, putative [Ricinus communis]

 Score =  471 bits (1212), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 268/578 (46%), Positives = 357/578 (61%), Gaps = 74/578 (12%)

Query: 81  SNNTA---SNTFTSNLN-ILFNQKLHSEAGKSLYYNASEGEFPDSVYGLYLCKFNVSFQS 136
           SN+TA   ++T+ +NLN +L + + ++    + +Y+ SEGE  D VYGL+ C  ++S + 
Sbjct: 32  SNSTAFTRNSTYQNNLNRLLLSIRTNAINRPNGFYDTSEGEGEDRVYGLFFCTADLSTEV 91

Query: 137 CQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHS-SSIMDTSAPLCMKIFQNTYN 195
           CQ+C+++A   ++ +C   K A +WY   EC++R+S+ +  SI+  S  L M   QN  +
Sbjct: 92  CQDCVISATRDIVGRCPIEKTAIVWYD--ECILRYSNQTIYSILALSPGLYMWNAQNVSD 149

Query: 196 -------VTKSLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRD 248
                  +  ++ ++ N   A   L + + AT   N +   +L T  QC P LS  D   
Sbjct: 150 QEGFSELLATTMIKTANQAAA--PLGAIKFATLVANFTASQKLYTLAQCTPDLSYSDSAQ 207

Query: 249 CLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYR-YSKVPAVGALAP----------- 296
           CL+  I  +  C D  G   GRIL+PSC + +E Y  Y++      ++P           
Sbjct: 208 CLHTAISNLPLCCD--GKRGGRILYPSCNIRYEFYPFYNETGFHREVSPFNNTTVVEGNP 265

Query: 297 -----------------------SSAPGGKRGRAISIAIGTTLSALIV--VLFGSFLWYR 331
                                      GG+  +     +  +++A IV  +LF SF +  
Sbjct: 266 HSPILPPPPPPPIHPPAPMEKLGKVEKGGEGSKPTRTKVIASVTAAIVGILLFSSFFYIT 325

Query: 332 RRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLALEATN 391
            RR                +  EGR R+ Y+   + G   + ++Q+FP+ P  +  EAT 
Sbjct: 326 WRRK---------------IQKEGRTRDEYSCENITG---EMDAQDFPMIPFDIIEEATE 367

Query: 392 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
           HFSD+ KLG+GGFGPVYKGTL DGK IAVKRLSRTSGQGL EF NEV LI KLQH+NLVR
Sbjct: 368 HFSDDAKLGEGGFGPVYKGTLPDGKEIAVKRLSRTSGQGLPEFMNEVTLIFKLQHRNLVR 427

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
           LLGCCLE  E LLIYEYMPNKSLDV LFD+   V+LDW+RR SII+GIARG+LYLHEDSR
Sbjct: 428 LLGCCLEKSEKLLIYEYMPNKSLDVFLFDSHMGVRLDWQRRLSIISGIARGLLYLHEDSR 487

Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 571
           L+IIHRDLKASNILLD DMNPKISDFG+ARIFGGN +++ TN I GTYGYM+PEYAM G+
Sbjct: 488 LRIIHRDLKASNILLDYDMNPKISDFGMARIFGGNDSKS-TNRIVGTYGYMSPEYAMEGL 546

Query: 572 FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTY 609
           FS+KSD+FSFGVLLLEIISGR+NN FY  E G++LLT+
Sbjct: 547 FSMKSDIFSFGVLLLEIISGRRNNRFYVEEEGESLLTF 584

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356575777|ref|XP_003556013.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 1 [Glycine max]

 Score =  434 bits (1117), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 253/552 (45%), Positives = 336/552 (60%), Gaps = 46/552 (8%)

Query: 78  CAVSNNTASNTFTSNLNILFNQKLHSEAGKSLYYNAS-EGEFP-DSVYGLYLCKFNVSFQ 135
           C  +  TA++TF  N+  LF+    +    +++YN++  G  P D+VYGL++C+ +V FQ
Sbjct: 37  CPSNGTTANSTFQINIRTLFSSLSSNATANNVFYNSTVAGANPSDTVYGLFMCRGDVPFQ 96

Query: 136 SCQNCIVAAVNSVLQ--KCSGTKEAFIWYQVQECMVRFSDHSS-SIMDTSAPLCM---KI 189
            C  C++ A   +    +CS +K+A IWY   ECMVR+S+ S  S +DT   + +     
Sbjct: 97  LCGQCVINATQKLSSDLQCSLSKQAVIWYD--ECMVRYSNRSFFSTVDTRPAIGLLNSAN 154

Query: 190 FQNTYNVTKSLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDC 249
             N  N  + +  + N+     ++ + + ATK+ NIS    L    QC P LS   CR C
Sbjct: 155 ISNQANFMRLMFDTMNETADEAAIGAKKYATKQANISGFQTLYCLVQCTPDLSTQGCRSC 214

Query: 250 LNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRY--SKVPAVGALAPSSAPGGKRGRA 307
           L++ I  +  C +  G   GRIL PSC + ++LY +  + V A  A  P +      G  
Sbjct: 215 LSDAIGLLPWCCE--GKQGGRILNPSCNVRYDLYPFYRTNVSAPPASVPPTDSSNSGGNI 272

Query: 308 IS-----IAIGTTLSALI-----VVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRI 357
           IS     I+ GT ++ ++     V+LF   +W   +R A+    KRNS   Q    E  I
Sbjct: 273 ISYGGSEISPGTIVAIVVPITVAVLLFIVGIWLLSKRAAK----KRNS--AQDPKTETEI 326

Query: 358 RNHYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKA 417
               A   LR             F       AT+ FSD NKLG+GGFG VYKG L  G+ 
Sbjct: 327 S---AVESLR-------------FDFSTIEAATDKFSDANKLGEGGFGEVYKGLLPSGQE 370

Query: 418 IAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVH 477
           +AVKRLS+ SGQG  EFKNEV ++AKLQHKNLVRLLG CLEG+E +L+YE++ NKSLD  
Sbjct: 371 VAVKRLSKNSGQGGTEFKNEVEVVAKLQHKNLVRLLGFCLEGEEKILVYEFVANKSLDYI 430

Query: 478 LFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF 537
           LFD  +   LDW RR  I+ GIARGI YLHEDSRLKIIHRDLKASN+LLD DMNPKISDF
Sbjct: 431 LFDPEKQKSLDWTRRYKIVEGIARGIQYLHEDSRLKIIHRDLKASNVLLDGDMNPKISDF 490

Query: 538 GLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF 597
           G+ARIFG +Q QANTN I GTYGYM+PEYAM G +S KSDV+SFGVL+LEIISG++N+ F
Sbjct: 491 GMARIFGVDQTQANTNRIVGTYGYMSPEYAMHGEYSAKSDVYSFGVLILEIISGKRNSSF 550

Query: 598 YFSEHGQTLLTY 609
           Y ++  + LL+Y
Sbjct: 551 YETDVAEDLLSY 562

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359474717|ref|XP_002267916.2| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 1 [Vitis vinifera]

 Score =  432 bits (1111), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 251/548 (45%), Positives = 333/548 (60%), Gaps = 56/548 (10%)

Query: 86  SNTFTSNLNILFNQKLHSEAGKSLYYNASEGEFP-DSVYGLYLCKFNVSFQSCQNCIVAA 144
           ++++ +NLN   +    +    + +YN + G  P D  YGL+LC+ +V+ Q CQ+C+  A
Sbjct: 38  NSSYETNLNFALSSLSSNATRDTGFYNVTAGRTPPDVAYGLFLCRGDVTSQVCQDCVATA 97

Query: 145 VN-SVLQKCSGTKEAFIWYQVQECMVRFSDHSSSIMDTSAPLCMKIFQNTYNVTKSLAQS 203
           VN +V Q+C G K+A IWY   ECM+R+S+ S     + +P       NT N+T+     
Sbjct: 98  VNETVRQRCRGFKQAIIWYD--ECMLRYSNESFFSQVSESPRVS--MWNTQNITE--PDQ 151

Query: 204 FNDVIAMPSLSSFRN-----------ATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNN 252
           FN V+   +L S R            ATK  N +   R+ +  QC P LS D C  CL  
Sbjct: 152 FNQVLG-DTLDSIRTQAVNDQSGKKFATKEENFTGFQRVYSLVQCTPDLSPDQCDRCLIG 210

Query: 253 TIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSK--------VPAVGALAPSSAPGGKR 304
           TI  +  C    G    R+LFPSC + +ELY + +         PA  +   +   GG  
Sbjct: 211 TIAILPDCCG--GKQGARVLFPSCNVRYELYPFYQSVAAPPSPPPARPSEPSTEGKGGIS 268

Query: 305 GRAISIAIGTTLSALIVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYN 364
            + I I +  T  +  VV+F    +   RR A+ + +   ++ V+F             N
Sbjct: 269 SKTIVIIVVPTFVS--VVIFSILCYCFIRRCAKKRYDTLEAENVEF-------------N 313

Query: 365 ILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLS 424
           I      Q        F L     ATN+FSD NK+G+GGFG VYKGTL+ G+ IA+KRLS
Sbjct: 314 ITTEQSLQ--------FDLATIQAATNNFSDHNKIGEGGFGAVYKGTLSSGQEIAIKRLS 365

Query: 425 RTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF---DA 481
           ++SGQG  EFKNEV L+AKLQH+NLVRLLG CLEG+E +L+YEY+PNKSLD  LF     
Sbjct: 366 KSSGQGAVEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEYVPNKSLDYFLFGLAQP 425

Query: 482 TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
           T+  QLDW RR  II GIARGILYLHEDSRL++IHRDLKASN+LLD DMNPKISDFG+AR
Sbjct: 426 TKRGQLDWSRRYKIIGGIARGILYLHEDSRLRVIHRDLKASNVLLDGDMNPKISDFGMAR 485

Query: 542 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE 601
           IFG +Q Q NTN + GTYGYM+PEYAM G FS+KSDV+SFGVL+LEIISG+++N F+ S+
Sbjct: 486 IFGVDQTQGNTNRVVGTYGYMSPEYAMHGRFSVKSDVYSFGVLVLEIISGKRSNCFHESD 545

Query: 602 HGQTLLTY 609
             + LL+Y
Sbjct: 546 QAEDLLSY 553

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359496705|ref|XP_003635307.1| PREDICTED: uncharacterized protein LOC100265431, partial [Vitis vinifera]

 Score =  431 bits (1108), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 265/619 (42%), Positives = 356/619 (57%), Gaps = 81/619 (13%)

Query: 49   SQAIRWLHLL-----------SIVSSV--------------------MSQYFAEEDMVLS 77
            S+A+RW+H+             ++SSV                    M ++F  +    S
Sbjct: 612  SEALRWIHIALLCVQEEPNDRPLMSSVALMLGSKSVNLPQPSAPPFSMGRHFMSDQ---S 668

Query: 78   CAVSNNTASNTFTSNLNILFNQKLHSEAGKSLYYNASEGEFPDSVYGLYLCKFNVSFQSC 137
                 +T +  + +NL  L +  L S+A    +YN S  +    +Y LYLC+ +V+  +C
Sbjct: 669  STTGTSTDNANYENNLTALLD-SLSSKASLYSFYNDSANQ----IYSLYLCRGDVNATTC 723

Query: 138  QNCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHSSSIMDTSAPLCMKIFQNTYNVT 197
            QNC+  A   V Q+C   + A IWY   EC +R+S  +   +  ++P  +    NT N +
Sbjct: 724  QNCVRTASQEVQQQCQSNRTAIIWYD--ECKLRYSSENFFGIAATSPYFL--LWNTRNNS 779

Query: 198  K-------SLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFG--QCIPVLSVDDCRD 248
                     LA  +  V   P+  +         ++N  +   +G  QC   +S D+CR 
Sbjct: 780  SPDERDVGGLAFIYTLVSKAPNSENMFGTDVAEAVNNASQ-NIYGSVQCTRDISNDECRS 838

Query: 249  CLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGALAPSSAP-------- 300
            CL   I  I+ C    G     I+ PSC M +E Y + + P +    P+S P        
Sbjct: 839  CLLQQIEEIEGCCQ--GKIGWNIMGPSCNMRYEQYLFYQQP-LAPSTPASQPMPDDNPVY 895

Query: 301  ------GGKRGRAISIAIGTTLSALIVVLFGSFLW---YRRRRHARDQEEKRNSQEVQFL 351
                  GGK    I+I   +T++    VL G +L+   +RR+R    + E+  S+E+  L
Sbjct: 896  NIVAGKGGKNTTDIAIITVSTVTG-AAVLLGFYLYCSIFRRKR----EPEEHVSEEI-LL 949

Query: 352  HWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGT 411
            H+     +    +I    + Q  S E   F L   L ATN+FSD NKLG+GGFGPVYKG 
Sbjct: 950  HYSTAATHFMEGHI--HARDQDNSGELHCFNLTTILTATNNFSDANKLGEGGFGPVYKGK 1007

Query: 412  LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN 471
            L +GK IAVKRLSR SGQGL+EFKNEV LI KLQHKNLVRLLGCC+E +E LL+YEYM N
Sbjct: 1008 LLNGKEIAVKRLSRKSGQGLEEFKNEVMLIVKLQHKNLVRLLGCCIEREEKLLVYEYMAN 1067

Query: 472  KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN 531
             SLD  LFD  +S QLDW +R +I+ GIARGILYLHEDSRLKIIHRDLKASN+LLD++MN
Sbjct: 1068 TSLDAFLFDPIKSRQLDWAKRAAIVGGIARGILYLHEDSRLKIIHRDLKASNVLLDEEMN 1127

Query: 532  PKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
            PKISDFG ARIFG NQ  ANTN + GT+GYMAPEYAM G+FS+KSD +SFGVLLLEI+SG
Sbjct: 1128 PKISDFGTARIFGSNQIDANTNKVVGTFGYMAPEYAMEGLFSMKSDTYSFGVLLLEILSG 1187

Query: 592  RKNNGFYFSEHGQTLLTYV 610
            +KN+GF+  +H Q LL++ 
Sbjct: 1188 KKNSGFHHPDHSQNLLSHA 1206

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356575779|ref|XP_003556014.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 2 [Glycine max]

 Score =  428 bits (1101), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 254/548 (46%), Positives = 337/548 (61%), Gaps = 43/548 (7%)

Query: 78  CAVSNNTASNTFTSNLNILFNQKLHSEAGKSLYYNAS-EGEFP-DSVYGLYLCKFNVSFQ 135
           C  +  TA++TF  N+  LF+    +    +++YN++  G  P D+VYGL++C+ +V FQ
Sbjct: 37  CPSNGTTANSTFQINIRTLFSSLSSNATANNVFYNSTVAGANPSDTVYGLFMCRGDVPFQ 96

Query: 136 SCQNCIVAA---VNSVLQKCSGTKEAFIWYQVQECMVRFSDHSS-SIMDTSAPLCM---K 188
            C  C++ A   ++S LQ CS +K+A IWY   ECMVR+S+ S  S +DT   + +    
Sbjct: 97  LCGQCVINATQKLSSDLQ-CSLSKQAVIWYD--ECMVRYSNRSFFSTVDTRPAIGLLNSA 153

Query: 189 IFQNTYNVTKSLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRD 248
              N  N  + +  + N+     ++ + + ATK+ NIS    L    QC P LS   CR 
Sbjct: 154 NISNQANFMRLMFDTMNETADEAAIGAKKYATKQANISGFQTLYCLVQCTPDLSTQGCRS 213

Query: 249 CLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRY--SKVPAVGALAPSSAPGGKRGR 306
           CL++ I  +  C +  G   GRIL PSC + ++LY +  + V A  A  P +      G 
Sbjct: 214 CLSDAIGLLPWCCE--GKQGGRILNPSCNVRYDLYPFYRTNVSAPPASVPPTDSSNSGGG 271

Query: 307 AISIAIGTTLSALI-----VVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHY 361
              I+ GT ++ ++     V+LF   +W   +R A+    KRNS   Q    E  I    
Sbjct: 272 GSEISPGTIVAIVVPITVAVLLFIVGIWLLSKRAAK----KRNS--AQDPKTETEIS--- 322

Query: 362 AYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVK 421
           A   LR             F       AT+ FSD NKLG+GGFG VYKG L  G+ +AVK
Sbjct: 323 AVESLR-------------FDFSTIEAATDKFSDANKLGEGGFGEVYKGLLPSGQEVAVK 369

Query: 422 RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA 481
           RLS+ SGQG  EFKNEV ++AKLQHKNLVRLLG CLEG+E +L+YE++ NKSLD  LFD 
Sbjct: 370 RLSKNSGQGGTEFKNEVEVVAKLQHKNLVRLLGFCLEGEEKILVYEFVANKSLDYILFDP 429

Query: 482 TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
            +   LDW RR  I+ GIARGI YLHEDSRLKIIHRDLKASN+LLD DMNPKISDFG+AR
Sbjct: 430 EKQKSLDWTRRYKIVEGIARGIQYLHEDSRLKIIHRDLKASNVLLDGDMNPKISDFGMAR 489

Query: 542 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE 601
           IFG +Q QANTN I GTYGYM+PEYAM G +S KSDV+SFGVL+LEIISG++N+ FY ++
Sbjct: 490 IFGVDQTQANTNRIVGTYGYMSPEYAMHGEYSAKSDVYSFGVLILEIISGKRNSSFYETD 549

Query: 602 HGQTLLTY 609
             + LL+Y
Sbjct: 550 VAEDLLSY 557

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356575781|ref|XP_003556015.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 3 [Glycine max]

 Score =  426 bits (1096), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 242/543 (44%), Positives = 328/543 (60%), Gaps = 40/543 (7%)

Query: 78  CAVSNNTASNTFTSNLNILFNQKLHSEAGKSLYYNAS-EGEFP-DSVYGLYLCKFNVSFQ 135
           C  +  TA++TF  N+  LF+    +    +++YN++  G  P D+VYGL++C+ +V FQ
Sbjct: 37  CPSNGTTANSTFQINIRTLFSSLSSNATANNVFYNSTVAGANPSDTVYGLFMCRGDVPFQ 96

Query: 136 SCQNCIVAAVNSVLQ--KCSGTKEAFIWYQVQECMVRFSDHSS-SIMDTSAPLCM---KI 189
            C  C++ A   +    +CS +K+A IWY   ECMVR+S+ S  S +DT   + +     
Sbjct: 97  LCGQCVINATQKLSSDLQCSLSKQAVIWYD--ECMVRYSNRSFFSTVDTRPAIGLLNSAN 154

Query: 190 FQNTYNVTKSLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDC 249
             N  N  + +  + N+     ++ + + ATK+ NIS    L    QC P LS   CR C
Sbjct: 155 ISNQANFMRLMFDTMNETADEAAIGAKKYATKQANISGFQTLYCLVQCTPDLSTQGCRSC 214

Query: 250 LNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGALAPSSAP---GGKRGR 306
           L++ I  +  C +  G   GRIL PSC + ++LY + +     +  P+S P       G 
Sbjct: 215 LSDAIGLLPWCCE--GKQGGRILNPSCNVRYDLYPFYRTNV--SAPPASVPPTDSSNSGG 270

Query: 307 AISIAIGTTLSALIVVLFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNIL 366
            I I        + V+LF   +W   +R A+                      H +++ L
Sbjct: 271 NIIIVAIVVPITVAVLLFIVGIWLLSKRAAK---------------------KHMSFHFL 309

Query: 367 RGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT 426
              + +  + E   F       AT+ FSD NKLG+GGFG VYKG L  G+ +AVKRLS+ 
Sbjct: 310 --AETEISAVESLRFDFSTIEAATDKFSDANKLGEGGFGEVYKGLLPSGQEVAVKRLSKN 367

Query: 427 SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ 486
           SGQG  EFKNEV ++AKLQHKNLVRLLG CLEG+E +L+YE++ NKSLD  LFD  +   
Sbjct: 368 SGQGGTEFKNEVEVVAKLQHKNLVRLLGFCLEGEEKILVYEFVANKSLDYILFDPEKQKS 427

Query: 487 LDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546
           LDW RR  I+ GIARGI YLHEDSRLKIIHRDLKASN+LLD DMNPKISDFG+ARIFG +
Sbjct: 428 LDWTRRYKIVEGIARGIQYLHEDSRLKIIHRDLKASNVLLDGDMNPKISDFGMARIFGVD 487

Query: 547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTL 606
           Q QANTN I GTYGYM+PEYAM G +S KSDV+SFGVL+LEIISG++N+ FY ++  + L
Sbjct: 488 QTQANTNRIVGTYGYMSPEYAMHGEYSAKSDVYSFGVLILEIISGKRNSSFYETDVAEDL 547

Query: 607 LTY 609
           L+Y
Sbjct: 548 LSY 550

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351721533|ref|NP_001238492.1| cysteine-rich protein precursor [Glycine max] gi|223452302|gb|ACM89479.1| cysteine-rich protein [Glycine max]

 Score =  425 bits (1093), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 252/562 (44%), Positives = 340/562 (60%), Gaps = 62/562 (11%)

Query: 77  SCAVSNNTASNTFTSNLNILFNQKLHSEAGKSLYYNASEG---EFPDSVYGLYLCKFNVS 133
           +C+  N TA++ +  NL  L    L S A  + + N + G      D VYGL++C+ +V 
Sbjct: 34  NCSGGNTTANSAYQLNLRTLLT-SLSSNATTTEFSNNTVGLGTSPSDRVYGLFMCRGDVP 92

Query: 134 FQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSDHSS-SIMDTSAPLCMKIFQN 192
              CQ C+V A   +  +CS  K+A IWY   EC VR+S+ S  S +DT   + +    N
Sbjct: 93  SALCQQCVVNATGRLRSQCSLAKQAVIWYD--ECTVRYSNRSFFSTVDTRPRVGL---LN 147

Query: 193 TYNVT------KSLAQSFN---DVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSV 243
           T N++      + L Q+ N   D  A  S+   + A  + NIS    L    QC P LS 
Sbjct: 148 TANISNQDSFMRLLFQTINRTADEAANFSVGLKKYAVNQANISGFQSLYCLAQCTPDLSQ 207

Query: 244 DDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSKVPAVGA---------- 293
           ++CR CL+  I  +  C    G   GR+L+PSC + +ELY + +V A             
Sbjct: 208 ENCRSCLSGVIGDLPWCCQ--GKQGGRVLYPSCNVRYELYPFYRVTASPPSSSPSPPTLL 265

Query: 294 ------LAPSSAPGGKRGRAISIAIGTTLSALIVVLFGSFLWYRRRRHARDQEEKRNSQE 347
                 ++P S+ G   G  ++I +  T++ LI ++   FL  R R+  +   +      
Sbjct: 266 PPPTSPISPGSS-GISAGTIVAIVVPITVAVLIFIVGICFLSRRARKKQQGSVK------ 318

Query: 348 VQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPV 407
                 EG+     AY+I        +S +F    +     ATN FS +NKLG+GGFG V
Sbjct: 319 ------EGKT----AYDI-----PTVDSLQFDFSTIE---AATNKFSADNKLGEGGFGEV 360

Query: 408 YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE 467
           YKGTL+ G+ +AVKRLS++SGQG +EFKNEV ++AKLQH+NLVRLLG CL+G+E +L+YE
Sbjct: 361 YKGTLSSGQVVAVKRLSKSSGQGGEEFKNEVVVVAKLQHRNLVRLLGFCLQGEEKILVYE 420

Query: 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 527
           Y+PNKSLD  LFD  +  +LDW RR  II GIARGI YLHEDSRL+IIHRDLKASNILLD
Sbjct: 421 YVPNKSLDYILFDPEKQRELDWGRRYKIIGGIARGIQYLHEDSRLRIIHRDLKASNILLD 480

Query: 528 DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLE 587
            DMNPKISDFG+ARIFG +Q Q NT+ I GTYGYMAPEYAM G FS+KSDV+SFGVLL+E
Sbjct: 481 GDMNPKISDFGMARIFGVDQTQGNTSRIVGTYGYMAPEYAMHGEFSVKSDVYSFGVLLME 540

Query: 588 IISGRKNNGFYFSEHGQTLLTY 609
           I+SG+KN+ FY ++  + LL+Y
Sbjct: 541 ILSGKKNSSFYQTDGAEDLLSY 562

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	621
TAIR|locus:2115728	675	CRK25 "cysteine-rich RLK (RECE	0.763	0.702	0.441	2.8e-98
TAIR|locus:2121676	669	CRK10 "cysteine-rich RLK (RECE	0.355	0.330	0.651	5.3e-98
TAIR|locus:2121686	645	CRK19 "cysteine-rich RLK (RECE	0.360	0.347	0.646	1.6e-96
TAIR|locus:2121636	659	CRK7 "cysteine-rich RLK (RECEP	0.355	0.335	0.647	1.6e-92
TAIR|locus:2121691	667	CRK11 "cysteine-rich RLK (RECE	0.355	0.331	0.647	6.1e-92
TAIR|locus:2121651	676	CRK8 "cysteine-rich RLK (RECEP	0.755	0.693	0.430	8.1e-92
TAIR|locus:2121626	830	CRK23 "cysteine-rich RLK (RECE	0.368	0.275	0.621	5.6e-90
TAIR|locus:2077147	676	CRK4 "cysteine-rich RLK (RECEP	0.360	0.331	0.629	1.5e-89
TAIR|locus:2123111	669	CRK34 "cysteine-rich RLK (RECE	0.368	0.342	0.630	1.5e-87
TAIR|locus:2123056	656	CRK32 "cysteine-rich RLK (RECE	0.363	0.344	0.584	1e-84

TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)]

 Score = 976 (348.6 bits), Expect = 2.8e-98, P = 2.8e-98
 Identities = 233/528 (44%), Positives = 314/528 (59%)

Query:   108 SLYYNASEGEFPDS--VYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQ 165
             SL+ NA+ GE  DS  VYG++LC+ +VS + C++C+  A N  LQ+C   K A IWY   
Sbjct:    66 SLFDNAAAGEENDSNRVYGVFLCRGDVSAEICRDCVAFAANETLQRCPREKVAVIWYD-- 123

Query:   166 ECMVRFSDHSSSIMDTSAPLCMKIF-QNTYNVTKSLAQSFN--------DVIAMPSLSSF 216
             ECMVR+S+ S        P    +F  N  N+T++    FN        DV    +LSS 
Sbjct:   124 ECMVRYSNQSIVGQMRIRP---GVFLTNKQNITENQVSRFNESLPALLIDVAVKAALSSR 180

Query:   217 RNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSC 276
             + AT++ N +    + +  QC P L+  DC  CL   I ++ RC D   +G GR++ PSC
Sbjct:   181 KFATEKANFTVFQTIYSLVQCTPDLTNQDCESCLRQVINYLPRCCDR-SVG-GRVIAPSC 238

Query:   277 IMGFELYR-YSKVPAVGALAP--SS---APG----GKRGRAISIAIGTTLSAL----IVV 322
                +ELY  Y++  A   +AP  SS   AP      ++G+  ++ +  T  A+     V+
Sbjct:   239 SFRYELYPFYNETIAAAPMAPPPSSTVTAPPLNIPSEKGKGKNLTVIVTAIAVPVSVCVL 298

Query:   323 LFGSFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFP 382
             L G+  W   RR        + S E + L  +G I +              E+ +F    
Sbjct:   299 LLGAMCWLLARRR-----NNKLSAETEDLDEDG-ITS-------------TETLQFQFSA 339

Query:   383 LRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIA 442
             +  A   TN FS+ NKLG GGFG VYKG L  G+ +A+KRLS+ S QG +EFKNEV+++A
Sbjct:   340 IEAA---TNKFSESNKLGHGGFGEVYKGQLITGETVAIKRLSQGSTQGAEEFKNEVDVVA 396

Query:   443 KLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG 502
             KLQH+NL +             +YE++PNKSLD  LFD  +   LDW+RR  II GIARG
Sbjct:   397 KLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEKRRVLDWQRRYKIIEGIARG 456

Query:   503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYM 562
             ILYLH DSRL IIHRDLKASNILLD DM+PKISDFG+ARIFG +Q QANT  I GTYGYM
Sbjct:   457 ILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIFGVDQTQANTKRIVGTYGYM 516

Query:   563 APEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYV 610
             +PEYA+ G +S+KSDV+SFGVL+LE+I+G+KN+ FY  +    L+TYV
Sbjct:   517 SPEYAIHGKYSVKSDVYSFGVLVLELITGKKNSSFYEEDGLGDLVTYV 564

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 746 (267.7 bits), Expect = 5.3e-98, Sum P(2) = 5.3e-98
 Identities = 144/221 (65%), Positives = 174/221 (78%)

Query:   389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
             AT+ F + NK+GQGGFG VYKGTL+DG  +AVKRLS++SGQG  EFKNEV L+AKLQH+N
Sbjct:   344 ATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRN 403

Query:   449 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
             LVR             +YEY+PNKSLD  LFD  +  QLDW RR  II G+ARGILYLH+
Sbjct:   404 LVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQ 463

Query:   509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
             DSRL IIHRDLKASNILLD DMNPKI+DFG+ARIFG +Q + NT+ I GTYGYM+PEYAM
Sbjct:   464 DSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAM 523

Query:   569 GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTY 609
              G +S+KSDV+SFGVL+LEIISG+KN+ FY ++    L++Y
Sbjct:   524 HGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVSY 564

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)]

 Score = 726 (260.6 bits), Expect = 1.6e-96, Sum P(2) = 1.6e-96
 Identities = 146/226 (64%), Positives = 174/226 (76%)

Query:   386 ALEA-TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL 444
             A+EA TN F   NKLGQGGFG VYKGTL+ G  +AVKRLS+TSGQG +EF+NEV ++AKL
Sbjct:   318 AIEAATNCFLPINKLGQGGFGEVYKGTLSSGLQVAVKRLSKTSGQGEKEFENEVVVVAKL 377

Query:   445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
             QH+NLV+             +YE++PNKSLD  LFD+T  ++LDW RR  II GIARGIL
Sbjct:   378 QHRNLVKLLGYCLEGEEKILVYEFVPNKSLDHFLFDSTMKMKLDWTRRYKIIGGIARGIL 437

Query:   505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
             YLH+DSRL IIHRDLKA NILLDDDMNPKI+DFG+ARIFG +Q +A T  + GTYGYM+P
Sbjct:   438 YLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFGMDQTEAMTRRVVGTYGYMSP 497

Query:   565 EYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY-FSEHGQTLLTY 609
             EYAM G FS+KSDV+SFGVL+LEIISG KN+  Y   E    L+TY
Sbjct:   498 EYAMYGQFSMKSDVYSFGVLVLEIISGMKNSSLYQMDESVGNLVTY 543

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0005886 "plasma membrane" evidence=IDA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2121636 CRK7 "cysteine-rich RLK (RECEPTOR-like protein kinase) 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 722 (259.2 bits), Expect = 1.6e-92, Sum P(2) = 1.6e-92
 Identities = 143/221 (64%), Positives = 170/221 (76%)

Query:   389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
             ATN FS+ NK+G+GGFG VYKGT ++G  +AVKRLS+TS QG  EFKNEV ++A L+HKN
Sbjct:   332 ATNDFSENNKIGRGGFGDVYKGTFSNGTEVAVKRLSKTSEQGDTEFKNEVVVVANLRHKN 391

Query:   449 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
             LVR             +YEY+ NKSLD  LFD  +  QL W +R  II GIARGILYLH+
Sbjct:   392 LVRILGFSIEREERILVYEYVENKSLDNFLFDPAKKGQLYWTQRYHIIGGIARGILYLHQ 451

Query:   509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
             DSRL IIHRDLKASNILLD DMNPKI+DFG+ARIFG +Q Q NT+ I GTYGYM+PEYAM
Sbjct:   452 DSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGMDQTQQNTSRIVGTYGYMSPEYAM 511

Query:   569 GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTY 609
              G FS+KSDV+SFGVL+LEIISGRKNN F  ++  Q L+T+
Sbjct:   512 RGQFSMKSDVYSFGVLVLEIISGRKNNSFIETDDAQDLVTH 552

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0034976 "response to endoplasmic reticulum stress" evidence=RCA

TAIR|locus:2121691 CRK11 "cysteine-rich RLK (RECEPTOR-like protein kinase) 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 724 (259.9 bits), Expect = 6.1e-92, Sum P(3) = 6.1e-92
 Identities = 145/224 (64%), Positives = 169/224 (75%)

Query:   389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
             ATN FS  NKLG+GGFG VYKG L++G  +AVKRLS+ SGQG +EF+NE  L+ KLQH+N
Sbjct:   346 ATNKFSTSNKLGEGGFGAVYKGKLSNGTDVAVKRLSKKSGQGTREFRNEAVLVTKLQHRN 405

Query:   449 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
             LVR             IYE++ NKSLD  LFD  +  QLDW RR  II GIARGILYLH+
Sbjct:   406 LVRLLGFCLEREEQILIYEFVHNKSLDYFLFDPEKQSQLDWTRRYKIIGGIARGILYLHQ 465

Query:   509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
             DSRLKIIHRDLKASNILLD DMNPKI+DFGLA IFG  Q Q NTN IAGTY YM+PEYAM
Sbjct:   466 DSRLKIIHRDLKASNILLDADMNPKIADFGLATIFGVEQTQGNTNRIAGTYAYMSPEYAM 525

Query:   569 GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQT---LLTY 609
              G +S+KSD++SFGVL+LEIISG+KN+G Y  +   T   L+TY
Sbjct:   526 HGQYSMKSDIYSFGVLVLEIISGKKNSGVYQMDETSTAGNLVTY 569

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IEP;RCA

GO:0009816 "defense response to bacterium, incompatible interaction" evidence=IEP

GO:0016020 "membrane" evidence=ISS

GO:0009611 "response to wounding" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 915 (327.2 bits), Expect = 8.1e-92, P = 8.1e-92
 Identities = 225/523 (43%), Positives = 300/523 (57%)

Query:   110 YYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQECMV 169
             + N   G+ PD V GL+LC+ ++S + C NC+  +VN  L +C   +EA  +Y+  EC++
Sbjct:    78 FQNIRAGQTPDRVTGLFLCRGDLSPEVCSNCVAFSVNESLTRCPNQREAVFYYE--ECIL 135

Query:   170 RFSDHSS--SIMDTSAPLCMK------IFQNTYNVTKSLAQSFNDVIAMPSLSSFRN-AT 220
             R+S H +  S +     L M+        QN  +    L QS  +  A  + +S R  +T
Sbjct:   136 RYS-HKNFLSTVTYEGELIMRNPNNISSIQNQRDQFIDLVQSNMNQAANEAANSSRKFST 194

Query:   221 KRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGF 280
              +T ++++  L    QC P L+  DC  CL ++I  +   F    +G  R  +PSC   +
Sbjct:   195 IKTELTSLQTLYGLVQCTPDLARQDCFSCLTSSINRMMPLFR---IG-ARQFWPSCNSRY 250

Query:   281 ELYRYSKVPAVGA-----LAPSSAPG-------GKRGRAISIAIGTTLSA--LIVVLFGS 326
             ELY +    A+G      L P S P        GK G +  + +   + A  L + L G 
Sbjct:   251 ELYAFYNETAIGTPSPPPLFPGSTPPLTSPSIPGKSGNSTVLVVAIVVLAVLLFIALVGY 310

Query:   327 FLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLA 386
                 +R +   D     ++ EV                    G   A +    L   R  
Sbjct:   311 CFLAQRTKKTFDTA---SASEV--------------------GDDMATADSLQL-DYRTI 346

Query:   387 LEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH 446
               ATN F++ NK+G+GGFG VYKGT ++GK +AVKRLS+ S QG  EFK EV ++AKLQH
Sbjct:   347 QTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQGEAEFKTEVVVVAKLQH 406

Query:   447 KNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             +NLVR             +YEYMPNKSLD  LFD T+  QLDW +R +II GIARGILYL
Sbjct:   407 RNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLDWMQRYNIIGGIARGILYL 466

Query:   507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
             H+DSRL IIHRDLKASNILLD D+NPKI+DFG+ARIFG +Q Q NT+ I GTYGYMAPEY
Sbjct:   467 HQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQDNTSRIVGTYGYMAPEY 526

Query:   567 AMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTY 609
             AM G FS+KSDV+SFGVL+LEIISGRKN+ F  S+  Q LLT+
Sbjct:   527 AMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDGAQDLLTH 569

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2121626 CRK23 "cysteine-rich RLK (RECEPTOR-like protein kinase) 23" [Arabidopsis thaliana (taxid:3702)]

 Score = 719 (258.2 bits), Expect = 5.6e-90, Sum P(2) = 5.6e-90
 Identities = 143/230 (62%), Positives = 169/230 (73%)

Query:   381 FPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNL 440
             F  +  + ATN+F   NKLGQGGFG VYKGT   G  +AVKRLS+TSGQG +EF+NEV +
Sbjct:   496 FDFKAIVAATNNFLPINKLGQGGFGEVYKGTFPSGVQVAVKRLSKTSGQGEREFENEVVV 555

Query:   441 IAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 500
             +AKLQH+NLVR             +YE++ NKSLD  LFD T   QLDW RR  II GIA
Sbjct:   556 VAKLQHRNLVRLLGYCLEGEEKILVYEFVHNKSLDYFLFDTTMKRQLDWTRRYKIIGGIA 615

Query:   501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 560
             RGILYLH+DSRL IIHRDLKA NILLD DMNPK++DFG+ARIFG +Q +ANT  + GTYG
Sbjct:   616 RGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARIFGMDQTEANTRRVVGTYG 675

Query:   561 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY-FSEHGQTLLTY 609
             YMAPEYAM G FS+KSDV+SFGVL+ EIISG KN+  Y   +    L+TY
Sbjct:   676 YMAPEYAMYGQFSMKSDVYSFGVLVFEIISGMKNSSLYQMDDSVSNLVTY 725

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006952 "defense response" evidence=TAS

TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 707 (253.9 bits), Expect = 1.5e-89, Sum P(2) = 1.5e-89
 Identities = 143/227 (62%), Positives = 169/227 (74%)

Query:   386 ALEA-TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL 444
             A+EA TN F + NKLGQGGFG VYKG    G  +AVKRLS+TSGQG +EF NEV ++AKL
Sbjct:   343 AIEAATNKFCETNKLGQGGFGEVYKGIFPSGVQVAVKRLSKTSGQGEREFANEVIVVAKL 402

Query:   445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
             QH+NLVR             +YE++PNKSLD  +FD+T    LDW RR  II GIARGIL
Sbjct:   403 QHRNLVRLLGFCLERDERILVYEFVPNKSLDYFIFDSTMQSLLDWTRRYKIIGGIARGIL 462

Query:   505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
             YLH+DSRL IIHRDLKA NILL DDMN KI+DFG+ARIFG +Q +ANT  I GTYGYM+P
Sbjct:   463 YLHQDSRLTIIHRDLKAGNILLGDDMNAKIADFGMARIFGMDQTEANTRRIVGTYGYMSP 522

Query:   565 EYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE--HGQTLLTY 609
             EYAM G FS+KSDV+SFGVL+LEIISG+KN+  Y  +      L+TY
Sbjct:   523 EYAMYGQFSMKSDVYSFGVLVLEIISGKKNSNVYQMDGTSAGNLVTY 569

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006952 "defense response" evidence=TAS

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0012501 "programmed cell death" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IEP

TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)]

 Score = 745 (267.3 bits), Expect = 1.5e-87, Sum P(2) = 1.5e-87
 Identities = 145/230 (63%), Positives = 177/230 (76%)

Query:   381 FPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNL 440
             F  +    AT+ FSD N +G+GGFG VY+G L+ G  +AVKRLS+TSGQG +EFKNE  L
Sbjct:   333 FSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSGPEVAVKRLSKTSGQGAEEFKNEAVL 392

Query:   441 IAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 500
             ++KLQHKNLVR             +YE++PNKSLD  LFD  +  +LDW RR +II GIA
Sbjct:   393 VSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPAKQGELDWTRRYNIIGGIA 452

Query:   501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 560
             RGILYLH+DSRL IIHRDLKASNILLD DMNPKI+DFG+ARIFG +Q+QANT  IAGT+G
Sbjct:   453 RGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGVDQSQANTRRIAGTFG 512

Query:   561 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY-FSEHGQTLLTY 609
             YM+PEYAM G FS+KSDV+SFGVL+LEIISG+KN+ FY   + G  L+T+
Sbjct:   513 YMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNSSFYNIDDSGSNLVTH 562

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2123056 CRK32 "cysteine-rich RLK (RECEPTOR-like protein kinase) 32" [Arabidopsis thaliana (taxid:3702)]

 Score = 675 (242.7 bits), Expect = 1.0e-84, Sum P(2) = 1.0e-84
 Identities = 138/236 (58%), Positives = 168/236 (71%)

Query:   385 LALEA-TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK 443
             + LEA T+ FS  NKLG+GGFG VYKG L +   +AVKRLS  SGQG QEFKNEV ++AK
Sbjct:   312 MTLEAATDKFSRNNKLGKGGFGEVYKGMLPNETEVAVKRLSSNSGQGTQEFKNEVVIVAK 371

Query:   444 LQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDV--------HLFDATRSVQLDWKRRQSI 495
             LQHKNLVR             +YE++PNKSL+         HL D T+  QLDWKRR +I
Sbjct:   372 LQHKNLVRLLGFCLERDEQILVYEFVPNKSLNYFLFGNKQKHLLDPTKKSQLDWKRRYNI 431

Query:   496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 555
             I GI RG+LYLH+DSRL IIHRD+KASNILLD DMNPKI+DFG+AR F  +Q + NT  +
Sbjct:   432 IGGITRGLLYLHQDSRLTIIHRDIKASNILLDADMNPKIADFGMARNFRVDQTEDNTRRV 491

Query:   556 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY-FSEHGQTLLTYV 610
              GT+GYM PEY   G FS KSDV+SFGVL+LEI+ G+KN+ FY   + G  L+T+V
Sbjct:   492 VGTFGYMPPEYVTHGQFSTKSDVYSFGVLILEIVCGKKNSSFYKIDDSGGNLVTHV 547

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	621
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-53
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-53
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	7e-53
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-52
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-51
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-51
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	9e-49
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-43
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-38
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-37
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-36
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-35
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-34
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-33
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-33
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-32
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-31
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-31
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-31
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-31
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-31
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	8e-31
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-30
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-29
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-29
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	8e-29
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-28
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-28
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-28
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-28
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-27
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-27
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-27
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-27
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-27
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-27
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-27
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-26
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-26
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-26
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-26
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-26
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-25
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-25
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-25
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-25
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-25
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-25
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-25
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	7e-25
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	7e-25
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	8e-25
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	9e-25
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-24
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-24
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-24
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-24
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-24
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-24
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-24
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-24
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-24
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-24
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-24
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-24
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-24
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-24
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-23
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-23
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-23
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-23
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-23
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-23
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-23
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-23
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-23
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-23
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	8e-23
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-22
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-22
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-22
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-22
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-22
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-22
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-21
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-21
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-21
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-21
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-21
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-21
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-21
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	6e-21
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	8e-21
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	9e-21
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-20
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-20
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-20
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-20
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-20
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-20
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-20
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-20
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-20
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-20
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-20
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-20
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-20
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-20
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-20
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-20
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-20
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-19
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-19
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-19
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-19
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-19
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-19
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-19
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-19
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-19
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-19
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-19
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-19
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	8e-19
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	8e-19
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	8e-19
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	9e-19
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	9e-19
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-18
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-18
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-18
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-18
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-18
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-18
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-18
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-18
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-18
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-18
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-18
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-18
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-18
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-18
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-18
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-18
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	7e-18
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	9e-18
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-17
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-17
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-17
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-17
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-17
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-17
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-17
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-17
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-17
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-17
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-17
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	8e-17
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	9e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-16
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-16
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-16
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	5e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-16
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	7e-16
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	7e-16
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-16
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	7e-16
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-16
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-15
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-15
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-15
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-15
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-15
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-15
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-15
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-15
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-15
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-15
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-15
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-15
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	7e-15
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-15
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	8e-15
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	9e-15
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	9e-15
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-14
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-14
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-14
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-14
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-14
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-14
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-14
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-14
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-14
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-14
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-14
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	6e-14
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-14
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	7e-14
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	9e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	9e-14
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-13
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-13
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-13
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-13
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	8e-13
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	8e-13
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-12
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-12
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-12
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-12
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-12
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-12
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-12
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-12
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-12
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-12
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-12
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-12
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	8e-12
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	8e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	9e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-11
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-11
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	9e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-10
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-10
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	6e-10
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	6e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	6e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	9e-10
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	9e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-09
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	6e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	7e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	8e-07
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-06
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	6e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	3e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	6e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	9e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.002
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.002

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  182 bits (464), Expect = 4e-53
 Identities = 81/203 (39%), Positives = 107/203 (52%), Gaps = 15/203 (7%)

Query: 396 ENKLGQGGFGPVYKGTLADGKA-----IAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 449
             KLG+G FG VYKGTL          +AVK L    S Q ++EF  E  ++ KL H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           V+LLG C E + L+++ EYMP   L  +L    R  +L      S    IARG+ YL   
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE-- 120

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ--NQANTNIIAGTYGYMAPEYA 567
                IHRDL A N L+ +++  KISDFGL+R    +         +      +MAPE  
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL---PIRWMAPESL 176

Query: 568 MGGIFSIKSDVFSFGVLLLEIIS 590
             G F+ KSDV+SFGVLL EI +
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  181 bits (462), Expect = 6e-53
 Identities = 78/203 (38%), Positives = 104/203 (51%), Gaps = 16/203 (7%)

Query: 396 ENKLGQGGFGPVYKGTLADGK-----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 449
             KLG+G FG VYKG L          +AVK L    S Q ++EF  E  ++ KL H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           V+LLG C E + L ++ EYM    L  +L       +L      S    IARG+ YL   
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE-- 119

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ--NQANTNIIAGTYGYMAPEYA 567
                IHRDL A N L+ +++  KISDFGL+R    +    +    +      +MAPE  
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL---PIRWMAPESL 175

Query: 568 MGGIFSIKSDVFSFGVLLLEIIS 590
             G F+ KSDV+SFGVLL EI +
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFT 198

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  181 bits (462), Expect = 7e-53
 Identities = 83/209 (39%), Positives = 110/209 (52%), Gaps = 22/209 (10%)

Query: 397 NKLGQGGFGPVYKGTLADGK----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
            KLG+G FG VYKG L         +AVK L    S +  ++F  E  ++ KL H N+VR
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHL------FDATRSVQLDWKRRQSIINGIARGILY 505
           LLG C E + L L+ EYM    L  +L      F +     L  K   S    IA+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTN---IIAGTYGY 561
           L      K +HRDL A N L+ +D+  KISDFGL+R ++  +  +  T     I     +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173

Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           MAPE    GIF+ KSDV+SFGVLL EI +
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  178 bits (453), Expect = 3e-52
 Identities = 75/194 (38%), Positives = 107/194 (55%), Gaps = 11/194 (5%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
           LG+GGFG VY       GK +A+K + +  S   L+E   E+ ++ KL H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
            +   L L+ EY    SL   L +     +L       I+  I  G+ YLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 517 RDLKASNILLD-DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSI 574
           RDLK  NILLD D+   K++DFGL+++   +++   T  I GT  YMAPE  +G G +S 
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173

Query: 575 KSDVFSFGVLLLEI 588
           KSD++S GV+L E+
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  177 bits (452), Expect = 2e-51
 Identities = 79/204 (38%), Positives = 108/204 (52%), Gaps = 19/204 (9%)

Query: 398 KLGQGGFGPVYKGTLADGKA-----IAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLVR 451
           KLG+G FG VYKGTL          +AVK L    S +  +EF  E +++ KL H N+VR
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
           LLG C +G+ L ++ EYMP   L   L      + L       +   IA+G+ YL     
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLL--QMALQIAKGMEYLES--- 120

Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAGTYG---YMAPEYA 567
              +HRDL A N L+ +++  KISDFGL+R I+  +  +       G      +MAPE  
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG----GGKLPIKWMAPESL 176

Query: 568 MGGIFSIKSDVFSFGVLLLEIISG 591
             G F+ KSDV+SFGVLL EI + 
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  177 bits (451), Expect = 2e-51
 Identities = 75/199 (37%), Positives = 105/199 (52%), Gaps = 12/199 (6%)

Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRL--SRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
           KLG G FG VYK      GK +AVK L       +  Q  + E+ ++ +L H N+VRL+ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
              +   L L+ EY     L  +L   +R   L     + I   I RG+ YLH      I
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHS---NGI 119

Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-FS 573
           IHRDLK  NILLD++   KI+DFGLA+      + ++     GT  YMAPE  +GG  + 
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLK--SSSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 574 IKSDVFSFGVLLLEIISGR 592
            K DV+S GV+L E+++G+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  170 bits (433), Expect = 9e-49
 Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 11/202 (5%)

Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLV 450
           +    KLG+G FG VY       GK +A+K + +   +  +E    E+ ++ KL+H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
           RL     +  +L L+ EY     L   L    +  +L     +  +  I   + YLH   
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLHS-- 115

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
              I+HRDLK  NILLD+D + K++DFGLAR     +         GT  YMAPE  +G 
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGTPEYMAPEVLLGK 171

Query: 571 IFSIKSDVFSFGVLLLEIISGR 592
            +    D++S GV+L E+++G+
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  154 bits (392), Expect = 6e-43
 Identities = 68/214 (31%), Positives = 102/214 (47%), Gaps = 37/214 (17%)

Query: 397 NKLGQGGFGPVYKGTLAD-GKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
             LG+G FG VY     D G+ +AVK   LS  S + L+  + E+ +++ LQH N+VR  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 454 GCCL--EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR-------------RQSIING 498
           G     E   L +  EY+   SL   L           K+             RQ     
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLL-----------KKFGKLPEPVIRKYTRQ----- 109

Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I  G+ YLH      I+HRD+K +NIL+D D   K++DFG A+  G  +    T  + GT
Sbjct: 110 ILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166

Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
             +MAPE   G  +   +D++S G  ++E+ +G+
Sbjct: 167 PYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  140 bits (356), Expect = 5e-38
 Identities = 77/201 (38%), Positives = 107/201 (53%), Gaps = 24/201 (11%)

Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE 458
           +G+G FG V  G    G+ +AVK L   S    Q F  E +++  L+H NLV+LLG  L+
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 459 GQELLLIYEYMPNKSLDVHLFDATRSV-----QLDWKRRQSIINGIARGILYLHEDSRLK 513
           G  L ++ EYM   SL  +L    R+V     QL +         +  G+ YL E     
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALD------VCEGMEYLEEK---N 122

Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI-IAGTYGYMAPEYAMGGIF 572
            +HRDL A N+L+ +D+  K+SDFGLA+    +Q Q +  + +  T    APE      F
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLPVKWT----APEALREKKF 176

Query: 573 SIKSDVFSFGVLLLEIIS-GR 592
           S KSDV+SFG+LL EI S GR
Sbjct: 177 STKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  139 bits (353), Expect = 2e-37
 Identities = 67/208 (32%), Positives = 108/208 (51%), Gaps = 21/208 (10%)

Query: 392 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
            F    K+G+GGFG VYK      GK +A+K +   S +  ++  NE+ ++ K +H N+V
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR--QSIINGIARGIL---- 504
           +  G  L+  EL ++ E+    SL     D  +S      +   +S I  + + +L    
Sbjct: 61  KYYGSYLKKDELWIVMEFCSGGSLK----DLLKS----TNQTLTESQIAYVCKELLKGLE 112

Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           YLH      IIHRD+KA+NILL  D   K+ DFGL+     +  +A   ++ GT  +MAP
Sbjct: 113 YLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMV-GTPYWMAP 166

Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E   G  +  K+D++S G+  +E+  G+
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  136 bits (344), Expect = 3e-36
 Identities = 74/202 (36%), Positives = 108/202 (53%), Gaps = 14/202 (6%)

Query: 393 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
           F+ E KLG G FG V++G   +   +A+K L        Q+F+ EV  + +L+HK+L+ L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGILYLHED 509
              C  G+ + +I E M   SL   L      V        S+I+    +A G+ YL E 
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVL----PVASLIDMACQVAEGMAYLEEQ 123

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN-QNQANTNIIAGTYGYMAPEYAM 568
                IHRDL A NIL+ +D+  K++DFGLAR+   +    ++  I    Y + APE A 
Sbjct: 124 ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI---PYKWTAPEAAS 177

Query: 569 GGIFSIKSDVFSFGVLLLEIIS 590
            G FS KSDV+SFG+LL E+ +
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  133 bits (336), Expect = 3e-35
 Identities = 76/204 (37%), Positives = 105/204 (51%), Gaps = 19/204 (9%)

Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
           E KLG G FG V+ GT      +AVK L +      + F  E  ++ KL+H  LV+L   
Sbjct: 11  ERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69

Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGILYLHEDSRL 512
           C E + + ++ EYM   SL   L            R   +++    IA G+ YL      
Sbjct: 70  CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKL----RLPQLVDMAAQIAEGMAYLE---SR 122

Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI---IAGTYGYMAPEYAMG 569
             IHRDL A NIL+ +++  KI+DFGLAR+   ++  A       I  T    APE A  
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAANY 178

Query: 570 GIFSIKSDVFSFGVLLLEIIS-GR 592
           G F+IKSDV+SFG+LL EI++ GR
Sbjct: 179 GRFTIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  131 bits (331), Expect = 2e-34
 Identities = 65/220 (29%), Positives = 104/220 (47%), Gaps = 43/220 (19%)

Query: 392 HFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKN 448
           ++   + +G+G FG VYKG  L  G  +A+K++S      + L+    E++L+  L+H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING---------- 498
           +V+ +G       L +I EY  N SL                  + II            
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSL------------------RQIIKKFGPFPESLVA 102

Query: 499 -----IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
                + +G+ YLHE     +IHRD+KA+NIL   D   K++DFG+A           + 
Sbjct: 103 VYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS- 158

Query: 554 IIAGTYGYMAPE-YAMGGIFSIKSDVFSFGVLLLEIISGR 592
            + GT  +MAPE   M G  S  SD++S G  ++E+++G 
Sbjct: 159 -VVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  128 bits (323), Expect = 3e-33
 Identities = 80/239 (33%), Positives = 119/239 (49%), Gaps = 43/239 (17%)

Query: 377 EFPLFPLRLALEATNHFSDENKLGQGGFGPVYKG---TLADGK---AIAVKRLSRT-SGQ 429
           E PL  +R        F +E  LG+G FG VYKG      +     ++A+K L      +
Sbjct: 1   EIPLSAVR--------FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK 50

Query: 430 GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL-----------DVHL 478
             QEF+ E  L++ LQH N+V LLG C + Q   +++EY+ +  L           DV  
Sbjct: 51  VQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGA 110

Query: 479 FDATRSVQ--LDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISD 536
                +V+  LD      I   IA G+ YL   S    +HRDL A N L+ + +  KISD
Sbjct: 111 ESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISD 167

Query: 537 FGLAR-IFGGN----QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           FGL+R I+  +    Q+++   +      +M PE  + G F+ +SD++SFGV+L EI S
Sbjct: 168 FGLSRDIYSADYYRVQSKSLLPV-----RWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  128 bits (323), Expect = 4e-33
 Identities = 70/209 (33%), Positives = 109/209 (52%), Gaps = 17/209 (8%)

Query: 397 NKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLV 450
            +LG+G FG V            G+ +AVK L+ +   Q   +F+ E+ ++  L H+N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 451 RLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
           +  G C +  G+ L LI EY+P+ SL  +L       Q++ KR     + I +G+ YL  
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN--QANTNIIAGTYGYMAPEY 566
               + IHRDL A NIL++ +   KISDFGLA++   +++         +  + Y APE 
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183

Query: 567 AMGGIFSIKSDVFSFGVLLLEIIS-GRKN 594
                FS  SDV+SFGV L E+ + G  +
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  126 bits (318), Expect = 1e-32
 Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 21/207 (10%)

Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
            ++G+G FG VY     +DGK   +K   LS  S +  ++  NEV ++ KL H N+++  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-------LDWKRRQSIINGIARGILYL 506
               E  +L ++ EY     L   +    +  +       LDW      +  +   + YL
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW-----FVQ-LCLALKYL 119

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H     KI+HRD+K  NI L  +   K+ DFG++++     + A T +  GT  Y++PE 
Sbjct: 120 HSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV--GTPYYLSPEL 174

Query: 567 AMGGIFSIKSDVFSFGVLLLEIISGRK 593
                ++ KSD++S G +L E+ + + 
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKH 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  122 bits (308), Expect = 4e-31
 Identities = 69/206 (33%), Positives = 114/206 (55%), Gaps = 21/206 (10%)

Query: 399 LGQGGFGPVYKGT-LADGK----AIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRL 452
           LG G FG VYKG  + +G+     +A+K L   +  +  +E  +E  ++A + H ++VRL
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLF---DATRSVQ-LDWKRRQSIINGIARGILYLHE 508
           LG CL   ++ LI + MP   L  ++    D   S   L+W  +      IA+G+ YL E
Sbjct: 75  LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYL-E 126

Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
           + RL  +HRDL A N+L+    + KI+DFGLA++   ++ + +         +MA E  +
Sbjct: 127 EKRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184

Query: 569 GGIFSIKSDVFSFGVLLLEIIS-GRK 593
             I++ KSDV+S+GV + E+++ G K
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  122 bits (308), Expect = 4e-31
 Identities = 70/227 (30%), Positives = 107/227 (47%), Gaps = 31/227 (13%)

Query: 399 LGQGGFGPVYKGTLADGKA------IAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVR 451
           LG+G FG V+ G     +       +AVK L  T+    ++ F+ E  L+   QH+N+V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 452 LLGCCLEGQELLLIYEYMP----NKSLDVHLFDATRSVQLDWKRRQ-------SIINGIA 500
             G C EG   ++++EYM     NK L  H  DA      D    +        I   IA
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAGT- 558
            G++YL   +    +HRDL   N L+  D+  KI DFG++R ++  +  +     + G  
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR-----VGGHT 184

Query: 559 ---YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 602
                +M PE  M   F+ +SDV+SFGV+L EI +  K   +  S  
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE 231

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  121 bits (306), Expect = 4e-31
 Identities = 70/200 (35%), Positives = 109/200 (54%), Gaps = 15/200 (7%)

Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 457
           KLG G FG V++G   +   +AVK L   +    ++F  E  ++ KL+H  L++L   C 
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 458 EGQELLLIYEYMPNKSLDVHL-FDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
             + + ++ E M   SL  +L   A R+++L   +   +   +A G+ YL   +    IH
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRALKL--PQLIDMAAQVASGMAYLEAQN---YIH 126

Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI---IAGTYGYMAPEYAMGGIFS 573
           RDL A N+L+ ++   K++DFGLAR+   +  +A       I  T    APE A+   FS
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT----APEAALYNRFS 182

Query: 574 IKSDVFSFGVLLLEIIS-GR 592
           IKSDV+SFG+LL EI++ GR
Sbjct: 183 IKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  121 bits (306), Expect = 5e-31
 Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 12/202 (5%)

Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
           F    KLG+G +G VYK      G+ +A+K +       LQE   E++++ +     +V+
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVK 62

Query: 452 LLGCCLEGQELLLIYEYMPNKS-LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
             G   +  +L ++ EY    S  D  +   T    L  +   +I+    +G+ YLH   
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSD--IMKITNK-TLTEEEIAAILYQTLKGLEYLH--- 116

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
             K IHRD+KA NILL+++   K++DFG++        + NT I  GT  +MAPE     
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI--GTPFWMAPEVIQEI 174

Query: 571 IFSIKSDVFSFGVLLLEIISGR 592
            ++ K+D++S G+  +E+  G+
Sbjct: 175 GYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  122 bits (308), Expect = 5e-31
 Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 16/221 (7%)

Query: 377 EFPLFPLRLALEA---TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQ 432
           E     L+  +        + +  K+G+G  G VYK T  A GK +A+K++ R   Q  +
Sbjct: 2   EELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKE 60

Query: 433 EFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR 492
              NE+ ++   +H N+V      L G EL ++ EYM   SL     D      +     
Sbjct: 61  LIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLT----DIITQNFVRMNEP 116

Query: 493 Q--SIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550
           Q   +   + +G+ YLH      +IHRD+K+ NILL  D + K++DFG A      +++ 
Sbjct: 117 QIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR 173

Query: 551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           N+  + GT  +MAPE      +  K D++S G++ +E+  G
Sbjct: 174 NS--VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  121 bits (304), Expect = 8e-31
 Identities = 76/201 (37%), Positives = 107/201 (53%), Gaps = 14/201 (6%)

Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
             KLG G FG V+ G       +A+K L + S    + F  E NL+ +LQH  LVRL   
Sbjct: 11  VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAV 69

Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
             + + + +I EYM N SL V        ++L   +   +   IA G+ ++    R   I
Sbjct: 70  VTQ-EPIYIITEYMENGSL-VDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYI 124

Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI---IAGTYGYMAPEYAMGGIF 572
           HRDL+A+NIL+ + +  KI+DFGLAR+   N+  A       I  T    APE    G F
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAINYGTF 180

Query: 573 SIKSDVFSFGVLLLEIIS-GR 592
           +IKSDV+SFG+LL EI++ GR
Sbjct: 181 TIKSDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  120 bits (303), Expect = 1e-30
 Identities = 72/233 (30%), Positives = 114/233 (48%), Gaps = 29/233 (12%)

Query: 398 KLGQGGFGPVYKGTL-ADGKAIAVKRL---SRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
            LGQG  G VYK      GK  A+K++        +  ++   E+  +   +   +V+  
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR--KQLLRELKTLRSCESPYVVKCY 65

Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL----YLHED 509
           G   +  E+ ++ EYM   SL     D  + V    K  + ++  IAR IL    YLH  
Sbjct: 66  GAFYKEGEISIVLEYMDGGSLA----DLLKKVG---KIPEPVLAYIARQILKGLDYLH-- 116

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 569
           ++  IIHRD+K SN+L++     KI+DFG++++     +Q NT +  GT  YM+PE   G
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV--GTVTYMSPERIQG 174

Query: 570 GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQ----TLLTYVCNSLSLSL 618
             +S  +D++S G+ LLE   G+    F F   GQ     L+  +C+    SL
Sbjct: 175 ESYSYAADIWSLGLTLLECALGK----FPFLPPGQPSFFELMQAICDGPPPSL 223

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  115 bits (291), Expect = 4e-29
 Identities = 75/203 (36%), Positives = 105/203 (51%), Gaps = 19/203 (9%)

Query: 397 NKLGQGGFGPVYKGT--LADGK--AIAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLVR 451
            +LG G FG V KG   +  GK   +AVK L +     G +EF  E +++A+L H  +VR
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
           L+G C  G+ L+L+ E  P   L  +L         D K    + + +A G+ YL     
Sbjct: 61  LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLK---ELAHQVAMGMAYLESK-- 114

Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN--QANTNIIAGTY--GYMAPEYA 567
              +HRDL A N+LL +    KISDFG++R  G   +  +A T   AG +   + APE  
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT---AGRWPLKWYAPECI 170

Query: 568 MGGIFSIKSDVFSFGVLLLEIIS 590
             G FS KSDV+S+GV L E  S
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  115 bits (289), Expect = 6e-29
 Identities = 65/195 (33%), Positives = 103/195 (52%), Gaps = 6/195 (3%)

Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGL-QEFKNEVNLIAKLQHKNLVRLLGCC 456
           K+G+G FG VYKG L     +AVK    T    L ++F  E  ++ +  H N+V+L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
           ++ Q + ++ E +P  SL   L    +  +L  K+   +    A G+ YL  +S+   IH
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYL--ESK-NCIH 116

Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDL A N L+ ++   KISDFG++R   G     +  +      + APE    G ++ +S
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176

Query: 577 DVFSFGVLLLEIISG 591
           DV+S+G+LL E  S 
Sbjct: 177 DVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  115 bits (289), Expect = 8e-29
 Identities = 74/194 (38%), Positives = 102/194 (52%), Gaps = 8/194 (4%)

Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 457
           KLG G FG V+ G   +   +AVK L +     +Q F  E NL+  LQH  LVRL     
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 458 EGQELLLIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
           + + + +I EYM   SL D    D    V L   +       IA G+ Y+    R   IH
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYIH 126

Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDL+A+N+L+ + +  KI+DFGLAR+   N+  A          + APE    G F+IKS
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG-AKFPIKWTAPEAINFGSFTIKS 185

Query: 577 DVFSFGVLLLEIIS 590
           DV+SFG+LL EI++
Sbjct: 186 DVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  114 bits (286), Expect = 2e-28
 Identities = 69/203 (33%), Positives = 107/203 (52%), Gaps = 9/203 (4%)

Query: 393 FSDENKLGQGGFGPVYKGTL-ADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNL 449
           F   NK+G+G FG V+K    AD +  A+K+  LS+ + +  +E  +E  ++AKL    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +R     L+  +L ++ EY  N  L   L    R   L   +       I  G+ +LH  
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLH-KLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 569
              KI+HRD+K+ N+ LD   N KI D G+A++   N N ANT  I GT  Y++PE    
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCED 175

Query: 570 GIFSIKSDVFSFGVLLLEIISGR 592
             ++ KSDV++ GV+L E  +G+
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  113 bits (285), Expect = 2e-28
 Identities = 68/202 (33%), Positives = 105/202 (51%), Gaps = 20/202 (9%)

Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVR 451
           LG+G FG V     K T   GK  A+K L +      + ++    E N+++++ H  +V+
Sbjct: 1   LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57

Query: 452 LLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
           L     + +E L L+ EY P   L  HL   ++  +   +R +     I   + YLH   
Sbjct: 58  LH-YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARFYAAEIVLALEYLH--- 110

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
            L II+RDLK  NILLD D + K++DFGLA+      ++ NT    GT  Y+APE  +G 
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGK 168

Query: 571 IFSIKSDVFSFGVLLLEIISGR 592
            +    D +S GVLL E+++G+
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  113 bits (284), Expect = 3e-28
 Identities = 70/201 (34%), Positives = 106/201 (52%), Gaps = 21/201 (10%)

Query: 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
           ++KLG G +G VY+G        +AVK L +     ++EF  E  ++ +++H NLV+LLG
Sbjct: 11  KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 69

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRS----VQLDWKRRQSIINGIARGILYLHEDS 510
            C       +I E+M   +L  +L +  R     V L +   Q     I+  + YL + +
Sbjct: 70  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ-----ISSAMEYLEKKN 124

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT---YGYMAPEYA 567
               IHRDL A N L+ ++   K++DFGL+R+  G+   A+    AG      + APE  
Sbjct: 125 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH----AGAKFPIKWTAPESL 177

Query: 568 MGGIFSIKSDVFSFGVLLLEI 588
               FSIKSDV++FGVLL EI
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  116 bits (290), Expect = 4e-28
 Identities = 71/207 (34%), Positives = 102/207 (49%), Gaps = 17/207 (8%)

Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQH-KNLVRLL 453
           KLG+G FG VY     D K +A+K L++      + ++ F  E+ ++A L H  N+V+L 
Sbjct: 7   KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
               +   L L+ EY+   SL+  L    R   L       I+  I   + YLH      
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KG 121

Query: 514 IIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQ----NQANTNIIAGTYGYMAPEYAM 568
           IIHRD+K  NILLD D    K+ DFGLA++           A  +   GT GYMAPE  +
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 569 GGIF---SIKSDVFSFGVLLLEIISGR 592
           G      S  SD++S G+ L E+++G 
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGL 208

Length = 384

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  112 bits (282), Expect = 1e-27
 Identities = 70/214 (32%), Positives = 105/214 (49%), Gaps = 33/214 (15%)

Query: 399 LGQGGFGPVYKGTLAD------GKAIAVKRLSR--TSGQGLQEFKNEVNLIAKLQHKNLV 450
           LGQG FG VY+G             +A+K ++   +  + + EF NE +++ +    ++V
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI-EFLNEASVMKEFNCHHVV 72

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLF----DATRSVQLDWKRRQSIIN---GIARGI 503
           RLLG    GQ  L++ E M    L  +L     +A  +  L     Q  I     IA G+
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNII-AGTYG- 560
            YL      K +HRDL A N ++ +D+  KI DFG+ R I+        T+    G  G 
Sbjct: 133 AYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY-------ETDYYRKGGKGL 182

Query: 561 ----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
               +MAPE    G+F+ KSDV+SFGV+L E+ +
Sbjct: 183 LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  110 bits (278), Expect = 3e-27
 Identities = 63/200 (31%), Positives = 103/200 (51%), Gaps = 10/200 (5%)

Query: 396 ENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLV 450
           E  +G G FG V +G L         +A+K L   S    + +F  E +++ +  H N++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
           RL G   + + +++I EYM N SLD  L       +    +   ++ GIA G+ YL   S
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---S 123

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
            +  +HRDL A NIL++ ++  K+SDFGL+R    ++    T        + APE     
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR 183

Query: 571 IFSIKSDVFSFGVLLLEIIS 590
            F+  SDV+SFG+++ E++S
Sbjct: 184 KFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  110 bits (276), Expect = 4e-27
 Identities = 73/199 (36%), Positives = 109/199 (54%), Gaps = 10/199 (5%)

Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
             KLG G FG V+ GT      +AVK L +      + F  E  ++ KL+H  LV+L   
Sbjct: 11  IKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV 69

Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
             E + + ++ EYM   SL   L D   R+++L       +   +A G+ Y+    R+  
Sbjct: 70  VSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKL--PNLVDMAAQVAAGMAYIE---RMNY 123

Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           IHRDL+++NIL+ D +  KI+DFGLAR+   N+  A          + APE A+ G F+I
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRFTI 182

Query: 575 KSDVFSFGVLLLEIIS-GR 592
           KSDV+SFG+LL E+++ GR
Sbjct: 183 KSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  111 bits (279), Expect = 4e-27
 Identities = 67/211 (31%), Positives = 111/211 (52%), Gaps = 26/211 (12%)

Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKR---------LSRTSGQGLQEFKNEVNLIA 442
           +    KLG+G +G VYK      G+ +A+K+         +  T+   L+E    ++L+ 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA---LRE----ISLLK 53

Query: 443 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG 502
           +L+H N+V+LL      ++L L++EY     +D+  +   R   L     +SI+  + RG
Sbjct: 54  ELKHPNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDKRPGPLSPNLIKSIMYQLLRG 110

Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYM 562
           + Y H  S  +I+HRDLK  NIL++ D   K++DFGLAR FG         ++  T  Y 
Sbjct: 111 LAYCH--SH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYR 165

Query: 563 APEYAMGG-IFSIKSDVFSFGVLLLEIISGR 592
           APE  +G   +S   D++S G +  E+I+G+
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  110 bits (275), Expect = 5e-27
 Identities = 75/217 (34%), Positives = 113/217 (52%), Gaps = 18/217 (8%)

Query: 377 EFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKN 436
           E P   LRL          E KLGQG FG V+ GT      +A+K L +      + F  
Sbjct: 2   EIPRESLRL----------EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQ 50

Query: 437 EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
           E  ++ KL+H+ LV+L     E + + ++ EYM   SL +          L   +   + 
Sbjct: 51  EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL-LDFLKGEMGKYLRLPQLVDMA 108

Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 556
             IA G+ Y+    R+  +HRDL+A+NIL+ +++  K++DFGLAR+   N+  A      
Sbjct: 109 AQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AK 164

Query: 557 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GR 592
               + APE A+ G F+IKSDV+SFG+LL E+ + GR
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  110 bits (276), Expect = 6e-27
 Identities = 77/210 (36%), Positives = 108/210 (51%), Gaps = 22/210 (10%)

Query: 399 LGQGGFGPVYKGT----LADGKA---IAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLV 450
           LG G FG VY+GT    L  G     +AVK L + +  Q  +EF  E +L++   H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDA----TRSVQLDWKRRQSIINGIARGILYL 506
           +LLG CL  +   +I E M    L  +L DA         L  K    I   +A+G +YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 507 HEDSRLKIIHRDLKASNILL-----DDDMNPKISDFGLAR-IFGGNQNQANTNIIAGTYG 560
               ++  IHRDL A N L+     D D   KI DFGLAR I+  +  +     +     
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178

Query: 561 YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           +MAPE  + G F+ +SDV+SFGVL+ EI++
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  110 bits (277), Expect = 8e-27
 Identities = 60/205 (29%), Positives = 106/205 (51%), Gaps = 19/205 (9%)

Query: 397 NKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEF----KNEVNLIAKLQHKNLVR 451
            ++G+G +G VYK      G+ +A+K++ R      + F      E+ L+ KL+H N+VR
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKI-RME-NEKEGFPITAIREIKLLQKLRHPNIVR 62

Query: 452 LLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           L           + +++EYM +   D+     +  V+    + +  +  +  G+ YLH +
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDH---DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN 119

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN-IIAGTYGYMAPEYAM 568
               I+HRD+K SNIL+++D   K++DFGLAR +    +   TN +I  T  Y  PE  +
Sbjct: 120 ---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI--TLWYRPPELLL 174

Query: 569 GGI-FSIKSDVFSFGVLLLEIISGR 592
           G   +  + D++S G +L E+  G+
Sbjct: 175 GATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  109 bits (274), Expect = 2e-26
 Identities = 74/241 (30%), Positives = 108/241 (44%), Gaps = 38/241 (15%)

Query: 397 NKLGQGGFGPVYKGTLADGKAI-AVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRLLG 454
           ++LG+G  G V K  L +   I A+K ++      LQ +   E+ +    +   +V+  G
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66

Query: 455 CCLEGQE--LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---------GIARGI 503
             L+     + +  EY    SLD        S+    K+R   I           + +G+
Sbjct: 67  AFLDESSSSIGIAMEYCEGGSLD--------SIYKKVKKRGGRIGEKVLGKIAESVLKGL 118

Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            YLH     KIIHRD+K SNILL      K+ DFG++       + A T    GT  YMA
Sbjct: 119 SYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--NSLAGT--FTGTSFYMA 171

Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQT------LLTYVCNSLSLS 617
           PE   G  +SI SDV+S G+ LLE+   R    F F   G+       LL+Y+ N  +  
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEVAQNR----FPFPPEGEPPLGPIELLSYIVNMPNPE 227

Query: 618 L 618
           L
Sbjct: 228 L 228

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  108 bits (272), Expect = 2e-26
 Identities = 69/224 (30%), Positives = 106/224 (47%), Gaps = 20/224 (8%)

Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRLLG 454
            +LG G  G V K      GK +AVK +     + +Q +   E++++ K     +V   G
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                 ++ +  EYM   SLD  L +    +      +  I   + +G+ YLHE    KI
Sbjct: 67  AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLHEK--HKI 122

Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           IHRD+K SNIL++     K+ DFG++       + A T    GT  YMAPE   G  +S+
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTF--VGTSSYMAPERIQGNDYSV 178

Query: 575 KSDVFSFGVLLLEIISGRKNNGFYFSEHGQT------LLTYVCN 612
           KSD++S G+ L+E+ +GR    F +            LL Y+ N
Sbjct: 179 KSDIWSLGLSLIELATGR----FPYPPENDPPDGIFELLQYIVN 218

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  108 bits (272), Expect = 2e-26
 Identities = 56/201 (27%), Positives = 103/201 (51%), Gaps = 11/201 (5%)

Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS-RTSGQGLQEFKNEVNLIAKLQHKNLV 450
           F+    +G+G FG VYK       + +A+K +    +   +++ + E+  +++ +   + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
           +  G  L+G +L +I EY    S      D  +  +LD      I+  +  G+ YLHE+ 
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
               IHRD+KA+NILL ++ + K++DFG++       ++ NT    GT  +MAPE     
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQS 173

Query: 571 IFSIKSDVFSFGVLLLEIISG 591
            +  K+D++S G+  +E+  G
Sbjct: 174 GYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  108 bits (271), Expect = 3e-26
 Identities = 68/212 (32%), Positives = 107/212 (50%), Gaps = 23/212 (10%)

Query: 398 KLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
           +LG+G FG V+           D   +AVK L   S    Q+F+ E  L+  LQH+++VR
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 452 LLGCCLEGQELLLIYEYMPNKSL---------DVHLFDATRSV---QLDWKRRQSIINGI 499
             G C EG+ LL+++EYM +  L         D  +      V   QL   +  +I + I
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAGT 558
           A G++YL   + L  +HRDL   N L+   +  KI DFG++R I+  +  +     +   
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +M PE  +   F+ +SD++SFGV+L EI +
Sbjct: 189 R-WMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  107 bits (269), Expect = 4e-26
 Identities = 65/203 (32%), Positives = 106/203 (52%), Gaps = 20/203 (9%)

Query: 399 LGQGGFGPVYKG-TLADGKAIAVKRLS-----RTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
           LG G FG VY+G  L DG   AVK +S     +T  + +++ + E+ L++KLQH N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHL--FDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
           LG   E   L +  E +P  SL   L  + +     +    RQ     I  G+ YLH+  
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ-----ILLGLEYLHDR- 121

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG- 569
               +HRD+K +NIL+D +   K++DFG+A+        +      G+  +MAPE     
Sbjct: 122 --NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIAQQ 176

Query: 570 GIFSIKSDVFSFGVLLLEIISGR 592
           G + + +D++S G  +LE+ +G+
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  106 bits (266), Expect = 1e-25
 Identities = 65/202 (32%), Positives = 105/202 (51%), Gaps = 19/202 (9%)

Query: 399 LGQGGFGPVYKGTLAD-GKAIAVKR-----LSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
           LGQG FG VY     D G+ +AVK+      S  + + +   + E+ L+  LQH+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHL--FDA-TRSVQLDWKRRQSIINGIARGILYLHED 509
            GC  + + L +  EYMP  S+   L  + A T +V   + R+      I  G+ YLH +
Sbjct: 70  YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQ------ILEGVEYLHSN 123

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLA-RIFGGNQNQANTNIIAGTYGYMAPEYAM 568
               I+HRD+K +NIL D   N K+ DFG + R+     +      + GT  +M+PE   
Sbjct: 124 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180

Query: 569 GGIFSIKSDVFSFGVLLLEIIS 590
           G  +  K+DV+S G  ++E+++
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  105 bits (265), Expect = 1e-25
 Identities = 70/207 (33%), Positives = 95/207 (45%), Gaps = 27/207 (13%)

Query: 398 KLGQGGFGPVYKGTL--ADGKAI--AVKRLSRTSGQG-LQEFKNEVNLIAKLQHKNLVRL 452
           KLG G FG V +G    + GK I  AVK L        + +F  E  ++  L H+NL+RL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 453 LGCCLEGQELLLIYEYMPNKSL-----DVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
            G  L    L+++ E  P  SL        L     S   D+  +      IA G+ YL 
Sbjct: 62  YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQ------IANGMRYLE 114

Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN----QANTNIIAGTYGYMA 563
                + IHRDL A NILL  D   KI DFGL R    N++    + +  +    + + A
Sbjct: 115 SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV---PFAWCA 168

Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           PE      FS  SDV+ FGV L E+ +
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  105 bits (264), Expect = 2e-25
 Identities = 72/215 (33%), Positives = 116/215 (53%), Gaps = 29/215 (13%)

Query: 391 NHFSDENKLGQGGFGPVYKGTL-ADGK---AIAVKRLS--RTSGQGLQEFKNEVNLIAKL 444
           +H + +  +G G FG V++G L   G+   A+A+K L    T  Q  Q+F +E +++ + 
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQ-RQDFLSEASIMGQF 63

Query: 445 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDAT---RSVQLDWKRRQSIINGIAR 501
            H N++RL G   + +  ++I EYM N +LD +L D      S QL       ++ GIA 
Sbjct: 64  SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-----VGMLRGIAA 118

Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG- 560
           G+ YL   S +  +HRDL A NIL++ ++  K+SDFGL+R+   +     T     T G 
Sbjct: 119 GMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT-----TSGG 170

Query: 561 -----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                + APE      F+  SDV+SFG+++ E++S
Sbjct: 171 KIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  105 bits (262), Expect = 2e-25
 Identities = 76/217 (35%), Positives = 112/217 (51%), Gaps = 18/217 (8%)

Query: 377 EFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKN 436
           E P   LRL          + KLGQG FG V+ GT      +A+K L +      + F  
Sbjct: 2   EIPRESLRL----------DVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQ 50

Query: 437 EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
           E  ++ KL+H  LV L     E + + ++ E+M   SL +          L   +   + 
Sbjct: 51  EAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSL-LDFLKEGDGKYLKLPQLVDMA 108

Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 556
             IA G+ Y+    R+  IHRDL+A+NIL+ D++  KI+DFGLAR+   N+  A      
Sbjct: 109 AQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQG-AK 164

Query: 557 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GR 592
               + APE A+ G F+IKSDV+SFG+LL E+++ GR
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  106 bits (265), Expect = 2e-25
 Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 35/211 (16%)

Query: 399 LGQGGFGPVYK---GTLAD--GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
           LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH N+V+  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 454 GCCLEG--QELLLIYEYMPNKSL------DVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           G C     + L L+ EY+P  SL           D  + +    +        I +G+ Y
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGMEY 123

Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN------QNQANTNIIAGTY 559
           L      + +HRDL   NIL++ +   KI DFGL ++   +      +    + I     
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF---- 176

Query: 560 GYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
            + APE      FS+ SDV+SFGV+L E+ +
Sbjct: 177 -WYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  105 bits (264), Expect = 4e-25
 Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 33/227 (14%)

Query: 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFK-----NEVNLIAKL 444
           + F     +G+G F  V         K  A+K L +   Q ++E K      E  ++ +L
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRL 58

Query: 445 -QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
             H  +++L     + + L  + EY PN  L  ++    +   LD K  +     I   +
Sbjct: 59  NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLAL 115

Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ---------------- 547
            YLH      IIHRDLK  NILLD DM+ KI+DFG A++   N                 
Sbjct: 116 EYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172

Query: 548 --NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
             N+       GT  Y++PE          SD+++ G ++ ++++G+
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  104 bits (260), Expect = 5e-25
 Identities = 60/196 (30%), Positives = 101/196 (51%), Gaps = 13/196 (6%)

Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 457
           ++G G FG V+ G   + + +A+K + R      ++F  E  ++ KL H  LV+L G C 
Sbjct: 11  EIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 458 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR 517
           E   + L++E+M +  L  +L    +  +   +    +   +  G+ YL   +   +IHR
Sbjct: 70  ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124

Query: 518 DLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT---YGYMAPEYAMGGIFSI 574
           DL A N L+ ++   K+SDFG+ R    +Q  ++T    GT     + +PE      +S 
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSS 180

Query: 575 KSDVFSFGVLLLEIIS 590
           KSDV+SFGVL+ E+ S
Sbjct: 181 KSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score =  103 bits (259), Expect = 7e-25
 Identities = 70/201 (34%), Positives = 108/201 (53%), Gaps = 14/201 (6%)

Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
           E KLG G FG V+  T      +AVK + +     ++ F  E N++  LQH  LV+L   
Sbjct: 11  EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL-HA 68

Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGILYLHEDSRL 512
            +  + + +I E+M   SL     D  +S +   +    +I+    IA G+ ++ + +  
Sbjct: 69  VVTKEPIYIITEFMAKGSL----LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-- 122

Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
             IHRDL+A+NIL+   +  KI+DFGLAR+   N+  A          + APE    G F
Sbjct: 123 -YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG-AKFPIKWTAPEAINFGSF 180

Query: 573 SIKSDVFSFGVLLLEIIS-GR 592
           +IKSDV+SFG+LL+EI++ GR
Sbjct: 181 TIKSDVWSFGILLMEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  104 bits (261), Expect = 7e-25
 Identities = 65/198 (32%), Positives = 93/198 (46%), Gaps = 11/198 (5%)

Query: 399 LGQGGFGPVYKGTLAD-GKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
           LG+GGFG V    +   GK  A K+L +      +G Q   NE  ++ K+  + +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                 +L L+   M    L  H+++          R       I  G+ +LH   + +I
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAAQIICGLEHLH---QRRI 116

Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           ++RDLK  N+LLDD  N +ISD GLA    G          AGT GYMAPE   G ++  
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAPEVLQGEVYDF 173

Query: 575 KSDVFSFGVLLLEIISGR 592
             D F+ G  L E+I+GR
Sbjct: 174 SVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  104 bits (260), Expect = 8e-25
 Identities = 71/221 (32%), Positives = 107/221 (48%), Gaps = 30/221 (13%)

Query: 392 HFSDEN-----KLGQGGFGPVY----KGTLADGK--AIAVKRLSRTSGQGLQ-EFKNEVN 439
            F   N      LG+G FG V+    KG   +G    + VK L +T  + LQ EF+ E++
Sbjct: 1   AFPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELD 60

Query: 440 LIAKLQHKNLVRLLGCCLEGQELLLIYEY----------MPNKSLDVHLFDATRSVQLDW 489
           +  KL HKN+VRLLG C E +   +I EY             KS D    +  +   L  
Sbjct: 61  MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKD----EKLKPPPLST 116

Query: 490 KRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549
           K++ ++   IA G+ +L   S  + +HRDL A N L+      K+S   L++    ++  
Sbjct: 117 KQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173

Query: 550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
              N +     ++APE      FS KSDV+SFGVL+ E+ +
Sbjct: 174 KLRNALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  103 bits (258), Expect = 9e-25
 Identities = 73/197 (37%), Positives = 103/197 (52%), Gaps = 16/197 (8%)

Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 457
            +G+G FG V +G    G+ +AVK +        Q F  E  ++ KL HKNLVRLLG  L
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 458 EGQELLLIYEYMPNKSLDVHLFDATRS-VQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
               L ++ E M   +L   L    R+ V +    + S+   +A G+ YL      K++H
Sbjct: 70  H-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL--DVAEGMEYLESK---KLVH 123

Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDL A NIL+ +D   K+SDFGLAR+        + + +     + APE      FS KS
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKLP--VKWTAPEALKHKKFSSKS 178

Query: 577 DVFSFGVLLLEIIS-GR 592
           DV+S+GVLL E+ S GR
Sbjct: 179 DVWSYGVLLWEVFSYGR 195

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 1e-24
 Identities = 66/198 (33%), Positives = 98/198 (49%), Gaps = 13/198 (6%)

Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE 458
           LG G FG V+ G       +A+K + R       +F  E  ++ KL H NLV+L G C +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 459 GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRD 518
            + + ++ EYM N  L  +L +    +  +W     + + +   + YL  +     IHRD
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNG---FIHRD 125

Query: 519 LKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT---YGYMAPEYAMGGIFSIK 575
           L A N L+ +D   K+SDFGLAR    +Q  ++     GT     +  PE      FS K
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFSSK 181

Query: 576 SDVFSFGVLLLEIISGRK 593
           SDV+SFGVL+ E+ S  K
Sbjct: 182 SDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  103 bits (259), Expect = 1e-24
 Identities = 70/220 (31%), Positives = 108/220 (49%), Gaps = 31/220 (14%)

Query: 399 LGQGGFGPVYKGT------LADGKAIAVKRLSRTSGQG-LQEFKNEVNLIAKLQHKNLVR 451
           LG+G FG V K T       A    +AVK L   +    L++  +E NL+ ++ H ++++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIING--------- 498
           L G C +   LLLI EY    SL   L ++ +     +  D  R  S ++          
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 499 --------IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550
                   I+RG+ YL E   +K++HRDL A N+L+ +    KISDFGL+R      +  
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +       +MA E     I++ +SDV+SFGVLL EI++
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  103 bits (259), Expect = 1e-24
 Identities = 67/222 (30%), Positives = 105/222 (47%), Gaps = 31/222 (13%)

Query: 396 ENKLGQGGFGPVYKGTLA------DGKAIAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKN 448
              +GQG FG V++              +AVK L    S     +F+ E  L+A+  H N
Sbjct: 10  VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPN 69

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDAT-------------------RSVQLDW 489
           +V+LLG C  G+ + L++EYM    L+  L   +                     + L  
Sbjct: 70  IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129

Query: 490 KRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQN 548
             +  I   +A G+ YL E    K +HRDL   N L+ ++M  KI+DFGL+R I+  +  
Sbjct: 130 TEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186

Query: 549 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           +A+ N  A    +M PE      ++ +SDV+++GV+L EI S
Sbjct: 187 KASEN-DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  103 bits (258), Expect = 1e-24
 Identities = 73/209 (34%), Positives = 100/209 (47%), Gaps = 19/209 (9%)

Query: 397 NKLGQGGFGPVYKGTLA--DGKA----IAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 449
             LG G FG VY+G     DG A    +AVK L    S Q   +F  E  +++K  H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFD----ATRSVQLDWKRRQSIINGIARGILY 505
           VRL+G   E     ++ E M    L   L +      R   L  K        +A+G  Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 506 LHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGLAR-IFGGNQNQANTNIIAGTYGY 561
           L E+     IHRD+ A N LL         KI+DFG+AR I+  +  +     +     +
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML-PIKW 187

Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           M PE  + GIF+ K+DV+SFGVLL EI S
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score =  103 bits (258), Expect = 2e-24
 Identities = 69/202 (34%), Positives = 114/202 (56%), Gaps = 20/202 (9%)

Query: 399 LGQGGFGPVYKGT-LADGKAI----AVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRL 452
           LG G FG VYKG  + +G+ +    A+K L+ T+G +   EF +E  ++A + H +LVRL
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 453 LGCCLEGQELLLIYEYMPNKSL----DVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
           LG CL    + L+ + MP+  L      H  +    + L+W  +      IA+G++YL E
Sbjct: 75  LGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127

Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
               +++HRDL A N+L+    + KI+DFGLAR+  G++ + N +       +MA E   
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184

Query: 569 GGIFSIKSDVFSFGVLLLEIIS 590
              F+ +SDV+S+GV + E+++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  102 bits (256), Expect = 2e-24
 Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 16/206 (7%)

Query: 397 NKLGQGGFGPVYKG-TLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
           NK+G G FG VY    L  G+ +AVK  R+     + ++E  +E+ ++  L+H NLV+  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRL 512
           G  +  +++ +  EY    +L     +       LD    +     +  G+ YLH     
Sbjct: 66  GVEVHREKVYIFMEYCSGGTL----EELLEHGRILDEHVIRVYTLQLLEGLAYLHSH--- 118

Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT--NIIAGTYGYMAPEYAMGG 570
            I+HRD+K +NI LD +   K+ DFG A     N          +AGT  YMAPE   GG
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178

Query: 571 IFSIK---SDVFSFGVLLLEIISGRK 593
                   +D++S G ++LE+ +G++
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 2e-24
 Identities = 61/203 (30%), Positives = 109/203 (53%), Gaps = 23/203 (11%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLS-RTSGQGLQEFKNEVNLIAKLQH---KNLVRLL 453
           +G+G +G VY+G  +  G+ +A+K ++  T    + + + EV L+++L+     N+ +  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL----YLHED 509
           G  L+G  L +I EY    S+        R++       +  I+ I R +L    Y+H+ 
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSV--------RTLMKAGPIAEKYISVIIREVLVALKYIHKV 120

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 569
               +IHRD+KA+NIL+ +  N K+ DFG+A +   NQN +  +   GT  +MAPE    
Sbjct: 121 G---VIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPEVITE 175

Query: 570 GI-FSIKSDVFSFGVLLLEIISG 591
           G  +  K+D++S G+ + E+ +G
Sbjct: 176 GKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score =  103 bits (257), Expect = 2e-24
 Identities = 80/225 (35%), Positives = 120/225 (53%), Gaps = 31/225 (13%)

Query: 389 ATNHFSDENKLGQGGFGPVYKGTL---ADG---KAIAVKRLS-RTSGQGLQEFKNEVNLI 441
           +T  F +E  LG+  FG VYKG L   A G   +A+A+K L  +  G   +EFK+E  + 
Sbjct: 5   STVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMR 62

Query: 442 AKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDW------KRRQS- 494
           ++LQH N+V LLG   + Q L +I+ Y  +   D+H F   RS   D       K  +S 
Sbjct: 63  SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHS--DLHEFLVMRSPHSDVGSTDDDKTVKST 120

Query: 495 --------IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGG 545
                   I+  IA G+ +L   S   ++H+DL   N+L+ D +N KISD GL R ++  
Sbjct: 121 LEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177

Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           +  +   N +     +M+PE  M G FSI SD++S+GV+L E+ S
Sbjct: 178 DYYKLMGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  102 bits (255), Expect = 2e-24
 Identities = 70/205 (34%), Positives = 107/205 (52%), Gaps = 23/205 (11%)

Query: 398 KLGQGGFGPVYK-GTLADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
           KLG+G +G VYK   L+D +  A+K   L   S +  ++  NE+ ++A + H N++    
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ-------SIINGIARGILYLH 507
             L+G +L ++ EY P   L      +    +   KR+         I   + RG+  LH
Sbjct: 67  AFLDGNKLCIVMEYAPFGDL------SKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
           E    KI+HRDLK++NILL  +   KI D G++++    +N A T I  GT  YMAPE  
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQI--GTPHYMAPEVW 173

Query: 568 MGGIFSIKSDVFSFGVLLLEIISGR 592
            G  +S KSD++S G LL E+ +  
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  102 bits (255), Expect = 3e-24
 Identities = 68/208 (32%), Positives = 110/208 (52%), Gaps = 20/208 (9%)

Query: 399 LGQGGFGPVYKGTLA-DGKAIAVKR--LSRTSGQG-------LQEFKNEVNLIAKLQHKN 448
           +G G FG VY G  A  G+ +AVK+  L   S          L     E+ L+ +LQH+N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
           +V+ LG  L+   L +  EY+P  S+   L         +    ++ +  I +G+ YLH 
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLH- 123

Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI----IAGTYGYMAP 564
            +R  IIHRD+K +NIL+D+    KISDFG+++    N     TN     + G+  +MAP
Sbjct: 124 -NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E      ++ K+D++S G L++E+++G+
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 3e-24
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 12/199 (6%)

Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN--EVNLIAKLQHKNLVRLLG 454
           K+G+G +G VYK      G+ +A+K++               E+ L+ +L H N+++LL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                 +L L++E+M     D++     R   L     +S +  + +G+ + H      I
Sbjct: 66  VFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGI 119

Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFS 573
           +HRDLK  N+L++ +   K++DFGLAR FG    +  T+ +  T  Y APE  +G   +S
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGS-PVRPYTHYVV-TRWYRAPELLLGDKGYS 177

Query: 574 IKSDVFSFGVLLLEIISGR 592
              D++S G +  E++S R
Sbjct: 178 TPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  102 bits (255), Expect = 6e-24
 Identities = 64/200 (32%), Positives = 109/200 (54%), Gaps = 13/200 (6%)

Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQHKNLVRLLG 454
           K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +L H N+VRLL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 455 CCLEGQELLLIYEYMPNKSLDV-HLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
                 +L L++E++    LD+    D++    LD    +S +  + +GI Y H  S  +
Sbjct: 66  VVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH--SH-R 119

Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IF 572
           ++HRDLK  N+L+D +   K++DFGLAR FG         ++  T  Y APE  +G   +
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGSRQY 177

Query: 573 SIKSDVFSFGVLLLEIISGR 592
           S   D++S G +  E+++ R
Sbjct: 178 STPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  101 bits (252), Expect = 7e-24
 Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 21/210 (10%)

Query: 395 DENK----LGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
           DEN     LG+G +G VY    L+    IA+K +     + +Q    E+ L + L+H+N+
Sbjct: 8   DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNI 67

Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL----Y 505
           V+ LG   E     +  E +P  SL   L    RS     K  +  I    + IL    Y
Sbjct: 68  VQYLGSDSENGFFKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIIFYTKQILEGLKY 123

Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           LH+    +I+HRD+K  N+L++      KISDFG ++   G      T    GT  YMAP
Sbjct: 124 LHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET--FTGTLQYMAP 178

Query: 565 EYAMGGI--FSIKSDVFSFGVLLLEIISGR 592
           E    G   +   +D++S G  ++E+ +G+
Sbjct: 179 EVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  101 bits (253), Expect = 9e-24
 Identities = 72/216 (33%), Positives = 107/216 (49%), Gaps = 30/216 (13%)

Query: 399 LGQGGFGPVYKGTLAD------GKAIAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHKNLV 450
           LG+G FG V K              +AVK L    + + L +  +E+ ++  + +HKN++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHL-----------FDATRSV--QLDWKRRQSIIN 497
            LLG C +   L ++ EY  + +L   L            D  R     L  K   S   
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139

Query: 498 GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIA 556
            +ARG+ +L   S+ K IHRDL A N+L+ +D   KI+DFGLAR I   +  +  TN   
Sbjct: 140 QVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN--- 193

Query: 557 G--TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           G     +MAPE     +++ +SDV+SFGVLL EI +
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  100 bits (250), Expect = 1e-23
 Identities = 69/196 (35%), Positives = 100/196 (51%), Gaps = 14/196 (7%)

Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE 458
           +G+G FG V  G    G  +AVK +   +    Q F  E +++ +L+H NLV+LLG  +E
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 459 GQ-ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR 517
            +  L ++ EYM   SL  +L    RSV L           +   + YL  ++    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEANN---FVHR 126

Query: 518 DLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSD 577
           DL A N+L+ +D   K+SDFGL +     Q+     +      + APE      FS KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKFSTKSD 181

Query: 578 VFSFGVLLLEIIS-GR 592
           V+SFG+LL EI S GR
Sbjct: 182 VWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  100 bits (250), Expect = 2e-23
 Identities = 64/213 (30%), Positives = 107/213 (50%), Gaps = 29/213 (13%)

Query: 399 LGQGGFGPVYKGTLAD-GKAIAVKR--LSRTSGQGLQE--------FKNEVNLIAKLQHK 447
           +G+G +G VY       G+ +AVK+  L  T                ++E+  +  L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 448 NLVRLLGCCLEGQELLLIY-EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
           N+V+ LG     +E L I+ EY+P  S+   L       + + +  +     +  G+ YL
Sbjct: 69  NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCL---RTYGRFEEQLVRFFTEQVLEGLAYL 124

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR----IFGGNQNQANTNIIAGTYGYM 562
           H      I+HRDLKA N+L+D D   KISDFG+++    I+    N  N + + G+  +M
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYD---NDQNMS-MQGSVFWM 177

Query: 563 APE--YAMGGIFSIKSDVFSFGVLLLEIISGRK 593
           APE  ++    +S K D++S G ++LE+ +GR+
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  100 bits (250), Expect = 2e-23
 Identities = 76/202 (37%), Positives = 103/202 (50%), Gaps = 18/202 (8%)

Query: 399 LGQGGFGPV----YKGTLAD-GKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRL 452
           LG+G FG V    Y       G+ +AVK L R  GQ     +K E+N++  L H+N+V+ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 453 LGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
            GCC E  G+ L LI EY+P  SL  +L     ++       Q I  G+A    YLH   
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMA----YLHSQ- 126

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIF--GGNQNQANTNIIAGTYGYMAPEYAM 568
               IHRDL A N+LLD+D   KI DFGLA+    G    +   +  +  + Y A E   
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLK 183

Query: 569 GGIFSIKSDVFSFGVLLLEIIS 590
              FS  SDV+SFGV L E+++
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  100 bits (250), Expect = 2e-23
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 20/208 (9%)

Query: 399 LGQGGFGPVYKGTLA--DGKA--IAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
           LG+G FG V +G L+  DG    +AVK  +L   +   ++EF +E   +    H N+++L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 453 LGCCLEGQEL------LLIYEYMPNKSLDVHLFD---ATRSVQLDWKRRQSIINGIARGI 503
           +G C E   L      ++I  +M +  L   L          +L  +     +  IA G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAGTYGYM 562
            YL   S    IHRDL A N +L +DM   ++DFGL++ I+ G+  +    I      ++
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYR-QGRIAKMPVKWI 182

Query: 563 APEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           A E     +++ KSDV++FGV + EI +
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  100 bits (250), Expect = 2e-23
 Identities = 64/206 (31%), Positives = 114/206 (55%), Gaps = 14/206 (6%)

Query: 393 FSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTS-GQGLQEFK-NEVNLIAKLQHKNL 449
           ++   K+G+G +G VYKG     G+ +A+K++   S  +G+      E++L+ +LQH N+
Sbjct: 2   YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61

Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLF-DATRSVQ-LDWKRRQSIINGIARGILYLH 507
           V L    ++   L LI+E++   S+D+  + D+    Q +D +  +S +  I +GIL+ H
Sbjct: 62  VCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118

Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
                +++HRDLK  N+L+D+    K++DFGLAR FG         ++  T  Y APE  
Sbjct: 119 ---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEVL 173

Query: 568 MGGI-FSIKSDVFSFGVLLLEIISGR 592
           +G   +S   D++S G +  E+ + +
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  100 bits (249), Expect = 2e-23
 Identities = 70/227 (30%), Positives = 115/227 (50%), Gaps = 28/227 (12%)

Query: 396 ENKLGQGGFGPVYKGT------LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
           + +LG+G FG V+           D   +AVK L   +    ++F+ E  L+  LQH+++
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69

Query: 450 VRLLGCCLEGQELLLIYEYMP----NKSLDVHLFDATRSVQLDWKRRQS----------- 494
           V+  G C +G  L++++EYM     NK L  H  DA   + +D + RQ+           
Sbjct: 70  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAM--ILVDGQPRQAKGELGLSQMLH 127

Query: 495 IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTN 553
           I + IA G++YL   +    +HRDL   N L+  ++  KI DFG++R ++  +  +   +
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184

Query: 554 IIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFS 600
            +     +M PE  M   F+ +SDV+SFGV+L EI +  K   F  S
Sbjct: 185 TMLPIR-WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 230

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 99.9 bits (249), Expect = 3e-23
 Identities = 65/201 (32%), Positives = 110/201 (54%), Gaps = 15/201 (7%)

Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFK-NEVNLIAKLQHKNLVRLLGC 455
           KLG+G +  VYKG     G+ +A+K +   + +G       E++L+ +L+H+N+VRL   
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66

Query: 456 CLEGQELLLIYEYMPN---KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                +L+L++EYM     K +D H         LD    +S    + +GI + HE+   
Sbjct: 67  IHTENKLMLVFEYMDKDLKKYMDTH----GVRGALDPNTVKSFTYQLLKGIAFCHEN--- 119

Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-I 571
           +++HRDLK  N+L++     K++DFGLAR FG   N  +  ++  T  Y AP+  +G   
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLGSRT 177

Query: 572 FSIKSDVFSFGVLLLEIISGR 592
           +S   D++S G ++ E+I+GR
Sbjct: 178 YSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =   99 bits (250), Expect = 3e-23
 Identities = 63/218 (28%), Positives = 100/218 (45%), Gaps = 43/218 (19%)

Query: 396 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN-----------EVNLIAK 443
             KLG+G +  VYK      G+ +A+K++       L E K            E+ L+ +
Sbjct: 5   GKKLGEGTYAVVYKARDKETGRIVAIKKIK------LGERKEAKDGINFTALREIKLLQE 58

Query: 444 LQHKNLVRLLGCCLEGQELLLIYEYMP--------NKSLDVHLFDATRSVQLDWKRRQSI 495
           L+H N++ LL        + L++E+M         +KS+   L  A      D K   S 
Sbjct: 59  LKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIV--LTPA------DIK---SY 107

Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 555
           +    RG+ YLH      I+HRDLK +N+L+  D   K++DFGLAR FG    +    ++
Sbjct: 108 MLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV 164

Query: 556 AGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGR 592
             T  Y APE   G   + +  D++S G +  E++   
Sbjct: 165 --TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 98.5 bits (246), Expect = 5e-23
 Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 24/211 (11%)

Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLS--RTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
             +G+G FG V K    +DGK +  K +     + +  Q+  +EVN++ +L+H N+VR  
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 454 GCCL--EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY-----L 506
              +    Q L ++ EY           D  + +Q   K R+ I       IL      L
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGG-------DLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118

Query: 507 HE-----DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           +E     D    ++HRDLK +NI LD + N K+ DFGLA+I G + + A T    GT  Y
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYY 176

Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           M+PE      +  KSD++S G L+ E+ +  
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 98.1 bits (244), Expect = 6e-23
 Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 23/201 (11%)

Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRLLGCCL 457
           LG+G FG V+KGTL D   +AVK       Q L+ +F +E  ++ +  H N+V+L+G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 458 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI--ARGILYLHEDSRLKII 515
           + Q + ++ E +P       L    R  + + K +Q +   +  A G+ YL   +    I
Sbjct: 63  QRQPIYIVMELVPGGDFLSFL----RKKKDELKTKQLVKFALDAAAGMAYLESKN---CI 115

Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT------YGYMAPEYAMG 569
           HRDL A N L+ ++   KISDFG++R       Q +  I + +        + APE    
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR-------QEDDGIYSSSGLKQIPIKWTAPEALNY 168

Query: 570 GIFSIKSDVFSFGVLLLEIIS 590
           G +S +SDV+S+G+LL E  S
Sbjct: 169 GRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 98.5 bits (245), Expect = 8e-23
 Identities = 78/237 (32%), Positives = 113/237 (47%), Gaps = 39/237 (16%)

Query: 377 EFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSR-TSGQG 430
           E PL  +R   E          LG+  FG +YKG L        + +A+K L    + Q 
Sbjct: 1   ELPLSAVRFMEE----------LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQ 50

Query: 431 LQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF----------- 479
             EF+ E +L+A+L H N+V LLG   + Q + +++EY+     D+H F           
Sbjct: 51  WGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQG--DLHEFLIMRSPHSDVG 108

Query: 480 -----DATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI 534
                D T    LD      I   IA G+ YL   S    +H+DL A NIL+ + ++ KI
Sbjct: 109 CSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKI 165

Query: 535 SDFGLAR-IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           SD GL+R I+  +  +     +     +M PE  M G FS  SD++SFGV+L EI S
Sbjct: 166 SDLGLSREIYSADYYRVQPKSLLPIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 98.2 bits (244), Expect = 1e-22
 Identities = 69/224 (30%), Positives = 112/224 (50%), Gaps = 21/224 (9%)

Query: 396 ENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
           + +LG+G FG V+           D   +AVK L   S    ++F  E  L+  LQH+++
Sbjct: 10  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69

Query: 450 VRLLGCCLEGQELLLIYEYMP----NKSLDVHLFDA------TRSVQLDWKRRQSIINGI 499
           V+  G C+EG  L++++EYM     NK L  H  DA       R  +L   +   I   I
Sbjct: 70  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129

Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAGT 558
           A G++YL   +    +HRDL   N L+ +++  KI DFG++R ++  +  +   + +   
Sbjct: 130 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186

Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 602
             +M PE  M   F+ +SDV+S GV+L EI +  K   +  S +
Sbjct: 187 R-WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 229

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 13/206 (6%)

Query: 392 HFSDENKLGQGGFGPVYKGTLADGKAI-AVKRLSRT---SGQGLQEFKNEVNLIAKLQHK 447
           HF     +G+G FG V      D K + A+K +++        ++   NE  ++ +L H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
            LV L     + + + L+ + +    L  HL   ++ V+   ++ +  I  I   + YLH
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHL---SQKVKFSEEQVKFWICEIVLALEYLH 117

Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
                 IIHRD+K  NILLD+  +  I+DF +A     +     T   +GT GYMAPE  
Sbjct: 118 SK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVL 171

Query: 568 MGGIFSIKSDVFSFGVLLLEIISGRK 593
               +S+  D +S GV   E + G++
Sbjct: 172 CRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 96.6 bits (241), Expect = 3e-22
 Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 25/206 (12%)

Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
           ++G+G  G V+K      G+ +A+K+  L R  G    +   E+  +   QH  +V+LL 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ--SIINGIARGILYLHEDSRL 512
               G   +L+ EYMP+      L +  R  +      Q  S +  + +G+ Y+H     
Sbjct: 67  VFPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---N 118

Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG--- 569
            I+HRDLK +N+L+  D   KI+DFGLAR+F   + +  ++ +A T  Y APE   G   
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRAPELLYGARK 177

Query: 570 ---GIFSIKSDVFSFGVLLLEIISGR 592
              G+     D+++ G +  E+++G 
Sbjct: 178 YDPGV-----DLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 96.2 bits (240), Expect = 4e-22
 Identities = 58/199 (29%), Positives = 105/199 (52%), Gaps = 19/199 (9%)

Query: 397 NKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
            ++G G +G VYK   +A G+ +A+K +    G   +  + E++++ + +H N+V   G 
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDSR 511
            L   +L ++ EY    SL   ++  TR     +Q+ +  R+++     +G+ YLHE   
Sbjct: 69  YLRRDKLWIVMEYCGGGSLQ-DIYQVTRGPLSELQIAYVCRETL-----KGLAYLHE--- 119

Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA---M 568
              IHRD+K +NILL +D + K++DFG++        +  + I  GT  +MAPE A    
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI--GTPYWMAPEVAAVER 177

Query: 569 GGIFSIKSDVFSFGVLLLE 587
            G +  K D+++ G+  +E
Sbjct: 178 KGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 96.3 bits (239), Expect = 5e-22
 Identities = 60/205 (29%), Positives = 107/205 (52%), Gaps = 11/205 (5%)

Query: 393 FSDENKLGQGGFGPVYKGTLADGK-AIAVKRLSRTSGQG-LQEFKNEVNLIAKLQHKNLV 450
           F+   ++G+G FG VYKG     K  +A+K +     +  +++ + E+ ++++     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
           R  G  L+G +L +I EY+   S      D  +   L+     +I+  I +G+ YLH + 
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSA----LDLLKPGPLEETYIATILREILKGLDYLHSER 121

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
           +   IHRD+KA+N+LL +  + K++DFG+A      Q + NT    GT  +MAPE     
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 176

Query: 571 IFSIKSDVFSFGVLLLEIISGRKNN 595
            +  K+D++S G+  +E+  G   N
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPN 201

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 95.7 bits (238), Expect = 5e-22
 Identities = 70/210 (33%), Positives = 111/210 (52%), Gaps = 29/210 (13%)

Query: 396 ENKLGQGGFGPVYKGTLA-DGK---AIAVKRLS--RTSGQGLQEFKNEVNLIAKLQHKNL 449
           E  +G G FG V  G L   GK    +A+K L    T  Q  ++F +E +++ +  H N+
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIMGQFDHPNI 67

Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHL--FDATRSV-QLDWKRRQSIINGIARGILYL 506
           + L G   + + ++++ EYM N SLD  L   D   +V QL       ++ GIA G+ YL
Sbjct: 68  IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL-----VGMLRGIASGMKYL 122

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG------ 560
              S +  +HRDL A NIL++ ++  K+SDFGL+R+   +   A T     T G      
Sbjct: 123 ---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT-----TRGGKIPIR 174

Query: 561 YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           + APE      F+  SDV+S+G+++ E++S
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 95.4 bits (237), Expect = 6e-22
 Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 20/208 (9%)

Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLS------RTSGQGLQEFKNEVNLIAKLQHKNLV 450
             LG+G +G VY G    G+ IAVK++         + +  ++ + EV+L+  L+H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHL--FDATRSVQLDWKRRQSIINGIARGILYLHE 508
           + LG CL+   + +  E++P  S+   L  F            +Q     I  G+ YLH 
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQ-----ILDGVAYLHN 120

Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLA-RIFGGNQNQANTNIIAGTYG---YMAP 564
           +    ++HRD+K +N++L  +   K+ DFG A R+     +  ++N++   +G   +MAP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177

Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E      +  KSD++S G  + E+ +G+
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 94.7 bits (236), Expect = 1e-21
 Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 10/202 (4%)

Query: 397 NKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
             +G G    VY    L + + +A+KR+        + E + EV  +++  H N+V+   
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 455 CCLEGQELLLIYEYMPNKS-LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
             + G EL L+  Y+   S LD+      R   LD     +++  + +G+ YLH + +  
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG-LDEAIIATVLKEVLKGLEYLHSNGQ-- 123

Query: 514 IIHRDLKASNILLDDDMNPKISDFGL-ARIFGGNQNQANT-NIIAGTYGYMAPEYAMGGI 571
            IHRD+KA NILL +D + KI+DFG+ A +  G            GT  +MAPE      
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182

Query: 572 -FSIKSDVFSFGVLLLEIISGR 592
            +  K+D++SFG+  +E+ +G 
Sbjct: 183 GYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 94.6 bits (235), Expect = 2e-21
 Identities = 66/198 (33%), Positives = 105/198 (53%), Gaps = 12/198 (6%)

Query: 399 LGQGGFGPVYKGT-LADGKAI----AVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
           LG G FG V+KG  + +G +I    A+K +  R+  Q  QE  + +  +  L H  +VRL
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
           LG C  G  L L+ +  P  SL  H+        LD +R  +    IA+G+ YL E    
Sbjct: 75  LGIC-PGASLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128

Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
           +++HR+L A NILL  D   +I+DFG+A +   +  +   +       +MA E  + G +
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188

Query: 573 SIKSDVFSFGVLLLEIIS 590
           + +SDV+S+GV + E++S
Sbjct: 189 THQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 95.0 bits (236), Expect = 2e-21
 Identities = 60/199 (30%), Positives = 103/199 (51%), Gaps = 18/199 (9%)

Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
           K+GQG  G VY    +A G+ +A+K+++       +   NE+ ++ + +H N+V  L   
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL----YLHEDSRL 512
           L G EL ++ EY+   SL     D      +D    +  I  + R  L    +LH +   
Sbjct: 86  LVGDELWVVMEYLAGGSLT----DVVTETCMD----EGQIAAVCRECLQALEFLHSN--- 134

Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
           ++IHRD+K+ NILL  D + K++DFG        Q++ +T  + GT  +MAPE      +
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAY 192

Query: 573 SIKSDVFSFGVLLLEIISG 591
             K D++S G++ +E++ G
Sbjct: 193 GPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 93.8 bits (233), Expect = 3e-21
 Identities = 66/200 (33%), Positives = 100/200 (50%), Gaps = 12/200 (6%)

Query: 399 LGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
           LG+GGFG V    + A GK  A K+L++      +G +    E  ++AK+ H   +  L 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59

Query: 455 CCLEGQ-ELLLIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRL 512
              + + +L L+   M    L  H+++    +      R       I  G+ +LH+    
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116

Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
           +II+RDLK  N+LLD+D N +ISD GLA      Q++  T   AGT G+MAPE   G  +
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEEY 174

Query: 573 SIKSDVFSFGVLLLEIISGR 592
               D F+ GV L E+I+ R
Sbjct: 175 DFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 94.3 bits (234), Expect = 4e-21
 Identities = 72/217 (33%), Positives = 117/217 (53%), Gaps = 20/217 (9%)

Query: 383 LRLALEATNHFSDENKLGQGGFGPVYKGT-LADGKAI----AVKRLSR-TSGQGLQEFKN 436
           LR+  E    F     LG G FG VYKG  + +G+ +    A+K L   TS +  +E  +
Sbjct: 1   LRILKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 58

Query: 437 EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
           E  ++A + + ++ RLLG CL    + LI + MP   L     D  R  + D    Q ++
Sbjct: 59  EAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCL----LDYVREHK-DNIGSQYLL 112

Query: 497 N---GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
           N    IA+G+ YL E+ RL  +HRDL A N+L+    + KI+DFGLA++ G ++ + +  
Sbjct: 113 NWCVQIAKGMNYL-EERRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE 169

Query: 554 IIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                  +MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 93.3 bits (232), Expect = 5e-21
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 23/205 (11%)

Query: 399 LGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
           LG G FG VYK      G  A  K I ++     S + L++F  E++++++ +H N+V L
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIE-----SEEELEDFMVEIDILSECKHPNIVGL 67

Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                   +L ++ E+    +LD  +        L   + + +   +   + +LH     
Sbjct: 68  YEAYFYENKLWILIEFCDGGALD-SIMLELERG-LTEPQIRYVCRQMLEALNFLHSH--- 122

Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
           K+IHRDLKA NILL  D + K++DFG++        + +T I  GT  +MAPE      F
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI--GTPYWMAPEVVACETF 180

Query: 573 S-----IKSDVFSFGVLLLEIISGR 592
                  K+D++S G+ L+E+    
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 93.0 bits (231), Expect = 5e-21
 Identities = 65/206 (31%), Positives = 113/206 (54%), Gaps = 19/206 (9%)

Query: 396 ENKLGQGGFGPVYKGTL-ADGKA---IAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLV 450
           E  +G G FG V +G L   GK    +A+K L S  + +  ++F +E +++ +  H N++
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLD--VHLFDATRSV-QLDWKRRQSIINGIARGILYLH 507
            L G   + + +++I E+M N +LD  +   D   +V QL       ++ GIA G+ YL 
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-----VGMLRGIAAGMKYLS 123

Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN-QNQANTNIIAGTYG--YMAP 564
           E   +  +HRDL A NIL++ ++  K+SDFGL+R    +  +   T+ + G     + AP
Sbjct: 124 E---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIIS 590
           E      F+  SDV+S+G+++ E++S
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 92.8 bits (230), Expect = 6e-21
 Identities = 59/207 (28%), Positives = 109/207 (52%), Gaps = 15/207 (7%)

Query: 393 FSDENKLGQGGFGPVYKGTLADGKA---IAVKRLSRTSGQG-LQEFKNEVNLIAKLQHKN 448
           F+   ++G+G FG V+KG   D +    +A+K +     +  +++ + E+ ++++     
Sbjct: 6   FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
           + +  G  L+G +L +I EY+   S      D  R+   D  +  +++  I +G+ YLH 
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHS 119

Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
           +   K IHRD+KA+N+LL +  + K++DFG+A      Q + NT    GT  +MAPE   
Sbjct: 120 E---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQ 174

Query: 569 GGIFSIKSDVFSFGVLLLEIISGRKNN 595
              +  K+D++S G+  +E+  G   N
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPN 201

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 92.8 bits (230), Expect = 8e-21
 Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 23/202 (11%)

Query: 398 KLGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
           +LG G FG VYK      G LA  K I  K     S + L+++  E+ ++A   H  +V+
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVK 73

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
           LLG      +L ++ E+ P  ++D  + +  R +     + Q I   +   + YLH    
Sbjct: 74  LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLT--EPQIQVICRQMLEALQYLHS--- 128

Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM--- 568
           +KIIHRDLKA N+LL  D + K++DFG++        + ++ I  GT  +MAPE  M   
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI--GTPYWMAPEVVMCET 186

Query: 569 --GGIFSIKSDVFSFGVLLLEI 588
                +  K+D++S G+ L+E+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 93.1 bits (232), Expect = 9e-21
 Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 23/223 (10%)

Query: 389 ATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRL---SRTSGQGLQEFKNEVNLIAKL 444
               +    KLG+G FG VYK   +  G+ +A+K++   +   G  +   + E+ ++ KL
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKL 64

Query: 445 QHKNLVRLLGCCLE-----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 499
           +H N+V L+   +E      ++   +Y   P    D+       SV+L   + +  +  +
Sbjct: 65  KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQL 124

Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG-- 557
             GI YLHE+    I+HRD+KA+NIL+D+    KI+DFGLAR + G           G  
Sbjct: 125 LEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181

Query: 558 -------TYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
                  T  Y  PE  +G   ++   D++  G +  E+ + R
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 91.8 bits (228), Expect = 1e-20
 Identities = 76/206 (36%), Positives = 111/206 (53%), Gaps = 25/206 (12%)

Query: 399 LGQGGFGPVYKGTL--ADGKAI--AVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
           +G+G FG VY GTL  +DG+ I  AVK L+R T  + +++F  E  ++    H N++ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 454 GCCL--EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING--IARGILYLHED 509
           G CL  EG  L+++  YM  K  D+  F   RS   +   +  I  G  +A+G+ YL   
Sbjct: 63  GICLPSEGSPLVVL-PYM--KHGDLRNF--IRSETHNPTVKDLIGFGLQVAKGMEYLASK 117

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGN----QNQANTNIIAGTYGYMAP 564
              K +HRDL A N +LD+    K++DFGLAR I+        N     +      +MA 
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL---PVKWMAL 171

Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIIS 590
           E      F+ KSDV+SFGVLL E+++
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 92.0 bits (228), Expect = 1e-20
 Identities = 68/211 (32%), Positives = 109/211 (51%), Gaps = 29/211 (13%)

Query: 398 KLGQGGFGPVYKGTLADG-------KAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNL 449
           +LGQG FG VY+G +A G         +A+K ++  +    + EF NE +++ +    ++
Sbjct: 13  ELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71

Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLD-----------WKRRQSIING 498
           VRLLG   +GQ  L+I E M    L  +L    RS++ +            K+   +   
Sbjct: 72  VRLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVQAPPSLKKMIQMAGE 127

Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAG 557
           IA G+ YL+ +   K +HRDL A N ++ +D   KI DFG+ R I+  +  +     +  
Sbjct: 128 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 558 TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEI 588
              +M+PE    G+F+  SDV+SFGV+L EI
Sbjct: 185 VR-WMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 93.2 bits (231), Expect = 1e-20
 Identities = 70/215 (32%), Positives = 104/215 (48%), Gaps = 26/215 (12%)

Query: 399 LGQGGFGPVY--------KGTLADGKAIAVKRLSR-TSGQGLQEFKNEVNLIAKL-QHKN 448
           LG+G FG V         K        +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHL-----------FDATR--SVQLDWKRRQSI 495
           ++ LLG C +   L ++ EY    +L  +L           FD  +    QL +K   S 
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 555
              +ARG+ YL   +  K IHRDL A N+L+ +D   KI+DFGLAR          T   
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 556 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                +MAPE     +++ +SDV+SFGVLL EI +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 92.2 bits (229), Expect = 1e-20
 Identities = 69/203 (33%), Positives = 103/203 (50%), Gaps = 18/203 (8%)

Query: 399 LGQGGFGPVYKGT---LADGKA---IAVKRLSRTSGQGLQE-FKNEVNLIAKL-QHKNLV 450
           LG G FG V + T   L+   A   +AVK L  T+    +E   +E+ +++ L  H+N+V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
            LLG C  G  +L+I EY     L ++     R   L  +   S    +A+G+ +L   +
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDL-LNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN 161

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN---QANTNIIAGTYGYMAPEYA 567
               IHRDL A N+LL      KI DFGLAR    + N   + N  +      +MAPE  
Sbjct: 162 ---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL---PVKWMAPESI 215

Query: 568 MGGIFSIKSDVFSFGVLLLEIIS 590
              +++ +SDV+S+G+LL EI S
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 90.8 bits (225), Expect = 2e-20
 Identities = 67/202 (33%), Positives = 100/202 (49%), Gaps = 21/202 (10%)

Query: 398 KLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRLLGC 455
           ++G+G FG V+ G L AD   +AVK    T    L+ +F  E  ++ +  H N+VRL+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
           C + Q + ++ E +  +  D   F  T   +L  K    ++   A G+ YL        I
Sbjct: 62  CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116

Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-------YMAPEYAM 568
           HRDL A N L+ +    KISDFG++R       +    + A T G       + APE   
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR-------EEEDGVYASTGGMKQIPVKWTAPEALN 169

Query: 569 GGIFSIKSDVFSFGVLLLEIIS 590
            G +S +SDV+SFG+LL E  S
Sbjct: 170 YGRYSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 91.9 bits (228), Expect = 2e-20
 Identities = 71/218 (32%), Positives = 108/218 (49%), Gaps = 32/218 (14%)

Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNE------VNLIAKLQ------- 445
           LG+G FG V +   A+   I   R  +T    ++  K+        +LI++++       
Sbjct: 20  LGEGCFGQVVR---AEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK 76

Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-----------FDATRSV--QLDWKRR 492
           HKN++ LLG C +   L +I EY    +L   L           FD T+    QL +K  
Sbjct: 77  HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136

Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
            S    +ARG+ YL  +SR + IHRDL A N+L+ +D   KI+DFGLAR          T
Sbjct: 137 VSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193

Query: 553 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           +       +MAPE     +++ +SDV+SFG+L+ EI +
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 90.8 bits (226), Expect = 3e-20
 Identities = 56/199 (28%), Positives = 88/199 (44%), Gaps = 15/199 (7%)

Query: 399 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQE-FKNEVNLIAKLQHKNLVRLLG 454
           LG GGFG V    +    +  A+K + +      G QE   +E  ++ +  H  +V+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSV-QLDWKRRQSIINGIARGILYLHEDSRLK 513
              + + + ++ EY     L    +   R     D    +  I  +     YLH      
Sbjct: 61  TFKDKKYIYMLMEYCLGGEL----WTILRDRGLFDEYTARFYIACVVLAFEYLH---NRG 113

Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 573
           II+RDLK  N+LLD +   K+ DFG A+     Q    T    GT  Y+APE  +   + 
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYD 170

Query: 574 IKSDVFSFGVLLLEIISGR 592
              D +S G+LL E+++GR
Sbjct: 171 FSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 91.4 bits (227), Expect = 3e-20
 Identities = 65/206 (31%), Positives = 109/206 (52%), Gaps = 25/206 (12%)

Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAKLQHKN 448
           F+D  ++G G FG VY    +   + +A+K++S +  Q  +++++   EV  + +L+H N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKS---LDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
            +   GC L      L+ EY    +   L+VH     + V++      +I +G  +G+ Y
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLGSASDILEVHK-KPLQEVEI-----AAICHGALQGLAY 130

Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           LH     + IHRD+KA NILL +    K++DFG A +     + AN+ +  GT  +MAPE
Sbjct: 131 LHS---HERIHRDIKAGNILLTEPGTVKLADFGSASL----VSPANSFV--GTPYWMAPE 181

Query: 566 --YAMG-GIFSIKSDVFSFGVLLLEI 588
              AM  G +  K DV+S G+  +E+
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 91.3 bits (226), Expect = 3e-20
 Identities = 55/200 (27%), Positives = 106/200 (53%), Gaps = 10/200 (5%)

Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
           ++   K+GQG  G V+    +A G+ +A+K+++       +   NE+ ++ +L++ N+V 
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
            L   L G EL ++ EY+   SL     D      +D  +  ++     + + +LH +  
Sbjct: 81  FLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQALEFLHAN-- 134

Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 571
            ++IHRD+K+ N+LL  D + K++DFG        Q++ +T  + GT  +MAPE      
Sbjct: 135 -QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 191

Query: 572 FSIKSDVFSFGVLLLEIISG 591
           +  K D++S G++ +E++ G
Sbjct: 192 YGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 90.2 bits (224), Expect = 3e-20
 Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 25/206 (12%)

Query: 399 LGQGGFGP--VYKGTLADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
           LG+G FG   +Y+ T  D   +  K   L+R S +  ++  NE+ +++ LQH N++    
Sbjct: 8   LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 455 CCLEGQELLLIYEYMPNKSL-------DVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
             ++   LL+  EY    +L          LF+      + W   Q     I   + Y+H
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEE---MVLWYLFQ-----IVSAVSYIH 118

Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
           +     I+HRD+K  NI L      K+ DFG+++I G   + A T  + GT  YM+PE  
Sbjct: 119 KAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELC 173

Query: 568 MGGIFSIKSDVFSFGVLLLEIISGRK 593
            G  ++ KSD+++ G +L E+++ ++
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 91.2 bits (226), Expect = 3e-20
 Identities = 68/215 (31%), Positives = 105/215 (48%), Gaps = 26/215 (12%)

Query: 399 LGQGGFGPVY--------KGTLADGKAIAVKRLS-RTSGQGLQEFKNEVNLIAKL-QHKN 448
           LG+G FG V         K    +   +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHL-----------FDATR--SVQLDWKRRQSI 495
           ++ LLG C +   L +I EY    +L  +L           +D  R    Q+ +K   S 
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 555
              +ARG+ YL   +  K IHRDL A N+L+ ++   KI+DFGLAR          T   
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 556 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                +MAPE     +++ +SDV+SFGVL+ EI +
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 90.4 bits (224), Expect = 4e-20
 Identities = 62/200 (31%), Positives = 94/200 (47%), Gaps = 15/200 (7%)

Query: 399 LGQGGFGPV------YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
           LG+GGFG V        G +   K +  KRL + SG+ +   + E+  + K+    +V L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58

Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                    L L+   M    L  H+++      L+ +R       I  GIL+LH    +
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHS---M 114

Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
            I++RD+K  N+LLDD  N ++SD GLA      +        AGT GYMAPE      +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKEEPY 171

Query: 573 SIKSDVFSFGVLLLEIISGR 592
           S   D F+ G  + E+++GR
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 90.8 bits (226), Expect = 4e-20
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 15/201 (7%)

Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN----EVNLIAKLQHKNLVRL 452
            +G+G +G V K    A G+ +A+K+   +     ++ K     EV ++ +L+H+N+V L
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLRHENIVNL 65

Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                    L L++EY+    L+  L +A+    L     +S I  + + I Y H     
Sbjct: 66  KEAFRRKGRLYLVFEYVERTLLE--LLEASPG-GLPPDAVRSYIWQLLQAIAYCH---SH 119

Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
            IIHRD+K  NIL+ +    K+ DFG AR          T+ +A T  Y APE  +G   
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELLVGDTN 178

Query: 573 SIKS-DVFSFGVLLLEIISGR 592
             K  DV++ G ++ E++ G 
Sbjct: 179 YGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 89.9 bits (223), Expect = 4e-20
 Identities = 63/202 (31%), Positives = 106/202 (52%), Gaps = 23/202 (11%)

Query: 399 LGQGGFGPVYKGTLADGKA---------IAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
           +G+G FG V+   L   KA         I V+++++      Q   NE  ++  L H N+
Sbjct: 8   VGRGAFGIVH---LCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNI 61

Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +      LE + L+++ EY P  +L  ++     S+ LD     +I++   + +L LH  
Sbjct: 62  IEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LD---EDTILHFFVQILLALHHV 117

Query: 510 SRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
               I+HRDLK  NILLD   M  KI DFG+++I   ++++A T  + GT  Y++PE   
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYT--VVGTPCYISPELCE 174

Query: 569 GGIFSIKSDVFSFGVLLLEIIS 590
           G  ++ KSD+++ G +L E+ S
Sbjct: 175 GKPYNQKSDIWALGCVLYELAS 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 90.1 bits (223), Expect = 5e-20
 Identities = 57/201 (28%), Positives = 102/201 (50%), Gaps = 11/201 (5%)

Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-LQEFKNEVNLIAKLQHKNLV 450
           F+   K+G+G FG V+KG      K +A+K +     +  +++ + E+ ++++     + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
           +  G  L+  +L +I EY+   S      D      LD  +  +I+  I +G+ YLH + 
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHSEK 121

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
           +   IHRD+KA+N+LL +    K++DFG+A        Q   N   GT  +MAPE     
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQS 176

Query: 571 IFSIKSDVFSFGVLLLEIISG 591
            +  K+D++S G+  +E+  G
Sbjct: 177 AYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 89.6 bits (222), Expect = 5e-20
 Identities = 63/195 (32%), Positives = 98/195 (50%), Gaps = 11/195 (5%)

Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 457
           +LG G FG V  G       +A+K +   S     EF  E  ++ KL H+ LV+L G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 458 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR 517
           + + + ++ EYM N  L  +L +  +  Q    +   +   +  G+ YL      + IHR
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKRFQP--SQLLEMCKDVCEGMAYLESK---QFIHR 124

Query: 518 DLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTY--GYMAPEYAMGGIFSIK 575
           DL A N L+DD    K+SDFGL+R    ++    T+ +   +   +  PE  +   FS K
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLLYSKFSSK 181

Query: 576 SDVFSFGVLLLEIIS 590
           SDV++FGVL+ E+ S
Sbjct: 182 SDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 89.4 bits (222), Expect = 7e-20
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 26/212 (12%)

Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQ 445
             +F  E K+G+G F  VYK   L DG+ +A+K++        +  Q+   E++L+ +L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSL---------DVHLFDATRSVQLDWKRRQSII 496
           H N+++ L   +E  EL ++ E      L            L    R++   WK      
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPE-RTI---WK----YF 112

Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 556
             +   + ++H     +I+HRD+K +N+ +      K+ D GL R F      A++ +  
Sbjct: 113 VQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-- 167

Query: 557 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEI 588
           GT  YM+PE      ++ KSD++S G LL E+
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 89.7 bits (222), Expect = 8e-20
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 25/203 (12%)

Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
           +LG G FG VYK    +   +A  ++  T S + L+++  E++++A   H N+V+LL   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                L ++ E+    ++D  + +  R   L   + + +       + YLHE+   KIIH
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNYLHEN---KIIH 126

Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA------GTYGYMAPEYAMGG 570
           RDLKA NIL   D + K++DFG++          NT  I       GT  +MAPE  M  
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTPYWMAPEVVMCE 178

Query: 571 I-----FSIKSDVFSFGVLLLEI 588
                 +  K+DV+S G+ L+E+
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 89.2 bits (221), Expect = 1e-19
 Identities = 74/234 (31%), Positives = 117/234 (50%), Gaps = 37/234 (15%)

Query: 399 LGQGGFGPVY------KGTLADGKAIAVKRLS-RTSGQGLQEFKNEVNLIAKLQHKNLVR 451
           LG+G FG V       +G    G+ +AVK L   + G  + + K E+ ++  L H+N+V+
Sbjct: 12  LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70

Query: 452 LLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
             G C E  G  + LI E++P+ SL  +L      + L  + + ++   I +G+ YL   
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAV--QICKGMDYL--G 126

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN--QANTNIIAGTYGYMAPEYA 567
           SR + +HRDL A N+L++ +   KI DFGL +    ++       ++ +  + Y APE  
Sbjct: 127 SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECL 184

Query: 568 MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLSLSLSLF 621
           +   F I SDV+SFGV L E                  LLTY C+S S  ++LF
Sbjct: 185 IQSKFYIASDVWSFGVTLYE------------------LLTY-CDSESSPMTLF 219

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 89.6 bits (222), Expect = 1e-19
 Identities = 74/247 (29%), Positives = 120/247 (48%), Gaps = 54/247 (21%)

Query: 377 EFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKA----------------IAV 420
           EFP   LRL          + KLG+G FG V+    A+G A                +AV
Sbjct: 1   EFPRQQLRL----------KEKLGEGQFGEVHLCE-AEGLAEFLGEGAPEFDGQPVLVAV 49

Query: 421 KRL-SRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF 479
           K L +  +     +F  E+ ++++L++ N++RLLG C+    L +I EYM N   D++ F
Sbjct: 50  KMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENG--DLNQF 107

Query: 480 DATRSVQLDWKRRQSIIN-----------GIARGILYLHEDSRLKIIHRDLKASNILLDD 528
            + R ++  +    +I +            IA G+ YL   + L  +HRDL   N L+ +
Sbjct: 108 LSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGN 164

Query: 529 DMNPKISDFGLAR-IFGGN----QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGV 583
               KI+DFG++R ++ G+    Q +A   I      +MA E  + G F+  SDV++FGV
Sbjct: 165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPI-----RWMAWESILLGKFTTASDVWAFGV 219

Query: 584 LLLEIIS 590
            L E+ +
Sbjct: 220 TLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 89.1 bits (221), Expect = 1e-19
 Identities = 58/204 (28%), Positives = 109/204 (53%), Gaps = 11/204 (5%)

Query: 393 FSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQHKNL 449
           F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +L H N+
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           V+LL       +L L++E++ ++ L   + DA+    +     +S +  + +G+ + H  
Sbjct: 62  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 569
              +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y APE  +G
Sbjct: 120 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLG 174

Query: 570 G-IFSIKSDVFSFGVLLLEIISGR 592
              +S   D++S G +  E+++ R
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 88.9 bits (220), Expect = 2e-19
 Identities = 70/212 (33%), Positives = 108/212 (50%), Gaps = 27/212 (12%)

Query: 398 KLGQGGFGPVYKGTLAD---GKA---IAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLV 450
           +LGQG FG VY+G   D   G+A   +AVK ++ + S +   EF NE +++      ++V
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ-----------SIINGI 499
           RLLG   +GQ  L++ E M +  L  +L    RS++ + +               +   I
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEMIQMAAEI 128

Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAGT 558
           A G+ YL+     K +HRDL A N ++  D   KI DFG+ R I+  +  +     +   
Sbjct: 129 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185

Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
              MAPE    G+F+  SD++SFGV+L EI S
Sbjct: 186 RW-MAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 89.3 bits (221), Expect = 2e-19
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 19/203 (9%)

Query: 393 FSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQHKN 448
           FSD  ++G G FG VY    + + + +A+K++S   + S +  Q+   EV  + KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
            ++  GC L      L+ EY    + D  L +  +   L      ++ +G  +G+ YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKK-PLQEVEIAAVTHGALQGLAYLHS 133

Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
            +   +IHRD+KA NILL +    K+ DFG A I       A  N   GT  +MAPE  +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184

Query: 569 G---GIFSIKSDVFSFGVLLLEI 588
               G +  K DV+S G+  +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 67/230 (29%), Positives = 101/230 (43%), Gaps = 51/230 (22%)

Query: 398 KLGQGGFGPVY------------KGTLADGKA-----IAVKRLSRT-SGQGLQEFKNEVN 439
           KLG+G FG V+            K    +  A     +AVK L    S    ++F  EV 
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 440 LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-----FDATRSVQLDWKRRQS 494
           ++++L   N+ RLLG C     L +I EYM N  L+  L       +  +         +
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131

Query: 495 IIN---GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
           ++     IA G+ YL     L  +HRDL   N L+  +   KI+DFG++R          
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR---------- 178

Query: 552 TNIIAGTY-----------GYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
            N+ +  Y            +MA E  + G F+ KSDV++FGV L EI++
Sbjct: 179 -NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 62/203 (30%), Positives = 109/203 (53%), Gaps = 19/203 (9%)

Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLS-RTSGQGL-QEFKNEVNLIAKLQ---HKNLV 450
            ++G+G +G VYK   L  G+ +A+K++    S +G+      E+ L+ +L+   H N+V
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 451 RLLGCCL-----EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           RLL  C         +L L++E++ ++ L  +L    +   L  +  + ++  + RG+ +
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPG-LPPETIKDLMRQLLRGVDF 122

Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           LH     +I+HRDLK  NIL+  D   KI+DFGLARI+      A T+++  T  Y APE
Sbjct: 123 LHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS--FEMALTSVVV-TLWYRAPE 176

Query: 566 YAMGGIFSIKSDVFSFGVLLLEI 588
             +   ++   D++S G +  E+
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 88.6 bits (219), Expect = 2e-19
 Identities = 56/195 (28%), Positives = 103/195 (52%), Gaps = 10/195 (5%)

Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
           K+GQG  G VY    +A G+ +A+K+++       +   NE+ ++ + ++ N+V  L   
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85

Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
           L G EL ++ EY+   SL     D      +D  +  ++     + + +LH +   ++IH
Sbjct: 86  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSN---QVIH 138

Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RD+K+ NILL  D + K++DFG        Q++ +T  + GT  +MAPE      +  K 
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKV 196

Query: 577 DVFSFGVLLLEIISG 591
           D++S G++ +E++ G
Sbjct: 197 DIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 87.7 bits (217), Expect = 2e-19
 Identities = 69/207 (33%), Positives = 104/207 (50%), Gaps = 22/207 (10%)

Query: 398 KLGQGGFGPVYKG---TLADGKAIAVKRLSRTSGQGL--QEFKNEVNLIAKLQHKNLVRL 452
           +LG G FG V KG        K +AVK L   +       E   E N++ +L +  +VR+
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
           +G C E +  +L+ E      L+  L    ++  +  K    +++ ++ G+ YL E +  
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115

Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-----YMAPEYA 567
             +HRDL A N+LL      KISDFGL++  G ++N       A T+G     + APE  
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK----AKTHGKWPVKWYAPECM 170

Query: 568 MGGIFSIKSDVFSFGVLLLEIIS-GRK 593
               FS KSDV+SFGVL+ E  S G+K
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 87.0 bits (215), Expect = 5e-19
 Identities = 64/210 (30%), Positives = 108/210 (51%), Gaps = 29/210 (13%)

Query: 399 LGQGGFGPVYKGTLAD-GKAIAVKRL-----SRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
           LGQG FG VY    AD G+ +AVK++     S  + + +   + E+ L+  L H+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 453 LGCCLEGQE--LLLIYEYMPNKSLDVHL--FDA-TRSVQLDWKRRQSIINGIARGILYLH 507
            GC  +  E  L +  E+MP  S+   L  + A T +V   + R+      I  G+ YLH
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQ------ILEGVSYLH 123

Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-----IFGGNQNQANTNIIAGTYGYM 562
            +    I+HRD+K +NIL D   N K+ DFG ++        G   ++    + GT  +M
Sbjct: 124 SN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS----VTGTPYWM 176

Query: 563 APEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           +PE   G  +  K+D++S G  ++E+++ +
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 87.8 bits (217), Expect = 6e-19
 Identities = 63/206 (30%), Positives = 103/206 (50%), Gaps = 25/206 (12%)

Query: 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQHKN 448
           F+D  ++G G FG VY        + +A+K++S   + S +  Q+   EV  + +++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKS---LDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
            +   GC L      L+ EY    +   L+VH     + V++      +I +G  +G+ Y
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEI-----AAITHGALQGLAY 140

Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           LH  +   +IHRD+KA NILL +    K++DFG A I       +  N   GT  +MAPE
Sbjct: 141 LHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPE 191

Query: 566 YAMG---GIFSIKSDVFSFGVLLLEI 588
             +    G +  K DV+S G+  +E+
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 87.1 bits (216), Expect = 6e-19
 Identities = 56/201 (27%), Positives = 103/201 (51%), Gaps = 18/201 (8%)

Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTS-GQGLQEFK-NEVNLIAKLQHKNLVRLLG 454
           K+G+G +G V+K       + +A+KR+      +G+      E+ L+ +L+HKN+VRL  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 455 CCLEGQELLLIYEYMPNKSLDVHL---FDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
                ++L L++EY      D  L   FD+     +D +  +S +  + +G+ + H    
Sbjct: 67  VLHSDKKLTLVFEY-----CDQDLKKYFDSCNG-DIDPEIVKSFMFQLLKGLAFCHSH-- 118

Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG- 570
             ++HRDLK  N+L++ +   K++DFGLAR FG      +  ++  T  Y  P+   G  
Sbjct: 119 -NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAK 175

Query: 571 IFSIKSDVFSFGVLLLEIISG 591
           ++S   D++S G +  E+ + 
Sbjct: 176 LYSTSIDMWSAGCIFAELANA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 88.0 bits (218), Expect = 8e-19
 Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 27/207 (13%)

Query: 397 NKLGQGGFGPVYK----GTLADGKAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVR 451
           N++G G  G VYK     T   G+  A+K +       ++ +   E+ ++  + H N+V+
Sbjct: 80  NRIGSGAGGTVYKVIHRPT---GRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136

Query: 452 LLGCCLEGQELLLIYEYMPNKSLD-VHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                    E+ ++ E+M   SL+  H+ D      L    RQ I++GIA    YLH   
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIAD---EQFLADVARQ-ILSGIA----YLH--- 185

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE----- 565
           R  I+HRD+K SN+L++   N KI+DFG++RI     +  N+++  GT  YM+PE     
Sbjct: 186 RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV--GTIAYMSPERINTD 243

Query: 566 YAMGGIFSIKSDVFSFGVLLLEIISGR 592
              G       D++S GV +LE   GR
Sbjct: 244 LNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 86.7 bits (215), Expect = 8e-19
 Identities = 53/201 (26%), Positives = 103/201 (51%), Gaps = 12/201 (5%)

Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
             +  K+G+G  G V   T  + G+ +AVK++     Q  +   NEV ++   QH N+V 
Sbjct: 21  LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVE 80

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
           +    L G EL ++ E++   +L     D     +++ ++  ++   + + + +LH    
Sbjct: 81  MYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ-- 134

Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGL-ARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
             +IHRD+K+ +ILL  D   K+SDFG  A++   ++       + GT  +MAPE     
Sbjct: 135 -GVIHRDIKSDSILLTSDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMAPEVISRL 190

Query: 571 IFSIKSDVFSFGVLLLEIISG 591
            +  + D++S G++++E++ G
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 87.4 bits (216), Expect = 8e-19
 Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 25/206 (12%)

Query: 393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ---GLQEFKNEVNLIAKLQHKN 448
           F   +++G G FG VY  T +   + +AVK++S +  Q     Q+   EV  + +L+H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKS---LDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
            +   GC L+     L+ EY    +   L+VH     + V++      +I +G  +G+ Y
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHK-KPLQEVEI-----AAITHGALQGLAY 136

Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           LH  +   +IHRD+KA NILL +    K++DFG A         +  N   GT  +MAPE
Sbjct: 137 LHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASK------SSPANSFVGTPYWMAPE 187

Query: 566 YAMG---GIFSIKSDVFSFGVLLLEI 588
             +    G +  K DV+S G+  +E+
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 86.2 bits (213), Expect = 9e-19
 Identities = 65/204 (31%), Positives = 108/204 (52%), Gaps = 21/204 (10%)

Query: 399 LGQGGFGPVYKGTLAD-GKAIAVKRL-----SRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
           LG+G FG VY    AD G+ +AVK++     S+ + + +   + E+ L+  L+H  +V+ 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 453 LGCCLEGQE--LLLIYEYMPNKSLDVHL--FDA-TRSVQLDWKRRQSIINGIARGILYLH 507
            GC  + +E  L +  EYMP  S+   L  + A T +V   + R+      I +G+ YLH
Sbjct: 70  YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQ------ILQGVSYLH 123

Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLA-RIFGGNQNQANTNIIAGTYGYMAPEY 566
            +    I+HRD+K +NIL D   N K+ DFG + RI     +      + GT  +M+PE 
Sbjct: 124 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180

Query: 567 AMGGIFSIKSDVFSFGVLLLEIIS 590
             G  +  K+DV+S    ++E+++
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 86.5 bits (214), Expect = 9e-19
 Identities = 60/210 (28%), Positives = 106/210 (50%), Gaps = 28/210 (13%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQG---LQEFKNEVNLIAKLQHKNLVR 451
           LG G F   Y+   +  G  +AVK+++    TS +    ++  + E+ L+A+L H +++R
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDA---TRSVQLDWKRRQSIINGIARGILYLHE 508
           +LG   E     L  E+M   S+   L        +V +++  +      + RG+ YLHE
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQ------LLRGLSYLHE 121

Query: 509 DSRLKIIHRDLKASNILLDDD-MNPKISDFGLA-----RIFGGNQNQANTNIIAGTYGYM 562
           +   +IIHRD+K +N+L+D      +I+DFG A     +  G  + Q     + GT  +M
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ---LLGTIAFM 175

Query: 563 APEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           APE   G  +    DV+S G +++E+ + +
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 87.0 bits (215), Expect = 1e-18
 Identities = 67/214 (31%), Positives = 110/214 (51%), Gaps = 26/214 (12%)

Query: 396 ENKLGQGGFGPVYKGTL-ADGKAI--AVKRLSRTSGQG-LQEFKNEVNLIAKL-QHKNLV 450
           ++ +G+G FG V K  +  DG  +  A+KR+   + +   ++F  E+ ++ KL  H N++
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLD-----WKRRQSIING------- 498
            LLG C     L L  EY P+ +L +     +R ++ D          S ++        
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNL-LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130

Query: 499 --IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 556
             +ARG+ YL   S+ + IHRDL A NIL+ ++   KI+DFGL+R   G +      +  
Sbjct: 131 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGR 184

Query: 557 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
               +MA E     +++  SDV+S+GVLL EI+S
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 86.3 bits (213), Expect = 1e-18
 Identities = 66/206 (32%), Positives = 108/206 (52%), Gaps = 21/206 (10%)

Query: 399 LGQGGFGPVYKGTLAD-GKAIAVKRL-----SRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
           LGQG FG VY     D G+ +A K++     S  + + +   + E+ L+  LQH+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 453 LGCCLE-GQELLLIY-EYMPNKSLDVHL--FDA-TRSVQLDWKRRQSIINGIARGILYLH 507
            GC  +  ++ L I+ EYMP  S+   L  + A T SV   + R+      I  G+ YLH
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQ------ILEGMSYLH 123

Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLA-RIFGGNQNQANTNIIAGTYGYMAPEY 566
            +    I+HRD+K +NIL D   N K+ DFG + R+     +      + GT  +M+PE 
Sbjct: 124 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180

Query: 567 AMGGIFSIKSDVFSFGVLLLEIISGR 592
             G  +  K+DV+S G  ++E+++ +
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 86.7 bits (214), Expect = 1e-18
 Identities = 57/196 (29%), Positives = 104/196 (53%), Gaps = 12/196 (6%)

Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
           K+GQG  G VY    +A G+ +A+++++       +   NE+ ++ + ++ N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
           L G EL ++ EY+   SL     D      +D  +  ++     + + +LH +   ++IH
Sbjct: 87  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139

Query: 517 RDLKASNILLDDDMNPKISDFGL-ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           RD+K+ NILL  D + K++DFG  A+I      Q+  + + GT  +MAPE      +  K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 576 SDVFSFGVLLLEIISG 591
            D++S G++ +E+I G
Sbjct: 197 VDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 86.2 bits (213), Expect = 1e-18
 Identities = 62/205 (30%), Positives = 106/205 (51%), Gaps = 19/205 (9%)

Query: 399 LGQGGFGPVYKGTLADGKAI---AVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
           LG+G FG V +G L    +I   AVK  +++  +   +++F +E   + +  H N++RL+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 454 GCCLEGQEL------LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGIL 504
           G CL+  E       ++I  +M +  L   L  +       +   Q ++     IA G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA-RIFGGNQNQANTNIIAGTYGYMA 563
           YL   S    IHRDL A N +L+++MN  ++DFGL+ +I+ G+  +    I      ++A
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQG-RIAKMPVKWIA 182

Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEI 588
            E     +++ KSDV+SFGV + EI
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 26/208 (12%)

Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQG---LQEFKNEVNLIAKLQHKNLVR 451
           + +G +G V+    K T   G   A+K + +        + +   E +++++ Q   +V+
Sbjct: 1   ISKGAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57

Query: 452 LLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
           L     +G++ L L+ EY+P   L   L +   S+  D  R    I  I   + YLH   
Sbjct: 58  LY-YSFQGKKNLYLVMEYLPGGDL-ASLLENVGSLDEDVAR--IYIAEIVLALEYLH--- 110

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI-------IAGTYGYMA 563
              IIHRDLK  NIL+D + + K++DFGL++  G  + Q N N        I GT  Y+A
Sbjct: 111 SNGIIHRDLKPDNILIDSNGHLKLTDFGLSK-VGLVRRQINLNDDEKEDKRIVGTPDYIA 169

Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           PE  +G   S   D +S G +L E + G
Sbjct: 170 PEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 87.0 bits (216), Expect = 1e-18
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 18/213 (8%)

Query: 393 FSDENKLGQGGFGPVYKG---TLADGKAIAVKRL--SRTSGQGL-QEFKNEVNLIAKLQH 446
           +  E  +G+G +G VYK       DGK  A+K+    +    G+ Q    E+ L+ +L+H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 447 KNLVRLLGCCLEGQE--LLLIYEYMPNKSLDV-HLFDATRSVQLDWKRRQSIINGIARGI 503
           +N+V L+   LE  +  + L+++Y  +    +       + V +     +S++  I  G+
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121

Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNP----KISDFGLARIFGGNQNQ-ANTNIIAGT 558
            YLH +    ++HRDLK +NIL+  +       KI D GLAR+F       A+ + +  T
Sbjct: 122 HYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVT 178

Query: 559 YGYMAPEYAMGGIFSIKS-DVFSFGVLLLEIIS 590
             Y APE  +G     K+ D+++ G +  E+++
Sbjct: 179 IWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 86.6 bits (214), Expect = 1e-18
 Identities = 59/209 (28%), Positives = 108/209 (51%), Gaps = 21/209 (10%)

Query: 398 KLGQGGFGPVYKGTLA----DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
           K+G+G  G V    +A     G+ +AVK +     Q  +   NEV ++   QH+N+V + 
Sbjct: 28  KIGEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84

Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
              L G+EL ++ E++   +L     D     +L+ ++  ++   + + + YLH      
Sbjct: 85  KSYLVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG--- 137

Query: 514 IIHRDLKASNILLDDDMNPKISDFGL-ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
           +IHRD+K+ +ILL  D   K+SDFG  A+I   +++      + GT  +MAPE      +
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVISRTPY 194

Query: 573 SIKSDVFSFGVLLLEIISGRKNNGFYFSE 601
             + D++S G++++E++ G      YFS+
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPP---YFSD 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 85.8 bits (212), Expect = 1e-18
 Identities = 66/201 (32%), Positives = 108/201 (53%), Gaps = 18/201 (8%)

Query: 399 LGQGGFGPVYKGTLA-DGKAI----AVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
           LG G FG VYKG    DG+ +    A+K L   TS +  +E  +E  ++A +    + RL
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGILYLHED 509
           LG CL    + L+ + MP   L     D  R  + D    Q ++N    IA+G+ YL E 
Sbjct: 75  LGICLT-STVQLVTQLMPYGCL----LDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEE- 127

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 569
             ++++HRDL A N+L+    + KI+DFGLAR+   ++ + + +       +MA E  + 
Sbjct: 128 --VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH 185

Query: 570 GIFSIKSDVFSFGVLLLEIIS 590
             F+ +SDV+S+GV + E+++
Sbjct: 186 RRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 85.3 bits (211), Expect = 2e-18
 Identities = 59/193 (30%), Positives = 94/193 (48%), Gaps = 7/193 (3%)

Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 457
           +LG G FG V+ G       +A+K +        ++F  E  ++ KL H  LV+L G C 
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 458 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR 517
           + + L ++ E+M N  L  +L    R  +L      S+   +  G+ YL  +S    IHR
Sbjct: 70  QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124

Query: 518 DLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSD 577
           DL A N L+      K+SDFG+ R    ++  +++        +  PE      +S KSD
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG-AKFPVKWSPPEVFNFSKYSSKSD 183

Query: 578 VFSFGVLLLEIIS 590
           V+SFGVL+ E+ +
Sbjct: 184 VWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 86.0 bits (213), Expect = 2e-18
 Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 18/210 (8%)

Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHK 447
           + +    K+G+G +G VYK       + IA+K  RL +           E++L+ ++QH 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHL---FDATRSVQLDWKRRQSIINGIARGIL 504
           N+VRL       + L L++EY     LD+ L    D++     + +  ++ +  I RGI 
Sbjct: 62  NIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116

Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
           Y H  S  +++HRDLK  N+L+D   N  K++DFGLAR FG         ++  T  Y A
Sbjct: 117 YCH--SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRA 171

Query: 564 PEYAMGG-IFSIKSDVFSFGVLLLEIISGR 592
           PE  +G   +S   D++S G +  E+++ +
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 66/215 (30%), Positives = 101/215 (46%), Gaps = 24/215 (11%)

Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQH-K 447
               D  ++G+G FG V K      G  +AVKR+  T  +  Q     +++++ +     
Sbjct: 4   EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63

Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR--QSIINGIA----R 501
            +V+  G      +  +  E M     D+ L    + V    K    + I+  IA    +
Sbjct: 64  YIVKFYGALFREGDCWICMELM-----DISLDKFYKYVYEVLKSVIPEEILGKIAVATVK 118

Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
            + YL E+  LKIIHRD+K SNILLD + N K+ DFG   I G   +       AG   Y
Sbjct: 119 ALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFG---ISGQLVDSIAKTRDAGCRPY 173

Query: 562 MAPE----YAMGGIFSIKSDVFSFGVLLLEIISGR 592
           MAPE     A  G + ++SDV+S G+ L E+ +G+
Sbjct: 174 MAPERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 86.2 bits (213), Expect = 2e-18
 Identities = 71/218 (32%), Positives = 104/218 (47%), Gaps = 32/218 (14%)

Query: 399 LGQGGFGPVYKGTLADG-----------KAIAVKRL-SRTSGQGLQEFKNEVNLIAKL-Q 445
           LG+G FG V    +A+              +AVK L S  + + L +  +E+ ++  + +
Sbjct: 26  LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82

Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF-------------DATRSVQLDWKRR 492
           HKN++ LLG C +   L +I EY    +L  +L                    QL +K  
Sbjct: 83  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142

Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
            S    +ARG+ YL   +  K IHRDL A N+L+ +D   KI+DFGLAR          T
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199

Query: 553 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                   +MAPE     I++ +SDV+SFGVLL EI +
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 67/214 (31%), Positives = 107/214 (50%), Gaps = 26/214 (12%)

Query: 396 ENKLGQGGFGPVYKGTLA-DGKAI--AVKRLSR-TSGQGLQEFKNEVNLIAKL-QHKNLV 450
           E+ +G+G FG V +  +  DG  +  A+K L    S    ++F  E+ ++ KL  H N++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLD------------WKRRQ--SII 496
            LLG C     L +  EY P  +L +     +R ++ D               +Q     
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNL-LDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125

Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 556
           + +A G+ YL E    + IHRDL A N+L+ +++  KI+DFGL+R   G +      +  
Sbjct: 126 SDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGR 179

Query: 557 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
               +MA E     +++ KSDV+SFGVLL EI+S
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 86.0 bits (213), Expect = 2e-18
 Identities = 60/211 (28%), Positives = 109/211 (51%), Gaps = 20/211 (9%)

Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAK 443
           E TN + D   +G G FG V        G+ +A+K++ +   T     + ++ E+ L+  
Sbjct: 7   EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKH 65

Query: 444 LQHKNLVRLLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG 502
           L+H+N++ L    +   E +  + E +     D+H    +R ++  +   Q  +  I RG
Sbjct: 66  LRHENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQFI--QYFLYQILRG 120

Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYM 562
           + Y+H      ++HRDLK SNIL++++ + KI DFGLARI    Q+   T  ++  Y Y 
Sbjct: 121 LKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRY-YR 172

Query: 563 APEYAMG-GIFSIKSDVFSFGVLLLEIISGR 592
           APE  +    + ++ D++S G +  E++ G+
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 34/214 (15%)

Query: 399 LGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCC 456
           +G+G +G VYK      G+ +A+K +        +E K E N++ K   H N+    G  
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAF 72

Query: 457 L------EGQELLLIYEYMPNKSLDVHLFDATRSVQ--LDWKRRQS------IINGIARG 502
           +         +L L+ E     S        T  V+      +R        I+    RG
Sbjct: 73  IKKNPPGNDDQLWLVMELCGGGS-------VTDLVKGLRKKGKRLKEEWIAYILRETLRG 125

Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYM 562
           + YLHE+   K+IHRD+K  NILL  +   K+ DFG++        + NT I  GT  +M
Sbjct: 126 LAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI--GTPYWM 180

Query: 563 APE-----YAMGGIFSIKSDVFSFGVLLLEIISG 591
           APE           +  +SDV+S G+  +E+  G
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 85.1 bits (210), Expect = 3e-18
 Identities = 57/206 (27%), Positives = 107/206 (51%), Gaps = 15/206 (7%)

Query: 398 KLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
           K+G+G  G V   T+ + GK +AVK++     Q  +   NEV ++   QH+N+V +    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
           L G EL ++ E++   +L     D     +++ ++  ++   + + +  LH      +IH
Sbjct: 87  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139

Query: 517 RDLKASNILLDDDMNPKISDFGL-ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           RD+K+ +ILL  D   K+SDFG  A++   ++       + GT  +MAPE      +  +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMAPELISRLPYGPE 196

Query: 576 SDVFSFGVLLLEIISGRKNNGFYFSE 601
            D++S G++++E++ G      YF+E
Sbjct: 197 VDIWSLGIMVIEMVDGEPP---YFNE 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 85.3 bits (212), Expect = 5e-18
 Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 39/222 (17%)

Query: 392 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------EVNLI 441
            +     +G G +G V        G+ +A+K++S         F +         E+ L+
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-------FDDLIDAKRILREIKLL 53

Query: 442 AKLQHKNLVRLL-----GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSI 495
             L+H+N++ LL         +  ++ ++ E M     +  L    +S Q L     Q  
Sbjct: 54  RHLRHENIIGLLDILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLTDDHIQYF 108

Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TN 553
           +  I RG+ YLH      +IHRDLK SNIL++ + + KI DFGLAR    ++++    T 
Sbjct: 109 LYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165

Query: 554 IIAGTYGYMAPEYAMGGI---FSIKSDVFSFGVLLLEIISGR 592
            +  T  Y APE  +       +I  D++S G +  E+++ +
Sbjct: 166 YVV-TRWYRAPELLLSSSRYTKAI--DIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score = 79.0 bits (195), Expect = 7e-18
 Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 6/94 (6%)

Query: 83  NTASNTFTSNLNILFNQKLHSEAGKS---LYYNASEGEFPDSVYGLYLCKFNVSFQSCQN 139
            TA++TF SNLN L +  L S A  S    +   + G  PD+VYGL  C+ ++S   C++
Sbjct: 13  TTANSTFESNLNALLSS-LSSNAASSSGKGFAAGTSGAAPDTVYGLAQCRGDLSASDCRS 71

Query: 140 CIVAAVNSVLQKCSGTKEAFIWYQVQECMVRFSD 173
           C+  AV+ + + C   K   IWY    C +R+  
Sbjct: 72  CLATAVSELRRCCPNKKGGRIWY--DSCFLRYES 103

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 83.3 bits (206), Expect = 9e-18
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 23/206 (11%)

Query: 399 LGQGGFGPVYK--GTLADGKAIAVKRLS----------RTSGQGLQEFKNEVNLIAK-LQ 445
           LG G FG VYK          +A+K ++          R   + + +  +EV +I + L+
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGIL 504
           H N+VR     LE   L ++ + +    L  H        Q    +R  +I   +   + 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI--IAGTYGYM 562
           YLH++ R  I+HRDL  +NI+L +D    I+DFGLA+     Q Q  + +  + GT  Y 
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK-----QKQPESKLTSVVGTILYS 180

Query: 563 APEYAMGGIFSIKSDVFSFGVLLLEI 588
            PE      +  K+DV++FG +L ++
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 83.4 bits (206), Expect = 1e-17
 Identities = 65/216 (30%), Positives = 97/216 (44%), Gaps = 39/216 (18%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRLLGCC 456
           LG G  G VYK   L   + +AVK +       LQ +  +E+ ++ K     ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA----RGILYLHEDSRL 512
                + +  E+M   SLDV+            K  + ++  IA    +G+ YL     L
Sbjct: 69  FVENRISICTEFMDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLWS---L 114

Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTY----GYMAPEYAM 568
           KI+HRD+K SN+L++     K+ DFG++            N IA TY     YMAPE   
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL--------VNSIAKTYVGTNAYMAPERIS 166

Query: 569 GGIFSIKSDVFSFGVLLLEIISGR-------KNNGF 597
           G  + I SDV+S G+  +E+  GR       KN G 
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS 202

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 83.2 bits (205), Expect = 2e-17
 Identities = 59/206 (28%), Positives = 105/206 (50%), Gaps = 15/206 (7%)

Query: 398 KLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
           K+G+G  G V   T    GK +AVK++     Q  +   NEV ++    H+N+V +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
           L G EL ++ E++   +L     D     +++ ++  ++   + R + YLH      +IH
Sbjct: 89  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141

Query: 517 RDLKASNILLDDDMNPKISDFGL-ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           RD+K+ +ILL  D   K+SDFG  A++   ++       + GT  +MAPE      +  +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQV---SKEVPKRKSLVGTPYWMAPEVISRLPYGTE 198

Query: 576 SDVFSFGVLLLEIISGRKNNGFYFSE 601
            D++S G++++E+I G      YF+E
Sbjct: 199 VDIWSLGIMVIEMIDGEPP---YFNE 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 16/198 (8%)

Query: 398 KLGQGGFGPVYKGTLADGKA------IAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
           K+G+G FG +Y   LA  K+      I    L++   +  +  K EV L+AK++H N+V 
Sbjct: 7   KIGEGSFGKIY---LAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVT 63

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
                 E   L ++ EY     L +   +  R V     +  S    I+ G+ ++H+   
Sbjct: 64  FFASFQENGRLFIVMEYCDGGDL-MKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR-- 120

Query: 512 LKIIHRDLKASNILLDDD-MNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
            KI+HRD+K+ NI L  + M  K+ DFG+AR    +   A T    GT  Y++PE     
Sbjct: 121 -KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPYYLSPEICQNR 177

Query: 571 IFSIKSDVFSFGVLLLEI 588
            ++ K+D++S G +L E+
Sbjct: 178 PYNNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 83.1 bits (205), Expect = 2e-17
 Identities = 71/238 (29%), Positives = 109/238 (45%), Gaps = 59/238 (24%)

Query: 398 KLGQGGFGPV---------------YKGTLADGKA--IAVKRL-SRTSGQGLQEFKNEVN 439
           KLG+G FG V               +   +  G+   +AVK L    +     +F  EV 
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 440 LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDV-----HLFDAT--------RSVQ 486
           ++++L+  N++RLLG C++   L +I EYM N  L+      HL D           +  
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131

Query: 487 LDWKRRQSIIN---GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
           L      S+++    IA G+ YL   S L  +HRDL   N L+ +++  KI+DFG++R  
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSR-- 186

Query: 544 GGNQNQANTNIIAGTY-----------GYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                    N+ AG Y            +MA E  + G F+  SDV++FGV L EI+ 
Sbjct: 187 ---------NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 15/205 (7%)

Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRLSRTSGQGLQEFK---NEVNLIAKLQH 446
             F    ++GQGG+G V+     D   I A+KR+ ++    L E +    E +++   + 
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
           + LV+LL    + + L L  EY+P       L +    +  D  R       +A     +
Sbjct: 61  EWLVKLLYAFQDDEYLYLAMEYVPGGDFRT-LLNNLGVLSEDHARFY-----MAEMFEAV 114

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
                L  IHRDLK  N L+D   + K++DFGL++   G    AN+  + G+  YMAPE 
Sbjct: 115 DALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANS--VVGSPDYMAPEV 169

Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
             G  +    D +S G +L E + G
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 81.5 bits (201), Expect = 3e-17
 Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 29/208 (13%)

Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFK--------NEVNLIAKLQHK 447
           + +LG+G FG VY   + D KA+A +RL       + E           E  L++KL H 
Sbjct: 5   QQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62

Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-------LDWKRRQSIINGIA 500
            +V+     LE     +I EY   + LD  L +   + +        +W         + 
Sbjct: 63  AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW------FIQLL 116

Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 560
            G+ Y+H+    +I+HRDLKA NI L +++  KI DFG++R+  G+ + A T    GT  
Sbjct: 117 LGVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPY 170

Query: 561 YMAPEYAMGGIFSIKSDVFSFGVLLLEI 588
           YM+PE      +  KSD++S G +L E+
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 82.4 bits (203), Expect = 3e-17
 Identities = 62/201 (30%), Positives = 104/201 (51%), Gaps = 15/201 (7%)

Query: 397 NKLGQGGFGPVYKG--TLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
           +KLG+G +  VYKG   L D   +A+K  RL    G      + EV+L+  L+H N+V L
Sbjct: 12  DKLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 69

Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                  + L L++EY+ +K L  +L D   S+ +     +  +  + RG+ Y H   R 
Sbjct: 70  HDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINM--HNVKLFLFQLLRGLNYCH---RR 123

Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI- 571
           K++HRDLK  N+L+++    K++DFGLAR         +  ++  T  Y  P+  +G   
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTD 181

Query: 572 FSIKSDVFSFGVLLLEIISGR 592
           +S + D++  G +  E+ +GR
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 81.6 bits (201), Expect = 4e-17
 Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 18/205 (8%)

Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQHKN 448
           F  E K+G+G F  VY+ T L D K +A+K++        +  Q+   E++L+ +L H N
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLD--VHLFDATRSV---QLDWKRRQSIINGIARGI 503
           +++ L   +E  EL ++ E      L   +  F   + +   +  WK    + + +    
Sbjct: 64  VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE--- 120

Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
              H  SR +++HRD+K +N+ +      K+ D GL R F      A++  + GT  YM+
Sbjct: 121 ---HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMS 174

Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEI 588
           PE      ++ KSD++S G LL E+
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 81.7 bits (201), Expect = 4e-17
 Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 26/211 (12%)

Query: 399 LGQGGFGPVYKGTLA-DGKAI--AVKRLSRTSGQG-LQEFKNEVNLIAKL-QHKNLVRLL 453
           +G+G FG V K  +  DG  +  A+KR+   + +   ++F  E+ ++ KL  H N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLD--WKRRQSIINGI------------ 499
           G C     L L  EY P+ +L +     +R ++ D  +    S  + +            
Sbjct: 63  GACEHRGYLYLAIEYAPHGNL-LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTY 559
           ARG+ YL +    + IHRDL A NIL+ ++   KI+DFGL+R   G +      +     
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPV 175

Query: 560 GYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
            +MA E     +++  SDV+S+GVLL EI+S
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 81.1 bits (200), Expect = 5e-17
 Identities = 61/205 (29%), Positives = 107/205 (52%), Gaps = 18/205 (8%)

Query: 398 KLGQGGFGPVYKGTLADGKA---IAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRLL 453
           +LG G FG V KG     K    +A+K L   + + ++ E   E  ++ +L +  +VR++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
           G C E + L+L+ E      L  + F + +  ++       +++ ++ G+ YL   +   
Sbjct: 62  GVC-EAEALMLVMEMASGGPL--NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115

Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN--QANTNIIAGTY--GYMAPEYAMG 569
            +HRDL A N+LL +    KISDFGL++  G + +  +A +   AG +   + APE    
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS---AGKWPLKWYAPECINF 172

Query: 570 GIFSIKSDVFSFGVLLLEIIS-GRK 593
             FS +SDV+S+G+ + E  S G+K
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 81.4 bits (202), Expect = 6e-17
 Identities = 67/214 (31%), Positives = 98/214 (45%), Gaps = 49/214 (22%)

Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRT----SGQGLQEFKNEVNLIAKLQHKNLV 450
           LG G FG V    +KG+   GK  A+K LS+       Q ++   NE  ++  ++H  LV
Sbjct: 9   LGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLV 64

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR--------G 502
            L G   +   L L+ EY+P   L  HL           ++       +AR         
Sbjct: 65  NLYGSFQDDSNLYLVMEYVPGGELFSHL-----------RKSGRFPEPVARFYAAQVVLA 113

Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYM 562
           + YLH    L I++RDLK  N+LLD D   KI+DFG A+   G      T  + GT  Y+
Sbjct: 114 LEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLCGTPEYL 165

Query: 563 APEYAMGGIFSIK-----SDVFSFGVLLLEIISG 591
           APE     I   K      D ++ G+L+ E+++G
Sbjct: 166 APE-----IILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 81.5 bits (201), Expect = 6e-17
 Identities = 66/224 (29%), Positives = 107/224 (47%), Gaps = 39/224 (17%)

Query: 398 KLGQGGFGPVY------------KGTLADGKA-----IAVKRLSRTSGQGLQ-EFKNEVN 439
           KLG+G FG V+            K    D        +AVK L   + +  + +F  E+ 
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 440 LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL--------FDATRSVQLDWKR 491
           ++++L+  N++RLL  C+    L +I EYM N  L+  L         +    V + +  
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGN---- 546
              +   IA G+ YL   S L  +HRDL   N L+  +   KI+DFG++R ++ G+    
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188

Query: 547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           Q +A   I      +M+ E  + G F+  SDV++FGV L EI++
Sbjct: 189 QGRAVLPI-----RWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 80.9 bits (199), Expect = 8e-17
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 18/205 (8%)

Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCL 457
           +G G +G VYKG       +A  ++   +G   +E K E+N++ K   H+N+    G  +
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 458 EGQ------ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
           +        +L L+ E+    S+   L   T+   L  +    I   I RG+ +LH+   
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130

Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM--- 568
            K+IHRD+K  N+LL ++   K+ DFG++        + NT I  GT  +MAPE      
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYWMAPEVIACDE 187

Query: 569 --GGIFSIKSDVFSFGVLLLEIISG 591
                +  KSD++S G+  +E+  G
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 81.5 bits (202), Expect = 9e-17
 Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 42/218 (19%)

Query: 397 NKLGQGGFGPVYKGTLAD---GKAIAVKRL-----SRTSGQG-------LQEFKNEVNLI 441
            KLG+G +G V+K    D    + +A+K++     + T  Q        LQE  +     
Sbjct: 13  QKLGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD----- 65

Query: 442 AKLQHKNLVRLLGC--CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 499
               H N+V+LL        +++ L++EYM     D+H     R+  L+   ++ I+  +
Sbjct: 66  ----HPNIVKLLNVIKAENDKDIYLVFEYMET---DLH--AVIRANILEDVHKRYIMYQL 116

Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF----GGNQNQANTNII 555
            + + Y+H  S   +IHRDLK SNILL+ D   K++DFGLAR         +N   T+ +
Sbjct: 117 LKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173

Query: 556 AGTYGYMAPEYAMGGIFSIKS-DVFSFGVLLLEIISGR 592
           A T  Y APE  +G     K  D++S G +L E++ G+
Sbjct: 174 A-TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 80.6 bits (199), Expect = 1e-16
 Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 19/200 (9%)

Query: 399 LGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
           LG G  G V K      GT+   K + +   S    Q L+E    + ++ + +   +V  
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRE----LQIMHECRSPYIVSF 68

Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
            G  L    + +  E+M   SLD  ++     + ++   +  I   +  G+ YL+   R 
Sbjct: 69  YGAFLNENNICMCMEFMDCGSLD-RIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVHR- 124

Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
            I+HRD+K SNIL++     K+ DFG++    G    +  +   GT  YM+PE   GG +
Sbjct: 125 -IMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGKY 179

Query: 573 SIKSDVFSFGVLLLEIISGR 592
           ++KSDV+S G+ ++E+  G+
Sbjct: 180 TVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 58/199 (29%), Positives = 103/199 (51%), Gaps = 14/199 (7%)

Query: 398 KLGQGGFGPVYKGTLAD-GKAIAVKR-LSRTSGQGLQEFK-NEVNLIAKLQHKNLVRLLG 454
            +G+G +G V K    + G+ +A+K+ L     + +++    E+ ++ +L+H+NLV L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGILYLHEDSRLK 513
                + L L++E++ +  LD    D  +    LD  R +  +  I RGI + H  +   
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLD----DLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--- 120

Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-F 572
           IIHRD+K  NIL+      K+ DFG AR       +  T+ +A T  Y APE  +G   +
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYTDYVA-TRWYRAPELLVGDTKY 178

Query: 573 SIKSDVFSFGVLLLEIISG 591
               D+++ G L+ E+++G
Sbjct: 179 GRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 56/206 (27%), Positives = 100/206 (48%), Gaps = 18/206 (8%)

Query: 392 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQHK 447
           +F  E K+G+G F  VY+ T L DG  +A+K++        +   +   E++L+ +L H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLD--VHLFDATRSV---QLDWKRRQSIINGIARG 502
           N+++     +E  EL ++ E      L   +  F   + +   +  WK    + + +   
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120

Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYM 562
               H  SR +++HRD+K +N+ +      K+ D GL R F      A++  + GT  YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173

Query: 563 APEYAMGGIFSIKSDVFSFGVLLLEI 588
           +PE      ++ KSD++S G LL E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 80.1 bits (198), Expect = 3e-16
 Identities = 67/207 (32%), Positives = 100/207 (48%), Gaps = 29/207 (14%)

Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL------QHKN 448
           LG+G FG V     KGT    +  AVK L +     LQ+   E  +  K       +H  
Sbjct: 3   LGKGSFGKVLLAELKGT---DELYAVKVLKK--DVILQDDDVECTMTEKRVLALAGKHPF 57

Query: 449 LVRLLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
           L +L   C + ++ L  + EY+    L  H+    RS + D  R +     I  G+ +LH
Sbjct: 58  LTQLH-SCFQTKDRLFFVMEYVNGGDLMFHI---QRSGRFDEPRARFYAAEIVLGLQFLH 113

Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR--IFGGNQNQANTNIIAGTYGYMAPE 565
           E     II+RDLK  N+LLD + + KI+DFG+ +  I GG      T+   GT  Y+APE
Sbjct: 114 ER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT----TSTFCGTPDYIAPE 166

Query: 566 YAMGGIFSIKSDVFSFGVLLLEIISGR 592
                 +    D ++ GVLL E+++G+
Sbjct: 167 ILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 82.2 bits (203), Expect = 3e-16
 Identities = 58/210 (27%), Positives = 102/210 (48%), Gaps = 18/210 (8%)

Query: 395 DENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
           +EN + +G  G  YKG ++ +G    VK ++  +     E  +    + KLQH N+V+L+
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLI 749

Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
           G C   +   LI+EY+  K+L   L +      L W+RR+ I  GIA+ + +LH      
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPA 803

Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 573
           ++  +L    I++D    P +    L  +   +        I+    Y+APE       +
Sbjct: 804 VVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----TKCFISS--AYVAPETRETKDIT 856

Query: 574 IKSDVFSFGVLLLEIISGRKNNGFYFSEHG 603
            KSD++ FG++L+E+++G+      F  HG
Sbjct: 857 EKSDIYGFGLILIELLTGKSPADAEFGVHG 886

Length = 968

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 78.7 bits (195), Expect = 4e-16
 Identities = 49/148 (33%), Positives = 73/148 (49%), Gaps = 10/148 (6%)

Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN--EVNLIAKLQ-HKNLVRLL 453
           +LG G FG VY       G+ +A+K++ +      +E  N  EV  + KL  H N+V+L 
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKF-YSWEECMNLREVKSLRKLNEHPNIVKLK 64

Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
               E  EL  ++EYM   +L   L    +         +SII  I +G+ ++H   +  
Sbjct: 65  EVFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHG 119

Query: 514 IIHRDLKASNILLDDDMNPKISDFGLAR 541
             HRDLK  N+L+      KI+DFGLAR
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 79.4 bits (196), Expect = 5e-16
 Identities = 63/203 (31%), Positives = 94/203 (46%), Gaps = 54/203 (26%)

Query: 415 GKAIAVKRLSRTSGQGLQEFKN---------EVNLIAKLQHKNLVRLLGCCLEGQELLLI 465
           G+ +A+K+LSR        F+N         E+ L+  + HKN++ LL            
Sbjct: 41  GQNVAIKKLSRP-------FQNVTHAKRAYRELVLMKLVNHKNIIGLLNV---------- 83

Query: 466 YEYMPNKSLD--------VHLFDAT--RSVQ--LDWKRRQSIINGIARGILYLHEDSRLK 513
             + P KSL+        + L DA   + +Q  LD +R   ++  +  GI +LH      
Sbjct: 84  --FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG--- 138

Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTY----GYMAPEYAMG 569
           IIHRDLK SNI++  D   KI DFGLAR        A T+ +   Y     Y APE  +G
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLART-------AGTSFMMTPYVVTRYYRAPEVILG 191

Query: 570 GIFSIKSDVFSFGVLLLEIISGR 592
             +    D++S G ++ E+I G 
Sbjct: 192 MGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 78.6 bits (194), Expect = 7e-16
 Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 24/211 (11%)

Query: 393 FSDENKLGQGGFGPVYKG-TLADGKAIAVK--RLSRTSG----QGLQEFKNEVNLIAKLQ 445
           F   N++G+G +G VY+      G+ +A+K  R+           L+E    + L+  L+
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLRE----ITLLLNLR 64

Query: 446 HKNLVRLLGCCLEGQEL---LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG 502
           H N+V L    + G+ L    L+ EY   + L   L +          + + ++  + RG
Sbjct: 65  HPNIVELKEV-VVGKHLDSIFLVMEYC-EQDLASLLDNMPTP--FSESQVKCLMLQLLRG 120

Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYM 562
           + YLHE+    IIHRDLK SN+LL D    KI+DFGLAR +G         ++  T  Y 
Sbjct: 121 LQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYR 175

Query: 563 APEYAMGGIFSIKS-DVFSFGVLLLEIISGR 592
           APE  +G      + D+++ G +L E+++ +
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 78.1 bits (192), Expect = 7e-16
 Identities = 60/200 (30%), Positives = 92/200 (46%), Gaps = 15/200 (7%)

Query: 399 LGQGGFGPV------YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
           LG+GGFG V        G +   K +  KR+ +  G+ +    NE  ++ K+  + +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65

Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                    L L+   M    L  H++    +   +  R       I  G+  LH++   
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYHMGEA-GFEEGRAVFYAAEICCGLEDLHQE--- 121

Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
           +I++RDLK  NILLDD  + +ISD GLA      Q         GT GYMAPE      +
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAPEVVKNERY 178

Query: 573 SIKSDVFSFGVLLLEIISGR 592
           +   D ++ G LL E+I+G+
Sbjct: 179 TFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 77.7 bits (191), Expect = 7e-16
 Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 25/207 (12%)

Query: 396 ENKLGQGGFGPVYKGTLA-DGK---AIAVKRLSRTSGQGLQE--FKNEVNLIAKLQHKNL 449
           E  LG G FG + +G L    K    +A+  L R      Q   F  E   + +  H N+
Sbjct: 10  ERILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSNI 68

Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           VRL G    G  ++++ EYM N +LD  L       QL   +   ++ G+A G+ YL E 
Sbjct: 69  VRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYLSE- 125

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG------YMA 563
             +  +H+ L A  +L++ D+  KIS F         ++++    I  T        + A
Sbjct: 126 --MGYVHKGLAAHKVLVNSDLVCKISGFR-----RLQEDKSEA--IYTTMSGKSPVLWAA 176

Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           PE      FS  SDV+SFG+++ E++S
Sbjct: 177 PEAIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 77.8 bits (191), Expect = 7e-16
 Identities = 57/197 (28%), Positives = 102/197 (51%), Gaps = 16/197 (8%)

Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
           ++G G +G VYK   L  G+  AVK +    G      + E+ ++ + +H N+V   G  
Sbjct: 16  RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75

Query: 457 LEGQELLLIYEYMPNKSL-DV-HLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
           L  ++L +  EY    SL D+ H+      +Q+ +  R+++     +G+ YLH   ++  
Sbjct: 76  LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGKM-- 128

Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM---GGI 571
            HRD+K +NILL D+ + K++DFG+A        +  + I  GT  +MAPE A     G 
Sbjct: 129 -HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI--GTPYWMAPEVAAVEKNGG 185

Query: 572 FSIKSDVFSFGVLLLEI 588
           ++   D+++ G+  +E+
Sbjct: 186 YNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 78.2 bits (193), Expect = 7e-16
 Identities = 47/132 (35%), Positives = 74/132 (56%), Gaps = 9/132 (6%)

Query: 461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK 520
           E+ +  E+M   SLD  L  A R +  +   + SI   + RG+ YL E  + KI+HRD+K
Sbjct: 73  EISICMEHMDGGSLDQVLKKAGR-IPENILGKISI--AVLRGLTYLRE--KHKIMHRDVK 127

Query: 521 ASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFS 580
            SNIL++     K+ DFG++    G    +  N   GT  YM+PE   G  ++++SD++S
Sbjct: 128 PSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWS 183

Query: 581 FGVLLLEIISGR 592
            G+ L+E+  GR
Sbjct: 184 LGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 78.5 bits (194), Expect = 9e-16
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 15/215 (6%)

Query: 384 RLALEATNHFSDENKLGQGGFGPVYKGTLADGKA-IAVKRLSRTSGQGLQEFKN---EVN 439
           +   E  + + + + +G G +G V           +A+K+LSR   Q     K    E+ 
Sbjct: 8   KTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELR 66

Query: 440 LIAKLQHKNLVRLLGCCLEGQELLLIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIING 498
           L+  + H+N++ LL        L    + Y+    +   L +  +  +L     Q ++  
Sbjct: 67  LLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQ 126

Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I RG+ Y+H      IIHRDLK SNI +++D   KI DFGLAR                T
Sbjct: 127 ILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTGYVAT 178

Query: 559 YGYMAPEYAMGGIFSIKS-DVFSFGVLLLEIISGR 592
             Y APE  +  +   ++ D++S G ++ E+++G+
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 27/205 (13%)

Query: 398 KLGQGGFGPVYKGTLA----DGKAIAVKRL--SRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
           K+G+G FG   K  L     DGK   +K +  S+ S +  +E + EV +++ ++H N+V+
Sbjct: 7   KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ------LDWKRRQSIINGIARGILY 505
                 E   L ++ +Y     L     +A R V       LDW  +      I   + +
Sbjct: 64  YQESFEENGNLYIVMDYCEGGDL-YKKINAQRGVLFPEDQILDWFVQ------ICLALKH 116

Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           +H+    KI+HRD+K+ NI L  D   K+ DFG+AR+       A T I  GT  Y++PE
Sbjct: 117 VHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI--GTPYYLSPE 171

Query: 566 YAMGGIFSIKSDVFSFGVLLLEIIS 590
                 ++ KSD+++ G +L E+ +
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 77.2 bits (190), Expect = 2e-15
 Identities = 64/201 (31%), Positives = 93/201 (46%), Gaps = 17/201 (8%)

Query: 399 LGQGGFGPVYKGTL-ADGKAIAVKRLS-----RTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
           LG+GGFG V    + A GK  A K+L      +  G+ +    NE  ++ K+  + +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65

Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                    L L+   M    L  H+++       D +R       I  G+  LH   R 
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYNMGNP-GFDEERAVFYAAEITCGLEDLH---RE 121

Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLA-RIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 571
           +I++RDLK  NILLDD  + +ISD GLA  I  G   +       GT GYMAPE      
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV----GTVGYMAPEVVKNER 177

Query: 572 FSIKSDVFSFGVLLLEIISGR 592
           ++   D +  G L+ E+I G+
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 77.3 bits (190), Expect = 2e-15
 Identities = 60/201 (29%), Positives = 102/201 (50%), Gaps = 15/201 (7%)

Query: 397 NKLGQGGFGPVYKG--TLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
            KLG+G +  V+KG   L +   +A+K  RL    G      + EV+L+  L+H N+V L
Sbjct: 12  EKLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 69

Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                  + L L++EY+ +K L  ++ D    + +     +  +  I RG+ Y H   R 
Sbjct: 70  HDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSM--HNVKIFLYQILRGLAYCH---RR 123

Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI- 571
           K++HRDLK  N+L+++    K++DFGLAR         +  ++  T  Y  P+  +G   
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSE 181

Query: 572 FSIKSDVFSFGVLLLEIISGR 592
           +S + D++  G +  E+ SGR
Sbjct: 182 YSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 24/207 (11%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFK---NEVNLIAKLQH-KNLVRLL 453
           LG+G +G V K   +  G  +AVKR+  T     QE K    ++++  +       V   
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVTFY 66

Query: 454 GCCLEGQELLLIYEYMPNKSLD---VHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
           G      ++ +  E M + SLD     ++D   ++  D   +  I   I + + YLH   
Sbjct: 67  GALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGK--IAVSIVKALEYLHS-- 121

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE----- 565
           +L +IHRD+K SN+L++ +   K+ DFG   I G   +     I AG   YMAPE     
Sbjct: 122 KLSVIHRDVKPSNVLINRNGQVKLCDFG---ISGYLVDSVAKTIDAGCKPYMAPERINPE 178

Query: 566 YAMGGIFSIKSDVFSFGVLLLEIISGR 592
               G + +KSDV+S G+ ++E+ +GR
Sbjct: 179 LNQKG-YDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 31/210 (14%)

Query: 401 QGGFGPVYKGTLADGK-----AIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLG 454
           +G FG ++ G L D K      + VK +   + +  +     E  L+  L H+N++ +L 
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 455 CCLEGQEL-LLIYEYMPNKSLDVHL-----FDATRSVQLDWKRRQSIINGIARGILYLHE 508
            C+E  E   ++Y YM   +L + L      +A     L  ++   +   IA G+ YLH 
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134

Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IF-------GGNQNQANTNIIAGTYG 560
             +  +IH+D+ A N ++D+++  KI+D  L+R +F       G N+N+           
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP--------VK 184

Query: 561 YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           +MA E  +   +S  SDV+SFGVLL E+++
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 76.9 bits (189), Expect = 2e-15
 Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 23/204 (11%)

Query: 399 LGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK------LQHKNLVR 451
           LG+G FG V+   L    +  A+K L +     L +   E  ++ K       +H  L  
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 452 LLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
           L  C  + +E L  + EY+    L  H+    +    D  R       I  G+ +LH   
Sbjct: 61  LY-CTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLHSKG 116

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLAR--IFGGNQNQANTNIIAGTYGYMAPEYAM 568
              I++RDLK  NILLD D + KI+DFG+ +  + G     A T    GT  Y+APE  +
Sbjct: 117 ---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGTPDYIAPEILL 169

Query: 569 GGIFSIKSDVFSFGVLLLEIISGR 592
           G  ++   D +SFGVLL E++ G+
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 12/198 (6%)

Query: 398 KLGQGGFGPVYKGTLADGK----AIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRL 452
            +G+G FG VY+G     +    A+AVK     +   ++E F  E  ++ +  H ++V+L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
           +G   E   + ++ E  P   L  +L        LD          ++  + YL      
Sbjct: 73  IGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126

Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
           + +HRD+ A N+L+      K+ DFGL+R    +++    +       +MAPE      F
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESINFRRF 185

Query: 573 SIKSDVFSFGVLLLEIIS 590
           +  SDV+ FGV + EI+ 
Sbjct: 186 TSASDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 76.1 bits (187), Expect = 3e-15
 Identities = 48/150 (32%), Positives = 72/150 (48%), Gaps = 9/150 (6%)

Query: 397 NKLGQGGFGPVYKGTLADGKAIA---VKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRL 452
           +++G G FG V  G    G + A   VK L  ++    Q  F  EV    +L H N+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR--QSIINGIARGILYLHEDS 510
           LG C+E    LL+ E+ P   L  +L      V    ++   Q +   +A G+L+LH   
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLA 540
           +   IH DL   N  L  D++ KI D+GLA
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLA 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 76.5 bits (188), Expect = 4e-15
 Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 17/200 (8%)

Query: 399 LGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK------LQHKNLVR 451
           LG+G FG V    L   G+  AVK L +     LQ+   E  +  K        H  L +
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
           L  C      L  + E++    L   +F   +S + D  R +     I   +++LH+   
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG- 116

Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 571
             II+RDLK  N+LLD + + K++DFG+ +   G  N   T+   GT  Y+APE     +
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEML 172

Query: 572 FSIKSDVFSFGVLLLEIISG 591
           +    D ++ GVLL E++ G
Sbjct: 173 YGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 76.4 bits (188), Expect = 4e-15
 Identities = 62/199 (31%), Positives = 106/199 (53%), Gaps = 14/199 (7%)

Query: 399 LGQGGFGPVY---KGTLAD-GKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRL 452
           LGQG FG V+   K T  D G+  A+K L + +   +     K E +++A++ H  +V+L
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                   +L LI +++    L   L   ++ V    +  +  +  +A  + +LH    L
Sbjct: 64  HYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLH---SL 117

Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
            II+RDLK  NILLD++ + K++DFGL++    ++ +A +    GT  YMAPE       
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRGH 175

Query: 573 SIKSDVFSFGVLLLEIISG 591
           +  +D +SFGVL+ E+++G
Sbjct: 176 TQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 62/199 (31%), Positives = 93/199 (46%), Gaps = 13/199 (6%)

Query: 399 LGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
           LG+GGFG V    + A GK  A KRL +      +G     NE  ++ K+  + +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                  L L+   M    L  H+++       + +R       I  G+  LH ++    
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFEEERALFYAAEILCGLEDLHREN---T 123

Query: 515 IHRDLKASNILLDDDMNPKISDFGLA-RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 573
           ++RDLK  NILLDD  + +ISD GLA +I  G   +       GT GYMAPE      ++
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV----GTVGYMAPEVLNNQRYT 179

Query: 574 IKSDVFSFGVLLLEIISGR 592
           +  D +  G L+ E+I G+
Sbjct: 180 LSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 57/207 (27%), Positives = 107/207 (51%), Gaps = 20/207 (9%)

Query: 398 KLGQGGFGPVYKG-TLADG-KAIAVKRLS-RTSGQGLQ-EFKNEVNLIAKLQ---HKNLV 450
           ++G+G +G V+K   L +G + +A+KR+  +T  +G+      EV ++  L+   H N+V
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 451 RLLGCCLEGQ-----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           RL   C   +     +L L++E++ ++ L  +L D      +  +  + ++  + RG+ +
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125

Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           LH     +++HRDLK  NIL+      K++DFGLARI+     Q     +  T  Y APE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPE 179

Query: 566 YAMGGIFSIKSDVFSFGVLLLEIISGR 592
             +   ++   D++S G +  E+   +
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 76.1 bits (187), Expect = 5e-15
 Identities = 68/203 (33%), Positives = 101/203 (49%), Gaps = 21/203 (10%)

Query: 399 LGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK----LQHKN-LVRL 452
           LG+G FG V    L   G+  AVK L +     L +   E  ++ K    L  +N  +  
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVV--LIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 453 LGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
           L C  + +E L  + E++    L  H+ D  R    D  R       I  G+ +LH    
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLHSKG- 116

Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLAR--IFGGNQNQANTNIIAGTYGYMAPEYAMG 569
             II+RDLK  N++LD D + KI+DFG+ +  +FG   N+A+T    GT  Y+APE   G
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRAST--FCGTPDYIAPEILQG 170

Query: 570 GIFSIKSDVFSFGVLLLEIISGR 592
             ++   D +SFGVLL E++ G+
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 75.1 bits (184), Expect = 5e-15
 Identities = 52/197 (26%), Positives = 98/197 (49%), Gaps = 16/197 (8%)

Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
           ++G G +G VYK   +  G+  A+K +    G+     + E+ ++   +H N+V   G  
Sbjct: 16  RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75

Query: 457 LEGQELLLIYEYMPNKSLD--VHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
           L   +L +  E+    SL    H+       Q+ +  R+++     +G+ YLH   +   
Sbjct: 76  LRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGK--- 127

Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM---GGI 571
           +HRD+K +NILL D+ + K++DFG++        +  + I  GT  +MAPE A     G 
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI--GTPYWMAPEVAAVERKGG 185

Query: 572 FSIKSDVFSFGVLLLEI 588
           ++   D+++ G+  +E+
Sbjct: 186 YNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 75.6 bits (186), Expect = 7e-15
 Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 38/212 (17%)

Query: 399 LGQGGFGPVY---KGTLAD-GKAIAVKRLSR----TSGQGLQEFKNEVNLIAKLQHKNLV 450
           LG+GG+G V+   K T AD GK  A+K L +     + +     K E N++  ++H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI---------INGIAR 501
            L+     G +L LI EY+    L +HL             R+ I         ++ I+ 
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGELFMHL------------EREGIFMEDTACFYLSEISL 111

Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR--IFGGNQNQANTNIIAGTY 559
            + +LH   +  II+RDLK  NILLD   + K++DFGL +  I  G      T+   GT 
Sbjct: 112 ALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFCGTI 164

Query: 560 GYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
            YMAPE  M        D +S G L+ ++++G
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 75.5 bits (186), Expect = 8e-15
 Identities = 68/266 (25%), Positives = 127/266 (47%), Gaps = 46/266 (17%)

Query: 374 ESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRL---SRTSGQ 429
           +  EFP        +  + +    K+GQG FG V+K       + +A+K++   +   G 
Sbjct: 1   DQYEFPF------CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGF 54

Query: 430 GLQEFKNEVNLIAKLQHKNLVRLLGCC---------LEGQELLLIYEYMPNKSLDVHLFD 480
            +   + E+ ++  L+H+N+V L+  C          +G    L++E+  +   D+    
Sbjct: 55  PITALR-EIKILQLLKHENVVNLIEICRTKATPYNRYKGS-FYLVFEFCEH---DLAGLL 109

Query: 481 ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
           + ++V+      + ++  +  G+ Y+H   R KI+HRD+KA+NIL+  D   K++DFGLA
Sbjct: 110 SNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA 166

Query: 541 RIFGGNQNQAN---TNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLE------IIS 590
           R F  ++N      TN +  T  Y  PE  +G   +    D++  G ++ E      I+ 
Sbjct: 167 RAFSLSKNSKPNRYTNRVV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQ 225

Query: 591 GRKNNGFYFSEHGQ-TLLTYVCNSLS 615
           G        +E  Q TL++ +C S++
Sbjct: 226 GN-------TEQHQLTLISQLCGSIT 244

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 75.2 bits (185), Expect = 8e-15
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 27/211 (12%)

Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKR-LSRTSGQGLQEFK-NEVNLIAKLQHKN-LVRLL 453
           K+G+G +G VYK      GK +A+K+       +G+      E++L+  L     +VRLL
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 454 GCCLEGQE-------LLLIYEYMPNKSLDVHLF-DATR---SVQLDWKRRQSIINGIARG 502
              +E  E       L L++EY+     D+  F D+        L  K  +S +  + +G
Sbjct: 68  --DVEHVEEKNGKPSLYLVFEYL---DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122

Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGY 561
           + + H   +  ++HRDLK  N+L+D      KI+D GL R F          I+  T  Y
Sbjct: 123 VAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--TLWY 177

Query: 562 MAPEYAMGGI-FSIKSDVFSFGVLLLEIISG 591
            APE  +G   +S   D++S G +  E+   
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 75.8 bits (186), Expect = 9e-15
 Identities = 64/193 (33%), Positives = 94/193 (48%), Gaps = 36/193 (18%)

Query: 415 GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL 474
           G  +AVK+LSR        F+N+ +  AK  ++ LV LL C      + L+  + P KSL
Sbjct: 46  GINVAVKKLSRP-------FQNQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKSL 95

Query: 475 D--------VHLFDATRS----VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKAS 522
           +        + L DA       ++LD +R   ++  +  GI +LH      IIHRDLK S
Sbjct: 96  EEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS 152

Query: 523 NILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTY----GYMAPEYAMGGIFSIKSDV 578
           NI++  D   KI DFGLAR        A TN +   Y     Y APE  +G  +    D+
Sbjct: 153 NIVVKSDCTLKILDFGLAR-------TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDI 205

Query: 579 FSFGVLLLEIISG 591
           +S G ++ E++ G
Sbjct: 206 WSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 9e-15
 Identities = 60/219 (27%), Positives = 106/219 (48%), Gaps = 35/219 (15%)

Query: 392 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS---------RTSGQGLQEFKNEVNLI 441
            + + + +G+G +G V   T    G  +A+K++S         RT    L+E K    ++
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT----LREIK----IL 57

Query: 442 AKLQHKNLVRLL-----GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
            + +H+N++ +L            ++ ++ E M     D++     ++  L     Q  +
Sbjct: 58  RRFKHENIIGILDIIRPPSFESFNDVYIVQELMET---DLY--KLIKTQHLSNDHIQYFL 112

Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TNI 554
             I RG+ Y+H  +   ++HRDLK SN+LL+ + + KI DFGLARI     +     T  
Sbjct: 113 YQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY 169

Query: 555 IAGTYGYMAPEYAMGGIFSIKS-DVFSFGVLLLEIISGR 592
           +A T  Y APE  +      K+ D++S G +L E++S R
Sbjct: 170 VA-TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 75.7 bits (186), Expect = 1e-14
 Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 9/154 (5%)

Query: 437 EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
           E  L+  + H +++R+    + G    ++   +P+ S D++ +   RS  L   +   I 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163

Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 556
             I  G+ YLH     +IIHRD+K  NI ++D     I D G A+             +A
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLA 217

Query: 557 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           GT    APE      ++ K+D++S G++L E+++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 24/208 (11%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCC 456
           +G G +G VYKG  +  G+  A+K +  T  +  +E K E+N++ K   H+N+    G  
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYGAF 82

Query: 457 LE----GQ--ELLLIYEYMPNKSLDVHLFDATR--SVQLDWKRRQSIINGIARGILYLHE 508
           ++    G   +L L+ E+    S+   L   T+  +++ DW     I   I RG+ +LH 
Sbjct: 83  IKKSPPGHDDQLWLVMEFCGAGSV-TDLVKNTKGNALKEDWI--AYICREILRGLAHLHA 139

Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
               K+IHRD+K  N+LL ++   K+ DFG++        + NT I  GT  +MAPE   
Sbjct: 140 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYWMAPEVIA 194

Query: 569 -----GGIFSIKSDVFSFGVLLLEIISG 591
                   +  +SD++S G+  +E+  G
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 75.1 bits (184), Expect = 1e-14
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 13/198 (6%)

Query: 398 KLGQGGFGPVYKG-TLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
           KLG+G +  VYKG +  +GK +A+K  RL    G      + E +L+  L+H N+V L  
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHD 70

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                + L L++EY+     D+  +       L  +  +  +  + RG+ Y+H+     I
Sbjct: 71  IIHTKETLTLVFEYV---HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---I 124

Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-FS 573
           +HRDLK  N+L+ D    K++DFGLAR      +  +  ++  T  Y  P+  +G   +S
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLLGSTEYS 182

Query: 574 IKSDVFSFGVLLLEIISG 591
              D++  G + +E+I G
Sbjct: 183 TCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 19/202 (9%)

Query: 399 LGQGGFGPVYKGTLADGKAI-AVKRLSRTSGQGLQEFKNEVNLIAK------LQHKNLVR 451
           LG+G FG V    L       A+K L +     L++   E  ++ +       +H  L  
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVV--LEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 452 LLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
           L  C  + +E L  + EY+    L  H+  + R    D  R +     I  G+ +LH+  
Sbjct: 61  LF-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGR---FDEARARFYAAEIICGLQFLHKKG 116

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
              II+RDLK  N+LLD D + KI+DFG+ +     + +A+T    GT  Y+APE   G 
Sbjct: 117 ---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAPEILKGQ 171

Query: 571 IFSIKSDVFSFGVLLLEIISGR 592
            ++   D +SFGVLL E++ G+
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 52/196 (26%), Positives = 87/196 (44%), Gaps = 17/196 (8%)

Query: 401 QGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN----EVNLIAKLQHKNLVRLLGC 455
           +G FG VY     + G   A+K L ++      +  N       ++ + +   + +L   
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65

Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                 L L+ EY+        L      +  DW ++   I  +  G+  LH+     II
Sbjct: 66  FQSKDYLYLVMEYLNGGDCAS-LIKTLGGLPEDWAKQ--YIAEVVLGVEDLHQRG---II 119

Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRD+K  N+L+D   + K++DFGL+R   G +N+       GT  Y+APE  +G      
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRN--GLENKK----FVGTPDYLAPETILGVGDDKM 173

Query: 576 SDVFSFGVLLLEIISG 591
           SD +S G ++ E + G
Sbjct: 174 SDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 61/219 (27%), Positives = 109/219 (49%), Gaps = 27/219 (12%)

Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRL---SRTSGQGLQEFKNEVNLIAKLQH 446
           + F    ++G+G +G VYK    D G+ +A+K++   +   G  +   + E+ ++ +L H
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNH 65

Query: 447 KNLVRLLGCCLEGQELL----------LIYEYMPNKSLDVHLFDATRSVQLDWKRRQ--S 494
           +N+V L     + Q+ L          L++EYM     D  L     S  + +      S
Sbjct: 66  RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHIKS 120

Query: 495 IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
            +  +  G+ Y H+ + L   HRD+K SNILL++    K++DFGLAR++   +++  TN 
Sbjct: 121 FMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK 177

Query: 555 IAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGR 592
           +  T  Y  PE  +G   +    DV+S G +L E+ + +
Sbjct: 178 VI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 59/202 (29%), Positives = 104/202 (51%), Gaps = 19/202 (9%)

Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQ-GLQ-EFKNEVNLIAKLQ---HKNLVR 451
           ++G G +G VYK      G  +A+K +   + + GL      EV L+ +L+   H N+VR
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 452 LLGCCLEGQ-----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
           L+  C   +     ++ L++E++ ++ L  +L D      L  +  + ++    RG+ +L
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H +    I+HRDLK  NIL+      K++DFGLARI+  +   A T ++  T  Y APE 
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY--SCQMALTPVVV-TLWYRAPEV 178

Query: 567 AMGGIFSIKSDVFSFGVLLLEI 588
            +   ++   D++S G +  E+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 74.9 bits (184), Expect = 1e-14
 Identities = 41/92 (44%), Positives = 54/92 (58%), Gaps = 3/92 (3%)

Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +ARG+ +L   SR K IHRDL A NILL ++   KI DFGLAR    + +          
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +MAPE     +++ +SDV+SFGVLL EI S
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 74.7 bits (183), Expect = 2e-14
 Identities = 50/156 (32%), Positives = 83/156 (53%), Gaps = 9/156 (5%)

Query: 437 EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
           E+ ++ +     +V   G      E+ +  E+M   SLD  L +A R +  +   + SI 
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR-IPEEILGKVSI- 110

Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 556
             + RG+ YL E  + +I+HRD+K SNIL++     K+ DFG++    G    +  N   
Sbjct: 111 -AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFV 163

Query: 557 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           GT  YM+PE   G  +S++SD++S G+ L+E+  GR
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 74.7 bits (183), Expect = 2e-14
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 15/211 (7%)

Query: 388 EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAK 443
           E    + + + +G G +G V        G  +AVK+LSR   Q +   K    E+ L+  
Sbjct: 14  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKH 72

Query: 444 LQHKNLVRLLGCCLEGQELLLIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG 502
           ++H+N++ LL      + L    + Y+    +   L +  +  +L     Q +I  I RG
Sbjct: 73  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 132

Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYM 562
           + Y+H      IIHRDLK SN+ +++D   KI DFGLAR    + +   T  +A T  Y 
Sbjct: 133 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVA-TRWYR 184

Query: 563 APEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           APE  +  + ++   D++S G ++ E+++GR
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 58/207 (28%), Positives = 108/207 (52%), Gaps = 24/207 (11%)

Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRL---SRTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
           N++ +G +G VY+      G+ +A+K+L       G  +   + E+N++ KLQH N+V +
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQHPNIVTV 69

Query: 453 ----LGCCLEGQELLLIYEYMPN--KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
               +G  L+  ++ ++ EY+ +  KSL   +    +         + ++  +  G+ +L
Sbjct: 70  KEVVVGSNLD--KIYMVMEYVEHDLKSL---METMKQPFLQ--SEVKCLMLQLLSGVAHL 122

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H++    I+HRDLK SN+LL++    KI DFGLAR +G         ++  T  Y APE 
Sbjct: 123 HDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV--TLWYRAPEL 177

Query: 567 AMG-GIFSIKSDVFSFGVLLLEIISGR 592
            +G   +S   D++S G +  E+++ +
Sbjct: 178 LLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 73.9 bits (182), Expect = 3e-14
 Identities = 60/203 (29%), Positives = 90/203 (44%), Gaps = 22/203 (10%)

Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRL------SRTSGQGLQEFKNEVNLIAKLQHKN 448
           LG+G FG V    YK T   G+  A+K L      +R   + L   K         +H  
Sbjct: 7   LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
           LV L  C      +  + EY     L +H+            R       +  G+ YLHE
Sbjct: 64  LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHE 119

Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
           +   KI++RDLK  N+LLD +   KI+DFGL +   G  ++ +T    GT  ++APE   
Sbjct: 120 N---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST--FCGTPEFLAPEVLT 174

Query: 569 GGIFSIKSDVFSFGVLLLEIISG 591
              ++   D +  GVL+ E++ G
Sbjct: 175 ETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 73.9 bits (181), Expect = 3e-14
 Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 17/207 (8%)

Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFK-NEVNLIAKLQHKNLVRLLGCC 456
           K+G+G +G VYK    DGK      L +  G G+      E+ L+ +L+H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 457 LE--GQELLLIYEYMPNKSLDVHLFDAT-----RSVQLDWKRRQSIINGIARGILYLHED 509
           L    +++ L+++Y  +    +  F        + VQL     +S++  I  GI YLH +
Sbjct: 68  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127

Query: 510 SRLKIIHRDLKASNILL----DDDMNPKISDFGLARIFGGN-QNQANTNIIAGTYGYMAP 564
               ++HRDLK +NIL+     +    KI+D G AR+F    +  A+ + +  T+ Y AP
Sbjct: 128 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 565 EYAMGGIFSIKS-DVFSFGVLLLEIIS 590
           E  +G     K+ D+++ G +  E+++
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 73.0 bits (179), Expect = 4e-14
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 20/207 (9%)

Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
           ++LG+G +G VYK      G  +A+K  RL     +   +   E++++ K     +V   
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFY 65

Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
           G       + +  EYM   SLD        +  +     + I   + +G+ +L E+    
Sbjct: 66  GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HN 123

Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGN--QNQANTNIIAGTYGYMAPEYAMGG- 570
           IIHRD+K +N+L++ +   K+ DFG++    GN   + A TNI  G   YMAPE    G 
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNI--GCQSYMAPERIKSGG 177

Query: 571 -----IFSIKSDVFSFGVLLLEIISGR 592
                 ++++SDV+S G+ +LE+  GR
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 73.1 bits (179), Expect = 4e-14
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 13/199 (6%)

Query: 399 LGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
           LG+GGFG V    + A GK  A K+L +      +G     NE  ++ K+  + +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                  L L+   M    L  H+++       D +R       +  G+  L    R +I
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFDEQRAIFYAAELCCGLEDLQ---RERI 123

Query: 515 IHRDLKASNILLDDDMNPKISDFGLA-RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 573
           ++RDLK  NILLDD  + +ISD GLA +I  G   +       GT GYMAPE      ++
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV----GTVGYMAPEVINNEKYT 179

Query: 574 IKSDVFSFGVLLLEIISGR 592
              D +  G L+ E+I G+
Sbjct: 180 FSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 72.4 bits (178), Expect = 6e-14
 Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 47/217 (21%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAKLQH--KNLVRL 452
           +G G  G VYK      G  +AVK++ RT  +  +E K    +++++ K  H    +V+ 
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLK-SHDCPYIVKC 79

Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL-------- 504
            G  +   ++ +  E M              S  LD K  + I   I   IL        
Sbjct: 80  YGYFITDSDVFICMELM--------------STCLD-KLLKRIQGPIPEDILGKMTVAIV 124

Query: 505 ----YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA-RIFGGNQNQANTNIIAGTY 559
               YL E     +IHRD+K SNILLD   N K+ DFG++ R+     ++A T   AG  
Sbjct: 125 KALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTR-SAGCA 178

Query: 560 GYMAPEY----AMGGIFSIKSDVFSFGVLLLEIISGR 592
            YMAPE          + I++DV+S G+ L+E+ +G+
Sbjct: 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 72.1 bits (177), Expect = 7e-14
 Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 20/205 (9%)

Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKN-L 449
           LG G +G V+     G    GK  A+K L + +     +  +  + E  ++  ++    L
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           V L        +L LI +Y+    L  HL+             +  I  I   + +LH+ 
Sbjct: 68  VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH---FTESEVRVYIAEIVLALDHLHQ- 123

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIF-GGNQNQANTNIIAGTYGYMAPEYAM 568
             L II+RD+K  NILLD + +  ++DFGL++ F    + +A +    GT  YMAPE   
Sbjct: 124 --LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS--FCGTIEYMAPEVIR 179

Query: 569 GGI--FSIKSDVFSFGVLLLEIISG 591
           GG        D +S GVL  E+++G
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 72.8 bits (178), Expect = 7e-14
 Identities = 58/207 (28%), Positives = 104/207 (50%), Gaps = 17/207 (8%)

Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFK-NEVNLIAKLQHKNLVRLLGCC 456
           K+G+G +G VYK    DGK      L +  G G+      E+ L+ +L+H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 457 L--EGQELLLIYEYMPNKSLDVHLFDAT-----RSVQLDWKRRQSIINGIARGILYLHED 509
           L    +++ L+++Y  +    +  F        + +QL     +S++  I  GI YLH +
Sbjct: 68  LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127

Query: 510 SRLKIIHRDLKASNILL----DDDMNPKISDFGLARIFGGN-QNQANTNIIAGTYGYMAP 564
               ++HRDLK +NIL+     +    KI+D G AR+F    +  A+ + +  T+ Y AP
Sbjct: 128 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 565 EYAMGGIFSIKS-DVFSFGVLLLEIIS 590
           E  +G     K+ D+++ G +  E+++
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 71.5 bits (176), Expect = 9e-14
 Identities = 60/203 (29%), Positives = 104/203 (51%), Gaps = 22/203 (10%)

Query: 397 NKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN--EVNLIAKLQ-HKNLVRL 452
            K+G+G F  V K  +   GK  A+K + +   + L++  N  E+  + +L  H N++RL
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF-KSLEQVNNLREIQALRRLSPHPNILRL 63

Query: 453 LGCCLEGQE--LLLIYEYMPNKSLDVHLFDATRSVQ--LDWKRRQSIINGIARGILYLHE 508
           +    + +   L L++E M     D++L++  +  +  L  KR +S +  + + + ++H 
Sbjct: 64  IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH- 117

Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
             R  I HRD+K  NIL+ DD   K++DFG  R  G       T  I+ T  Y APE  +
Sbjct: 118 --RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYIS-TRWYRAPECLL 171

Query: 569 -GGIFSIKSDVFSFGVLLLEIIS 590
             G +  K D+++ G +  EI+S
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 71.5 bits (175), Expect = 9e-14
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 30/213 (14%)

Query: 399 LGQGGFGPVYKGTL----ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRL 452
           LG+G FG V +  L       + +AVK L     S   ++EF  E   + +  H N+++L
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 453 LGCCLEGQEL------LLIYEYMPNKSLDVHLF-----DATRSVQLDWKRRQSIINGIAR 501
           +G  L  +        ++I  +M  K  D+H F            L  +     +  IA 
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFM--KHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGN---QNQANTNIIAG 557
           G+ YL   S    IHRDL A N +L+++M   ++DFGL++ I+ G+   Q  A+   +  
Sbjct: 125 GMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK- 180

Query: 558 TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
              ++A E     +++  SDV++FGV + EI++
Sbjct: 181 ---WLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 13/200 (6%)

Query: 397 NKLGQGGFGPVYKG-TLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
           +KLG+G +  V+KG +      +A+K  RL    G      + EV+L+  L+H N+V L 
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69

Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
                 + L L++EY+ +   D+  +       +     +  +  + RG+ Y H   + K
Sbjct: 70  DIIHTERCLTLVFEYLDS---DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRK 123

Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-F 572
           I+HRDLK  N+L+++    K++DFGLAR         +  ++  T  Y  P+  +G   +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEY 181

Query: 573 SIKSDVFSFGVLLLEIISGR 592
           S   D++  G +L E+ +GR
Sbjct: 182 STPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 13/203 (6%)

Query: 393 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGL--QEFKNEVNLIAKLQHKNLV 450
           F   ++LG G  G V+K +      I  ++L     +     +   E+ ++ +     +V
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHED 509
              G      E+ +  E+M   SLD  L  A R   Q+  K   ++I    +G+ YL E 
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI----KGLTYLRE- 121

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 569
            + KI+HRD+K SNIL++     K+ DFG++    G    +  N   GT  YM+PE   G
Sbjct: 122 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQG 176

Query: 570 GIFSIKSDVFSFGVLLLEIISGR 592
             +S++SD++S G+ L+E+  GR
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 71.0 bits (174), Expect = 3e-13
 Identities = 63/198 (31%), Positives = 92/198 (46%), Gaps = 13/198 (6%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---EVN-LIAKLQHKNLVRLL 453
           +G+G FG V      ADGK  AVK L + +    +E K+   E N L+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
                  +L  + +Y+    L  HL    R       R +     IA  + YLH    L 
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHL---QRERSFPEPRARFYAAEIASALGYLHS---LN 116

Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 573
           II+RDLK  NILLD   +  ++DFGL +   G ++   T+   GT  Y+APE      + 
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPYD 174

Query: 574 IKSDVFSFGVLLLEIISG 591
              D +  G +L E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 71.2 bits (175), Expect = 3e-13
 Identities = 62/234 (26%), Positives = 97/234 (41%), Gaps = 57/234 (24%)

Query: 399 LGQGGFGPVYKGTLA----DGKAIAVKRLSRT----SGQGLQEFKNEVNLIAKLQHKNLV 450
           +G+G FG V+   L      G+  A+K L ++      Q +   + E +++A      +V
Sbjct: 9   IGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIV 64

Query: 451 RLLGCCLEGQE-LLLIYEYMPNKSL-----DVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +L     + +E L L+ EYMP   L        +F        +  R       IA  +L
Sbjct: 65  KLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE------ETARFY-----IAELVL 112

Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA------------------------ 540
            L    +L  IHRD+K  NIL+D D + K++DFGL                         
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172

Query: 541 ---RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
              R     Q +   N   GT  Y+APE   G  + ++ D +S GV+L E++ G
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 70.8 bits (173), Expect = 4e-13
 Identities = 60/189 (31%), Positives = 93/189 (49%), Gaps = 28/189 (14%)

Query: 416 KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLD 475
           + +A+K+LSR        F+N+ +  AK  ++ LV L+ C      + L+  + P KSL+
Sbjct: 50  RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 99

Query: 476 --------VHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASN 523
                   + L DA       ++LD +R   ++  +  GI +LH      IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156

Query: 524 ILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGV 583
           I++  D   KI DFGLAR   G        ++  T  Y APE  +G  +    D++S G 
Sbjct: 157 IVVKSDCTLKILDFGLART-AGTSFMMTPYVV--TRYYRAPEVILGMGYKENVDIWSVGC 213

Query: 584 LLLEIISGR 592
           ++ E+I G 
Sbjct: 214 IMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 69.6 bits (170), Expect = 5e-13
 Identities = 70/231 (30%), Positives = 107/231 (46%), Gaps = 23/231 (9%)

Query: 378 FPLFPLRLALEATNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQ 432
           FP     L LE+    +D       +G+G +G VYK T   DG   AVK L   S    +
Sbjct: 5   FPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-E 63

Query: 433 EFKNEVNLIAKL-QHKNLVRLLGCC-----LEGQELLLIYEYMPNKSLDVHLFDATRSVQ 486
           E + E N++  L  H N+V+  G       L G +L L+ E     S+   +       Q
Sbjct: 64  EIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ 123

Query: 487 -LDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
            LD      I+ G   G+ +LH +   +IIHRD+K +NILL  +   K+ DFG++     
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180

Query: 546 NQNQANTNIIAGTYGYMAPEY-----AMGGIFSIKSDVFSFGVLLLEIISG 591
            + + NT++  GT  +MAPE           +  + DV+S G+  +E+  G
Sbjct: 181 TRLRRNTSV--GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 69.2 bits (169), Expect = 8e-13
 Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 13/199 (6%)

Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFK--NEVNLIAKLQHKNLVRLLG 454
           KLG+G +  VYKG +  +G+ +A+K +S  + +G+  F    E +L+  L+H N+V L  
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHD 70

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                + L  ++EYM     D+  +       L     +  +  + RG+ Y+H      I
Sbjct: 71  IIHTKETLTFVFEYM---HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHI 124

Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-FS 573
           +HRDLK  N+L+      K++DFGLAR         ++ ++  T  Y  P+  +G   +S
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDYS 182

Query: 574 IKSDVFSFGVLLLEIISGR 592
              D++  G + +E++ G+
Sbjct: 183 SALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 69.7 bits (170), Expect = 8e-13
 Identities = 41/92 (44%), Positives = 55/92 (59%), Gaps = 3/92 (3%)

Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +A+G+ +L   SR K IHRDL A NILL ++   KI DFGLAR    + +          
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +MAPE     +++I+SDV+SFGVLL EI S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 68.4 bits (167), Expect = 1e-12
 Identities = 63/201 (31%), Positives = 93/201 (46%), Gaps = 18/201 (8%)

Query: 399 LGQGGFGPVYKGTLAD-GKAIAVKRLSRTS---GQGLQEFKNE---VNLIAKLQHKNLVR 451
           +G+GGFG VY    AD GK  A+K L +      QG     NE   ++L++      +V 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
           +        +L  I + M    L  HL       Q        +    A  IL L     
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHL------SQHGVFSEAEMRFYAAEIILGLEHMHN 115

Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 571
             +++RDLK +NILLD+  + +ISD GLA  F   +  A+     GT+GYMAPE    G+
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGV 171

Query: 572 -FSIKSDVFSFGVLLLEIISG 591
            +   +D FS G +L +++ G
Sbjct: 172 AYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 69.6 bits (170), Expect = 1e-12
 Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 17/216 (7%)

Query: 384 RLALEATNHFSDENKLGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGL--QEFKNEVNL 440
           +   E  + + D  ++G G +G V        G  +A+K+L R     L  +    E+ L
Sbjct: 8   KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRL 67

Query: 441 IAKLQHKNLVRLLGCCLEGQELLLIYEY---MPNKSLDVHLFDATRSVQLDWKRRQSIIN 497
           +  ++H+N++ LL        L   +++   MP    D  L    +  +L   R Q ++ 
Sbjct: 68  LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTD--LGKLMKHEKLSEDRIQFLVY 125

Query: 498 GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG 557
            + +G+ Y+H      IIHRDLK  N+ +++D   KI DFGLAR     Q  +       
Sbjct: 126 QMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVV 177

Query: 558 TYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 178 TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 23/204 (11%)

Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK------LQHKN 448
           LG+G FG V     KGT    +  A+K L +     LQ+   +  +  K       +H  
Sbjct: 3   LGKGSFGKVMLAELKGT---DEVYAIKVLKKDVI--LQDDDVDCTMTEKRILALAAKHPF 57

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
           L  L  C      L  + EY+    L   +F   RS + D  R +     +   +++LH 
Sbjct: 58  LTALHCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLH- 113

Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
             R  +I+RDLK  NILLD + + K++DFG+ +   G  N   T    GT  Y+APE   
Sbjct: 114 --RHGVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQ 169

Query: 569 GGIFSIKSDVFSFGVLLLEIISGR 592
              +    D ++ GVL+ E+++G+
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 31/212 (14%)

Query: 399 LGQGGFGPVYKGTL-------ADGKAIAVKRLSRTSGQGLQ---EFKNEVNLIAKLQHKN 448
           LGQG F  +YKG L         G    V  + +  G   +    F    +L+++L HK+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
           LV+L G C+   E +++ EY+    LDV L     +V L WK    +   +A  + YL +
Sbjct: 63  LVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED 119

Query: 509 DSRLKIIHRDLKASNILL---DDDMNP----KISDFGLARIFGGNQNQANTNIIAGTYGY 561
               K++H ++   NIL+     +       K+SD G+           +         +
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL------SREERVERIPW 170

Query: 562 MAPEYAMGGIFSIKS--DVFSFGVLLLEIISG 591
           +APE    G  S+    D +SFG  LLEI S 
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSN 202

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 68.7 bits (168), Expect = 2e-12
 Identities = 38/96 (39%), Positives = 56/96 (58%), Gaps = 9/96 (9%)

Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR--IFGGNQNQANTNIIA 556
           IA G+ +LH      II+RDLK  N++LD + + KI+DFG+ +  IFGG      T    
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----KTTRTFC 162

Query: 557 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           GT  Y+APE      +    D ++FGVLL E+++G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 16/200 (8%)

Query: 398 KLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN----EVNLIAKLQHKNLVRL 452
           K+G+G +G V+K    + G+ +A+K+   +    +   K     E+ ++ +L+H NLV L
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV--IKKIALREIRMLKQLKHPNLVNL 65

Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
           +      ++L L++EY  +  L  +  +      +     + II    + + + H   + 
Sbjct: 66  IEVFRRKRKLHLVFEYCDHTVL--NELEK-NPRGVPEHLIKKIIWQTLQAVNFCH---KH 119

Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI- 571
             IHRD+K  NIL+      K+ DFG ARI  G      T+ +A T  Y APE  +G   
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTG-PGDDYTDYVA-TRWYRAPELLVGDTQ 177

Query: 572 FSIKSDVFSFGVLLLEIISG 591
           +    DV++ G +  E+++G
Sbjct: 178 YGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 63/201 (31%), Positives = 98/201 (48%), Gaps = 18/201 (8%)

Query: 399 LGQGGFGPVYKGTLAD-GKAIAVKRLSRTS---GQGLQEFKNE---VNLIAKLQHKNLVR 451
           +G+GGFG VY    AD GK  A+K L +      QG     NE   ++L++      +V 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
           +        +L  I + M    L  HL   ++      K  +     I  G+ ++H  +R
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHL---SQHGVFSEKEMRFYATEIILGLEHMH--NR 116

Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 571
             +++RDLK +NILLD+  + +ISD GLA  F   +  A+     GT+GYMAPE    G 
Sbjct: 117 F-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGT 171

Query: 572 -FSIKSDVFSFGVLLLEIISG 591
            +   +D FS G +L +++ G
Sbjct: 172 AYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 48/222 (21%)

Query: 398 KLGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQG------------LQEFKNEVNLI 441
           +LGQG +G V       T ++ + +A+K+++    +             L+ F+      
Sbjct: 7   ELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG----- 60

Query: 442 AKLQHKNLVRLLGCCLEGQELLL------IYEYMPNKSLDVHLFDATRS-VQLDWKRRQS 494
               HKN+      CL   +++       +Y Y      D+H     RS   L     QS
Sbjct: 61  ----HKNIT-----CLYDMDIVFPGNFNELYLYEELMEADLH--QIIRSGQPLTDAHFQS 109

Query: 495 IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--- 551
            I  I  G+ Y+H  +   ++HRDLK  N+L++ D   KI DFGLAR F  N  +     
Sbjct: 110 FIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM 166

Query: 552 TNIIAGTYGYMAPEYAMGGIFSIKS-DVFSFGVLLLEIISGR 592
           T  +A T  Y APE  +      K+ DV+S G +L E++  +
Sbjct: 167 TEYVA-TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 68.2 bits (166), Expect = 2e-12
 Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 33/212 (15%)

Query: 393 FSDENKLGQGGFGPV---YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
           + +   +G G  G V   Y   L   + +A+K+LSR        F+N+ +  AK  ++ L
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRP-------FQNQTH--AKRAYREL 67

Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLD--------VHLFDATR----SVQLDWKRRQSIIN 497
           V L+ C      + L+  + P KSL+        + L DA       ++LD +R   ++ 
Sbjct: 68  V-LMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 126

Query: 498 GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG 557
            +  GI +LH      IIHRDLK SNI++  D   KI DFGLAR  G   +   T  +  
Sbjct: 127 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVT 181

Query: 558 TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEII 589
            Y Y APE  +G  +    D++S G ++ E++
Sbjct: 182 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 41/92 (44%), Positives = 54/92 (58%), Gaps = 3/92 (3%)

Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +ARG+ +L   SR K IHRDL A NILL ++   KI DFGLAR    + +          
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +MAPE     +++ +SDV+SFGVLL EI S
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 31/205 (15%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
           +G G FG V+           A+K ++       +  Q   NE  ++ ++ H  ++RL  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR--------GILYL 506
              + + L ++ EY+P   L  +L           +      N             + YL
Sbjct: 69  TEHDQRFLYMLMEYVPGGELFSYL-----------RNSGRFSNSTGLFYASEIVCALEYL 117

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H     +I++RDLK  NILLD + + K++DFG A+     + +  T  + GT  Y+APE 
Sbjct: 118 HS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPEV 169

Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
                 +   D ++ G+L+ E++ G
Sbjct: 170 IQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 67.9 bits (166), Expect = 3e-12
 Identities = 55/227 (24%), Positives = 100/227 (44%), Gaps = 41/227 (18%)

Query: 397 NKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN--------------EVNLI 441
             LG+G +G V K      GK +A+K++                           E+ ++
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 442 AKLQHKNLVRLLGCCLEGQELLLIYEYMPN---KSLDVHLFDATRSVQLDWKRRQSIING 498
            +++H+N++ L+   +EG  + L+ + M +   K +D       R ++L   + + I+  
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVD-------RKIRLTESQVKCILLQ 127

Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN----------QN 548
           I  G+  LH+      +HRDL  +NI ++     KI+DFGLAR +G              
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 549 QANTNIIAG--TYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGR 592
           Q    + +   T  Y APE  MG   +    D++S G +  E+++G+
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 67.8 bits (165), Expect = 3e-12
 Identities = 46/147 (31%), Positives = 73/147 (49%), Gaps = 8/147 (5%)

Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           H  LV L  C      L  + EY+    L   +F   R  +L  +  +     I+  + Y
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 111

Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           LHE     II+RDLK  N+LLD + + K++D+G+ +   G +    T+   GT  Y+APE
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPE 166

Query: 566 YAMGGIFSIKSDVFSFGVLLLEIISGR 592
              G  +    D ++ GVL+ E+++GR
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 67.6 bits (165), Expect = 4e-12
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 18/201 (8%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSR--TSGQGLQEFKNEVNLIAKLQHKNLVRLLG- 454
           +G G +G V        G+ +A+K+LSR   S    +    E+ L+  +QH+N++ LL  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 455 --CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
               + G E    Y  MP    D+          L   + Q ++  +  G+ Y+H     
Sbjct: 83  FTSAVSGDEFQDFYLVMPYMQTDLQ---KIMGHPLSEDKVQYLVYQMLCGLKYIHSAG-- 137

Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
            IIHRDLK  N+ +++D   KI DFGLAR        A       T  Y APE  +  + 
Sbjct: 138 -IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILNWMH 191

Query: 573 SIKS-DVFSFGVLLLEIISGR 592
             ++ D++S G ++ E+++G+
Sbjct: 192 YNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 27/206 (13%)

Query: 398 KLGQGGFGPVYKG-TLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
           KLG+G +  VYKG +   G+ +A+K  RL    G      + E +L+  L+H N+V L  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                + L L++EY+ +  L  ++ D    + +   R    +  + RG+ Y H   + ++
Sbjct: 71  IIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVR--LFLFQLLRGLAYCH---QRRV 124

Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-------YMAPEYA 567
           +HRDLK  N+L+ +    K++DFGLAR           ++ + TY        Y  P+  
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLARA---------KSVPSKTYSNEVVTLWYRPPDVL 175

Query: 568 MGGI-FSIKSDVFSFGVLLLEIISGR 592
           +G   +S   D++  G +  E+ +GR
Sbjct: 176 LGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 67.4 bits (164), Expect = 5e-12
 Identities = 46/144 (31%), Positives = 71/144 (49%), Gaps = 8/144 (5%)

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
           LV L  C      L L+ EY+    L   +F   R  +L  +  +     I   + +LHE
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE 114

Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
                II+RDLK  N+LLD D + K++D+G+ +   G      T+   GT  Y+APE   
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILR 169

Query: 569 GGIFSIKSDVFSFGVLLLEIISGR 592
           G  +    D ++ GVL+ E+++GR
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 67.1 bits (164), Expect = 5e-12
 Identities = 46/166 (27%), Positives = 81/166 (48%), Gaps = 24/166 (14%)

Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
           + D   LG G  G V+    +D  K +AVK++  T  Q ++    E+ +I +L H N+V+
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 452 L--------------LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN 497
           +              +G   E   + ++ EYM     +  L +      L  +  +  + 
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLSEEHARLFMY 121

Query: 498 GIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARI 542
            + RG+ Y+H  +   ++HRDLK +N+ ++ +D+  KI DFGLARI
Sbjct: 122 QLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARI 164

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 66.6 bits (162), Expect = 6e-12
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 18/204 (8%)

Query: 399 LGQGGFGPVY---KGTLAD-GKAIAVKRLSRTS----GQGLQEFKNEVNLIAKL-QHKNL 449
           LG G +G V+   K +  D GK  A+K L + +     +  +  + E  ++  + Q   L
Sbjct: 8   LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67

Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           V L        +L LI +Y+    L  HL   ++  +   +  Q     I   + +LH  
Sbjct: 68  VTLHYAFQTDTKLHLILDYINGGELFTHL---SQRERFKEQEVQIYSGEIVLALEHLH-- 122

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 569
            +L II+RD+K  NILLD + +  ++DFGL++ F  ++ +   +   GT  YMAP+   G
Sbjct: 123 -KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEYMAPDIVRG 180

Query: 570 GI--FSIKSDVFSFGVLLLEIISG 591
           G        D +S GVL+ E+++G
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 65.7 bits (160), Expect = 8e-12
 Identities = 51/150 (34%), Positives = 74/150 (49%), Gaps = 11/150 (7%)

Query: 398 KLGQGGFGPVYKGTLADG---KAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLL 453
           ++G G FG V  G +  G     + VK L  ++  Q   +F  E      LQH NL++ L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQL---DWKRRQSIINGIARGILYLHEDS 510
           G C E    LL+ E+ P   L  +L  + R  +L   D    Q +   IA G+L+LH+++
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYL-RSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLA 540
               IH DL   N LL  D+  KI D+GL+
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 66.6 bits (162), Expect = 8e-12
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 19/213 (8%)

Query: 388 EATNHFSDENKLGQGGFGPV---YKGTLADGKAIAVKRLSRTSGQGLQEFKN---EVNLI 441
           E    + +   +G G +G V   Y   L   + +AVK+LSR   Q L   +    E+ L+
Sbjct: 12  EVPERYQNLTPVGSGAYGSVCSAYDTRLR--QKVAVKKLSRPF-QSLIHARRTYRELRLL 68

Query: 442 AKLQHKNLVRLLGCCLEGQELLLIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 500
             ++H+N++ LL        +    E Y+    +   L +  +  +L  +  Q +I  + 
Sbjct: 69  KHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLL 128

Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 560
           RG+ Y+H      IIHRDLK SN+ +++D   +I DFGLAR      +   T  +A T  
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMTGYVA-TRW 180

Query: 561 YMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           Y APE  +  + ++   D++S G ++ E++ G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 66.4 bits (162), Expect = 9e-12
 Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 37/210 (17%)

Query: 397 NKLGQGGFGPV----YKGTLADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNL 449
             LG G FG V    +KGT   G+  A+K L +      + +Q    E +++ +L H  +
Sbjct: 24  ETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI 80

Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR-------- 501
           V ++    +   +  + E++    L  HL  A R             N +A+        
Sbjct: 81  VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR-----------FPNDVAKFYHAELVL 129

Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
              YLH      II+RDLK  N+LLD+  + K++DFG A+     +    T  + GT  Y
Sbjct: 130 AFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEY 181

Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           +APE           D ++ GVLL E I+G
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 65.9 bits (160), Expect = 1e-11
 Identities = 62/208 (29%), Positives = 90/208 (43%), Gaps = 14/208 (6%)

Query: 399 LGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAKLQHKNLVRLLG 454
           LG+G FG V      A GK  A+K L +       E  +   E  ++   +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                  L  + EY+    L  HL   +R       R +     I   + YLH     KI
Sbjct: 63  SFQTKDRLCFVMEYVNGGELFFHL---SRERVFSEDRTRFYGAEIVSALDYLHSG---KI 116

Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           ++RDLK  N++LD D + KI+DFGL +   G  + A      GT  Y+APE      +  
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174

Query: 575 KSDVFSFGVLLLEIISGRKNNGFYFSEH 602
             D +  GV++ E++ GR    FY  +H
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP--FYNQDH 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 42/210 (20%)

Query: 399 LGQGGFGPVYKGTL----ADGKAIAVKRLS--RTSGQGLQEFKNEVNLIAKLQHKNLVR- 451
           +G+G +G V   +L     DGK   +K+L+    S +  +  + E  L+++L+H N+V  
Sbjct: 8   VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64

Query: 452 -------------LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING 498
                        ++G C EG +L     Y   K     L    + V  +W  +      
Sbjct: 65  RESWEGEDGLLYIVMGFC-EGGDL-----YHKLKEQKGKLLPENQVV--EWFVQ------ 110

Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           IA  + YLHE     I+HRDLK  N+ L      K+ D G+AR+     + A+T I  GT
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI--GT 165

Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEI 588
             YM+PE      ++ KSDV++ G  + E+
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 61/198 (30%), Positives = 92/198 (46%), Gaps = 13/198 (6%)

Query: 399 LGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAK-LQHKNLVRLL 453
           +G+G FG V      +DG   AVK L + +    +E  +   E N++ K L+H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
                 ++L  + +Y+    L  HL    R       R +     +A  I YLH    L 
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHL---QRERCFLEPRARFYAAEVASAIGYLHS---LN 116

Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 573
           II+RDLK  NILLD   +  ++DFGL +   G + +  T+   GT  Y+APE      + 
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174

Query: 574 IKSDVFSFGVLLLEIISG 591
              D +  G +L E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 67.2 bits (164), Expect = 2e-11
 Identities = 51/192 (26%), Positives = 90/192 (46%), Gaps = 22/192 (11%)

Query: 415 GKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVRLL--GCCLEGQELLLIYEYM 469
           G  +A+K L   + +   +   F+ E  L A+L H N+V LL  G    G  L  ++EY+
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEYV 61

Query: 470 PNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL-- 526
           P ++L +V   D         +    +++ +A      H      I+HRDLK  NI++  
Sbjct: 62  PGRTLREVLAADGALPAGETGRLMLQVLDALACA----H---NQGIVHRDLKPQNIMVSQ 114

Query: 527 -DDDMNPKISDFGLARIFGGNQNQANTNIIA-----GTYGYMAPEYAMGGIFSIKSDVFS 580
                + K+ DFG+  +  G ++     +       GT  Y APE   G   +  SD+++
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174

Query: 581 FGVLLLEIISGR 592
           +G++ LE ++G+
Sbjct: 175 WGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 14/207 (6%)

Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRLSRTSGQGLQEFKN----EVNLIAKLQ 445
           N F     +G+G +G V K    + K I A+K+   +     +E K     E+ ++  L+
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLK 58

Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
            +N+V L        +L L++EY+    L++ L +    V  +  + +S I  + + I +
Sbjct: 59  QENIVELKEAFRRRGKLYLVFEYVEKNMLEL-LEEMPNGVPPE--KVRSYIYQLIKAIHW 115

Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
            H++    I+HRD+K  N+L+  +   K+ DFG AR      N   T  +A T  Y +PE
Sbjct: 116 CHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA-TRWYRSPE 171

Query: 566 YAMGGIFSIKSDVFSFGVLLLEIISGR 592
             +G  +    D++S G +L E+  G+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 65.2 bits (159), Expect = 3e-11
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 33/211 (15%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAKLQHKNLVRLLG 454
           +G G FG V+  T   DGK +A+K++     Q L   K    E+ ++   +H N++  L 
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSAL- 65

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWK----RRQSI--------INGIARG 502
                 ++L      P+      ++  T  +Q D        Q +        +  I RG
Sbjct: 66  ------DIL----QPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRG 115

Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYM 562
           + YLH      I+HRD+K  N+L++ +   KI DFGLAR+   ++++  T  +   Y Y 
Sbjct: 116 LKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YR 171

Query: 563 APEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           APE  MG   ++   D++S G +  E++  R
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 44/147 (29%), Positives = 73/147 (49%), Gaps = 8/147 (5%)

Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           H  LV L  C      L  + E++    L  H+    R  +L  +  +     I+  + +
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM---QRQRKLPEEHARFYSAEISLALNF 111

Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           LHE     II+RDLK  N+LLD + + K++D+G+ +   G +    T+   GT  Y+APE
Sbjct: 112 LHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPE 166

Query: 566 YAMGGIFSIKSDVFSFGVLLLEIISGR 592
              G  +    D ++ GVL+ E+++GR
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 17/203 (8%)

Query: 399 LGQGGFGPVY---KGTLAD-GKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLV 450
           LG G +G V+   K T  D GK  A+K L + +     + ++  + E N++  ++    +
Sbjct: 8   LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67

Query: 451 RLLGCCLEGQ-ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
             L    + + +L LI +Y+    +  HL+      Q D      +       IL L   
Sbjct: 68  VTLHYAFQTEAKLHLILDYVSGGEMFTHLY------QRDNFSEDEVRFYSGEIILALEHL 121

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 569
            +L I++RD+K  NILLD + +  ++DFGL++ F  ++ +  T    GT  YMAPE   G
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCGTIEYMAPEIIRG 180

Query: 570 GIFSIKS-DVFSFGVLLLEIISG 591
                K+ D +S G+L+ E+++G
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (156), Expect = 4e-11
 Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 16/201 (7%)

Query: 399 LGQGGFGPVYKGTLADGKAI-AVKRLSRTSGQGLQEFKN---EVNLIAKLQHKNLVRLLG 454
           +G+G FG VY+    D + I A+K LS+      +E  +   E N++ +        ++G
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 455 CCLEGQ---ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
                Q   +L L+ +YM    L  HL    R       R +  I  +   + +LH+   
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR---FSEDRAKFYIAELVLALEHLHKYD- 116

Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 571
             I++RDLK  NILLD   +  + DFGL++      +   TN   GT  Y+APE  +   
Sbjct: 117 --IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEK 172

Query: 572 -FSIKSDVFSFGVLLLEIISG 591
            ++   D +S GVL+ E+  G
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 63.9 bits (155), Expect = 5e-11
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 31/208 (14%)

Query: 399 LGQGGFGPVYKGTLADGKAI----AVKRLSRTSGQGLQEFKNEVNLIAK----LQHKN-- 448
           LG+G FG V    LA+ K      A+K L +     +Q+   E  ++ K    LQ K   
Sbjct: 8   LGKGSFGKV---MLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALQDKPPF 62

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING--IARGILYL 506
           L +L  C      L  + EY+    L  H+    +     +K  Q++     I+ G+ +L
Sbjct: 63  LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK-----FKEPQAVFYAAEISVGLFFL 117

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR--IFGGNQNQANTNIIAGTYGYMAP 564
           H      II+RDLK  N++LD + + KI+DFG+ +  +  G      T    GT  Y+AP
Sbjct: 118 HRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----VTTRTFCGTPDYIAP 170

Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E      +    D +++GVLL E+++G+
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 62.7 bits (152), Expect = 9e-11
 Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 19/206 (9%)

Query: 399 LGQGGFGPVYK-GTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCC 456
           +G+G +G V+K     +G   AVK L        +E + E N++  L  H N+V+  G  
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 457 LE-----GQELLLIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
            +     G +L L+ E     S+ D+      R  +++      I++    G+ +LH + 
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY---- 566
             K IHRD+K +NILL  +   K+ DFG++      + + NT++  GT  +MAPE     
Sbjct: 144 --KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--GTPFWMAPEVIACE 199

Query: 567 -AMGGIFSIKSDVFSFGVLLLEIISG 591
             +   +  + DV+S G+  +E+  G
Sbjct: 200 QQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 31/208 (14%)

Query: 399 LGQGGFGPVYKGTLADGKAI----AVKRLSRTSGQGLQEFKNEVNLIAK----LQHKN-- 448
           LG+G FG V    LA+ K      A+K L +     +Q+   E  ++ K    L  K   
Sbjct: 8   LGKGSFGKV---MLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALSGKPPF 62

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING--IARGILYL 506
           L +L  C      L  + EY+    L   +    R     +K   ++     IA G+ +L
Sbjct: 63  LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR-----FKEPHAVFYAAEIAIGLFFL 117

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR--IFGGNQNQANTNIIAGTYGYMAP 564
           H      II+RDLK  N++LD + + KI+DFG+ +  ++ G      T    GT  Y+AP
Sbjct: 118 HSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG----VTTKTFCGTPDYIAP 170

Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E      +    D ++FGVLL E+++G+
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 63.6 bits (154), Expect = 1e-10
 Identities = 49/183 (26%), Positives = 89/183 (48%), Gaps = 20/183 (10%)

Query: 416 KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI--YEYMPNKS 473
           + +  KR+   S   +Q  +NE+  + +L H+N++++       +E+L      YM  + 
Sbjct: 193 ERLIAKRVKAGSRAAIQ-LENEILALGRLNHENILKI-------EEILRSEANTYMITQK 244

Query: 474 LDVHLFDATRSVQLDWKRR------QSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 527
            D  L+        DWK R      ++I+  +   + Y+H+    K+IHRD+K  NI L+
Sbjct: 245 YDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301

Query: 528 DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLE 587
            D    + DFG A  F   + +A      GT    +PE   G  +   +D++S G++LL+
Sbjct: 302 CDGKIVLGDFGTAMPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLD 360

Query: 588 IIS 590
           ++S
Sbjct: 361 MLS 363

Length = 501

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 49/164 (29%), Positives = 80/164 (48%), Gaps = 18/164 (10%)

Query: 437 EVNLIAKLQHKNLVRLLGCCLEGQ-----ELLLIYEYMPNKSLDVHLFDATRSVQ-LDWK 490
           E+ L+  L H+N++ +             ++ ++YE M     D  L    RS Q L   
Sbjct: 54  EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDD 108

Query: 491 RRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550
             Q  +  + RG+ Y+H  +   ++HRDLK SN+LL+ + + KI DFGLAR      +  
Sbjct: 109 HCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM 165

Query: 551 NTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRK 593
              ++  T  Y APE  +    ++   DV+S G +  E++ GRK
Sbjct: 166 TEYVV--TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 63.6 bits (155), Expect = 2e-10
 Identities = 57/222 (25%), Positives = 95/222 (42%), Gaps = 33/222 (14%)

Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRT-SGQGL--QEFKNEVNLIAKLQHKNLVRLL 453
            +G+GG G VY        + +A+K++    S   L  + F  E  + A L H  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATR---SVQLDWKRRQS------IINGIARGIL 504
             C +G  +     Y+   +L   L  +     S+  +   + S      I + I   I 
Sbjct: 69  SICSDGDPVYYTMPYIEGYTLK-SLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127

Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ-------------AN 551
           Y+H  S+  ++HRDLK  NILL       I D+G A      +               ++
Sbjct: 128 YVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184

Query: 552 TNI---IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             I   I GT  YMAPE  +G   S  +D+++ GV+L ++++
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 62.6 bits (152), Expect = 2e-10
 Identities = 37/95 (38%), Positives = 53/95 (55%), Gaps = 14/95 (14%)

Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQN---QANTNIIAGTYGYMAPEYAMGGI 571
           IHRD+ A N+LL D    KI DFGLAR    + N   + N  +      +MAPE     +
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL---PVKWMAPESIFDCV 290

Query: 572 FSIKSDVFSFGVLLLEIIS-GRK-------NNGFY 598
           ++++SDV+S+G+LL EI S G+        N+ FY
Sbjct: 291 YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY 325

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 61.9 bits (150), Expect = 3e-10
 Identities = 59/198 (29%), Positives = 89/198 (44%), Gaps = 13/198 (6%)

Query: 399 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKN---EVNLIAK-LQHKNLVRLL 453
           +G+G FG V       DGK  AVK L +      +E K+   E N++ K ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
                 ++L  + +++    L  HL    R       R +     IA  + YLH    + 
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHL---QRERSFPEPRARFYAAEIASALGYLHS---IN 116

Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 573
           I++RDLK  NILLD   +  ++DFGL +   G      T    GT  Y+APE      + 
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174

Query: 574 IKSDVFSFGVLLLEIISG 591
              D +  G +L E++ G
Sbjct: 175 NTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 60.7 bits (147), Expect = 4e-10
 Identities = 44/153 (28%), Positives = 68/153 (44%), Gaps = 20/153 (13%)

Query: 398 KLGQGGFGPVYKGTLADGKAIA---VKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRLL 453
           ++G G FG V    +     +A   VK L   +    Q EF  + +    LQH N+++ L
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR-------QSIINGIARGILYL 506
           G C+E    LL++EY     L  +L       Q  W RR       Q +   IA G+ ++
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYL------SQEQWHRRNSQLLLLQRMACEIAAGVTHM 115

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539
           H   +   +H DL   N  L  D+  K+ D+G+
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 61.2 bits (148), Expect = 5e-10
 Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 13/208 (6%)

Query: 399 LGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAKLQHKNLVRLLG 454
           LG+G FG V      A G+  A+K L +       E  +   E  ++   +H  L  L  
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                  L  + EY     L  HL   +R       R +     I   + YLH  S   +
Sbjct: 63  SFQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLH--SEKNV 117

Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           ++RDLK  N++LD D + KI+DFGL +   G ++ A      GT  Y+APE      +  
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175

Query: 575 KSDVFSFGVLLLEIISGRKNNGFYFSEH 602
             D +  GV++ E++ GR    FY  +H
Sbjct: 176 AVDWWGLGVVMYEMMCGRLP--FYNQDH 201

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 60.7 bits (147), Expect = 5e-10
 Identities = 52/197 (26%), Positives = 93/197 (47%), Gaps = 12/197 (6%)

Query: 399 LGQGGFGPVYKGTLADGKAI----AVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
           +G+G FG V +    D + I     +++    S   +     E  ++A++    +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                ++L L+  ++    L  HL    R  + D  R +     +   +  LH+     +
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHL---QREGRFDLSRARFYTAELLCALENLHK---FNV 114

Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           I+RDLK  NILLD   +  + DFGL ++   + ++ NT    GT  Y+APE  +G  ++ 
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGTPEYLAPELLLGHGYTK 172

Query: 575 KSDVFSFGVLLLEIISG 591
             D ++ GVLL E+++G
Sbjct: 173 AVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 20/198 (10%)

Query: 399 LGQGGFGP--VYKGTLADGK-AIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
           +G+G FG   + +   +D K A+   RL ++S   +++ + E  L+AK++H N+V     
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKES 66

Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDA-----TRSVQLDWKRRQSIINGIARGILYLHEDS 510
                 L ++ EY     L   +             L W         +  G+ ++HE  
Sbjct: 67  FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW------FVQMCLGVQHIHEK- 119

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
             +++HRD+K+ NI L  +   K+ DFG AR+       A T +  GT  Y+ PE     
Sbjct: 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV--GTPYYVPPEIWENM 175

Query: 571 IFSIKSDVFSFGVLLLEI 588
            ++ KSD++S G +L E+
Sbjct: 176 PYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 61.1 bits (148), Expect = 6e-10
 Identities = 36/92 (39%), Positives = 50/92 (54%), Gaps = 3/92 (3%)

Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +A+G+ +L   +    IHRDL A NILL      KI DFGLAR    + N          
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279

Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +MAPE     +++ +SDV+S+G+LL EI S
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 59.9 bits (145), Expect = 6e-10
 Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 28/210 (13%)

Query: 399 LGQGGFGPVYKGT---LADGKA-----IAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
           LGQG F  ++KG    + D        + +K L ++     + F    +++++L HK+LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
              G C+ G E +++ EY+   SLD +L      + + WK    +   +A  + +L +  
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLE--VAKQLAWALHFLEDK- 119

Query: 511 RLKIIHRDLKASNILL-----DDDMNP---KISDFGLARIFGGNQNQANTNIIAGTYGYM 562
              + H ++ A N+LL         NP   K+SD G++             I+     ++
Sbjct: 120 --GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV------LPKEILLERIPWV 171

Query: 563 APE-YAMGGIFSIKSDVFSFGVLLLEIISG 591
            PE        S+ +D +SFG  L EI SG
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 60.0 bits (145), Expect = 9e-10
 Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 14/208 (6%)

Query: 399 LGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAKLQHKNLVRLLG 454
           LG+G FG V      A G+  A+K L +       E  +   E  ++   +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                  L  + EY     L  HL   +R      +R +     I   + YLH      +
Sbjct: 63  AFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHSRD---V 116

Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           ++RD+K  N++LD D + KI+DFGL +   G  + A      GT  Y+APE      +  
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174

Query: 575 KSDVFSFGVLLLEIISGRKNNGFYFSEH 602
             D +  GV++ E++ GR    FY  +H
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP--FYNQDH 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 60.8 bits (147), Expect = 9e-10
 Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 3/92 (3%)

Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +ARG+ +L   +    +HRDL A N+LL      KI DFGLAR    + N  +       
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +MAPE     +++  SDV+S+G+LL EI S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 59.5 bits (144), Expect = 3e-09
 Identities = 31/91 (34%), Positives = 53/91 (58%)

Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYM 562
           +L +H      +IHRD+K++NILL  +   K+ DFG ++++    +        GT  Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 563 APEYAMGGIFSIKSDVFSFGVLLLEIISGRK 593
           APE      +S K+D+FS GVLL E+++ ++
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 26/203 (12%)

Query: 399 LGQGGFGPVYKGTLADGK--AIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLL 453
           LG G FG V   T  +     +A+KR  ++     + +    +E  ++  + H   V L 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI-----ARGILYLHE 508
           G   +   L L+ E++        L           +R +   N +     A+ +L    
Sbjct: 98  GSFKDESYLYLVLEFVIGGEFFTFL-----------RRNKRFPNDVGCFYAAQIVLIFEY 146

Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
              L I++RDLK  N+LLD D   K++DFG A++         T  + GT  Y+APE  +
Sbjct: 147 LQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIAPEILL 201

Query: 569 GGIFSIKSDVFSFGVLLLEIISG 591
                  +D ++ G+ + EI+ G
Sbjct: 202 NVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 58.7 bits (142), Expect = 3e-09
 Identities = 61/257 (23%), Positives = 96/257 (37%), Gaps = 69/257 (26%)

Query: 391 NHFSDENKLGQGGFGPV-YKGTLADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQH 446
             F     +G+G FG V        GK  A+K L ++       L   K E +++A+   
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF-------DATRSVQLDWKRRQSIINGI 499
             +V L     + Q L LI E++P   L   L        D TR               +
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFY-------------M 107

Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA-------------RIFGGN 546
           A  +L +    +L  IHRD+K  NIL+D   + K+SDFGL+             ++  G 
Sbjct: 108 AECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGK 167

Query: 547 QNQ----------------------------ANTNIIA----GTYGYMAPEYAMGGIFSI 574
            N+                             N  ++A    GT  Y+APE  +   +  
Sbjct: 168 SNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227

Query: 575 KSDVFSFGVLLLEIISG 591
           + D +S G ++ E + G
Sbjct: 228 ECDWWSLGAIMFECLIG 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 58.5 bits (142), Expect = 4e-09
 Identities = 33/100 (33%), Positives = 56/100 (56%), Gaps = 11/100 (11%)

Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN---TNII 555
           + RG+ Y+H      +IHRDLK SN+L+++D   +I DFG+AR    +  +     T  +
Sbjct: 116 LLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172

Query: 556 AGTYGYMAPE--YAMGGIFSIKSDVFSFGVLLLEIISGRK 593
           A T  Y APE   ++   ++   D++S G +  E++ GR+
Sbjct: 173 A-TRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEML-GRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 58.3 bits (141), Expect = 4e-09
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 7/104 (6%)

Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I   + YLH      +++RDLK  N++LD D + KI+DFGL +   G  + A      GT
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158

Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 602
             Y+APE      +    D +  GV++ E++ GR    FY  +H
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 58.3 bits (141), Expect = 4e-09
 Identities = 50/173 (28%), Positives = 81/173 (46%), Gaps = 33/173 (19%)

Query: 437 EVNLIAKLQHKNLVRLLGCCL-----EGQELLLIYEYMPNKSLDVHLF-----DATRSVQ 486
           E+ L+  L+H ++V +    L     E +++ +++E M +   D+H       D T    
Sbjct: 49  EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES---DLHQVIKANDDLTP--- 102

Query: 487 LDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546
              +  Q  +  + R + Y+H  +   + HRDLK  NIL + D   KI DFGLAR+    
Sbjct: 103 ---EHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV---A 153

Query: 547 QNQANTNII----AGTYGYMAPEYAMGGIFSIKS---DVFSFGVLLLEIISGR 592
            N   T I       T  Y APE   G  FS  +   D++S G +  E+++G+
Sbjct: 154 FNDTPTAIFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 57.3 bits (138), Expect = 7e-09
 Identities = 59/198 (29%), Positives = 91/198 (45%), Gaps = 13/198 (6%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFK---NEVNLIAK-LQHKNLVRLL 453
           +G+G FG V      A+ K  AVK L + +    +E K   +E N++ K ++H  LV L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
                  +L  + +Y+    L  HL    R       R +     IA  + YLH    L 
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHL---QRERCFLEPRARFYAAEIASALGYLHS---LN 116

Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 573
           I++RDLK  NILLD   +  ++DFGL +     ++   T+   GT  Y+APE      + 
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174

Query: 574 IKSDVFSFGVLLLEIISG 591
              D +  G +L E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 56.7 bits (137), Expect = 1e-08
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 22/215 (10%)

Query: 391 NHFSDENKLGQGGFGPVY----KGTLADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAK 443
             F  ++ +G+G FG V     K T   G   A+K + ++   + + +  F+ E ++++ 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57

Query: 444 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
                + +L     +   L L+ EY P   L + L +     Q D    Q  +  +   I
Sbjct: 58  SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDL-LSLLNRYED-QFDEDMAQFYLAELVLAI 115

Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
             +H+   +  +HRD+K  N+L+D   + K++DFG A     N+   N+ +  GT  Y+A
Sbjct: 116 HSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGTPDYIA 171

Query: 564 PEY------AMGGIFSIKSDVFSFGVLLLEIISGR 592
           PE          G + ++ D +S GV+  E+I GR
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 3/92 (3%)

Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +A G+ +L   +    +HRDL A N+L+ +    KI DFGLAR    + N  +       
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +MAPE     +++  SDV+SFG+LL EI +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 56.2 bits (136), Expect = 2e-08
 Identities = 32/145 (22%), Positives = 57/145 (39%), Gaps = 15/145 (10%)

Query: 399 LGQGGFGPVYKGTLADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
                   + K        +AVK+  L   S + L+  + E+    +LQH N++  +   
Sbjct: 10  FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68

Query: 457 LEGQELLLIYEYMPNKS----LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
           +   EL ++   M   S    L  H  +    + + +     I+  +   + Y+H     
Sbjct: 69  IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-----ILKDVLNALDYIH---SK 120

Query: 513 KIIHRDLKASNILLDDDMNPKISDF 537
             IHR +KAS+ILL  D    +S  
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 55.0 bits (132), Expect = 5e-08
 Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 8/156 (5%)

Query: 437 EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
           E +++  + H ++++L G     +   LI   +P    D++ + A +   +      +I 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKR-NIAICDILAIE 188

Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 556
             + R I YLHE+    IIHRD+KA NI ++   +  + DFG A  F  + N       A
Sbjct: 189 RSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWA 244

Query: 557 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           GT    APE      +    D++S G++L E+ +  
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 53.5 bits (129), Expect = 2e-07
 Identities = 60/244 (24%), Positives = 97/244 (39%), Gaps = 68/244 (27%)

Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLV 450
           +G+G FG V     K T   G   A+K+L ++      Q +   + E +++A+  +  +V
Sbjct: 9   IGRGAFGEVRLVQKKDT---GHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEADNPWVV 64

Query: 451 RLLGCCLEGQELLLIYEYMPNKSL-------DVHLFDATRSVQLDWKRRQSIINGIARGI 503
           +L     +   L LI EY+P   +       D    + TR               IA  I
Sbjct: 65  KLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFY-------------IAETI 111

Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL------------ARIFGGNQNQAN 551
           L +    +L  IHRD+K  N+LLD   + K+SDFGL             RI         
Sbjct: 112 LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171

Query: 552 TNIIA------------------------GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLE 587
            + I+                        GT  Y+APE  +   ++ + D +S GV++ E
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231

Query: 588 IISG 591
           ++ G
Sbjct: 232 MLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 22/204 (10%)

Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVR 451
           +G+G FG V    +K T    K  A+K LS+       +   F  E +++A      +V+
Sbjct: 51  IGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
           L     + + L ++ EYMP   L V+L  +   V   W R  +     A  +L L     
Sbjct: 108 LFYAFQDDRYLYMVMEYMPGGDL-VNLM-SNYDVPEKWARFYT-----AEVVLALDAIHS 160

Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG-- 569
           +  IHRD+K  N+LLD   + K++DFG        +     +   GT  Y++PE      
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 570 --GIFSIKSDVFSFGVLLLEIISG 591
             G +  + D +S GV L E++ G
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 22/204 (10%)

Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVR 451
           +G+G FG V    +K   +  K  A+K LS+       +   F  E +++A      +V+
Sbjct: 51  IGRGAFGEVQLVRHK---SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
           L     + + L ++ EYMP   L V+L  +   V   W +  +     A  +L L     
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDL-VNLM-SNYDVPEKWAKFYT-----AEVVLALDAIHS 160

Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG-- 569
           + +IHRD+K  N+LLD   + K++DFG              +   GT  Y++PE      
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM-DETGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 570 --GIFSIKSDVFSFGVLLLEIISG 591
             G +  + D +S GV L E++ G
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 19/163 (11%)

Query: 434 FKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ 493
           F    +L++++ H +L  + G C+ G E +++ E++ +  LDV L      V + WK   
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK--I 120

Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNIL-----LDDDMNP--KISDFGLARIFGGN 546
           ++   +A  + YL ED  L  +H ++ A NIL     L +  +P  K+SD G++  F   
Sbjct: 121 TVAQQLASALSYL-EDKNL--VHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTAL 175

Query: 547 QNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEI 588
             +     I     ++APE   GG   S  +D +SFG  LLEI
Sbjct: 176 SREERVERIP----WIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 43/158 (27%), Positives = 80/158 (50%), Gaps = 6/158 (3%)

Query: 435 KNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQS 494
           ++E++ +A   H  +V+         +LLLI EY     L+  +    +   L ++  + 
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKE-HLPFQEYEV 171

Query: 495 IINGIA--RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
              G+   + +L L E    K++HRDLK++NI L      K+ DFG ++ +  + +    
Sbjct: 172 ---GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228

Query: 553 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           +   GT  Y+APE      +S K+D++S GV+L E+++
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 52.2 bits (125), Expect = 4e-07
 Identities = 38/152 (25%), Positives = 71/152 (46%), Gaps = 7/152 (4%)

Query: 437 EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
           E++++  + H+ ++ L+        + ++   MP    D+  +   RS  L  ++  +I 
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTY-VDRSGPLPLEQAITIQ 191

Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 556
             +   + YLH      IIHRD+K  NI LD+  N  + DFG A     + +       +
Sbjct: 192 RRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS 248

Query: 557 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEI 588
           GT    +PE      +  K+D++S G++L E+
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 52.0 bits (124), Expect = 6e-07
 Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 25/208 (12%)

Query: 397 NKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLVRLLG 454
           N +G G FG VY+    D  + +A+K++ +       ++KN E+ ++  L H N++ L  
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKD 126

Query: 455 C----CLEGQE----LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
                C +  E    L ++ E++P          A  +  L     +     + R + Y+
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLAR-IFGGNQNQANTNIIAGTYGYMAP 564
           H      I HRDLK  N+L+D + +  K+ DFG A+ +  G   Q + + I   + Y AP
Sbjct: 187 HSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG---QRSVSYICSRF-YRAP 239

Query: 565 EYAMGGI-FSIKSDVFSFGVLLLEIISG 591
           E  +G   ++   D++S G ++ E+I G
Sbjct: 240 ELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 51.3 bits (123), Expect = 7e-07
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 22/204 (10%)

Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVR 451
           +G+G FG V    +K +    +  A+K LS+       +   F  E +++A    + +V+
Sbjct: 51  IGRGAFGEVQLVRHKSS---KQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQ 107

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
           L     + + L ++ EYMP   L V+L  +   +   W R        A  +L L     
Sbjct: 108 LHYAFQDDKYLYMVMEYMPGGDL-VNLM-SNYDIPEKWARFY-----TAEVVLALDAIHS 160

Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG-- 569
           +  IHRD+K  N+LLD   + K++DFG       N      +   GT  Y++PE      
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN-GMVRCDTAVGTPDYISPEVLKSQG 219

Query: 570 --GIFSIKSDVFSFGVLLLEIISG 591
             G +  + D +S GV L E++ G
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 52.0 bits (124), Expect = 8e-07
 Identities = 70/255 (27%), Positives = 115/255 (45%), Gaps = 66/255 (25%)

Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSR------TSGQGLQEFKN-----EVN 439
           N +    K+G G FG V+         +  KR          S +GL+E +      EVN
Sbjct: 13  NEYEVIKKIGNGRFGEVF--------LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVN 64

Query: 440 LIAKLQHKNLVRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI-- 495
           ++ +L+HKN+VR +   L    Q+L ++ E+           D +R++Q  +K    I  
Sbjct: 65  VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAG-------DLSRNIQKCYKMFGKIEE 117

Query: 496 --INGIARGIL----YLHE----DSRLKIIHRDLKASNILLD-------------DDMN- 531
             I  I R +L    Y H      +  +++HRDLK  NI L              +++N 
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177

Query: 532 ---PKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI--KSDVFSFGVLLL 586
               KI DFGL++   G ++ A++ +  GT  Y +PE  +    S   KSD+++ G ++ 
Sbjct: 178 RPIAKIGDFGLSKNI-GIESMAHSCV--GTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234

Query: 587 EIISGR----KNNGF 597
           E+ SG+    K N F
Sbjct: 235 ELCSGKTPFHKANNF 249

Length = 1021

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 6/152 (3%)

Query: 436 NEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI 495
           +E  L+ +L H  ++ LL   + G    L+   +P    D++ +   R   L   +  ++
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQVTAV 265

Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 555
              +   I Y+H +    IIHRD+K  N+L++   +  + DFG A    G+ +      I
Sbjct: 266 ARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI 322

Query: 556 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLE 587
           AGT    APE   G  ++   D++S G+++ E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 48.9 bits (116), Expect = 5e-06
 Identities = 55/237 (23%), Positives = 95/237 (40%), Gaps = 45/237 (18%)

Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKN 448
           F     +G+G FG V      D G   A+K L +      + +   + E +++ +     
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
           +V++     +   L LI E++P   +       T  ++ D    +     IA  +L +  
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDM------MTLLMKKDTLTEEETQFYIAETVLAIDS 116

Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGL----------------------------- 539
             +L  IHRD+K  N+LLD   + K+SDFGL                             
Sbjct: 117 IHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176

Query: 540 -----ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
                A  +  N+ Q   + + GT  Y+APE  M   ++   D +S GV++ E++ G
Sbjct: 177 NSKRKAETWKRNRRQLAFSTV-GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 48.5 bits (115), Expect = 5e-06
 Identities = 53/237 (22%), Positives = 96/237 (40%), Gaps = 45/237 (18%)

Query: 393 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG----QGLQEFKNEVNLIAKLQHKN 448
           F     +G+G FG V      D   I   ++ R +     + +   + E +++ +     
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
           +V++     + + L LI E++P   +       T  ++ D    ++    IA  +L +  
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDM------MTLLMKKDTLSEEATQFYIAETVLAIDA 116

Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGL----------------------------- 539
             +L  IHRD+K  N+LLD   + K+SDFGL                             
Sbjct: 117 IHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176

Query: 540 -----ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
                A  +  N+ Q   + + GT  Y+APE  M   ++   D +S GV++ E++ G
Sbjct: 177 NSKRKAETWKKNRRQLAYSTV-GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score = 45.1 bits (107), Expect = 6e-06
 Identities = 20/51 (39%), Positives = 27/51 (52%), Gaps = 2/51 (3%)

Query: 235 GQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRY 285
            QC   LS  DCR CL   +  ++RC  P   G GRI + SC + +E Y +
Sbjct: 58  AQCRGDLSASDCRSCLATAVSELRRCC-PNKKG-GRIWYDSCFLRYESYPF 106

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 47.4 bits (113), Expect = 1e-05
 Identities = 42/196 (21%), Positives = 87/196 (44%), Gaps = 22/196 (11%)

Query: 407 VYKGTLADGKAIAVKRL---SRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL 463
           +YKG   + K + ++      +     +   +NE+  + ++   N++++ G  ++  + L
Sbjct: 36  IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 464 ----LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDL 519
               LI EY     L   L    +   L +K +  +     +G+  L+        +++L
Sbjct: 95  PRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLY--KYTNKPYKNL 149

Query: 520 KASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS---IKS 576
            + + L+ ++   KI   GL +I   +    N N +     Y + +  +  IFS   IK 
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKILS-SPPFKNVNFMV----YFSYKM-LNDIFSEYTIKD 203

Query: 577 DVFSFGVLLLEIISGR 592
           D++S GV+L EI +G+
Sbjct: 204 DIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 47.3 bits (113), Expect = 1e-05
 Identities = 61/239 (25%), Positives = 86/239 (35%), Gaps = 49/239 (20%)

Query: 392 HFSDENKLGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAKL 444
           HF     LG+G  G V+    KGT   GK  A+K L +       + K    E  ++A L
Sbjct: 2   HFKKIKLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATL 58

Query: 445 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
            H  L  L         L L+ +Y P               Q      + +    A  +L
Sbjct: 59  DHPFLPTLYASFQTETYLCLVMDYCPGGE-----LFRLLQRQPGKCLSEEVARFYAAEVL 113

Query: 505 ----YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL---------ARIF-------G 544
               YLH    L I++RDLK  NILL +  +  +SDF L                     
Sbjct: 114 LALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170

Query: 545 GNQNQ-----------ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
            + N              +N   GT  Y+APE   G       D ++ G+LL E++ G 
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 31/99 (31%), Positives = 54/99 (54%), Gaps = 8/99 (8%)

Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG-LARIFGGNQNQANTNIIAG 557
           +A  +L +    +L  +HRD+K  N+LLD + + +++DFG   R+      Q  +N+  G
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ--SNVAVG 165

Query: 558 TYGYMAPEY--AMG---GIFSIKSDVFSFGVLLLEIISG 591
           T  Y++PE   AM    G +  + D +S GV + E++ G
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 47.5 bits (113), Expect = 2e-05
 Identities = 46/175 (26%), Positives = 73/175 (41%), Gaps = 32/175 (18%)

Query: 393 FSDENKLGQGGFGPVYKGTLADGKAIAVKR--LSRTSGQGLQE-FKNE------VNLIAK 443
           F    KLG+G FG VYK +L + ++    +  L + +  G  E + NE       N  A 
Sbjct: 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCAD 193

Query: 444 LQHKNLVRLLGCCLEGQELLLIYEY---------MPNK----SLDVHLFDATRSVQLDWK 490
             +  L  +     +  E  L++ Y         M +K    +++ +L    + +    +
Sbjct: 194 FVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLE 251

Query: 491 RRQSIINGIARGILY----LHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLA 540
           R   II  I R IL+    LH      I+HRD+K  NI+  +     KI D G A
Sbjct: 252 RENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 28/98 (28%), Positives = 52/98 (53%), Gaps = 6/98 (6%)

Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           IA  +L +H   +L  +HRD+K  N+LLD + + +++DFG + +         +++  GT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGT 166

Query: 559 YGYMAPEYAMG-----GIFSIKSDVFSFGVLLLEIISG 591
             Y++PE         G +  + D +S GV + E++ G
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 47/192 (24%), Positives = 88/192 (45%), Gaps = 18/192 (9%)

Query: 410 GTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469
           GTL     + +  L   + + L+  +NEV L    +H N++        G  L +I  +M
Sbjct: 25  GTLV---TVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81

Query: 470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD 529
              S +  L        +      +I+ G  RG+ YLH++     IHR++KAS+IL+  D
Sbjct: 82  AYGSAN-SLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGD 137

Query: 530 MNPKISDFGLARIFGGNQNQANTNII-------AGTYGYMAPEYAMGGI--FSIKSDVFS 580
               +S  GL+ ++   +N     ++            +++PE     +  +++KSD++S
Sbjct: 138 GLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYS 195

Query: 581 FGVLLLEIISGR 592
            G+   E+ +GR
Sbjct: 196 VGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 33/151 (21%), Positives = 54/151 (35%), Gaps = 15/151 (9%)

Query: 394 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV--R 451
           S    L  G    VY     D   + +K           + + EV ++  L  K L   +
Sbjct: 1   SSIKLLKGGLTNRVYLLGTKDEDYV-LKINPSREKG--ADREREVAILQLLARKGLPVPK 57

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
           +L          L+ E++  ++LD          + +    Q     +A  +  LH+   
Sbjct: 58  VLASGESDGWSYLLMEWIEGETLDE-----VSEEEKEDIAEQ-----LAELLAKLHQLPL 107

Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARI 542
           L + H DL   NIL+DD     I D+  A  
Sbjct: 108 LVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 46.3 bits (110), Expect = 3e-05
 Identities = 54/246 (21%), Positives = 98/246 (39%), Gaps = 51/246 (20%)

Query: 392 HFSDENKLGQGGFGPVYKGTLADGKAI-AVKRLSRTS---GQGLQEFKNEVNLIAKLQHK 447
            F     +G G FG V      D  A+ A+K L +            K E +++A+  ++
Sbjct: 2   MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNE 61

Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
            +V+L     +   L  + +Y+P   + + L       + D  R    I  +   I  +H
Sbjct: 62  WVVKLYYSFQDKDNLYFVMDYIPGGDM-MSLLIRLGIFEEDLAR--FYIAELTCAIESVH 118

Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGL---------ARIFGGNQN---------- 548
              ++  IHRD+K  NIL+D D + K++DFGL         ++ +    +          
Sbjct: 119 ---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175

Query: 549 ------------------QANTNIIA----GTYGYMAPEYAMGGIFSIKSDVFSFGVLLL 586
                             + +   +A    GT  Y+APE  +   ++   D +S GV+L 
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235

Query: 587 EIISGR 592
           E++ G+
Sbjct: 236 EMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.4 bits (110), Expect = 4e-05
 Identities = 44/152 (28%), Positives = 76/152 (50%), Gaps = 22/152 (14%)

Query: 401 QGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
           +G FG VY G    + K  AVK + +    +   + + + E + +A  +   +V L    
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73

Query: 457 LEGQELLLIYEYMPN---KSLDVHL---FDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                + L+ EY+     KSL +H+   FD   +V+         I+ +A  + YLH   
Sbjct: 74  QSANNVYLVMEYLIGGDVKSL-LHIYGYFDEEMAVKY--------ISEVALALDYLH--- 121

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
           R  IIHRDLK  N+L+ ++ + K++DFGL+++
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 45.4 bits (107), Expect = 6e-05
 Identities = 57/243 (23%), Positives = 95/243 (39%), Gaps = 55/243 (22%)

Query: 399 LGQGGFGPVYKGTLADGKAI-AVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLG 454
           LG G FG V      D KA+ A+K L +        +   K E +++A+  ++ +VRL  
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
              +   L  + +Y+P   + + L         D  R       IA     +    ++  
Sbjct: 69  SFQDKDNLYFVMDYIPGGDM-MSLLIRMGIFPEDLARFY-----IAELTCAVESVHKMGF 122

Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIF-----------GGNQNQANTNI--------- 554
           IHRD+K  NIL+D D + K++DFGL   F           G +  Q + +          
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 555 -------------------------IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEII 589
                                    + GT  Y+APE  +   ++   D +S GV+L E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 590 SGR 592
            G+
Sbjct: 243 VGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 44.2 bits (104), Expect = 9e-05
 Identities = 50/211 (23%), Positives = 88/211 (41%), Gaps = 32/211 (15%)

Query: 399 LGQGGFGPVYKGTLAD---------GKAIAVKRLSRTSGQGLQE----FKNEVNLIAKLQ 445
           LG+G    +Y G L                +K + +      ++    F    +++ ++ 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           HK++V L G C+   E +++ E++    LD+ +   +  +   WK +  +   +A  + Y
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFK--VAKQLASALSY 120

Query: 506 LHEDSRLKIIHRDLKASNILL-----DDDMNP--KISDFGLARIFGGNQNQANTNIIAGT 558
           L ED  L  +H ++   NILL     D +  P  K+SD G+       Q           
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE------R 171

Query: 559 YGYMAPEYAM-GGIFSIKSDVFSFGVLLLEI 588
             ++APE        SI +D +SFG  L EI
Sbjct: 172 IPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 44.3 bits (104), Expect = 1e-04
 Identities = 48/204 (23%), Positives = 90/204 (44%), Gaps = 19/204 (9%)

Query: 399 LGQGGFGPVYKGTLADG-KAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVRLLG 454
           +G+G FG V    L +  K  A+K L++       E   F+ E +++    ++ +  L  
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
              +   L L+ +Y     L   L      +  D  R       +A  ++ +    +L  
Sbjct: 69  AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----LAEMVIAIDSVHQLHY 123

Query: 515 IHRDLKASNILLDDDMNPKISDFG--LARIFGGNQNQANTNIIAGTYGYMAPEYAMG--- 569
           +HRD+K  NIL+D + + +++DFG  L  +  G      +++  GT  Y++PE       
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT---VQSSVAVGTPDYISPEILQAMED 180

Query: 570 --GIFSIKSDVFSFGVLLLEIISG 591
             G +  + D +S GV + E++ G
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 44.0 bits (104), Expect = 1e-04
 Identities = 31/103 (30%), Positives = 50/103 (48%), Gaps = 22/103 (21%)

Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI---------- 554
           YLH      I+HRDLK  N+L+    + K++DFGL++I  G  +   TN+          
Sbjct: 116 YLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKI--GLMSLT-TNLYEGHIEKDTR 169

Query: 555 ------IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
                 + GT  Y+APE  +   +    D ++ G++L E + G
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 55/243 (22%), Positives = 97/243 (39%), Gaps = 55/243 (22%)

Query: 399 LGQGGFGPVYKGTLADGKAI-AVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
           LG G FG V      D  A+ A+K L +    +   +   K E +++A+  ++ +V+L  
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
              +   L  + +Y+P   +   L      ++++          IA   L +    ++  
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLL------IRMEVFPEVLARFYIAELTLAIESVHKMGF 122

Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQN----QANTNI---------------- 554
           IHRD+K  NIL+D D + K++DFGL   F    N    Q  ++I                
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 555 -------------------------IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEII 589
                                    + GT  Y+APE  +   ++   D +S GV+L E++
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 590 SGR 592
            G+
Sbjct: 243 VGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 35/103 (33%), Positives = 49/103 (47%), Gaps = 18/103 (17%)

Query: 374 ESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGT-LADGK-----AIAVKRLSRTS 427
           E  EFP   L+              LG G FG V + T    GK      +AVK L  ++
Sbjct: 31  EKWEFPRDNLQFG----------KTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA 80

Query: 428 GQGLQE-FKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEY 468
               +E   +E+ +++ L QHKN+V LLG C  G  +L+I EY
Sbjct: 81  HTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEY 123

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 22/52 (42%), Positives = 32/52 (61%), Gaps = 1/52 (1%)

Query: 490 KRRQSIINGIARGILY-LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA 540
           KR  ++I G+ R +L  L +  R+ I+HRD+K  N+L+  D   KI DFG A
Sbjct: 305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 39.2 bits (92), Expect = 0.002
 Identities = 37/167 (22%), Positives = 55/167 (32%), Gaps = 51/167 (30%)

Query: 398 KLGQGGFGPVYKGTLADGKAIAVK----------------RLSRTSGQGLQEFKNEVNLI 441
            + QG    +Y        A+ VK                R  RT        + E  ++
Sbjct: 3   LIKQGAEAIIYLTDFLGLPAV-VKERIPKRYRHPELDEKLRRERT--------RREARIL 53

Query: 442 AKLQHKNLVRLLGCC------LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI 495
           AK       R  G        ++    L++ EY+  + L     DA    + D  R    
Sbjct: 54  AKA------REAGVPVPIVYDVDPDNGLIVMEYIEGELLK----DALEEARPDLLRE--- 100

Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
              + R +  LH+     I+H DL  SNI+L         DFGL   
Sbjct: 101 ---VGRLVGKLHKA---GIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140

Length = 204

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	621
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.98
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.98
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.98
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.98
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.98
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.98
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.98
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.98
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.98
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.98
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.98
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.98
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.98
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.98
KOG0589	426	consensus Serine/threonine protein kinase [General	99.98
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.98
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.98
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.98
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.98
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.98
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.98
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.98
PHA03207	392	serine/threonine kinase US3; Provisional	99.97
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.97
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.97
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.97
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.97
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.97
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.97
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.97
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.97
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.97
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.97
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.97
PHA03211	461	serine/threonine kinase US3; Provisional	99.97
PTZ00036	440	glycogen synthase kinase; Provisional	99.97
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.97
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.97
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.97
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.97
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.97
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.97
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.97
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.97
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.97
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.97
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.97
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.97
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.97
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.97
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.97
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.97
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.97
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.97
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.97
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.97
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.97
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.97
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.97
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.97
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.97
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.97
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.97
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.97
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.97
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.97
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.97
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.97
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.97
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.97
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.97
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.97
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.97
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.97
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.97
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.97
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.97
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.97
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.97
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.97
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.97
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.97
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.97
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.97
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.97
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.97
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.97
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.97
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.97
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.97
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.97
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.97
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.97
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.97
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.97
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.97
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.97
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.97
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.97
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.97
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.97
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.97
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.97
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.97
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.97
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.97
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.97
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.97
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.97
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.97
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.97
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.97
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.97
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.97
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.97
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.97
PTZ00284	467	protein kinase; Provisional	99.97
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.97
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.97
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.97
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.97
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.97
KOG0584	632	consensus Serine/threonine protein kinase [General	99.97
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.97
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.97
PHA03209	357	serine/threonine kinase US3; Provisional	99.97
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.97
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.97
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.97
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.97
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.97
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.97
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.97
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.97
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.97
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.97
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.97
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.97
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.97
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.97
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.97
KOG0586	596	consensus Serine/threonine protein kinase [General	99.97
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.97
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.97
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.97
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.97
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.97
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.97
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.97
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.97
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.97
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.97
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.97
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.97
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.97
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.97
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.97
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.97
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.97
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.97
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.97
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.97
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.97
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.97
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.97
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.97
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.97
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.97
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.97
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.97
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.97
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.97
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.97
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.97
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.97
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.97
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.97
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.97
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.97
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.97
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.97
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.97
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.97
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.97
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.96
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.96
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.96
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.96
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.96
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.96
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.96
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.96
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.96
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.96
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.96
PLN00009	294	cyclin-dependent kinase A; Provisional	99.96
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.96
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.96
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.96
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.96
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.96
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.96
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.96
PHA03210	501	serine/threonine kinase US3; Provisional	99.96
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.96
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.96
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.96
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.96
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.96
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.96
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.96
PHA02882	294	putative serine/threonine kinase; Provisional	99.96
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.96
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.96
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.96
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.96
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.96
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.96
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.96
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.96
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.96
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.96
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.96
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.96
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.96
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.96
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.96
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.96
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.96
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.96
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.96
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.96
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.96
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.96
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.96
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.96
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.96
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.96
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.95
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.95
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.95
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.95
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.95
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.95
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.95
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.95
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.95
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.95
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.95
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.95
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.95
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.95
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.95
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.94
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.94
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.94
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.94
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.93
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.93
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.91
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.91
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.9
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.9
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.89
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.89
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.88
PF01657	106	Stress-antifung: Salt stress response/antifungal;	99.88
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.85
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.85
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.84
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.84
PLN00181	793	protein SPA1-RELATED; Provisional	99.83
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.82
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.81
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.81
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.78
PRK12274	218	serine/threonine protein kinase; Provisional	99.78
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.78
PF01657	106	Stress-antifung: Salt stress response/antifungal;	99.75
PRK10345	210	hypothetical protein; Provisional	99.74
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.71
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.71
smart00090	237	RIO RIO-like kinase.	99.7
PRK14879	211	serine/threonine protein kinase; Provisional	99.69
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.68
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.68
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.68
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.67
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.66
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.66
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.6
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.6
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.59
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.53
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.52
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.49
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.43
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.41
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.4
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.3
KOG1243	690	consensus Protein kinase [General function predict	99.23
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.2
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.13
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.13
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.11
KOG3087	229	consensus Serine/threonine protein kinase [General	99.02
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.01
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.95
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.91
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.83
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.78
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.68
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.67
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.59
COG4248	637	Uncharacterized protein with protein kinase and he	98.57
PRK09902	216	hypothetical protein; Provisional	98.51
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.5
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.41
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.39
PF01636	239	APH: Phosphotransferase enzyme family This family	98.23
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.13
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.11
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.1
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.0
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.0
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.0
PLN02876	822	acyl-CoA dehydrogenase	97.96
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.95
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.93
PRK10593	297	hypothetical protein; Provisional	97.84
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.81
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.75
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.71
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.69
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.62
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.42
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.41
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.26
PRK05231	319	homoserine kinase; Provisional	97.18
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.04
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.86
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.82
PLN02236	344	choline kinase	96.76
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.72
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.68
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.5
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	96.2
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.04
KOG2270	520	consensus Serine/threonine protein kinase involved	96.01
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.97
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.84
PF08693	40	SKG6: Transmembrane alpha-helix domain; InterPro:	95.72
PLN02756	418	S-methyl-5-thioribose kinase	95.63
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.59
COG2334	331	Putative homoserine kinase type II (protein kinase	95.57
PRK11768	325	serine/threonine protein kinase; Provisional	95.48
PRK12396	409	5-methylribose kinase; Reviewed	95.18
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	95.04
PTZ00384	383	choline kinase; Provisional	94.75
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.58
PRK06148	1013	hypothetical protein; Provisional	94.23
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.11

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-46  Score=392.52  Aligned_cols=238  Identities=50%  Similarity=0.815  Sum_probs=211.6

Q ss_pred             CccccchHHHHHHhCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEE
Q 007006          377 EFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC  456 (621)
Q Consensus       377 ~~~~~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~  456 (621)
                      ....|++.++..+|++|...+.||+|+||.||+|.+.+|..||||++.....+..++|.+|++++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56678999999999999999999999999999999999999999988765543146699999999999999999999999


Q ss_pred             eeCc-eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEe
Q 007006          457 LEGQ-ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS  535 (621)
Q Consensus       457 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~  535 (621)
                      .+.+ +.+||||||++|+|+++|+..... +++|.+|++|+.++|+||+|||+...++|+||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9998 599999999999999999865444 89999999999999999999999888899999999999999999999999


Q ss_pred             eecCceecCCCCCCcccccc-cccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCcCCCCCChHHHHHHhh
Q 007006          536 DFGLARIFGGNQNQANTNII-AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSL  614 (621)
Q Consensus       536 Dfgla~~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~v~~~~  614 (621)
                      |||+++.....  ....... .||.+|+|||++..+..+.|+|||||||+|+||+||++|.+...+...+++++|+|..+
T Consensus       220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            99999654331  1111112 78999999999999999999999999999999999999988776667778999999998


Q ss_pred             ccc
Q 007006          615 SLS  617 (621)
Q Consensus       615 ~~~  617 (621)
                      .++
T Consensus       298 ~~~  300 (361)
T KOG1187|consen  298 EEG  300 (361)
T ss_pred             HCc
Confidence            775

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-42  Score=347.41  Aligned_cols=201  Identities=29%  Similarity=0.518  Sum_probs=180.1

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ..+|...+.||+|+|++||+|+++ ++..||||.+.+.  .....+.+..|+++|+.++|||||++++++++++..+|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            467888899999999999999965 5899999999876  4556677889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC------CCeEEeeecCc
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD------MNPKISDFGLA  540 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~------~~vkL~Dfgla  540 (621)
                      |||.||+|..|++.   ...+++..+..++.||+.||++||+++   ||||||||.||||+..      -.+||+|||++
T Consensus        89 EyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            99999999999964   346999999999999999999999986   9999999999999865      45899999999


Q ss_pred             eecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          541 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       541 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      +.+....   .....+|++-|||||+++...|+.|+|+||+|++|||+++|+.||....
T Consensus       163 R~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  163 RFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             hhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            9876432   2345799999999999999999999999999999999999999998443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-40  Score=328.89  Aligned_cols=202  Identities=31%  Similarity=0.463  Sum_probs=180.0

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      .++|++.+.||+|+||.|+.++. ++++.+|+|++++..   ....+...+|..+|.+++||.||+++-.|++.+.+|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            46899999999999999999985 468999999998763   33456788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      +||+.||.|..+|.   +...+++..+.-++..|+.||.|||+.+   |+||||||+|||||++|+++|+|||+++..-.
T Consensus       104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            99999999998884   4556999999999999999999999987   99999999999999999999999999986433


Q ss_pred             CCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      .  ...+...+||+.|||||++.+..|+..+|+||+|+++|||++|.+||...+
T Consensus       178 ~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~  229 (357)
T KOG0598|consen  178 D--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED  229 (357)
T ss_pred             C--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence            2  223344799999999999999999999999999999999999999986443

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=339.75  Aligned_cols=202  Identities=40%  Similarity=0.613  Sum_probs=175.5

Q ss_pred             CCccceeccCCceeEEEEEecCCcEEEEEEeccCCcc--cHHHHHHHHHHHHhcccCCceeEeeEEeeCc-eEEEEEEec
Q 007006          393 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ--GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-ELLLIYEYM  469 (621)
Q Consensus       393 f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~-~~~lV~e~~  469 (621)
                      +...+.||+|+||+||+|.+.....||||++......  ..+.|.+|+.+|.+++|||||+++|+|.++. .+.+||||+
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            3445669999999999999975555999999865422  2568999999999999999999999999987 799999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC-CeEEeeecCceecCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIFGGNQN  548 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~vkL~Dfgla~~~~~~~~  548 (621)
                      ++|+|..+++.. +...+++..+++++.||++||.|||+.++  ||||||||+|||++.++ ++||+|||+++...... 
T Consensus       123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-  198 (362)
T KOG0192|consen  123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-  198 (362)
T ss_pred             CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence            999999999764 45679999999999999999999999853  99999999999999998 99999999998754322 


Q ss_pred             CcccccccccCCccChhccc--CCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          549 QANTNIIAGTYGYMAPEYAM--GGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~--~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                       .......||+.|||||++.  ...++.|+|||||||++|||+||+.||....
T Consensus       199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~  250 (362)
T KOG0192|consen  199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA  250 (362)
T ss_pred             -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC
Confidence             2222357999999999999  6689999999999999999999999997554

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-39  Score=341.57  Aligned_cols=200  Identities=29%  Similarity=0.467  Sum_probs=183.4

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      .+|...+.||+|+|..+|+++. ..|+.||+|++.+.   .....+.+.+||++.+.|+|||||+++++|++.+..|+|+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688999999999999999996 78999999999874   3455678899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      |+|++++|..++.   +++++++.++..+++||+.||.|||+++   |+|||||..|+||+++.++||+|||||..+..+
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999998884   5678999999999999999999999986   999999999999999999999999999988654


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ..  +....+|||-|+|||++.+..++..+||||+|||+|-|++|++||+-.
T Consensus       172 ~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk  221 (592)
T KOG0575|consen  172 GE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK  221 (592)
T ss_pred             cc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence            33  334589999999999999999999999999999999999999999754

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=324.34  Aligned_cols=214  Identities=31%  Similarity=0.421  Sum_probs=184.4

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC-CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCc-eEEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-ELLLIYE  467 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~-~~~lV~e  467 (621)
                      .+.+..+.||+|..|+|||++++ +++.+|+|.+... +....+++.+|++++++.+||+||+++|.|..+. ...++||
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            35566789999999999999976 6888999999544 4455678999999999999999999999999998 5999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      ||++|+|+.++...   +.+++...-+|+.++++||.|||+.  .+||||||||+||||+..|++||+|||.+..+... 
T Consensus       159 YMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  159 YMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             hcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence            99999999999543   5699999999999999999999974  25999999999999999999999999999876443 


Q ss_pred             CCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCc--CCCCCChHHHHHHh
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF--SEHGQTLLTYVCNS  613 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~--~~~~~~l~~~v~~~  613 (621)
                         ..+..+||..|||||.+.+..|+.++||||||++++|+.+|+.|+....  .....+|+.++...
T Consensus       233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~  297 (364)
T KOG0581|consen  233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE  297 (364)
T ss_pred             ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC
Confidence               3455789999999999999999999999999999999999999997652  22334555555543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-40  Score=315.36  Aligned_cols=205  Identities=27%  Similarity=0.418  Sum_probs=178.0

Q ss_pred             CCCCccceeccCCceeEEEEE-ecCCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEee-EEeeCce-EEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLG-CCLEGQE-LLLI  465 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g-~~~~~~~-~~lV  465 (621)
                      .+|.++++||+|.||+|||+. +.+|..+|.|.+.-.  +....++...|+.+|++|+|||||++++ -+.++.+ +.+|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            368889999999999999998 678999999998733  3455678899999999999999999998 4444444 8999


Q ss_pred             EEecCCCChhhhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCeEeccCCCCCEEEcCCCCeEEeeecCceec
Q 007006          466 YEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSR-LKIIHRDLKASNILLDDDMNPKISDFGLARIF  543 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~  543 (621)
                      ||++..|+|...+...+ ....++++.+++++.|++.||.++|+..+ .-|.||||||.||+|+.+|.+||+|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            99999999999887643 34568999999999999999999998532 23999999999999999999999999999988


Q ss_pred             CCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          544 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       544 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .....  .....+|||.||+||.+.+..|+.||||||+||++|||..-++||..
T Consensus       179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g  230 (375)
T KOG0591|consen  179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG  230 (375)
T ss_pred             cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc
Confidence            65433  33457899999999999999999999999999999999999999863

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.4e-39  Score=320.26  Aligned_cols=201  Identities=28%  Similarity=0.446  Sum_probs=173.2

Q ss_pred             HhCCCCccceeccCCceeEEEEE-ecCCcEEEEEEeccCCcc-------cHHHHHHHHHHHHhcccCCceeEeeEEeeCc
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQ-------GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ  460 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~-------~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~  460 (621)
                      ..+.|.+.+.||+|+||.|-+|. .++|+.||||++.+....       ......+|+++|++|+|||||++++++..++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            34678889999999999999998 457999999999765211       2234579999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC---CCeEEeee
Q 007006          461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD---MNPKISDF  537 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~vkL~Df  537 (621)
                      ..|+||||++||.|.+++-.   +..+.+.....++.|++.|+.|||++|   |+||||||+|||+..+   -.+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence            99999999999999988843   345777888899999999999999997   9999999999999866   67999999


Q ss_pred             cCceecCCCCCCcccccccccCCccChhcccCCC---CChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          538 GLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI---FSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       538 gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      |+|+..+   .....+..+||+.|.|||++.+..   +..+.|+||+||+||-+++|.+||+-.
T Consensus       324 GlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~  384 (475)
T KOG0615|consen  324 GLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEE  384 (475)
T ss_pred             chhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccc
Confidence            9999865   344566789999999999997655   345889999999999999999998643

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=329.99  Aligned_cols=201  Identities=37%  Similarity=0.543  Sum_probs=175.9

Q ss_pred             CCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCC
Q 007006          393 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK  472 (621)
Q Consensus       393 f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  472 (621)
                      +...+.||+|.||.||.|.++....||+|.++... ...+.|.+|+.+|++|+|+|||+++|+|..++.++||||||+.|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            34568899999999999999888899999997652 33578899999999999999999999999999999999999999


Q ss_pred             ChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCccc
Q 007006          473 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT  552 (621)
Q Consensus       473 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~  552 (621)
                      +|.+||.. .....++..+.+.++.|||+|++||+++.   +|||||.++||||+++..+||+||||++...++......
T Consensus       287 sLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~  362 (468)
T KOG0197|consen  287 SLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE  362 (468)
T ss_pred             cHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence            99999975 34566899999999999999999999985   999999999999999999999999999965554443322


Q ss_pred             ccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCCc
Q 007006          553 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYF  599 (621)
Q Consensus       553 ~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~~  599 (621)
                       ...-+..|.|||.+..+.++.|||||||||+||||+| |+.|+.-+.
T Consensus       363 -~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms  409 (468)
T KOG0197|consen  363 -GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS  409 (468)
T ss_pred             -CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC
Confidence             2234678999999999999999999999999999999 888876444

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=6.5e-38  Score=340.78  Aligned_cols=207  Identities=35%  Similarity=0.532  Sum_probs=177.4

Q ss_pred             CCCCccceeccCCceeEEEEEec------CCcEEEEEEeccCCcc-cHHHHHHHHHHHHhcccCCceeEeeEEeeCceEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL  463 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~  463 (621)
                      .+.+..+.||+|.||.||+|+..      +...||||.+++.... ..++|++|+++|+.++|||||+|+|+|.+++.++
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            45566789999999999999843      3567999999987655 7889999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCe
Q 007006          464 LIYEYMPNKSLDVHLFDATR-----------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP  532 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~v  532 (621)
                      +|+|||..|+|.+||.-...           ..+|+..+.+.|+.|||.|++||-++.   +|||||..+|+||.++..|
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence            99999999999999963211           234899999999999999999999875   9999999999999999999


Q ss_pred             EEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCCcC
Q 007006          533 KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFS  600 (621)
Q Consensus       533 kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~~~  600 (621)
                      ||+|||+++..-+.+.........-+.+|||||.+..+.||++||||||||+|||+++ |+.||.-...
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn  711 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN  711 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch
Confidence            9999999997544443332222234679999999999999999999999999999999 8889754443

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-38  Score=318.62  Aligned_cols=196  Identities=34%  Similarity=0.535  Sum_probs=165.2

Q ss_pred             CCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHh--cccCCceeEeeEEeeCc----eEEEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK--LQHKNLVRLLGCCLEGQ----ELLLI  465 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~h~nIv~l~g~~~~~~----~~~lV  465 (621)
                      .....+.||+|.||.||||.+. ++.||||++...+   .+.|.+|-++.+.  ++|+||+++++.-...+    +++||
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc-CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            4455688999999999999985 6999999997543   4567777776655  58999999999877655    89999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEeccCCCCCEEEcCCCCeEEeeecC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS------RLKIIHRDLKASNILLDDDMNPKISDFGL  539 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~iiH~Dlkp~NILl~~~~~vkL~Dfgl  539 (621)
                      ++|.++|+|.+||.    ...++|....+|+..+++||+|||+.-      +++|+|||||++||||.+|++..|+|||+
T Consensus       287 t~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             eeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            99999999999994    456999999999999999999999763      46899999999999999999999999999


Q ss_pred             ceecCCCCCCcccccccccCCccChhcccCCCC------ChhhhHHHHHHHHHHHHcCCCCC
Q 007006          540 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF------SIKSDVFSFGVLLLEIISGRKNN  595 (621)
Q Consensus       540 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~------s~~sDVwS~Gvll~elltG~~p~  595 (621)
                      +.++.........-.-+||.+|||||++.+...      -.+.||||+|.|||||++.-.-.
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~  424 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA  424 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence            999876555554445689999999999966542      24689999999999999875543

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-37  Score=297.65  Aligned_cols=199  Identities=30%  Similarity=0.413  Sum_probs=179.9

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|+..+.||.|+||.|.+++.+ +|..+|+|++++..   -.+.+...+|..+|+.+.||+++++.+.+.+.+.+++||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            57888999999999999999965 58899999998764   344566789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||++||.|..+++.   ..++++..+.-++.||+.||+|||+.+   |++|||||+|||||.+|.+||+|||.++.... 
T Consensus       124 eyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-  196 (355)
T ss_pred             eccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence            99999999999954   456999999999999999999999986   99999999999999999999999999997543 


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCcC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFS  600 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~  600 (621)
                          .+-..+||+.|+|||++....+...+|+|+|||++|||+.|.+||.....
T Consensus       197 ----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~  246 (355)
T KOG0616|consen  197 ----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP  246 (355)
T ss_pred             ----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence                35567999999999999999999999999999999999999999875544

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-37  Score=317.29  Aligned_cols=205  Identities=28%  Similarity=0.471  Sum_probs=177.1

Q ss_pred             hCCCCccceeccCCceeEEEEE-ecCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeC--ceEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLL  464 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~~l  464 (621)
                      .+.|+.+++||+|.||.||+++ +.+|+.||+|+++...  ........+||.+|++|+||||++|.+...+.  ..+||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            3568889999999999999998 5689999999997553  44455678999999999999999999999987  68999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      |+|||+. +|..++.  .....+++.++..++.||+.||.|+|+.+   |+|||||.+|||||.+|.+||+|||||+++.
T Consensus       196 VFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence            9999975 4555553  34557999999999999999999999987   9999999999999999999999999999887


Q ss_pred             CCCCCcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCCCcCC
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSE  601 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~~~~~  601 (621)
                      .......++ .+-|++|.|||.+.+. .|+...|+||.||||.||++|++.++..++.
T Consensus       270 ~~~~~~~T~-rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv  326 (560)
T KOG0600|consen  270 PSGSAPYTS-RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV  326 (560)
T ss_pred             CCCCccccc-ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH
Confidence            766555444 3569999999998876 4899999999999999999999998765543

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3e-37  Score=318.53  Aligned_cols=197  Identities=30%  Similarity=0.501  Sum_probs=176.8

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      ++|-+.+.||+|.||.||||+.+ +.+.||+|.+.+..  +...+.+.+|++++++++|||||.++++|+...++++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46778899999999999999854 68899999997653  3456779999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |+.| +|..+|.+   +..++++.+..|+.+++.||.|||+.+   |+|||+||.|||++.++.+|++|||+++....+ 
T Consensus        82 ~a~g-~L~~il~~---d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-  153 (808)
T KOG0597|consen   82 YAVG-DLFTILEQ---DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-  153 (808)
T ss_pred             hhhh-hHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence            9987 99999954   456999999999999999999999986   999999999999999999999999999976543 


Q ss_pred             CCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                       ..-...+.||+.|||||...+..|+..+|+||+||++||+++|++||-
T Consensus       154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~  201 (808)
T KOG0597|consen  154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY  201 (808)
T ss_pred             -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch
Confidence             223345789999999999999999999999999999999999999983

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.8e-36  Score=313.24  Aligned_cols=208  Identities=25%  Similarity=0.373  Sum_probs=180.8

Q ss_pred             HHhCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEE
Q 007006          388 EATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL  463 (621)
Q Consensus       388 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~  463 (621)
                      ...++|+.+.+||+|+||.||+++- .+|..+|+|++++..   ..+.+.++.|-.+|...++|+||+|+..|++.+.+|
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence            3568999999999999999999985 469999999998874   455677889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceec
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF  543 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~  543 (621)
                      |||||++||++..+|.   +...|++..+..++.+++.|+.-||+.|   +|||||||+|+|||..|++||+||||+.-+
T Consensus       218 LiMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             EEEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence            9999999999999984   4567999999999999999999999987   999999999999999999999999998543


Q ss_pred             CCC----------------------CCCc----c-------------------cccccccCCccChhcccCCCCChhhhH
Q 007006          544 GGN----------------------QNQA----N-------------------TNIIAGTYGYMAPEYAMGGIFSIKSDV  578 (621)
Q Consensus       544 ~~~----------------------~~~~----~-------------------~~~~~gt~~y~aPE~l~~~~~s~~sDV  578 (621)
                      ...                      +...    .                   ....+|||.|||||++.+..|+..+|+
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw  371 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW  371 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence            210                      0000    0                   012469999999999999999999999


Q ss_pred             HHHHHHHHHHHcCCCCCCCCcCC
Q 007006          579 FSFGVLLLEIISGRKNNGFYFSE  601 (621)
Q Consensus       579 wS~Gvll~elltG~~p~~~~~~~  601 (621)
                      ||||||+||||.|-+||...++.
T Consensus       372 WSLG~ImyEmLvGyPPF~s~tp~  394 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSETPQ  394 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999999866554

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-36  Score=311.03  Aligned_cols=205  Identities=29%  Similarity=0.432  Sum_probs=179.3

Q ss_pred             HHhCCCCccceeccCCceeEEEEE-ecCCcEEEEEEeccCC---cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceE
Q 007006          388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL  462 (621)
Q Consensus       388 ~~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~  462 (621)
                      ...++|...+.||+|+|++|++++ ...++++|||++.+.-   ....+-+..|-+.|.+| .||.|++|+.-|+++..+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            345689999999999999999998 4579999999997652   22234466788899999 899999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      |+|+||.++|+|.++|...   +.+++.-...++.+|+.||+|||+.|   ||||||||+|||||.|+++||+|||.++.
T Consensus       150 YFvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             EEEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence            9999999999999999653   56999999999999999999999987   99999999999999999999999999998


Q ss_pred             cCCCCCC---------cc--cccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          543 FGGNQNQ---------AN--TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       543 ~~~~~~~---------~~--~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      +...+..         ..  ...++||..|.+||++..+..+..+|+|+|||+||+|+.|++||...
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~  290 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA  290 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc
Confidence            8643222         11  14578999999999999999999999999999999999999998643

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.1e-36  Score=293.81  Aligned_cols=199  Identities=24%  Similarity=0.401  Sum_probs=171.9

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc--ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      +.|+.+.++|+|++|+||+++++ +|+.||||++.....  .-.+-.++|+++|++++|+|+|.++.+|.....++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45788899999999999999976 599999999976543  233457899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |++..-|++.-+   ....++.+.+.+++.|+++|+.|+|++.   +|||||||+||||+.++.+||+|||+|+.+..+.
T Consensus        82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence            998776665432   2345899999999999999999999986   9999999999999999999999999999876422


Q ss_pred             CCcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                        ...+..+.|.+|.|||.+.+ .+|+..+|||++||++.||++|.+-|..
T Consensus       156 --d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG  204 (396)
T KOG0593|consen  156 --DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPG  204 (396)
T ss_pred             --chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCC
Confidence              22234567999999999988 6799999999999999999999998753

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-36  Score=314.41  Aligned_cols=198  Identities=30%  Similarity=0.508  Sum_probs=179.7

Q ss_pred             CCCCccceeccCCceeEEEEE-ecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      ..|....+||+|..|.||.+. ..+++.||||++........+-+.+|+.+|+..+|+|||.++..+...+++|+|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            457778899999999999997 5678999999998776666677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++|+|.+.+..    ..+++.++..|++++++||+|||.++   |+|||||.+|||++.+|.+||+|||++..+...+. 
T Consensus       353 ~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-  424 (550)
T KOG0578|consen  353 EGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-  424 (550)
T ss_pred             CCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence            99999988843    34999999999999999999999987   99999999999999999999999999998766554 


Q ss_pred             cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                       .....+||+.|||||++....|++|.||||||+|++||+-|++||=.
T Consensus       425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln  471 (550)
T KOG0578|consen  425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN  471 (550)
T ss_pred             -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC
Confidence             33346899999999999999999999999999999999999999753

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=7.5e-36  Score=283.65  Aligned_cols=198  Identities=30%  Similarity=0.516  Sum_probs=172.7

Q ss_pred             CCCCccceeccCCceeEEEEE-ecCCcEEEEEEeccCCc--ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      ++|...++||+|.||.||+|+ .++|+.||||+++....  .-.....+||+.|+.++|+||+.++++|...+.+.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            467788999999999999998 46799999999986532  223456899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      ||+ .+|+..+++  +...++..++..++.++++||+|||+++   |+||||||.|+|++++|.+||+|||+++.+..+.
T Consensus        82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            996 789888854  4567999999999999999999999997   9999999999999999999999999999987654


Q ss_pred             CCcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      ......  +-|.+|.|||.+.+. .|+...||||.||++.||+-|.+-|.
T Consensus       156 ~~~~~~--V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp  203 (318)
T KOG0659|consen  156 RIQTHQ--VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP  203 (318)
T ss_pred             cccccc--eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC
Confidence            443332  568899999998775 58999999999999999998887654

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-35  Score=308.40  Aligned_cols=201  Identities=28%  Similarity=0.462  Sum_probs=176.8

Q ss_pred             HhCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC----Cc-ccHHHHHHHHHHHHhcc-cCCceeEeeEEeeCce
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT----SG-QGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQE  461 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~----~~-~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~  461 (621)
                      ..++|...+.||+|+||.|+.+.+ .+++.||+|++.+.    .. ...+.+.+|+.+++.++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            356899999999999999999975 56899999977654    12 23456678999999998 9999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC-CCeEEeeecCc
Q 007006          462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGLA  540 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~vkL~Dfgla  540 (621)
                      .++||||+.+|+|.+++.+   ..++.+..+.++++|++.|++|||+.+   |+||||||+|||++.+ +++||+|||++
T Consensus        95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            9999999999999999954   456899999999999999999999986   9999999999999999 99999999999


Q ss_pred             eecCCCCCCcccccccccCCccChhcccCCC-C-ChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          541 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-F-SIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       541 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~-s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ....  .........+|++.|+|||++.+.. | ..++||||+||+||-|++|+.||..
T Consensus       169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d  225 (370)
T KOG0583|consen  169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD  225 (370)
T ss_pred             cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence            9764  1223344578999999999999877 7 5889999999999999999999986

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-35  Score=296.94  Aligned_cols=206  Identities=26%  Similarity=0.422  Sum_probs=179.0

Q ss_pred             hCCCCccceeccCCceeEEEEE-ecCCcEEEEEEeccCCc-ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      .+.|++.+.||.|..++||+|+ ...++.||||++..... ...+.+.+|+..|+.++||||++++..|..+..+|+||+
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            4689999999999999999998 56789999999975532 336889999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC-C
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG-N  546 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~-~  546 (621)
                      ||.+||+.+++...-.. .+++..+..|++++++||.|||.+|   .||||||+.||||+++|.|||+|||.+-.+.. .
T Consensus       105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            99999999999765443 4999999999999999999999987   99999999999999999999999998765433 2


Q ss_pred             CCCccc-ccccccCCccChhcccC--CCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          547 QNQANT-NIIAGTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       547 ~~~~~~-~~~~gt~~y~aPE~l~~--~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      ...... +...||+.|||||+++.  ..|+.|+||||||++..||.+|..||+-+-
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p  236 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP  236 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence            222222 56789999999999654  348999999999999999999999997554

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=300.96  Aligned_cols=203  Identities=30%  Similarity=0.510  Sum_probs=173.1

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCc--eEEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ--ELLLIYE  467 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~--~~~lV~e  467 (621)
                      .+|...+.||+|+||.||++... +|...|||.+...+....+.+.+|+.+|.+++|||||+++|......  .+.+.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            45777899999999999999965 49999999987664444677899999999999999999999855544  6899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC-CCCeEEeeecCceecCC-
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFGG-  545 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~vkL~Dfgla~~~~~-  545 (621)
                      |+++|+|.+++.....  .+++..+.+++.||++||.|||+++   |+|+||||+||||+. ++.+||+|||++..... 
T Consensus        97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            9999999999965432  6999999999999999999999886   999999999999999 79999999999987654 


Q ss_pred             CCCCcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ...........||+.|||||++..+ ....++|||||||++.||+||++||...
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~  225 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF  225 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence            1122223456899999999999864 3446999999999999999999999753

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-35  Score=311.27  Aligned_cols=205  Identities=28%  Similarity=0.421  Sum_probs=179.0

Q ss_pred             HHhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceE
Q 007006          388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL  462 (621)
Q Consensus       388 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~  462 (621)
                      ..-++|...++||+|.||.|+++..+ +++.+|||.+++..   .+..+..+.|-+++... +||.++.++..++.++++
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            34578999999999999999999965 58899999998764   45566778888888777 599999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      ++||||+.||++..+.    +...+++..+.-++..|+.||+|||+++   ||+||||.+|||||.+|.+||+|||+++.
T Consensus       445 ~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             EEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence            9999999999954333    3456999999999999999999999987   99999999999999999999999999986


Q ss_pred             cCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCcCC
Q 007006          543 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE  601 (621)
Q Consensus       543 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~~  601 (621)
                      .-.  ....+..++||+.|||||++.+..|+..+|+|+|||+||||+.|+.||...+++
T Consensus       518 ~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe  574 (694)
T KOG0694|consen  518 GMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE  574 (694)
T ss_pred             cCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence            422  223566789999999999999999999999999999999999999999854443

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-35  Score=296.46  Aligned_cols=208  Identities=28%  Similarity=0.412  Sum_probs=173.3

Q ss_pred             CCccccchHHHHHHhCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHh--cccCCceeEe
Q 007006          376 QEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK--LQHKNLVRLL  453 (621)
Q Consensus       376 ~~~~~~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~h~nIv~l~  453 (621)
                      .....+|+-..+....+....+.||+|.||+||+|.++ |+.||||++...++.   .+.+|.++.+.  |+|+||+.++
T Consensus       196 GSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~---SWfrEtEIYqTvmLRHENILgFI  271 (513)
T KOG2052|consen  196 GSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDER---SWFRETEIYQTVMLRHENILGFI  271 (513)
T ss_pred             CCCCCchhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccchh---hhhhHHHHHHHHHhccchhhhhh
Confidence            33455666677777888999999999999999999995 999999999876554   44556665554  5999999999


Q ss_pred             eEEeeC----ceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEeccCCCCCE
Q 007006          454 GCCLEG----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-----SRLKIIHRDLKASNI  524 (621)
Q Consensus       454 g~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~iiH~Dlkp~NI  524 (621)
                      +.-..+    .+++||.+|.+.|||.+||.    +.+++.+..++++..+|.||+|||-.     |++.|.|||||+.||
T Consensus       272 aaD~~~~gs~TQLwLvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNI  347 (513)
T KOG2052|consen  272 AADNKDNGSWTQLWLVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNI  347 (513)
T ss_pred             hccccCCCceEEEEEeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccE
Confidence            987654    37899999999999999994    35799999999999999999999954     788999999999999


Q ss_pred             EEcCCCCeEEeeecCceecCCC--CCCcccccccccCCccChhcccCCC----C--ChhhhHHHHHHHHHHHHcC
Q 007006          525 LLDDDMNPKISDFGLARIFGGN--QNQANTNIIAGTYGYMAPEYAMGGI----F--SIKSDVFSFGVLLLEIISG  591 (621)
Q Consensus       525 Ll~~~~~vkL~Dfgla~~~~~~--~~~~~~~~~~gt~~y~aPE~l~~~~----~--s~~sDVwS~Gvll~elltG  591 (621)
                      |+..++...|+|+|||-.+...  +.....+..+||.+|||||++....    +  -..+||||||.|+||+...
T Consensus       348 LVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarR  422 (513)
T KOG2052|consen  348 LVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARR  422 (513)
T ss_pred             EEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHH
Confidence            9999999999999999887654  3334456779999999999986543    2  2368999999999999754

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-35  Score=330.06  Aligned_cols=206  Identities=37%  Similarity=0.560  Sum_probs=175.4

Q ss_pred             CCCCccceeccCCceeEEEEEecC--Cc----EEEEEEeccC-CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLAD--GK----AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL  463 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~--g~----~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~  463 (621)
                      .+....+.||+|.||.||.|...+  |.    .||||.+.+. +.+...+|.+|..+|++++|||||+++|++.+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            455677899999999999998643  43    4899999876 4566778999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecC
Q 007006          464 LIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL  539 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgl  539 (621)
                      +++|||++|+|..||++.+.    ...++..+.+.++.|||+|+.||+++.   +|||||..+|+||++...+||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence            99999999999999976421    456999999999999999999999875   99999999999999999999999999


Q ss_pred             ceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCCc
Q 007006          540 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYF  599 (621)
Q Consensus       540 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~~  599 (621)
                      |+.+...+.........-+.+|||||.+..+.++.|+|||||||+|||++| |..||....
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~  909 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS  909 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc
Confidence            995433322222222334568999999999999999999999999999999 888886443

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.2e-34  Score=307.88  Aligned_cols=201  Identities=25%  Similarity=0.366  Sum_probs=173.7

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|+..+.||+|+||.||++... +++.||+|++++..   ......+.+|+.++.+++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47889999999999999999854 68999999997542   233456788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            99999999999853   346899999999999999999999986   999999999999999999999999998754321


Q ss_pred             CCC---------------------------------cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCC
Q 007006          547 QNQ---------------------------------ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRK  593 (621)
Q Consensus       547 ~~~---------------------------------~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~  593 (621)
                      ...                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            100                                 00123468999999999999999999999999999999999999


Q ss_pred             CCCC
Q 007006          594 NNGF  597 (621)
Q Consensus       594 p~~~  597 (621)
                      ||..
T Consensus       235 Pf~~  238 (363)
T cd05628         235 PFCS  238 (363)
T ss_pred             CCCC
Confidence            9964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-36  Score=318.66  Aligned_cols=201  Identities=31%  Similarity=0.503  Sum_probs=175.9

Q ss_pred             CCCCccceeccCCceeEEEEEecC----CcEEEEEEeccC-CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      ....+.++||.|.||+|++|+++-    ...||||.++.. .+.++.+|+.|+.+|.+++||||++|.|+.......++|
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi  708 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII  708 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence            356778999999999999999753    457999999866 356678899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      .|||+||+|+.||+.  ++.++++.+...++++|+.|+.||-+.+   +|||||.++|||++.+...|++|||+++.+.+
T Consensus       709 TEyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  709 TEYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             hhhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence            999999999999965  4567999999999999999999999875   99999999999999999999999999998865


Q ss_pred             CCCCcc-cccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCC
Q 007006          546 NQNQAN-TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNG  596 (621)
Q Consensus       546 ~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~  596 (621)
                      +..... +.-..-+.+|.|||.+....++.++|||||||++||.++ |.+||-
T Consensus       784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW  836 (996)
T KOG0196|consen  784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW  836 (996)
T ss_pred             CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc
Confidence            542222 222233678999999999999999999999999999877 999963

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.4e-35  Score=293.45  Aligned_cols=200  Identities=25%  Similarity=0.459  Sum_probs=179.8

Q ss_pred             CCCCccceeccCCceeEEEEE-ecCCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      .+|++.+.||+|.||.|-++. +..|+.||||.+++..   ++..-.+++||++|+.|+||||++++.+|+..+...+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            468888999999999999998 5789999999998653   455556889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||..+|.|.+|+.+   +..|++.+...+++||..|+.|+|.++   ++|||||.+|||+|.++++||+|||++-.+...
T Consensus       133 EYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  133 EYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             EecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            99999999999954   456999999999999999999999885   999999999999999999999999999876543


Q ss_pred             CCCcccccccccCCccChhcccCCCC-ChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                         .....++|++.|.+||++.+.+| .+..|-|||||+||-|+.|..||+..+
T Consensus       207 ---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D  257 (668)
T KOG0611|consen  207 ---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD  257 (668)
T ss_pred             ---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch
Confidence               23345799999999999999988 789999999999999999999997554

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.8e-34  Score=301.02  Aligned_cols=205  Identities=31%  Similarity=0.461  Sum_probs=170.1

Q ss_pred             hCCCCccceeccCCceeEEEEEe------cCCcEEEEEEeccCC-cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCc-
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ-  460 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~-  460 (621)
                      .++|.+.++||+|+||.||++..      .++..||+|++.... ....+.+.+|+.++.++ +||||+++++++...+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            46789999999999999999974      235689999997543 23346789999999999 8999999999887654 


Q ss_pred             eEEEEEEecCCCChhhhhhhccC---------------------------------------------------------
Q 007006          461 ELLLIYEYMPNKSLDVHLFDATR---------------------------------------------------------  483 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------  483 (621)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            57899999999999998864211                                                         


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcccccccccCCc
Q 007006          484 --SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY  561 (621)
Q Consensus       484 --~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y  561 (621)
                        ..++++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++...............+++.|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              134788899999999999999999986   999999999999999999999999999865432222222223456789


Q ss_pred             cChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       562 ~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      +|||++.+..++.++||||||+++|||++ |+.||..
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~  279 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG  279 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999999999997 9999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-35  Score=299.36  Aligned_cols=197  Identities=29%  Similarity=0.439  Sum_probs=171.8

Q ss_pred             hCCCCccceeccCCceeEEEEE-ecCCcEEEEEEeccCCcccHHH--HHHHHHHHHhcc-cCCceeEeeEEeeCc-eEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE--FKNEVNLIAKLQ-HKNLVRLLGCCLEGQ-ELLL  464 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~--~~~Ei~~l~~l~-h~nIv~l~g~~~~~~-~~~l  464 (621)
                      -++|...++||.|.||.||+|+ ...|..||||++++.-.. +++  =++|+..|++++ |||||++.+++.+.+ .+++
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            4678899999999999999998 557999999999876433 333  358999999998 999999999999988 9999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      |||||+ .+|.+.+.+  ++..+++..+..|+.||++||+|+|.+|   +.|||+||+|||+.....+||+|||+|+...
T Consensus        88 VfE~Md-~NLYqLmK~--R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   88 VFEFMD-CNLYQLMKD--RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eHHhhh-hhHHHHHhh--cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence            999995 788888865  3678999999999999999999999987   9999999999999999999999999999765


Q ss_pred             CCCCCcccccccccCCccChhcc-cCCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYA-MGGIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l-~~~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      +..   ..+..+.|.+|.|||++ +.+.|+.+.|||++|||++||.+-++-|-
T Consensus       162 Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFP  211 (538)
T KOG0661|consen  162 SKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFP  211 (538)
T ss_pred             cCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCC
Confidence            432   23345789999999987 45678999999999999999999998775

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1e-33  Score=290.56  Aligned_cols=199  Identities=30%  Similarity=0.438  Sum_probs=172.6

Q ss_pred             CCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          393 FSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       393 f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      |...+.||+|+||.||++.. .+++.||+|++....   ......+.+|+.++++++|+||+++.+.+.+.+..++|+||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            67789999999999999985 579999999987542   23334678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++|+|..++... ....+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++........
T Consensus        82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence            9999998887543 2346899999999999999999999986   99999999999999999999999999987533221


Q ss_pred             CcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                         .....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~  204 (285)
T cd05631         158 ---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKR  204 (285)
T ss_pred             ---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCC
Confidence               12346899999999999999999999999999999999999998743

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-34  Score=283.41  Aligned_cols=199  Identities=27%  Similarity=0.454  Sum_probs=169.6

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCc-ccH-HHHHHHHHHHHhcccCCceeEeeEEeeC--ceEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG-QGL-QEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLLI  465 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~-~~~-~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~~lV  465 (621)
                      +.|+.++.|++|+||.||+|+. ++++.||+|+++-... .+. -.-++||.+|.+.+|||||.+..+....  +..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            5789999999999999999995 4789999999975432 211 2347899999999999999999988754  579999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      |||++ -+|...+....  .++...++..+..|+++|++|||.++   |+|||||++|+|++..|.+||+|||+|+.+++
T Consensus       156 Me~~E-hDLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  156 MEYVE-HDLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             HHHHH-hhHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence            99997 46777775433  56889999999999999999999998   99999999999999999999999999999876


Q ss_pred             CCCCcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      +...  .+..+-|++|.|||.+.+. .|++..|+||+|||+.||+++++-|..
T Consensus       230 p~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G  280 (419)
T KOG0663|consen  230 PLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPG  280 (419)
T ss_pred             Cccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCC
Confidence            5322  2335669999999998775 589999999999999999999998764

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-35  Score=303.55  Aligned_cols=186  Identities=33%  Similarity=0.494  Sum_probs=166.2

Q ss_pred             ccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCCCh
Q 007006          395 DENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL  474 (621)
Q Consensus       395 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~gsL  474 (621)
                      .++-||.|+.|.||+|+++ ++.||||+++.-.       ..+|+-|++|+||||+.|.|+|.....+++|||||+.|-|
T Consensus       128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL  199 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL  199 (904)
T ss_pred             hhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence            3578999999999999995 8899999886432       4578889999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCccccc
Q 007006          475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI  554 (621)
Q Consensus       475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~  554 (621)
                      ..+|+.   ..++.......+..+||.|+.|||.+.   |||||||+-||||..+..|||+|||-++...+.   ...-.
T Consensus       200 ~~VLka---~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMS  270 (904)
T KOG4721|consen  200 YEVLKA---GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMS  270 (904)
T ss_pred             HHHHhc---cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhh
Confidence            999953   446888899999999999999999985   999999999999999999999999999876443   22334


Q ss_pred             ccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          555 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       555 ~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ++||..|||||++.+.+.++|+||||||||||||+||..||.-
T Consensus       271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkd  313 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKD  313 (904)
T ss_pred             hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccc
Confidence            6899999999999999999999999999999999999999853

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-34  Score=307.83  Aligned_cols=201  Identities=27%  Similarity=0.369  Sum_probs=172.0

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|.+.++||+|+||.||++.. .+++.||||++.+..   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4688899999999999999985 478999999986532   334567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99999999998853   345889999999999999999999986   999999999999999999999999998643211


Q ss_pred             CCC------------c---------------------------------ccccccccCCccChhcccCCCCChhhhHHHH
Q 007006          547 QNQ------------A---------------------------------NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSF  581 (621)
Q Consensus       547 ~~~------------~---------------------------------~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~  581 (621)
                      ...            .                                 ......||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            000            0                                 0012368999999999999999999999999


Q ss_pred             HHHHHHHHcCCCCCCC
Q 007006          582 GVLLLEIISGRKNNGF  597 (621)
Q Consensus       582 Gvll~elltG~~p~~~  597 (621)
                      ||++|||++|++||..
T Consensus       235 Gvil~elltG~~Pf~~  250 (377)
T cd05629         235 GAIMFECLIGWPPFCS  250 (377)
T ss_pred             chhhhhhhcCCCCCCC
Confidence            9999999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.8e-34  Score=307.18  Aligned_cols=202  Identities=26%  Similarity=0.369  Sum_probs=172.6

Q ss_pred             CCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      .|+..+.||+|+||.||+++. .+++.||+|++.+..   ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            578899999999999999985 468899999997542   3345678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            9999999998854   345889999999999999999999886   9999999999999999999999999976432100


Q ss_pred             C---------------------------------------------CcccccccccCCccChhcccCCCCChhhhHHHHH
Q 007006          548 N---------------------------------------------QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFG  582 (621)
Q Consensus       548 ~---------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~G  582 (621)
                      .                                             ........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0                                             0001234689999999999988899999999999


Q ss_pred             HHHHHHHcCCCCCCCCc
Q 007006          583 VLLLEIISGRKNNGFYF  599 (621)
Q Consensus       583 vll~elltG~~p~~~~~  599 (621)
                      |++|||++|+.||....
T Consensus       236 ~il~elltG~~Pf~~~~  252 (381)
T cd05626         236 VILFEMLVGQPPFLAPT  252 (381)
T ss_pred             hHHHHHHhCCCCCcCCC
Confidence            99999999999996543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-34  Score=295.40  Aligned_cols=196  Identities=26%  Similarity=0.347  Sum_probs=172.9

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|.+.+.||+|+||.||++... +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46888999999999999999965 68999999986532   234566889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++++|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            99999999998853   345899999999999999999999986   999999999999999999999999998765322


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                           .....|++.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~  200 (291)
T cd05612         155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD  200 (291)
T ss_pred             -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                 1234689999999999988899999999999999999999999864

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-35  Score=303.94  Aligned_cols=208  Identities=30%  Similarity=0.454  Sum_probs=179.5

Q ss_pred             hCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcc-cHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      .+...+.++||+|-||.|..+....+..||||+++..... ...+|..|+++|.+++||||++++|+|..++.+++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            3456778999999999999999988899999999876543 458899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      |++|+|.+|+...+.. .+......+|+.||+.||+||.+.   +++||||.++|+|++.++++||+|||+++-+-..+.
T Consensus       617 mEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             HhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCc
Confidence            9999999999654322 246667778999999999999987   499999999999999999999999999996655544


Q ss_pred             CcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHH--cCCCCCCCCcCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEII--SGRKNNGFYFSE  601 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ell--tG~~p~~~~~~~  601 (621)
                      .......+-+.+|||||.+..+.++.++|||+||+++||++  +...||+....+
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e  747 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE  747 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH
Confidence            44444556678999999999999999999999999999985  578888765544

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-34  Score=304.79  Aligned_cols=201  Identities=25%  Similarity=0.382  Sum_probs=173.7

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|++.+.||+|+||.||+++.. +++.||||++....   ......+.+|++++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47889999999999999999964 68999999997542   334456788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            99999999999854   345899999999999999999999986   999999999999999999999999998764321


Q ss_pred             CCCc------------------------------------ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc
Q 007006          547 QNQA------------------------------------NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS  590 (621)
Q Consensus       547 ~~~~------------------------------------~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt  590 (621)
                      ....                                    ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            1100                                    0012358999999999999999999999999999999999


Q ss_pred             CCCCCCC
Q 007006          591 GRKNNGF  597 (621)
Q Consensus       591 G~~p~~~  597 (621)
                      |+.||..
T Consensus       235 G~~Pf~~  241 (364)
T cd05599         235 GYPPFCS  241 (364)
T ss_pred             CCCCCCC
Confidence            9999864

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.4e-34  Score=306.63  Aligned_cols=201  Identities=25%  Similarity=0.380  Sum_probs=171.8

Q ss_pred             CCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      .|+..++||+|+||.||+++. .+++.||+|++.+..   ....+.+.+|++++++++||||+++++.+.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            588899999999999999985 468899999987542   2345678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            9999999998854   245889999999999999999999986   9999999999999999999999999975331100


Q ss_pred             C---------------------------------------------CcccccccccCCccChhcccCCCCChhhhHHHHH
Q 007006          548 N---------------------------------------------QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFG  582 (621)
Q Consensus       548 ~---------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~G  582 (621)
                      .                                             ........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence            0                                             0001224689999999999999999999999999


Q ss_pred             HHHHHHHcCCCCCCCC
Q 007006          583 VLLLEIISGRKNNGFY  598 (621)
Q Consensus       583 vll~elltG~~p~~~~  598 (621)
                      |++|||++|++||...
T Consensus       236 vil~elltG~~Pf~~~  251 (382)
T cd05625         236 VILYEMLVGQPPFLAQ  251 (382)
T ss_pred             HHHHHHHhCCCCCCCC
Confidence            9999999999999643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.2e-34  Score=300.10  Aligned_cols=198  Identities=25%  Similarity=0.351  Sum_probs=173.5

Q ss_pred             hCCCCccceeccCCceeEEEEEecC--CcEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLAD--GKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~--g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      .++|.+.+.||+|+||.||++...+  +..||+|++...   .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3578999999999999999998543  368999998653   23345678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      ||||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            9999999999998853   345899999999999999999999986   9999999999999999999999999998654


Q ss_pred             CCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ..     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~  231 (340)
T PTZ00426        183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN  231 (340)
T ss_pred             CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC
Confidence            32     22356899999999999888999999999999999999999998643

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.6e-34  Score=299.33  Aligned_cols=196  Identities=27%  Similarity=0.385  Sum_probs=173.8

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|.+.+.||+|+||.||+++.. +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            57888999999999999999965 68999999987542   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            99999999998854   345889999999999999999999986   999999999999999999999999999865432


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .     ....|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       172 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  217 (329)
T PTZ00263        172 T-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD  217 (329)
T ss_pred             c-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC
Confidence            2     234689999999999999999999999999999999999999853

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-34  Score=300.35  Aligned_cols=197  Identities=27%  Similarity=0.421  Sum_probs=174.2

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|.+.+.||+|+||.||+++.. +++.||+|++.+..   ......+.+|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46889999999999999999965 58999999997542   234566889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..... 
T Consensus        81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            99999999999853   345899999999999999999999986   99999999999999999999999999876533 


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                          ......|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~  201 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS  201 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC
Confidence                223356899999999999999999999999999999999999998643

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=287.91  Aligned_cols=202  Identities=28%  Similarity=0.469  Sum_probs=168.6

Q ss_pred             HHhCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCc--------------ccHHHHHHHHHHHHhcccCCceeE
Q 007006          388 EATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG--------------QGLQEFKNEVNLIAKLQHKNLVRL  452 (621)
Q Consensus       388 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~--------------~~~~~~~~Ei~~l~~l~h~nIv~l  452 (621)
                      ..-++|++.+.||+|.||.|-+++. .+++.||||++.+...              ...+...+||.+|++++|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            3447899999999999999999985 4799999999976421              123578999999999999999999


Q ss_pred             eeEEeeC--ceEEEEEEecCCCChhhhhhhccCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC
Q 007006          453 LGCCLEG--QELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD  529 (621)
Q Consensus       453 ~g~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~  529 (621)
                      +.+..+.  +.+|||+|||..|.+...    ....+ +++.++++++++++.||+|||.++   ||||||||+|+||+++
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD  246 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence            9998775  588999999998876432    22334 999999999999999999999997   9999999999999999


Q ss_pred             CCeEEeeecCceecCCCCCCc---ccccccccCCccChhcccCCC----CChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          530 MNPKISDFGLARIFGGNQNQA---NTNIIAGTYGYMAPEYAMGGI----FSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       530 ~~vkL~Dfgla~~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~----~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      |++||+|||.+..........   .-...+||+.|+|||...++.    .+.+.||||+||+||.|+.|+.||-
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~  320 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF  320 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence            999999999998763221111   112368999999999887633    4778999999999999999999984

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.3e-34  Score=305.17  Aligned_cols=203  Identities=25%  Similarity=0.363  Sum_probs=172.7

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|++.++||+|+||.||+++.. +++.||+|++.+..   ......+.+|++++++++||||+++++.+.+++.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36889999999999999999854 68999999986532   233466889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            99999999999854   345889999999999999999999986   999999999999999999999999997533100


Q ss_pred             C-----------------------------------------CCcccccccccCCccChhcccCCCCChhhhHHHHHHHH
Q 007006          547 Q-----------------------------------------NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL  585 (621)
Q Consensus       547 ~-----------------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll  585 (621)
                      .                                         .........||+.|+|||++.+..++.++|||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            0                                         00001124689999999999999999999999999999


Q ss_pred             HHHHcCCCCCCCCc
Q 007006          586 LEIISGRKNNGFYF  599 (621)
Q Consensus       586 ~elltG~~p~~~~~  599 (621)
                      |||++|+.||....
T Consensus       235 yell~G~~Pf~~~~  248 (376)
T cd05598         235 YEMLVGQPPFLADT  248 (376)
T ss_pred             eehhhCCCCCCCCC
Confidence            99999999996443

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=305.08  Aligned_cols=201  Identities=35%  Similarity=0.496  Sum_probs=170.8

Q ss_pred             CCCCccceeccCCceeEEEEEecC--C--cE-EEEEEecc---CCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLAD--G--KA-IAVKRLSR---TSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL  462 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~--g--~~-vavK~l~~---~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~  462 (621)
                      ++....++||+|.||.||+|.+..  +  .. ||+|..+.   .......+|.+|+++|++++|||||+++|+...+.++
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence            455566899999999999998643  2  23 89998874   3466778999999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      ++|||++.||+|+++|....  ..++..++.+++.+.+.||+|||+..   ++||||.++|+|++.++.+||+|||+++.
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~  311 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRA  311 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccC
Confidence            99999999999999996533  26999999999999999999999986   99999999999999999999999999875


Q ss_pred             cCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          543 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       543 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      -........  ...-+..|+|||.+..+.++.++|||||||++||+++ |..||...
T Consensus       312 ~~~~~~~~~--~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~  366 (474)
T KOG0194|consen  312 GSQYVMKKF--LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM  366 (474)
T ss_pred             Ccceeeccc--cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC
Confidence            431111111  1134678999999999999999999999999999999 78887543

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-34  Score=301.45  Aligned_cols=197  Identities=30%  Similarity=0.437  Sum_probs=175.8

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      .-|...+.||+|+-|.|-.|++ .+|+.+|||++.+.   +......+.+||.+|+-+.||||++++++++++.++|+|+
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            4577889999999999999985 57999999999765   2333456889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++|-|.+++.   +.+++++.++.++++||+.|+.|+|..+   |+||||||+|+|||..+++||+|||+|.+-..+
T Consensus        92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            9999999999985   4567999999999999999999999875   999999999999999999999999999874333


Q ss_pred             CCCcccccccccCCccChhcccCCCC-ChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      ..   -...+|.+.|.+||++++..| +.++||||-||||+.|+||+.||+
T Consensus       166 kl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd  213 (786)
T KOG0588|consen  166 KL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD  213 (786)
T ss_pred             cc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC
Confidence            22   234599999999999999998 889999999999999999999998

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=301.42  Aligned_cols=202  Identities=34%  Similarity=0.570  Sum_probs=172.8

Q ss_pred             HhCCCCccceeccCCceeEEEEEecCCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ..+.+.+...||+|.||+||+|++.  -.||||++...  ..+..+.|++|+.++++-+|.||+-+.|+|..+.. .+|.
T Consensus       390 p~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT  466 (678)
T KOG0193|consen  390 PPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT  466 (678)
T ss_pred             CHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence            3455677889999999999999984  36899998754  45677899999999999999999999999998876 9999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      .+|+|.+|..+++..+  ..++..+...|++||++|+.|||.+.   |||||||..||++.++++|||+|||++..-..-
T Consensus       467 qwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w  541 (678)
T KOG0193|consen  467 QWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW  541 (678)
T ss_pred             hhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeee
Confidence            9999999999997643  45889999999999999999999885   999999999999999999999999999864433


Q ss_pred             CCCcccccccccCCccChhcccC---CCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ..........|...|||||+++.   .+|+..+||||||+++|||+||..||...
T Consensus       542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~  596 (678)
T KOG0193|consen  542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ  596 (678)
T ss_pred             ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC
Confidence            22222333456778999999864   45899999999999999999999999843

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.3e-33  Score=295.03  Aligned_cols=194  Identities=27%  Similarity=0.354  Sum_probs=167.6

Q ss_pred             ceeccCCceeEEEEEe-cCCcEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCC
Q 007006          397 NKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK  472 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  472 (621)
                      +.||+|+||.||++.. .+|..||+|+++..   .......+.+|+++++.++||||+++++.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999985 46899999999754   2334456788999999999999999999999999999999999999


Q ss_pred             ChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCccc
Q 007006          473 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT  552 (621)
Q Consensus       473 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~  552 (621)
                      +|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......  ...
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~  152 (323)
T cd05595          81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM  152 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence            99888743   346899999999999999999999986   9999999999999999999999999987532211  112


Q ss_pred             ccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          553 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       553 ~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ....|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~  198 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  198 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC
Confidence            2356899999999999999999999999999999999999998643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=8.3e-34  Score=296.64  Aligned_cols=193  Identities=28%  Similarity=0.350  Sum_probs=167.8

Q ss_pred             ceeccCCceeEEEEEe-cCCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCC
Q 007006          397 NKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK  472 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  472 (621)
                      +.||+|+||.||+++. .+|+.||+|++++..   ......+.+|++++++++||||+++++++..++..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999985 468999999997542   233456788999999999999999999999999999999999999


Q ss_pred             ChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCccc
Q 007006          473 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT  552 (621)
Q Consensus       473 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~  552 (621)
                      +|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~  152 (323)
T cd05571          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATM  152 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcc
Confidence            99888853   346899999999999999999999986   999999999999999999999999998753221  1122


Q ss_pred             ccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          553 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       553 ~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~  197 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  197 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC
Confidence            345689999999999999999999999999999999999999854

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-34  Score=270.78  Aligned_cols=202  Identities=30%  Similarity=0.458  Sum_probs=179.4

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      -++|++.+.||+|.||.||.++. +++-.||+|++.+..   .+-.+++.+|+++-+.|+||||+++++++.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            36899999999999999999995 467889999997653   33346789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      +||.++|++...|++ .+..++++.....++.|+|.||.|+|...   ++||||||+|+|++.++..||+|||.+-.-. 
T Consensus       101 lEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            999999999999964 34566899999999999999999999874   9999999999999999999999999987532 


Q ss_pred             CCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                         .......+||..|.+||...+..++...|+|++|++.||++.|.+||....
T Consensus       176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~  226 (281)
T KOG0580|consen  176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS  226 (281)
T ss_pred             ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence               333456799999999999999999999999999999999999999997654

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.9e-33  Score=294.45  Aligned_cols=193  Identities=28%  Similarity=0.366  Sum_probs=167.8

Q ss_pred             ceeccCCceeEEEEEe-cCCcEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCC
Q 007006          397 NKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK  472 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  472 (621)
                      +.||+|+||.||++.. .+++.||+|++.+.   .......+.+|+.+++.++||||+++.+++.+.+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999985 46899999999754   2334567889999999999999999999999999999999999999


Q ss_pred             ChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCccc
Q 007006          473 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT  552 (621)
Q Consensus       473 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~  552 (621)
                      +|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~  152 (328)
T cd05593          81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM  152 (328)
T ss_pred             CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence            99888743   346899999999999999999999886   9999999999999999999999999987532211  122


Q ss_pred             ccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          553 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       553 ~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~  197 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  197 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC
Confidence            335689999999999998999999999999999999999999854

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.1e-33  Score=301.08  Aligned_cols=201  Identities=24%  Similarity=0.332  Sum_probs=172.6

Q ss_pred             HhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      ..++|++.+.||+|+||.||+++.. +++.+|+|++.+.   .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3468999999999999999999965 5889999998653   22334567899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      ||||+++|+|.+++..    ..+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||++....
T Consensus       121 v~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         121 VMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            9999999999998843    24788999999999999999999986   9999999999999999999999999998764


Q ss_pred             CCCCCcccccccccCCccChhcccCCC----CChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMGGI----FSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~~~----~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .... .......||+.|+|||++.+..    ++.++|||||||++|||++|+.||..
T Consensus       194 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~  249 (370)
T cd05621         194 ETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA  249 (370)
T ss_pred             cCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence            3221 1223457899999999986543    78899999999999999999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5e-33  Score=287.97  Aligned_cols=204  Identities=30%  Similarity=0.472  Sum_probs=169.9

Q ss_pred             CCCCccceeccCCceeEEEEEecC-----------------CcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLAD-----------------GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRL  452 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l  452 (621)
                      ++|.+.++||+|+||.||++.+.+                 +..||+|.+.... .....++.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578889999999999999997532                 3469999987643 3345678999999999999999999


Q ss_pred             eeEEeeCceEEEEEEecCCCChhhhhhhcc----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 007006          453 LGCCLEGQELLLIYEYMPNKSLDVHLFDAT----------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH  516 (621)
Q Consensus       453 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH  516 (621)
                      ++++.+.+..++||||+++++|.+++....                ....+++..+++++.||+.||.|||+.+   |+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence            999999999999999999999999885421                1134788999999999999999999986   999


Q ss_pred             ccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc--CCCC
Q 007006          517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS--GRKN  594 (621)
Q Consensus       517 ~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt--G~~p  594 (621)
                      |||||+|||++.++.+||+|||+++...............++..|+|||++..+.++.++||||||+++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999986543322222223345778999999988899999999999999999987  5566


Q ss_pred             CCC
Q 007006          595 NGF  597 (621)
Q Consensus       595 ~~~  597 (621)
                      |..
T Consensus       242 ~~~  244 (304)
T cd05096         242 YGE  244 (304)
T ss_pred             CCc
Confidence            653

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-33  Score=292.40  Aligned_cols=191  Identities=27%  Similarity=0.379  Sum_probs=166.9

Q ss_pred             eccCCceeEEEEEec-CCcEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCCCh
Q 007006          399 LGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL  474 (621)
Q Consensus       399 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~gsL  474 (621)
                      ||+|+||.||++... +++.||+|++.+.   .......+..|++++.+++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999865 5889999998753   234456678899999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCccccc
Q 007006          475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI  554 (621)
Q Consensus       475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~  554 (621)
                      .+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~  152 (312)
T cd05585          81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT  152 (312)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence            998853   345899999999999999999999986   9999999999999999999999999987543221  12234


Q ss_pred             ccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          555 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       555 ~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~  195 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD  195 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC
Confidence            5689999999999999999999999999999999999999863

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.3e-33  Score=306.26  Aligned_cols=203  Identities=21%  Similarity=0.294  Sum_probs=176.4

Q ss_pred             CCCccceeccCCceeEEEEEec-C-CcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-D-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      .|.+.+.||+|+||.||++... + +..||+|.+..........+.+|+.+++.++||||+++++++..++..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4888999999999999999743 3 6788888876555555567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          470 PNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       470 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      ++|+|.+++.+. ....++++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999988643 23456899999999999999999999986   99999999999999999999999999987654333


Q ss_pred             CcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~  273 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG  273 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence            2233445789999999999999999999999999999999999999864

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.2e-33  Score=299.94  Aligned_cols=202  Identities=25%  Similarity=0.367  Sum_probs=173.6

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|+..+.||+|+||.||++... +++.||+|+++..   .......+.+|+.++..++||||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999864 6899999999753   2334567888999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++|+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            99999999998853   345899999999999999999999986   999999999999999999999999998754321


Q ss_pred             CCC---------------------------------cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCC
Q 007006          547 QNQ---------------------------------ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRK  593 (621)
Q Consensus       547 ~~~---------------------------------~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~  593 (621)
                      ...                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            100                                 00112468999999999999999999999999999999999999


Q ss_pred             CCCCC
Q 007006          594 NNGFY  598 (621)
Q Consensus       594 p~~~~  598 (621)
                      ||...
T Consensus       235 Pf~~~  239 (360)
T cd05627         235 PFCSE  239 (360)
T ss_pred             CCCCC
Confidence            98643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=8.1e-33  Score=290.17  Aligned_cols=199  Identities=28%  Similarity=0.393  Sum_probs=174.6

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      .++|++.+.||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            368999999999999999999965 68889999987542 3345678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+.+  +|+||||||+|||++.++.+||+|||++...... 
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  157 (331)
T cd06649          84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (331)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence            9999999999854   335899999999999999999999853  5999999999999999999999999998765322 


Q ss_pred             CCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                         ......+++.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence               12234688999999999998999999999999999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4e-33  Score=277.78  Aligned_cols=201  Identities=29%  Similarity=0.461  Sum_probs=169.6

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCc-c-cHHHHHHHHHHHHhcccCC-ceeEeeEEeeCc------
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG-Q-GLQEFKNEVNLIAKLQHKN-LVRLLGCCLEGQ------  460 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~-~-~~~~~~~Ei~~l~~l~h~n-Iv~l~g~~~~~~------  460 (621)
                      ..|...++||+|+||+||+|+. .+|+.||+|+++.... + --....+|+.+|++++|+| |+++.+++.+.+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            3566778899999999999994 5789999999986543 2 2345689999999999999 999999999877      


Q ss_pred             eEEEEEEecCCCChhhhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecC
Q 007006          461 ELLLIYEYMPNKSLDVHLFDATRS-VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL  539 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgl  539 (621)
                      .+++|+||+. .+|..++...... ..++...+..++.||++||+|||+++   |+||||||.||||+++|.+||+|||+
T Consensus        91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence            7899999984 7888888654322 45777899999999999999999986   99999999999999999999999999


Q ss_pred             ceecCCCCCCcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          540 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       540 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ++.+.-+...  ....+.|.+|.|||++.+. .|+...||||+||++.||+++++-|..
T Consensus       167 Ara~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG  223 (323)
T KOG0594|consen  167 ARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPG  223 (323)
T ss_pred             HHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCC
Confidence            9966533322  2234679999999999887 689999999999999999998887753

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=7.4e-33  Score=289.97  Aligned_cols=208  Identities=25%  Similarity=0.413  Sum_probs=172.7

Q ss_pred             ceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEEEEecCC
Q 007006          397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN  471 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~  471 (621)
                      +.||+|+||.||++... +++.||+|++++..   ....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999864 57899999997642   23445678899999888 699999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcc
Q 007006          472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN  551 (621)
Q Consensus       472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~  551 (621)
                      ++|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~  152 (327)
T cd05617          81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT  152 (327)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence            999888743   346999999999999999999999986   9999999999999999999999999987532211  12


Q ss_pred             cccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCcCCCCCChHHHHHH
Q 007006          552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCN  612 (621)
Q Consensus       552 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~v~~  612 (621)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||.............++++
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~  213 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ  213 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHH
Confidence            2345689999999999999999999999999999999999999975444333333333333

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=8.2e-33  Score=284.23  Aligned_cols=200  Identities=27%  Similarity=0.415  Sum_probs=169.5

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      ++|.+.++||+|+||.||++..+ ++..||+|+++... ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46889999999999999999864 68899999987543 23345678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++ +|.+++...  ...+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||++........
T Consensus        85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            975 888887432  335789999999999999999999986   99999999999999999999999999976533221


Q ss_pred             CcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      .  .....+++.|+|||.+.+ ..++.++||||+|+++|||++|++||...
T Consensus       159 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~  207 (288)
T cd07871         159 T--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS  207 (288)
T ss_pred             c--ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            1  122457889999998865 56899999999999999999999998643

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.9e-33  Score=297.93  Aligned_cols=202  Identities=24%  Similarity=0.323  Sum_probs=173.0

Q ss_pred             HHhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEE
Q 007006          388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL  463 (621)
Q Consensus       388 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~  463 (621)
                      ...++|++.+.||+|+||.||++... +++.+|+|++.+..   ....+.+.+|+.+++.++||||+++++.+.+++..+
T Consensus        40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (371)
T cd05622          40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY  119 (371)
T ss_pred             cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            34578999999999999999999965 58899999986432   233456788999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceec
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF  543 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~  543 (621)
                      +||||+++|+|..++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       120 lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~  192 (371)
T cd05622         120 MVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (371)
T ss_pred             EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence            99999999999998843    34788899999999999999999986   999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccCCccChhcccCC----CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          544 GGNQNQANTNIIAGTYGYMAPEYAMGG----IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       544 ~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ..... .......||+.|+|||++...    .++.++|||||||++|||++|+.||..
T Consensus       193 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~  249 (371)
T cd05622         193 NKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA  249 (371)
T ss_pred             CcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence            43221 122345789999999998654    378999999999999999999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.8e-33  Score=290.84  Aligned_cols=193  Identities=31%  Similarity=0.433  Sum_probs=166.6

Q ss_pred             ceeccCCceeEEEEEe----cCCcEEEEEEeccCC----cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          397 NKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      ++||+|+||.||+++.    .+++.||+|++++..    ......+.+|+++++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6899999999999975    357899999987532    23345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++++|..++..   ...+.+..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (323)
T cd05584          82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-  154 (323)
T ss_pred             CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence            999999988843   345788899999999999999999986   9999999999999999999999999987543221 


Q ss_pred             CcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                       .......|++.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~  202 (323)
T cd05584         155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA  202 (323)
T ss_pred             -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC
Confidence             122335689999999999988899999999999999999999999864

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-33  Score=297.44  Aligned_cols=202  Identities=27%  Similarity=0.418  Sum_probs=176.2

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|.+.+.||+|+||.||+++.. +++.||+|+++...   ......+.+|++++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46889999999999999999965 68999999997542   244567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++++|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999998543   56899999999999999999999976   999999999999999999999999999865433


Q ss_pred             C---------------------------CCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          547 Q---------------------------NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       547 ~---------------------------~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      .                           .........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            2                           001122346899999999999999999999999999999999999998643

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.4e-33  Score=290.21  Aligned_cols=193  Identities=25%  Similarity=0.426  Sum_probs=167.0

Q ss_pred             ceeccCCceeEEEEEec-CCcEEEEEEeccC---CcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEEEEecCC
Q 007006          397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN  471 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~  471 (621)
                      +.||+|+||.||++... +++.||+|++++.   .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999864 6889999999754   233345678899999998 799999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcc
Q 007006          472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN  551 (621)
Q Consensus       472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~  551 (621)
                      ++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~  152 (329)
T cd05588          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT  152 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence            999888743   346999999999999999999999986   9999999999999999999999999987422111  12


Q ss_pred             cccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       552 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  198 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence            2335789999999999999999999999999999999999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.8e-33  Score=284.78  Aligned_cols=200  Identities=25%  Similarity=0.396  Sum_probs=172.1

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      ++|.+.+.||+|+||.||+++.+ +++.||+|++....  ....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46889999999999999999975 58899999987542  3345678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |++++.+..+..   ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            999887765442   2346899999999999999999999886   9999999999999999999999999998764322


Q ss_pred             CCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .. ......+++.|+|||++.+..++.++|||||||++|||++|++||..
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~  203 (287)
T cd07848         155 NA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPG  203 (287)
T ss_pred             cc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCC
Confidence            21 12234678999999999988899999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.2e-32  Score=285.00  Aligned_cols=200  Identities=28%  Similarity=0.416  Sum_probs=169.2

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc-ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      .++|.+.++||+|+||.||++... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999965 689999999875432 233467889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |++ ++|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||++.......
T Consensus        84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            996 577666643  2345889999999999999999999986   9999999999999999999999999987543222


Q ss_pred             CCcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .  ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  206 (303)
T cd07869         158 H--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG  206 (303)
T ss_pred             c--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            1  1123457889999998865 4578999999999999999999999964

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=7e-33  Score=289.64  Aligned_cols=199  Identities=27%  Similarity=0.366  Sum_probs=169.7

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      +|.+.+.||+|+||.||+++.. +++.||+|++.+..   ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999865 57899999987542   23334567788888877 5899999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++|+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||++......
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            99999999888843   345899999999999999999999986   999999999999999999999999998754321


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~  204 (323)
T cd05616         155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE  204 (323)
T ss_pred             C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC
Confidence            1  1223456899999999999999999999999999999999999998643

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=8.3e-33  Score=289.17  Aligned_cols=199  Identities=27%  Similarity=0.366  Sum_probs=169.9

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccC---CcccHHHHHHHHHHHHhcccC-CceeEeeEEeeCceEEEEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHK-NLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~-nIv~l~g~~~~~~~~~lV~  466 (621)
                      +|.+.+.||+|+||.||+|+.. +++.||+|++.+.   .....+.+..|.+++..++|+ +|+++.+++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788899999999999999865 5789999998753   233456678899999999765 5888999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++|+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            99999999988853   345889999999999999999999986   999999999999999999999999998753221


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~  204 (324)
T cd05587         155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE  204 (324)
T ss_pred             C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence            1  1223456899999999999999999999999999999999999998643

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-33  Score=291.21  Aligned_cols=201  Identities=22%  Similarity=0.343  Sum_probs=171.8

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|.+.+.||+|+||.||+++.. +++.||+|++.+.   .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46889999999999999999964 5899999998753   2233456889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++++|..++..  ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            99999999999853  2345899999999999999999999986   999999999999999999999999998765432


Q ss_pred             CCCcccccccccCCccChhcccC-----CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMG-----GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .. .......||+.|+|||++..     ..++.++|||||||++|||++|+.||..
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  210 (331)
T cd05597         156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence            22 11223468999999999863     4578899999999999999999999854

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.7e-33  Score=278.93  Aligned_cols=217  Identities=26%  Similarity=0.330  Sum_probs=181.8

Q ss_pred             CCCCccceeccCCceeEEEEEecC-CcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|+..+.||.|.-|+||++++++ +..+|+|++.+..   .....+.+.|-++|+.++||.++.|++.++.++..+++|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            357778999999999999999764 6889999998764   334456778999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC-
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG-  545 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~-  545 (621)
                      |||+||+|...+. ......+++..+.-++..++-||+|||-.|   ||.|||||+||||.++|++-|+||.|+..... 
T Consensus       157 eyCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             ecCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            9999999988774 455667999999999999999999999886   99999999999999999999999998754310 


Q ss_pred             --------------------------------CCC---------------------CcccccccccCCccChhcccCCCC
Q 007006          546 --------------------------------NQN---------------------QANTNIIAGTYGYMAPEYAMGGIF  572 (621)
Q Consensus       546 --------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~l~~~~~  572 (621)
                                                      ...                     ....+..+||-.|+|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            000                     011233578999999999999999


Q ss_pred             ChhhhHHHHHHHHHHHHcCCCCCCCCcCCCCCChHHHHHHh
Q 007006          573 SIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNS  613 (621)
Q Consensus       573 s~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~v~~~  613 (621)
                      +.++|+|.|||++|||+.|+.||....  ..+++.++|.+.
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~--~~~Tl~NIv~~~  351 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSN--NKETLRNIVGQP  351 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCC--chhhHHHHhcCC
Confidence            999999999999999999999997543  344666665543

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=8.7e-33  Score=289.97  Aligned_cols=200  Identities=28%  Similarity=0.413  Sum_probs=170.4

Q ss_pred             CCCccceeccCCceeEEEEEe----cCCcEEEEEEeccCC----cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceE
Q 007006          392 HFSDENKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL  462 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~  462 (621)
                      +|++.+.||+|+||.||+++.    .+++.||+|++.+..    ....+.+..|+.++..+ +||||+++++++.+++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478889999999999999875    358899999987532    23345678899999999 599999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      ++||||+++|+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            999999999999998853   345899999999999999999999986   99999999999999999999999999886


Q ss_pred             cCCCCCCcccccccccCCccChhcccCCC-CChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          543 FGGNQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       543 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ....... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||...
T Consensus       155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  210 (332)
T cd05614         155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE  210 (332)
T ss_pred             ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence            5332221 222356899999999987654 788999999999999999999999643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.1e-33  Score=296.76  Aligned_cols=200  Identities=25%  Similarity=0.344  Sum_probs=171.5

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      .++|++.+.||+|+||.||+++.. +++.||+|++.+.   .......+.+|+.+++.++||||+++++++.++...++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            467999999999999999999864 6889999998653   223345578899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      |||+++|+|..++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       122 ~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         122 MEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            999999999998843    34788889999999999999999986   99999999999999999999999999986543


Q ss_pred             CCCCcccccccccCCccChhcccCC----CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGG----IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~----~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||..
T Consensus       195 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~  249 (370)
T cd05596         195 NGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA  249 (370)
T ss_pred             CCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC
Confidence            221 122335689999999998653    378999999999999999999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.9e-33  Score=291.81  Aligned_cols=201  Identities=22%  Similarity=0.323  Sum_probs=172.2

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|.+.+.||+|+||.||+++.. +++.||+|++.+.   .......+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47889999999999999999865 6889999998753   2233455788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++|+|..++...  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999999542  346899999999999999999999886   999999999999999999999999999876433


Q ss_pred             CCCcccccccccCCccChhcccC-----CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMG-----GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ... ......|++.|+|||++.+     +.++.++||||||+++|||++|+.||..
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~  210 (331)
T cd05624         156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence            221 1223568999999999865     4578899999999999999999999853

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.1e-33  Score=291.60  Aligned_cols=195  Identities=27%  Similarity=0.348  Sum_probs=166.8

Q ss_pred             ceeccCCceeEEEEEe-cCCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCC
Q 007006          397 NKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK  472 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  472 (621)
                      +.||+|+||.||++.. .+++.||+|++.+..   ......+.+|++++..++||||+++.+++.+++..++||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999985 468999999997542   233456788999999999999999999999999999999999999


Q ss_pred             ChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCccc
Q 007006          473 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT  552 (621)
Q Consensus       473 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~  552 (621)
                      +|..++..   ...+++..+..++.||+.||.|||+..  +|+||||||+|||++.++.+||+|||++.......  ...
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~--~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~  153 (325)
T cd05594          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATM  153 (325)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--ccc
Confidence            99888743   346899999999999999999999731  49999999999999999999999999987532221  112


Q ss_pred             ccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          553 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       553 ~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~  199 (325)
T cd05594         154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  199 (325)
T ss_pred             ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence            2346899999999999999999999999999999999999998543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1e-32  Score=287.45  Aligned_cols=193  Identities=31%  Similarity=0.457  Sum_probs=164.5

Q ss_pred             ceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEEEEecCC
Q 007006          397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN  471 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~  471 (621)
                      +.||+|+||.||+++.. +++.||+|+++...   ....+.+..|..++... +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999864 58899999987532   23344556677777654 899999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcc
Q 007006          472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN  551 (621)
Q Consensus       472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~  551 (621)
                      |+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~  152 (316)
T cd05592          81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence            999988853   345899999999999999999999986   9999999999999999999999999997643222  22


Q ss_pred             cccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       552 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~  198 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG  198 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC
Confidence            2345689999999999998999999999999999999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=9.3e-33  Score=288.80  Aligned_cols=197  Identities=28%  Similarity=0.417  Sum_probs=167.1

Q ss_pred             CCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHH---HhcccCCceeEeeEEeeCceEEEE
Q 007006          393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLI---AKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       393 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l---~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      |.+.+.||+|+||.||++... +++.||||++++..   ....+.+..|++++   ..++||||+++++++.+.+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567889999999999999864 68999999997542   23345566676655   466799999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      |||+++++|..++.    ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            99999999988774    245899999999999999999999986   99999999999999999999999999875322


Q ss_pred             CCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      .  ........|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       154 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~  204 (324)
T cd05589         154 F--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD  204 (324)
T ss_pred             C--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Confidence            1  11223456899999999999999999999999999999999999998643

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=6.9e-33  Score=295.42  Aligned_cols=205  Identities=33%  Similarity=0.488  Sum_probs=170.9

Q ss_pred             CCCCccceeccCCceeEEEEEec------CCcEEEEEEeccCC-cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL  462 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~  462 (621)
                      ++|++.+.||+|+||.||+++..      ++..||+|+++... ......+.+|+++++.+ +|+||+++++.+.+.+..
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            47889999999999999998732      34579999997543 33346688999999999 899999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhcc------------------------------------------------------------
Q 007006          463 LLIYEYMPNKSLDVHLFDAT------------------------------------------------------------  482 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~------------------------------------------------------------  482 (621)
                      ++||||+++|+|.+++....                                                            
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            99999999999999885321                                                            


Q ss_pred             -------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcccccc
Q 007006          483 -------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII  555 (621)
Q Consensus       483 -------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~  555 (621)
                             ...++++..+.+++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||++...............
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence                   1124788999999999999999999986   999999999999999999999999999865433221112222


Q ss_pred             cccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          556 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       556 ~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      .++..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus       275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~  318 (374)
T cd05106         275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI  318 (374)
T ss_pred             CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccc
Confidence            34567999999998999999999999999999997 99998643

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.5e-32  Score=281.60  Aligned_cols=191  Identities=19%  Similarity=0.335  Sum_probs=164.9

Q ss_pred             ceeccCCceeEEEEEecCCcEEEEEEeccCCccc---HHHHHHHHHHHHhcccCCceeEeeEEee----CceEEEEEEec
Q 007006          397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG---LQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELLLIYEYM  469 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~---~~~~~~Ei~~l~~l~h~nIv~l~g~~~~----~~~~~lV~e~~  469 (621)
                      ..||+|++|.||+|.. +|+.||||+++......   .+.+.+|+.+|.+++||||++++|++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            6799999999999998 68999999997654333   4678899999999999999999999877    34679999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++|+|.+++..   ...+++....+++.+++.||.|||+..  +++||||||+|||+++++.+||+|||+++......  
T Consensus       105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            99999999954   346899999999999999999999742  37899999999999999999999999988654321  


Q ss_pred             cccccccccCCccChhcccC--CCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                         ....++..|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~  225 (283)
T PHA02988        178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL  225 (283)
T ss_pred             ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC
Confidence               12356889999999976  67899999999999999999999999744

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=9e-33  Score=288.54  Aligned_cols=194  Identities=27%  Similarity=0.408  Sum_probs=166.7

Q ss_pred             ceeccCCceeEEEEEec-CCcEEEEEEeccC---CcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEEEEecCC
Q 007006          397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN  471 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~  471 (621)
                      +.||+|+||.||+|+.. +++.||+|++++.   .....+.+..|.+++..+ +||||+++++++.+++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999865 5889999998754   233445677889998876 799999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcc
Q 007006          472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN  551 (621)
Q Consensus       472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~  551 (621)
                      ++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++........  .
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~  152 (321)
T cd05591          81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--T  152 (321)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--c
Confidence            999888853   345899999999999999999999986   99999999999999999999999999875432221  1


Q ss_pred             cccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       552 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      .....|++.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~  199 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD  199 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC
Confidence            22356899999999999989999999999999999999999999643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.5e-32  Score=287.84  Aligned_cols=193  Identities=26%  Similarity=0.436  Sum_probs=166.2

Q ss_pred             ceeccCCceeEEEEEec-CCcEEEEEEeccC---CcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEEEEecCC
Q 007006          397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN  471 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~  471 (621)
                      +.||+|+||.||++... +++.+|+|++++.   .....+.+..|+.++.++ +||||+++++++.+++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999964 5889999999754   223345677889888877 899999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcc
Q 007006          472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN  551 (621)
Q Consensus       472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~  551 (621)
                      ++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~  152 (329)
T cd05618          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT  152 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence            999887743   346899999999999999999999986   9999999999999999999999999987532211  12


Q ss_pred             cccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       552 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~  198 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence            2335689999999999999999999999999999999999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.5e-33  Score=293.85  Aligned_cols=201  Identities=26%  Similarity=0.388  Sum_probs=173.5

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|.+.+.||+|+||.||++... +++.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46888999999999999999854 68999999997542   234566889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++++|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999999998543  246899999999999999999999986   999999999999999999999999999876433


Q ss_pred             CCCcccccccccCCccChhccc------CCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAM------GGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~------~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ... ......+|+.|+|||++.      ...++.++||||||+++|||++|+.||..
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~  211 (330)
T cd05601         156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE  211 (330)
T ss_pred             Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC
Confidence            222 222346899999999986      45678999999999999999999999854

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.8e-32  Score=280.48  Aligned_cols=194  Identities=34%  Similarity=0.484  Sum_probs=167.9

Q ss_pred             eccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCCCh
Q 007006          399 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL  474 (621)
Q Consensus       399 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~gsL  474 (621)
                      ||+|+||+||++... +++.+|+|++....   ....+.+..|+++++.++||||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999854 68999999987542   22345678899999999999999999999999999999999999999


Q ss_pred             hhhhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcccc
Q 007006          475 DVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN  553 (621)
Q Consensus       475 ~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~  553 (621)
                      ..++... .....+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.++|+|||++.........  ..
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence            8887543 23456899999999999999999999986   999999999999999999999999999866433221  22


Q ss_pred             cccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          554 IIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       554 ~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ...|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  199 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA  199 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence            34688999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2e-32  Score=287.41  Aligned_cols=200  Identities=28%  Similarity=0.395  Sum_probs=174.0

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      .++|++.++||+|+||.||++... ++..+|+|.+.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            368999999999999999999965 58889999887542 3334678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |+++++|.+++..   ...+++..+..++.+++.||.|||+..  +++||||||+|||+++++.+||+|||++...... 
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-  157 (333)
T cd06650          84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (333)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence            9999999999854   345889999999999999999999753  4999999999999999999999999998754322 


Q ss_pred             CCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                         ......++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence               112346789999999999888999999999999999999999998754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-34  Score=287.79  Aligned_cols=202  Identities=27%  Similarity=0.462  Sum_probs=178.4

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC-CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      ..|...+.||+|.||.||+|.. ..++.||+|++... .....+++.+|+.+|..++++||.+++|.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            4577778999999999999984 56899999999855 345578899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +.+|++.+.|.   ....+++..+.-|+++++.||.|||.++   .+|||||+.|||+..+|.+||+|||.+-.+.....
T Consensus        93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            99999999883   3334588888889999999999999986   99999999999999999999999999987755443


Q ss_pred             CcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCcC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFS  600 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~  600 (621)
                      ..  ...+||+.|||||++....|+.|+||||||++.+||.+|.+|+.-..+
T Consensus       167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP  216 (467)
T KOG0201|consen  167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP  216 (467)
T ss_pred             cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence            33  567999999999999988999999999999999999999999865443

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.5e-32  Score=287.11  Aligned_cols=199  Identities=26%  Similarity=0.376  Sum_probs=169.5

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcc-cCCceeEeeEEeeCceEEEEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      +|...+.||+|+||.||++... +++.||+|++.+..   ....+.+..|..++..+. |++|+++.+++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3677899999999999999854 68999999987542   233456778899988885 577888999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++|+|..++..   ...+++.++..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            99999999988843   345899999999999999999999986   999999999999999999999999998754222


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      .  .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~  204 (323)
T cd05615         155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE  204 (323)
T ss_pred             C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC
Confidence            1  1223356899999999999989999999999999999999999998654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.4e-32  Score=286.93  Aligned_cols=194  Identities=29%  Similarity=0.451  Sum_probs=166.7

Q ss_pred             ceeccCCceeEEEEEec-CCcEEEEEEeccC---CcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEEEEecCC
Q 007006          397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN  471 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~  471 (621)
                      +.||+|+||.||+++.+ +++.||+|++.+.   .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 5889999998753   233456677888888877 699999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcc
Q 007006          472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN  551 (621)
Q Consensus       472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~  551 (621)
                      ++|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~  152 (320)
T cd05590          81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT  152 (320)
T ss_pred             chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence            999988853   345899999999999999999999886   9999999999999999999999999987532211  12


Q ss_pred             cccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       552 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~  199 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE  199 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence            23356899999999999889999999999999999999999999644

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.4e-32  Score=293.28  Aligned_cols=205  Identities=34%  Similarity=0.464  Sum_probs=171.4

Q ss_pred             hCCCCccceeccCCceeEEEEEe------cCCcEEEEEEeccCC-cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCce
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE  461 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~  461 (621)
                      .++|++.++||+|+||.||++..      .++..||||+++... ....+.+.+|+.++..+ +||||+++++++.+.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            34688899999999999999963      246689999987543 33456788999999999 89999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhhccC----------------------------------------------------------
Q 007006          462 LLLIYEYMPNKSLDVHLFDATR----------------------------------------------------------  483 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~----------------------------------------------------------  483 (621)
                      .++||||+++|+|.+++.....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999998864221                                                          


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          484 --------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       484 --------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                                    ...+++..+.+++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                          125789999999999999999999876   999999999999999999999999999866433222


Q ss_pred             cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~  319 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPG  319 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence            11222334567999999999999999999999999999998 8888754

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=9.8e-33  Score=289.67  Aligned_cols=201  Identities=22%  Similarity=0.322  Sum_probs=171.1

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|.+.++||+|+||.||+++.+ +++.+|+|++.+.   .......+.+|+.++..++|+||+++.+.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46888999999999999999965 5788999998643   2233445788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++|+|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            999999999999542  345899999999999999999999986   999999999999999999999999998765332


Q ss_pred             CCCcccccccccCCccChhccc-----CCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .. .......||+.|+|||++.     ...++.++|||||||++|||++|+.||..
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~  210 (332)
T cd05623         156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA  210 (332)
T ss_pred             Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence            21 1222356899999999986     34578999999999999999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.7e-32  Score=288.12  Aligned_cols=199  Identities=24%  Similarity=0.408  Sum_probs=166.3

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeC-----ceEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QELL  463 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~-----~~~~  463 (621)
                      +|.+.++||+|+||.||+++.. ++..||+|++...  .......+.+|++++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4788899999999999999854 6899999998743  223345688999999999999999999988643     2479


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceec
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF  543 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~  543 (621)
                      +||||++ ++|.+++..   ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 688887743   345899999999999999999999986   999999999999999999999999999864


Q ss_pred             CCCCC-CcccccccccCCccChhcccC--CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          544 GGNQN-QANTNIIAGTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       544 ~~~~~-~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ..... ........+++.|+|||++.+  ..++.++|||||||++|||++|++||..
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~  210 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG  210 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence            32211 111233568999999999866  6789999999999999999999999854

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.3e-32  Score=278.75  Aligned_cols=200  Identities=26%  Similarity=0.431  Sum_probs=166.0

Q ss_pred             CCCCccceeccCCceeEEEEEe-c-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhc---ccCCceeEeeEEee-----
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-A-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKL---QHKNLVRLLGCCLE-----  458 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l---~h~nIv~l~g~~~~-----  458 (621)
                      ++|.+.+.||+|+||.||+++. . +++.||+|+++...  ......+.+|+.+++.+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            3688899999999999999986 3 46889999987543  22334566788777766   69999999999852     


Q ss_pred             CceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeec
Q 007006          459 GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG  538 (621)
Q Consensus       459 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfg  538 (621)
                      ...+++|+||++ ++|..++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            346899999996 6888888542 2345899999999999999999999986   9999999999999999999999999


Q ss_pred             CceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          539 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       539 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ++......   .......+++.|+|||.+.+..++.++||||||+++|||++|++||...
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  212 (290)
T cd07862         156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS  212 (290)
T ss_pred             ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCC
Confidence            99875433   2223346889999999998889999999999999999999999998743

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.1e-32  Score=289.69  Aligned_cols=195  Identities=30%  Similarity=0.461  Sum_probs=164.8

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      ++|+..++||+|+||.||+++.. +++.||||++.... ......+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            45677889999999999999864 68999999986543 23346789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++++|....       ..++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||++........
T Consensus       154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            9999986432       3567788899999999999999986   99999999999999999999999999987643221


Q ss_pred             CcccccccccCCccChhcccC-----CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMG-----GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                        ......|+..|+|||++..     ...+.++|||||||++|||++|+.||..
T Consensus       224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~  275 (353)
T PLN00034        224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV  275 (353)
T ss_pred             --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence              1223468999999998743     2345689999999999999999999974

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-32  Score=279.22  Aligned_cols=200  Identities=31%  Similarity=0.441  Sum_probs=172.5

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      +|+..++||+|+||.||++... +++.||+|++....   ......+.+|+.+++.++||||+++++.+.+++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4778899999999999999854 68999999987542   2223457789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |+++++|..++... ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            99999999887542 2346899999999999999999999986   9999999999999999999999999988654322


Q ss_pred             CCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      .   .....|++.|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~  204 (285)
T cd05605         157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR  204 (285)
T ss_pred             c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence            1   12346789999999999888999999999999999999999999743

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.5e-32  Score=283.49  Aligned_cols=194  Identities=30%  Similarity=0.459  Sum_probs=165.4

Q ss_pred             ceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEEEEecCC
Q 007006          397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN  471 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~  471 (621)
                      +.||+|+||.||++... +++.||+|+++...   ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 57899999997542   23345567788888765 899999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcc
Q 007006          472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN  551 (621)
Q Consensus       472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~  551 (621)
                      |+|..++..   ...+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05619          81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence            999988853   345889999999999999999999986   9999999999999999999999999987532211  12


Q ss_pred             cccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       552 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~  199 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH  199 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC
Confidence            23356899999999999989999999999999999999999998643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.6e-32  Score=300.53  Aligned_cols=206  Identities=23%  Similarity=0.325  Sum_probs=175.8

Q ss_pred             HhCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCc-----
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-----  460 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~-----  460 (621)
                      ..++|.+.+.||+|+||.||+++. .+++.||||++...  .......+.+|+..+..++|+||+++...+...+     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            346899999999999999999984 57999999998754  2344566889999999999999999988775432     


Q ss_pred             ---eEEEEEEecCCCChhhhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEee
Q 007006          461 ---ELLLIYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISD  536 (621)
Q Consensus       461 ---~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~D  536 (621)
                         ..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEe
Confidence               3689999999999999986432 3456899999999999999999999885   99999999999999999999999


Q ss_pred             ecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          537 FGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       537 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ||+++.+.............||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~  247 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG  247 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            9999876543333333456789999999999999999999999999999999999999864

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.2e-32  Score=288.07  Aligned_cols=193  Identities=28%  Similarity=0.384  Sum_probs=163.5

Q ss_pred             ceeccCCceeEEEEEe-cCCcEEEEEEeccCC---cccHHHHHHHHH-HHHhcccCCceeEeeEEeeCceEEEEEEecCC
Q 007006          397 NKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVN-LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN  471 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~-~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  471 (621)
                      +.||+|+||.||+++. .+|+.+|+|++.+..   ......+..|.. +++.++||||+++++.+..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999985 468999999987542   223345555655 46778999999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcc
Q 007006          472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN  551 (621)
Q Consensus       472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~  551 (621)
                      ++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||++.......  ..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~  152 (325)
T cd05604          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT  152 (325)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence            999887743   346899999999999999999999986   9999999999999999999999999987532211  12


Q ss_pred             cccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       552 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .....|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~  198 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC  198 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC
Confidence            2345689999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.9e-32  Score=276.77  Aligned_cols=202  Identities=29%  Similarity=0.406  Sum_probs=170.2

Q ss_pred             hCCCCccceeccCCceeEEEEEec----CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      .++|++.+.||+|+||.||+|.++    .+..||+|.++... ......+.+|+..+.+++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            356888999999999999999753    36789999987653 2334578899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      ||||+++++|++++...  ...+++..++.++.||+.||+|||+.+   ++||||||+|||++.++.++++|||.+....
T Consensus        84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            99999999999998542  346899999999999999999999886   9999999999999999999999999876532


Q ss_pred             CCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      .... .......++..|+|||.+.+..++.++||||||+++|||++ |++||..
T Consensus       159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~  211 (266)
T cd05064         159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD  211 (266)
T ss_pred             ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence            2111 11112234578999999999999999999999999999875 9999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.6e-32  Score=284.30  Aligned_cols=201  Identities=31%  Similarity=0.513  Sum_probs=169.6

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCc----EEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      .+|+..+.||+|+||.||+|++. ++.    .||+|+++... ....+++.+|+.+++.++||||++++|++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            56899999999999999999853 343    48999987543 34456789999999999999999999999865 5679


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      ++||+++|+|.+++...  ...+++..+++++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            99999999999998643  345889999999999999999999986   9999999999999999999999999998765


Q ss_pred             CCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      .............+..|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~  214 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG  214 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence            4333222222334678999999999999999999999999999998 9999864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.1e-32  Score=286.02  Aligned_cols=193  Identities=30%  Similarity=0.389  Sum_probs=163.3

Q ss_pred             ceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHH-HHHhcccCCceeEeeEEeeCceEEEEEEecCC
Q 007006          397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVN-LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN  471 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~-~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  471 (621)
                      +.||+|+||.||+++.. +|+.||+|++.+..   ......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999964 68999999987542   222344555554 56788999999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcc
Q 007006          472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN  551 (621)
Q Consensus       472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~  551 (621)
                      ++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......  ...
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~  152 (323)
T cd05575          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKT  152 (323)
T ss_pred             CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCc
Confidence            999988853   346899999999999999999999986   999999999999999999999999998753221  112


Q ss_pred             cccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       552 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~  198 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS  198 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC
Confidence            2345689999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.7e-32  Score=307.41  Aligned_cols=204  Identities=25%  Similarity=0.353  Sum_probs=173.5

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|++.++||+|+||.||+|... +++.||+|+++...   ....+++.+|++++++++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            47889999999999999999864 58999999997542   223457899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhcc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeec
Q 007006          467 EYMPNKSLDVHLFDAT--------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG  538 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfg  538 (621)
                      ||+++++|.+++....        ....+++..+++++.||++||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999885421        1234667888999999999999999986   9999999999999999999999999


Q ss_pred             CceecCCCCCC----------------cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          539 LARIFGGNQNQ----------------ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       539 la~~~~~~~~~----------------~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ++.........                .......||+.|+|||.+.+..++.++|||||||++|||+||+.||..
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            99876211100                011224689999999999999999999999999999999999999864

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.3e-33  Score=278.99  Aligned_cols=196  Identities=28%  Similarity=0.446  Sum_probs=161.0

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCc-----eEEEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-----ELLLI  465 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~-----~~~lV  465 (621)
                      .|...+++|.|+||.||+|++. +++.||||+.-...+..    ..|+++|++++|||||+++.+|....     ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4566789999999999999954 57999999986544321    46899999999999999999887542     34689


Q ss_pred             EEecCCCChhhhhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC-CCeEEeeecCceec
Q 007006          466 YEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGLARIF  543 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~vkL~Dfgla~~~  543 (621)
                      ||||| .+|..+++.. ..+..++...+.-+..||.+||.|||+.+   |+||||||.|+|+|.+ |.+||+|||.|+.+
T Consensus       101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            99997 5677777642 22445788888889999999999999975   9999999999999976 99999999999988


Q ss_pred             CCCCCCcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          544 GGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       544 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ..+....   ...-|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|...
T Consensus       177 ~~~epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~  229 (364)
T KOG0658|consen  177 VKGEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD  229 (364)
T ss_pred             ccCCCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC
Confidence            6554332   22347789999998775 5899999999999999999999988753

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.5e-32  Score=283.43  Aligned_cols=193  Identities=30%  Similarity=0.444  Sum_probs=165.2

Q ss_pred             ceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEEEEecCC
Q 007006          397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN  471 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~  471 (621)
                      +.||+|+||.||+++.+ +|..||+|+++...   ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999965 68899999997542   23345567788888765 899999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcc
Q 007006          472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN  551 (621)
Q Consensus       472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~  551 (621)
                      ++|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05620          81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence            999988853   345889999999999999999999986   9999999999999999999999999987532211  12


Q ss_pred             cccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       552 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~  198 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG  198 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence            2345689999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.1e-32  Score=290.78  Aligned_cols=192  Identities=23%  Similarity=0.275  Sum_probs=165.8

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      ++|++.+.||+|+||.||++.. .+++.||+|+...      +.+.+|++++++++||||+++++++..+...++|+|++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            5799999999999999999985 4689999997542      34688999999999999999999999999999999998


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      . ++|..++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....... .
T Consensus       166 ~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~  237 (391)
T PHA03212        166 K-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-A  237 (391)
T ss_pred             C-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-c
Confidence            5 678777743   345899999999999999999999986   9999999999999999999999999987543221 1


Q ss_pred             cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.|+-
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~  284 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF  284 (391)
T ss_pred             cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence            12223578999999999999999999999999999999999998853

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.2e-32  Score=285.58  Aligned_cols=194  Identities=29%  Similarity=0.375  Sum_probs=163.1

Q ss_pred             ceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHH-HHHhcccCCceeEeeEEeeCceEEEEEEecCC
Q 007006          397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVN-LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN  471 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~-~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  471 (621)
                      +.||+|+||.||+++.. +++.||+|++.+..   ......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999964 68899999987542   222344555554 57888999999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcc
Q 007006          472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN  551 (621)
Q Consensus       472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~  551 (621)
                      ++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~  152 (321)
T cd05603          81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET  152 (321)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence            999887743   345888999999999999999999886   9999999999999999999999999987532211  12


Q ss_pred             cccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       552 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      .....|++.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  199 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR  199 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC
Confidence            23456899999999999889999999999999999999999998643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=5.2e-32  Score=290.37  Aligned_cols=205  Identities=33%  Similarity=0.433  Sum_probs=172.0

Q ss_pred             hCCCCccceeccCCceeEEEEEec------CCcEEEEEEeccCCc-ccHHHHHHHHHHHHhcc-cCCceeEeeEEeeCce
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQE  461 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~  461 (621)
                      .++|.+.++||+|+||.||+|...      .+..||||++..... ...+.+.+|++++++++ ||||+++++++.+.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            467888999999999999999852      235799999975432 33467899999999996 9999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhhccC----------------------------------------------------------
Q 007006          462 LLLIYEYMPNKSLDVHLFDATR----------------------------------------------------------  483 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~----------------------------------------------------------  483 (621)
                      .++||||+++|+|.+++.....                                                          
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            9999999999999998864211                                                          


Q ss_pred             -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC
Q 007006          484 -----------------------------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD  528 (621)
Q Consensus       484 -----------------------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~  528 (621)
                                                         ...+++..+.+++.||+.||.|||+.+   |+||||||+|||++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence                                               124788889999999999999999876   999999999999999


Q ss_pred             CCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          529 DMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       529 ~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      ++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~  342 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG  342 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence            99999999999987643322222223346778999999998899999999999999999997 9999854

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.8e-32  Score=277.45  Aligned_cols=204  Identities=31%  Similarity=0.508  Sum_probs=173.8

Q ss_pred             CCCCccceeccCCceeEEEEEecC------CcEEEEEEeccCCcc-cHHHHHHHHHHHHhcccCCceeEeeEEeeCceEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL  463 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~  463 (621)
                      ++|.+.+.||+|+||.||+|...+      +..||+|+++..... ..+.+.+|++++++++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            457888999999999999998633      478999999765443 4578999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhcc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCe
Q 007006          464 LIYEYMPNKSLDVHLFDAT-----------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP  532 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~v  532 (621)
                      +||||+++++|.+++....           ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence            9999999999999986432           2345889999999999999999999886   9999999999999999999


Q ss_pred             EEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          533 KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       533 kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      ||+|||++................+++.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~  227 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYG  227 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCC
Confidence            9999999986533322222223345678999999999999999999999999999998 9999753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-34  Score=276.07  Aligned_cols=198  Identities=30%  Similarity=0.493  Sum_probs=177.4

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      +-|.++++||+|++|.||++.++ .|+.+|||.+...  ...+++..|+.+|++++.|+||+++|.+.....+|+|||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            34778899999999999999865 5999999998654  45788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ..|++.++++  .+++++++.++..++++.++||+|||..   +-+|||||+.|||++.+|.+||+|||.+..+.+.  -
T Consensus       111 GAGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--M  183 (502)
T KOG0574|consen  111 GAGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--M  183 (502)
T ss_pred             CCCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh--H
Confidence            9999999995  3567899999999999999999999986   4799999999999999999999999999866432  2


Q ss_pred             cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ...+...||+.|||||++..-.|..++||||||+...||..|++||..
T Consensus       184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsD  231 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSD  231 (502)
T ss_pred             HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccc
Confidence            233457899999999999999999999999999999999999999853

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.3e-32  Score=276.96  Aligned_cols=204  Identities=35%  Similarity=0.531  Sum_probs=172.6

Q ss_pred             CCCCccceeccCCceeEEEEEecC------CcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL  463 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~  463 (621)
                      ++|++.+.||+|+||.||+|....      ...|++|.+.... ......+.+|+.++.+++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            368888999999999999998542      2579999987543 334567899999999999999999999999988999


Q ss_pred             EEEEecCCCChhhhhhhccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC
Q 007006          464 LIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM  530 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~  530 (621)
                      ++|||+++++|.+++.....             ...+++..++.++.|++.||.|||+.+   ++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999999864321             145889999999999999999999986   99999999999999999


Q ss_pred             CeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          531 NPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       531 ~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      .++|+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~  229 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG  229 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence            999999999986543322222233456788999999988899999999999999999998 9999854

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.2e-32  Score=287.23  Aligned_cols=194  Identities=29%  Similarity=0.392  Sum_probs=167.6

Q ss_pred             ceeccCCceeEEEEEe----cCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecC
Q 007006          397 NKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP  470 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~----~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  470 (621)
                      +.||+|+||.||+++.    .+|+.+|+|++....  ......+.+|++++++++||||+++++++.+++..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    358899999997542  2234557789999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc
Q 007006          471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA  550 (621)
Q Consensus       471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~  550 (621)
                      +++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......  .
T Consensus        82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~  153 (318)
T cd05582          82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K  153 (318)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence            9999988843   345899999999999999999999986   9999999999999999999999999987643321  1


Q ss_pred             ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~  201 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK  201 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC
Confidence            222356899999999999888999999999999999999999998643

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3e-32  Score=275.66  Aligned_cols=199  Identities=39%  Similarity=0.610  Sum_probs=165.9

Q ss_pred             ccceeccCCceeEEEEEec-----CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          395 DENKLGQGGFGPVYKGTLA-----DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       395 ~~~~LG~G~fG~Vy~~~~~-----~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      ..+.||+|.||.||+|.+.     .+..|+||.++... ....+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3578999999999999976     36789999996543 33478899999999999999999999999988889999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++|+|.+++... ....+++..+..|+.||++||.|||+.+   ++|+||+++||++++++.+||+|||++........
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999999654 2456899999999999999999999985   99999999999999999999999999987633222


Q ss_pred             CcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      ............|+|||.+....++.++||||||+++|||++ |+.|+..
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~  208 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSD  208 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            222223345678999999998889999999999999999999 7888754

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.6e-32  Score=284.51  Aligned_cols=193  Identities=27%  Similarity=0.353  Sum_probs=162.1

Q ss_pred             ceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHH-HHHHhcccCCceeEeeEEeeCceEEEEEEecCC
Q 007006          397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEV-NLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN  471 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei-~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  471 (621)
                      +.||+|+||.||+++.. +++.||+|++.+..   ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999865 57889999987532   12223444444 456788999999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcc
Q 007006          472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN  551 (621)
Q Consensus       472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~  551 (621)
                      ++|..++..   ...+.+..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~  152 (325)
T cd05602          81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT  152 (325)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence            999988853   345788889999999999999999986   9999999999999999999999999987532211  12


Q ss_pred             cccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       552 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  198 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS  198 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC
Confidence            2345689999999999999999999999999999999999999863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.98  E-value=1.8e-32  Score=299.84  Aligned_cols=207  Identities=29%  Similarity=0.355  Sum_probs=174.7

Q ss_pred             hCCCCccceeccCCceeEEEEEecCC-cEEEEEEeccCCcccHHHHHHHHHHHHhcc-cCCceeEee-EEee------Cc
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADG-KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLG-CCLE------GQ  460 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g-~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~l~g-~~~~------~~  460 (621)
                      ..++.+.+.|.+|||+.||.+.+..+ ..+|+|++-..++...+.+.+||++|++|+ |+|||.+++ ....      .-
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            45678889999999999999997665 999999998888888999999999999996 999999999 3322      13


Q ss_pred             eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCc
Q 007006          461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA  540 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla  540 (621)
                      +.+|.||||++|.|-+++....... |++.++++|+.++++|+.+||.. +++|||||||.+||||+.+++.||+|||.+
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence            6789999999999999997654443 99999999999999999999998 478999999999999999999999999998


Q ss_pred             eecCCCCCCccc-------ccccccCCccChhcc---cCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          541 RIFGGNQNQANT-------NIIAGTYGYMAPEYA---MGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       541 ~~~~~~~~~~~~-------~~~~gt~~y~aPE~l---~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ............       -...-|+-|.|||++   .+..+++|+|||+|||+||-|+....||+..
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s  261 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES  261 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence            743222111100       011348899999987   5778999999999999999999999999754

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.98  E-value=9.1e-33  Score=294.03  Aligned_cols=204  Identities=29%  Similarity=0.446  Sum_probs=178.0

Q ss_pred             CCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCc------eEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------ELL  463 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~------~~~  463 (621)
                      .|...+.||+|+||.||+|++ ..|+.||||.++... ....+....|+++|++++|||||+++++-.+..      ...
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            455678899999999999995 579999999998653 344567789999999999999999999876543      578


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc--CCCC--eEEeeecC
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD--DDMN--PKISDFGL  539 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~--~~~~--vkL~Dfgl  539 (621)
                      +|||||.+|+|...|...++...|++.+.+.+..++..||.|||+++   |+||||||.||++-  ++|+  .||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            99999999999999998888899999999999999999999999986   99999999999984  3344  79999999


Q ss_pred             ceecCCCCCCcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCCCcCC
Q 007006          540 ARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE  601 (621)
Q Consensus       540 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~~~~~  601 (621)
                      |+.++++.   ......||..|.+||.... +.|+..+|.|||||++||.+||..||.+....
T Consensus       171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            99886654   3345789999999999874 88999999999999999999999999876554

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.98  E-value=7.6e-32  Score=276.03  Aligned_cols=204  Identities=34%  Similarity=0.488  Sum_probs=171.7

Q ss_pred             CCCCccceeccCCceeEEEEEe-----cCCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      ++|++.+.||+|+||.||+|..     ..+..+++|.+.... .+....+.+|++++++++||||+++++++..+...++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4577889999999999999984     246789999997543 3445678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC
Q 007006          465 IYEYMPNKSLDVHLFDATR--------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM  530 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~  530 (621)
                      ||||+++++|.+++.....              ...+++.+.+.++.|++.||.|||+.+   ++||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            9999999999998853211              235889999999999999999999986   99999999999999999


Q ss_pred             CeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          531 NPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       531 ~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      .+||+|||++................++..|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~  229 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG  229 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence            999999999986543322222223345678999999988889999999999999999999 9888753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.98  E-value=6.5e-32  Score=281.67  Aligned_cols=193  Identities=31%  Similarity=0.433  Sum_probs=166.2

Q ss_pred             ceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEEEEecCC
Q 007006          397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN  471 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~  471 (621)
                      +.||+|+||.||++... +++.||+|++++..   ......+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999865 58899999997542   33455677899999888 799999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcc
Q 007006          472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN  551 (621)
Q Consensus       472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~  551 (621)
                      ++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||++++++.+||+|||++.......  ..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~  152 (318)
T cd05570          81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT  152 (318)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence            999888743   336899999999999999999999886   9999999999999999999999999987532211  11


Q ss_pred             cccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       552 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .....+++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~  198 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG  198 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC
Confidence            2234689999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.98  E-value=8.5e-32  Score=276.58  Aligned_cols=204  Identities=31%  Similarity=0.530  Sum_probs=173.7

Q ss_pred             CCCCccceeccCCceeEEEEEec------CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      ++|.+.+.||+|+||.||++...      ++..+++|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            46888899999999999999742      345689999887665666789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhhcc----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEE
Q 007006          465 IYEYMPNKSLDVHLFDAT----------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI  534 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL  534 (621)
                      |+||+++++|.+++....          +...+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence            999999999999986432          2235899999999999999999999886   999999999999999999999


Q ss_pred             eeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          535 SDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       535 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      +|||++................++..|+|||.+.+..++.++||||||+++|||++ |++||..
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~  225 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ  225 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999886543222112222345678999999998889999999999999999998 8999754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.98  E-value=1.4e-31  Score=319.30  Aligned_cols=206  Identities=27%  Similarity=0.493  Sum_probs=170.3

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      ...+...+.||+|+||.||+|+. .++..||+|++......    ...|++.+++++|||||+++|++.+++..++||||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            34577788999999999999996 57999999998754322    13568899999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++|+|.+++.      .++|.++.+++.|+++||+|||.....+|+||||||+||+++.++.+++. |+........  
T Consensus       765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--  835 (968)
T PLN00113        765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--  835 (968)
T ss_pred             CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence            99999999984      28999999999999999999997655679999999999999999888875 6655432111  


Q ss_pred             CcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCcCCCCCChHHHHHHh
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNS  613 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~v~~~  613 (621)
                          ....+++.|+|||++.+..++.++|||||||++|||+||+.||..... ....+.+|++..
T Consensus       836 ----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~  895 (968)
T PLN00113        836 ----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYC  895 (968)
T ss_pred             ----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHh
Confidence                122578899999999999999999999999999999999999864333 234566665543

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.3e-32  Score=273.18  Aligned_cols=207  Identities=27%  Similarity=0.417  Sum_probs=174.3

Q ss_pred             HhCCCCccceeccCCceeEEEEEe-cCCcEEEEEEecc--CCcccHHHHHHHHHHHHhcccCCceeEeeEEee-----Cc
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSR--TSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-----GQ  460 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~-----~~  460 (621)
                      ....|...+.||+|++|.|+.+.. .+|+.||||++..  ...-..++..+|+++|+.++|+||+.+.+++..     -.
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            345566678999999999999985 4789999999973  344556778999999999999999999999875     24


Q ss_pred             eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCc
Q 007006          461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA  540 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla  540 (621)
                      ..|+|+|+| ..+|...++   .+..++...+..++.||++||.|+|+.+   |+||||||+|+|++.+..+||+|||+|
T Consensus       100 DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             eeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence            789999999 678888884   2334999999999999999999999986   999999999999999999999999999


Q ss_pred             eecCCCCCCcccccccccCCccChhccc-CCCCChhhhHHHHHHHHHHHHcCCCCCCCCcCCC
Q 007006          541 RIFGGNQNQANTNIIAGTYGYMAPEYAM-GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH  602 (621)
Q Consensus       541 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~~~  602 (621)
                      +...........+..+.|.+|.|||++. ...|+...||||.||++.||++|++-|...+.-+
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~  235 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVH  235 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHH
Confidence            9886543333334567799999999874 4679999999999999999999999987555443

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.98  E-value=1.2e-31  Score=270.33  Aligned_cols=200  Identities=30%  Similarity=0.435  Sum_probs=171.5

Q ss_pred             CCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecC
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP  470 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  470 (621)
                      ++|++.+.||+|+||.||++.++++..+|+|.+.... ....++.+|++++++++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            4577889999999999999998888899999886443 334678999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc
Q 007006          471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA  550 (621)
Q Consensus       471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~  550 (621)
                      +|+|.+++...  ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||.+..........
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            99999988542  235899999999999999999999886   9999999999999999999999999987653322211


Q ss_pred             ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                       .....++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~  204 (256)
T cd05114         158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK  204 (256)
T ss_pred             -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC
Confidence             112234568999999988889999999999999999999 8999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.98  E-value=1.8e-31  Score=272.77  Aligned_cols=193  Identities=32%  Similarity=0.447  Sum_probs=165.4

Q ss_pred             eccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCCCh
Q 007006          399 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL  474 (621)
Q Consensus       399 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~gsL  474 (621)
                      ||+|+||.||+++.+ +|+.+|+|++....   ......+..|++++++++||||+++.+.+.++...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999864 68999999986432   12234456799999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCccccc
Q 007006          475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI  554 (621)
Q Consensus       475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~  554 (621)
                      ..++... ....+++..+..++.||+.||+|||+.+   ++||||||+||++++++.++|+|||++.......   ....
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~  153 (277)
T cd05607          81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ  153 (277)
T ss_pred             HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence            8887543 2345899999999999999999999886   9999999999999999999999999988654322   1123


Q ss_pred             ccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          555 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       555 ~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ..++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~  197 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH  197 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence            46788999999999888999999999999999999999998643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.98  E-value=8.7e-32  Score=274.71  Aligned_cols=206  Identities=31%  Similarity=0.467  Sum_probs=171.2

Q ss_pred             HhCCCCccceeccCCceeEEEEEec------CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCce
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE  461 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~  461 (621)
                      .+++|+..+.||+|+||.||+|...      .+..||+|++.... .....++.+|+.+++.++||||+++++++.++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3567999999999999999998753      35679999986543 2334568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhhccC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEE
Q 007006          462 LLLIYEYMPNKSLDVHLFDATR-------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI  534 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL  534 (621)
                      .++||||+++++|.+++.....       ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            9999999999999999864221       234688899999999999999999875   999999999999999999999


Q ss_pred             eeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          535 SDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       535 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      +|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~  224 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG  224 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence            99999876533222111122344678999999998889999999999999999999 7888753

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.98  E-value=1.7e-31  Score=274.13  Aligned_cols=199  Identities=31%  Similarity=0.443  Sum_probs=171.3

Q ss_pred             CCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc---ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       393 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      |+..+.||+|+||.||++... +++.||+|.+.....   .....+.+|+.++++++|+||+++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677889999999999999854 689999999875422   2234577899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++++|..++... ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++........
T Consensus        82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            9999999888543 2345899999999999999999999875   99999999999999999999999999876533221


Q ss_pred             CcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                         .....|+..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~  204 (285)
T cd05630         158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR  204 (285)
T ss_pred             ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence               12236889999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.98  E-value=1.2e-31  Score=271.11  Aligned_cols=201  Identities=35%  Similarity=0.518  Sum_probs=173.9

Q ss_pred             CCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecC
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP  470 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  470 (621)
                      ++|++.++||+|+||.||+|...++..|++|.+.... ...+.+.+|+.+++.++|+||+++++.+.+.+..++++||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            5788999999999999999998888899999886543 335788999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc
Q 007006          471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA  550 (621)
Q Consensus       471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~  550 (621)
                      +++|.+++... ....+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++..........
T Consensus        85 ~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05072          85 KGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA  160 (261)
T ss_pred             CCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence            99999998643 2345889999999999999999999875   9999999999999999999999999998764432211


Q ss_pred             ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                       .....++..|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       161 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~  207 (261)
T cd05072         161 -REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG  207 (261)
T ss_pred             -cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC
Confidence             122335678999999988889999999999999999998 9999853

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.98  E-value=1.2e-31  Score=275.80  Aligned_cols=204  Identities=30%  Similarity=0.500  Sum_probs=174.0

Q ss_pred             CCCCccceeccCCceeEEEEEec------CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      .+|.+.+.||+|+||.||+++..      ++..+++|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            35778899999999999999742      356789999876665556789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhhcc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCC
Q 007006          465 IYEYMPNKSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN  531 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~  531 (621)
                      ||||+++++|.+++....             ....+++..+++++.||+.||+|||+.+   ++||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999986432             1235899999999999999999999886   999999999999999999


Q ss_pred             eEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          532 PKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       532 vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      ++|+|||++................++..|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  228 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ  228 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999976544322222223446778999999999999999999999999999999 9999754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.98  E-value=1.9e-31  Score=269.63  Aligned_cols=202  Identities=33%  Similarity=0.486  Sum_probs=173.4

Q ss_pred             hCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      .++|.+.+.||+|++|.||++...++..||+|.++... ...+++.+|+.++++++||||+++++++...+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            35688899999999999999998778899999987543 34567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++++|.+++.... ...+++..+.+++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++.........
T Consensus        84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            9999999985432 346899999999999999999999886   999999999999999999999999999876532211


Q ss_pred             cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      . ......+..|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus       160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~  207 (261)
T cd05068         160 A-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG  207 (261)
T ss_pred             c-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence            1 111122457999999998899999999999999999999 9999854

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.98  E-value=1.4e-32  Score=285.33  Aligned_cols=204  Identities=27%  Similarity=0.403  Sum_probs=180.2

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCce-EEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE-LLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~-~~lV~  466 (621)
                      ++|...+++|+|+||.++..+++ ++..+++|++.-.  +....+...+|+.++++++|||||.+.+.+.+++. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57888999999999999999865 5788999988643  33444577899999999999999999999999988 89999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      +|++||++.+.+.+.+ ...++++.+.+++.|++.|+.|||+..   |+|||||+.||+++.+..|||+|||+++.+..+
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999996543 567999999999999999999999764   999999999999999999999999999988665


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCcC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFS  600 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~  600 (621)
                      .  .......||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+.
T Consensus       160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m  211 (426)
T KOG0589|consen  160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM  211 (426)
T ss_pred             h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch
Confidence            4  233457899999999999999999999999999999999999999875443

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.98  E-value=8.9e-33  Score=260.27  Aligned_cols=211  Identities=26%  Similarity=0.305  Sum_probs=178.1

Q ss_pred             HhCCCCccceeccCCceeEEEEE-ecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCc-----eE
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-----EL  462 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~-----~~  462 (621)
                      ..++|.+.+.||+|||+.||.++ ..++..+|+|++...+.++.+..++|++.-++++||||++++++...+.     +.
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            35789999999999999999998 6789999999998887788889999999999999999999998876543     48


Q ss_pred             EEEEEecCCCChhhhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCce
Q 007006          463 LLIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR  541 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~  541 (621)
                      |++++|...|+|.+.+..... ...+++.+++.|+.+|++||++||+.. ++++||||||.|||+.+.+.++|.|||.+.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence            999999999999998865433 347999999999999999999999985 579999999999999999999999999987


Q ss_pred             ecCCCCCCcc-------cccccccCCccChhccc---CCCCChhhhHHHHHHHHHHHHcCCCCCCCCcC
Q 007006          542 IFGGNQNQAN-------TNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFS  600 (621)
Q Consensus       542 ~~~~~~~~~~-------~~~~~gt~~y~aPE~l~---~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~  600 (621)
                      ...-......       ...-..|..|.|||.+.   +...++++|||||||+||+|+.|..||+.-.+
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~  246 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ  246 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh
Confidence            5432111110       01123578899999874   45579999999999999999999999976444

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.98  E-value=3.5e-31  Score=270.76  Aligned_cols=194  Identities=27%  Similarity=0.418  Sum_probs=169.4

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC-CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      ++|+..++||+|+||.||++.. .+++.||+|++... .....+.+.+|++++++++||||+++++.+...+..++|+||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3577889999999999999985 56889999998654 233456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++++|..+.       .+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.++|+|||++......  
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--  148 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--  148 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence            9999986543       3688889999999999999999986   999999999999999999999999998765332  


Q ss_pred             CcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                        ......++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~  196 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI  196 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence              122346788999999999889999999999999999999999998643

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.98  E-value=1.4e-31  Score=273.83  Aligned_cols=202  Identities=33%  Similarity=0.480  Sum_probs=167.8

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCc----EEEEEEeccCCc-ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      ++|.+.+.||+|+||.||+|... +++    .+++|.+..... ....++..|+..+++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            46788899999999999999863 444    477887754432 234567888889999999999999998764 45788


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      ++||+++|+|.+++...  ...+++..+..++.||+.||.|||+.+   ++||||||+|||+++++.+||+|||+++...
T Consensus        86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            99999999999999542  346899999999999999999999876   9999999999999999999999999998764


Q ss_pred             CCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      ............++..|+|||.+.++.++.++||||||+++|||++ |+.||...
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~  215 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM  215 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            3332222333456778999999998899999999999999999998 99998643

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=3.1e-31  Score=268.05  Aligned_cols=201  Identities=29%  Similarity=0.484  Sum_probs=172.5

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC-----cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS-----GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      ++|.+.+.||+|++|.||++.. .+++.+++|.+....     ....+.+.+|++++++++||||+++++++.+++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5788999999999999999985 468999999986442     1234568899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      |+||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||++....
T Consensus        82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            9999999999998853   345889999999999999999999886   9999999999999999999999999987654


Q ss_pred             CCCCCcc-cccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          545 GNQNQAN-TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       545 ~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ....... .....++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  209 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE  209 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence            3221111 1234567889999999998899999999999999999999999853

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.1e-32  Score=276.64  Aligned_cols=204  Identities=32%  Similarity=0.439  Sum_probs=181.2

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      +.|..-+.||+|+||.||-++.. +|+.+|.|++.+.   ...+....++|-.+|.+++.+.||.+--.++..+.+++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            67888899999999999999854 6999999998654   3445566789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ..|.||+|.-+|.+... ..++++++.-++.+|+.||++||+..   ||.||+||+|||+|+.|+++|+|+|+|..+...
T Consensus       265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999999976543 56999999999999999999999885   999999999999999999999999999987654


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCcCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE  601 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~~  601 (621)
                      +...   ..+||.+|||||++.++.|+...|+||+||++|||+.|+.||.....+
T Consensus       341 ~~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK  392 (591)
T KOG0986|consen  341 KPIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK  392 (591)
T ss_pred             Cccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh
Confidence            4332   238999999999999999999999999999999999999999765544

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.98  E-value=2.3e-31  Score=269.87  Aligned_cols=201  Identities=32%  Similarity=0.499  Sum_probs=171.7

Q ss_pred             CCCCccceeccCCceeEEEEEecC----CcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      ++|++.+.||+|+||.||+|.+..    ...|++|.++... .....++.+|+.++++++||||+++++.+.+.+..+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            568889999999999999998642    4579999987543 33456788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      |||+++++|.+++...  ...+++..+.+++.|++.||.|||+.+   |+|+||||+||++++++.++|+|||++.....
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            9999999999998542  236899999999999999999999875   99999999999999999999999999987652


Q ss_pred             CCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNG  596 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~  596 (621)
                      ...........++..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~  210 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYW  210 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCC
Confidence            222222222334678999999998899999999999999999998 999984

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.98  E-value=2.9e-31  Score=272.31  Aligned_cols=199  Identities=31%  Similarity=0.436  Sum_probs=171.5

Q ss_pred             CCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          393 FSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       393 f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      |+..+.||+|+||+||++.. .+++.+|+|.+....   ......+.+|+++++.++|+||+++.+.+..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            66778999999999999986 468999999986542   22234578899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++++|..++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++....... 
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05632          82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-  156 (285)
T ss_pred             ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence            9999999888643 2346999999999999999999999886   9999999999999999999999999987653221 


Q ss_pred             CcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                        ......++..|+|||++.+..++.++|+||||+++|||++|+.||...
T Consensus       157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~  204 (285)
T cd05632         157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR  204 (285)
T ss_pred             --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence              112346889999999999889999999999999999999999998643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=2.1e-31  Score=285.92  Aligned_cols=198  Identities=22%  Similarity=0.296  Sum_probs=170.4

Q ss_pred             hCCCCccceeccCCceeEEEEEec---CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ..+|.+.++||+|+||.||++...   .+..|++|.+...     ....+|++++++++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            457999999999999999999743   3678999988643     23468999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      |++. ++|..++.   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.++|+|||++......
T Consensus       166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9986 67777772   3456899999999999999999999986   999999999999999999999999999876544


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      ..........||+.|+|||++....++.++|||||||++|||++|+.||....
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~  291 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ  291 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence            33333334578999999999999999999999999999999999999985443

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.97  E-value=3.1e-31  Score=268.93  Aligned_cols=199  Identities=26%  Similarity=0.417  Sum_probs=172.2

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++.+++||||+++++.+..++..++|+||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            35799999999999999999995 56889999999766555556788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.++|+|||++........
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA  161 (267)
T ss_pred             CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence            999999998853   346899999999999999999999875   99999999999999999999999999987643221


Q ss_pred             CcccccccccCCccChhccc---CCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                        ......++..|+|||.+.   ...++.++||||||+++|||++|+.||.
T Consensus       162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~  210 (267)
T cd06646         162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF  210 (267)
T ss_pred             --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence              112345788999999874   3457889999999999999999999974

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.4e-31  Score=268.22  Aligned_cols=201  Identities=31%  Similarity=0.458  Sum_probs=171.0

Q ss_pred             CCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecC
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP  470 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  470 (621)
                      .+|.+.+.||+|+||.||++..+++..+|+|++.+... ...++.+|++++++++||||+++++++.+.+..++|+||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            35778899999999999999987778899999865432 34578899999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc
Q 007006          471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA  550 (621)
Q Consensus       471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~  550 (621)
                      +++|.+++...  ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.........
T Consensus        83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            99999998543  236899999999999999999999986   9999999999999999999999999987654322111


Q ss_pred             ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                       .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       158 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  205 (256)
T cd05059         158 -SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF  205 (256)
T ss_pred             -cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC
Confidence             111223457999999998899999999999999999999 89998643

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.97  E-value=2.6e-31  Score=268.19  Aligned_cols=201  Identities=31%  Similarity=0.468  Sum_probs=171.7

Q ss_pred             CCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecC
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP  470 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  470 (621)
                      ++|.+.+.||+|+||.||++...++..+|+|.+.... ...+++.+|+.++++++||||+++++++.+.+..+++|||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            3577889999999999999998777789999987543 334678999999999999999999999999889999999999


Q ss_pred             CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc
Q 007006          471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA  550 (621)
Q Consensus       471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~  550 (621)
                      +++|.+++....  ..+++..+++++.||+.||.|||+.+   ++|+||||+||++++++.+||+|||.++.........
T Consensus        83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            999999885432  36899999999999999999999886   9999999999999999999999999987654322111


Q ss_pred             ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                       .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       158 -~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~  205 (256)
T cd05113         158 -SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF  205 (256)
T ss_pred             -cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence             111234567999999988889999999999999999999 99998643

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.97  E-value=1.2e-31  Score=281.95  Aligned_cols=204  Identities=32%  Similarity=0.465  Sum_probs=169.5

Q ss_pred             CCCCccceeccCCceeEEEEEec------CCcEEEEEEeccCC-cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeC-ce
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG-QE  461 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~-~~  461 (621)
                      ++|.+.+.||+|+||.||++...      +++.||+|+++... ....+.+..|+.++.++ +|+||+++++++... ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            47889999999999999999632      35789999987543 23345678899999999 899999999988754 56


Q ss_pred             EEEEEEecCCCChhhhhhhccC----------------------------------------------------------
Q 007006          462 LLLIYEYMPNKSLDVHLFDATR----------------------------------------------------------  483 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~----------------------------------------------------------  483 (621)
                      .++++||+++++|.+++.....                                                          
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            7899999999999988853221                                                          


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcccccccccCCccC
Q 007006          484 SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA  563 (621)
Q Consensus       484 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~a  563 (621)
                      ..++++..+.+++.||+.||.|||+.+   |+||||||+|||+++++.++|+|||++..+.............++..|+|
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence            136899999999999999999999876   99999999999999999999999999987643322222223445678999


Q ss_pred             hhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          564 PEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       564 PE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      ||++.+..++.++|||||||++|||++ |+.||..
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~  278 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG  278 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCC
Confidence            999999999999999999999999998 9999854

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.5e-33  Score=289.32  Aligned_cols=193  Identities=33%  Similarity=0.507  Sum_probs=170.0

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ..|..++.||.|+||.||.++. .+.+.||||++.-.   +.+.|+++..|+..|.+++|||++.+.|+|..+...||||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            4577788999999999999984 57889999999744   4456789999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      |||- |+-.+++.-  ..+++.+.++..|+.+.+.||+|||+++   .||||||+.|||+++.|.|||+|||.+.+..  
T Consensus       106 EYCl-GSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~--  177 (948)
T KOG0577|consen  106 EYCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA--  177 (948)
T ss_pred             HHHh-ccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC--
Confidence            9995 566666632  3457899999999999999999999986   9999999999999999999999999987643  


Q ss_pred             CCCcccccccccCCccChhcc---cCCCCChhhhHHHHHHHHHHHHcCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYA---MGGIFSIKSDVFSFGVLLLEIISGRKNN  595 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l---~~~~~s~~sDVwS~Gvll~elltG~~p~  595 (621)
                          ..+.++|||.|||||++   ..+.|+-|+||||||++..||.-.++|.
T Consensus       178 ----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPl  225 (948)
T KOG0577|consen  178 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL  225 (948)
T ss_pred             ----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCc
Confidence                33457899999999987   4678999999999999999999999994

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.97  E-value=2.5e-31  Score=275.98  Aligned_cols=201  Identities=26%  Similarity=0.424  Sum_probs=168.9

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      ++|.+.++||+|+||.||+++.+ +++.||+|.++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888999999999999999864 68889999987543 23345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++ +|..++...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            975 777777432  345889999999999999999999986   99999999999999999999999999876433222


Q ss_pred             CcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          549 QANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      .  .....+++.|+|||.+.+ ..++.++||||||+++|||+||++||....
T Consensus       160 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~  209 (309)
T cd07872         160 T--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST  209 (309)
T ss_pred             c--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            1  122356889999998865 458999999999999999999999986443

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.97  E-value=2.7e-31  Score=266.95  Aligned_cols=196  Identities=31%  Similarity=0.479  Sum_probs=165.3

Q ss_pred             ceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCCCh
Q 007006          397 NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL  474 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~gsL  474 (621)
                      +.||+|+||.||++... +++.+|+|.+.... .+....+.+|++++++++||||+++++++......++|+||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999864 78999999886543 34456789999999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCccccc
Q 007006          475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI  554 (621)
Q Consensus       475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~  554 (621)
                      .+++..  ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++..............
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            999853  2345899999999999999999999886   99999999999999999999999999875432211111111


Q ss_pred             ccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          555 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       555 ~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      ...+..|+|||.+.++.++.++||||||+++|||++ |..||..
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~  199 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN  199 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence            123457999999998889999999999999999998 8888854

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.97  E-value=2e-31  Score=284.16  Aligned_cols=199  Identities=27%  Similarity=0.434  Sum_probs=167.3

Q ss_pred             CCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCc-----eEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-----ELL  463 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~-----~~~  463 (621)
                      +|+..++||+|+||.||++.. .+++.||+|++...  .....+.+.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477889999999999999985 47899999998653  2234567889999999999999999999998776     789


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceec
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF  543 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~  543 (621)
                      +|+||+. ++|..++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999997 56776663   2346899999999999999999999986   999999999999999999999999999865


Q ss_pred             CCCCCCcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          544 GGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       544 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ...... ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus       154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  208 (372)
T cd07853         154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ  208 (372)
T ss_pred             ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC
Confidence            432221 11223568899999998774 4799999999999999999999998643

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.97  E-value=1.6e-31  Score=270.01  Aligned_cols=203  Identities=35%  Similarity=0.533  Sum_probs=177.3

Q ss_pred             hCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      ..+|...++||+|+||.||+|...++..+++|.+..........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            35688899999999999999998889999999998776656678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++++|.+++... ....+++..+.+++.||+.||.|||+.+   ++|+||+|+||++++++.+||+|||.+.........
T Consensus        85 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~  160 (261)
T cd05148          85 EKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL  160 (261)
T ss_pred             ccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence            999999999653 2356899999999999999999999886   999999999999999999999999999765432221


Q ss_pred             cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      ..  ...++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       161 ~~--~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~  208 (261)
T cd05148         161 SS--DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM  208 (261)
T ss_pred             cc--CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC
Confidence            11  2234668999999988889999999999999999998 89998643

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.97  E-value=4e-31  Score=265.95  Aligned_cols=202  Identities=31%  Similarity=0.455  Sum_probs=175.4

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      +|...+.||+|++|.||++... +++.|++|.+...  .....+.+.+|++++++++||||+++++++.+++..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677899999999999999864 6899999998643  334456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++++|.+++... ....+++..+.+++.+++.||.|||+.+   ++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            9999999998653 2356899999999999999999999875   99999999999999999999999999887654322


Q ss_pred             CcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      .  .....+++.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  205 (256)
T cd08529         157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN  205 (256)
T ss_pred             h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence            1  223457889999999999999999999999999999999999986443

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.97  E-value=2.5e-31  Score=271.90  Aligned_cols=203  Identities=33%  Similarity=0.516  Sum_probs=172.4

Q ss_pred             CCCCccceeccCCceeEEEEEec------CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      .++...++||+|+||.||++...      ++..+++|.+........+.+.+|+++++.++|+||+++++++.+.+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46778899999999999999632      356899999887666667789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhhccC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCe
Q 007006          465 IYEYMPNKSLDVHLFDATR------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP  532 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~v  532 (621)
                      ++||+++++|.+++.....            ...+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            9999999999999864321            135889999999999999999999886   9999999999999999999


Q ss_pred             EEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCC
Q 007006          533 KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNG  596 (621)
Q Consensus       533 kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~  596 (621)
                      ||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |++||.
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~  226 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWY  226 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCc
Confidence            9999999876543222111222334678999999998899999999999999999998 899984

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=279.94  Aligned_cols=201  Identities=28%  Similarity=0.425  Sum_probs=178.9

Q ss_pred             HhCCCCccceeccCCceeEEEEEecC-CcEEEEEEeccCCcc---cHHHHHHHHHHHHhcc-cCCceeEeeEEeeCceEE
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQ---GLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELL  463 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~  463 (621)
                      ....|++.+.||+|.||.||+++.+. |+.+|+|.+.+....   ....+.+|+.+|+++. |||||.+.+.+.+....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            34678888999999999999999664 999999999876433   3468999999999998 999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC----CCeEEeeecC
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD----MNPKISDFGL  539 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~----~~vkL~Dfgl  539 (621)
                      +|||++.||.|.+.+...    .+++..+..++.|++.++.|||+.+   |+||||||+|+|+...    +.+|++|||+
T Consensus       113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999988654    2999999999999999999999986   9999999999999643    4799999999


Q ss_pred             ceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          540 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       540 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      +.....   .......+||+.|+|||++....|+..+||||+||++|.|++|.+||....
T Consensus       186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~  242 (382)
T KOG0032|consen  186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET  242 (382)
T ss_pred             ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence            998765   334556799999999999999999999999999999999999999987544

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=4.3e-31  Score=286.89  Aligned_cols=194  Identities=24%  Similarity=0.304  Sum_probs=166.6

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      ...|.+.+.||+|+||.||++.+. .++.||||....      ..+.+|+++|++++|+||+++++++..++..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            347999999999999999999965 478899996432      3457899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +. ++|..++..  ....+++..++.|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            85 688777743  2346999999999999999999999986   99999999999999999999999999987644322


Q ss_pred             CcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNN  595 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~  595 (621)
                      ........||..|+|||++.+..++.++|||||||++|||++|..|+
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            22223456899999999999999999999999999999999988764

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.97  E-value=2.4e-31  Score=289.18  Aligned_cols=198  Identities=24%  Similarity=0.383  Sum_probs=161.8

Q ss_pred             HhCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeC--------
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--------  459 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--------  459 (621)
                      ...+|.+.+.||+|+||.||+|.. .+++.||||++....    ....+|+.+|+.++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            346799999999999999999986 468999999886432    2335799999999999999999887532        


Q ss_pred             ceEEEEEEecCCCChhhhhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC-CeEEeee
Q 007006          460 QELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDF  537 (621)
Q Consensus       460 ~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~vkL~Df  537 (621)
                      ..+++||||+++ +|..++... .....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence            246789999985 666665432 23456899999999999999999999986   99999999999999664 6999999


Q ss_pred             cCceecCCCCCCcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          538 GLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       538 gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      |+++.+.....   .....+++.|+|||++.+. .++.++|||||||++|||++|++||..
T Consensus       216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~  273 (440)
T PTZ00036        216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSG  273 (440)
T ss_pred             ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            99986543221   1224678999999988664 689999999999999999999999864

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.97  E-value=3.8e-31  Score=272.98  Aligned_cols=198  Identities=27%  Similarity=0.467  Sum_probs=174.3

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      .+|+..+.||+|++|.||+++. .+++.|++|.+........+.+.+|+.+++.++||||+++++.+..+...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            5788899999999999999985 468999999998766556678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++++|.+++..    ..+++.++..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.........
T Consensus       100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  172 (296)
T cd06654         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (296)
T ss_pred             CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence            99999998843    34789999999999999999999886   999999999999999999999999998765332211


Q ss_pred             cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                        .....+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       173 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~  218 (296)
T cd06654         173 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN  218 (296)
T ss_pred             --cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence              1223578899999999888899999999999999999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.97  E-value=3.9e-31  Score=268.09  Aligned_cols=202  Identities=25%  Similarity=0.421  Sum_probs=173.4

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|++.+.||+|+||.||+++. .+++.||+|.+...   .......+.+|+++++.++||||+++++++.+.+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            4788999999999999999985 47899999987643   2333456889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          467 EYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      ||+++++|..++.... +...+++..+..++.|+++||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999998885432 2345899999999999999999999886   99999999999999999999999999887643


Q ss_pred             CCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ...  ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||..
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~  208 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG  208 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence            322  11224578899999999888899999999999999999999999743

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.97  E-value=5.4e-32  Score=287.48  Aligned_cols=194  Identities=28%  Similarity=0.402  Sum_probs=167.3

Q ss_pred             CCCccceeccCCceeEEEEE-ecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcc-c-----CCceeEeeEEeeCceEEE
Q 007006          392 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-H-----KNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-h-----~nIv~l~g~~~~~~~~~l  464 (621)
                      +|++++.||+|.||.|-++. .++++.||||+++.... ...+-..|+.+|..|+ |     -|+|++++++...++++|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            78999999999999999998 45799999999987643 3445578999999997 4     389999999999999999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC--CeEEeeecCcee
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM--NPKISDFGLARI  542 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~--~vkL~Dfgla~~  542 (621)
                      |+|.+ .-+|.+++... +-..++...+..|+.||+.||.+||+.+   |||+||||+||||.+-.  .+||+|||++..
T Consensus       266 VfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence            99987 57899999654 3456999999999999999999999886   99999999999997644  599999999987


Q ss_pred             cCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          543 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       543 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      ......     ....+..|.|||++.+.+|+.+.||||||||+.||++|.+-|.
T Consensus       341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp  389 (586)
T KOG0667|consen  341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP  389 (586)
T ss_pred             cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence            543322     3456778999999999999999999999999999999976654

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=8.7e-33  Score=295.79  Aligned_cols=200  Identities=32%  Similarity=0.480  Sum_probs=175.7

Q ss_pred             CCccceeccCCceeEEEEEe-cCC----cEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          393 FSDENKLGQGGFGPVYKGTL-ADG----KAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       393 f~~~~~LG~G~fG~Vy~~~~-~~g----~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ....++||.|+||+||+|.+ .+|    -+||+|++.... .+...++++|+..|.+++|||+++++|+|.... +.||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            45578999999999999984 344    468999987653 455688999999999999999999999998876 88999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      +||+.|+|.+|++.  .+..+..+..+.|..||++||.|||++.   ++||||..+|||+..-..+||.|||+++....+
T Consensus       777 q~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            99999999999975  4456888999999999999999999875   999999999999999999999999999998777


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      ..........-.+.|||-|.+....|+.++|||||||.+|||+| |..|++-.
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi  904 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI  904 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC
Confidence            66666655566788999999999999999999999999999998 89997543

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.97  E-value=6.1e-31  Score=273.96  Aligned_cols=198  Identities=28%  Similarity=0.468  Sum_probs=160.5

Q ss_pred             cceeccCCceeEEEEEec---CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEee--CceEEEEEEecC
Q 007006          396 ENKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLLIYEYMP  470 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~--~~~~~lV~e~~~  470 (621)
                      .++||+|+||.||+++..   +++.+|+|.+....  ....+.+|+.++++++||||+++++++..  +...++++||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            368999999999999854   46789999986543  23457889999999999999999999864  356789999986


Q ss_pred             CCChhhhhhhc------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE----cCCCCeEEeeecCc
Q 007006          471 NKSLDVHLFDA------TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLA  540 (621)
Q Consensus       471 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~vkL~Dfgla  540 (621)
                       ++|..++...      .+...+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             4777666422      12235899999999999999999999986   9999999999999    45678999999999


Q ss_pred             eecCCCCCC-cccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          541 RIFGGNQNQ-ANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       541 ~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      +........ .......+|+.|+|||++.+. .++.++||||+||++|||++|++||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            876543221 222345689999999998764 58999999999999999999999996433

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.97  E-value=6.4e-31  Score=267.10  Aligned_cols=202  Identities=28%  Similarity=0.465  Sum_probs=167.9

Q ss_pred             CCccceeccCCceeEEEEEecC----CcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCce-----
Q 007006          393 FSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE-----  461 (621)
Q Consensus       393 f~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~-----  461 (621)
                      |.+.+.||+|+||.||+|.+..    +..||+|+++...  ......+.+|++.++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4567899999999999998642    3679999987542  2334678999999999999999999999876554     


Q ss_pred             -EEEEEEecCCCChhhhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeee
Q 007006          462 -LLLIYEYMPNKSLDVHLFDAT---RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF  537 (621)
Q Consensus       462 -~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Df  537 (621)
                       .++++||+++++|..++....   ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             799999999999998885432   2346899999999999999999999876   999999999999999999999999


Q ss_pred             cCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          538 GLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       538 gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      |+++................+..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~  218 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG  218 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence            99987644332222222334678999999988889999999999999999999 8888753

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.97  E-value=2.1e-31  Score=272.69  Aligned_cols=203  Identities=34%  Similarity=0.472  Sum_probs=169.8

Q ss_pred             CCCccceeccCCceeEEEEEec------CCcEEEEEEeccCCcc-cHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      +|.+.++||+|+||.||+|...      .+..||+|+++..... ..+.+.+|+.++..++||||+++++++.+.+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4667889999999999999853      2578999999755432 34568899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhhc-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCC
Q 007006          465 IYEYMPNKSLDVHLFDA-------------TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN  531 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~  531 (621)
                      ++||+++++|..++...             .....+++..+.+++.|++.||.|||+.+   ++||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence            99999999999988421             11235889999999999999999999886   999999999999999999


Q ss_pred             eEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          532 PKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       532 vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      +||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..||..
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~  229 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG  229 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence            99999999886543322222223345678999999988889999999999999999998 8888754

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.97  E-value=3.3e-31  Score=281.10  Aligned_cols=198  Identities=30%  Similarity=0.397  Sum_probs=166.9

Q ss_pred             HhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCc-----
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-----  460 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~-----  460 (621)
                      ..++|.+.+.||+|+||.||++... +|..||+|++...  .......+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3578999999999999999999864 6899999999754  2334567889999999999999999999986543     


Q ss_pred             -eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecC
Q 007006          461 -ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL  539 (621)
Q Consensus       461 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgl  539 (621)
                       ..++||||+++ +|...+.     ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence             47999999975 4554442     24788999999999999999999986   99999999999999999999999999


Q ss_pred             ceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          540 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       540 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ++......   ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~  225 (359)
T cd07876         170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT  225 (359)
T ss_pred             ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            87543221   122346789999999999999999999999999999999999999743

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.97  E-value=3.3e-31  Score=267.07  Aligned_cols=198  Identities=34%  Similarity=0.559  Sum_probs=171.7

Q ss_pred             CCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHH--HHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQ--EFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       393 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~--~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      |++.+.||+|+||+||+++.. +++.+|+|++.........  ...+|+.++++++||||+++++++.+....++|||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            567789999999999999965 5678999999877543322  3456999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++++|.+++.   +...+++..+..++.|+++||.+||+.+   ++|+||||+||++++++.++|+|||.+....  ...
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENN  152 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STT
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--ccc
Confidence            9999999995   3456899999999999999999999986   9999999999999999999999999998651  122


Q ss_pred             cccccccccCCccChhccc-CCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAM-GGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~-~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      .......++..|+|||++. +...+.++||||+|+++|+|++|+.||...
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~  202 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES  202 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            2333456788999999998 788999999999999999999999998755

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.97  E-value=5.3e-31  Score=273.49  Aligned_cols=199  Identities=29%  Similarity=0.384  Sum_probs=171.7

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      ++|++.+.||+|+||.||++... ++..+++|.+.... .....++.+|++++.+++||||+++++.+.+++..++|+||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46889999999999999999864 68889999886542 23345688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++++|.+++...   ..+++..+..++.|+++||.|||+..  +++|+||||+|||++.++.+||+|||++......  
T Consensus        81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  153 (308)
T cd06615          81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  153 (308)
T ss_pred             cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence            9999999998542   45899999999999999999999742  4999999999999999999999999998754322  


Q ss_pred             CcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                        ......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~  201 (308)
T cd06615         154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP  201 (308)
T ss_pred             --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence              112346788999999998888999999999999999999999998543

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.97  E-value=4.3e-31  Score=268.30  Aligned_cols=199  Identities=27%  Similarity=0.375  Sum_probs=160.6

Q ss_pred             ceeccCCceeEEEEEecC---CcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCC
Q 007006          397 NKLGQGGFGPVYKGTLAD---GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK  472 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~~---g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  472 (621)
                      +.||+|+||.||+|...+   ...+++|.+.... ......+.+|++.++.++||||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            368999999999997543   4568888876543 233456889999999999999999999999999999999999999


Q ss_pred             ChhhhhhhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc
Q 007006          473 SLDVHLFDATR--SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA  550 (621)
Q Consensus       473 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~  550 (621)
                      +|.+++.....  ....++.....++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999965432  233567888999999999999999986   9999999999999999999999999986543222111


Q ss_pred             ccccccccCCccChhcccC-------CCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          551 NTNIIAGTYGYMAPEYAMG-------GIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~-------~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      ......++..|+|||++..       ..++.++||||||+++|||++ |+.||...
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  213 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL  213 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence            1222345678999998743       356889999999999999999 78887643

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.97  E-value=3.7e-31  Score=268.39  Aligned_cols=198  Identities=26%  Similarity=0.425  Sum_probs=172.1

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      ++|.+.++||+|+||.||++.. .+++.||+|.++.........+.+|+.+++.++||||+++++.+.+.+..++|+||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            4788889999999999999985 468899999987665555567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++++|.+++..   ...+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......  
T Consensus        89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--  160 (267)
T cd06645          89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI--  160 (267)
T ss_pred             CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence            99999998843   346899999999999999999999986   9999999999999999999999999987654321  


Q ss_pred             cccccccccCCccChhccc---CCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      .......++..|+|||++.   ...++.++|||||||++|||++|+.||.
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~  210 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF  210 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence            1122346789999999874   4558899999999999999999999974

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.97  E-value=8.1e-31  Score=268.34  Aligned_cols=200  Identities=31%  Similarity=0.478  Sum_probs=169.6

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      +|++.+.||+|++|.||+|+.. ++..||+|+++...  ....+.+.+|+.+++.++||||+++++++.+++..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778899999999999999864 68999999986542  23346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      ++ ++|.+++........+++..+..++.||+.||.|||+.+   ++||||+|+||++++++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            97 688888755444467999999999999999999999886   99999999999999999999999999876543221


Q ss_pred             CcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .  .....+++.|+|||.+.+. .++.++||||||+++|||+||++||..
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~  204 (285)
T cd07861         157 V--YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHG  204 (285)
T ss_pred             c--ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            1  1123457889999988654 478999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.97  E-value=4.8e-31  Score=269.33  Aligned_cols=205  Identities=33%  Similarity=0.472  Sum_probs=170.3

Q ss_pred             hCCCCccceeccCCceeEEEEEecC------CcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL  462 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~  462 (621)
                      .++|.+.+.||+|++|.||++.+.+      +..|++|.+.... ......+.+|+.+++.++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4678899999999999999998653      5678999886543 33345689999999999999999999999999899


Q ss_pred             EEEEEecCCCChhhhhhhccC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC---CeEEe
Q 007006          463 LLIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM---NPKIS  535 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~vkL~  535 (621)
                      ++||||+++++|.+++.....    ...+++..+.+++.||+.||.|||+.+   ++||||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence            999999999999999865321    235899999999999999999999986   99999999999998754   59999


Q ss_pred             eecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          536 DFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       536 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      |||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~  224 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPG  224 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence            9999986633222111112233567999999999999999999999999999997 9999864

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.97  E-value=5.5e-31  Score=267.64  Aligned_cols=199  Identities=29%  Similarity=0.404  Sum_probs=163.2

Q ss_pred             ceeccCCceeEEEEEecC---CcEEEEEEeccCCc-ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCC
Q 007006          397 NKLGQGGFGPVYKGTLAD---GKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK  472 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~~---g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  472 (621)
                      +.||+|+||.||+|...+   +..+++|.++.... .....+.+|+.++++++||||+++++.+.+....++||||++++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998543   46799998876542 33457889999999999999999999999998999999999999


Q ss_pred             Chhhhhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc
Q 007006          473 SLDVHLFDAT--RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA  550 (621)
Q Consensus       473 sL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~  550 (621)
                      +|.+++....  .....++..+..++.|++.||.|||+.+   ++|+||||+||+++.++++||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999986432  2235677888899999999999999886   9999999999999999999999999987543322222


Q ss_pred             ccccccccCCccChhcccCC-------CCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          551 NTNIIAGTYGYMAPEYAMGG-------IFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~-------~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      ......++..|+|||++.+.       .++.++||||||+++|||++ |+.||...
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~  213 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL  213 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence            22234567889999988542       35789999999999999996 99998644

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.97  E-value=5.2e-31  Score=266.90  Aligned_cols=201  Identities=32%  Similarity=0.488  Sum_probs=171.5

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      .+|.+.++||+|++|.||++... .+..|++|++... .....++.+|++++++++||||+++++++..++..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            35778899999999999999864 5889999998754 334567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++++|.+++... ....+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++.........
T Consensus        85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            999999998543 2345899999999999999999999876   999999999999999999999999998866432211


Q ss_pred             cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      . ......+..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus       161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~  208 (263)
T cd05052         161 A-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG  208 (263)
T ss_pred             c-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence            1 111233567999999998899999999999999999998 9999753

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.97  E-value=4.1e-31  Score=271.47  Aligned_cols=206  Identities=30%  Similarity=0.441  Sum_probs=170.6

Q ss_pred             HhCCCCccceeccCCceeEEEEEec------CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCce
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE  461 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~  461 (621)
                      ..++|.+.+.||+|+||.||+|..+      .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3568999999999999999999743      24589999886543 2234567889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhhccC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEE
Q 007006          462 LLLIYEYMPNKSLDVHLFDATR-------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI  534 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL  534 (621)
                      .++||||+++|+|.+++.....       ...+++..+.+++.|++.||.|||+.+   |+||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999964221       234577888999999999999999886   999999999999999999999


Q ss_pred             eeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          535 SDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       535 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      +|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~  224 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG  224 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999886543222222222344678999999998899999999999999999998 7888753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.97  E-value=7.6e-31  Score=269.96  Aligned_cols=201  Identities=29%  Similarity=0.461  Sum_probs=173.2

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      .+.|++.++||+|+||.||+|... +++.+++|.+........+.+.+|+++++.++||||+++++.+..++..++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            357888999999999999999965 5899999999877666677889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++++|..++.+.  ...+++..+..++.|++.+|.|||+.+   ++||||||+||+++.++.++|+|||++....... 
T Consensus        91 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-  164 (292)
T cd06644          91 CPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-  164 (292)
T ss_pred             CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence            9999998877542  345899999999999999999999875   9999999999999999999999999987543221 


Q ss_pred             CcccccccccCCccChhccc-----CCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                       .......+++.|+|||++.     ...++.++||||||+++|||++|++||..
T Consensus       165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  217 (292)
T cd06644         165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE  217 (292)
T ss_pred             -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc
Confidence             1122345788999999884     34468899999999999999999999864

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.97  E-value=7.7e-31  Score=266.63  Aligned_cols=201  Identities=29%  Similarity=0.487  Sum_probs=165.1

Q ss_pred             CccceeccCCceeEEEEEecC-Cc--EEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeC------ceE
Q 007006          394 SDENKLGQGGFGPVYKGTLAD-GK--AIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------QEL  462 (621)
Q Consensus       394 ~~~~~LG~G~fG~Vy~~~~~~-g~--~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~------~~~  462 (621)
                      .+.+.||+|+||.||+|...+ +.  .+|+|.++..  .....+.+..|+++++.++||||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456889999999999998654 33  6899988654  234456788999999999999999999987532      246


Q ss_pred             EEEEEecCCCChhhhhhhc---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecC
Q 007006          463 LLIYEYMPNKSLDVHLFDA---TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL  539 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgl  539 (621)
                      ++++||+++++|..++...   .....+++.....++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence            8999999999999887432   12345899999999999999999999875   99999999999999999999999999


Q ss_pred             ceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          540 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       540 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      +................+++.|++||++.+..++.++||||||+++|||++ |+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  217 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG  217 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC
Confidence            987643322112222345678999999999999999999999999999999 8888853

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.97  E-value=7.8e-31  Score=270.82  Aligned_cols=199  Identities=27%  Similarity=0.457  Sum_probs=175.2

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      .+|.+.+.||+|++|.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            5788999999999999999985 579999999998665555677889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++++|.+++..    ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++.........
T Consensus        99 ~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~  171 (297)
T cd06656          99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (297)
T ss_pred             CCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence            99999998843    34789999999999999999999886   999999999999999999999999998765433221


Q ss_pred             cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                        .....+++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       172 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~  218 (297)
T cd06656         172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE  218 (297)
T ss_pred             --cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence              12345788999999999888999999999999999999999998543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.97  E-value=6.1e-31  Score=270.40  Aligned_cols=203  Identities=33%  Similarity=0.478  Sum_probs=169.3

Q ss_pred             CCCccceeccCCceeEEEEEec------CCcEEEEEEeccCCc-ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      +|.+.+.||+|+||.||+|...      ....+++|.+..... ...+++.+|+.+++.++||||+++++.+..++..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4677899999999999999853      235788888875432 335678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhhcc---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCC
Q 007006          465 IYEYMPNKSLDVHLFDAT---------------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASN  523 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~N  523 (621)
                      ++||+++++|.+++....                     ....+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999875321                     1235889999999999999999999876   9999999999


Q ss_pred             EEEcCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          524 ILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       524 ILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      ||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~  232 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  232 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence            9999999999999999886533222112222345678999999988889999999999999999999 9999853

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.97  E-value=5.3e-31  Score=269.27  Aligned_cols=205  Identities=27%  Similarity=0.428  Sum_probs=173.0

Q ss_pred             hCCCCccceeccCCceeEEEEEecC-----CcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEee-CceE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLAD-----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-GQEL  462 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~-----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~-~~~~  462 (621)
                      .++|.+.+.||+|+||.||+|...+     +..|++|++.... ....+.+.+|+.++++++||||+++++++.. +...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678889999999999999999765     6889999887542 3445678899999999999999999998776 4678


Q ss_pred             EEEEEecCCCChhhhhhhccCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeee
Q 007006          463 LLIYEYMPNKSLDVHLFDATRS-----VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF  537 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Df  537 (621)
                      ++++||+++++|..++......     ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999998654322     46899999999999999999999875   999999999999999999999999


Q ss_pred             cCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          538 GLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       538 gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      |+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||..
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~  222 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE  222 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc
Confidence            99986543322211222345678999999988889999999999999999999 9999864

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.97  E-value=8.2e-31  Score=267.81  Aligned_cols=202  Identities=30%  Similarity=0.473  Sum_probs=168.7

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCc----EEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGK----AIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL  463 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~----~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~  463 (621)
                      .++|...++||+|+||.||+|.+ .+++    .||+|.+.... ......+.+|+.++..++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            35788899999999999999984 3454    48999987543 33456788999999999999999999998764 567


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceec
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF  543 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~  543 (621)
                      +++||+++|+|.+++...  ...+++..++.++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++..
T Consensus        85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence            899999999999988542  346899999999999999999999986   999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          544 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       544 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      .............+++.|+|||.+.+..++.++||||||+++|||++ |+.||+.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~  214 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG  214 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence            53322222222234678999999988889999999999999999998 9999864

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.97  E-value=7.4e-31  Score=268.58  Aligned_cols=198  Identities=29%  Similarity=0.465  Sum_probs=170.7

Q ss_pred             CCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCC
Q 007006          393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN  471 (621)
Q Consensus       393 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  471 (621)
                      |++.+.||+|+||.||++... ++..+++|.+........+.+.+|+++++.++||||+++++.+..++..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            567789999999999999965 5788899998766656667889999999999999999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcc
Q 007006          472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN  551 (621)
Q Consensus       472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~  551 (621)
                      ++|..++..  ...++++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......  ..
T Consensus        87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~  159 (282)
T cd06643          87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR  159 (282)
T ss_pred             CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--cc
Confidence            999888753  2346899999999999999999999986   9999999999999999999999999987643221  11


Q ss_pred             cccccccCCccChhccc-----CCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          552 TNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       552 ~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .....++..|+|||++.     +..++.++|||||||++|||++|++||..
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~  210 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE  210 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccc
Confidence            22346788999999874     34578899999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.97  E-value=1.2e-30  Score=264.06  Aligned_cols=202  Identities=26%  Similarity=0.434  Sum_probs=175.1

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|.+.+.||+|+||.||++... +|+.|++|.++..   .....+.+.+|++++++++|+||+++++.+.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57889999999999999999976 7999999988643   2334567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          467 EYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       467 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      ||+++++|..++... .....+++.++..++.+++.||.|||+.+   ++||||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999988643 23456899999999999999999999986   99999999999999999999999999876543


Q ss_pred             CCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ....  .....++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  208 (267)
T cd08224         159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG  208 (267)
T ss_pred             CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCccc
Confidence            3221  1223578889999999988899999999999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=4.4e-31  Score=272.26  Aligned_cols=204  Identities=28%  Similarity=0.434  Sum_probs=168.5

Q ss_pred             CCCCccceeccCCceeEEEEEecC---------------CcEEEEEEeccC-CcccHHHHHHHHHHHHhcccCCceeEee
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLAD---------------GKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLG  454 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~---------------g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~l~g  454 (621)
                      ++|++.+.||+|+||.||++....               ...||+|.++.. .......+.+|++++++++||||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578899999999999999987532               235899998754 2334567899999999999999999999


Q ss_pred             EEeeCceEEEEEEecCCCChhhhhhhccC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEE
Q 007006          455 CCLEGQELLLIYEYMPNKSLDVHLFDATR---------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNIL  525 (621)
Q Consensus       455 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NIL  525 (621)
                      ++...+..++||||+++++|.+++.....         ...+++..+++++.|++.||.|||+.+   ++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence            99999999999999999999998854221         124788999999999999999999986   999999999999


Q ss_pred             EcCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc--CCCCCCC
Q 007006          526 LDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS--GRKNNGF  597 (621)
Q Consensus       526 l~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt--G~~p~~~  597 (621)
                      +++++.+||+|||++................++..|+|||++.++.++.++||||||+++|||++  |..||..
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~  235 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL  235 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence            99999999999999876533222222222344678999999988889999999999999999998  5566654

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.97  E-value=7.5e-31  Score=270.85  Aligned_cols=199  Identities=27%  Similarity=0.475  Sum_probs=175.0

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      .+|+..+.||.|++|.||++.. .+++.|++|.+........+.+.+|+++++.++||||+++++.+...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4688899999999999999985 578999999997665555678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++++|..++..    ..+++.++..++.+++.||.|||+.+   ++||||||+||+++.++.+||+|||++.........
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  171 (296)
T cd06655          99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK  171 (296)
T ss_pred             CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence            99999998843    35899999999999999999999986   999999999999999999999999998765433221


Q ss_pred             cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                        .....++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       172 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~  218 (296)
T cd06655         172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE  218 (296)
T ss_pred             --CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence              12245788999999999888999999999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.97  E-value=8.9e-31  Score=265.38  Aligned_cols=201  Identities=28%  Similarity=0.452  Sum_probs=169.4

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-----cccHHHHHHHHHHHHhcccCCceeEeeEEeeC--ceE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-----GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QEL  462 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~  462 (621)
                      ++|.+.+.||+|+||.||++... ++..|++|.+....     ....+.+.+|+.++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46888999999999999999864 58999999886332     12345788899999999999999999988764  467


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      ++++||+++++|.+++..   ...+++....+++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            899999999999998853   235788999999999999999999886   99999999999999999999999999876


Q ss_pred             cCCCCCC-cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          543 FGGNQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       543 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  211 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE  211 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence            5332111 112234578899999999888899999999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=9.6e-31  Score=267.93  Aligned_cols=201  Identities=31%  Similarity=0.540  Sum_probs=169.3

Q ss_pred             CCCCccceeccCCceeEEEEEe-----cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeC--ceEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELL  463 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~~  463 (621)
                      ++|.+.+.||+|+||.||++..     .++..|++|++........+.+.+|++++++++||||+++++++...  ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            5788899999999999999974     25789999999877666677899999999999999999999987543  4689


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceec
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF  543 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~  543 (621)
                      +|+||+++++|.+++...  ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++...
T Consensus        84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            999999999999998542  345899999999999999999999886   999999999999999999999999999876


Q ss_pred             CCCCCCc-ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          544 GGNQNQA-NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       544 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      ....... ......++..|+|||++.+..++.++||||||+++|||++|..|+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~  212 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC  212 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence            4322211 1111223456999999998889999999999999999999877653

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=5.1e-31  Score=268.69  Aligned_cols=205  Identities=30%  Similarity=0.443  Sum_probs=172.6

Q ss_pred             hCCCCccceeccCCceeEEEEEec------CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL  462 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~  462 (621)
                      .++|.+.+.||+|+||.||++...      .+..|++|.+.... ......+.+|+.+++.++||||+++++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            357888999999999999999864      24689999987553 23345788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEe
Q 007006          463 LLIYEYMPNKSLDVHLFDATR-------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS  535 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~  535 (621)
                      ++||||+++++|.+++.....       ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            999999999999999864321       234789999999999999999999875   9999999999999999999999


Q ss_pred             eecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          536 DFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       536 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      |||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  224 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG  224 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc
Confidence            9999876543322222223345778999999988889999999999999999998 9999853

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.97  E-value=1e-30  Score=263.02  Aligned_cols=199  Identities=28%  Similarity=0.476  Sum_probs=175.1

Q ss_pred             hCCCCccceeccCCceeEEEEEecC-CcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      .++|+..++||+|+||.||++...+ ++.+++|.+.....  .+++.+|++++++++||||+++++.+.+....++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            3678899999999999999999764 88999999875533  67899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++++|.+++..  ....+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||++........
T Consensus        80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            999999998853  2356899999999999999999999886   99999999999999999999999999886543321


Q ss_pred             CcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                        ......++..|+|||.+.+..++.++||||||+++|||++|++||..
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~  201 (256)
T cd06612         155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD  201 (256)
T ss_pred             --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence              12234578899999999888899999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.97  E-value=6.5e-31  Score=272.61  Aligned_cols=204  Identities=34%  Similarity=0.476  Sum_probs=169.8

Q ss_pred             CCCCccceeccCCceeEEEEEec--------CCcEEEEEEeccCC-cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCc
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ  460 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~  460 (621)
                      ++|.+.+.||+|+||.||++...        +...+|+|.++... .....++.+|+++++++ +||||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            57899999999999999999742        23579999997542 33456788999999999 7999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhhccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc
Q 007006          461 ELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD  527 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~  527 (621)
                      ..++||||+++++|.+++.....             ...+++.++++++.|++.||+|||+.+   ++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence            99999999999999999965321             235899999999999999999999876   99999999999999


Q ss_pred             CCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          528 DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       528 ~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      .++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~  245 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG  245 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc
Confidence            999999999999876533221111212234568999999998889999999999999999998 8888753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.97  E-value=1.1e-30  Score=262.91  Aligned_cols=199  Identities=40%  Similarity=0.570  Sum_probs=172.2

Q ss_pred             ceeccCCceeEEEEEecC----CcEEEEEEeccCCcc-cHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCC
Q 007006          397 NKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN  471 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  471 (621)
                      ++||+|+||.||++....    +..+++|.+...... ..+.+.+|++.+..++|+||+++++++.+....++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999998653    889999999765433 367889999999999999999999999999999999999999


Q ss_pred             CChhhhhhhccC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          472 KSLDVHLFDATR------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       472 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      ++|.+++.....      ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999965421      367999999999999999999999976   99999999999999999999999999987654


Q ss_pred             CCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      ...........++..|+|||.+....++.++||||+|++++||++ |+.||...
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  211 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL  211 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence            432222333456889999999988889999999999999999999 69998654

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.97  E-value=9.6e-31  Score=269.02  Aligned_cols=197  Identities=30%  Similarity=0.441  Sum_probs=173.3

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|.+.+.||+|++|.||++... +++.+|+|.+....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888999999999999999864 68999999986542   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++++|.+++...   ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            999999999988542   46899999999999999999999976   999999999999999999999999998865433


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                           .....+++.|+|||.+.+...+.++||||||+++|||++|+.||...
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  201 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD  201 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence                 22346788999999998888899999999999999999999998643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.97  E-value=1.3e-30  Score=264.72  Aligned_cols=205  Identities=28%  Similarity=0.427  Sum_probs=172.0

Q ss_pred             HHhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       388 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      .+++++.....||+|+||.||+|... ++..|++|.+........+.+.+|+.++++++|+||+++++++..++..++|+
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            34556666789999999999999854 67889999988776666778999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC-CCCeEEeeecCceecCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFGG  545 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~vkL~Dfgla~~~~~  545 (621)
                      ||+++++|..++.........++..+..++.||+.||.|||+.+   |+||||||+||+++. ++.++|+|||++.....
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            99999999999864322222378889999999999999999876   999999999999986 67899999999876543


Q ss_pred             CCCCcccccccccCCccChhcccCCC--CChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGI--FSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ...  ......++..|+|||++.+..  ++.++||||||+++|||++|+.||.-
T Consensus       162 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~  213 (268)
T cd06624         162 INP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE  213 (268)
T ss_pred             CCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence            221  122235788999999986644  78999999999999999999999853

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.97  E-value=7.5e-31  Score=278.91  Aligned_cols=198  Identities=30%  Similarity=0.399  Sum_probs=167.1

Q ss_pred             HhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeC------
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------  459 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~------  459 (621)
                      ..++|.+.+.||+|+||.||++... .++.||||++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3578999999999999999999854 6889999999754  233456788999999999999999999987643      


Q ss_pred             ceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecC
Q 007006          460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL  539 (621)
Q Consensus       460 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgl  539 (621)
                      ...++||||+++ +|..++.     ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence            357999999975 5665552     24788999999999999999999986   99999999999999999999999999


Q ss_pred             ceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          540 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       540 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ++......   ......++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  228 (364)
T cd07875         173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT  228 (364)
T ss_pred             ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence            98653321   122346789999999999999999999999999999999999998643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.97  E-value=8.7e-31  Score=268.67  Aligned_cols=198  Identities=27%  Similarity=0.458  Sum_probs=163.6

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc--ccHHHHHHHHHHHHhc---ccCCceeEeeEEeeC-----c
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKL---QHKNLVRLLGCCLEG-----Q  460 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l---~h~nIv~l~g~~~~~-----~  460 (621)
                      +|++.+.||+|+||.||++... +++.||+|.++....  .....+.+|+++++.+   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999865 689999999875422  2234556777777665   699999999988652     4


Q ss_pred             eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCc
Q 007006          461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA  540 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla  540 (621)
                      ..++++||+++ +|..++... ....+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            57999999984 787777542 2345899999999999999999999986   999999999999999999999999999


Q ss_pred             eecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          541 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       541 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ........   .....++..|+|||++.+..++.++|||||||++|||++|++||..
T Consensus       156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~  209 (288)
T cd07863         156 RIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG  209 (288)
T ss_pred             ccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCC
Confidence            86543221   1234578899999999988999999999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.5e-31  Score=280.49  Aligned_cols=191  Identities=28%  Similarity=0.398  Sum_probs=159.9

Q ss_pred             eccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhc---ccCCceeEeeEEeeCceEEEEEEecCC
Q 007006          399 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL---QHKNLVRLLGCCLEGQELLLIYEYMPN  471 (621)
Q Consensus       399 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l---~h~nIv~l~g~~~~~~~~~lV~e~~~~  471 (621)
                      ||+|+||.||+++.. +++.||+|++.+..   ......+..|..++...   +||||+++++.+.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999864 68999999986532   12233455666776665   699999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcc
Q 007006          472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN  551 (621)
Q Consensus       472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~  551 (621)
                      ++|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~  152 (330)
T cd05586          81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT  152 (330)
T ss_pred             ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence            999888843   345899999999999999999999986   9999999999999999999999999987532221  12


Q ss_pred             cccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          552 TNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       552 ~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~  199 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA  199 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC
Confidence            2345689999999998765 479999999999999999999999854

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.97  E-value=8e-31  Score=271.42  Aligned_cols=203  Identities=33%  Similarity=0.468  Sum_probs=171.4

Q ss_pred             CCCCccceeccCCceeEEEEEec------CCcEEEEEEeccCC-cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL  462 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~  462 (621)
                      ++|...+.||+|+||.||++...      .+..||+|.++... ....+.+.+|+++++++ +||||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            57889999999999999999741      35579999987553 33356789999999999 799999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      +++|||+++++|.+++.... ...+++.++.+++.|++.||+|||+.+   ++|+||||+|||++.++.++|+|||++..
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccccc
Confidence            99999999999999985422 234899999999999999999999886   99999999999999999999999999886


Q ss_pred             cCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          543 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       543 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      ..............++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~  246 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG  246 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCC
Confidence            543322111222345678999999999999999999999999999998 9999753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.2e-30  Score=263.44  Aligned_cols=200  Identities=26%  Similarity=0.424  Sum_probs=175.0

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      ++|+..+.||+|+||.||++... +++.+++|.+........+.+.+|++++++++||||+++++.+.+....+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57888999999999999999864 57889999998766666788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++++|.+++...  ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++........ 
T Consensus        83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  156 (262)
T cd06613          83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-  156 (262)
T ss_pred             CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence            999999988542  246899999999999999999999876   99999999999999999999999999876543211 


Q ss_pred             cccccccccCCccChhcccCC---CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGG---IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~---~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                       ......++..|+|||.+.+.   .++.++||||||+++|||++|++||..
T Consensus       157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~  206 (262)
T cd06613         157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD  206 (262)
T ss_pred             -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence             11234577889999998776   789999999999999999999999854

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.97  E-value=1.2e-30  Score=264.13  Aligned_cols=200  Identities=35%  Similarity=0.518  Sum_probs=169.4

Q ss_pred             CCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecC
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP  470 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  470 (621)
                      ++|.+.++||+|+||.||+|+..+...|++|+++... ...+.+.+|++++++++||||+++++.+.+ ...++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence            5688999999999999999998777789999997533 234678999999999999999999998754 56799999999


Q ss_pred             CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc
Q 007006          471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA  550 (621)
Q Consensus       471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~  550 (621)
                      +++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||.+..........
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~  159 (262)
T cd05071          84 KGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  159 (262)
T ss_pred             CCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence            99999999642 2345799999999999999999999876   9999999999999999999999999998664332211


Q ss_pred             ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                       .....++..|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus       160 -~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~  206 (262)
T cd05071         160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG  206 (262)
T ss_pred             -ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence             112345678999999988889999999999999999999 8888753

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.97  E-value=1.1e-30  Score=264.50  Aligned_cols=200  Identities=29%  Similarity=0.489  Sum_probs=171.6

Q ss_pred             CCCccceeccCCceeEEEEEecCCcEEEEEEeccCCc------ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      +|...+.||+|+||.||+|...+++.+|+|.+.....      .....+.+|+++++.++|+||+++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4778899999999999999988899999998864321      2235688999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      +||+++++|.+++..   ...+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            999999999999853   245889999999999999999999876   99999999999999999999999999876432


Q ss_pred             CC----CCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          546 NQ----NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       546 ~~----~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ..    .........++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~  210 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS  210 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence            11    11112234578899999999988899999999999999999999999864

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.2e-30  Score=265.80  Aligned_cols=198  Identities=28%  Similarity=0.457  Sum_probs=174.0

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      ++|+..+.||.|++|.||+++.. +++.|++|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36788899999999999999864 68899999987553 34456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++++|.+++..    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            999999998853    26899999999999999999999876   99999999999999999999999999987654321


Q ss_pred             CcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                        ......++..|+|||++.+..++.++||||||+++|||+||+.||..
T Consensus       154 --~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~  200 (274)
T cd06609         154 --KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD  200 (274)
T ss_pred             --ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence              12234578889999999988899999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.97  E-value=1.8e-30  Score=260.55  Aligned_cols=195  Identities=32%  Similarity=0.470  Sum_probs=166.5

Q ss_pred             ceeccCCceeEEEEEecCCcEEEEEEeccCCc-ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCCChh
Q 007006          397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLD  475 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~gsL~  475 (621)
                      ++||+|+||.||+|...++..+|+|++..... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999988899999999876543 33456889999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcccccc
Q 007006          476 VHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII  555 (621)
Q Consensus       476 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~  555 (621)
                      +++...  ...+++..+..++.|++.+|.|||+.+   ++||||||+||++++++.+||+|||++......... .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~  154 (250)
T cd05085          81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK  154 (250)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence            988532  345899999999999999999999886   999999999999999999999999998754332211 11122


Q ss_pred             cccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          556 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       556 ~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      .++..|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~  197 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPG  197 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCC
Confidence            34567999999998889999999999999999998 9999853

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2e-31  Score=272.44  Aligned_cols=205  Identities=25%  Similarity=0.365  Sum_probs=176.8

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ..-|...+.||+|.|.+|-++++ -+|..||||++.+..  ......+.+|++.|+.++|||||+++.+......+|||+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            35688889999999999999874 479999999998764  334456889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC-CCCeEEeeecCceecCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFGG  545 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~vkL~Dfgla~~~~~  545 (621)
                      |.=.+|+|.+|+..  ....+++....+++.||+.|+.|+|+..   ++||||||+||.+-+ -|-+||.|||++-.+..
T Consensus        97 ELGD~GDl~DyImK--He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMK--HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EecCCchHHHHHHh--hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            99999999999954  3456999999999999999999999875   999999999987754 68899999999877654


Q ss_pred             CCCCcccccccccCCccChhcccCCCC-ChhhhHHHHHHHHHHHHcCCCCCCCCcCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYFSEH  602 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwS~Gvll~elltG~~p~~~~~~~~  602 (621)
                      ....   ...+|.+.|.|||++.+..| .++.||||||||||-|++|++||+-....+
T Consensus       172 G~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE  226 (864)
T KOG4717|consen  172 GKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE  226 (864)
T ss_pred             cchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh
Confidence            3322   34689999999999999988 567999999999999999999998555443

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.97  E-value=1e-30  Score=280.30  Aligned_cols=204  Identities=31%  Similarity=0.462  Sum_probs=170.4

Q ss_pred             CCCCccceeccCCceeEEEEEec------CCcEEEEEEeccCCc-ccHHHHHHHHHHHHhcc-cCCceeEeeEEeeCceE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQEL  462 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~  462 (621)
                      ++|.+.++||+|+||.||++++.      .+..||+|+++.... ...+.+.+|+++|.++. ||||+++++.+..++..
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            46778899999999999999853      346899999976532 33457889999999997 99999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccC-----------------------------------------------------------
Q 007006          463 LLIYEYMPNKSLDVHLFDATR-----------------------------------------------------------  483 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~-----------------------------------------------------------  483 (621)
                      ++|+||+++|+|.++++....                                                           
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            999999999999999864321                                                           


Q ss_pred             ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc
Q 007006          484 ------------------------------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD  527 (621)
Q Consensus       484 ------------------------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~  527 (621)
                                                          ...+++..+.+++.||+.||.|||+.+   ++||||||+|||++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~  273 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLIC  273 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEe
Confidence                                                123678889999999999999999875   99999999999999


Q ss_pred             CCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          528 DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       528 ~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      +++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~  344 (401)
T cd05107         274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE  344 (401)
T ss_pred             CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence            999999999999986543322222222346788999999998889999999999999999998 8889854

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=6.4e-31  Score=268.67  Aligned_cols=202  Identities=27%  Similarity=0.440  Sum_probs=174.5

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      .++|++.+.||+|++|.||++... ++..+++|.++.......+.+..|++++++++||||+++++.+.++...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            457889999999999999999864 6889999999876666667899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++++|..++...  ...+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            9999999988542  346899999999999999999999986   99999999999999999999999998875432211


Q ss_pred             CcccccccccCCccChhccc-----CCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                        ......+++.|+|||.+.     ...++.++||||||+++|||++|+.||...
T Consensus       159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~  211 (280)
T cd06611         159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL  211 (280)
T ss_pred             --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence              122345788999999874     344688999999999999999999998643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.97  E-value=5.9e-31  Score=270.72  Aligned_cols=205  Identities=32%  Similarity=0.483  Sum_probs=171.8

Q ss_pred             hCCCCccceeccCCceeEEEEEec------CCcEEEEEEeccCC-cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCce
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE  461 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~  461 (621)
                      .++|+..+.||+|+||.||++...      ....+|+|.+.... .....++.+|++++.++ +|+||+++++++..++.
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   90 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP   90 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence            457888999999999999999853      23679999987542 33446688999999999 89999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhhc-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC
Q 007006          462 LLLIYEYMPNKSLDVHLFDA-------------TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD  528 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~  528 (621)
                      .+++|||+++++|..++...             .....+++..+++++.|++.||.|||+.+   |+||||||+||++++
T Consensus        91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~  167 (293)
T cd05053          91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTE  167 (293)
T ss_pred             eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcC
Confidence            99999999999999998542             22346899999999999999999999875   999999999999999


Q ss_pred             CCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          529 DMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       529 ~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      ++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus       168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  237 (293)
T cd05053         168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG  237 (293)
T ss_pred             CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC
Confidence            99999999999987644322221222234567999999988899999999999999999998 8888753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.97  E-value=8.8e-31  Score=270.11  Aligned_cols=204  Identities=28%  Similarity=0.449  Sum_probs=169.6

Q ss_pred             CCCCccceeccCCceeEEEEEec-----------------CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-----------------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRL  452 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-----------------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l  452 (621)
                      ++|++.++||+|+||.||++...                 ++..+|+|++.... ....+++.+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            46889999999999999998532                 24468999987543 3445678999999999999999999


Q ss_pred             eeEEeeCceEEEEEEecCCCChhhhhhhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCE
Q 007006          453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATR--------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNI  524 (621)
Q Consensus       453 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NI  524 (621)
                      ++++...+..++||||+++++|.+++.....        ...+++..+.+++.|++.||+|||+.+   ++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence            9999999999999999999999999865321        134788899999999999999999986   99999999999


Q ss_pred             EEcCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc--CCCCCCC
Q 007006          525 LLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS--GRKNNGF  597 (621)
Q Consensus       525 Ll~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt--G~~p~~~  597 (621)
                      |++.++.++|+|||++..+..............+..|++||....+.++.++||||||+++|||++  |..||..
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence            999999999999999886543322221222234678999999888889999999999999999998  6777753

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.97  E-value=9.6e-31  Score=270.91  Aligned_cols=204  Identities=32%  Similarity=0.493  Sum_probs=171.3

Q ss_pred             hCCCCccceeccCCceeEEEEEec--------CCcEEEEEEeccCC-cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeC
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG  459 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~  459 (621)
                      .++|.+.+.||+|+||.||+++..        ++..|++|.+.... ....+++.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            457888899999999999999731        24579999887542 34456789999999999 899999999999999


Q ss_pred             ceEEEEEEecCCCChhhhhhhccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE
Q 007006          460 QELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL  526 (621)
Q Consensus       460 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl  526 (621)
                      ...++||||+++++|.+++.....             ...+++..+..++.||+.||.|||+.+   ++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence            999999999999999999865321             235888999999999999999999986   9999999999999


Q ss_pred             cCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCC
Q 007006          527 DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNG  596 (621)
Q Consensus       527 ~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~  596 (621)
                      ++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~  241 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP  241 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999987644332222222345678999999988889999999999999999998 778764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.97  E-value=1.6e-30  Score=262.59  Aligned_cols=194  Identities=29%  Similarity=0.480  Sum_probs=161.6

Q ss_pred             eeccCCceeEEEEEec---CCcEEEEEEeccCCc-ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCCC
Q 007006          398 KLGQGGFGPVYKGTLA---DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKS  473 (621)
Q Consensus       398 ~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~gs  473 (621)
                      .||+|+||.||+|.+.   .+..||+|++..... ...+.+.+|+.++++++||||+++++++.. +..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            4899999999999753   356799999876533 334678999999999999999999998864 57899999999999


Q ss_pred             hhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcc-c
Q 007006          474 LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN-T  552 (621)
Q Consensus       474 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~-~  552 (621)
                      |.+++..  +...+++..+++++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........... .
T Consensus        81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            9998853  2346899999999999999999999886   99999999999999999999999999986543322111 1


Q ss_pred             ccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          553 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       553 ~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      ....++..|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~  201 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKK  201 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCc
Confidence            11223568999999988889999999999999999996 9999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.97  E-value=7.8e-31  Score=265.82  Aligned_cols=201  Identities=25%  Similarity=0.429  Sum_probs=173.5

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|.+.+.||+|+||.||++.. .++..++||.+....   .....++.+|+.+++.++||||+++++++.+++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4678889999999999999995 579999999886532   233467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          467 EYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      ||+++++|.+++.... ....+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999999886422 2456899999999999999999999886   99999999999999999999999999876543


Q ss_pred             CCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      ....  .....++..|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus       159 ~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  207 (267)
T cd08229         159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY  207 (267)
T ss_pred             CCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcc
Confidence            2221  122457889999999988889999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.97  E-value=9.3e-31  Score=266.03  Aligned_cols=202  Identities=28%  Similarity=0.478  Sum_probs=170.6

Q ss_pred             HhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeC------c
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG------Q  460 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~------~  460 (621)
                      +++.|+..+.||+|+||.||+|... +++.||+|++.... .....+..|+.++.++ +||||+++++++...      .
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            4667888999999999999999864 58899999987543 3446788999999999 799999999998753      4


Q ss_pred             eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCc
Q 007006          461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA  540 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla  540 (621)
                      ..+++|||+++++|.+++... ....+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.++|+|||++
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence            579999999999999988642 3346899999999999999999999986   999999999999999999999999998


Q ss_pred             eecCCCCCCcccccccccCCccChhccc-----CCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          541 RIFGGNQNQANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       541 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .......  .......|+..|+|||++.     ...++.++|||||||++|||++|+.||..
T Consensus       159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~  218 (272)
T cd06637         159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD  218 (272)
T ss_pred             eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            8654322  1223356788999999985     34578899999999999999999999853

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-32  Score=258.83  Aligned_cols=209  Identities=27%  Similarity=0.409  Sum_probs=174.9

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++.|++-+.||+|.|+.|++..+ .+|+.+|+|++...  +..+.+++.+|+.+-+.|+||||+++...+.+....++|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            45688889999999999999975 57999999887533  3446788999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC---CeEEeeecCceec
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM---NPKISDFGLARIF  543 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~vkL~Dfgla~~~  543 (621)
                      |+|.|++|..-+-   .+...++..+-..++||+.+|.|+|.++   |+|||+||+|+++....   -+||+|||++..+
T Consensus        90 e~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   90 DLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             ecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            9999999865442   2245788888899999999999999986   99999999999996433   4999999999987


Q ss_pred             CCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCcCCCCCChHHHH
Q 007006          544 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYV  610 (621)
Q Consensus       544 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~v  610 (621)
                      .+...   ..-..|||+|||||++...+++..+|||+-||+||-|+.|.+||-.   ++..+|.+.+
T Consensus       164 ~~g~~---~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~---~~~~rlye~I  224 (355)
T KOG0033|consen  164 NDGEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD---EDQHRLYEQI  224 (355)
T ss_pred             CCccc---cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC---ccHHHHHHHH
Confidence            63222   2235799999999999999999999999999999999999999863   2333444444

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.97  E-value=1.3e-30  Score=269.11  Aligned_cols=201  Identities=32%  Similarity=0.495  Sum_probs=166.9

Q ss_pred             CCCCccceeccCCceeEEEEEecC-C--cEEEEEEeccC-CcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLAD-G--KAIAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~-g--~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      ++|++.+.||+|+||.||++..++ +  ..+++|.++.. .....+.+.+|++++.++ +||||+++++++.+.+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            478889999999999999998653 3  34788888743 334456789999999999 799999999999999999999


Q ss_pred             EEecCCCChhhhhhhcc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCe
Q 007006          466 YEYMPNKSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP  532 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~v  532 (621)
                      +||+++++|.+++....             ....+++..+..++.|++.||+|||+.+   ++||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999986422             1135889999999999999999999876   9999999999999999999


Q ss_pred             EEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          533 KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       533 kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      ||+|||++.......   .......+..|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~  221 (297)
T cd05089         159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG  221 (297)
T ss_pred             EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence            999999986422110   1111123457999999988889999999999999999998 9999854

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.97  E-value=1.9e-30  Score=265.62  Aligned_cols=199  Identities=26%  Similarity=0.418  Sum_probs=170.1

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      ++|+..+.||+|++|.||++..+ +++.||+|++....  ....+.+.+|+++++.++||||+++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888899999999999999975 58999999986542  2334567899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |+++++|..++..   ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            9999988877632   335899999999999999999999976   9999999999999999999999999998764432


Q ss_pred             CCcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ..  .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.-
T Consensus       155 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~  203 (286)
T cd07847         155 DD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG  203 (286)
T ss_pred             cc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            21  122346788999999876 4578999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.97  E-value=1.7e-30  Score=262.48  Aligned_cols=200  Identities=36%  Similarity=0.532  Sum_probs=170.1

Q ss_pred             CCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecC
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP  470 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  470 (621)
                      ++|++.++||+|+||.||++...++..+++|.+..... ..+.+.+|+.++++++|+|++++++++.+ ...+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecC
Confidence            46888999999999999999988888999999876433 34678999999999999999999998754 56789999999


Q ss_pred             CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc
Q 007006          471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA  550 (621)
Q Consensus       471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~  550 (621)
                      +++|.+++... ....+++..+.+++.+++.||.|||+.+   ++||||||+||++++++.++|+|||++..........
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05070          84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence            99999998642 2345899999999999999999999986   9999999999999999999999999998764332211


Q ss_pred             ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                       .....++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       160 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~  206 (260)
T cd05070         160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG  206 (260)
T ss_pred             -ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCC
Confidence             111234567999999988889999999999999999999 8888854

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.97  E-value=1.3e-30  Score=268.56  Aligned_cols=204  Identities=31%  Similarity=0.453  Sum_probs=171.9

Q ss_pred             CCCCccceeccCCceeEEEEEecC-----------------CcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLAD-----------------GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRL  452 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l  452 (621)
                      ++|++.+.||+|+||.||++...+                 +..||+|++.... ....+.+.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            578899999999999999987542                 2468999987653 3446678999999999999999999


Q ss_pred             eeEEeeCceEEEEEEecCCCChhhhhhhcc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCE
Q 007006          453 LGCCLEGQELLLIYEYMPNKSLDVHLFDAT--------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNI  524 (621)
Q Consensus       453 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NI  524 (621)
                      ++++..++..++++||+++++|..++....        ....+++..++.++.|++.||.|||+.+   ++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Ni  161 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhce
Confidence            999999999999999999999999986532        1236899999999999999999999886   99999999999


Q ss_pred             EEcCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc--CCCCCCC
Q 007006          525 LLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS--GRKNNGF  597 (621)
Q Consensus       525 Ll~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt--G~~p~~~  597 (621)
                      +++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++  |..||..
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            999999999999999886543332222233445778999999988889999999999999999998  6667653

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.97  E-value=7.4e-31  Score=278.00  Aligned_cols=197  Identities=30%  Similarity=0.393  Sum_probs=166.4

Q ss_pred             HhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeC------
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------  459 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~------  459 (621)
                      ..++|.+.+.||+|+||.||++... .++.||+|++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4578999999999999999999854 68899999997542  23346678899999999999999999988643      


Q ss_pred             ceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecC
Q 007006          460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL  539 (621)
Q Consensus       460 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgl  539 (621)
                      ...++||||+++ +|...+.     ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence            357999999975 5555552     24788999999999999999999986   99999999999999999999999999


Q ss_pred             ceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          540 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       540 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ++......   ......+|..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  220 (355)
T cd07874         166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG  220 (355)
T ss_pred             cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            98653321   12234678999999999998999999999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.97  E-value=1.9e-30  Score=270.00  Aligned_cols=196  Identities=29%  Similarity=0.477  Sum_probs=159.1

Q ss_pred             ceeccCCceeEEEEEec---CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEee--CceEEEEEEecCC
Q 007006          397 NKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLLIYEYMPN  471 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~--~~~~~lV~e~~~~  471 (621)
                      .+||+|+||.||+++..   ++..||+|.+....  ....+.+|++++++++||||+++++++..  +...++|+||+++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            58999999999999864   35789999887543  23467889999999999999999999854  4578999999875


Q ss_pred             CChhhhhhhc------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE----cCCCCeEEeeecCce
Q 007006          472 KSLDVHLFDA------TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLAR  541 (621)
Q Consensus       472 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~vkL~Dfgla~  541 (621)
                       +|.+++...      .....+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             666665321      12335889999999999999999999986   9999999999999    566789999999998


Q ss_pred             ecCCCCCC-cccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          542 IFGGNQNQ-ANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       542 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ........ .......+|+.|+|||++.+. .++.++||||||+++|||+||++||...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            76543221 122335678999999998764 5799999999999999999999998643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=1e-30  Score=297.60  Aligned_cols=205  Identities=26%  Similarity=0.398  Sum_probs=169.5

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeC--ceEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLL  464 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~~l  464 (621)
                      .++|.+.++||+|+||.||++... .+..+|+|.+...  .......+..|+.++++++|||||++++++.+.  ..+++
T Consensus        12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI   91 (1021)
T PTZ00266         12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI   91 (1021)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence            468999999999999999999864 5778899988654  233456788999999999999999999988653  56899


Q ss_pred             EEEecCCCChhhhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEeccCCCCCEEEcCC----------
Q 007006          465 IYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSR----LKIIHRDLKASNILLDDD----------  529 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~----~~iiH~Dlkp~NILl~~~----------  529 (621)
                      ||||+++++|..+|.... ....+++..++.|+.||+.||.|||+.+.    .+|+||||||+||||+.+          
T Consensus        92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~  171 (1021)
T PTZ00266         92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ  171 (1021)
T ss_pred             EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence            999999999999986432 23569999999999999999999998542    359999999999999642          


Q ss_pred             -------CCeEEeeecCceecCCCCCCcccccccccCCccChhcccC--CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          530 -------MNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       530 -------~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                             +.+||+|||++..+.....   .....||+.|+|||++.+  ..++.++|||||||+||||+||+.||..
T Consensus       172 ~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        172 ANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             ccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                   3489999999986543221   223468999999999854  4588999999999999999999999863

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=1.8e-30  Score=263.22  Aligned_cols=200  Identities=32%  Similarity=0.549  Sum_probs=170.6

Q ss_pred             CCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcc---------cHHHHHHHHHHHHhcccCCceeEeeEEeeCce
Q 007006          392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQ---------GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE  461 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~---------~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~  461 (621)
                      +|.+...||+|++|.||+|.. .+++.+++|.+......         ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            367778999999999999985 46889999988654322         22568889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCce
Q 007006          462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR  541 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~  541 (621)
                      .++|+||+++++|..++..   ...+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            9999999999999999853   345889999999999999999999886   9999999999999999999999999988


Q ss_pred             ecCCCCCCc----ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          542 IFGGNQNQA----NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       542 ~~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ....+....    ......++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  214 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD  214 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence            765321111    11123578899999999988899999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.9e-30  Score=262.12  Aligned_cols=202  Identities=37%  Similarity=0.546  Sum_probs=173.6

Q ss_pred             hCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      .++|.+.++||+|+||.||++..++++.+++|.+.... ...+++.+|+.++++++||||+++++++.+....++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            46788999999999999999998888899999987543 34577899999999999999999999999888999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++++|.+++... ....+++..+..++.+++.||.|||+.+   ++|+||||+||++++++.+||+|||++.........
T Consensus        84 ~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (261)
T cd05034          84 SKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT  159 (261)
T ss_pred             CCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence            999999998643 2345899999999999999999999886   999999999999999999999999998876432111


Q ss_pred             cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      . ......+..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       160 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  207 (261)
T cd05034         160 A-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG  207 (261)
T ss_pred             h-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            1 111223567999999998889999999999999999999 9999853

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.97  E-value=1.7e-30  Score=262.50  Aligned_cols=201  Identities=36%  Similarity=0.533  Sum_probs=171.8

Q ss_pred             hCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      .++|.+.++||+|+||.||++..++++.||+|.+..... ...++.+|+.++++++||||+++++++. .+..++++||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            357888999999999999999988899999999875443 3567899999999999999999999874 45689999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++++|.+++... ....+++.++..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++.........
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            999999988543 3456899999999999999999999876   999999999999999999999999999876532211


Q ss_pred             cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      . .....++..|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       159 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~  206 (260)
T cd05067         159 A-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPG  206 (260)
T ss_pred             c-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCC
Confidence            1 112234678999999998889999999999999999999 9999863

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.97  E-value=1.5e-30  Score=262.03  Aligned_cols=200  Identities=24%  Similarity=0.353  Sum_probs=173.0

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccC-CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      +|++.++||+|+||.||++... +++.+++|.++.. .....+.+.+|+.+++.++||||+++++.+.+++..++++||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778899999999999999854 6889999998643 2344567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++++|.+++... ....+++.....++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++........ 
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence            999999888532 3345889999999999999999999886   99999999999999999999999999886643221 


Q ss_pred             cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                       ......+++.|+|||++.+..++.++|+||||+++|+|++|+.||..
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~  202 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA  202 (255)
T ss_pred             -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC
Confidence             12234678899999999888899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.97  E-value=1.1e-30  Score=265.27  Aligned_cols=201  Identities=30%  Similarity=0.508  Sum_probs=168.8

Q ss_pred             CCCccceeccCCceeEEEEEecC-C---cEEEEEEeccC-CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTLAD-G---KAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~~-g---~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      .|.+.+.||+|+||.||+|.... +   ..|++|.+... .....++|..|+.+++.++||||+++++++.++...++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            47788999999999999998643 3   36999998754 3344578999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++++|..++...  ...+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++......
T Consensus        85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence            999999999998543  346899999999999999999999986   999999999999999999999999998765432


Q ss_pred             CCCcccc-ccc--ccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          547 QNQANTN-IIA--GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~-~~~--gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      ....... ...  .+..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~  214 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD  214 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCC
Confidence            2211111 111  1347999999998999999999999999999886 9999853

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.97  E-value=1.8e-31  Score=254.07  Aligned_cols=198  Identities=30%  Similarity=0.473  Sum_probs=170.6

Q ss_pred             HhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC----ccc----HHHHHHHHHHHHhc-ccCCceeEeeEEee
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS----GQG----LQEFKNEVNLIAKL-QHKNLVRLLGCCLE  458 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~----~~~----~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~  458 (621)
                      -.+.|...+.||.|..++|-++.++ +|.+.|+|++....    .+.    .+.-..|+.+|+++ .||+|+++.++++.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            3457788899999999999998854 68899999986432    111    23456799999999 79999999999999


Q ss_pred             CceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeec
Q 007006          459 GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG  538 (621)
Q Consensus       459 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfg  538 (621)
                      +...++|+|.|+.|.|.++|.   ....++++...+|+.|+..|+.|||...   |+||||||+|||++++.++||+|||
T Consensus        95 ~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             cchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccc
Confidence            999999999999999999994   3467999999999999999999999875   9999999999999999999999999


Q ss_pred             CceecCCCCCCcccccccccCCccChhccc------CCCCChhhhHHHHHHHHHHHHcCCCCC
Q 007006          539 LARIFGGNQNQANTNIIAGTYGYMAPEYAM------GGIFSIKSDVFSFGVLLLEIISGRKNN  595 (621)
Q Consensus       539 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~s~~sDVwS~Gvll~elltG~~p~  595 (621)
                      ++..+....   .-...+||++|+|||.+.      ...|+...|+|+.||++|.|+.|.+||
T Consensus       169 Fa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPF  228 (411)
T KOG0599|consen  169 FACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPF  228 (411)
T ss_pred             eeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCch
Confidence            998765432   234579999999999873      345899999999999999999999997

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=1e-30  Score=267.94  Aligned_cols=201  Identities=26%  Similarity=0.440  Sum_probs=171.1

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC-CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      ++|++.+.||+|+||.||++... ++..||+|.++.. .......+.+|++++.+++||||+++++.+..++..++|+||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36788899999999999999965 7899999988754 333356788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++++|..++........+++..+..++.+++.||.|||+..  +++|+||||+||+++.++.+||+|||++..+.... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence            999999998865433446899999999999999999999742  49999999999999999999999999987653221 


Q ss_pred             CcccccccccCCccChhcccCCC------CChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGI------FSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~------~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                         .....++..|+|||.+.+..      ++.++|||||||++|||++|+.||..
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  209 (286)
T cd06622         158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP  209 (286)
T ss_pred             ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence               22235778899999885443      58899999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.97  E-value=1.4e-30  Score=262.36  Aligned_cols=195  Identities=34%  Similarity=0.498  Sum_probs=167.4

Q ss_pred             ceeccCCceeEEEEEecC--C--cEEEEEEeccCCc-ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCC
Q 007006          397 NKLGQGGFGPVYKGTLAD--G--KAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN  471 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~~--g--~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  471 (621)
                      ++||+|++|.||++.+.+  +  ..||+|.+..... ...+.+.+|+.++++++||||+++++.+.+ ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643  3  3689999987655 566789999999999999999999999988 889999999999


Q ss_pred             CChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc-
Q 007006          472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA-  550 (621)
Q Consensus       472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~-  550 (621)
                      ++|.+++..... ..+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++..+....... 
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999865332 56899999999999999999999886   9999999999999999999999999998764422111 


Q ss_pred             ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCC
Q 007006          551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNG  596 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~  596 (621)
                      ......++..|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~  202 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWA  202 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            1112346778999999998899999999999999999999 999985

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.97  E-value=1.4e-30  Score=264.34  Aligned_cols=203  Identities=32%  Similarity=0.535  Sum_probs=170.5

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CC---cEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DG---KAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g---~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      .++|+..+.||+|+||.||+++.. ++   ..+++|+++... ....+++.+|++++++++||||+++.+++.+.+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            346788899999999999999864 23   379999987553 3345678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      ||||+++++|..++..  ....+++.++..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence            9999999999999854  2346899999999999999999999886   9999999999999999999999999988664


Q ss_pred             CCCCCccc-ccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          545 GNQNQANT-NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       545 ~~~~~~~~-~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      ........ .....+..|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~  213 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD  213 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCc
Confidence            32221111 11223457999999988889999999999999999997 9999853

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.97  E-value=2.6e-30  Score=260.36  Aligned_cols=200  Identities=26%  Similarity=0.432  Sum_probs=174.3

Q ss_pred             CCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      +|+..+.||+|+||.||.++. .+++.+++|++...  +....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            478889999999999999984 46889999998654  344556789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++++|.+++.... ...+++..+..++.|++.+|.|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999886432 456899999999999999999999876   99999999999999999999999999987644332


Q ss_pred             CcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                        ......+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~  203 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA  203 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC
Confidence              22234678999999999888889999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.97  E-value=1.5e-30  Score=270.92  Aligned_cols=204  Identities=33%  Similarity=0.484  Sum_probs=169.7

Q ss_pred             CCCCccceeccCCceeEEEEEec--------CCcEEEEEEeccCC-cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCc
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ  460 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~  460 (621)
                      ++|.+.++||+|+||.||++...        ....+|+|.++... .....++.+|+++++++ +||||+++++++.+.+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            46888999999999999999742        24578999987543 34456788999999999 6999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhhcc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc
Q 007006          461 ELLLIYEYMPNKSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD  527 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~  527 (621)
                      ..++++||+++++|.+++....             ....+++.++.+++.||+.||.|||+.+   ++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence            9999999999999999986532             1245899999999999999999999886   99999999999999


Q ss_pred             CCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          528 DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       528 ~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      +++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~  239 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG  239 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence            999999999999986543222111112233467999999998889999999999999999999 8888753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.97  E-value=1.8e-30  Score=268.42  Aligned_cols=200  Identities=27%  Similarity=0.429  Sum_probs=168.6

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      ++|.+.++||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+++..++|+||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            56889999999999999999864 68899999987543 33345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      ++ ++|..++...  ...+++..+..++.||++||.|||+.+   ++|+||||+||++++++.+||+|||++........
T Consensus        86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            97 5888877542  345889999999999999999999886   99999999999999999999999999876432221


Q ss_pred             CcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      .  .....+++.|+|||.+.+. .++.++||||||+++|||++|++||...
T Consensus       160 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~  208 (301)
T cd07873         160 T--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS  208 (301)
T ss_pred             c--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            1  1223467899999988654 4788999999999999999999998643

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=9.5e-31  Score=275.80  Aligned_cols=197  Identities=28%  Similarity=0.427  Sum_probs=166.5

Q ss_pred             HHhCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeC-----
Q 007006          388 EATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----  459 (621)
Q Consensus       388 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~-----  459 (621)
                      +..++|.+.+.||+|+||.||++.. .+++.||+|++....  ....+.+.+|++++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            3457899999999999999999985 468899999987542  23345678899999999999999999987643     


Q ss_pred             -ceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeec
Q 007006          460 -QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG  538 (621)
Q Consensus       460 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfg  538 (621)
                       ...++++|++ +++|..++.    ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence             3568999987 788887763    345899999999999999999999986   9999999999999999999999999


Q ss_pred             CceecCCCCCCcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          539 LARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       539 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ++......     .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus       164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  218 (343)
T cd07878         164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG  218 (343)
T ss_pred             cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            99865432     123467899999999876 5689999999999999999999999864

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.97  E-value=2.4e-30  Score=261.83  Aligned_cols=204  Identities=27%  Similarity=0.456  Sum_probs=176.4

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      ++|++.+.||.|+||.||++... ++..+++|++.... ....+.+.+|++.++.++|+||+++++.+...+..++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888999999999999999854 68899999987543 33567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++++|.+++........+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999865433356899999999999999999999886   99999999999999999999999999876654332


Q ss_pred             Cc--ccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          549 QA--NTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       549 ~~--~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ..  ......++..|+|||++... .++.++|+||||+++|||++|+.||..
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~  209 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSK  209 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccc
Confidence            21  22334678899999998777 789999999999999999999999864

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.97  E-value=8.9e-31  Score=271.19  Aligned_cols=202  Identities=33%  Similarity=0.501  Sum_probs=167.6

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCc--EEEEEEeccC-CcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGK--AIAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~--~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~l  464 (621)
                      .++|++.+.||+|+||.||++.++ ++.  .+++|.+... .......+.+|++++.++ +||||+++++++.+++..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            357888999999999999999864 454  4577777643 234456788999999999 89999999999999999999


Q ss_pred             EEEecCCCChhhhhhhcc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCC
Q 007006          465 IYEYMPNKSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN  531 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~  531 (621)
                      |+||+++++|.+++....             ....+++.+++.++.||+.||+|||+.+   ++||||||+|||+++++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence            999999999999986432             1235899999999999999999999886   999999999999999999


Q ss_pred             eEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          532 PKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       532 vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      +||+|||++......   ........+..|+|||++.+..++.++||||||+++|||+| |..||..
T Consensus       163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~  226 (303)
T cd05088         163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG  226 (303)
T ss_pred             EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCccc
Confidence            999999998632111   11111223567999999988889999999999999999998 9999853

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.6e-32  Score=262.46  Aligned_cols=203  Identities=29%  Similarity=0.345  Sum_probs=176.9

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|+.++.||+|.||.|.+++- ..++.+|+|++++.-   ......-+.|-++|+..+||.+..+.-.++..+.+++||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            6899999999999999999984 469999999998763   233344567889999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||..||.|.-+|.   +...+++....-+...|+.||.|||+.+   |+.||||.+|+|+|.+|++||+|||+++.-.. 
T Consensus       248 eyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-  320 (516)
T KOG0690|consen  248 EYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-  320 (516)
T ss_pred             EEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc-
Confidence            9999999988774   3456888888889999999999999975   99999999999999999999999999985322 


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCcCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE  601 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~~  601 (621)
                       ....++..+||+.|+|||++....|....|+|.+||++|||++|+.||--.+.+
T Consensus       321 -~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~  374 (516)
T KOG0690|consen  321 -YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE  374 (516)
T ss_pred             -ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh
Confidence             233456689999999999999999999999999999999999999998654444

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.97  E-value=2.6e-30  Score=262.20  Aligned_cols=201  Identities=29%  Similarity=0.469  Sum_probs=169.5

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC-----cccHHHHHHHHHHHHhcccCCceeEeeEEeeC--ceE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS-----GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QEL  462 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~  462 (621)
                      .+|...+.||+|+||.||++.. .++..|++|++....     ....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4688899999999999999986 468999999886432     12345688899999999999999999998763  567


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      ++++||+++++|.+++..   ...+++...+.++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            899999999999998853   235889999999999999999999875   99999999999999999999999999876


Q ss_pred             cCCCCC-CcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          543 FGGNQN-QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       543 ~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ...... ........++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~  211 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE  211 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccc
Confidence            532211 1112234578899999999988899999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.97  E-value=1.5e-30  Score=267.08  Aligned_cols=204  Identities=31%  Similarity=0.523  Sum_probs=171.1

Q ss_pred             hCCCCccceeccCCceeEEEEEec------CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL  462 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~  462 (621)
                      .++|++.+.||+|+||.||++...      ++..||+|.+.... .....++.+|+.++++++||||+++++++.+++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467889999999999999999853      46789999987543 33456789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhcc-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCC
Q 007006          463 LLIYEYMPNKSLDVHLFDAT-------------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASN  523 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~N  523 (621)
                      ++|+||+++++|.+++....                   ....+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999986421                   1234788999999999999999999886   9999999999


Q ss_pred             EEEcCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCC
Q 007006          524 ILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNG  596 (621)
Q Consensus       524 ILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~  596 (621)
                      |++++++.++|+|||++.................+..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~  234 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY  234 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999876543322111222234567999999988899999999999999999998 888874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=1.8e-30  Score=266.01  Aligned_cols=200  Identities=26%  Similarity=0.407  Sum_probs=173.3

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      ++|++.+.||+|+||+||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++.+...+..++|+||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            56788899999999999999854 68899999886543 34457789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++++|..++..   ...+++..+..++.+++.+|.|||+..  +++||||+|+||++++++.++|+|||++......  
T Consensus        85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--  157 (284)
T cd06620          85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--  157 (284)
T ss_pred             CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence            999999988853   346899999999999999999999742  4999999999999999999999999998654221  


Q ss_pred             CcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                        ......++..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~  206 (284)
T cd06620         158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN  206 (284)
T ss_pred             --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence              1223467899999999988889999999999999999999999997544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.97  E-value=2.6e-30  Score=260.87  Aligned_cols=194  Identities=34%  Similarity=0.494  Sum_probs=162.7

Q ss_pred             eeccCCceeEEEEEe---cCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCC
Q 007006          398 KLGQGGFGPVYKGTL---ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK  472 (621)
Q Consensus       398 ~LG~G~fG~Vy~~~~---~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  472 (621)
                      .||+|+||.||+|.+   .++..+|+|+++...  ....+++.+|+.+++.++||||+++++++.. +..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            589999999999964   357889999987543  2345678999999999999999999998854 5678999999999


Q ss_pred             ChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcc-
Q 007006          473 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN-  551 (621)
Q Consensus       473 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~-  551 (621)
                      +|.+++..   ...+++..+.+++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........... 
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            99998853   345899999999999999999999886   99999999999999999999999999987644322111 


Q ss_pred             cccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       552 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      .....++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  202 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM  202 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            112234578999999988889999999999999999998 99998643

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.97  E-value=2.5e-30  Score=260.36  Aligned_cols=198  Identities=30%  Similarity=0.482  Sum_probs=172.0

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-----cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-----GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      +|...+.||+|++|.||+|... ++..|++|.+....     .+..+.+.+|+++++.++|+||+++++++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677789999999999999975 78999999986543     23456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      +||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999999853   235889999999999999999999886   99999999999999999999999999886543


Q ss_pred             CCCCcccccccccCCccChhcccCCC-CChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ..   ......++..|++||.+.... ++.++|+||||+++|||++|+.||...
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~  205 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL  205 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence            32   122345788999999987776 899999999999999999999998643

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=2e-30  Score=265.58  Aligned_cols=198  Identities=35%  Similarity=0.506  Sum_probs=166.0

Q ss_pred             CCccceeccCCceeEEEEEe-----cCCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeC--ceEEE
Q 007006          393 FSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLL  464 (621)
Q Consensus       393 f~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~~l  464 (621)
                      |...+.||+|+||.||++..     .++..||+|.++... ......+.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37889999999999988652     357889999987543 23456788999999999999999999988754  35789


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      +|||+++++|.+++..    ..+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.++|+|||++....
T Consensus        86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence            9999999999998853    34899999999999999999999986   9999999999999999999999999988664


Q ss_pred             CCCCCcc-cccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          545 GNQNQAN-TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       545 ~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ....... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~  212 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS  212 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence            3222111 1122345679999999888899999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.9e-30  Score=265.15  Aligned_cols=203  Identities=31%  Similarity=0.495  Sum_probs=169.9

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCc----EEEEEEeccCCc-ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      .+|.+.+.||+|+||.||+|... +|.    .+++|.+..... .....+.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            56788899999999999999854 333    589998876543 345678899999999999999999999987 78899


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      |+||+++++|.+++...  ...+++..+..++.||+.||+|||+.+   ++||||||+||++++++.+||+|||+++...
T Consensus        86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            99999999999998543  335899999999999999999999975   9999999999999999999999999998764


Q ss_pred             CCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCCc
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYF  599 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~~  599 (621)
                      ............++..|+|||.+....++.++|+||||+++|||++ |+.||....
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  216 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP  216 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC
Confidence            3322211111223567999999988889999999999999999999 999986543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.97  E-value=1.5e-30  Score=274.45  Aligned_cols=205  Identities=31%  Similarity=0.454  Sum_probs=168.2

Q ss_pred             hCCCCccceeccCCceeEEEEEe------cCCcEEEEEEeccCC-cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeC-c
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG-Q  460 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~-~  460 (621)
                      .++|.+.+.||+|+||.||+|..      .+++.||||+++... ......+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            35789999999999999999973      357889999997543 23345688999999999 689999999988754 4


Q ss_pred             eEEEEEEecCCCChhhhhhhccC---------------------------------------------------------
Q 007006          461 ELLLIYEYMPNKSLDVHLFDATR---------------------------------------------------------  483 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------  483 (621)
                      ..+++|||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            67899999999999998854210                                                         


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCccccccc
Q 007006          484 -------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA  556 (621)
Q Consensus       484 -------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~  556 (621)
                             ...+++..+.+++.||++||+|||+.+   |+||||||+|||+++++.+||+|||++................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   124688889999999999999999886   9999999999999999999999999988653322211222233


Q ss_pred             ccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          557 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       557 gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      ++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~  284 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  284 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            4677999999988899999999999999999997 9999854

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>PTZ00284 protein kinase; Provisional

Probab=99.97  E-value=9.7e-31  Score=287.20  Aligned_cols=200  Identities=21%  Similarity=0.299  Sum_probs=162.7

Q ss_pred             HHhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccC------CceeEeeEEeeC-
Q 007006          388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK------NLVRLLGCCLEG-  459 (621)
Q Consensus       388 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~------nIv~l~g~~~~~-  459 (621)
                      ..+++|.+.++||+|+||.||++... .++.||||+++... ....++..|+.+++.++|.      +++++++++..+ 
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~  204 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET  204 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence            34578999999999999999999864 58899999996532 2234567788888887654      588888888765 


Q ss_pred             ceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC---------
Q 007006          460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM---------  530 (621)
Q Consensus       460 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---------  530 (621)
                      ...++|||++ +++|.+++..   ...+++..+..|+.||+.||.|||++  .+|+||||||+|||++.++         
T Consensus       205 ~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~  278 (467)
T PTZ00284        205 GHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNR  278 (467)
T ss_pred             ceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccccccccc
Confidence            4688999987 6778777743   34689999999999999999999974  1499999999999998765         


Q ss_pred             -------CeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          531 -------NPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       531 -------~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                             .+||+|||++....     .......||+.|+|||++.+..++.++|||||||++|||++|++||....
T Consensus       279 ~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        279 ALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             ccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                   49999999875321     12234578999999999999999999999999999999999999996533

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-31  Score=281.68  Aligned_cols=192  Identities=33%  Similarity=0.517  Sum_probs=170.2

Q ss_pred             eeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCCChhh
Q 007006          398 KLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDV  476 (621)
Q Consensus       398 ~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~gsL~~  476 (621)
                      +||+|.+|+||.|+.. +...+|||.+...+....+.+.+||.+-+.|+|.|||+++|.+.+++.+-+.||-+|||+|..
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            6999999999999954 567899999988877778889999999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc-CCCCeEEeeecCceecCCCCCCcccc
Q 007006          477 HLFDATRSVQL--DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQNQANTN  553 (621)
Q Consensus       477 ~l~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~vkL~Dfgla~~~~~~~~~~~~~  553 (621)
                      +|..  +-+++  ++.+.-.+..||++||.|||++.   |+|||||-+||||+ -.|.+||+|||-++.+..  ..+-+.
T Consensus       662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TE  734 (1226)
T KOG4279|consen  662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTE  734 (1226)
T ss_pred             HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccc
Confidence            9954  34555  88888899999999999999985   99999999999996 578999999999887643  233344


Q ss_pred             cccccCCccChhcccCCC--CChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          554 IIAGTYGYMAPEYAMGGI--FSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       554 ~~~gt~~y~aPE~l~~~~--~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      .+-||+-|||||++..++  |+.++|||||||.+.||.||++||-
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~  779 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFV  779 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCee
Confidence            567999999999998765  8999999999999999999999984

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.97  E-value=4e-30  Score=259.74  Aligned_cols=201  Identities=29%  Similarity=0.429  Sum_probs=177.0

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc-ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      ++|++.+.||+|++|.||+++.. +++.|++|++..... ...+.+.+|++.+.+++|+||+++++++...+..++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36888899999999999999976 599999999876644 4467899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE-DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      +++++|.+++...   ..+++..++.++.|+++||.|||+ .+   ++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            9999999999543   568999999999999999999998 75   9999999999999999999999999988764332


Q ss_pred             CCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      ...  ....++..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       155 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~  204 (264)
T cd06623         155 DQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG  204 (264)
T ss_pred             Ccc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            221  23457889999999999899999999999999999999999986554

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.8e-30  Score=267.85  Aligned_cols=204  Identities=27%  Similarity=0.350  Sum_probs=174.0

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc---ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|...+.||+|++|.||++... +++.+|+|.+.....   ...+.+.+|++++..++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888899999999999999865 589999999976532   24567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+.+++|.+++.. .....+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            99999999998853 23456899999999999999999999886   999999999999999999999999998754321


Q ss_pred             CCC---------------------------cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          547 QNQ---------------------------ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       547 ~~~---------------------------~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ...                           ...+...|+..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            110                           1112345788999999999888999999999999999999999998533

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.97  E-value=3.7e-30  Score=258.38  Aligned_cols=196  Identities=33%  Similarity=0.502  Sum_probs=167.6

Q ss_pred             ceeccCCceeEEEEEecCCcEEEEEEeccCCcc-cHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCCChh
Q 007006          397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLD  475 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~gsL~  475 (621)
                      ++||+|+||.||++...+++.|++|+++..... ....+.+|++++++++||||+++++++.+....++|+||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            479999999999999777999999998765443 5567899999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcccccc
Q 007006          476 VHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII  555 (621)
Q Consensus       476 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~  555 (621)
                      +++...  ...+++..+..++.+++.+|.|||+++   ++||||+|+||+++.++.+||+|||++...............
T Consensus        81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            988542  335889999999999999999999886   999999999999999999999999998865432222111222


Q ss_pred             cccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          556 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       556 ~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      ..+..|+|||.+.++.++.++||||||+++|||+| |..||..
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~  198 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG  198 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCcc
Confidence            33567999999988889999999999999999999 8888754

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=3.7e-30  Score=259.37  Aligned_cols=198  Identities=36%  Similarity=0.530  Sum_probs=172.4

Q ss_pred             hCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      .++|.+.+.||+|+||.||++... |+.|++|.+..... ..+++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            357888999999999999999874 88999999976644 5678899999999999999999999999988999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||.++....... 
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            9999999985432 236899999999999999999999886   99999999999999999999999999986532211 


Q ss_pred             cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                          ....+..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus       158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  203 (256)
T cd05039         158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI  203 (256)
T ss_pred             ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence                1234567999999988889999999999999999997 99998544

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=1.2e-31  Score=282.31  Aligned_cols=193  Identities=28%  Similarity=0.467  Sum_probs=166.0

Q ss_pred             ccceeccCCceeEEEEEec-CCcEEEEEEecc----CCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCc--eEEEEEE
Q 007006          395 DENKLGQGGFGPVYKGTLA-DGKAIAVKRLSR----TSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ--ELLLIYE  467 (621)
Q Consensus       395 ~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~----~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~--~~~lV~e  467 (621)
                      ....||+|.|-+||||... +|.+||---++.    .++...++|..|+.+|+.|+||||++++..+.+..  ...+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            3468999999999999864 588887443322    23455688999999999999999999999998765  4789999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC-CCCeEEeeecCceecCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFGGN  546 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~vkL~Dfgla~~~~~~  546 (621)
                      .+..|+|..|+.+.   ..++.+.+..|++||++||.|||++. +||||||||-+||+|+. .|.|||+|+|||......
T Consensus       124 L~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  124 LFTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             cccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            99999999999643   45889999999999999999999985 78999999999999985 589999999999976433


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                          ..+...|||.|||||+.. ..|++.+||||||+.++||+|+..||.
T Consensus       200 ----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs  244 (632)
T KOG0584|consen  200 ----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS  244 (632)
T ss_pred             ----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh
Confidence                334478999999999776 889999999999999999999999986

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.97  E-value=4.6e-30  Score=259.47  Aligned_cols=200  Identities=36%  Similarity=0.522  Sum_probs=169.2

Q ss_pred             CCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecC
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP  470 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  470 (621)
                      ++|.+.++||+|++|.||++....+..+++|++.... ...+.+.+|+.++++++|||++++++++.. +..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence            4588889999999999999998777789999886543 334678899999999999999999998754 56789999999


Q ss_pred             CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc
Q 007006          471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA  550 (621)
Q Consensus       471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~  550 (621)
                      +++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++..........
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05069          84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence            99999998643 2345899999999999999999999876   9999999999999999999999999998664332211


Q ss_pred             ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                       .....++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       160 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~  206 (260)
T cd05069         160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG  206 (260)
T ss_pred             -cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence             112235678999999988889999999999999999999 8999854

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.97  E-value=2.6e-30  Score=262.39  Aligned_cols=203  Identities=30%  Similarity=0.489  Sum_probs=170.1

Q ss_pred             CCCCccceeccCCceeEEEEEec----CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      .+|.+.+.||+|+||.||+|...    .+..+|+|.++... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46788899999999999999853    23479999987543 23456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      |||+++++|.+++...  ...+++.+++.++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++.....
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            9999999999998543  345899999999999999999999886   99999999999999999999999999986643


Q ss_pred             CCCCcc-cccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          546 NQNQAN-TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       546 ~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      ...... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||...
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~  213 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM  213 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC
Confidence            222111 111223567999999998889999999999999999887 99998543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=4.1e-30  Score=272.46  Aligned_cols=193  Identities=25%  Similarity=0.312  Sum_probs=163.8

Q ss_pred             HHhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       388 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ....+|.+.+.||+|+||.||+++.. ++..||+|+....      ....|+.++++++||||+++++++.+....++|+
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            34468999999999999999999965 5788999975432      2356899999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      |++. ++|..++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            9985 677777743  3456899999999999999999999986   999999999999999999999999998753221


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNN  595 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~  595 (621)
                         .......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence               1122346899999999999999999999999999999999865553

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.97  E-value=3.3e-30  Score=267.09  Aligned_cols=200  Identities=22%  Similarity=0.325  Sum_probs=170.3

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|...+.||+|+||.||++... .++.|++|.+....   ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46888999999999999999865 57899999987553   233457889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            99999999999854   245899999999999999999999876   999999999999999999999999998642111


Q ss_pred             CCC-------------cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          547 QNQ-------------ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       547 ~~~-------------~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      ...             .......++..|+|||.+.+..++.++|+||||+++|||++|+.||.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~  217 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF  217 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            000             01112356788999999988889999999999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=3.3e-30  Score=261.18  Aligned_cols=190  Identities=24%  Similarity=0.367  Sum_probs=159.4

Q ss_pred             ceeccCCceeEEEEEecC-------------CcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEE
Q 007006          397 NKLGQGGFGPVYKGTLAD-------------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL  463 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~~-------------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~  463 (621)
                      +.||+|+||.||+|....             ...|++|.+..........+.+|+.++..++||||+++++++.++...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998532             2358899887655555667889999999999999999999999998999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCC-------eEEee
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN-------PKISD  536 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-------vkL~D  536 (621)
                      +||||+++++|+.++..  +...+++..+++++.||++||+|||+.+   |+||||||+|||++.++.       ++++|
T Consensus        81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            99999999999988753  2345899999999999999999999876   999999999999987664       89999


Q ss_pred             ecCceecCCCCCCcccccccccCCccChhccc-CCCCChhhhHHHHHHHHHHHH-cCCCCCCC
Q 007006          537 FGLARIFGGNQNQANTNIIAGTYGYMAPEYAM-GGIFSIKSDVFSFGVLLLEII-SGRKNNGF  597 (621)
Q Consensus       537 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~~sDVwS~Gvll~ell-tG~~p~~~  597 (621)
                      ||++......      ....++..|+|||.+. +..++.++||||||+++|||+ +|+.|+..
T Consensus       156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~  212 (262)
T cd05077         156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD  212 (262)
T ss_pred             CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            9998654321      1234678899999886 466899999999999999998 58888754

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.97  E-value=3.3e-30  Score=270.73  Aligned_cols=204  Identities=33%  Similarity=0.480  Sum_probs=169.9

Q ss_pred             CCCCccceeccCCceeEEEEEec--------CCcEEEEEEeccCC-cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCc
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ  460 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~  460 (621)
                      .+|.+.+.||+|+||.||++...        .+..||+|.+.... ....+++.+|+++++++ +||||+++++++.+.+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46888999999999999999742        12368999887542 34457889999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhhcc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc
Q 007006          461 ELLLIYEYMPNKSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD  527 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~  527 (621)
                      ..++++||+++++|.+++....             ....+++.++..++.|++.||.|||+.+   ++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence            9999999999999999986422             2335889999999999999999999986   99999999999999


Q ss_pred             CCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          528 DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       528 ~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      +++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  239 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG  239 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence            999999999999986543222222222234567999999999999999999999999999998 8888753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.97  E-value=3.8e-30  Score=269.41  Aligned_cols=199  Identities=18%  Similarity=0.255  Sum_probs=164.0

Q ss_pred             ccceeccC--CceeEEEEEe-cCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          395 DENKLGQG--GFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       395 ~~~~LG~G--~fG~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      +.++||+|  +|++||++.. .+|+.||+|++....  ....+.+.+|+++++.++||||+++++++..++..++|+||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  7899999985 578999999997542  233456778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC-
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN-  548 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~-  548 (621)
                      ++++|.+++.... ...+++..+.+++.|++.||.|||+.+   |+||||||+|||++.++.++++||+.......... 
T Consensus        82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            9999999885422 235899999999999999999999886   99999999999999999999999986543321110 


Q ss_pred             ----CcccccccccCCccChhcccC--CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          549 ----QANTNIIAGTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       549 ----~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                          ........++..|+|||++.+  ..++.++|||||||++|||++|+.||..
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence                011122346678999999876  4589999999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.97  E-value=7.3e-30  Score=257.09  Aligned_cols=200  Identities=25%  Similarity=0.377  Sum_probs=170.8

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeC-ceEEEEEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-QELLLIYE  467 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~-~~~~lV~e  467 (621)
                      +|++.+.||+|++|.||++..+ +++.+++|++....  ....+.+.+|++++++++|+|++++++.+... ...++++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788999999999999999864 57899999986542  33456788999999999999999999887644 46789999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |+++++|.+++... ....+++.++..++.+++.||.+||+.+   ++||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            99999999988643 3346899999999999999999999886   9999999999999999999999999998764322


Q ss_pred             CCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .  ......+++.|+|||.+.+..++.++||||||++++||++|+.||..
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~  204 (257)
T cd08223         157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA  204 (257)
T ss_pred             C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence            2  12234578899999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.97  E-value=4.2e-30  Score=264.22  Aligned_cols=201  Identities=27%  Similarity=0.410  Sum_probs=167.8

Q ss_pred             HhCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCc-ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++++|.+.+.||+|+||.||+|.. .++..|++|++..... .....+.+|+.+++.++|+||+++.+++.+++..++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            356899999999999999999985 4689999999875533 23346788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+. ++|..++..  ....+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++......
T Consensus        83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            9996 667666643  2345788889999999999999999886   999999999999999999999999998754332


Q ss_pred             CCCcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ...  .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus       157 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~  206 (291)
T cd07870         157 SQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG  206 (291)
T ss_pred             CCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            211  1223468899999998764 478899999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=2.9e-30  Score=264.59  Aligned_cols=200  Identities=31%  Similarity=0.521  Sum_probs=168.6

Q ss_pred             CCCCccceeccCCceeEEEEEe-----cCCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeC--ceE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QEL  462 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~  462 (621)
                      ..|.+.+.||+|+||.||+++.     .++..||+|.++... ......+.+|+.+++.++||||+++.+++.+.  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3578889999999999999974     357889999987553 34456789999999999999999999998875  568


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      ++||||+++++|.+++...  ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            9999999999999998532  235899999999999999999999986   99999999999999999999999999986


Q ss_pred             cCCCCCC-cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCC
Q 007006          543 FGGNQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNN  595 (621)
Q Consensus       543 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~  595 (621)
                      +...... .......++..|+|||++.+..++.++||||||+++|||++++.|.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~  212 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE  212 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence            6433221 1112345677899999998888999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-31  Score=296.32  Aligned_cols=205  Identities=24%  Similarity=0.350  Sum_probs=178.3

Q ss_pred             HHHHHHhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeC
Q 007006          384 RLALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG  459 (621)
Q Consensus       384 ~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~  459 (621)
                      +.++-..++|.+++.||+|+||.|..++++ +++.+|+|++.+.   ......-|..|-++|..-+.+.|+++.-.|+++
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            444455689999999999999999999975 5889999999873   234456789999999999999999999999999


Q ss_pred             ceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecC
Q 007006          460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL  539 (621)
Q Consensus       460 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgl  539 (621)
                      ..+|+|||||+||+|-.++....   .+++.-+..++..|+-||.-||+.|   +|||||||+|||||..|++||+|||.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs  221 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS  221 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence            99999999999999999885432   6889989999999999999999876   99999999999999999999999999


Q ss_pred             ceecCCCCCCcccccccccCCccChhccc----C-CCCChhhhHHHHHHHHHHHHcCCCCC
Q 007006          540 ARIFGGNQNQANTNIIAGTYGYMAPEYAM----G-GIFSIKSDVFSFGVLLLEIISGRKNN  595 (621)
Q Consensus       540 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~----~-~~~s~~sDVwS~Gvll~elltG~~p~  595 (621)
                      +-.+..+. .-.....+|||.|++||++.    + +.|++..|+||+||++|||+.|..||
T Consensus       222 Clkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPF  281 (1317)
T KOG0612|consen  222 CLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPF  281 (1317)
T ss_pred             HHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcc
Confidence            88775432 22334578999999999984    2 66899999999999999999999997

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=5.2e-30  Score=259.72  Aligned_cols=201  Identities=28%  Similarity=0.459  Sum_probs=169.7

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC-----CcccHHHHHHHHHHHHhcccCCceeEeeEEeeC--ceE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT-----SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QEL  462 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~  462 (621)
                      .+|.+.+.||+|+||.||++.. .++..|++|++...     .......+.+|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4688899999999999999985 46899999987532     123345788999999999999999999998764  467


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      ++++||+++++|.+++..   ...+++....+++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            899999999999988853   235889999999999999999999886   99999999999999999999999999986


Q ss_pred             cCCCCCC-cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          543 FGGNQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       543 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  211 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE  211 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence            5322111 111234578899999999888899999999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.97  E-value=2.1e-30  Score=267.63  Aligned_cols=194  Identities=27%  Similarity=0.451  Sum_probs=169.2

Q ss_pred             ccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCCC
Q 007006          395 DENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKS  473 (621)
Q Consensus       395 ~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~gs  473 (621)
                      ...+||+|+||.||++... +++.|++|.+........+.+.+|+.++..++||||+++++.+..++..++|+||+++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            3457999999999999864 689999999976555556778899999999999999999999999999999999999999


Q ss_pred             hhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcccc
Q 007006          474 LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN  553 (621)
Q Consensus       474 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~  553 (621)
                      |..++..    ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||++........  ...
T Consensus       105 L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~  175 (297)
T cd06659         105 LTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRK  175 (297)
T ss_pred             HHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--ccc
Confidence            9887732    35899999999999999999999886   99999999999999999999999999875533221  122


Q ss_pred             cccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          554 IIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       554 ~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ...++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  219 (297)
T cd06659         176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS  219 (297)
T ss_pred             ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            34678899999999988899999999999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.97  E-value=1.5e-30  Score=267.97  Aligned_cols=197  Identities=27%  Similarity=0.444  Sum_probs=170.6

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecC
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP  470 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  470 (621)
                      .|.....||+|+||.||++... ++..||||++........+.+.+|+.+++.++||||+++++.+...+..++||||++
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~  102 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE  102 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence            3444567999999999999864 688999999876555556778999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc
Q 007006          471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA  550 (621)
Q Consensus       471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~  550 (621)
                      +++|.+++..    ..+++..+..++.||+.||.|||+.+   ++||||||+||++++++.++|+|||++........  
T Consensus       103 ~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--  173 (292)
T cd06658         103 GGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--  173 (292)
T ss_pred             CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--
Confidence            9999988732    35889999999999999999999986   99999999999999999999999999875533221  


Q ss_pred             ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ......++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~  220 (292)
T cd06658         174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN  220 (292)
T ss_pred             cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            12234578899999999888899999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.97  E-value=3.4e-30  Score=266.75  Aligned_cols=202  Identities=34%  Similarity=0.553  Sum_probs=167.6

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCc----EEEEEEeccCCc-ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL  463 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~  463 (621)
                      .++|+..+.||+|+||.||++... ++.    .+|+|.+..... ....++.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            356788899999999999999853 444    578888865432 2334688999999999999999999998764 467


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceec
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF  543 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~  543 (621)
                      +++||+++|+|.+++...  ...+++..++.++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||+++..
T Consensus        85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence            899999999999988542  335889999999999999999999886   999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          544 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       544 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      .............++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~  214 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG  214 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            54332222223345678999999998899999999999999999997 8999853

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=5e-30  Score=260.79  Aligned_cols=199  Identities=29%  Similarity=0.485  Sum_probs=168.6

Q ss_pred             CCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCc----------ccHHHHHHHHHHHHhcccCCceeEeeEEeeCc
Q 007006          392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG----------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ  460 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~----------~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~  460 (621)
                      +|...+.||+|+||.||+|.. .+|+.+|+|.++....          ...+.+.+|+.+++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            467788999999999999985 4689999998864211          11245788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCc
Q 007006          461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA  540 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla  540 (621)
                      ..++|+||+++++|.+++...   ..+++..+..++.||+.||.|||+.+   ++||||+|+||++++++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999988543   46899999999999999999999875   999999999999999999999999998


Q ss_pred             eecCCCCCCcccccccccCCccChhcccCCC--CChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          541 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGI--FSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       541 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      ................++..|+|||.+....  ++.++||||||+++|||++|+.||.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~  213 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS  213 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCc
Confidence            7654322222223345788999999987655  7899999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.97  E-value=6.5e-30  Score=257.41  Aligned_cols=200  Identities=29%  Similarity=0.478  Sum_probs=171.1

Q ss_pred             CCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecC
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP  470 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  470 (621)
                      .+|+..+.||+|+||.||++...++..+++|++.... .....+.+|++++++++|||++++++++......++|+||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            4677889999999999999998778899999987543 234678999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc
Q 007006          471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA  550 (621)
Q Consensus       471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~  550 (621)
                      +++|.+++...  ...++++.+..++.+++.+|.|||+.+   ++|+||||+||+++.++.++|+|||++..........
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            99999988542  245889999999999999999999886   9999999999999999999999999988654322111


Q ss_pred             ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                       .....++..|+|||.+.++.++.++||||||+++|||++ |+.||..
T Consensus       158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~  204 (256)
T cd05112         158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN  204 (256)
T ss_pred             -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc
Confidence             112234568999999998889999999999999999998 9999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.97  E-value=5.2e-30  Score=263.45  Aligned_cols=199  Identities=27%  Similarity=0.435  Sum_probs=167.4

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc-ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      ++|+..+.||+|++|.||++..+ +++.||+|.+..... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888999999999999999965 689999999875432 2234567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++ +|.+++...  ...+++..+..++.|+++||.|||+.+   ++||||||+||++++++.+||+|||+++.......
T Consensus        85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            985 888887543  236899999999999999999999886   99999999999999999999999999875432211


Q ss_pred             CcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ..  ....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||..
T Consensus       159 ~~--~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~  206 (291)
T cd07844         159 TY--SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG  206 (291)
T ss_pred             cc--cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            11  11235788999998865 4578999999999999999999999854

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.97  E-value=1.9e-30  Score=264.87  Aligned_cols=197  Identities=29%  Similarity=0.515  Sum_probs=170.5

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      .|+..+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++.+..++..++|+||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            4666788999999999999854 57899999987543 344567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++++|.+++.    ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++........ 
T Consensus        85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06642          85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence            9999998874    245899999999999999999999875   99999999999999999999999999876543221 


Q ss_pred             cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                       ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~  203 (277)
T cd06642         157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD  203 (277)
T ss_pred             -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcc
Confidence             12224578889999999988899999999999999999999999853

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.97  E-value=5.6e-30  Score=258.83  Aligned_cols=201  Identities=34%  Similarity=0.507  Sum_probs=171.1

Q ss_pred             hCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      .++|.+.++||+|+||.||++...++..+++|.+.... ...+.+.+|++++++++|+||+++.+.+.+ ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            35788999999999999999998778889999887542 335678999999999999999999999887 7789999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||.+.........
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            999999998543 2345889999999999999999999875   999999999999999999999999999865432211


Q ss_pred             cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      . .....++..|+|||++....++.++|+||||+++|||++ |+.||..
T Consensus       159 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~  206 (260)
T cd05073         159 A-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG  206 (260)
T ss_pred             c-ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCC
Confidence            1 112234567999999988889999999999999999999 8999854

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.97  E-value=5.9e-30  Score=261.28  Aligned_cols=199  Identities=28%  Similarity=0.496  Sum_probs=172.6

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      ..|+..++||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++.++||||+++++.+.++...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35777889999999999999864 58899999987543 34456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++++|.+++..    .++++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            999999998842    35889999999999999999999875   99999999999999999999999999976643321


Q ss_pred             CcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                        ......++..|+|||++.+..++.++|+||||+++|||++|+.||...
T Consensus       157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~  204 (277)
T cd06640         157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM  204 (277)
T ss_pred             --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCc
Confidence              122345788899999998888999999999999999999999998643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.97  E-value=2.6e-30  Score=264.78  Aligned_cols=199  Identities=27%  Similarity=0.430  Sum_probs=169.5

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc--ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      ++|+..++||+|+||.||++..+ +++.||+|++.....  ...+.+.+|+++++.++||||+++++++.+++..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888999999999999999975 589999999865432  234668899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |+++++|..+...   ...+++..+..++.||+.||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            9999999877643   234899999999999999999999886   9999999999999999999999999988654332


Q ss_pred             CCcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ..  .....++..|+|||++.+. .++.++||||||+++|||++|++||..
T Consensus       155 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~  203 (286)
T cd07846         155 EV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG  203 (286)
T ss_pred             cc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence            11  1223568899999988753 478899999999999999999998853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=1.1e-30  Score=274.78  Aligned_cols=199  Identities=29%  Similarity=0.461  Sum_probs=177.2

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ...|.+.++||+|.|+.|..+++. ++..||||.+++..  ...++.+.+|+++|..++|||||+++.+...+..+++||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            467899999999999999999854 69999999998763  344466889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||..+|.+.+++..   ...+.+..+..++.|+.++++|||++.   |+|||||++||||+.+.++||+|||++..+...
T Consensus       135 eya~~ge~~~yl~~---~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  135 EYASGGELFDYLVK---HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             EeccCchhHHHHHh---cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence            99999999999954   344667888999999999999999986   999999999999999999999999999988643


Q ss_pred             CCCcccccccccCCccChhcccCCCC-ChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .   .....+|++.|.|||+..+..+ ++++|+||+|++||-|+.|..||+.
T Consensus       209 ~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG  257 (596)
T KOG0586|consen  209 L---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG  257 (596)
T ss_pred             c---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC
Confidence            3   2334689999999999988876 8899999999999999999999974

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.97  E-value=7.3e-30  Score=257.29  Aligned_cols=195  Identities=34%  Similarity=0.475  Sum_probs=166.3

Q ss_pred             CCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEe-eCceEEEEEEec
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL-EGQELLLIYEYM  469 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~-~~~~~~lV~e~~  469 (621)
                      ++|.+.+.||+|+||.||++... |..+++|.++...  ..+.+.+|+.++++++|+|++++++++. +++..++++||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46888899999999999999864 7889999886442  3467899999999999999999999765 445789999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++++|.+++... ....+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++........ 
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-  157 (256)
T cd05082          83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-  157 (256)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccCC-
Confidence            999999998543 2335889999999999999999999886   99999999999999999999999999876433221 


Q ss_pred             cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                          ....+..|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus       158 ----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~  202 (256)
T cd05082         158 ----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR  202 (256)
T ss_pred             ----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence                1233567999999988889999999999999999997 9999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.97  E-value=7e-30  Score=259.73  Aligned_cols=194  Identities=34%  Similarity=0.525  Sum_probs=161.1

Q ss_pred             ceeccCCceeEEEEEecC-Cc--EEEEEEeccC-CcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEEEEecCC
Q 007006          397 NKLGQGGFGPVYKGTLAD-GK--AIAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPN  471 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~~-g~--~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~  471 (621)
                      +.||+|+||.||+|.+++ +.  .+++|.+... .....+.+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999753 43  5688888753 334456788999999999 899999999999999999999999999


Q ss_pred             CChhhhhhhcc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeec
Q 007006          472 KSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG  538 (621)
Q Consensus       472 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfg  538 (621)
                      ++|.+++....             ....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999986432             1235889999999999999999999876   9999999999999999999999999


Q ss_pred             CceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCC
Q 007006          539 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNG  596 (621)
Q Consensus       539 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~  596 (621)
                      ++......   ........+..|+|||++....++.++||||||+++|||++ |+.||.
T Consensus       158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~  213 (270)
T cd05047         158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC  213 (270)
T ss_pred             Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence            98532211   11111223567999999988889999999999999999997 999984

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.97  E-value=7.2e-30  Score=258.03  Aligned_cols=201  Identities=30%  Similarity=0.517  Sum_probs=173.9

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcc--cHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ--GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      +|...+.||+|+||.||++... +++.|++|.++.....  ..+.+.+|++++++++|+||+++++.+.+.+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4778899999999999999864 6899999998766443  567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++++|.+++..   ...+++..+..++.++++||.|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            999999998853   234789999999999999999999986   99999999999999999999999999887654332


Q ss_pred             Ccc--cccccccCCccChhcccCCC---CChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          549 QAN--TNIIAGTYGYMAPEYAMGGI---FSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       549 ~~~--~~~~~gt~~y~aPE~l~~~~---~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ...  .....++..|+|||++.+..   .+.++||||||+++|||++|+.||...
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~  209 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL  209 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence            211  12345678999999998766   889999999999999999999998643

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.97  E-value=5.2e-30  Score=264.11  Aligned_cols=199  Identities=28%  Similarity=0.467  Sum_probs=174.0

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      ++|.+.+.||+|+||.||++.. .++..|++|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            5788899999999999999985 468899999987655555677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++++|.+++..    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.........
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~  171 (293)
T cd06647          99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (293)
T ss_pred             CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence            99999998843    34789999999999999999999886   999999999999999999999999998765433221


Q ss_pred             cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                        .....+++.|++||.+.+..++.++||||||+++|||++|+.||...
T Consensus       172 --~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~  218 (293)
T cd06647         172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE  218 (293)
T ss_pred             --cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence              12235788899999998888999999999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.97  E-value=5e-30  Score=261.20  Aligned_cols=202  Identities=31%  Similarity=0.444  Sum_probs=170.7

Q ss_pred             CCCCccceeccCCceeEEEEEec------CCcEEEEEEeccCCcc-cHHHHHHHHHHHHhcccCCceeEeeEEeeCceEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL  463 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~  463 (621)
                      ++|++...||+|+||.||+++.+      +.+.+++|.+...... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56888999999999999999854      3467999988765443 4577999999999999999999999999988999


Q ss_pred             EEEEecCCCChhhhhhhccCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeee
Q 007006          464 LIYEYMPNKSLDVHLFDATRS------VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF  537 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Df  537 (621)
                      +||||+++++|.+++......      ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999998653322      26899999999999999999999886   999999999999999999999999


Q ss_pred             cCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCC
Q 007006          538 GLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNG  596 (621)
Q Consensus       538 gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~  596 (621)
                      |++........ .......++..|+|||.+.+...+.++||||||+++|||++ |..||.
T Consensus       162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~  220 (275)
T cd05046         162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFY  220 (275)
T ss_pred             ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence            99864432211 11222345677999999988888999999999999999999 788874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=5.2e-30  Score=258.33  Aligned_cols=189  Identities=29%  Similarity=0.463  Sum_probs=159.4

Q ss_pred             ceeccCCceeEEEEEecCCc-----------EEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          397 NKLGQGGFGPVYKGTLADGK-----------AIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~~g~-----------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      +.||+|+||.||+|.+.+..           .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46899999999999975432           5788877654433 6788999999999999999999999988 778999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC-------CeEEeeec
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-------NPKISDFG  538 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-------~vkL~Dfg  538 (621)
                      +||+++++|.+++....  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            99999999999986432  26899999999999999999999875   99999999999999887       79999999


Q ss_pred             CceecCCCCCCcccccccccCCccChhcccCC--CCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          539 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGG--IFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       539 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      ++.....      .....++..|+|||++.+.  .++.++||||||+++|||++ |..|+...
T Consensus       154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~  210 (259)
T cd05037         154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL  210 (259)
T ss_pred             ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence            9886533      1123456789999998876  78999999999999999999 57776544

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.97  E-value=7.3e-30  Score=265.29  Aligned_cols=206  Identities=28%  Similarity=0.434  Sum_probs=169.8

Q ss_pred             CCCccceeccCCceeEEEEEec---CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeC--ceEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELL  463 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~~  463 (621)
                      +|.+.++||+|+||.||+|...   ++..||+|.+....   ....+.+.+|+.++++++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4778899999999999999964   47899999998643   34456778899999999999999999999988  7899


Q ss_pred             EEEEecCCCChhhhhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC----CCCeEEeee
Q 007006          464 LIYEYMPNKSLDVHLFDAT--RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD----DMNPKISDF  537 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~----~~~vkL~Df  537 (621)
                      +||||+++ +|..++....  ....+++..+..++.||+.||.|||+.+   |+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 5655554322  2236899999999999999999999886   999999999999999    899999999


Q ss_pred             cCceecCCCCC-CcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCCCcCC
Q 007006          538 GLARIFGGNQN-QANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSE  601 (621)
Q Consensus       538 gla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~~~~~  601 (621)
                      |++........ ........++..|+|||.+.+. .++.++||||||++++||++|++||.....+
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~  222 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAK  222 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccc
Confidence            99886643322 1222334678899999988664 5799999999999999999999999754443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.7e-31  Score=255.13  Aligned_cols=199  Identities=26%  Similarity=0.405  Sum_probs=169.3

Q ss_pred             cceeccCCceeEEEEE-ecCCcEEEEEEeccCCcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEEEEecCCCC
Q 007006          396 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPNKS  473 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~~gs  473 (621)
                      .+.||+|+++.|--++ +.+|.++|||++.+.....+.+..+|++++... .|+||++++++|++++.+|||||-|.||+
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            3689999999999887 778999999999998877788999999999999 59999999999999999999999999999


Q ss_pred             hhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCC---eEEeeecCceecCCCC---
Q 007006          474 LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN---PKISDFGLARIFGGNQ---  547 (621)
Q Consensus       474 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---vkL~Dfgla~~~~~~~---  547 (621)
                      |..++.+   +..+++.++.++..+|+.||.+||..|   |.||||||+|||-.....   +||+||.+..-...+.   
T Consensus       163 lLshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s  236 (463)
T KOG0607|consen  163 LLSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS  236 (463)
T ss_pred             HHHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence            9988854   456999999999999999999999987   999999999999976544   8999999876432211   


Q ss_pred             --CCcccccccccCCccChhccc-----CCCCChhhhHHHHHHHHHHHHcCCCCCCCCcC
Q 007006          548 --NQANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFS  600 (621)
Q Consensus       548 --~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~  600 (621)
                        ..+.-...+|+..|||||+..     ...|+.+.|.||||||||-|++|-+||...=.
T Consensus       237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg  296 (463)
T KOG0607|consen  237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG  296 (463)
T ss_pred             CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence              111122346888999999762     23489999999999999999999999965433

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.97  E-value=5.3e-30  Score=260.45  Aligned_cols=201  Identities=26%  Similarity=0.379  Sum_probs=168.2

Q ss_pred             CCCCccceeccCCceeEEEEEecC----CcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      ++|.+.+.||+|+||.||+|...+    ...|++|...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457888999999999999998643    3468999887654 4456689999999999999999999998875 457899


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      |||+++++|.+++...  ...+++..++.++.+++.||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence            9999999999999542  235899999999999999999999876   99999999999999999999999999886644


Q ss_pred             CCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      ..... .....++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus       160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~  212 (270)
T cd05056         160 ESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGV  212 (270)
T ss_pred             cccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence            32211 112234567999999988889999999999999999986 99998543

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=4.3e-30  Score=262.13  Aligned_cols=189  Identities=26%  Similarity=0.376  Sum_probs=157.2

Q ss_pred             eeccCCceeEEEEEecC-------------------------CcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeE
Q 007006          398 KLGQGGFGPVYKGTLAD-------------------------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRL  452 (621)
Q Consensus       398 ~LG~G~fG~Vy~~~~~~-------------------------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l  452 (621)
                      .||+|+||.||+|.+..                         ...|++|++..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997421                         13588998876555555678899999999999999999


Q ss_pred             eeEEeeCceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC--
Q 007006          453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM--  530 (621)
Q Consensus       453 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~--  530 (621)
                      ++++.++...++||||+++++|+.++...  ...+++..+.+++.||++||+|||+.+   |+||||||+|||++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            99999999999999999999999888542  346889999999999999999999875   99999999999997644  


Q ss_pred             -----CeEEeeecCceecCCCCCCcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHH-HcCCCCCCC
Q 007006          531 -----NPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEI-ISGRKNNGF  597 (621)
Q Consensus       531 -----~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~el-ltG~~p~~~  597 (621)
                           .+|++|||++......      ....++..|+|||.+.+ ..++.++||||||+++||| ++|+.||..
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~  224 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE  224 (274)
T ss_pred             cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence                 3799999987643221      11246778999998865 5689999999999999999 479999854

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.97  E-value=6.1e-30  Score=259.27  Aligned_cols=200  Identities=28%  Similarity=0.487  Sum_probs=171.0

Q ss_pred             CCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCc------ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      +|+..+.||+|++|.||++.. .+++.+|+|.+.....      ...+.+.+|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477789999999999999985 5789999999875431      134678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC-CeEEeeecCceec
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIF  543 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~vkL~Dfgla~~~  543 (621)
                      |+||+++++|.+++.+   ..++++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++ .+||+|||++...
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            9999999999999854   346889999999999999999999986   99999999999998776 5999999998776


Q ss_pred             CCCCCC--cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          544 GGNQNQ--ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       544 ~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ......  .......++..|+|||.+.+..++.++||||+|++++||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  210 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA  210 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence            433111  112234578899999999888899999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.97  E-value=1.2e-29  Score=255.10  Aligned_cols=200  Identities=39%  Similarity=0.572  Sum_probs=170.2

Q ss_pred             CCccceeccCCceeEEEEEecC-----CcEEEEEEeccCCcc-cHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          393 FSDENKLGQGGFGPVYKGTLAD-----GKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       393 f~~~~~LG~G~fG~Vy~~~~~~-----g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      +++.+.||+|+||.||+++..+     +..||+|++...... ..+.+.+|++++..++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567899999999999998653     488999999765433 5678999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++++|.+++..... ..+++..+..++.|++.||.+||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            99999999999854222 22899999999999999999999886   999999999999999999999999999876543


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      ...... ...+++.|+|||.+.+..++.++||||+|++++||++ |++||..
T Consensus       157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~  207 (258)
T smart00219      157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG  207 (258)
T ss_pred             cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence            222111 2236789999999988889999999999999999998 7888753

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.97  E-value=8.7e-30  Score=260.73  Aligned_cols=199  Identities=28%  Similarity=0.459  Sum_probs=170.7

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      +|.+.+.||+|++|.||++... +|+.|++|++....  ....+.+.+|+.++++++||||+++++++.++...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4778899999999999999864 68999999987653  33456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      + +++|.+++....  ..+++.++..++.||+.+|.|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 999999885432  56899999999999999999999886   99999999999999999999999999887644322


Q ss_pred             CcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                       .......++..|+|||.+.+. .++.++||||+|++++||++|++||..
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~  203 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG  203 (286)
T ss_pred             -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC
Confidence             112234578899999988654 468999999999999999999887753

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.97  E-value=3.9e-30  Score=260.98  Aligned_cols=198  Identities=38%  Similarity=0.543  Sum_probs=165.5

Q ss_pred             ceeccCCceeEEEEEecC-------CcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          397 NKLGQGGFGPVYKGTLAD-------GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~~-------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      +.||+|+||.||+|+..+       +..+++|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998642       2578999886543 24456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC-----CeEEeeecC
Q 007006          469 MPNKSLDVHLFDAT----RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-----NPKISDFGL  539 (621)
Q Consensus       469 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-----~vkL~Dfgl  539 (621)
                      +++++|.+++....    ....+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999996432    2234889999999999999999999875   99999999999999877     899999999


Q ss_pred             ceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          540 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       540 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      +.................+..|+|||++.++.++.++||||||+++|||++ |+.||..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~  216 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA  216 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcc
Confidence            876543322222222345678999999999999999999999999999998 9999853

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.97  E-value=9.6e-30  Score=256.19  Aligned_cols=200  Identities=25%  Similarity=0.423  Sum_probs=172.5

Q ss_pred             CCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      +|+..+.||+|+||.+|++.. .+|+.|++|++...  .....+++.+|++++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            478889999999999999985 46899999998653  233446789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++++|.+++... ....+++..+++++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            9999999888542 2335789999999999999999999876   99999999999999999999999999986643321


Q ss_pred             CcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .  .....+++.|+|||++.+...+.++|+||||++++||++|+.||..
T Consensus       157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~  203 (256)
T cd08218         157 L--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA  203 (256)
T ss_pred             h--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC
Confidence            1  1233578889999999988899999999999999999999999854

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.97  E-value=4.4e-30  Score=262.87  Aligned_cols=197  Identities=26%  Similarity=0.441  Sum_probs=165.7

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      +|+..+.||+|+||.||+++.. +|+.+++|+++...  ......+.+|++++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4778899999999999999964 68999999987542  22335678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      ++ ++|..++..  ....+++..+..++.||++||.|||+.+   ++||||||+||+++.++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          81 CD-QDLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            97 477776643  2345899999999999999999999986   99999999999999999999999999886543221


Q ss_pred             CcccccccccCCccChhcccCCC-CChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~-~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      .  .....++..|+|||.+.+.. ++.++||||||+++|||+||+.|+.
T Consensus       155 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~  201 (284)
T cd07839         155 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  201 (284)
T ss_pred             C--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence            1  12235678999999987654 6899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.3e-29  Score=255.72  Aligned_cols=195  Identities=36%  Similarity=0.555  Sum_probs=162.9

Q ss_pred             ceeccCCceeEEEEEec--C--CcEEEEEEeccCCc-ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCC
Q 007006          397 NKLGQGGFGPVYKGTLA--D--GKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN  471 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~--~--g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  471 (621)
                      ++||+|+||.||+|+..  +  +..+|+|.+..... ...+++.+|+.+++.++||||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999743  2  36899999876543 34567899999999999999999999876 4567999999999


Q ss_pred             CChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcc
Q 007006          472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN  551 (621)
Q Consensus       472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~  551 (621)
                      ++|.+++...   ..+++..+..++.|++.+|.|||+.+   ++|+||||+|||++.++.+||+|||++...........
T Consensus        80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            9999999543   36899999999999999999999876   99999999999999999999999999986643322111


Q ss_pred             -cccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          552 -TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       552 -~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                       .....++..|+|||.+.+..++.++||||||+++|||++ |++||...
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~  202 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM  202 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC
Confidence             111223467999999998899999999999999999998 99998643

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.97  E-value=6.7e-30  Score=259.68  Aligned_cols=196  Identities=24%  Similarity=0.365  Sum_probs=157.3

Q ss_pred             eeccCCceeEEEEEecCC---cEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCCC
Q 007006          398 KLGQGGFGPVYKGTLADG---KAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKS  473 (621)
Q Consensus       398 ~LG~G~fG~Vy~~~~~~g---~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~gs  473 (621)
                      .||+|+||.||++...++   ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            699999999999975433   345677665443 2345678999999999999999999999999999999999999999


Q ss_pred             hhhhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCccc
Q 007006          474 LDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT  552 (621)
Q Consensus       474 L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~  552 (621)
                      |.+++..... ...+++..+..++.||++||.|||+.+   ++||||||+|||++.++.+||+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            9999965322 234677788899999999999999875   999999999999999999999999997643222111122


Q ss_pred             ccccccCCccChhcccC-------CCCChhhhHHHHHHHHHHHHc-CCCCCC
Q 007006          553 NIIAGTYGYMAPEYAMG-------GIFSIKSDVFSFGVLLLEIIS-GRKNNG  596 (621)
Q Consensus       553 ~~~~gt~~y~aPE~l~~-------~~~s~~sDVwS~Gvll~ellt-G~~p~~  596 (621)
                      ....++..|+|||++..       ..++.++||||||+++|||++ |..||.
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~  210 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS  210 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Confidence            23456789999998743       235789999999999999997 566774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.97  E-value=1.2e-29  Score=260.06  Aligned_cols=205  Identities=26%  Similarity=0.397  Sum_probs=170.4

Q ss_pred             HHhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhc-ccCCceeEeeEEe-----eCc
Q 007006          388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCL-----EGQ  460 (621)
Q Consensus       388 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~-----~~~  460 (621)
                      ...++|++.+.||+|+||.||++... +++.+++|++..... ....+.+|+.+++++ +||||+++++++.     .++
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   93 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD   93 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence            45688999999999999999999864 588999998865322 235678899999999 6999999999884     345


Q ss_pred             eEEEEEEecCCCChhhhhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecC
Q 007006          461 ELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL  539 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgl  539 (621)
                      ..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+
T Consensus        94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~  170 (286)
T cd06638          94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGV  170 (286)
T ss_pred             eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCc
Confidence            689999999999999887532 23456899999999999999999999875   99999999999999999999999999


Q ss_pred             ceecCCCCCCcccccccccCCccChhcccC-----CCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          540 ARIFGGNQNQANTNIIAGTYGYMAPEYAMG-----GIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       540 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      +........  ......++..|+|||++..     ..++.++|||||||++|||++|+.|+...
T Consensus       171 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~  232 (286)
T cd06638         171 SAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL  232 (286)
T ss_pred             eeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence            886543221  2223468899999998753     44788999999999999999999998543

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1e-29  Score=259.14  Aligned_cols=198  Identities=28%  Similarity=0.531  Sum_probs=171.0

Q ss_pred             CCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC-CcccHHHHHHHHHHHHhcc---cCCceeEeeEEeeCceEEEEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~---h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      .|+..+.||+|+||.||+|.. .+++.+++|.++.. ......++.+|+.++++++   |||++++++++.++...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            477788999999999999995 56899999998754 3445567889999999997   999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++++|.+++..    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999988843    26899999999999999999999886   999999999999999999999999999876543


Q ss_pred             CCCcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ...  .....++..|+|||.+.++ .++.++||||||+++|||++|+.||...
T Consensus       155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~  205 (277)
T cd06917         155 SSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV  205 (277)
T ss_pred             ccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC
Confidence            321  2234578899999988654 4689999999999999999999998643

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.97  E-value=1.1e-29  Score=259.85  Aligned_cols=201  Identities=31%  Similarity=0.500  Sum_probs=170.5

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc-ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      +|+..++||+|++|.||+|+.. +|..||+|+++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788899999999999999975 688999999876533 33466788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++ +|.+++........+++..+.+++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||++.........
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~  156 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT  156 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence            85 78888765444456999999999999999999999886   999999999999999999999999998755432211


Q ss_pred             cccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                        .....++..|++||++.+. .++.++||||||+++|||++|+.||...
T Consensus       157 --~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~  204 (284)
T cd07836         157 --FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT  204 (284)
T ss_pred             --cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence              1123467889999988664 4689999999999999999999998643

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.8e-31  Score=273.76  Aligned_cols=199  Identities=33%  Similarity=0.524  Sum_probs=173.9

Q ss_pred             CCCccceeccCCceeEEEEEecC-CcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecC
Q 007006          392 HFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP  470 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  470 (621)
                      +....++||-|-||.||.|.++. .-.||||.++... -..++|+.|..+|+.++|||+|+|+|+|..+..+|+|.|||.
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~  346 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC  346 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence            44556899999999999999864 6789999997654 346899999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc
Q 007006          471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA  550 (621)
Q Consensus       471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~  550 (621)
                      .|+|.+||++..+ ..++....+.++.||..|++||....   +|||||.++|+|+.++..+|++|||+++++..+....
T Consensus       347 yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA  422 (1157)
T KOG4278|consen  347 YGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA  422 (1157)
T ss_pred             CccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence            9999999987654 34778888999999999999999764   9999999999999999999999999999987665544


Q ss_pred             ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCC
Q 007006          551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNG  596 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~  596 (621)
                      ... ..-...|.|||-+.-..++.|+|||+|||+||||.| |..||-
T Consensus       423 HAG-AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP  468 (1157)
T KOG4278|consen  423 HAG-AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP  468 (1157)
T ss_pred             ccC-ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC
Confidence            322 123568999999999999999999999999999998 777763

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.97  E-value=7e-30  Score=261.69  Aligned_cols=200  Identities=27%  Similarity=0.408  Sum_probs=171.5

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      ++|+..++||+|++|.||++... +++.|++|+++..  .....+.+.+|++++++++|+||+++++++.+++..++++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999865 5889999998754  23445778999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |++++.+..+..   +...+++..+..++.||+.||.|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            999877766553   2345899999999999999999999886   9999999999999999999999999988765433


Q ss_pred             CCcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .. ......++..|+|||++.+. .++.++||||||+++|||++|++||..
T Consensus       155 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~  204 (288)
T cd07833         155 AS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG  204 (288)
T ss_pred             cc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            21 11234567889999999888 789999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.97  E-value=3.7e-30  Score=259.65  Aligned_cols=199  Identities=29%  Similarity=0.416  Sum_probs=174.5

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      +|++.+.||.|+||.||++... ++..+++|.+.+..   ....+.+.+|++++++++||||+++++.+.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788899999999999999965 58999999997543   2346788999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |+++++|..++...   .++++..+..++.||++||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            99999999988542   46899999999999999999999886   9999999999999999999999999988654332


Q ss_pred             CCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                         ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  203 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS  203 (258)
T ss_pred             ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence               1123457788999999988889999999999999999999999987654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.97  E-value=1.2e-29  Score=257.66  Aligned_cols=201  Identities=27%  Similarity=0.465  Sum_probs=169.8

Q ss_pred             CCCccceeccCCceeEEEEEecC--CcEEEEEEeccCC----------cccHHHHHHHHHHHHh-cccCCceeEeeEEee
Q 007006          392 HFSDENKLGQGGFGPVYKGTLAD--GKAIAVKRLSRTS----------GQGLQEFKNEVNLIAK-LQHKNLVRLLGCCLE  458 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~~--g~~vavK~l~~~~----------~~~~~~~~~Ei~~l~~-l~h~nIv~l~g~~~~  458 (621)
                      +|++.+.||+|+||.||++....  ++.+|+|.+....          .....++.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788999999999999999754  7889999875321          2233557788888875 699999999999999


Q ss_pred             CceEEEEEEecCCCChhhhhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeee
Q 007006          459 GQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF  537 (621)
Q Consensus       459 ~~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Df  537 (621)
                      ++..+++|||+++++|.+++... .....+++..+++++.|++.+|.|||+..  +++|+||+|+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999887542 23456899999999999999999999632  4999999999999999999999999


Q ss_pred             cCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          538 GLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       538 gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      |++.......   ......++..|++||.+.+..++.++||||||+++|||++|+.||..
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~  215 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS  215 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc
Confidence            9998754432   22334678899999999988899999999999999999999999854

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.97  E-value=4.3e-30  Score=259.96  Aligned_cols=199  Identities=30%  Similarity=0.446  Sum_probs=173.5

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      ++|+..+.||+|++|.||++... +++.+++|++.... ....+++.+|++++++++||||+++++.+..+...++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            36778899999999999999975 68999999987653 34456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE-DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      +++++|.+++....  ..+++..+..++.|++.+|.|||+ .+   ++|+||||+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            99999999985432  568999999999999999999998 64   9999999999999999999999999987553221


Q ss_pred             CCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ..    ...++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       156 ~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  202 (265)
T cd06605         156 AK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE  202 (265)
T ss_pred             hh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            11    156788999999999889999999999999999999999998654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.97  E-value=1.1e-29  Score=261.20  Aligned_cols=208  Identities=29%  Similarity=0.394  Sum_probs=171.9

Q ss_pred             HHHHHhCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeC---
Q 007006          385 LALEATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG---  459 (621)
Q Consensus       385 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~---  459 (621)
                      .+..++++|.+.+.||+|+||.||++.. .+++.+|+|++.... .....+.+|+.++.++ +|||++++++++...   
T Consensus        16 ~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~   94 (291)
T cd06639          16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL   94 (291)
T ss_pred             cCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence            3344578899999999999999999986 468899999986543 2245678899999999 899999999998754   


Q ss_pred             --ceEEEEEEecCCCChhhhhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEee
Q 007006          460 --QELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISD  536 (621)
Q Consensus       460 --~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~D  536 (621)
                        +..++|+||+++++|.+++... .....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|
T Consensus        95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~d  171 (291)
T cd06639          95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVD  171 (291)
T ss_pred             CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEee
Confidence              3589999999999999988532 23456899999999999999999999875   99999999999999999999999


Q ss_pred             ecCceecCCCCCCcccccccccCCccChhcccCCC-----CChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          537 FGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-----FSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       537 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-----~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ||++.........  .....++..|+|||.+....     ++.++||||||+++|||++|+.||...
T Consensus       172 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~  236 (291)
T cd06639         172 FGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM  236 (291)
T ss_pred             cccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence            9998765432221  12245788999999875433     688999999999999999999998643

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.97  E-value=1.1e-29  Score=256.61  Aligned_cols=195  Identities=32%  Similarity=0.465  Sum_probs=158.6

Q ss_pred             ceeccCCceeEEEEEec----CCcEEEEEEeccC-CcccHHHHHHHHHHHHhcccCCceeEeeEEee-CceEEEEEEecC
Q 007006          397 NKLGQGGFGPVYKGTLA----DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-GQELLLIYEYMP  470 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~-~~~~~lV~e~~~  470 (621)
                      +.||+|+||.||+|...    ++..+|+|++... .....+.+.+|+.+++.++||||+++++++.. ++..++++||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    2457999998643 23445678899999999999999999998764 456789999999


Q ss_pred             CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC-
Q 007006          471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ-  549 (621)
Q Consensus       471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~-  549 (621)
                      +++|.+++...  ...+++..+..++.|+++||.|||+.+   ++||||||+|||+++++.+||+|||+++........ 
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            99999998542  234678888999999999999999875   999999999999999999999999998755332111 


Q ss_pred             -cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcC-CCCCC
Q 007006          550 -ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG-RKNNG  596 (621)
Q Consensus       550 -~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG-~~p~~  596 (621)
                       .......++..|+|||.+.+..++.++||||||+++|||++| .+||.
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~  204 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP  204 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCC
Confidence             111123456789999999888899999999999999999995 55554

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.97  E-value=1.2e-29  Score=261.53  Aligned_cols=198  Identities=29%  Similarity=0.455  Sum_probs=167.7

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcc-----cHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ-----GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      +|...+.||+|++|.||+|... +++.|++|+++.....     ....+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4777889999999999999864 6899999999765322     234577899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      |||+ +++|..++....  ..+++..+..++.||++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 899999885422  36999999999999999999999986   99999999999999999999999999987644


Q ss_pred             CCCCcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .....  ....++..|+|||.+.+ ..++.++||||||+++|||++|.+||..
T Consensus       155 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~  205 (298)
T cd07841         155 PNRKM--THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG  205 (298)
T ss_pred             CCccc--cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccC
Confidence            32211  12245778999998855 4578999999999999999999877653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=1.2e-29  Score=259.30  Aligned_cols=202  Identities=34%  Similarity=0.505  Sum_probs=170.9

Q ss_pred             CCCCccceeccCCceeEEEEEec-----CCcEEEEEEeccCCcc-cHHHHHHHHHHHHhcccCCceeEeeEEee--CceE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-----DGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQEL  462 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-----~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~--~~~~  462 (621)
                      .+|...+.||+|+||.||++++.     ++..+|+|++...... ..+.+.+|+++++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            35777899999999999999853     3688999999865443 46789999999999999999999999887  5578


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      +++|||+++++|.+++...  ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            9999999999999999543  235899999999999999999999886   99999999999999999999999999987


Q ss_pred             cCCCCCCc-ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          543 FGGNQNQA-NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       543 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ........ ......++..|++||.+.+..++.++||||||+++|||++|+.|+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~  214 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS  214 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccc
Confidence            65322211 11122345679999999888899999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.97  E-value=2.3e-29  Score=251.55  Aligned_cols=199  Identities=33%  Similarity=0.548  Sum_probs=175.9

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecC
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP  470 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  470 (621)
                      +|...+.||+|++|.||++... ++..+++|++........+.+.+|++++++++|+|++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4777899999999999999975 688999999987655566789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc
Q 007006          471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA  550 (621)
Q Consensus       471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~  550 (621)
                      +++|.+++....  ..+++..+..++.|++.+|.+||+.+   ++||||+|+||++++++.++|+|||.+........  
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            999999885432  46899999999999999999999875   99999999999999999999999999887644321  


Q ss_pred             ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                       .....++..|++||.+.+...+.++||||||++++||++|+.||...
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  200 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL  200 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence             23346788999999998888999999999999999999999998654

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.97  E-value=1.3e-29  Score=259.26  Aligned_cols=201  Identities=27%  Similarity=0.428  Sum_probs=164.9

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHHH-HHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNL-IAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~-l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      ++|++.+.||+|+||.||+++.. +|+.||+|+++... .....++..|+.. ++.++||||+++++++..++..++++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888999999999999999865 69999999987543 2233455666665 566689999999999999999999999


Q ss_pred             ecCCCChhhhhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          468 YMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       468 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      |++ ++|.+++... .....+++..++.++.||+.||.|||++.  +++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            996 6787777542 23456899999999999999999999862  4999999999999999999999999998865322


Q ss_pred             CCCcccccccccCCccChhcccC----CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMG----GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~----~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .   ......++..|+|||.+.+    ..++.++|+||||+++|||++|+.||..
T Consensus       158 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  209 (283)
T cd06617         158 V---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS  209 (283)
T ss_pred             c---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence            1   1122357888999998854    4468899999999999999999999863

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.97  E-value=1.6e-29  Score=259.18  Aligned_cols=201  Identities=29%  Similarity=0.487  Sum_probs=175.5

Q ss_pred             HhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      .++.|+..+.||+|++|.||++..+ ++..+++|++..... ..+.+.+|+++++.++|+||+++++.+...+..++++|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4567888899999999999999976 688999999976544 56778999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |+++++|.+++....  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            999999999996532  36999999999999999999999875   9999999999999999999999999987554322


Q ss_pred             CCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .  ......++..|++||.+.+..++.++||||||+++|||++|+.||..
T Consensus       171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~  218 (286)
T cd06614         171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR  218 (286)
T ss_pred             h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence            1  11223467889999999888899999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.97  E-value=2.1e-29  Score=257.16  Aligned_cols=197  Identities=29%  Similarity=0.496  Sum_probs=170.8

Q ss_pred             CCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      -|+..+.||+|+||.||+|.. .++..+|+|.+.... ....+.+.+|++++++++||||+++++.+.+++..++|+||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            467788999999999999985 468899999986543 334567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++++|..++.    ...+++..+..++.+++.++.|||+.+   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06641          85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence            9999998884    235899999999999999999999876   99999999999999999999999999876543221 


Q ss_pred             cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                       ......++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  203 (277)
T cd06641         157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE  203 (277)
T ss_pred             -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc
Confidence             12224578889999999888889999999999999999999999863

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.97  E-value=1.9e-29  Score=253.71  Aligned_cols=200  Identities=28%  Similarity=0.436  Sum_probs=171.7

Q ss_pred             CCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      +|+..+.||+|++|.||++.. .+++.+++|.+....  ....+.+.+|+++++.++||||+++++.+..++..++|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            478889999999999999985 468899999987542  33456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC-CeEEeeecCceecCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIFGGNQ  547 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~vkL~Dfgla~~~~~~~  547 (621)
                      +++++|.+++... ....+++..+.+++.+++.+|.|||+++   ++|+||+|+||++++++ .+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            9999999999642 2345899999999999999999999986   99999999999998654 58999999998764332


Q ss_pred             CCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      .   .....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~  204 (256)
T cd08220         157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA  204 (256)
T ss_pred             c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC
Confidence            1   12245788999999998888899999999999999999999998643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.97  E-value=1.8e-29  Score=256.65  Aligned_cols=202  Identities=27%  Similarity=0.459  Sum_probs=165.8

Q ss_pred             CCccceeccCCceeEEEEEec----CCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCc------
Q 007006          393 FSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------  460 (621)
Q Consensus       393 f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~------  460 (621)
                      |.+.+.||+|+||.||+|.+.    +++.||+|++...  .....+++.+|+.++++++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            556789999999999999853    3688999998754  2344567889999999999999999999886542      


Q ss_pred             eEEEEEEecCCCChhhhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeee
Q 007006          461 ELLLIYEYMPNKSLDVHLFDAT---RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF  537 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Df  537 (621)
                      ..++++||+++++|..++....   +...+++....+++.|++.||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            2478899999999988875321   2235889999999999999999999876   999999999999999999999999


Q ss_pred             cCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          538 GLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       538 gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      |+++...............+++.|++||.+....++.++||||||+++|||++ |++||..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~  218 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG  218 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC
Confidence            99886543322222222345678999999998889999999999999999999 8888753

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.97  E-value=2.1e-29  Score=258.51  Aligned_cols=197  Identities=26%  Similarity=0.439  Sum_probs=170.8

Q ss_pred             CCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecC
Q 007006          392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP  470 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  470 (621)
                      .|...++||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++||||+++++++...+..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            345567999999999999985 4688999999876555556678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc
Q 007006          471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA  550 (621)
Q Consensus       471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~  550 (621)
                      +++|.+++..    ..+++..+..++.|++.||+|||+.+   ++||||+|+||+++.++.++|+|||.+........  
T Consensus       100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--  170 (285)
T cd06648         100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--  170 (285)
T ss_pred             CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence            9999998854    35899999999999999999999986   99999999999999999999999998775433221  


Q ss_pred             ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ......++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~  217 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN  217 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC
Confidence            11224578899999999888899999999999999999999999743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.97  E-value=1.8e-29  Score=257.76  Aligned_cols=194  Identities=34%  Similarity=0.486  Sum_probs=165.8

Q ss_pred             eccCCceeEEEEEe-cCCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCCCh
Q 007006          399 LGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL  474 (621)
Q Consensus       399 LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~gsL  474 (621)
                      ||+|+||.||++.. .+|+.+++|.+....   ......+.+|+++++.++||||+++++.+...+..++|+||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999985 468999999986532   23345677899999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCccccc
Q 007006          475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI  554 (621)
Q Consensus       475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~  554 (621)
                      .+++.... ...+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||++.......   ....
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~  153 (277)
T cd05577          81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG  153 (277)
T ss_pred             HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence            99886433 246899999999999999999999986   9999999999999999999999999987653311   1122


Q ss_pred             ccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          555 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       555 ~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      ..++..|+|||.+.+..++.++||||||++++||++|+.||....
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  198 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK  198 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence            356788999999988889999999999999999999999986543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.97  E-value=4.9e-29  Score=250.22  Aligned_cols=202  Identities=30%  Similarity=0.495  Sum_probs=176.2

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc--ccHHHHHHHHHHHHhcccCCceeEeeEEeeC--ceEEEEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLLIY  466 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~~lV~  466 (621)
                      +|...+.||+|++|.||+|... ++..|++|++.....  ...+.+.+|++.+++++||||+++++.+.+.  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677899999999999999976 689999999876542  4567889999999999999999999999988  8899999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++++|.+++....   .+++..+..++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            9999999999985432   7899999999999999999999975   999999999999999999999999999877554


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      ..........++..|+|||.+.+...+.++||||||++++||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  207 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG  207 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            32111233467889999999988889999999999999999999999986543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=9e-31  Score=253.54  Aligned_cols=208  Identities=28%  Similarity=0.424  Sum_probs=171.4

Q ss_pred             HHhCCCCccceeccCCceeEEEEEecC-----CcEEEEEEeccCCc--ccHHHHHHHHHHHHhcccCCceeEeeEEee-C
Q 007006          388 EATNHFSDENKLGQGGFGPVYKGTLAD-----GKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-G  459 (621)
Q Consensus       388 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~-----g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~-~  459 (621)
                      +.-..|+....||+|.+|.||+++-++     ...+|+|+++....  .-.....+|+.+++.++||||+.+..++.+ +
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            334578899999999999999996432     23789999975522  223456899999999999999999999988 6


Q ss_pred             ceEEEEEEecCCCChhhhhhh--ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC----CCeE
Q 007006          460 QELLLIYEYMPNKSLDVHLFD--ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD----MNPK  533 (621)
Q Consensus       460 ~~~~lV~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~----~~vk  533 (621)
                      ...++++||.+. +|..+++.  ..+...++...+..|+.||+.|+.|||+++   |+||||||.|||+..+    |.||
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VK  176 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVK  176 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeE
Confidence            789999999875 55555542  233457999999999999999999999999   9999999999999877    8999


Q ss_pred             EeeecCceecCCCCCCc-ccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          534 ISDFGLARIFGGNQNQA-NTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       534 L~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      |+|+|+++++..+-... .....+-|.+|.|||.+.+. .|+.+.|||+.||++.||+|-++-|.-.+
T Consensus       177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E  244 (438)
T KOG0666|consen  177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE  244 (438)
T ss_pred             eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence            99999999986654332 34556779999999998876 48999999999999999999998886444

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.97  E-value=1.5e-29  Score=259.03  Aligned_cols=199  Identities=27%  Similarity=0.467  Sum_probs=167.8

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      +|+..+.||+|++|.||+++.. +++.|+||++....  ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999864 68999999987542  23345788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +. ++|..++... ....+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            96 6788887543 2356899999999999999999999876   99999999999999999999999999876543221


Q ss_pred             CcccccccccCCccChhcccCCC-CChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~-~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .  .....++..|+|||.+.+.. ++.++||||||+++|||+||+.||..
T Consensus       156 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~  203 (284)
T cd07860         156 T--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG  203 (284)
T ss_pred             c--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            1  12234578899999886644 68899999999999999999999854

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.97  E-value=1.6e-29  Score=258.64  Aligned_cols=207  Identities=27%  Similarity=0.453  Sum_probs=171.3

Q ss_pred             HHHHHHhCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhc-ccCCceeEeeEEee---
Q 007006          384 RLALEATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLE---  458 (621)
Q Consensus       384 ~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~---  458 (621)
                      .......+.|++.+.||+|+||.||++.. .+++.+|+|++.... ....++..|+.++.++ +||||+++++++..   
T Consensus         9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   87 (282)
T cd06636           9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP   87 (282)
T ss_pred             hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence            33444567899999999999999999996 468899999886543 2345678899999999 79999999999863   


Q ss_pred             ---CceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEe
Q 007006          459 ---GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS  535 (621)
Q Consensus       459 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~  535 (621)
                         ....+++|||+++++|.+++... ....+++..+..++.||+.||.|||+.+   ++|+||+|+||++++++.++|+
T Consensus        88 ~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~  163 (282)
T cd06636          88 PGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLV  163 (282)
T ss_pred             cCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEe
Confidence               35789999999999999988542 2345888999999999999999999986   9999999999999999999999


Q ss_pred             eecCceecCCCCCCcccccccccCCccChhccc-----CCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          536 DFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       536 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      |||++........  ......++..|+|||.+.     ...++.++||||||+++|||++|+.||..
T Consensus       164 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~  228 (282)
T cd06636         164 DFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD  228 (282)
T ss_pred             eCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccc
Confidence            9999875532211  122346788999999875     34578899999999999999999999854

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.97  E-value=2e-29  Score=253.80  Aligned_cols=195  Identities=35%  Similarity=0.503  Sum_probs=166.0

Q ss_pred             CCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecC
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP  470 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  470 (621)
                      ++|.+.+.||+|+||.||++.. +++.||+|.++...  ..+.+.+|+.++++++|||++++++++..+ ..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4588889999999999999975 67889999986542  346789999999999999999999998765 4789999999


Q ss_pred             CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc
Q 007006          471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA  550 (621)
Q Consensus       471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~  550 (621)
                      +++|.+++... ....+++..+.+++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......   
T Consensus        82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence            99999998643 2345899999999999999999999875   9999999999999999999999999987643221   


Q ss_pred             ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                        .....+..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  201 (254)
T cd05083         155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM  201 (254)
T ss_pred             --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence              11233567999999988899999999999999999998 99998543

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.97  E-value=2.7e-29  Score=253.45  Aligned_cols=205  Identities=28%  Similarity=0.431  Sum_probs=172.1

Q ss_pred             CCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEee--CceEEEEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLLIY  466 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~--~~~~~lV~  466 (621)
                      +|++.+.||.|+||.||++.. .++..+++|++....  ....+.+.+|++++++++||||+++++++..  +...++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477889999999999999985 468899999987542  3345678899999999999999999998764  34679999


Q ss_pred             EecCCCChhhhhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeccCCCCCEEEcCCCCeEEeeecCceec
Q 007006          467 EYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDS--RLKIIHRDLKASNILLDDDMNPKISDFGLARIF  543 (621)
Q Consensus       467 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~  543 (621)
                      ||+++++|.+++... .....+++..++.++.||+.||.|||..+  ..+++|+||+|+||++++++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998643 22457899999999999999999999332  235999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          544 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       544 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ......  .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus       161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  213 (265)
T cd08217         161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR  213 (265)
T ss_pred             cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence            543321  12245788999999999888999999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-31  Score=276.45  Aligned_cols=200  Identities=28%  Similarity=0.458  Sum_probs=175.0

Q ss_pred             hCCCCccceeccCCceeEEEEEecC-CcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      .+.|.++..||-|+||.||+++.++ +..-|.|++...+.+..+++.-||++|+.++||+||+|++.|..++.+++..||
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            3467788899999999999999764 445578888888888899999999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      |+||-.+.++.+-  ...|++.++.-++.|++.||.|||++.   |||||||+.|||++-+|.++|+|||.+.....  .
T Consensus       111 C~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t  183 (1187)
T KOG0579|consen  111 CGGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--T  183 (1187)
T ss_pred             cCCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--H
Confidence            9999999988653  456999999999999999999999985   99999999999999999999999999765322  2


Q ss_pred             CcccccccccCCccChhccc-----CCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      ......+.||+.|||||+.+     ..+|+.++||||||+.|.||..+.+|..
T Consensus       184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh  236 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH  236 (1187)
T ss_pred             HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc
Confidence            22334578999999999874     4669999999999999999999999954

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.97  E-value=2.9e-29  Score=256.65  Aligned_cols=192  Identities=30%  Similarity=0.393  Sum_probs=158.0

Q ss_pred             eeccCCceeEEEEEec-CCcEEEEEEeccCCc---ccHHHHHHHHHHHHh---cccCCceeEeeEEeeCceEEEEEEecC
Q 007006          398 KLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAK---LQHKNLVRLLGCCLEGQELLLIYEYMP  470 (621)
Q Consensus       398 ~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~---l~h~nIv~l~g~~~~~~~~~lV~e~~~  470 (621)
                      .||+|+||.||++... +++.+|+|.+.+...   .....+.+|..++..   .+||||+.+.+.+..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999864 689999998865421   112334455444443   479999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc
Q 007006          471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA  550 (621)
Q Consensus       471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~  550 (621)
                      +++|..++..   ...+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.++|+|||++.......   
T Consensus        81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---  151 (279)
T cd05633          81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (279)
T ss_pred             CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence            9999988853   345999999999999999999999986   9999999999999999999999999987553321   


Q ss_pred             ccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          551 NTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                       .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  200 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK  200 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence             122367899999998864 557999999999999999999999986443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-30  Score=275.22  Aligned_cols=199  Identities=33%  Similarity=0.473  Sum_probs=170.9

Q ss_pred             CCccceeccCCceeEEEEEecC--C--cEEEEEEeccCCcc-cHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          393 FSDENKLGQGGFGPVYKGTLAD--G--KAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       393 f~~~~~LG~G~fG~Vy~~~~~~--g--~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      ....++||+|.||.|++|.++.  |  ..||||.++..... ...+|++|+.+|.+|+|+|+++|+|+..+ ....+|+|
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            3456789999999999998753  4  36899999876543 67899999999999999999999999988 67889999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      .++.|+|.+-|+. .....+-......++.|||.||.||.+++   +|||||..+|+||-....|||+|||+.+-+..+.
T Consensus       191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            9999999999976 44556888889999999999999999885   9999999999999999999999999999876544


Q ss_pred             CCcc-cccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCC
Q 007006          548 NQAN-TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNG  596 (621)
Q Consensus       548 ~~~~-~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~  596 (621)
                      .... .....-.+.|+|||.+....++.++|||+|||++|||+| |..||-
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~  317 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWV  317 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCC
Confidence            3322 122234668999999999999999999999999999999 688884

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=5.5e-29  Score=255.57  Aligned_cols=201  Identities=30%  Similarity=0.424  Sum_probs=171.4

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc-ccHHHHHHHHHHHHhcccCCceeEeeEEeeC--ceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~~lV~  466 (621)
                      ++|+..+.||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++++.+.  +.+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46788899999999999999974 588999999875433 3456789999999999999999999998654  4689999


Q ss_pred             EecCCCChhhhhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          467 EYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       467 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      ||+++++|.+++... .....+++..+..++.||+.||.|||+.+   ++|+||+|+||++++++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999999887532 23456899999999999999999999986   99999999999999999999999999875432


Q ss_pred             CCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ...    ....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (287)
T cd06621         158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE  206 (287)
T ss_pred             ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            211    1235678899999999889999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.96  E-value=6e-29  Score=255.51  Aligned_cols=199  Identities=29%  Similarity=0.417  Sum_probs=168.6

Q ss_pred             CCCccceeccCCceeEEEEEe----cCCcEEEEEEeccCC----cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceE
Q 007006          392 HFSDENKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL  462 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~  462 (621)
                      +|++.+.||+|+||.||++..    .+|..||+|++....    ....+.+.+|+.++.++ +|+||+++.+.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999985    368999999987532    23346678899999999 699999999999999899


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      ++|+||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++||||+|+|||+++++.+||+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            999999999999998853   345889999999999999999999876   99999999999999999999999999986


Q ss_pred             cCCCCCCcccccccccCCccChhcccCC--CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          543 FGGNQNQANTNIIAGTYGYMAPEYAMGG--IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       543 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ....... ......++..|+|||.+...  .++.++||||||+++|||++|+.||..
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~  210 (290)
T cd05613         155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV  210 (290)
T ss_pred             ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence            5432221 12234578899999998653  467899999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.96  E-value=2.7e-29  Score=253.96  Aligned_cols=192  Identities=29%  Similarity=0.412  Sum_probs=167.5

Q ss_pred             eccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCCCh
Q 007006          399 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL  474 (621)
Q Consensus       399 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~gsL  474 (621)
                      ||+|++|.||+++.. +++.+++|++.+..   ....+.+.+|+.+++.++||||+++++.+.++...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999965 58999999987543   23446789999999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCccccc
Q 007006          475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI  554 (621)
Q Consensus       475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~  554 (621)
                      .+++..   ...+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......   ....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~  151 (262)
T cd05572          81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT  151 (262)
T ss_pred             HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence            999854   235899999999999999999999976   9999999999999999999999999998664332   1223


Q ss_pred             ccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          555 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       555 ~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      ..++..|++||.+.+..++.++|+||||+++|||++|+.||....
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  196 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD  196 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence            467889999999988889999999999999999999999987554

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.96  E-value=2.9e-29  Score=258.22  Aligned_cols=199  Identities=27%  Similarity=0.436  Sum_probs=167.9

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeC--ceEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLLI  465 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~~lV  465 (621)
                      ++|+..+.||+|+||.||+|... +++.+++|.++...  ......+.+|++++.+++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888999999999999999965 58899999987543  22234567899999999999999999999877  789999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      +||++ ++|.+++...  ...+++..+..++.||+.||+|||+.+   ++|+||||+||+++.++.+||+|||++.....
T Consensus        85 ~e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            99997 4888877542  236899999999999999999999986   99999999999999999999999999987654


Q ss_pred             CCCCcccccccccCCccChhcccCCC-CChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ....  .....+++.|+|||.+.+.. ++.++|+||||+++|||++|++||..
T Consensus       159 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~  209 (293)
T cd07843         159 PLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG  209 (293)
T ss_pred             Cccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCC
Confidence            3211  12234678899999886644 68999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.96  E-value=4.7e-29  Score=256.73  Aligned_cols=201  Identities=27%  Similarity=0.391  Sum_probs=166.1

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcc-cCCceeEeeEEeeCce-----
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQE-----  461 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~-----  461 (621)
                      ++|++.+.||+|+||.||++... +++.||+|+++...  ......+.+|+.+++.++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888999999999999999964 68999999886543  223467888999999995 6999999999987665     


Q ss_pred             EEEEEEecCCCChhhhhhhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC-CCCeEEeeec
Q 007006          462 LLLIYEYMPNKSLDVHLFDATR--SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFG  538 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~vkL~Dfg  538 (621)
                      .++||||+++ +|..++.....  ...+++..++.++.||+.||.|||+.+   ++||||+|+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999985 78887754322  346899999999999999999999886   999999999999998 8899999999


Q ss_pred             CceecCCCCCCcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          539 LARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       539 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ++..+......  .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus       157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~  214 (295)
T cd07837         157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG  214 (295)
T ss_pred             cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Confidence            98865332211  112245788999998865 4579999999999999999999999864

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.96  E-value=2.1e-29  Score=261.03  Aligned_cols=204  Identities=25%  Similarity=0.435  Sum_probs=166.2

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCc------
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------  460 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~------  460 (621)
                      -++|++.++||+|+||.||++... +++.||+|++....  ......+.+|++++++++||||+++++++...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            357999999999999999999864 68999999986542  222345678999999999999999999987654      


Q ss_pred             --eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeec
Q 007006          461 --ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG  538 (621)
Q Consensus       461 --~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfg  538 (621)
                        ..++||||+.+ +|..++..  ....+++.++..++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence              45999999974 77776643  2346899999999999999999999986   9999999999999999999999999


Q ss_pred             CceecCCCCCC--cccccccccCCccChhcccCCC-CChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          539 LARIFGGNQNQ--ANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       539 la~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~-~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      ++..+......  .......++..|+|||.+.+.. ++.++||||||+++|||++|++||....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~  228 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT  228 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            99866432221  1112235678899999886654 6889999999999999999999986543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.96  E-value=8.2e-30  Score=257.44  Aligned_cols=190  Identities=26%  Similarity=0.427  Sum_probs=159.1

Q ss_pred             ceeccCCceeEEEEEecC--------CcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          397 NKLGQGGFGPVYKGTLAD--------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      +.||+|+||.||+|....        ...+++|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999998532        234888888765555567789999999999999999999999998899999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCC--------eEEeeecCc
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN--------PKISDFGLA  540 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--------vkL~Dfgla  540 (621)
                      +++|+|..++...  ...+++..+++++.||+.||.|||+.+   |+||||||+||+++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            9999999998543  236899999999999999999999886   999999999999987765        699999987


Q ss_pred             eecCCCCCCcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCC-CCCCC
Q 007006          541 RIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGR-KNNGF  597 (621)
Q Consensus       541 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~-~p~~~  597 (621)
                      .....      .....++..|+|||++.+. .++.++||||||+++|||++|. .|+..
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~  208 (258)
T cd05078         156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA  208 (258)
T ss_pred             cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh
Confidence            65432      1224567889999999764 5799999999999999999995 55543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.96  E-value=3e-29  Score=258.36  Aligned_cols=193  Identities=27%  Similarity=0.441  Sum_probs=168.3

Q ss_pred             cceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCCCh
Q 007006          396 ENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL  474 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~gsL  474 (621)
                      ..+||+|+||.||++.. .+++.||+|++..........+.+|+.+++.++|+||+++++.+...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            46899999999999986 46899999998765555566789999999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCccccc
Q 007006          475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI  554 (621)
Q Consensus       475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~  554 (621)
                      .+++..    ..+++..+..++.|++.+|+|||+.+   ++||||+|+||+++.++.++|+|||++........  ....
T Consensus       105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~  175 (292)
T cd06657         105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS  175 (292)
T ss_pred             HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence            987732    35899999999999999999999986   99999999999999999999999999876543221  1223


Q ss_pred             ccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          555 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       555 ~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ..++..|+|||.+.+..++.++|+||||+++|||++|+.||..
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~  218 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN  218 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            4578899999999888889999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=3.1e-29  Score=254.64  Aligned_cols=203  Identities=29%  Similarity=0.470  Sum_probs=171.1

Q ss_pred             HhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCc------
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ------  460 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~------  460 (621)
                      .+++|++.+.||+|++|.||++... +++.+++|++..... ..+.+.+|+++++++ +|+||+++++++.+..      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4578999999999999999999974 578999999876543 346789999999999 7999999999997644      


Q ss_pred             eEEEEEEecCCCChhhhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecC
Q 007006          461 ELLLIYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL  539 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgl  539 (621)
                      ..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence            4899999999999999885422 2456899999999999999999999886   99999999999999999999999999


Q ss_pred             ceecCCCCCCcccccccccCCccChhcccC-----CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          540 ARIFGGNQNQANTNIIAGTYGYMAPEYAMG-----GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       540 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      +........  ......++..|+|||.+..     ..++.++||||||++++||++|+.||..
T Consensus       160 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  220 (275)
T cd06608         160 SAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD  220 (275)
T ss_pred             ceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence            876543221  1223457889999998753     3467899999999999999999999863

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.96  E-value=3.7e-29  Score=259.45  Aligned_cols=195  Identities=31%  Similarity=0.487  Sum_probs=165.8

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      +.|...+.||+|+||.||+++.. +++.|++|++....   ....+++.+|+++++.++||||+++++++.+.+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            56888899999999999999864 68999999986443   233457889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||++ |++.+++..  ....+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||++......
T Consensus        95 e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          95 EYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            9997 566666532  2345899999999999999999999886   999999999999999999999999998764322


Q ss_pred             CCCcccccccccCCccChhccc---CCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                            ....++..|+|||.+.   ...++.++||||||+++|||++|++||..
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~  216 (307)
T cd06607         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  216 (307)
T ss_pred             ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence                  1235678899999874   45688999999999999999999999753

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.96  E-value=5.5e-29  Score=254.48  Aligned_cols=191  Identities=30%  Similarity=0.404  Sum_probs=158.1

Q ss_pred             eeccCCceeEEEEEe-cCCcEEEEEEeccCCc---ccHHHHHHHHHH---HHhcccCCceeEeeEEeeCceEEEEEEecC
Q 007006          398 KLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG---QGLQEFKNEVNL---IAKLQHKNLVRLLGCCLEGQELLLIYEYMP  470 (621)
Q Consensus       398 ~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~Ei~~---l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  470 (621)
                      .||+|+||.||++.. .+++.||+|.+.+...   .....+..|..+   +....||||+++++.+.+.+..++|+||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999985 4588999999875421   212234445443   344579999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc
Q 007006          471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA  550 (621)
Q Consensus       471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~  550 (621)
                      +++|..++..   ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++.......   
T Consensus        81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---  151 (278)
T cd05606          81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (278)
T ss_pred             CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence            9999988843   346999999999999999999999976   9999999999999999999999999987553221   


Q ss_pred             ccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          551 NTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                       .....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||...
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~  199 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence             1234688999999998754 5899999999999999999999998654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.96  E-value=6.6e-29  Score=255.70  Aligned_cols=200  Identities=29%  Similarity=0.473  Sum_probs=165.4

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      ++|++.+.||+|.+|.||+|... +++.|++|++....  ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888999999999999999865 68999999986543  2334668899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC-CCCeEEeeecCceecCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFGGN  546 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~vkL~Dfgla~~~~~~  546 (621)
                      |++ ++|..++... ....+++..+..++.||+.||+|||+.+   ++|+||+|+||+++. ++.+||+|||++......
T Consensus        82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            996 5777766432 2334688889999999999999999875   999999999999985 567999999999765332


Q ss_pred             CCCcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ...  .....+++.|+|||++.+. .++.++||||||+++|||+||++||..
T Consensus       157 ~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~  206 (294)
T PLN00009        157 VRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG  206 (294)
T ss_pred             ccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            111  1223467899999988664 578999999999999999999999864

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.96  E-value=2.8e-29  Score=253.30  Aligned_cols=194  Identities=28%  Similarity=0.436  Sum_probs=167.2

Q ss_pred             eccCCceeEEEEEec-CCcEEEEEEeccCCc---ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCCCh
Q 007006          399 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL  474 (621)
Q Consensus       399 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~gsL  474 (621)
                      ||+|+||.||+++.. +|+.+++|.+.....   ...+.+.+|++++++++||||+++++.+..+...++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999976 499999999875533   4456789999999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC------
Q 007006          475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN------  548 (621)
Q Consensus       475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~------  548 (621)
                      .+++...   ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++........      
T Consensus        81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            9988542   36899999999999999999999886   99999999999999999999999999876433211      


Q ss_pred             CcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ........++..|++||.......+.++||||||+++|||++|+.||...
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~  204 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE  204 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            11223345778899999998888999999999999999999999998643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.96  E-value=4.3e-29  Score=255.44  Aligned_cols=198  Identities=30%  Similarity=0.481  Sum_probs=166.6

Q ss_pred             CCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       393 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      |++.+.||+|++|.||++... +|..|++|++....  ......+.+|++++++++|||++++++++.+.+..++++||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567889999999999999864 79999999987543  233467889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      + ++|.+++.... ...+++..+..++.|+++||.|||+.+   ++||||+|+||+++.++.++|+|||++.........
T Consensus        81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            5 68888885422 246899999999999999999999875   999999999999999999999999998765332211


Q ss_pred             cccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                        .....++..|+|||++.+. .++.++||||||+++|||++|++||..
T Consensus       156 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  202 (283)
T cd07835         156 --YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPG  202 (283)
T ss_pred             --cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence              1122457889999987664 578999999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.96  E-value=4.5e-29  Score=264.15  Aligned_cols=198  Identities=31%  Similarity=0.404  Sum_probs=167.4

Q ss_pred             HhCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeC------
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------  459 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~------  459 (621)
                      ..++|+..+.||+|+||.||++.. .+++.||+|++.+.  .......+.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            357899999999999999999985 46899999998653  233445678899999999999999999988644      


Q ss_pred             ceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecC
Q 007006          460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL  539 (621)
Q Consensus       460 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgl  539 (621)
                      ...++|+||+. ++|...+..     .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence            35799999996 477776632     2889999999999999999999986   99999999999999999999999999


Q ss_pred             ceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          540 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       540 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      +........   .....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~  220 (353)
T cd07850         165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT  220 (353)
T ss_pred             ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence            987543221   22235688999999999999999999999999999999999998643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.96  E-value=7.5e-30  Score=266.12  Aligned_cols=203  Identities=28%  Similarity=0.446  Sum_probs=172.7

Q ss_pred             CCCCccceeccCCceeEEEEEec---CC--cEEEEEEeccC-CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA---DG--KAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~---~g--~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      +.....++||+|-||.||+|...   .|  -.||||.-+.. ..+..+.|+.|..+|++++||||++++|+|.+. ..|+
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi  467 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI  467 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence            34556688999999999999843   23  35889988763 456688999999999999999999999999875 6899


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      |||.++-|.|..||...  ...++......++.||+.+|.|||+.   +++||||..+|||+...--+||+|||+++.+.
T Consensus       468 vmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLE  542 (974)
T ss_pred             EEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhcc
Confidence            99999999999999643  34588899999999999999999987   49999999999999999999999999999887


Q ss_pred             CCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCCcC
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFS  600 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~~~  600 (621)
                      ++...... ...-+..|||||.+.-..++.++|||-|||.+||++. |..||+--..
T Consensus       543 d~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN  598 (974)
T KOG4257|consen  543 DDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN  598 (974)
T ss_pred             ccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc
Confidence            65544333 2334678999999999999999999999999999876 9999965443

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.96  E-value=3.4e-30  Score=263.99  Aligned_cols=193  Identities=28%  Similarity=0.470  Sum_probs=170.6

Q ss_pred             cceeccCCceeEEEEEe-cCCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCC
Q 007006          396 ENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK  472 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  472 (621)
                      .+.||.|-||+||-|++ ++|+.||||++++.  ...+...+++|+.+|+++.||.||.+.-.|+..+..++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            57899999999999986 57999999999864  4555678999999999999999999999999999999999999877


Q ss_pred             ChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC---CCeEEeeecCceecCCCCCC
Q 007006          473 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD---MNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       473 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~vkL~Dfgla~~~~~~~~~  549 (621)
                      -|+-+|..  ....+++..-.-++.||+.||.|||.++   |+|.||||+|||+.+.   .++||+|||.++++++.+. 
T Consensus       649 MLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-  722 (888)
T KOG4236|consen  649 MLEMILSS--EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-  722 (888)
T ss_pred             HHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence            77766643  3456899888889999999999999885   9999999999999754   3699999999999876543 


Q ss_pred             cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                        .+..+||+.|+|||+++.+.|...-|+||.||++|--++|..||.
T Consensus       723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN  767 (888)
T KOG4236|consen  723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN  767 (888)
T ss_pred             --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC
Confidence              345689999999999999999999999999999999999999986

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.96  E-value=1.2e-28  Score=250.55  Aligned_cols=192  Identities=24%  Similarity=0.321  Sum_probs=160.5

Q ss_pred             hCCCCcccee--ccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEE
Q 007006          390 TNHFSDENKL--GQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       390 ~~~f~~~~~L--G~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      .++|++.+.+  |+|+||.||++.. .++..+++|.+.......     .|+.....+ +||||+++++.+..++..++|
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv   87 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLI   87 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence            3566666666  9999999999985 468889999986542211     123222223 799999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC-CeEEeeecCceecC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIFG  544 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~vkL~Dfgla~~~~  544 (621)
                      |||+++++|.+++...   ..+++..+..++.|+++||.|||+.+   ++||||||+||+++.++ .++|+|||++....
T Consensus        88 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~  161 (267)
T PHA03390         88 MDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG  161 (267)
T ss_pred             EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence            9999999999998542   37999999999999999999999986   99999999999999988 99999999987654


Q ss_pred             CCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ...      ...++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       162 ~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  209 (267)
T PHA03390        162 TPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED  209 (267)
T ss_pred             CCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            321      235788999999999989999999999999999999999999743

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.96  E-value=6.5e-29  Score=254.07  Aligned_cols=200  Identities=28%  Similarity=0.463  Sum_probs=168.5

Q ss_pred             CCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeC--ceEEEEEE
Q 007006          393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLLIYE  467 (621)
Q Consensus       393 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~~lV~e  467 (621)
                      |.+.+.||+|++|.||+++.. +++.+++|++....  ......+.+|+++++.++|||++++++++.+.  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567789999999999999865 58899999998663  34456788999999999999999999999988  78999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |+++ +|..++...  ...+++..++.++.||++||.|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9975 888777432  246899999999999999999999886   9999999999999999999999999998765433


Q ss_pred             CCcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          548 NQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      .. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus       155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~  206 (287)
T cd07840         155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST  206 (287)
T ss_pred             cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            21 1122345778999998765 457999999999999999999999986433

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=3.8e-30  Score=236.26  Aligned_cols=207  Identities=27%  Similarity=0.395  Sum_probs=170.0

Q ss_pred             HhCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC-CcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEE
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      ..++......||+|++|.|-+-++ .+|...|+|++... ..+..++.+.|+++..+. ..|.+|.++|.+......++.
T Consensus        44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc  123 (282)
T KOG0984|consen   44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC  123 (282)
T ss_pred             chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence            344555667899999999988885 57999999999755 334456678888876666 789999999999999999999


Q ss_pred             EEecCCCChhhhhhh-ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          466 YEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      ||.|. .||+.|-.+ ..+...+++..+-+|+..+.+||.|||++  +.++|||+||+||||+.+|++|++|||++..+.
T Consensus       124 ME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~  200 (282)
T KOG0984|consen  124 MELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLV  200 (282)
T ss_pred             HHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence            99884 778776654 23456789999999999999999999996  579999999999999999999999999998764


Q ss_pred             CCCCCcccccccccCCccChhcccC----CCCChhhhHHHHHHHHHHHHcCCCCCCCCcCC
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMG----GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE  601 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~----~~~s~~sDVwS~Gvll~elltG~~p~~~~~~~  601 (621)
                      +...   .....|...|||||.+..    ..|+.|+||||||+.+.||.+++.||..+..+
T Consensus       201 dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp  258 (282)
T KOG0984|consen  201 DSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP  258 (282)
T ss_pred             hhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence            3221   122356778999998743    46899999999999999999999999876554

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.96  E-value=6.4e-29  Score=257.85  Aligned_cols=200  Identities=30%  Similarity=0.474  Sum_probs=166.3

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc--ccHHHHHHHHHHHHhcccCCceeEeeEEeeC--ceEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLL  464 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~~l  464 (621)
                      .++|++.+.||+|+||.||++... +|+.||+|+++....  .....+.+|+.++++++|+||+++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467899999999999999999964 689999999874432  2233467899999999999999999998765  46899


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      ||||+.+ +|.+++...  ...+++.++..++.||+.||.|||+.+   ++||||||+||++++++.+||+|||++....
T Consensus        86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999974 787777532  256899999999999999999999986   9999999999999999999999999998765


Q ss_pred             CCCCCcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .....  .....++..|+|||.+.+ ..++.++||||||+++|||++|++||..
T Consensus       160 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~  211 (309)
T cd07845         160 LPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPG  211 (309)
T ss_pred             CccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            43211  112234778999998865 4579999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=3.3e-29  Score=276.62  Aligned_cols=201  Identities=23%  Similarity=0.369  Sum_probs=157.8

Q ss_pred             HhCCCCccceeccCCceeEEEEEecC--CcEEEEEE--------------ecc---CCcccHHHHHHHHHHHHhcccCCc
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLAD--GKAIAVKR--------------LSR---TSGQGLQEFKNEVNLIAKLQHKNL  449 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~~--g~~vavK~--------------l~~---~~~~~~~~~~~Ei~~l~~l~h~nI  449 (621)
                      ..++|.+.++||+|+||.||++.++.  +...+.|.              +.+   ........+.+|+++|++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            34689999999999999999987532  22222221              111   112234568899999999999999


Q ss_pred             eeEeeEEeeCceEEEEEEecCCCChhhhhhhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc
Q 007006          450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATR--SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD  527 (621)
Q Consensus       450 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~  527 (621)
                      +++++++.+.+..++|+|++. ++|..++.....  ........+..++.||+.||.|||+.+   |+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence            999999999999999999985 566666643211  122345677889999999999999986   99999999999999


Q ss_pred             CCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCC
Q 007006          528 DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKN  594 (621)
Q Consensus       528 ~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p  594 (621)
                      .++.+||+|||++..+...... ......||..|+|||++.+..++.++|||||||++|||++|+.+
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~  367 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC  367 (501)
T ss_pred             CCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            9999999999999876543221 22235689999999999999999999999999999999998754

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1e-28  Score=247.70  Aligned_cols=198  Identities=30%  Similarity=0.473  Sum_probs=173.5

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc--ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      +|++.+.||+|++|.||+++.. +++.+++|.+.....  ...+.+.+|++++++++|||++++++++.++...++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999864 688999999976643  4557789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++++|.+++...   ..+++..+..++.|++.+|.|||+.+   ++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            9999999988532   56899999999999999999999886   99999999999999999999999999987654322


Q ss_pred             CcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .  .....++..|+|||.+.+...+.++|||++|+++|||++|+.||..
T Consensus       155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~  201 (254)
T cd06627         155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD  201 (254)
T ss_pred             c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence            1  2234578899999999888889999999999999999999999853

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.96  E-value=5.1e-29  Score=250.76  Aligned_cols=200  Identities=27%  Similarity=0.438  Sum_probs=171.0

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      +|...+.||+|+||.||++... +|..+|+|.+....  ....+.+.+|+++++.++|+||+++++.+.+....++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778899999999999999965 58899999986542  23446788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCC-eEEeeecCceecCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN-PKISDFGLARIFGGNQ  547 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-vkL~Dfgla~~~~~~~  547 (621)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++. +||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            9999999988542 2335799999999999999999999886   999999999999998864 6999999988664322


Q ss_pred             CCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .  ......+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  204 (257)
T cd08225         157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG  204 (257)
T ss_pred             c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            1  11223578899999999888899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.96  E-value=4.3e-29  Score=262.42  Aligned_cols=200  Identities=27%  Similarity=0.435  Sum_probs=165.7

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeC-----ceE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QEL  462 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~-----~~~  462 (621)
                      +++|.+.++||+|+||.||+|+. .+|+.||+|++.... ......+.+|+.++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46899999999999999999985 468999999987432 33446678899999999999999999987654     357


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      ++++||+++ +|..++.    ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            999999974 6666653    346899999999999999999999986   99999999999999999999999999886


Q ss_pred             cCCCCCCc-ccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          543 FGGNQNQA-NTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       543 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~  212 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG  212 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            54322211 1123467889999998754 5689999999999999999999999853

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.96  E-value=1.3e-28  Score=247.25  Aligned_cols=202  Identities=24%  Similarity=0.418  Sum_probs=176.1

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc--ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      +|.+.+.||+|++|.||++... +++.+++|++.....  ...+.+.+|+++++.++|||++++++.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778899999999999999964 689999999976533  4566789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          469 MPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       469 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      +++++|.+++.... ....+++..+..++.+++.||.|||+.+   ++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999886532 2367999999999999999999999986   9999999999999999999999999998765433


Q ss_pred             CCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                        .......+++.|+|||.+.+..++.++||||+|+++++|++|+.||...
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~  206 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE  206 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence              1222346788999999998888999999999999999999999998654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=8.5e-29  Score=250.01  Aligned_cols=189  Identities=26%  Similarity=0.364  Sum_probs=159.3

Q ss_pred             ceeccCCceeEEEEEe-cCCcEEEEEEeccCCc---ccHHHHHHHHHHH-HhcccCCceeEeeEEeeCceEEEEEEecCC
Q 007006          397 NKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG---QGLQEFKNEVNLI-AKLQHKNLVRLLGCCLEGQELLLIYEYMPN  471 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~Ei~~l-~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  471 (621)
                      +.||+|+||.||++.. .+++.||+|.+.+...   .....+..|..++ ...+|+|++++++++.+++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5799999999999986 4689999999875432   2223344555444 445899999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcc
Q 007006          472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN  551 (621)
Q Consensus       472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~  551 (621)
                      ++|..++..   ...+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||++.....      
T Consensus        82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------  149 (260)
T cd05611          82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------  149 (260)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence            999998853   245899999999999999999999986   99999999999999999999999999875432      


Q ss_pred             cccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       552 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  195 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA  195 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCC
Confidence            1223577889999999888889999999999999999999999853

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.96  E-value=6.7e-29  Score=249.60  Aligned_cols=201  Identities=31%  Similarity=0.463  Sum_probs=173.7

Q ss_pred             CCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      +|++.++||+|++|.||+++. .+++.+++|++....  .....++.+|+++++.++|+||+++++++.+....++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            477889999999999999985 468899999987542  33356778999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          469 MPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       469 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      +++++|..++.... ....+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999999886522 2356899999999999999999999886   999999999999999999999999999876543 


Q ss_pred             CCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                         ......++..|++||.+.+..++.++|+||||+++|||++|+.||...+
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~  205 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS  205 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence               1122356889999999998889999999999999999999999986543

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.96  E-value=6e-29  Score=261.41  Aligned_cols=201  Identities=28%  Similarity=0.461  Sum_probs=167.0

Q ss_pred             HhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC--CcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeC--ceE
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG--QEL  462 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~--~~~  462 (621)
                      ..++|.+.+.||+|+||.||+|... ++..+++|++...  .......+..|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3467889999999999999999965 5889999988643  233445677899999999 999999999998654  368


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      ++|+||++ ++|..++..    ..+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999997 588877743    26889999999999999999999876   99999999999999999999999999986


Q ss_pred             cCCCCCC---cccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          543 FGGNQNQ---ANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       543 ~~~~~~~---~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .......   .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~  215 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG  215 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence            6433221   12223467889999998755 4578999999999999999999999853

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.96  E-value=1.2e-28  Score=254.17  Aligned_cols=202  Identities=19%  Similarity=0.255  Sum_probs=152.0

Q ss_pred             hCCCCccceeccCCceeEEEEEecC----CcEEEEEEeccCCcccH-----------HHHHHHHHHHHhcccCCceeEee
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTSGQGL-----------QEFKNEVNLIAKLQHKNLVRLLG  454 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~~~~~-----------~~~~~Ei~~l~~l~h~nIv~l~g  454 (621)
                      .++|.+.++||+|+||.||+|...+    +..+++|+.........           .....+...+..++|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3679999999999999999998654    34566665433221110           11122334455668999999999


Q ss_pred             EEeeCc----eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC
Q 007006          455 CCLEGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM  530 (621)
Q Consensus       455 ~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~  530 (621)
                      ++....    ..++++|++. .++.+.+..   ....++..+..++.|++.||.|||+.+   |+||||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence            776543    3366777664 345554422   223578888999999999999999875   99999999999999999


Q ss_pred             CeEEeeecCceecCCCCCC-----cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          531 NPKISDFGLARIFGGNQNQ-----ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       531 ~vkL~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      .++|+|||+++.+..+...     .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~  236 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF  236 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence            9999999999876432211     1122346899999999999999999999999999999999999999754

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.96  E-value=1.5e-28  Score=256.23  Aligned_cols=194  Identities=31%  Similarity=0.498  Sum_probs=164.5

Q ss_pred             CCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      .|...+.||+|+||.||+++. .++..+|+|++....   ......+.+|++++++++|||++++++++.++...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            477788999999999999985 468899999987542   2334578899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |+++ +|.+.+..  ....+++.++..++.+++.||.|||+.+   ++||||+|+||+++.++.++|+|||++...... 
T Consensus       106 ~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-  178 (317)
T cd06635         106 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-  178 (317)
T ss_pred             CCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence            9975 67666643  2345899999999999999999999886   999999999999999999999999998754321 


Q ss_pred             CCcccccccccCCccChhccc---CCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                           ....++..|+|||++.   .+.++.++||||||+++|||++|+.||..
T Consensus       179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~  226 (317)
T cd06635         179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  226 (317)
T ss_pred             -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence                 2235778899999873   45689999999999999999999999753

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.1e-30  Score=255.55  Aligned_cols=203  Identities=27%  Similarity=0.359  Sum_probs=171.8

Q ss_pred             HhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEE
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELL  463 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~  463 (621)
                      ...+|..+.+||+|+||.|.++..+ +.+.+|||++++.-   ....+--+.|-++|+.. +-|.++++..+++.-+.++
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            3457888999999999999999854 46789999998652   22233345677777776 5688999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceec
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF  543 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~  543 (621)
                      +||||+.||+|--++.+   -..+.+..+.-++..|+-||-+||++|   |+.||||.+|||+|.+|++||+|||+++.-
T Consensus       427 FVMEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             eEEEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence            99999999999777744   344778888889999999999999987   999999999999999999999999999853


Q ss_pred             CCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          544 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       544 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      --  ....++..+||+.|+|||++.-.+|+..+|+|||||+||||+.|++||+..+
T Consensus       501 i~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD  554 (683)
T KOG0696|consen  501 IF--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED  554 (683)
T ss_pred             cc--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC
Confidence            21  2334567899999999999999999999999999999999999999987433

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.96  E-value=5.4e-29  Score=253.75  Aligned_cols=202  Identities=28%  Similarity=0.433  Sum_probs=174.2

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcc-cCCceeEeeEEeeCceEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV  465 (621)
                      ++|...+.||+|++|.||++... +++.|++|++....   ....+.+.+|++++.+++ ||||+++++++.+++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888999999999999999865 69999999987532   233467889999999998 99999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      |||+++++|.+++..   ...+++..+..++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            999999999998854   336999999999999999999999886   99999999999999999999999999886644


Q ss_pred             CCCC------------------cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          546 NQNQ------------------ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       546 ~~~~------------------~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ....                  .......++..|+|||.......+.++||||||++++|+++|+.||...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  225 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS  225 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence            3221                  1122345788999999998888999999999999999999999998744

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.1e-29  Score=265.05  Aligned_cols=208  Identities=25%  Similarity=0.363  Sum_probs=175.8

Q ss_pred             CCCCccceeccCCceeEEEEE-ecCCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      .-|..++.||-|+||+|.++. .++...+|+|.+++.+   ..+....+.|-++|+.-+++.||+|+-.|++++.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            468888999999999999997 4557789999998764   344556788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC--
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG--  544 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~--  544 (621)
                      ||++||++-.+|.+   -..+.+..+..++..+..|+++.|..|   +|||||||+|||||.+|++||.||||+.-+.  
T Consensus       709 dYIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             eccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence            99999999888843   345888888889999999999999876   9999999999999999999999999986431  


Q ss_pred             -------CCC------CC-------------------------cccccccccCCccChhcccCCCCChhhhHHHHHHHHH
Q 007006          545 -------GNQ------NQ-------------------------ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLL  586 (621)
Q Consensus       545 -------~~~------~~-------------------------~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~  586 (621)
                             ..+      ..                         ......+||+.|+|||++....++...|+||.|||||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence                   000      00                         0011246999999999999999999999999999999


Q ss_pred             HHHcCCCCCCCCcCCCCC
Q 007006          587 EIISGRKNNGFYFSEHGQ  604 (621)
Q Consensus       587 elltG~~p~~~~~~~~~~  604 (621)
                      ||+.|++||-...+.+.+
T Consensus       863 em~~g~~pf~~~tp~~tq  880 (1034)
T KOG0608|consen  863 EMLVGQPPFLADTPGETQ  880 (1034)
T ss_pred             HHhhCCCCccCCCCCcce
Confidence            999999999776665443

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.96  E-value=1.3e-28  Score=254.37  Aligned_cols=202  Identities=27%  Similarity=0.453  Sum_probs=167.0

Q ss_pred             HhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCc-----
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-----  460 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~-----  460 (621)
                      ..++|++.+.||+|+||.||+|..+ +++.|++|+++...  ......+.+|++++++++||||+++++++.+..     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            4568999999999999999999975 58899999987543  233456788999999999999999999987654     


Q ss_pred             -----eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEe
Q 007006          461 -----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS  535 (621)
Q Consensus       461 -----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~  535 (621)
                           ..++|+||+++ ++..++..  ....+++..+..++.||+.||+|||+.+   |+|+||||+||++++++.+||+
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence                 78999999986 66666533  2346899999999999999999999886   9999999999999999999999


Q ss_pred             eecCceecCCCCCCcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          536 DFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       536 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      |||++........... ....++..|+|||.+.+. .++.++||||||+++|||++|++||..
T Consensus       159 dfg~~~~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~  220 (302)
T cd07864         159 DFGLARLYNSEESRPY-TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA  220 (302)
T ss_pred             cccccccccCCccccc-ccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            9999986644322111 122356789999988654 578999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.4e-30  Score=259.20  Aligned_cols=207  Identities=33%  Similarity=0.440  Sum_probs=173.2

Q ss_pred             hCCCCccceeccCCceeEEEEE-ecCCcEEEEEEeccCCc-------ccHHHHHHHHHHHHhcccCCceeEeeEEee-Cc
Q 007006          390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSG-------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-GQ  460 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~-------~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~-~~  460 (621)
                      .++|..++.||+|+|+.||++. +...+-||+|+-..+..       ...+...+|.++-+.|+||-||++++++.- .+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            4578888999999999999998 56788899998654321       122346778999999999999999999974 56


Q ss_pred             eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC---CCCeEEeee
Q 007006          461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDF  537 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~vkL~Df  537 (621)
                      .++-|+||++|.+|+-||..   ...++++++..|++||+.||.||.+. ++||||-||||.|||+-+   -|.+||.||
T Consensus       542 sFCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             cceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence            78999999999999999954   45689999999999999999999987 478999999999999954   478999999


Q ss_pred             cCceecCCCCCCc-----ccccccccCCccChhcccCC----CCChhhhHHHHHHHHHHHHcCCCCCCCCcC
Q 007006          538 GLARIFGGNQNQA-----NTNIIAGTYGYMAPEYAMGG----IFSIKSDVFSFGVLLLEIISGRKNNGFYFS  600 (621)
Q Consensus       538 gla~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~----~~s~~sDVwS~Gvll~elltG~~p~~~~~~  600 (621)
                      |++++++.+....     .+....||.+|++||++.-+    ..+.|+||||.||++|..+.|+.||+....
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs  689 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS  689 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence            9999987655442     24557899999999987433    378899999999999999999999986443

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.96  E-value=1.8e-28  Score=250.44  Aligned_cols=196  Identities=27%  Similarity=0.362  Sum_probs=161.6

Q ss_pred             CCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC-cccHHHHHHHHHHHHhcc-cCCceeEeeEEeeC--ceEEEEEE
Q 007006          393 FSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEG--QELLLIYE  467 (621)
Q Consensus       393 f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~--~~~~lV~e  467 (621)
                      |.+.++||+|+||.||++.. .+++.+|+|+++... ........+|+.++.++. ||||+++++++.++  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            56778999999999999985 468999999987642 222234457888999885 99999999999987  88999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |++ ++|.+++...  ...+++.++..++.|++.||.|||+.+   ++||||+|+||+++. +.+||+|||++.......
T Consensus        81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            997 5777777432  246899999999999999999999986   999999999999999 999999999998654322


Q ss_pred             CCcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ..   ....++..|+|||++.. ..++.++|||||||++|||++|++||...
T Consensus       154 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~  202 (282)
T cd07831         154 PY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT  202 (282)
T ss_pred             Cc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC
Confidence            11   12356889999997654 55788999999999999999999999643

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=9e-31  Score=293.15  Aligned_cols=207  Identities=30%  Similarity=0.445  Sum_probs=175.0

Q ss_pred             HhCCCCccceeccCCceeEEEEE-ecCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      .+-+|....+||.|.||.||-+. ..+|+..|+|.+...+  ....+...+|+.++..++|||+|+++|+-.+.+..++.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            34567778899999999999998 5679999999887553  33446678999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      ||||++|+|.+.+...   ...++.....+..|++.|+.|||++|   ||||||||.||+|+.+|.+|++|||.|..+..
T Consensus      1313 MEyC~~GsLa~ll~~g---ri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHG---RIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHHhccCcHHHHHHhc---chhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence            9999999999988432   23566666678899999999999997   99999999999999999999999999998765


Q ss_pred             CCC--CcccccccccCCccChhcccCC---CCChhhhHHHHHHHHHHHHcCCCCCCCCcCC
Q 007006          546 NQN--QANTNIIAGTYGYMAPEYAMGG---IFSIKSDVFSFGVLLLEIISGRKNNGFYFSE  601 (621)
Q Consensus       546 ~~~--~~~~~~~~gt~~y~aPE~l~~~---~~s~~sDVwS~Gvll~elltG~~p~~~~~~~  601 (621)
                      +..  ...-+...||+-|||||++.+.   ....++||||+|||++||+||++||.-++.+
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne 1447 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE 1447 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch
Confidence            421  1223456899999999999653   3577899999999999999999999866654

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.96  E-value=8.4e-29  Score=254.07  Aligned_cols=200  Identities=29%  Similarity=0.410  Sum_probs=164.0

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcc-cCCceeEeeEEeeCceEEEEEEe
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      +|...+.||+|+||.||++... +++.+|+|++.... ......+.+|+.++.++. ||||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            5666789999999999999854 68999999987543 234567889999999996 99999999999998899999999


Q ss_pred             cCCCChhhhhhh--ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          469 MPNKSLDVHLFD--ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       469 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ++. ++..+...  ......+++..+.+++.+++.||+|||+..  +++||||||+||+++.++.+||+|||++......
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            864 55443321  122356899999999999999999999752  4999999999999999999999999998765332


Q ss_pred             CCCcccccccccCCccChhcccCC---CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGG---IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~---~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ...   ....++..|+|||.+.+.   .++.++||||||+++|||++|+.||..
T Consensus       162 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  212 (288)
T cd06616         162 IAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK  212 (288)
T ss_pred             Ccc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence            211   223578889999998776   689999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.96  E-value=9.1e-30  Score=242.65  Aligned_cols=198  Identities=27%  Similarity=0.437  Sum_probs=164.3

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcc-cCCceeEeeEEeeCceEEEEEEe
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      +...+..||.|..|.||+.+.. .|..+|||.+.+.. .+..++++..++++.+-+ .|+||+.+|+|..+...++.||.
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            4455678999999999999864 68999999998764 455677888888877764 89999999999999999999998


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      |. ..++.++..  -..++++..+-++...+.+||.||.++.  +|+|||+||+|||+|+.|++||+|||++..+-+...
T Consensus       173 Ms-~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA  247 (391)
T KOG0983|consen  173 MS-TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA  247 (391)
T ss_pred             HH-HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc
Confidence            74 445555533  2346889999999999999999999865  799999999999999999999999999987644322


Q ss_pred             CcccccccccCCccChhcccC---CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ..   ...|.+.|||||.+.-   ..|+.++||||||+.|+||.||+.||..
T Consensus       248 ht---rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~  296 (391)
T KOG0983|consen  248 HT---RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG  296 (391)
T ss_pred             cc---cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence            22   2468889999999853   4589999999999999999999999875

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=3.4e-29  Score=259.12  Aligned_cols=203  Identities=26%  Similarity=0.419  Sum_probs=172.0

Q ss_pred             hCCCCccceeccCCceeEEEEEecCCcEEEEEEecc--CCcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSR--TSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~--~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ...|+++++||+||.+.||++...+.+.+|+|++..  .+.+....|.+|++.|.+| .|.+||+|++|-..++.+|+||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            357999999999999999999998889999998753  3566678899999999999 5999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      || ...+|..+|..... ....| .+..+..|++.++.++|.+|   |||.||||.|+|+- .|.+||+|||+|..+..+
T Consensus       440 E~-Gd~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  440 EC-GDIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD  512 (677)
T ss_pred             ec-ccccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence            96 56888888865332 23334 67778899999999999987   99999999999885 458999999999988776


Q ss_pred             CCCcccccccccCCccChhcccCCC-----------CChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGI-----------FSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~-----------~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      ........-+||+-||+||.+....           .++++||||+|||||+|+.|++||+.+.
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~  576 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII  576 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH
Confidence            6666566678999999999884322           5688999999999999999999997543

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.96  E-value=8.1e-29  Score=260.13  Aligned_cols=201  Identities=22%  Similarity=0.403  Sum_probs=167.7

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEee----CceE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQEL  462 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~----~~~~  462 (621)
                      .++|++.+.||+|++|.||++... ++..|++|++....  ....+.+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            368899999999999999999854 69999999987542  2345677889999999999999999998763    3468


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      ++|+||+. ++|..++..   ...+++..+..++.||+.||.|||+.+   ++||||||+||++++++.+||+|||++..
T Consensus        84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence            99999996 688888743   345899999999999999999999876   99999999999999999999999999986


Q ss_pred             cCCCCCCc--ccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          543 FGGNQNQA--NTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       543 ~~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ........  ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~  214 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPG  214 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCC
Confidence            54332211  1123467889999998865 4588999999999999999999999853

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.96  E-value=3.9e-28  Score=248.49  Aligned_cols=197  Identities=29%  Similarity=0.477  Sum_probs=164.7

Q ss_pred             CCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc--ccHHHHHHHHHHHHhc---ccCCceeEeeEEeeCce-----
Q 007006          393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKL---QHKNLVRLLGCCLEGQE-----  461 (621)
Q Consensus       393 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l---~h~nIv~l~g~~~~~~~-----  461 (621)
                      |++.+.||+|+||.||+++.+ +++.+|+|+++....  .....+.+|+.++.++   +||||+++++++.+.+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567789999999999999976 489999999975422  2234566788877766   59999999999998776     


Q ss_pred             EEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCce
Q 007006          462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR  541 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~  541 (621)
                      .+++|||+++ +|.+++.... ...+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||++.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999974 7888775432 235899999999999999999999986   9999999999999999999999999998


Q ss_pred             ecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          542 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       542 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .+......   ....++..|+|||.+.+..++.++||||||+++|||++|++||..
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~  208 (287)
T cd07838         156 IYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRG  208 (287)
T ss_pred             eccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccC
Confidence            76433221   123467889999999998999999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.96  E-value=2.1e-28  Score=254.46  Aligned_cols=197  Identities=20%  Similarity=0.227  Sum_probs=162.0

Q ss_pred             cceeccCCceeEEEEEecCCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCCC
Q 007006          396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKS  473 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~gs  473 (621)
                      .+.+|.|+++.|+++.. +++.||+|++...  .....+.+.+|+++++.++||||+++++++.+.+..+++|||+++++
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34455556666666555 6999999998754  34456789999999999999999999999999999999999999999


Q ss_pred             hhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC-----
Q 007006          474 LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN-----  548 (621)
Q Consensus       474 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~-----  548 (621)
                      |.+++.... ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||.+........     
T Consensus        86 l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          86 CEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             HHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            999986432 345889999999999999999999986   99999999999999999999999998875532211     


Q ss_pred             CcccccccccCCccChhcccCC--CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGG--IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~--~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ........++..|+|||++...  .++.++||||||+++|||++|+.||..
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~  212 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD  212 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence            1112233467789999998763  578999999999999999999999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.96  E-value=2.7e-28  Score=257.44  Aligned_cols=200  Identities=29%  Similarity=0.433  Sum_probs=166.4

Q ss_pred             HHHHHhCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeC--
Q 007006          385 LALEATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--  459 (621)
Q Consensus       385 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--  459 (621)
                      .+...+++|.+.+.||+|+||.||++.. .+++.||+|++....  ....+.+.+|++++++++||||+++++++...  
T Consensus        11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~   90 (345)
T cd07877          11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS   90 (345)
T ss_pred             HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence            4445678999999999999999999985 578999999987542  22345678899999999999999999988643  


Q ss_pred             ----ceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEe
Q 007006          460 ----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS  535 (621)
Q Consensus       460 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~  535 (621)
                          ...+++++++ +++|..++.    ...+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+||+
T Consensus        91 ~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~  162 (345)
T cd07877          91 LEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL  162 (345)
T ss_pred             ccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEe
Confidence                2467788876 788877763    235899999999999999999999986   9999999999999999999999


Q ss_pred             eecCceecCCCCCCcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          536 DFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       536 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      |||++......     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       163 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  220 (345)
T cd07877         163 DFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG  220 (345)
T ss_pred             ccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99998754321     122456888999998866 4678999999999999999999999853

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=3.3e-29  Score=249.24  Aligned_cols=207  Identities=24%  Similarity=0.331  Sum_probs=175.1

Q ss_pred             hCCCCccceeccCCceeEEEEEecC------CcEEEEEEeccC-CcccHHHHHHHHHHHHhcccCCceeEeeEEeeC-ce
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-QE  461 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~-~~  461 (621)
                      ..++.....+.+|.||.||+|.+.+      .+.|-+|.++.. +.-+...++.|.-++..+.|||+.++.+++.+. +.
T Consensus       283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~  362 (563)
T KOG1024|consen  283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT  362 (563)
T ss_pred             hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence            4568888899999999999997643      456778877655 344566788999999999999999999999865 46


Q ss_pred             EEEEEEecCCCChhhhhh-----hccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEee
Q 007006          462 LLLIYEYMPNKSLDVHLF-----DATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISD  536 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~D  536 (621)
                      ++++++++.-|+|+.||.     +......++..+...++.|++.|++|||+++   +||.||..+|++||+..++||+|
T Consensus       363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltD  439 (563)
T KOG1024|consen  363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTD  439 (563)
T ss_pred             ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEecc
Confidence            789999999999999998     3344456888899999999999999999986   99999999999999999999999


Q ss_pred             ecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCCc
Q 007006          537 FGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYF  599 (621)
Q Consensus       537 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~~  599 (621)
                      =.+++.+-..+.......-.++..||+||.+.+..|+..+|||||||+||||+| |+.|+.--+
T Consensus       440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID  503 (563)
T KOG1024|consen  440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID  503 (563)
T ss_pred             chhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC
Confidence            999997765555544444456789999999999999999999999999999998 899975433

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.96  E-value=6.1e-31  Score=249.86  Aligned_cols=204  Identities=30%  Similarity=0.422  Sum_probs=165.5

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc-ccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      ++.+.+..||.|.||+|+|-.++ .|+..|||+++.... ...++++.|.+...+- +.||||+++|.+..++..|+.||
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            34555678999999999999865 699999999986643 4456788888865555 78999999999999999999999


Q ss_pred             ecCCCChhhhhhh--ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          468 YMPNKSLDVHLFD--ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       468 ~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      .|. .||+.+...  ..+...+++...-+|+.-.+.||.||...  .+|||||+||+|||++..|.+||+|||++..+..
T Consensus       144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            984 666654431  22345689999999999999999999885  4799999999999999999999999999875532


Q ss_pred             CCCCcccccccccCCccChhcccC--CCCChhhhHHHHHHHHHHHHcCCCCCCCCcC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGRKNNGFYFS  600 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwS~Gvll~elltG~~p~~~~~~  600 (621)
                      ..   ....-.|...|||||.+..  ..|+.+|||||||++|+|+.||+.|+.-+.+
T Consensus       221 Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s  274 (361)
T KOG1006|consen  221 SI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS  274 (361)
T ss_pred             HH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH
Confidence            21   1223467778999999853  3589999999999999999999999876554

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.96  E-value=2e-28  Score=251.32  Aligned_cols=199  Identities=29%  Similarity=0.424  Sum_probs=167.8

Q ss_pred             CCCccceeccCCceeEEEEEe----cCCcEEEEEEeccCC----cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceE
Q 007006          392 HFSDENKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL  462 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~  462 (621)
                      +|.+.+.||+|++|.||+++.    .++..||+|.+++..    ....+.+.+|++++.++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            367789999999999999874    357889999987532    22345688999999999 599999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      ++||||+++++|..++..   ...+++..+..++.|++++|.|||+.+   ++||||+|+||+++.++.++|+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            999999999999988853   345889999999999999999999875   99999999999999999999999999876


Q ss_pred             cCCCCCCcccccccccCCccChhcccCCC--CChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          543 FGGNQNQANTNIIAGTYGYMAPEYAMGGI--FSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       543 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ....... ......++..|+|||.+.+..  .+.++||||||+++|||++|+.||..
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~  210 (288)
T cd05583         155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV  210 (288)
T ss_pred             ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence            5433211 122345788999999987665  78899999999999999999999863

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.96  E-value=2.7e-28  Score=251.57  Aligned_cols=199  Identities=28%  Similarity=0.448  Sum_probs=164.3

Q ss_pred             CCCCccceeccCCceeEEEEEecC-CcEEEEEEeccCC-cccHHHHHHHHHHHHhcc-cCCceeEeeEEeeCceEEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      ++|.+.+.||+|++|.||++...+ ++.||||.++... ......+..|++++.+.. ||||+++++++.+....+++||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            568889999999999999999764 8999999997543 233456677887777774 9999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |++ ++|..++...  ...+++..+..++.||+.||.|||+..  +|+||||+|+||++++++.+||+|||++..+....
T Consensus        95 ~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          95 LMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             ccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            985 4666665432  237899999999999999999999742  49999999999999999999999999987654322


Q ss_pred             CCcccccccccCCccChhcccCCC----CChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGGI----FSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~~----~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ..   ....++..|+|||.+.+..    ++.++||||||+++|||++|+.||..
T Consensus       170 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  220 (296)
T cd06618         170 AK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN  220 (296)
T ss_pred             cc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence            21   1234678899999986553    78899999999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-29  Score=225.92  Aligned_cols=197  Identities=27%  Similarity=0.437  Sum_probs=165.3

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      +|...++||+|.+|+||+++.. +++.||+|+++..+  +.--....+|+-+++.++|+|||+++++...+..+.+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4566789999999999999954 58889999987543  33335678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      |. .+|..+..  .-+..++.+....++.|+++||.++|++.   +.|||+||.|.||+.+|++||+|||+++-++-+..
T Consensus        83 cd-qdlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   83 CD-QDLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             hh-HHHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            95 46666663  23456899999999999999999999985   99999999999999999999999999998765443


Q ss_pred             CcccccccccCCccChhcccCCC-CChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~-~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      ....  .+-|.+|.+|.++.+.. |+...|+||-||++.||.....|.-
T Consensus       157 cysa--evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplf  203 (292)
T KOG0662|consen  157 CYSA--EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  203 (292)
T ss_pred             eeec--eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCC
Confidence            3222  24589999999987754 8999999999999999998666643

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.96  E-value=3.2e-28  Score=248.57  Aligned_cols=197  Identities=29%  Similarity=0.461  Sum_probs=168.2

Q ss_pred             CCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc--ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       393 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      |...+.||+|++|.||++... +++.+++|++.....  .....+.+|++++++++|+||+++++++.+++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            566789999999999999864 688999999876532  24567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++ +|..++...  ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-  153 (283)
T cd05118          81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-  153 (283)
T ss_pred             CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence            75 787777542  256899999999999999999999986   99999999999999999999999999987654431 


Q ss_pred             cccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                       ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||..
T Consensus       154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~  201 (283)
T cd05118         154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPG  201 (283)
T ss_pred             -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence             11123467789999998776 789999999999999999999999854

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.96  E-value=3.3e-28  Score=256.56  Aligned_cols=197  Identities=26%  Similarity=0.434  Sum_probs=165.9

Q ss_pred             HhCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCc-----
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-----  460 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~-----  460 (621)
                      ..++|.+.+.||+|+||.||++.. .++..||+|++....  ....+.+.+|++++++++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            457899999999999999999984 478999999986432  223456889999999999999999999987653     


Q ss_pred             -eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecC
Q 007006          461 -ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL  539 (621)
Q Consensus       461 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgl  539 (621)
                       ..++|+||+ +++|..++.    ...+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.++|+|||+
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence             458999998 678887773    245899999999999999999999886   99999999999999999999999999


Q ss_pred             ceecCCCCCCcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          540 ARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       540 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      +......     .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...
T Consensus       165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  219 (343)
T cd07880         165 ARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH  219 (343)
T ss_pred             ccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            8764322     122356788999998876 45789999999999999999999998643

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.96  E-value=1.8e-28  Score=257.79  Aligned_cols=199  Identities=25%  Similarity=0.415  Sum_probs=166.2

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeC-----ce
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QE  461 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~-----~~  461 (621)
                      .++|.+.+.||+|+||.||+++. .++..||||.+...  .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45789999999999999999985 46899999998753  233345678899999999999999999988654     24


Q ss_pred             EEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCce
Q 007006          462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR  541 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~  541 (621)
                      .++|+||+. ++|..++..   ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 678777743   346899999999999999999999886   9999999999999999999999999998


Q ss_pred             ecCCCCCCcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          542 IFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       542 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ......  .......++..|+|||.+.. ..++.++||||||+++|||++|++||..
T Consensus       157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  211 (337)
T cd07858         157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG  211 (337)
T ss_pred             ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Confidence            654321  11223356888999998765 4689999999999999999999999854

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.96  E-value=7.7e-28  Score=250.41  Aligned_cols=193  Identities=32%  Similarity=0.488  Sum_probs=163.2

Q ss_pred             CCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCc---ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          393 FSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       393 f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      |...++||+|+||.||+|+. .+++.|++|++.....   ...+.+.+|+++++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            66678899999999999986 4688999999875432   3345688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +. +++..++..  ...++++..+..++.||+.+|.|||+.+   ++|+||+|+||+++.++.+||+|||++.....   
T Consensus       103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---  173 (313)
T cd06633         103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---  173 (313)
T ss_pred             CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence            96 566666643  2346899999999999999999999886   99999999999999999999999998864221   


Q ss_pred             CcccccccccCCccChhccc---CCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                         .....++..|+|||++.   ...++.++||||||+++|||++|++|+..
T Consensus       174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~  222 (313)
T cd06633         174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  222 (313)
T ss_pred             ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence               12346788999999874   45688999999999999999999999753

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.96  E-value=4.2e-28  Score=254.75  Aligned_cols=201  Identities=26%  Similarity=0.407  Sum_probs=164.8

Q ss_pred             CCCCc-cceeccCCceeEEEEEec-CCcEEEEEEeccCCccc--------------HHHHHHHHHHHHhcccCCceeEee
Q 007006          391 NHFSD-ENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQG--------------LQEFKNEVNLIAKLQHKNLVRLLG  454 (621)
Q Consensus       391 ~~f~~-~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~--------------~~~~~~Ei~~l~~l~h~nIv~l~g  454 (621)
                      ++|.. .+.||+|+||.||++... +++.||+|+++......              ...+.+|+++++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            45653 467999999999999854 68999999986543211              124778999999999999999999


Q ss_pred             EEeeCceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEE
Q 007006          455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI  534 (621)
Q Consensus       455 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL  534 (621)
                      ++...+..++||||++ ++|.+++..   ...+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.++|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence            9999999999999997 688888743   345899999999999999999999886   999999999999999999999


Q ss_pred             eeecCceecCCCCC------------CcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          535 SDFGLARIFGGNQN------------QANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       535 ~Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      +|||++........            ........++..|+|||.+.+. .++.++||||||+++|||++|++||...
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~  237 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE  237 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999986641110            1111123457789999998764 4689999999999999999999998643

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.96  E-value=3.9e-28  Score=254.33  Aligned_cols=198  Identities=29%  Similarity=0.465  Sum_probs=166.8

Q ss_pred             HHhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEee-CceEE
Q 007006          388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-GQELL  463 (621)
Q Consensus       388 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~-~~~~~  463 (621)
                      ..+++|++.+.||+|+||.||++... +++.||+|++.+.  .....+.+.+|+++++.++||||+++.+++.. ....+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            46788999999999999999999854 7999999988643  22345678899999999999999999999876 45789


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceec
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF  543 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~  543 (621)
                      +++||+ +++|..++.    ..++++.....++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||++...
T Consensus        87 lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          87 FVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             EEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            999998 568887773    235788889999999999999999986   999999999999999999999999998754


Q ss_pred             CCCCCCcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          544 GGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       544 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ...     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       159 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~  209 (328)
T cd07856         159 DPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK  209 (328)
T ss_pred             CCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            321     112356788999998766 56899999999999999999999998644

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.96  E-value=2.7e-28  Score=252.81  Aligned_cols=202  Identities=30%  Similarity=0.476  Sum_probs=164.2

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc--ccHHHHHHHHHHHHhcccCCceeEeeEEeeCc------
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------  460 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~------  460 (621)
                      .++|.+.++||+|++|.||++... +++.+++|++.....  .....+.+|+++++.++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999864 689999999865432  22346788999999999999999999875433      


Q ss_pred             --eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeec
Q 007006          461 --ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG  538 (621)
Q Consensus       461 --~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfg  538 (621)
                        ..++|+||+.+ +|...+..  ....+++..+..++.|+++||.|||+.+   ++|+||||+||++++++.++|+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              46999999875 56655533  2346999999999999999999999986   9999999999999999999999999


Q ss_pred             CceecCCCCCCcc---------cccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          539 LARIFGGNQNQAN---------TNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       539 la~~~~~~~~~~~---------~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ++...........         .....+++.|+|||.+.+. .++.++||||||+++|||++|++||..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~  229 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG  229 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence            9986543221111         1223567889999987654 578999999999999999999999853

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.96  E-value=2.8e-28  Score=255.38  Aligned_cols=200  Identities=27%  Similarity=0.416  Sum_probs=170.4

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCc-----eEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-----ELL  463 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~-----~~~  463 (621)
                      +|.+.+.||+|++|.||+++.. +++.+++|++....  ....+.+.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778899999999999999965 58999999987653  344567899999999999999999999998775     789


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceec
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF  543 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~  543 (621)
                      ++|||++ ++|..++..   ...+++..+..++.+|+.||.|||+.+   |+||||||+|||++.++.++|+|||++...
T Consensus        81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999998 478877743   237999999999999999999999986   999999999999999999999999999876


Q ss_pred             CCCCCC-cccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          544 GGNQNQ-ANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       544 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ...... .......++..|+|||.+.+. .++.++||||||+++|+|++|++||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~  210 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR  210 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCC
Confidence            543211 112234568889999999887 7899999999999999999999998543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.96  E-value=3.1e-28  Score=256.66  Aligned_cols=199  Identities=26%  Similarity=0.421  Sum_probs=165.1

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeC----------
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG----------  459 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~----------  459 (621)
                      .+|.+.+.||+|+||.||+|.. .++..|++|++........+.+.+|++++++++||||+++++.+...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            6789999999999999999986 46899999999776666677889999999999999999999776543          


Q ss_pred             ----ceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc-CCCCeEE
Q 007006          460 ----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKI  534 (621)
Q Consensus       460 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~vkL  534 (621)
                          ...++|+||++ ++|..++.    ...+++..+..++.||+.||.|||+.+   ++||||||+||+++ +++.+||
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence                35789999997 58877773    235889999999999999999999886   99999999999997 4567899


Q ss_pred             eeecCceecCCCCCCc-ccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          535 SDFGLARIFGGNQNQA-NTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       535 ~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      +|||++.......... ......++..|+|||.+.. ..++.++||||||+++|||++|+.||..
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~  221 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAG  221 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999998654321111 1122356788999998754 5578899999999999999999999853

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.96  E-value=6.1e-28  Score=252.83  Aligned_cols=198  Identities=24%  Similarity=0.338  Sum_probs=161.4

Q ss_pred             ceeccC--CceeEEEEEe-cCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCC
Q 007006          397 NKLGQG--GFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN  471 (621)
Q Consensus       397 ~~LG~G--~fG~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  471 (621)
                      ..||+|  +||+||++.. .+|+.||+|++....  ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  8999999986 479999999987542  23346788999999999999999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc-
Q 007006          472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA-  550 (621)
Q Consensus       472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~-  550 (621)
                      ++|.+++.... ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++++||+.+.......... 
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            99999886532 235899999999999999999999876   9999999999999999999999998654332111100 


Q ss_pred             ----ccccccccCCccChhcccCC--CCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          551 ----NTNIIAGTYGYMAPEYAMGG--IFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       551 ----~~~~~~gt~~y~aPE~l~~~--~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                          ......++..|+|||++.+.  .++.++||||||+++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  213 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM  213 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence                01112345679999998764  4789999999999999999999998643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.96  E-value=4.8e-28  Score=247.15  Aligned_cols=197  Identities=32%  Similarity=0.489  Sum_probs=168.0

Q ss_pred             CCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       393 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      |+..+.||+|.+|.||+++.. +++.+++|++....  ....+.+..|++++++++|+|++++++++.+.+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456788999999999999965 59999999998653  334467789999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      + ++|.+++....  ..+++..+.+++.+++.||.|||+.+   ++||||+|+||++++++.++|+|||++.........
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  154 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT  154 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence            8 58998885432  46899999999999999999999986   999999999999999999999999998865432211


Q ss_pred             cccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                        .....++..|+|||.+.+. .++.++||||||+++|||++|++||..
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~  201 (282)
T cd07829         155 --YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPG  201 (282)
T ss_pred             --cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence              1123456789999998776 789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.95  E-value=5.4e-28  Score=254.76  Aligned_cols=194  Identities=27%  Similarity=0.452  Sum_probs=162.2

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCc------
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------  460 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~------  460 (621)
                      .++|...+.||+|+||.||+|+. .+|+.||+|++....  ......+.+|+.+++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            36888999999999999999985 468999999987542  233456789999999999999999999987542      


Q ss_pred             eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCc
Q 007006          461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA  540 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla  540 (621)
                      ..++|+||+.. +|..++     ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            46899999864 665544     235889999999999999999999886   999999999999999999999999998


Q ss_pred             eecCCCCCCcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          541 RIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       541 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ......     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~  217 (342)
T cd07879         165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG  217 (342)
T ss_pred             cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            754321     112356788999999876 4588999999999999999999999864

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.95  E-value=9.7e-28  Score=240.40  Aligned_cols=192  Identities=33%  Similarity=0.477  Sum_probs=166.9

Q ss_pred             eccCCceeEEEEEec-CCcEEEEEEeccCCc---ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCCCh
Q 007006          399 LGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSL  474 (621)
Q Consensus       399 LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~gsL  474 (621)
                      ||+|+||.||++... +++.+++|.+.....   .....+.+|++++++++||||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999865 589999999876532   2456789999999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCccccc
Q 007006          475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI  554 (621)
Q Consensus       475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~  554 (621)
                      .+++...   ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~  152 (250)
T cd05123          81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT  152 (250)
T ss_pred             HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence            9998532   35899999999999999999999975   9999999999999999999999999988754332  12233


Q ss_pred             ccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          555 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       555 ~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ..++..|++||...+...+.++|+||||+++|||++|+.||...
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~  196 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE  196 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            45788999999998888899999999999999999999998643

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.95  E-value=6.6e-28  Score=250.28  Aligned_cols=195  Identities=33%  Similarity=0.504  Sum_probs=164.4

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      +.|...+.||+|+||.||+|+.. ++..+++|.+...   .....+++.+|+++++.++|+|++++.+++......++|+
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34777789999999999999964 6888999988643   2233456889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+. +++..++...  ...+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            9997 5777666432  345899999999999999999999886   999999999999999999999999998765322


Q ss_pred             CCCcccccccccCCccChhccc---CCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                            ....++..|+|||.+.   ...++.++||||||+++|||++|+.||..
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  216 (308)
T cd06634         169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  216 (308)
T ss_pred             ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcc
Confidence                  1235678999999874   35678899999999999999999999743

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=7.3e-28  Score=246.19  Aligned_cols=198  Identities=29%  Similarity=0.395  Sum_probs=165.6

Q ss_pred             CCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc-ccHHHHHHHHHHHHhcc-cCCceeEeeEEeeCceEEEEEEec
Q 007006          393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       393 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      |.+.+.||+|++|.||+|+.. +++.|++|++..... .......+|+..+.+++ ||||+++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567789999999999999975 578999999875432 22234567999999998 999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                       +++|.+++.... ...+++..+..++.|++.+|.|||+.+   ++|+||+|+||++++++.++|+|||++........ 
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-  154 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence             788888875432 246899999999999999999999986   99999999999999999999999999986543221 


Q ss_pred             cccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                        .....++..|+|||++.+ ..++.++|+||||++++||++|++||...
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~  202 (283)
T cd07830         155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS  202 (283)
T ss_pred             --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence              122356788999998754 45789999999999999999999998543

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.95  E-value=1.1e-27  Score=251.42  Aligned_cols=199  Identities=29%  Similarity=0.396  Sum_probs=162.7

Q ss_pred             CCCccceeccCCceeEEEEEec-C--CcEEEEEEeccCC--cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeC----ce
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-D--GKAIAVKRLSRTS--GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG----QE  461 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~--g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~----~~  461 (621)
                      +|.+.+.||+|+||.||+++.. .  +..||+|++....  ....+.+.+|++++.++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4777899999999999999964 3  7889999987532  22346678899999999 599999999875432    35


Q ss_pred             EEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCce
Q 007006          462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR  541 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~  541 (621)
                      .++++||+. ++|..++..   ...+++..+..++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||++.
T Consensus        81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            678888876 688887743   346899999999999999999999886   9999999999999999999999999998


Q ss_pred             ecCCCCCC--cccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          542 IFGGNQNQ--ANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       542 ~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .+......  .......++..|+|||.+.+ ..++.++||||||+++|||++|++||..
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~  212 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG  212 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence            66432221  11223467899999998765 4689999999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.95  E-value=1.5e-28  Score=274.37  Aligned_cols=198  Identities=32%  Similarity=0.502  Sum_probs=158.2

Q ss_pred             HHhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeC------
Q 007006          388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------  459 (621)
Q Consensus       388 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~------  459 (621)
                      .-..+|+..+.||+|+||.||+++.+ ||+.+|||++.... ......+.+|+.+|++|+|||||+++..+.+.      
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            34578999999999999999999965 89999999998653 33446688999999999999999987655320      


Q ss_pred             --------------------------------------------------------------------------------
Q 007006          460 --------------------------------------------------------------------------------  459 (621)
Q Consensus       460 --------------------------------------------------------------------------------  459 (621)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------------ceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHH
Q 007006          460 ---------------------------------QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL  506 (621)
Q Consensus       460 ---------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL  506 (621)
                                                       ..+|+-||||+..++..++.+....  -.....++++++|+.||.|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHH
Confidence                                             0146778888887777777432211  14677899999999999999


Q ss_pred             HhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC------C----------CCCCcccccccccCCccChhcccCC
Q 007006          507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG------G----------NQNQANTNIIAGTYGYMAPEYAMGG  570 (621)
Q Consensus       507 H~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~------~----------~~~~~~~~~~~gt~~y~aPE~l~~~  570 (621)
                      |++|   ||||||||.||+++++..|||+|||++....      .          .......+..+||.-|+|||++.+.
T Consensus       714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            9987   9999999999999999999999999998721      0          0111122346799999999998665


Q ss_pred             C---CChhhhHHHHHHHHHHHHc
Q 007006          571 I---FSIKSDVFSFGVLLLEIIS  590 (621)
Q Consensus       571 ~---~s~~sDVwS~Gvll~ellt  590 (621)
                      .   |+.|+|+||+|||++||+.
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y  813 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY  813 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc
Confidence            4   9999999999999999974

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.95  E-value=1.2e-27  Score=241.72  Aligned_cols=199  Identities=29%  Similarity=0.434  Sum_probs=164.2

Q ss_pred             CCCccceeccCCceeEEEEEecC-CcEEEEEEeccC-----CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRT-----SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      +|.+.++||+|+||.||+++... +..+++|.++..     .......+..|+.++++++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47788999999999999998643 445555555432     122334567899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          466 YEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      +||+++++|..++... .....+++..++.++.|++.||.|||+.+   ++|+||+|+||++++ +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999888642 23456999999999999999999999876   999999999999975 569999999987754


Q ss_pred             CCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      .....  .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.
T Consensus       157 ~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~  206 (260)
T cd08222         157 GSCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFE  206 (260)
T ss_pred             CCccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            32221  223456888999999988888999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-27  Score=267.56  Aligned_cols=204  Identities=33%  Similarity=0.468  Sum_probs=169.2

Q ss_pred             hCCCCccceeccCCceeEEEEEec----C----CcEEEEEEeccCC-cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeC
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA----D----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG  459 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~----~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~  459 (621)
                      .++..+.+.||+|.||.|++|...    .    ...||||.++... ....+.+..|+++|..+ +|+||+.++|+|.++
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~  374 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD  374 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence            344456679999999999999743    1    4579999998653 34567899999999999 699999999999999


Q ss_pred             ceEEEEEEecCCCChhhhhhhcc-----------CC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE
Q 007006          460 QELLLIYEYMPNKSLDVHLFDAT-----------RS--VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL  526 (621)
Q Consensus       460 ~~~~lV~e~~~~gsL~~~l~~~~-----------~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl  526 (621)
                      +..++|.||+..|+|..+|+..+           ..  ..++..+.+.++.||+.|++||++..   ++||||.++|||+
T Consensus       375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi  451 (609)
T KOG0200|consen  375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLI  451 (609)
T ss_pred             CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEe
Confidence            99999999999999999997654           01  23899999999999999999999874   9999999999999


Q ss_pred             cCCCCeEEeeecCceecCCCCCCccc-ccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCC
Q 007006          527 DDDMNPKISDFGLARIFGGNQNQANT-NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNG  596 (621)
Q Consensus       527 ~~~~~vkL~Dfgla~~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~  596 (621)
                      +.+..+||+|||+++........... ....-+..|||||.+....|+.++|||||||+||||+| |..||.
T Consensus       452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp  523 (609)
T KOG0200|consen  452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYP  523 (609)
T ss_pred             cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence            99999999999999965433222111 11012456999999999999999999999999999999 788875

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.95  E-value=8.3e-28  Score=253.45  Aligned_cols=196  Identities=29%  Similarity=0.454  Sum_probs=165.9

Q ss_pred             HhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCce----
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE----  461 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~----  461 (621)
                      ..++|.+.+.||+|++|.||+++.. +++.||+|++...  .....+.+.+|+.++++++||||+++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3578999999999999999999965 5889999998653  22334567889999999999999999988876554    


Q ss_pred             --EEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecC
Q 007006          462 --LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL  539 (621)
Q Consensus       462 --~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgl  539 (621)
                        .++|+||+ +++|.+++..    ..+++..+..++.|++.||.|||+.+   |+||||+|+||++++++.++|+|||+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence              89999998 5688887743    46899999999999999999999876   99999999999999999999999999


Q ss_pred             ceecCCCCCCcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          540 ARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       540 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      +......     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~  218 (343)
T cd07851         165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG  218 (343)
T ss_pred             ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            8865332     122356788999998865 3678999999999999999999999853

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.7e-29  Score=255.83  Aligned_cols=201  Identities=26%  Similarity=0.357  Sum_probs=176.0

Q ss_pred             CCCCccceeccCCceeEEEEEecCCc-EEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADGK-AIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g~-~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      .++..+..||-|+||.|-++...+.. .+|+|++++.   +..+.+.+..|-.+|...+.|.||+++--|.++...|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            35566778999999999999865433 4788888765   3455567888999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      |-|-||.|...|.+   +..++.....-++..+++|++|||+++   ||.|||||+|+|++.+|-+||.|||+++.+...
T Consensus       500 EaClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  500 EACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             HhhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            99999999998854   456888888889999999999999986   999999999999999999999999999987654


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCcC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFS  600 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~  600 (621)
                      .   .+-.++||+.|.|||++.+...+..+|.|+||+++|||++|++||+..++
T Consensus       574 ~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp  624 (732)
T KOG0614|consen  574 R---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP  624 (732)
T ss_pred             C---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch
Confidence            3   33457999999999999999999999999999999999999999986654

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1.5e-27  Score=258.84  Aligned_cols=209  Identities=27%  Similarity=0.466  Sum_probs=178.0

Q ss_pred             hHHHHHHhCCCCccceeccCCceeEEEEE-ecCCcEEEEEEeccCCcccHHHHHHHHHHHHhc-ccCCceeEeeEEee--
Q 007006          383 LRLALEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLE--  458 (621)
Q Consensus       383 ~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~--  458 (621)
                      +......++.|++.+.||.|.+|.||+++ .++++..|+|++..... ..+++..|.++++.+ .|||++.++|++..  
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            33334456789999999999999999998 45789999999876543 336678889999888 69999999999974  


Q ss_pred             ---CceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEe
Q 007006          459 ---GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS  535 (621)
Q Consensus       459 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~  535 (621)
                         ++++|||||||.+||.-+++.... ...+.|.-+..|++.++.||.+||...   ++|||||-.|||++.++.|||.
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLv  165 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLV  165 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEe
Confidence               468999999999999999997654 677999999999999999999999874   9999999999999999999999


Q ss_pred             eecCceecCCCCCCcccccccccCCccChhcccCC-----CCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          536 DFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-----IFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       536 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      |||.+..+++.  ..+.+...||+.|||||++...     .|+.++|+||||++..||.-|.+|+-.+
T Consensus       166 DFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm  231 (953)
T KOG0587|consen  166 DFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM  231 (953)
T ss_pred             eeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc
Confidence            99999876543  3445567899999999998543     3788999999999999999999997533

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=8.5e-28  Score=234.56  Aligned_cols=201  Identities=26%  Similarity=0.423  Sum_probs=173.5

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC---CcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      ++|..+.+||+|++..|..++++ +.+.+|+|++++.   +.+..+-.+.|-.+..+- +||.+|.+..+++.+..+++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            57889999999999999999864 5788999998764   344455566677777666 799999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      .||++||+|--++   .++..++++.+.-+...|..||.|||+.|   |+.||||.+|||+|.+|++||.|||+++.--.
T Consensus       330 ieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~  403 (593)
T KOG0695|consen  330 IEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG  403 (593)
T ss_pred             EEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC
Confidence            9999999986555   44556999999999999999999999987   99999999999999999999999999985322


Q ss_pred             CCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      +  ...+...+||+.|+|||++++..|....|+|++||+++||+.|+.||++--
T Consensus       404 ~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivg  455 (593)
T KOG0695|consen  404 P--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVG  455 (593)
T ss_pred             C--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceec
Confidence            2  223456899999999999999999999999999999999999999997643

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.95  E-value=5.4e-27  Score=267.07  Aligned_cols=145  Identities=27%  Similarity=0.419  Sum_probs=129.9

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|.+.++||+|+||.||++... +++.||||+++...   ......+..|+.++..++||||+++++.+......++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57889999999999999999965 68999999997543   223467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCce
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR  541 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~  541 (621)
                      ||+++++|..++..   ...+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999998854   235889999999999999999999875   9999999999999999999999999976

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.95  E-value=3e-27  Score=235.77  Aligned_cols=179  Identities=21%  Similarity=0.214  Sum_probs=152.1

Q ss_pred             CCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCCChhhhhhh
Q 007006          402 GGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD  480 (621)
Q Consensus       402 G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~  480 (621)
                      |.+|.||+++. .+++.+|+|+++...     .+..|...+....||||+++++++.+.+..++||||+++++|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            89999999985 468999999997653     234455556666899999999999999999999999999999998854


Q ss_pred             ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcccccccccCC
Q 007006          481 ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG  560 (621)
Q Consensus       481 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~  560 (621)
                      .   ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||.+.......     ....++..
T Consensus        79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~  147 (237)
T cd05576          79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM  147 (237)
T ss_pred             h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence            2   35899999999999999999999876   9999999999999999999999999876543321     11234667


Q ss_pred             ccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          561 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       561 y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      |+|||.+.+..++.++||||+|+++|||++|+.|+.
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~  183 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE  183 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence            999999988889999999999999999999998764

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.95  E-value=4.8e-27  Score=255.27  Aligned_cols=204  Identities=24%  Similarity=0.307  Sum_probs=154.0

Q ss_pred             HhCCCCccceeccCCceeEEEEEe-----------------cCCcEEEEEEeccCCcccHHHH--------------HHH
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTL-----------------ADGKAIAVKRLSRTSGQGLQEF--------------KNE  437 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~-----------------~~g~~vavK~l~~~~~~~~~~~--------------~~E  437 (621)
                      ..++|++.++||+|+||.||+|.+                 ..++.||||++........++|              ..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            367899999999999999999964                 2356899999875433322333              346


Q ss_pred             HHHHHhcccCCc-----eeEeeEEee--------CceEEEEEEecCCCChhhhhhhccC---------------------
Q 007006          438 VNLIAKLQHKNL-----VRLLGCCLE--------GQELLLIYEYMPNKSLDVHLFDATR---------------------  483 (621)
Q Consensus       438 i~~l~~l~h~nI-----v~l~g~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~---------------------  483 (621)
                      +.++.+++|.++     ++++++|..        .+..+|||||+++++|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777778876654     677787753        3568999999999999998864211                     


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcccccccccCCccC
Q 007006          484 SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA  563 (621)
Q Consensus       484 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~a  563 (621)
                      ...+++..+..++.|++.+|.|||+.+   |+||||||+|||++.++.+||+|||++......... ......+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence            123567889999999999999999875   999999999999999999999999999765332111 1112234789999


Q ss_pred             hhcccCCCC----------------------ChhhhHHHHHHHHHHHHcCCC-CCC
Q 007006          564 PEYAMGGIF----------------------SIKSDVFSFGVLLLEIISGRK-NNG  596 (621)
Q Consensus       564 PE~l~~~~~----------------------s~~sDVwS~Gvll~elltG~~-p~~  596 (621)
                      ||.+.....                      ..+.||||+||+++||++|.. |+.
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~  434 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA  434 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence            998754321                      224699999999999999986 553

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.95  E-value=4.5e-28  Score=233.93  Aligned_cols=196  Identities=25%  Similarity=0.319  Sum_probs=162.9

Q ss_pred             HhCCCCcc-ceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhc-ccCCceeEeeEEee----Cce
Q 007006          389 ATNHFSDE-NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLE----GQE  461 (621)
Q Consensus       389 ~~~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~----~~~  461 (621)
                      .+++|.+. ++||-|-.|.|-.+.++ +++.+|+|++...     ...++|+++--.. .|||||.+++++..    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            34556553 57999999999999854 6899999999765     3447888864444 79999999999875    357


Q ss_pred             EEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC---CCCeEEeeec
Q 007006          462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFG  538 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~vkL~Dfg  538 (621)
                      +++|||+|+||.|..-+.+ .....+++.++-.|+.||..|+.|||+..   |.||||||+|+|...   |..+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence            8999999999999888854 34567999999999999999999999875   999999999999975   4459999999


Q ss_pred             CceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          539 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       539 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      +++.-..+.   .....+-|+.|.|||++....|+...|+||+||++|-|++|-+||=
T Consensus       210 FAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFY  264 (400)
T KOG0604|consen  210 FAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY  264 (400)
T ss_pred             cccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccc
Confidence            998754322   2233467999999999999999999999999999999999999974

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=2.3e-26  Score=225.96  Aligned_cols=198  Identities=33%  Similarity=0.496  Sum_probs=170.8

Q ss_pred             CCccceeccCCceeEEEEEecC-CcEEEEEEeccCCcc-cHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecC
Q 007006          393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP  470 (621)
Q Consensus       393 f~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  470 (621)
                      |...+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++.+...+..++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567899999999999999765 899999999876544 57789999999999999999999999999899999999999


Q ss_pred             CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc
Q 007006          471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA  550 (621)
Q Consensus       471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~  550 (621)
                      +++|.+++.....  .+++.....++.+++.++.+||+.+   ++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-  154 (225)
T smart00221       81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-  154 (225)
T ss_pred             CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence            9999998854221  2889999999999999999999885   999999999999999999999999999876543211 


Q ss_pred             ccccccccCCccChhcc-cCCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          551 NTNIIAGTYGYMAPEYA-MGGIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l-~~~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      ......++..|++||.+ ....++.++|||+||++++||++|+.||.
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            22234567789999998 66678889999999999999999999984

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=9.9e-29  Score=232.99  Aligned_cols=214  Identities=25%  Similarity=0.456  Sum_probs=169.5

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEecc-CCc-ccHHHHHHHHHHHHhcccCCceeEeeEEeeC--------
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSR-TSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--------  459 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~-~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--------  459 (621)
                      ..|+...+||+|.||+||+++.+ .|+.||+|++-- +.+ ..-....+|+++|..++|+|++.++.+|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            35666789999999999999854 578889887643 222 2224458899999999999999999988642        


Q ss_pred             ceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecC
Q 007006          460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL  539 (621)
Q Consensus       460 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgl  539 (621)
                      ..+++||++++. +|..+|.  .....++..++.+++.++..||.|+|...   |+|||+||.|+||+.++.+||+|||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLs--n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLS--NRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhc--CccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence            358999999974 5555663  23356889999999999999999999874   99999999999999999999999999


Q ss_pred             ceecCCCC--CCcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCCCcCCCCCChHHHH
Q 007006          540 ARIFGGNQ--NQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYV  610 (621)
Q Consensus       540 a~~~~~~~--~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~v  610 (621)
                      ++.+....  ..+.....+-|++|.+||.+.+ ..++++.|||.-||++.||+||.+-++.....+...+++..
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L  244 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL  244 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence            98764322  2233334456999999998876 46899999999999999999999988766655555555543

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=1.5e-27  Score=247.54  Aligned_cols=195  Identities=24%  Similarity=0.405  Sum_probs=166.1

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--------cccHHHHHHHHHHHHhcc---cCCceeEeeEEee
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--------GQGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLE  458 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~---h~nIv~l~g~~~~  458 (621)
                      .+|...+.+|+|+||.|+.+.++ +...|+||.+.+..        .......-.||.+|..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            45888999999999999999975 46788999887642        111233567999999997   9999999999999


Q ss_pred             CceEEEEEEecC-CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeee
Q 007006          459 GQELLLIYEYMP-NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF  537 (621)
Q Consensus       459 ~~~~~lV~e~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Df  537 (621)
                      ++.++|++|-.. +-+|.+++.   ....+++.++.-|+.|++-|+++||+++   |+|||||-+||.++.+|-+||+||
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence            999999999764 456677773   3445999999999999999999999997   999999999999999999999999


Q ss_pred             cCceecCCCCCCcccccccccCCccChhcccCCCC-ChhhhHHHHHHHHHHHHcCCCCC
Q 007006          538 GLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNN  595 (621)
Q Consensus       538 gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwS~Gvll~elltG~~p~  595 (621)
                      |.+....+.    .....+||..|.|||++.+..| ...-|||++|++||.++....||
T Consensus       715 gsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  715 GSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             cchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            998765332    3345789999999999999887 77789999999999999998886

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.94  E-value=1.9e-27  Score=221.51  Aligned_cols=197  Identities=21%  Similarity=0.408  Sum_probs=165.8

Q ss_pred             hCCCCccceeccCCceeEEEEE-ecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcc-cCCceeEeeEEeeCc--eEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQ--ELLLI  465 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~--~~~lV  465 (621)
                      .++|++.+++|+|.+++||.|. ..+++.++||+++...   .+.+.+|+++|+.|. ||||++++++..++.  .+.||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            4689999999999999999998 5678999999997543   367889999999996 999999999998764  67899


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC-CCeEEeeecCceecC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGLARIFG  544 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~vkL~Dfgla~~~~  544 (621)
                      +||+.+.+...+.      ..++..++...+.++++||.|+|+.|   |.|||+||.|+|||.. ..++|+|+|+|..+.
T Consensus       114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence            9999998876544      24777888899999999999999987   9999999999999964 569999999999875


Q ss_pred             CCCCCcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCCCcCC
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSE  601 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~~~~~  601 (621)
                      ....-   +..+.+..|.-||.+..- .|+..-|+|||||+|.+|+..+.||-...++
T Consensus       185 p~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN  239 (338)
T KOG0668|consen  185 PGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN  239 (338)
T ss_pred             CCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC
Confidence            54332   233456678999988654 4789999999999999999999998655544

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-26  Score=245.95  Aligned_cols=194  Identities=25%  Similarity=0.360  Sum_probs=162.1

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      ++.|.....+|.|+|+.|-++.. .+++..++|++.+...    +-.+|+.++... +||||+++.+.+.+..+.++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            56788888899999999999985 4688999999987632    235677776666 79999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE-cCCCCeEEeeecCceecCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL-DDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl-~~~~~vkL~Dfgla~~~~~~  546 (621)
                      .+.++-+.+-++..    +.....+..|+.+|+.++.|||++|   ++||||||+|||+ ++.++++|+|||.++.....
T Consensus       397 ~l~g~ell~ri~~~----~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSK----PEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hccccHHHHHHHhc----chhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            99998776665322    2223677789999999999999986   9999999999999 58999999999999876543


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                           ....+-|..|.|||++....+++++||||||++||||++|+.||...-
T Consensus       470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P  517 (612)
T KOG0603|consen  470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHP  517 (612)
T ss_pred             -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCC
Confidence                 112244778999999999999999999999999999999999987543

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.6e-28  Score=233.76  Aligned_cols=202  Identities=27%  Similarity=0.413  Sum_probs=164.4

Q ss_pred             CccceeccCCceeEEEEEe-cCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCc-----eEEEE
Q 007006          394 SDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-----ELLLI  465 (621)
Q Consensus       394 ~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~-----~~~lV  465 (621)
                      +..+.||.|.||.||.+.. ++|+.|++|++...-  -...+.+.+|+++|..++|.|++..+++.+-..     ++|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            4467899999999999985 579999999986532  233467889999999999999999998876542     45777


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      .|.|. .+|+.++   .....++...+.-+..||++||.|||+.+   |.||||||.|+|++.+..+||+|||+++..+.
T Consensus       136 TELmQ-SDLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  136 TELMQ-SDLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHH-hhhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence            78774 5666666   23456888888889999999999999986   99999999999999999999999999998765


Q ss_pred             CCCCcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCCCcCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHG  603 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~~~~~~~  603 (621)
                      ++...-+. -+-|..|.|||++++. .|+...||||.||++.||+..+.-|+...+-++
T Consensus       209 d~~~hMTq-EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQ  266 (449)
T KOG0664|consen  209 RDRLNMTH-EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQ  266 (449)
T ss_pred             hhhhhhHH-HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHH
Confidence            54443332 3457889999999876 489999999999999999999988876555443

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.94  E-value=9.4e-26  Score=223.66  Aligned_cols=186  Identities=34%  Similarity=0.507  Sum_probs=163.8

Q ss_pred             CceeEEEEEec-CCcEEEEEEeccCCccc-HHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCCChhhhhhh
Q 007006          403 GFGPVYKGTLA-DGKAIAVKRLSRTSGQG-LQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD  480 (621)
Q Consensus       403 ~fG~Vy~~~~~-~g~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~  480 (621)
                      +||.||+++.. +++.+++|++....... .+.+.+|++.+++++|+||+++++.+......++++||+++++|..++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999976 48999999998765544 68899999999999999999999999999999999999999999998854


Q ss_pred             ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcccccccccCC
Q 007006          481 ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG  560 (621)
Q Consensus       481 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~  560 (621)
                      ..   .+++..++.++.+++.++.+||+.+   ++|+||+|+||++++++.++|+|||.+.......   ......++..
T Consensus        81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence            32   2899999999999999999999985   9999999999999999999999999998765432   2223456788


Q ss_pred             ccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          561 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       561 y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      |++||.+....++.++|||+||++++||++|+.||..
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~  188 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG  188 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999888899999999999999999999999865

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.93  E-value=1.2e-26  Score=231.52  Aligned_cols=200  Identities=23%  Similarity=0.299  Sum_probs=167.8

Q ss_pred             HhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhccc--CC----ceeEeeEEeeCce
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH--KN----LVRLLGCCLEGQE  461 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h--~n----Iv~l~g~~~~~~~  461 (621)
                      .+++|.+...+|+|.||.|-.+... .+..||||+++..... .+..+-|+++|.++.+  |+    +|++.+|+.-.++
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            3678999999999999999999743 4789999999765433 3455789999999942  33    7889999999999


Q ss_pred             EEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC-------------
Q 007006          462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-------------  528 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-------------  528 (621)
                      .++|+|.+ |.|+.++|.. ++-.+++...+..|+.|+++++.+||+.+   ++|-||||+|||+.+             
T Consensus       166 iCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             eEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence            99999976 6689999954 34567899999999999999999999985   999999999999831             


Q ss_pred             -------CCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          529 -------DMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       529 -------~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                             +..++|+|||.+..-....     ..++.|..|.|||++.+-.++.++||||+||||.||.||..-|+-.+
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe  313 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE  313 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence                   2248999999998643322     45678999999999999999999999999999999999999987655

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.93  E-value=1.9e-25  Score=248.54  Aligned_cols=200  Identities=23%  Similarity=0.297  Sum_probs=140.5

Q ss_pred             HhCCCCccceeccCCceeEEEEEec-C----CcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeE------Ee
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA-D----GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC------CL  457 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~----g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~------~~  457 (621)
                      ..++|+..++||+|+||.||+|.+. +    +..||+|++......  +...+|  .+....+.++..++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            3568999999999999999999965 4    689999987643211  111111  1122222222222211      23


Q ss_pred             eCceEEEEEEecCCCChhhhhhhccCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCC
Q 007006          458 EGQELLLIYEYMPNKSLDVHLFDATRS-----------------VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK  520 (621)
Q Consensus       458 ~~~~~~lV~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk  520 (621)
                      .....++|+||+++++|.+++......                 .......+..++.||+.||.|||+.+   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            456789999999999999888542210                 11123446679999999999999886   9999999


Q ss_pred             CCCEEEcC-CCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCC----------------------CCChhhh
Q 007006          521 ASNILLDD-DMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG----------------------IFSIKSD  577 (621)
Q Consensus       521 p~NILl~~-~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----------------------~~s~~sD  577 (621)
                      |+|||+++ ++.+||+|||+++.+...... ......+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 579999999999865432221 22345678999999965322                      2345679


Q ss_pred             HHHHHHHHHHHHcCCCCCC
Q 007006          578 VFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       578 VwS~Gvll~elltG~~p~~  596 (621)
                      ||||||+||||+++..|++
T Consensus       362 VwSlGviL~el~~~~~~~~  380 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSD  380 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCc
Confidence            9999999999999776643

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.91  E-value=1.8e-25  Score=241.76  Aligned_cols=198  Identities=31%  Similarity=0.451  Sum_probs=160.8

Q ss_pred             CCccceeccCCcee-EEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEEEEecC
Q 007006          393 FSDENKLGQGGFGP-VYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMP  470 (621)
Q Consensus       393 f~~~~~LG~G~fG~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~~  470 (621)
                      |...+.+|.|+.|+ ||+|.. +|++||||++-...   ..-..+|+..|+.- +|||||++++.-.++...|+..|.| 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            45567899999976 899998 58999999986432   23457899999988 6999999999999999999999998 


Q ss_pred             CCChhhhhhhccCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC---C--CCeEEeeecCceecC
Q 007006          471 NKSLDVHLFDATRSV-QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---D--MNPKISDFGLARIFG  544 (621)
Q Consensus       471 ~gsL~~~l~~~~~~~-~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~--~~vkL~Dfgla~~~~  544 (621)
                      ..+|++++....... .......+.+..|+++||+|||+.+   |+||||||.||||+-   +  ..++|+|||+++.+.
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            478999986531111 1121445678899999999999975   999999999999975   3  469999999999886


Q ss_pred             CCCCC-cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcC-CCCCCCC
Q 007006          545 GNQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG-RKNNGFY  598 (621)
Q Consensus       545 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG-~~p~~~~  598 (621)
                      .+... .+.....||.+|+|||.+....-+..+||+|+||++|+.++| +.||+..
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~  718 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS  718 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch
Confidence            54432 223456799999999999998888899999999999999997 9999753

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.91  E-value=4.9e-23  Score=198.86  Aligned_cols=183  Identities=39%  Similarity=0.648  Sum_probs=158.2

Q ss_pred             eccCCceeEEEEEecC-CcEEEEEEeccCCcc-cHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCCChhh
Q 007006          399 LGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDV  476 (621)
Q Consensus       399 LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~gsL~~  476 (621)
                      ||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++|+++++++......++++|++++++|..
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999754 899999999765432 35678999999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC-CCCeEEeeecCceecCCCCCCcccccc
Q 007006          477 HLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFGGNQNQANTNII  555 (621)
Q Consensus       477 ~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~vkL~Dfgla~~~~~~~~~~~~~~~  555 (621)
                      ++....  ..+++..+..++.++++++.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........  .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            985432  46899999999999999999999985   999999999999999 89999999999987644321  12223


Q ss_pred             cccCCccChhcccCC-CCChhhhHHHHHHHHHHH
Q 007006          556 AGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEI  588 (621)
Q Consensus       556 ~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~el  588 (621)
                      .+...|++||..... ..+.+.|+|++|+++++|
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            467789999998877 789999999999999999

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.90  E-value=4.1e-25  Score=226.87  Aligned_cols=213  Identities=22%  Similarity=0.296  Sum_probs=178.4

Q ss_pred             cchHHHHHHhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhccc------CCceeEe
Q 007006          381 FPLRLALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH------KNLVRLL  453 (621)
Q Consensus       381 ~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h------~nIv~l~  453 (621)
                      +.....+....+|.+....|+|-|++|.+|... -|..||||+++.+..-. +.=+.|+++|++|+.      -|+++++
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            334444555678999999999999999999854 48899999998764221 223679999999952      4899999


Q ss_pred             eEEeeCceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC-Ce
Q 007006          454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NP  532 (621)
Q Consensus       454 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~v  532 (621)
                      -.|...++++||+|.+ ..+|.++|....++..|....+..++.|+..||..|...+   |+|.||||+|||+++.- .+
T Consensus       501 r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iL  576 (752)
T KOG0670|consen  501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNIL  576 (752)
T ss_pred             HHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCccee
Confidence            9999999999999977 5789999998888889999999999999999999999876   99999999999999764 58


Q ss_pred             EEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCcCCC
Q 007006          533 KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH  602 (621)
Q Consensus       533 kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~~~  602 (621)
                      ||+|||.|.....+...+.    .-+-.|.|||++.+-.|+...|+||.||.||||.||+..|.....++
T Consensus       577 KLCDfGSA~~~~eneitPY----LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~  642 (752)
T KOG0670|consen  577 KLCDFGSASFASENEITPY----LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ  642 (752)
T ss_pred             eeccCccccccccccccHH----HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH
Confidence            9999999987765544332    22456999999999999999999999999999999999887655543

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.90  E-value=3.8e-24  Score=204.20  Aligned_cols=212  Identities=20%  Similarity=0.347  Sum_probs=162.0

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhc-ccCCceeEeeE-EeeCceEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGC-CLEGQELLLIY  466 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~-~~~~~~~~lV~  466 (621)
                      .+.|.+.+.||+|.||.+-++.++ .+..+++|-+... .....+|.+|...--.| .|.||+.-+++ |+..+.+++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            457889999999999999999976 4778888887654 23457888888765555 58999886654 55667888999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc--CCCCeEEeeecCceecC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD--DDMNPKISDFGLARIFG  544 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~--~~~~vkL~Dfgla~~~~  544 (621)
                      ||+|.|+|.+-+.    ...+.+....+++.|+++|+.|+|+..   ++|||||.+||||-  +..++||+|||+.+..+
T Consensus       102 E~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  102 EFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             ccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence            9999999987663    345788889999999999999999985   99999999999994  33479999999987643


Q ss_pred             CCCCCcccccccccCCccChhcccCC---C--CChhhhHHHHHHHHHHHHcCCCCCCCCcCCCCCChHHHHHHhhccc
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMGG---I--FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLSLS  617 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~~---~--~s~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~v~~~~~~~  617 (621)
                      ...     ....-+..|.+||.....   .  ..+.+|||.||++++.++||+.||+ ........+.  =|..|..+
T Consensus       175 ~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ-ka~~~d~~Y~--~~~~w~~r  244 (378)
T KOG1345|consen  175 TTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ-KASIMDKPYW--EWEQWLKR  244 (378)
T ss_pred             cee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch-hhhccCchHH--HHHHHhcc
Confidence            321     112235679999976432   2  4678999999999999999999999 3333343443  34455443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.89  E-value=1.7e-24  Score=228.52  Aligned_cols=197  Identities=27%  Similarity=0.441  Sum_probs=173.9

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      .++|+....+|.|.+|.|||++. ..++..|+|.++-.......-..+|+-+++..+|||||.++|.+...+.+++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            46889999999999999999995 46899999999988777778888999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +.+|+|.+.-+-   ..++++.++..+.+..++||.|||+.|   -+|||||-.|||+++.|.+|++|||.+..+...  
T Consensus        94 cgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat--  165 (829)
T KOG0576|consen   94 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT--  165 (829)
T ss_pred             cCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh--
Confidence            999999886643   456899999999999999999999987   789999999999999999999999998755322  


Q ss_pred             CcccccccccCCccChhcc---cCCCCChhhhHHHHHHHHHHHHcCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYA---MGGIFSIKSDVFSFGVLLLEIISGRKN  594 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l---~~~~~s~~sDVwS~Gvll~elltG~~p  594 (621)
                      -...+...||+.|||||+.   +.+.|..++|||+.|+...|+---++|
T Consensus       166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpp  214 (829)
T KOG0576|consen  166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPP  214 (829)
T ss_pred             hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCc
Confidence            2233456899999999976   567799999999999999999877777

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.89  E-value=2.8e-23  Score=210.15  Aligned_cols=198  Identities=28%  Similarity=0.465  Sum_probs=165.0

Q ss_pred             HhCCCCccceeccCCceeEEEEEec----CCcEEEEEEeccCCcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEE
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELL  463 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~  463 (621)
                      ..+.|..+++||+|.|++||++.+.    ..+.||+|.+...+..  ..+.+|+++|..+ .+.||+++.+++..++...
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~  111 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA  111 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence            4467889999999999999999853    4678999998765433  5688999999999 5899999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC-CCCeEEeeecCcee
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLARI  542 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~vkL~Dfgla~~  542 (621)
                      +|+||++.....++...      ++..++..+++.+.+||.++|.+|   ||||||||+|+|.+. .+.-.|.|||++..
T Consensus       112 ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~  182 (418)
T KOG1167|consen  112 IVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQR  182 (418)
T ss_pred             EEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHH
Confidence            99999999998888843      678899999999999999999987   999999999999985 56789999999973


Q ss_pred             cCCCC-------------CC----------------c-------------ccccccccCCccChhcccCCC-CChhhhHH
Q 007006          543 FGGNQ-------------NQ----------------A-------------NTNIIAGTYGYMAPEYAMGGI-FSIKSDVF  579 (621)
Q Consensus       543 ~~~~~-------------~~----------------~-------------~~~~~~gt~~y~aPE~l~~~~-~s~~sDVw  579 (621)
                      .+..+             ..                +             ......||++|.|||++.... .++++|||
T Consensus       183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw  262 (418)
T KOG1167|consen  183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW  262 (418)
T ss_pred             HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence            21100             00                0             001235899999999987654 68999999


Q ss_pred             HHHHHHHHHHcCCCCCCC
Q 007006          580 SFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       580 S~Gvll~elltG~~p~~~  597 (621)
                      |-|||++-+++++.||-.
T Consensus       263 s~GVI~Lslls~~~PFf~  280 (418)
T KOG1167|consen  263 SAGVILLSLLSRRYPFFK  280 (418)
T ss_pred             eccceeehhhcccccccc
Confidence            999999999999999754

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.88  E-value=3.1e-23  Score=202.66  Aligned_cols=194  Identities=31%  Similarity=0.417  Sum_probs=159.2

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeC------c
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------Q  460 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~------~  460 (621)
                      ..+|.-+..+|.|.- .|-.+.. -.++.||+|++...  .....++..+|..++..++|+||++++.++.-.      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            356777888898887 4444432 35899999988654  234456778999999999999999999998643      3


Q ss_pred             eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCc
Q 007006          461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA  540 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla  540 (621)
                      +.++|||+|. .+|...+.     ..++=++...|..|++.|++|||+.+   |+||||||+||++..+..+||.|||++
T Consensus        95 e~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   95 EVYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             hHHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence            5799999995 67777774     23667888899999999999999986   999999999999999999999999999


Q ss_pred             eecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          541 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       541 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      +.-+..   -.....+.|..|.|||++.+..+.+.+||||+||++.||++|+.-|.
T Consensus       166 r~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~  218 (369)
T KOG0665|consen  166 RTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP  218 (369)
T ss_pred             cccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence            864322   23344567888999999998889999999999999999999998775

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=99.88  E-value=2.4e-23  Score=180.10  Aligned_cols=99  Identities=31%  Similarity=0.634  Sum_probs=76.8

Q ss_pred             cccCC---CCcc-CCCChHHHHHHHHHhhcccccccc---cCceecccCCCCCcEEEEEeccCCCCccchHHHHHHHHHH
Q 007006           75 VLSCA---VSNN-TASNTFTSNLNILFNQKLHSEAGK---SLYYNASEGEFPDSVYGLYLCKFNVSFQSCQNCIVAAVNS  147 (621)
Q Consensus        75 ~~~C~---~~~~-~~~s~~~~nl~~ll~~l~~~~~~~---~~f~~~~~g~~~~~vygl~qC~~D~~~~~C~~Cl~~a~~~  147 (621)
                      |+.|+   .++| +++++|++||+.||+.|. +.++.   .+|+++..|.++++|||++||++|+++++|..||+.|+..
T Consensus         1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~-~~a~~~~~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~   79 (106)
T PF01657_consen    1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLV-SNAASSSSKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVAN   79 (106)
T ss_dssp             ---E---SSB----TT-THHHHHHHHHHHHH-HHGGGTT-TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHCC
T ss_pred             CCcCCCCCCCCcCCCCchHHHHHHHHHHHHH-HHHhhccccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHHH
Confidence            57798   5567 578889999999999999 66554   4899998899999999999999999999999999999999


Q ss_pred             HHhcCCCCCceEEEeecCceEEeecCCCC
Q 007006          148 VLQKCSGTKEAFIWYQVQECMVRFSDHSS  176 (621)
Q Consensus       148 ~~~~C~~~~~a~~~~~~~~C~lry~~~~f  176 (621)
                      +...|+.+++|+||+++  |+||||+++|
T Consensus        80 ~~~~C~~~~g~~v~~~~--C~lRY~~~~F  106 (106)
T PF01657_consen   80 ISSCCPGSRGGRVWYDS--CFLRYENYPF  106 (106)
T ss_dssp             HHHHTTSBSSEEEEESS--EEEEEESS--
T ss_pred             HHHhCCCCceEEEECCC--EEEEEECCCC
Confidence            99999999999999999  9999999998

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=1.6e-22  Score=211.17  Aligned_cols=166  Identities=20%  Similarity=0.220  Sum_probs=128.4

Q ss_pred             HhCCCCccceeccCCceeEEEEEec--CCcEEEEEEeccC-----CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCce
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA--DGKAIAVKRLSRT-----SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE  461 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~  461 (621)
                      ..++|.+.+.||+|+||+||++.+.  +++.+|||++...     .....+.+.+|+++|++++|+|+++.+..   .+.
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~   92 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK   92 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence            4578999999999999999999864  5778899987533     12234568999999999999999853322   245


Q ss_pred             EEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC-CCCCEEEcCCCCeEEeeecCc
Q 007006          462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDL-KASNILLDDDMNPKISDFGLA  540 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dl-kp~NILl~~~~~vkL~Dfgla  540 (621)
                      .++||||+++++|....    .   ..   ...++.+++++|.|||+.+   |+|||| ||+|||++.++.+||+|||++
T Consensus        93 ~~LVmE~~~G~~L~~~~----~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         93 DGLVRGWTEGVPLHLAR----P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             cEEEEEccCCCCHHHhC----c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccc
Confidence            79999999999996221    1   11   1467889999999999986   999999 999999999999999999999


Q ss_pred             eecCCCCCCcc------cccccccCCccChhcccCC
Q 007006          541 RIFGGNQNQAN------TNIIAGTYGYMAPEYAMGG  570 (621)
Q Consensus       541 ~~~~~~~~~~~------~~~~~gt~~y~aPE~l~~~  570 (621)
                      +.+........      -....+++.|+|||++...
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            97754322111      1245678889999988543

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=2.4e-21  Score=202.21  Aligned_cols=204  Identities=23%  Similarity=0.305  Sum_probs=166.6

Q ss_pred             CCCccceeccCCceeEEEEEecC--CcEEEEEEeccCCcccHHHHHHHHHHHHhccc----CCceeEeeEE-eeCceEEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTLAD--GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH----KNLVRLLGCC-LEGQELLL  464 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~~--g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h----~nIv~l~g~~-~~~~~~~l  464 (621)
                      +|.+.++||+|+||.||.+....  ...+|+|............+..|..++..+..    +++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            79999999999999999999654  35788888776543333367889999999873    6899999888 46677899


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC-----CCeEEeeecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-----MNPKISDFGL  539 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-----~~vkL~Dfgl  539 (621)
                      ||+.+ |.+|.++..... ...++..+.++|+.|++.+|++||+.|   ++||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99865 789988775443 567999999999999999999999987   9999999999999765     4599999999


Q ss_pred             ce--ecCCCCC----Ccc--cccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCcC
Q 007006          540 AR--IFGGNQN----QAN--TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFS  600 (621)
Q Consensus       540 a~--~~~~~~~----~~~--~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~  600 (621)
                      ++  .+.....    ...  .....||..|.+++...+...+++.|+||++.++.|++.|..||.....
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~  242 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM  242 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence            99  4322221    111  2235599999999999999999999999999999999999999965443

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=7.1e-21  Score=195.14  Aligned_cols=132  Identities=24%  Similarity=0.367  Sum_probs=109.4

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcc-----c---CCceeEeeEEeeC--
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-----H---KNLVRLLGCCLEG--  459 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----h---~nIv~l~g~~~~~--  459 (621)
                      .+|-+.++||=|.|++||++.. .+.+-||+|+.+.. ....+....||++|++++     |   .+||+|++.|...  
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            6889999999999999999984 56788999988643 233456789999999984     3   3699999999854  


Q ss_pred             --ceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc
Q 007006          460 --QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD  527 (621)
Q Consensus       460 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~  527 (621)
                        .+.++|+|++ |.+|..++.. .....++...+.+|++||+.||.|||...  +|||-||||+|||+.
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~-s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKY-SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHH-hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence              4899999998 5666666643 33456899999999999999999999986  799999999999984

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=2.8e-21  Score=181.83  Aligned_cols=204  Identities=22%  Similarity=0.301  Sum_probs=169.5

Q ss_pred             HhCCCCccceeccCCceeEEEEE-ecCCcEEEEEEeccCCcccHHHHHHHHHHHHhccc-CCceeEeeEEeeCceEEEEE
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH-KNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h-~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ..+.|.++++||.|+||.+|.|. ..+|++||||.-+....  ...+..|.++...|++ ..|+.+..+..+...-.+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            34689999999999999999998 67899999998765432  2456788999999976 66777888888888889999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC---CCeEEeeecCceec
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD---MNPKISDFGLARIF  543 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~vkL~Dfgla~~~  543 (621)
                      |.+ |.+|++...-.++  .++.++++-++-|++.-++|+|..+   ++||||||+|.|..-+   ..+.|+|||+++.+
T Consensus        91 dLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             ecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence            976 7899888765544  4788999999999999999999986   9999999999999644   45899999999987


Q ss_pred             CCCCCCc-----ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCcC
Q 007006          544 GGNQNQA-----NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFS  600 (621)
Q Consensus       544 ~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~  600 (621)
                      .+.....     ..+...||.+|.+-....+.+.+.+.|+-|+|.+|..+-.|..||+....
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka  226 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA  226 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence            5433222     22346789999999888888889999999999999999999999986554

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=1.3e-20  Score=184.93  Aligned_cols=202  Identities=22%  Similarity=0.339  Sum_probs=170.5

Q ss_pred             hCCCCccceeccCCceeEEEEE-ecCCcEEEEEEeccCCcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      .-+|.+.++||+|.||+++.|+ +-+++.||||.-...++  ..++..|.+..+.| ..+.|...+-+-.++.+-.||+|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            3579999999999999999998 66899999997655443  35667888888888 46899999988888888899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC-----CeEEeeecCcee
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-----NPKISDFGLARI  542 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-----~vkL~Dfgla~~  542 (621)
                      .+ |-||+++..-+.  ..++.+++..++.|++.-++|+|++.   +|.|||||+|+||..-+     .+.|+|||+++.
T Consensus       105 LL-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  105 LL-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hh-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            76 788988775443  35899999999999999999999986   99999999999996543     489999999998


Q ss_pred             cCCCCCCcc-----cccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          543 FGGNQNQAN-----TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       543 ~~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      +.++.....     .+...||.+||+-....+.+.+.+.|+-|+|-|+...+.|..||+-..
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK  240 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  240 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence            876544332     234679999999999999999999999999999999999999997544

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.84  E-value=1.4e-19  Score=186.17  Aligned_cols=202  Identities=34%  Similarity=0.502  Sum_probs=169.7

Q ss_pred             CCccceeccCCceeEEEEEecCCcEEEEEEeccCCcc---cHHHHHHHHHHHHhcccC-CceeEeeEEeeCceEEEEEEe
Q 007006          393 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ---GLQEFKNEVNLIAKLQHK-NLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       393 f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~h~-nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      |...+.||.|+||.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            566789999999999999976  88899998765432   367899999999999988 799999999777778999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC-CeEEeeecCceecCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIFGGNQ  547 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~vkL~Dfgla~~~~~~~  547 (621)
                      +.++++..++........+.......+..|++.++.|+|+.+   ++|||+||+||+++..+ .+++.|||++.......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999966643211136889999999999999999999986   99999999999999988 79999999998665443


Q ss_pred             CCc----ccccccccCCccChhcccC---CCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          548 NQA----NTNIIAGTYGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       548 ~~~----~~~~~~gt~~y~aPE~l~~---~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      ...    ......++..|++||.+.+   ...+...|+|++|++++++++|..|+....
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~  215 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK  215 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            322    2345678999999999987   578999999999999999999999955433

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.83  E-value=4e-21  Score=224.06  Aligned_cols=148  Identities=20%  Similarity=0.238  Sum_probs=112.2

Q ss_pred             hccc-CCceeEeeEE-------eeCceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 007006          443 KLQH-KNLVRLLGCC-------LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI  514 (621)
Q Consensus       443 ~l~h-~nIv~l~g~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i  514 (621)
                      .++| +||+++++++       .+.+.+++++|++ +++|.+++..  ....+++.+++.++.||++||.|||+++   |
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            4455 5788888877       2334677888887 5699999953  2345999999999999999999999886   9


Q ss_pred             EeccCCCCCEEEcCC-------------------CCeEEeeecCceecCCCCC--------------CcccccccccCCc
Q 007006          515 IHRDLKASNILLDDD-------------------MNPKISDFGLARIFGGNQN--------------QANTNIIAGTYGY  561 (621)
Q Consensus       515 iH~Dlkp~NILl~~~-------------------~~vkL~Dfgla~~~~~~~~--------------~~~~~~~~gt~~y  561 (621)
                      +||||||+||||+..                   +.+|++|||+++.......              ........||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            999999999999654                   4455666666553211000              0001113578889


Q ss_pred             cChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          562 MAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       562 ~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      ||||++.+..++.++|||||||+||||++|.+|+.
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~  216 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSRE  216 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence            99999999999999999999999999999998864

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.82  E-value=7.2e-20  Score=175.78  Aligned_cols=139  Identities=17%  Similarity=0.196  Sum_probs=108.3

Q ss_pred             cceeccCCceeEEEEEecCCcEEEEEEeccCCcc--c-------HHH-----------------HHHHHHHHHhcccCCc
Q 007006          396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ--G-------LQE-----------------FKNEVNLIAKLQHKNL  449 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~--~-------~~~-----------------~~~Ei~~l~~l~h~nI  449 (621)
                      ...||+|+||.||+|...+|+.||||+++.....  .       ...                 ...|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999999888999999999754211  1       112                 2349999999988877


Q ss_pred             eeEeeEEeeCceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeccCCCCCEEEcC
Q 007006          450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL-HEDSRLKIIHRDLKASNILLDD  528 (621)
Q Consensus       450 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiH~Dlkp~NILl~~  528 (621)
                      .....+...  ..++||||++++++.....   ....+++.....++.|++.+|.+| |+.+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence            443333222  2389999999887764432   234688999999999999999999 6765   99999999999998 


Q ss_pred             CCCeEEeeecCceec
Q 007006          529 DMNPKISDFGLARIF  543 (621)
Q Consensus       529 ~~~vkL~Dfgla~~~  543 (621)
                      ++.++|+|||++...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.81  E-value=4.6e-20  Score=179.64  Aligned_cols=171  Identities=14%  Similarity=0.161  Sum_probs=132.7

Q ss_pred             HhCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHH---H------HHHHHHHHHhcccCCceeEeeEEeeC
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQ---E------FKNEVNLIAKLQHKNLVRLLGCCLEG  459 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~---~------~~~Ei~~l~~l~h~nIv~l~g~~~~~  459 (621)
                      ..++|...+.||.|+||.||.... ++..+|+|.++........   .      +.+|+..+.++.|++|..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            458999999999999999999655 5778999999755332222   2      57899999999999999998886643


Q ss_pred             --------ceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCC
Q 007006          460 --------QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN  531 (621)
Q Consensus       460 --------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~  531 (621)
                              +..+++|||++|.+|.++..       ++.    ....+++.+|..+|+.+   ++|||++|+||++++++ 
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence                    35789999999999977641       222    24558999999999986   99999999999999988 


Q ss_pred             eEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHH
Q 007006          532 PKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEII  589 (621)
Q Consensus       532 vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ell  589 (621)
                      ++|+|||.......+...              ..+.....+..++|+|+||+.+.-+.
T Consensus       173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            999999987654211100              11344555667999999999887653

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.81  E-value=6.2e-19  Score=169.68  Aligned_cols=141  Identities=19%  Similarity=0.264  Sum_probs=111.5

Q ss_pred             cceeccCCceeEEEEEecCCcEEEEEEeccCCcc---------------------c-----HHHHHHHHHHHHhcccCCc
Q 007006          396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ---------------------G-----LQEFKNEVNLIAKLQHKNL  449 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~---------------------~-----~~~~~~Ei~~l~~l~h~nI  449 (621)
                      ...||+|++|.||+|...+|+.||||+++.....                     .     ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999999878999999998764211                     0     1123578999999999987


Q ss_pred             eeEeeEEeeCceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCEEEcC
Q 007006          450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE-DSRLKIIHRDLKASNILLDD  528 (621)
Q Consensus       450 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~  528 (621)
                      .....+...  ..++||||++++++.....   ....++......++.|++.++.+||+ .+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            554444333  2489999999886543321   12457888999999999999999999 75   99999999999999 


Q ss_pred             CCCeEEeeecCceecCC
Q 007006          529 DMNPKISDFGLARIFGG  545 (621)
Q Consensus       529 ~~~vkL~Dfgla~~~~~  545 (621)
                      ++.++|+|||++.....
T Consensus       153 ~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCEEEEEcccceecCC
Confidence            88999999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.78  E-value=5.4e-19  Score=167.58  Aligned_cols=106  Identities=26%  Similarity=0.218  Sum_probs=92.6

Q ss_pred             CChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcc
Q 007006          472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN  551 (621)
Q Consensus       472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~  551 (621)
                      |+|.+++..  +...+++.+++.++.||++||.|||+.+         ||+|||++.++.+|+  ||++.......    
T Consensus         1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence            688888853  2346999999999999999999999874         999999999999999  99988754322    


Q ss_pred             cccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       552 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                         ..|++.|+|||++.+..++.++||||||+++|||+||+.||..
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~  106 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNE  106 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence               2578999999999999999999999999999999999999853

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=5.4e-18  Score=161.73  Aligned_cols=184  Identities=18%  Similarity=0.129  Sum_probs=138.4

Q ss_pred             CccceeccCCceeEEEEEecCCcEEEEEEeccCCcc----cHHHHHHHHHHHHhcc-cCCceeEeeEEeeCceEEEEEEe
Q 007006          394 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ----GLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       394 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~----~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      .+...|++|+||+||.+.. .+..++.+.+......    ....+.+|+++|++++ |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3467899999999997665 6788888877654331    1235789999999995 5889999886    346899999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC-CCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDL-KASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dl-kp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      +.|.+|...+..          ....++.|++.+|.++|++|   |+|||| ||+|||++.++.++|+|||++.......
T Consensus        80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            999988643310          11357789999999999987   999999 7999999999999999999998654322


Q ss_pred             CC----cc-------cccccccCCccChhcccC--CCCChhhhHHHHHHHHHHHHcCCCCC
Q 007006          548 NQ----AN-------TNIIAGTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGRKNN  595 (621)
Q Consensus       548 ~~----~~-------~~~~~gt~~y~aPE~l~~--~~~s~~sDVwS~Gvll~elltG~~p~  595 (621)
                      ..    ..       ......++.|++|+...-  ..--...++++-|..+|.++|++.|+
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence            10    00       011235778888885422  22336789999999999999999984

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.78  E-value=1.5e-19  Score=172.84  Aligned_cols=193  Identities=26%  Similarity=0.364  Sum_probs=153.1

Q ss_pred             ccceeccCCceeEEEEEecCCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCC
Q 007006          395 DENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNK  472 (621)
Q Consensus       395 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~g  472 (621)
                      ..-+|.+...|+.|+|+++ |..+++|++...  .....++|.+|.-.|+.+.||||++++|.|..+..+.++..||+.|
T Consensus       194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            3457889999999999996 556667777543  3334467999999999999999999999999999999999999999


Q ss_pred             ChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEe--eecCceecCCCCCCc
Q 007006          473 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS--DFGLARIFGGNQNQA  550 (621)
Q Consensus       473 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~--Dfgla~~~~~~~~~~  550 (621)
                      +|...|++.. ....+..++.+++.++++|++|||+..+ -|.---|.+..|+||++.+++|+  |--++..     ...
T Consensus       273 slynvlhe~t-~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsfq-----e~g  345 (448)
T KOG0195|consen  273 SLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSFQ-----EVG  345 (448)
T ss_pred             HHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeeee-----ccc
Confidence            9999997643 4457888999999999999999999863 24444689999999999988875  3222110     111


Q ss_pred             ccccccccCCccChhcccCCC---CChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          551 NTNIIAGTYGYMAPEYAMGGI---FSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~~---~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                          ..-.+.||+||.+...+   .-..+|+|||++++|||.|...||.-..
T Consensus       346 ----r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadls  393 (448)
T KOG0195|consen  346 ----RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLS  393 (448)
T ss_pred             ----cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCC
Confidence                12257899999997765   3457999999999999999999996443

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=99.75  E-value=1.3e-18  Score=150.43  Aligned_cols=91  Identities=29%  Similarity=0.353  Sum_probs=73.4

Q ss_pred             hhcHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccCccceeEEeeecCCCCccchhhHHHHHHHhhhhccCCCCCcce
Q 007006          190 FQNTYNVTKSLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGFG  269 (621)
Q Consensus       190 ~~~~~~~~~~l~~~l~~~a~~~~~~~~~~a~~~~~~~~~~~vy~laQCt~DLs~~~C~~CL~~~~~~~~~~c~~~~~~~g  269 (621)
                      ...|+..+.++|..|.+.++.  .++.+|++++. ..+..+||||+||+|||+++||+.||..++..++.+|+.+  .||
T Consensus        16 ~~~f~~~l~~ll~~l~~~a~~--~~~~~f~~~~~-~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~~~~C~~~--~g~   90 (106)
T PF01657_consen   16 NSTFEQNLNSLLSSLVSNAAS--SSSKGFATGSA-GSGPDTVYGLAQCRGDLSPSDCRACLADAVANISSCCPGS--RGG   90 (106)
T ss_dssp             T-THHHHHHHHHHHHHHHGGG--TT-TEEEEEE---ST---EEEEEEE-TTS-HHHHHHHHHHHHCCHHHHTTSB--SSE
T ss_pred             CchHHHHHHHHHHHHHHHHhh--ccccCcEEeec-CCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHHHHhCCCC--ceE
Confidence            345999999999999999872  23589999986 5578899999999999999999999999999999999987  999


Q ss_pred             EEEccccccceeeccc
Q 007006          270 RILFPSCIMGFELYRY  285 (621)
Q Consensus       270 ~v~~~~C~lry~~~~f  285 (621)
                      +|++++|++||+.++|
T Consensus        91 ~v~~~~C~lRY~~~~F  106 (106)
T PF01657_consen   91 RVWYDSCFLRYENYPF  106 (106)
T ss_dssp             EEEESSEEEEEESS--
T ss_pred             EEECCCEEEEEECCCC
Confidence            9999999999999987

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>PRK10345 hypothetical protein; Provisional

Probab=99.74  E-value=2.3e-17  Score=160.16  Aligned_cols=136  Identities=19%  Similarity=0.297  Sum_probs=105.9

Q ss_pred             CccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhc-----ccCCceeEeeEEeeCc---e-EEE
Q 007006          394 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-----QHKNLVRLLGCCLEGQ---E-LLL  464 (621)
Q Consensus       394 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-----~h~nIv~l~g~~~~~~---~-~~l  464 (621)
                      ...+.||+|+||.||.  +++....+||++........+.+.+|+.+++.+     +||||++++|++.++.   . ..+
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            4467899999999996  433333479988765555567899999999999     5799999999999874   3 347


Q ss_pred             EEEe--cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEeccCCCCCEEEcC----CCCeEEeee
Q 007006          465 IYEY--MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI-LYLHEDSRLKIIHRDLKASNILLDD----DMNPKISDF  537 (621)
Q Consensus       465 V~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~iiH~Dlkp~NILl~~----~~~vkL~Df  537 (621)
                      |+||  +++++|.+++.+.    .+++.  ..++.+++.++ +|||+++   |+||||||+|||++.    ++.++|+|+
T Consensus        83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            8999  5579999999432    25555  35677888777 8999986   999999999999974    347999994


Q ss_pred             cCc
Q 007006          538 GLA  540 (621)
Q Consensus       538 gla  540 (621)
                      +.+
T Consensus       154 ~G~  156 (210)
T PRK10345        154 IGE  156 (210)
T ss_pred             CCC
Confidence            443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.71  E-value=1.2e-18  Score=185.18  Aligned_cols=186  Identities=29%  Similarity=0.345  Sum_probs=154.2

Q ss_pred             eeccCCceeEEEEE----ecCCcEEEEEEeccCCccc--HHHHHHHHHHHHhcc-cCCceeEeeEEeeCceEEEEEEecC
Q 007006          398 KLGQGGFGPVYKGT----LADGKAIAVKRLSRTSGQG--LQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEYMP  470 (621)
Q Consensus       398 ~LG~G~fG~Vy~~~----~~~g~~vavK~l~~~~~~~--~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV~e~~~  470 (621)
                      .+|+|.||.|+.+.    .+.|..+|+|.+++.....  ......|..++...+ ||.+|++...++.+...++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37899999999864    3457888999887653211  124456788888886 9999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc
Q 007006          471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA  550 (621)
Q Consensus       471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~  550 (621)
                      +|.|...+.   +...+++.........++-+++++|+.+   ++|||+|++||+++.+|++++.|||+++..-....  
T Consensus        81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--  152 (612)
T KOG0603|consen   81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--  152 (612)
T ss_pred             cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence            999876663   3344677777778888999999999886   99999999999999999999999999886532221  


Q ss_pred             ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                          .+||..|||||++.  .....+|.||||++++||+||-.||..
T Consensus       153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence                18899999999988  567789999999999999999999976

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=3.4e-18  Score=190.19  Aligned_cols=203  Identities=27%  Similarity=0.365  Sum_probs=158.5

Q ss_pred             CccceeccCCceeEEEEEe-cCCcEEEEEEec----cCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          394 SDENKLGQGGFGPVYKGTL-ADGKAIAVKRLS----RTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       394 ~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~----~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ...+.+|.|.+|.|+.... ......+.|..+    ...  ......+..|+.+-..+.|||++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            3567899999997777653 233334444332    111  111122556777777889999998888887777666669


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++ +|..++..   ...+...++..++.|+..|+.|||+.|   |.|||+|++|++++.+|.+||+|||.+..+..+
T Consensus       401 E~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 99888843   246888999999999999999999987   999999999999999999999999999887554


Q ss_pred             CCC--cccccccccCCccChhcccCCCCCh-hhhHHHHHHHHHHHHcCCCCCCCCcCCCC
Q 007006          547 QNQ--ANTNIIAGTYGYMAPEYAMGGIFSI-KSDVFSFGVLLLEIISGRKNNGFYFSEHG  603 (621)
Q Consensus       547 ~~~--~~~~~~~gt~~y~aPE~l~~~~~s~-~sDVwS~Gvll~elltG~~p~~~~~~~~~  603 (621)
                      ...  ......+|+..|+|||.+.+..|.+ ..||||.|+++..|.+|+.||.....++.
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~  533 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDN  533 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccccc
Confidence            443  3344567899999999999999855 58999999999999999999987666544

>smart00090 RIO RIO-like kinase

Probab=99.70  E-value=1.7e-16  Score=157.61  Aligned_cols=144  Identities=17%  Similarity=0.183  Sum_probs=112.1

Q ss_pred             CCCCccceeccCCceeEEEEE--ecCCcEEEEEEeccCCcc------------------------cHHHHHHHHHHHHhc
Q 007006          391 NHFSDENKLGQGGFGPVYKGT--LADGKAIAVKRLSRTSGQ------------------------GLQEFKNEVNLIAKL  444 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~--~~~g~~vavK~l~~~~~~------------------------~~~~~~~Ei~~l~~l  444 (621)
                      ..|.+.+.||+|++|.||+|.  ..+|+.||+|+++.....                        ....+..|+..+.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            357888999999999999998  568999999998753210                        012356899999999


Q ss_pred             ccC--CceeEeeEEeeCceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCC
Q 007006          445 QHK--NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKAS  522 (621)
Q Consensus       445 ~h~--nIv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~  522 (621)
                      .+.  .++++++.    ...++||||+++.+|......   ...+...+...++.||+.++.+||+.+  +++||||||+
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~  178 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY  178 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh
Confidence            763  34455543    234899999999888665422   234566677889999999999999874  4999999999


Q ss_pred             CEEEcCCCCeEEeeecCceecC
Q 007006          523 NILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       523 NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      ||+++ +++++|+|||.+...+
T Consensus       179 NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhccC
Confidence            99999 8899999999987543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.69  E-value=2.5e-16  Score=154.00  Aligned_cols=134  Identities=19%  Similarity=0.305  Sum_probs=112.6

Q ss_pred             ceeccCCceeEEEEEecCCcEEEEEEeccCCcc--------cHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ--------GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~--------~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      +.||+|++|.||+|.. +|..+++|+.......        ....+.+|++++..++|++++....++.+.+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 6788999976543211        123577899999999999988877777777788999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      ++|++|.+++...      .+ .+..++.+++.+|.+||+.+   ++|||++|.|||++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999888431      12 78889999999999999986   99999999999999 78899999999875

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.68  E-value=3.9e-16  Score=151.29  Aligned_cols=139  Identities=22%  Similarity=0.221  Sum_probs=109.7

Q ss_pred             hCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcc----------------------cHHHHHHHHHHHHhcccC
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ----------------------GLQEFKNEVNLIAKLQHK  447 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~----------------------~~~~~~~Ei~~l~~l~h~  447 (621)
                      ...|.+.++||+|+||.||++..++|+.||||+++.....                      ....+..|+.++..+.|+
T Consensus        14 ~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   93 (198)
T cd05144          14 GVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE   93 (198)
T ss_pred             CchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence            3347778999999999999999888999999987643210                      012356789999999887


Q ss_pred             --CceeEeeEEeeCceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEE
Q 007006          448 --NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNIL  525 (621)
Q Consensus       448 --nIv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NIL  525 (621)
                        .+++.++.    ...++||||+++++|.....         ......++.+++.++.++|+.+   ++||||+|+||+
T Consensus        94 ~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nil  157 (198)
T cd05144          94 GFPVPKPIDW----NRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNIL  157 (198)
T ss_pred             CCCCCceeec----CCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEE
Confidence              45555542    34589999999999875441         0335678899999999999975   999999999999


Q ss_pred             EcCCCCeEEeeecCceecC
Q 007006          526 LDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       526 l~~~~~vkL~Dfgla~~~~  544 (621)
                      +++++.++|+|||++....
T Consensus       158 l~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         158 VDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             EcCCCcEEEEECCccccCC
Confidence            9999999999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.68  E-value=1.4e-16  Score=180.78  Aligned_cols=197  Identities=20%  Similarity=0.250  Sum_probs=155.0

Q ss_pred             hCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcc---cCCceeEeeEEeeCceEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      .+.|.+.+.||+|+||.||+|...+|+.||+|.-+.....   +|.-=.+++.+|+   -+.|..+...+.-.+.-+||+
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~  773 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS  773 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence            3578888999999999999999888999999987655432   1222223445554   234444555555566778999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC-------CCCeEEeeecC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-------DMNPKISDFGL  539 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-------~~~vkL~Dfgl  539 (621)
                      ||.+.|+|.+++.   ..+.++|.....++.|+++.+++||..+   ||||||||+|.||..       ..-++|+|||-
T Consensus       774 ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~  847 (974)
T KOG1166|consen  774 EYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGR  847 (974)
T ss_pred             eccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEeccc
Confidence            9999999999995   5567999999999999999999999986   999999999999942       23489999998


Q ss_pred             ceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCC
Q 007006          540 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNN  595 (621)
Q Consensus       540 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~  595 (621)
                      +-.+..-......+..++|-.+--+|...+..++...|.|.++-+++-|+.|+..-
T Consensus       848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q  903 (974)
T KOG1166|consen  848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME  903 (974)
T ss_pred             ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH
Confidence            86543222223334567888999999999999999999999999999999998763

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.68  E-value=2.5e-17  Score=183.31  Aligned_cols=198  Identities=21%  Similarity=0.257  Sum_probs=150.3

Q ss_pred             CCCccceeccCCceeEEEEEecCCcEEEEEEeccCC-cccHHHHHHHHHHH--HhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          392 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS-GQGLQEFKNEVNLI--AKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l--~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      ++...+.||.+.|=.|.++++++|. |+||++-+.. .-..+.|.++++-+  ..+++||++++.-+...+...|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5667789999999999999998888 8999987664 44455666555444  445899999998887777777888888


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC-CC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG-NQ  547 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~-~~  547 (621)
                      ..+ +|.+-+   ..+..+...+..-|+.|++.||..+|..+   |+|||||.+||||+...-+.|+||...+..-- .+
T Consensus       103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            753 455544   23445777788889999999999999886   99999999999999999999999998764321 22


Q ss_pred             CCcccccc----cccCCccChhcccCC----------C-CChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          548 NQANTNII----AGTYGYMAPEYAMGG----------I-FSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       548 ~~~~~~~~----~gt~~y~aPE~l~~~----------~-~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      +......+    .+-..|+|||.+...          . .+++.||||+||++.||++ |++||..
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L  241 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL  241 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence            22221122    233469999976431          1 6788999999999999988 6888753

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.67  E-value=2.3e-16  Score=158.34  Aligned_cols=201  Identities=21%  Similarity=0.288  Sum_probs=132.2

Q ss_pred             CCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcc----------cCCceeEeeEEee
Q 007006          393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQ----------HKNLVRLLGCCLE  458 (621)
Q Consensus       393 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~----------h~nIv~l~g~~~~  458 (621)
                      +...+.||.|+++.||.+++. +|+++|+|++....   ....+++++|.-....+.          |-.++-.++...-
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            344678999999999999975 59999999886432   344667777765555432          2222222222221


Q ss_pred             ------------Cc-----eEEEEEEecCCCChhhhhh---hcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 007006          459 ------------GQ-----ELLLIYEYMPNKSLDVHLF---DAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR  517 (621)
Q Consensus       459 ------------~~-----~~~lV~e~~~~gsL~~~l~---~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~  517 (621)
                                  ..     ..+++|+-+ .++|..++.   ... ....+....++.+..|+++.+++||+.|   ++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence                        11     235677766 577877653   111 1233555666788899999999999997   9999


Q ss_pred             cCCCCCEEEcCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccC--------CCCChhhhHHHHHHHHHHHH
Q 007006          518 DLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG--------GIFSIKSDVFSFGVLLLEII  589 (621)
Q Consensus       518 Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~s~~sDVwS~Gvll~ell  589 (621)
                      ||+|+|++++.+|.++|+||+.....+.....     ...+..|.+||....        -.++.+.|.|++|+++|.|+
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            99999999999999999999987764432111     123467999997643        24788999999999999999


Q ss_pred             cCCCCCCCCcCCC
Q 007006          590 SGRKNNGFYFSEH  602 (621)
Q Consensus       590 tG~~p~~~~~~~~  602 (621)
                      +|+.||+...++.
T Consensus       245 C~~lPf~~~~~~~  257 (288)
T PF14531_consen  245 CGRLPFGLSSPEA  257 (288)
T ss_dssp             HSS-STCCCGGGS
T ss_pred             HccCCCCCCCccc
Confidence            9999998766553

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.66  E-value=7e-16  Score=149.45  Aligned_cols=130  Identities=22%  Similarity=0.349  Sum_probs=105.3

Q ss_pred             eeccCCceeEEEEEecCCcEEEEEEeccCCc--------ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSG--------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       398 ~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~--------~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      .||+|+||.||+|.. ++..+++|.......        ....++.+|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999985 578899998654321        11255778999999999887655555555666778999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      +|++|.+++....          ..++.+++.+|.+||+.+   ++|||++|+||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999988774311          078999999999999886   99999999999999 88999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.66  E-value=6e-16  Score=172.52  Aligned_cols=138  Identities=19%  Similarity=0.304  Sum_probs=111.5

Q ss_pred             hCCCCccceeccCCceeEEEEEecCCcEEEEEE-eccCC-------cccHHHHHHHHHHHHhcccCCceeEeeEEeeCce
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKR-LSRTS-------GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE  461 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~-l~~~~-------~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~  461 (621)
                      ...|...++||+|+||.||+|.+.... +++|+ +.+..       ....+.+.+|++++.+++|++++....++.+...
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            344566789999999999999875443 44443 22211       1123568899999999999999988888777778


Q ss_pred             EEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCce
Q 007006          462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR  541 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~  541 (621)
                      .++||||+++++|.+++.           ....++.+++.+|.+||+.+   ++||||||+|||+ +++.++|+|||+++
T Consensus       411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            899999999999998873           35678999999999999986   9999999999999 67789999999997


Q ss_pred             ec
Q 007006          542 IF  543 (621)
Q Consensus       542 ~~  543 (621)
                      ..
T Consensus       476 ~~  477 (535)
T PRK09605        476 YS  477 (535)
T ss_pred             cC
Confidence            64

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.60  E-value=2e-15  Score=160.97  Aligned_cols=168  Identities=28%  Similarity=0.482  Sum_probs=132.9

Q ss_pred             HHhcccCCceeEeeEEeeCceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCC
Q 007006          441 IAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK  520 (621)
Q Consensus       441 l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk  520 (621)
                      |+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+..  ....+++.....++++|++||.|||+.. . ..|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeeec
Confidence            3568899999999999999999999999999999999965  4567999999999999999999999853 2 3999999


Q ss_pred             CCCEEEcCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCC-------CChhhhHHHHHHHHHHHHcCCC
Q 007006          521 ASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-------FSIKSDVFSFGVLLLEIISGRK  593 (621)
Q Consensus       521 p~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-------~s~~sDVwS~Gvll~elltG~~  593 (621)
                      +.|+++|..+.+||+|||+.................-...|.|||.+....       .+.+.||||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            999999999999999999988764311111111112345799999986632       4778999999999999999999


Q ss_pred             CCCCCcCCC-CCChHHHHHH
Q 007006          594 NNGFYFSEH-GQTLLTYVCN  612 (621)
Q Consensus       594 p~~~~~~~~-~~~l~~~v~~  612 (621)
                      ||....... ...++..+.+
T Consensus       157 ~~~~~~~~~~~~eii~~~~~  176 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKK  176 (484)
T ss_pred             ccccccccCChHHHHHHHHh
Confidence            998644332 2334444433

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.60  E-value=1.2e-14  Score=133.07  Aligned_cols=135  Identities=22%  Similarity=0.224  Sum_probs=114.8

Q ss_pred             ccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhccc--CCceeEeeEEeeCceEEEEEEecCCC
Q 007006          395 DENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH--KNLVRLLGCCLEGQELLLIYEYMPNK  472 (621)
Q Consensus       395 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h--~nIv~l~g~~~~~~~~~lV~e~~~~g  472 (621)
                      +.+.||+|.++.||++...+ ..+++|.......  ...+.+|+..++.++|  .++++++++....+..++++||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45789999999999999854 7899998865433  5678999999999977  58999999888878899999999988


Q ss_pred             ChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          473 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       473 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      .+..+          +......++.+++++|.+||.....+++|+|++|+||+++..+.++++|||.+..
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77543          5566778899999999999986545699999999999999989999999998763

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.59  E-value=1.1e-14  Score=139.48  Aligned_cols=137  Identities=20%  Similarity=0.264  Sum_probs=99.2

Q ss_pred             cceeccCCceeEEEEEecCCcEEEEEEeccCCcc--cHHH----------------------HHHHHHHHHhcccC--Cc
Q 007006          396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ--GLQE----------------------FKNEVNLIAKLQHK--NL  449 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~--~~~~----------------------~~~Ei~~l~~l~h~--nI  449 (621)
                      .+.||+|+||.||++...+++.||||++......  ....                      ...|...+.++.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999999888999999998753211  1111                      13566666666544  35


Q ss_pred             eeEeeEEeeCceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCEEEcC
Q 007006          450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE-DSRLKIIHRDLKASNILLDD  528 (621)
Q Consensus       450 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~  528 (621)
                      .+.++.    ...++||||++++.+.........   .. .....++.+++.++.++|. .+   |+|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence            555543    245899999999554321111000   11 5678899999999999998 64   99999999999999 


Q ss_pred             CCCeEEeeecCceecC
Q 007006          529 DMNPKISDFGLARIFG  544 (621)
Q Consensus       529 ~~~vkL~Dfgla~~~~  544 (621)
                      ++.++|+|||.+....
T Consensus       150 ~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCcEEEEECccccccc
Confidence            8899999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.53  E-value=1.1e-13  Score=137.79  Aligned_cols=134  Identities=23%  Similarity=0.289  Sum_probs=104.3

Q ss_pred             ceec-cCCceeEEEEEecCCcEEEEEEeccCC-------------cccHHHHHHHHHHHHhcccCCc--eeEeeEEeeCc
Q 007006          397 NKLG-QGGFGPVYKGTLADGKAIAVKRLSRTS-------------GQGLQEFKNEVNLIAKLQHKNL--VRLLGCCLEGQ  460 (621)
Q Consensus       397 ~~LG-~G~fG~Vy~~~~~~g~~vavK~l~~~~-------------~~~~~~~~~Ei~~l~~l~h~nI--v~l~g~~~~~~  460 (621)
                      ..|| .|+.|+||++... +..++||++....             ......+.+|++++.+++|++|  ++.+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            5687 8999999999874 7789999875321             1223567889999999998875  67777654432


Q ss_pred             ----eEEEEEEecCC-CChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEe
Q 007006          461 ----ELLLIYEYMPN-KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS  535 (621)
Q Consensus       461 ----~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~  535 (621)
                          ..++|+|++++ .+|.+++..    ..++..    .+.+|+.+|.+||+.|   |+||||||.|||++.++.++|+
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence                23599999997 688887743    234443    3567999999999987   9999999999999999999999


Q ss_pred             eecCcee
Q 007006          536 DFGLARI  542 (621)
Q Consensus       536 Dfgla~~  542 (621)
                      |||.+..
T Consensus       185 Dfg~~~~  191 (239)
T PRK01723        185 DFDRGEL  191 (239)
T ss_pred             ECCCccc
Confidence            9999875

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.52  E-value=8.3e-15  Score=163.39  Aligned_cols=169  Identities=23%  Similarity=0.312  Sum_probs=119.5

Q ss_pred             hCCCCccceeccCCceeEEEEEecC-CcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      ..+|..++.|..|++|.||..+++. -+.+|+|+-+++.     -+++   ++....+|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-----ilRn---ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-----ILRN---ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccch-----hhhc---cccccCCccee------------------
Confidence            4689999999999999999998764 5667774322211     0011   22222334333                  


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC-
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ-  547 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~-  547 (621)
                         |+=...+.   .-.+++..        ++.+++|||+.+   |+|||+||+|.+|+.-|++|+.|||+.+...... 
T Consensus       136 ---gDc~tllk---~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 ---GDCATLLK---NIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ---chhhhhcc---cCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence               21111221   11222222        277899999876   9999999999999999999999999987542111 


Q ss_pred             ------------CCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCcCC
Q 007006          548 ------------NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE  601 (621)
Q Consensus       548 ------------~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~~  601 (621)
                                  ..-..+..+||+.|+|||++....|...+|+|++|+++||.+.|+.||.-..+|
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe  264 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE  264 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH
Confidence                        111234568999999999999999999999999999999999999998765444

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.49  E-value=7.1e-15  Score=153.91  Aligned_cols=124  Identities=31%  Similarity=0.457  Sum_probs=107.7

Q ss_pred             eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCc
Q 007006          461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA  540 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla  540 (621)
                      .+++.|+++...+|.++|.........++...+.++.|++.++.|   ++   .+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            578999999999999999766666678899999999999999999   44   999999999999999999999999998


Q ss_pred             eecCCCC----CCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc
Q 007006          541 RIFGGNQ----NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS  590 (621)
Q Consensus       541 ~~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt  590 (621)
                      .......    .........||..||+||.+.+..|+.|+|||+||++|+||+.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            7654433    1122334579999999999999999999999999999999998

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.43  E-value=4.9e-13  Score=134.82  Aligned_cols=144  Identities=26%  Similarity=0.382  Sum_probs=106.0

Q ss_pred             ccCCceeEeeEEee---------------------------CceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHH
Q 007006          445 QHKNLVRLLGCCLE---------------------------GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN  497 (621)
Q Consensus       445 ~h~nIv~l~g~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  497 (621)
                      +|||||++.+.|.+                           +..+|+||.-++ .+|.++++..    ..+.....-|+.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~----~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR----HRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC----CCchHHHHHHHH
Confidence            59999999988764                           235788888764 6788888642    356666777899


Q ss_pred             HHHHHHHHHHhCCCCCeEeccCCCCCEEEc--CCC--CeEEeeecCceecCC--CCC--CcccccccccCCccChhcccC
Q 007006          498 GIARGILYLHEDSRLKIIHRDLKASNILLD--DDM--NPKISDFGLARIFGG--NQN--QANTNIIAGTYGYMAPEYAMG  569 (621)
Q Consensus       498 ~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~--~~~--~vkL~Dfgla~~~~~--~~~--~~~~~~~~gt~~y~aPE~l~~  569 (621)
                      |+++|+.|||.+|   |.|||+|++||||.  +|+  .+.|+|||.+---+.  -+.  ....-...|.-.-||||+...
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999987   99999999999994  343  478999997643211  000  111112345667899998754


Q ss_pred             CC------CChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          570 GI------FSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       570 ~~------~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      .+      .-.|+|.|+.|-+.||+++...||=
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY  458 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFY  458 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCccc
Confidence            32      2348999999999999999999973

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.41  E-value=1.3e-12  Score=141.36  Aligned_cols=142  Identities=23%  Similarity=0.278  Sum_probs=100.3

Q ss_pred             cceeccCCceeEEEEEecCCcEEEEEEeccCCcccH----------------------------------------HHHH
Q 007006          396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGL----------------------------------------QEFK  435 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~----------------------------------------~~~~  435 (621)
                      .+.||.|++|.||+|++++|+.||||+.+.......                                        -+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            468999999999999999999999999865321100                                        0244


Q ss_pred             HHHHHHHhcc----cCCceeEeeEEe-eCceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHH-HHHHHHhC
Q 007006          436 NEVNLIAKLQ----HKNLVRLLGCCL-EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR-GILYLHED  509 (621)
Q Consensus       436 ~Ei~~l~~l~----h~nIv~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~L~yLH~~  509 (621)
                      +|...+.+++    |.+-+.+-.++. ..+..+|||||++|++|.++......  ..   ...+++..++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence            5565555552    333333333332 23457999999999999887643211  12   23456666665 46788887


Q ss_pred             CCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       510 ~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      |   ++|+|++|.||+++++++++++|||++..++.
T Consensus       277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             C---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            5   99999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.40  E-value=3.6e-14  Score=158.13  Aligned_cols=207  Identities=25%  Similarity=0.365  Sum_probs=164.9

Q ss_pred             CCCCccceeccCCceeEEEEEec--CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcc-cCCceeEeeEEeeCceEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA--DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV  465 (621)
                      ..|.+.+.||+|.|+.|-.....  ....+++|.+....  .........|..+-..+. |+|++.+++...+.+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            45667788999999999887653  34556777665543  223344455777766775 99999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCC-CCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEeccCCCCCEEEcCCC-CeEEeeecCcee
Q 007006          466 YEYMPNKSLDVHLFDATRSV-QLDWKRRQSIINGIARGILYLH-EDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARI  542 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~-~l~~~~~~~i~~~ia~~L~yLH-~~~~~~iiH~Dlkp~NILl~~~~-~vkL~Dfgla~~  542 (621)
                      ++|..++++...+..  ... ..+....-..+.|+..++.|+| ..+   +.|+|+||+|.+++..+ ..+++|||++..
T Consensus       100 ~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             cCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence            999999998877631  122 4566667778999999999999 665   99999999999999999 999999999998


Q ss_pred             cCC-CCCCcccccccc-cCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCCCcCCC
Q 007006          543 FGG-NQNQANTNIIAG-TYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH  602 (621)
Q Consensus       543 ~~~-~~~~~~~~~~~g-t~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~~~~~~  602 (621)
                      +.. +.........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+......+
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~  237 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD  237 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc
Confidence            766 444444455677 9999999998874 45778999999999999999999998766654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.30  E-value=1.5e-11  Score=115.73  Aligned_cols=131  Identities=22%  Similarity=0.188  Sum_probs=97.6

Q ss_pred             cceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCce-eEeeEEeeCceEEEEEEecCCCCh
Q 007006          396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV-RLLGCCLEGQELLLIYEYMPNKSL  474 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv-~l~g~~~~~~~~~lV~e~~~~gsL  474 (621)
                      .+.|+.|.++.||++... +..+++|....... ....+..|+++++.+.+.+++ +++...  .+..++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            367899999999999875 77899998765432 223467899999999765544 455443  3345799999999887


Q ss_pred             hhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS--RLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      ....        .   ....+..+++++|..||..+  +..++|+|++|.||+++ ++.++++||+.+..
T Consensus        79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            5420        0   11235678999999999875  23469999999999999 66899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.23  E-value=8e-11  Score=127.09  Aligned_cols=166  Identities=20%  Similarity=0.278  Sum_probs=128.1

Q ss_pred             ecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCCChhhhhhhccCCCCCCHHH
Q 007006          412 LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR  491 (621)
Q Consensus       412 ~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~  491 (621)
                      ..++.+|.|...+...........+.++.|+.++||||++++.....++..|||+|-+.  .|..++.+      +....
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~  105 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE  105 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence            45688899988887666445567888999999999999999999999999999999874  45555633      33555


Q ss_pred             HHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCC
Q 007006          492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI  571 (621)
Q Consensus       492 ~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~  571 (621)
                      ..-.+.||+.||.+||+.+  .++|++|.-..|++++.|+.||++|.++........  ......---.|..|+.+....
T Consensus       106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence            6667899999999999876  699999999999999999999999998765432221  111111223467777654433


Q ss_pred             CChhhhHHHHHHHHHHHHcC
Q 007006          572 FSIKSDVFSFGVLLLEIISG  591 (621)
Q Consensus       572 ~s~~sDVwS~Gvll~elltG  591 (621)
                        ...|.|.||++++|++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              346999999999999999

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.20  E-value=8.8e-11  Score=128.68  Aligned_cols=144  Identities=17%  Similarity=0.209  Sum_probs=94.3

Q ss_pred             CCCCccceeccCCceeEEEEEecC-CcEEEEEEeccCCcc----------------------------------cHH---
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQ----------------------------------GLQ---  432 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~----------------------------------~~~---  432 (621)
                      ..|+. +.||+|++|.||++++++ |+.||||+.+..-..                                  ..+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            35665 789999999999999887 999999999754210                                  011   


Q ss_pred             ---HHHHHHHHHHhcc----cCCceeEeeEEee-CceEEEEEEecCCCChhhhhhhccCC---CCCCHHHHHHHHHHHHH
Q 007006          433 ---EFKNEVNLIAKLQ----HKNLVRLLGCCLE-GQELLLIYEYMPNKSLDVHLFDATRS---VQLDWKRRQSIINGIAR  501 (621)
Q Consensus       433 ---~~~~Ei~~l~~l~----h~nIv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~~ia~  501 (621)
                         ++.+|+..+.+++    +.+.+.+-.++.+ ....+|||||++|+.+.++..-....   ..+.......++.|+  
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence               1344444444442    3333443344433 34678999999999997643211111   112233333333333  


Q ss_pred             HHHHHHhCCCCCeEeccCCCCCEEEcCCC----CeEEeeecCceecCC
Q 007006          502 GILYLHEDSRLKIIHRDLKASNILLDDDM----NPKISDFGLARIFGG  545 (621)
Q Consensus       502 ~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~vkL~Dfgla~~~~~  545 (621)
                           ...|   ++|+|++|.||+++.++    ++++.|||+...++.
T Consensus       277 -----f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 -----FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -----HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                 3444   99999999999999888    999999999987754

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.13  E-value=6.7e-10  Score=109.05  Aligned_cols=142  Identities=18%  Similarity=0.291  Sum_probs=110.9

Q ss_pred             cceeccCCceeEEEEEecCCcEEEEEEeccCCc-ccHHHHHHHHHHHHhccc--CCceeEeeEEeeCc---eEEEEEEec
Q 007006          396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQH--KNLVRLLGCCLEGQ---ELLLIYEYM  469 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~h--~nIv~l~g~~~~~~---~~~lV~e~~  469 (621)
                      .+.|+.|..+.||++...+|..+++|....... .....+..|.++++.+.+  .++++++.+.....   ..++||||+
T Consensus         3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            357899999999999987778999999765432 234678899999999975  45677888776543   568999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS---------------------------------------  510 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------------  510 (621)
                      ++.++...+..    ..++..+...++.++++.|..||+..                                       
T Consensus        83 ~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          83 DGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            99988765421    34677778888888888888888531                                       


Q ss_pred             --------------CCCeEeccCCCCCEEEcC--CCCeEEeeecCce
Q 007006          511 --------------RLKIIHRDLKASNILLDD--DMNPKISDFGLAR  541 (621)
Q Consensus       511 --------------~~~iiH~Dlkp~NILl~~--~~~vkL~Dfgla~  541 (621)
                                    +..++|+|+.+.||++++  ++.+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                          245799999999999998  6668999999875

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.13  E-value=1.3e-09  Score=104.24  Aligned_cols=136  Identities=14%  Similarity=0.172  Sum_probs=99.3

Q ss_pred             cceeccCCceeEEEEEecC-------CcEEEEEEeccCC------------c----------ccHHHHH----HHHHHHH
Q 007006          396 ENKLGQGGFGPVYKGTLAD-------GKAIAVKRLSRTS------------G----------QGLQEFK----NEVNLIA  442 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~-------g~~vavK~l~~~~------------~----------~~~~~~~----~Ei~~l~  442 (621)
                      ...||.|--+.||.|...+       +..+|||+.+...            .          ...+.+.    +|+..|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999998543       4799999875321            0          0012233    7999999


Q ss_pred             hccc--CCceeEeeEEeeCceEEEEEEecCCCChhh-hhhhccCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecc
Q 007006          443 KLQH--KNLVRLLGCCLEGQELLLIYEYMPNKSLDV-HLFDATRSVQLDWKRRQSIINGIARGILYL-HEDSRLKIIHRD  518 (621)
Q Consensus       443 ~l~h--~nIv~l~g~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiH~D  518 (621)
                      ++..  -++++++++    ..-++||||+.+..+.. .+    +...++..+...+..+++.+|..| |..+   ++|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L----kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD  150 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL----KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD  150 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh----hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence            9954  577788865    34589999998754422 12    122355566777889999999999 7765   99999


Q ss_pred             CCCCCEEEcCCCCeEEeeecCceec
Q 007006          519 LKASNILLDDDMNPKISDFGLARIF  543 (621)
Q Consensus       519 lkp~NILl~~~~~vkL~Dfgla~~~  543 (621)
                      |++.|||++ ++.+.|+|||.+-..
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCCceeC
Confidence            999999997 467999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.11  E-value=9.7e-11  Score=115.93  Aligned_cols=157  Identities=23%  Similarity=0.299  Sum_probs=119.4

Q ss_pred             HHHHHHhcccCCceeEeeEEeeCc-----eEEEEEEecCCCChhhhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 007006          437 EVNLIAKLQHKNLVRLLGCCLEGQ-----ELLLIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDS  510 (621)
Q Consensus       437 Ei~~l~~l~h~nIv~l~g~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~  510 (621)
                      -..-|-.+-|.|||+++.|+.+..     ...++.|||..|++..+|.+..+ ...+..+...+++.||..||.|||+..
T Consensus       117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~  196 (458)
T KOG1266|consen  117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence            344566678999999999987643     56889999999999999986433 456888899999999999999999985


Q ss_pred             CCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC--CCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHH
Q 007006          511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG--NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEI  588 (621)
Q Consensus       511 ~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~--~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~el  588 (621)
                       ++|+|+++..+.|++..++-+|+.--.-......  ......+....+-++|.+||+=.....+..+|||+||+..+||
T Consensus       197 -PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  197 -PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             -CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence             7899999999999999998888753211111000  0001111223457899999987666778889999999999999


Q ss_pred             HcCCCC
Q 007006          589 ISGRKN  594 (621)
Q Consensus       589 ltG~~p  594 (621)
                      .-|..-
T Consensus       276 ailEiq  281 (458)
T KOG1266|consen  276 AILEIQ  281 (458)
T ss_pred             HHheec
Confidence            888765

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.02  E-value=4.4e-09  Score=96.81  Aligned_cols=144  Identities=24%  Similarity=0.318  Sum_probs=104.2

Q ss_pred             ccceeccCCceeEEEEEecCCcEEEEEE-eccCC-------cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          395 DENKLGQGGFGPVYKGTLADGKAIAVKR-LSRTS-------GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       395 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~-l~~~~-------~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ....|-+|+-+.|+++..+ |+...||. +.+.-       .-..++..+|++.|.++.--.|.-..-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4678899999999999884 77766664 33221       122456788999999997555544444455555667899


Q ss_pred             EecCC-CChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCC---eEEeeecCcee
Q 007006          467 EYMPN-KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN---PKISDFGLARI  542 (621)
Q Consensus       467 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---vkL~Dfgla~~  542 (621)
                      ||+++ .++.+++...-... ........++..|-+.+.-||..+   |+||||..+||+|.+++.   +.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 57788886533322 222333678888999999999986   999999999999976553   68999999875


Q ss_pred             c
Q 007006          543 F  543 (621)
Q Consensus       543 ~  543 (621)
                      .
T Consensus       166 s  166 (229)
T KOG3087|consen  166 S  166 (229)
T ss_pred             c
Confidence            3

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.01  E-value=3.5e-09  Score=98.00  Aligned_cols=131  Identities=24%  Similarity=0.334  Sum_probs=97.9

Q ss_pred             ceeccCCceeEEEEEecCCcEEEEEEeccCC---c-----ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTS---G-----QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~---~-----~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      ..+++|+-+.+|.+.+. |.++++|.-..+.   +     -....-.+|+.++.+++--.|.-..=+..+.+...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35788999999999764 4445666432221   1     1123467899999999766655555556677778899999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      ++|..|.+.+...          ...++..+-.-+.-||..+   |+||||.++||++..+. +.++|||++..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888542          2456666777788999987   99999999999998775 99999999874

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.95  E-value=8.9e-10  Score=118.09  Aligned_cols=198  Identities=25%  Similarity=0.277  Sum_probs=152.2

Q ss_pred             CCCccceecc--CCceeEEEEEe---cCCcEEEEEEeccCC--cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEE
Q 007006          392 HFSDENKLGQ--GGFGPVYKGTL---ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELL  463 (621)
Q Consensus       392 ~f~~~~~LG~--G~fG~Vy~~~~---~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~  463 (621)
                      .|.....+|+  |.+|.||.+..   .++..+|+|+-+...  +.....=.+|+....++ .|+|.++....+.+.+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4566778999  99999999986   357889999854332  22223335667766677 4999999888888889999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEeccCCCCCEEEcCC-CCeEEeeec
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR----GILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFG  538 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~vkL~Dfg  538 (621)
                      +-+|.+. .+|..+.+.  ....++....+....+...    ||.++|+..   ++|-|+||.||++..+ ...+++|||
T Consensus       195 iqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             eeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence            9999875 777766643  3334677777888888888    999999875   9999999999999999 789999999


Q ss_pred             CceecCCCCCCccc---ccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          539 LARIFGGNQNQANT---NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       539 la~~~~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      +...+.........   ....+...|++||.+ ++.++..+|+|++|.+.+|-.+|..+..
T Consensus       269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~  328 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPS  328 (524)
T ss_pred             eeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhccccc
Confidence            99887654422221   222567789999965 5567889999999999999998877653

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.91  E-value=1.8e-08  Score=105.93  Aligned_cols=169  Identities=24%  Similarity=0.371  Sum_probs=128.7

Q ss_pred             ceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEee----CceEEEEEEecCC-CChhhh
Q 007006          404 FGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELLLIYEYMPN-KSLDVH  477 (621)
Q Consensus       404 fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~----~~~~~lV~e~~~~-gsL~~~  477 (621)
                      -.+.||+.. .+|..|++|+++............-++.++++.|+|||++..++..    +..+++||+|.|+ ++|.+.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            356888874 5899999999954333322233456889999999999999999873    3478999999996 566554


Q ss_pred             hhhc------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          478 LFDA------------TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       478 l~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      -+..            ......++..+|.++.|+..||.++|+.|   +..+-|.+++|+++.+.+++|+..|+......
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            4321            12234788999999999999999999987   88899999999999999999999888776544


Q ss_pred             CCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKN  594 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p  594 (621)
                      +....                +.   --.+-|.=.||.+++.|.||...
T Consensus       446 d~~~~----------------le---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPTEP----------------LE---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCcc----------------hh---HHhhhhHHHHHHHHHHHhhcccc
Confidence            33111                11   12357999999999999999765

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.83  E-value=4.4e-08  Score=93.33  Aligned_cols=125  Identities=26%  Similarity=0.301  Sum_probs=81.8

Q ss_pred             eEEEEEecCCcEEEEEEeccCC-------------cc--------c-----HHHHHHHHHHHHhcccC--CceeEeeEEe
Q 007006          406 PVYKGTLADGKAIAVKRLSRTS-------------GQ--------G-----LQEFKNEVNLIAKLQHK--NLVRLLGCCL  457 (621)
Q Consensus       406 ~Vy~~~~~~g~~vavK~l~~~~-------------~~--------~-----~~~~~~Ei~~l~~l~h~--nIv~l~g~~~  457 (621)
                      .||.|...+|..+|+|+.+...             ..        .     .....+|.+.|.++..-  ++++++.+. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3899998899999999875321             00        0     12367899999999765  577777553 


Q ss_pred             eCceEEEEEEecC--CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEeccCCCCCEEEcCCCCeEE
Q 007006          458 EGQELLLIYEYMP--NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY-LHEDSRLKIIHRDLKASNILLDDDMNPKI  534 (621)
Q Consensus       458 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y-LH~~~~~~iiH~Dlkp~NILl~~~~~vkL  534 (621)
                         .-.|||||++  +..+..+... .    ++......++.+++..+.. +|..|   |+||||.+.|||++++ .+.|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~-~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDV-D----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHC-G----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhc-c----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence               3479999999  6555443311 1    1133455677777776665 46665   9999999999999988 9999


Q ss_pred             eeecCceec
Q 007006          535 SDFGLARIF  543 (621)
Q Consensus       535 ~Dfgla~~~  543 (621)
                      +|||.+...
T Consensus       148 IDf~qav~~  156 (188)
T PF01163_consen  148 IDFGQAVDS  156 (188)
T ss_dssp             --GTTEEET
T ss_pred             EecCcceec
Confidence            999988754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.78  E-value=1.6e-07  Score=94.88  Aligned_cols=133  Identities=20%  Similarity=0.170  Sum_probs=97.5

Q ss_pred             eeEEEEEecCCcEEEEEEeccCCc-----------ccHHHHHHHHHHHHhcccCC--ceeEeeEEee-----CceEEEEE
Q 007006          405 GPVYKGTLADGKAIAVKRLSRTSG-----------QGLQEFKNEVNLIAKLQHKN--LVRLLGCCLE-----GQELLLIY  466 (621)
Q Consensus       405 G~Vy~~~~~~g~~vavK~l~~~~~-----------~~~~~~~~Ei~~l~~l~h~n--Iv~l~g~~~~-----~~~~~lV~  466 (621)
                      ..|.+..+ +|+.+.||+......           .....+.+|...+.++...+  .++++++...     ...-++|+
T Consensus        36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            34667665 578899997643321           11124789999999995444  4455666543     23468999


Q ss_pred             EecCCC-ChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC-------CCCeEEeeec
Q 007006          467 EYMPNK-SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-------DMNPKISDFG  538 (621)
Q Consensus       467 e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-------~~~vkL~Dfg  538 (621)
                      |++++. +|.+++.+.. ..+.+......++.+++..+.-||..|   |+|+|++++|||++.       ++.+.|+||+
T Consensus       115 e~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~  190 (268)
T PRK15123        115 EDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLH  190 (268)
T ss_pred             eeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence            999986 8888874321 234566777889999999999999987   999999999999975       4679999999


Q ss_pred             Ccee
Q 007006          539 LARI  542 (621)
Q Consensus       539 la~~  542 (621)
                      .++.
T Consensus       191 r~~~  194 (268)
T PRK15123        191 RAQI  194 (268)
T ss_pred             cccc
Confidence            8864

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.68  E-value=9.6e-09  Score=110.23  Aligned_cols=195  Identities=23%  Similarity=0.221  Sum_probs=145.7

Q ss_pred             HhCCCCccceeccCCceeEEEEEec--CCcEEEEEEeccCCcccHHH--HHHHHHHHHhc-ccCCceeEeeEEeeCceEE
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA--DGKAIAVKRLSRTSGQGLQE--FKNEVNLIAKL-QHKNLVRLLGCCLEGQELL  463 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vavK~l~~~~~~~~~~--~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~  463 (621)
                      ...+|..+..||.|.|+.|++...+  ++..+++|.+.+.......+  -..|+-+...+ .|.++++....+......+
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            3467888999999999999998743  57788999887654332222  24566666666 5888888877777777778


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC-CCeEEeeecCcee
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGLARI  542 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~vkL~Dfgla~~  542 (621)
                      +-.||+.++++...+.   -...+++..++++..|++.++.++|+..   ++|+|++|+||++..+ +.-++.|||....
T Consensus       343 ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             CchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence            9999999998876552   2234778889999999999999999875   9999999999999886 7889999998864


Q ss_pred             cCCCCCCcccccccccCCcc--ChhcccCCCCChhhhHHHHHHHHHHHHcCCCC
Q 007006          543 FGGNQNQANTNIIAGTYGYM--APEYAMGGIFSIKSDVFSFGVLLLEIISGRKN  594 (621)
Q Consensus       543 ~~~~~~~~~~~~~~gt~~y~--aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p  594 (621)
                      +.-...     ...+.-+++  +|+......+..+.|++|||.-+.|.++|..-
T Consensus       417 ~~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l  465 (524)
T KOG0601|consen  417 LAFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL  465 (524)
T ss_pred             cceecc-----cccccccccccchhhccccccccccccccccccccccccCccc
Confidence            221111     112233444  55555666789999999999999998888654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.67  E-value=4.7e-09  Score=118.25  Aligned_cols=210  Identities=21%  Similarity=0.271  Sum_probs=145.0

Q ss_pred             HHHhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceE
Q 007006          387 LEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL  462 (621)
Q Consensus       387 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~  462 (621)
                      ....+.+.+.+.+.+|.++.++...-. .|...++|......   ....+....+-.++-..++|-++...--+.-....
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            345577888889999999999877632 34333444332221   11112222222222223456666555444456678


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      .|+++|..+++|...|+...   ..+.+-....+..+...+++||..   .+.|+|++|.|+++..++..++.|||....
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~  953 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSK  953 (1205)
T ss_pred             chhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccc
Confidence            99999999999988886432   345555555666788899999975   389999999999999999999999984332


Q ss_pred             cC------CC-------------------CCC----cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCC
Q 007006          543 FG------GN-------------------QNQ----ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRK  593 (621)
Q Consensus       543 ~~------~~-------------------~~~----~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~  593 (621)
                      ..      ..                   +..    .......+|+.|.+||.+.+......+|+|++|+.++|.++|.+
T Consensus       954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen  954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred             cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence            21      00                   000    11223568999999999999999999999999999999999999


Q ss_pred             CCCCCcCCC
Q 007006          594 NNGFYFSEH  602 (621)
Q Consensus       594 p~~~~~~~~  602 (621)
                      ||...++++
T Consensus      1034 p~na~tpq~ 1042 (1205)
T KOG0606|consen 1034 PFNAETPQQ 1042 (1205)
T ss_pred             CCCCcchhh
Confidence            998666543

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.59  E-value=4.5e-07  Score=89.03  Aligned_cols=135  Identities=21%  Similarity=0.221  Sum_probs=97.1

Q ss_pred             CCCccceeccCCceeEEEEEecCCcEEEEEEeccCC----------------------cccHHHHHHHHHHHHhcccC--
Q 007006          392 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS----------------------GQGLQEFKNEVNLIAKLQHK--  447 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~----------------------~~~~~~~~~Ei~~l~~l~h~--  447 (621)
                      -..+.++||.|--+.||.|..++|.++|||.-+...                      .......++|.+.|.+|...  
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            345568999999999999999999999999643210                      00123467899999999755  


Q ss_pred             CceeEeeEEeeCceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc
Q 007006          448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD  527 (621)
Q Consensus       448 nIv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~  527 (621)
                      .|++.+++-    .-.+|||++++-.|...-        ++.+..-.++..|+.-+..+-..|   |+|||+++=||+++
T Consensus       172 ~VP~P~~~n----RHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~  236 (304)
T COG0478         172 KVPKPIAWN----RHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVT  236 (304)
T ss_pred             CCCCccccc----cceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEe
Confidence            788888763    457999999986654221        123333344444555444444444   99999999999999


Q ss_pred             CCCCeEEeeecCce
Q 007006          528 DDMNPKISDFGLAR  541 (621)
Q Consensus       528 ~~~~vkL~Dfgla~  541 (621)
                      ++|.+.++||--+.
T Consensus       237 ~dg~~~vIDwPQ~v  250 (304)
T COG0478         237 EDGDIVVIDWPQAV  250 (304)
T ss_pred             cCCCEEEEeCcccc
Confidence            99999999996554

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.57  E-value=6.3e-07  Score=92.21  Aligned_cols=191  Identities=17%  Similarity=0.200  Sum_probs=126.1

Q ss_pred             ccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhc-ccCCceeEeeEEe------eC-ceEEEEE
Q 007006          395 DENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCL------EG-QELLLIY  466 (621)
Q Consensus       395 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~------~~-~~~~lV~  466 (621)
                      ..+.||+|+-+.+|-.-  +-..-+.|+..........   +.++.|.+. .||-+-.-+.|=+      +. ....+.|
T Consensus        15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecc--hhhchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            34679999999998532  2222355777665443222   234444454 4654333121111      12 2356777


Q ss_pred             EecCCCC-hhhhhhh---ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          467 EYMPNKS-LDVHLFD---ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       467 e~~~~gs-L~~~l~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      +.+++.- +..++.-   ...-...+|.-.+++++.++.+.+-||..|   .+-||++++|+|+.+++.+.|.|=....+
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence            7776642 2222221   112234789999999999999999999987   88999999999999999999998766554


Q ss_pred             cCCCCCCcccccccccCCccChhccc-----CCCCChhhhHHHHHHHHHHHHcC-CCCCC
Q 007006          543 FGGNQNQANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISG-RKNNG  596 (621)
Q Consensus       543 ~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwS~Gvll~elltG-~~p~~  596 (621)
                      ....   ....-.+|...|.+||.-.     +..-+...|.|.|||++++|+.| +.||+
T Consensus       167 ~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPys  223 (637)
T COG4248         167 NANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYS  223 (637)
T ss_pred             ccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCC
Confidence            3111   1111235788999999653     34457789999999999999887 99985

>PRK09902 hypothetical protein; Provisional

Probab=98.51  E-value=3.1e-06  Score=81.27  Aligned_cols=139  Identities=18%  Similarity=0.150  Sum_probs=103.2

Q ss_pred             eccCCceeEEEEEecCCcEEEEEEeccC------CcccHHHHHHHHHHHHhccc--CCceeEeeEEeeC----ceEEEEE
Q 007006          399 LGQGGFGPVYKGTLADGKAIAVKRLSRT------SGQGLQEFKNEVNLIAKLQH--KNLVRLLGCCLEG----QELLLIY  466 (621)
Q Consensus       399 LG~G~fG~Vy~~~~~~g~~vavK~l~~~------~~~~~~~~~~Ei~~l~~l~h--~nIv~l~g~~~~~----~~~~lV~  466 (621)
                      -|+||-+.|++-.+. |..+-+|+-...      .+-+...|.+|+..|.++..  -.+++++......    -.-+||+
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            366888889987764 457888876421      13466889999999999954  3355655322221    2468999


Q ss_pred             EecCC-CChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCC--eEEeeecCcee
Q 007006          467 EYMPN-KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN--PKISDFGLARI  542 (621)
Q Consensus       467 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--vkL~Dfgla~~  542 (621)
                      |-+++ -+|.+++.+. ...+.+...+..++.++++.+.-||+.+   +.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            98765 6787777432 2235678888899999999999999987   999999999999986667  99999987653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.50  E-value=1.1e-06  Score=85.51  Aligned_cols=107  Identities=27%  Similarity=0.292  Sum_probs=85.3

Q ss_pred             HHHHHHHHHHHHhccc--CCceeEeeEEeeCc----eEEEEEEecCCC-ChhhhhhhccCCCCCCHHHHHHHHHHHHHHH
Q 007006          431 LQEFKNEVNLIAKLQH--KNLVRLLGCCLEGQ----ELLLIYEYMPNK-SLDVHLFDATRSVQLDWKRRQSIINGIARGI  503 (621)
Q Consensus       431 ~~~~~~Ei~~l~~l~h--~nIv~l~g~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L  503 (621)
                      .....+|...+..+..  -.+++.+++.....    .-++|+|++++. +|.+++.....   ++......++.+++..+
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI  131 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence            3467889998888854  34567777766532    458999999984 78888854222   56677888999999999


Q ss_pred             HHHHhCCCCCeEeccCCCCCEEEcCCC---CeEEeeecCceec
Q 007006          504 LYLHEDSRLKIIHRDLKASNILLDDDM---NPKISDFGLARIF  543 (621)
Q Consensus       504 ~yLH~~~~~~iiH~Dlkp~NILl~~~~---~vkL~Dfgla~~~  543 (621)
                      .-||+.|   |+|+|+++.|||++.+.   .+.|+||+.++..
T Consensus       132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999987   99999999999999887   8999999987753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.41  E-value=1.3e-06  Score=95.41  Aligned_cols=141  Identities=18%  Similarity=0.243  Sum_probs=92.8

Q ss_pred             ceeccCCceeEEEEEecCCcEEEEEEeccCCccc--------------------------H--------------HHHHH
Q 007006          397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG--------------------------L--------------QEFKN  436 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~--------------------------~--------------~~~~~  436 (621)
                      +.|+.++-|.||+|++++|+.||||+.+..-.+.                          .              -++..
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            6899999999999999999999999876431110                          0              11344


Q ss_pred             HHHHHHhcc----cCCceeEeeEEee-CceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHH-HHHHHhCC
Q 007006          437 EVNLIAKLQ----HKNLVRLLGCCLE-GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG-ILYLHEDS  510 (621)
Q Consensus       437 Ei~~l~~l~----h~nIv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~-L~yLH~~~  510 (621)
                      |..-+.+++    +..-+.+=.++.+ .+...|+|||++|-.+.+......  ...+.+.+   +..++++ +..+-.. 
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~i---a~~~~~~f~~q~~~d-  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKEL---AELLVRAFLRQLLRD-  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHH---HHHHHHHHHHHHHhc-
Confidence            555555542    2222223233332 456789999999999888753222  23443333   3333322 2222223 


Q ss_pred             CCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       511 ~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                        +++|.|..|.||+++.++++.+.|||+...+++
T Consensus       285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             --CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence              499999999999999999999999999887654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.39  E-value=7.3e-06  Score=80.92  Aligned_cols=139  Identities=17%  Similarity=0.211  Sum_probs=86.3

Q ss_pred             ceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCC--ceeEeeEEeeCceEEEEEEecCCCC-
Q 007006          397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN--LVRLLGCCLEGQELLLIYEYMPNKS-  473 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~n--Iv~l~g~~~~~~~~~lV~e~~~~gs-  473 (621)
                      .+||+|..+.||+.   .+..+++|......  ......+|.++++.+..-.  +++.+++....+...+|||+++|.. 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57899999999984   25567788876432  3355789999999996443  5778888877777889999999863 


Q ss_pred             hhhhh---------------------hhccCCCCCCHHHHH-HHHH----------HHHH-HHHHHHhC-CCCCeEeccC
Q 007006          474 LDVHL---------------------FDATRSVQLDWKRRQ-SIIN----------GIAR-GILYLHED-SRLKIIHRDL  519 (621)
Q Consensus       474 L~~~l---------------------~~~~~~~~l~~~~~~-~i~~----------~ia~-~L~yLH~~-~~~~iiH~Dl  519 (621)
                      +...+                     +.- .....+..... .+..          .+.. ...+|... ....++|+|+
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~-~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHST-KCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCC-CCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence            21111                     100 00001111100 0000          0011 11222211 1345789999


Q ss_pred             CCCCEEEcCCCCeEEeeecCcee
Q 007006          520 KASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       520 kp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      .|.||++++++ +.|+||+.+..
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcCc
Confidence            99999999988 99999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.23  E-value=1.6e-05  Score=78.38  Aligned_cols=144  Identities=23%  Similarity=0.244  Sum_probs=86.0

Q ss_pred             cceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccC--CceeEeeEEeeC---ceEEEEEEecC
Q 007006          396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK--NLVRLLGCCLEG---QELLLIYEYMP  470 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~--nIv~l~g~~~~~---~~~~lV~e~~~  470 (621)
                      ++.|+.|..+.||+....+ ..+++|.....  .....+..|..+++.+...  .+++++......   ...+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            4678999999999999876 69999987654  3456778999999998543  356777654333   35689999999


Q ss_pred             CCChhh----------------hh---hhc-cCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 007006          471 NKSLDV----------------HL---FDA-TRSVQLDWKR---------RQSI------------INGIAR-GILYLHE  508 (621)
Q Consensus       471 ~gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~ia~-~L~yLH~  508 (621)
                      +..+..                .+   +.. .......+..         ....            ...+.. .+..++.
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            988776                11   011 0001111100         0000            111222 2333332


Q ss_pred             ----CCCCCeEeccCCCCCEEEc-CCCCeEEeeecCcee
Q 007006          509 ----DSRLKIIHRDLKASNILLD-DDMNPKISDFGLARI  542 (621)
Q Consensus       509 ----~~~~~iiH~Dlkp~NILl~-~~~~vkL~Dfgla~~  542 (621)
                          ..+..++|+|+.|+|||++ +++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence                1345699999999999999 666668999998753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.13  E-value=5.5e-05  Score=73.05  Aligned_cols=137  Identities=18%  Similarity=0.177  Sum_probs=89.6

Q ss_pred             HhCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHH---------HHHHHHHHhccc---CCceeEeeEE
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEF---------KNEVNLIAKLQH---KNLVRLLGCC  456 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~---------~~Ei~~l~~l~h---~nIv~l~g~~  456 (621)
                      ..++|...+.+-......|.+-.. +|..+++|..+.......+.|         .+++..+.+++.   .....++.+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            346788777777777666766555 578899998876543322222         233344444432   2233322222


Q ss_pred             e-----eCceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCC
Q 007006          457 L-----EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN  531 (621)
Q Consensus       457 ~-----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~  531 (621)
                      .     -....+++|||++|..|.++..       +++    .+...+..++.-||..|   +.|||..|.|+++++++ 
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence            2     1235678999999988765431       222    24456777899999987   99999999999998665 


Q ss_pred             eEEeeecCce
Q 007006          532 PKISDFGLAR  541 (621)
Q Consensus       532 vkL~Dfgla~  541 (621)
                      ++++||+..+
T Consensus       173 i~iID~~~k~  182 (229)
T PF06176_consen  173 IRIIDTQGKR  182 (229)
T ss_pred             EEEEECcccc
Confidence            9999998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.11  E-value=4.4e-05  Score=74.55  Aligned_cols=137  Identities=20%  Similarity=0.313  Sum_probs=95.4

Q ss_pred             ceeccCCceeEEEEEecCCcEEEEEEeccCCcc-------------------cHHH-----HHHHHHHHHhcc--cCCce
Q 007006          397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ-------------------GLQE-----FKNEVNLIAKLQ--HKNLV  450 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~-------------------~~~~-----~~~Ei~~l~~l~--h~nIv  450 (621)
                      ..|..|--..||+|...++..+|+|+.+.....                   +..+     ...|+.-|.++.  +-.++
T Consensus        54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            356678888999999888999999998643211                   1111     245666777773  44566


Q ss_pred             eEeeEEeeCceEEEEEEecCCCCh-hhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC
Q 007006          451 RLLGCCLEGQELLLIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD  529 (621)
Q Consensus       451 ~l~g~~~~~~~~~lV~e~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~  529 (621)
                      +.+++..    -.|||||+..... .-.|    +..++...+...+..++++.+.-|-...  +++|+||+.=|||+. +
T Consensus       134 ~Pi~~~~----nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~  202 (268)
T COG1718         134 EPIAFRN----NVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-D  202 (268)
T ss_pred             CceeecC----CeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-C
Confidence            6676543    3799999975421 1111    2223444467777888888888887733  599999999999999 8


Q ss_pred             CCeEEeeecCceecC
Q 007006          530 MNPKISDFGLARIFG  544 (621)
Q Consensus       530 ~~vkL~Dfgla~~~~  544 (621)
                      +.+.++|||-+....
T Consensus       203 ~~p~iID~~QaV~~~  217 (268)
T COG1718         203 GEPYIIDVSQAVTID  217 (268)
T ss_pred             CeEEEEECccccccC
Confidence            899999999887543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.10  E-value=4.6e-05  Score=76.16  Aligned_cols=140  Identities=15%  Similarity=0.141  Sum_probs=86.4

Q ss_pred             eeccCCc-eeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcc-cCCceeEeeEEeeCceEEEEEEecCCCChh
Q 007006          398 KLGQGGF-GPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEYMPNKSLD  475 (621)
Q Consensus       398 ~LG~G~f-G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV~e~~~~gsL~  475 (621)
                      .|..|.. ..||+.... +..+.+|+.....   ..++..|++++..+. +--+++++++....+..++|||+++|.++.
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            3455555 778998764 4778888875443   345678999998884 445677888777666789999999998876


Q ss_pred             hhhh-------------------hccC-CCCCCH--HHHHHHHH--------------------HHHHHHHHHHhC----
Q 007006          476 VHLF-------------------DATR-SVQLDW--KRRQSIIN--------------------GIARGILYLHED----  509 (621)
Q Consensus       476 ~~l~-------------------~~~~-~~~l~~--~~~~~i~~--------------------~ia~~L~yLH~~----  509 (621)
                      ....                   .... ..++..  .....-..                    .+...+..|-..    
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            4321                   0000 001110  00000000                    011112222111    


Q ss_pred             CCCCeEeccCCCCCEEEcCCCCeEEeeecCce
Q 007006          510 SRLKIIHRDLKASNILLDDDMNPKISDFGLAR  541 (621)
Q Consensus       510 ~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~  541 (621)
                      ..+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            23458999999999999998778899999775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.00  E-value=7.7e-07  Score=96.05  Aligned_cols=185  Identities=19%  Similarity=0.170  Sum_probs=132.3

Q ss_pred             CCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCC-ceeEeeEEeeCceEEEEEEecCC
Q 007006          393 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN-LVRLLGCCLEGQELLLIYEYMPN  471 (621)
Q Consensus       393 f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~n-Iv~l~g~~~~~~~~~lV~e~~~~  471 (621)
                      +...+-+++++.+.++|.+-...+....+.+...     ....-++++|.+++||| .+..++-+..++..+++++++..
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~  318 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST  318 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence            3344567889999999887544444445555433     44567899999999999 77777777777788999999887


Q ss_pred             C-ChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc
Q 007006          472 K-SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA  550 (621)
Q Consensus       472 g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~  550 (621)
                      + +-..-.  ......+..-+...+.+.-.+++++||+..   -+|+|    ||+..+ +..+..||+....+....   
T Consensus       319 ~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---  385 (829)
T KOG0576|consen  319 GRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---  385 (829)
T ss_pred             CccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---
Confidence            6 211111  011122333444556666778899999752   47888    777766 578999999887665433   


Q ss_pred             ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCC
Q 007006          551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNN  595 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~  595 (621)
                      ..+...+++.|+|||+...+.+..+.|+|++|+-..++.-|-+|-
T Consensus       386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            344567899999999999999999999999999888888887774

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.00  E-value=1.2e-06  Score=95.74  Aligned_cols=95  Identities=27%  Similarity=0.542  Sum_probs=74.7

Q ss_pred             HHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcc-------cccccccCCccChhcccCC
Q 007006          498 GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN-------TNIIAGTYGYMAPEYAMGG  570 (621)
Q Consensus       498 ~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~-------~~~~~gt~~y~aPE~l~~~  570 (621)
                      +++.||.|+|...  ++||++|.|++|.++.++.+||..|+.+.....+...+.       .-.......|.|||++.+.
T Consensus       107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            4559999999864  799999999999999999999999998765433211111       1112345679999999998


Q ss_pred             CCChhhhHHHHHHHHHHHHcCCCC
Q 007006          571 IFSIKSDVFSFGVLLLEIISGRKN  594 (621)
Q Consensus       571 ~~s~~sDVwS~Gvll~elltG~~p  594 (621)
                      ..+.++|++|+|+++|-+..|..+
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~  208 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKS  208 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcc
Confidence            889999999999999999955444

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.00  E-value=3.3e-05  Score=73.81  Aligned_cols=105  Identities=23%  Similarity=0.234  Sum_probs=82.7

Q ss_pred             HHHHHHHHhccc-CCceeEeeEEeeCceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 007006          435 KNEVNLIAKLQH-KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK  513 (621)
Q Consensus       435 ~~Ei~~l~~l~h-~nIv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~  513 (621)
                      .+|.-+|+.+++ +++++++|.|-.    +++.||.+.+++...-..-..-...+|..+.+|+.++++.+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            468888999976 699999999943    678999987765321000011124689999999999999999999864445


Q ss_pred             eEeccCCCCCEEEcCCCCeEEeeecCceec
Q 007006          514 IIHRDLKASNILLDDDMNPKISDFGLARIF  543 (621)
Q Consensus       514 iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~  543 (621)
                      +.-.|++++|+-+++++++|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            888999999999999999999999887654

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=97.96  E-value=0.00014  Score=85.61  Aligned_cols=79  Identities=16%  Similarity=0.379  Sum_probs=58.6

Q ss_pred             cceeccCCceeEEEEEecCC---cEEEEEEeccCC-cccHHHHHHHHHHHHhcc-cCCc--eeEeeEEeeC---ceEEEE
Q 007006          396 ENKLGQGGFGPVYKGTLADG---KAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQ-HKNL--VRLLGCCLEG---QELLLI  465 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~g---~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-h~nI--v~l~g~~~~~---~~~~lV  465 (621)
                      .+.++.|.+..+|+....++   ..+++|+..... ......+.+|+++|+.+. |+++  ++++.++.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            57789999999999876554   467777764332 123457889999999995 6664  7888888764   467899


Q ss_pred             EEecCCCCh
Q 007006          466 YEYMPNKSL  474 (621)
Q Consensus       466 ~e~~~~gsL  474 (621)
                      |||+++..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999998653

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.95  E-value=0.00014  Score=69.86  Aligned_cols=129  Identities=19%  Similarity=0.279  Sum_probs=90.7

Q ss_pred             ccceeccCCceeEEEEEecCCcEEEEEEeccCC----------------cccHHHHHHHHHHHHhcc------cCCceeE
Q 007006          395 DENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS----------------GQGLQEFKNEVNLIAKLQ------HKNLVRL  452 (621)
Q Consensus       395 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~----------------~~~~~~~~~Ei~~l~~l~------h~nIv~l  452 (621)
                      ....||+|+.-.||.  +++.....||+.....                ....++..+|+.....+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            356899999999984  5667777888887654                223456677777666665      7889999


Q ss_pred             eeEEeeCceEEEEEEecCC------CChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE
Q 007006          453 LGCCLEGQELLLIYEYMPN------KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL  526 (621)
Q Consensus       453 ~g~~~~~~~~~lV~e~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl  526 (621)
                      +|+.+++..+.+|+|.+.+      -+|.+++.    ...++. ...+.+.   .-..||-++.   |+.+|++|+||++
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIVV  151 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEEE
Confidence            9999999999999998764      34566663    334555 3333333   3345666554   9999999999999


Q ss_pred             cCCC----CeEEee
Q 007006          527 DDDM----NPKISD  536 (621)
Q Consensus       527 ~~~~----~vkL~D  536 (621)
                      ....    .+.|+|
T Consensus       152 ~~~~~~~~~lvlID  165 (199)
T PF10707_consen  152 QRRDSGEFRLVLID  165 (199)
T ss_pred             EecCCCceEEEEEe
Confidence            6432    477776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.93  E-value=7.7e-05  Score=81.51  Aligned_cols=142  Identities=15%  Similarity=0.173  Sum_probs=89.9

Q ss_pred             cceeccCCceeEEEEEecCCcEEEEEEeccCCccc-------------------------------------HHHHHHHH
Q 007006          396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG-------------------------------------LQEFKNEV  438 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~-------------------------------------~~~~~~Ei  438 (621)
                      .+.||..+.|.||++++++|+.||||+-+..-+..                                     .-+|.+|.
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            46899999999999999999999999765321110                                     01244454


Q ss_pred             HHHHhc----ccCC---ceeEeeEEee-CceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 007006          439 NLIAKL----QHKN---LVRLLGCCLE-GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS  510 (621)
Q Consensus       439 ~~l~~l----~h~n---Iv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~  510 (621)
                      +-..+.    .|-+   -|.+=.++.+ .....|+||||+|..+.+...-.  ...++...+..-+.+...-+-+-|   
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~--~~gi~~~~i~~~l~~~~~~qIf~~---  320 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID--KRGISPHDILNKLVEAYLEQIFKT---  320 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH--HcCCCHHHHHHHHHHHHHHHHHhc---
Confidence            433333    4555   1112223332 34679999999998887664322  223555544433333222222222   


Q ss_pred             CCCeEeccCCCCCEEEcC----CCCeEEeeecCceecC
Q 007006          511 RLKIIHRDLKASNILLDD----DMNPKISDFGLARIFG  544 (621)
Q Consensus       511 ~~~iiH~Dlkp~NILl~~----~~~vkL~Dfgla~~~~  544 (621)
                        +++|.|-.|.||+++.    ++.+.+-|||+...+.
T Consensus       321 --GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  321 --GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             --CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence              4999999999999984    6679999999987653

>PRK10593 hypothetical protein; Provisional

Probab=97.84  E-value=0.00037  Score=71.86  Aligned_cols=77  Identities=9%  Similarity=0.043  Sum_probs=57.5

Q ss_pred             ccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhccc---CCceeEeeEEeeC---ceEEEEEEe
Q 007006          395 DENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH---KNLVRLLGCCLEG---QELLLIYEY  468 (621)
Q Consensus       395 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h---~nIv~l~g~~~~~---~~~~lV~e~  468 (621)
                      ..+.||+|..+.||+....+++ +.+|..+..  .....+..|.+.|+.+..   ..++++++++...   +..++|||+
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQGN-PMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eeeecCCccceeEEEEEcCCCC-EEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            3568999999999998766564 566664321  123578899999999953   4688899887643   568999999


Q ss_pred             cCCCCh
Q 007006          469 MPNKSL  474 (621)
Q Consensus       469 ~~~gsL  474 (621)
                      +++.++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            998765

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.81  E-value=0.00021  Score=71.03  Aligned_cols=73  Identities=15%  Similarity=0.269  Sum_probs=47.2

Q ss_pred             ceeccCCce-eEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccC---CceeEeeEEeeCc---eEEEEEEec
Q 007006          397 NKLGQGGFG-PVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK---NLVRLLGCCLEGQ---ELLLIYEYM  469 (621)
Q Consensus       397 ~~LG~G~fG-~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~---nIv~l~g~~~~~~---~~~lV~e~~  469 (621)
                      +.|+.|+.. .||+.    +..+++|..+..  .....+..|.+++..+...   .+.++++.....+   ..+++|+++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            467767766 48875    345677765432  2345788999999988532   3555555443322   347899999


Q ss_pred             CCCChh
Q 007006          470 PNKSLD  475 (621)
Q Consensus       470 ~~gsL~  475 (621)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            997764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.75  E-value=0.00044  Score=68.60  Aligned_cols=75  Identities=17%  Similarity=0.267  Sum_probs=50.2

Q ss_pred             cceeccCCceeEEEEEecC--CcEEEEEEeccCCcccHHHHHHHHHHHHhcccCC-ceeEeeEEeeCceEEEEEEecCCC
Q 007006          396 ENKLGQGGFGPVYKGTLAD--GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN-LVRLLGCCLEGQELLLIYEYMPNK  472 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~--g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~n-Iv~l~g~~~~~~~~~lV~e~~~~g  472 (621)
                      .+.|..|-...+|+....+  +..+++|+....... .-+..+|+.++..+.... .+++++...    -.++|||++|.
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~   77 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR   77 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence            3567788889999988664  678889977643222 123357898998885433 445544332    24799999987


Q ss_pred             Chh
Q 007006          473 SLD  475 (621)
Q Consensus       473 sL~  475 (621)
                      ++.
T Consensus        78 ~l~   80 (235)
T cd05157          78 TLE   80 (235)
T ss_pred             cCC
Confidence            763

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.71  E-value=0.00031  Score=65.11  Aligned_cols=129  Identities=22%  Similarity=0.246  Sum_probs=88.5

Q ss_pred             CccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCcee-EeeEEeeCceEEEEEEecCCC
Q 007006          394 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR-LLGCCLEGQELLLIYEYMPNK  472 (621)
Q Consensus       394 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~-l~g~~~~~~~~~lV~e~~~~g  472 (621)
                      ...+.|++|.+|.||+|.+. |..+|+|+-+..+  ....+..|+++|..+.-.++.+ ++.+-.    -++.|||+.|-
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence            34578999999999999986 5588888765443  3477899999999998777654 444432    24559999998


Q ss_pred             ChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCC-CCCEEEcCCCCeEEeeecCcee
Q 007006          473 SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK-ASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       473 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk-p~NILl~~~~~vkL~Dfgla~~  542 (621)
                      .|...-...      +.+...+    ++..---|...   +|-|+.|. |...+|-.++.+.|+||..|..
T Consensus        98 ~L~~~~~~~------~rk~l~~----vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          98 PLGKLEIGG------DRKHLLR----VLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             chhhhhhcc------cHHHHHH----HHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            887654211      2223332    33333334433   48899887 5556666666999999999874

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.69  E-value=0.00081  Score=71.63  Aligned_cols=76  Identities=13%  Similarity=0.232  Sum_probs=55.0

Q ss_pred             cceeccCCceeEEEEEecCC-cEEEEEEeccC-----C--cccHHHHHHHHHHHHhcc---cCCceeEeeEEeeCceEEE
Q 007006          396 ENKLGQGGFGPVYKGTLADG-KAIAVKRLSRT-----S--GQGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~g-~~vavK~l~~~-----~--~~~~~~~~~Ei~~l~~l~---h~nIv~l~g~~~~~~~~~l  464 (621)
                      .+.||.|.+..||++...+| +.++||.-...     .  +...+.+..|.+.|..+.   ..++++++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            35789999999999998877 58999974321     1  123456778888888873   2467778876  4455789


Q ss_pred             EEEecCCCC
Q 007006          465 IYEYMPNKS  473 (621)
Q Consensus       465 V~e~~~~gs  473 (621)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998643

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.62  E-value=0.00041  Score=69.90  Aligned_cols=139  Identities=16%  Similarity=0.120  Sum_probs=80.3

Q ss_pred             eeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCc-eeEeeEEeeCceEEEEEEecCCCChhh
Q 007006          398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEYMPNKSLDV  476 (621)
Q Consensus       398 ~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nI-v~l~g~~~~~~~~~lV~e~~~~gsL~~  476 (621)
                      .+..|-...+|+... ++..+++|..........-+..+|.++++.+....+ +++++...    -++|+||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            355677888998873 577888887654332211235789999998864433 44554432    368999999876542


Q ss_pred             h-----------------hhhcc-CCCCCCHHHH-HHHHHH---------HHHHHHHHHhC-----CCCCeEeccCCCCC
Q 007006          477 H-----------------LFDAT-RSVQLDWKRR-QSIING---------IARGILYLHED-----SRLKIIHRDLKASN  523 (621)
Q Consensus       477 ~-----------------l~~~~-~~~~l~~~~~-~~i~~~---------ia~~L~yLH~~-----~~~~iiH~Dlkp~N  523 (621)
                      -                 +|... ...+++.... .....+         +...+..+-..     .+..++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 11110 0111222211 111111         11112222221     12358999999999


Q ss_pred             EEEcCCCCeEEeeecCcee
Q 007006          524 ILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       524 ILl~~~~~vkL~Dfgla~~  542 (621)
                      |++++++ +.|+||..+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999877 78999998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.42  E-value=0.0016  Score=67.06  Aligned_cols=143  Identities=20%  Similarity=0.204  Sum_probs=86.8

Q ss_pred             cceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccC--CceeEeeE------EeeCceEEEEEE
Q 007006          396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK--NLVRLLGC------CLEGQELLLIYE  467 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~--nIv~l~g~------~~~~~~~~lV~e  467 (621)
                      .+.|..|....+|+....+ ..+++|+...   ........|++++..+.+.  .+++++..      ....+..+++++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            5677778888999987644 4688888764   2235567788888888543  34555432      122345689999


Q ss_pred             ecCCCChhh----h----------hhhccCC--------CCCCHHHHH----------HHHHHHHHHHHHHHh----CCC
Q 007006          468 YMPNKSLDV----H----------LFDATRS--------VQLDWKRRQ----------SIINGIARGILYLHE----DSR  511 (621)
Q Consensus       468 ~~~~gsL~~----~----------l~~~~~~--------~~l~~~~~~----------~i~~~ia~~L~yLH~----~~~  511 (621)
                      |++|..+..    .          ++.....        ....|....          .....+...+.++..    ..+
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999877532    0          1110000        111222111          011123344455543    123


Q ss_pred             CCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          512 LKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       512 ~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      ..++|+|+.|.||+++++..+.|+||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            4699999999999999987778999998763

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.41  E-value=0.0022  Score=61.42  Aligned_cols=125  Identities=25%  Similarity=0.376  Sum_probs=88.1

Q ss_pred             CCCCccceeccCCc-eeEEEEEecCCcEEEEEEeccC---Cc------------------ccHHHHHHHHHHHHhcc---
Q 007006          391 NHFSDENKLGQGGF-GPVYKGTLADGKAIAVKRLSRT---SG------------------QGLQEFKNEVNLIAKLQ---  445 (621)
Q Consensus       391 ~~f~~~~~LG~G~f-G~Vy~~~~~~g~~vavK~l~~~---~~------------------~~~~~~~~Ei~~l~~l~---  445 (621)
                      .+++..+.||+|.- |.||++++ +|+.+|+|.++.-   ..                  .....|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67888999999999 99999998 5789999994321   00                  11235788988888875   


Q ss_pred             cCCc--eeEeeEEeeCc------------------eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHH
Q 007006          446 HKNL--VRLLGCCLEGQ------------------ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY  505 (621)
Q Consensus       446 h~nI--v~l~g~~~~~~------------------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y  505 (621)
                      +.++  |+.+||..-..                  ...+|.||.+...            .+...    -+.+|.+-|..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~----~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIR----DIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchh----HHHHHHHHHHH
Confidence            4455  99999984321                  2356777665432            12222    34556677788


Q ss_pred             HHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCc
Q 007006          506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA  540 (621)
Q Consensus       506 LH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla  540 (621)
                      +|..|   |+-+|+++.|..     .-||+|||.+
T Consensus       180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            99876   999999999985     3478999864

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.26  E-value=0.0024  Score=65.92  Aligned_cols=141  Identities=25%  Similarity=0.363  Sum_probs=85.2

Q ss_pred             ceeccCCceeEEEEEecC-------CcEEEEEEeccCCcccHHHHHHHHHHHHhcccCC-ceeEeeEEeeCceEEEEEEe
Q 007006          397 NKLGQGGFGPVYKGTLAD-------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN-LVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~~-------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~n-Iv~l~g~~~~~~~~~lV~e~  468 (621)
                      +.|..|-...+|+....+       ++.+++|+...... ...+..+|.+++..+.... .+++++.+..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            456667777899988654       57899998765432 2244578888888885433 3456665532    358999


Q ss_pred             cCCCChhhh-h----------------hhccCCC------CCC--HHHHHH--------------------------HHH
Q 007006          469 MPNKSLDVH-L----------------FDATRSV------QLD--WKRRQS--------------------------IIN  497 (621)
Q Consensus       469 ~~~gsL~~~-l----------------~~~~~~~------~l~--~~~~~~--------------------------i~~  497 (621)
                      ++|..+... +                |......      ..+  +.....                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            998776431 1                1100000      000  111100                          112


Q ss_pred             HHHHHHHHHHh------CCCCCeEeccCCCCCEEEcCC----CCeEEeeecCcee
Q 007006          498 GIARGILYLHE------DSRLKIIHRDLKASNILLDDD----MNPKISDFGLARI  542 (621)
Q Consensus       498 ~ia~~L~yLH~------~~~~~iiH~Dlkp~NILl~~~----~~vkL~Dfgla~~  542 (621)
                      .+..-+..|..      ..+..++|+|+.+.|||++++    +.++++||..+..
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            22233344432      134578999999999999985    8899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.18  E-value=0.0082  Score=62.49  Aligned_cols=143  Identities=17%  Similarity=0.199  Sum_probs=79.9

Q ss_pred             cceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccC--CceeEeeE------EeeCceEEEEEE
Q 007006          396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK--NLVRLLGC------CLEGQELLLIYE  467 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~--nIv~l~g~------~~~~~~~~lV~e  467 (621)
                      .+.|+.|....+|+....+| .+++|+....   ..+....|+.++..|...  .+++++..      ....+..++++|
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             cchhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            35677788789999887655 6888987522   224445566666666422  24444421      122456789999


Q ss_pred             ecCCCChhh-----h---------hhhccCC--------CCCCH-HHHHH------------HH-HHHHHHHHHHHhC--
Q 007006          468 YMPNKSLDV-----H---------LFDATRS--------VQLDW-KRRQS------------II-NGIARGILYLHED--  509 (621)
Q Consensus       468 ~~~~gsL~~-----~---------l~~~~~~--------~~l~~-~~~~~------------i~-~~ia~~L~yLH~~--  509 (621)
                      |++|..+..     .         ++.....        ..+.| .....            .. ..+...+..+...  
T Consensus       103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  182 (319)
T PRK05231        103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW  182 (319)
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence            999875421     0         1111100        01112 11111            11 1111222333211  


Q ss_pred             --CCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          510 --SRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       510 --~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                        -+.+++|+|+.|.||+++.+...-|+||+.+..
T Consensus       183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence              234699999999999999765568999998753

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.04  E-value=0.014  Score=60.45  Aligned_cols=143  Identities=17%  Similarity=0.182  Sum_probs=83.7

Q ss_pred             cceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccC--CceeEeeEE------eeCceEEEEEE
Q 007006          396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK--NLVRLLGCC------LEGQELLLIYE  467 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~--nIv~l~g~~------~~~~~~~lV~e  467 (621)
                      .+.++.|....+|+....++ .+++|+.....  .......|++++..|...  .+++++...      ...+..++++|
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            45677787789999876545 57788765432  234556777888777432  244444321      12346789999


Q ss_pred             ecCCCChhhh--------------hhhccCC------C---CCCHHHHH------------HHHHHHHHHHHHHHh----
Q 007006          468 YMPNKSLDVH--------------LFDATRS------V---QLDWKRRQ------------SIINGIARGILYLHE----  508 (621)
Q Consensus       468 ~~~~gsL~~~--------------l~~~~~~------~---~l~~~~~~------------~i~~~ia~~L~yLH~----  508 (621)
                      |++|..+...              ++.....      .   .-.|....            .....+.+.++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9998654210              1110010      0   01111110            011123344555542    


Q ss_pred             CCCCCeEeccCCCCCEEEcCCCCeEEeeecCce
Q 007006          509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLAR  541 (621)
Q Consensus       509 ~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~  541 (621)
                      .-+..++|+|+.+.||++++++...|+||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            223579999999999999988777899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.86  E-value=0.014  Score=60.10  Aligned_cols=138  Identities=17%  Similarity=0.290  Sum_probs=83.1

Q ss_pred             ceeccCCceeEEEEEecCCcEEEEEEec-cCCcccHHHHHHHHHHHHhccc--CCceeEeeEEeeCc--eEEEEEEecCC
Q 007006          397 NKLGQGGFGPVYKGTLADGKAIAVKRLS-RTSGQGLQEFKNEVNLIAKLQH--KNLVRLLGCCLEGQ--ELLLIYEYMPN  471 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~-~~~~~~~~~~~~Ei~~l~~l~h--~nIv~l~g~~~~~~--~~~lV~e~~~~  471 (621)
                      +.+..|..-.+|..... ++.+++.+-. ........+..+|.++|+.+.-  --+...++.|.++.  ..+.||+|++|
T Consensus        31 ~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veG  109 (321)
T COG3173          31 EEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEG  109 (321)
T ss_pred             eeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecc
Confidence            33433433444544433 7778888321 1223445566788888888853  34566777787766  67999999988


Q ss_pred             CChhhhhhhccCCCCCCHHHHHHHH-HHHHHHH-----------------------------------------------
Q 007006          472 KSLDVHLFDATRSVQLDWKRRQSII-NGIARGI-----------------------------------------------  503 (621)
Q Consensus       472 gsL~~~l~~~~~~~~l~~~~~~~i~-~~ia~~L-----------------------------------------------  503 (621)
                      ..+...+....    ..    ..++ ..++..|                                               
T Consensus       110 e~~~~~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~  181 (321)
T COG3173         110 EVVWSALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD  181 (321)
T ss_pred             eeccCcCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence            43322211000    00    0111 1233333                                               


Q ss_pred             ---HHHHhC-----CCCCeEeccCCCCCEEEcCCCCeEEeeecCceec
Q 007006          504 ---LYLHED-----SRLKIIHRDLKASNILLDDDMNPKISDFGLARIF  543 (621)
Q Consensus       504 ---~yLH~~-----~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~  543 (621)
                         .+|+.+     ++..++|||+.+.|++++.+.-+-|.||+++..-
T Consensus       182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence               344333     2356999999999999999888999999998754

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.82  E-value=0.0083  Score=61.32  Aligned_cols=75  Identities=17%  Similarity=0.274  Sum_probs=49.4

Q ss_pred             CccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcc---cCCceeEeeEEeeCceEEEEEEecC
Q 007006          394 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLEGQELLLIYEYMP  470 (621)
Q Consensus       394 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---h~nIv~l~g~~~~~~~~~lV~e~~~  470 (621)
                      ...+.++.|....+|+.. .+++.+.||.-..   .....|..|.+-|+.|.   --.+++++++....+..+||+||++
T Consensus        20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            345678889999999987 5788899998762   23356788999888883   3458889998887777899999998


Q ss_pred             CC
Q 007006          471 NK  472 (621)
Q Consensus       471 ~g  472 (621)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            76

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02236 choline kinase

Probab=96.76  E-value=0.017  Score=60.88  Aligned_cols=141  Identities=19%  Similarity=0.291  Sum_probs=83.9

Q ss_pred             ceeccCCceeEEEEEecC-----CcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCc-eeEeeEEeeCceEEEEEEecC
Q 007006          397 NKLGQGGFGPVYKGTLAD-----GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEYMP  470 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nI-v~l~g~~~~~~~~~lV~e~~~  470 (621)
                      ..|-.|-.-.+|+....+     ++.+++|+..........+ .+|..+++.+...++ +++++.+...    .|.+|++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            456567778899987532     3678899886654333333 779999998865444 4566665332    5799998


Q ss_pred             CCChhhh-----------------hhhcc--C-CCCCCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 007006          471 NKSLDVH-----------------LFDAT--R-SVQLDWKRRQSIINGI-----------------ARGILYL----HE-  508 (621)
Q Consensus       471 ~gsL~~~-----------------l~~~~--~-~~~l~~~~~~~i~~~i-----------------a~~L~yL----H~-  508 (621)
                      +.++...                 +|...  . .....+.+..++..++                 ...+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            8776421                 11100  0 0111233332332211                 1112222    21 


Q ss_pred             CCCCCeEeccCCCCCEEEcC-CCCeEEeeecCcee
Q 007006          509 DSRLKIIHRDLKASNILLDD-DMNPKISDFGLARI  542 (621)
Q Consensus       509 ~~~~~iiH~Dlkp~NILl~~-~~~vkL~Dfgla~~  542 (621)
                      ..+..++|+|+++.|||+++ ++.+.|+||..+..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            22346899999999999986 46899999998765

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.72  E-value=0.018  Score=58.71  Aligned_cols=31  Identities=29%  Similarity=0.583  Sum_probs=26.0

Q ss_pred             CCeEeccCCCCCEEEcCCCC-eEEeeecCcee
Q 007006          512 LKIIHRDLKASNILLDDDMN-PKISDFGLARI  542 (621)
Q Consensus       512 ~~iiH~Dlkp~NILl~~~~~-vkL~Dfgla~~  542 (621)
                      ..++|+|+.+.|||+++++. .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            35899999999999997555 46999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.68  E-value=0.0022  Score=64.92  Aligned_cols=142  Identities=17%  Similarity=0.140  Sum_probs=96.0

Q ss_pred             hHHHHHHhCCCCccceeccCCceeEEEEEecCCcEEEEEEeccC-----------------CcccH-----HHHHHHHHH
Q 007006          383 LRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT-----------------SGQGL-----QEFKNEVNL  440 (621)
Q Consensus       383 ~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~-----------------~~~~~-----~~~~~Ei~~  440 (621)
                      ++.+.....-+++.++||-|--+.||.+...+|.+.++|.-+..                 ....|     -....|...
T Consensus        84 lktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfaf  163 (465)
T KOG2268|consen   84 LKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAF  163 (465)
T ss_pred             HHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHH
Confidence            33333333456778999999999999999999999999853211                 01111     124578888


Q ss_pred             HHhccc--CCceeEeeEEeeCceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 007006          441 IAKLQH--KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRD  518 (621)
Q Consensus       441 l~~l~h--~nIv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~D  518 (621)
                      |+.|..  --|++.+++.    ..++|||++.+-.|...-      ...+..++..-   +..-+.-|..+|   +||+|
T Consensus       164 mkaL~e~gfpVPkpiD~~----RH~Vvmelv~g~Pl~~v~------~v~d~~~ly~~---lm~~Iv~la~~G---lIHgD  227 (465)
T KOG2268|consen  164 MKALYERGFPVPKPIDHN----RHCVVMELVDGYPLRQVR------HVEDPPTLYDD---LMGLIVRLANHG---LIHGD  227 (465)
T ss_pred             HHHHHHcCCCCCCccccc----ceeeHHHhhcccceeeee------ecCChHHHHHH---HHHHHHHHHHcC---ceecc
Confidence            888843  2366666553    458999999887765432      11333444433   333344566665   99999


Q ss_pred             CCCCCEEEcCCCCeEEeeecCc
Q 007006          519 LKASNILLDDDMNPKISDFGLA  540 (621)
Q Consensus       519 lkp~NILl~~~~~vkL~Dfgla  540 (621)
                      ..-=||++++++.++++||--.
T Consensus       228 FNEFNimv~dd~~i~vIDFPQm  249 (465)
T KOG2268|consen  228 FNEFNIMVKDDDKIVVIDFPQM  249 (465)
T ss_pred             cchheeEEecCCCEEEeechHh
Confidence            9999999999999999999643

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.50  E-value=0.042  Score=57.57  Aligned_cols=72  Identities=15%  Similarity=0.213  Sum_probs=47.6

Q ss_pred             eeccCCceeEEEEEecCC-cEEEEEEecc-------CCcccHHHHHHHHHHHHhcc--cC-CceeEeeEEeeCceEEEEE
Q 007006          398 KLGQGGFGPVYKGTLADG-KAIAVKRLSR-------TSGQGLQEFKNEVNLIAKLQ--HK-NLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       398 ~LG~G~fG~Vy~~~~~~g-~~vavK~l~~-------~~~~~~~~~~~Ei~~l~~l~--h~-nIv~l~g~~~~~~~~~lV~  466 (621)
                      .||-|....||++..++| +.|+||.-..       .-+-..++..-|.+.|....  -| .+++++.+  +++...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            478999999999997654 5899986421       11233445566777776663  24 45555543  455567999


Q ss_pred             EecCC
Q 007006          467 EYMPN  471 (621)
Q Consensus       467 e~~~~  471 (621)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99965

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=96.20  E-value=0.016  Score=67.71  Aligned_cols=155  Identities=21%  Similarity=0.186  Sum_probs=107.3

Q ss_pred             HHHHHHHHHHhcccCCceeEeeEEeeCceEE----EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 007006          433 EFKNEVNLIAKLQHKNLVRLLGCCLEGQELL----LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE  508 (621)
Q Consensus       433 ~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~----lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~  508 (621)
                      ...-|.+.+.+..|+|++.++++-.+....-    +..+++..-++...+.   .-..++....+.+..++.+||.|+|+
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHHH
Confidence            3455777888899999999999877653322    2345666666655552   23457888888899999999999998


Q ss_pred             CCCCCeEeccCCCC---CEEEcCCCCeEEe--eecCceecCCCCCCcccccccccCCccChhcccCCCCCh--hhhHHHH
Q 007006          509 DSRLKIIHRDLKAS---NILLDDDMNPKIS--DFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI--KSDVFSF  581 (621)
Q Consensus       509 ~~~~~iiH~Dlkp~---NILl~~~~~vkL~--Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~--~sDVwS~  581 (621)
                      ..   ..|.-+..+   +.-.+.++.+.++  ||+....+........   ...+..+.+||......+..  ..|+|.+
T Consensus       305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~l  378 (1351)
T KOG1035|consen  305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWCL  378 (1351)
T ss_pred             hc---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHHHH
Confidence            74   555555554   4555666667766  8888776543322111   12345678888877666544  4799999


Q ss_pred             HHHHHHHHcCCCCCC
Q 007006          582 GVLLLEIISGRKNNG  596 (621)
Q Consensus       582 Gvll~elltG~~p~~  596 (621)
                      |.++..+..|..+..
T Consensus       379 gll~~~~~~~~~i~~  393 (1351)
T KOG1035|consen  379 GLLLLQLSQGEDISE  393 (1351)
T ss_pred             HHHHhhhhhcCcccc
Confidence            999999999987743

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.04  E-value=0.068  Score=55.97  Aligned_cols=141  Identities=15%  Similarity=0.255  Sum_probs=81.1

Q ss_pred             ceeccCCceeEEEEEecC----CcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCc-eeEeeEEeeCceEEEEEEecCC
Q 007006          397 NKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEYMPN  471 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nI-v~l~g~~~~~~~~~lV~e~~~~  471 (621)
                      +.|..|-.-.+|+....+    +..|++|+......... +-.+|..+++.+..-++ +++++++. .+   +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVI-DRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEe-chHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            455557777889886543    23788898765543322 23688999999865554 45666653 22   58999987


Q ss_pred             CChhhh-------h----------hhcc---CCCCCCHHHHHHHHHHH----------------------HHHHHHHH--
Q 007006          472 KSLDVH-------L----------FDAT---RSVQLDWKRRQSIINGI----------------------ARGILYLH--  507 (621)
Q Consensus       472 gsL~~~-------l----------~~~~---~~~~l~~~~~~~i~~~i----------------------a~~L~yLH--  507 (621)
                      ..|..-       +          |...   ...+--|..+.++..++                      ..-+..+.  
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            665321       1          1100   00011223222222211                      11111111  


Q ss_pred             --h-CCCCCeEeccCCCCCEEEcC-CCCeEEeeecCcee
Q 007006          508 --E-DSRLKIIHRDLKASNILLDD-DMNPKISDFGLARI  542 (621)
Q Consensus       508 --~-~~~~~iiH~Dlkp~NILl~~-~~~vkL~Dfgla~~  542 (621)
                        . ..+.-++|+|+.+.|||+++ ++.++++||..+..
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence              1 12234799999999999975 57899999998764

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.01  E-value=0.056  Score=56.02  Aligned_cols=142  Identities=18%  Similarity=0.222  Sum_probs=98.0

Q ss_pred             CccceeccCCceeEEEEEecCCcEEEEEEeccCC-----------cc-----------cHH----HHHHHHHHHHhcccC
Q 007006          394 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS-----------GQ-----------GLQ----EFKNEVNLIAKLQHK  447 (621)
Q Consensus       394 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~-----------~~-----------~~~----~~~~Ei~~l~~l~h~  447 (621)
                      .+...|..|--..||.+.-.+|..+|||+.+..-           .+           .++    -...|++-|.+++..
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            4456788899999999999999999999875320           00           011    134577778888665


Q ss_pred             CceeEeeEEeeCceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc
Q 007006          448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD  527 (621)
Q Consensus       448 nIv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~  527 (621)
                      .|+-.--+...  .-.|||+|+....   +-.-..+...++...+..+-.+++.-+.-|.+.+  ++||.||.-=|+|+.
T Consensus       227 GIP~PePIlLk--~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh  299 (520)
T KOG2270|consen  227 GIPCPEPILLK--NHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH  299 (520)
T ss_pred             CCCCCCceeee--cceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence            54322212211  2378999986422   2222234456777788888889999999888876  699999999999885


Q ss_pred             CCCCeEEeeecCceec
Q 007006          528 DDMNPKISDFGLARIF  543 (621)
Q Consensus       528 ~~~~vkL~Dfgla~~~  543 (621)
                       +|.+.|+|.+-+-..
T Consensus       300 -dG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  300 -DGKLYIIDVSQSVEH  314 (520)
T ss_pred             -CCEEEEEEccccccC
Confidence             457999998876544

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.97  E-value=0.15  Score=52.80  Aligned_cols=64  Identities=16%  Similarity=0.273  Sum_probs=40.0

Q ss_pred             eEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccC--CceeEeeE------EeeCceEEEEEEecCCCCh
Q 007006          406 PVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK--NLVRLLGC------CLEGQELLLIYEYMPNKSL  474 (621)
Q Consensus       406 ~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~--nIv~l~g~------~~~~~~~~lV~e~~~~gsL  474 (621)
                      .||+....+| .+++|+....    ...+..|+..+..|...  .+++++..      ...++..++++||++|..+
T Consensus        11 ~v~~v~t~~g-~~~LK~~~~~----~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~   82 (313)
T TIGR02906        11 NVYKVETDSG-NKCLKKINYP----PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC   82 (313)
T ss_pred             cEEEEEeCCC-CeEEEEcCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence            4888876555 6888987532    23455677777777433  34444432      1224567899999998655

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.84  E-value=0.025  Score=55.13  Aligned_cols=123  Identities=20%  Similarity=0.271  Sum_probs=60.9

Q ss_pred             CcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCc-eeEeeEEeeCceEEEEEEecCCCChhhh-------h--------
Q 007006          415 GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEYMPNKSLDVH-------L--------  478 (621)
Q Consensus       415 g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nI-v~l~g~~~~~~~~~lV~e~~~~gsL~~~-------l--------  478 (621)
                      ++.|+||+....+ ...-+-..|..+++.+....+ +++++.+.+    ..|.+|+++..|..-       +        
T Consensus         2 ~~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~   76 (211)
T PF01633_consen    2 PEKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA   76 (211)
T ss_dssp             TSEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence            4678888876653 334455789999998865444 556665533    257799977665321       1        


Q ss_pred             --hhccC----CCCCCHHHHHHH----------------------HHHHHHHHHHHHh---C--CCCCeEeccCCCCCEE
Q 007006          479 --FDATR----SVQLDWKRRQSI----------------------INGIARGILYLHE---D--SRLKIIHRDLKASNIL  525 (621)
Q Consensus       479 --~~~~~----~~~l~~~~~~~i----------------------~~~ia~~L~yLH~---~--~~~~iiH~Dlkp~NIL  525 (621)
                        |....    ....-|....++                      ...+..-+..+.+   .  .+.-++|+|+.+.|||
T Consensus        77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil  156 (211)
T PF01633_consen   77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL  156 (211)
T ss_dssp             HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred             HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence              00000    001111212111                      0111112222211   1  1235899999999999


Q ss_pred             E-cCCCCeEEeeecCcee
Q 007006          526 L-DDDMNPKISDFGLARI  542 (621)
Q Consensus       526 l-~~~~~vkL~Dfgla~~  542 (621)
                      + +.++.++++||..+..
T Consensus       157 ~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  157 INNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             ETSSSSCEEE--GTT-EE
T ss_pred             eccCCCeEEEecHHHHhh
Confidence            9 8889999999998764

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ]

Probab=95.72  E-value=0.019  Score=39.12  Aligned_cols=30  Identities=23%  Similarity=0.468  Sum_probs=16.1

Q ss_pred             CceeEEEEhhhHHHHHHHHHhhheeEEeec
Q 007006          305 GRAISIAIGTTLSALIVVLFGSFLWYRRRR  334 (621)
Q Consensus       305 ~~~~~i~i~~~~~~~~~~~~~~~~~~~~rr  334 (621)
                      ..++++++++.++++++++.+++++++||+
T Consensus        10 ~vaIa~~VvVPV~vI~~vl~~~l~~~~rR~   39 (40)
T PF08693_consen   10 TVAIAVGVVVPVGVIIIVLGAFLFFWYRRK   39 (40)
T ss_pred             eEEEEEEEEechHHHHHHHHHHhheEEecc
Confidence            345555555556665555555555444443

This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis [].

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.63  E-value=0.19  Score=53.63  Aligned_cols=73  Identities=11%  Similarity=0.090  Sum_probs=49.8

Q ss_pred             cceeccCCceeEEEEEecCCcEEEEEEeccC----Cc---ccHHHHHHHHHHHHhcc---cCCceeEeeEEeeCceEEEE
Q 007006          396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRT----SG---QGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~----~~---~~~~~~~~Ei~~l~~l~---h~nIv~l~g~~~~~~~~~lV  465 (621)
                      .+.||.|....||+.... +..++||.-...    ..   -...+-..|.+.|+.+.   ..++++++.++.+  .-+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEE
Confidence            567899999999998764 556889975411    11   12333345566666653   3578889988774  45788


Q ss_pred             EEecCC
Q 007006          466 YEYMPN  471 (621)
Q Consensus       466 ~e~~~~  471 (621)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999976

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.59  E-value=0.15  Score=52.89  Aligned_cols=32  Identities=25%  Similarity=0.371  Sum_probs=28.4

Q ss_pred             CCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          511 RLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       511 ~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      +..++|+|+.++|||+++++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            45699999999999999999999999988763

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.57  E-value=0.19  Score=52.34  Aligned_cols=141  Identities=24%  Similarity=0.348  Sum_probs=83.4

Q ss_pred             eeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCC---cee---Eee----EEeeCceEEEEEE
Q 007006          398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN---LVR---LLG----CCLEGQELLLIYE  467 (621)
Q Consensus       398 ~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~n---Iv~---l~g----~~~~~~~~~lV~e  467 (621)
                      .|.+ .-..+|+....+|+. ++|+....  ....++..|++.|..|.-..   .++   +=|    ....+.....+++
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~  108 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE  108 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence            4444 556789988877777 78877654  34566777888888884221   112   111    1112236788999


Q ss_pred             ecCCCChhh-h--------------hhhcc------CC---CCCCHHH-------------HHHHHHHHHHHHHHHHhC-
Q 007006          468 YMPNKSLDV-H--------------LFDAT------RS---VQLDWKR-------------RQSIINGIARGILYLHED-  509 (621)
Q Consensus       468 ~~~~gsL~~-~--------------l~~~~------~~---~~l~~~~-------------~~~i~~~ia~~L~yLH~~-  509 (621)
                      |++|..+.. -              ++...      +.   ....|..             ......++...+..+.+. 
T Consensus       109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~  188 (331)
T COG2334         109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL  188 (331)
T ss_pred             ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence            999988772 1              11100      10   1123320             011233344444444433 


Q ss_pred             ---CCC-C--eEeccCCCCCEEEcCCCC-eEEeeecCcee
Q 007006          510 ---SRL-K--IIHRDLKASNILLDDDMN-PKISDFGLARI  542 (621)
Q Consensus       510 ---~~~-~--iiH~Dlkp~NILl~~~~~-vkL~Dfgla~~  542 (621)
                         -+. +  +||+|+.|.||+++++.. +.++||+-+..
T Consensus       189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             hhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence               112 2  999999999999999885 88999998753

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.48  E-value=0.71  Score=48.21  Aligned_cols=72  Identities=14%  Similarity=0.067  Sum_probs=45.9

Q ss_pred             CCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccC--CceeEe---e--EEeeCceEEEEEEecCCCCh
Q 007006          402 GGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK--NLVRLL---G--CCLEGQELLLIYEYMPNKSL  474 (621)
Q Consensus       402 G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~--nIv~l~---g--~~~~~~~~~lV~e~~~~gsL  474 (621)
                      +.-..||+....++..+++|+.+.. ......+..|++.+..|...  .++..+   |  ....++..+.++++++|...
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            4456799998878888999987532 23456677888888877422  122222   1  11224567889999987654

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.18  E-value=0.18  Score=53.62  Aligned_cols=74  Identities=9%  Similarity=0.113  Sum_probs=50.1

Q ss_pred             cceeccCCceeEEEEEecC-CcEEEEEEecc------CCcccHHHHHHHHHHHHhcc--cC-CceeEeeEEeeCceEEEE
Q 007006          396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSR------TSGQGLQEFKNEVNLIAKLQ--HK-NLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~------~~~~~~~~~~~Ei~~l~~l~--h~-nIv~l~g~~~~~~~~~lV  465 (621)
                      .+.||-|.-..||++...+ +..|+||.-..      .-+-..++..-|.+.|+...  -| .+++++.+  +++...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            4678999999999999753 56789885321      11334556677888887763  34 45566654  44556788


Q ss_pred             EEecCC
Q 007006          466 YEYMPN  471 (621)
Q Consensus       466 ~e~~~~  471 (621)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999864

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=95.04  E-value=0.0047  Score=73.58  Aligned_cols=159  Identities=13%  Similarity=-0.025  Sum_probs=110.0

Q ss_pred             HHHHHHHHhcccCCceeEeeEEee--CceEEEEEEecCCCChhhhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC-
Q 007006          435 KNEVNLIAKLQHKNLVRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDS-  510 (621)
Q Consensus       435 ~~Ei~~l~~l~h~nIv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~-  510 (621)
                      ..|.+.++...|+++.....-...  ..+.+.+++++..|.+...+....+ ...++..-+...-.+......-+|+.. 
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence            344445556688887765554433  3356888999999999888765433 333444444443343344555545442 


Q ss_pred             -CCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHH
Q 007006          511 -RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEII  589 (621)
Q Consensus       511 -~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ell  589 (621)
                       ..-.+|+++|+-|.+|..+.++|+.++|+.++...  .........+++.|+.|+....-.++.++|+|..|..+|++-
T Consensus      1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             CCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence             23468999999999999999999999999883211  122223345677899999888888999999999999999988


Q ss_pred             cCCCCC
Q 007006          590 SGRKNN  595 (621)
Q Consensus       590 tG~~p~  595 (621)
                      -|..+|
T Consensus      1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred             cccHHH
Confidence            777765

>PTZ00384 choline kinase; Provisional

Probab=94.75  E-value=0.37  Score=51.41  Aligned_cols=75  Identities=21%  Similarity=0.370  Sum_probs=46.4

Q ss_pred             cceeccCCceeEEEEEecCC--cE-----EEEEEeccCCcccHHHHHHHHHHHHhcccCCc-eeEeeEEeeCceEEEEEE
Q 007006          396 ENKLGQGGFGPVYKGTLADG--KA-----IAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~g--~~-----vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nI-v~l~g~~~~~~~~~lV~e  467 (621)
                      .+.|..|-...+|++...++  ..     |.++.......... +-.+|+++++.+...++ .++++.+..    +++.|
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e  129 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE  129 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEe-ccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence            34566688889999876443  22     33333222222222 23678999999965544 556666543    58999


Q ss_pred             ecCCCChh
Q 007006          468 YMPNKSLD  475 (621)
Q Consensus       468 ~~~~gsL~  475 (621)
                      |++|.+|.
T Consensus       130 fIeGr~l~  137 (383)
T PTZ00384        130 WVEGNTMG  137 (383)
T ss_pred             EeccccCC
Confidence            99987764

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.58  E-value=0.27  Score=51.14  Aligned_cols=71  Identities=23%  Similarity=0.288  Sum_probs=56.2

Q ss_pred             eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCc
Q 007006          461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA  540 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla  540 (621)
                      ..+++|++. |+++..       .....+++...|+++.+..+.-+...  .+.-|||+.-.||||+ +|++-|+||-++
T Consensus       300 y~yl~~kdh-gt~is~-------ik~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfkls  368 (488)
T COG5072         300 YLYLHFKDH-GTPISI-------IKADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLS  368 (488)
T ss_pred             EEEEEEecC-Cceeee-------eecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeee
Confidence            456777753 454431       22357899999999988888877764  5799999999999999 999999999999


Q ss_pred             ee
Q 007006          541 RI  542 (621)
Q Consensus       541 ~~  542 (621)
                      +.
T Consensus       369 Rl  370 (488)
T COG5072         369 RL  370 (488)
T ss_pred             ec
Confidence            85

>PRK06148 hypothetical protein; Provisional

Probab=94.23  E-value=0.6  Score=56.37  Aligned_cols=141  Identities=21%  Similarity=0.279  Sum_probs=78.5

Q ss_pred             ceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcc--cCC--ceeEee--------EEee-Cc--e
Q 007006          397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ--HKN--LVRLLG--------CCLE-GQ--E  461 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~--h~n--Iv~l~g--------~~~~-~~--~  461 (621)
                      +.|+ |..-.+|+....+|..+++|+......  ......|...|..|.  ++.  +.+++-        .... ++  .
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            4454 455778988887888999999875432  234445566666552  122  223221        1111 12  4


Q ss_pred             EEEEEEecCCCChhhhh-----------------hh----cc---CCCCCCHHH-----------------HHHHHHHHH
Q 007006          462 LLLIYEYMPNKSLDVHL-----------------FD----AT---RSVQLDWKR-----------------RQSIINGIA  500 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l-----------------~~----~~---~~~~l~~~~-----------------~~~i~~~ia  500 (621)
                      .+-+++|++|..+....                 +.    ..   ....+.|..                 ...++.++.
T Consensus       108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~  187 (1013)
T PRK06148        108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL  187 (1013)
T ss_pred             EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence            56789999997775410                 00    00   011122211                 112222333


Q ss_pred             HHHH-----HHHhCCCCCeEeccCCCCCEEEcCCC--CeE-EeeecCce
Q 007006          501 RGIL-----YLHEDSRLKIIHRDLKASNILLDDDM--NPK-ISDFGLAR  541 (621)
Q Consensus       501 ~~L~-----yLH~~~~~~iiH~Dlkp~NILl~~~~--~vk-L~Dfgla~  541 (621)
                      ..+.     .|.+. +..+||+|+.+.|||++.+.  ++. |+|||.+.
T Consensus       188 ~~~~~~v~p~l~~L-p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        188 ARFERNVAPRLAAL-PAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             HHHHHHHHHHHhcC-CcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            2222     22222 34699999999999999875  555 99999875

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.11  E-value=0.32  Score=47.17  Aligned_cols=116  Identities=16%  Similarity=0.173  Sum_probs=72.3

Q ss_pred             CCceeEEEEEecCCcEEEEEEeccCCcc-cHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCCChhhhhhh
Q 007006          402 GGFGPVYKGTLADGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD  480 (621)
Q Consensus       402 G~fG~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~  480 (621)
                      ++..+.-+++.+-| +..+|+++..+-. ...-|.++.++++++.  .|+++..=  +.....++.|.|-.-..      
T Consensus        73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------  141 (308)
T ss_pred             CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence            33444444443333 3455666544433 4466788888888875  35555521  23356788888753221      


Q ss_pred             ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecC
Q 007006          481 ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL  539 (621)
Q Consensus       481 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgl  539 (621)
                            +   ..-.|.. =++.|.-.|+. ....+|||-.|+|||-|..|.+||.|-+.
T Consensus       142 ------~---~~N~i~a-gi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  142 ------N---FSNFITA-GIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             ------c---hhHHHHH-hHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhh
Confidence                  0   0111222 24678888965 34799999999999999999999999874

The function of this family is unknown.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	621
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-41
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-40
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		7e-35
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-34
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-34
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-34
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-34
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-32
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-23
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		6e-23
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-23
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		6e-23
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		6e-23
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-23
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-23
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-23
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		7e-23
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		8e-23
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		9e-23
2pl0_A	289	Lck Bound To Imatinib Length = 289		9e-23
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-22
3a4o_X	286	Lyn Kinase Domain Length = 286		7e-22
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-21
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-21
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-21
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-21
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-21
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-21
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-21
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-21
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		8e-21
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		9e-21
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		9e-21
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		9e-21
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-20
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-20
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-20
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-20
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-20
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-20
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-20
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-20
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-20
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-20
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-20
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-20
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-20
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-20
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-19
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-19
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-19
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-19
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-19
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-19
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-19
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-19
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-19
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-19
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		9e-19
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-18
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-18
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-18
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-18
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-18
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-17
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-17
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-17
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		7e-17
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		8e-17
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-17
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		9e-17
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-16
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-16
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-16
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-16
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		8e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-15
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-15
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-15
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-15
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-15
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-15
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-15
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-15
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-15
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-15
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-15
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-15
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-15
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-15
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-15
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-15
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-15
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-15
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-15
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-15
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-15
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-15
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-15
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-15
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-15
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-15
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-15
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-15
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-15
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-15
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-15
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-15
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-15
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-15
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-15
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		7e-15
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-15
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-14
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-14
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-14
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-14
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-14
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-14
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-14
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-14
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-14
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-14
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-14
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-14
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-14
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-14
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-14
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-14
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-14
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-14
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-14
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-14
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-14
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-14
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-14
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-14
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-14
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-14
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-14
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-14
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-14
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-14
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-14
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-14
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-14
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-14
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-14
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-14
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-14
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-14
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-14
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-14
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-14
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-14
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-14
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		6e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		7e-14
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		7e-14
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-14
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		8e-14
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		8e-14
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		8e-14
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		8e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		9e-14
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-14
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		9e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		9e-14
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		9e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-13
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-13
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-13
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-13
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-13
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-13
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-13
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-13
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-13
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-13
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-13
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-13
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-13
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-13
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-13
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-13
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-13
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-13
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-13
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-13
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-13
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-13
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-13
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-13
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-13
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-13
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-13
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-13
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-13
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-13
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-13
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-13
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-13
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-13
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-13
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-13
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		5e-13
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-13
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-13
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-13
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-13
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-13
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-13
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		6e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-13
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-13
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-13
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		6e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		7e-13
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		7e-13
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		7e-13
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-13
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-13
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		7e-13
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		7e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		7e-13
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		7e-13
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		7e-13
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		7e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		7e-13
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-13
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-13
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		8e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		8e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-13
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		9e-13
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		9e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		9e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		9e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		9e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		9e-13
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-13
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-12
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-12
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-12
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-12
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-12
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-12
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-12
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-12
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-12
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-12
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-12
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-12
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-12
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-12
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-12
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-12
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		5e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-12
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-12
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-12
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-12
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-12
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-12
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-12
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-12
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-12
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-12
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		6e-12
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-12
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		6e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-12
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-12
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		6e-12
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-12
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-12
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-12
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		6e-12
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-12
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		6e-12
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-12
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-12
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-12
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-12
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		7e-12
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		7e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		7e-12
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		7e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-12
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		7e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		8e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		8e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		8e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		8e-12
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		8e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		8e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		8e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		9e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		9e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		9e-12
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		9e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-12
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-11
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-11
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-11
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-11
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-11
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-11
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-11
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-11
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-11
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-11
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-11
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-11
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-11
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-11
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-11
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-11
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-11
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-11
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-11
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-11
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-11
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-11
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-11
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-11
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-11
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-11
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-11
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-11
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-11
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		6e-11
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		6e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		6e-11
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		7e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-11
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		7e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		7e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		7e-11
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-11
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		8e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		9e-11
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-10
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-10
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-10
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-10
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-10
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-10
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-10
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-10
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-10
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-10
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-10
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-10
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-10
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-10
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-10
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-10
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-10
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-10
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-10
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-10
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		7e-10
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-10
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-10
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		7e-10
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		8e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		9e-10
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		9e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		9e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-09
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-09
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-09
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-09
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-09
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-09
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-09
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-09
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-09
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-09
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-09
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-09
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-09
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-09
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-09
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-09
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-09
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-09
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-09
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-09
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		5e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		5e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		5e-09
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		6e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		6e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		6e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		7e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		8e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		8e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		9e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		9e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		9e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		9e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-08
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-08
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-08
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		5e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		5e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		7e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		8e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		8e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		8e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		8e-08
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		9e-08
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-07
3soa_A	444	Full-Length Human Camkii Length = 444		2e-07
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		6e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		7e-07
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		7e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		7e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		7e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		7e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		7e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		7e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		9e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		9e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		9e-07
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		9e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		4e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-06
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-06
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-06
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-06
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		5e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		5e-06
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		5e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-06
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		6e-06
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		7e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		7e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		8e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		8e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		8e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		8e-06
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-05
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-05
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-05
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		4e-05
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-05
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		5e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		5e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-05
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-05
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		9e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-04
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-04
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-04
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-04
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-04
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-04
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-04
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-04
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-04
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-04
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-04
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-04
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  167 bits (424), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 94/215 (43%), Positives = 133/215 (61%), Gaps = 3/215 (1%)
Query: 381 FPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQ-EFKNEVN 439
           F LR    A+++FS++N LG+GGFG VYKG LADG  +AVKRL     QG + +F+ EV 
Sbjct: 28  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVE 87
Query: 440 LIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRS-VQLDWKRRQSIING 498
           +I+   H+NL+R             +Y YM N S+   L +   S   LDW +RQ I  G
Sbjct: 88  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 147
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
            ARG+ YLH+    KIIHRD+KA+NILLD++    + DFGLA++    ++      + GT
Sbjct: 148 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDXHVXXAVRGT 206
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRK 593
            G++APEY   G  S K+DVF +GV+LLE+I+G++
Sbjct: 207 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 241

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 95/216 (43%), Positives = 132/216 (61%), Gaps = 5/216 (2%)
Query: 381 FPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRL--SRTSGQGLQEFKNEV 438
           F LR    A+++F ++N LG+GGFG VYKG LADG  +AVKRL   RT G  LQ F+ EV
Sbjct: 20  FSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQ-FQTEV 78
Query: 439 NLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRS-VQLDWKRRQSIIN 497
            +I+   H+NL+R             +Y YM N S+   L +   S   LDW +RQ I  
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 498 GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG 557
           G ARG+ YLH+    KIIHRD+KA+NILLD++    + DFGLA++    ++      + G
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDXHVXXAVRG 197
Query: 558 TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRK 593
             G++APEY   G  S K+DVF +GV+LLE+I+G++
Sbjct: 198 XIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 233

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  145 bits (366), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 89/221 (40%), Positives = 133/221 (60%), Gaps = 9/221 (4%)
Query: 374 ESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQE 433
           ES   PL  L    EATN+F  +  +G G FG VYKG L DG  +A+KR +  S QG++E
Sbjct: 25  ESYRVPLVDLE---EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEE 81
Query: 434 FKNEVNLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDAT-RSVQLDWKRR 492
           F+ E+  ++  +H +LV              IY+YM N +L  HL+ +   ++ + W++R
Sbjct: 82  FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141
Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN- 551
             I  G ARG+ YLH  +   IIHRD+K+ NILLD++  PKI+DFG+++  G   +Q + 
Sbjct: 142 LEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK-GTELDQTHL 197
Query: 552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
             ++ GT GY+ PEY + G  + KSDV+SFGV+L E++  R
Sbjct: 198 XXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 89/221 (40%), Positives = 132/221 (59%), Gaps = 9/221 (4%)
Query: 374 ESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQE 433
           ES   PL  L    EATN+F  +  +G G FG VYKG L DG  +A+KR +  S QG++E
Sbjct: 25  ESYRVPLVDLE---EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEE 81
Query: 434 FKNEVNLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDAT-RSVQLDWKRR 492
           F+ E+  ++  +H +LV              IY+YM N +L  HL+ +   ++ + W++R
Sbjct: 82  FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141
Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN- 551
             I  G ARG+ YLH  +   IIHRD+K+ NILLD++  PKI+DFG+++  G    Q + 
Sbjct: 142 LEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK-GTELGQTHL 197
Query: 552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
             ++ GT GY+ PEY + G  + KSDV+SFGV+L E++  R
Sbjct: 198 XXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  144 bits (362), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 90/212 (42%), Positives = 121/212 (57%), Gaps = 15/212 (7%)
Query: 390 TNHFSDE------NKLGQGGFGPVYKGTLADGKAIAVKRLSR----TSGQGLQEFKNEVN 439
           TN+F +       NK+G+GGFG VYKG + +   +AVK+L+     T+ +  Q+F  E+ 
Sbjct: 24  TNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIK 82
Query: 440 LIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 499
           ++AK QH+NLV              +Y YMPN SL   L     +  L W  R  I  G 
Sbjct: 83  VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGA 142
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTY 559
           A GI +LHE+     IHRD+K++NILLD+    KISDFGLAR           + I GT 
Sbjct: 143 ANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTT 199
Query: 560 GYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
            YMAPE A+ G  + KSD++SFGV+LLEII+G
Sbjct: 200 AYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  143 bits (361), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 90/212 (42%), Positives = 120/212 (56%), Gaps = 15/212 (7%)
Query: 390 TNHFSDE------NKLGQGGFGPVYKGTLADGKAIAVKRLSR----TSGQGLQEFKNEVN 439
           TN+F +       NK+G+GGFG VYKG + +   +AVK+L+     T+ +  Q+F  E+ 
Sbjct: 24  TNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIK 82
Query: 440 LIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 499
           ++AK QH+NLV              +Y YMPN SL   L     +  L W  R  I  G 
Sbjct: 83  VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGA 142
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTY 559
           A GI +LHE+     IHRD+K++NILLD+    KISDFGLAR             I GT 
Sbjct: 143 ANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTT 199
Query: 560 GYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
            YMAPE A+ G  + KSD++SFGV+LLEII+G
Sbjct: 200 AYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  143 bits (361), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 90/212 (42%), Positives = 120/212 (56%), Gaps = 15/212 (7%)
Query: 390 TNHFSDE------NKLGQGGFGPVYKGTLADGKAIAVKRLSR----TSGQGLQEFKNEVN 439
           TN+F +       NK+G+GGFG VYKG + +   +AVK+L+     T+ +  Q+F  E+ 
Sbjct: 18  TNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIK 76
Query: 440 LIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 499
           ++AK QH+NLV              +Y YMPN SL   L     +  L W  R  I  G 
Sbjct: 77  VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGA 136
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTY 559
           A GI +LHE+     IHRD+K++NILLD+    KISDFGLAR             I GT 
Sbjct: 137 ANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTT 193
Query: 560 GYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
            YMAPE A+ G  + KSD++SFGV+LLEII+G
Sbjct: 194 AYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 224

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 88/212 (41%), Positives = 117/212 (55%), Gaps = 15/212 (7%)
Query: 390 TNHFSDE------NKLGQGGFGPVYKGTLADGKAIAVKRLSR----TSGQGLQEFKNEVN 439
           TN+F +       NK G+GGFG VYKG + +   +AVK+L+     T+ +  Q+F  E+ 
Sbjct: 15  TNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIK 73
Query: 440 LIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 499
           + AK QH+NLV              +Y Y PN SL   L     +  L W  R  I  G 
Sbjct: 74  VXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGA 133
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTY 559
           A GI +LHE+     IHRD+K++NILLD+    KISDFGLAR           + I GT 
Sbjct: 134 ANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTT 190
Query: 560 GYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
            Y APE A+ G  + KSD++SFGV+LLEII+G
Sbjct: 191 AYXAPE-ALRGEITPKSDIYSFGVVLLEIITG 221

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 72/194 (37%), Positives = 101/194 (52%), Gaps = 7/194 (3%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            +LG G FG V+ G       +AVK L + S      F  E NL+ +LQH+ LVR     
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   I EYM N SL V        ++L   +   +   IA G+ ++ E +    IH
Sbjct: 78  TQEPIYI-ITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDL+A+NIL+ D ++ KI+DFGLAR+   N+  A          + APE    G F+IKS
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG-AKFPIKWTAPEAINYGTFTIKS 191
Query: 577 DVFSFGVLLLEIIS 590
           DV+SFG+LL EI++
Sbjct: 192 DVWSFGILLTEIVT 205

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 72/194 (37%), Positives = 101/194 (52%), Gaps = 7/194 (3%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            +LG G FG V+ G       +AVK L + S      F  E NL+ +LQH+ LVR     
Sbjct: 20  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 78
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   I EYM N SL V        ++L   +   +   IA G+ ++ E +    IH
Sbjct: 79  TQEPIYI-ITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 133
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDL+A+NIL+ D ++ KI+DFGLAR+   N+  A          + APE    G F+IKS
Sbjct: 134 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG-AKFPIKWTAPEAINYGTFTIKS 192
Query: 577 DVFSFGVLLLEIIS 590
           DV+SFG+LL EI++
Sbjct: 193 DVWSFGILLTEIVT 206

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 72/194 (37%), Positives = 101/194 (52%), Gaps = 7/194 (3%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            +LG G FG V+ G       +AVK L + S      F  E NL+ +LQH+ LVR     
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   I EYM N SL V        ++L   +   +   IA G+ ++ E +    IH
Sbjct: 78  TQEPIYI-ITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDL+A+NIL+ D ++ KI+DFGLAR+   N+  A          + APE    G F+IKS
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG-AKFPIKWTAPEAINYGTFTIKS 191
Query: 577 DVFSFGVLLLEIIS 590
           DV+SFG+LL EI++
Sbjct: 192 DVWSFGILLTEIVT 205

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 72/194 (37%), Positives = 101/194 (52%), Gaps = 7/194 (3%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            +LG G FG V+ G       +AVK L + S      F  E NL+ +LQH+ LVR     
Sbjct: 21  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 79
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   I EYM N SL V        ++L   +   +   IA G+ ++ E +    IH
Sbjct: 80  TQEPIYI-ITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 134
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDL+A+NIL+ D ++ KI+DFGLAR+   N+  A          + APE    G F+IKS
Sbjct: 135 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG-AKFPIKWTAPEAINYGTFTIKS 193
Query: 577 DVFSFGVLLLEIIS 590
           DV+SFG+LL EI++
Sbjct: 194 DVWSFGILLTEIVT 207

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 72/194 (37%), Positives = 101/194 (52%), Gaps = 7/194 (3%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            +LG G FG V+ G       +AVK L + S      F  E NL+ +LQH+ LVR     
Sbjct: 28  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 86
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   I EYM N SL V        ++L   +   +   IA G+ ++ E +    IH
Sbjct: 87  TQEPIYI-ITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 141
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDL+A+NIL+ D ++ KI+DFGLAR+   N+  A          + APE    G F+IKS
Sbjct: 142 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG-AKFPIKWTAPEAINYGTFTIKS 200
Query: 577 DVFSFGVLLLEIIS 590
           DV+SFG+LL EI++
Sbjct: 201 DVWSFGILLTEIVT 214

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 72/194 (37%), Positives = 101/194 (52%), Gaps = 7/194 (3%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            +LG G FG V+ G       +AVK L + S      F  E NL+ +LQH+ LVR     
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   I EYM N SL V        ++L   +   +   IA G+ ++ E +    IH
Sbjct: 84  TQEPIYI-ITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 138
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDL+A+NIL+ D ++ KI+DFGLAR+   N+  A          + APE    G F+IKS
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG-AKFPIKWTAPEAINYGTFTIKS 197
Query: 577 DVFSFGVLLLEIIS 590
           DV+SFG+LL EI++
Sbjct: 198 DVWSFGILLTEIVT 211

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 72/194 (37%), Positives = 101/194 (52%), Gaps = 7/194 (3%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            +LG G FG V+ G       +AVK L + S      F  E NL+ +LQH+ LVR     
Sbjct: 24  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 82
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   I EYM N SL V        ++L   +   +   IA G+ ++ E +    IH
Sbjct: 83  TQEPIYI-ITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 137
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDL+A+NIL+ D ++ KI+DFGLAR+   N+  A          + APE    G F+IKS
Sbjct: 138 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAINYGTFTIKS 196
Query: 577 DVFSFGVLLLEIIS 590
           DV+SFG+LL EI++
Sbjct: 197 DVWSFGILLTEIVT 210

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 72/194 (37%), Positives = 101/194 (52%), Gaps = 7/194 (3%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            +LG G FG V+ G       +AVK L + S      F  E NL+ +LQH+ LVR     
Sbjct: 27  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 85
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   I EYM N SL V        ++L   +   +   IA G+ ++ E +    IH
Sbjct: 86  TQEPIYI-ITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 140
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDL+A+NIL+ D ++ KI+DFGLAR+   N+  A          + APE    G F+IKS
Sbjct: 141 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG-AKFPIKWTAPEAINYGTFTIKS 199
Query: 577 DVFSFGVLLLEIIS 590
           DV+SFG+LL EI++
Sbjct: 200 DVWSFGILLTEIVT 213

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 72/194 (37%), Positives = 101/194 (52%), Gaps = 7/194 (3%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            +LG G FG V+ G       +AVK L + S      F  E NL+ +LQH+ LVR     
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   I EYM N SL V        ++L   +   +   IA G+ ++ E +    IH
Sbjct: 84  TQEPIYI-ITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 138
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDL+A+NIL+ D ++ KI+DFGLAR+   N+  A          + APE    G F+IKS
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAINYGTFTIKS 197
Query: 577 DVFSFGVLLLEIIS 590
           DV+SFG+LL EI++
Sbjct: 198 DVWSFGILLTEIVT 211

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 72/194 (37%), Positives = 101/194 (52%), Gaps = 7/194 (3%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            +LG G FG V+ G       +AVK L + S      F  E NL+ +LQH+ LVR     
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   I EYM N SL V        ++L   +   +   IA G+ ++ E +    IH
Sbjct: 78  TQEPIYI-ITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDL+A+NIL+ D ++ KI+DFGLAR+   N+  A          + APE    G F+IKS
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAINYGTFTIKS 191
Query: 577 DVFSFGVLLLEIIS 590
           DV+SFG+LL EI++
Sbjct: 192 DVWSFGILLTEIVT 205

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 72/194 (37%), Positives = 101/194 (52%), Gaps = 7/194 (3%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            +LG G FG V+ G       +AVK L + S      F  E NL+ +LQH+ LVR     
Sbjct: 14  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 72
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   I EYM N SL V        ++L   +   +   IA G+ ++ E +    IH
Sbjct: 73  TQEPIYI-ITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 127
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDL+A+NIL+ D ++ KI+DFGLAR+   N+  A          + APE    G F+IKS
Sbjct: 128 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAINYGTFTIKS 186
Query: 577 DVFSFGVLLLEIIS 590
           DV+SFG+LL EI++
Sbjct: 187 DVWSFGILLTEIVT 200

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 72/194 (37%), Positives = 101/194 (52%), Gaps = 7/194 (3%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            +LG G FG V+ G       +AVK L + S      F  E NL+ +LQH+ LVR     
Sbjct: 29  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 87
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   I EYM N SL V        ++L   +   +   IA G+ ++ E +    IH
Sbjct: 88  TQEPIYI-ITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 142
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDL+A+NIL+ D ++ KI+DFGLAR+   N+  A          + APE    G F+IKS
Sbjct: 143 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAINYGTFTIKS 201
Query: 577 DVFSFGVLLLEIIS 590
           DV+SFG+LL EI++
Sbjct: 202 DVWSFGILLTEIVT 215

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 71/194 (36%), Positives = 101/194 (52%), Gaps = 7/194 (3%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            +LG G FG V+ G       +AVK L + S      F  E NL+ +LQH+ LVR     
Sbjct: 15  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 73
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   I EYM N SL V        ++L   +   +   IA G+ ++ E +    IH
Sbjct: 74  TQEPIYI-ITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 128
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           R+L+A+NIL+ D ++ KI+DFGLAR+   N+  A          + APE    G F+IKS
Sbjct: 129 RNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAINYGTFTIKS 187
Query: 577 DVFSFGVLLLEIIS 590
           DV+SFG+LL EI++
Sbjct: 188 DVWSFGILLTEIVT 201

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 68/194 (35%), Positives = 97/194 (50%), Gaps = 6/194 (3%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            +LG G FG V+ G   +   +AVK L +     +Q F  E NL+  LQH  LVR     
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   I EYM   SL +    +    ++   +       IA G+ Y+    R   IH
Sbjct: 78  TREEPIYIITEYMAKGSL-LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIH 133
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDL+A+N+L+ + +  KI+DFGLAR+   N+  A          + APE    G F+IKS
Sbjct: 134 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG-AKFPIKWTAPEAINFGCFTIKS 192
Query: 577 DVFSFGVLLLEIIS 590
           DV+SFG+LL EI++
Sbjct: 193 DVWSFGILLYEIVT 206

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 112/227 (49%), Gaps = 6/227 (2%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRXX 453
           + K+G G FG V++     G  +AVK L       + + EF  EV ++ +L+H N+V   
Sbjct: 42  KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 454 XXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
                      + EY+   SL   L  +    QLD +RR S+   +A+G+ YLH +    
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPP 159
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 573
           I+HRDLK+ N+L+D     K+ DFGL+R+         +   AGT  +MAPE       +
Sbjct: 160 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAS--XFLXSKXAAGTPEWMAPEVLRDEPSN 217
Query: 574 IKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLSLSLSL 620
            KSDV+SFGV+L E+ + ++  G          + + C  L +  +L
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNL 264

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 113/227 (49%), Gaps = 6/227 (2%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRXX 453
           + K+G G FG V++     G  +AVK L       + + EF  EV ++ +L+H N+V   
Sbjct: 42  KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 454 XXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
                      + EY+   SL   L  +    QLD +RR S+   +A+G+ YLH +    
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPP 159
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 573
           I+HR+LK+ N+L+D     K+ DFGL+R+       + +   AGT  +MAPE       +
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS--AAGTPEWMAPEVLRDEPSN 217
Query: 574 IKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLSLSLSL 620
            KSDV+SFGV+L E+ + ++  G          + + C  L +  +L
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNL 264

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 97/194 (50%), Gaps = 6/194 (3%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            KLG G FG V+ G   +   +AVK L +     +Q F  E NL+  LQH  LVR     
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   I E+M   SL +    +    ++   +       IA G+ Y+    R   IH
Sbjct: 77  TKEEPIYIITEFMAKGSL-LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIH 132
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDL+A+N+L+ + +  KI+DFGLAR+   N+  A          + APE    G F+IKS
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG-AKFPIKWTAPEAINFGCFTIKS 191
Query: 577 DVFSFGVLLLEIIS 590
           +V+SFG+LL EI++
Sbjct: 192 NVWSFGILLYEIVT 205

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/194 (36%), Positives = 99/194 (51%), Gaps = 7/194 (3%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            +LG G  G V+ G       +AVK L + S      F  E NL+ +LQH+ LVR     
Sbjct: 19  ERLGAGQAGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   I EYM N SL V        ++L   +   +   IA G+ ++ E +    IH
Sbjct: 78  TQEPIYI-ITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDL+A+NIL+ D ++ KI+DFGLAR+    +  A          + APE    G F+IKS
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREG-AKFPIKWTAPEAINYGTFTIKS 191
Query: 577 DVFSFGVLLLEIIS 590
           DV+SFG+LL EI++
Sbjct: 192 DVWSFGILLTEIVT 205

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 102/195 (52%), Gaps = 7/195 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           E KLGQG FG V+ GT      +A+K L +      + F  E  ++ KL+H+ LV+    
Sbjct: 13  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 71
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    + EYM   SL +          L   +   +   IA G+ Y+    R+  +
Sbjct: 72  VSEEPIXI-VTEYMSKGSL-LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 126
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRDL+A+NIL+ +++  K++DFGLAR+   N+  A          + APE A+ G F+IK
Sbjct: 127 HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQG-AKFPIKWTAPEAALYGRFTIK 185
Query: 576 SDVFSFGVLLLEIIS 590
           SDV+SFG+LL E+ +
Sbjct: 186 SDVWSFGILLTELTT 200

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXXX 457
           ++G G FG VYKG      A+ +  ++  + Q LQ FKNEV ++ K +H N++       
Sbjct: 19  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYS 77
Query: 458 XXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR 517
                  + ++    SL  HL  +    + + K+   I    ARG+ YLH  S   IIHR
Sbjct: 78  TKPQLAIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHR 132
Query: 518 DLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM---GGIFSI 574
           DLK++NI L +D   KI DFGLA +            ++G+  +MAPE         +S 
Sbjct: 133 DLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 192
Query: 575 KSDVFSFGVLLLEIISGR 592
           +SDV++FG++L E+++G+
Sbjct: 193 QSDVYAFGIVLYELMTGQ 210

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 101/195 (51%), Gaps = 7/195 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           E KLGQG FG V+ GT      +A+K L +      + F  E  ++ KL+H+ LV+    
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    I EYM   SL +          L   +   +   IA G+ Y+    R+  +
Sbjct: 82  VSEEPIYIVI-EYMSKGSL-LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRDL+A+NIL+ +++  K++DFGLAR+   N+  A          + APE A+ G F+IK
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQG-AKFPIKWTAPEAALYGRFTIK 195
Query: 576 SDVFSFGVLLLEIIS 590
           SDV+SFG+LL E+ +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 101/195 (51%), Gaps = 7/195 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           E KLGQG FG V+ GT      +A+K L +      + F  E  ++ KL+H+ LV+    
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    I EYM   SL +          L   +   +   IA G+ Y+    R+  +
Sbjct: 82  VSEEPIYIVI-EYMSKGSL-LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRDL+A+NIL+ +++  K++DFGLAR+   N+  A          + APE A+ G F+IK
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRFTIK 195
Query: 576 SDVFSFGVLLLEIIS 590
           SDV+SFG+LL E+ +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 101/195 (51%), Gaps = 7/195 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           E KLGQG FG V+ GT      +A+K L +      + F  E  ++ KL+H+ LV+    
Sbjct: 16  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 74
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    + EYM   SL +          L   +   +   IA G+ Y+    R+  +
Sbjct: 75  VSEEPIYI-VTEYMSKGSL-LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 129
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRDL+A+NIL+ +++  K++DFGLAR+   N+  A          + APE A+ G F+IK
Sbjct: 130 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRFTIK 188
Query: 576 SDVFSFGVLLLEIIS 590
           SDV+SFG+LL E+ +
Sbjct: 189 SDVWSFGILLTELTT 203

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 101/195 (51%), Gaps = 7/195 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           E KLGQG FG V+ GT      +A+K L +      + F  E  ++ KL+H+ LV+    
Sbjct: 12  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 70
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    + EYM   SL +          L   +   +   IA G+ Y+    R+  +
Sbjct: 71  VSEEPIYI-VTEYMSKGSL-LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 125
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRDL+A+NIL+ +++  K++DFGLAR+   N+  A          + APE A+ G F+IK
Sbjct: 126 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRFTIK 184
Query: 576 SDVFSFGVLLLEIIS 590
           SDV+SFG+LL E+ +
Sbjct: 185 SDVWSFGILLTELTT 199

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 101/195 (51%), Gaps = 7/195 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           E KLGQG FG V+ GT      +A+K L +      + F  E  ++ KL+H+ LV+    
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    + EYM   SL +          L   +   +   IA G+ Y+    R+  +
Sbjct: 248 VSEEPIYI-VTEYMSKGSL-LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRDL+A+NIL+ +++  K++DFGLAR+   N+  A          + APE A+ G F+IK
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRFTIK 361
Query: 576 SDVFSFGVLLLEIIS 590
           SDV+SFG+LL E+ +
Sbjct: 362 SDVWSFGILLTELTT 376

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 101/195 (51%), Gaps = 7/195 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           E KLGQG FG V+ GT      +A+K L +      + F  E  ++ KL+H+ LV+    
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    + EYM   SL +          L   +   +   IA G+ Y+    R+  +
Sbjct: 248 VSEEPIYI-VTEYMSKGSL-LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRDL+A+NIL+ +++  K++DFGLAR+   N+  A          + APE A+ G F+IK
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRFTIK 361
Query: 576 SDVFSFGVLLLEIIS 590
           SDV+SFG+LL E+ +
Sbjct: 362 SDVWSFGILLTELTT 376

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 101/195 (51%), Gaps = 7/195 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           E KLGQG FG V+ GT      +A+K L +      + F  E  ++ KL+H+ LV+    
Sbjct: 14  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 72
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    + EYM   SL +          L   +   +   IA G+ Y+    R+  +
Sbjct: 73  VSEEPIYI-VTEYMSKGSL-LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 127
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRDL+A+NIL+ +++  K++DFGLAR+   N+  A          + APE A+ G F+IK
Sbjct: 128 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRFTIK 186
Query: 576 SDVFSFGVLLLEIIS 590
           SDV+SFG+LL E+ +
Sbjct: 187 SDVWSFGILLTELTT 201

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           E KLGQG FG V+ GT      +A+K L +      + F  E  ++ KL+H+ LV+    
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGILYLHEDSRL 512
                    + EYM   SL     D  +     + R   +++    IA G+ Y+    R+
Sbjct: 82  VSEEPIYI-VTEYMSKGSL----LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RM 133
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
             +HRDL+A+NIL+ +++  K++DFGLAR+   N+  A          + APE A+ G F
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRF 192
Query: 573 SIKSDVFSFGVLLLEIIS 590
           +IKSDV+SFG+LL E+ +
Sbjct: 193 TIKSDVWSFGILLTELTT 210

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 101/195 (51%), Gaps = 7/195 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           E KLGQG FG V+ GT      +A+K L +      + F  E  ++ KL+H+ LV+    
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    + EYM   SL +          L   +   +   IA G+ Y+    R+  +
Sbjct: 82  VSEEPIYI-VCEYMSKGSL-LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRDL+A+NIL+ +++  K++DFGLAR+   N+  A          + APE A+ G F+IK
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRFTIK 195
Query: 576 SDVFSFGVLLLEIIS 590
           SDV+SFG+LL E+ +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 101/195 (51%), Gaps = 7/195 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           E KLGQG FG V+ GT      +A+K L +      + F  E  ++ KL+H+ LV+    
Sbjct: 20  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    + EYM NK   +          L   +   +   IA G+ Y+    R+  +
Sbjct: 79  VSEEPIYI-VTEYM-NKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYV 133
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRDL+A+NIL+ +++  K++DFGLAR+   N+  A          + APE A+ G F+IK
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRFTIK 192
Query: 576 SDVFSFGVLLLEIIS 590
           SDV+SFG+LL E+ +
Sbjct: 193 SDVWSFGILLTELTT 207

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 101/195 (51%), Gaps = 7/195 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           E KLGQG FG V+ GT      +A+K L +      + F  E  ++ KL+H+ LV+    
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    + EYM   SL +          L   +   +   IA G+ Y+    R+  +
Sbjct: 248 VSEEPIYI-VGEYMSKGSL-LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRDL+A+NIL+ +++  K++DFGLAR+   N+  A          + APE A+ G F+IK
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRFTIK 361
Query: 576 SDVFSFGVLLLEIIS 590
           SDV+SFG+LL E+ +
Sbjct: 362 SDVWSFGILLTELTT 376

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 101/195 (51%), Gaps = 7/195 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           E KLGQG FG V+ GT      +A+K L +      + F  E  ++ KL+H+ LV+    
Sbjct: 20  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    + EYM NK   +          L   +   +   IA G+ Y+    R+  +
Sbjct: 79  VSEEPIYI-VTEYM-NKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYV 133
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRDL+A+NIL+ +++  K++DFGLAR+   N+  A          + APE A+ G F+IK
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQG-AKFPIKWTAPEAALYGRFTIK 192
Query: 576 SDVFSFGVLLLEIIS 590
           SDV+SFG+LL E+ +
Sbjct: 193 SDVWSFGILLTELTT 207

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 107/202 (52%), Gaps = 17/202 (8%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXXX 457
           ++G G FG VYKG      A+ +  ++  + Q LQ FKNEV ++ K +H N++       
Sbjct: 31  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYS 89
Query: 458 XXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR 517
                  + ++    SL  HL  +    + + K+   I    ARG+ YLH  S   IIHR
Sbjct: 90  TKPQLAIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHR 144
Query: 518 DLKASNILLDDDMNPKISDFGLA----RIFGGNQNQANTNIIAGTYGYMAPEYAM---GG 570
           DLK++NI L +D   KI DFGLA    R  G +Q +     ++G+  +MAPE        
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ----LSGSILWMAPEVIRMQDSN 200
Query: 571 IFSIKSDVFSFGVLLLEIISGR 592
            +S +SDV++FG++L E+++G+
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 107/202 (52%), Gaps = 17/202 (8%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXXX 457
           ++G G FG VYKG      A+ +  ++  + Q LQ FKNEV ++ K +H N++       
Sbjct: 31  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYS 89
Query: 458 XXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR 517
                  + ++    SL  HL  +    + + K+   I    ARG+ YLH  S   IIHR
Sbjct: 90  TAPQLAIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHR 144
Query: 518 DLKASNILLDDDMNPKISDFGLA----RIFGGNQNQANTNIIAGTYGYMAPEYAM---GG 570
           DLK++NI L +D   KI DFGLA    R  G +Q +     ++G+  +MAPE        
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ----LSGSILWMAPEVIRMQDSN 200
Query: 571 IFSIKSDVFSFGVLLLEIISGR 592
            +S +SDV++FG++L E+++G+
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQ 222

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 101/195 (51%), Gaps = 7/195 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           E KLGQG FG V+ GT      +A+K L +      + F  E  ++ KL+H+ LV+    
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    + EYM +K   +          L   +   +   IA G+ Y+    R+  +
Sbjct: 82  VSEEPIYI-VMEYM-SKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRDL+A+NIL+ +++  K++DFGLAR+   N+  A          + APE A+ G F+IK
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRFTIK 195
Query: 576 SDVFSFGVLLLEIIS 590
           SDV+SFG+LL E+ +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 101/195 (51%), Gaps = 7/195 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           E KLGQG FG V+ GT      +A+K L +      + F  E  ++ KL+H+ LV+    
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    + EYM   SL +          L   +   +   IA G+ Y+    R+  +
Sbjct: 331 VSEEPIYI-VTEYMSKGSL-LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 385
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRDL+A+NIL+ +++  K++DFGLAR+   N+  A          + APE A+ G F+IK
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRFTIK 444
Query: 576 SDVFSFGVLLLEIIS 590
           SDV+SFG+LL E+ +
Sbjct: 445 SDVWSFGILLTELTT 459

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 104/198 (52%), Gaps = 13/198 (6%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           E KLGQG FG V+ GT      +A+K L +      + F  E  ++ K++H+ LV+    
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKIRHEKLVQLYAV 81
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGILYLHEDSRL 512
                    + EYM   SL     D  +     + R   +++    IA G+ Y+    R+
Sbjct: 82  VSEEPIYI-VTEYMSKGSL----LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RM 133
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
             +HRDL+A+NIL+ +++  K++DFGLAR+   N+  A          + APE A+ G F
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRF 192
Query: 573 SIKSDVFSFGVLLLEIIS 590
           +IKSDV+SFG+LL E+ +
Sbjct: 193 TIKSDVWSFGILLTELTT 210

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 103/198 (52%), Gaps = 13/198 (6%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           E KLGQG FG V+ GT      +A+K L +      + F  E  ++ KL+H+ LV+    
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGILYLHEDSRL 512
                    + EYM   SL     D  +     + R   +++    IA G+ Y+    R+
Sbjct: 82  VSEEPIYI-VTEYMSKGSL----LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RM 133
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
             +HRDL A+NIL+ +++  K++DFGLAR+   N+  A          + APE A+ G F
Sbjct: 134 NYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRF 192
Query: 573 SIKSDVFSFGVLLLEIIS 590
           +IKSDV+SFG+LL E+ +
Sbjct: 193 TIKSDVWSFGILLTELTT 210

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 100/195 (51%), Gaps = 7/195 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           E KLGQG FG V+ GT      +A+K L +      + F  E  ++ KL+H+ LV+    
Sbjct: 190 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKLVQLYAV 248
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    + EYM   SL +          L   +   +   IA G+ Y+    R+  +
Sbjct: 249 VSEEPIYI-VTEYMSKGSL-LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 303
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRDL+A+NIL+ +++  K++DFGL R+   N+  A          + APE A+ G F+IK
Sbjct: 304 HRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQG-AKFPIKWTAPEAALYGRFTIK 362
Query: 576 SDVFSFGVLLLEIIS 590
           SDV+SFG+LL E+ +
Sbjct: 363 SDVWSFGILLTELTT 377

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 101/195 (51%), Gaps = 7/195 (3%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           E KLGQG FG V+ GT      +A+K L +      + F  E  ++ KL+H+ LV+    
Sbjct: 23  EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    + EYM +K   +          L   +   +   IA G+ Y+    R+  +
Sbjct: 82  VSEEPIYI-VTEYM-SKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRDL+A+NIL+ +++  K++DFGLAR+   N+  A          + APE A+ G F+IK
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRFTIK 195
Query: 576 SDVFSFGVLLLEIIS 590
           SDV+SFG+LL E+ +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 102/199 (51%), Gaps = 9/199 (4%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            ++G G FG VYKG      A+ +  ++  + Q LQ FKNEV ++ K +H N++      
Sbjct: 16  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 74
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + ++    SL  HL       + +  +   I    A+G+ YLH  S   IIH
Sbjct: 75  STKPQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---IIH 129
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM---GGIFS 573
           RDLK++NI L +D+  KI DFGLA +            ++G+  +MAPE         +S
Sbjct: 130 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 189
Query: 574 IKSDVFSFGVLLLEIISGR 592
            +SDV++FG++L E+++G+
Sbjct: 190 FQSDVYAFGIVLYELMTGQ 208

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 102/199 (51%), Gaps = 9/199 (4%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            ++G G FG VYKG      A+ +  ++  + Q LQ FKNEV ++ K +H N++      
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 72
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + ++    SL  HL       + +  +   I    A+G+ YLH  S   IIH
Sbjct: 73  STAPQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM---GGIFS 573
           RDLK++NI L +D+  KI DFGLA +            ++G+  +MAPE         +S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 574 IKSDVFSFGVLLLEIISGR 592
            +SDV++FG++L E+++G+
Sbjct: 188 FQSDVYAFGIVLYELMTGQ 206

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 106/212 (50%), Gaps = 27/212 (12%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLVR 451
           E  +G GGFG VY+     G  +AVK           Q ++  + E  L A L+H N++ 
Sbjct: 12  EEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 452 XXXXXXXXXXXXXIYEYMPNKSLDVHLFDATR---SVQLDWKRRQSIINGIARGILYLHE 508
                        + E+     L+  +    R    + ++W  +      IARG+ YLH+
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLN-RVLSGKRIPPDILVNWAVQ------IARGMNYLHD 123
Query: 509 DSRLKIIHRDLKASNILL-----DDDMNPKI---SDFGLARIFGGNQNQANTNIIAGTYG 560
           ++ + IIHRDLK+SNIL+     + D++ KI   +DFGLAR      ++      AG Y 
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYA 179
Query: 561 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           +MAPE     +FS  SDV+S+GVLL E+++G 
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 102/199 (51%), Gaps = 9/199 (4%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            ++G G FG VYKG      A+ +  ++  + Q LQ FKNEV ++ K +H N++      
Sbjct: 19  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 77
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + ++    SL  HL       + +  +   I    A+G+ YLH  S   IIH
Sbjct: 78  STKPQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---IIH 132
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM---GGIFS 573
           RDLK++NI L +D+  KI DFGLA +            ++G+  +MAPE         +S
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 192
Query: 574 IKSDVFSFGVLLLEIISGR 592
            +SDV++FG++L E+++G+
Sbjct: 193 FQSDVYAFGIVLYELMTGQ 211

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 102/199 (51%), Gaps = 9/199 (4%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            ++G G FG VYKG      A+ +  ++  + Q LQ FKNEV ++ K +H N++      
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 72
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + ++    SL  HL       + +  +   I    A+G+ YLH  S   IIH
Sbjct: 73  STKPQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM---GGIFS 573
           RDLK++NI L +D+  KI DFGLA +            ++G+  +MAPE         +S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 574 IKSDVFSFGVLLLEIISGR 592
            +SDV++FG++L E+++G+
Sbjct: 188 FQSDVYAFGIVLYELMTGQ 206

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 102/199 (51%), Gaps = 9/199 (4%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            ++G G FG VYKG      A+ +  ++  + Q LQ FKNEV ++ K +H N++      
Sbjct: 19  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 77
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + ++    SL  HL       + +  +   I    A+G+ YLH  S   IIH
Sbjct: 78  STKPQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---IIH 132
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM---GGIFS 573
           RDLK++NI L +D+  KI DFGLA +            ++G+  +MAPE         +S
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 192
Query: 574 IKSDVFSFGVLLLEIISGR 592
            +SDV++FG++L E+++G+
Sbjct: 193 FQSDVYAFGIVLYELMTGQ 211

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 102/195 (52%), Gaps = 9/195 (4%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            +LG G FG V+ GT      +A+K L +      + F  E  ++ KL+H  LV+     
Sbjct: 15  KRLGNGQFGEVWMGTWNGNTKVAIKTL-KPGTMSPESFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                   + EYM   SL   L D   R+++L       +   +A G+ Y+    R+  I
Sbjct: 74  SEEPIYI-VTEYMNKGSLLDFLKDGEGRALKL--PNLVDMAAQVAAGMAYIE---RMNYI 127
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRDL+++NIL+ + +  KI+DFGLAR+   N+  A          + APE A+ G F+IK
Sbjct: 128 HRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQG-AKFPIKWTAPEAALYGRFTIK 186
Query: 576 SDVFSFGVLLLEIIS 590
           SDV+SFG+LL E+++
Sbjct: 187 SDVWSFGILLTELVT 201

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 102/199 (51%), Gaps = 9/199 (4%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            ++G G FG VYKG      A+ +  ++  + Q LQ FKNEV ++ K +H N++      
Sbjct: 41  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 99
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + ++    SL  HL       + +  +   I    A+G+ YLH  S   IIH
Sbjct: 100 STKPQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---IIH 154
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM---GGIFS 573
           RDLK++NI L +D+  KI DFGLA +            ++G+  +MAPE         +S
Sbjct: 155 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 214
Query: 574 IKSDVFSFGVLLLEIISGR 592
            +SDV++FG++L E+++G+
Sbjct: 215 FQSDVYAFGIVLYELMTGQ 233

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 102/199 (51%), Gaps = 9/199 (4%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            ++G G FG VYKG      A+ +  ++  + Q LQ FKNEV ++ K +H N++      
Sbjct: 42  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 100
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + ++    SL  HL       + +  +   I    A+G+ YLH  S   IIH
Sbjct: 101 STKPQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---IIH 155
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM---GGIFS 573
           RDLK++NI L +D+  KI DFGLA +            ++G+  +MAPE         +S
Sbjct: 156 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 215
Query: 574 IKSDVFSFGVLLLEIISGR 592
            +SDV++FG++L E+++G+
Sbjct: 216 FQSDVYAFGIVLYELMTGQ 234

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 106/203 (52%), Gaps = 17/203 (8%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            ++G G FG VYKG      A+ +  ++  + Q LQ FKNEV ++ K +H N++      
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 72
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + ++    SL  HL       + +  +   I    A+G+ YLH  S   IIH
Sbjct: 73  STKPQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 517 RDLKASNILLDDDMNPKISDFGLA----RIFGGNQNQANTNIIAGTYGYMAPEYAM---G 569
           RDLK++NI L +D+  KI DFGLA    R  G +Q +     ++G+  +MAPE       
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ----LSGSILWMAPEVIRMQDK 183
Query: 570 GIFSIKSDVFSFGVLLLEIISGR 592
             +S +SDV++FG++L E+++G+
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 106/203 (52%), Gaps = 17/203 (8%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            ++G G FG VYKG      A+ +  ++  + Q LQ FKNEV ++ K +H N++      
Sbjct: 34  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 92
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + ++    SL  HL       + +  +   I    A+G+ YLH  S   IIH
Sbjct: 93  STKPQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---IIH 147
Query: 517 RDLKASNILLDDDMNPKISDFGLA----RIFGGNQNQANTNIIAGTYGYMAPEYAM---G 569
           RDLK++NI L +D+  KI DFGLA    R  G +Q +     ++G+  +MAPE       
Sbjct: 148 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ----LSGSILWMAPEVIRMQDK 203
Query: 570 GIFSIKSDVFSFGVLLLEIISGR 592
             +S +SDV++FG++L E+++G+
Sbjct: 204 NPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 106/203 (52%), Gaps = 17/203 (8%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            ++G G FG VYKG      A+ +  ++  + Q LQ FKNEV ++ K +H N++      
Sbjct: 42  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 100
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + ++    SL  HL       + +  +   I    A+G+ YLH  S   IIH
Sbjct: 101 STKPQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---IIH 155
Query: 517 RDLKASNILLDDDMNPKISDFGLA----RIFGGNQNQANTNIIAGTYGYMAPEYAM---G 569
           RDLK++NI L +D+  KI DFGLA    R  G +Q +     ++G+  +MAPE       
Sbjct: 156 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ----LSGSILWMAPEVIRMQDK 211
Query: 570 GIFSIKSDVFSFGVLLLEIISGR 592
             +S +SDV++FG++L E+++G+
Sbjct: 212 NPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 103/201 (51%), Gaps = 14/201 (6%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           E KLG G FG V+  T      +AVK + +     ++ F  E N++  LQH  LV+    
Sbjct: 20  EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 78
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGILYLHEDSRL 512
                    I E+M   SL     D  +S +   +    +I+    IA G+ ++ + +  
Sbjct: 79  VTKEPIYI-ITEFMAKGSL----LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-- 131
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
             IHRDL+A+NIL+   +  KI+DFGLAR+   N+  A          + APE    G F
Sbjct: 132 -YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG-AKFPIKWTAPEAINFGSF 189
Query: 573 SIKSDVFSFGVLLLEIIS-GR 592
           +IKSDV+SFG+LL+EI++ GR
Sbjct: 190 TIKSDVWSFGILLMEIVTYGR 210

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 73/215 (33%), Positives = 109/215 (50%), Gaps = 25/215 (11%)
Query: 397 NKLGQGGFGPVYKGTL---ADG---KAIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 449
            +LG+  FG VYKG L   A G   +A+A+K L  +  G   +EF++E  L A+LQH N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSL-----------DVHLFDATRSVQ--LDWKRRQSII 496
           V              I+ Y  +  L           DV   D  R+V+  L+      ++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNII 555
             IA G+ YL   S   ++H+DL   N+L+ D +N KISD GL R ++  +  +   N +
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 556 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                +MAPE  M G FSI SD++S+GV+L E+ S
Sbjct: 192 LPIR-WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/215 (33%), Positives = 109/215 (50%), Gaps = 25/215 (11%)
Query: 397 NKLGQGGFGPVYKGTL---ADG---KAIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 449
            +LG+  FG VYKG L   A G   +A+A+K L  +  G   +EF++E  L A+LQH N+
Sbjct: 32  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 91
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSL-----------DVHLFDATRSVQ--LDWKRRQSII 496
           V              I+ Y  +  L           DV   D  R+V+  L+      ++
Sbjct: 92  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNII 555
             IA G+ YL   S   ++H+DL   N+L+ D +N KISD GL R ++  +  +   N +
Sbjct: 152 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 208
Query: 556 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                +MAPE  M G FSI SD++S+GV+L E+ S
Sbjct: 209 LPIR-WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 101/198 (51%), Gaps = 13/198 (6%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           E KLG G FG V+  T      +AVK + +     ++ F  E N++  LQH  LV+    
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGILYLHEDSRL 512
                    I E+M   SL     D  +S +   +    +I+    IA G+ ++ + +  
Sbjct: 252 VTKEPIYI-ITEFMAKGSL----LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-- 304
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
             IHRDL+A+NIL+   +  KI+DFGLAR+   N+  A          + APE    G F
Sbjct: 305 -YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG-AKFPIKWTAPEAINFGSF 362
Query: 573 SIKSDVFSFGVLLLEIIS 590
           +IKSDV+SFG+LL+EI++
Sbjct: 363 TIKSDVWSFGILLMEIVT 380

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 19/209 (9%)
Query: 399 LGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXXX 457
           LG+G FG   K T  + G+ + +K L R   +  + F  EV ++  L+H N+++      
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 458 XXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR 517
                  I EY+   +L   +   +   Q  W +R S    IA G+ YLH    + IIHR
Sbjct: 78  KDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHR 132
Query: 518 DLKASNILLDDDMNPKISDFGLARIFGGNQNQA------------NTNIIAGTYGYMAPE 565
           DL + N L+ ++ N  ++DFGLAR+    + Q                 + G   +MAPE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 566 YAMGGIFSIKSDVFSFGVLLLEIISGRKN 594
              G  +  K DVFSFG++L EII GR N
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEII-GRVN 220

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/231 (30%), Positives = 117/231 (50%), Gaps = 27/231 (11%)
Query: 377 EFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQG----- 430
           EFP    RL   A N    E ++G+GGFG V+KG L  D   +A+K L     +G     
Sbjct: 7   EFPKS--RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 431 --LQEFKNEVNLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLD 488
              QEF+ EV +++ L H N+V+             + E++P   L   L D    ++  
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVK--LYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIK-- 120
Query: 489 WKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD--DDMNP---KISDFGLARIF 543
           W  +  ++  IA GI Y+ ++    I+HRDL++ NI L   D+  P   K++DFGL++  
Sbjct: 121 WSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-- 177
Query: 544 GGNQNQANTNIIAGTYGYMAPEY--AMGGIFSIKSDVFSFGVLLLEIISGR 592
              Q+  + + + G + +MAPE   A    ++ K+D +SF ++L  I++G 
Sbjct: 178 ---QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 18/215 (8%)
Query: 387 LEATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFK-NEVNLIAKL 444
           + +++ F    KLG G +  VYKG     G  +A+K +   S +G       E++L+ +L
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPN---KSLDVHLFDAT-RSVQLDWKR--RQSIING 498
           +H+N+VR             ++E+M N   K +D      T R ++L+  +  +  ++ G
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +A    + HE+   KI+HRDLK  N+L++     K+ DFGLAR FG   N  ++ ++  T
Sbjct: 121 LA----FCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--T 171
Query: 559 YGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGR 592
             Y AP+  MG   +S   D++S G +L E+I+G+
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 116/231 (50%), Gaps = 27/231 (11%)
Query: 377 EFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQG----- 430
           EFP    RL   A N    E ++G+GGFG V+KG L  D   +A+K L     +G     
Sbjct: 7   EFPKS--RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 431 --LQEFKNEVNLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLD 488
              QEF+ EV +++ L H N+V+             + E++P   L   L D    ++  
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVK--LYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIK-- 120
Query: 489 WKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD--DDMNP---KISDFGLARIF 543
           W  +  ++  IA GI Y+ ++    I+HRDL++ NI L   D+  P   K++DFG ++  
Sbjct: 121 WSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-- 177
Query: 544 GGNQNQANTNIIAGTYGYMAPEY--AMGGIFSIKSDVFSFGVLLLEIISGR 592
              Q+  + + + G + +MAPE   A    ++ K+D +SF ++L  I++G 
Sbjct: 178 ---QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 116/231 (50%), Gaps = 27/231 (11%)
Query: 377 EFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQG----- 430
           EFP    RL   A N    E ++G+GGFG V+KG L  D   +A+K L     +G     
Sbjct: 7   EFPKS--RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 431 --LQEFKNEVNLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLD 488
              QEF+ EV +++ L H N+V+             + E++P   L   L D    ++  
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVK--LYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIK-- 120
Query: 489 WKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD--DDMNP---KISDFGLARIF 543
           W  +  ++  IA GI Y+ ++    I+HRDL++ NI L   D+  P   K++DF L++  
Sbjct: 121 WSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-- 177
Query: 544 GGNQNQANTNIIAGTYGYMAPEY--AMGGIFSIKSDVFSFGVLLLEIISGR 592
              Q+  + + + G + +MAPE   A    ++ K+D +SF ++L  I++G 
Sbjct: 178 ---QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 97/198 (48%), Gaps = 9/198 (4%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            ++G G FG VYKG      A+ + ++   + +  Q F+NEV ++ K +H N++      
Sbjct: 42  TRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNIL-LFMGY 100
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + ++    SL  HL       Q+   +   I    A+G+ YLH  +   IIH
Sbjct: 101 MTKDNLAIVTQWCEGSSLYKHLHVQETKFQM--FQLIDIARQTAQGMDYLHAKN---IIH 155
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM---GGIFS 573
           RD+K++NI L + +  KI DFGLA +              G+  +MAPE         FS
Sbjct: 156 RDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFS 215
Query: 574 IKSDVFSFGVLLLEIISG 591
            +SDV+S+G++L E+++G
Sbjct: 216 FQSDVYSYGIVLYELMTG 233

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 113/214 (52%), Gaps = 20/214 (9%)
Query: 399 LGQGGFGPVYKGT-LADGKAI----AVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRX 452
           LG G FG VYKG  + +G+ +    A+K L+ T+G     EF +E  ++A + H +LVR 
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 453 XXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGILYLHED 509
                       + + MP+  L  ++ +   ++       Q ++N    IA+G++YL E 
Sbjct: 83  LGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIG-----SQLLLNWCVQIAKGMMYLEER 136
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 569
              +++HRDL A N+L+    + KI+DFGLAR+  G++ + N +       +MA E    
Sbjct: 137 ---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 193
Query: 570 GIFSIKSDVFSFGVLLLEIIS--GRKNNGFYFSE 601
             F+ +SDV+S+GV + E+++  G+  +G    E
Sbjct: 194 RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE 227

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 113/214 (52%), Gaps = 20/214 (9%)
Query: 399 LGQGGFGPVYKGT-LADGK----AIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRX 452
           LG G FG VYKG  + +G+     +A+K L+ T+G     EF +E  ++A + H +LVR 
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 453 XXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGILYLHED 509
                       + + MP+  L  ++ +   ++       Q ++N    IA+G++YL E 
Sbjct: 106 LGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIG-----SQLLLNWCVQIAKGMMYLEER 159
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 569
              +++HRDL A N+L+    + KI+DFGLAR+  G++ + N +       +MA E    
Sbjct: 160 ---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 216
Query: 570 GIFSIKSDVFSFGVLLLEIIS--GRKNNGFYFSE 601
             F+ +SDV+S+GV + E+++  G+  +G    E
Sbjct: 217 RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE 250

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 13/207 (6%)
Query: 392 HFSDENKLGQGGFGPVYK---GTLAD--GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH 446
           H     +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH
Sbjct: 14  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 73
Query: 447 KNLVRXXXX--XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
            N+V+               I EY+P  SL  +L     + ++D  +     + I +G+ 
Sbjct: 74  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QAHAERIDHIKLLQYTSQICKGME 131
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT-YGYMA 563
           YL      + IHRDL   NIL++++   KI DFGL ++   ++          +   + A
Sbjct: 132 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 188
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           PE      FS+ SDV+SFGV+L E+ +
Sbjct: 189 PESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           ++KLG G +G VY G        +AVK L   + + ++EF  E  ++ +++H NLV+   
Sbjct: 37  KHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 95
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDS 510
                     + EYMP  +L  +L +  R    +V L +   Q     I+  + YL + +
Sbjct: 96  VCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQ-----ISSAMEYLEKKN 150
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
               IHRDL A N L+ ++   K++DFGL+R+  G+   A+         + APE     
Sbjct: 151 ---FIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYN 206
Query: 571 IFSIKSDVFSFGVLLLEIIS 590
            FSIKSDV++FGVLL EI +
Sbjct: 207 TFSIKSDVWAFGVLLWEIAT 226

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 100/198 (50%), Gaps = 23/198 (11%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           E KLG G FG V+  T      +AVK + +     ++ F  E N++  LQH  LV+    
Sbjct: 187 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 245
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGILYLHEDSRL 512
                    I E+M   SL     D  +S +   +    +I+    IA G+ ++ + +  
Sbjct: 246 VTKEPIYI-ITEFMAKGSL----LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-- 298
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
             IHRDL+A+NIL+   +  KI+DFGLAR+       A   I      + APE    G F
Sbjct: 299 -YIHRDLRAANILVSASLVCKIADFGLARV------GAKFPI-----KWTAPEAINFGSF 346
Query: 573 SIKSDVFSFGVLLLEIIS 590
           +IKSDV+SFG+LL+EI++
Sbjct: 347 TIKSDVWSFGILLMEIVT 364

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 11/201 (5%)
Query: 396 ENKLGQGGFGPVYKGTL-ADGK---AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLV 450
           E  +G G  G V  G L   G+    +A+K L    + +  ++F +E +++ +  H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
           R             + EYM N SLD  L   T   Q    +   ++ G+  G+ YL   S
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG-TYGYMAPEYAMG 569
            L  +HRDL A N+L+D ++  K+SDFGL+R+   + + A T         + APE    
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAF 228
Query: 570 GIFSIKSDVFSFGVLLLEIIS 590
             FS  SDV+SFGV++ E+++
Sbjct: 229 RTFSSASDVWSFGVVMWEVLA 249

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 13/207 (6%)
Query: 392 HFSDENKLGQGGFGPVYK---GTLAD--GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH 446
           H     +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH
Sbjct: 10  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 69
Query: 447 KNLVRXXXX--XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
            N+V+               I EY+P  SL  +L       ++D  +     + I +G+ 
Sbjct: 70  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 127
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT-YGYMA 563
           YL      + IHRDL   NIL++++   KI DFGL ++   ++          +   + A
Sbjct: 128 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 184
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           PE      FS+ SDV+SFGV+L E+ +
Sbjct: 185 PESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 13/207 (6%)
Query: 392 HFSDENKLGQGGFGPVYK---GTLAD--GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH 446
           H     +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH
Sbjct: 42  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 101
Query: 447 KNLVRXXXX--XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
            N+V+               I EY+P  SL  +L       ++D  +     + I +G+ 
Sbjct: 102 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 159
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT-YGYMA 563
           YL      + IHRDL   NIL++++   KI DFGL ++   ++          +   + A
Sbjct: 160 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 216
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           PE      FS+ SDV+SFGV+L E+ +
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 13/207 (6%)
Query: 392 HFSDENKLGQGGFGPVYK---GTLAD--GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH 446
           H     +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH
Sbjct: 9   HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 68
Query: 447 KNLVRXXXX--XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
            N+V+               I EY+P  SL  +L       ++D  +     + I +G+ 
Sbjct: 69  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 126
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT-YGYMA 563
           YL      + IHRDL   NIL++++   KI DFGL ++   ++          +   + A
Sbjct: 127 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 183
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           PE      FS+ SDV+SFGV+L E+ +
Sbjct: 184 PESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 13/207 (6%)
Query: 392 HFSDENKLGQGGFGPVYK---GTLAD--GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH 446
           H     +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH
Sbjct: 15  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 74
Query: 447 KNLVRXXXX--XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
            N+V+               I EY+P  SL  +L       ++D  +     + I +G+ 
Sbjct: 75  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 132
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT-YGYMA 563
           YL      + IHRDL   NIL++++   KI DFGL ++   ++          +   + A
Sbjct: 133 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 189
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           PE      FS+ SDV+SFGV+L E+ +
Sbjct: 190 PESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 13/207 (6%)
Query: 392 HFSDENKLGQGGFGPVYK---GTLAD--GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH 446
           H     +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH
Sbjct: 11  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 70
Query: 447 KNLVRXXXX--XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
            N+V+               I EY+P  SL  +L       ++D  +     + I +G+ 
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 128
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT-YGYMA 563
           YL      + IHRDL   NIL++++   KI DFGL ++   ++          +   + A
Sbjct: 129 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 185
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           PE      FS+ SDV+SFGV+L E+ +
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 13/207 (6%)
Query: 392 HFSDENKLGQGGFGPVYK---GTLAD--GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH 446
           H     +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH
Sbjct: 17  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 76
Query: 447 KNLVRXXXX--XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
            N+V+               I EY+P  SL  +L       ++D  +     + I +G+ 
Sbjct: 77  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 134
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT-YGYMA 563
           YL      + IHRDL   NIL++++   KI DFGL ++   ++          +   + A
Sbjct: 135 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 191
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           PE      FS+ SDV+SFGV+L E+ +
Sbjct: 192 PESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 106/216 (49%), Gaps = 24/216 (11%)
Query: 387 LEATNHFSDENKLGQGGFGPVYKG--TLADGKAIAVK----RLSRTSGQGLQEFKNEVNL 440
           L+ATN  S +  +G G FG V  G   L   K I+V     ++  T  Q  ++F  E ++
Sbjct: 42  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASI 99
Query: 441 IAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 500
           + +  H N++R             + EYM N SLD  L       Q    +   ++ GIA
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIA 157
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 560
            G+ YL   S +  +HRDL A NIL++ ++  K+SDFGLAR+   +   A T     T G
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYT-----TRG 209
Query: 561 ------YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                 + +PE      F+  SDV+S+G++L E++S
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 398 KLGQGGFGPVYK---GTLAD--GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRX 452
           +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH N+V+ 
Sbjct: 22  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 453 XXX--XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                         I EY+P  SL  +L       ++D  +     + I +G+ YL    
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 136
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT-YGYMAPEYAMG 569
             + IHRDL   NIL++++   KI DFGL ++   ++          +   + APE    
Sbjct: 137 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 196
Query: 570 GIFSIKSDVFSFGVLLLEIIS 590
             FS+ SDV+SFGV+L E+ +
Sbjct: 197 SKFSVASDVWSFGVVLYELFT 217

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 13/207 (6%)
Query: 392 HFSDENKLGQGGFGPVYK---GTLAD--GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH 446
           H     +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH
Sbjct: 11  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 70
Query: 447 KNLVRXXXX--XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
            N+V+               I EY+P  SL  +L       ++D  +     + I +G+ 
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 128
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT-YGYMA 563
           YL      + IHRDL   NIL++++   KI DFGL ++   ++          +   + A
Sbjct: 129 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 185
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           PE      FS+ SDV+SFGV+L E+ +
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 396 ENKLGQGGFGPVYKGTL-ADGK---AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLV 450
           E  +G G  G V  G L   G+    +A+K L +  + +  ++F +E +++ +  H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
           R             + EYM N SLD  L   T   Q    +   ++ G+  G+ YL   S
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG-TYGYMAPEYAMG 569
            L  +HRDL A N+L+D ++  K+SDFGL+R+   + + A T         + APE    
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 570 GIFSIKSDVFSFGVLLLEIIS 590
             FS  SDV+SFGV++ E+++
Sbjct: 229 RTFSSASDVWSFGVVMWEVLA 249

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 107/213 (50%), Gaps = 16/213 (7%)
Query: 399 LGQGGFGPVYKGTL--ADGK---AIAVKRLSR--TSGQGLQEFKNEVNLIAKLQHKNLVR 451
           +G G FG VYKG L  + GK    +A+K L    T  Q + +F  E  ++ +  H N++R
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV-DFLGEAGIMGQFSHHNIIR 110
Query: 452 XXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
                        I EYM N +LD  L +  +  +    +   ++ GIA G+ YL   + 
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYL---AN 165
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG--YMAPEYAMG 569
           +  +HRDL A NIL++ ++  K+SDFGL+R+   +  +A      G     + APE    
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 570 GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 602
             F+  SDV+SFG+++ E+++  +   +  S H
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERPYWELSNH 257

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 398 KLGQGGFGPVYK---GTLAD--GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRX 452
           +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 453 XXX--XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                         I EY+P  SL  +L       ++D  +     + I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 134
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT-YGYMAPEYAMG 569
             + IHRDL   NIL++++   KI DFGL ++   ++          +   + APE    
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 570 GIFSIKSDVFSFGVLLLEIIS 590
             FS+ SDV+SFGV+L E+ +
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 398 KLGQGGFGPVYK---GTLAD--GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRX 452
           +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH N+V+ 
Sbjct: 24  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 453 XXX--XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                         I EY+P  SL  +L       ++D  +     + I +G+ YL    
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 138
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT-YGYMAPEYAMG 569
             + IHRDL   NIL++++   KI DFGL ++   ++          +   + APE    
Sbjct: 139 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 198
Query: 570 GIFSIKSDVFSFGVLLLEIIS 590
             FS+ SDV+SFGV+L E+ +
Sbjct: 199 SKFSVASDVWSFGVVLYELFT 219

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 13/207 (6%)
Query: 392 HFSDENKLGQGGFGPVYK---GTLAD--GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH 446
           H     +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH
Sbjct: 29  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 88
Query: 447 KNLVRXXXX--XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
            N+V+               I EY+P  SL  +L       ++D  +     + I +G+ 
Sbjct: 89  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 146
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT-YGYMA 563
           YL      + IHRDL   NIL++++   KI DFGL ++   ++          +   + A
Sbjct: 147 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 203
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           PE      FS+ SDV+SFGV+L E+ +
Sbjct: 204 PESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 108/206 (52%), Gaps = 19/206 (9%)
Query: 396 ENKLGQGGFGPVYKGTL-ADGK---AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLV 450
           E  +G G FG V +G L A GK    +A+K L    + +  +EF +E +++ + +H N++
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLD--VHLFDATRSV-QLDWKRRQSIINGIARGILYLH 507
           R             + E+M N +LD  + L D   +V QL       ++ GIA G+ YL 
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQL-----VGMLRGIASGMRYLA 133
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN-TNIIAGTYG--YMAP 564
           E   +  +HRDL A NIL++ ++  K+SDFGL+R    N +    T+ + G     + AP
Sbjct: 134 E---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAP 190
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIIS 590
           E      F+  SD +S+G+++ E++S
Sbjct: 191 EAIAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 13/207 (6%)
Query: 392 HFSDENKLGQGGFGPVYK---GTLAD--GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH 446
           H     +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH
Sbjct: 29  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 88
Query: 447 KNLVRXXXX--XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
            N+V+               I EY+P  SL  +L       ++D  +     + I +G+ 
Sbjct: 89  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 146
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT-YGYMA 563
           YL      + IHRDL   NIL++++   KI DFGL ++   ++          +   + A
Sbjct: 147 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 203
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           PE      FS+ SDV+SFGV+L E+ +
Sbjct: 204 PESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 11/209 (5%)
Query: 388 EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAK 443
           E    F   N LG+G F  VY+  ++  G  +A+K + + +      +Q  +NEV +  +
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 444 LQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
           L+H +++              + E   N  ++ +L +  +    +  R    ++ I  G+
Sbjct: 68  LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH--FMHQIITGM 125
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
           LYLH      I+HRDL  SN+LL  +MN KI+DFGLA        +  T  + GT  Y++
Sbjct: 126 LYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYIS 180
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           PE A      ++SDV+S G +   ++ GR
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 108/206 (52%), Gaps = 19/206 (9%)
Query: 396 ENKLGQGGFGPVYKGTL-ADGK---AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLV 450
           E  +G G FG V +G L A GK    +A+K L    + +  +EF +E +++ + +H N++
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLD--VHLFDATRSV-QLDWKRRQSIINGIARGILYLH 507
           R             + E+M N +LD  + L D   +V QL       ++ GIA G+ YL 
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQL-----VGMLRGIASGMRYLA 135
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN-QNQANTNIIAGTYG--YMAP 564
           E   +  +HRDL A NIL++ ++  K+SDFGL+R    N  +   T+ + G     + AP
Sbjct: 136 E---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAP 192
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIIS 590
           E      F+  SD +S+G+++ E++S
Sbjct: 193 EAIAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 106/216 (49%), Gaps = 24/216 (11%)
Query: 387 LEATNHFSDENKLGQGGFGPVYKG--TLADGKAIAVK----RLSRTSGQGLQEFKNEVNL 440
           L+ATN  S +  +G G FG V  G   L   K I+V     ++  T  Q  ++F  E ++
Sbjct: 13  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASI 70
Query: 441 IAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 500
           + +  H N++R             + EYM N SLD  L       Q    +   ++ GIA
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIA 128
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 560
            G+ YL   S +  +HRDL A NIL++ ++  K+SDFGL+R+   +   A T     T G
Sbjct: 129 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-----TRG 180
Query: 561 ------YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                 + +PE      F+  SDV+S+G++L E++S
Sbjct: 181 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 106/216 (49%), Gaps = 24/216 (11%)
Query: 387 LEATNHFSDENKLGQGGFGPVYKG--TLADGKAIAVK----RLSRTSGQGLQEFKNEVNL 440
           L+ATN  S +  +G G FG V  G   L   K I+V     ++  T  Q  ++F  E ++
Sbjct: 42  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASI 99
Query: 441 IAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 500
           + +  H N++R             + EYM N SLD  L       Q    +   ++ GIA
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIA 157
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 560
            G+ YL   S +  +HRDL A NIL++ ++  K+SDFGL+R+   +   A T     T G
Sbjct: 158 SGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-----TRG 209
Query: 561 ------YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                 + +PE      F+  SDV+S+G++L E++S
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQHKNLVRXXX 454
            K+G+G +G VYK   + G+ +A+KR+      +G+      E++L+ +L H N+V    
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                     ++E+M  K L   + D  ++   D  + +  +  + RG+ + H+    +I
Sbjct: 87  VIHSERCLTLVFEFM-EKDLK-KVLDENKTGLQD-SQIKIYLYQLLRGVAHCHQH---RI 140
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFS 573
           +HRDLK  N+L++ D   K++DFGLAR FG         ++  T  Y AP+  MG   +S
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVLMGSKKYS 198
Query: 574 IKSDVFSFGVLLLEIISGR 592
              D++S G +  E+I+G+
Sbjct: 199 TSVDIWSIGCIFAEMITGK 217

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 106/216 (49%), Gaps = 24/216 (11%)
Query: 387 LEATNHFSDENKLGQGGFGPVYKG--TLADGKAIAVK----RLSRTSGQGLQEFKNEVNL 440
           L+ATN  S +  +G G FG V  G   L   K I+V     ++  T  Q  ++F  E ++
Sbjct: 30  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASI 87
Query: 441 IAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 500
           + +  H N++R             + EYM N SLD  L       Q    +   ++ GIA
Sbjct: 88  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIA 145
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 560
            G+ YL   S +  +HRDL A NIL++ ++  K+SDFGL+R+   +   A T     T G
Sbjct: 146 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-----TRG 197
Query: 561 ------YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                 + +PE      F+  SDV+S+G++L E++S
Sbjct: 198 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 398 KLGQGGFGPVYK---GTLAD--GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRX 452
           +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 453 XXX--XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                         I E++P  SL  +L       ++D  +     + I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 134
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT-YGYMAPEYAMG 569
             + IHRDL   NIL++++   KI DFGL ++   ++          +   + APE    
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 570 GIFSIKSDVFSFGVLLLEIIS 590
             FS+ SDV+SFGV+L E+ +
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQHKNLVRXXX 454
            K+G+G +G VYK   + G+ +A+KR+      +G+      E++L+ +L H N+V    
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                     ++E+M  K L   + D  ++   D  + +  +  + RG+ + H+    +I
Sbjct: 87  VIHSERCLTLVFEFM-EKDLK-KVLDENKTGLQD-SQIKIYLYQLLRGVAHCHQH---RI 140
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFS 573
           +HRDLK  N+L++ D   K++DFGLAR FG         ++  T  Y AP+  MG   +S
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVLMGSKKYS 198
Query: 574 IKSDVFSFGVLLLEIISGR 592
              D++S G +  E+I+G+
Sbjct: 199 TSVDIWSIGCIFAEMITGK 217

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 106/216 (49%), Gaps = 24/216 (11%)
Query: 387 LEATNHFSDENKLGQGGFGPVYKG--TLADGKAIAVK----RLSRTSGQGLQEFKNEVNL 440
           L+ATN  S +  +G G FG V  G   L   K I+V     ++  T  Q  ++F  E ++
Sbjct: 42  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASI 99
Query: 441 IAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 500
           + +  H N++R             + EYM N SLD  L       Q    +   ++ GIA
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIA 157
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 560
            G+ YL   S +  +HRDL A NIL++ ++  K+SDFGL+R+   +   A T     T G
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-----TRG 209
Query: 561 ------YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                 + +PE      F+  SDV+S+G++L E++S
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 106/216 (49%), Gaps = 24/216 (11%)
Query: 387 LEATNHFSDENKLGQGGFGPVYKG--TLADGKAIAVK----RLSRTSGQGLQEFKNEVNL 440
           L+ATN  S +  +G G FG V  G   L   K I+V     ++  T  Q  ++F  E ++
Sbjct: 42  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASI 99
Query: 441 IAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 500
           + +  H N++R             + EYM N SLD  L       Q    +   ++ GIA
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIA 157
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 560
            G+ YL   S +  +HRDL A NIL++ ++  K+SDFGL+R+   +   A T     T G
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-----TRG 209
Query: 561 ------YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                 + +PE      F+  SDV+S+G++L E++S
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 106/216 (49%), Gaps = 24/216 (11%)
Query: 387 LEATNHFSDENKLGQGGFGPVYKG--TLADGKAIAVK----RLSRTSGQGLQEFKNEVNL 440
           L+ATN  S +  +G G FG V  G   L   K I+V     ++  T  Q  ++F  E ++
Sbjct: 42  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASI 99
Query: 441 IAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 500
           + +  H N++R             + EYM N SLD  L       Q    +   ++ GIA
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIA 157
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 560
            G+ YL   S +  +HRDL A NIL++ ++  K+SDFGL+R+   +   A T     T G
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-----TRG 209
Query: 561 ------YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                 + +PE      F+  SDV+S+G++L E++S
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 106/216 (49%), Gaps = 24/216 (11%)
Query: 387 LEATNHFSDENKLGQGGFGPVYKG--TLADGKAIAVK----RLSRTSGQGLQEFKNEVNL 440
           L+ATN  S +  +G G FG V  G   L   K I+V     ++  T  Q  ++F  E ++
Sbjct: 40  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASI 97
Query: 441 IAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 500
           + +  H N++R             + EYM N SLD  L       Q    +   ++ GIA
Sbjct: 98  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIA 155
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 560
            G+ YL   S +  +HRDL A NIL++ ++  K+SDFGL+R+   +   A T     T G
Sbjct: 156 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-----TRG 207
Query: 561 ------YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                 + +PE      F+  SDV+S+G++L E++S
Sbjct: 208 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 106/216 (49%), Gaps = 24/216 (11%)
Query: 387 LEATNHFSDENKLGQGGFGPVYKG--TLADGKAIAVK----RLSRTSGQGLQEFKNEVNL 440
           L+ATN  S +  +G G FG V  G   L   K I+V     ++  T  Q  ++F  E ++
Sbjct: 42  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASI 99
Query: 441 IAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 500
           + +  H N++R             + EYM N SLD  L       Q    +   ++ GIA
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIA 157
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 560
            G+ YL   S +  +HRDL A NIL++ ++  K+SDFGL+R+   +   A T     T G
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-----TRG 209
Query: 561 ------YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                 + +PE      F+  SDV+S+G++L E++S
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 392 HFSDENKLGQGGFGPVYK---GTLAD--GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH 446
           H     +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH
Sbjct: 11  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 70
Query: 447 KNLVRXXXX--XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
            N+V+               I EY+P  SL  +L       ++D  +     + I +G+ 
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 128
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN--QANTNIIAGTYGYM 562
           YL      + IHRDL   NIL++++   KI DFGL ++   ++   +      +  + Y 
Sbjct: 129 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY- 184
Query: 563 APEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           APE      FS+ SDV+SFGV+L E+ +
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 387 LEATNHFSDENKLGQGGFGPVYKG--TLADGKAIAVK----RLSRTSGQGLQEFKNEVNL 440
           L+ATN  S +  +G G FG V  G   L   K I+V     ++  T  Q  ++F  E ++
Sbjct: 42  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASI 99
Query: 441 IAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 500
           + +  H N++R             + EYM N SLD  L       Q    +   ++ GIA
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIA 157
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 560
            G+ YL   S +  +HRDL A NIL++ ++  K+SDFGL R+   +   A T     T G
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT-----TRG 209
Query: 561 ------YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                 + +PE      F+  SDV+S+G++L E++S
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 13/207 (6%)
Query: 392 HFSDENKLGQGGFGPVYK---GTLAD--GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH 446
           H     +LG+G FG V       L D  G+ +AVK+L  ++ + L++F+ E+ ++  LQH
Sbjct: 12  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 71
Query: 447 KNLVRXXXX--XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
            N+V+               I EY+P  SL  +L       ++D  +     + I +G+ 
Sbjct: 72  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGME 129
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT-YGYMA 563
           YL      + IHR+L   NIL++++   KI DFGL ++   ++          +   + A
Sbjct: 130 YL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA 186
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           PE      FS+ SDV+SFGV+L E+ +
Sbjct: 187 PESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           ++KLG G FG VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+   
Sbjct: 16  KHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 74
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDS 510
                     I E+M   +L  +L +  R    +V L +   Q     I+  + YL + +
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-----ISSAMEYLEKKN 129
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
               IHRDL A N L+ ++   K++DFGL+R+  G+   A+         + APE     
Sbjct: 130 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAG-AKFPIKWTAPESLAYN 185
Query: 571 IFSIKSDVFSFGVLLLEIIS 590
            FSIKSDV++FGVLL EI +
Sbjct: 186 KFSIKSDVWAFGVLLWEIAT 205

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+   
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                     I E+M   +L  +L +  R  +++      +   I+  + YL + +    
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 132
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           IHRDL A N L+ ++   K++DFGL+R+  G+   A+         + APE      FSI
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNKFSI 191
Query: 575 KSDVFSFGVLLLEIIS 590
           KSDV++FGVLL EI +
Sbjct: 192 KSDVWAFGVLLWEIAT 207

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+   
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                     I E+M   +L  +L +  R  +++      +   I+  + YL + +    
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 137
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           IHRDL A N L+ ++   K++DFGL+R+  G+   A+         + APE      FSI
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAG-AKFPIKWTAPESLAYNKFSI 196
Query: 575 KSDVFSFGVLLLEIIS 590
           KSDV++FGVLL EI +
Sbjct: 197 KSDVWAFGVLLWEIAT 212

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+   
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                     I E+M   +L  +L +  R  +++      +   I+  + YL + +    
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 132
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           IHRDL A N L+ ++   K++DFGL+R+  G+   A+         + APE      FSI
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNKFSI 191
Query: 575 KSDVFSFGVLLLEIIS 590
           KSDV++FGVLL EI +
Sbjct: 192 KSDVWAFGVLLWEIAT 207

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+   
Sbjct: 16  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 74
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDS 510
                     I E+M   +L  +L +  R    +V L +   Q     I+  + YL + +
Sbjct: 75  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-----ISSAMEYLEKKN 129
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
               IHRDL A N L+ ++   K++DFGL+R+  G+   A+         + APE     
Sbjct: 130 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAG-AKFPIKWTAPESLAYN 185
Query: 571 IFSIKSDVFSFGVLLLEIIS 590
            FSIKSDV++FGVLL EI +
Sbjct: 186 KFSIKSDVWAFGVLLWEIAT 205

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+   
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                     I E+M   +L  +L +  R  +++      +   I+  + YL + +    
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 137
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           IHRDL A N L+ ++   K++DFGL+R+  G+   A+         + APE      FSI
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNKFSI 196
Query: 575 KSDVFSFGVLLLEIIS 590
           KSDV++FGVLL EI +
Sbjct: 197 KSDVWAFGVLLWEIAT 212

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+   
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                     I E+M   +L  +L +  R  +++      +   I+  + YL + +    
Sbjct: 82  VCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 137
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           IHRDL A N L+ ++   K++DFGL+R+  G+   A+         + APE      FSI
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNKFSI 196
Query: 575 KSDVFSFGVLLLEIIS 590
           KSDV++FGVLL EI +
Sbjct: 197 KSDVWAFGVLLWEIAT 212

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 108/227 (47%), Gaps = 28/227 (12%)
Query: 396 ENKLGQGGFGPVYKG------TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
           + +LG+G FG V+           D   +AVK L   +    ++F+ E  L+  LQH+++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 450 VRXXXXXXXXXXXXXIYEYMP----NKSLDVHLFDATRSVQLDWKRRQS----------- 494
           V+             ++EYM     NK L  H  DA   + +D + RQ+           
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAM--ILVDGQPRQAKGELGLSQMLH 137
Query: 495 IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTN 553
           I + IA G++YL   +    +HRDL   N L+  ++  KI DFG++R ++  +  +   +
Sbjct: 138 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194
Query: 554 IIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFS 600
            +     +M PE  M   F+ +SDV+SFGV+L EI +  K   F  S
Sbjct: 195 TMLPIR-WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 240

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+   
Sbjct: 19  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 77
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                     I E+M   +L  +L +  R  +++      +   I+  + YL + +    
Sbjct: 78  VCTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 133
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           IHRDL A N L+ ++   K++DFGL+R+  G+   A+         + APE      FSI
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAG-AKFPIKWTAPESLAYNKFSI 192
Query: 575 KSDVFSFGVLLLEIIS 590
           KSDV++FGVLL EI +
Sbjct: 193 KSDVWAFGVLLWEIAT 208

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/236 (32%), Positives = 111/236 (47%), Gaps = 20/236 (8%)
Query: 372 QAESQEF--PLFPLRLA----LEA----TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAV 420
           QA  QEF   L+ LR      LEA     + F D   LG+GGFG V+   + A GK  A 
Sbjct: 156 QAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYAC 215
Query: 421 KRLSRTSGQ---GLQEFKNEVNLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVH 477
           K+L++   +   G Q    E  ++AK+  + +V              +   M    +  H
Sbjct: 216 KKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYH 275
Query: 478 LFDATRSVQLDWKRRQSIING-IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISD 536
           +++         + R       I  G+ +LH+ +   II+RDLK  N+LLDDD N +ISD
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISD 332
Query: 537 FGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
            GLA      Q +  T   AGT G+MAPE  +G  +    D F+ GV L E+I+ R
Sbjct: 333 LGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 387 LEATNHFSDENKLGQGGFGPVYKG--TLADGKAIAVK----RLSRTSGQGLQEFKNEVNL 440
           L+ATN  S +  +G G FG V  G   L   K I+V     ++  T  Q  ++F  E ++
Sbjct: 13  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASI 70
Query: 441 IAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 500
           + +  H N++R             + E M N SLD  L       Q    +   ++ GIA
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQFTVIQLVGMLRGIA 128
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 560
            G+ YL   S +  +HRDL A NIL++ ++  K+SDFGL+R+   +   A T     T G
Sbjct: 129 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-----TRG 180
Query: 561 ------YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                 + +PE      F+  SDV+S+G++L E++S
Sbjct: 181 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+   
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 80
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                     I E+M   +L  +L +  R  +++      +   I+  + YL + +    
Sbjct: 81  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 136
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           IHRDL A N L+ ++   K++DFGL+R+  G+   A+         + APE      FSI
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNKFSI 195
Query: 575 KSDVFSFGVLLLEIIS 590
           KSDV++FGVLL EI +
Sbjct: 196 KSDVWAFGVLLWEIAT 211

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 23/222 (10%)
Query: 398 KLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
           +LG+G FG V+           D   +AVK L   S    Q+F+ E  L+  LQH+++VR
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 452 XXXXXXXXXXXXXIYEYMPNKSL---------DVHLFDATRSV---QLDWKRRQSIINGI 499
                        ++EYM +  L         D  L      V    L   +  ++ + +
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAGT 558
           A G++YL   + L  +HRDL   N L+   +  KI DFG++R I+  +  +     +   
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFS 600
             +M PE  +   F+ +SDV+SFGV+L EI +  K   +  S
Sbjct: 202 R-WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 242

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+   
Sbjct: 31  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 89
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                     I E+M   +L  +L +  R  +++      +   I+  + YL + +    
Sbjct: 90  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 145
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           IHRDL A N L+ ++   K++DFGL+R+  G+   A+         + APE      FSI
Sbjct: 146 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNKFSI 204
Query: 575 KSDVFSFGVLLLEIIS 590
           KSDV++FGVLL EI +
Sbjct: 205 KSDVWAFGVLLWEIAT 220

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+   
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                     I E+M   +L  +L +  R  +++      +   I+  + YL + +    
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 134
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           IHRDL A N L+ ++   K++DFGL+R+  G+   A+         + APE      FSI
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNKFSI 193
Query: 575 KSDVFSFGVLLLEIIS 590
           KSDV++FGVLL EI +
Sbjct: 194 KSDVWAFGVLLWEIAT 209

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+   
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDS 510
                     I E+M   +L  +L +  R    +V L +   Q     I+  + YL + +
Sbjct: 77  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-----ISSAMEYLEKKN 131
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
               IHRDL A N L+ ++   K++DFGL+R+  G+   A+         + APE     
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYN 187
Query: 571 IFSIKSDVFSFGVLLLEIIS 590
            FSIKSDV++FGVLL EI +
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+   
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDS 510
                     I E+M   +L  +L +  R    +V L +   Q     I+  + YL + +
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-----ISSAMEYLEKKN 131
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
               IHRDL A N L+ ++   K++DFGL+R+  G+   A+         + APE     
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYN 187
Query: 571 IFSIKSDVFSFGVLLLEIIS 590
            FSIKSDV++FGVLL EI +
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 387 LEATNHFSDENKLGQGGFGPVYKG--TLADGKAIAVK----RLSRTSGQGLQEFKNEVNL 440
           L+ATN  S +  +G G FG V  G   L   K I+V     ++  T  Q  ++F  E ++
Sbjct: 42  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASI 99
Query: 441 IAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 500
           + +  H N++R             + E M N SLD  L       Q    +   ++ GIA
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQFTVIQLVGMLRGIA 157
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 560
            G+ YL   S +  +HRDL A NIL++ ++  K+SDFGL+R+   +   A T     T G
Sbjct: 158 SGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-----TRG 209
Query: 561 ------YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                 + +PE      F+  SDV+S+G++L E++S
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 23/222 (10%)
Query: 398 KLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
           +LG+G FG V+           D   +AVK L   S    Q+F+ E  L+  LQH+++VR
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 452 XXXXXXXXXXXXXIYEYMPNKSL---------DVHLFDATRSV---QLDWKRRQSIINGI 499
                        ++EYM +  L         D  L      V    L   +  ++ + +
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAGT 558
           A G++YL   + L  +HRDL   N L+   +  KI DFG++R I+  +  +     +   
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFS 600
             +M PE  +   F+ +SDV+SFGV+L EI +  K   +  S
Sbjct: 196 R-WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 236

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+   
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDS 510
                     I E+M   +L  +L +  R    +V L +   Q     I+  + YL + +
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-----ISSAMEYLEKKN 131
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
               IHRDL A N L+ ++   K++DFGL+R+  G+   A+         + APE     
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYN 187
Query: 571 IFSIKSDVFSFGVLLLEIIS 590
            FSIKSDV++FGVLL EI +
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+   
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                     I E+M   +L  +L +  R  +++      +   I+  + YL + +    
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 134
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           IHRDL A N L+ ++   K++DFGL+R+  G+   A+         + APE      FSI
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNKFSI 193
Query: 575 KSDVFSFGVLLLEIIS 590
           KSDV++FGVLL EI +
Sbjct: 194 KSDVWAFGVLLWEIAT 209

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 25/206 (12%)
Query: 393 FSDENKLGQGGFGPVY-KGTLADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQHKN 448
           FSD  ++G G FG VY    + + + +A+K++S   + S +  Q+   EV  + KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 449 LVRXXXXXXXXXXXXXIYEYMPNKS---LDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
            ++             + EY    +   L+VH     + V++      ++ +G  +G+ Y
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEI-----AAVTHGALQGLAY 130
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           LH  +   +IHRD+KA NILL +    K+ DFG A I       A  N   GT  +MAPE
Sbjct: 131 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPE 181
Query: 566 YAMG---GIFSIKSDVFSFGVLLLEI 588
             +    G +  K DV+S G+  +E+
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIEL 207

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/236 (32%), Positives = 111/236 (47%), Gaps = 20/236 (8%)
Query: 372 QAESQEF--PLFPLRLA----LEA----TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAV 420
           QA  QEF   L+ LR      LEA     + F D   LG+GGFG V+   + A GK  A 
Sbjct: 156 QAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYAC 215
Query: 421 KRLSRTSGQ---GLQEFKNEVNLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVH 477
           K+L++   +   G Q    E  ++AK+  + +V              +   M    +  H
Sbjct: 216 KKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYH 275
Query: 478 LFDATRSVQLDWKRRQSIING-IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISD 536
           +++         + R       I  G+ +LH+ +   II+RDLK  N+LLDDD N +ISD
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISD 332
Query: 537 FGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
            GLA      Q +  T   AGT G+MAPE  +G  +    D F+ GV L E+I+ R
Sbjct: 333 LGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 13/201 (6%)
Query: 397 NKLGQGGFGPVY--KGTLADGKAIAVKRL---SRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
           +KLG GG   VY  + T+ + K +A+K +    R   + L+ F+ EV+  ++L H+N+V 
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIK-VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 452 XXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
                        + EY+   +L  ++ ++   + +D     +  N I  GI + H+   
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAI--NFTNQILDGIKHAHD--- 129
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 571
           ++I+HRD+K  NIL+D +   KI DFG+A+      +   TN + GT  Y +PE A G  
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 572 FSIKSDVFSFGVLLLEIISGR 592
               +D++S G++L E++ G 
Sbjct: 189 TDECTDIYSIGIVLYEMLVGE 209

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/236 (32%), Positives = 111/236 (47%), Gaps = 20/236 (8%)
Query: 372 QAESQEF--PLFPLRLA----LEA----TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAV 420
           QA  QEF   L+ LR      LEA     + F D   LG+GGFG V+   + A GK  A 
Sbjct: 156 QAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYAC 215
Query: 421 KRLSRTSGQ---GLQEFKNEVNLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVH 477
           K+L++   +   G Q    E  ++AK+  + +V              +   M    +  H
Sbjct: 216 KKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYH 275
Query: 478 LFDATRSVQLDWKRRQSIING-IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISD 536
           +++         + R       I  G+ +LH+ +   II+RDLK  N+LLDDD N +ISD
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISD 332
Query: 537 FGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
            GLA      Q +  T   AGT G+MAPE  +G  +    D F+ GV L E+I+ R
Sbjct: 333 LGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+   
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDS 510
                     I E+M   +L  +L +  R    +V L +   Q     I+  + YL + +
Sbjct: 77  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-----ISSAMEYLEKKN 131
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
               IHRDL A N L+ ++   K++DFGL+R+  G+   A+         + APE     
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYN 187
Query: 571 IFSIKSDVFSFGVLLLEIIS 590
            FSIKSDV++FGVLL EI +
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 99/207 (47%), Gaps = 10/207 (4%)
Query: 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQ---GLQEFKNEVNLIAKLQH 446
           + F D   LG+GGFG V+   + A GK  A K+L++   +   G Q    E  ++AK+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 447 KNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING-IARGILY 505
           + +V              +   M    +  H+++         + R       I  G+ +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           LH+ +   II+RDLK  N+LLDDD N +ISD GLA      Q +  T   AGT G+MAPE
Sbjct: 305 LHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPE 359
Query: 566 YAMGGIFSIKSDVFSFGVLLLEIISGR 592
             +G  +    D F+ GV L E+I+ R
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+   
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                     I E+M   +L  +L +  R  +++      +   I+  + YL + +    
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 137
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           IHRDL A N L+ ++   K++DFGL+R+  G+   A+         + APE      FSI
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNKFSI 196
Query: 575 KSDVFSFGVLLLEIIS 590
           KSDV++FGVLL EI +
Sbjct: 197 KSDVWAFGVLLWEIAT 212

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 25/206 (12%)
Query: 393 FSDENKLGQGGFGPVY-KGTLADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQHKN 448
           FSD  ++G G FG VY    + + + +A+K++S   + S +  Q+   EV  + KL+H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 449 LVRXXXXXXXXXXXXXIYEYMPNKS---LDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
            ++             + EY    +   L+VH     + V++      ++ +G  +G+ Y
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEI-----AAVTHGALQGLAY 169
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           LH  +   +IHRD+KA NILL +    K+ DFG A I       A  N   GT  +MAPE
Sbjct: 170 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPE 220
Query: 566 YAMG---GIFSIKSDVFSFGVLLLEI 588
             +    G +  K DV+S G+  +E+
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIEL 246

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 387 LEATNHFSDENKLGQGGFGPVYKG--TLADGKAIAVK----RLSRTSGQGLQEFKNEVNL 440
           L+ATN  S +  +G G FG V  G   L   K I+V     ++  T  Q  ++F  E ++
Sbjct: 42  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASI 99
Query: 441 IAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 500
           + +  H N++R             + E M N SLD  L       Q    +   ++ GIA
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQFTVIQLVGMLRGIA 157
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 560
            G+ YL   S +  +HRDL A NIL++ ++  K+SDFGL+R+   +   A T     T G
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-----TRG 209
Query: 561 ------YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                 + +PE      F+  SDV+S+G++L E++S
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 108/212 (50%), Gaps = 13/212 (6%)
Query: 386 ALEATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIA 442
            L +  +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ 
Sbjct: 1   PLGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 443 KLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLF-DATRSVQLDWKRRQSIINGIAR 501
           +L H N+V+             ++E++   S+D+  F DA+    +     +S +  + +
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ + H     +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y
Sbjct: 118 GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 172
Query: 562 MAPEYAMG-GIFSIKSDVFSFGVLLLEIISGR 592
            APE  +G   +S   D++S G +  E+++ R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+   
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDS 510
                     I E+M   +L  +L +  R    +V L +   Q     I+  + YL + +
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-----ISSAMEYLEKKN 136
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
               IHRDL A N L+ ++   K++DFGL+R+  G+   A+         + APE     
Sbjct: 137 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYN 192
Query: 571 IFSIKSDVFSFGVLLLEIIS 590
            FSIKSDV++FGVLL EI +
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT 212

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 21/222 (9%)
Query: 396 ENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
           + +LG+G FG V+           D   +AVK L   S    ++F  E  L+  LQH+++
Sbjct: 18  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 77
Query: 450 VRXXXXXXXXXXXXXIYEYMP----NKSLDVHLFDAT------RSVQLDWKRRQSIINGI 499
           V+             ++EYM     NK L  H  DA          +L   +   I   I
Sbjct: 78  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAGT 558
           A G++YL   +    +HRDL   N L+ +++  KI DFG++R ++  +  +   + +   
Sbjct: 138 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 194
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFS 600
             +M PE  M   F+ +SDV+S GV+L EI +  K   +  S
Sbjct: 195 R-WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 235

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+   
Sbjct: 16  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 74
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDS 510
                     I E+M   +L  +L +  R    +V L +   Q     I+  + YL + +
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-----ISSAMEYLEKKN 129
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
               IHRDL A N L+ ++   K++DFGL+R+  G+   A+         + APE     
Sbjct: 130 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAG-AKFPIKWTAPESLAYN 185
Query: 571 IFSIKSDVFSFGVLLLEIIS 590
            FSIKSDV++FGVLL EI +
Sbjct: 186 KFSIKSDVWAFGVLLWEIAT 205

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 100/196 (51%), Gaps = 7/196 (3%)
Query: 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+   
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                     I E+M   +L  +L +  R  +++      +   I+  + YL + +    
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 134
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           IHRDL A N L+ ++   K++DFGL+R+  G+   A          + APE      FSI
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAG-AKFPIKWTAPESLAYNKFSI 193
Query: 575 KSDVFSFGVLLLEIIS 590
           KSDV++FGVLL EI +
Sbjct: 194 KSDVWAFGVLLWEIAT 209

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 100/196 (51%), Gaps = 7/196 (3%)
Query: 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+   
Sbjct: 19  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 77
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                     I E+M   +L  +L +  R  +++      +   I+  + YL + +    
Sbjct: 78  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 133
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           IHRDL A N L+ ++   K++DFGL+R+  G+   A          + APE      FSI
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAG-AKFPIKWTAPESLAYNKFSI 192
Query: 575 KSDVFSFGVLLLEIIS 590
           KSDV++FGVLL EI +
Sbjct: 193 KSDVWAFGVLLWEIAT 208

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 23/222 (10%)
Query: 398 KLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
           +LG+G FG V+           D   +AVK L   S    Q+F+ E  L+  LQH+++VR
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 452 XXXXXXXXXXXXXIYEYMPNKSL---------DVHLFDATRSV---QLDWKRRQSIINGI 499
                        ++EYM +  L         D  L      V    L   +  ++ + +
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAGT 558
           A G++YL   + L  +HRDL   N L+   +  KI DFG++R I+  +  +     +   
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFS 600
             +M PE  +   F+ +SDV+SFGV+L EI +  K   +  S
Sbjct: 225 R-WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 108/212 (50%), Gaps = 13/212 (6%)
Query: 386 ALEATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIA 442
            L +  +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ 
Sbjct: 1   PLGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 443 KLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLF-DATRSVQLDWKRRQSIINGIAR 501
           +L H N+V+             ++E++   S+D+  F DA+    +     +S +  + +
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ + H     +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y
Sbjct: 118 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 172
Query: 562 MAPEYAMG-GIFSIKSDVFSFGVLLLEIISGR 592
            APE  +G   +S   D++S G +  E+++ R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 107/209 (51%), Gaps = 13/209 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQ 445
           +  +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLF-DATRSVQLDWKRRQSIINGIARGIL 504
           H N+V+             ++E++   S+D+  F DA+    +     +S +  + +G+ 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           + H     +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y AP
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 173
Query: 565 EYAMG-GIFSIKSDVFSFGVLLLEIISGR 592
           E  +G   +S   D++S G +  E+++ R
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 108/211 (51%), Gaps = 13/211 (6%)
Query: 387 LEATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAK 443
           L +  +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +
Sbjct: 1   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 60
Query: 444 LQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLF-DATRSVQLDWKRRQSIINGIARG 502
           L H N+V+             ++E++   S+D+  F DA+    +     +S +  + +G
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQG 117
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYM 562
           + + H     +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y 
Sbjct: 118 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 172
Query: 563 APEYAMG-GIFSIKSDVFSFGVLLLEIISGR 592
           APE  +G   +S   D++S G +  E+++ R
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 13/197 (6%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
           +LG G FG VYK    +   +A  ++  T S + L+++  E++++A   H N+V+     
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + E+    ++D  + +  R   L   + Q +       + YLH++   KIIH
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI----- 571
           RDLKA NIL   D + K++DFG++      +     +   GT  +MAPE  M        
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSA--KNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRP 216
Query: 572 FSIKSDVFSFGVLLLEI 588
           +  K+DV+S G+ L+E+
Sbjct: 217 YDYKADVWSLGITLIEM 233

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 23/207 (11%)
Query: 396 ENKLGQGGFGPVYKGTLA-DGK-----AIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
           E  +G G FG V  G L   GK     AI   ++  T  Q  ++F  E +++ +  H N+
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNI 85
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +              + EYM N SLD  L       Q    +   ++ GI+ G+ YL   
Sbjct: 86  IHLEGVVTKSKPVMIVTEYMENGSLDTFL--KKNDGQFTVIQLVGMLRGISAGMKYL--- 140
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG------YMA 563
           S +  +HRDL A NIL++ ++  K+SDFGL+R+   +   A T     T G      + A
Sbjct: 141 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-----TRGGKIPIRWTA 195
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           PE      F+  SDV+S+G+++ E++S
Sbjct: 196 PEAIAFRKFTSASDVWSYGIVMWEVVS 222

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 13/197 (6%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
           +LG G FG VYK    +   +A  ++  T S + L+++  E++++A   H N+V+     
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + E+    ++D  + +  R   L   + Q +       + YLH++   KIIH
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI----- 571
           RDLKA NIL   D + K++DFG++        + ++ I  GT  +MAPE  M        
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVVMCETSKDRP 216
Query: 572 FSIKSDVFSFGVLLLEI 588
           +  K+DV+S G+ L+E+
Sbjct: 217 YDYKADVWSLGITLIEM 233

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 108/229 (47%), Gaps = 19/229 (8%)
Query: 392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQ---EFKNEVNLIAKLQHK 447
           H+   + LG G FG V  G     G  +AVK L+R   + L    + + E+  +   +H 
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 448 NLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIARGILYL 506
           ++++             + EY+    L    FD   ++ +LD K  + +   I  G+ Y 
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVDYC 132
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H   R  ++HRDLK  N+LLD  MN KI+DFGL+ +    +    +    G+  Y APE 
Sbjct: 133 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXS---CGSPNYAAPEV 186
Query: 567 AMGGIFS-IKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSL 614
             G +++  + D++S GV+L  ++ G      +  +H  TL   +C+ +
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLP---FDDDHVPTLFKKICDGI 232

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 7/197 (3%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            ++G G FG V+ G   +   +A+K + R      ++F  E  ++ KL H  LV+     
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   ++E+M +  L  +L   T+      +    +   +  G+ YL E S   +IH
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAS---VIH 126
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDL A N L+ ++   K+SDFG+ R    +Q  ++T        + +PE      +S KS
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVFSFSRYSSKS 185
Query: 577 DVFSFGVLLLEIISGRK 593
           DV+SFGVL+ E+ S  K
Sbjct: 186 DVWSFGVLMWEVFSEGK 202

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 13/197 (6%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
           +LG G FG VYK    +   +A  ++  T S + L+++  E++++A   H N+V+     
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + E+    ++D  + +  R   L   + Q +       + YLH++   KIIH
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI----- 571
           RDLKA NIL   D + K++DFG++      +     +   GT  +MAPE  M        
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSA--KNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRP 216
Query: 572 FSIKSDVFSFGVLLLEI 588
           +  K+DV+S G+ L+E+
Sbjct: 217 YDYKADVWSLGITLIEM 233

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 95/198 (47%), Gaps = 15/198 (7%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           +G+G F  V     +  GK +AVK + +T  +   LQ+   EV ++  L H N+V+    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    + EY     +  +L    R   +  K  ++    I   + Y H+     I+
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR---MKEKEARAKFRQIVSAVQYCHQKF---IV 135
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFG-GNQNQANTNIIAGTYGYMAPEYAMGGIFS- 573
           HRDLKA N+LLD DMN KI+DFG +  F  GN+     +   G+  Y APE   G  +  
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGSPPYAAPELFQGKKYDG 191
Query: 574 IKSDVFSFGVLLLEIISG 591
            + DV+S GV+L  ++SG
Sbjct: 192 PEVDVWSLGVILYTLVSG 209

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 95/198 (47%), Gaps = 15/198 (7%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           +G+G F  V     +  GK +AVK + +T  +   LQ+   EV ++  L H N+V+    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    + EY     +  +L    R   +  K  ++    I   + Y H+     I+
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR---MKEKEARAKFRQIVSAVQYCHQKF---IV 135
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFG-GNQNQANTNIIAGTYGYMAPEYAMGGIFS- 573
           HRDLKA N+LLD DMN KI+DFG +  F  GN+     +   G+  Y APE   G  +  
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGSPPYAAPELFQGKKYDG 191
Query: 574 IKSDVFSFGVLLLEIISG 591
            + DV+S GV+L  ++SG
Sbjct: 192 PEVDVWSLGVILYTLVSG 209

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 94/198 (47%), Gaps = 15/198 (7%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           +G+G F  V     +  GK +AVK + +T  +   LQ+   EV ++  L H N+V+    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    + EY     +  +L    R   +  K  ++    I   + Y H+     I+
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR---MKEKEARAKFRQIVSAVQYCHQKF---IV 135
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFG-GNQNQANTNIIAGTYGYMAPEYAMGGIFS- 573
           HRDLKA N+LLD DMN KI+DFG +  F  GN+  A      G   Y APE   G  +  
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA----FCGAPPYAAPELFQGKKYDG 191
Query: 574 IKSDVFSFGVLLLEIISG 591
            + DV+S GV+L  ++SG
Sbjct: 192 PEVDVWSLGVILYTLVSG 209

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 7/197 (3%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            ++G G FG V+ G   +   +A+K + R      ++F  E  ++ KL H  LV+     
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   ++E+M +  L  +L   T+      +    +   +  G+ YL E     +IH
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 124
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDL A N L+ ++   K+SDFG+ R    +Q  ++T        + +PE      +S KS
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVFSFSRYSSKS 183
Query: 577 DVFSFGVLLLEIISGRK 593
           DV+SFGVL+ E+ S  K
Sbjct: 184 DVWSFGVLMWEVFSEGK 200

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 95/199 (47%), Gaps = 17/199 (8%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           +G+G F  V     +  G+ +A+K + +T  +   LQ+   EV ++  L H N+V+    
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    I EY     +  +L    R   +  K  +S    I   + Y H+    +I+
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCHQK---RIV 133
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIF--GGNQNQANTNIIAGTYGYMAPEYAMGGIFS 573
           HRDLKA N+LLD DMN KI+DFG +  F  GG       +   G+  Y APE   G  + 
Sbjct: 134 HRDLKAENLLLDADMNIKIADFGFSNEFTVGG-----KLDTFCGSPPYAAPELFQGKKYD 188
Query: 574 -IKSDVFSFGVLLLEIISG 591
             + DV+S GV+L  ++SG
Sbjct: 189 GPEVDVWSLGVILYTLVSG 207

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 13/203 (6%)
Query: 396 ENKLGQGGFGPVYKGTLA-DGKA---IAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLV 450
           E  +G G FG V  G L   GK    +A+K L S  + +  ++F +E +++ +  H N++
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                         I E+M N SLD  L       Q    +   ++ GIA G+ YL +  
Sbjct: 98  HLEGVVTKSTPVMIITEFMENGSLDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYLAD-- 153
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN-TNIIAGTYG--YMAPEYA 567
            +  +HRDL A NIL++ ++  K+SDFGL+R    + +    T+ + G     + APE  
Sbjct: 154 -MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 212
Query: 568 MGGIFSIKSDVFSFGVLLLEIIS 590
               F+  SDV+S+G+++ E++S
Sbjct: 213 QYRKFTSASDVWSYGIVMWEVMS 235

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 11/205 (5%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGK-AIAVKRLS-RTSGQGLQEFKNEVNLIAKLQHKNLV 450
           F+  +++G+G FG VYKG     K  +A+K +    +   +++ + E+ ++++     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
           R             I EY+   S      D  +   L+     +I+  I +G+ YLH + 
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSA----LDLLKPGPLEETYIATILREILKGLDYLHSER 136
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
           +   IHRD+KA+N+LL +  + K++DFG+A        Q   N   GT  +MAPE     
Sbjct: 137 K---IHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNXFVGTPFWMAPEVIKQS 191
Query: 571 IFSIKSDVFSFGVLLLEIISGRKNN 595
            +  K+D++S G+  +E+  G   N
Sbjct: 192 AYDFKADIWSLGITAIELAKGEPPN 216

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           +G+G F  V     +  G+ +A+K + +T  +   LQ+   EV ++  L H N+V+    
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    I EY     +  +L    R   +  K  +S    I   + Y H+    +I+
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCHQK---RIV 136
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIF--GGNQNQANTNIIAGTYGYMAPEYAMGGIFS 573
           HRDLKA N+LLD DMN KI+DFG +  F  GG       +   G   Y APE   G  + 
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNEFTVGG-----KLDAFCGAPPYAAPELFQGKKYD 191
Query: 574 -IKSDVFSFGVLLLEIISG 591
             + DV+S GV+L  ++SG
Sbjct: 192 GPEVDVWSLGVILYTLVSG 210

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 27/209 (12%)
Query: 396 ENKLGQGGFGPVYKGTL-ADGK---AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLV 450
           E  +G G FG V  G L   GK    +A+K L    + +  ++F +E +++ +  H N++
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLF--DATRSV-QLDWKRRQSIINGIARGILYLH 507
                         I EYM N SLD  L   D   +V QL       ++ GI  G+ YL 
Sbjct: 94  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL-----VGMLRGIGSGMKYL- 147
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG------Y 561
             S +  +HRDL A NIL++ ++  K+SDFG++R+   +   A T     T G      +
Sbjct: 148 --SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT-----TRGGKIPIRW 200
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
            APE      F+  SDV+S+G+++ E++S
Sbjct: 201 TAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 7/197 (3%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            ++G G FG V+ G   +   +A+K + R      ++F  E  ++ KL H  LV+     
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   ++E+M +  L  +L   T+      +    +   +  G+ YL E     +IH
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 126
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDL A N L+ ++   K+SDFG+ R    +Q  ++T        + +PE      +S KS
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVFSFSRYSSKS 185
Query: 577 DVFSFGVLLLEIISGRK 593
           DV+SFGVL+ E+ S  K
Sbjct: 186 DVWSFGVLMWEVFSEGK 202

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 102/216 (47%), Gaps = 34/216 (15%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNL--IAKLQHKNLVR----- 451
           +G+G +G VYKG+L D + +AVK  S  + Q    F NE N+  +  ++H N+ R     
Sbjct: 21  IGRGRYGAVYKGSL-DERPVAVKVFSFANRQN---FINEKNIYRVPLMEHDNIARFIVGD 76
Query: 452 XXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-- 509
                        + EY PN SL  +L   T     DW     + + + RG+ YLH +  
Sbjct: 77  ERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAYLHTELP 132
Query: 510 ----SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ-----NQANTNII-AGTY 559
                +  I HRDL + N+L+ +D    ISDFGL+    GN+      + N  I   GT 
Sbjct: 133 RGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTI 192
Query: 560 GYMAPEYAMGGI------FSIKS-DVFSFGVLLLEI 588
            YMAPE   G +       ++K  D+++ G++  EI
Sbjct: 193 RYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 7/197 (3%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            ++G G FG V+ G   +   +A+K + R      ++F  E  ++ KL H  LV+     
Sbjct: 16  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   ++E+M +  L  +L   T+      +    +   +  G+ YL E     +IH
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 129
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDL A N L+ ++   K+SDFG+ R    +Q  ++T        + +PE      +S KS
Sbjct: 130 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVFSFSRYSSKS 188
Query: 577 DVFSFGVLLLEIISGRK 593
           DV+SFGVL+ E+ S  K
Sbjct: 189 DVWSFGVLMWEVFSEGK 205

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 15/198 (7%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           +G+G F  V     +  GK +AV+ + +T  +   LQ+   EV ++  L H N+V+    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    + EY     +  +L    R   +  K  ++    I   + Y H+     I+
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR---MKEKEARAKFRQIVSAVQYCHQKF---IV 135
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFG-GNQNQANTNIIAGTYGYMAPEYAMGGIFS- 573
           HRDLKA N+LLD DMN KI+DFG +  F  GN+     +   G+  Y APE   G  +  
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGSPPYAAPELFQGKKYDG 191
Query: 574 IKSDVFSFGVLLLEIISG 591
            + DV+S GV+L  ++SG
Sbjct: 192 PEVDVWSLGVILYTLVSG 209

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 90/196 (45%), Gaps = 7/196 (3%)
Query: 397 NKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRXXX 454
            ++G+G FG V+ G L AD   +AVK    T    L+ +F  E  ++ +  H N+VR   
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                     + E +  +  D   F  T   +L  K    ++   A G+ YL        
Sbjct: 180 VCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           IHRDL A N L+ +    KISDFG++R        A+  +      + APE    G +S 
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 575 KSDVFSFGVLLLEIIS 590
           +SDV+SFG+LL E  S
Sbjct: 295 ESDVWSFGILLWETFS 310

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 389 ATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQ 445
           +  +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           H N+V+             ++E++     D    DA+    +     +S +  + +G+ +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKD--FMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
            H     +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y APE
Sbjct: 119 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 173
Query: 566 YAMG-GIFSIKSDVFSFGVLLLEIISGR 592
             +G   +S   D++S G +  E+++ R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 27/209 (12%)
Query: 396 ENKLGQGGFGPVYKGTL-ADGK---AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLV 450
           E  +G G FG V  G L   GK    +A+K L    + +  ++F +E +++ +  H N++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLF--DATRSV-QLDWKRRQSIINGIARGILYLH 507
                         I EYM N SLD  L   D   +V QL       ++ GI  G+ YL 
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL-----VGMLRGIGSGMKYL- 126
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG------Y 561
             S +  +HRDL A NIL++ ++  K+SDFG++R+   +   A T     T G      +
Sbjct: 127 --SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT-----TRGGKIPIRW 179
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
            APE      F+  SDV+S+G+++ E++S
Sbjct: 180 TAPEAIAYRKFTSASDVWSYGIVMWEVMS 208

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 27/209 (12%)
Query: 396 ENKLGQGGFGPVYKGTL-ADGK---AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLV 450
           E  +G G FG V  G L   GK    +A+K L    + +  ++F +E +++ +  H N++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLF--DATRSV-QLDWKRRQSIINGIARGILYLH 507
                         I EYM N SLD  L   D   +V QL       ++ GI  G+ YL 
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL-----VGMLRGIGSGMKYL- 132
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG------Y 561
             S +  +HRDL A NIL++ ++  K+SDFG++R+   +   A T     T G      +
Sbjct: 133 --SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT-----TRGGKIPIRW 185
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
            APE      F+  SDV+S+G+++ E++S
Sbjct: 186 TAPEAIAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+   
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDS 510
                     I E+M   +L  +L +  R    +V L +   Q     I+  + YL + +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-----ISSAMEYLEKKN 338
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
               IHR+L A N L+ ++   K++DFGL+R+  G+   A+         + APE     
Sbjct: 339 ---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYN 394
Query: 571 IFSIKSDVFSFGVLLLEIIS 590
            FSIKSDV++FGVLL EI +
Sbjct: 395 KFSIKSDVWAFGVLLWEIAT 414

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 111/243 (45%), Gaps = 27/243 (11%)
Query: 390 TNHFSDEN-----KLGQGGFGPVYKGTLADGKA----IAVKRL--SRTSGQGLQ-EFKNE 437
           T HF+ ++      LG+G FG VY   LA  K     +A+K L  S+   +G++ + + E
Sbjct: 17  TRHFTIDDFEIGRPLGKGKFGNVY---LAREKKSHFIVALKVLFKSQIEKEGVEHQLRRE 73
Query: 438 VNLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN 497
           + + A L H N++R             I EY P   L   L    +S   D +R  +I+ 
Sbjct: 74  IEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL---QKSCTFDEQRTATIME 130
Query: 498 GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG 557
            +A  ++Y H     K+IHRD+K  N+LL      KI+DFG    +  +        + G
Sbjct: 131 ELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFG----WSVHAPSLRRKTMCG 183
Query: 558 TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLSLS 617
           T  Y+ PE   G + + K D++  GVL  E++ G  N  F  + H +T    V   L   
Sbjct: 184 TLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG--NPPFESASHNETYRRIVKVDLKFP 241
Query: 618 LSL 620
            S+
Sbjct: 242 ASV 244

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 105/209 (50%), Gaps = 11/209 (5%)
Query: 388 EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKL 444
           E   +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +L
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
            H N+V+             ++E++ ++ L     DA+    +     +S +  + +G+ 
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLA 124
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           + H     +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y AP
Sbjct: 125 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAP 179
Query: 565 EYAMG-GIFSIKSDVFSFGVLLLEIISGR 592
           E  +G   +S   D++S G +  E+++ R
Sbjct: 180 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 90/196 (45%), Gaps = 7/196 (3%)
Query: 397 NKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRXXX 454
            ++G+G FG V+ G L AD   +AVK    T    L+ +F  E  ++ +  H N+VR   
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                     + E +  +  D   F  T   +L  K    ++   A G+ YL        
Sbjct: 180 VCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           IHRDL A N L+ +    KISDFG++R        A+  +      + APE    G +S 
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 575 KSDVFSFGVLLLEIIS 590
           +SDV+SFG+LL E  S
Sbjct: 295 ESDVWSFGILLWETFS 310

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+   
Sbjct: 264 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 322
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                     I E+M   +L  +L +  R  +++      +   I+  + YL + +    
Sbjct: 323 VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 378
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           IHR+L A N L+ ++   K++DFGL+R+  G+   A+         + APE      FSI
Sbjct: 379 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNKFSI 437
Query: 575 KSDVFSFGVLLLEIIS 590
           KSDV++FGVLL EI +
Sbjct: 438 KSDVWAFGVLLWEIAT 453

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 11/210 (5%)
Query: 385 LALEATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLS-RTSGQGLQEFKNEVNLIA 442
           ++L+    F+   K+G+G FG V+KG      K +A+K +    +   +++ + E+ +++
Sbjct: 1   MSLDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS 60
Query: 443 KLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG 502
           +     + +             I EY+   S      D      LD  +  +I+  I +G
Sbjct: 61  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKG 116
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYM 562
           + YLH + +   IHRD+KA+N+LL +    K++DFG+A      Q + NT    GT  +M
Sbjct: 117 LDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWM 171
Query: 563 APEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           APE      +  K+D++S G+  +E+  G 
Sbjct: 172 APEVIKQSAYDSKADIWSLGITAIELARGE 201

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 105/209 (50%), Gaps = 11/209 (5%)
Query: 388 EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKL 444
           E   +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +L
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
            H N+V+             ++E++ ++ L     DA+    +     +S +  + +G+ 
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLA 124
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           + H     +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y AP
Sbjct: 125 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAP 179
Query: 565 EYAMG-GIFSIKSDVFSFGVLLLEIISGR 592
           E  +G   +S   D++S G +  E+++ R
Sbjct: 180 EILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 106/211 (50%), Gaps = 11/211 (5%)
Query: 386 ALEATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIA 442
            L +  +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ 
Sbjct: 1   PLGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 443 KLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG 502
           +L H N+V+             ++E++ ++ L     DA+    +     +S +  + +G
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLK-KFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYM 562
           + + H     +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y 
Sbjct: 119 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 173
Query: 563 APEYAMG-GIFSIKSDVFSFGVLLLEIISGR 592
           APE  +G   +S   D++S G +  E+++ R
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 97/196 (49%), Gaps = 10/196 (5%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
           K+GQG  G VY    +A G+ +A+++++       +   NE+ ++ + ++ N+V      
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + EY+   SL     D      +D  +  ++     + + +LH +   ++IH
Sbjct: 87  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RD+K+ NILL  D + K++DFG        Q++ +T  + GT  +MAPE      +  K 
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKV 197
Query: 577 DVFSFGVLLLEIISGR 592
           D++S G++ +E+I G 
Sbjct: 198 DIWSLGIMAIEMIEGE 213

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 391 NHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQHK 447
            +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 448 NLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
           N+V+             ++E++ ++ L     DA+    +     +S +  + +G+ + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
                +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y APE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEIL 175
Query: 568 MG-GIFSIKSDVFSFGVLLLEIISGR 592
           +G   +S   D++S G +  E+++ R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 391 NHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQHK 447
            +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 448 NLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
           N+V+             ++E++ ++ L     DA+    +     +S +  + +G+ + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
                +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEIL 174
Query: 568 MG-GIFSIKSDVFSFGVLLLEIISGR 592
           +G   +S   D++S G +  E+++ R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 15/198 (7%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           +G+G F  V     +  GK +AV+ + +T  +   LQ+   EV ++  L H N+V+    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    + EY     +  +L    R   +  K  ++    I   + Y H+     I+
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR---MKEKEARAKFRQIVSAVQYCHQKF---IV 135
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFG-GNQNQANTNIIAGTYGYMAPEYAMGGIFS- 573
           HRDLKA N+LLD DMN KI+DFG +  F  GN+     +   G+  Y APE   G  +  
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDEFCGSPPYAAPELFQGKKYDG 191
Query: 574 IKSDVFSFGVLLLEIISG 591
            + DV+S GV+L  ++SG
Sbjct: 192 PEVDVWSLGVILYTLVSG 209

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 95/201 (47%), Gaps = 21/201 (10%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           +G+G F  V     +  GK +AVK + +T  +   LQ+   EV ++  L H N+V+    
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDW---KRRQSIINGIARGILYLHEDSRL 512
                    + EY     +    FD    V   W   K  ++    I   + Y H+    
Sbjct: 75  IETEKTLYLVMEYASGGEV----FDYL--VAHGWMKEKEARAKFRQIVSAVQYCHQKF-- 126
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFG-GNQNQANTNIIAGTYGYMAPEYAMGGI 571
            I+HRDLKA N+LLD DMN KI+DFG +  F  GN+     +   G+  Y APE   G  
Sbjct: 127 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGSPPYAAPELFQGKK 181
Query: 572 FS-IKSDVFSFGVLLLEIISG 591
           +   + DV+S GV+L  ++SG
Sbjct: 182 YDGPEVDVWSLGVILYTLVSG 202

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 399 LGQGGFGPVYKGTLADGKAI-AVKRLSRTSGQ--GLQ-EFKNEVNLIAKLQHKNLVRXXX 454
           LG+G FG VY       K I A+K L +T  +  G++ + + EV + + L+H N++R   
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                     I EY P  ++   L   +R    D +R  + I  +A  + Y H     ++
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSR---FDEQRTATYITELANALSYCHSK---RV 133
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           IHRD+K  N+LL  +   KI+DFG    +  +   +  + + GT  Y+ PE   G +   
Sbjct: 134 IHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDE 189
Query: 575 KSDVFSFGVLLLEIISG 591
           K D++S GVL  E + G
Sbjct: 190 KVDLWSLGVLCYEFLVG 206

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 396 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRX 452
           +  +G+G F  V     +  G+ +AVK + +T  +   LQ+   EV ++  L H N+V+ 
Sbjct: 20  QKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 453 XXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                       + EY     +  +L    R   +  K  ++    I   + Y H+    
Sbjct: 80  FEVIETEKTLYLVMEYASGGEVFDYLVAHGR---MKEKEARAKFRQIVSAVQYCHQKY-- 134
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFG-GNQNQANTNIIAGTYGYMAPEYAMGGI 571
            I+HRDLKA N+LLD DMN KI+DFG +  F  GN+     +   G+  Y APE   G  
Sbjct: 135 -IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNK----LDTFCGSPPYAAPELFQGKK 189
Query: 572 FS-IKSDVFSFGVLLLEIISG 591
           +   + DV+S GV+L  ++SG
Sbjct: 190 YDGPEVDVWSLGVILYTLVSG 210

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 13/208 (6%)
Query: 391 NHFSDENKLGQGGFGPV---YKGTLAD--GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ 445
            H    ++LG+G FG V       L D  G  +AVK+L  +     ++F+ E+ ++  L 
Sbjct: 7   RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 66
Query: 446 HKNLV--RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
              +V  R             + EY+P+  L    F      +LD  R     + I +G+
Sbjct: 67  SDFIVKYRGVSYGPGRPELRLVMEYLPSGCL--RDFLQRHRARLDASRLLLYSSQICKGM 124
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA-GTYGYM 562
            YL   SR + +HRDL A NIL++ + + KI+DFGLA++   +++             + 
Sbjct: 125 EYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWY 181
Query: 563 APEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           APE     IFS +SDV+SFGV+L E+ +
Sbjct: 182 APESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 389 ATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQ 445
           +  +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           H N+V+             ++E++ ++ L     DA+    +     +S +  + +G+ +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
            H     +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y APE
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPE 174
Query: 566 YAMG-GIFSIKSDVFSFGVLLLEIISGR 592
             +G   +S   D++S G +  E+++ R
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 389 ATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQ 445
           +  +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           H N+V+             ++E++ ++ L   + DA+    +     +S +  + +G+ +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
            H     +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y APE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 176
Query: 566 YAMG-GIFSIKSDVFSFGVLLLEIISGR 592
             +G   +S   D++S G +  E+++ R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 106/211 (50%), Gaps = 11/211 (5%)
Query: 386 ALEATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIA 442
            L +  +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ 
Sbjct: 2   PLGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 61
Query: 443 KLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG 502
           +L H N+V+             ++E++ ++ L     DA+    +     +S +  + +G
Sbjct: 62  ELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLK-KFMDASALTGIPLPLIKSYLFQLLQG 119
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYM 562
           + + H     +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y 
Sbjct: 120 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 174
Query: 563 APEYAMG-GIFSIKSDVFSFGVLLLEIISGR 592
           APE  +G   +S   D++S G +  E+++ R
Sbjct: 175 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 391 NHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQHK 447
            +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 448 NLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
           N+V+             ++E++ ++ L     DA+    +     +S +  + +G+ + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
                +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEIL 174
Query: 568 MG-GIFSIKSDVFSFGVLLLEIISGR 592
           +G   +S   D++S G +  E+++ R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 391 NHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQHK 447
            +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 448 NLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
           N+V+             ++E++ ++ L     DA+    +     +S +  + +G+ + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
                +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y APE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEIL 175
Query: 568 MG-GIFSIKSDVFSFGVLLLEIISGR 592
           +G   +S   D++S G +  E+++ R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 104/222 (46%), Gaps = 23/222 (10%)
Query: 382 PLRLALEATNHFSDENK----LGQGGFGPVY--KGTLADGKAIAVKRLSR---TSGQGLQ 432
           P      +T  FSD  K    LG+G FG V   K  +  G+  AVK +S+         +
Sbjct: 19  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKE 77
Query: 433 EFKNEVNLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRR 492
               EV L+ +L H N+++             + E      L   +    R  ++D  R 
Sbjct: 78  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR- 136
Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFGGNQNQ 549
             II  +  GI Y+H++   KI+HRDLK  N+LL+    D N +I DFGL+  F  ++  
Sbjct: 137 --IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 191
Query: 550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
            +     GT  Y+APE  + G +  K DV+S GV+L  ++SG
Sbjct: 192 KDK---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 389 ATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQ 445
           +  +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           H N+V+             ++E++ ++ L     DA+    +     +S +  + +G+ +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
            H     +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y APE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 173
Query: 566 YAMG-GIFSIKSDVFSFGVLLLEIISGR 592
             +G   +S   D++S G +  E+++ R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 399 LGQGGFGPVYKGTLADGKAI-AVKRLSRTSGQ--GLQ-EFKNEVNLIAKLQHKNLVRXXX 454
           LG+G FG VY       K I A+K L +T  +  G++ + + EV + + L+H N++R   
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                     I EY P  ++   L   +R    D +R  + I  +A  + Y H     ++
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSR---FDEQRTATYITELANALSYCHSK---RV 133
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           IHRD+K  N+LL  +   KI+DFG    +  +   +    + GT  Y+ PE   G +   
Sbjct: 134 IHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE 189
Query: 575 KSDVFSFGVLLLEIISG 591
           K D++S GVL  E + G
Sbjct: 190 KVDLWSLGVLCYEFLVG 206

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 92/198 (46%), Gaps = 11/198 (5%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXXXXX 456
           LG+G +G V         +A+AVK +         E  K E+ + A L H+N+V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                     EY     L    FD     + +     Q   + +  G++YLH    + I 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRD+K  N+LLD+  N KISDFGLA +F  N  +   N + GT  Y+APE      F  +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 576 S-DVFSFGVLLLEIISGR 592
             DV+S G++L  +++G 
Sbjct: 188 PVDVWSCGIVLTAMLAGE 205

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQHKNLVRXXXX 455
           K+G+G +G VYK     G+  A+K++      +G+      E++++ +L+H N+V+    
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    ++E++ ++ L   L D      L+    +S +  +  GI Y H+    +++
Sbjct: 69  IHTKKRLVLVFEHL-DQDLK-KLLDVCEG-GLESVTAKSFLLQLLNGIAYCHDR---RVL 122
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSI 574
           HRDLK  N+L++ +   KI+DFGLAR FG    +    I+  T  Y AP+  MG   +S 
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDVLMGSKKYST 180
Query: 575 KSDVFSFGVLLLEIISG 591
             D++S G +  E+++G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 104/207 (50%), Gaps = 13/207 (6%)
Query: 391 NHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQHK 447
            +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 448 NLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLF-DATRSVQLDWKRRQSIINGIARGILYL 506
           N+V+             ++E++     D+  F DA+    +     +S +  + +G+ + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQ---DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H     +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y APE 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEI 173
Query: 567 AMG-GIFSIKSDVFSFGVLLLEIISGR 592
            +G   +S   D++S G +  E+++ R
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 389 ATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQ 445
           +  +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           H N+V+             ++E++ ++ L     DA+    +     +S +  + +G+ +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
            H     +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y APE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 173
Query: 566 YAMG-GIFSIKSDVFSFGVLLLEIISGR 592
             +G   +S   D++S G +  E+++ R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 391 NHFSDENKLGQGGFGPV---YKGTLAD--GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ 445
            H    ++LG+G FG V       L D  G  +AVK+L  +     ++F+ E+ ++  L 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 446 HKNLV--RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
              +V  R             + EY+P+  L    F      +LD  R     + I +G+
Sbjct: 83  SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCL--RDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN------QANTNIIAG 557
            YL   SR + +HRDL A NIL++ + + KI+DFGLA++   +++         + I   
Sbjct: 141 EYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF-- 195
Query: 558 TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
              + APE     IFS +SDV+SFGV+L E+ +
Sbjct: 196 ---WYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 389 ATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQ 445
           +  +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           H N+V+             ++E++ ++ L     DA+    +     +S +  + +G+ +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
            H     +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y APE
Sbjct: 121 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 175
Query: 566 YAMG-GIFSIKSDVFSFGVLLLEIISGR 592
             +G   +S   D++S G +  E+++ R
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 391 NHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQHK 447
            +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 448 NLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
           N+V+             ++E++ ++ L     DA+    +     +S +  + +G+ + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
                +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y APE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEIL 175
Query: 568 MG-GIFSIKSDVFSFGVLLLEIISGR 592
           +G   +S   D++S G +  E+++ R
Sbjct: 176 LGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 391 NHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQHK 447
            +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +L H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 448 NLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
           N+V+             ++E++ ++ L     DA+    +     +S +  + +G+ + H
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
                +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y APE  
Sbjct: 125 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEIL 179
Query: 568 MG-GIFSIKSDVFSFGVLLLEIISGR 592
           +G   +S   D++S G +  E+++ R
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 391 NHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQHK 447
            +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 448 NLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
           N+V+             ++E++ ++ L     DA+    +     +S +  + +G+ + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
                +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y APE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEIL 175
Query: 568 MG-GIFSIKSDVFSFGVLLLEIISGR 592
           +G   +S   D++S G +  E+++ R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 389 ATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQ 445
           +  +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           H N+V+             ++E++ ++ L     DA+    +     +S +  + +G+ +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
            H     +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y APE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 175
Query: 566 YAMG-GIFSIKSDVFSFGVLLLEIISGR 592
             +G   +S   D++S G +  E+++ R
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 391 NHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQHK 447
            +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 448 NLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
           N+V+             ++E++ ++ L     DA+    +     +S +  + +G+ + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
                +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEIL 174
Query: 568 MG-GIFSIKSDVFSFGVLLLEIISGR 592
           +G   +S   D++S G +  E+++ R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 389 ATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQ 445
           +  +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           H N+V+             ++E++ ++ L     DA+    +     +S +  + +G+ +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
            H     +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y APE
Sbjct: 120 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 174
Query: 566 YAMG-GIFSIKSDVFSFGVLLLEIISGR 592
             +G   +S   D++S G +  E+++ R
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 391 NHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQHK 447
            +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 448 NLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
           N+V+             ++E++ ++ L     DA+    +     +S +  + +G+ + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
                +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEIL 174
Query: 568 MG-GIFSIKSDVFSFGVLLLEIISGR 592
           +G   +S   D++S G +  E+++ R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 389 ATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQ 445
           +  +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           H N+V+             ++E++ ++ L     DA+    +     +S +  + +G+ +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
            H     +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y APE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 175
Query: 566 YAMG-GIFSIKSDVFSFGVLLLEIISGR 592
             +G   +S   D++S G +  E+++ R
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 11/201 (5%)
Query: 396 ENKLGQGGFGPVYKGTLA-DGK---AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLV 450
           E  +G G FG V  G L   GK   A+A+K L    + +  ++F  E +++ +  H N+V
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                         + E+M N +LD  L       Q    +   ++ GIA G+ YL +  
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFL--RKHDGQFTVIQLVGMLRGIAAGMRYLAD-- 163
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG-TYGYMAPEYAMG 569
            +  +HRDL A NIL++ ++  K+SDFGL+R+   +     T         + APE    
Sbjct: 164 -MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQY 222
Query: 570 GIFSIKSDVFSFGVLLLEIIS 590
             F+  SDV+S+G+++ E++S
Sbjct: 223 RKFTSASDVWSYGIVMWEVMS 243

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 105/209 (50%), Gaps = 13/209 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQ 445
           +  +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLF-DATRSVQLDWKRRQSIINGIARGIL 504
           H N+V+             ++E++     D+  F DA+    +     +S +  + +G+ 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           + H     +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y AP
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 565 EYAMG-GIFSIKSDVFSFGVLLLEIISGR 592
           E  +G   +S   D++S G +  E+++ R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 389 ATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQ 445
           +  +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           H N+V+             ++E++ ++ L     DA+    +     +S +  + +G+ +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
            H     +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y APE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 173
Query: 566 YAMG-GIFSIKSDVFSFGVLLLEIISGR 592
             +G   +S   D++S G +  E+++ R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 92/197 (46%), Gaps = 7/197 (3%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            ++G G FG V+ G   +   +A+K + R      ++F  E  ++ KL H  LV+     
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + E+M +  L  +L   T+      +    +   +  G+ YL E     +IH
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDL A N L+ ++   K+SDFG+ R    +Q  ++T        + +PE      +S KS
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVFSFSRYSSKS 186
Query: 577 DVFSFGVLLLEIISGRK 593
           DV+SFGVL+ E+ S  K
Sbjct: 187 DVWSFGVLMWEVFSEGK 203

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 15/206 (7%)
Query: 398 KLGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
           K+G+G  G V        G+ +AVK +     Q  +   NEV ++   QH N+V      
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + E++   +L     D    V+L+ ++  ++   + + + YLH      +IH
Sbjct: 112 LVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIH 164
Query: 517 RDLKASNILLDDDMNPKISDFGL-ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           RD+K+ +ILL  D   K+SDFG  A+I   +++      + GT  +MAPE     +++ +
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKXLVGTPYWMAPEVISRSLYATE 221
Query: 576 SDVFSFGVLLLEIISGRKNNGFYFSE 601
            D++S G++++E++ G      YFS+
Sbjct: 222 VDIWSLGIMVIEMVDGEPP---YFSD 244

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 389 ATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQ 445
           +  +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           H N+V+             ++E++ ++ L     DA+    +     +S +  + +G+ +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
            H     +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y APE
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 174
Query: 566 YAMG-GIFSIKSDVFSFGVLLLEIISGR 592
             +G   +S   D++S G +  E+++ R
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 98/197 (49%), Gaps = 10/197 (5%)
Query: 397 NKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
            KLG+G +G VYK    + G+ +A+K++   S   LQE   E++++ +    ++V+    
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    + EY    S  V      R+  L      +I+    +G+ YLH    ++ I
Sbjct: 93  YFKNTDLWIVMEYCGAGS--VSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKI 147
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRD+KA NILL+ + + K++DFG+A         A  N + GT  +MAPE      ++  
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVAGQL--TDXMAKRNXVIGTPFWMAPEVIQEIGYNCV 205
Query: 576 SDVFSFGVLLLEIISGR 592
           +D++S G+  +E+  G+
Sbjct: 206 ADIWSLGITAIEMAEGK 222

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 389 ATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQ 445
           +  +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           H N+V+             ++E++ ++ L     DA+    +     +S +  + +G+ +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
            H     +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y APE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 176
Query: 566 YAMG-GIFSIKSDVFSFGVLLLEIISGR 592
             +G   +S   D++S G +  E+++ R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 100/210 (47%), Gaps = 11/210 (5%)
Query: 385 LALEATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLS-RTSGQGLQEFKNEVNLIA 442
           ++L+    F+   K+G+G FG V+KG      K +A+K +    +   +++ + E+ +++
Sbjct: 1   MSLDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS 60
Query: 443 KLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG 502
           +     + +             I EY+   S      D      LD  +  +I+  I +G
Sbjct: 61  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKG 116
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYM 562
           + YLH + +   IHRD+KA+N+LL +    K++DFG+A        Q   N   GT  +M
Sbjct: 117 LDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNXFVGTPFWM 171
Query: 563 APEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           APE      +  K+D++S G+  +E+  G 
Sbjct: 172 APEVIKQSAYDSKADIWSLGITAIELARGE 201

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 391 NHFSDENKLGQGGFGPV---YKGTLAD--GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ 445
            H    ++LG+G FG V       L D  G  +AVK+L  +     ++F+ E+ ++  L 
Sbjct: 10  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 69
Query: 446 HKNLV--RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
              +V  R             + EY+P+  L    F      +LD  R     + I +G+
Sbjct: 70  SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCL--RDFLQRHRARLDASRLLLYSSQICKGM 127
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN------QANTNIIAG 557
            YL   SR + +HRDL A NIL++ + + KI+DFGLA++   +++         + I   
Sbjct: 128 EYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF-- 182
Query: 558 TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
              + APE     IFS +SDV+SFGV+L E+ +
Sbjct: 183 ---WYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 391 NHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQHK 447
            +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 448 NLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
           N+V+             ++E++ ++ L     DA+    +     +S +  + +G+ + H
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
                +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y APE  
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEIL 176
Query: 568 MG-GIFSIKSDVFSFGVLLLEIISGR 592
           +G   +S   D++S G +  E+++ R
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 391 NHFSDENKLGQGGFGPV---YKGTLAD--GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ 445
            H    ++LG+G FG V       L D  G  +AVK+L  +     ++F+ E+ ++  L 
Sbjct: 11  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 70
Query: 446 HKNLV--RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
              +V  R             + EY+P+  L    F      +LD  R     + I +G+
Sbjct: 71  SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCL--RDFLQRHRARLDASRLLLYSSQICKGM 128
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN------QANTNIIAG 557
            YL   SR + +HRDL A NIL++ + + KI+DFGLA++   +++         + I   
Sbjct: 129 EYL--GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF-- 183
Query: 558 TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
              + APE     IFS +SDV+SFGV+L E+ +
Sbjct: 184 ---WYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQHKNLVRXXXX 455
           K+G+G +G VYK     G+  A+K++      +G+      E++++ +L+H N+V+    
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    ++E++ ++ L   L D      L+    +S +  +  GI Y H+    +++
Sbjct: 69  IHTKKRLVLVFEHL-DQDLK-KLLDVCEG-GLESVTAKSFLLQLLNGIAYCHDR---RVL 122
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSI 574
           HRDLK  N+L++ +   KI+DFGLAR FG    +    ++  T  Y AP+  MG   +S 
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV--TLWYRAPDVLMGSKKYST 180
Query: 575 KSDVFSFGVLLLEIISG 591
             D++S G +  E+++G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQHKNLVRXXXX 455
           K+G+G +G VYK     G+  A+K++      +G+      E++++ +L+H N+V+    
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    ++E++ ++ L   L D      L+    +S +  +  GI Y H+    +++
Sbjct: 69  IHTKKRLVLVFEHL-DQDLK-KLLDVCEG-GLESVTAKSFLLQLLNGIAYCHDR---RVL 122
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSI 574
           HRDLK  N+L++ +   KI+DFGLAR FG    +    ++  T  Y AP+  MG   +S 
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV--TLWYRAPDVLMGSKKYST 180
Query: 575 KSDVFSFGVLLLEIISG 591
             D++S G +  E+++G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 98/228 (42%), Gaps = 23/228 (10%)
Query: 399 LGQGGFGPVYKGTLADGK------AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVR 451
           LG G FG VY+G ++          +AVK L    S Q   +F  E  +I+KL H+N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 452 XXXXXXXXXXXXXIYEYMPNKSLDVHLFD----ATRSVQLDWKRRQSIINGIARGILYLH 507
                        + E M    L   L +     ++   L       +   IA G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 508 EDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           E+     IHRD+ A N LL         KI DFG+AR                   +M P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF--YFSEHGQTLLTYV 610
           E  M GIF+ K+D +SFGVLL EI S     G+  Y S+  Q +L +V
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSNQEVLEFV 259

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 98/228 (42%), Gaps = 23/228 (10%)
Query: 399 LGQGGFGPVYKGTLADGK------AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVR 451
           LG G FG VY+G ++          +AVK L    S Q   +F  E  +I+KL H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 452 XXXXXXXXXXXXXIYEYMPNKSLDVHLFD----ATRSVQLDWKRRQSIINGIARGILYLH 507
                        + E M    L   L +     ++   L       +   IA G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 508 EDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           E+     IHRD+ A N LL         KI DFG+AR                   +M P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF--YFSEHGQTLLTYV 610
           E  M GIF+ K+D +SFGVLL EI S     G+  Y S+  Q +L +V
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSNQEVLEFV 273

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 98/197 (49%), Gaps = 12/197 (6%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
           K+GQG  G VY    +A G+ +A+++++       +   NE+ ++ + ++ N+V      
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + EY+   SL     D      +D  +  ++     + + +LH +   ++IH
Sbjct: 88  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 140
Query: 517 RDLKASNILLDDDMNPKISDFGL-ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           RD+K+ NILL  D + K++DFG  A+I      Q+  + + GT  +MAPE      +  K
Sbjct: 141 RDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSXMVGTPYWMAPEVVTRKAYGPK 197
Query: 576 SDVFSFGVLLLEIISGR 592
            D++S G++ +E+I G 
Sbjct: 198 VDIWSLGIMAIEMIEGE 214

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKL 444
             F     LG G FG VYKG  + +G+     +A+K L   TS +  +E  +E  ++A +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING---IAR 501
            + ++ R             I + MP   L     D  R  + D    Q ++N    IA+
Sbjct: 69  DNPHVCRLLGICLTSTVQL-ITQLMPFGCL----LDYVREHK-DNIGSQYLLNWCVQIAK 122
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ YL ED RL  +HRDL A N+L+    + KI+DFGLA++ G  + + +         +
Sbjct: 123 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 20/222 (9%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKL 444
             F     LG G FG VYKG  + +G+     +A+K L   TS +  +E  +E  ++A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIAR 501
            + ++ R             I + MP   L     D  R  + D    Q ++N    IA+
Sbjct: 75  DNPHVCRLLGICLTSTVQL-IMQLMPFGCL----LDYVREHK-DNIGSQYLLNWCVQIAK 128
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ YL ED RL  +HRDL A N+L+    + KI+DFGLA++ G  + + +         +
Sbjct: 129 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS--GRKNNGFYFSE 601
           MA E  +  I++ +SDV+S+GV + E+++   +  +G   SE
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 92/197 (46%), Gaps = 7/197 (3%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            ++G G FG V+ G   +   +A+K +   S     +F  E  ++ KL H  LV+     
Sbjct: 33  QEIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   ++E+M +  L  +L   T+      +    +   +  G+ YL E     +IH
Sbjct: 92  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 146
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDL A N L+ ++   K+SDFG+ R    +Q  ++T        + +PE      +S KS
Sbjct: 147 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVFSFSRYSSKS 205
Query: 577 DVFSFGVLLLEIISGRK 593
           DV+SFGVL+ E+ S  K
Sbjct: 206 DVWSFGVLMWEVFSEGK 222

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 93/199 (46%), Gaps = 16/199 (8%)
Query: 399 LGQGGFGPVYK-GTLADGKAIAVKRLSRTSGQG--LQEFKNEVNLIAKLQHKNLVRXXXX 455
           LG+G FG V K       +  AVK +++ S +         EV L+ KL H N+++    
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    + E      L   +    R  + D  R   II  +  GI Y+H+ +   I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN---IV 143
Query: 516 HRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
           HRDLK  NILL   + D + KI DFGL+  F  N    +     GT  Y+APE  + G +
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPE-VLRGTY 199
Query: 573 SIKSDVFSFGVLLLEIISG 591
             K DV+S GV+L  ++SG
Sbjct: 200 DEKCDVWSAGVILYILLSG 218

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 98/197 (49%), Gaps = 12/197 (6%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
           K+GQG  G VY    +A G+ +A+++++       +   NE+ ++ + ++ N+V      
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + EY+   SL     D      +D  +  ++     + + +LH +   ++IH
Sbjct: 87  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 517 RDLKASNILLDDDMNPKISDFGL-ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           RD+K+ NILL  D + K++DFG  A+I      Q+  + + GT  +MAPE      +  K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSXMVGTPYWMAPEVVTRKAYGPK 196
Query: 576 SDVFSFGVLLLEIISGR 592
            D++S G++ +E+I G 
Sbjct: 197 VDIWSLGIMAIEMIEGE 213

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 93/199 (46%), Gaps = 16/199 (8%)
Query: 399 LGQGGFGPVYK-GTLADGKAIAVKRLSRTSGQG--LQEFKNEVNLIAKLQHKNLVRXXXX 455
           LG+G FG V K       +  AVK +++ S +         EV L+ KL H N+++    
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    + E      L   +    R  + D  R   II  +  GI Y+H+ +   I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN---IV 143
Query: 516 HRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
           HRDLK  NILL   + D + KI DFGL+  F  N    +     GT  Y+APE  + G +
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPE-VLRGTY 199
Query: 573 SIKSDVFSFGVLLLEIISG 591
             K DV+S GV+L  ++SG
Sbjct: 200 DEKCDVWSAGVILYILLSG 218

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKL 444
             F     LG G FG VYKG  + +G+     +A+K L   TS +  +E  +E  ++A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING---IAR 501
            + ++ R             I + MP   L     D  R  + D    Q ++N    IA+
Sbjct: 75  DNPHVCRLLGICLTSTVQL-ITQLMPFGCL----LDYVREHK-DNIGSQYLLNWCVQIAK 128
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ YL ED RL  +HRDL A N+L+    + KI+DFGLA++ G  + + +         +
Sbjct: 129 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 20/222 (9%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKL 444
             F     LG G FG VYKG  + +G+     +A+K L   TS +  +E  +E  ++A +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIAR 501
            + ++ R             I + MP   L     D  R  + D    Q ++N    IA+
Sbjct: 76  DNPHVCRLLGICLTSTVQL-IMQLMPFGCL----LDYVREHK-DNIGSQYLLNWCVQIAK 129
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ YL ED RL  +HRDL A N+L+    + KI+DFGLA++ G  + + +         +
Sbjct: 130 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS--GRKNNGFYFSE 601
           MA E  +  I++ +SDV+S+GV + E+++   +  +G   SE
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 228

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 389 ATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQ 445
           +  +F    K+G+G +G VYK      G+ +A+K++   T  +G+      E++L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           H N+V+             ++E++ ++ L     DA+    +     +S +  + +G+ +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHV-DQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
            H     +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y APE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 176
Query: 566 YAMG-GIFSIKSDVFSFGVLLLEIISGR 592
             +G   +S   D++S G +  E+++ R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 11/209 (5%)
Query: 386 ALEATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLS-RTSGQGLQEFKNEVNLIAK 443
           +++    F+   K+G+G FG V+KG      K +A+K +    +   +++ + E+ ++++
Sbjct: 22  SMDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ 81
Query: 444 LQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
                + +             I EY+   S      D      LD  +  +I+  I +G+
Sbjct: 82  CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGL 137
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            YLH + +   IHRD+KA+N+LL +    K++DFG+A      Q + NT    GT  +MA
Sbjct: 138 DYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMA 192
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           PE      +  K+D++S G+  +E+  G 
Sbjct: 193 PEVIKQSAYDSKADIWSLGITAIELARGE 221

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 14/208 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNEVNLIAKL 444
           A   F     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +H N++R             I EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +  + + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDTLCGTLDYLPP 176
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E   G +   K D++S GVL  E + G+
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 399 LGQGGFGPVYK-GTLADGKAIAVKRL---SRTSGQGLQEFKNEVNLIAKLQHKNLVR--X 452
           +G G +G   K    +DGK +  K L   S T  +  Q   +EVNL+ +L+H N+VR   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKHPNIVRYYD 72
Query: 453 XXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGILYLHE--D 509
                       + EY     L   +   T+  Q LD +    ++  +   +   H   D
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 569
               ++HRDLK +N+ LD   N K+ DFGLARI   + + A T    GT  YM+PE    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNR 190
Query: 570 GIFSIKSDVFSFGVLLLEI 588
             ++ KSD++S G LL E+
Sbjct: 191 MSYNEKSDIWSLGCLLYEL 209

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 20/222 (9%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKL 444
             F     LG G FG VYKG  + +G+     +A+K L   TS +  +E  +E  ++A +
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIAR 501
            + ++ R             I + MP   L     D  R  + D    Q ++N    IA+
Sbjct: 81  DNPHVCRLLGICLTSTVQL-ITQLMPFGCL----LDYVREHK-DNIGSQYLLNWCVQIAK 134
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ YL ED RL  +HRDL A N+L+    + KI+DFGLA++ G  + + +         +
Sbjct: 135 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 191
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS--GRKNNGFYFSE 601
           MA E  +  I++ +SDV+S+GV + E+++   +  +G   SE
Sbjct: 192 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 233

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKL 444
             F     LG G FG VYKG  + +G+     +A+K L   TS +  +E  +E  ++A +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIAR 501
            + ++ R             I + MP   L     D  R  + D    Q ++N    IA+
Sbjct: 76  DNPHVCRLLGICLTSTVQL-IMQLMPFGXL----LDYVREHK-DNIGSQYLLNWCVQIAK 129
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ YL ED RL  +HRDL A N+L+    + KI+DFGLA++ G  + + +         +
Sbjct: 130 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 104/222 (46%), Gaps = 23/222 (10%)
Query: 382 PLRLALEATNHFSDENK----LGQGGFGPVY--KGTLADGKAIAVKRLSR---TSGQGLQ 432
           P      +T  FSD  K    LG+G FG V   K  +  G+  AVK +S+         +
Sbjct: 13  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKE 71
Query: 433 EFKNEVNLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRR 492
               EV L+ +L H N+++             + E      L   +    R  ++D  R 
Sbjct: 72  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR- 130
Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFGGNQNQ 549
             II  +  GI Y+H++   KI+HRDLK  N+LL+    D N +I DFGL+  F  ++  
Sbjct: 131 --IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185
Query: 550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
            +     GT  Y+APE  + G +  K DV+S GV+L  ++SG
Sbjct: 186 KDK---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 13/203 (6%)
Query: 396 ENKLGQGGFGPVYKGTLA-DGKA---IAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLV 450
           E  +G G FG V  G L   GK    +A+K L S  + +  ++F +E +++ +  H N++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                         I E+M N SLD  L       Q    +   ++ GIA G+ YL +  
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYLAD-- 127
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN-TNIIAGTYG--YMAPEYA 567
            +  +HR L A NIL++ ++  K+SDFGL+R    + +    T+ + G     + APE  
Sbjct: 128 -MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 186
Query: 568 MGGIFSIKSDVFSFGVLLLEIIS 590
               F+  SDV+S+G+++ E++S
Sbjct: 187 QYRKFTSASDVWSYGIVMWEVMS 209

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKL 444
             F     LG G FG VYKG  + +G+     +A+K L   TS +  +E  +E  ++A +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIAR 501
            + ++ R             I + MP   L     D  R  + D    Q ++N    IA+
Sbjct: 78  DNPHVCRLLGICLTSTVQL-IMQLMPFGCL----LDYVREHK-DNIGSQYLLNWCVQIAK 131
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ YL ED RL  +HRDL A N+L+    + KI+DFGLA++ G  + + +         +
Sbjct: 132 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 20/222 (9%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKL 444
             F     LG G FG VYKG  + +G+     +A+K L   TS +  +E  +E  ++A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIAR 501
            + ++ R             I + MP   L     D  R  + D    Q ++N    IA+
Sbjct: 75  DNPHVCRLLGICLTSTVQL-ITQLMPFGCL----LDYVREHK-DNIGSQYLLNWCVQIAK 128
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ YL ED RL  +HRDL A N+L+    + KI+DFGLA++ G  + + +         +
Sbjct: 129 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS--GRKNNGFYFSE 601
           MA E  +  I++ +SDV+S+GV + E+++   +  +G   SE
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 20/222 (9%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKL 444
             F     LG G FG VYKG  + +G+     +A+K L   TS +  +E  +E  ++A +
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIAR 501
            + ++ R             I + MP   L     D  R  + D    Q ++N    IA+
Sbjct: 85  DNPHVCRLLGICLTSTVQL-ITQLMPFGCL----LDYVREHK-DNIGSQYLLNWCVQIAK 138
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ YL ED RL  +HRDL A N+L+    + KI+DFGLA++ G  + + +         +
Sbjct: 139 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 195
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS--GRKNNGFYFSE 601
           MA E  +  I++ +SDV+S+GV + E+++   +  +G   SE
Sbjct: 196 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 237

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKL 444
             F     LG G FG VYKG  + +G+     +A+K L   TS +  +E  +E  ++A +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIAR 501
            + ++ R             I + MP   L     D  R  + D    Q ++N    IA+
Sbjct: 77  DNPHVCRLLGICLTSTVQL-IMQLMPFGCL----LDYVREHK-DNIGSQYLLNWCVQIAK 130
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ YL ED RL  +HRDL A N+L+    + KI+DFGLA++ G  + + +         +
Sbjct: 131 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 20/222 (9%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKL 444
             F     LG G FG VYKG  + +G+     +A+K L   TS +  +E  +E  ++A +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIAR 501
            + ++ R             I + MP   L     D  R  + D    Q ++N    IA+
Sbjct: 79  DNPHVCRLLGICLTSTVQL-IMQLMPFGCL----LDYVREHK-DNIGSQYLLNWCVQIAK 132
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ YL ED RL  +HRDL A N+L+    + KI+DFGLA++ G  + + +         +
Sbjct: 133 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 189
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS--GRKNNGFYFSE 601
           MA E  +  I++ +SDV+S+GV + E+++   +  +G   SE
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 231

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 397 NKLGQGGFGPVYKGT--LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRX 452
           +KLG+G +  VYKG   L D   +A+K  RL    G      + EV+L+  L+H N+V  
Sbjct: 8   DKLGEGTYATVYKGKSKLTDN-LVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTL 65
Query: 453 XXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                       ++EY+ +K L  +L D    + +     +  +  + RG+ Y H   R 
Sbjct: 66  HDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINM--HNVKLFLFQLLRGLAYCH---RQ 119
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI- 571
           K++HRDLK  N+L+++    K++DFGLAR         +  ++  T  Y  P+  +G   
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILLGSTD 177
Query: 572 FSIKSDVFSFGVLLLEIISGR 592
           +S + D++  G +  E+ +GR
Sbjct: 178 YSTQIDMWGVGCIFYEMATGR 198

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 97/196 (49%), Gaps = 10/196 (5%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
           K+GQG  G VY    +A G+ +A+++++       +   NE+ ++ + ++ N+V      
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + EY+   SL     D      +D  +  ++     + + +LH +   ++IH
Sbjct: 88  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 140
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           R++K+ NILL  D + K++DFG        Q++ +T  + GT  +MAPE      +  K 
Sbjct: 141 RNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKV 198
Query: 577 DVFSFGVLLLEIISGR 592
           D++S G++ +E+I G 
Sbjct: 199 DIWSLGIMAIEMIEGE 214

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 14/208 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNEVNLIAKL 444
           A   F     LG+G FG VY     + K I A+K L  ++    G++ + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +H N++R             I EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           Y H     K+IHRD+K  N+LL      KI+DFG +     ++  A    + GT  Y+ P
Sbjct: 123 YCHSK---KVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA----LCGTLDYLPP 175
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E   G +   K D++S GVL  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKL 444
             F     LG G FG VYKG  + +G+     +A+K L   TS +  +E  +E  ++A +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIAR 501
            + ++ R             I + MP   L     D  R  + D    Q ++N    IA+
Sbjct: 77  DNPHVCRLLGICLTSTVQL-ITQLMPFGCL----LDYVREHK-DNIGSQYLLNWCVQIAK 130
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ YL ED RL  +HRDL A N+L+    + KI+DFGLA++ G  + + +         +
Sbjct: 131 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 92/198 (46%), Gaps = 15/198 (7%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           +G+G F  V     +  GK +AVK + +T  +   LQ+   EV +   L H N+V+    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    + EY     +  +L    R  +   K  ++    I   + Y H+     I+
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKE---KEARAKFRQIVSAVQYCHQKF---IV 135
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFG-GNQNQANTNIIAGTYGYMAPEYAMGGIFS- 573
           HRDLKA N+LLD D N KI+DFG +  F  GN+  A      G   Y APE   G  +  
Sbjct: 136 HRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA----FCGAPPYAAPELFQGKKYDG 191
Query: 574 IKSDVFSFGVLLLEIISG 591
            + DV+S GV+L  ++SG
Sbjct: 192 PEVDVWSLGVILYTLVSG 209

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNEVNLIAKL 444
           A   F     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +H N++R             I EY P   +   L   ++    D +R  + I  +A  + 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELANALS 127
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E   G +   K D++S GVL  E + G+
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 17/215 (7%)
Query: 382 PLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNE 437
           P + ALE    F     LG+G FG VY       K I A+K L  ++    G++ + + E
Sbjct: 2   PRQWALE---DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 438 VNLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN 497
           V + + L+H N++R             I EY P   L     +  +  + D +R  + I 
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYIT 115
Query: 498 GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG 557
            +A  + Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + G
Sbjct: 116 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCG 168
Query: 558 TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           T  Y+ PE   G +   K D++S GVL  E + G+
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKL 444
             F     LG G FG VYKG  + +G+     +A+K L   TS +  +E  +E  ++A +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIAR 501
            + ++ R             I + MP   L     D  R  + D    Q ++N    IA+
Sbjct: 78  DNPHVCRLLGICLTSTVQL-ITQLMPFGCL----LDYVREHK-DNIGSQYLLNWCVQIAK 131
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ YL ED RL  +HRDL A N+L+    + KI+DFGLA++ G  + + +         +
Sbjct: 132 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 398 KLGQGGFGPVYKGTLAD---GKA---IAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLV 450
           +LGQG FG VY+G   D   G+A   +AVK ++ ++  +   EF NE +++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING-------IARGI 503
           R             + E M +  L  +L       + +  R    +         IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            YL+     K +HRDL A N ++  D   KI DFG+ R                   +MA
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           PE    G+F+  SD++SFGV+L EI S
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 398 KLGQGGFGPVYKGTLAD---GKA---IAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLV 450
           +LGQG FG VY+G   D   G+A   +AVK ++ ++  +   EF NE +++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING-------IARGI 503
           R             + E M +  L  +L       + +  R    +         IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            YL+     K +HRDL A N ++  D   KI DFG+ R                   +MA
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           PE    G+F+  SD++SFGV+L EI S
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 14/208 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNEVNLIAKL 444
           A   F     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +H N++R             I EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    ++GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSCHAPSSRRTTLSGTLDYLPP 176
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E   G +   K D++S GVL  E + G+
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKL 444
             F     LG G FG VYKG  + +G+     +A+K L   TS +  +E  +E  ++A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIAR 501
            + ++ R             I + MP   L     D  R  + D    Q ++N    IA+
Sbjct: 75  DNPHVCRLLGICLTSTVQL-ITQLMPFGXL----LDYVREHK-DNIGSQYLLNWCVQIAK 128
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ YL ED RL  +HRDL A N+L+    + KI+DFGLA++ G  + + +         +
Sbjct: 129 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 398 KLGQGGFGPVYKGTLAD---GKA---IAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLV 450
           +LGQG FG VY+G   D   G+A   +AVK ++ ++  +   EF NE +++      ++V
Sbjct: 21  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING-------IARGI 503
           R             + E M +  L  +L       + +  R    +         IA G+
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            YL+     K +HRDL A N ++  D   KI DFG+ R                   +MA
Sbjct: 141 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 197
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           PE    G+F+  SD++SFGV+L EI S
Sbjct: 198 PESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKL 444
             F     LG G FG VYKG  + +G+     +A+K L   TS +  +E  +E  ++A +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIAR 501
            + ++ R             I + MP   L     D  R  + D    Q ++N    IA+
Sbjct: 78  DNPHVCRLLGICLTSTVQL-ITQLMPFGCL----LDYVREHK-DNIGSQYLLNWCVQIAK 131
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ YL ED RL  +HRDL A N+L+    + KI+DFGLA++ G  + + +         +
Sbjct: 132 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 97/228 (42%), Gaps = 23/228 (10%)
Query: 399 LGQGGFGPVYKGTLADGK------AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVR 451
           LG G FG VY+G ++          +AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 452 XXXXXXXXXXXXXIYEYMPNKSLDVHLFD----ATRSVQLDWKRRQSIINGIARGILYLH 507
                        + E M    L   L +     ++   L       +   IA G  YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 508 EDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           E+     IHRD+ A N LL         KI DFG+AR                   +M P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF--YFSEHGQTLLTYV 610
           E  M GIF+ K+D +SFGVLL EI S     G+  Y S+  Q +L +V
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSNQEVLEFV 258

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKL 444
             F     LG G FG VYKG  + +G+     +A+K L   TS +  +E  +E  ++A +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIAR 501
            + ++ R             I + MP   L     D  R  + D    Q ++N    IA+
Sbjct: 78  DNPHVCRLLGICLTSTVQL-ITQLMPFGCL----LDYVREHK-DNIGSQYLLNWCVQIAK 131
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ YL ED RL  +HRDL A N+L+    + KI+DFGLA++ G  + + +         +
Sbjct: 132 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 399 LGQGGFGPVYK-GTLADGKAIAVKRL---SRTSGQGLQEFKNEVNLIAKLQHKNLVR--X 452
           +G G +G   K    +DGK +  K L   S T  +  Q   +EVNL+ +L+H N+VR   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKHPNIVRYYD 72
Query: 453 XXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGILYLHE--D 509
                       + EY     L   +   T+  Q LD +    ++  +   +   H   D
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 569
               ++HRDLK +N+ LD   N K+ DFGLARI   N + +      GT  YM+PE    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVGTPYYMSPEQMNR 190
Query: 570 GIFSIKSDVFSFGVLLLEI 588
             ++ KSD++S G LL E+
Sbjct: 191 MSYNEKSDIWSLGCLLYEL 209

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNEVNLIAKL 444
           A   F     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +H N++R             I EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E   G +   K D++S GVL  E + G+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 91/198 (45%), Gaps = 11/198 (5%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXXXXX 456
           LG+G +G V         +A+AVK +         E  K E+ +   L H+N+V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                     EY     L    FD     + +     Q   + +  G++YLH    + I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRD+K  N+LLD+  N KISDFGLA +F  N  +   N + GT  Y+APE      F  +
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 576 S-DVFSFGVLLLEIISGR 592
             DV+S G++L  +++G 
Sbjct: 187 PVDVWSCGIVLTAMLAGE 204

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 105/230 (45%), Gaps = 35/230 (15%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADG-------KAIAVKRLSRTSGQGLQ-EFKNEVNLIA 442
           N+      +G+G FG V++   A G         +AVK L   +   +Q +F+ E  L+A
Sbjct: 47  NNIEYVRDIGEGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 105
Query: 443 KLQHKNLVRXXXXXXXXXXXXXIYEYMPN-------KSLDVHLFDATRSVQLDWKRRQS- 494
           +  + N+V+             ++EYM         +S+  H   +     L  + R S 
Sbjct: 106 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165
Query: 495 -------------IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
                        I   +A G+ YL E    K +HRDL   N L+ ++M  KI+DFGL+R
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR 222
Query: 542 -IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
            I+  +  +A+ N  A    +M PE      ++ +SDV+++GV+L EI S
Sbjct: 223 NIYSADYYKADGN-DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 103/206 (50%), Gaps = 11/206 (5%)
Query: 391 NHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQHK 447
            +F    K+G+G +G VYK      G+ +A+ ++   T  +G+      E++L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 448 NLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
           N+V+             ++E++ ++ L     DA+    +     +S +  + +G+ + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
                +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y APE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEIL 175
Query: 568 MG-GIFSIKSDVFSFGVLLLEIISGR 592
           +G   +S   D++S G +  E+++ R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKL 444
             F     LG G FG VYKG  + +G+     +A+K L   TS +  +E  +E  ++A +
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIAR 501
            + ++ R             I + MP   L     D  R  + D    Q ++N    IA+
Sbjct: 100 DNPHVCRLLGICLTSTVQL-ITQLMPFGCL----LDYVREHK-DNIGSQYLLNWCVQIAK 153
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ YL ED RL  +HRDL A N+L+    + KI+DFGLA++ G  + + +         +
Sbjct: 154 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 210
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 211 MALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 103/206 (50%), Gaps = 11/206 (5%)
Query: 391 NHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQHK 447
            +F    K+G+G +G VYK      G+ +A+ ++   T  +G+      E++L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 448 NLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
           N+V+             ++E++ ++ L     DA+    +     +S +  + +G+ + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
                +++HRDLK  N+L++ +   K++DFGLAR FG         ++  T  Y APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEIL 174
Query: 568 MG-GIFSIKSDVFSFGVLLLEIISGR 592
           +G   +S   D++S G +  E+++ R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 9/209 (4%)
Query: 385 LALEATNHFSDENKLGQGGFG-PVYKGTLADGKAIAVKRL--SRTSGQGLQEFKNEVNLI 441
           L  ++   +    K+G+G FG  +   +  DG+   +K +  SR S +  +E + EV ++
Sbjct: 18  LYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVL 77
Query: 442 AKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR 501
           A ++H N+V+             + +Y     L     +A + V     +   I++   +
Sbjct: 78  ANMKHPNIVQYRESFEENGSLYIVMDYCEGGDL-FKRINAQKGVLF---QEDQILDWFVQ 133
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
             L L      KI+HRD+K+ NI L  D   ++ DFG+AR+       A   I  GT  Y
Sbjct: 134 ICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI--GTPYY 191
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           ++PE      ++ KSD+++ G +L E+ +
Sbjct: 192 LSPEICENKPYNNKSDIWALGCVLYELCT 220

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 97/228 (42%), Gaps = 23/228 (10%)
Query: 399 LGQGGFGPVYKGTLADGK------AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVR 451
           LG G FG VY+G ++          +AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 452 XXXXXXXXXXXXXIYEYMPNKSLDVHLFD----ATRSVQLDWKRRQSIINGIARGILYLH 507
                        + E M    L   L +     ++   L       +   IA G  YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 508 EDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           E+     IHRD+ A N LL         KI DFG+AR                   +M P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF--YFSEHGQTLLTYV 610
           E  M GIF+ K+D +SFGVLL EI S     G+  Y S+  Q +L +V
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSNQEVLEFV 258

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXXXXX 456
           LG+G +G V         +A+AVK +         E  K E+ +   L H+N+V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                     EY     L    FD     + +     Q   + +  G++YLH    + I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRD+K  N+LLD+  N KISDFGLA +F  N  +   N + GT  Y+APE      F  +
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 576 S-DVFSFGVLLLEIISG 591
             DV+S G++L  +++G
Sbjct: 187 PVDVWSCGIVLTAMLAG 203

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 98/197 (49%), Gaps = 12/197 (6%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
           K+GQG  G VY    +A G+ +A+++++       +   NE+ ++ + ++ N+V      
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + EY+   SL     D      +D  +  ++     + + +LH +   ++IH
Sbjct: 87  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 517 RDLKASNILLDDDMNPKISDFGL-ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           RD+K+ NILL  D + K++DFG  A+I      Q+  + + GT  +MAPE      +  K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSEMVGTPYWMAPEVVTRKAYGPK 196
Query: 576 SDVFSFGVLLLEIISGR 592
            D++S G++ +E+I G 
Sbjct: 197 VDIWSLGIMAIEMIEGE 213

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKL 444
             F     LG G FG VYKG  + +G+     +A+K L   TS +  +E  +E  ++A +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIAR 501
            + ++ R             I + MP   L     D  R  + D    Q ++N    IA+
Sbjct: 82  DNPHVCRLLGICLTSTVQL-ITQLMPFGCL----LDYVREHK-DNIGSQYLLNWCVQIAK 135
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ YL ED RL  +HRDL A N+L+    + KI+DFGLA++ G  + + +         +
Sbjct: 136 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 91/198 (45%), Gaps = 11/198 (5%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXXXXX 456
           LG+G +G V         +A+AVK +         E  K E+ +   L H+N+V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                     EY     L    FD     + +     Q   + +  G++YLH    + I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRD+K  N+LLD+  N KISDFGLA +F  N  +   N + GT  Y+APE      F  +
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 576 S-DVFSFGVLLLEIISGR 592
             DV+S G++L  +++G 
Sbjct: 187 PVDVWSCGIVLTAMLAGE 204

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 91/198 (45%), Gaps = 11/198 (5%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXXXXX 456
           LG+G +G V         +A+AVK +         E  K E+ +   L H+N+V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                     EY     L    FD     + +     Q   + +  G++YLH    + I 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRD+K  N+LLD+  N KISDFGLA +F  N  +   N + GT  Y+APE      F  +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 576 S-DVFSFGVLLLEIISGR 592
             DV+S G++L  +++G 
Sbjct: 188 PVDVWSCGIVLTAMLAGE 205

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 97/228 (42%), Gaps = 23/228 (10%)
Query: 399 LGQGGFGPVYKGTLADGK------AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVR 451
           LG G FG VY+G ++          +AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 452 XXXXXXXXXXXXXIYEYMPNKSLDVHLFD----ATRSVQLDWKRRQSIINGIARGILYLH 507
                        + E M    L   L +     ++   L       +   IA G  YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 508 EDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           E+     IHRD+ A N LL         KI DFG+AR                   +M P
Sbjct: 175 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 231
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF--YFSEHGQTLLTYV 610
           E  M GIF+ K+D +SFGVLL EI S     G+  Y S+  Q +L +V
Sbjct: 232 EAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSNQEVLEFV 275

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 15/207 (7%)
Query: 392 HFSDENKLGQGGFGPVYKGTLAD--GKAI--AVKRLSRTSGQG-LQEFKNEVNLIAKLQH 446
           HF++   +G+G FG VY GTL D  GK I  AVK L+R +  G + +F  E  ++    H
Sbjct: 32  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 89
Query: 447 KNLVRXXXX-XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
            N++               +  YM +  L   + + T +  +  K        +A+G+ Y
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 147
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG--TYGYMA 563
           L   +  K +HRDL A N +LD+    K++DFGLAR     +  +  N         +MA
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMA 204
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
            E      F+ KSDV+SFGVLL E+++
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNEVNLIAKL 444
           A   F     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +H N++R             I EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E   G +   K D++S GVL  E + G+
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNEVNLIAKL 444
           A   F     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +H N++R             I EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 121
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 122 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 174
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E   G +   K D++S GVL  E + G+
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/230 (31%), Positives = 101/230 (43%), Gaps = 27/230 (11%)
Query: 399 LGQGGFGPVYKGTLADGK------AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVR 451
           LG G FG VY+G ++          +AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 452 XXXXXXXXXXXXXIYEYMPNKSLDVHLFD----ATRSVQLDWKRRQSIINGIARGILYLH 507
                        + E M    L   L +     ++   L       +   IA G  YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 508 EDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIF--GGNQNQANTNIIAGTYGYM 562
           E+     IHRD+ A N LL         KI DFG+AR     G   +    ++     +M
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLP--VKWM 253
Query: 563 APEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF--YFSEHGQTLLTYV 610
            PE  M GIF+ K+D +SFGVLL EI S     G+  Y S+  Q +L +V
Sbjct: 254 PPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSNQEVLEFV 299

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 399 LGQGGFGPVYK-GTLADGKAIAVKRL---SRTSGQGLQEFKNEVNLIAKLQHKNLVR--X 452
           +G G +G   K    +DGK +  K L   S T  +  Q   +EVNL+ +L+H N+VR   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKHPNIVRYYD 72
Query: 453 XXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGILYLHE--D 509
                       + EY     L   +   T+  Q LD +    ++  +   +   H   D
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 569
               ++HRDLK +N+ LD   N K+ DFGLARI   +++ A      GT  YM+PE    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKE--FVGTPYYMSPEQMNR 190
Query: 570 GIFSIKSDVFSFGVLLLEI 588
             ++ KSD++S G LL E+
Sbjct: 191 MSYNEKSDIWSLGCLLYEL 209

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 97/228 (42%), Gaps = 23/228 (10%)
Query: 399 LGQGGFGPVYKGTLADGK------AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVR 451
           LG G FG VY+G ++          +AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 452 XXXXXXXXXXXXXIYEYMPNKSLDVHLFD----ATRSVQLDWKRRQSIINGIARGILYLH 507
                        + E M    L   L +     ++   L       +   IA G  YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 508 EDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           E+     IHRD+ A N LL         KI DFG+AR                   +M P
Sbjct: 150 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 206
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF--YFSEHGQTLLTYV 610
           E  M GIF+ K+D +SFGVLL EI S     G+  Y S+  Q +L +V
Sbjct: 207 EAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSNQEVLEFV 250

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNEVNLIAKL 444
           A   F     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +H N++R             I EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E   G +   K D++S GVL  E + G+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 109/222 (49%), Gaps = 20/222 (9%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKL 444
             F     LG G FG VYKG  + +G+     +A+K L   TS +  +E  +E  ++A +
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING---IAR 501
            + ++ R             I + MP   L     D  R  + D    Q ++N    IA 
Sbjct: 72  DNPHVCRLLGICLTSTVQL-ITQLMPFGCL----LDYVREHK-DNIGSQYLLNWCVQIAE 125
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ YL ED RL  +HRDL A N+L+    + KI+DFGLA++ G  + + +         +
Sbjct: 126 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 182
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS--GRKNNGFYFSE 601
           MA E  +  I++ +SDV+S+GV + E+++   +  +G   SE
Sbjct: 183 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 224

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/230 (31%), Positives = 101/230 (43%), Gaps = 27/230 (11%)
Query: 399 LGQGGFGPVYKGTLADGK------AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVR 451
           LG G FG VY+G ++          +AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 452 XXXXXXXXXXXXXIYEYMPNKSLDVHLFD----ATRSVQLDWKRRQSIINGIARGILYLH 507
                        + E M    L   L +     ++   L       +   IA G  YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 508 EDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIF--GGNQNQANTNIIAGTYGYM 562
           E+     IHRD+ A N LL         KI DFG+AR     G   +    ++     +M
Sbjct: 176 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLP--VKWM 230
Query: 563 APEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF--YFSEHGQTLLTYV 610
            PE  M GIF+ K+D +SFGVLL EI S     G+  Y S+  Q +L +V
Sbjct: 231 PPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSNQEVLEFV 276

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 93/202 (46%), Gaps = 31/202 (15%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXXXX 458
           +G+G FG V  G    G  +AVK +   +    Q F  E +++ +L+H NLV+       
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 459 XXXXXXIY-EYMPNKSLDVHLFDATRSVQLDWKRRQSIING---------IARGILYLHE 508
                 I  EYM   SL     D  RS      R +S++ G         +   + YL  
Sbjct: 77  EKGGLYIVTEYMAKGSL----VDYLRS------RGRSVLGGDCLLKFSLDVCEAMEYLEG 126
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
           ++    +HRDL A N+L+ +D   K+SDFGL +     Q+     +      + APE   
Sbjct: 127 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALR 178
Query: 569 GGIFSIKSDVFSFGVLLLEIIS 590
              FS KSDV+SFG+LL EI S
Sbjct: 179 EAAFSTKSDVWSFGILLWEIYS 200

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/250 (30%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 354 EGRIRNHYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENK----LGQGGFGPVY- 408
           E R R H A      G            P      +T  FSD  K    LG+G FG V  
Sbjct: 14  EPRSRGHAA------GTSGGPGDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVIL 67
Query: 409 -KGTLADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQHKNLVRXXXXXXXXXXXXX 464
            K  +  G+  AVK +S+         +    EV L+ +L H N+++             
Sbjct: 68  CKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 126
Query: 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNI 524
           + E      L   +    R  ++D  R   II  +  GI Y+H++   KI+HRDLK  N+
Sbjct: 127 VGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYMHKN---KIVHRDLKPENL 180
Query: 525 LLD---DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSF 581
           LL+    D N +I DFGL+  F  ++   +     GT  Y+APE  + G +  K DV+S 
Sbjct: 181 LLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGTAYYIAPE-VLHGTYDEKCDVWST 236
Query: 582 GVLLLEIISG 591
           GV+L  ++SG
Sbjct: 237 GVILYILLSG 246

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 91/198 (45%), Gaps = 11/198 (5%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXXXXX 456
           LG+G +G V         +A+AVK +         E  K E+ +   L H+N+V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                     EY     L    FD     + +     Q   + +  G++YLH    + I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRD+K  N+LLD+  N KISDFGLA +F  N  +   N + GT  Y+APE      F  +
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 576 S-DVFSFGVLLLEIISGR 592
             DV+S G++L  +++G 
Sbjct: 187 PVDVWSCGIVLTAMLAGE 204

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 111/234 (47%), Gaps = 22/234 (9%)
Query: 399 LGQGGFGPV----YKGTLAD-GKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRX 452
           LG+G FG V    Y     + G+ +AVK L   SG   + + K E+ ++  L H+N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 453 XX--XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                         I E++P+ SL  +L      + L  + + ++   I +G+ YL   S
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV--QICKGMDYL--GS 132
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT-NIIAGTYGYMAPEYAMG 569
           R + +HRDL A N+L++ +   KI DFGL +    ++      +       + APE  M 
Sbjct: 133 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 191
Query: 570 GIFSIKSDVFSFGVLLLEIISGRKNNGFYFS--------EHGQTLLTYVCNSLS 615
             F I SDV+SFGV L E+++   ++    +         HGQ  +T + N+L 
Sbjct: 192 SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 245

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 97/228 (42%), Gaps = 23/228 (10%)
Query: 399 LGQGGFGPVYKGTLADGK------AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVR 451
           LG G FG VY+G ++          +AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 452 XXXXXXXXXXXXXIYEYMPNKSLDVHLFD----ATRSVQLDWKRRQSIINGIARGILYLH 507
                        + E M    L   L +     ++   L       +   IA G  YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 508 EDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           E+     IHRD+ A N LL         KI DFG+AR                   +M P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF--YFSEHGQTLLTYV 610
           E  M GIF+ K+D +SFGVLL EI S     G+  Y S+  Q +L +V
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSNQEVLEFV 273

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXXXXX 456
           LG+G +G V         +A+AVK +         E  K E+ +   L H+N+V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                     EY     L    FD     + +     Q   + +  G++YLH    + I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRD+K  N+LLD+  N KISDFGLA +F  N  +   N + GT  Y+APE      F  +
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 576 S-DVFSFGVLLLEIISG 591
             DV+S G++L  +++G
Sbjct: 187 PVDVWSCGIVLTAMLAG 203

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/250 (30%), Positives = 110/250 (44%), Gaps = 29/250 (11%)
Query: 354 EGRIRNHYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENK----LGQGGFGPVY- 408
           E R R H A      G            P      +T  FSD  K    LG+G FG V  
Sbjct: 15  EPRSRGHAA------GTSGGPGDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVIL 68
Query: 409 -KGTLADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQHKNLVRXXXXXXXXXXXXX 464
            K  +  G+  AVK +S+         +    EV L+ +L H N+++             
Sbjct: 69  CKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 127
Query: 465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNI 524
           + E      L   +    R  ++D  R   II  +  GI Y+H++   KI+HRDLK  N+
Sbjct: 128 VGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYMHKN---KIVHRDLKPENL 181
Query: 525 LLDD---DMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSF 581
           LL+    D N +I DFGL+  F  ++   +     GT  Y+APE  + G +  K DV+S 
Sbjct: 182 LLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGTAYYIAPE-VLHGTYDEKCDVWST 237
Query: 582 GVLLLEIISG 591
           GV+L  ++SG
Sbjct: 238 GVILYILLSG 247

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXXXXX 456
           LG+G +G V         +A+AVK +         E  K E+ +   L H+N+V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                     EY     L    FD     + +     Q   + +  G++YLH    + I 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRD+K  N+LLD+  N KISDFGLA +F  N  +   N + GT  Y+APE      F  +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 576 S-DVFSFGVLLLEIISG 591
             DV+S G++L  +++G
Sbjct: 188 PVDVWSCGIVLTAMLAG 204

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 97/228 (42%), Gaps = 23/228 (10%)
Query: 399 LGQGGFGPVYKGTLADGK------AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVR 451
           LG G FG VY+G ++          +AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 452 XXXXXXXXXXXXXIYEYMPNKSLDVHLFD----ATRSVQLDWKRRQSIINGIARGILYLH 507
                        + E M    L   L +     ++   L       +   IA G  YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 508 EDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           E+     IHRD+ A N LL         KI DFG+AR                   +M P
Sbjct: 165 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 221
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF--YFSEHGQTLLTYV 610
           E  M GIF+ K+D +SFGVLL EI S     G+  Y S+  Q +L +V
Sbjct: 222 EAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSNQEVLEFV 265

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 97/228 (42%), Gaps = 23/228 (10%)
Query: 399 LGQGGFGPVYKGTLADGK------AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVR 451
           LG G FG VY+G ++          +AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 452 XXXXXXXXXXXXXIYEYMPNKSLDVHLFD----ATRSVQLDWKRRQSIINGIARGILYLH 507
                        + E M    L   L +     ++   L       +   IA G  YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 508 EDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           E+     IHRD+ A N LL         KI DFG+AR                   +M P
Sbjct: 185 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 241
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF--YFSEHGQTLLTYV 610
           E  M GIF+ K+D +SFGVLL EI S     G+  Y S+  Q +L +V
Sbjct: 242 EAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSNQEVLEFV 285

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXXXXX 456
           LG+G +G V         +A+AVK +         E  K E+ +   L H+N+V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                     EY     L    FD     + +     Q   + +  G++YLH    + I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRD+K  N+LLD+  N KISDFGLA +F  N  +   N + GT  Y+APE      F  +
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 576 S-DVFSFGVLLLEIISG 591
             DV+S G++L  +++G
Sbjct: 187 PVDVWSCGIVLTAMLAG 203

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 93/199 (46%), Gaps = 16/199 (8%)
Query: 399 LGQGGFGPVYK-GTLADGKAIAVKRLSRTSGQG--LQEFKNEVNLIAKLQHKNLVRXXXX 455
           LG+G FG V K       +  AVK +++ S +         EV L+ KL H N+++    
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    + E      L   +    R  + D  R   II  +  GI Y+H+ +   I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN---IV 143
Query: 516 HRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
           HRDLK  NILL   + D + KI DFGL+  F  N    +     GT  Y+APE  + G +
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPE-VLRGTY 199
Query: 573 SIKSDVFSFGVLLLEIISG 591
             K DV+S GV+L  ++SG
Sbjct: 200 DEKCDVWSAGVILYILLSG 218

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 97/228 (42%), Gaps = 23/228 (10%)
Query: 399 LGQGGFGPVYKGTLADGK------AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVR 451
           LG G FG VY+G ++          +AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 452 XXXXXXXXXXXXXIYEYMPNKSLDVHLFD----ATRSVQLDWKRRQSIINGIARGILYLH 507
                        + E M    L   L +     ++   L       +   IA G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 508 EDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           E+     IHRD+ A N LL         KI DFG+AR                   +M P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF--YFSEHGQTLLTYV 610
           E  M GIF+ K+D +SFGVLL EI S     G+  Y S+  Q +L +V
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSNQEVLEFV 259

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXXXXX 456
           LG+G +G V         +A+AVK +         E  K E+ +   L H+N+V+     
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                     EY     L    FD     + +     Q   + +  G++YLH    + I 
Sbjct: 73  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 125
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRD+K  N+LLD+  N KISDFGLA +F  N  +   N + GT  Y+APE      F  +
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185
Query: 576 S-DVFSFGVLLLEIISG 591
             DV+S G++L  +++G
Sbjct: 186 PVDVWSCGIVLTAMLAG 202

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNEVNLIAKL 444
           A   F     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +H N++R             I EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 126
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 179
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E   G +   K D++S GVL  E + G+
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNEVNLIAKL 444
           A   F     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +H N++R             I EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 139
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 140 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 192
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E   G +   K D++S GVL  E + G+
Sbjct: 193 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXXXXX 456
           LG+G +G V         +A+AVK +         E  K E+ +   L H+N+V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                     EY     L    FD     + +     Q   + +  G++YLH    + I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRD+K  N+LLD+  N KISDFGLA +F  N  +   N + GT  Y+APE      F  +
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186
Query: 576 S-DVFSFGVLLLEIISG 591
             DV+S G++L  +++G
Sbjct: 187 PVDVWSCGIVLTAMLAG 203

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 111/234 (47%), Gaps = 22/234 (9%)
Query: 399 LGQGGFGPV----YKGTLAD-GKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRX 452
           LG+G FG V    Y     + G+ +AVK L   SG   + + K E+ ++  L H+N+V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 453 XX--XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                         I E++P+ SL  +L      + L  + + ++   I +G+ YL   S
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV--QICKGMDYL--GS 144
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT-NIIAGTYGYMAPEYAMG 569
           R + +HRDL A N+L++ +   KI DFGL +    ++      +       + APE  M 
Sbjct: 145 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 203
Query: 570 GIFSIKSDVFSFGVLLLEIISGRKNNGFYFS--------EHGQTLLTYVCNSLS 615
             F I SDV+SFGV L E+++   ++    +         HGQ  +T + N+L 
Sbjct: 204 SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNEVNLIAKL 444
           A   F     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +H N++R             I EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGTLDYLPP 175
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E   G +   K D++S GVL  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNEVNLIAKL 444
           A   F     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +H N++R             I EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 177
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E   G +   K D++S GVL  E + G+
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 93/202 (46%), Gaps = 31/202 (15%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXXXX 458
           +G+G FG V  G    G  +AVK +   +    Q F  E +++ +L+H NLV+       
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 459 XXXXXXIY-EYMPNKSLDVHLFDATRSVQLDWKRRQSIING---------IARGILYLHE 508
                 I  EYM   SL     D  RS      R +S++ G         +   + YL  
Sbjct: 258 EKGGLYIVTEYMAKGSL----VDYLRS------RGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
           ++    +HRDL A N+L+ +D   K+SDFGL +     Q+     +      + APE   
Sbjct: 308 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALR 359
Query: 569 GGIFSIKSDVFSFGVLLLEIIS 590
              FS KSDV+SFG+LL EI S
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYS 381

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXXXXX 456
           LG+G +G V         +A+AVK +         E  K E+ +   L H+N+V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                     EY     L    FD     + +     Q   + +  G++YLH    + I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRD+K  N+LLD+  N KISDFGLA +F  N  +   N + GT  Y+APE      F  +
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186
Query: 576 S-DVFSFGVLLLEIISG 591
             DV+S G++L  +++G
Sbjct: 187 PVDVWSCGIVLTAMLAG 203

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 102/205 (49%), Gaps = 11/205 (5%)
Query: 393 FSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLS-RTSGQGLQEFKNEVNLIAKLQHKNLV 450
           F+   ++G+G FG V+KG      + +A+K +    +   +++ + E+ ++++     + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
           +             I EY+   S      D  R+   D  +  +++  I +G+ YLH + 
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 140
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
           +   IHRD+KA+N+LL +  + K++DFG+A      Q + NT +  GT  +MAPE     
Sbjct: 141 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIQQS 195
Query: 571 IFSIKSDVFSFGVLLLEIISGRKNN 595
            +  K+D++S G+  +E+  G   N
Sbjct: 196 AYDSKADIWSLGITAIELAKGEPPN 220

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXXXXX 456
           LG+G +G V         +A+AVK +         E  K E+ +   L H+N+V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                     EY     L    FD     + +     Q   + +  G++YLH    + I 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRD+K  N+LLD+  N KISDFGLA +F  N  +   N + GT  Y+APE      F  +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 187
Query: 576 S-DVFSFGVLLLEIISG 591
             DV+S G++L  +++G
Sbjct: 188 PVDVWSCGIVLTAMLAG 204

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNEVNLIAKL 444
           A   F     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +H N++R             I EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 201
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E   G +   K D++S GVL  E + G+
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNEVNLIAKL 444
           A   F     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +H N++R             I EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 119
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 120 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 172
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E   G +   K D++S GVL  E + G+
Sbjct: 173 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 17/215 (7%)
Query: 382 PLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNE 437
           P + ALE    F     LG+G FG VY       K I A+K L  ++    G++ + + E
Sbjct: 2   PRQWALE---DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 438 VNLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN 497
           V + + L+H N++R             I EY P   L     +  +  + D +R  + I 
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYIT 115
Query: 498 GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG 557
            +A  + Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + G
Sbjct: 116 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELCG 168
Query: 558 TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           T  Y+ PE   G +   K D++S GVL  E + G+
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 15/207 (7%)
Query: 392 HFSDENKLGQGGFGPVYKGTLAD--GKAI--AVKRLSRTSGQG-LQEFKNEVNLIAKLQH 446
           HF++   +G+G FG VY GTL D  GK I  AVK L+R +  G + +F  E  ++    H
Sbjct: 28  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 85
Query: 447 KNLVRXXXX-XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
            N++               +  YM +  L   + + T +  +  K        +A+G+ Y
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 143
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG--TYGYMA 563
           L   +  K +HRDL A N +LD+    K++DFGLAR     +  +  N         +MA
Sbjct: 144 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
            E      F+ KSDV+SFGVLL E+++
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXXXXX 456
           LG+G +G V         +A+AVK +         E  K E+ +   L H+N+V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                     EY     L    FD     + +     Q   + +  G++YLH    + I 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRD+K  N+LLD+  N KISDFGLA +F  N  +   N + GT  Y+APE      F  +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 576 S-DVFSFGVLLLEIISG 591
             DV+S G++L  +++G
Sbjct: 188 PVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXXXXX 456
           LG+G +G V         +A+AVK +         E  K E+ +   L H+N+V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                     EY     L    FD     + +     Q   + +  G++YLH    + I 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRD+K  N+LLD+  N KISDFGLA +F  N  +   N + GT  Y+APE      F  +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 576 S-DVFSFGVLLLEIISG 591
             DV+S G++L  +++G
Sbjct: 188 PVDVWSCGIVLTAMLAG 204

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 14/208 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNEVNLIAKL 444
           A   F     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +H N++R             I EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           Y H     ++IHRD+K  N+LL      KI+DFG +     ++  A    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA----LCGTLDYLPP 178
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E   G +   K D++S GVL  E + G+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXXXXX 456
           LG+G +G V         +A+AVK +         E  K E+ +   L H+N+V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                     EY     L    FD     + +     Q   + +  G++YLH    + I 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRD+K  N+LLD+  N KISDFGLA +F  N  +   N + GT  Y+APE      F  +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 576 S-DVFSFGVLLLEIISG 591
             DV+S G++L  +++G
Sbjct: 188 PVDVWSCGIVLTAMLAG 204

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXXXXX 456
           LG+G +G V         +A+AVK +         E  K E+ +   L H+N+V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                     EY     L    FD     + +     Q   + +  G++YLH    + I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRD+K  N+LLD+  N KISDFGLA +F  N  +   N + GT  Y+APE      F  +
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186
Query: 576 S-DVFSFGVLLLEIISG 591
             DV+S G++L  +++G
Sbjct: 187 PVDVWSCGIVLTAMLAG 203

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 97/228 (42%), Gaps = 23/228 (10%)
Query: 399 LGQGGFGPVYKGTLADGK------AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVR 451
           LG G FG VY+G ++          +AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 452 XXXXXXXXXXXXXIYEYMPNKSLDVHLFD----ATRSVQLDWKRRQSIINGIARGILYLH 507
                        + E M    L   L +     ++   L       +   IA G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 508 EDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           E+     IHRD+ A N LL         KI DFG+AR                   +M P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF--YFSEHGQTLLTYV 610
           E  M GIF+ K+D +SFGVLL EI S     G+  Y S+  Q +L +V
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSNQEVLEFV 273

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNEVNLIAKL 444
           A   F     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +H N++R             I EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 175
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E   G +   K D++S GVL  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 15/207 (7%)
Query: 392 HFSDENKLGQGGFGPVYKGTLAD--GKAI--AVKRLSRTSGQG-LQEFKNEVNLIAKLQH 446
           HF++   +G+G FG VY GTL D  GK I  AVK L+R +  G + +F  E  ++    H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 447 KNLVRXXXX-XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
            N++               +  YM +  L   + + T +  +  K        +A+G+ Y
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 148
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG--TYGYMA 563
           L   +  K +HRDL A N +LD+    K++DFGLAR     +  +  N         +MA
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
            E      F+ KSDV+SFGVLL E+++
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXXXXX 456
           LG+G +G V         +A+AVK +         E  K E+ +   L H+N+V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                     EY         LFD     + +     Q   + +  G++YLH    + I 
Sbjct: 75  REGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRD+K  N+LLD+  N KISDFGLA +F  N  +   N + GT  Y+APE      F  +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 576 S-DVFSFGVLLLEIISG 591
             DV+S G++L  +++G
Sbjct: 188 PVDVWSCGIVLTAMLAG 204

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 15/207 (7%)
Query: 392 HFSDENKLGQGGFGPVYKGTLAD--GKAI--AVKRLSRTSGQG-LQEFKNEVNLIAKLQH 446
           HF++   +G+G FG VY GTL D  GK I  AVK L+R +  G + +F  E  ++    H
Sbjct: 30  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 447 KNLVRXXXX-XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
            N++               +  YM +  L   + + T +  +  K        +A+G+ Y
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 145
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG--TYGYMA 563
           L   +  K +HRDL A N +LD+    K++DFGLAR     +  +  N         +MA
Sbjct: 146 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 202
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
            E      F+ KSDV+SFGVLL E+++
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 15/207 (7%)
Query: 392 HFSDENKLGQGGFGPVYKGTLAD--GKAI--AVKRLSRTSGQG-LQEFKNEVNLIAKLQH 446
           HF++   +G+G FG VY GTL D  GK I  AVK L+R +  G + +F  E  ++    H
Sbjct: 31  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 88
Query: 447 KNLVRXXXX-XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
            N++               +  YM +  L   + + T +  +  K        +A+G+ Y
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 146
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG--TYGYMA 563
           L   +  K +HRDL A N +LD+    K++DFGLAR     +  +  N         +MA
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 203
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
            E      F+ KSDV+SFGVLL E+++
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 103/219 (47%), Gaps = 15/219 (6%)
Query: 398 KLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
           K+G+G  G V   T    GK +AVK++     Q  +   NEV ++    H N+V      
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + E++   +L     D     +++ ++  ++   + R + YLH      +IH
Sbjct: 112 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 164
Query: 517 RDLKASNILLDDDMNPKISDFGL-ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           RD+K+ +ILL  D   K+SDFG  A++   ++       + GT  +MAPE      +  +
Sbjct: 165 RDIKSDSILLTSDGRIKLSDFGFCAQV---SKEVPKRKXLVGTPYWMAPEVISRLPYGTE 221
Query: 576 SDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSL 614
            D++S G++++E+I G      YF+E     +  + +SL
Sbjct: 222 VDIWSLGIMVIEMIDGEPP---YFNEPPLQAMRRIRDSL 257

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNEVNLIAKL 444
           A   F     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +H N++R             I EY P   +   L   ++    D +R  + I  +A  + 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELANALS 127
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLXGTLDYLPP 180
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E   G +   K D++S GVL  E + G+
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 15/207 (7%)
Query: 392 HFSDENKLGQGGFGPVYKGTLAD--GKAI--AVKRLSRTSGQG-LQEFKNEVNLIAKLQH 446
           HF++   +G+G FG VY GTL D  GK I  AVK L+R +  G + +F  E  ++    H
Sbjct: 32  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 89
Query: 447 KNLVRXXXX-XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
            N++               +  YM +  L   + + T +  +  K        +A+G+ Y
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 147
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG--TYGYMA 563
           L   +  K +HRDL A N +LD+    K++DFGLAR     +  +  N         +MA
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 204
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
            E      F+ KSDV+SFGVLL E+++
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 15/207 (7%)
Query: 392 HFSDENKLGQGGFGPVYKGTLAD--GKAI--AVKRLSRTSGQG-LQEFKNEVNLIAKLQH 446
           HF++   +G+G FG VY GTL D  GK I  AVK L+R +  G + +F  E  ++    H
Sbjct: 25  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 82
Query: 447 KNLVRXXXX-XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
            N++               +  YM +  L   + + T +  +  K        +A+G+ Y
Sbjct: 83  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 140
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG--TYGYMA 563
           L   +  K +HRDL A N +LD+    K++DFGLAR     +  +  N         +MA
Sbjct: 141 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 197
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
            E      F+ KSDV+SFGVLL E+++
Sbjct: 198 LESLQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 93/202 (46%), Gaps = 31/202 (15%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXXXX 458
           +G+G FG V  G    G  +AVK +   +    Q F  E +++ +L+H NLV+       
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 459 XXXXXXIY-EYMPNKSLDVHLFDATRSVQLDWKRRQSIING---------IARGILYLHE 508
                 I  EYM   SL     D  RS      R +S++ G         +   + YL  
Sbjct: 71  EKGGLYIVTEYMAKGSL----VDYLRS------RGRSVLGGDCLLKFSLDVCEAMEYLEG 120
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
           ++    +HRDL A N+L+ +D   K+SDFGL +     Q+     +      + APE   
Sbjct: 121 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALR 172
Query: 569 GGIFSIKSDVFSFGVLLLEIIS 590
              FS KSDV+SFG+LL EI S
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYS 194

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 15/207 (7%)
Query: 392 HFSDENKLGQGGFGPVYKGTLAD--GKAI--AVKRLSRTSGQG-LQEFKNEVNLIAKLQH 446
           HF++   +G+G FG VY GTL D  GK I  AVK L+R +  G + +F  E  ++    H
Sbjct: 52  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 109
Query: 447 KNLVRXXXX-XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
            N++               +  YM +  L   + + T +  +  K        +A+G+ Y
Sbjct: 110 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 167
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG--TYGYMA 563
           L   +  K +HRDL A N +LD+    K++DFGLAR     +  +  N         +MA
Sbjct: 168 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 224
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
            E      F+ KSDV+SFGVLL E+++
Sbjct: 225 LESLQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNEVNLIAKL 444
           A   F     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +H N++R             I EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 178
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E   G +   K D++S GVL  E + G+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXXXXX 456
           LG+G +G V         +A+AVK +         E  K E+ +   L H+N+V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                     EY         LFD     + +     Q   + +  G++YLH    + I 
Sbjct: 74  REGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRD+K  N+LLD+  N KISDFGLA +F  N  +   N + GT  Y+APE      F  +
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 576 S-DVFSFGVLLLEIISG 591
             DV+S G++L  +++G
Sbjct: 187 PVDVWSCGIVLTAMLAG 203

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNEVNLIAKL 444
           A   F     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +H N++R             I EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 175
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E   G +   K D++S GVL  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 15/207 (7%)
Query: 392 HFSDENKLGQGGFGPVYKGTLAD--GKAI--AVKRLSRTSGQG-LQEFKNEVNLIAKLQH 446
           HF++   +G+G FG VY GTL D  GK I  AVK L+R +  G + +F  E  ++    H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 447 KNLVRXXXX-XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
            N++               +  YM +  L   + + T +  +  K        +A+G+ Y
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 148
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG--TYGYMA 563
           L   +  K +HRDL A N +LD+    K++DFGLAR     +  +  N         +MA
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
            E      F+ KSDV+SFGVLL E+++
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNEVNLIAKL 444
           A   F     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +H N++R             I EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 176
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E   G +   K D++S GVL  E + G+
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 11/202 (5%)
Query: 393 FSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLS-RTSGQGLQEFKNEVNLIAKLQHKNLV 450
           F+   K+G+G FG V+KG      K +A+K +    +   +++ + E+ ++++     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
           +             I EY+   S      D      LD  +  +I+  I +G+ YLH + 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHSEK 139
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
           +   IHRD+KA+N+LL +    K++DFG+A        Q   N   GT  +MAPE     
Sbjct: 140 K---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNXFVGTPFWMAPEVIKQS 194
Query: 571 IFSIKSDVFSFGVLLLEIISGR 592
            +  K+D++S G+  +E+  G 
Sbjct: 195 AYDSKADIWSLGITAIELARGE 216

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNEVNLIAKL 444
           A   F     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +H N++R             I EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 175
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E   G +   K D++S GVL  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 14/208 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNEVNLIAKL 444
           A   F     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +H N++R             I EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           Y H     ++IHRD+K  N+LL      KI+DFG +     ++  A    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA----LCGTLDYLPP 175
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E   G +   K D++S GVL  E + G+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 101/201 (50%), Gaps = 19/201 (9%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           LG+G FG V   T     + +A+K +SR            + E++ +  L+H ++++   
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRR--QSIINGIARGILYLHEDSRL 512
                     + EY   +  D ++ +  R  + D  RR  Q II  I     Y H   R 
Sbjct: 77  VITTPTDIVMVIEYAGGELFD-YIVEKKRMTE-DEGRRFFQQIICAIE----YCH---RH 127
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
           KI+HRDLK  N+LLDD++N KI+DFGL+ I   + N   T+   G+  Y APE   G ++
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLKTS--CGSPNYAAPEVINGKLY 184
Query: 573 S-IKSDVFSFGVLLLEIISGR 592
           +  + DV+S G++L  ++ GR
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGR 205

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 14/208 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNEVNLIAKL 444
           A   F     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +H N++R             I EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +  + + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLPP 178
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E   G +   K D++S GVL  E + G+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNEVNLIAKL 444
           A   F     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +H N++R             I EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 180
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E   G +   K D++S GVL  E + G+
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 98/197 (49%), Gaps = 13/197 (6%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
           +LG G FG VYK    +  A+A  ++  T S + L+++  E+ ++A   H  +V+     
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + E+ P  ++D  + +  R   L   + Q +   +   + +LH     +IIH
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHSK---RIIH 132
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM-----GGI 571
           RDLKA N+L+  + + +++DFG++        + ++ I  GT  +MAPE  M        
Sbjct: 133 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI--GTPYWMAPEVVMCETMKDTP 190
Query: 572 FSIKSDVFSFGVLLLEI 588
           +  K+D++S G+ L+E+
Sbjct: 191 YDYKADIWSLGITLIEM 207

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 106/233 (45%), Gaps = 37/233 (15%)
Query: 386 ALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL 444
           +L   + F +   LGQG FG V K   A D +  A+K++ R + + L    +EV L+A L
Sbjct: 1   SLRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASL 59
Query: 445 QH-------------KNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKR 491
            H             +N V+               EY  N++L    +D   S  L+ +R
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTL----YDLIHSENLNQQR 115
Query: 492 RQ--SIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA--------- 540
            +   +   I   + Y+H      IIHRDLK  NI +D+  N KI DFGLA         
Sbjct: 116 DEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 541 -RIFGGNQNQANTNIIA--GTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEII 589
            ++   N   ++ N+ +  GT  Y+A E   G G ++ K D++S G++  E+I
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 98/197 (49%), Gaps = 13/197 (6%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
           +LG G FG VYK    +  A+A  ++  T S + L+++  E+ ++A   H  +V+     
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + E+ P  ++D  + +  R   L   + Q +   +   + +LH     +IIH
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHSK---RIIH 140
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM-----GGI 571
           RDLKA N+L+  + + +++DFG++        + ++ I  GT  +MAPE  M        
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI--GTPYWMAPEVVMCETMKDTP 198
Query: 572 FSIKSDVFSFGVLLLEI 588
           +  K+D++S G+ L+E+
Sbjct: 199 YDYKADIWSLGITLIEM 215

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 14/208 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNEVNLIAKL 444
           A   F     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +H N++R             I EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +    + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPP 180
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E   G     K D++S GVL  E + G+
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 400 GQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXXXXX 459
            +G FG V+K  L + + +AVK       Q  Q  + EV  +  ++H+N+++        
Sbjct: 33  ARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRG 90
Query: 460 XXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-------SRL 512
                    +        L D  ++  + W     I   +ARG+ YLHED        + 
Sbjct: 91  TSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKP 150
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI- 571
            I HRD+K+ N+LL +++   I+DFGLA  F   ++  +T+   GT  YMAPE   G I 
Sbjct: 151 AISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAIN 210
Query: 572 FS----IKSDVFSFGVLLLEIIS 590
           F     ++ D+++ G++L E+ S
Sbjct: 211 FQRDAFLRIDMYAMGLVLWELAS 233

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 14/208 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNEVNLIAKL 444
           A   F     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +H N++R             I EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           Y H     ++IHRD+K  N+LL      KI+DFG    +  +   +  + + GT  Y+ P
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLPP 201
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E   G +   K D++S GVL  E + G+
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 31/217 (14%)
Query: 399 LGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXXXXX 456
           LG+GGFG V++     D    A+KR+   + +  +E    EV  +AKL+H  +VR     
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDW--------KRRQS----IINGIARGIL 504
                   +    P   L + +    +    DW        +R +S    I   IA  + 
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA-------- 556
           +LH      ++HRDLK SNI    D   K+ DFGL  +   +Q++    ++         
Sbjct: 133 FLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGL--VTAMDQDEEEQTVLTPMPAYARH 187
Query: 557 ----GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEII 589
               GT  YM+PE   G  +S K D+FS G++L E++
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 398 KLGQGGFGPVYKGTLAD---GKA---IAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLV 450
           +LGQG FG VY+G   D   G+A   +AVK ++ ++  +   EF NE +++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING-------IARGI 503
           R             + E M +  L  +L       + +  R    +         IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAGTYGYM 562
            YL+     K +HRDL A N ++  D   KI DFG+ R I+  +  +     +     +M
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-WM 199
Query: 563 APEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           APE    G+F+  SD++SFGV+L EI S
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXXXXX 456
           LG+G +G V         +A+AVK +         E  K E+ +   L H+N+V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                     EY     L    FD     + +     Q   + +  G++YLH    + I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRD+K  N+LLD+  N KISDFGLA +F  N  +   N + GT  Y+APE      F  +
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186
Query: 576 S-DVFSFGVLLLEIISG 591
             DV+S G++L  +++G
Sbjct: 187 PVDVWSCGIVLTAMLAG 203

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 93/202 (46%), Gaps = 31/202 (15%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXXXX 458
           +G+G FG V  G    G  +AVK +   +    Q F  E +++ +L+H NLV+       
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 459 XXXXXXIY-EYMPNKSLDVHLFDATRSVQLDWKRRQSIING---------IARGILYLHE 508
                 I  EYM   SL     D  RS      R +S++ G         +   + YL  
Sbjct: 86  EKGGLYIVTEYMAKGSL----VDYLRS------RGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
           ++    +HRDL A N+L+ +D   K+SDFGL +     Q+     +      + APE   
Sbjct: 136 NN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALR 187
Query: 569 GGIFSIKSDVFSFGVLLLEIIS 590
              FS KSDV+SFG+LL EI S
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYS 209

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 99/215 (46%), Gaps = 26/215 (12%)
Query: 399 LGQGGFGPVY--------KGTLADGKAIAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHKN 448
           LG+G FG V         K    +   +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 449 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHL-----------FDATR--SVQLDWKRRQSI 495
           ++              I EY    +L  +L           +D  R    Q+ +K   S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 555
              +ARG+ YL   +  K IHRDL A N+L+ ++   KI+DFGLAR         NT   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 556 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                +MAPE     +++ +SDV+SFGVL+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 15/207 (7%)
Query: 392 HFSDENKLGQGGFGPVYKGTLAD--GKAI--AVKRLSRTSGQG-LQEFKNEVNLIAKLQH 446
           HF++   +G+G FG VY GTL D  GK I  AVK L+R +  G + +F  E  ++    H
Sbjct: 51  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 108
Query: 447 KNLVRXXXX-XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
            N++               +  YM +  L   + + T +  +  K        +A+G+ Y
Sbjct: 109 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 166
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG--TYGYMA 563
           L   +  K +HRDL A N +LD+    K++DFGLAR     +  +  N         +MA
Sbjct: 167 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 223
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
            E      F+ KSDV+SFGVLL E+++
Sbjct: 224 LESLQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 102/222 (45%), Gaps = 23/222 (10%)
Query: 382 PLRLALEATNHFSDENK----LGQGGFGPVY--KGTLADGKAIAVKRLSR---TSGQGLQ 432
           P      +T  FSD  K    LG+G FG V   K  +  G+  AVK +S+         +
Sbjct: 13  PGXFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKE 71
Query: 433 EFKNEVNLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRR 492
               EV L+ +L H N+ +             + E      L   +    R  ++D  R 
Sbjct: 72  SLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR- 130
Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFGGNQNQ 549
             II  +  GI Y H++   KI+HRDLK  N+LL+    D N +I DFGL+  F  ++  
Sbjct: 131 --IIRQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKX 185
Query: 550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
            +     GT  Y+APE  + G +  K DV+S GV+L  ++SG
Sbjct: 186 KDK---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 11/196 (5%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            +LG G FG V  G       +A+K +   S     EF  E  ++  L H+ LV+     
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   I EYM N  L  +L +     Q   ++   +   +   + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLH 143
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG--YMAPEYAMGGIFSI 574
           RDL A N L++D    K+SDFGL+R    ++    T+ +   +   +  PE  M   FS 
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---ETSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 575 KSDVFSFGVLLLEIIS 590
           KSD+++FGVL+ EI S
Sbjct: 201 KSDIWAFGVLMWEIYS 216

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 395 DENK----LGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
           DEN     LG+G +G VY G  L++   IA+K +     +  Q    E+ L   L+HKN+
Sbjct: 22  DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI 81
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           V+               E +P  SL   L      ++ + +        I  G+ YLH++
Sbjct: 82  VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 141
Query: 510 SRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
              +I+HRD+K  N+L++      KISDFG ++   G      T    GT  YMAPE   
Sbjct: 142 ---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIID 196
Query: 569 GGI--FSIKSDVFSFGVLLLEIISGR 592
            G   +   +D++S G  ++E+ +G+
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 395 DENK----LGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
           DEN     LG+G +G VY G  L++   IA+K +     +  Q    E+ L   L+HKN+
Sbjct: 8   DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI 67
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           V+               E +P  SL   L      ++ + +        I  G+ YLH++
Sbjct: 68  VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 127
Query: 510 SRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
              +I+HRD+K  N+L++      KISDFG ++   G      T    GT  YMAPE   
Sbjct: 128 ---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIID 182
Query: 569 GGI--FSIKSDVFSFGVLLLEIISGR 592
            G   +   +D++S G  ++E+ +G+
Sbjct: 183 KGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 11/196 (5%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            +LG G FG V  G       +A+K +   S     EF  E  ++  L H+ LV+     
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   I EYM N  L  +L +     Q   ++   +   +   + YL      + +H
Sbjct: 73  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLH 127
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG--YMAPEYAMGGIFSI 574
           RDL A N L++D    K+SDFGL+R    ++    T+ +   +   +  PE  M   FS 
Sbjct: 128 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSKFSS 184
Query: 575 KSDVFSFGVLLLEIIS 590
           KSD+++FGVL+ EI S
Sbjct: 185 KSDIWAFGVLMWEIYS 200

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 20/222 (9%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKL 444
             F     LG G FG VYKG  + +G+     +A+K L   TS +  +E  +E  ++A +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIAR 501
            + ++ R             I + MP   L     D  R  + D    Q ++N    IA+
Sbjct: 79  DNPHVCRLLGICLTSTVQL-IMQLMPFGCL----LDYVREHK-DNIGSQYLLNWCVQIAK 132
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ YL ED RL  +HRDL A N+L+    + KI+DFG A++ G  + + +         +
Sbjct: 133 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 189
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS--GRKNNGFYFSE 601
           MA E  +  I++ +SDV+S+GV + E+++   +  +G   SE
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 231

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 20/222 (9%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKL 444
             F     LG G FG VYKG  + +G+     +A+  L   TS +  +E  +E  ++A +
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIAR 501
            + ++ R             I + MP   L     D  R  + D    Q ++N    IA+
Sbjct: 109 DNPHVCRLLGICLTSTVQL-ITQLMPFGCL----LDYVREHK-DNIGSQYLLNWCVQIAK 162
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ YL ED RL  +HRDL A N+L+    + KI+DFGLA++ G  + + +         +
Sbjct: 163 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 219
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS--GRKNNGFYFSE 601
           MA E  +  I++ +SDV+S+GV + E+++   +  +G   SE
Sbjct: 220 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 261

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 398 KLGQGGFGPVYKGTLAD---GKA---IAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLV 450
           +LGQG FG VY+G   D   G+A   +AVK ++ ++  +   EF NE +++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING-------IARGI 503
           R             + E M +  L  +L       + +  R    +         IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            YL+     K +HRDL A N ++  D   KI DFG+ R                   +MA
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMA 200
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           PE    G+F+  SD++SFGV+L EI S
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 20/222 (9%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKL 444
             F     L  G FG VYKG  + +G+     +A+K L   TS +  +E  +E  ++A +
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIAR 501
            + ++ R             I + MP   L     D  R  + D    Q ++N    IA+
Sbjct: 75  DNPHVCRLLGICLTSTVQL-ITQLMPFGCL----LDYVREHK-DNIGSQYLLNWCVQIAK 128
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ YL ED RL  +HRDL A N+L+    + KI+DFGLA++ G  + + +         +
Sbjct: 129 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS--GRKNNGFYFSE 601
           MA E  +  I++ +SDV+S+GV + E+++   +  +G   SE
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 104/220 (47%), Gaps = 31/220 (14%)
Query: 399 LGQGGFGPVYKGTL--ADGKA----IAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLVR 451
           LG+G FG V K T     G+A    +AVK L    S   L++  +E N++ ++ H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 452 XXXXXXXXXXXXXIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIING 498
                        I EY    SL   L ++ +             S  LD    +++  G
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 499 --------IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550
                   I++G+ YL E   +K++HRDL A NIL+ +    KISDFGL+R      +  
Sbjct: 151 DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +       +MA E     I++ +SDV+SFGVLL EI++
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 11/196 (5%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            +LG G FG V  G       +A+K +   S     EF  E  ++  L H+ LV+     
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   I EYM N  L  +L +     Q   ++   +   +   + YL      + +H
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLH 123
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG--YMAPEYAMGGIFSI 574
           RDL A N L++D    K+SDFGL+R    ++    T+ +   +   +  PE  M   FS 
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 575 KSDVFSFGVLLLEIIS 590
           KSD+++FGVL+ EI S
Sbjct: 181 KSDIWAFGVLMWEIYS 196

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 18/209 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKL 444
             F     LG G FG VYKG  + +G+     +A+K L   TS +  +E  +E  ++A +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIAR 501
            + ++ R             I + MP   L     D  R  + D    Q ++N    IA+
Sbjct: 77  DNPHVCRLLGICLTSTVQL-IMQLMPFGCL----LDYVREHK-DNIGSQYLLNWCVQIAK 130
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ YL ED RL  +HRDL A N+L+    + KI+DFG A++ G  + + +         +
Sbjct: 131 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNEVNLIAKL 444
           A   F     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +H N++R             I EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           Y H     ++IHRD+K  N+LL      KI++FG    +  +   +    + GT  Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPP 177
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E   G +   K D++S GVL  E + G+
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 11/196 (5%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            +LG G FG V  G       +A+K +   S     EF  E  ++  L H+ LV+     
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   I EYM N  L  +L +     Q   ++   +   +   + YL      + +H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLH 128
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG--YMAPEYAMGGIFSI 574
           RDL A N L++D    K+SDFGL+R    ++    T+ +   +   +  PE  M   FS 
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSKFSS 185
Query: 575 KSDVFSFGVLLLEIIS 590
           KSD+++FGVL+ EI S
Sbjct: 186 KSDIWAFGVLMWEIYS 201

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 18/209 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKL 444
             F     LG G FG VYKG  + +G+     +A+K L   TS +  +E  +E  ++A +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIAR 501
            + ++ R             I + MP   L     D  R  + D    Q ++N    IA+
Sbjct: 77  DNPHVCRLLGICLTSTVQL-IMQLMPFGCL----LDYVREHK-DNIGSQYLLNWCVQIAK 130
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ YL ED RL  +HRDL A N+L+    + KI+DFG A++ G  + + +         +
Sbjct: 131 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 398 KLGQGGFGPVYKGTLAD---GKA---IAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLV 450
           +LGQG FG VY+G   D   G+A   +AVK ++ ++  +   EF NE +++      ++V
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING-------IARGI 503
           R             + E M +  L  +L       + +  R    +         IA G+
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAGTYGYM 562
            YL+     K +HRDL A N ++  D   KI DFG+ R I+  +  +     +     +M
Sbjct: 143 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-WM 198
Query: 563 APEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           APE    G+F+  SD++SFGV+L EI S
Sbjct: 199 APESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 18/209 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKL 444
             F     L  G FG VYKG  + +G+     +A+K L   TS +  +E  +E  ++A +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIAR 501
            + ++ R             I + MP   L     D  R  + D    Q ++N    IA+
Sbjct: 82  DNPHVCRLLGICLTSTVQL-IMQLMPFGCL----LDYVREHK-DNIGSQYLLNWCVQIAK 135
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ YL ED RL  +HRDL A N+L+    + KI+DFGLA++ G  + + +         +
Sbjct: 136 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 18/209 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKL 444
             F     LG G FG VYKG  + +G+     +A+K L   TS +  +E  +E  ++A +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIAR 501
            + ++ R             I + MP   L     D  R  + D    Q ++N    IA+
Sbjct: 75  DNPHVCRLLGICLTSTVQL-ITQLMPFGCL----LDYVREHK-DNIGSQYLLNWCVQIAK 128
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ YL ED RL  +HRDL A N+L+    + KI+DFG A++ G  + + +         +
Sbjct: 129 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 185
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 11/196 (5%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            +LG G FG V  G       +A+K +   S     EF  E  ++  L H+ LV+     
Sbjct: 21  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   I EYM N  L  +L +     Q   ++   +   +   + YL      + +H
Sbjct: 80  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLH 134
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG--YMAPEYAMGGIFSI 574
           RDL A N L++D    K+SDFGL+R    ++    T+ +   +   +  PE  M   FS 
Sbjct: 135 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSKFSS 191
Query: 575 KSDVFSFGVLLLEIIS 590
           KSD+++FGVL+ EI S
Sbjct: 192 KSDIWAFGVLMWEIYS 207

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 392 HFSDENKLGQGGFGPVYKGTLAD--GKAI--AVKRLSRTSGQG-LQEFKNEVNLIAKLQH 446
           HF++   +G+G FG VY GTL D  GK I  AVK L+R +  G + +F  E  ++    H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 447 KNLVRXXXX-XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
            N++               +  YM +  L   + + T +  +  K        +A+G+ +
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 148
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI-----FGGNQNQANTNIIAGTYG 560
           L   +  K +HRDL A N +LD+    K++DFGLAR      F    N+    +      
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL---PVK 202
Query: 561 YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 203 WMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 392 HFSDENKLGQGGFGPVYKGTLAD--GKAI--AVKRLSRTSGQG-LQEFKNEVNLIAKLQH 446
           HF++   +G+G FG VY GTL D  GK I  AVK L+R +  G + +F  E  ++    H
Sbjct: 31  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 88
Query: 447 KNLVRXXXX-XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
            N++               +  YM +  L   + + T +  +  K        +A+G+ +
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 146
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI-----FGGNQNQANTNIIAGTYG 560
           L   +  K +HRDL A N +LD+    K++DFGLAR      F    N+    +      
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL---PVK 200
Query: 561 YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 201 WMALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNEVNLIAKL 444
           A   F     LG+G FG VY       K I A+K L  ++    G++ + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +H N++R             I EY P   L     +  +  + D +R  + I  +A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           Y H     ++IHRD+K  N+LL      KI++FG    +  +   +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPP 178
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E   G +   K D++S GVL  E + G+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 18/209 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKL 444
             F     LG G FG VYKG  + +G+     +A+K L   TS +  +E  +E  ++A +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIAR 501
            + ++ R             I + MP   L     D  R  + D    Q ++N    IA+
Sbjct: 77  DNPHVCRLLGICLTSTVQL-ITQLMPFGCL----LDYVREHK-DNIGSQYLLNWCVQIAK 130
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ YL ED RL  +HRDL A N+L+    + KI+DFG A++ G  + + +         +
Sbjct: 131 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 97/228 (42%), Gaps = 23/228 (10%)
Query: 399 LGQGGFGPVYKGTLADGK------AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVR 451
           LG G FG VY+G ++          +AVK L    S Q   +F  E  +I+K  H+N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 452 XXXXXXXXXXXXXIYEYMPNKSLDVHLFD----ATRSVQLDWKRRQSIINGIARGILYLH 507
                        + E M    L   L +     ++   L       +   IA G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 508 EDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           E+     IHRD+ A N LL         KI DFG+A+                   +M P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPP 215
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF--YFSEHGQTLLTYV 610
           E  M GIF+ K+D +SFGVLL EI S     G+  Y S+  Q +L +V
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSNQEVLEFV 259

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 19/201 (9%)
Query: 399 LGQGGFGPV---YKGTLADGKAIAV---KRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRX 452
           LG+G FG V   Y  T     A+ +   K L+++  QG    + E++ +  L+H ++++ 
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHIIKL 69
Query: 453 XXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                       + EY  N+  D  +     S Q   +  Q II+ +     Y H   R 
Sbjct: 70  YDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVE----YCH---RH 122
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
           KI+HRDLK  N+LLD+ +N KI+DFGL+ I   + N   T+   G+  Y APE   G ++
Sbjct: 123 KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTS--CGSPNYAAPEVISGKLY 179
Query: 573 S-IKSDVFSFGVLLLEIISGR 592
           +  + DV+S GV+L  ++  R
Sbjct: 180 AGPEVDVWSCGVILYVMLCRR 200

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 392 HFSDENKLGQGGFGPVYKGTLAD--GKAI--AVKRLSRTSGQG-LQEFKNEVNLIAKLQH 446
           HF++   +G+G FG VY GTL D  GK I  AVK L+R +  G + +F  E  ++    H
Sbjct: 34  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 91
Query: 447 KNLVRXXXX-XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
            N++               +  YM +  L   + + T +  +  K        +A+G+ +
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 149
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI-----FGGNQNQANTNIIAGTYG 560
           L   +  K +HRDL A N +LD+    K++DFGLAR      F    N+    +      
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL---PVK 203
Query: 561 YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 204 WMALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 91/199 (45%), Gaps = 11/199 (5%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           E  +G+G FG V K      K +A+K++   S +  + F  E+  ++++ H N+V+    
Sbjct: 13  EEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 69
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    + EY    SL   L  A            S     ++G+ YLH      +I
Sbjct: 70  CLNPVCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 516 HRDLKASNILL-DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           HRDLK  N+LL       KI DFG A      Q     N   G+  +MAPE   G  +S 
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNN--KGSAAWMAPEVFEGSNYSE 182
Query: 575 KSDVFSFGVLLLEIISGRK 593
           K DVFS+G++L E+I+ RK
Sbjct: 183 KCDVFSWGIILWEVITRRK 201

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 91/199 (45%), Gaps = 11/199 (5%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           E  +G+G FG V K      K +A+K++   S +  + F  E+  ++++ H N+V+    
Sbjct: 14  EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 70
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    + EY    SL   L  A            S     ++G+ YLH      +I
Sbjct: 71  CLNPVCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 128
Query: 516 HRDLKASNILL-DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           HRDLK  N+LL       KI DFG A      Q     N   G+  +MAPE   G  +S 
Sbjct: 129 HRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNN--KGSAAWMAPEVFEGSNYSE 183
Query: 575 KSDVFSFGVLLLEIISGRK 593
           K DVFS+G++L E+I+ RK
Sbjct: 184 KCDVFSWGIILWEVITRRK 202

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 392 HFSDENKLGQGGFGPVYKGTLAD--GKAI--AVKRLSRTSGQG-LQEFKNEVNLIAKLQH 446
           HF++   +G+G FG VY GTL D  GK I  AVK L+R +  G + +F  E  ++    H
Sbjct: 34  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 91
Query: 447 KNLVRXXXX-XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
            N++               +  YM +  L   + + T +  +  K        +A+G+ +
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 149
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI-----FGGNQNQANTNIIAGTYG 560
           L   +  K +HRDL A N +LD+    K++DFGLAR      F    N+    +      
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKL---PVK 203
Query: 561 YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 204 WMALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 18/209 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKL 444
             F     L  G FG VYKG  + +G+     +A+K L   TS +  +E  +E  ++A +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIAR 501
            + ++ R             I + MP   L     D  R  + D    Q ++N    IA+
Sbjct: 82  DNPHVCRLLGICLTSTVQL-ITQLMPFGCL----LDYVREHK-DNIGSQYLLNWCVQIAK 135
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ YL ED RL  +HRDL A N+L+    + KI+DFGLA++ G  + + +         +
Sbjct: 136 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 19/201 (9%)
Query: 399 LGQGGFGPV---YKGTLADGKAIAV---KRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRX 452
           LG+G FG V   Y  T     A+ +   K L+++  QG    + E++ +  L+H ++++ 
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHIIKL 79
Query: 453 XXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                       + EY  N+  D  +     S Q   +  Q II+ +     Y H   R 
Sbjct: 80  YDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVE----YCH---RH 132
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
           KI+HRDLK  N+LLD+ +N KI+DFGL+ I   + N   T+   G+  Y APE   G ++
Sbjct: 133 KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTS--CGSPNYAAPEVISGKLY 189
Query: 573 S-IKSDVFSFGVLLLEIISGR 592
           +  + DV+S GV+L  ++  R
Sbjct: 190 AGPEVDVWSCGVILYVMLCRR 210

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXXXXX 456
           LG+G  G V         +A+AVK +         E  K E+ +   L H+N+V+     
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                     EY     L    FD     + +     Q   + +  G++YLH    + I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRD+K  N+LLD+  N KISDFGLA +F  N  +   N + GT  Y+APE      F  +
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 576 S-DVFSFGVLLLEIISG 591
             DV+S G++L  +++G
Sbjct: 187 PVDVWSCGIVLTAMLAG 203

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 392 HFSDENKLGQGGFGPVYKGTLAD--GKAI--AVKRLSRTSGQG-LQEFKNEVNLIAKLQH 446
           HF++   +G+G FG VY GTL D  GK I  AVK L+R +  G + +F  E  ++    H
Sbjct: 38  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 95
Query: 447 KNLVRXXXX-XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
            N++               +  YM +  L   + + T +  +  K        +A+G+ +
Sbjct: 96  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 153
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI-----FGGNQNQANTNIIAGTYG 560
           L   +  K +HRDL A N +LD+    K++DFGLAR      F    N+    +      
Sbjct: 154 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL---PVK 207
Query: 561 YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 208 WMALESLQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 18/209 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKL 444
             F     LG G FG VYKG  + +G+     +A+K L   TS +  +E  +E  ++A +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIAR 501
            + ++ R             I + MP   L     D  R  + D    Q ++N    IA+
Sbjct: 82  DNPHVCRLLGICLTSTVQL-ITQLMPFGCL----LDYVREHK-DNIGSQYLLNWCVQIAK 135
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ YL ED RL  +HRDL A N+L+    + KI+DFG A++ G  + + +         +
Sbjct: 136 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 192
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           MA E  +  I++ +SDV+S+GV + E+++
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 11/196 (5%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            +LG G FG V  G       +A+K +   S     EF  E  ++  L H+ LV+     
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   I EYM N  L  +L +     Q   ++   +   +   + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLH 143
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG--YMAPEYAMGGIFSI 574
           RDL A N L++D    K+SDFGL+R    ++    T+ +   +   +  PE  M   FS 
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 575 KSDVFSFGVLLLEIIS 590
           KSD+++FGVL+ EI S
Sbjct: 201 KSDIWAFGVLMWEIYS 216

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 104/220 (47%), Gaps = 31/220 (14%)
Query: 399 LGQGGFGPVYKGTL--ADGKA----IAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLVR 451
           LG+G FG V K T     G+A    +AVK L    S   L++  +E N++ ++ H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 452 XXXXXXXXXXXXXIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIING 498
                        I EY    SL   L ++ +             S  LD    +++  G
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 499 --------IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550
                   I++G+ YL E   +K++HRDL A NIL+ +    KISDFGL+R      +  
Sbjct: 151 DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +       +MA E     I++ +SDV+SFGVLL EI++
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 19/201 (9%)
Query: 399 LGQGGFGPV---YKGTLADGKAIAV---KRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRX 452
           LG+G FG V   Y  T     A+ +   K L+++  QG    + E++ +  L+H ++++ 
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHIIKL 78
Query: 453 XXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                       + EY  N+  D  +     S Q   +  Q II+ +     Y H   R 
Sbjct: 79  YDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVE----YCH---RH 131
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
           KI+HRDLK  N+LLD+ +N KI+DFGL+ I   + N   T+   G+  Y APE   G ++
Sbjct: 132 KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTS--CGSPNYAAPEVISGKLY 188
Query: 573 S-IKSDVFSFGVLLLEIISGR 592
           +  + DV+S GV+L  ++  R
Sbjct: 189 AGPEVDVWSCGVILYVMLCRR 209

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 13/210 (6%)
Query: 388 EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN--EVNLIAKL 444
           E    +   + +G G +G V     +  G  IAVK+LSR     +   +   E+ L+  +
Sbjct: 48  EVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHM 107
Query: 445 QHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
           +H+N++                + Y+    +   L +  +  +L     Q +I  I RG+
Sbjct: 108 KHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 167
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            Y+H      IIHRDLK SN+ +++D   KI DFGLAR    + +   T  +A T  Y A
Sbjct: 168 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVA-TRWYRA 219
Query: 564 PEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           PE  +  + +++  D++S G ++ E+++GR
Sbjct: 220 PEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 392 HFSDENKLGQGGFGPVYKGTLAD--GKAI--AVKRLSRTSGQG-LQEFKNEVNLIAKLQH 446
           HF++   +G+G FG VY GTL D  GK I  AVK L+R +  G + +F  E  ++    H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 447 KNLVRXXXX-XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
            N++               +  YM +  L   + + T +  +  K        +A+G+ +
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 148
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI-----FGGNQNQANTNIIAGTYG 560
           L   +  K +HRDL A N +LD+    K++DFGLAR      F    N+    +      
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL---PVK 202
Query: 561 YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 203 WMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 19/201 (9%)
Query: 399 LGQGGFGPV---YKGTLADGKAIAV---KRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRX 452
           LG+G FG V   Y  T     A+ +   K L+++  QG    + E++ +  L+H ++++ 
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHIIKL 73
Query: 453 XXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                       + EY  N+  D  +     S Q   +  Q II+ +     Y H   R 
Sbjct: 74  YDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVE----YCH---RH 126
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
           KI+HRDLK  N+LLD+ +N KI+DFGL+ I   + N   T+   G+  Y APE   G ++
Sbjct: 127 KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTS--CGSPNYAAPEVISGKLY 183
Query: 573 S-IKSDVFSFGVLLLEIISGR 592
           +  + DV+S GV+L  ++  R
Sbjct: 184 AGPEVDVWSCGVILYVMLCRR 204

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 116/260 (44%), Gaps = 22/260 (8%)
Query: 368 GGKQQAESQEFPLFPLRLALEATNHFSDEN-------KLGQGGFGPVYKGTL-ADGKAIA 419
           G   Q E Q       R AL+      D         K+G+G  G V   T+ + GK +A
Sbjct: 1   GSSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVA 60
Query: 420 VKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLF 479
           VK++     Q  +   NEV ++   QH+N+V              + E++   +L     
Sbjct: 61  VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT---- 116
Query: 480 DATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL 539
           D     +++ ++  ++   + + +  LH      +IHRD+K+ +ILL  D   K+SDFG 
Sbjct: 117 DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGF 173
Query: 540 -ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY 598
            A++   ++       + GT  +MAPE      +  + D++S G++++E++ G      Y
Sbjct: 174 CAQV---SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP---Y 227
Query: 599 FSEHGQTLLTYVCNSLSLSL 618
           F+E     +  + ++L   L
Sbjct: 228 FNEPPLKAMKMIRDNLPPRL 247

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 106/228 (46%), Gaps = 30/228 (13%)
Query: 390 TNHFSDENKLGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ 445
           ++ F  E++LG+G    VY    KGT    K  A+K L +T  + +   + E+ ++ +L 
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGT---QKPYALKVLKKTVDKKI--VRTEIGVLLRLS 106
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDW---KRRQSIINGIARG 502
           H N+++             + E +        LFD  R V+  +   +     +  I   
Sbjct: 107 HPNIIKLKEIFETPTEISLVLELVTGG----ELFD--RIVEKGYYSERDAADAVKQILEA 160
Query: 503 ILYLHEDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFGGNQNQANTNIIAGTY 559
           + YLHE+    I+HRDLK  N+L      D   KI+DFGL++I    ++Q     + GT 
Sbjct: 161 VAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGTP 214
Query: 560 GYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLL 607
           GY APE   G  +  + D++S G++   ++ G +    ++ E G   +
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP---FYDERGDQFM 259

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQ---EFKNEVNLIAKLQH 446
            H+   + LG G FG V  G     G  +AVK L+R   + L    + K E+  +   +H
Sbjct: 11  GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 447 KNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
            ++++             + EY+    L  ++    R  +++ +R   +   I   + Y 
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR---LFQQILSAVDYC 127
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H   R  ++HRDLK  N+LLD  MN KI+DFGL+ +    +   ++    G+  Y APE 
Sbjct: 128 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS---CGSPNYAAPEV 181
Query: 567 AMGGIFS-IKSDVFSFGVLLLEIISG 591
             G +++  + D++S GV+L  ++ G
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 25/211 (11%)
Query: 398 KLGQGGFGPVY----KGTLADGKA--IAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLV 450
           +LGQG FG VY    KG + D     +A+K ++  +    + EF NE +++ +    ++V
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWK-----------RRQSIINGI 499
           R             I E M    L  +L    RS++ + +           +   +   I
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLSKMIQMAGEI 141
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTY 559
           A G+ YL+ +   K +HRDL A N ++ +D   KI DFG+ R                  
Sbjct: 142 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 198
Query: 560 GYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
            +M+PE    G+F+  SDV+SFGV+L EI +
Sbjct: 199 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 87/194 (44%), Gaps = 7/194 (3%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            +LG G FG V  G       +AVK +   S     EF  E   + KL H  LV+     
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + EY+ N  L  +L    +   L+  +   +   +  G+ +L      + IH
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDL A N L+D D+  K+SDFG+ R    +Q  ++         + APE      +S KS
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG-TKFPVKWSAPEVFHYFKYSSKS 186
Query: 577 DVFSFGVLLLEIIS 590
           DV++FG+L+ E+ S
Sbjct: 187 DVWAFGILMWEVFS 200

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 399 LGQGGFGPVY--------KGTLADGKAIAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHKN 448
           LG+G FG V         K    +   +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 449 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHL-----------FDATR--SVQLDWKRRQSI 495
           ++              I EY    +L  +L           +D  R    Q+ +K   S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 555
              +ARG+ YL   +  K IHRDL A N+L+ ++   KI+DFGLAR          T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 556 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                +MAPE     +++ +SDV+SFGVL+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 399 LGQGGFGPVY--------KGTLADGKAIAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHKN 448
           LG+G FG V         K    +   +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 449 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHL-----------FDATR--SVQLDWKRRQSI 495
           ++              I EY    +L  +L           +D  R    Q+ +K   S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 555
              +ARG+ YL   +  K IHRDL A N+L+ ++   KI+DFGLAR          T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 556 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                +MAPE     +++ +SDV+SFGVL+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 14/207 (6%)
Query: 391 NHFSDENKLGQGGFGPVY---KGTLAD-GKAIAVKRLSRTSGQGLQEF--KNEVNLIAKL 444
           +HF     LGQG FG V+   K T  D G   A+K L + + +       K E +++A +
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADV 87
Query: 445 QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
            H  +V+             I +++    L   L   ++ V    +  +  +  +A G+ 
Sbjct: 88  NHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALGLD 144
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           +LH    L II+RDLK  NILLD++ + K++DFGL++    ++ +A +    GT  YMAP
Sbjct: 145 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCGTVEYMAP 199
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISG 591
           E       S  +D +S+GVL+ E+++G
Sbjct: 200 EVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 392 HFSDENKLGQGGFGPVYKGTLAD--GKAI--AVKRLSRTSGQG-LQEFKNEVNLIAKLQH 446
           HF++   +G+G FG VY GTL D  GK I  AVK L+R +  G + +F  E  ++    H
Sbjct: 92  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 149
Query: 447 KNLVRXXXX-XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
            N++               +  YM +  L   + + T +  +  K        +A+G+ +
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 207
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI-----FGGNQNQANTNIIAGTYG 560
           L   +  K +HRDL A N +LD+    K++DFGLAR      F    N+    +      
Sbjct: 208 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL---PVK 261
Query: 561 YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           +MA E      F+ KSDV+SFGVLL E+++
Sbjct: 262 WMALESLQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 107/224 (47%), Gaps = 15/224 (6%)
Query: 398 KLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
           K+G+G  G V   T+ + GK +AVK++     Q  +   NEV ++   QH+N+V      
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + E++   +L     D     +++ ++  ++   + + +  LH      +IH
Sbjct: 87  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 139
Query: 517 RDLKASNILLDDDMNPKISDFGL-ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           RD+K+ +ILL  D   K+SDFG  A++   ++       + GT  +MAPE      +  +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPELISRLPYGPE 196
Query: 576 SDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLSLSLS 619
            D++S G++++E++ G      YF+E     +  + ++L   L 
Sbjct: 197 VDIWSLGIMVIEMVDGEPP---YFNEPPLKAMKMIRDNLPPRLK 237

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 25/211 (11%)
Query: 398 KLGQGGFGPVY----KGTLADGKA--IAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLV 450
           +LGQG FG VY    KG + D     +A+K ++  +    + EF NE +++ +    ++V
Sbjct: 17  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 76
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWK-----------RRQSIINGI 499
           R             I E M    L  +L    RS++ + +           +   +   I
Sbjct: 77  RLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLSKMIQMAGEI 132
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTY 559
           A G+ YL+ +   K +HRDL A N ++ +D   KI DFG+ R                  
Sbjct: 133 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 189
Query: 560 GYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
            +M+PE    G+F+  SDV+SFGV+L EI +
Sbjct: 190 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 107/223 (47%), Gaps = 15/223 (6%)
Query: 398 KLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
           K+G+G  G V   T+ + GK +AVK++     Q  +   NEV ++   QH+N+V      
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + E++   +L     D     +++ ++  ++   + + +  LH      +IH
Sbjct: 96  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 148
Query: 517 RDLKASNILLDDDMNPKISDFGL-ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           RD+K+ +ILL  D   K+SDFG  A++   ++       + GT  +MAPE      +  +
Sbjct: 149 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPELISRLPYGPE 205
Query: 576 SDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLSLSL 618
            D++S G++++E++ G      YF+E     +  + ++L   L
Sbjct: 206 VDIWSLGIMVIEMVDGEPP---YFNEPPLKAMKMIRDNLPPRL 245

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 87/194 (44%), Gaps = 7/194 (3%)
Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
            +LG G FG V  G       +A+K +   S     EF  E  ++  L H+ LV+     
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   I EYM N  L  +L +     Q   ++   +   +   + YL      + +H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLESK---QFLH 128
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDL A N L++D    K+SDFGL+R    ++  ++         +  PE  M   FS KS
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRG-SKFPVRWSPPEVLMYSKFSSKS 187
Query: 577 DVFSFGVLLLEIIS 590
           D+++FGVL+ EI S
Sbjct: 188 DIWAFGVLMWEIYS 201

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 105/233 (45%), Gaps = 37/233 (15%)
Query: 386 ALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL 444
           +L   + F +   LGQG FG V K   A D +  A+K++ R + + L    +EV L+A L
Sbjct: 1   SLRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASL 59
Query: 445 QH-------------KNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKR 491
            H             +N V+               EY  N +L    +D   S  L+ +R
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQR 115
Query: 492 RQ--SIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA--------- 540
            +   +   I   + Y+H      IIHRDLK  NI +D+  N KI DFGLA         
Sbjct: 116 DEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 541 -RIFGGNQNQANTNIIA--GTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEII 589
            ++   N   ++ N+ +  GT  Y+A E   G G ++ K D++S G++  E+I
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 107/223 (47%), Gaps = 15/223 (6%)
Query: 398 KLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
           K+G+G  G V   T+ + GK +AVK++     Q  +   NEV ++   QH+N+V      
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + E++   +L     D     +++ ++  ++   + + +  LH      +IH
Sbjct: 91  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 143
Query: 517 RDLKASNILLDDDMNPKISDFGL-ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           RD+K+ +ILL  D   K+SDFG  A++   ++       + GT  +MAPE      +  +
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPELISRLPYGPE 200
Query: 576 SDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLSLSL 618
            D++S G++++E++ G      YF+E     +  + ++L   L
Sbjct: 201 VDIWSLGIMVIEMVDGEPP---YFNEPPLKAMKMIRDNLPPRL 240

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 14/206 (6%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQ---EFKNEVNLIAKLQH 446
            H+   + LG G FG V  G     G  +AVK L+R   + L    + K E+  +   +H
Sbjct: 11  GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 447 KNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
            ++++             + EY+    L  ++    R  +++ +R   +   I   + Y 
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR---LFQQILSAVDYC 127
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H   R  ++HRDLK  N+LLD  MN KI+DFGL+ +    +    +    G+  Y APE 
Sbjct: 128 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPEV 181
Query: 567 AMGGIFS-IKSDVFSFGVLLLEIISG 591
             G +++  + D++S GV+L  ++ G
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 110/238 (46%), Gaps = 19/238 (7%)
Query: 365 ILRGGKQQAESQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAI 418
           + RG      SQE P F  R  L     E    + + + +G G +G V        G  +
Sbjct: 15  VPRGSHMLEMSQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRV 73
Query: 419 AVKRLSRTSGQGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLD 475
           AVK+LSR     +   +   E+ L+  ++H+N++                + Y+    + 
Sbjct: 74  AVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG 133
Query: 476 VHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS 535
             L +  +  +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI 
Sbjct: 134 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKIL 190
Query: 536 DFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           DFGLAR    + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 191 DFGLAR----HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/92 (46%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +ARG+ +L   S  K IHRDL A NILL ++   KI DFGLAR    N +          
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +MAPE     I+S KSDV+S+GVLL EI S
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 399 LGQGGFGPVY--------KGTLADGKAIAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHKN 448
           LG+G FG V         K    +   +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 449 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHL-----------FDATR--SVQLDWKRRQSI 495
           ++              I EY    +L  +L           +D  R    Q+ +K   S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 555
              +ARG+ YL   +  K IHRDL A N+L+ ++   KI+DFGLAR          T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 556 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                +MAPE     +++ +SDV+SFGVL+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 398 KLGQGGFGPVYKGTLAD---GKA---IAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLV 450
           +LGQG FG VY+G   D   G+A   +AVK ++ ++  +   EF NE +++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING-------IARGI 503
           R             + E M +  L  +L       + +  R    +         IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAGTYGYM 562
            YL+     K +HR+L A N ++  D   KI DFG+ R I+  +  +     +     +M
Sbjct: 144 AYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-WM 199
Query: 563 APEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           APE    G+F+  SD++SFGV+L EI S
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 398 KLGQGGFGPVYKGTLAD---GKA---IAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLV 450
           +LGQG FG VY+G   D   G+A   +AVK ++ ++  +   EF NE +++      ++V
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING-------IARGI 503
           R             + E M +  L  +L       + +  R    +         IA G+
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAGTYGYM 562
            YL+     K +HR+L A N ++  D   KI DFG+ R I+  +  +     +     +M
Sbjct: 145 AYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-WM 200
Query: 563 APEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           APE    G+F+  SD++SFGV+L EI S
Sbjct: 201 APESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 399 LGQGGFGPVY--------KGTLADGKAIAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHKN 448
           LG+G FG V         K    +   +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 449 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHL-----------FDATR--SVQLDWKRRQSI 495
           ++              I EY    +L  +L           +D  R    Q+ +K   S 
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 555
              +ARG+ YL   +  K IHRDL A N+L+ ++   KI+DFGLAR          T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 556 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                +MAPE     +++ +SDV+SFGVL+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 15/204 (7%)
Query: 400 GQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXXXXX 459
            +G FG V+K  L +   +AVK       Q  Q  + E+     ++H+NL++        
Sbjct: 24  ARGRFGCVWKAQLMN-DFVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRG 81
Query: 460 XXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED--------SR 511
                    +        L D  +   + W     +   ++RG+ YLHED         +
Sbjct: 82  SNLEVELWLITAFHDKGSLTDYLKGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHK 141
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 571
             I HRD K+ N+LL  D+   ++DFGLA  F   +   +T+   GT  YMAPE   G I
Sbjct: 142 PSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAI 201
Query: 572 -FS----IKSDVFSFGVLLLEIIS 590
            F     ++ D+++ G++L E++S
Sbjct: 202 NFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 107/224 (47%), Gaps = 15/224 (6%)
Query: 398 KLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
           K+G+G  G V   T+ + GK +AVK++     Q  +   NEV ++   QH+N+V      
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + E++   +L     D     +++ ++  ++   + + +  LH      +IH
Sbjct: 141 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 193
Query: 517 RDLKASNILLDDDMNPKISDFGL-ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           RD+K+ +ILL  D   K+SDFG  A++   ++       + GT  +MAPE      +  +
Sbjct: 194 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPELISRLPYGPE 250
Query: 576 SDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLSLSLS 619
            D++S G++++E++ G      YF+E     +  + ++L   L 
Sbjct: 251 VDIWSLGIMVIEMVDGEPP---YFNEPPLKAMKMIRDNLPPRLK 291

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 105/233 (45%), Gaps = 37/233 (15%)
Query: 386 ALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL 444
           +L   + F +   LGQG FG V K   A D +  A+K++ R + + L    +EV L+A L
Sbjct: 1   SLRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASL 59
Query: 445 QH-------------KNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKR 491
            H             +N V+               EY  N++L    +D   S  L+ +R
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTL----YDLIHSENLNQQR 115
Query: 492 RQ--SIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA--------- 540
            +   +   I   + Y+H      IIHR+LK  NI +D+  N KI DFGLA         
Sbjct: 116 DEYWRLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 541 -RIFGGNQNQANTNIIA--GTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEII 589
            ++   N   ++ N+ +  GT  Y+A E   G G ++ K D +S G++  E I
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 399 LGQGGFGPVY--------KGTLADGKAIAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHKN 448
           LG+G FG V         K    +   +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 449 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHL-----------FDATR--SVQLDWKRRQSI 495
           ++              I EY    +L  +L           +D  R    Q+ +K   S 
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 555
              +ARG+ YL   +  K IHRDL A N+L+ ++   KI+DFGLAR          T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 556 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                +MAPE     +++ +SDV+SFGVL+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 31/220 (14%)
Query: 399 LGQGGFGPVYKGTL--ADGKA----IAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLVR 451
           LG+G FG V K T     G+A    +AVK L    S   L++  +E N++ ++ H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 452 XXXXXXXXXXXXXIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIING 498
                        I EY    SL   L ++ +             S  LD    +++  G
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 499 --------IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA 550
                   I++G+ YL E   + ++HRDL A NIL+ +    KISDFGL+R      +  
Sbjct: 151 DLISFAWQISQGMQYLAE---MSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +       +MA E     I++ +SDV+SFGVLL EI++
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 27/212 (12%)
Query: 398 KLGQGGFGPVY----KGTLADGKA--IAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLV 450
           +LGQG FG VY    KG + D     +A+K ++  +    + EF NE +++ +    ++V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQ-----------SIINGI 499
           R             I E M    L  +L    RS++ + +               +   I
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLSKMIQMAGEI 147
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAGT 558
           A G+ YL+ +   K +HRDL A N ++ +D   KI DFG+ R I+  +  +     +   
Sbjct: 148 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 204
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +M+PE    G+F+  SDV+SFGV+L EI +
Sbjct: 205 R-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 398 KLGQGGFGPVY----KGTLADGKA--IAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLV 450
           +LGQG FG VY    KG + D     +A+K ++  +    + EF NE +++ +    ++V
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWK-----------RRQSIINGI 499
           R             I E M    L  +L    RS++ + +           +   +   I
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLSKMIQMAGEI 141
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAGT 558
           A G+ YL+ +   K +HRDL A N ++ +D   KI DFG+ R I+  +  +     +   
Sbjct: 142 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 198
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +M+PE    G+F+  SDV+SFGV+L EI +
Sbjct: 199 R-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 32/218 (14%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEV------NLIAKLQ------- 445
           LG+G FG V    LA+   +   + +R +   ++  K++       +LI++++       
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHL-----------FDATRSV--QLDWKRR 492
           HKN++              I EY    +L  +L           F+ + +   QL  K  
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDL 152
Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
            S    +ARG+ YL   +  K IHRDL A N+L+ +D   KI+DFGLAR          T
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKT 209
Query: 553 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                   +MAPE     I++ +SDV+SFGVLL EI +
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 398 KLGQGGFGPVY----KGTLADGKA--IAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLV 450
           +LGQG FG VY    KG + D     +A+K ++  +    + EF NE +++ +    ++V
Sbjct: 23  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 82
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWK-----------RRQSIINGI 499
           R             I E M    L  +L    RS++ + +           +   +   I
Sbjct: 83  RLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLSKMIQMAGEI 138
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAGT 558
           A G+ YL+ +   K +HRDL A N ++ +D   KI DFG+ R I+  +  +     +   
Sbjct: 139 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 195
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +M+PE    G+F+  SDV+SFGV+L EI +
Sbjct: 196 R-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 398 KLGQGGFGPVY----KGTLADGKA--IAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLV 450
           +LGQG FG VY    KG + D     +A+K ++  +    + EF NE +++ +    ++V
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWK-----------RRQSIINGI 499
           R             I E M    L  +L    RS++ + +           +   +   I
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLSKMIQMAGEI 140
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAGT 558
           A G+ YL+ +   K +HRDL A N ++ +D   KI DFG+ R I+  +  +     +   
Sbjct: 141 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 197
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +M+PE    G+F+  SDV+SFGV+L EI +
Sbjct: 198 R-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 107/223 (47%), Gaps = 15/223 (6%)
Query: 398 KLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
           K+G+G  G V   T+ + GK +AVK++     Q  +   NEV ++   QH+N+V      
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + E++   +L     D     +++ ++  ++   + + +  LH      +IH
Sbjct: 218 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIH 270
Query: 517 RDLKASNILLDDDMNPKISDFGL-ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           RD+K+ +ILL  D   K+SDFG  A++   ++       + GT  +MAPE      +  +
Sbjct: 271 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKXLVGTPYWMAPELISRLPYGPE 327
Query: 576 SDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLSLSL 618
            D++S G++++E++ G      YF+E     +  + ++L   L
Sbjct: 328 VDIWSLGIMVIEMVDGEPP---YFNEPPLKAMKMIRDNLPPRL 367

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 398 KLGQGGFGPVY----KGTLADGKA--IAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLV 450
           +LGQG FG VY    KG + D     +A+K ++  +    + EF NE +++ +    ++V
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWK-----------RRQSIINGI 499
           R             I E M    L  +L    RS++ + +           +   +   I
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLSKMIQMAGEI 134
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAGT 558
           A G+ YL+ +   K +HRDL A N ++ +D   KI DFG+ R I+  +  +     +   
Sbjct: 135 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 191
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +M+PE    G+F+  SDV+SFGV+L EI +
Sbjct: 192 R-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 20/225 (8%)
Query: 375 SQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQE 433
           ++E P   ++L +E    F     LG+G FG V+        +  A+K L +     L +
Sbjct: 4   NKERPSLQIKLKIED---FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--LMD 58
Query: 434 FKNEVNLIAK------LQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQL 487
              E  ++ K       +H  L               + EY+    L  H+       + 
Sbjct: 59  DDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKF 115
Query: 488 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
           D  R       I  G+ +LH      I++RDLK  NILLD D + KI+DFG+ +      
Sbjct: 116 DLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK--ENML 170
Query: 548 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
             A TN   GT  Y+APE  +G  ++   D +SFGVLL E++ G+
Sbjct: 171 GDAKTNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 399 LGQGGFGPVY--------KGTLADGKAIAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHKN 448
           LG+G FG V         K    +   +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 449 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHL-----------FDATR--SVQLDWKRRQSI 495
           ++              I EY    +L  +L           +D  R    Q+ +K   S 
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 555
              +ARG+ YL   +  K IHRDL A N+L+ ++   KI+DFGLAR          T   
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 556 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                +MAPE     +++ +SDV+SFGVL+ EI +
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 20/225 (8%)
Query: 375 SQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQE 433
           ++E P   ++L +E    F     LG+G FG V+        +  A+K L +     L +
Sbjct: 5   NKERPSLQIKLKIED---FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--LMD 59
Query: 434 FKNEVNLIAK------LQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQL 487
              E  ++ K       +H  L               + EY+    L  H+       + 
Sbjct: 60  DDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKF 116
Query: 488 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
           D  R       I  G+ +LH      I++RDLK  NILLD D + KI+DFG+ +      
Sbjct: 117 DLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK--ENML 171
Query: 548 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
             A TN   GT  Y+APE  +G  ++   D +SFGVLL E++ G+
Sbjct: 172 GDAKTNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 96/205 (46%), Gaps = 24/205 (11%)
Query: 399 LGQGGFG--------PVYKGTLADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNL 449
           LG+G FG        P   GT   G+ +AVK L   +G Q    +K E++++  L H+++
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 450 VRXXX--XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
           ++               + EY+P  SL  +L   +  +       Q I  G+A    YLH
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMA----YLH 151
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF--GGNQNQANTNIIAGTYGYMAPE 565
                  IHRDL A N+LLD+D   KI DFGLA+    G    +   +  +  + Y APE
Sbjct: 152 AQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWY-APE 207
Query: 566 YAMGGIFSIKSDVFSFGVLLLEIIS 590
                 F   SDV+SFGV L E+++
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 398 KLGQGGFGPVY----KGTLADGKA--IAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLV 450
           +LGQG FG VY    KG + D     +A+K ++  +    + EF NE +++ +    ++V
Sbjct: 54  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 113
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWK-----------RRQSIINGI 499
           R             I E M    L  +L    RS++ + +           +   +   I
Sbjct: 114 RLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLSKMIQMAGEI 169
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAGT 558
           A G+ YL+ +   K +HRDL A N ++ +D   KI DFG+ R I+  +  +     +   
Sbjct: 170 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 226
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +M+PE    G+F+  SDV+SFGV+L EI +
Sbjct: 227 R-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 398 KLGQGGFGPVY----KGTLADGKA--IAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLV 450
           +LGQG FG VY    KG + D     +A+K ++  +    + EF NE +++ +    ++V
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWK-----------RRQSIINGI 499
           R             I E M    L  +L    RS++ + +           +   +   I
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLSKMIQMAGEI 140
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAGT 558
           A G+ YL+ +   K +HRDL A N ++ +D   KI DFG+ R I+  +  +     +   
Sbjct: 141 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 197
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +M+PE    G+F+  SDV+SFGV+L EI +
Sbjct: 198 R-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 13/210 (6%)
Query: 388 EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN--EVNLIAKL 444
           E    + + + +G G +G V        G  +AVK+LSR     +   +   E+ L+  +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 445 QHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
           +H+N++                + Y+    +   L +  +  +L     Q +I  I RG+
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGL 134
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            Y+H      IIHRDLK SN+ +++D   KI DFGLAR    + +   T  +A T  Y A
Sbjct: 135 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVA-TRWYRA 186
Query: 564 PEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           PE  +  + ++   D++S G ++ E+++GR
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 96/193 (49%), Gaps = 27/193 (13%)
Query: 416 KAIAVKRLSRTSG-----QGLQEFKN----EVNLIAKLQ-HKNLVRXXXXXXXXXXXXXI 465
           K  AVK +  T G     + +QE +     EV+++ K+  H N+++             +
Sbjct: 43  KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 102
Query: 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNIL 525
           ++ M    L  +L   T  V L  K  + I+  +   I  LH   +L I+HRDLK  NIL
Sbjct: 103 FDLMKKGELFDYL---TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENIL 156
Query: 526 LDDDMNPKISDFGLA-RIFGGNQNQANTNIIAGTYGYMAPEYAMGGI------FSIKSDV 578
           LDDDMN K++DFG + ++  G + ++    + GT  Y+APE     +      +  + D+
Sbjct: 157 LDDDMNIKLTDFGFSCQLDPGEKLRS----VCGTPSYLAPEIIECSMNDNHPGYGKEVDM 212
Query: 579 FSFGVLLLEIISG 591
           +S GV++  +++G
Sbjct: 213 WSTGVIMYTLLAG 225

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 399 LGQGGFGPVY--------KGTLADGKAIAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHKN 448
           LG+G FG V         K    +   +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 449 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHL-----------FDATR--SVQLDWKRRQSI 495
           ++              I EY    +L  +L           +D  R    Q+ +K   S 
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 555
              +ARG+ YL   +  K IHRDL A N+L+ ++   KI+DFGLAR          T   
Sbjct: 152 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 556 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                +MAPE     +++ +SDV+SFGVL+ EI +
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 26/219 (11%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAI--AVKRLSR-TSGQGLQEFKNEVNLIAKL-Q 445
           N    ++ +G+G FG V K  +  DG  +  A+KR+    S    ++F  E+ ++ KL  
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWK-----------RRQS 494
           H N++                EY P+ +L +     +R ++ D               Q 
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNL-LDFLRKSRVLETDPAFAIANSTASTLSSQQ 133
Query: 495 IIN---GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
           +++    +ARG+ YL   S+ + IHRDL A NIL+ ++   KI+DFGL+R   G +    
Sbjct: 134 LLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVK 187
Query: 552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +      +MA E     +++  SDV+S+GVLL EI+S
Sbjct: 188 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 399 LGQGGFGPVY--------KGTLADGKAIAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHKN 448
           LG+G FG V         K    +   +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 449 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHL-----------FDATR--SVQLDWKRRQSI 495
           ++              I EY    +L  +L           +D  R    Q+ +K   S 
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 555
              +ARG+ YL   +  K IHRDL A N+L+ ++   KI+DFGLAR          T   
Sbjct: 155 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 556 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                +MAPE     +++ +SDV+SFGVL+ EI +
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 14/213 (6%)
Query: 385 LALEATNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQE--FKNEVNLI 441
           L  ++   + +   +G+G +G V K    D G+ +A+K+   +    + +     E+ L+
Sbjct: 19  LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLL 78
Query: 442 AKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLD-VHLFDATRSVQLDWKRRQSIINGIA 500
            +L+H+NLV              ++E++ +  LD + LF      Q+  K    IINGI 
Sbjct: 79  KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI- 137
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 560
            G  + H      IIHRD+K  NIL+      K+ DFG AR         +  +   T  
Sbjct: 138 -GFCHSH-----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV--ATRW 189
Query: 561 YMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           Y APE  +G + +    DV++ G L+ E+  G 
Sbjct: 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 18/205 (8%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVR------ 451
           +G G +G VYKG       +A  ++   +G   +E K E+N++ K   H+N+        
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 452 XXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
                        + E+    S+   L   T+   L  +    I   I RG+ +LH+   
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 148
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM--- 568
            K+IHRD+K  N+LL ++   K+ DFG++        + NT I  GT  +MAPE      
Sbjct: 149 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYWMAPEVIACDE 205
Query: 569 --GGIFSIKSDVFSFGVLLLEIISG 591
                +  KSD++S G+  +E+  G
Sbjct: 206 NPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 54/93 (58%), Gaps = 3/93 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I   + YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  N   GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
             Y++PE       S  SD+++ G ++ ++++G
Sbjct: 198 AQYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 399 LGQGGFGPVY--------KGTLADGKAIAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHKN 448
           LG+G FG V         K    +   +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 449 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHL-----------FDATR--SVQLDWKRRQSI 495
           ++              I EY    +L  +L           +D  R    Q+ +K   S 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 555
              +ARG+ YL   +  K IHRDL A N+L+ ++   KI+DFGLAR          T   
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 556 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                +MAPE     +++ +SDV+SFGVL+ EI +
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 2   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ 60
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 174 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 2   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 174 HTDDEMTGYVA-TRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 30/207 (14%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           LG+GGF   Y+ T  D K +   ++   S        ++   E+ +   L + ++V    
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 455 XXXXXXXXXXIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIAR--------GILY 505
                     + E    +SL ++H            KRR+++    AR        G+ Y
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLELH------------KRRKAVTEPEARYFMRQTIQGVQY 157
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           LH +   ++IHRDLK  N+ L+DDM+ KI DFGLA     +  +  T  + GT  Y+APE
Sbjct: 158 LHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT--LCGTPNYIAPE 212
Query: 566 YAMGGIFSIKSDVFSFGVLLLEIISGR 592
                  S + D++S G +L  ++ G+
Sbjct: 213 VLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 8   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ 66
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 67  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 126
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 127 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 179
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 180 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 91/192 (47%), Gaps = 25/192 (13%)
Query: 416 KAIAVKRLSRTSG-----QGLQEFKN----EVNLIAKLQ-HKNLVRXXXXXXXXXXXXXI 465
           K  AVK +  T G     + +QE +     EV+++ K+  H N+++             +
Sbjct: 30  KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 89
Query: 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNIL 525
           ++ M    L  +L   T  V L  K  + I+  +   I  LH   +L I+HRDLK  NIL
Sbjct: 90  FDLMKKGELFDYL---TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENIL 143
Query: 526 LDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI------FSIKSDVF 579
           LDDDMN K++DFG +      +       + GT  Y+APE     +      +  + D++
Sbjct: 144 LDDDMNIKLTDFGFSCQLDPGEKLRE---VCGTPSYLAPEIIECSMNDNHPGYGKEVDMW 200
Query: 580 SFGVLLLEIISG 591
           S GV++  +++G
Sbjct: 201 STGVIMYTLLAG 212

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 91/192 (47%), Gaps = 25/192 (13%)
Query: 416 KAIAVKRLSRTSG-----QGLQEFKN----EVNLIAKLQ-HKNLVRXXXXXXXXXXXXXI 465
           K  AVK +  T G     + +QE +     EV+++ K+  H N+++             +
Sbjct: 43  KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 102
Query: 466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNIL 525
           ++ M    L  +L   T  V L  K  + I+  +   I  LH   +L I+HRDLK  NIL
Sbjct: 103 FDLMKKGELFDYL---TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENIL 156
Query: 526 LDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI------FSIKSDVF 579
           LDDDMN K++DFG +      +       + GT  Y+APE     +      +  + D++
Sbjct: 157 LDDDMNIKLTDFGFSCQLDPGEKLRE---VCGTPSYLAPEIIECSMNDNHPGYGKEVDMW 213
Query: 580 SFGVLLLEIISG 591
           S GV++  +++G
Sbjct: 214 STGVIMYTLLAG 225

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 26/219 (11%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAI--AVKRLSR-TSGQGLQEFKNEVNLIAKL-Q 445
           N    ++ +G+G FG V K  +  DG  +  A+KR+    S    ++F  E+ ++ KL  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWK-----------RRQS 494
           H N++                EY P+ +L +     +R ++ D               Q 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNL-LDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 495 IIN---GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
           +++    +ARG+ YL   S+ + IHRDL A NIL+ ++   KI+DFGL+R   G +    
Sbjct: 144 LLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVK 197
Query: 552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +      +MA E     +++  SDV+S+GVLL EI+S
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 21  SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ 79
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 80  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 139
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 140 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 192
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 193 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 399 LGQGGFGPVY--------KGTLADGKAIAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHKN 448
           LG+G FG V         K    +   +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 449 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHL-----------FDATR--SVQLDWKRRQSI 495
           ++              I EY    +L  +L           +D  R    Q+ +K   S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 555
              +ARG+ YL   +  K IHRDL A N+L+ ++   +I+DFGLAR          T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 556 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                +MAPE     +++ +SDV+SFGVL+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 22  SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ 80
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 81  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 140
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 141 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 193
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 194 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 13/197 (6%)
Query: 399 LGQGGFGPVYK-GTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXXX 457
           LG G FG V+K    A G  +A K +     +  +E KNE++++ +L H NL++      
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 458 XXXXXXXIYEYMPNKSLDVHLFDATRSV-QLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                  + EY+    L   + D + ++ +LD       +  I  GI ++H+   + I+H
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYNLTELD---TILFMKQICEGIRHMHQ---MYILH 210
Query: 517 RDLKASNILL--DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
            DLK  NIL    D    KI DFGLAR +   + +    +  GT  ++APE       S 
Sbjct: 211 LDLKPENILCVNRDAKQIKIIDFGLARRY---KPREKLKVNFGTPEFLAPEVVNYDFVSF 267
Query: 575 KSDVFSFGVLLLEIISG 591
            +D++S GV+   ++SG
Sbjct: 268 PTDMWSVGVIAYMLLSG 284

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/126 (37%), Positives = 72/126 (57%), Gaps = 9/126 (7%)
Query: 467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 526
           E+M   SLD  L +A R +  +   + SI   + RG+ YL E  + +I+HRD+K SNIL+
Sbjct: 94  EHMDGGSLDQVLKEAKR-IPEEILGKVSI--AVLRGLAYLRE--KHQIMHRDVKPSNILV 148
Query: 527 DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLL 586
           +     K+ DFG++    G    +  N   GT  YMAPE   G  +S++SD++S G+ L+
Sbjct: 149 NSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLV 204
Query: 587 EIISGR 592
           E+  GR
Sbjct: 205 ELAVGR 210

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 101/235 (42%), Gaps = 30/235 (12%)
Query: 374 ESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGT-LADGK-----AIAVKRLSRTS 427
           E  EFP           N+      LG G FG V + T    GK      +AVK L  T+
Sbjct: 39  EKWEFP----------RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA 88
Query: 428 GQGLQE-FKNEVNLIAKL-QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSV 485
               +E   +E+ +++ L QH+N+V              I EY     L   L   +R +
Sbjct: 89  HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVL 148
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRL----------KIIHRDLKASNILLDDDMNPKIS 535
           + D     +I N  A     LH  S++            IHRD+ A N+LL +    KI 
Sbjct: 149 ETD--PAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIG 206
Query: 536 DFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           DFGLAR    + N            +MAPE     +++++SDV+S+G+LL EI S
Sbjct: 207 DFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 7   SQERPTF-YRQELNKTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 65
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 66  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 125
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 126 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR---- 178
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 179 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 108/230 (46%), Gaps = 19/230 (8%)
Query: 373 AESQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRT 426
           + SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR 
Sbjct: 2   SHSQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 60
Query: 427 SGQGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATR 483
               +   +   E+ L+  ++H+N++                + Y+    +   L +  +
Sbjct: 61  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 120
Query: 484 SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
             +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR  
Sbjct: 121 CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-- 175
Query: 544 GGNQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
             + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 176 --HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 13/210 (6%)
Query: 388 EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN--EVNLIAKL 444
           E    + + + +G G +G V        G  +AVK+LSR     +   +   E+ L+  +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 445 QHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
           +H+N++                + Y+    +   L +  +  +L     Q +I  I RG+
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            Y+H      IIHRDLK SN+ +++D   KI DFGLAR    + +   T  +A T  Y A
Sbjct: 135 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVA-TRWYRA 186
Query: 564 PEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           PE  +  + ++   D++S G ++ E+++GR
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 2   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 174 HTDDEMTGXVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 34/209 (16%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           LG+GGF   Y+ T  D K +   ++   S        ++   E+ +   L + ++V    
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 455 XXXXXXXXXXIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIAR--------GILY 505
                     + E    +SL ++H            KRR+++    AR        G+ Y
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLELH------------KRRKAVTEPEARYFMRQTIQGVQY 157
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI--FGGNQNQANTNIIAGTYGYMA 563
           LH +   ++IHRDLK  N+ L+DDM+ KI DFGLA    F G + +     + GT  Y+A
Sbjct: 158 LHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKX----LCGTPNYIA 210
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           PE       S + D++S G +L  ++ G+
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEV------NLIAKLQ------- 445
           LG+G FG V    LA+   +   + +R +   ++  K++       +LI++++       
Sbjct: 21  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDW--------------KR 491
           HKN++              I EY    +L  +L  A R   L++              K 
Sbjct: 78  HKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYCYNPSHNPEEQLSSKD 136
Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
             S    +ARG+ YL   +  K IHRDL A N+L+ +D   KI+DFGLAR          
Sbjct: 137 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           T        +MAPE     I++ +SDV+SFGVLL EI +
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 2   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 174 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 2   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 174 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 398 KLGQGGFGPVY----KGTLADGKA--IAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLV 450
           +LGQG FG VY    KG + D     +A+K ++  +    + EF NE +++ +    ++V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSV-------QLDWKRRQSIINGIARGI 503
           R             I E M    L  +L     ++            +   +   IA G+
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAGTYGYM 562
            YL+ +   K +HRDL A N ++ +D   KI DFG+ R I+  +  +     +     +M
Sbjct: 152 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-WM 207
Query: 563 APEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           +PE    G+F+  SDV+SFGV+L EI +
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 7   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 65
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 66  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 125
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 126 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 178
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 179 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 2   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 174 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 9   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 67
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 68  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 127
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 180
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 181 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 7   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 65
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 66  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 125
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 126 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR---- 178
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 179 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 7   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 65
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 66  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 125
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 126 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 178
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 179 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 1   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 59
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 60  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 119
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 120 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 172
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 173 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I   + YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  N   GT
Sbjct: 117 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
             Y++PE          SD+++ G ++ ++++G
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I   + YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  N   GT
Sbjct: 119 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 175
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
             Y++PE          SD+++ G ++ ++++G
Sbjct: 176 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 2   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 174 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 398 KLGQGGFGPVY----KGTLADGKA--IAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLV 450
           +LGQG FG VY    KG + D     +A+K ++  +    + EF NE +++ +    ++V
Sbjct: 22  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 81
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSV-------QLDWKRRQSIINGIARGI 503
           R             I E M    L  +L     ++            +   +   IA G+
Sbjct: 82  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 141
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAGTYGYM 562
            YL+ +   K +HRDL A N ++ +D   KI DFG+ R I+  +  +     +     +M
Sbjct: 142 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-WM 197
Query: 563 APEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           +PE    G+F+  SDV+SFGV+L EI +
Sbjct: 198 SPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 93/205 (45%), Gaps = 23/205 (11%)
Query: 399 LGQGGFGPVYKGTLADGKA----IAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKN-LVRX 452
           +G+G FG VY G   D        A+K LSR T  Q ++ F  E  L+  L H N L   
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 453 XXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING--IARGILYLHEDS 510
                       +  YM +  L        RS Q +   +  I  G  +ARG+ YL E  
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDL----LQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ- 143
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARI-----FGGNQNQANTNIIAGTYGYMAPE 565
             K +HRDL A N +LD+    K++DFGLAR      +   Q   +  +      + A E
Sbjct: 144 --KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL---PVKWTALE 198
Query: 566 YAMGGIFSIKSDVFSFGVLLLEIIS 590
                 F+ KSDV+SFGVLL E+++
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 2   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 174 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 2   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 174 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 13  SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 71
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 72  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 131
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 132 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR---- 184
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 185 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEV------NLIAKLQ------- 445
           LG+G FG V    LA+   +   + +R +   ++  K++       +LI++++       
Sbjct: 29  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 85
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDW--------------KR 491
           HKN++              I EY    +L  +L  A R   L++              K 
Sbjct: 86  HKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQLSSKD 144
Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
             S    +ARG+ YL   +  K IHRDL A N+L+ +D   KI+DFGLAR          
Sbjct: 145 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 201
Query: 552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           T        +MAPE     I++ +SDV+SFGVLL EI +
Sbjct: 202 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I   + YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  N   GT
Sbjct: 118 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 174
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
             Y++PE          SD+++ G ++ ++++G
Sbjct: 175 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 8   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 66
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 67  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 126
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 127 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 179
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 180 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 8   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 66
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 67  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 126
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 127 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 179
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 180 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I   + YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  N   GT
Sbjct: 116 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 172
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
             Y++PE          SD+++ G ++ ++++G
Sbjct: 173 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 99/227 (43%), Gaps = 53/227 (23%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXXX 457
           +G GGFG V+K     DGK   ++R+   +    ++ + EV  +AKL H N+V       
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWD 75
Query: 458 XXXXXXXIYEYMP---NKSLDVHLFDATRS------------VQLD---------W--KR 491
                   ++Y P   + SL+   +D   S            +Q++         W  KR
Sbjct: 76  G-------FDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 492 RQSIING---------IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
           R   ++          I +G+ Y+H     K+IHRDLK SNI L D    KI DFGL   
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 543 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEII 589
               +N        GT  YM+PE      +  + D+++ G++L E++
Sbjct: 186 L---KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 14/197 (7%)
Query: 399 LGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNEVNLIAKLQHKNLVRXXX 454
           LG+G FG VY       K I A+K L  S+   +G++ + + E+ + + L+H N++R   
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                     + E+ P   L   L    R    D +R  + +  +A  + Y HE    K+
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALHYCHER---KV 135
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           IHRD+K  N+L+      KI+DFG    +  +        + GT  Y+ PE   G     
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPPEMIEGKTHDE 191
Query: 575 KSDVFSFGVLLLEIISG 591
           K D++  GVL  E + G
Sbjct: 192 KVDLWCAGVLCYEFLVG 208

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 14  SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 72
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 73  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 132
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 133 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 185
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 186 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 14  SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 72
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 73  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 132
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 133 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 185
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 186 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 2   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQ 120
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR---- 173
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 174 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 4   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 62
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 63  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 122
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 123 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 175
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 176 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 2   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 174 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 15/216 (6%)
Query: 387 LEATNHFSDENKLGQ----GGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQ---EFKNEV 438
           +   +H SD  +LG+    GG   V+    L D + +AVK L     +       F+ E 
Sbjct: 4   MTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREA 63
Query: 439 NLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLD-VHLFDATRSV-QLDWKRRQSII 496
              A L H  +V              +  Y+  + +D V L D   +   +  KR   +I
Sbjct: 64  QNAAALNHPAIVAVYDTGEAETPAGPL-PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVI 122
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA-NTNII 555
               + + + H++    IIHRD+K +NIL+      K+ DFG+AR    + N    T  +
Sbjct: 123 ADACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAV 179
Query: 556 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
            GT  Y++PE A G     +SDV+S G +L E+++G
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEV------NLIAKLQ------- 445
           LG+G FG V    LA+   +   + +R +   ++  K++       +LI++++       
Sbjct: 25  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 81
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDW--------------KR 491
           HKN++              I EY    +L  +L  A R   L++              K 
Sbjct: 82  HKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQLSSKD 140
Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
             S    +ARG+ YL   +  K IHRDL A N+L+ +D   KI+DFGLAR          
Sbjct: 141 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 197
Query: 552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           T        +MAPE     I++ +SDV+SFGVLL EI +
Sbjct: 198 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + +   +G G +G V        G  +AVK+LSR   
Sbjct: 12  SQERPTF-YRQELNKTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ 70
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 71  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 130
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 131 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 183
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 184 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 27/212 (12%)
Query: 398 KLGQGGFGPVY----KGTLADGKA--IAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLV 450
           +LGQG FG VY    KG + D     +A+K ++  +    + EF NE +++ +    ++V
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWK-----------RRQSIINGI 499
           R             I E M    L  +L    RS++ + +           +   +   I
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYL----RSLRPEMENNPVLAPPSLSKMIQMAGEI 134
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQANTNIIAGT 558
           A G+ YL+ +   K +HRDL A N  + +D   KI DFG+ R I+  +  +     +   
Sbjct: 135 ADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 191
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +M+PE    G+F+  SDV+SFGV+L EI +
Sbjct: 192 R-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 4   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 62
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 63  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 122
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 123 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 175
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 176 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 17/218 (7%)
Query: 385 LALEATNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRT-SGQGLQEFKNEVNLIA 442
           L  +    +  + +LG GGFG V +    D G+ +A+K+  +  S +  + +  E+ ++ 
Sbjct: 8   LPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMK 67
Query: 443 KLQHKNLVRXXXXXXXXXXXXX------IYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
           KL H N+V                      EY     L  +L        L     ++++
Sbjct: 68  KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL 127
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFGGNQNQANTN 553
           + I+  + YLHE+   +IIHRDLK  NI+L      +  KI D G A+    +Q +  T 
Sbjct: 128 SDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTE 182
Query: 554 IIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
            + GT  Y+APE      +++  D +SFG L  E I+G
Sbjct: 183 FV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 34/209 (16%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           LG+GGF   Y+ T  D K +   ++   S        ++   E+ +   L + ++V    
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 455 XXXXXXXXXXIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIAR--------GILY 505
                     + E    +SL ++H            KRR+++    AR        G+ Y
Sbjct: 94  FFEDDDFVYVVLEICRRRSLLELH------------KRRKAVTEPEARYFMRQTIQGVQY 141
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI--FGGNQNQANTNIIAGTYGYMA 563
           LH +   ++IHRDLK  N+ L+DDM+ KI DFGLA    F G + +     + GT  Y+A
Sbjct: 142 LHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD----LCGTPNYIA 194
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           PE       S + D++S G +L  ++ G+
Sbjct: 195 PEVLCKKGHSFEVDIWSLGCILYTLLVGK 223

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 13  SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 71
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 72  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 131
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 132 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 184
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 185 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEV------NLIAKLQ------- 445
           LG+G FG V    LA+   +   + +R +   ++  K++       +LI++++       
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDW--------------KR 491
           HKN++              I EY    +L  +L  A R   L++              K 
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQLSSKD 151
Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
             S    +ARG+ YL   +  K IHRDL A N+L+ +D   KI+DFGLAR          
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           T        +MAPE     I++ +SDV+SFGVLL EI +
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 22  SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 80
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 81  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 140
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 141 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 193
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 194 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 2   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQ 120
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 174 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 17/218 (7%)
Query: 385 LALEATNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRT-SGQGLQEFKNEVNLIA 442
           L  +    +  + +LG GGFG V +    D G+ +A+K+  +  S +  + +  E+ ++ 
Sbjct: 9   LPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMK 68
Query: 443 KLQHKNLVRXXXXXXXXXXXXX------IYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
           KL H N+V                      EY     L  +L        L     ++++
Sbjct: 69  KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL 128
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFGGNQNQANTN 553
           + I+  + YLHE+   +IIHRDLK  NI+L      +  KI D G A+    +Q +  T 
Sbjct: 129 SDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTE 183
Query: 554 IIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
            + GT  Y+APE      +++  D +SFG L  E I+G
Sbjct: 184 FV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 34/209 (16%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           LG+GGF   Y+ T  D K +   ++   S        ++   E+ +   L + ++V    
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 455 XXXXXXXXXXIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIAR--------GILY 505
                     + E    +SL ++H            KRR+++    AR        G+ Y
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLELH------------KRRKAVTEPEARYFMRQTIQGVQY 157
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI--FGGNQNQANTNIIAGTYGYMA 563
           LH +   ++IHRDLK  N+ L+DDM+ KI DFGLA    F G + +     + GT  Y+A
Sbjct: 158 LHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD----LCGTPNYIA 210
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           PE       S + D++S G +L  ++ G+
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEV------NLIAKLQ------- 445
           LG+G FG V    LA+   +   + +R +   ++  K++       +LI++++       
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDW--------------KR 491
           HKN++              I EY    +L  +L  A R   L++              K 
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYCYNPSHNPEEQLSSKD 151
Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
             S    +ARG+ YL   +  K IHRDL A N+L+ +D   KI+DFGLAR          
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           T        +MAPE     I++ +SDV+SFGVLL EI +
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 21  SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 79
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 80  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 139
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 140 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 192
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 193 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEV------NLIAKLQ------- 445
           LG+G FG V    LA+   +   + +R +   ++  K++       +LI++++       
Sbjct: 28  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 84
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDW--------------KR 491
           HKN++              I EY    +L  +L  A R   L++              K 
Sbjct: 85  HKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQLSSKD 143
Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
             S    +ARG+ YL   +  K IHRDL A N+L+ +D   KI+DFGLAR          
Sbjct: 144 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 200
Query: 552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           T        +MAPE     I++ +SDV+SFGVLL EI +
Sbjct: 201 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 4   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 62
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 63  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 122
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 123 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLAR---- 175
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 176 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I   + YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  N   GT
Sbjct: 123 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 179
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
             Y++PE          SD+++ G ++ ++++G
Sbjct: 180 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 2   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +S 
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQ 120
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGL R    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLCR---- 173
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 174 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I   + YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  N   GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
             Y++PE          SD+++ G ++ ++++G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 8   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 66
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 67  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 126
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 127 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLAR---- 179
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 180 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I   + YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  N   GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
             Y++PE          SD+++ G ++ ++++G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I   + YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  N   GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
             Y++PE          SD+++ G ++ ++++G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I   + YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  N   GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGT 195
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
             Y++PE          SD+++ G ++ ++++G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I   + YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  N   GT
Sbjct: 138 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 194
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
             Y++PE          SD+++ G ++ ++++G
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 14/197 (7%)
Query: 399 LGQGGFGPVYKGTLADGKAI-AVKRL--SRTSGQGLQ-EFKNEVNLIAKLQHKNLVRXXX 454
           LG+G FG VY       K I A+K L  S+   +G++ + + E+ + + L+H N++R   
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                     + E+ P   L   L    R    D +R  + +  +A  + Y HE    K+
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALHYCHER---KV 136
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           IHRD+K  N+L+      KI+DFG    +  +        + GT  Y+ PE   G     
Sbjct: 137 IHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPPEMIEGKTHDE 192
Query: 575 KSDVFSFGVLLLEIISG 591
           K D++  GVL  E + G
Sbjct: 193 KVDLWCAGVLCYEFLVG 209

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I   + YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  N   GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
             Y++PE          SD+++ G ++ ++++G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I   + YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  N   GT
Sbjct: 146 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 202
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
             Y++PE          SD+++ G ++ ++++G
Sbjct: 203 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I   + YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  N   GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
             Y++PE          SD+++ G ++ ++++G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 32/218 (14%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEV------NLIAKLQ------- 445
           LG+G FG V    LA+   +   + +R +   ++  K++       +LI++++       
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHL-----------FDATRSV--QLDWKRR 492
           HKN++              I EY    +L  +L           ++ + +   QL  K  
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
            S    +ARG+ YL   +  K IHRDL A N+L+ +D   KI+DFGLAR          T
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 553 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                   +MAPE     I++ +SDV+SFGVLL EI +
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 13/210 (6%)
Query: 388 EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN--EVNLIAKL 444
           E    + + + +G G +G V        G  +AVK+LSR     +   +   E+ L+  +
Sbjct: 16  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 75
Query: 445 QHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
           +H+N++                + Y+    +   L +  +  +L     Q +I  I RG+
Sbjct: 76  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 135
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            Y+H      IIHRDLK SN+ +++D   KI DFGLAR    + +   T  +A T  Y A
Sbjct: 136 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVA-TRWYRA 187
Query: 564 PEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           PE  +  + ++   D++S G ++ E+++GR
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I   + YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  N   GT
Sbjct: 142 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 198
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
             Y++PE          SD+++ G ++ ++++G
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I   + YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  N   GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
             Y++PE          SD+++ G ++ ++++G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 13/210 (6%)
Query: 388 EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN--EVNLIAKL 444
           E    + + + +G G +G V        G  +AVK+LSR     +   +   E+ L+  +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 445 QHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
           +H+N++                + Y+    +   L +  +  +L     Q +I  I RG+
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            Y+H      IIHRDLK SN+ +++D   KI DFGLAR    + +   T  +A T  Y A
Sbjct: 135 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVA-TRWYRA 186
Query: 564 PEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           PE  +  + ++   D++S G ++ E+++GR
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 13/210 (6%)
Query: 388 EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN--EVNLIAKL 444
           E    + + + +G G +G V        G  +AVK+LSR     +   +   E+ L+  +
Sbjct: 16  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 75
Query: 445 QHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
           +H+N++                + Y+    +   L +  +  +L     Q +I  I RG+
Sbjct: 76  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 135
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            Y+H      IIHRDLK SN+ +++D   KI DFGLAR    + +   T  +A T  Y A
Sbjct: 136 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVA-TRWYRA 187
Query: 564 PEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           PE  +  + ++   D++S G ++ E+++GR
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I   + YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  N   GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
             Y++PE          SD+++ G ++ ++++G
Sbjct: 198 AQYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I   + YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  N   GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
             Y++PE          SD+++ G ++ ++++G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 13/210 (6%)
Query: 388 EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN--EVNLIAKL 444
           E    + + + +G G +G V        G  +AVK+LSR     +   +   E+ L+  +
Sbjct: 17  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 76
Query: 445 QHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
           +H+N++                + Y+    +   L +  +  +L     Q +I  I RG+
Sbjct: 77  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 136
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            Y+H      IIHRDLK SN+ +++D   KI DFGLAR    + +   T  +A T  Y A
Sbjct: 137 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVA-TRWYRA 188
Query: 564 PEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           PE  +  + ++   D++S G ++ E+++GR
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I   + YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  N   GT
Sbjct: 144 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 200
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
             Y++PE          SD+++ G ++ ++++G
Sbjct: 201 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 2   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ 60
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +      +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 174 HTDDEMAGFVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEV------NLIAKLQ------- 445
           LG+G FG V    LA+   +   + +R +   ++  K++       +LI++++       
Sbjct: 77  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDW--------------KR 491
           HKN++              I EY    +L  +L  A R   L++              K 
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
             S    +ARG+ YL   +  K IHRDL A N+L+ +D   KI+DFGLAR          
Sbjct: 193 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           T        +MAPE     I++ +SDV+SFGVLL EI +
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 2   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ 60
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 173
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +      +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 174 HTDDEMAGFVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 97/205 (47%), Gaps = 24/205 (11%)
Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLS-RTSGQGLQEFK-NEVNLIAKLQHKNLVRXX 453
            KLG+G +G VYK       + +A+KR+      +G+      EV+L+ +LQH+N++   
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELK 99
Query: 454 XXXXXXXXXXXIYEYMPN---KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                      I+EY  N   K +D +   + R +       +S +  +  G+ + H  S
Sbjct: 100 SVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVI-------KSFLYQLINGVNFCH--S 150
Query: 511 RLKIIHRDLKASNILL---DDDMNP--KISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           R + +HRDLK  N+LL   D    P  KI DFGLAR FG    Q    II  T  Y  PE
Sbjct: 151 R-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII--TLWYRPPE 207
Query: 566 YAMGGI-FSIKSDVFSFGVLLLEII 589
             +G   +S   D++S   +  E++
Sbjct: 208 ILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 15/216 (6%)
Query: 387 LEATNHFSDENKLGQ----GGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQ---EFKNEV 438
           +   +H SD  +LG+    GG   V+    L D + +AVK L     +       F+ E 
Sbjct: 4   MTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREA 63
Query: 439 NLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLD-VHLFDATRSV-QLDWKRRQSII 496
              A L H  +V              +  Y+  + +D V L D   +   +  KR   +I
Sbjct: 64  QNAAALNHPAIVAVYDTGEAETPAGPL-PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVI 122
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN-TNII 555
               + + + H++    IIHRD+K +NI++      K+ DFG+AR    + N    T  +
Sbjct: 123 ADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 556 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
            GT  Y++PE A G     +SDV+S G +L E+++G
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 26/215 (12%)
Query: 399 LGQGGFGPVY--------KGTLADGKAIAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHKN 448
           LG+G FG V         K    +   +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 449 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHL-----------FDATR--SVQLDWKRRQSI 495
           ++              I  Y    +L  +L           +D  R    Q+ +K   S 
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 555
              +ARG+ YL   +  K IHRDL A N+L+ ++   KI+DFGLAR          T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 556 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                +MAPE     +++ +SDV+SFGVL+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 100/232 (43%), Gaps = 28/232 (12%)
Query: 374 ESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGT-LADGK-----AIAVKRLSRTS 427
           E  EFP           N+      LG G FG V + T    GK      +AVK L  T+
Sbjct: 31  EKWEFP----------RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA 80
Query: 428 GQGLQE-FKNEVNLIAKL-QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHL------- 478
               +E   +E+ +++ L QH+N+V              I EY     L   L       
Sbjct: 81  HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAD 140
Query: 479 FDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538
            D      L+ +      + +A+G+ +L   +    IHRD+ A N+LL +    KI DFG
Sbjct: 141 LDKEDGRPLELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFG 197
Query: 539 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           LAR    + N            +MAPE     +++++SDV+S+G+LL EI S
Sbjct: 198 LARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 26/207 (12%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV------- 450
           +G GGFG V+K     DGK   +KR+   +    ++ + EV  +AKL H N+V       
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWD 74
Query: 451 ------RXXXXXXXXXXXXXIYEYMP--NKSLDVHLFDATRSVQLDWKRRQSIINGIARG 502
                               ++  M   +K       +  R  +LD      +   I +G
Sbjct: 75  GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKG 134
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYM 562
           + Y+H     K+I+RDLK SNI L D    KI DFGL       +N        GT  YM
Sbjct: 135 VDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRXRSKGTLRYM 188
Query: 563 APEYAMGGIFSIKSDVFSFGVLLLEII 589
           +PE      +  + D+++ G++L E++
Sbjct: 189 SPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 15/216 (6%)
Query: 387 LEATNHFSDENKLGQ----GGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQ---EFKNEV 438
           +   +H SD  +LG+    GG   V+    L D + +AVK L     +       F+ E 
Sbjct: 4   MTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREA 63
Query: 439 NLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLD-VHLFDATRSV-QLDWKRRQSII 496
              A L H  +V              +  Y+  + +D V L D   +   +  KR   +I
Sbjct: 64  QNAAALNHPAIVAVYDTGEAETPAGPL-PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVI 122
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ-ANTNII 555
               + + + H++    IIHRD+K +NI++      K+ DFG+AR    + N    T  +
Sbjct: 123 ADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 556 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
            GT  Y++PE A G     +SDV+S G +L E+++G
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I   + YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  N   GT
Sbjct: 138 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 194
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
             Y++PE          SD+++ G ++ ++++G
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 34/214 (15%)
Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLV 450
           F  +  LG G F  V      A GK  AVK + + + +G +   +NE+ ++ K++H+N+V
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDV-------HLFDATRSVQLDW---KRRQSIINGIA 500
                         IYE  PN    V        LFD  R V+  +   K   ++I  + 
Sbjct: 84  ----------ALEDIYE-SPNHLYLVMQLVSGGELFD--RIVEKGFYTEKDASTLIRQVL 130
Query: 501 RGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAG 557
             + YLH   R+ I+HRDLK  N+L    D++    ISDFGL+++ G     +      G
Sbjct: 131 DAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTA---CG 184
Query: 558 TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           T GY+APE      +S   D +S GV+   ++ G
Sbjct: 185 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 9   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 67
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 68  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 127
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 180
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           +     T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 181 HTADEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 9   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 67
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 68  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 127
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 180
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           +     T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 181 HTADEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 3/93 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I   + YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  N   GT
Sbjct: 142 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 198
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
             Y++PE          SD+++ G ++ ++++G
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTS---GQGLQEFKNE---VNLIAK 443
           N FS    +G+GGFG VY    AD GK  A+K L +      QG     NE   ++L++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 444 LQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
                +V              I + M    L  HL       + D +   +    I  G+
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA---EIILGL 305
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            ++H  +R  +++RDLK +NILLD+  + +ISD GLA  F   +  A+     GT+GYMA
Sbjct: 306 EHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMA 358
Query: 564 PEYAMGGI-FSIKSDVFSFGVLLLEIISG 591
           PE    G+ +   +D FS G +L +++ G
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTS---GQGLQEFKNE---VNLIAK 443
           N FS    +G+GGFG VY    AD GK  A+K L +      QG     NE   ++L++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 444 LQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
                +V              I + M    L  HL       + D +   +    I  G+
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA---EIILGL 305
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            ++H  +R  +++RDLK +NILLD+  + +ISD GLA  F   +  A+     GT+GYMA
Sbjct: 306 EHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMA 358
Query: 564 PEYAMGGI-FSIKSDVFSFGVLLLEIISG 591
           PE    G+ +   +D FS G +L +++ G
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 102/201 (50%), Gaps = 18/201 (8%)
Query: 399 LGQGGFGPVYKGT-LADGK----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLVRX 452
           LG G FG VYKG  + DG+     +A+K L   TS +  +E  +E  ++A +    + R 
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 453 XXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGILYLHED 509
                       + + MP   L  H+ +    +       Q ++N    IA+G+ YL ED
Sbjct: 85  LGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLG-----SQDLLNWCMQIAKGMSYL-ED 137
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 569
            RL  +HRDL A N+L+    + KI+DFGLAR+   ++ + + +       +MA E  + 
Sbjct: 138 VRL--VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILR 195
Query: 570 GIFSIKSDVFSFGVLLLEIIS 590
             F+ +SDV+S+GV + E+++
Sbjct: 196 RRFTHQSDVWSYGVTVWELMT 216

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 9/199 (4%)
Query: 399 LGQGGFGPVYKGTLADGKA-IAVKRLSRTSGQGL-QEFKNEVNLIAKLQHKNLVRXXXXX 456
           +G+G +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++      
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                      Y+    ++  L+   +S QL        +  I RG+ Y+H  +   ++H
Sbjct: 111 RASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN---VLH 167
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TNIIAGTYGYMAPEYAMGGIFSI 574
           RDLK SN+L++   + KI DFGLARI     +     T  +A T  Y APE  +      
Sbjct: 168 RDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVA-TRWYRAPEIMLNSKGYT 226
Query: 575 KS-DVFSFGVLLLEIISGR 592
           KS D++S G +L E++S R
Sbjct: 227 KSIDIWSVGCILAEMLSNR 245

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 9   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 67
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 68  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 127
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 180
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           +     T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 181 HTADEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 101/198 (51%), Gaps = 15/198 (7%)
Query: 399 LGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-----EVNLIAKLQHKNLVRX 452
           LG+G F  VYK    +  + +A+K++        ++  N     E+ L+ +L H N++  
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 453 XXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                       ++++M     D+ +     S+ L     ++ +    +G+ YLH+    
Sbjct: 78  LDAFGHKSNISLVFDFM---ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 132
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-I 571
            I+HRDLK +N+LLD++   K++DFGLA+ F G+ N+A  + +  T  Y APE   G  +
Sbjct: 133 -ILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYXHQVV-TRWYRAPELLFGARM 189
Query: 572 FSIKSDVFSFGVLLLEII 589
           + +  D+++ G +L E++
Sbjct: 190 YGVGVDMWAVGCILAELL 207

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTS---GQGLQEFKNE---VNLIAK 443
           N FS    +G+GGFG VY    AD GK  A+K L +      QG     NE   ++L++ 
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 444 LQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
                +V              I + M    L  HL       + D +   +    I  G+
Sbjct: 248 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA---EIILGL 304
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            ++H  +R  +++RDLK +NILLD+  + +ISD GLA  F   +  A+     GT+GYMA
Sbjct: 305 EHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMA 357
Query: 564 PEYAMGGI-FSIKSDVFSFGVLLLEIISG 591
           PE    G+ +   +D FS G +L +++ G
Sbjct: 358 PEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 2   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI D+GLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGLAR---- 173
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 174 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTS---GQGLQEFKNE---VNLIAK 443
           N FS    +G+GGFG VY    AD GK  A+K L +      QG     NE   ++L++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 444 LQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
                +V              I + M    L  HL       + D +   +    I  G+
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA---EIILGL 305
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            ++H  +R  +++RDLK +NILLD+  + +ISD GLA  F   +  A+     GT+GYMA
Sbjct: 306 EHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMA 358
Query: 564 PEYAMGGI-FSIKSDVFSFGVLLLEIISG 591
           PE    G+ +   +D FS G +L +++ G
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 118/244 (48%), Gaps = 29/244 (11%)
Query: 354 EGRIRNHYAYNILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVY---KG 410
           EG I+     + ++ G ++A+  +F L  +               LGQG FG V+   K 
Sbjct: 2   EGSIKEIAITHHVKEGHEKADPSQFELLKV---------------LGQGSFGKVFLVKKI 46
Query: 411 TLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE 467
           + +D + +   ++ + +   +++    K E +++ ++ H  +V+             I +
Sbjct: 47  SGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILD 106
Query: 468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD 527
           ++    L   L   ++ V    +  +  +  +A  + +LH    L II+RDLK  NILLD
Sbjct: 107 FLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLD 160
Query: 528 DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLE 587
           ++ + K++DFGL++    ++ +A +    GT  YMAPE       +  +D +SFGVL+ E
Sbjct: 161 EEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFE 218
Query: 588 IISG 591
           +++G
Sbjct: 219 MLTG 222

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/92 (42%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +A+G+ +L   +  K IHRDL A NILL +    KI DFGLAR    + +          
Sbjct: 148 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 204
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +MAPE     +++I+SDV+SFGVLL EI S
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/92 (42%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +A+G+ +L   +  K IHRDL A NILL +    KI DFGLAR    + +          
Sbjct: 148 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 204
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +MAPE     +++I+SDV+SFGVLL EI S
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 389 ATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQ-GLQ-EFKNEVNLIAKLQ 445
           AT+ +    ++G G +G VYK      G  +A+K +   +G+ GL      EV L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 446 ---HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHL---FDATRSVQLDWKRRQSIINGI 499
              H N+VR             I   +  + +D  L    D      L  +  + ++   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTY 559
            RG+ +LH +    I+HRDLK  NIL+      K++DFGLARI+     Q   + +  T 
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALDPVVVTL 175
Query: 560 GYMAPEYAMGGIFSIKSDVFSFGVLLLEI 588
            Y APE  +   ++   D++S G +  E+
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/92 (42%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +A+G+ +L   +  K IHRDL A NILL +    KI DFGLAR    + +          
Sbjct: 157 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +MAPE     +++I+SDV+SFGVLL EI S
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 105/219 (47%), Gaps = 26/219 (11%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLA-DGKAI--AVKRLSR-TSGQGLQEFKNEVNLIAKL-Q 445
           N    ++ +G+G FG V K  +  DG  +  A+KR+    S    ++F  E+ ++ KL  
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWK-----------RRQS 494
           H N++                EY P+ +L +     +R ++ D               Q 
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNL-LDFLRKSRVLETDPAFAIANSTASTLSSQQ 140
Query: 495 IIN---GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
           +++    +ARG+ YL   S+ + IHR+L A NIL+ ++   KI+DFGL+R   G +    
Sbjct: 141 LLHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR---GQEVYVK 194
Query: 552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +      +MA E     +++  SDV+S+GVLL EI+S
Sbjct: 195 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 388 EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN--EVNLIAKL 444
           E    + + + +G G +G V        G  +AVK+LSR     +   +   E+ L+  +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 445 QHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
           +H+N++                + Y+    +   L +  +  +L     Q +I  I RG+
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            Y+H      IIHRDLK SN+ +++D   KI DFGLAR    + +      +A T  Y A
Sbjct: 135 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMAGFVA-TRWYRA 186
Query: 564 PEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           PE  +  + ++   D++S G ++ E+++GR
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 107/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LS+   
Sbjct: 14  SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQ 72
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 73  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 132
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 133 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 185
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 186 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 39/92 (42%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +A+G+ +L   +  K IHRDL A NILL +    KI DFGLAR    + +          
Sbjct: 157 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +MAPE     +++I+SDV+SFGVLL EI S
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 392 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRL---SRTSGQGLQEFKNEVNLIAKLQHK 447
           +F  E K+G+G F  VY+   L DG  +A+K++        +   +   E++L+ +L H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 448 NLVRXXXXXXXXXXXXXIYEYMPNKSLD---VHLFDATRSV--QLDWKRRQSIINGIARG 502
           N+++             + E      L     H     R +  +  WK    + + +   
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE-- 150
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYM 562
               H  SR +++HRD+K +N+ +      K+ D GL R F      A++  + GT  YM
Sbjct: 151 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 203
Query: 563 APEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           +PE      ++ KSD++S G LL E+ +
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAA 231

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 22  SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ 80
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 81  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 140
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR    
Sbjct: 141 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---- 193
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +      +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 194 HTDDEMXGXVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 95/205 (46%), Gaps = 24/205 (11%)
Query: 399 LGQGGFG--------PVYKGTLADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNL 449
           LG+G FG        P   GT   G+ +AVK L    G Q    +K E++++  L H+++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 450 VRXXX--XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
           ++               + EY+P  SL  +L   +  +       Q I  G+A    YLH
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMA----YLH 134
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF--GGNQNQANTNIIAGTYGYMAPE 565
                  IHR+L A N+LLD+D   KI DFGLA+    G    +   +  +  + Y APE
Sbjct: 135 SQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APE 190
Query: 566 YAMGGIFSIKSDVFSFGVLLLEIIS 590
                 F   SDV+SFGV L E+++
Sbjct: 191 CLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLV 450
           ++D   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 76
Query: 451 R------XXXXXXXXXXXXXIYEYMPNKSLDV--HLFDATRSVQLDWKRRQSIINGIARG 502
           R                   + +Y+P     V  H   A +++ + + +    +  + R 
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL--YMYQLFRS 134
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGY 561
           + Y+H      I HRD+K  N+LLD D    K+ DFG A+     + + N + I   Y Y
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-Y 188
Query: 562 MAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
            APE   G   ++   DV+S G +L E++ G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLV 450
           ++D   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 76
Query: 451 R------XXXXXXXXXXXXXIYEYMPNKSLDV--HLFDATRSVQLDWKRRQSIINGIARG 502
           R                   + +Y+P     V  H   A +++ + + +    +  + R 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL--YMYQLFRS 134
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGY 561
           + Y+H      I HRD+K  N+LLD D    K+ DFG A+     + + N + I   Y Y
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-Y 188
Query: 562 MAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
            APE   G   ++   DV+S G +L E++ G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 103/238 (43%), Gaps = 36/238 (15%)
Query: 374 ESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGT-LADGK-----AIAVKRLSRTS 427
           E  EFP           N+      LG G FG V + T    GK      +AVK L  T+
Sbjct: 39  EKWEFP----------RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA 88
Query: 428 GQGLQE-FKNEVNLIAKL-QHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSV 485
               +E   +E+ +++ L QH+N+V              I EY     L   L   +R +
Sbjct: 89  HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVL 148
Query: 486 QLDWKRRQSIING-------------IARGILYLHEDSRLKIIHRDLKASNILLDDDMNP 532
           + D     +I N              +A+G+ +L   +    IHRD+ A N+LL +    
Sbjct: 149 ETD--PAFAIANSTLSTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVA 203
Query: 533 KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           KI DFGLAR    + N            +MAPE     +++++SDV+S+G+LL EI S
Sbjct: 204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLV 450
           ++D   +G G FG VY+  L D G+ +A+K++     QG + FKN E+ ++ KL H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QG-KAFKNRELQIMRKLDHCNIV 76
Query: 451 R------XXXXXXXXXXXXXIYEYMPNKSLDV--HLFDATRSVQLDWKRRQSIINGIARG 502
           R                   + +Y+P     V  H   A +++ + + +    +  + R 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL--YMYQLFRS 134
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGY 561
           + Y+H      I HRD+K  N+LLD D    K+ DFG A+     + + N + I   Y Y
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-Y 188
Query: 562 MAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
            APE   G   ++   DV+S G +L E++ G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 95/205 (46%), Gaps = 24/205 (11%)
Query: 399 LGQGGFG--------PVYKGTLADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNL 449
           LG+G FG        P   GT   G+ +AVK L    G Q    +K E++++  L H+++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 450 VRXXX--XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
           ++               + EY+P  SL  +L   +  +       Q I  G+A    YLH
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMA----YLH 134
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF--GGNQNQANTNIIAGTYGYMAPE 565
                  IHR+L A N+LLD+D   KI DFGLA+    G    +   +  +  + Y APE
Sbjct: 135 AQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APE 190
Query: 566 YAMGGIFSIKSDVFSFGVLLLEIIS 590
                 F   SDV+SFGV L E+++
Sbjct: 191 CLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 399 LGQGGFGPVYKGT-LADGK-----AIAVKRLSRTSGQGLQE-FKNEVNLIAKL-QHKNLV 450
           LG G FG V + T    GK      +AVK L  T+    +E   +E+ +++ L QH+N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHL-------FDATRSVQLDWKRRQSIINGIARGI 503
                         I EY     L   L        D      L+ +      + +A+G+
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 173
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            +L   +    IHRD+ A N+LL +    KI DFGLAR    + N            +MA
Sbjct: 174 AFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMA 230
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           PE     +++++SDV+S+G+LL EI S
Sbjct: 231 PESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRT-----SGQGLQEFKNEVNLIAKLQHKNLVRX 452
           KLG G FG V+   L + ++  ++R+ +T     S   +++ + E+ ++  L H N+++ 
Sbjct: 29  KLGSGAFGDVH---LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 453 XXXXXXXXXXXXIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSR 511
                       + E      L   +  A  R   L       ++  +   + Y H    
Sbjct: 86  FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH- 144
Query: 512 LKIIHRDLKASNILLDDDMNP----KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
             ++H+DLK  NIL   D +P    KI DFGLA +F  +++  N    AGT  YMAPE  
Sbjct: 145 --VVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEHSTNA---AGTALYMAPEVF 198
Query: 568 MGGIFSIKSDVFSFGVLLLEIISG 591
              + + K D++S GV++  +++G
Sbjct: 199 KRDV-TFKCDIWSAGVVMYFLLTG 221

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 26/215 (12%)
Query: 399 LGQGGFGPVY--------KGTLADGKAIAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHKN 448
           LG+G FG V         K    +   +AVK L    + + L +  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 449 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHL-----------FDATR--SVQLDWKRRQSI 495
           ++              I  Y    +L  +L           +D  R    Q+ +K   S 
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 555
              +ARG+ YL   +  K IHRDL A N+L+ ++   KI+DFGLAR          T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 556 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                +MAPE     +++ +SDV+SFGVL+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLV 450
           ++D   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 76
Query: 451 R------XXXXXXXXXXXXXIYEYMPNKSLDV--HLFDATRSVQLDWKRRQSIINGIARG 502
           R                   + +Y+P     V  H   A +++ + + +    +  + R 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL--YMYQLFRS 134
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGY 561
           + Y+H      I HRD+K  N+LLD D    K+ DFG A+     + + N + I   Y Y
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-Y 188
Query: 562 MAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
            APE   G   ++   DV+S G +L E++ G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLV 450
           ++D   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 77
Query: 451 R------XXXXXXXXXXXXXIYEYMPNKSLDV--HLFDATRSVQLDWKRRQSIINGIARG 502
           R                   + +Y+P     V  H   A +++ + + +    +  + R 
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL--YMYQLFRS 135
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGY 561
           + Y+H      I HRD+K  N+LLD D    K+ DFG A+     + + N + I   Y Y
Sbjct: 136 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-Y 189
Query: 562 MAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
            APE   G   ++   DV+S G +L E++ G+
Sbjct: 190 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 18/206 (8%)
Query: 399 LGQGGFGPVYKGTLADGK-AIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRXXXXX 456
           +G G    V     A  K  +A+KR++    Q  + E   E+  +++  H N+V      
Sbjct: 18  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 77
Query: 457 XXXXXXXXIYEYMPNKS-LDV--HLF--DATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
                   + + +   S LD+  H+      +S  LD     +I+  +  G+ YLH++ +
Sbjct: 78  VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ 137
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIF--GGN--QNQANTNIIAGTYGYMAPEYA 567
              IHRD+KA NILL +D + +I+DFG++     GG+  +N+     + GT  +MAPE  
Sbjct: 138 ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTPCWMAPE-V 192
Query: 568 MGGI--FSIKSDVFSFGVLLLEIISG 591
           M  +  +  K+D++SFG+  +E+ +G
Sbjct: 193 MEQVRGYDFKADIWSFGITAIELATG 218

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 93/205 (45%), Gaps = 24/205 (11%)
Query: 399 LGQGGFG--------PVYKGTLADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNL 449
           LG+G FG        P   GT   G+ +AVK L    G  L+  ++ E+ ++  L H+++
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 450 VRXX--XXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
           V+               + EY+P  SL  +L      +       Q I  G+A    YLH
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMA----YLH 128
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF--GGNQNQANTNIIAGTYGYMAPE 565
                  IHR L A N+LLD+D   KI DFGLA+    G    +   +  +  + Y APE
Sbjct: 129 AQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APE 184
Query: 566 YAMGGIFSIKSDVFSFGVLLLEIIS 590
                 F   SDV+SFGV L E+++
Sbjct: 185 CLKECKFYYASDVWSFGVTLYELLT 209

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/127 (37%), Positives = 71/127 (55%), Gaps = 11/127 (8%)
Query: 467 EYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNIL 525
           E+M   SLD  L  A R   Q+  K   ++I    +G+ YL E  + KI+HRD+K SNIL
Sbjct: 146 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVI----KGLTYLRE--KHKIMHRDVKPSNIL 199
Query: 526 LDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 585
           ++     K+ DFG++    G    +  N   GT  YM+PE   G  +S++SD++S G+ L
Sbjct: 200 VNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 255
Query: 586 LEIISGR 592
           +E+  GR
Sbjct: 256 VEMAVGR 262

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 103/232 (44%), Gaps = 19/232 (8%)
Query: 371 QQAESQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS 424
           Q   SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LS
Sbjct: 21  QSNASQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS 79
Query: 425 RTSGQGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDA 481
           R     +   +   E+ L+  ++H+N++                + Y+    +   L + 
Sbjct: 80  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 139
Query: 482 TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
            +  +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR
Sbjct: 140 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 196
Query: 542 IFGGNQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
                           T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 197 -----HTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 93/205 (45%), Gaps = 24/205 (11%)
Query: 399 LGQGGFG--------PVYKGTLADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNL 449
           LG+G FG        P   GT   G+ +AVK L    G  L+  ++ E+ ++  L H+++
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 450 VRXX--XXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
           V+               + EY+P  SL  +L      +       Q I  G+A    YLH
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMA----YLH 129
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF--GGNQNQANTNIIAGTYGYMAPE 565
                  IHR L A N+LLD+D   KI DFGLA+    G    +   +  +  + Y APE
Sbjct: 130 AQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APE 185
Query: 566 YAMGGIFSIKSDVFSFGVLLLEIIS 590
                 F   SDV+SFGV L E+++
Sbjct: 186 CLKECKFYYASDVWSFGVTLYELLT 210

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLV 450
           ++D   +G G FG VY+  L D G+ +A+K++     QG + FKN E+ ++ KL H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QG-KAFKNRELQIMRKLDHCNIV 76
Query: 451 R------XXXXXXXXXXXXXIYEYMPNKSLDV--HLFDATRSVQLDWKRRQSIINGIARG 502
           R                   + +Y+P     V  H   A +++ + + +    +  + R 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL--YMYQLFRS 134
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGY 561
           + Y+H      I HRD+K  N+LLD D    K+ DFG A+     + + N + I   Y Y
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-Y 188
Query: 562 MAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
            APE   G   ++   DV+S G +L E++ G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 18/206 (8%)
Query: 399 LGQGGFGPVYKGTLADGK-AIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRXXXXX 456
           +G G    V     A  K  +A+KR++    Q  + E   E+  +++  H N+V      
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 457 XXXXXXXXIYEYMPNKS-LDV--HLF--DATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
                   + + +   S LD+  H+      +S  LD     +I+  +  G+ YLH++ +
Sbjct: 83  VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ 142
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIF--GGN--QNQANTNIIAGTYGYMAPEYA 567
              IHRD+KA NILL +D + +I+DFG++     GG+  +N+     + GT  +MAPE  
Sbjct: 143 ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTPCWMAPE-V 197
Query: 568 MGGI--FSIKSDVFSFGVLLLEIISG 591
           M  +  +  K+D++SFG+  +E+ +G
Sbjct: 198 MEQVRGYDFKADIWSFGITAIELATG 223

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 39/92 (42%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +A+G+ +L   +  K IHRDL A NILL +    KI DFGLAR    + +          
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +MAPE     +++I+SDV+SFGVLL EI S
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLV 450
           ++D   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 80
Query: 451 R------XXXXXXXXXXXXXIYEYMPNKSLDV--HLFDATRSVQLDWKRRQSIINGIARG 502
           R                   + +Y+P     V  H   A +++ + + +    +  + R 
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL--YMYQLFRS 138
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGY 561
           + Y+H      I HRD+K  N+LLD D    K+ DFG A+     + + N + I   Y Y
Sbjct: 139 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRY-Y 192
Query: 562 MAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
            APE   G   ++   DV+S G +L E++ G+
Sbjct: 193 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 9/205 (4%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKA-IAVKRLSRTSGQGL-QEFKNEVNLIAKLQHKNLV 450
           +++ + +G+G +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                            Y+    ++  L+   ++  L        +  I RG+ Y+H  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TNIIAGTYGYMAPEYAM 568
              ++HRDLK SN+LL+   + KI DFGLAR+   + +     T  +A T  Y APE  +
Sbjct: 145 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIML 200
Query: 569 GGIFSIKS-DVFSFGVLLLEIISGR 592
                 KS D++S G +L E++S R
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLV 450
           ++D   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 76
Query: 451 R------XXXXXXXXXXXXXIYEYMPNKSLDV--HLFDATRSVQLDWKRRQSIINGIARG 502
           R                   + +Y+P     V  H   A +++ + + +    +  + R 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL--YMYQLFRS 134
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGY 561
           + Y+H      I HRD+K  N+LLD D    K+ DFG A+     + + N + I   Y Y
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY-Y 188
Query: 562 MAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
            APE   G   ++   DV+S G +L E++ G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLV 450
           ++D   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 110
Query: 451 R------XXXXXXXXXXXXXIYEYMPNKSLDV--HLFDATRSVQLDWKRRQSIINGIARG 502
           R                   + +Y+P     V  H   A +++ + + +    +  + R 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL--YMYQLFRS 168
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGY 561
           + Y+H      I HRD+K  N+LLD D    K+ DFG A+     + + N + I   Y Y
Sbjct: 169 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRY-Y 222
Query: 562 MAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
            APE   G   ++   DV+S G +L E++ G+
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 9/205 (4%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKA-IAVKRLSRTSGQGL-QEFKNEVNLIAKLQHKNLV 450
           +++ + +G+G +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                            Y+    ++  L+   ++  L        +  I RG+ Y+H  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TNIIAGTYGYMAPEYAM 568
              ++HRDLK SN+LL+   + KI DFGLAR+   + +     T  +A T  Y APE  +
Sbjct: 145 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIML 200
Query: 569 GGIFSIKS-DVFSFGVLLLEIISGR 592
                 KS D++S G +L E++S R
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/127 (37%), Positives = 71/127 (55%), Gaps = 11/127 (8%)
Query: 467 EYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNIL 525
           E+M   SLD  L  A R   Q+  K   ++I    +G+ YL E  + KI+HRD+K SNIL
Sbjct: 103 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVI----KGLTYLRE--KHKIMHRDVKPSNIL 156
Query: 526 LDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 585
           ++     K+ DFG++    G    +  N   GT  YM+PE   G  +S++SD++S G+ L
Sbjct: 157 VNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 212
Query: 586 LEIISGR 592
           +E+  GR
Sbjct: 213 VEMAVGR 219

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLV 450
           ++D   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 81
Query: 451 R------XXXXXXXXXXXXXIYEYMPNKSLDV--HLFDATRSVQLDWKRRQSIINGIARG 502
           R                   + +Y+P     V  H   A +++ + + +    +  + R 
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL--YMYQLFRS 139
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGY 561
           + Y+H      I HRD+K  N+LLD D    K+ DFG A+     + + N + I   Y Y
Sbjct: 140 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-Y 193
Query: 562 MAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
            APE   G   ++   DV+S G +L E++ G+
Sbjct: 194 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 9/205 (4%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKA-IAVKRLSRTSGQGL-QEFKNEVNLIAKLQHKNLV 450
           +++ + +G+G +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                            Y+    ++  L+   ++  L        +  I RG+ Y+H  +
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 146
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TNIIAGTYGYMAPEYAM 568
              ++HRDLK SN+LL+   + KI DFGLAR+   + +     T  +A T  Y APE  +
Sbjct: 147 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIML 202
Query: 569 GGIFSIKS-DVFSFGVLLLEIISGR 592
                 KS D++S G +L E++S R
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLV 450
           ++D   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 104
Query: 451 R------XXXXXXXXXXXXXIYEYMPNKSLDV--HLFDATRSVQLDWKRRQSIINGIARG 502
           R                   + +Y+P     V  H   A +++ + + +    +  + R 
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL--YMYQLFRS 162
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGY 561
           + Y+H      I HRD+K  N+LLD D    K+ DFG A+     + + N + I   Y Y
Sbjct: 163 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-Y 216
Query: 562 MAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
            APE   G   ++   DV+S G +L E++ G+
Sbjct: 217 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLV 450
           ++D   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 89
Query: 451 R------XXXXXXXXXXXXXIYEYMPNKSLDV--HLFDATRSVQLDWKRRQSIINGIARG 502
           R                   + +Y+P     V  H   A +++ + + +    +  + R 
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL--YMYQLFRS 147
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGY 561
           + Y+H      I HRD+K  N+LLD D    K+ DFG A+     + + N + I   Y Y
Sbjct: 148 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY-Y 201
Query: 562 MAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
            APE   G   ++   DV+S G +L E++ G+
Sbjct: 202 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLV 450
           ++D   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 88
Query: 451 R------XXXXXXXXXXXXXIYEYMPNKSLDV--HLFDATRSVQLDWKRRQSIINGIARG 502
           R                   + +Y+P     V  H   A +++ + + +    +  + R 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL--YMYQLFRS 146
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGY 561
           + Y+H      I HRD+K  N+LLD D    K+ DFG A+     + + N + I   Y Y
Sbjct: 147 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRY-Y 200
Query: 562 MAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
            APE   G   ++   DV+S G +L E++ G+
Sbjct: 201 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 107/231 (46%), Gaps = 27/231 (11%)
Query: 399 LGQGGFGPVYKGTLA--DGKA--IAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRX 452
           LG+G FG V +G L   DG +  +AVK  +L  +S + ++EF +E   +    H N++R 
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 453 -----XXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGIL 504
                            I  +M    L  +L  +           Q+++     IA G+ 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA-RIFGGNQNQANTNIIAGTYGYMA 563
           YL   S    +HRDL A N +L DDM   ++DFGL+ +I+ G+  +    I      ++A
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG-RIAKMPVKWIA 217
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS-------GRKNNGFY-FSEHGQTL 606
            E     +++ KSDV++FGV + EI +       G +N+  Y +  HG  L
Sbjct: 218 IESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL 268

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLV 450
           ++D   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 84
Query: 451 R------XXXXXXXXXXXXXIYEYMPNKSLDV--HLFDATRSVQLDWKRRQSIINGIARG 502
           R                   + +Y+P     V  H   A +++ + + +    +  + R 
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL--YMYQLFRS 142
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGY 561
           + Y+H      I HRD+K  N+LLD D    K+ DFG A+     + + N + I   Y Y
Sbjct: 143 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-Y 196
Query: 562 MAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
            APE   G   ++   DV+S G +L E++ G+
Sbjct: 197 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLV 450
           ++D   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 88
Query: 451 R------XXXXXXXXXXXXXIYEYMPNKSLDV--HLFDATRSVQLDWKRRQSIINGIARG 502
           R                   + +Y+P     V  H   A +++ + + +    +  + R 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL--YMYQLFRS 146
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGY 561
           + Y+H      I HRD+K  N+LLD D    K+ DFG A+     + + N + I   Y Y
Sbjct: 147 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRY-Y 200
Query: 562 MAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
            APE   G   ++   DV+S G +L E++ G+
Sbjct: 201 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLV 450
           ++D   +G G FG VY+  L D G+ +A+K++     QG + FKN E+ ++ KL H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QG-KAFKNRELQIMRKLDHCNIV 76
Query: 451 R------XXXXXXXXXXXXXIYEYMPNKSLDV--HLFDATRSVQLDWKRRQSIINGIARG 502
           R                   + +Y+P     V  H   A +++ + + +    +  + R 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKL--YMYQLFRS 134
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGY 561
           + Y+H      I HRD+K  N+LLD D    K+ DFG A+     + + N + I   Y Y
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRY-Y 188
Query: 562 MAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
            APE   G   ++   DV+S G +L E++ G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLV 450
           ++D   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 110
Query: 451 R------XXXXXXXXXXXXXIYEYMPNKSLDV--HLFDATRSVQLDWKRRQSIINGIARG 502
           R                   + +Y+P     V  H   A +++ + + +    +  + R 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL--YMYQLFRS 168
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGY 561
           + Y+H      I HRD+K  N+LLD D    K+ DFG A+     + + N + I   Y Y
Sbjct: 169 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-Y 222
Query: 562 MAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
            APE   G   ++   DV+S G +L E++ G+
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 9/205 (4%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKA-IAVKRLSRTSGQGL-QEFKNEVNLIAKLQHKNLV 450
           +++ + +G+G +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                            Y+    ++  L+   ++  L        +  I RG+ Y+H  +
Sbjct: 105 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 164
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TNIIAGTYGYMAPEYAM 568
              ++HRDLK SN+LL+   + KI DFGLAR+   + +     T  +A T  Y APE  +
Sbjct: 165 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIML 220
Query: 569 GGIFSIKS-DVFSFGVLLLEIISGR 592
                 KS D++S G +L E++S R
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLV 450
           ++D   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 95
Query: 451 R------XXXXXXXXXXXXXIYEYMPNKSLDV--HLFDATRSVQLDWKRRQSIINGIARG 502
           R                   + +Y+P     V  H   A +++ + + +    +  + R 
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL--YMYQLFRS 153
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGY 561
           + Y+H      I HRD+K  N+LLD D    K+ DFG A+     + + N + I   Y Y
Sbjct: 154 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-Y 207
Query: 562 MAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
            APE   G   ++   DV+S G +L E++ G+
Sbjct: 208 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 9/205 (4%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKA-IAVKRLSRTSGQGL-QEFKNEVNLIAKLQHKNLV 450
           +++ + +G+G +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                            Y+    ++  L+   ++  L        +  I RG+ Y+H  +
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 149
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TNIIAGTYGYMAPEYAM 568
              ++HRDLK SN+LL+   + KI DFGLAR+   + +     T  +A T  Y APE  +
Sbjct: 150 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIML 205
Query: 569 GGIFSIKS-DVFSFGVLLLEIISGR 592
                 KS D++S G +L E++S R
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 9/205 (4%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKA-IAVKRLSRTSGQGL-QEFKNEVNLIAKLQHKNLV 450
           +++ + +G+G +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 90
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                            Y+    ++  L+   ++  L        +  I RG+ Y+H  +
Sbjct: 91  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 150
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TNIIAGTYGYMAPEYAM 568
              ++HRDLK SN+LL+   + KI DFGLAR+   + +     T  +A T  Y APE  +
Sbjct: 151 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIML 206
Query: 569 GGIFSIKS-DVFSFGVLLLEIISGR 592
                 KS D++S G +L E++S R
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 9/205 (4%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKA-IAVKRLSRTSGQGL-QEFKNEVNLIAKLQHKNLV 450
           +++ + +G+G +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 81
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                            Y+    ++  L+   ++  L        +  I RG+ Y+H  +
Sbjct: 82  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 141
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TNIIAGTYGYMAPEYAM 568
              ++HRDLK SN+LL+   + KI DFGLAR+   + +     T  +A T  Y APE  +
Sbjct: 142 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIML 197
Query: 569 GGIFSIKS-DVFSFGVLLLEIISGR 592
                 KS D++S G +L E++S R
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 9/205 (4%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKA-IAVKRLSRTSGQGL-QEFKNEVNLIAKLQHKNLV 450
           +++ + +G+G +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                            Y+    ++  L+   ++  L        +  I RG+ Y+H  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TNIIAGTYGYMAPEYAM 568
              ++HRDLK SN+LL+   + KI DFGLAR+   + +     T  +A T  Y APE  +
Sbjct: 149 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIML 204
Query: 569 GGIFSIKS-DVFSFGVLLLEIISGR 592
                 KS D++S G +L E++S R
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 37/210 (17%)
Query: 399 LGQGGFGPV---YKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXX 453
           +G G  G V   Y   L   + +A+K+LSR   +    +    E+ L+  + HKN++   
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNII--- 86
Query: 454 XXXXXXXXXXXIYEYMPNKSLD--------VHLFDATRS----VQLDWKRRQSIINGIAR 501
                      +  + P KSL+        + L DA  S    ++LD +R   ++  +  
Sbjct: 87  ---------GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLV 137
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           GI +LH      IIHRDLK SNI++  D   KI DFGLAR  G   +   T  +   Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG--TSFMMTPYVVTRY-Y 191
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
            APE  +G  +    D++S GV++ E+I G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 39/92 (42%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +A+G+ +L   +  K IHRDL A NILL +    KI DFGLAR    + +          
Sbjct: 148 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 204
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +MAPE     +++I+SDV+SFGVLL EI S
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 39/92 (42%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +A+G+ +L   +  K IHRDL A NILL +    KI DFGLAR    + +          
Sbjct: 157 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLP 213
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +MAPE     +++I+SDV+SFGVLL EI S
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/127 (37%), Positives = 71/127 (55%), Gaps = 11/127 (8%)
Query: 467 EYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNIL 525
           E+M   SLD  L  A R   Q+  K   ++I    +G+ YL E  + KI+HRD+K SNIL
Sbjct: 84  EHMDGGSLDQVLKKAGRIPEQILGKVSIAVI----KGLTYLRE--KHKIMHRDVKPSNIL 137
Query: 526 LDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 585
           ++     K+ DFG++    G    +  N   GT  YM+PE   G  +S++SD++S G+ L
Sbjct: 138 VNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 193
Query: 586 LEIISGR 592
           +E+  GR
Sbjct: 194 VEMAVGR 200

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 9/205 (4%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKA-IAVKRLSRTSGQGL-QEFKNEVNLIAKLQHKNLV 450
           +++ + +G+G +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                            Y+    ++  L+   ++  L        +  I RG+ Y+H  +
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 142
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TNIIAGTYGYMAPEYAM 568
              ++HRDLK SN+LL+   + KI DFGLAR+   + +     T  +A T  Y APE  +
Sbjct: 143 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIML 198
Query: 569 GGIFSIKS-DVFSFGVLLLEIISGR 592
                 KS D++S G +L E++S R
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 9/205 (4%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKA-IAVKRLSRTSGQGL-QEFKNEVNLIAKLQHKNLV 450
           +++ + +G+G +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                            Y+    ++  L+   ++  L        +  I RG+ Y+H  +
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 142
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TNIIAGTYGYMAPEYAM 568
              ++HRDLK SN+LL+   + KI DFGLAR+   + +     T  +A T  Y APE  +
Sbjct: 143 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIML 198
Query: 569 GGIFSIKS-DVFSFGVLLLEIISGR 592
                 KS D++S G +L E++S R
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/127 (37%), Positives = 71/127 (55%), Gaps = 11/127 (8%)
Query: 467 EYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNIL 525
           E+M   SLD  L  A R   Q+  K   ++I    +G+ YL E  + KI+HRD+K SNIL
Sbjct: 111 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVI----KGLTYLRE--KHKIMHRDVKPSNIL 164
Query: 526 LDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 585
           ++     K+ DFG++    G    +  N   GT  YM+PE   G  +S++SD++S G+ L
Sbjct: 165 VNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 220
Query: 586 LEIISGR 592
           +E+  GR
Sbjct: 221 VEMAVGR 227

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 9/205 (4%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKA-IAVKRLSRTSGQGL-QEFKNEVNLIAKLQHKNLV 450
           +++ + +G+G +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                            Y+    ++  L+   ++  L        +  I RG+ Y+H  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TNIIAGTYGYMAPEYAM 568
              ++HRDLK SN+LL+   + KI DFGLAR+   + +     T  +A T  Y APE  +
Sbjct: 145 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIML 200
Query: 569 GGIFSIKS-DVFSFGVLLLEIISGR 592
                 KS D++S G +L E++S R
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLV 450
           ++D   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 155
Query: 451 R------XXXXXXXXXXXXXIYEYMPNKSLDV--HLFDATRSVQLDWKRRQSIINGIARG 502
           R                   + +Y+P     V  H   A +++ + + +    +  + R 
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL--YMYQLFRS 213
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGY 561
           + Y+H      I HRD+K  N+LLD D    K+ DFG A+     + + N + I   Y Y
Sbjct: 214 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-Y 267
Query: 562 MAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
            APE   G   ++   DV+S G +L E++ G+
Sbjct: 268 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 9/205 (4%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKA-IAVKRLSRTSGQGL-QEFKNEVNLIAKLQHKNLV 450
           +++ + +G+G +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                            Y+    ++  L+   ++  L        +  I RG+ Y+H  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TNIIAGTYGYMAPEYAM 568
              ++HRDLK SN+LL+   + KI DFGLAR+   + +     T  +A T  Y APE  +
Sbjct: 149 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIML 204
Query: 569 GGIFSIKS-DVFSFGVLLLEIISGR 592
                 KS D++S G +L E++S R
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/127 (37%), Positives = 71/127 (55%), Gaps = 11/127 (8%)
Query: 467 EYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNIL 525
           E+M   SLD  L  A R   Q+  K   ++I    +G+ YL E  + KI+HRD+K SNIL
Sbjct: 84  EHMDGGSLDQVLKKAGRIPEQILGKVSIAVI----KGLTYLRE--KHKIMHRDVKPSNIL 137
Query: 526 LDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 585
           ++     K+ DFG++    G    +  N   GT  YM+PE   G  +S++SD++S G+ L
Sbjct: 138 VNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 193
Query: 586 LEIISGR 592
           +E+  GR
Sbjct: 194 VEMAVGR 200

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLV 450
           ++D   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 114
Query: 451 R------XXXXXXXXXXXXXIYEYMPNKSLDV--HLFDATRSVQLDWKRRQSIINGIARG 502
           R                   + +Y+P     V  H   A +++ + + +    +  + R 
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL--YMYQLFRS 172
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGY 561
           + Y+H      I HRD+K  N+LLD D    K+ DFG A+     + + N + I   Y Y
Sbjct: 173 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-Y 226
Query: 562 MAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
            APE   G   ++   DV+S G +L E++ G+
Sbjct: 227 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLV 450
           ++D   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 112
Query: 451 R------XXXXXXXXXXXXXIYEYMPNKSLDV--HLFDATRSVQLDWKRRQSIINGIARG 502
           R                   + +Y+P     V  H   A +++ + + +    +  + R 
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL--YMYQLFRS 170
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGY 561
           + Y+H      I HRD+K  N+LLD D    K+ DFG A+     + + N + I   Y Y
Sbjct: 171 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-Y 224
Query: 562 MAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
            APE   G   ++   DV+S G +L E++ G+
Sbjct: 225 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 9/205 (4%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKA-IAVKRLSRTSGQGL-QEFKNEVNLIAKLQHKNLV 450
           +++ + +G+G +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                            Y+    ++  L+   ++  L        +  I RG+ Y+H  +
Sbjct: 93  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 152
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TNIIAGTYGYMAPEYAM 568
              ++HRDLK SN+LL+   + KI DFGLAR+   + +     T  +A T  Y APE  +
Sbjct: 153 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIML 208
Query: 569 GGIFSIKS-DVFSFGVLLLEIISGR 592
                 KS D++S G +L E++S R
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 9/205 (4%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKA-IAVKRLSRTSGQGL-QEFKNEVNLIAKLQHKNLV 450
           +++ + +G+G +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                            Y+    ++  L+   ++  L        +  I RG+ Y+H  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TNIIAGTYGYMAPEYAM 568
              ++HRDLK SN+LL+   + KI DFGLAR+   + +     T  +A T  Y APE  +
Sbjct: 145 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIML 200
Query: 569 GGIFSIKS-DVFSFGVLLLEIISGR 592
                 KS D++S G +L E++S R
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/92 (42%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +A+G+ +L   +  K IHRDL A NILL +    KI DFGLAR    + +          
Sbjct: 148 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 204
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +MAPE     +++I+SDV+SFGVLL EI S
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 389 ATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQ-GLQ-EFKNEVNLIAKLQ 445
           AT+ +    ++G G +G VYK      G  +A+K +   +G+ GL      EV L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 446 ---HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHL---FDATRSVQLDWKRRQSIINGI 499
              H N+VR             I   +  + +D  L    D      L  +  + ++   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTY 559
            RG+ +LH +    I+HRDLK  NIL+      K++DFGLARI+      A   +   T 
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVV---TL 175
Query: 560 GYMAPEYAMGGIFSIKSDVFSFGVLLLEI 588
            Y APE  +   ++   D++S G +  E+
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/127 (37%), Positives = 71/127 (55%), Gaps = 11/127 (8%)
Query: 467 EYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNIL 525
           E+M   SLD  L  A R   Q+  K   ++I    +G+ YL E  + KI+HRD+K SNIL
Sbjct: 84  EHMDGGSLDQVLKKAGRIPEQILGKVSIAVI----KGLTYLRE--KHKIMHRDVKPSNIL 137
Query: 526 LDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 585
           ++     K+ DFG++    G    +  N   GT  YM+PE   G  +S++SD++S G+ L
Sbjct: 138 VNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 193
Query: 586 LEIISGR 592
           +E+  GR
Sbjct: 194 VEMAVGR 200

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/127 (37%), Positives = 71/127 (55%), Gaps = 11/127 (8%)
Query: 467 EYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNIL 525
           E+M   SLD  L  A R   Q+  K   ++I    +G+ YL E  + KI+HRD+K SNIL
Sbjct: 84  EHMDGGSLDQVLKKAGRIPEQILGKVSIAVI----KGLTYLRE--KHKIMHRDVKPSNIL 137
Query: 526 LDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 585
           ++     K+ DFG++    G    +  N   GT  YM+PE   G  +S++SD++S G+ L
Sbjct: 138 VNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 193
Query: 586 LEIISGR 592
           +E+  GR
Sbjct: 194 VEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/127 (37%), Positives = 71/127 (55%), Gaps = 11/127 (8%)
Query: 467 EYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNIL 525
           E+M   SLD  L  A R   Q+  K   ++I    +G+ YL E  + KI+HRD+K SNIL
Sbjct: 84  EHMDGGSLDQVLKKAGRIPEQILGKVSIAVI----KGLTYLRE--KHKIMHRDVKPSNIL 137
Query: 526 LDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 585
           ++     K+ DFG++    G    +  N   GT  YM+PE   G  +S++SD++S G+ L
Sbjct: 138 VNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 193
Query: 586 LEIISGR 592
           +E+  GR
Sbjct: 194 VEMAVGR 200

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 9/205 (4%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKA-IAVKRLSRTSGQGL-QEFKNEVNLIAKLQHKNLV 450
           +++ + +G+G +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                            Y+    ++  L+   ++  L        +  I RG+ Y+H  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TNIIAGTYGYMAPEYAM 568
              ++HRDLK SN+LL+   + KI DFGLAR+   + +     T  +A T  Y APE  +
Sbjct: 145 ---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIML 200
Query: 569 GGIFSIKS-DVFSFGVLLLEIISGR 592
                 KS D++S G +L E++S R
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 37/210 (17%)
Query: 399 LGQGGFGPV---YKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXX 453
           +G G  G V   Y   L   + +A+K+LSR   +    +    E+ L+  + HKN++   
Sbjct: 32  IGSGAQGIVVAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNII--- 86
Query: 454 XXXXXXXXXXXIYEYMPNKSLD--------VHLFDATRS----VQLDWKRRQSIINGIAR 501
                      +  + P KSL+        + L DA  S    ++LD +R   ++  +  
Sbjct: 87  ---------GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLV 137
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           GI +LH      IIHRDLK SNI++  D   KI DFGLAR  G   +   T  +   Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG--TSFMMTPYVVTRY-Y 191
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
            APE  +G  +    D++S GV++ E+I G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/92 (42%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +A+G+ +L   +  K IHRDL A NILL +    KI DFGLAR    + +          
Sbjct: 157 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 213
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +MAPE     +++I+SDV+SFGVLL EI S
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/92 (42%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +A+G+ +L   +  K IHRDL A NILL +    KI DFGLAR    + +          
Sbjct: 159 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 215
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +MAPE     +++I+SDV+SFGVLL EI S
Sbjct: 216 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 14/199 (7%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           LG+GGF   ++ + AD K +   ++   S        ++   E+++   L H+++V    
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 455 XXXXXXXXXXIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
                     + E    +SL ++H     R   L     +  +  I  G  YLH   R +
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLH---RNR 141
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 573
           +IHRDLK  N+ L++D+  KI DFGLA     +  +  T  + GT  Y+APE       S
Sbjct: 142 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHS 199
Query: 574 IKSDVFSFGVLLLEIISGR 592
            + DV+S G ++  ++ G+
Sbjct: 200 FEVDVWSIGCIMYTLLVGK 218

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 9/205 (4%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKA-IAVKRLSRTSGQG-LQEFKNEVNLIAKLQHKNLV 450
           +++ + +G+G +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENII 88
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                            Y+    ++  L+   ++  L        +  I RG+ Y+H  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TNIIAGTYGYMAPEYAM 568
              ++HRDLK SN+LL+   + KI DFGLAR+   + +     T  +A T  Y APE  +
Sbjct: 149 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIML 204
Query: 569 GGIFSIKS-DVFSFGVLLLEIISGR 592
                 KS D++S G +L E++S R
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 17/201 (8%)
Query: 399 LGQGGFGPV---YKGTLADGKAIAVKRLSRTSGQGLQEFKN--EVNLIAKLQHKNLVRXX 453
           +G G +G V   Y   L   + +AVK+LSR     +   +   E+ L+  L+H+N++   
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 454 XXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                        E Y+    +   L +  +S  L  +  Q ++  + RG+ Y+H     
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAG-- 151
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI- 571
            IIHRDLK SN+ +++D   +I DFGLAR      ++  T  +A T  Y APE  +  + 
Sbjct: 152 -IIHRDLKPSNVAVNEDSELRILDFGLAR----QADEEMTGYVA-TRWYRAPEIMLNWMH 205
Query: 572 FSIKSDVFSFGVLLLEIISGR 592
           ++   D++S G ++ E++ G+
Sbjct: 206 YNQTVDIWSVGCIMAELLQGK 226

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           LG+GGF   ++ + AD K +   ++   S        ++   E+++   L H+++V    
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 455 XXXXXXXXXXIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
                     + E    +SL ++H     R   L     +  +  I  G  YLH   R +
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLH---RNR 135
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 573
           +IHRDLK  N+ L++D+  KI DFGLA       +     ++ GT  Y+APE       S
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVLSKKGHS 193
Query: 574 IKSDVFSFGVLLLEIISGR 592
            + DV+S G ++  ++ G+
Sbjct: 194 FEVDVWSIGCIMYTLLVGK 212

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 14/199 (7%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           LG+GGF   ++ + AD K +   ++   S        ++   E+++   L H+++V    
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 455 XXXXXXXXXXIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
                     + E    +SL ++H     R   L     +  +  I  G  YLH   R +
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLH---RNR 137
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 573
           +IHRDLK  N+ L++D+  KI DFGLA     +  +  T  + GT  Y+APE       S
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHS 195
Query: 574 IKSDVFSFGVLLLEIISGR 592
            + DV+S G ++  ++ G+
Sbjct: 196 FEVDVWSIGCIMYTLLVGK 214

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/92 (42%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +A+G+ +L   +  K IHRDL A NILL +    KI DFGLAR    + +          
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +MAPE     +++I+SDV+SFGVLL EI S
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/92 (42%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +A+G+ +L   +  K IHRDL A NILL +    KI DFGLAR    + +          
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +MAPE     +++I+SDV+SFGVLL EI S
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/92 (42%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +A+G+ +L   +  K IHRDL A NILL +    KI DFGLAR    + +          
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +MAPE     +++I+SDV+SFGVLL EI S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 2   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ 60
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DF LAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFYLAR---- 173
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 174 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 14/199 (7%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           LG+GGF   ++ + AD K +   ++   S        ++   E+++   L H+++V    
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 455 XXXXXXXXXXIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
                     + E    +SL ++H     R   L     +  +  I  G  YLH   R +
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLH---RNR 137
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 573
           +IHRDLK  N+ L++D+  KI DFGLA     +  +  T  + GT  Y+APE       S
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHS 195
Query: 574 IKSDVFSFGVLLLEIISGR 592
            + DV+S G ++  ++ G+
Sbjct: 196 FEVDVWSIGCIMYTLLVGK 214

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 102/245 (41%), Gaps = 41/245 (16%)
Query: 374 ESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGT-LADGK-----AIAVKRLSRTS 427
           E  EFP           N+      LG G FG V + T    GK      +AVK L  T+
Sbjct: 24  EKWEFP----------RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA 73
Query: 428 GQGLQE-FKNEVNLIAKL-QHKNLVRXXXXXXXXXXXXXIYEY----------------M 469
               +E   +E+ +++ L QH+N+V              I EY                M
Sbjct: 74  HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAM 133
Query: 470 PNKSL----DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNIL 525
              SL    D    D      L+ +      + +A+G+ +L   +    IHRD+ A N+L
Sbjct: 134 LGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 190
Query: 526 LDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 585
           L +    KI DFGLAR    + N            +MAPE     +++++SDV+S+G+LL
Sbjct: 191 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 250
Query: 586 LEIIS 590
            EI S
Sbjct: 251 WEIFS 255

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 9/205 (4%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKA-IAVKRLSRTSGQGL-QEFKNEVNLIAKLQHKNLV 450
           +++ + +G+G +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                            Y+    ++  L+   +   L        +  I RG+ Y+H  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TNIIAGTYGYMAPEYAM 568
              ++HRDLK SN+LL+   + KI DFGLAR+   + +     T  +A T  Y APE  +
Sbjct: 149 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIML 204
Query: 569 GGIFSIKS-DVFSFGVLLLEIISGR 592
                 KS D++S G +L E++S R
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/92 (42%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +A+G+ +L   +  K IHRDL A NILL +    KI DFGLAR    + +          
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +MAPE     +++I+SDV+SFGVLL EI S
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 9/205 (4%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKA-IAVKRLSRTSGQGL-QEFKNEVNLIAKLQHKNLV 450
           +++ + +G+G +G V        K  +A+K++S    Q   Q    E+ ++   +H+N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                            Y+    ++  L+   ++  L        +  I RG+ Y+H  +
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 146
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TNIIAGTYGYMAPEYAM 568
              ++HRDLK SN+LL+   + KI DFGLAR+   + +     T  +A T  Y APE  +
Sbjct: 147 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIML 202
Query: 569 GGIFSIKS-DVFSFGVLLLEIISGR 592
                 KS D++S G +L E++S R
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/92 (42%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +A+G+ +L   +  K IHRDL A NILL +    KI DFGLAR    + +          
Sbjct: 194 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 250
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +MAPE     +++I+SDV+SFGVLL EI S
Sbjct: 251 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/92 (42%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +A+G+ +L   +  K IHRDL A NILL +    KI DFGLAR    + +          
Sbjct: 153 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 209
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +MAPE     +++I+SDV+SFGVLL EI S
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/127 (37%), Positives = 70/127 (55%), Gaps = 11/127 (8%)
Query: 467 EYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNIL 525
           E+M   SLD  L  A R   Q+  K   ++I    +G+ YL E  + KI+HRD+K SNIL
Sbjct: 87  EHMDGGSLDQVLKKAGRIPEQILGKVSIAVI----KGLTYLRE--KHKIMHRDVKPSNIL 140
Query: 526 LDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 585
           ++     K+ DFG++    G       N   GT  YM+PE   G  +S++SD++S G+ L
Sbjct: 141 VNSRGEIKLCDFGVS----GQLIDEMANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 196
Query: 586 LEIISGR 592
           +E+  GR
Sbjct: 197 VEMAVGR 203

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 9/205 (4%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKA-IAVKRLSRTSGQGL-QEFKNEVNLIAKLQHKNLV 450
           +++ + +G+G +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                            Y+    +   L+   ++  L        +  I RG+ Y+H  +
Sbjct: 105 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 164
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TNIIAGTYGYMAPEYAM 568
              ++HRDLK SN+LL+   + KI DFGLAR+   + +     T  +A T  Y APE  +
Sbjct: 165 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIML 220
Query: 569 GGIFSIKS-DVFSFGVLLLEIISGR 592
                 KS D++S G +L E++S R
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 39/92 (42%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +A+G+ +L   +  K IHRDL A NILL +    KI DFGLAR    + +          
Sbjct: 153 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLP 209
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +MAPE     +++I+SDV+SFGVLL EI S
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 389 ATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQ-GLQ-EFKNEVNLIAKLQ 445
           AT+ +    ++G G +G VYK      G  +A+K +   +G+ GL      EV L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 446 ---HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHL---FDATRSVQLDWKRRQSIINGI 499
              H N+VR             I   +  + +D  L    D      L  +  + ++   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTY 559
            RG+ +LH +    I+HRDLK  NIL+      K++DFGLARI+     Q     +  T 
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALFPVVVTL 175
Query: 560 GYMAPEYAMGGIFSIKSDVFSFGVLLLEI 588
            Y APE  +   ++   D++S G +  E+
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 9/205 (4%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKA-IAVKRLSRTSGQGL-QEFKNEVNLIAKLQHKNLV 450
           +++ + +G+G +G V        K  +A++++S    Q   Q    E+ ++ + +H+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                            Y+    ++  L+   ++  L        +  I RG+ Y+H  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TNIIAGTYGYMAPEYAM 568
              ++HRDLK SN+LL+   + KI DFGLAR+   + +     T  +A T  Y APE  +
Sbjct: 149 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIML 204
Query: 569 GGIFSIKS-DVFSFGVLLLEIISGR 592
                 KS D++S G +L E++S R
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 2   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI  FGLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGLAR---- 173
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 174 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           LG+GGF   ++ + AD K +   ++   S        ++   E+++   L H+++V    
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 455 XXXXXXXXXXIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
                     + E    +SL ++H     R   L     +  +  I  G  YLH   R +
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLH---RNR 159
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARI--FGGNQNQANTNIIAGTYGYMAPEYAMGGI 571
           +IHRDLK  N+ L++D+  KI DFGLA    + G + +    ++ GT  Y+APE      
Sbjct: 160 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK----VLCGTPNYIAPEVLSKKG 215
Query: 572 FSIKSDVFSFGVLLLEIISGR 592
            S + DV+S G ++  ++ G+
Sbjct: 216 HSFEVDVWSIGCIMYTLLVGK 236

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 15/223 (6%)
Query: 380 LFPLRLALEATNHFSDENKLGQG-GFGPVYKGTLADG----KAIAVKRLSRTSGQGLQ-- 432
           L P    +   +H SD  +LG+  GFG + +  LA      + +AVK L     +     
Sbjct: 14  LVPRGSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFY 73
Query: 433 -EFKNEVNLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLD-VHLFDATRSV-QLDW 489
             F+ E    A L H  +V              +  Y+  + +D V L D   +   +  
Sbjct: 74  LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL-PYIVMEYVDGVTLRDIVHTEGPMTP 132
Query: 490 KRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549
           KR   +I    + + + H++    IIHRD+K +NI++      K+ DFG+AR    + N 
Sbjct: 133 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 189
Query: 550 AN-TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
              T  + GT  Y++PE A G     +SDV+S G +L E+++G
Sbjct: 190 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 16/210 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAI-AVKRLSRTSGQGLQEFKN---EVNLIAKLQH 446
           +HF     +G+G FG V      D K + A+K +++       E +N   E+ ++  L+H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 447 KNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV              + + +    L  HL    ++V    +  +  I  +   + YL
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFKEETVKLFICELVMALDYL 131
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
                 +IIHRD+K  NILLD+  +  I+DF +A +      +     +AGT  YMAPE 
Sbjct: 132 QNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP---RETQITTMAGTKPYMAPEM 185
Query: 567 ---AMGGIFSIKSDVFSFGVLLLEIISGRK 593
                G  +S   D +S GV   E++ GR+
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 2   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI D GLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGLAR---- 173
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 174 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           LG+GGF   ++ + AD K +   ++   S        ++   E+++   L H+++V    
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 455 XXXXXXXXXXIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
                     + E    +SL ++H     R   L     +  +  I  G  YLH   R +
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLH---RNR 161
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 573
           +IHRDLK  N+ L++D+  KI DFGLA       +     ++ GT  Y+APE       S
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVLSKKGHS 219
Query: 574 IKSDVFSFGVLLLEIISGR 592
            + DV+S G ++  ++ G+
Sbjct: 220 FEVDVWSIGCIMYTLLVGK 238

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 102/199 (51%), Gaps = 14/199 (7%)
Query: 399 LGQGGFGPVY---KGTLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVRX 452
           LGQG FG V+   K + +D + +   ++ + +   +++    K E +++ ++ H  +V+ 
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 92
Query: 453 XXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                       I +++    L   L   ++ V    +  +  +  +A  + +LH    L
Sbjct: 93  HYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLHS---L 146
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
            II+RDLK  NILLD++ + K++DFGL++    ++ +A +    GT  YMAPE       
Sbjct: 147 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRGH 204
Query: 573 SIKSDVFSFGVLLLEIISG 591
           +  +D +SFGVL+ E+++G
Sbjct: 205 TQSADWWSFGVLMFEMLTG 223

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 26/214 (12%)
Query: 399 LGQGGFGPVYKGT-LADGK-----AIAVKRLSRTSGQGLQE-FKNEVNLIAKL-QHKNLV 450
           LG G FG V + T    GK      +AVK L  T+    +E   +E+ +++ L QH+N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQS--------------II 496
                         I EY     L ++     R   L++    S                
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDL-LNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFS 172
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 556
           + +A+G+ +L   +    IHRD+ A N+LL +    KI DFGLAR    + N        
Sbjct: 173 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 229
Query: 557 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
               +MAPE     +++++SDV+S+G+LL EI S
Sbjct: 230 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 102/199 (51%), Gaps = 14/199 (7%)
Query: 399 LGQGGFGPVY---KGTLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVRX 452
           LGQG FG V+   K + +D + +   ++ + +   +++    K E +++ ++ H  +V+ 
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 453 XXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                       I +++    L   L   ++ V    +  +  +  +A  + +LH    L
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLHS---L 145
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
            II+RDLK  NILLD++ + K++DFGL++    ++ +A +    GT  YMAPE       
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRGH 203
Query: 573 SIKSDVFSFGVLLLEIISG 591
           +  +D +SFGVL+ E+++G
Sbjct: 204 TQSADWWSFGVLMFEMLTG 222

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 95/204 (46%), Gaps = 7/204 (3%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKA-IAVKRLSRTSGQGL-QEFKNEVNLIAKLQHKNLV 450
           +++ + +G+G +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                            Y+    ++  L+   ++  L        +  I RG+ Y+H  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN-TNIIAGTYGYMAPEYAMG 569
              ++HRDLK SN+LL+   + KI DFGLAR+   + +          T  Y APE  + 
Sbjct: 149 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN 205
Query: 570 GIFSIKS-DVFSFGVLLLEIISGR 592
                KS D++S G +L E++S R
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 95/204 (46%), Gaps = 7/204 (3%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKA-IAVKRLSRTSGQGL-QEFKNEVNLIAKLQHKNLV 450
           +++ + +G+G +G V        K  +A+K++S    Q   Q    E+ ++ + +H+N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                            Y+    ++  L+   ++  L        +  I RG+ Y+H  +
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 149
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN-TNIIAGTYGYMAPEYAMG 569
              ++HRDLK SN+LL+   + KI DFGLAR+   + +          T  Y APE  + 
Sbjct: 150 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN 206
Query: 570 GIFSIKS-DVFSFGVLLLEIISGR 592
                KS D++S G +L E++S R
Sbjct: 207 SKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 109/223 (48%), Gaps = 38/223 (17%)
Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQ-HKNLVRX 452
           KLG+G +G V+K      G+ +AVK++    + S    + F+ E+ ++ +L  H+N+V  
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNL 74
Query: 453 XXXXXXXXXXXX--IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                         +++YM     D+H     R+  L+   +Q ++  + + I YLH   
Sbjct: 75  LNVLRADNDRDVYLVFDYM---ETDLHA--VIRANILEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG------------NQNQAN------- 551
              ++HRD+K SNILL+ + + K++DFGL+R F              N+N  N       
Sbjct: 130 ---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 552 -TNIIAGTYGYMAPEYAMGGIFSIKS-DVFSFGVLLLEIISGR 592
            T+ +A T  Y APE  +G     K  D++S G +L EI+ G+
Sbjct: 187 LTDYVA-TRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 2   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI D GLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGLAR---- 173
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 174 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 103/200 (51%), Gaps = 12/200 (6%)
Query: 398 KLGQGGFGPVYKGTLADGKAI-AVKRLS-RTSGQGLQEFK-NEVNLIAKLQHKNLVRXXX 454
           K+G+G +G V+K    +   I A+KR+      +G+      E+ L+ +L+HKN+VR   
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                     ++E+  ++ L  + FD+     LD +  +S +  + +G+ + H  SR  +
Sbjct: 69  VLHSDKKLTLVFEFC-DQDLKKY-FDSCNG-DLDPEIVKSFLFQLLKGLGFCH--SR-NV 122
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFS 573
           +HRDLK  N+L++ +   K++DFGLAR FG      +  ++  T  Y  P+   G  ++S
Sbjct: 123 LHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYS 180
Query: 574 IKSDVFSFGVLLLEIISGRK 593
              D++S G +  E+ +  +
Sbjct: 181 TSIDMWSAGCIFAELANAAR 200

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 387 LEATNHFSDENKLGQG-GFGPVYKGTLADG----KAIAVKRLSRTSGQGLQ---EFKNEV 438
           +   +H SD  +LG+  GFG + +  LA      + +AVK L     +       F+ E 
Sbjct: 4   MTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREA 63
Query: 439 NLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLD-VHLFDATRSV-QLDWKRRQSII 496
              A L H  +V              +  Y+  + +D V L D   +   +  KR   +I
Sbjct: 64  QNAAALNHPAIVAVYATGEAETPAGPL-PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVI 122
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN-TNII 555
               + + + H++    IIHRD+K +NI++      K+ DFG+AR    + N    T  +
Sbjct: 123 ADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 556 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
            GT  Y++PE A G     +SDV+S G +L E+++G
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 9/205 (4%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKA-IAVKRLSRTSGQGL-QEFKNEVNLIAKLQHKNLV 450
           +++ + +G+G +G V        K  +A+K++S    Q   Q    E+ ++   +H+N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                            Y+    ++  L+   ++  L        +  I RG+ Y+H  +
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 146
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TNIIAGTYGYMAPEYAM 568
              ++HRDLK SN+LL+   + KI DFGLAR+   + +     T  +A T  Y APE  +
Sbjct: 147 ---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIML 202
Query: 569 GGIFSIKS-DVFSFGVLLLEIISGR 592
                 KS D++S G +L E++S R
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 88/184 (47%), Gaps = 18/184 (9%)
Query: 415 GKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPN 471
           G  +AVK+LSR   +    +    E+ L+  + HKN++                + Y+  
Sbjct: 49  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 108
Query: 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN 531
           + +D +L      ++LD +R   ++  +  GI +LH      IIHRDLK SNI++  D  
Sbjct: 109 ELMDANLCQVIH-MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCT 164
Query: 532 PKISDFGLARIFGGNQNQANTNIIAGTYG----YMAPEYAMGGIFSIKSDVFSFGVLLLE 587
            KI DFGLAR        A TN +   Y     Y APE  +G  ++   D++S G ++ E
Sbjct: 165 LKILDFGLART-------ACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGE 217
Query: 588 IISG 591
           ++ G
Sbjct: 218 LVKG 221

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQ---GLQEFKNEVNLIAKLQH 446
           N F     LG+GGFG V    + A GK  A K+L +   +   G     NE  ++ K+  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 447 KNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING--IARGIL 504
           + +V              +   M    L  H++      Q  +   +++     I  G+ 
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG---QAGFPEARAVFYAAEICCGLE 300
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
            LH   R +I++RDLK  NILLDD  + +ISD GLA      Q         GT GYMAP
Sbjct: 301 DLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAP 354
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E      ++   D ++ G LL E+I+G+
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 20/202 (9%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAV----KRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRX 452
           LG G FG V+KG  + +G++I +    K +   SG Q  Q   + +  I  L H ++VR 
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 453 XXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQ----LDWKRRQSIINGIARGILYLHE 508
                       + +Y+P  SL  H+     ++     L+W  +      IA+G+ YL E
Sbjct: 81  LGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMYYLEE 133
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
                ++HR+L A N+LL      +++DFG+A +   +  Q   +       +MA E   
Sbjct: 134 HG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 569 GGIFSIKSDVFSFGVLLLEIIS 590
            G ++ +SDV+S+GV + E+++
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMT 212

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 19/228 (8%)
Query: 375 SQEFPLFPLRLAL-----EATNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSG 428
           SQE P F  R  L     E    + + + +G G +G V        G  +AVK+LSR   
Sbjct: 2   SQERPTF-YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 429 QGLQEFKN--EVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSV 485
             +   +   E+ L+  ++H+N++                + Y+    +   L +  +  
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 486 QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG 545
           +L     Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI D GLAR    
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGLAR---- 173
Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + +   T  +A T  Y APE  +  + ++   D++S G ++ E+++GR
Sbjct: 174 HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 399 LGQGGFGPV---YKGTLADGKAIAVKRLSRTSGQGLQEFKN--EVNLIAKLQHKNLVRXX 453
           +G G +G V   Y   L   + +AVK+LSR     +   +   E+ L+  L+H+N++   
Sbjct: 28  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 454 XXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                        E Y+    +   L +  +   L  +  Q ++  + RG+ Y+H     
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG-- 143
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI- 571
            IIHRDLK SN+ +++D   +I DFGLAR      ++  T  +A T  Y APE  +  + 
Sbjct: 144 -IIHRDLKPSNVAVNEDCELRILDFGLAR----QADEEMTGYVA-TRWYRAPEIMLNWMH 197
Query: 572 FSIKSDVFSFGVLLLEIISGR 592
           ++   D++S G ++ E++ G+
Sbjct: 198 YNQTVDIWSVGCIMAELLQGK 218

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 16/198 (8%)
Query: 399 LGQGGFGPVY--KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXX 456
           LG G F  V+  K  L  GK  A+K + ++        +NE+ ++ K++H+N+V      
Sbjct: 17  LGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   + + +    L   + +  R V  + K    +I  +   + YLHE+    I+H
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRILE--RGVYTE-KDASLVIQQVLSAVKYLHENG---IVH 129
Query: 517 RDLKASNIL-LDDDMNPK--ISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 573
           RDLK  N+L L  + N K  I+DFGL+++    +     +   GT GY+APE      +S
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVLAQKPYS 185
Query: 574 IKSDVFSFGVLLLEIISG 591
              D +S GV+   ++ G
Sbjct: 186 KAVDCWSIGVITYILLCG 203

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 387 LEATNHFSDENKLGQG-GFGPVYKGTLADG----KAIAVKRLSRTSGQGLQ---EFKNEV 438
           +   +H SD  +LG+  GFG + +  LA      + +AVK L     +       F+ E 
Sbjct: 4   MTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREA 63
Query: 439 NLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLD-VHLFDATRSV-QLDWKRRQSII 496
              A L H  +V              +  Y+  + +D V L D   +   +  KR   +I
Sbjct: 64  QNAAALNHPAIVAVYDTGEAETPAGPL-PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVI 122
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN-TNII 555
               + + + H++    IIHRD+K +NI++      K+ DFG+AR    + N    T  +
Sbjct: 123 ADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 556 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
            GT  Y++PE A G     +SDV+S G +L E+++G
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 38/92 (41%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +A+G+ +L   S    +HRDL A N+L+      KI DFGLAR    + N          
Sbjct: 181 VAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 237
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +MAPE    GI++IKSDV+S+G+LL EI S
Sbjct: 238 VKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 37/210 (17%)
Query: 399 LGQGGFGPV---YKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXX 453
           +G G  G V   Y   L   + +A+K+LSR   +    +    E+ L+  + HKN++   
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNII--- 86
Query: 454 XXXXXXXXXXXIYEYMPNKSLD--------VHLFDATRS----VQLDWKRRQSIINGIAR 501
                      +  + P KSL+        + L DA  S    ++LD +R   ++  +  
Sbjct: 87  ---------GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLV 137
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           GI +LH      IIHRDLK SNI++  D   KI DFGLAR  G +     T  +   Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM--TPYVVTRY-Y 191
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
            APE  +G  +    D++S G ++ E+I G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 20/202 (9%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAV----KRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRX 452
           LG G FG V+KG  + +G++I +    K +   SG Q  Q   + +  I  L H ++VR 
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 453 XXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQ----LDWKRRQSIINGIARGILYLHE 508
                       + +Y+P  SL  H+     ++     L+W  +      IA+G+ YL E
Sbjct: 99  LGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMYYLEE 151
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
                ++HR+L A N+LL      +++DFG+A +   +  Q   +       +MA E   
Sbjct: 152 HG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 208
Query: 569 GGIFSIKSDVFSFGVLLLEIIS 590
            G ++ +SDV+S+GV + E+++
Sbjct: 209 FGKYTHQSDVWSYGVTVWELMT 230

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 88/184 (47%), Gaps = 18/184 (9%)
Query: 415 GKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPN 471
           G  +AVK+LSR   +    +    E+ L+  + HKN++                + Y+  
Sbjct: 47  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 106
Query: 472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN 531
           + +D +L      ++LD +R   ++  +  GI +LH      IIHRDLK SNI++  D  
Sbjct: 107 ELMDANLCQVIH-MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCT 162
Query: 532 PKISDFGLARIFGGNQNQANTNIIAGTYG----YMAPEYAMGGIFSIKSDVFSFGVLLLE 587
            KI DFGLAR        A+TN +   Y     Y APE  +G  +    D++S G ++ E
Sbjct: 163 LKILDFGLART-------ASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 215
Query: 588 IISG 591
           ++ G
Sbjct: 216 LVKG 219

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 37/216 (17%)
Query: 398 KLGQGGFGPVYKGTLADG---KAIAVKRLSR-------TSGQGLQEFK----NEVNLIAK 443
           KLG G +G V      +G   KAI V + S+          + +++F     NE++L+  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 444 LQHKNLVRXXXXXXXXXXXXXIYEYMPNKSL-----DVHLFDATRSVQLDWKRRQSIING 498
           L H N+++             + E+     L     + H FD   +         +I+  
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA--------NIMKQ 154
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDD---MNPKISDFGLARIFGGNQNQANTNII 555
           I  GI YLH+ +   I+HRD+K  NILL++    +N KI DFGL+  F  +    +    
Sbjct: 155 ILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR--- 208
Query: 556 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
            GT  Y+APE  +   ++ K DV+S GV++  ++ G
Sbjct: 209 LGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQ---GLQEFKNEVNLIAKLQH 446
           N F     LG+GGFG V    + A GK  A K+L +   +   G     NE  ++ K+  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 447 KNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING--IARGIL 504
           + +V              +   M    L  H++      Q  +   +++     I  G+ 
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG---QAGFPEARAVFYAAEICCGLE 300
Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
            LH   R +I++RDLK  NILLDD  + +ISD GLA      Q         GT GYMAP
Sbjct: 301 DLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAP 354
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E      ++   D ++ G LL E+I+G+
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 89/205 (43%), Gaps = 20/205 (9%)
Query: 397 NKLGQGGFGPVYKGTL--ADGK--AIAVKRLSR---TSGQGLQEFKNEVNLIAKLQHKNL 449
            KLG G FG V +G      GK  ++AVK L     +  + + +F  EVN +  L H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +R             + E  P  SL   L        L    R ++   +A G+ YL   
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN----QANTNIIAGTYGYMAPE 565
              + IHRDL A N+LL      KI DFGL R    N +    Q +  +    + + APE
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV---PFAWCAPE 184
Query: 566 YAMGGIFSIKSDVFSFGVLLLEIIS 590
                 FS  SD + FGV L E+ +
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 399 LGQGGFGPV---YKGTLADGKAIAVKRLSRTSGQGLQEFKN--EVNLIAKLQHKNLVRXX 453
           +G G +G V   Y   L   + +AVK+LSR     +   +   E+ L+  L+H+N++   
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 454 XXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                        E Y+    +   L +  +   L  +  Q ++  + RG+ Y+H     
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG-- 151
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI- 571
            IIHRDLK SN+ +++D   +I DFGLAR      ++  T  +A T  Y APE  +  + 
Sbjct: 152 -IIHRDLKPSNVAVNEDSELRILDFGLAR----QADEEMTGYVA-TRWYRAPEIMLNWMH 205
Query: 572 FSIKSDVFSFGVLLLEIISGR 592
           ++   D++S G ++ E++ G+
Sbjct: 206 YNQTVDIWSVGCIMAELLQGK 226

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 89/205 (43%), Gaps = 20/205 (9%)
Query: 397 NKLGQGGFGPVYKGTL--ADGK--AIAVKRLSR---TSGQGLQEFKNEVNLIAKLQHKNL 449
            KLG G FG V +G      GK  ++AVK L     +  + + +F  EVN +  L H+NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +R             + E  P  SL   L        L    R ++   +A G+ YL   
Sbjct: 78  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 134
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN----QANTNIIAGTYGYMAPE 565
              + IHRDL A N+LL      KI DFGL R    N +    Q +  +    + + APE
Sbjct: 135 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV---PFAWCAPE 188
Query: 566 YAMGGIFSIKSDVFSFGVLLLEIIS 590
                 FS  SD + FGV L E+ +
Sbjct: 189 SLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 89/205 (43%), Gaps = 20/205 (9%)
Query: 397 NKLGQGGFGPVYKGTL--ADGK--AIAVKRLSR---TSGQGLQEFKNEVNLIAKLQHKNL 449
            KLG G FG V +G      GK  ++AVK L     +  + + +F  EVN +  L H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +R             + E  P  SL   L        L    R ++   +A G+ YL   
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN----QANTNIIAGTYGYMAPE 565
              + IHRDL A N+LL      KI DFGL R    N +    Q +  +    + + APE
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV---PFAWCAPE 184
Query: 566 YAMGGIFSIKSDVFSFGVLLLEIIS 590
                 FS  SD + FGV L E+ +
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 37/210 (17%)
Query: 399 LGQGGFGPV---YKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXX 453
           +G G  G V   Y   L   + +A+K+LSR   +    +    E+ L+  + HKN++   
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNII--- 86
Query: 454 XXXXXXXXXXXIYEYMPNKSLD--------VHLFDATRS----VQLDWKRRQSIINGIAR 501
                      +  + P KSL+        + L DA  S    ++LD +R   ++  +  
Sbjct: 87  ---------GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLC 137
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           GI +LH      IIHRDLK SNI++  D   KI DFGLAR  G +     T  +   Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM--TPYVVTRY-Y 191
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
            APE  +G  +    D++S G ++ E+I G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 89/205 (43%), Gaps = 20/205 (9%)
Query: 397 NKLGQGGFGPVYKGTL--ADGK--AIAVKRLSR---TSGQGLQEFKNEVNLIAKLQHKNL 449
            KLG G FG V +G      GK  ++AVK L     +  + + +F  EVN +  L H+NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +R             + E  P  SL   L        L    R ++   +A G+ YL   
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN----QANTNIIAGTYGYMAPE 565
              + IHRDL A N+LL      KI DFGL R    N +    Q +  +    + + APE
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV---PFAWCAPE 194
Query: 566 YAMGGIFSIKSDVFSFGVLLLEIIS 590
                 FS  SD + FGV L E+ +
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 89/205 (43%), Gaps = 20/205 (9%)
Query: 397 NKLGQGGFGPVYKGTL--ADGK--AIAVKRLSR---TSGQGLQEFKNEVNLIAKLQHKNL 449
            KLG G FG V +G      GK  ++AVK L     +  + + +F  EVN +  L H+NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +R             + E  P  SL   L        L    R ++   +A G+ YL   
Sbjct: 78  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 134
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN----QANTNIIAGTYGYMAPE 565
              + IHRDL A N+LL      KI DFGL R    N +    Q +  +    + + APE
Sbjct: 135 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV---PFAWCAPE 188
Query: 566 YAMGGIFSIKSDVFSFGVLLLEIIS 590
                 FS  SD + FGV L E+ +
Sbjct: 189 SLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 103/239 (43%), Gaps = 32/239 (13%)
Query: 366 LRGGKQQAESQEFPLFPLRLALEATNHFSD----ENKLGQGGFGPVYK------GTLADG 415
           + GG+Q     EF        + A+  FSD    + +LG+G F  V +      G     
Sbjct: 7   MTGGQQMGRGSEF-------MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAA 59
Query: 416 KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLD 475
           K I  K+LS    +  Q+ + E  +  KLQH N+VR             +++ +    L 
Sbjct: 60  KIINTKKLS---ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF 116
Query: 476 VHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP--- 532
             +       + D       I  I   I Y H +    I+HR+LK  N+LL         
Sbjct: 117 EDIVAREFYSEAD---ASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAV 170
Query: 533 KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           K++DFGLA     N ++A  +  AGT GY++PE      +S   D+++ GV+L  ++ G
Sbjct: 171 KLADFGLA--IEVNDSEA-WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 89/205 (43%), Gaps = 20/205 (9%)
Query: 397 NKLGQGGFGPVYKGTL--ADGK--AIAVKRLSR---TSGQGLQEFKNEVNLIAKLQHKNL 449
            KLG G FG V +G      GK  ++AVK L     +  + + +F  EVN +  L H+NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +R             + E  P  SL   L        L    R ++   +A G+ YL   
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN----QANTNIIAGTYGYMAPE 565
              + IHRDL A N+LL      KI DFGL R    N +    Q +  +    + + APE
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV---PFAWCAPE 194
Query: 566 YAMGGIFSIKSDVFSFGVLLLEIIS 590
                 FS  SD + FGV L E+ +
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 89/205 (43%), Gaps = 20/205 (9%)
Query: 397 NKLGQGGFGPVYKGTL--ADGK--AIAVKRLSR---TSGQGLQEFKNEVNLIAKLQHKNL 449
            KLG G FG V +G      GK  ++AVK L     +  + + +F  EVN +  L H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +R             + E  P  SL   L        L    R ++   +A G+ YL   
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN----QANTNIIAGTYGYMAPE 565
              + IHRDL A N+LL      KI DFGL R    N +    Q +  +    + + APE
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV---PFAWCAPE 184
Query: 566 YAMGGIFSIKSDVFSFGVLLLEIIS 590
                 FS  SD + FGV L E+ +
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 37/210 (17%)
Query: 399 LGQGGFGPV---YKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXX 453
           +G G  G V   Y   L   + +A+K+LSR   +    +    E+ L+  + HKN++   
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII--- 86
Query: 454 XXXXXXXXXXXIYEYMPNKSLD--------VHLFDATRS----VQLDWKRRQSIINGIAR 501
                      +  + P KSL+        + L DA  S    ++LD +R   ++  +  
Sbjct: 87  ---------GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLC 137
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           GI +LH      IIHRDLK SNI++  D   KI DFGLAR  G   +   T  +   Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-Y 191
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
            APE  +G  +    D++S G ++ E+I G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 37/210 (17%)
Query: 399 LGQGGFGPV---YKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXX 453
           +G G  G V   Y   L   + +A+K+LSR   +    +    E+ L+  + HKN++   
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII--- 86
Query: 454 XXXXXXXXXXXIYEYMPNKSLD--------VHLFDATRS----VQLDWKRRQSIINGIAR 501
                      +  + P KSL+        + L DA  S    ++LD +R   ++  +  
Sbjct: 87  ---------GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLC 137
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           GI +LH      IIHRDLK SNI++  D   KI DFGLAR  G   +   T  +   Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG--TSFMMTPYVVTRY-Y 191
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
            APE  +G  +    D++S G ++ E+I G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 98/216 (45%), Gaps = 18/216 (8%)
Query: 384 RLALEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGL--QEFKNEVNL 440
           + A E    +     +G G +G V        G+ +A+K+LSR     +  +    E+ L
Sbjct: 17  KTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLL 76
Query: 441 IAKLQHKNLVRXXXXXXXXXXXXXIYEY---MPNKSLDVHLFDATRSVQLDWKRRQSIIN 497
           +  +QH+N++               Y++   MP    D+        ++   ++ Q ++ 
Sbjct: 77  LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQ---KIMGLKFSEEKIQYLVY 133
Query: 498 GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG 557
            + +G+ Y+H      ++HRDLK  N+ +++D   KI DFGLAR        A       
Sbjct: 134 QMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVV 185
Query: 558 TYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 186 TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 98/216 (45%), Gaps = 18/216 (8%)
Query: 384 RLALEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGL--QEFKNEVNL 440
           + A E    +     +G G +G V        G+ +A+K+LSR     +  +    E+ L
Sbjct: 35  KTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLL 94
Query: 441 IAKLQHKNLVRXXXXXXXXXXXXXIYEY---MPNKSLDVHLFDATRSVQLDWKRRQSIIN 497
           +  +QH+N++               Y++   MP    D+        ++   ++ Q ++ 
Sbjct: 95  LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQ---KIMGMEFSEEKIQYLVY 151
Query: 498 GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG 557
            + +G+ Y+H      ++HRDLK  N+ +++D   KI DFGLAR        A       
Sbjct: 152 QMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVV 203
Query: 558 TYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           T  Y APE  +  + ++   D++S G ++ E+++G+
Sbjct: 204 TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 11/204 (5%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
           +H+    +LG G FG V++ T  A G   A K +        +  + E+  ++ L+H  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           V              IYE+M    L   + D    +  D       +  + +G+ ++HE+
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHEN 274
Query: 510 SRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
           +    +H DLK  NI+     +   K+ DFGL       Q+     +  GT  + APE A
Sbjct: 275 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVA 328
Query: 568 MGGIFSIKSDVFSFGVLLLEIISG 591
            G      +D++S GVL   ++SG
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 34/206 (16%)
Query: 400 GQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXXXXXX 457
            QG     Y   L   + +A+K+LSR   +    +    E+ L+  + HKN++       
Sbjct: 36  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII------- 86
Query: 458 XXXXXXXIYEYMPNKSLD--------VHLFDATR----SVQLDWKRRQSIINGIARGILY 505
                  +  + P KSL+        + L DA       ++LD +R   ++  +  GI +
Sbjct: 87  -----GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           LH      IIHRDLK SNI++  D   KI DFGLAR   G        ++  T  Y APE
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPEVV--TRYYRAPE 195
Query: 566 YAMGGIFSIKSDVFSFGVLLLEIISG 591
             +G  +    D++S G ++ E+I G
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 11/204 (5%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
           +H+    +LG G FG V++ T  A G   A K +        +  + E+  ++ L+H  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           V              IYE+M    L   + D    +  D       +  + +G+ ++HE+
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHEN 168
Query: 510 SRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
           +    +H DLK  NI+     +   K+ DFGL       Q+     +  GT  + APE A
Sbjct: 169 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVA 222
Query: 568 MGGIFSIKSDVFSFGVLLLEIISG 591
            G      +D++S GVL   ++SG
Sbjct: 223 EGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 398 KLGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXX 453
           KLG G +G V     K T  + +AI + R +  S     +   EV ++  L H N+++  
Sbjct: 44  KLGSGAYGEVLLCRDKVTHVE-RAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 454 XXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
                      + E      L   +    +  ++D      II  +  G+ YLH+ +   
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVD---AAVIIKQVLSGVTYLHKHN--- 156
Query: 514 IIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
           I+HRDLK  N+LL   + D   KI DFGL+ +F   +NQ       GT  Y+APE  +  
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKERLGTAYYIAPE-VLRK 212
Query: 571 IFSIKSDVFSFGVLLLEIISG 591
            +  K DV+S GV+L  +++G
Sbjct: 213 KYDEKCDVWSIGVILFILLAG 233

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 21/218 (9%)
Query: 384 RLALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGL--QEFKNEVNL 440
           + A E    + D   +G G +G V        G  +A+K+L R     L  +    E+ L
Sbjct: 18  KTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 77
Query: 441 IAKLQHKN---LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN 497
           +  ++H+N   L+               Y  MP    D  L    +  +L   R Q ++ 
Sbjct: 78  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD--LGKLMKHEKLGEDRIQFLVY 135
Query: 498 GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG 557
            + +G+ Y+H      IIHRDLK  N+ +++D   KI DFGLAR       QA++ +   
Sbjct: 136 QMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-------QADSEMXGX 185
Query: 558 --TYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
             T  Y APE  +  + ++   D++S G ++ E+I+G+
Sbjct: 186 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 34/206 (16%)
Query: 400 GQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXXXXXX 457
            QG     Y   L   + +A+K+LSR   +    +    E+ L+  + HKN++       
Sbjct: 36  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII------- 86
Query: 458 XXXXXXXIYEYMPNKSLD--------VHLFDATR----SVQLDWKRRQSIINGIARGILY 505
                  +  + P KSL+        + L DA       ++LD +R   ++  +  GI +
Sbjct: 87  -----GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           LH      IIHRDLK SNI++  D   KI DFGLAR  G   +   T  +   Y Y APE
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-YRAPE 195
Query: 566 YAMGGIFSIKSDVFSFGVLLLEIISG 591
             +G  +    D++S G ++ E+I G
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 68/122 (55%), Gaps = 15/122 (12%)
Query: 478 LFD-ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISD 536
           LFD  T  V L  K  +SI+  +   + +LH ++   I+HRDLK  NILLDD+M  ++SD
Sbjct: 187 LFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSD 243
Query: 537 FGLA-RIFGGNQNQANTNIIAGTYGYMAPEYAMGGI------FSIKSDVFSFGVLLLEII 589
           FG +  +  G + +     + GT GY+APE     +      +  + D+++ GV+L  ++
Sbjct: 244 FGFSCHLEPGEKLRE----LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL 299
Query: 590 SG 591
           +G
Sbjct: 300 AG 301

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 34/206 (16%)
Query: 400 GQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXXXXXX 457
            QG     Y   L   + +A+K+LSR   +    +    E+ L+  + HKN++       
Sbjct: 37  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII------- 87
Query: 458 XXXXXXXIYEYMPNKSLD--------VHLFDATR----SVQLDWKRRQSIINGIARGILY 505
                  +  + P KSL+        + L DA       ++LD +R   ++  +  GI +
Sbjct: 88  -----GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 142
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           LH      IIHRDLK SNI++  D   KI DFGLAR  G   +   T  +   Y Y APE
Sbjct: 143 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-YRAPE 196
Query: 566 YAMGGIFSIKSDVFSFGVLLLEIISG 591
             +G  +    D++S G ++ E+I G
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 104/200 (52%), Gaps = 13/200 (6%)
Query: 398 KLGQGGFGPVYKGTLADGKAI-AVKRLS-RTSGQGLQEFK-NEVNLIAKLQHKNLVRXXX 454
           K+G+G +G V+K    +   I A+KR+      +G+      E+ L+ +L+HKN+VR   
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                     ++E+  ++ L  + FD+     LD +  +S +  + +G+ + H  SR  +
Sbjct: 69  VLHSDKKLTLVFEFC-DQDLKKY-FDSCNG-DLDPEIVKSFLFQLLKGLGFCH--SR-NV 122
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFS 573
           +HRDLK  N+L++ +   K+++FGLAR FG      +  ++  T  Y  P+   G  ++S
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYS 180
Query: 574 IKSDVFSFGVLLLEII-SGR 592
              D++S G +  E+  +GR
Sbjct: 181 TSIDMWSAGCIFAELANAGR 200

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 389 ATNHFSDENKLGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIA 442
           AT+ +    ++G G +G VYK      G     K++ V       G        EV L+ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 443 KLQ---HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHL---FDATRSVQLDWKRRQSII 496
           +L+   H N+VR             I   +  + +D  L    D      L  +  + ++
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 556
               RG+ +LH +    I+HRDLK  NIL+      K++DFGLARI+  +   A T ++ 
Sbjct: 127 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALTPVVV 181
Query: 557 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEI 588
            T  Y APE  +   ++   D++S G +  E+
Sbjct: 182 -TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 13/213 (6%)
Query: 384 RLALEATNHFSDENKLGQGGFGPVYKGTLADGKA---IAVKRLSR-TSGQGLQEFKNEVN 439
           +L L+  N    + +LG G FG V +G     K    +A+K L + T     +E   E  
Sbjct: 3   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 62
Query: 440 LIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 499
           ++ +L +  +VR             + E      L  H F   +  ++       +++ +
Sbjct: 63  IMHQLDNPYIVRLIGVCQAEALML-VMEMAGGGPL--HKFLVGKREEIPVSNVAELLHQV 119
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTY 559
           + G+ YL E +    +HRDL A N+LL +    KISDFGL++  G + +   T   AG +
Sbjct: 120 SMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKW 175
Query: 560 --GYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
              + APE      FS +SDV+S+GV + E +S
Sbjct: 176 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 208

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 34/206 (16%)
Query: 400 GQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXXXXXX 457
            QG     Y   L   + +A+K+LSR   +    +    E+ L+  + HKN++       
Sbjct: 36  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII------- 86
Query: 458 XXXXXXXIYEYMPNKSLD--------VHLFDATR----SVQLDWKRRQSIINGIARGILY 505
                  +  + P KSL+        + L DA       ++LD +R   ++  +  GI +
Sbjct: 87  -----GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           LH      IIHRDLK SNI++  D   KI DFGLAR  G   +   T  +   Y Y APE
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-YRAPE 195
Query: 566 YAMGGIFSIKSDVFSFGVLLLEIISG 591
             +G  +    D++S G ++ E+I G
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 399 LGQGGFGPVYKGTLADGK----AIAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRXX 453
           LG G F  V    LA+ K     +A+K +++ + +G +   +NE+ ++ K++H N+V   
Sbjct: 26  LGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 454 XXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
                      I + +    L   + +     + D  R   +I  +   + YLH+   L 
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLHD---LG 136
Query: 514 IIHRDLKASNIL---LDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
           I+HRDLK  N+L   LD+D    ISDFGL+++       +  +   GT GY+APE     
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 571 IFSIKSDVFSFGVLLLEIISG 591
            +S   D +S GV+   ++ G
Sbjct: 194 PYSKAVDCWSIGVIAYILLCG 214

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 399 LGQGGFGPV---YKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXX 453
           +G G  G V   Y   L   + +A+K+LSR   +    +    E+ L+  + HKN++   
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 454 XXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                        + Y+  + +D +L    + ++LD +R   ++  +  GI +LH     
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQ-MELDHERMSYLLYQMLXGIKHLHSAG-- 146
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
            IIHRDLK SNI++  D   KI DFGLAR  G   +   T  +   Y Y APE  +G  +
Sbjct: 147 -IIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGY 202
Query: 573 SIKSDVFSFGVLLLEIISGR 592
               D++S G ++ E++  +
Sbjct: 203 KENVDIWSVGCIMGEMVRHK 222

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 399 LGQGGFGPVYKGTLADGKA----IAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRXX 453
           LG G F  V    LA+ K     +A+K +++ + +G +   +NE+ ++ K++H N+V   
Sbjct: 26  LGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 454 XXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
                      I + +    L   + +     + D  R   +I  +   + YLH+   L 
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLHD---LG 136
Query: 514 IIHRDLKASNIL---LDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
           I+HRDLK  N+L   LD+D    ISDFGL+++       +  +   GT GY+APE     
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 571 IFSIKSDVFSFGVLLLEIISG 591
            +S   D +S GV+   ++ G
Sbjct: 194 PYSKAVDCWSIGVIAYILLCG 214

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 88/202 (43%), Gaps = 18/202 (8%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXXXX 458
           +G+G FG VY G      AI +  + R +   L+ FK EV    + +H+N+V        
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 459 XXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRD 518
                 I      ++L   + DA   + LD  + + I   I +G+ YLH      I+H+D
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 519 LKASNILLDDDMNPKISDFGLARIFG---GNQNQANTNIIAGTYGYMAPEYAM------- 568
           LK+ N+  D+     I+DFGL  I G     + +    I  G   ++APE          
Sbjct: 156 LKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214
Query: 569 --GGIFSIKSDVFSFGVLLLEI 588
                FS  SDVF+ G +  E+
Sbjct: 215 EDKLPFSKHSDVFALGTIWYEL 236

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 399 LGQGGFGPVYKGTLADGKA----IAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRXX 453
           LG G F  V    LA+ K     +A+K +++ + +G +   +NE+ ++ K++H N+V   
Sbjct: 26  LGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 454 XXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
                      I + +    L   + +     + D  R   +I  +   + YLH+   L 
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLHD---LG 136
Query: 514 IIHRDLKASNIL---LDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
           I+HRDLK  N+L   LD+D    ISDFGL+++       +  +   GT GY+APE     
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 571 IFSIKSDVFSFGVLLLEIISG 591
            +S   D +S GV+   ++ G
Sbjct: 194 PYSKAVDCWSIGVIAYILLCG 214

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 391 NHFSDENKLGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGL--QEFKNEVNLIA 442
           +++    +LG G F  V K      G     K I  KR +++S +G+  ++ + EV+++ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 443 KLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIAR 501
           ++QH N++              I E +        LFD       L  +     +  I  
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILN 125
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPK----ISDFGLA-RIFGGNQNQANTNIIA 556
           G+ YLH    L+I H DLK  NI+L D   PK    I DFGLA +I  GN+ +     I 
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IF 178
Query: 557 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           GT  ++APE        +++D++S GV+   ++SG
Sbjct: 179 GTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 398 KLGQGGFGPVYKGTLAD--GKAIAVKRLSRTSGQGLQEFKN--EVNLIAKLQ---HKNLV 450
           ++G+G +G V+K       G+ +A+KR+   +G+         EV ++  L+   H N+V
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 451 R-----XXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           R                  ++E++ ++ L  +L D      +  +  + ++  + RG+ +
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 135
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           LH     +++HRDLK  NIL+      K++DFGLARI+  +   A T+++  T  Y APE
Sbjct: 136 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVV-TLWYRAPE 189
Query: 566 YAMGGIFSIKSDVFSFGVLLLEI 588
             +   ++   D++S G +  E+
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEM 212

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 399 LGQGGFGPVYKGTLADGKA----IAVKRLSRTSGQGLQ-EFKNEVNLIAKLQHKNLVRXX 453
           LG G F  V    LA+ K     +A+K +++ + +G +   +NE+ ++ K++H N+V   
Sbjct: 26  LGTGAFSEV---ILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 454 XXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
                      I + +    L   + +     + D  R   +I  +   + YLH+   L 
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLHD---LG 136
Query: 514 IIHRDLKASNIL---LDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
           I+HRDLK  N+L   LD+D    ISDFGL+++       +  +   GT GY+APE     
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 571 IFSIKSDVFSFGVLLLEIISG 591
            +S   D +S GV+   ++ G
Sbjct: 194 PYSKAVDCWSIGVIAYILLCG 214

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 398 KLGQGGFGPVYKGTLAD--GKAIAVKRLSRTSGQGLQEFKN--EVNLIAKLQ---HKNLV 450
           ++G+G +G V+K       G+ +A+KR+   +G+         EV ++  L+   H N+V
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 451 R-----XXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           R                  ++E++ ++ L  +L D      +  +  + ++  + RG+ +
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 135
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           LH     +++HRDLK  NIL+      K++DFGLARI+  +   A T+++  T  Y APE
Sbjct: 136 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVV-TLWYRAPE 189
Query: 566 YAMGGIFSIKSDVFSFGVLLLEI 588
             +   ++   D++S G +  E+
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEM 212

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 37/216 (17%)
Query: 393 FSDENKLGQGGFGPV---YKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHK 447
           + +   +G G  G V   Y   L   + +A+K+LSR   +    +    E+ L+  + HK
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 85
Query: 448 NLVRXXXXXXXXXXXXXIYEYMPNKSLD--------VHLFDATR----SVQLDWKRRQSI 495
           N++              +  + P KSL+        + L DA       ++LD +R   +
Sbjct: 86  NII------------GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 133
Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 555
           +  +  GI +LH      IIHRDLK SNI++  D   KI DFGLAR  G +       + 
Sbjct: 134 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVV- 189
Query: 556 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
             T  Y APE  +G  +    D++S G ++ E+I G
Sbjct: 190 --TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 26/205 (12%)
Query: 398 KLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGL--QEFKNEVNLIAKLQHKNLVRXXX 454
           K+G+G +G V+K    D G+ +A+K+   +    +  +    E+ ++ +L+H NLV    
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRR-------QSIINGIARGILYLH 507
                     ++EY           D T   +LD  +R       +SI     + + + H
Sbjct: 70  VFRRKRRLHLVFEYC----------DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
           + +    IHRD+K  NIL+      K+ DFG AR+  G  +  +  +   T  Y +PE  
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV--ATRWYRSPELL 174
Query: 568 MGGI-FSIKSDVFSFGVLLLEIISG 591
           +G   +    DV++ G +  E++SG
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 398 KLGQGGFGPVYKGTLAD--GKAIAVKRLSRTSGQGLQEFKN--EVNLIAKLQ---HKNLV 450
           ++G+G +G V+K       G+ +A+KR+   +G+         EV ++  L+   H N+V
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 451 R-----XXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           R                  ++E++ ++ L  +L D      +  +  + ++  + RG+ +
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 135
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           LH     +++HRDLK  NIL+      K++DFGLARI+  +   A T+++  T  Y APE
Sbjct: 136 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVV-TLWYRAPE 189
Query: 566 YAMGGIFSIKSDVFSFGVLLLEI 588
             +   ++   D++S G +  E+
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 399 LGQGGFGPV---YKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXX 453
           +G G  G V   Y   L   + +A+K+LSR   +    +    E+ L+  + HKN++   
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 454 XXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                        + Y+  + +D +L    + ++LD +R   ++  +  GI +LH     
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQ-MELDHERMSYLLYQMLCGIKHLHSAG-- 146
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
            IIHRDLK SNI++  D   KI DFGLAR  G +     T  +   Y Y APE  +G  +
Sbjct: 147 -IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGY 202
Query: 573 SIKSDVFSFGVLLLEIISGR 592
               D++S G ++ E++  +
Sbjct: 203 KENVDIWSVGCIMGEMVRHK 222

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 393 FSDENKLGQGGFGPV---YKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHK 447
           + +   +G G  G V   Y   L   + +A+K+LSR   +    +    E+ L+  + HK
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 448 NLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
           N++                + Y+  + +D +L    + ++LD +R   ++  +  GI +L
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ-MELDHERMSYLLYQMLXGIKHL 135
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H      IIHRDLK SNI++  D   KI DFGLAR  G +     T  +   Y Y APE 
Sbjct: 136 HSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEV 189
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISGR 592
            +G  +    D++S G ++ E++  +
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 103/237 (43%), Gaps = 27/237 (11%)
Query: 388 EATNHFSDENKLGQGGFGPVYK------GTLADGKAIAVKRLSRTS-GQGLQEFKNEVNL 440
           +  +H+    +LG G F  V K      G     K I  +RLS +  G   +E + EVN+
Sbjct: 9   DVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 68
Query: 441 IAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGI 499
           + +++H N++              I E +    L    FD       L        +  I
Sbjct: 69  LREIRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQI 124
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDD--MNPKIS--DFGLA-RIFGGNQNQANTNI 554
             G+ YLH     +I H DLK  NI+L D    NP+I   DFG+A +I  GN+ +     
Sbjct: 125 LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---- 177
Query: 555 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVC 611
           I GT  ++APE        +++D++S GV+   ++SG      +  E  Q  LT + 
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---FLGETKQETLTNIS 231

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 400 GQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXXXXXX 457
            QG     Y   L   + +A+K+LSR   +    +    E+ L+  + HKN++       
Sbjct: 36  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFT 93
Query: 458 XXXXXXXIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                    + Y+  + +D +L    + ++LD +R   ++  +  GI +LH      IIH
Sbjct: 94  PQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAG---IIH 149
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDLK SNI++  D   KI DFGLAR  G +     T  +   Y Y APE  +G  +    
Sbjct: 150 RDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENV 206
Query: 577 DVFSFGVLLLEIISGR 592
           D++S G ++ E++  +
Sbjct: 207 DIWSVGCIMGEMVRHK 222

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 399 LGQGGFGPV---YKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXX 453
           +G G  G V   Y   L   + +A+K+LSR   +    +    E+ L+  + HKN++   
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 454 XXXXXXXXXXXIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                        + Y+  + +D +L    + ++LD +R   ++  +  GI +LH     
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQ-MELDHERMSYLLYQMLXGIKHLHSAG-- 146
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
            IIHRDLK SNI++  D   KI DFGLAR  G   +   T  +   Y Y APE  +G  +
Sbjct: 147 -IIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVTRY-YRAPEVILGMGY 202
Query: 573 SIKSDVFSFGVLLLEIISGR 592
               D++S G ++ E++  +
Sbjct: 203 KENVDIWSVGCIMGEMVRHK 222

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 117/261 (44%), Gaps = 24/261 (9%)
Query: 368 GGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRL--- 423
           G  +Q +S E P        +  + +    K+GQG FG V+K      G+ +A+K++   
Sbjct: 1   GPAKQYDSVECPF------CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME 54
Query: 424 SRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXXXXXXX-----XXXIYEYMPNKSLDVHL 478
           +   G  +   + E+ ++  L+H+N+V                   IY        D+  
Sbjct: 55  NEKEGFPITALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAG 113
Query: 479 FDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538
             +   V+      + ++  +  G+ Y+H   R KI+HRD+KA+N+L+  D   K++DFG
Sbjct: 114 LLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFG 170
Query: 539 LARIFGGNQN-QAN--TNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKN 594
           LAR F   +N Q N   N +  T  Y  PE  +G   +    D++  G ++ E+ +    
Sbjct: 171 LARAFSLAKNSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 229
Query: 595 NGFYFSEHGQTLLTYVCNSLS 615
                 +H   L++ +C S++
Sbjct: 230 MQGNTEQHQLALISQLCGSIT 250

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 17/200 (8%)
Query: 399 LGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKL------QHKNLVR 451
           LG+G FG V    + + G   AVK L +     LQ+   E  +  K        H  L +
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 452 XXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
                        + E++    L   +F   +S + D  R +     I   +++LH+   
Sbjct: 89  LFCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEIISALMFLHDKG- 144
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 571
             II+RDLK  N+LLD + + K++DFG+ +   G  N   T    GT  Y+APE     +
Sbjct: 145 --IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEILQEML 200
Query: 572 FSIKSDVFSFGVLLLEIISG 591
           +    D ++ GVLL E++ G
Sbjct: 201 YGPAVDWWAMGVLLYEMLCG 220

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 391 NHFSDENKLGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGL--QEFKNEVNLIA 442
           +++    +LG G F  V K      G     K I  KR +++S +G+  ++ + EV+++ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 443 KLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIAR 501
           ++QH N++              I E +        LFD       L  +     +  I  
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILN 125
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPK----ISDFGLA-RIFGGNQNQANTNIIA 556
           G+ YLH    L+I H DLK  NI+L D   PK    I DFGLA +I  GN+ +     I 
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IF 178
Query: 557 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           GT  ++APE        +++D++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 102/234 (43%), Gaps = 27/234 (11%)
Query: 391 NHFSDENKLGQGGFGPVYK------GTLADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAK 443
           +H+    +LG G F  V K      G     K I  +RLS +  G   +E + EVN++ +
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 444 LQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIARG 502
           ++H N++              I E +    L    FD       L        +  I  G
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQILDG 120
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDD--MNPKIS--DFGLA-RIFGGNQNQANTNIIAG 557
           + YLH     +I H DLK  NI+L D    NP+I   DFG+A +I  GN+ +     I G
Sbjct: 121 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN----IFG 173
Query: 558 TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVC 611
           T  ++APE        +++D++S GV+   ++SG      +  E  Q  LT + 
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---FLGETKQETLTNIS 224

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/90 (42%), Positives = 50/90 (55%), Gaps = 7/90 (7%)
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    LKIIHRD+K SNILLD   N K+ DFG++   G   +       AG   YMAPE 
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS---GQLVDSIAKTRDAGCRPYMAPER 196
Query: 567 ----AMGGIFSIKSDVFSFGVLLLEIISGR 592
               A    + ++SDV+S G+ L E+ +GR
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 91/193 (47%), Gaps = 12/193 (6%)
Query: 400 GQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXXXXXX 457
            QG     Y   L   + +A+K+LSR   +    +    E+ L+  + HKN++       
Sbjct: 74  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 131
Query: 458 XXXXXXXIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                    + Y+  + +D +L    + ++LD +R   ++  +  GI +LH      IIH
Sbjct: 132 PQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAG---IIH 187
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDLK SNI++  D   KI DFGLAR  G +     T  +   Y Y APE  +G  +    
Sbjct: 188 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENV 244
Query: 577 DVFSFGVLLLEII 589
           D++S G ++ E++
Sbjct: 245 DIWSVGCIMGEMV 257

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 391 NHFSDENKLGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGL--QEFKNEVNLIA 442
           +++    +LG G F  V K      G     K I  KR +++S +G+  ++ + EV+++ 
Sbjct: 11  DYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 443 KLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIAR 501
           ++QH N++              I E +        LFD       L  +     +  I  
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILN 125
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPK----ISDFGLA-RIFGGNQNQANTNIIA 556
           G+ YLH    L+I H DLK  NI+L D   PK    I DFGLA +I  GN+ +     I 
Sbjct: 126 GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IF 178
Query: 557 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           GT  ++APE        +++D++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 117/261 (44%), Gaps = 24/261 (9%)
Query: 368 GGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRL--- 423
           G  +Q +S E P        +  + +    K+GQG FG V+K      G+ +A+K++   
Sbjct: 1   GPAKQYDSVECPF------CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME 54
Query: 424 SRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXXXXXXX-----XXXIYEYMPNKSLDVHL 478
           +   G  +   + E+ ++  L+H+N+V                   IY        D+  
Sbjct: 55  NEKEGFPITALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG 113
Query: 479 FDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538
             +   V+      + ++  +  G+ Y+H   R KI+HRD+KA+N+L+  D   K++DFG
Sbjct: 114 LLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFG 170
Query: 539 LARIFGGNQN-QAN--TNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKN 594
           LAR F   +N Q N   N +  T  Y  PE  +G   +    D++  G ++ E+ +    
Sbjct: 171 LARAFSLAKNSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 229
Query: 595 NGFYFSEHGQTLLTYVCNSLS 615
                 +H   L++ +C S++
Sbjct: 230 MQGNTEQHQLALISQLCGSIT 250

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 399 LGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRX 452
           +G+G F  V +      G     K + V + + + G   ++ K E ++   L+H ++V  
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 453 XXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL----YLHE 508
                       ++E+M    L    F+  +     +   +++ +   R IL    Y H+
Sbjct: 92  LETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 509 DSRLKIIHRDLKASNILLDDDMNP---KISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           ++   IIHRD+K  N+LL    N    K+ DFG+A   G +   A   +  GT  +MAPE
Sbjct: 149 NN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRV--GTPHFMAPE 203
Query: 566 YAMGGIFSIKSDVFSFGVLLLEIISG 591
                 +    DV+  GV+L  ++SG
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 400 GQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXXXXXX 457
            QG     Y   L   + +A+K+LSR   +    +    E+ L+  + HKN++       
Sbjct: 74  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 131
Query: 458 XXXXXXXIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                    + Y+  + +D +L    + ++LD +R   ++  +  GI +LH      IIH
Sbjct: 132 PQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAG---IIH 187
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDLK SNI++  D   KI DFGLAR  G +     T  +   Y Y APE  +G  +    
Sbjct: 188 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENV 244
Query: 577 DVFSFGVLLLEIISGR 592
           D++S G ++ E++  +
Sbjct: 245 DIWSVGCIMGEMVRHK 260

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 117/261 (44%), Gaps = 24/261 (9%)
Query: 368 GGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRL--- 423
           G  +Q +S E P        +  + +    K+GQG FG V+K      G+ +A+K++   
Sbjct: 1   GPAKQYDSVECPF------CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME 54
Query: 424 SRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXXXXXXX-----XXXIYEYMPNKSLDVHL 478
           +   G  +   + E+ ++  L+H+N+V                   IY        D+  
Sbjct: 55  NEKEGFPITALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG 113
Query: 479 FDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538
             +   V+      + ++  +  G+ Y+H   R KI+HRD+KA+N+L+  D   K++DFG
Sbjct: 114 LLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFG 170
Query: 539 LARIFGGNQN-QAN--TNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKN 594
           LAR F   +N Q N   N +  T  Y  PE  +G   +    D++  G ++ E+ +    
Sbjct: 171 LARAFSLAKNSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 229
Query: 595 NGFYFSEHGQTLLTYVCNSLS 615
                 +H   L++ +C S++
Sbjct: 230 MQGNTEQHQLALISQLCGSIT 250

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 34/207 (16%)
Query: 400 GQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXXXXXX 457
            QG     Y   L   + +A+K+LSR   +    +    E+ L+  + HKN++       
Sbjct: 36  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII------- 86
Query: 458 XXXXXXXIYEYMPNKSLD--------VHLFDATR----SVQLDWKRRQSIINGIARGILY 505
                  +  + P KSL+        + L DA       ++LD +R   ++  +  GI +
Sbjct: 87  -----GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           LH      IIHRDLK SNI++  D   KI DFGLAR   G        ++  T  Y APE
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMEPEVV--TRYYRAPE 195
Query: 566 YAMGGIFSIKSDVFSFGVLLLEIISGR 592
             +G  +    D++S G ++ E++  +
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 391 NHFSDENKLGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGL--QEFKNEVNLIA 442
           +++    +LG G F  V K      G     K I  KR +++S +G+  ++ + EV+++ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 443 KLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIAR 501
           ++QH N++              I E +        LFD       L  +     +  I  
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILN 125
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPK----ISDFGLA-RIFGGNQNQANTNIIA 556
           G+ YLH    L+I H DLK  NI+L D   PK    I DFGLA +I  GN+ +     I 
Sbjct: 126 GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IF 178
Query: 557 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           GT  ++APE        +++D++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 16/224 (7%)
Query: 381 FPLRLALEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQ--GLQEFKNE 437
            P R+    ++ F  ++ LG+G +G V   T    G+ +A+K++         L+  + E
Sbjct: 1   MPKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-E 59
Query: 438 VNLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN 497
           + ++   +H+N++                 Y+  + +   L     +  L     Q  I 
Sbjct: 60  IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY 119
Query: 498 GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ--------NQ 549
              R +  LH  +   +IHRDLK SN+L++ + + K+ DFGLARI   +          Q
Sbjct: 120 QTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 550 ANTNIIAGTYGYMAPEYAM-GGIFSIKSDVFSFGVLLLEIISGR 592
           +       T  Y APE  +    +S   DV+S G +L E+   R
Sbjct: 177 SGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 391 NHFSDENKLGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGL--QEFKNEVNLIA 442
           +++    +LG G F  V K      G     K I  KR +++S +G+  ++ + EV+++ 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 68
Query: 443 KLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIAR 501
           ++QH N++              I E +        LFD       L  +     +  I  
Sbjct: 69  EIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILN 124
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPK----ISDFGLA-RIFGGNQNQANTNIIA 556
           G+ YLH    L+I H DLK  NI+L D   PK    I DFGLA +I  GN+ +     I 
Sbjct: 125 GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IF 177
Query: 557 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           GT  ++APE        +++D++S GV+   ++SG
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 400 GQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXXXXXX 457
            QG     Y   L   + +A+K+LSR   +    +    E+ L+  + HKN++       
Sbjct: 35  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 92
Query: 458 XXXXXXXIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                    + Y+  + +D +L    + ++LD +R   ++  +  GI +LH      IIH
Sbjct: 93  PQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAG---IIH 148
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDLK SNI++  D   KI DFGLAR  G +     T  +   Y Y APE  +G  +    
Sbjct: 149 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENV 205
Query: 577 DVFSFGVLLLEIISGR 592
           D++S G ++ E++  +
Sbjct: 206 DIWSVGCIMGEMVRHK 221

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 391 NHFSDENKLGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGL--QEFKNEVNLIA 442
           +++    +LG G F  V K      G     K I  KR +++S +G+  ++ + EV+++ 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 68
Query: 443 KLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIAR 501
           ++QH N++              I E +        LFD       L  +     +  I  
Sbjct: 69  EIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILN 124
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPK----ISDFGLA-RIFGGNQNQANTNIIA 556
           G+ YLH    L+I H DLK  NI+L D   PK    I DFGLA +I  GN+ +     I 
Sbjct: 125 GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IF 177
Query: 557 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           GT  ++APE        +++D++S GV+   ++SG
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 400 GQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXXXXXX 457
            QG     Y   L   + +A+K+LSR   +    +    E+ L+  + HKN++       
Sbjct: 29  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 86
Query: 458 XXXXXXXIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                    + Y+  + +D +L    + ++LD +R   ++  +  GI +LH      IIH
Sbjct: 87  PQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAG---IIH 142
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDLK SNI++  D   KI DFGLAR  G +     T  +   Y Y APE  +G  +    
Sbjct: 143 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENV 199
Query: 577 DVFSFGVLLLEIISGR 592
           D++S G ++ E++  +
Sbjct: 200 DIWSVGCIMGEMVRHK 215

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 400 GQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXXXXXX 457
            QG     Y   L   + +A+K+LSR   +    +    E+ L+  + HKN++       
Sbjct: 30  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 87
Query: 458 XXXXXXXIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                    + Y+  + +D +L    + ++LD +R   ++  +  GI +LH      IIH
Sbjct: 88  PQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAG---IIH 143
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDLK SNI++  D   KI DFGLAR  G +     T  +   Y Y APE  +G  +    
Sbjct: 144 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENV 200
Query: 577 DVFSFGVLLLEIISGR 592
           D++S G ++ E++  +
Sbjct: 201 DIWSVGCIMGEMVRHK 216

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 400 GQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXXXXXX 457
            QG     Y   L   + +A+K+LSR   +    +    E+ L+  + HKN++       
Sbjct: 37  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 94
Query: 458 XXXXXXXIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                    + Y+  + +D +L    + ++LD +R   ++  +  GI +LH      IIH
Sbjct: 95  PQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAG---IIH 150
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDLK SNI++  D   KI DFGLAR  G +     T  +   Y Y APE  +G  +    
Sbjct: 151 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENV 207
Query: 577 DVFSFGVLLLEIISGR 592
           D++S G ++ E++  +
Sbjct: 208 DIWSVGCIMGEMVRHK 223

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 400 GQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXXXXXX 457
            QG     Y   L   + +A+K+LSR   +    +    E+ L+  + HKN++       
Sbjct: 36  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 93
Query: 458 XXXXXXXIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                    + Y+  + +D +L    + ++LD +R   ++  +  GI +LH      IIH
Sbjct: 94  PQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAG---IIH 149
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDLK SNI++  D   KI DFGLAR  G +     T  +   Y Y APE  +G  +    
Sbjct: 150 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENV 206
Query: 577 DVFSFGVLLLEIISGR 592
           D++S G ++ E++  +
Sbjct: 207 DIWSVGCIMGEMVRHK 222

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 16/224 (7%)
Query: 381 FPLRLALEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQ--GLQEFKNE 437
            P R+    ++ F  ++ LG+G +G V   T    G+ +A+K++         L+  + E
Sbjct: 1   MPKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-E 59
Query: 438 VNLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN 497
           + ++   +H+N++                 Y+  + +   L     +  L     Q  I 
Sbjct: 60  IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY 119
Query: 498 GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ--------NQ 549
              R +  LH  +   +IHRDLK SN+L++ + + K+ DFGLARI   +          Q
Sbjct: 120 QTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 550 ANTNIIAGTYGYMAPEYAM-GGIFSIKSDVFSFGVLLLEIISGR 592
           +       T  Y APE  +    +S   DV+S G +L E+   R
Sbjct: 177 SGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 391 NHFSDENKLGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGL--QEFKNEVNLIA 442
           +++    +LG G F  V K      G     K I  KR +++S +G+  ++ + EV+++ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 443 KLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIAR 501
           ++QH N++              I E +        LFD       L  +     +  I  
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILN 125
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPK----ISDFGLA-RIFGGNQNQANTNIIA 556
           G+ YLH    L+I H DLK  NI+L D   PK    I DFGLA +I  GN+ +     I 
Sbjct: 126 GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IF 178
Query: 557 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           GT  ++APE        +++D++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 391 NHFSDENKLGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGL--QEFKNEVNLIA 442
           +++    +LG G F  V K      G     K I  KR +++S +G+  ++ + EV+++ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 443 KLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIAR 501
           ++QH N++              I E +        LFD       L  +     +  I  
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILN 125
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPK----ISDFGLA-RIFGGNQNQANTNIIA 556
           G+ YLH    L+I H DLK  NI+L D   PK    I DFGLA +I  GN+ +     I 
Sbjct: 126 GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IF 178
Query: 557 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           GT  ++APE        +++D++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 400 GQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXXXXXX 457
            QG     Y   L   + +A+K+LSR   +    +    E+ L+  + HKN++       
Sbjct: 36  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 93
Query: 458 XXXXXXXIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                    + Y+  + +D +L    + ++LD +R   ++  +  GI +LH      IIH
Sbjct: 94  PQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAG---IIH 149
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDLK SNI++  D   KI DFGLAR  G +     T  +   Y Y APE  +G  +    
Sbjct: 150 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENV 206
Query: 577 DVFSFGVLLLEIISGR 592
           D++S G ++ E++  +
Sbjct: 207 DIWSVGCIMGEMVRHK 222

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 105/231 (45%), Gaps = 15/231 (6%)
Query: 368 GGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPV---YKGTLADGKAIAVKRLS 424
           G K + ++Q + +            + +   +G G  G V   Y   L   + +A+K+LS
Sbjct: 2   GSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLS 59
Query: 425 RT--SGQGLQEFKNEVNLIAKLQHKNLVRXXXXXXXXXXXXXIYE-YMPNKSLDVHLFDA 481
           R   +    +    E+ L+  + HKN++                + Y+  + +D +L   
Sbjct: 60  RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV 119
Query: 482 TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
            + ++LD +R   ++  +  GI +LH      IIHRDLK SNI++  D   KI DFGLAR
Sbjct: 120 IQ-MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175
Query: 542 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
             G +     T  +   Y Y APE  +G  +    D++S G ++ E++  +
Sbjct: 176 TAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 391 NHFSDENKLGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGL--QEFKNEVNLIA 442
           +++    +LG G F  V K      G     K I  KR +++S +G+  ++ + EV+++ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 443 KLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIAR 501
           ++QH N++              I E +        LFD       L  +     +  I  
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILN 125
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPK----ISDFGLA-RIFGGNQNQANTNIIA 556
           G+ YLH    L+I H DLK  NI+L D   PK    I DFGLA +I  GN+ +     I 
Sbjct: 126 GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IF 178
Query: 557 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           GT  ++APE        +++D++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 400 GQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXXXXXX 457
            QG     Y   L   + +A+K+LSR   +    +    E+ L+  + HKN++       
Sbjct: 30  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 87
Query: 458 XXXXXXXIYE-YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                    + Y+  + +D +L    + ++LD +R   ++  +  GI +LH      IIH
Sbjct: 88  PQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAG---IIH 143
Query: 517 RDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           RDLK SNI++  D   KI DFGLAR  G +     T  +   Y Y APE  +G  +    
Sbjct: 144 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENV 200
Query: 577 DVFSFGVLLLEIISGR 592
           D++S G ++ E++  +
Sbjct: 201 DIWSVGCIMGEMVRHK 216

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 391 NHFSDENKLGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGL--QEFKNEVNLIA 442
           +++    +LG G F  V K      G     K I  KR +++S +G+  ++ + EV+++ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 443 KLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIAR 501
           ++QH N++              I E +        LFD       L  +     +  I  
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILN 125
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPK----ISDFGLA-RIFGGNQNQANTNIIA 556
           G+ YLH    L+I H DLK  NI+L D   PK    I DFGLA +I  GN+ +     I 
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IF 178
Query: 557 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           GT  ++APE        +++D++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 391 NHFSDENKLGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGL--QEFKNEVNLIA 442
           +++    +LG G F  V K      G     K I  KR +++S +G+  ++ + EV+++ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 443 KLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIAR 501
           ++QH N++              I E +        LFD       L  +     +  I  
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILN 125
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPK----ISDFGLA-RIFGGNQNQANTNIIA 556
           G+ YLH    L+I H DLK  NI+L D   PK    I DFGLA +I  GN+ +     I 
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IF 178
Query: 557 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           GT  ++APE        +++D++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 23/225 (10%)
Query: 381 FPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNL 440
            PL +            ++G+G +G V+ G    G+ +AVK +  T+ +     + E+  
Sbjct: 27  LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVK-VFFTTEEASWFRETEIYQ 84
Query: 441 IAKLQHKNLV----RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
              ++H+N++                  I +Y  N SL    +D  +S  LD K    + 
Sbjct: 85  TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLA 140
Query: 497 NGIARGILYLHED-----SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
                G+ +LH +      +  I HRDLK+ NIL+  +    I+D GLA  F  + N+ +
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVD 200
Query: 552 --TNIIAGTYGYMAPEYAMGGIFS------IKSDVFSFGVLLLEI 588
              N   GT  YM PE     +        I +D++SFG++L E+
Sbjct: 201 IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 391 NHFSDENKLGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGL--QEFKNEVNLIA 442
           +++    +LG G F  V K      G     K I  KR +++S +G+  ++ + EV+++ 
Sbjct: 11  DYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 443 KLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIAR 501
           ++QH N++              I E +        LFD       L  +     +  I  
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILN 125
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPK----ISDFGLA-RIFGGNQNQANTNIIA 556
           G+ YLH    L+I H DLK  NI+L D   PK    I DFGLA +I  GN+ +     I 
Sbjct: 126 GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IF 178
Query: 557 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           GT  ++APE        +++D++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 55/94 (58%), Gaps = 5/94 (5%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I+  + YLHE     II+RDLK  N+LLD + + K++D+G+ +   G +    T+   GT
Sbjct: 162 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGT 216
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
             Y+APE   G  +    D ++ GVL+ E+++GR
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 34/207 (16%)
Query: 400 GQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXXXXXX 457
            QG     Y   L   + +A+K+LSR   +    +    E+ L+  + HKN++       
Sbjct: 36  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII------- 86
Query: 458 XXXXXXXIYEYMPNKSLD--------VHLFDATR----SVQLDWKRRQSIINGIARGILY 505
                  +  + P KSL+        + L DA       ++LD +R   ++  +  GI +
Sbjct: 87  -----GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           LH      IIHRDLK SNI++  D   KI DFGLAR   G        ++  T  Y APE
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMEPEVV--TRYYRAPE 195
Query: 566 YAMGGIFSIKSDVFSFGVLLLEIISGR 592
             +G  +    D++S G ++ E++  +
Sbjct: 196 VILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 55/94 (58%), Gaps = 5/94 (5%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I+  + YLHE     II+RDLK  N+LLD + + K++D+G+ +   G +    T+   GT
Sbjct: 130 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGT 184
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
             Y+APE   G  +    D ++ GVL+ E+++GR
Sbjct: 185 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 218

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 101/234 (43%), Gaps = 27/234 (11%)
Query: 391 NHFSDENKLGQGGFGPVYK------GTLADGKAIAVKRL-SRTSGQGLQEFKNEVNLIAK 443
           +H+    +LG G F  V K      G     K I  +RL S   G   +E + EVN++ +
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 444 LQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIARG 502
           ++H N++              I E +    L    FD       L        +  I  G
Sbjct: 86  IRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQILDG 141
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDD--MNPKIS--DFGLA-RIFGGNQNQANTNIIAG 557
           + YLH     +I H DLK  NI+L D    NP+I   DFG+A +I  GN+ +     I G
Sbjct: 142 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN----IFG 194
Query: 558 TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVC 611
           T  ++APE        +++D++S GV+   ++SG      +  E  Q  LT + 
Sbjct: 195 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---FLGETKQETLTNIS 245

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 13/213 (6%)
Query: 384 RLALEATNHFSDENKLGQGGFGPVYKGTLADGKA---IAVKRLSR-TSGQGLQEFKNEVN 439
           +L L+  N    + +LG G FG V +G     K    +A+K L + T     +E   E  
Sbjct: 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 388
Query: 440 LIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 499
           ++ +L +  +VR             + E      L  H F   +  ++       +++ +
Sbjct: 389 IMHQLDNPYIVRLIGVCQAEALML-VMEMAGGGPL--HKFLVGKREEIPVSNVAELLHQV 445
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTY 559
           + G+ YL E +    +HR+L A N+LL +    KISDFGL++  G + +   T   AG +
Sbjct: 446 SMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKW 501
Query: 560 G--YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
              + APE      FS +SDV+S+GV + E +S
Sbjct: 502 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 21/211 (9%)
Query: 390 TNHFSDENKLGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK 443
           ++++  + +LG+G F  V +      G     K I  K+LS    +  Q+ + E  +  K
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---ARDFQKLEREARICRK 60
Query: 444 LQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
           LQH N+VR             +++ +    L   +       + D       I  I   I
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD---ASHCIQQILESI 117
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNP---KISDFGLARIFGGNQNQANTNIIAGTYG 560
            Y H +    I+HR+LK  N+LL         K++DFGLA     N ++A  +  AGT G
Sbjct: 118 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHGFAGTPG 171
Query: 561 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           Y++PE      +S   D+++ GV+L  ++ G
Sbjct: 172 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 21/211 (9%)
Query: 390 TNHFSDENKLGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK 443
           ++++  + +LG+G F  V +      G     K I  K+LS    +  Q+ + E  +  K
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---ARDFQKLEREARICRK 61
Query: 444 LQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
           LQH N+VR             +++ +    L   +       + D       I  I   I
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD---ASHCIQQILESI 118
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNP---KISDFGLARIFGGNQNQANTNIIAGTYG 560
            Y H +    I+HR+LK  N+LL         K++DFGLA     N ++A  +  AGT G
Sbjct: 119 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHGFAGTPG 172
Query: 561 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           Y++PE      +S   D+++ GV+L  ++ G
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 107/231 (46%), Gaps = 18/231 (7%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRL---SRTSGQGLQEFKNEVNLIAKLQHKNLVRXX 453
           K+GQG FG V+K      G+ +A+K++   +   G  +   + E+ ++  L+H+N+V   
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLI 82
Query: 454 XXXXXXXX-----XXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
                           IY        D+    +   V+      + ++  +  G+ Y+H 
Sbjct: 83  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH- 141
Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN-QAN--TNIIAGTYGYMAPE 565
             R KI+HRD+KA+N+L+  D   K++DFGLAR F   +N Q N   N +  T  Y  PE
Sbjct: 142 --RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYRPPE 198
Query: 566 YAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLS 615
             +G   +    D++  G ++ E+ +          +H   L++ +C S++
Sbjct: 199 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 16/223 (7%)
Query: 382 PLRLALEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQ--GLQEFKNEV 438
           P R+    ++ F  ++ LG+G +G V   T    G+ +A+K++         L+  + E+
Sbjct: 2   PKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EI 60
Query: 439 NLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING 498
            ++   +H+N++                 Y+  + +   L     +  L     Q  I  
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ 120
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF--GGNQNQANTNIIA 556
             R +  LH  +   +IHRDLK SN+L++ + + K+ DFGLARI       N   T   +
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 557 G------TYGYMAPEYAM-GGIFSIKSDVFSFGVLLLEIISGR 592
           G      T  Y APE  +    +S   DV+S G +L E+   R
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 34/207 (16%)
Query: 400 GQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXXXXXX 457
            QG     Y   L   + +A+K+LSR   +    +    E+ L+  + HKN++       
Sbjct: 30  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV-- 85
Query: 458 XXXXXXXIYEYMPNKSLD--------VHLFDATR----SVQLDWKRRQSIINGIARGILY 505
                     + P KSL+        + L DA       ++LD +R   ++  +  GI +
Sbjct: 86  ----------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 135
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           LH      IIHRDLK SNI++  D   KI DFGLAR  G +     T  +   Y Y APE
Sbjct: 136 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPE 189
Query: 566 YAMGGIFSIKSDVFSFGVLLLEIISGR 592
             +G  +    D++S G ++ E++  +
Sbjct: 190 VILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 55/94 (58%), Gaps = 5/94 (5%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I+  + YLHE     II+RDLK  N+LLD + + K++D+G+ +   G +    T+   GT
Sbjct: 115 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGT 169
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
             Y+APE   G  +    D ++ GVL+ E+++GR
Sbjct: 170 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 203

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 55/94 (58%), Gaps = 5/94 (5%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I+  + YLHE     II+RDLK  N+LLD + + K++D+G+ +   G +    T+   GT
Sbjct: 119 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGT 173
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
             Y+APE   G  +    D ++ GVL+ E+++GR
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 34/204 (16%)
Query: 400 GQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRXXXXXX 457
            QG     Y   L   + +A+K+LSR   +    +    E+ L+  + HKN++       
Sbjct: 41  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII------- 91
Query: 458 XXXXXXXIYEYMPNKSLD--------VHLFDATR----SVQLDWKRRQSIINGIARGILY 505
                  +  + P KSL+        + L DA       ++LD +R   ++  +  GI +
Sbjct: 92  -----GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 146
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           LH      IIHRDLK SNI++  D   KI DFGLAR  G   +   T  +   Y Y APE
Sbjct: 147 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-YRAPE 200
Query: 566 YAMGGIFSIKSDVFSFGVLLLEII 589
             +G  +    D++S G ++ E++
Sbjct: 201 VILGMGYKENVDLWSVGCIMGEMV 224

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 21/211 (9%)
Query: 390 TNHFSDENKLGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK 443
           ++++  + +LG+G F  V +      G     K I  K+LS    +  Q+ + E  +  K
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---ARDFQKLEREARICRK 61
Query: 444 LQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
           LQH N+VR             +++ +    L   +       + D       I  I   I
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD---ASHCIQQILESI 118
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNP---KISDFGLARIFGGNQNQANTNIIAGTYG 560
            Y H +    I+HR+LK  N+LL         K++DFGLA     N ++A  +  AGT G
Sbjct: 119 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHGFAGTPG 172
Query: 561 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           Y++PE      +S   D+++ GV+L  ++ G
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 391 NHFSDENKLGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGL--QEFKNEVNLIA 442
           +++    +LG G F  V K      G     K I  KR +++S +G+  ++ + EV+++ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 443 KLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIAR 501
           ++QH N++              I E +        LFD       L  +     +  I  
Sbjct: 70  EIQHPNVITLHEVYENKTDVILIGELVAGG----ELFDFLAEKESLTEEEATEFLKQILN 125
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPK----ISDFGLA-RIFGGNQNQANTNIIA 556
           G+ YLH    L+I H DLK  NI+L D   PK    I DFGLA +I  GN+ +     I 
Sbjct: 126 GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IF 178
Query: 557 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           GT  ++APE        +++D++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 391 NHFSDENKLGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGL--QEFKNEVNLIA 442
           +++    +LG G F  V K      G     K I  KR +++S +G+  ++ + EV+++ 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 443 KLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIAR 501
           ++QH N++              I E +        LFD       L  +     +  I  
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILN 125
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPK----ISDFGLA-RIFGGNQNQANTNIIA 556
           G+ YLH    L+I H DLK  NI+L D   PK    I DFGLA +I  GN+ +     I 
Sbjct: 126 GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IF 178
Query: 557 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           GT  ++APE        +++D++S GV+   ++SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 92/222 (41%), Gaps = 13/222 (5%)
Query: 385 LALEATNHFSDENKLGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGLQEFKN---EVNL 440
           +A    N F     LG+G FG V      A G+  A+K L +       E  +   E  +
Sbjct: 3   MARVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV 62
Query: 441 IAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 500
           +   +H  L               + EY     L  HL   +R       R +     I 
Sbjct: 63  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAEIV 119
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 560
             + YLH  S   +++RDLK  N++LD D + KI+DFGL +   G ++ A      GT  
Sbjct: 120 SALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPE 175
Query: 561 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 602
           Y+APE      +    D +  GV++ E++ GR    FY  +H
Sbjct: 176 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 215

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 90/216 (41%), Gaps = 13/216 (6%)
Query: 391 NHFSDENKLGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAKLQH 446
           N F     LG+G FG V      A G+  A+K L +       E  +   E  ++   +H
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 447 KNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             L               + EY     L  HL   +R       R +     I   + YL
Sbjct: 68  PFLTALKYSFQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYL 124
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H  S   +++RDLK  N++LD D + KI+DFGL +   G ++ A      GT  Y+APE 
Sbjct: 125 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEV 180
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 602
                +    D +  GV++ E++ GR    FY  +H
Sbjct: 181 LEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 214

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 90/216 (41%), Gaps = 13/216 (6%)
Query: 391 NHFSDENKLGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAKLQH 446
           N F     LG+G FG V      A G+  A+K L +       E  +   E  ++   +H
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 447 KNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             L               + EY     L  HL   +R       R +     I   + YL
Sbjct: 70  PFLTALKYSFQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYL 126
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H  S   +++RDLK  N++LD D + KI+DFGL +   G ++ A      GT  Y+APE 
Sbjct: 127 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEV 182
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 602
                +    D +  GV++ E++ GR    FY  +H
Sbjct: 183 LEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 216

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 19/214 (8%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLS-RTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXXX 457
           +G+G +G V++G+   G+ +AVK  S R      +E   E+     L+H+N++       
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIASDM 72
Query: 458 XXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH-----EDSRL 512
                      + +      L+D  +   LD      I+  IA G+ +LH        + 
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 132
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT--NIIAGTYGYMAPEYAMGG 570
            I HRDLK+ NIL+  +    I+D GLA +   + NQ +   N   GT  YMAPE  +  
Sbjct: 133 AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE-VLDE 191
Query: 571 IFSI-------KSDVFSFGVLLLEIISGRKNNGF 597
              +       + D+++FG++L E+     +NG 
Sbjct: 192 TIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 88/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVY-KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V     +  G   A+K L +     L+E ++ +N    LQ  N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY P   +  HL    R  +      +     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+++D     K++DFGLA+   G      T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 90/216 (41%), Gaps = 13/216 (6%)
Query: 391 NHFSDENKLGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAKLQH 446
           N F     LG+G FG V      A G+  A+K L +       E  +   E  ++   +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 447 KNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             L               + EY     L  HL   +R       R +     I   + YL
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYL 264
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H  S   +++RDLK  N++LD D + KI+DFGL +   G ++ A      GT  Y+APE 
Sbjct: 265 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEV 320
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 602
                +    D +  GV++ E++ GR    FY  +H
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 354

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 55/104 (52%), Gaps = 6/104 (5%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I   + YLH  S   +++RDLK  N++LD D + KI+DFGL +   G ++ A      GT
Sbjct: 260 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 315
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 602
             Y+APE      +    D +  GV++ E++ GR    FY  +H
Sbjct: 316 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 357

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 19/214 (8%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLS-RTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXXX 457
           +G+G +G V++G+   G+ +AVK  S R      +E   E+     L+H+N++       
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIASDM 72
Query: 458 XXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH-----EDSRL 512
                      + +      L+D  +   LD      I+  IA G+ +LH        + 
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 132
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT--NIIAGTYGYMAPEYAMGG 570
            I HRDLK+ NIL+  +    I+D GLA +   + NQ +   N   GT  YMAPE  +  
Sbjct: 133 AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE-VLDE 191
Query: 571 IFSI-------KSDVFSFGVLLLEIISGRKNNGF 597
              +       + D+++FG++L E+     +NG 
Sbjct: 192 TIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/102 (38%), Positives = 56/102 (54%), Gaps = 12/102 (11%)
Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
            +++ ++ G+ YL E +    +HRDL A N+LL      KISDFGL++    ++N     
Sbjct: 115 ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYK-- 169
Query: 554 IIAGTYG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             A T+G     + APE      FS KSDV+SFGVL+ E  S
Sbjct: 170 --AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 17/207 (8%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFK-NEVNLIAKLQHKNLV--RXXX 454
           K+G+G +G VYK    DGK      L +  G G+      E+ L+ +L+H N++  +   
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDAT-----RSVQLDWKRRQSIINGIARGILYLHED 509
                     +++Y  +    +  F        + VQL     +S++  I  GI YLH +
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147
Query: 510 SRLKIIHRDLKASNILL----DDDMNPKISDFGLARIFGGN-QNQANTNIIAGTYGYMAP 564
               ++HRDLK +NIL+     +    KI+D G AR+F    +  A+ + +  T+ Y AP
Sbjct: 148 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204
Query: 565 EYAMGGIFSIKS-DVFSFGVLLLEIIS 590
           E  +G     K+ D+++ G +  E+++
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLT 231

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/102 (38%), Positives = 56/102 (54%), Gaps = 12/102 (11%)
Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
            +++ ++ G+ YL E +    +HRDL A N+LL      KISDFGL++    ++N     
Sbjct: 111 ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-- 165
Query: 554 IIAGTYG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             A T+G     + APE      FS KSDV+SFGVL+ E  S
Sbjct: 166 --AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +A+G+ +L   +    IHRDL A NILL      KI DFGLAR    + N          
Sbjct: 170 VAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 226
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +MAPE     +++ +SDV+S+G+ L E+ S
Sbjct: 227 VKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +A+G+ +L   +    IHRDL A NILL      KI DFGLAR    + N          
Sbjct: 177 VAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 233
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +MAPE     +++ +SDV+S+G+ L E+ S
Sbjct: 234 VKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 16/206 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAI--AVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
            +++ EN +G+G +G V K  +  G  I  A K++ +   + +  FK E+ ++  L H N
Sbjct: 26  QYYTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 84
Query: 449 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
           ++R             + E      L   +       + D  R   I+  +   + Y H 
Sbjct: 85  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR---IMKDVLSAVAYCH- 140
Query: 509 DSRLKIIHRDLKASNILL--DDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
             +L + HRDLK  N L   D   +P K+ DFGLA  F   +         GT  Y++P+
Sbjct: 141 --KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK---VGTPYYVSPQ 195
Query: 566 YAMGGIFSIKSDVFSFGVLLLEIISG 591
             + G++  + D +S GV++  ++ G
Sbjct: 196 -VLEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/102 (38%), Positives = 56/102 (54%), Gaps = 12/102 (11%)
Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
            +++ ++ G+ YL E +    +HRDL A N+LL      KISDFGL++    ++N     
Sbjct: 131 ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-- 185
Query: 554 IIAGTYG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             A T+G     + APE      FS KSDV+SFGVL+ E  S
Sbjct: 186 --AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/102 (38%), Positives = 56/102 (54%), Gaps = 12/102 (11%)
Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
            +++ ++ G+ YL E +    +HRDL A N+LL      KISDFGL++    ++N     
Sbjct: 131 ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-- 185
Query: 554 IIAGTYG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             A T+G     + APE      FS KSDV+SFGVL+ E  S
Sbjct: 186 --AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +A+G+ +L   +    IHRDL A NILL      KI DFGLAR    + N          
Sbjct: 172 VAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 228
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +MAPE     +++ +SDV+S+G+ L E+ S
Sbjct: 229 VKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +A+G+ +L   +    IHRDL A NILL      KI DFGLAR    + N          
Sbjct: 177 VAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLP 233
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +MAPE     +++ +SDV+S+G+ L E+ S
Sbjct: 234 VKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/102 (38%), Positives = 56/102 (54%), Gaps = 12/102 (11%)
Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
            +++ ++ G+ YL E +    +HRDL A N+LL      KISDFGL++    ++N     
Sbjct: 129 ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-- 183
Query: 554 IIAGTYG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             A T+G     + APE      FS KSDV+SFGVL+ E  S
Sbjct: 184 --AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/102 (38%), Positives = 56/102 (54%), Gaps = 12/102 (11%)
Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
            +++ ++ G+ YL E +    +HRDL A N+LL      KISDFGL++    ++N     
Sbjct: 121 ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-- 175
Query: 554 IIAGTYG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             A T+G     + APE      FS KSDV+SFGVL+ E  S
Sbjct: 176 --AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 19/214 (8%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLS-RTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXXX 457
           +G+G +G V++G+   G+ +AVK  S R      +E   E+     L+H+N++       
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIASDM 101
Query: 458 XXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH-----EDSRL 512
                      + +      L+D  +   LD      I+  IA G+ +LH        + 
Sbjct: 102 TSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 161
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT--NIIAGTYGYMAPEYAMGG 570
            I HRDLK+ NIL+  +    I+D GLA +   + NQ +   N   GT  YMAPE  +  
Sbjct: 162 AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE-VLDE 220
Query: 571 IFSI-------KSDVFSFGVLLLEIISGRKNNGF 597
              +       + D+++FG++L E+     +NG 
Sbjct: 221 TIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 254

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 16/206 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAI--AVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
            +++ EN +G+G +G V K  +  G  I  A K++ +   + +  FK E+ ++  L H N
Sbjct: 9   QYYTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 449 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
           ++R             + E      L   +       + D  R   I+  +   + Y H 
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR---IMKDVLSAVAYCH- 123
Query: 509 DSRLKIIHRDLKASNILL--DDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
             +L + HRDLK  N L   D   +P K+ DFGLA  F   +         GT  Y++P+
Sbjct: 124 --KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK---VGTPYYVSPQ 178
Query: 566 YAMGGIFSIKSDVFSFGVLLLEIISG 591
             + G++  + D +S GV++  ++ G
Sbjct: 179 -VLEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/102 (38%), Positives = 56/102 (54%), Gaps = 12/102 (11%)
Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
            +++ ++ G+ YL E +    +HRDL A N+LL      KISDFGL++    ++N     
Sbjct: 109 ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-- 163
Query: 554 IIAGTYG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             A T+G     + APE      FS KSDV+SFGVL+ E  S
Sbjct: 164 --AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 89/207 (42%), Gaps = 22/207 (10%)
Query: 397 NKLGQGGFGPVYK-----GTLADGKAIAVKRLSRTSGQGL--QEFKNEVNLIAKLQHKNL 449
            +LG G F  V K       L        KR SR S +G+  +E + EV+++ ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIARGILYLHE 508
           +              I E +    L    FD   +   L  +   S I  I  G+ YLH 
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 509 DSRLKIIHRDLKASNILLDDDMNP----KISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
               KI H DLK  NI+L D   P    K+ DFGLA          N   I GT  ++AP
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVAP 187
Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISG 591
           E        +++D++S GV+   ++SG
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/102 (38%), Positives = 56/102 (54%), Gaps = 12/102 (11%)
Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
            +++ ++ G+ YL E +    +HRDL A N+LL      KISDFGL++    ++N     
Sbjct: 115 ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-- 169
Query: 554 IIAGTYG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             A T+G     + APE      FS KSDV+SFGVL+ E  S
Sbjct: 170 --AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +A+G+ +L   +    IHRDL A NILL      KI DFGLAR    + N          
Sbjct: 154 VAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 210
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             +MAPE     +++ +SDV+S+G+ L E+ S
Sbjct: 211 VKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVY-KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     +G G FG V     +  G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EYMP   +  HL    R  +      +     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     K++DFG A+   G      T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVY-KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     +G G FG V     +  G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EYMP   +  HL    R  +      +     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     K++DFG A+   G      T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 13/161 (8%)
Query: 432 QEFKNEVNLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSL---DVHLF--DATRSVQ 486
            +FKNE+ +I  ++++  +              IYEYM N S+   D + F  D   +  
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 487 LDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN 546
           +  +  + II  +     Y+H +    I HRD+K SNIL+D +   K+SDFG +      
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205
Query: 547 QNQANTNIIAGTYGYMAPEY--AMGGIFSIKSDVFSFGVLL 585
           + + +     GTY +M PE+          K D++S G+ L
Sbjct: 206 KIKGS----RGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 34/210 (16%)
Query: 399 LGQGGFGPVY---KGTLAD-GKAIAVKRLSRT----SGQGLQEFKNEVNLIAKLQHKNLV 450
           LG+GG+G V+   K T A+ GK  A+K L +     + +     K E N++ +++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI---------INGIAR 501
                         I EY+    L + L             R+ I         +  I+ 
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQL------------EREGIFMEDTACFYLAEISM 132
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
            + +LH+     II+RDLK  NI+L+   + K++DFGL +      +   T+   GT  Y
Sbjct: 133 ALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEY 187
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           MAPE  M    +   D +S G L+ ++++G
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 397 NKLGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGL--QEFKNEVNLIAKLQHKN 448
            +LG G F  V K      G     K I  KR SR S +G+  +E + EV+++ ++ H N
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIK-KRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 449 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIARGILYLH 507
           ++              I E +    L    FD   +   L  +   S I  I  G+ YLH
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 508 EDSRLKIIHRDLKASNILLDDDMNP----KISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
                KI H DLK  NI+L D   P    K+ DFGLA          N   I GT  ++A
Sbjct: 133 TK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVA 186
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           PE        +++D++S GV+   ++SG
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 39/102 (38%), Positives = 56/102 (54%), Gaps = 12/102 (11%)
Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
            +++ ++ G+ YL E +    +HRDL A N+LL      KISDFGL++    ++N     
Sbjct: 474 ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-- 528
Query: 554 IIAGTYG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             A T+G     + APE      FS KSDV+SFGVL+ E  S
Sbjct: 529 --AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 39/102 (38%), Positives = 56/102 (54%), Gaps = 12/102 (11%)
Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
            +++ ++ G+ YL E +    +HRDL A N+LL      KISDFGL++    ++N     
Sbjct: 473 ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-- 527
Query: 554 IIAGTYG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             A T+G     + APE      FS KSDV+SFGVL+ E  S
Sbjct: 528 --AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 397 NKLGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGL--QEFKNEVNLIAKLQHKN 448
            +LG G F  V K      G     K I  KR SR S +G+  +E + EV+++ ++ H N
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIK-KRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 449 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIARGILYLH 507
           ++              I E +    L    FD   +   L  +   S I  I  G+ YLH
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 508 EDSRLKIIHRDLKASNILLDDDMNP----KISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
                KI H DLK  NI+L D   P    K+ DFGLA          N   I GT  ++A
Sbjct: 133 TK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVA 186
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           PE        +++D++S GV+   ++SG
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 41/221 (18%)
Query: 390 TNHFSDENKLGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ 445
           ++ +    KLG G +G V     K T A+     +K+ S T+        +EV ++ +L 
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQL--DWKRRQS--------I 495
           H N+++             +YE+  +K     + +  R  +L  +   RQ         I
Sbjct: 80  HPNIMK-------------LYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVI 126
Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGLARIF--GGNQNQA 550
           +  +  G  YLH+ +   I+HRDLK  N+LL+    D   KI DFGL+  F  GG   + 
Sbjct: 127 MKQVLSGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER 183
Query: 551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
                 GT  Y+APE  +   +  K DV+S GV+L  ++ G
Sbjct: 184 -----LGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 397 NKLGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGL--QEFKNEVNLIAKLQHKN 448
            +LG G F  V K      G     K I  KR SR S +G+  +E + EV+++ ++ H N
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIK-KRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 449 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIARGILYLH 507
           ++              I E +    L    FD   +   L  +   S I  I  G+ YLH
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 508 EDSRLKIIHRDLKASNILLDDDMNP----KISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
                KI H DLK  NI+L D   P    K+ DFGLA          N   I GT  ++A
Sbjct: 133 TK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVA 186
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           PE        +++D++S GV+   ++SG
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 397 NKLGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGL--QEFKNEVNLIAKLQHKN 448
            +LG G F  V K      G     K I  KR SR S +G+  +E + EV+++ ++ H N
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIK-KRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 449 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIARGILYLH 507
           ++              I E +    L    FD   +   L  +   S I  I  G+ YLH
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 508 EDSRLKIIHRDLKASNILLDDDMNP----KISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
                KI H DLK  NI+L D   P    K+ DFGLA          N   I GT  ++A
Sbjct: 133 TK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVA 186
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           PE        +++D++S GV+   ++SG
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVY-KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V     +  G   A+K L +     L+E ++ +N    LQ  N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY P   +  HL    R  +      +     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+++D     +++DFGLA+   G      T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 34/210 (16%)
Query: 399 LGQGGFGPVY---KGTLAD-GKAIAVKRLSRT----SGQGLQEFKNEVNLIAKLQHKNLV 450
           LG+GG+G V+   K T A+ GK  A+K L +     + +     K E N++ +++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI---------INGIAR 501
                         I EY+    L + L             R+ I         +  I+ 
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQL------------EREGIFMEDTACFYLAEISM 132
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
            + +LH+     II+RDLK  NI+L+   + K++DFGL +      +   T+   GT  Y
Sbjct: 133 ALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFCGTIEY 187
Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           MAPE  M    +   D +S G L+ ++++G
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 14/208 (6%)
Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS--RTSGQGLQEFKNEVNLIAKLQH 446
           T+ +     +G+G F  V +   L  G   A K ++  + S +  Q+ + E  +   L+H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 447 KNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
            N+VR             +++ +    L   +       + D       I  I   +L+ 
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEAD---ASHCIQQILEAVLHC 119
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNP---KISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
           H+   + ++HRDLK  N+LL         K++DFGLA    G+Q QA     AGT GY++
Sbjct: 120 HQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQ-QAWFGF-AGTPGYLS 174
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           PE      +    D+++ GV+L  ++ G
Sbjct: 175 PEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 91/216 (42%), Gaps = 14/216 (6%)
Query: 391 NHFSDENKLGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVN---LIAKLQH 446
           N F     LG+G FG V      A G+  A+K L +       E  + V    ++   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 447 KNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             L               + EY     L  HL   +R      +R +     I   + YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYL 121
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H  SR  +++RD+K  N++LD D + KI+DFGL +   G  + A      GT  Y+APE 
Sbjct: 122 H--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEV 176
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 602
                +    D +  GV++ E++ GR    FY  +H
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 210

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 31/205 (15%)
Query: 399 LGQGGFGPVYK-GTLADGKAIAVKRLSRTSGQGLQEFK---NEVNLIAKLQHKNLVRXXX 454
           LG G FG V+   +  +G+  A+K L +     L++ +   +E  +++ + H  ++R   
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR--------GILYL 506
                     I +Y+    L    F   R       + Q   N +A+         + YL
Sbjct: 74  TFQDAQQIFMIMDYIEGGEL----FSLLR-------KSQRFPNPVAKFYAAEVCLALEYL 122
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H      II+RDLK  NILLD + + KI+DFG A+          T  + GT  Y+APE 
Sbjct: 123 HSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLCGTPDYIAPEV 174
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
                ++   D +SFG+L+ E+++G
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 91/216 (42%), Gaps = 14/216 (6%)
Query: 391 NHFSDENKLGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVN---LIAKLQH 446
           N F     LG+G FG V      A G+  A+K L +       E  + V    ++   +H
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 447 KNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             L               + EY     L  HL   +R      +R +     I   + YL
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYL 124
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H  SR  +++RD+K  N++LD D + KI+DFGL +   G  + A      GT  Y+APE 
Sbjct: 125 H--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEV 179
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 602
                +    D +  GV++ E++ GR    FY  +H
Sbjct: 180 LEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 213

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 101/232 (43%), Gaps = 37/232 (15%)
Query: 391 NHFSDENKLGQGGFGPVY------KGTLADGKAIAVKRLSRTSG---------------- 428
           N ++ ++++G+G +G V         T    K ++ K+L R +G                
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 429 -----QGLQEFKNEVNLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATR 483
                  +++   E+ ++ KL H N+V+                +       V      +
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK 132
Query: 484 SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
            +  D  R       + +GI YLH     KIIHRD+K SN+L+ +D + KI+DFG++  F
Sbjct: 133 PLSEDQAR--FYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 544 GGNQNQANTNIIAGTYGYMAPE--YAMGGIFSIKS-DVFSFGVLLLEIISGR 592
            G+    +  +  GT  +MAPE       IFS K+ DV++ GV L   + G+
Sbjct: 188 KGSDALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 12/207 (5%)
Query: 399 LGQGGFGPVYKGTLADGKA----IAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLVRXX 453
           LG+G FG VY+G   + K     +AVK   +  +    ++F +E  ++  L H ++V+  
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 454 XXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
                      I E  P   L  +L     S+++      S+   I + + YL     + 
Sbjct: 76  GIIEEEPTWI-IMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAYLES---IN 129
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 573
            +HRD+   NIL+      K+ DFGL+R +  +++    ++      +M+PE      F+
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESINFRRFT 188
Query: 574 IKSDVFSFGVLLLEIISGRKNNGFYFS 600
             SDV+ F V + EI+S  K   F+  
Sbjct: 189 TASDVWMFAVCMWEILSFGKQPFFWLE 215

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 397 NKLGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
            +LG+G F  V +      G     K I  K+LS    Q L+    E  +   L+H N+V
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLE---REARICRLLKHPNIV 84
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
           R             I++ +    L   +       + D       I  I   +L+ H+  
Sbjct: 85  RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEAD---ASHCIQQILEAVLHCHQ-- 139
Query: 511 RLKIIHRDLKASNILLDDDMNP---KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
            + ++HRDLK  N+LL   +     K++DFGLA    G Q QA     AGT GY++PE  
Sbjct: 140 -MGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGF-AGTPGYLSPEVL 196
Query: 568 MGGIFSIKSDVFSFGVLLLEIISG 591
               +    D+++ GV+L  ++ G
Sbjct: 197 RKDPYGKPVDLWACGVILYILLVG 220

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 397 NKLGQGGFGPVYK------GTLADGKAIAVKRLSRTSGQGL--QEFKNEVNLIAKLQHKN 448
            +LG G F  V K      G     K I  KR SR S +G+  +E + EV+++ ++ H N
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIK-KRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 449 LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIARGILYLH 507
           ++              I E +    L    FD   +   L  +   S I  I  G+ YLH
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 508 EDSRLKIIHRDLKASNILLDDDMNP----KISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
                KI H DLK  NI+L D   P    K+ DFGLA          N   I GT  ++A
Sbjct: 133 TK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVA 186
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           PE        +++D++S GV+   ++SG
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR--IFGGNQNQANTNIIA 556
           IA G+ +L       II+RDLK  N++LD + + KI+DFG+ +  I+ G      T    
Sbjct: 451 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG----VTTKXFC 503
Query: 557 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           GT  Y+APE      +    D ++FGVLL E+++G+
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 91/216 (42%), Gaps = 14/216 (6%)
Query: 391 NHFSDENKLGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVN---LIAKLQH 446
           N F     LG+G FG V      A G+  A+K L +       E  + V    ++   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 447 KNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             L               + EY     L  HL   +R      +R +     I   + YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYL 121
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H  SR  +++RD+K  N++LD D + KI+DFGL +   G  + A      GT  Y+APE 
Sbjct: 122 H--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEV 176
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 602
                +    D +  GV++ E++ GR    FY  +H
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 210

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 91/216 (42%), Gaps = 14/216 (6%)
Query: 391 NHFSDENKLGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVN---LIAKLQH 446
           N F     LG+G FG V      A G+  A+K L +       E  + V    ++   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 447 KNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             L               + EY     L  HL   +R      +R +     I   + YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYL 121
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H  SR  +++RD+K  N++LD D + KI+DFGL +   G  + A      GT  Y+APE 
Sbjct: 122 H--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEV 176
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 602
                +    D +  GV++ E++ GR    FY  +H
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 210

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVY-KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V     +  G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+P   +  HL    R  +      +     I     YL
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 143
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+APE 
Sbjct: 144 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEYLAPEI 195
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 196 ILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 12/207 (5%)
Query: 399 LGQGGFGPVYKGTLADGKA----IAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLVRXX 453
           LG+G FG VY+G   + K     +AVK   +  +    ++F +E  ++  L H ++V+  
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 454 XXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
                      I E  P   L  +L     S+++      S+   I + + YL     + 
Sbjct: 92  GIIEEEPTWI-IMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAYLES---IN 145
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 573
            +HRD+   NIL+      K+ DFGL+R +  +++    ++      +M+PE      F+
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESINFRRFT 204
Query: 574 IKSDVFSFGVLLLEIISGRKNNGFYFS 600
             SDV+ F V + EI+S  K   F+  
Sbjct: 205 TASDVWMFAVCMWEILSFGKQPFFWLE 231

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVY-KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V     +  G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+P   +  HL    R  +      +     I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+APE 
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEYLAPEI 210
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 91/216 (42%), Gaps = 14/216 (6%)
Query: 391 NHFSDENKLGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVN---LIAKLQH 446
           N F     LG+G FG V      A G+  A+K L +       E  + V    ++   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 447 KNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             L               + EY     L  HL   +R      +R +     I   + YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYL 121
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H  SR  +++RD+K  N++LD D + KI+DFGL +   G  + A      GT  Y+APE 
Sbjct: 122 H--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEV 176
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 602
                +    D +  GV++ E++ GR    FY  +H
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 210

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 399 LGQGGFGPVY---KGTLAD-GKAIAVKRLSRTS----GQGLQEFKNEVNLIAKL-QHKNL 449
           LG G +G V+   K +  D GK  A+K L + +     +  +  + E  ++  + Q   L
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           V              I +Y+    L  HL    R  +      Q  +  I   + +LH  
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE---HEVQIYVGEIVLALEHLH-- 176
Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 569
            +L II+RD+K  NILLD + +  ++DFGL++ F  ++ +   +   GT  YMAP+   G
Sbjct: 177 -KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAPDIVRG 234
Query: 570 GI--FSIKSDVFSFGVLLLEIISG 591
           G        D +S GVL+ E+++G
Sbjct: 235 GDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 91/216 (42%), Gaps = 14/216 (6%)
Query: 391 NHFSDENKLGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVN---LIAKLQH 446
           N F     LG+G FG V      A G+  A+K L +       E  + V    ++   +H
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 447 KNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             L               + EY     L  HL   +R      +R +     I   + YL
Sbjct: 70  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYL 126
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H  SR  +++RD+K  N++LD D + KI+DFGL +   G  + A      GT  Y+APE 
Sbjct: 127 H--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEV 181
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 602
                +    D +  GV++ E++ GR    FY  +H
Sbjct: 182 LEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 215

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 12/207 (5%)
Query: 399 LGQGGFGPVYKGTLADGKA----IAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLVRXX 453
           LG+G FG VY+G   + K     +AVK   +  +    ++F +E  ++  L H ++V+  
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 454 XXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
                      I E  P   L  +L     S+++      S+   I + + YL     + 
Sbjct: 80  GIIEEEPTWI-IMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAYLES---IN 133
Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 573
            +HRD+   NIL+      K+ DFGL+R +  +++    ++      +M+PE      F+
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESINFRRFT 192
Query: 574 IKSDVFSFGVLLLEIISGRKNNGFYFS 600
             SDV+ F V + EI+S  K   F+  
Sbjct: 193 TASDVWMFAVCMWEILSFGKQPFFWLE 219

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 91/216 (42%), Gaps = 14/216 (6%)
Query: 391 NHFSDENKLGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVN---LIAKLQH 446
           N F     LG+G FG V      A G+  A+K L +       E  + V    ++   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 447 KNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             L               + EY     L  HL   +R      +R +     I   + YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYL 121
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H  SR  +++RD+K  N++LD D + KI+DFGL +   G  + A      GT  Y+APE 
Sbjct: 122 H--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEV 176
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 602
                +    D +  GV++ E++ GR    FY  +H
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDH 210

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVY-KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     +G G FG V     +  G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+P   +  HL    R  +      +     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     K++DFG A+   G      T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 21/208 (10%)
Query: 391 NHFSDENKLGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH 446
           + F     LG G FG V    +K T   G   A+K L +     L++ ++ +N    LQ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKET---GNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 447 KN---LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
            N   LV+             + EY+P   +  HL    R  +      +     I    
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTF 154
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            YLH    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+A
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLA 206
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           PE  +   ++   D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 21/208 (10%)
Query: 391 NHFSDENKLGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH 446
           + F     LG G FG V    +K T   G   A+K L +     L++ ++ +N    LQ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKET---GNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 447 KN---LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
            N   LV+             + EY+P   +  HL    R  +      +     I    
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTF 154
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            YLH    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+A
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLA 206
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           PE  +   ++   D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVY-KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V     +  G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+P   +  HL    R  +      +     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 21/208 (10%)
Query: 391 NHFSDENKLGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH 446
           + F     LG G FG V    +K T   G   A+K L +     L++ ++ +N    LQ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKET---GNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 447 KN---LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
            N   LV+             + EY+P   +  HL    R  +      +     I    
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTF 154
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            YLH    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+A
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLA 206
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           PE  +   ++   D ++ GVL+ E+ +G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVY-KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V     +  G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+P   +  HL    R  +      +     I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+APE 
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 21/208 (10%)
Query: 391 NHFSDENKLGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH 446
           + F     LG G FG V    +K T   G   A+K L +     L++ ++ +N    LQ 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 447 KN---LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
            N   LV+             + EY+P   +  HL    R  +      +     I    
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE---PHARFYAAQIVLTF 147
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            YLH    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+A
Sbjct: 148 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLA 199
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           PE  +   ++   D ++ GVL+ E+ +G
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVY-KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V     +  G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+P   +  HL    R  +      +     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVY-KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V     +  G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+P   +  HL    R  +      +     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVY-KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V     +  G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+P   +  HL    R  +      +     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVY-KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V     +  G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+P   +  HL    R  +      +     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVY-KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V     +  G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+P   +  HL    R  +      +     I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYL 158
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+APE 
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 21/208 (10%)
Query: 391 NHFSDENKLGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH 446
           + F     LG G FG V    +K T   G   A+K L +     L++ ++ +N    LQ 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 447 KN---LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
            N   LV+             + EY+P   +  HL    R  +      +     I    
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTF 147
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            YLH    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+A
Sbjct: 148 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLA 199
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           PE  +   ++   D ++ GVL+ E+ +G
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR--IFGGNQNQANTNIIA 556
           IA G+ +L       II+RDLK  N++LD + + KI+DFG+ +  I+ G      T    
Sbjct: 130 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG----VTTKXFC 182
Query: 557 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           GT  Y+APE      +    D ++FGVLL E+++G+
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 399 LGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRXXXXX 456
           LG+G +  V    +L +GK  AVK + + +G        EV  + + Q +KN++      
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 457 XXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
                   ++E +   S+  H+    +    + +    ++  +A  + +LH      I H
Sbjct: 81  EDDTRFYLVFEKLQGGSILAHI---QKQKHFNEREASRVVRDVAAALDFLHTKG---IAH 134
Query: 517 RDLKASNILLD--DDMNP-KISDFGLARIFGGNQNQANTNIIA-------GTYGYMAPEY 566
           RDLK  NIL +  + ++P KI DF L    G   N + T I         G+  YMAPE 
Sbjct: 135 RDLKPENILCESPEKVSPVKICDFDLGS--GMKLNNSCTPITTPELTTPCGSAEYMAPEV 192
Query: 567 A-----MGGIFSIKSDVFSFGVLLLEIISG 591
                     +  + D++S GV+L  ++SG
Sbjct: 193 VEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 87/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVY-KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V     +  G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY P   +  HL    R  +      +     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+++D     K++DFG A+   G      T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 56/94 (59%), Gaps = 9/94 (9%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I + + +LH  S+L +IHRD+K SN+L++     K+ DFG++   G   +    +I AG 
Sbjct: 118 IVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS---GYLVDDVAKDIDAGC 172
Query: 559 YGYMAPEYAMGGI----FSIKSDVFSFGVLLLEI 588
             YMAPE     +    +S+KSD++S G+ ++E+
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 21/208 (10%)
Query: 391 NHFSDENKLGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH 446
           + F     LG G FG V    +K T   G   A+K L +     L++ ++ +N    LQ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 447 KN---LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
            N   LV+             + EY+P   +  HL    R  +      +     I    
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTF 155
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            YLH    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+A
Sbjct: 156 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLA 207
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           PE  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 87/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVY-KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V     +  G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY P   +  HL    R  +      +     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+++D     K++DFG A+   G      T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 21/208 (10%)
Query: 391 NHFSDENKLGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH 446
           + F     LG G FG V    +K T   G   A+K L +     L++ ++ +N    LQ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 447 KN---LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
            N   LV+             + EY+P   +  HL    R  +      +     I    
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTF 155
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            YLH    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+A
Sbjct: 156 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLA 207
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           PE  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 21/208 (10%)
Query: 391 NHFSDENKLGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH 446
           + F     LG G FG V    +K T   G   A+K L +     L++ ++ +N    LQ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 447 KN---LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
            N   LV+             + EY+P   +  HL    R  +      +     I    
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTF 155
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            YLH    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+A
Sbjct: 156 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLA 207
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           PE  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 41/221 (18%)
Query: 390 TNHFSDENKLGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ 445
           ++ +    KLG G +G V     K T A+     +K+ S T+        +EV ++ +L 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQL--DWKRRQS--------I 495
           H N+++             +YE+  +K     + +  R  +L  +   RQ         I
Sbjct: 63  HPNIMK-------------LYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVI 109
Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGLARIF--GGNQNQA 550
           +  +  G  YLH+ +   I+HRDLK  N+LL+    D   KI DFGL+  F  GG   + 
Sbjct: 110 MKQVLSGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER 166
Query: 551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
                 GT  Y+APE  +   +  K DV+S GV+L  ++ G
Sbjct: 167 -----LGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 21/208 (10%)
Query: 391 NHFSDENKLGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH 446
           + F     LG G FG V    +K T   G   A+K L +     L++ ++ +N    LQ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 447 KN---LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
            N   LV+             + EY P   +  HL    R  +      +     I    
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTF 155
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            YLH    L +I+RDLK  N+++D     K++DFG A+   G      T  + GT  Y+A
Sbjct: 156 EYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLA 207
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           PE  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 52/103 (50%), Gaps = 17/103 (16%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA-- 556
           IA  + +LH      ++HRDLK SNI    D   K+ DFGL  +   +Q++    ++   
Sbjct: 173 IAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGL--VTAMDQDEEEQTVLTPM 227
Query: 557 ----------GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEII 589
                     GT  YM+PE   G  +S K D+FS G++L E++
Sbjct: 228 PAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 56/99 (56%), Gaps = 10/99 (10%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I + + YL E  +  +IHRD+K SNILLD+    K+ DFG++     ++ +  +   AG 
Sbjct: 133 IVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS---AGC 187
Query: 559 YGYMAPEY-----AMGGIFSIKSDVFSFGVLLLEIISGR 592
             YMAPE           + I++DV+S G+ L+E+ +G+
Sbjct: 188 AAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 21/208 (10%)
Query: 391 NHFSDENKLGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH 446
           + F     LG G FG V    +K T   G   A+K L +     L++ ++ +N    LQ 
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 447 KN---LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
            N   LV+             + EY+P   +  HL    R  +      +     I    
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTF 175
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            YLH    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+A
Sbjct: 176 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLA 227
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           PE  +   ++   D ++ GVL+ E+ +G
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 55/94 (58%), Gaps = 9/94 (9%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I + + +LH  S+L +IHRD+K SN+L++     K+ DFG++   G   +     I AG 
Sbjct: 162 IVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS---GYLVDSVAKTIDAGC 216
Query: 559 YGYMAPEYAMGGI----FSIKSDVFSFGVLLLEI 588
             YMAPE     +    +S+KSD++S G+ ++E+
Sbjct: 217 KPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 250

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 28/220 (12%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLA--DGK--AIAVKRLSR--TSGQGLQEFKNEVNLIAKL 444
             F+    LG+G FG V +  L   DG    +AVK L     +   ++EF  E   + + 
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 445 QHKNLVRXXXXXXXXXXX------XXIYEYMPNKSLDVHLFDATR----SVQLDWKRRQS 494
            H ++ +                   I  +M +  L   L  A+R       L  +    
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL-ASRIGENPFNLPLQTLVR 141
Query: 495 IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGN---QNQA 550
            +  IA G+ YL   S    IHRDL A N +L +DM   ++DFGL+R I+ G+   Q  A
Sbjct: 142 FMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCA 198
Query: 551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           +   +     ++A E     ++++ SDV++FGV + EI++
Sbjct: 199 SKLPVK----WLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 101/213 (47%), Gaps = 16/213 (7%)
Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
           + D   LG GG G V+     D  K +A+K++  T  Q ++    E+ +I +L H N+V+
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 452 X-----XXXXXXXXXXXXIYE----YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG 502
                             + E    Y+  + ++  L +      L  +  +  +  + RG
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRG 132
Query: 503 ILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGN-QNQANTNIIAGTYG 560
           + Y+H  +   ++HRDLK +N+ ++ +D+  KI DFGLARI   +  ++ + +    T  
Sbjct: 133 LKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW 189
Query: 561 YMAPEYAMGGIFSIKS-DVFSFGVLLLEIISGR 592
           Y +P   +      K+ D+++ G +  E+++G+
Sbjct: 190 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 18/209 (8%)
Query: 393 FSDE----NKLGQGGFGPV---YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ 445
           F+D+     +LG+G F  V    K T     A  +    + S +  Q+ + E  +   L+
Sbjct: 29  FTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLK 88
Query: 446 HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           H N+VR             +++ +    L   +       + D       I+ I   + +
Sbjct: 89  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEAD---ASHCIHQILESVNH 145
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNP---KISDFGLARIFGGNQNQANTNIIAGTYGYM 562
           +H+     I+HRDLK  N+LL         K++DFGLA    G Q QA     AGT GY+
Sbjct: 146 IHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQ-QAWFGF-AGTPGYL 200
Query: 563 APEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           +PE      +    D+++ GV+L  ++ G
Sbjct: 201 SPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 97/211 (45%), Gaps = 36/211 (17%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLVRXXX--- 454
           +G G FG V++  L +   +A+K++ +      + FKN E+ ++  ++H N+V       
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 455 ---XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI--------INGIARGI 503
                        + EY+P       ++ A+R      K +Q++        +  + R +
Sbjct: 103 SNGDKKDEVFLNLVLEYVPET-----VYRASRHYA---KLKQTMPMLLIKLYMYQLLRSL 154
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYM 562
            Y+H    + I HRD+K  N+LLD      K+ DFG A+I      + N + I   Y Y 
Sbjct: 155 AYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA--GEPNVSXICSRY-YR 208
Query: 563 APEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           APE   G   ++   D++S G ++ E++ G+
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I+ G+ +LH   +  II+RDLK  N++LD + + KI+DFG+ +      +   T    GT
Sbjct: 129 ISIGLFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTREFCGT 183
Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
             Y+APE      +    D +++GVLL E+++G+
Sbjct: 184 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVY-KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V     +  G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY P   +  HL    R  +      +     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+++D     +++DFG A+   G      T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 86/205 (41%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVY-KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V     +  G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             L +             + EY P   +  HL    R  +      +     I     YL
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYL 158
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+++D     K++DFG A+   G      T  + GT  Y+APE 
Sbjct: 159 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 86/205 (41%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVY-KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V     +  G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             L +             + EY P   +  HL    R  +      +     I     YL
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+++D     K++DFG A+   G      T  + GT  Y+APE 
Sbjct: 159 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 86/205 (41%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVY-KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V     +  G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             L +             + EY P   +  HL    R  +      +     I     YL
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+++D     K++DFG A+   G      T  + GT  Y+APE 
Sbjct: 159 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 81/183 (44%), Gaps = 15/183 (8%)
Query: 416 KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLD 475
           K + V + + + G   ++ K E ++   L+H ++V              ++E+M    L 
Sbjct: 57  KIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL- 115
Query: 476 VHLFDATRSVQLDWKRRQSIINGIARGIL----YLHEDSRLKIIHRDLKASNILLDDDMN 531
              F+  +     +   +++ +   R IL    Y H+++   IIHRD+K   +LL    N
Sbjct: 116 --CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKEN 170
Query: 532 P---KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEI 588
               K+  FG+A   G +   A   +  GT  +MAPE      +    DV+  GV+L  +
Sbjct: 171 SAPVKLGGFGVAIQLGESGLVAGGRV--GTPHFMAPEVVKREPYGKPVDVWGCGVILFIL 228
Query: 589 ISG 591
           +SG
Sbjct: 229 LSG 231

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 81/183 (44%), Gaps = 15/183 (8%)
Query: 416 KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLD 475
           K + V + + + G   ++ K E ++   L+H ++V              ++E+M    L 
Sbjct: 55  KIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL- 113
Query: 476 VHLFDATRSVQLDWKRRQSIINGIARGIL----YLHEDSRLKIIHRDLKASNILLDDDMN 531
              F+  +     +   +++ +   R IL    Y H+++   IIHRD+K   +LL    N
Sbjct: 114 --CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKEN 168
Query: 532 P---KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEI 588
               K+  FG+A   G +   A   +  GT  +MAPE      +    DV+  GV+L  +
Sbjct: 169 SAPVKLGGFGVAIQLGESGLVAGGRV--GTPHFMAPEVVKREPYGKPVDVWGCGVILFIL 226
Query: 589 ISG 591
           +SG
Sbjct: 227 LSG 229

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/107 (36%), Positives = 56/107 (52%), Gaps = 16/107 (14%)
Query: 502 GILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
            + YLHE+    IIHRDLK  N+LL   ++D   KI+DFG ++I G     +    + GT
Sbjct: 125 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCGT 178
Query: 559 YGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 602
             Y+APE  +      ++   D +S GV+L   +SG       FSEH
Sbjct: 179 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP----FSEH 221

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/107 (36%), Positives = 56/107 (52%), Gaps = 16/107 (14%)
Query: 502 GILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
            + YLHE+    IIHRDLK  N+LL   ++D   KI+DFG ++I G     +    + GT
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCGT 179
Query: 559 YGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 602
             Y+APE  +      ++   D +S GV+L   +SG       FSEH
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP----FSEH 222

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/107 (36%), Positives = 56/107 (52%), Gaps = 16/107 (14%)
Query: 502 GILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
            + YLHE+    IIHRDLK  N+LL   ++D   KI+DFG ++I G     +    + GT
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCGT 179
Query: 559 YGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 602
             Y+APE  +      ++   D +S GV+L   +SG       FSEH
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP----FSEH 222

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/107 (36%), Positives = 56/107 (52%), Gaps = 16/107 (14%)
Query: 502 GILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
            + YLHE+    IIHRDLK  N+LL   ++D   KI+DFG ++I G     +    + GT
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCGT 179
Query: 559 YGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 602
             Y+APE  +      ++   D +S GV+L   +SG       FSEH
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP----FSEH 222

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/107 (36%), Positives = 56/107 (52%), Gaps = 16/107 (14%)
Query: 502 GILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
            + YLHE+    IIHRDLK  N+LL   ++D   KI+DFG ++I G     +    + GT
Sbjct: 132 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCGT 185
Query: 559 YGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 602
             Y+APE  +      ++   D +S GV+L   +SG       FSEH
Sbjct: 186 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP----FSEH 228

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 21/208 (10%)
Query: 391 NHFSDENKLGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH 446
           + F     LG G FG V    +K T   G   A+K L +     L++ ++ +N     Q 
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRIQQA 98
Query: 447 KN---LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
            N   LV+             + EY P   +  HL    R  +      +     I    
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTF 155
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            YLH    L +I+RDLK  N+L+D     K++DFG A+   G      T  + GT  Y+A
Sbjct: 156 EYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLA 207
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           PE  +   ++   D ++ GVL+ E+ +G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 90/201 (44%), Gaps = 19/201 (9%)
Query: 399 LGQGGFGPVYKGTLADGKA----IAVKRLSRTSGQGLQEFKN---EVNLIAK-LQHKNLV 450
           +G+G FG V    LA  KA     AVK L + +    +E K+   E N++ K ++H  LV
Sbjct: 46  IGKGSFGKV---LLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                         + +Y+    L  HL    R       R +     IA  + YLH   
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHL---QRERCFLEPRARFYAAEIASALGYLHS-- 157
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
            L I++RDLK  NILLD   +  ++DFGL +     ++ + T+   GT  Y+APE     
Sbjct: 158 -LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVLHKQ 214
Query: 571 IFSIKSDVFSFGVLLLEIISG 591
            +    D +  G +L E++ G
Sbjct: 215 PYDRTVDWWCLGAVLYEMLYG 235

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 14/201 (6%)
Query: 397 NKLGQGGFGPVYK--GTLADGK-AIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXX 453
            +LG+G F  V +    LA  + A  +    + S +  Q+ + E  +   L+H N+VR  
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 454 XXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
                      I++ +    L   +       + D       I  I   +L+ H+   + 
Sbjct: 77  DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEAD---ASHCIQQILEAVLHCHQ---MG 130
Query: 514 IIHRDLKASNILLDDDMNP---KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
           ++HR+LK  N+LL   +     K++DFGLA    G Q QA     AGT GY++PE     
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGF-AGTPGYLSPEVLRKD 188
Query: 571 IFSIKSDVFSFGVLLLEIISG 591
            +    D+++ GV+L  ++ G
Sbjct: 189 PYGKPVDLWACGVILYILLVG 209

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/217 (22%), Positives = 96/217 (44%), Gaps = 13/217 (5%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXXXX 458
           LG+G FG V++      K   + +  +  G      K E++++   +H+N++        
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 459 XXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRD 518
                 I+E++    LD+     T + +L+ +   S ++ +   + +LH  +   I H D
Sbjct: 73  MEELVMIFEFISG--LDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFD 127
Query: 519 LKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS 576
           ++  NI+     +   KI +FG AR         N  ++     Y APE     + S  +
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 577 DVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNS 613
           D++S G L+  ++SG   N F  +E  Q ++  + N+
Sbjct: 185 DMWSLGTLVYVLLSG--INPF-LAETNQQIIENIMNA 218

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 21/211 (9%)
Query: 396 ENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRXX 453
           E+ LG+G    V     L   +  AVK + +  G        EV ++ + Q H+N++   
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 454 XXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
                      ++E M   S+  H+       +L+      ++  +A  + +LH      
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELE---ASVVVQDVASALDFLHNKG--- 131
Query: 514 IIHRDLKASNILLD--DDMNP-KISDFGLA---RIFGGNQNQANTNII--AGTYGYMAPE 565
           I HRDLK  NIL +  + ++P KI DFGL    ++ G     +   ++   G+  YMAPE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 566 YA-----MGGIFSIKSDVFSFGVLLLEIISG 591
                     I+  + D++S GV+L  ++SG
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/107 (36%), Positives = 56/107 (52%), Gaps = 16/107 (14%)
Query: 502 GILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
            + YLHE+    IIHRDLK  N+LL   ++D   KI+DFG ++I G     +    + GT
Sbjct: 251 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCGT 304
Query: 559 YGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 602
             Y+APE  +      ++   D +S GV+L   +SG       FSEH
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP----FSEH 347

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/107 (36%), Positives = 56/107 (52%), Gaps = 16/107 (14%)
Query: 502 GILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
            + YLHE+    IIHRDLK  N+LL   ++D   KI+DFG ++I G     +    + GT
Sbjct: 265 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCGT 318
Query: 559 YGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 602
             Y+APE  +      ++   D +S GV+L   +SG       FSEH
Sbjct: 319 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP----FSEH 361

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 97/213 (45%), Gaps = 28/213 (13%)
Query: 392 HFSDENKL----GQGGFGPVYKGTLADGKA---IAVKRLSRTSGQGLQE-FKNEVNLIAK 443
           H SD  +L    G G FG      + D +A   +AVK + R  G+ + E  K E+     
Sbjct: 16  HDSDRYELVKDIGAGNFG--VARLMRDKQANELVAVKYIER--GEKIDENVKREIINHRS 71
Query: 444 LQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRR--QSIINGIAR 501
           L+H N+VR             + EY     L   + +A R  + D  R   Q +I+G++ 
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE-DEARFFFQQLISGVS- 129
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNIIAGTY 559
              Y H    +++ HRDLK  N LLD    P  KI+DFG ++    +   +      GT 
Sbjct: 130 ---YAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSK---ASVLHSQPKSAVGTP 180
Query: 560 GYMAPEYAMGGIFSIK-SDVFSFGVLLLEIISG 591
            Y+APE  +   +  K +DV+S GV L  ++ G
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V      + G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+    +  HL    R  +      +     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     +++DFG A+   G      T  +AGT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLAGTPEYLAPEI 209
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 88/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V      + G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+    +  HL    R  +      +     I     YL
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 144
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y+APE 
Sbjct: 145 HS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 196
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 197 ILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVY-KGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V     +  G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+    +  HL    R  +      +     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           +LG+G +G V K   +  G+  AVKR+  T + Q  +    ++++  +            
Sbjct: 41  ELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYG 100
Query: 456 XXXXXXXXXIYEYMPNKSLDV---HLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                    I   + + SLD     + D  +++  D   + ++   I + + +LH  S+L
Sbjct: 101 ALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAV--SIVKALEHLH--SKL 156
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI- 571
            +IHRD+K SN+L++     K  DFG++   G   +    +I AG   Y APE     + 
Sbjct: 157 SVIHRDVKPSNVLINALGQVKXCDFGIS---GYLVDDVAKDIDAGCKPYXAPERINPELN 213
Query: 572 ---FSIKSDVFSFGVLLLEI 588
              +S+KSD++S G+  +E+
Sbjct: 214 QKGYSVKSDIWSLGITXIEL 233

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V      + G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+    +  HL    R  +      +     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 97/213 (45%), Gaps = 28/213 (13%)
Query: 392 HFSDENKL----GQGGFGPVYKGTLADGKA---IAVKRLSRTSGQGLQE-FKNEVNLIAK 443
           H SD  +L    G G FG      + D ++   +AVK + R  G+ + E  K E+     
Sbjct: 15  HDSDRYELVKDIGSGNFG--VARLMRDKQSNELVAVKYIER--GEKIDENVKREIINHRS 70
Query: 444 LQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRR--QSIINGIAR 501
           L+H N+VR             + EY     L   + +A R  + D  R   Q +I+G++ 
Sbjct: 71  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE-DEARFFFQQLISGVS- 128
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNIIAGTY 559
              Y H    +++ HRDLK  N LLD    P  KI DFG ++    +    +T    GT 
Sbjct: 129 ---YCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTP 179
Query: 560 GYMAPEYAMGGIFSIK-SDVFSFGVLLLEIISG 591
            Y+APE  +   +  K +DV+S GV L  ++ G
Sbjct: 180 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 20/213 (9%)
Query: 388 EATNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRT--------SGQGLQEFKNEV 438
           E +  +S  + LG G FG V+     +  K + VK + +             L +   E+
Sbjct: 21  EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEI 80
Query: 439 NLIAKLQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING 498
            ++++++H N+++             + E      LD+  F   R  +LD      I   
Sbjct: 81  AILSRVEHANIIKVLDIFENQGFFQLVMEKH-GSGLDLFAF-IDRHPRLDEPLASYIFRQ 138
Query: 499 IARGILYLHEDSRLK-IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG 557
           +   + YL    RLK IIHRD+K  NI++ +D   K+ DFG A      +         G
Sbjct: 139 LVSAVGYL----RLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYTFCG 191
Query: 558 TYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEII 589
           T  Y APE  MG  +   + +++S GV L  ++
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V      + G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+    +  HL    R  +      +     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAE---PHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V      + G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+    +  HL    R  +      +     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V      + G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+    +  HL    R  +      +     I     YL
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYL 152
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+APE 
Sbjct: 153 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 204
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 205 ILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V      + G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+    +  HL    R  +      +     I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+APE 
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 87/205 (42%), Gaps = 31/205 (15%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAV-------KRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
           ++G+G F  VYKG L     + V       ++L+++     Q FK E   +  LQH N+V
Sbjct: 33  EIGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSE---RQRFKEEAEXLKGLQHPNIV 88
Query: 451 RXXXXXXXXXXXXX----IYEYMPNKSLDVHL--FDATR-SVQLDWKRRQSIINGIARGI 503
           R                 + E   + +L  +L  F   +  V   W R+      I +G+
Sbjct: 89  RFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQ------ILKGL 142
Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYM 562
            +LH  +   IIHRDLK  NI +       KI D GLA +    +  +    + GT  + 
Sbjct: 143 QFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFX 197
Query: 563 APEYAMGGIFSIKSDVFSFGVLLLE 587
           APE      +    DV++FG   LE
Sbjct: 198 APE-XYEEKYDESVDVYAFGXCXLE 221

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 41/225 (18%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXXXXX 458
           +G+G +G V++G L  G+++AVK  S    Q     + E+     L+H N++        
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFR-ETEIYNTVLLRHDNILGFIASDMT 73
Query: 459 XXXXXX-------------IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
                              +Y+++  ++L+ HL  A R           +    A G+ +
Sbjct: 74  SRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHL--ALR-----------LAVSAACGLAH 120
Query: 506 LHED-----SRLKIIHRDLKASNILLDDDMNPKISDFGLARIF--GGNQNQANTNIIAGT 558
           LH +      +  I HRD K+ N+L+  ++   I+D GLA +   G +      N   GT
Sbjct: 121 LHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGT 180
Query: 559 YGYMAPEYAMGGIFS------IKSDVFSFGVLLLEIISGRKNNGF 597
             YMAPE     I +        +D+++FG++L EI      NG 
Sbjct: 181 KRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGI 225

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V      + G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+    +  HL    R  +      +     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V      + G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+    +  HL    R  +      +     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 14/208 (6%)
Query: 390 TNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS--RTSGQGLQEFKNEVNLIAKLQH 446
           T+ +    +LG+G F  V +   +  G+  A K ++  + S +  Q+ + E  +   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 447 KNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
            N+VR             +++ +    L   +       + D       I  I   + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEAD---ASHCIQQILESVNHC 119
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNP---KISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
           H +    I+HRDLK  N+LL         K++DFGLA    G+Q QA     AGT GY++
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWFGF-AGTPGYLS 174
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           PE      +    D+++ GV+L  ++ G
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V      + G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+    +  HL    R  +      +     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V      + G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+    +  HL    R  +      +     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V      + G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+    +  HL    R  +      +     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V      + G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+    +  HL    R  +      +     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V      + G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+    +  HL    R  +      +     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLXGTPEYLAPEI 209
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V      + G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+    +  HL    R  +      +     I     YL
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYL 178
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+APE 
Sbjct: 179 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 230
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 92/201 (45%), Gaps = 22/201 (10%)
Query: 399 LGQGGFGP--VYKGTLADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXXXX 455
           +G G FG   + +  L   + +AVK + R  G  + E  + E+     L+H N+VR    
Sbjct: 28  IGSGNFGVARLMRDKLT-KELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRR--QSIINGIARGILYLHEDSRLK 513
                    I EY     L   + +A R  + D  R   Q +++G++    Y H    ++
Sbjct: 85  ILTPTHLAIIMEYASGGELYERICNAGRFSE-DEARFFFQQLLSGVS----YCHS---MQ 136
Query: 514 IIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 571
           I HRDLK  N LLD    P  KI DFG ++    +    +T    GT  Y+APE  +   
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLRQE 193
Query: 572 FSIK-SDVFSFGVLLLEIISG 591
           +  K +DV+S GV L  ++ G
Sbjct: 194 YDGKIADVWSCGVTLYVMLVG 214

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
            +LG G FG V++    A G+    K ++          KNE++++ +L H  L+     
Sbjct: 57  EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQS-IINGIAR---GILYLHEDSR 511
                    I E++        LFD  R    D+K  ++ +IN + +   G+ ++HE S 
Sbjct: 117 FEDKYEMVLILEFLSGGE----LFD--RIAAEDYKMSEAEVINYMRQACEGLKHMHEHS- 169
Query: 512 LKIIHRDLKASNILLDDDM--NPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 569
             I+H D+K  NI+ +     + KI DFGLA     ++      +   T  + APE    
Sbjct: 170 --IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDR 224
Query: 570 GIFSIKSDVFSFGVLLLEIISG 591
                 +D+++ GVL   ++SG
Sbjct: 225 EPVGFYTDMWAIGVLGYVLLSG 246

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 115/262 (43%), Gaps = 54/262 (20%)
Query: 367 RGGKQQAESQ--EFPLFPLRLALEATNHFSDENKLGQGGFGPV-YKGTLADGKAIAVKRL 423
           RGGK+  +S+    P F   L     N    E  LG G  G V ++G+   G+ +AVKR+
Sbjct: 11  RGGKKGRKSRIANIPNFEQSLK----NLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRM 65
Query: 424 SRTSGQGLQEFKN----EVNLIAKLQ-HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHL 478
                  L +F +    E+ L+ +   H N++R              + Y+  +  +++L
Sbjct: 66  -------LIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDR-----FLYIALELCNLNL 113
Query: 479 FDATRSVQLDWKRRQ--------SIINGIARGILYLHEDSRLKIIHRDLKASNILLD--- 527
            D   S  +  +  +        S++  IA G+ +LH    LKIIHRDLK  NIL+    
Sbjct: 114 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSS 170
Query: 528 ----------DDMNPKISDFGLARIFGGNQN--QANTNIIAGTYGYMAPEY---AMGGIF 572
                     +++   ISDFGL +     Q   + N N  +GT G+ APE    +     
Sbjct: 171 RFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRL 230
Query: 573 SIKSDVFSFGVLLLEIISGRKN 594
           +   D+FS G +   I+S  K+
Sbjct: 231 TRSIDIFSMGCVFYYILSKGKH 252

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V      + G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+    +  HL    R  +      +     I     YL
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 178
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+APE 
Sbjct: 179 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----ATWTLCGTPEYLAPEI 230
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 14/208 (6%)
Query: 390 TNHFSDENKLGQGGFGPVYKG-TLADGKAIAVKRLS--RTSGQGLQEFKNEVNLIAKLQH 446
           T+ +    +LG+G F  V +   +  G+  A K ++  + S +  Q+ + E  +   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 447 KNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
            N+VR             +++ +    L   +       + D       I  I   + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEAD---ASHCIQQILESVNHC 119
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNP---KISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
           H +    I+HRDLK  N+LL         K++DFGLA    G+Q QA     AGT GY++
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWFGF-AGTPGYLS 174
Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           PE      +    D+++ GV+L  ++ G
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 115/262 (43%), Gaps = 54/262 (20%)
Query: 367 RGGKQQAESQ--EFPLFPLRLALEATNHFSDENKLGQGGFGPV-YKGTLADGKAIAVKRL 423
           RGGK+  +S+    P F   L     N    E  LG G  G V ++G+   G+ +AVKR+
Sbjct: 11  RGGKKGRKSRIANIPNFEQSLK----NLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRM 65
Query: 424 SRTSGQGLQEFKN----EVNLIAKLQ-HKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHL 478
                  L +F +    E+ L+ +   H N++R              + Y+  +  +++L
Sbjct: 66  -------LIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDR-----FLYIALELCNLNL 113
Query: 479 FDATRSVQLDWKRRQ--------SIINGIARGILYLHEDSRLKIIHRDLKASNILLD--- 527
            D   S  +  +  +        S++  IA G+ +LH    LKIIHRDLK  NIL+    
Sbjct: 114 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSS 170
Query: 528 ----------DDMNPKISDFGLARIFGGNQN--QANTNIIAGTYGYMAPEY---AMGGIF 572
                     +++   ISDFGL +     Q   + N N  +GT G+ APE    +     
Sbjct: 171 RFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRL 230
Query: 573 SIKSDVFSFGVLLLEIISGRKN 594
           +   D+FS G +   I+S  K+
Sbjct: 231 TRSIDIFSMGCVFYYILSKGKH 252

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 21/211 (9%)
Query: 396 ENKLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRXX 453
           E+ LG+G    V     L   +  AVK + +  G        EV ++ + Q H+N++   
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 454 XXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
                      ++E M   S+  H+       +L+      ++  +A  + +LH      
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELE---ASVVVQDVASALDFLHNKG--- 131
Query: 514 IIHRDLKASNILLD--DDMNP-KISDFGLA---RIFGGNQNQANTNII--AGTYGYMAPE 565
           I HRDLK  NIL +  + ++P KI DF L    ++ G     +   ++   G+  YMAPE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 566 YA-----MGGIFSIKSDVFSFGVLLLEIISG 591
                     I+  + D++S GV+L  ++SG
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 7/102 (6%)
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMN-PKISDFGLARIF---GGNQNQANTNIIAG 557
           G+ YLH     +I+H D+KA N+LL  D +   + DFG A      G  ++    + I G
Sbjct: 178 GLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 234
Query: 558 TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF 599
           T  +MAPE  MG     K D++S   ++L +++G      YF
Sbjct: 235 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 276

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 87/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V      + G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+    +  HL    R  +      +     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+++D     +++DFG A+   G      T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 210 IISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 7/102 (6%)
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMN-PKISDFGLARIF---GGNQNQANTNIIAG 557
           G+ YLH     +I+H D+KA N+LL  D +   + DFG A      G  ++    + I G
Sbjct: 162 GLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 558 TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF 599
           T  +MAPE  MG     K D++S   ++L +++G      YF
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 87/205 (42%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V      + G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+    +  HL    R  +      +     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ ++ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 102/255 (40%), Gaps = 54/255 (21%)
Query: 387 LEATNHFSDENKLGQGGFGPVYKGTLADGKAI-AVK-----RLSRTSGQGLQEFKNEVNL 440
           LE    +  +  +GQG +G V        +AI A+K     ++ + + + ++  K EV L
Sbjct: 22  LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRL 81
Query: 441 IAKLQHKNLVRXXXXXXXXXXXXXIYE-----YMPNKSLDVHLFDATRSV---------- 485
           + KL H N+ R             + E     ++ +K L+V + D+T             
Sbjct: 82  MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDK-LNVFIDDSTGKCAMDVVKTQIC 140
Query: 486 -------------------QLDWKRRQSIINGIARGIL----YLHEDSRLKIIHRDLKAS 522
                               LD+ +R+ +I+ I R I     YLH      I HRD+K  
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPE 197
Query: 523 NILL--DDDMNPKISDFGLARIFG--GNQNQANTNIIAGTYGYMAPEY--AMGGIFSIKS 576
           N L   +     K+ DFGL++ F    N         AGT  ++APE        +  K 
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 577 DVFSFGVLLLEIISG 591
           D +S GVLL  ++ G
Sbjct: 258 DAWSAGVLLHLLLMG 272

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 7/102 (6%)
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMN-PKISDFGLARIF---GGNQNQANTNIIAG 557
           G+ YLH     +I+H D+KA N+LL  D +   + DFG A      G  ++    + I G
Sbjct: 176 GLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 232
Query: 558 TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF 599
           T  +MAPE  MG     K D++S   ++L +++G      YF
Sbjct: 233 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 274

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 21/210 (10%)
Query: 399 LGQGGFGPVYKGTLADGK----AIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXX 453
           +G+G FG V++G     +    A+A+K     +   ++E F  E   + +  H ++V+  
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 454 XXXXXXXXXXXIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                      ++  M   +L ++  F   R   LD          ++  + YL      
Sbjct: 78  GVITENP----VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK--- 130
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
           + +HRD+ A N+L+  +   K+ DFGL+R +  +      +       +MAPE      F
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTXXKASKGKLPIKWMAPESINFRRF 189
Query: 573 SIKSDVFSFGVLLLEII-------SGRKNN 595
           +  SDV+ FGV + EI+        G KNN
Sbjct: 190 TSASDVWMFGVCMWEILMHGVKPFQGVKNN 219

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 7/94 (7%)
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGLARIF---GGNQNQANTNIIAG 557
           G+ YLH  SR +I+H D+KA N+LL  D  +  + DFG A      G  ++    + I G
Sbjct: 178 GLEYLH--SR-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPG 234
Query: 558 TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           T  +MAPE  +G     K DV+S   ++L +++G
Sbjct: 235 TETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 99/237 (41%), Gaps = 43/237 (18%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           ++G GG   V++      +  A+K   L     Q L  ++NE+  + KLQ  +  +    
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRL 93
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    IY  M   ++D++ +   +     W+R+ S    +   +  +H+     I+
Sbjct: 94  YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQHG---IV 149
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII-----AGTYGYMAPEYAMGG 570
           H DLK +N L+ D M  K+ DFG+A     NQ Q +T  +      GT  YM PE A+  
Sbjct: 150 HSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQVGTVNYMPPE-AIKD 202
Query: 571 IFSIKS------------DVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLS 615
           + S +             DV+S G +L            Y+  +G+T    + N +S
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCIL------------YYMTYGKTPFQQIINQIS 247

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 101/242 (41%), Gaps = 43/242 (17%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
           +S   ++G GG   V++      +  A+K   L     Q L  ++NE+  + KLQ  +  
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-D 68
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
           +             IY  M   ++D++ +   +     W+R+ S    +   +  +H+  
Sbjct: 69  KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQHG 127
Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII-----AGTYGYMAPE 565
              I+H DLK +N L+ D M  K+ DFG+A     NQ Q +T  +      GT  YM PE
Sbjct: 128 ---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQVGTVNYMPPE 178
Query: 566 YAMGGIFSIKS------------DVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNS 613
            A+  + S +             DV+S G +L            Y+  +G+T    + N 
Sbjct: 179 -AIKDMSSSRENGKSKSKISPKSDVWSLGCIL------------YYMTYGKTPFQQIINQ 225
Query: 614 LS 615
           +S
Sbjct: 226 IS 227

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 7/94 (7%)
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGLARIF---GGNQNQANTNIIAG 557
           G+ YLH  SR +I+H D+KA N+LL  D  +  + DFG A      G  ++    + I G
Sbjct: 197 GLEYLH--SR-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPG 253
Query: 558 TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           T  +MAPE  +G     K DV+S   ++L +++G
Sbjct: 254 TETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 99/237 (41%), Gaps = 43/237 (18%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           ++G GG   V++      +  A+K   L     Q L  ++NE+  + KLQ  +  +    
Sbjct: 19  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRL 77
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    IY  M   ++D++ +   +     W+R+ S    +   +  +H+     I+
Sbjct: 78  YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQHG---IV 133
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII-----AGTYGYMAPEYAMGG 570
           H DLK +N L+ D M  K+ DFG+A     NQ Q +T  +      GT  YM PE A+  
Sbjct: 134 HSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQVGTVNYMPPE-AIKD 186
Query: 571 IFSIKS------------DVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLS 615
           + S +             DV+S G +L            Y+  +G+T    + N +S
Sbjct: 187 MSSSRENGKSKSKISPKSDVWSLGCIL------------YYMTYGKTPFQQIINQIS 231

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 99/237 (41%), Gaps = 43/237 (18%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           ++G GG   V++      +  A+K   L     Q L  ++NE+  + KLQ  +  +    
Sbjct: 16  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRL 74
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    IY  M   ++D++ +   +     W+R+ S    +   +  +H+     I+
Sbjct: 75  YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQHG---IV 130
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII-----AGTYGYMAPEYAMGG 570
           H DLK +N L+ D M  K+ DFG+A     NQ Q +T  +      GT  YM PE A+  
Sbjct: 131 HSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQVGTVNYMPPE-AIKD 183
Query: 571 IFSIKS------------DVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLS 615
           + S +             DV+S G +L            Y+  +G+T    + N +S
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCIL------------YYMTYGKTPFQQIINQIS 228

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 58/123 (47%), Gaps = 25/123 (20%)
Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNILLD-------------DDMNPKISDFGLA 540
           S++  IA G+ +LH    LKIIHRDLK  NIL+              +++   ISDFGL 
Sbjct: 119 SLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
Query: 541 RIFGGNQNQANTNI--IAGTYGYMAPE-------YAMGGIFSIKSDVFSFGVLLLEIISG 591
           +     Q+   TN+   +GT G+ APE              +   D+FS G +   I+S 
Sbjct: 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
Query: 592 RKN 594
            K+
Sbjct: 236 GKH 238

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 28/213 (13%)
Query: 392 HFSDENKL----GQGGFGPVYKGTLADGKA---IAVKRLSRTSGQGLQ-EFKNEVNLIAK 443
           H SD  +L    G G FG      + D ++   +AVK + R  G+ +    K E+     
Sbjct: 16  HDSDRYELVKDIGSGNFG--VARLMRDKQSNELVAVKYIER--GEKIAANVKREIINHRS 71
Query: 444 LQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRR--QSIINGIAR 501
           L+H N+VR             + EY     L   + +A R  + D  R   Q +I+G++ 
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE-DEARFFFQQLISGVS- 129
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNIIAGTY 559
              Y H    +++ HRDLK  N LLD    P  KI DFG ++    +    +T    GT 
Sbjct: 130 ---YCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTP 180
Query: 560 GYMAPEYAMGGIFSIK-SDVFSFGVLLLEIISG 591
            Y+APE  +   +  K +DV+S GV L  ++ G
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 99/237 (41%), Gaps = 43/237 (18%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           ++G GG   V++      +  A+K   L     Q L  ++NE+  + KLQ  +  +    
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRL 121
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    IY  M   ++D++ +   +     W+R+ S    +   +  +H+     I+
Sbjct: 122 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQHG---IV 177
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII-----AGTYGYMAPEYAMGG 570
           H DLK +N L+ D M  K+ DFG+A     NQ Q +T  +      GT  YM PE A+  
Sbjct: 178 HSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQVGTVNYMPPE-AIKD 230
Query: 571 IFSIKS------------DVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLS 615
           + S +             DV+S G +L            Y+  +G+T    + N +S
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCIL------------YYMTYGKTPFQQIINQIS 275

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 57/115 (49%), Gaps = 12/115 (10%)
Query: 495 IINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQAN 551
           I+  +   + ++H+   + ++HRDLK  N+L    +D++  KI DFG AR+   +     
Sbjct: 111 IMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167
Query: 552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTL 606
           T     T  Y APE      +    D++S GV+L  ++SG+      F  H ++L
Sbjct: 168 TPCF--TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ----VPFQSHDRSL 216

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 56/104 (53%), Gaps = 15/104 (14%)
Query: 495 IINGIARGILYLHEDSRLKIIHRDLKASNIL-LDDDMNP---KISDFGLARIFGGNQNQA 550
           +++ I + + YLH      ++HRDLK SNIL +D+  NP   +I DFG A+     Q +A
Sbjct: 126 VLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAK-----QLRA 177
Query: 551 NTNIIAG---TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
              ++     T  ++APE      +    D++S G+LL  +++G
Sbjct: 178 ENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 91/217 (41%), Gaps = 23/217 (10%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG-----------LQEFKNEVNLIAKLQHK 447
           +  G +G V  G  ++G  +A+KR+  T   G            +    E+ L+    H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 448 NLV--RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           N++  R             +Y        D+      + + +  +  Q  +  I  G+  
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHV 149
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           LHE     ++HRDL   NILL D+ +  I DF LAR    + N+  T+ +   + Y APE
Sbjct: 150 LHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANK--THYVTHRW-YRAPE 203
Query: 566 YAMG-GIFSIKSDVFSFGVLLLEIISGR---KNNGFY 598
             M    F+   D++S G ++ E+ + +   + + FY
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 28/213 (13%)
Query: 392 HFSDENKL----GQGGFGPVYKGTLADGKA---IAVKRLSRTSGQGLQE-FKNEVNLIAK 443
           H SD  +L    G G FG      + D ++   +AVK + R  G+ + E  K E+     
Sbjct: 16  HDSDRYELVKDIGSGNFG--VARLMRDKQSNELVAVKYIER--GEKIDENVKREIINHRS 71
Query: 444 LQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRR--QSIINGIAR 501
           L+H N+VR             + EY     L   + +A R  + D  R   Q +I+G++ 
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE-DEARFFFQQLISGVS- 129
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNIIAGTY 559
              Y H    +++ HRDLK  N LLD    P  KI  FG ++    +    +T    GT 
Sbjct: 130 ---YCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDT---VGTP 180
Query: 560 GYMAPEYAMGGIFSIK-SDVFSFGVLLLEIISG 591
            Y+APE  +   +  K +DV+S GV L  ++ G
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 86/205 (41%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V      + G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+    +  HL    R  +      +     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT  Y+AP  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPAI 209
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 21/210 (10%)
Query: 399 LGQGGFGPVYKGTLADGK----AIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXX 453
           +G+G FG V++G     +    A+A+K     +   ++E F  E   + +  H ++V+  
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 454 XXXXXXXXXXXIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                      ++  M   +L ++  F   R   LD          ++  + YL      
Sbjct: 78  GVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--- 130
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
           + +HRD+ A N+L+  +   K+ DFGL+R +  +      +       +MAPE      F
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 573 SIKSDVFSFGVLLLEII-------SGRKNN 595
           +  SDV+ FGV + EI+        G KNN
Sbjct: 190 TSASDVWMFGVCMWEILMHGVKPFQGVKNN 219

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 91/217 (41%), Gaps = 23/217 (10%)
Query: 399 LGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG-----------LQEFKNEVNLIAKLQHK 447
           +  G +G V  G  ++G  +A+KR+  T   G            +    E+ L+    H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 448 NLV--RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           N++  R             +Y        D+      + + +  +  Q  +  I  G+  
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHV 149
Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           LHE     ++HRDL   NILL D+ +  I DF LAR    + N+  T+ +   + Y APE
Sbjct: 150 LHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANK--THYVTHRW-YRAPE 203
Query: 566 YAMG-GIFSIKSDVFSFGVLLLEIISGR---KNNGFY 598
             M    F+   D++S G ++ E+ + +   + + FY
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 56/104 (53%), Gaps = 15/104 (14%)
Query: 495 IINGIARGILYLHEDSRLKIIHRDLKASNIL-LDDDMNP---KISDFGLARIFGGNQNQA 550
           +++ I + + YLH      ++HRDLK SNIL +D+  NP   +I DFG A+     Q +A
Sbjct: 126 VLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAK-----QLRA 177
Query: 551 NTNIIAG---TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
              ++     T  ++APE      +    D++S G+LL  +++G
Sbjct: 178 ENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 21/210 (10%)
Query: 399 LGQGGFGPVYKGTLADGK----AIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXX 453
           +G+G FG V++G     +    A+A+K     +   ++E F  E   + +  H ++V+  
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 454 XXXXXXXXXXXIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                      ++  M   +L ++  F   R   LD          ++  + YL      
Sbjct: 78  GVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--- 130
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
           + +HRD+ A N+L+  +   K+ DFGL+R +  +      +       +MAPE      F
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 573 SIKSDVFSFGVLLLEII-------SGRKNN 595
           +  SDV+ FGV + EI+        G KNN
Sbjct: 190 TSASDVWMFGVCMWEILMHGVKPFQGVKNN 219

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 21/210 (10%)
Query: 399 LGQGGFGPVYKGTLADGK----AIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXX 453
           +G+G FG V++G     +    A+A+K     +   ++E F  E   + +  H ++V+  
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 454 XXXXXXXXXXXIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                      ++  M   +L ++  F   R   LD          ++  + YL      
Sbjct: 75  GVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--- 127
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
           + +HRD+ A N+L+  +   K+ DFGL+R +  +      +       +MAPE      F
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 573 SIKSDVFSFGVLLLEII-------SGRKNN 595
           +  SDV+ FGV + EI+        G KNN
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNN 216

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 21/210 (10%)
Query: 399 LGQGGFGPVYKGTLADGK----AIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXX 453
           +G+G FG V++G     +    A+A+K     +   ++E F  E   + +  H ++V+  
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 454 XXXXXXXXXXXIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                      ++  M   +L ++  F   R   LD          ++  + YL      
Sbjct: 106 GVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--- 158
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
           + +HRD+ A N+L+  +   K+ DFGL+R +  +      +       +MAPE      F
Sbjct: 159 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 217
Query: 573 SIKSDVFSFGVLLLEII-------SGRKNN 595
           +  SDV+ FGV + EI+        G KNN
Sbjct: 218 TSASDVWMFGVCMWEILMHGVKPFQGVKNN 247

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF--GGNQNQANTNIIAGT 558
           RG+ Y+H     ++IHRDLK SN+L++++   KI DFG+AR       ++Q        T
Sbjct: 170 RGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 226
Query: 559 YGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRK 593
             Y APE  +    ++   D++S G +  E+++ R+
Sbjct: 227 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 95/232 (40%), Gaps = 33/232 (14%)
Query: 398 KLGQGGFGPVYKGTLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXXX 455
           ++G GG   V++      +  A+K   L     Q L  ++NE+  + KLQ  +  +    
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRL 93
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
                    IY  M   ++D++ +   +     W+R+ S    +   +  +H+     I+
Sbjct: 94  YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQHG---IV 149
Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           H DLK +N L+ D M  K+ DFG+A     +      +   GT  YM PE A+  + S +
Sbjct: 150 HSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPE-AIKDMSSSR 207
Query: 576 S------------DVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLS 615
                        DV+S G +L            Y+  +G+T    + N +S
Sbjct: 208 ENGKSKSKISPKSDVWSLGCIL------------YYMTYGKTPFQQIINQIS 247

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 102/238 (42%), Gaps = 45/238 (18%)
Query: 398 KLGQGGFGPVYKGTLADGKAI-AVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           ++G GG   V++  L + K I A+K   L     Q L  ++NE+  + KLQ  +  +   
Sbjct: 63  QIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIR 120
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                     IY  M   ++D++ +   +     W+R+ S    +   +  +H+     I
Sbjct: 121 LYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQHG---I 176
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII-----AGTYGYMAPEYAMG 569
           +H DLK +N L+ D M  K+ DFG+A     NQ Q +T  +      GT  YM PE A+ 
Sbjct: 177 VHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQVGTVNYMPPE-AIK 229
Query: 570 GIFSIKS------------DVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLS 615
            + S +             DV+S G +L            Y+  +G+T    + N +S
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCIL------------YYMTYGKTPFQQIINQIS 275

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 28/213 (13%)
Query: 392 HFSDENKL----GQGGFGPVYKGTLADGKA---IAVKRLSRTSGQGLQE-FKNEVNLIAK 443
           H SD  +L    G G FG      + D ++   +AVK + R  G+ + E  K E+     
Sbjct: 16  HDSDRYELVKDIGSGNFG--VARLMRDKQSNELVAVKYIER--GEKIDENVKREIINHRS 71
Query: 444 LQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRR--QSIINGIAR 501
           L+H N+VR             + EY     L   + +A R  + D  R   Q +I+G++ 
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE-DEARFFFQQLISGVS- 129
Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNIIAGTY 559
              Y H    +++ HRDLK  N LLD    P  KI  FG ++    +    +T    GT 
Sbjct: 130 ---YCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKST---VGTP 180
Query: 560 GYMAPEYAMGGIFSIK-SDVFSFGVLLLEIISG 591
            Y+APE  +   +  K +DV+S GV L  ++ G
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 21/210 (10%)
Query: 399 LGQGGFGPVYKGTLADGK----AIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXX 453
           +G+G FG V++G     +    A+A+K     +   ++E F  E   + +  H ++V+  
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 454 XXXXXXXXXXXIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                      ++  M   +L ++  F   R   LD          ++  + YL      
Sbjct: 80  GVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--- 132
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
           + +HRD+ A N+L+  +   K+ DFGL+R +  +      +       +MAPE      F
Sbjct: 133 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 191
Query: 573 SIKSDVFSFGVLLLEII-------SGRKNN 595
           +  SDV+ FGV + EI+        G KNN
Sbjct: 192 TSASDVWMFGVCMWEILMHGVKPFQGVKNN 221

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 100/255 (39%), Gaps = 40/255 (15%)
Query: 391 NHFSDENKLGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
            H+    KLG+GGF  V     L DG   A+KR+     Q  +E + E ++     H N+
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 450 VRXXXX-XXXXXXXXXIYEYMPNKSLDVHLFDATR---------SVQLDWKRRQSIINGI 499
           +R               +  +P         +  R           Q+ W     ++ GI
Sbjct: 89  LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW-----LLLGI 143
Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG-----LARIFGGNQNQANTNI 554
            RG+  +H        HRDLK +NILL D+  P + D G        + G  Q     + 
Sbjct: 144 CRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200
Query: 555 IAG--TYGYMAPEYAMGGIFSIKS--------DVFSFGVLLLEIISGRKNNGFYFSEHGQ 604
            A   T  Y APE     +FS++S        DV+S G +L  ++ G       F + G 
Sbjct: 201 AAQRCTISYRAPE-----LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK-GD 254
Query: 605 TLLTYVCNSLSLSLS 619
           ++   V N LS+  S
Sbjct: 255 SVALAVQNQLSIPQS 269

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNIL-LDDDMNP---KISDFGLARIFGGNQNQ 549
           +++  I + + YLH      ++HRDLK SNIL +D+  NP   +I DFG A+     Q +
Sbjct: 120 AVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK-----QLR 171
Query: 550 ANTNIIAG---TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           A   ++     T  ++APE      +    D++S GVLL  +++G
Sbjct: 172 AENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 21/210 (10%)
Query: 399 LGQGGFGPVYKGTLADGK----AIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXX 453
           +G+G FG V++G     +    A+A+K     +   ++E F  E   + +  H ++V+  
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 454 XXXXXXXXXXXIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                      ++  M   +L ++  F   R   LD          ++  + YL      
Sbjct: 83  GVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--- 135
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
           + +HRD+ A N+L+  +   K+ DFGL+R +  +      +       +MAPE      F
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 573 SIKSDVFSFGVLLLEII-------SGRKNN 595
           +  SDV+ FGV + EI+        G KNN
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKPFQGVKNN 224

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF--GGNQNQANTNIIAGT 558
           RG+ Y+H     ++IHRDLK SN+L++++   KI DFG+AR       ++Q        T
Sbjct: 169 RGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 225
Query: 559 YGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRK 593
             Y APE  +    ++   D++S G +  E+++ R+
Sbjct: 226 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 86/204 (42%), Gaps = 22/204 (10%)
Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVR 451
           +G+G FG V    +K T    K  A+K LS+       +   F  E +++A      +V+
Sbjct: 82  IGRGAFGEVQLVRHKSTR---KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 138
Query: 452 XXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
                        + EYMP   L V+L  +   V   W R  +     A  +L L     
Sbjct: 139 LFYAFQDDRYLYMVMEYMPGGDL-VNLM-SNYDVPEKWARFYT-----AEVVLALDAIHS 191
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY----A 567
           +  IHRD+K  N+LLD   + K++DFG        +     +   GT  Y++PE      
Sbjct: 192 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 568 MGGIFSIKSDVFSFGVLLLEIISG 591
             G +  + D +S GV L E++ G
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 21/210 (10%)
Query: 399 LGQGGFGPVYKGTLADGK----AIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXX 453
           +G+G FG V++G     +    A+A+K     +   ++E F  E   + +  H ++V+  
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 454 XXXXXXXXXXXIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                      ++  M   +L ++  F   R   LD          ++  + YL      
Sbjct: 81  GVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--- 133
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
           + +HRD+ A N+L+  +   K+ DFGL+R +  +      +       +MAPE      F
Sbjct: 134 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 192
Query: 573 SIKSDVFSFGVLLLEII-------SGRKNN 595
           +  SDV+ FGV + EI+        G KNN
Sbjct: 193 TSASDVWMFGVCMWEILMHGVKPFQGVKNN 222

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 86/204 (42%), Gaps = 22/204 (10%)
Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVR 451
           +G+G FG V    +K T    K  A+K LS+       +   F  E +++A      +V+
Sbjct: 82  IGRGAFGEVQLVRHKSTR---KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 138
Query: 452 XXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
                        + EYMP   L V+L  +   V   W R  +     A  +L L     
Sbjct: 139 LFYAFQDDRYLYMVMEYMPGGDL-VNLM-SNYDVPEKWARFYT-----AEVVLALDAIHS 191
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY----A 567
           +  IHRD+K  N+LLD   + K++DFG        +     +   GT  Y++PE      
Sbjct: 192 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 568 MGGIFSIKSDVFSFGVLLLEIISG 591
             G +  + D +S GV L E++ G
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 86/204 (42%), Gaps = 22/204 (10%)
Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVR 451
           +G+G FG V    +K T    K  A+K LS+       +   F  E +++A      +V+
Sbjct: 77  IGRGAFGEVQLVRHKSTR---KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133
Query: 452 XXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
                        + EYMP   L V+L  +   V   W R  +     A  +L L     
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDL-VNLM-SNYDVPEKWARFYT-----AEVVLALDAIHS 186
Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY----A 567
           +  IHRD+K  N+LLD   + K++DFG        +     +   GT  Y++PE      
Sbjct: 187 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAVGTPDYISPEVLKSQG 245
Query: 568 MGGIFSIKSDVFSFGVLLLEIISG 591
             G +  + D +S GV L E++ G
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 11/94 (11%)
Query: 495 IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP----KISDFGLARIFGGNQNQA 550
           +I  I  G+ YLH+++   I+H DLK  NILL   + P    KI DFG++R  G   +  
Sbjct: 136 LIKQILEGVYYLHQNN---IVHLDLKPQNILL-SSIYPLGDIKIVDFGMSRKIG---HAC 188
Query: 551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVL 584
               I GT  Y+APE       +  +D+++ G++
Sbjct: 189 ELREIMGTPEYLAPEILNYDPITTATDMWNIGII 222

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 86/205 (41%), Gaps = 15/205 (7%)
Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN- 448
           + F     LG G FG V      + G   A+K L +     L++ ++ +N    LQ  N 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 449 --LVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+             + EY+    +  HL    R  +      +     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT   +APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEALAPEI 209
Query: 567 AMGGIFSIKSDVFSFGVLLLEIISG 591
            +   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 57/123 (46%), Gaps = 25/123 (20%)
Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNILLD-------------DDMNPKISDFGLA 540
           S++  IA G+ +LH    LKIIHRDLK  NIL+              +++   ISDFGL 
Sbjct: 119 SLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
Query: 541 RIFGGNQN--QANTNIIAGTYGYMAPE-------YAMGGIFSIKSDVFSFGVLLLEIISG 591
           +     Q   + N N  +GT G+ APE              +   D+FS G +   I+S 
Sbjct: 176 KKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
Query: 592 RKN 594
            K+
Sbjct: 236 GKH 238

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 55/105 (52%), Gaps = 15/105 (14%)
Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNIL-LDDDMNP---KISDFGLARIFGGNQNQ 549
           +++  I + + YLH      ++HRDLK SNIL +D+  NP   +I DFG A+     Q +
Sbjct: 120 AVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK-----QLR 171
Query: 550 ANTNIIAG---TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
           A   ++     T  ++APE      +    D++S GVLL   ++G
Sbjct: 172 AENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 89/210 (42%), Gaps = 21/210 (10%)
Query: 399 LGQGGFGPVYKGTLADGK----AIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXX 453
           +G+G FG V++G     +    A+A+K     +   ++E F  E   + +  H ++V+  
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 454 XXXXXXXXXXXIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                      ++  M   +L ++  F   R   LD          ++  + YL      
Sbjct: 78  GVITENP----VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK--- 130
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
           + +HRD+ A N+L+      K+ DFGL+R +  +      +       +MAPE      F
Sbjct: 131 RFVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 573 SIKSDVFSFGVLLLEII-------SGRKNN 595
           +  SDV+ FGV + EI+        G KNN
Sbjct: 190 TSASDVWMFGVCMWEILMHGVKPFQGVKNN 219

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 39/223 (17%)
Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRL---SRTSGQGLQEFKNEVNLIAKLQH 446
           + F  E   GQG FG V  G   + G ++A+K++    R   + LQ  ++    +A L H
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQD----LAVLHH 78
Query: 447 KNLVRXXX-------XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 499
            N+V+                    + EY+P         D       ++ RRQ     I
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---------DTLHRCCRNYYRRQVAPPPI 129
Query: 500 ---------ARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFGGNQNQ 549
                     R I  LH  S + + HRD+K  N+L+++ D   K+ DFG A+    + ++
Sbjct: 130 LIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SPSE 186
Query: 550 ANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISG 591
            N   I   Y Y APE   G   ++   D++S G +  E++ G
Sbjct: 187 PNVAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 84/201 (41%), Gaps = 16/201 (7%)
Query: 393 FSDENKLGQGGFGPVYK-GTLADGKAIAVKR-LSRTSGQGLQEFK-NEVNLIAKL-QHKN 448
           F   ++LG G +G V+K  +  DG+  AVKR +S   G   +  K  EV    K+ QH  
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 449 LVRXXXXXXXXXXXXXIYEYM-PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
            VR               E   P+       + A+      W   +  +  +A    +LH
Sbjct: 119 CVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALA----HLH 174
Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
                 ++H D+K +NI L      K+ DFGL    G         +  G   YMAPE  
Sbjct: 175 SQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGDPRYMAPEL- 227
Query: 568 MGGIFSIKSDVFSFGVLLLEI 588
           + G +   +DVFS G+ +LE+
Sbjct: 228 LQGSYGTAADVFSLGLTILEV 248

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 21/210 (10%)
Query: 399 LGQGGFGPVYKGTLADGK----AIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXX 453
           +G+G FG V++G     +    A+A+K     +   ++E F  E   + +  H ++V+  
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 454 XXXXXXXXXXXIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                      ++  M   +L ++  F   R   LD          ++  + YL      
Sbjct: 458 GVITENP----VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK--- 510
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
           + +HRD+ A N+L+  +   K+ DFGL+R +  +      +       +MAPE      F
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 573 SIKSDVFSFGVLLLEII-------SGRKNN 595
           +  SDV+ FGV + EI+        G KNN
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKPFQGVKNN 599

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 85/201 (42%), Gaps = 16/201 (7%)
Query: 399 LGQGGFGPV-YKGTLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVRXXX 454
           +G+G FG V      A  K  A+K LS+       +   F  E +++A      +V+   
Sbjct: 83  IGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 142
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                     + EYMP   L V+L  +   V   W +  +     A  +L L     + +
Sbjct: 143 AFQDDKYLYMVMEYMPGGDL-VNLM-SNYDVPEKWAKFYT-----AEVVLALDAIHSMGL 195
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY----AMGG 570
           IHRD+K  N+LLD   + K++DFG            + +   GT  Y++PE        G
Sbjct: 196 IHRDVKPDNMLLDKHGHLKLADFGTCMKM-DETGMVHCDTAVGTPDYISPEVLKSQGGDG 254
Query: 571 IFSIKSDVFSFGVLLLEIISG 591
            +  + D +S GV L E++ G
Sbjct: 255 YYGRECDWWSVGVFLFEMLVG 275

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 28/210 (13%)
Query: 399 LGQGGFGPVYKGTLAD--------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
           LGQG F  ++KG   +           + +K L +      + F    ++++KL HK+LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                         + E++   SLD +L      + + WK    +   +A  + +L E++
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL--EVAKQLAAAMHFLEENT 133
Query: 511 RLKIIHRDLKASNILL--DDDM---NP---KISDFGLARIFGGNQNQANTNIIAGTYGYM 562
              +IH ++ A NILL  ++D    NP   K+SD G++            +I+     ++
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV------LPKDILQERIPWV 184
Query: 563 APEYAMGGI-FSIKSDVFSFGVLLLEIISG 591
            PE        ++ +D +SFG  L EI SG
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 101/238 (42%), Gaps = 45/238 (18%)
Query: 398 KLGQGGFGPVYKGTLADGKAI-AVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRXXX 454
           ++G GG   V++  L + K I A+K   L     Q L  ++NE+  + KLQ  +  +   
Sbjct: 63  QIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIR 120
Query: 455 XXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                     IY  M   ++D++ +   +     W+R+ S    +   +  +H+     I
Sbjct: 121 LYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQHG---I 176
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII-----AGTYGYMAPEYAMG 569
           +H DLK +N L+ D M  K+ DFG+A     NQ Q +T  +      G   YM PE A+ 
Sbjct: 177 VHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQVGAVNYMPPE-AIK 229
Query: 570 GIFSIKS------------DVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLS 615
            + S +             DV+S G +L            Y+  +G+T    + N +S
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCIL------------YYMTYGKTPFQQIINQIS 275

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 28/210 (13%)
Query: 399 LGQGGFGPVYKGTLAD--------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
           LGQG F  ++KG   +           + +K L +      + F    ++++KL HK+LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                         + E++   SLD +L      + + WK    +   +A  + +L E++
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL--EVAKQLAWAMHFLEENT 133
Query: 511 RLKIIHRDLKASNILL--DDDM---NP---KISDFGLARIFGGNQNQANTNIIAGTYGYM 562
              +IH ++ A NILL  ++D    NP   K+SD G++            +I+     ++
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV------LPKDILQERIPWV 184
Query: 563 APEYAMGGI-FSIKSDVFSFGVLLLEIISG 591
            PE        ++ +D +SFG  L EI SG
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 82/166 (49%), Gaps = 7/166 (4%)
Query: 387 LEATNHFSDENKLGQGGFGPVYKGTLADG-KAIAVKRLSRTSGQGL--QEFKNEVNLIAK 443
           ++  +++  ++ +G+G +G VY     +  K +A+K+++R     +  +    E+ ++ +
Sbjct: 24  VKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNR 83
Query: 444 LQHKNLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRS-VQLDWKRRQSIINGIARG 502
           L+   ++R                Y+  +  D  L    ++ + L  +  ++I+  +  G
Sbjct: 84  LKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLG 143
Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
             ++HE     IIHRDLK +N LL+ D + KI DFGLAR    +++
Sbjct: 144 EKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKD 186

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 66/149 (44%), Gaps = 29/149 (19%)
Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN---- 548
           ++++  +  G+ Y+H      I+HRDLK +N L++ D + K+ DFGLAR     +N    
Sbjct: 159 KTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215
Query: 549 ------QANTNIIA---------------GTYGYMAPEYA-MGGIFSIKSDVFSFGVLLL 586
                 + + N++                 T  Y APE   +   ++   DV+S G +  
Sbjct: 216 LPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFA 275
Query: 587 EIISGRKNNGFYFSEHGQTLLTYVCNSLS 615
           E+++  K N  Y ++ G       C  LS
Sbjct: 276 ELLNMIKENVAYHADRGPLFPGSSCFPLS 304

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 89/210 (42%), Gaps = 21/210 (10%)
Query: 399 LGQGGFGPVYKGTLADGK----AIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRXX 453
           +G+G FG V++G     +    A+A+K     +   ++E F  E   + +  H ++V+  
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 454 XXXXXXXXXXXIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                      ++  M   +L ++  F   R   LD          ++  + YL      
Sbjct: 458 GVITENP----VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK--- 510
Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
           + +HRD+ A N+L+      K+ DFGL+R +  +      +       +MAPE      F
Sbjct: 511 RFVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 573 SIKSDVFSFGVLLLEII-------SGRKNN 595
           +  SDV+ FGV + EI+        G KNN
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKPFQGVKNN 599

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 37/217 (17%)
Query: 393 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVR 451
           F  ++ LG G  G +    + D + +AVKR+     +       EV L+ +  +H N++R
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL---PECFSFADREVQLLRESDEHPNVIR 82
Query: 452 XXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWK-------RRQSIINGIARGIL 504
                         ++Y+      + L  AT    ++ K          +++     G+ 
Sbjct: 83  YFCTEKDRQ-----FQYIA-----IELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLA 132
Query: 505 YLHEDSRLKIIHRDLKASNILLD-----DDMNPKISDFGLARIFG-GNQNQANTNIIAGT 558
           +LH    L I+HRDLK  NIL+        +   ISDFGL +    G  + +  + + GT
Sbjct: 133 HLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
Query: 559 YGYMAPEY-----AMGGIFSIKSDVFSFGVLLLEIIS 590
            G++APE           +++  D+FS G +   +IS
Sbjct: 190 EGWIAPEMLSEDCKENPTYTV--DIFSAGCVFYYVIS 224

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLV---- 450
           +  +G+G FG V++G    G+ +AVK  S  S +    F+  E+     L+H+N++    
Sbjct: 9   QESIGKGRFGEVWRGKWR-GEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIA 65
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED- 509
                         + +Y  + SL  +L   T +V+   K   S  +G+A    +LH + 
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA----HLHMEI 121
Query: 510 ----SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT--NIIAGTYGYMA 563
                +  I HRDLK+ NIL+  +    I+D GLA       +  +   N   GT  YMA
Sbjct: 122 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 181
Query: 564 PEYA-----MGGIFSIK-SDVFSFGVLLLEI 588
           PE       M    S K +D+++ G++  EI
Sbjct: 182 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLV---- 450
           +  +G+G FG V++G    G+ +AVK  S  S +    F+  E+     L+H+N++    
Sbjct: 8   QESIGKGRFGEVWRGKWR-GEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIA 64
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED- 509
                         + +Y  + SL  +L   T +V+   K   S  +G+A    +LH + 
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA----HLHMEI 120
Query: 510 ----SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT--NIIAGTYGYMA 563
                +  I HRDLK+ NIL+  +    I+D GLA       +  +   N   GT  YMA
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 564 PEYA-----MGGIFSIK-SDVFSFGVLLLEI 588
           PE       M    S K +D+++ G++  EI
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 399 LGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKN------EVNLIAKLQ----HK 447
           LG+GGFG V+ G  L D   +A+K + R    G     +      EV L+ K+     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 448 NLVRXXXXXXXXXXXXXIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIARGILYL 506
            ++R             + E  P  + D  LFD  T    L     +     +   I + 
Sbjct: 99  GVIRLLDWFETQEGFMLVLE-RPLPAQD--LFDYITEKGPLGEGPSRCFFGQVVAAIQHC 155
Query: 507 HEDSRLKIIHRDLKASNILLDDDMN-PKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           H  SR  ++HRD+K  NIL+D      K+ DFG   +     ++  T+   GT  Y  PE
Sbjct: 156 H--SR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTD-FDGTRVYSPPE 208
Query: 566 Y-AMGGIFSIKSDVFSFGVLLLEIISG 591
           + +     ++ + V+S G+LL +++ G
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLV---- 450
           +  +G+G FG V++G    G+ +AVK  S  S +    F+  E+     L+H+N++    
Sbjct: 14  QESIGKGRFGEVWRGKWR-GEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIA 70
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED- 509
                         + +Y  + SL  +L   T +V+   K   S  +G+A    +LH + 
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA----HLHMEI 126
Query: 510 ----SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT--NIIAGTYGYMA 563
                +  I HRDLK+ NIL+  +    I+D GLA       +  +   N   GT  YMA
Sbjct: 127 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 186
Query: 564 PEYA-----MGGIFSIK-SDVFSFGVLLLEI 588
           PE       M    S K +D+++ G++  EI
Sbjct: 187 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLV---- 450
           +  +G+G FG V++G    G+ +AVK  S  S +    F+  E+     L+H+N++    
Sbjct: 34  QESIGKGRFGEVWRGKWR-GEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIA 90
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED- 509
                         + +Y  + SL  +L   T +V+   K   S  +G+A    +LH + 
Sbjct: 91  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA----HLHMEI 146
Query: 510 ----SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT--NIIAGTYGYMA 563
                +  I HRDLK+ NIL+  +    I+D GLA       +  +   N   GT  YMA
Sbjct: 147 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 206
Query: 564 PEYA-----MGGIFSIK-SDVFSFGVLLLEI 588
           PE       M    S K +D+++ G++  EI
Sbjct: 207 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLV---- 450
           +  +G+G FG V++G    G+ +AVK  S  S +    F+  E+     L+H+N++    
Sbjct: 47  QESIGKGRFGEVWRGKWR-GEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIA 103
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED- 509
                         + +Y  + SL  +L   T +V+   K   S  +G+A    +LH + 
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA----HLHMEI 159
Query: 510 ----SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TNIIAGTYGYMA 563
                +  I HRDLK+ NIL+  +    I+D GLA       +  +   N   GT  YMA
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 564 PEYA-----MGGIFSIK-SDVFSFGVLLLEI 588
           PE       M    S K +D+++ G++  EI
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHKNLV---- 450
           +  +G+G FG V++G    G+ +AVK  S  S +    F+  E+     L+H+N++    
Sbjct: 11  QESIGKGRFGEVWRGKWR-GEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIA 67
Query: 451 RXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED- 509
                         + +Y  + SL  +L   T +V+   K   S  +G+A    +LH + 
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA----HLHMEI 123
Query: 510 ----SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT--NIIAGTYGYMA 563
                +  I HRDLK+ NIL+  +    I+D GLA       +  +   N   GT  YMA
Sbjct: 124 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 183
Query: 564 PEYA-----MGGIFSIK-SDVFSFGVLLLEI 588
           PE       M    S K +D+++ G++  EI
Sbjct: 184 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 26/99 (26%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I   +L +    +L  +HRD+K  N+LLD + + +++DFG + +   +     +++  GT
Sbjct: 181 IGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGT 239
Query: 559 YGYMAPEYAMG-----GIFSIKSDVFSFGVLLLEIISGR 592
             Y++PE         G +  + D +S GV + E++ G 
Sbjct: 240 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 278

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 67/166 (40%), Gaps = 9/166 (5%)
Query: 430 GLQEFKNEVNLIAKLQHKNLVRXXXXX--XXXXXXXXIYEYMPNKSLDVHLFDATRSVQL 487
           G    K E+ L+ +L+HKN+++               + EY      +  + D+    + 
Sbjct: 49  GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRF 106
Query: 488 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
              +       +  G+ YLH      I+H+D+K  N+LL      KIS  G+A       
Sbjct: 107 PVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163
Query: 548 NQANTNIIAGTYGYMAPEYAMG-GIFS-IKSDVFSFGVLLLEIISG 591
                    G+  +  PE A G   FS  K D++S GV L  I +G
Sbjct: 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/99 (26%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           I   +L +    +L  +HRD+K  N+LLD + + +++DFG + +   +     +++  GT
Sbjct: 197 IGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGT 255
Query: 559 YGYMAPEYAMG-----GIFSIKSDVFSFGVLLLEIISGR 592
             Y++PE         G +  + D +S GV + E++ G 
Sbjct: 256 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 294

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 78/161 (48%), Gaps = 10/161 (6%)
Query: 399 LGQGGFGPVYKGTLADG-KAIAVKRLSRTSGQGL--QEFKNEVNLIAKLQHKNLVRXXXX 455
           +G+G +G VY     +  K +A+K+++R     +  +    E+ ++ +L+   ++R    
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 456 XXXXXXXXXIYEYMPNKSLDVHLFDATRS-VQLDWKRRQSIINGIARGILYLHEDSRLKI 514
                       Y+  +  D  L    ++ + L  +  ++I+  +  G  ++HE     I
Sbjct: 94  IIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---I 150
Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 555
           IHRDLK +N LL+ D + K+ DFGLAR       + +TNI+
Sbjct: 151 IHRDLKPANCLLNQDCSVKVCDFGLARTINS---EKDTNIV 188

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 20/204 (9%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN------EVNLIAKLQH--KNL 449
           LG GGFG VY G  ++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +R             I E  P    D+  F   R   L  +  +S    +   + + H  
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHN- 128
Query: 510 SRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
               ++HRD+K  NIL+D +    K+ DFG   +    ++   T+   GT  Y  PE+  
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIR 182
Query: 569 GGIFSIKS-DVFSFGVLLLEIISG 591
              +  +S  V+S G+LL +++ G
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 20/204 (9%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN------EVNLIAKLQH--KNL 449
           LG GGFG VY G  ++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +R             I E  P    D+  F   R   L  +  +S    +   + + H  
Sbjct: 91  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCH-- 146
Query: 510 SRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
               ++HRD+K  NIL+D +    K+ DFG   +    ++   T+   GT  Y  PE+  
Sbjct: 147 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIR 201
Query: 569 GGIFSIKS-DVFSFGVLLLEIISG 591
              +  +S  V+S G+LL +++ G
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 20/204 (9%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN------EVNLIAKLQH--KNL 449
           LG GGFG VY G  ++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +R             I E  P    D+  F   R   L  +  +S    +   + + H  
Sbjct: 75  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCH-- 130
Query: 510 SRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
               ++HRD+K  NIL+D +    K+ DFG   +    ++   T+   GT  Y  PE+  
Sbjct: 131 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIR 185
Query: 569 GGIFSIKS-DVFSFGVLLLEIISG 591
              +  +S  V+S G+LL +++ G
Sbjct: 186 YHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 20/204 (9%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN------EVNLIAKLQH--KNL 449
           LG GGFG VY G  ++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +R             I E  P    D+  F   R   L  +  +S    +   + + H  
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNX 129
Query: 510 SRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
               ++HRD+K  NIL+D +    K+ DFG   +    ++   T+   GT  Y  PE+  
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIR 182
Query: 569 GGIFSIKS-DVFSFGVLLLEIISG 591
              +  +S  V+S G+LL +++ G
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 20/204 (9%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN------EVNLIAKLQH--KNL 449
           LG GGFG VY G  ++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +R             I E  P    D+  F   R   L  +  +S    +   + + H  
Sbjct: 91  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCH-- 146
Query: 510 SRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
               ++HRD+K  NIL+D +    K+ DFG   +    ++   T+   GT  Y  PE+  
Sbjct: 147 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIR 201
Query: 569 GGIFSIKS-DVFSFGVLLLEIISG 591
              +  +S  V+S G+LL +++ G
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 20/204 (9%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN------EVNLIAKLQH--KNL 449
           LG GGFG VY G  ++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +R             I E  P    D+  F   R   L  +  +S    +   + + H  
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCH-- 127
Query: 510 SRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
               ++HRD+K  NIL+D +    K+ DFG   +    ++   T+   GT  Y  PE+  
Sbjct: 128 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIR 182
Query: 569 GGIFSIKS-DVFSFGVLLLEIISG 591
              +  +S  V+S G+LL +++ G
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 20/204 (9%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN------EVNLIAKLQH--KNL 449
           LG GGFG VY G  ++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +R             I E  P    D+  F   R   L  +  +S    +   + + H  
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCH-- 147
Query: 510 SRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
               ++HRD+K  NIL+D +    K+ DFG   +    ++   T+   GT  Y  PE+  
Sbjct: 148 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIR 202
Query: 569 GGIFSIKS-DVFSFGVLLLEIISG 591
              +  +S  V+S G+LL +++ G
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 20/204 (9%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN------EVNLIAKLQH--KNL 449
           LG GGFG VY G  ++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +R             I E  P    D+  F   R   L  +  +S    +   + + H  
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCH-- 147
Query: 510 SRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
               ++HRD+K  NIL+D +    K+ DFG   +    ++   T+   GT  Y  PE+  
Sbjct: 148 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIR 202
Query: 569 GGIFSIKS-DVFSFGVLLLEIISG 591
              +  +S  V+S G+LL +++ G
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 20/204 (9%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN------EVNLIAKLQH--KNL 449
           LG GGFG VY G  ++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +R             I E  P    D+  F   R   L  +  +S    +   + + H  
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHN- 160
Query: 510 SRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
               ++HRD+K  NIL+D +    K+ DFG   +    ++   T+   GT  Y  PE+  
Sbjct: 161 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIR 214
Query: 569 GGIFSIKS-DVFSFGVLLLEIISG 591
              +  +S  V+S G+LL +++ G
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 20/204 (9%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN------EVNLIAKLQH--KNL 449
           LG GGFG VY G  ++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +R             I E  P    D+  F   R   L  +  +S    +   + + H  
Sbjct: 119 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCH-- 174
Query: 510 SRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
               ++HRD+K  NIL+D +    K+ DFG   +    ++   T+   GT  Y  PE+  
Sbjct: 175 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIR 229
Query: 569 GGIFSIKS-DVFSFGVLLLEIISG 591
              +  +S  V+S G+LL +++ G
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 20/204 (9%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN------EVNLIAKLQH--KNL 449
           LG GGFG VY G  ++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +R             I E  P    D+  F   R   L  +  +S    +   + + H  
Sbjct: 76  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCH-- 131
Query: 510 SRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
               ++HRD+K  NIL+D +    K+ DFG   +    ++   T+   GT  Y  PE+  
Sbjct: 132 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIR 186
Query: 569 GGIFSIKS-DVFSFGVLLLEIISG 591
              +  +S  V+S G+LL +++ G
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 20/204 (9%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN------EVNLIAKLQH--KNL 449
           LG GGFG VY G  ++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +R             I E  P    D+  F   R   L  +  +S    +   + + H  
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCH-- 132
Query: 510 SRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
               ++HRD+K  NIL+D +    K+ DFG   +    ++   T+   GT  Y  PE+  
Sbjct: 133 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIR 187
Query: 569 GGIFSIKS-DVFSFGVLLLEIISG 591
              +  +S  V+S G+LL +++ G
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 20/204 (9%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN------EVNLIAKLQH--KNL 449
           LG GGFG VY G  ++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +R             I E  P    D+  F   R   L  +  +S    +   + + H  
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCH-- 160
Query: 510 SRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
               ++HRD+K  NIL+D +    K+ DFG   +    ++   T+   GT  Y  PE+  
Sbjct: 161 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIR 215
Query: 569 GGIFSIKS-DVFSFGVLLLEIISG 591
              +  +S  V+S G+LL +++ G
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 20/204 (9%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN------EVNLIAKLQH--KNL 449
           LG GGFG VY G  ++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +R             I E  P    D+  F   R   L  +  +S    +   + + H  
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCH-- 132
Query: 510 SRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
               ++HRD+K  NIL+D +    K+ DFG   +    ++   T+   GT  Y  PE+  
Sbjct: 133 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIR 187
Query: 569 GGIFSIKS-DVFSFGVLLLEIISG 591
              +  +S  V+S G+LL +++ G
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 20/204 (9%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN------EVNLIAKLQH--KNL 449
           LG GGFG VY G  ++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +R             I E  P    D+  F   R   L  +  +S    +   + + H  
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCH-- 132
Query: 510 SRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
               ++HRD+K  NIL+D +    K+ DFG   +    ++   T+   GT  Y  PE+  
Sbjct: 133 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIR 187
Query: 569 GGIFSIKS-DVFSFGVLLLEIISG 591
              +  +S  V+S G+LL +++ G
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 20/204 (9%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN------EVNLIAKLQH--KNL 449
           LG GGFG VY G  ++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +R             I E  P    D+  F   R   L  +  +S    +   + + H  
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCH-- 160
Query: 510 SRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
               ++HRD+K  NIL+D +    K+ DFG   +    ++   T+   GT  Y  PE+  
Sbjct: 161 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIR 215
Query: 569 GGIFSIKS-DVFSFGVLLLEIISG 591
              +  +S  V+S G+LL +++ G
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 20/204 (9%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN------EVNLIAKLQH--KNL 449
           LG GGFG VY G  ++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +R             I E  P    D+  F   R   L  +  +S    +   + + H  
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCH-- 159
Query: 510 SRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
               ++HRD+K  NIL+D +    K+ DFG   +    ++   T+   GT  Y  PE+  
Sbjct: 160 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIR 214
Query: 569 GGIFSIKS-DVFSFGVLLLEIISG 591
              +  +S  V+S G+LL +++ G
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 20/204 (9%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN------EVNLIAKLQH--KNL 449
           LG GGFG VY G  ++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +R             I E  P    D+  F   R   L  +  +S    +   + + H  
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCH-- 147
Query: 510 SRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
               ++HRD+K  NIL+D +    K+ DFG   +    ++   T+   GT  Y  PE+  
Sbjct: 148 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIR 202
Query: 569 GGIFSIKS-DVFSFGVLLLEIISG 591
              +  +S  V+S G+LL +++ G
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 20/204 (9%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN------EVNLIAKLQH--KNL 449
           LG GGFG VY G  ++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +R             I E  P    D+  F   R   L  +  +S    +   + + H  
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCH-- 159
Query: 510 SRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
               ++HRD+K  NIL+D +    K+ DFG   +    ++   T+   GT  Y  PE+  
Sbjct: 160 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIR 214
Query: 569 GGIFSIKS-DVFSFGVLLLEIISG 591
              +  +S  V+S G+LL +++ G
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 20/204 (9%)
Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN------EVNLIAKLQH--KNL 449
           LG GGFG VY G  ++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 450 VRXXXXXXXXXXXXXIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +R             I E  P    D+  F   R   L  +  +S    +   + + H  
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCH-- 160
Query: 510 SRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
               ++HRD+K  NIL+D +    K+ DFG   +    ++   T+   GT  Y  PE+  
Sbjct: 161 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIR 215
Query: 569 GGIFSIKS-DVFSFGVLLLEIISG 591
              +  +S  V+S G+LL +++ G
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCG 239
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	621
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-126
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-123
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-113
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-87
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	9e-71
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-67
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-66
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-63
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-63
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-63
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-63
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-60
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	9e-60
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-58
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-54
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-53
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-53
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-51
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-48
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-48
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-48
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-48
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	7e-48
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-47
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-47
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-47
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-47
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-47
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-47
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-46
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-46
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-46
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-46
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-46
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-46
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-46
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-46
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-46
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-46
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-46
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-46
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-46
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-46
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	9e-46
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-46
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-45
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-45
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-45
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-45
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-45
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-45
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-45
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-45
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-45
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-45
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	8e-45
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-44
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-44
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-44
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-44
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-44
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-44
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-44
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-44
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	7e-44
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	8e-44
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-42
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-42
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-41
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-41
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-40
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-40
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-40
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-39
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-38
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-38
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-38
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	9e-38
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-37
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	8e-37
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-36
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-36
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-36
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-36
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	7e-36
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-35
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-35
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-35
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-35
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	9e-35
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	9e-35
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-34
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	9e-34
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-33
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-33
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-33
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-33
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	6e-33
3fme_A	290	Dual specificity mitogen-activated protein kinase;	7e-33
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-32
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-32
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-32
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-31
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-31
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-31
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-31
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-31
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-31
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	6e-31
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-30
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-30
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-30
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-30
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-30
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-30
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-30
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	8e-30
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-29
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-29
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-29
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-29
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-29
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-29
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-29
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-29
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-29
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	7e-29
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-28
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-28
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-28
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-28
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-28
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-28
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-28
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-28
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-28
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-27
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-27
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-27
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-27
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-27
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-27
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	8e-27
3bhy_A	283	Death-associated protein kinase 3; death associate	9e-27
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-26
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-26
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-26
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-26
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-26
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-26
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-26
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-26
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-26
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-26
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-26
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-26
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-26
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-26
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-26
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	9e-26
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-25
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-25
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-25
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-25
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	8e-25
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	9e-25
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-24
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-24
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-24
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-24
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-24
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	8e-24
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	8e-24
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-23
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-23
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-23
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-23
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-22
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-22
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-22
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-22
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-22
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-21
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-21
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-21
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-21
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-21
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-20
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-20
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-13
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-20
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-20
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-20
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-20
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	9e-20
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-19
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-19
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-18
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-18
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-18
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	8e-18
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	1e-17
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	9e-10
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-17
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	7e-17
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	8e-17
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-17
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-16
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-16
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-16
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-16
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-16
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-16
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-16
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-15
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	8e-15
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-13
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	8e-13
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-11
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-08
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-08
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	7e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-07
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	6e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	6e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	7e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	7e-06

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  373 bits (959), Expect = e-126
 Identities = 101/249 (40%), Positives = 135/249 (54%), Gaps = 17/249 (6%)

Query: 372 QAESQEFPLFPLRLALEATNHFSDE------NKLGQGGFGPVYKGTLADGKAIAVKRLS- 424
           +     F  F        TN+F +       NK+G+GGFG VYKG + +   +AVK+L+ 
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64

Query: 425 ---RTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA 481
               T+ +  Q+F  E+ ++AK QH+NLV LLG   +G +L L+Y YMPN SL   L   
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124

Query: 482 TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
             +  L W  R  I  G A GI +LHE+     IHRD+K++NILLD+    KISDFGLAR
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 181

Query: 542 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE 601
                     T+ I GT  YMAPE  + G  + KSD++SFGV+LLEII+G          
Sbjct: 182 ASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPA--VDEHR 238

Query: 602 HGQTLLTYV 610
             Q LL   
Sbjct: 239 EPQLLLDIK 247

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  367 bits (945), Expect = e-123
 Identities = 104/234 (44%), Positives = 145/234 (61%), Gaps = 5/234 (2%)

Query: 381 FPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQ-EFKNEVN 439
           F LR    A+++FS++N LG+GGFG VYKG LADG  +AVKRL     QG + +F+ EV 
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 440 LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRS-VQLDWKRRQSIING 498
           +I+   H+NL+RL G C+   E LL+Y YM N S+   L +   S   LDW +RQ I  G
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139

Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
            ARG+ YLH+    KIIHRD+KA+NILLD++    + DFGLA++         T  + GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGT 198

Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKN--NGFYFSEHGQTLLTYV 610
            G++APEY   G  S K+DVF +GV+LLE+I+G++        ++    LL +V
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  341 bits (876), Expect = e-113
 Identities = 92/216 (42%), Positives = 136/216 (62%), Gaps = 6/216 (2%)

Query: 381 FPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNL 440
            PL    EATN+F  +  +G G FG VYKG L DG  +A+KR +  S QG++EF+ E+  
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88

Query: 441 IAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGI 499
           ++  +H +LV L+G C E  E++LIY+YM N +L  HL+ +      + W++R  I  G 
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148

Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF-GGNQNQANTNIIAGT 558
           ARG+ YLH  +   IIHRD+K+ NILLD++  PKI+DFG+++     +Q   +T  + GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV-VKGT 204

Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKN 594
            GY+ PEY + G  + KSDV+SFGV+L E++  R  
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  273 bits (700), Expect = 4e-87
 Identities = 65/252 (25%), Positives = 109/252 (43%), Gaps = 22/252 (8%)

Query: 381 FPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNL 440
                    +          +G FG V+K  L   + +AVK       Q   + + EV  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71

Query: 441 IAKLQHKNLVRLLGCCLEG----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
           +  ++H+N+++ +G    G     +L LI  +    SL   L    ++  + W     I 
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127

Query: 497 NGIARGILYLHED-------SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549
             +ARG+ YLHED        +  I HRD+K+ N+LL +++   I+DFGLA  F   ++ 
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 550 ANTNIIAGTYGYMAPEYAMGGI-----FSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQ 604
            +T+   GT  YMAPE   G I       ++ D+++ G++L E+ S          E+  
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

Query: 605 TLLTYVCNSLSL 616
                +    SL
Sbjct: 248 PFEEEIGQHPSL 259

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  231 bits (590), Expect = 9e-71
 Identities = 64/234 (27%), Positives = 101/234 (43%), Gaps = 30/234 (12%)

Query: 389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
             ++      +G+G +G VYKG+L D + +AVK  S  + Q     K  +  +  ++H N
Sbjct: 11  DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYRVPLMEHDN 68

Query: 449 LVRLLGCCLEG-----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
           + R +            E LL+ EY PN SL  +L   T     DW     + + + RG+
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGL 124

Query: 504 LYLHED------SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN------QNQAN 551
            YLH +       +  I HRDL + N+L+ +D    ISDFGL+    GN      +    
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184

Query: 552 TNIIAGTYGYMAPEYAMGGI-------FSIKSDVFSFGVLLLEIISGRKNNGFY 598
                GT  YMAPE   G +          + D+++ G++  EI     +    
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  221 bits (566), Expect = 1e-67
 Identities = 68/199 (34%), Positives = 108/199 (54%), Gaps = 6/199 (3%)

Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRL--SRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
           + K+G G FG V++     G  +AVK L       + + EF  EV ++ +L+H N+V  +
Sbjct: 42  KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100

Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
           G   +   L ++ EY+   SL   L  +    QLD +RR S+   +A+G+ YLH      
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPP 159

Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 573
           I+HR+LK+ N+L+D     K+ DFGL+R+       + +   AGT  +MAPE       +
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGTPEWMAPEVLRDEPSN 217

Query: 574 IKSDVFSFGVLLLEIISGR 592
            KSDV+SFGV+L E+ + +
Sbjct: 218 EKSDVYSFGVILWELATLQ 236

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  218 bits (557), Expect = 2e-66
 Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 18/211 (8%)

Query: 396 ENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
              LG+G FG   K T    G+ + +K L R   +  + F  EV ++  L+H N+++ +G
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
              + + L  I EY+   +L   +       Q  W +R S    IA G+ YLH    + I
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLH---SMNI 129

Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI------------IAGTYGYM 562
           IHRDL + N L+ ++ N  ++DFGLAR+    + Q                 + G   +M
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189

Query: 563 APEYAMGGIFSIKSDVFSFGVLLLEIISGRK 593
           APE   G  +  K DVFSFG++L EII    
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  208 bits (532), Expect = 4e-63
 Identities = 72/209 (34%), Positives = 105/209 (50%), Gaps = 21/209 (10%)

Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRL----SRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
           E  +G GGFG VY+     G  +AVK           Q ++  + E  L A L+H N++ 
Sbjct: 12  EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
           L G CL+   L L+ E+     L           ++      +    IARG+ YLH+++ 
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPL----NRVLSGKRIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 512 LKIIHRDLKASNILLDDDMNP--------KISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
           + IIHRDLK+SNIL+   +          KI+DFGLAR +      +     AG Y +MA
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA----AGAYAWMA 182

Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           PE     +FS  SDV+S+GVLL E+++G 
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  208 bits (532), Expect = 7e-63
 Identities = 67/200 (33%), Positives = 105/200 (52%), Gaps = 9/200 (4%)

Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
             ++G G FG VYKG      A+ +  ++  + Q LQ FKNEV ++ K +H N++  +G 
Sbjct: 29  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88

Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
               Q L ++ ++    SL  HL       + + K+   I    ARG+ YLH      II
Sbjct: 89  STAPQ-LAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLH---AKSII 142

Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE---YAMGGIF 572
           HRDLK++NI L +D   KI DFGLA              ++G+  +MAPE         +
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202

Query: 573 SIKSDVFSFGVLLLEIISGR 592
           S +SDV++FG++L E+++G+
Sbjct: 203 SFQSDVYAFGIVLYELMTGQ 222

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  209 bits (533), Expect = 7e-63
 Identities = 67/204 (32%), Positives = 96/204 (47%), Gaps = 11/204 (5%)

Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
                E  +G+G FG V K      K +A+K++   S    + F  E+  ++++ H N+V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIV 64

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
           +L G CL    + L+ EY    SL   L  A            S     ++G+ YLH   
Sbjct: 65  KLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 511 RLKIIHRDLKASNILLDDDMN-PKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 569
              +IHRDLK  N+LL       KI DFG A      Q     N   G+  +MAPE   G
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACD---IQTHMTNNK--GSAAWMAPEVFEG 177

Query: 570 GIFSIKSDVFSFGVLLLEIISGRK 593
             +S K DVFS+G++L E+I+ RK
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK 201

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  200 bits (511), Expect = 4e-60
 Identities = 51/209 (24%), Positives = 85/209 (40%), Gaps = 17/209 (8%)

Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRL--SRTSGQGLQEFKNEVNLIAKLQHKN 448
              +   KL +   G ++KG    G  I VK L     S +  ++F  E   +    H N
Sbjct: 10  KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68

Query: 449 LVRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
           ++ +LG C         LI  +MP  SL   L + T  V +D  +       +ARG+ +L
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMAFL 127

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H      I    L + ++++D+DM  +IS   +   F                 ++APE 
Sbjct: 128 H-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-------MYAPAWVAPEA 179

Query: 567 AMG---GIFSIKSDVFSFGVLLLEIISGR 592
                       +D++SF VLL E+++  
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTRE 208

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  200 bits (511), Expect = 9e-60
 Identities = 63/218 (28%), Positives = 110/218 (50%), Gaps = 25/218 (11%)

Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-------LQEFKNEVNLIA 442
           N    E ++G+GGFG V+KG  + D   +A+K L     +G        QEF+ EV +++
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 443 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG 502
            L H N+V+L G         ++ E++P   L   L D  ++  + W  +  ++  IA G
Sbjct: 79  NLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134

Query: 503 ILYLHEDSRLKIIHRDLKASNILLD-----DDMNPKISDFGLARIFGGNQNQANTNIIAG 557
           I Y+  +    I+HRDL++ NI L        +  K++DFGL++        + +  + G
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSG-LLG 188

Query: 558 TYGYMAPE--YAMGGIFSIKSDVFSFGVLLLEIISGRK 593
            + +MAPE   A    ++ K+D +SF ++L  I++G  
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  198 bits (505), Expect = 1e-58
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)

Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRL--SRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
              +G+G FG VY G    G+ +A++ +   R +   L+ FK EV    + +H+N+V  +
Sbjct: 38  GELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95

Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
           G C+    L +I      ++L   + D    + LD  + + I   I +G+ YLH      
Sbjct: 96  GACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLH---AKG 150

Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN---IIAGTYGYMAPE----- 565
           I+H+DLK+ N+   D+    I+DFGL  I G  Q     +   I  G   ++APE     
Sbjct: 151 ILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209

Query: 566 ----YAMGGIFSIKSDVFSFGVLLLEIISGR 592
                     FS  SDVF+ G +  E+ +  
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHARE 240

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  186 bits (473), Expect = 3e-54
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 27/220 (12%)

Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNE--VNLIAKLQHKNLVRLL 453
              +G+G +G V++G+   G+ +AVK  S    +  + +  E  +     L+H+N++  +
Sbjct: 13  LECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFI 68

Query: 454 GCCLEGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
              +  +    +L LI  Y    SL  +L    +   LD      I+  IA G+ +LH +
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIE 124

Query: 510 -----SRLKIIHRDLKASNILLDDDMNPKISDFGLARIF--GGNQNQANTNIIAGTYGYM 562
                 +  I HRDLK+ NIL+  +    I+D GLA +     NQ     N   GT  YM
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184

Query: 563 APE------YAMGGIFSIKSDVFSFGVLLLEIISGRKNNG 596
           APE               + D+++FG++L E+     +NG
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  184 bits (469), Expect = 3e-53
 Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 27/220 (12%)

Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNE--VNLIAKLQHKNLVRLL 453
             ++G+G +G V+ G    G+ +AVK            +  E  +     ++H+N++  +
Sbjct: 42  VKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97

Query: 454 GCCLEGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
              ++G     +L LI +Y  N SL  +L    +S  LD K    +      G+ +LH +
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTE 153

Query: 510 -----SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN--TNIIAGTYGYM 562
                 +  I HRDLK+ NIL+  +    I+D GLA  F  + N+ +   N   GT  YM
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213

Query: 563 APEYAMGGI------FSIKSDVFSFGVLLLEIISGRKNNG 596
            PE     +        I +D++SFG++L E+     + G
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  178 bits (453), Expect = 7e-51
 Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 27/222 (12%)

Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNE--VNLIAKLQHKNLVRLL 453
           +  +G+G FG V++G    G+ +AVK  S    +  + +  E  +     L+H+N++  +
Sbjct: 47  QESIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFI 102

Query: 454 GCCLEGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
               +      +L L+ +Y  + SL    FD      +  +    +    A G+ +LH +
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 158

Query: 510 -----SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT--NIIAGTYGYM 562
                 +  I HRDLK+ NIL+  +    I+D GLA       +  +   N   GT  YM
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218

Query: 563 APEYAMGGI------FSIKSDVFSFGVLLLEIISGRKNNGFY 598
           APE     I         ++D+++ G++  EI       G +
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  170 bits (433), Expect = 2e-48
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 46/226 (20%)

Query: 396 ENKLGQGGFGPVYKGTLADGK------AIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
           + +LG+G FG V+     +         +AVK L   +    ++F+ E  L+  LQH+++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79

Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHL-------------FDATRSVQLDWKRRQSII 496
           V+  G C +G  L++++EYM +  L+  L                    +L   +   I 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 556
           + IA G++YL   +    +HRDL   N L+  ++  KI DFG++R           ++ +
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-----------DVYS 185

Query: 557 GTYGY------------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
             Y Y            M PE  M   F+ +SDV+SFGV+L EI +
Sbjct: 186 TDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  172 bits (439), Expect = 2e-48
 Identities = 62/197 (31%), Positives = 93/197 (47%), Gaps = 7/197 (3%)

Query: 396 ENKLGQGGFGPVYKGTL-ADGKAIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
             ++G+G FG V+ G L AD   +AVK            +F  E  ++ +  H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178

Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
           G C + Q + ++ E +        L   T   +L  K    ++   A G+ YL       
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES---KC 233

Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 573
            IHRDL A N L+ +    KISDFG++R        A+  +      + APE    G +S
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293

Query: 574 IKSDVFSFGVLLLEIIS 590
            +SDV+SFG+LL E  S
Sbjct: 294 SESDVWSFGILLWETFS 310

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  170 bits (434), Expect = 2e-48
 Identities = 66/228 (28%), Positives = 95/228 (41%), Gaps = 25/228 (10%)

Query: 396 ENKLGQGGFGPVYKGTL---ADGKAI--AVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNL 449
              LG+G FG V         DG     AVK L   +G Q    +K E++++  L H+++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 450 VRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
           ++  GCC +     L L+ EY+P  SL  +L        +   +       I  G+ YLH
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151

Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-----YM 562
                  IHRDL A N+LLD+D   KI DFGLA+                  G     + 
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWY 204

Query: 563 APEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTY 609
           APE      F   SDV+SFGV L E+++    +            +  
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ 252

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  170 bits (433), Expect = 4e-48
 Identities = 66/225 (29%), Positives = 106/225 (47%), Gaps = 45/225 (20%)

Query: 396 ENKLGQGGFGPVYKGTLADGK------AIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
           + +LG+G FG V+     +         +AVK L   S    Q+F+ E  L+  LQH+++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHL------------FDATRSVQLDWKRRQSIIN 497
           VR  G C EG+ LL+++EYM +  L+  L             +      L   +  ++ +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 498 GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG 557
            +A G++YL   + L  +HRDL   N L+   +  KI DFG++R           +I + 
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-----------DIYST 211

Query: 558 TYGY------------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
            Y Y            M PE  +   F+ +SDV+SFGV+L EI +
Sbjct: 212 DY-YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  168 bits (428), Expect = 7e-48
 Identities = 76/227 (33%), Positives = 106/227 (46%), Gaps = 47/227 (20%)

Query: 396 ENKLGQGGFGPVYKGTLADGK------AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKN 448
             +LG+  FG VYKG L          A+A+K L  +  G   +EF++E  L A+LQH N
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHL-------------FDATRSVQLDWKRRQSI 495
           +V LLG   + Q L +I+ Y  +  L   L              D T    L+      +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 496 INGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNII 555
           +  IA G+ YL   S   ++H+DL   N+L+ D +N KISD GL R            + 
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-----------EVY 179

Query: 556 AGTYGY------------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           A  Y Y            MAPE  M G FSI SD++S+GV+L E+ S
Sbjct: 180 AADY-YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  168 bits (427), Expect = 1e-47
 Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 23/228 (10%)

Query: 396 ENKLGQGGFGPVYKGTLA-----DGKAIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 449
              LG+G FG V            G+ +AVK L   + G  + + K E+ ++  L H+N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 450 VRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
           V+  G C E  G  + LI E++P+ SL  +L       +++ K++      I +G+ YL 
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLG 143

Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-----YM 562
                + +HRDL A N+L++ +   KI DFGL +    ++                  + 
Sbjct: 144 S---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT----VKDDRDSPVFWY 196

Query: 563 APEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYFSEHGQTLLTY 609
           APE  M   F I SDV+SFGV L E+++    ++            T+
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH 244

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  168 bits (428), Expect = 2e-47
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 21/207 (10%)

Query: 396 ENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
            ++LG+G FG V            G  +AVK+L  +     ++F+ E+ ++  L    +V
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87

Query: 451 RLLGCCLEGQE--LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
           +  G         L L+ EY+P+  L   L       +LD  R     + I +G+ YL  
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS 145

Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-----YMA 563
               + +HRDL A NIL++ + + KI+DFGLA++   +++      +    G     + A
Sbjct: 146 ---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYA 198

Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           PE     IFS +SDV+SFGV+L E+ +
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFT 225

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  167 bits (424), Expect = 3e-47
 Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 21/207 (10%)

Query: 396 ENKLGQGGFGPVYKGT---LADGKAI--AVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
             +LG+G FG V       L D      AVK+L  ++ + L++F+ E+ ++  LQH N+V
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74

Query: 451 RLLGCCLEGQE--LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
           +  G C       L LI EY+P  SL  +L       ++D  +     + I +G+ YL  
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT 132

Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-----YMA 563
               + IHRDL   NIL++++   KI DFGL ++   ++            G     + A
Sbjct: 133 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF----KVKEPGESPIFWYA 185

Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           PE      FS+ SDV+SFGV+L E+ +
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT 212

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  166 bits (423), Expect = 3e-47
 Identities = 65/201 (32%), Positives = 103/201 (51%), Gaps = 17/201 (8%)

Query: 396 ENKLGQGGFGPVYKGTLADGK-AIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
           ++KLG G +G VY+G        +AVK L +     ++EF  E  ++ +++H NLV+LLG
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
            C       +I E+M   +L  +L +  R  ++       +   I+  + YL    +   
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYL---EKKNF 132

Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-----YMAPEYAMG 569
           IHRDL A N L+ ++   K++DFGL+R+  G+   A+              + APE    
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG------AKFPIKWTAPESLAY 186

Query: 570 GIFSIKSDVFSFGVLLLEIIS 590
             FSIKSDV++FGVLL EI +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIAT 207

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  167 bits (425), Expect = 4e-47
 Identities = 66/220 (30%), Positives = 98/220 (44%), Gaps = 41/220 (18%)

Query: 397 NKLGQGGFGPVYKGTLADGK------AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 449
            +LGQG FG VY+G             +A+K +    S +   EF NE +++ +    ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHL-------FDATRSVQLDWKRRQSIINGIARG 502
           VRLLG   +GQ  L+I E M    L  +L        +          +   +   IA G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 503 ILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY- 561
           + YL+     K +HRDL A N ++ +D   KI DFG+ R           +I    Y Y 
Sbjct: 151 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----------DIYETDY-YR 195

Query: 562 -----------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                      M+PE    G+F+  SDV+SFGV+L EI +
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  167 bits (424), Expect = 6e-47
 Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 21/207 (10%)

Query: 396 ENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
             +LG+G FG V            G+ +AVK+L  ++ + L++F+ E+ ++  LQH N+V
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 451 RLLGCCLEGQE--LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
           +  G C       L LI EY+P  SL  +L       ++D  +     + I +G+ YL  
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT 163

Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-----YMA 563
               + IHRDL   NIL++++   KI DFGL ++   ++            G     + A
Sbjct: 164 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYA 216

Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           PE      FS+ SDV+SFGV+L E+ +
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFT 243

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  166 bits (423), Expect = 1e-46
 Identities = 64/212 (30%), Positives = 109/212 (51%), Gaps = 27/212 (12%)

Query: 396 ENKLGQGGFGPVYKGTLADGK-----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 449
              LG G FG VYKG            +A+K L   TS +  +E  +E  ++A + + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIIN---GIARGILYL 506
            RLLG CL    + LI + MP   L  ++ +   ++       Q ++N    IA+G+ YL
Sbjct: 80  CRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGS-----QYLLNWCVQIAKGMNYL 133

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI----IAGTYGYM 562
                 +++HRDL A N+L+    + KI+DFGLA++ G  + + +       I     +M
Sbjct: 134 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WM 186

Query: 563 APEYAMGGIFSIKSDVFSFGVLLLEIIS-GRK 593
           A E  +  I++ +SDV+S+GV + E+++ G K
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  165 bits (419), Expect = 1e-46
 Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 13/198 (6%)

Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
             +LG G FG V  G       +A+K + +       EF  E  ++  L H+ LV+L G 
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
           C + + + +I EYM N  L  +L       +   ++   +   +   + YL      + +
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFL 142

Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT---YGYMAPEYAMGGIF 572
           HRDL A N L++D    K+SDFGL+R    ++  ++     G+     +  PE  M   F
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV----GSKFPVRWSPPEVLMYSKF 198

Query: 573 SIKSDVFSFGVLLLEIIS 590
           S KSD+++FGVL+ EI S
Sbjct: 199 SSKSDIWAFGVLMWEIYS 216

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  165 bits (420), Expect = 2e-46
 Identities = 69/235 (29%), Positives = 102/235 (43%), Gaps = 55/235 (23%)

Query: 396 ENKLGQGGFGPVYKGTLADGK------AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKN 448
              LG+G FG V K T    K       +AVK L    S   L++  +E N++ ++ H +
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSL---------------------DVHLFDATRSVQL 487
           +++L G C +   LLLI EY    SL                     +    D      L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 488 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
                 S    I++G+ YL   + +K++HRDL A NIL+ +    KISDFGL+R      
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR------ 198

Query: 548 NQANTNIIAGTYGY------------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                ++      Y            MA E     I++ +SDV+SFGVLL EI++
Sbjct: 199 -----DVYEEDS-YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  165 bits (420), Expect = 2e-46
 Identities = 67/210 (31%), Positives = 109/210 (51%), Gaps = 22/210 (10%)

Query: 396 ENKLGQGGFGPVYKGTLADGK----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLV 450
           E  +G G  G V  G L         +A+K L +  + +  ++F +E +++ +  H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
           RL G    G+  +++ EYM N SLD  L   T   Q    +   ++ G+  G+ YL   S
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG------YMAP 564
            L  +HRDL A N+L+D ++  K+SDFGL+R+   + + A T     T G      + AP
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT-----TTGGKIPIRWTAP 223

Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIIS-GRK 593
           E      FS  SDV+SFGV++ E+++ G +
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGER 253

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  163 bits (416), Expect = 2e-46
 Identities = 61/202 (30%), Positives = 96/202 (47%), Gaps = 14/202 (6%)

Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
             +LG G FG V  G       +AVK + +       EF  E   + KL H  LV+  G 
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
           C +   + ++ EY+ N  L  +L   +    L+  +   +   +  G+ +L      + I
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFI 126

Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT---YGYMAPEYAMGGIF 572
           HRDL A N L+D D+  K+SDFG+ R    +Q  ++     GT     + APE      +
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV----GTKFPVKWSAPEVFHYFKY 182

Query: 573 SIKSDVFSFGVLLLEIIS-GRK 593
           S KSDV++FG+L+ E+ S G+ 
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKM 204

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  165 bits (420), Expect = 3e-46
 Identities = 74/288 (25%), Positives = 118/288 (40%), Gaps = 53/288 (18%)

Query: 328 LWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLAL 387
           + Y+ ++  + Q   +  +  +         N Y + I        E  EFP   L+   
Sbjct: 2   VDYKYKQKPKYQVRWKIIESYE--------GNSYTF-IDPTQLPYNEKWEFPRNNLQF-- 50

Query: 388 EATNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRL-SRTSGQGLQEFKNEVNL 440
                      LG G FG V + T            +AVK L S       +   +E+ +
Sbjct: 51  --------GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102

Query: 441 IAKL-QHKNLVRLLGCCLEGQELLLIYEYMPNKSL-----------DVHLFDATRSVQLD 488
           ++ L QH+N+V LLG C  G  +L+I EY     L           +     A  +    
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162

Query: 489 WKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQ 547
            +      + +A+G+ +L   +    IHRD+ A N+LL +    KI DFGLAR I   + 
Sbjct: 163 TRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219

Query: 548 NQANTNIIAGTYG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                N            +MAPE     +++++SDV+S+G+LL EI S
Sbjct: 220 YIVKGN------ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  163 bits (414), Expect = 4e-46
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 14/202 (6%)

Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
             ++G G FG V+ G   +   +A+K + R      ++F  E  ++ KL H  LV+L G 
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
           CLE   + L+ E+M +  L  +L   T+      +    +   +  G+ YL       +I
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVI 126

Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT---YGYMAPEYAMGGIF 572
           HRDL A N L+ ++   K+SDFG+ R    +Q  ++T    GT     + +PE      +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRY 182

Query: 573 SIKSDVFSFGVLLLEIIS-GRK 593
           S KSDV+SFGVL+ E+ S G+ 
Sbjct: 183 SSKSDVWSFGVLMWEVFSEGKI 204

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  165 bits (419), Expect = 4e-46
 Identities = 63/211 (29%), Positives = 109/211 (51%), Gaps = 23/211 (10%)

Query: 396 ENKLGQGGFGPVYKGTLADGKA-----IAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 449
           +  +G G FG VYKG L          +A+K L +  + +   +F  E  ++ +  H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +RL G   + + +++I EYM N +LD  L    +  +    +   ++ GIA G+ YL   
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYL--- 163

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG------YMA 563
           + +  +HRDL A NIL++ ++  K+SDFGL+R+   +     T     T G      + A
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT-----TSGGKIPIRWTA 218

Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIIS-GRK 593
           PE      F+  SDV+SFG+++ E+++ G +
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGER 249

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  163 bits (414), Expect = 5e-46
 Identities = 72/198 (36%), Positives = 104/198 (52%), Gaps = 13/198 (6%)

Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
             +LG G FG V+ G       +AVK L +        F  E NL+ +LQH+ LVRL   
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
             + + + +I EYM N SL   L      ++L   +   +   IA G+ ++        I
Sbjct: 77  VTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYI 131

Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT---YGYMAPEYAMGGIF 572
           HRDL+A+NIL+ D ++ KI+DFGLAR+   N+  A      G      + APE    G F
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE----GAKFPIKWTAPEAINYGTF 187

Query: 573 SIKSDVFSFGVLLLEIIS 590
           +IKSDV+SFG+LL EI++
Sbjct: 188 TIKSDVWSFGILLTEIVT 205

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  163 bits (414), Expect = 5e-46
 Identities = 67/206 (32%), Positives = 95/206 (46%), Gaps = 26/206 (12%)

Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
              +G+G FG V  G    G  +AVK +   +    Q F  E +++ +L+H NLV+LLG 
Sbjct: 26  LQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 82

Query: 456 CLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
            +E +  L ++ EYM   SL  +L    RS  L           +   + YL        
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYL---EGNNF 138

Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG------YMAPEYAM 568
           +HRDL A N+L+ +D   K+SDFGL +              +          + APE   
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTAPEALR 187

Query: 569 GGIFSIKSDVFSFGVLLLEIIS-GRK 593
              FS KSDV+SFG+LL EI S GR 
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRV 213

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  164 bits (418), Expect = 5e-46
 Identities = 68/224 (30%), Positives = 106/224 (47%), Gaps = 38/224 (16%)

Query: 396 ENKLGQGGFGPVYKGTLADGK--------AIAVKRL-SRTSGQGLQEFKNEVNLIAKL-Q 445
              LG+G FG V                  +AVK L    + + L +  +E+ ++  + +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-------------FDATRSVQLDWKRR 492
           HKN++ LLG C +   L +I EY    +L  +L              +     Q+ +K  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQAN 551
            S    +ARG+ YL   +  K IHRDL A N+L+ ++   KI+DFGLAR I   +  +  
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216

Query: 552 TNIIAGTYG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           TN      G     +MAPE     +++ +SDV+SFGVL+ EI +
Sbjct: 217 TN------GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  163 bits (415), Expect = 5e-46
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 19/206 (9%)

Query: 396 ENKLGQGGFGPVYKGTLADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLV 450
           +  +G+G FG VY G   D        A+K LSR T  Q ++ F  E  L+  L H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 451 RLLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
            L+G  L  +    ++  YM +  L   +    R+  +  K   S    +ARG+ YL   
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEYL--- 140

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-----YMAP 564
           +  K +HRDL A N +LD+    K++DFGLAR      ++   ++    +      + A 
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDI---LDREYYSVQQHRHARLPVKWTAL 197

Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIIS 590
           E      F+ KSDV+SFGVLL E+++
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  168 bits (428), Expect = 6e-46
 Identities = 64/196 (32%), Positives = 104/196 (53%), Gaps = 7/196 (3%)

Query: 396 ENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
           ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NLV+LLG
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
            C       +I E+M   +L  +L +  R  ++       +   I+  + YL    +   
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYL---EKKNF 339

Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           IHR+L A N L+ ++   K++DFGL+R+  G+   A+         + APE      FSI
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSI 398

Query: 575 KSDVFSFGVLLLEIIS 590
           KSDV++FGVLL EI +
Sbjct: 399 KSDVWAFGVLLWEIAT 414

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  167 bits (426), Expect = 6e-46
 Identities = 65/202 (32%), Positives = 93/202 (46%), Gaps = 25/202 (12%)

Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
              +G+G FG V  G    G  +AVK +   +    Q F  E +++ +L+H NLV+LLG 
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 254

Query: 456 CLEGQELL-LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
            +E +  L ++ EYM   SL  +L    RS  L           +   + YL        
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYL---EGNNF 310

Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG------YMAPEYAM 568
           +HRDL A N+L+ +D   K+SDFGL +              +          + APE   
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTAPEALR 359

Query: 569 GGIFSIKSDVFSFGVLLLEIIS 590
              FS KSDV+SFG+LL EI S
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYS 381

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  163 bits (416), Expect = 9e-46
 Identities = 70/259 (27%), Positives = 115/259 (44%), Gaps = 48/259 (18%)

Query: 357 IRNHYAYNILRGGKQQAESQEFPLFPL-RLALEATNHFSDENKLGQGGFGPVYKGTLADG 415
           ++ H+       GK   +   +P+     +  +        + +G+G FG V K  +   
Sbjct: 1   MKKHH---HHHHGKNNPDPTIYPVLDWNDIKFQ--------DVIGEGNFGQVLKARIKKD 49

Query: 416 KA---IAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMP 470
                 A+KR+    S    ++F  E+ ++ KL  H N++ LLG C     L L  EY P
Sbjct: 50  GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 109

Query: 471 NKSLDVHL-------------FDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR 517
           + +L   L                + +  L  ++       +ARG+ YL   S+ + IHR
Sbjct: 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHR 166

Query: 518 DLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI-IAGTYG-----YMAPEYAMGGI 571
           DL A NIL+ ++   KI+DFGL+R            + +  T G     +MA E     +
Sbjct: 167 DLAARNILVGENYVAKIADFGLSR---------GQEVYVKKTMGRLPVRWMAIESLNYSV 217

Query: 572 FSIKSDVFSFGVLLLEIIS 590
           ++  SDV+S+GVLL EI+S
Sbjct: 218 YTTNSDVWSYGVLLWEIVS 236

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  165 bits (419), Expect = 9e-46
 Identities = 78/302 (25%), Positives = 112/302 (37%), Gaps = 59/302 (19%)

Query: 326 SFLWYRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRL 385
           S+  +           +        L+++G + +       +  K +  +      P   
Sbjct: 2   SYYHHHHHHDYDIPTTEN-------LYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYC 54

Query: 386 ALEATNHFSDE-----------NKLGQGGFGPVYKGTLADGK------AIAVKRL-SRTS 427
               T+  SD              LG G FG VY+G ++          +AVK L    S
Sbjct: 55  FAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS 114

Query: 428 GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL----FDATR 483
            Q   +F  E  +I+K  H+N+VR +G  L+     ++ E M    L   L       ++
Sbjct: 115 EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQ 174

Query: 484 SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD---DDMNPKISDFGLA 540
              L       +   IA G  YL        IHRD+ A N LL         KI DFG+A
Sbjct: 175 PSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231

Query: 541 RIFGGNQNQANTNIIAGTYGY------------MAPEYAMGGIFSIKSDVFSFGVLLLEI 588
           R           +I    Y Y            M PE  M GIF+ K+D +SFGVLL EI
Sbjct: 232 R-----------DIYRAGY-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 279

Query: 589 IS 590
            S
Sbjct: 280 FS 281

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  164 bits (418), Expect = 1e-45
 Identities = 68/224 (30%), Positives = 106/224 (47%), Gaps = 38/224 (16%)

Query: 396 ENKLGQGGFGPVYKGTLADGK--------AIAVKRL-SRTSGQGLQEFKNEVNLIAKL-Q 445
              LG+G FG V                  +AVK L    + + L +  +E+ ++  + +
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-------------FDATRSVQLDWKRR 492
           HKN++ LLG C +   L +I EY    +L  +L              +     Q+ +K  
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQAN 551
            S    +ARG+ YL   +  K IHRDL A N+L+ ++   KI+DFGLAR I   +  +  
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262

Query: 552 TNIIAGTYG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           TN      G     +MAPE     +++ +SDV+SFGVL+ EI +
Sbjct: 263 TN------GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  166 bits (422), Expect = 2e-45
 Identities = 68/198 (34%), Positives = 102/198 (51%), Gaps = 13/198 (6%)

Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
           E KLG G FG V+  T      +AVK + +     ++ F  E N++  LQH  LV+L   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
             + + + +I E+M   SL   L     S +    +       IA G+ ++    +   I
Sbjct: 252 VTK-EPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFI---EQRNYI 306

Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT---YGYMAPEYAMGGIF 572
           HRDL+A+NIL+   +  KI+DFGLAR+   N+  A      G      + APE    G F
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAINFGSF 362

Query: 573 SIKSDVFSFGVLLLEIIS 590
           +IKSDV+SFG+LL+EI++
Sbjct: 363 TIKSDVWSFGILLMEIVT 380

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  162 bits (412), Expect = 2e-45
 Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 41/221 (18%)

Query: 396 ENKLGQGGFGPVYKGTLADGK----AIAVKRLSR--TSGQGLQEFKNEVNLIAKLQHKNL 449
              LG+G FG V +G L         +AVK +    +S + ++EF +E   +    H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 450 VRLLGCCLEGQ-----ELLLIYEYMPNKSLDVHL---FDATRSVQLDWKRRQSIINGIAR 501
           +RLLG C+E       + ++I  +M    L  +L      T    +  +     +  IA 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ YL   S    +HRDL A N +L DDM   ++DFGL++            I +G Y Y
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK-----------KIYSGDY-Y 203

Query: 562 ------------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                       +A E     +++ KSDV++FGV + EI +
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  161 bits (410), Expect = 3e-45
 Identities = 67/213 (31%), Positives = 91/213 (42%), Gaps = 27/213 (12%)

Query: 396 ENKLGQGGFGPVYKGTL--ADGKAI--AVKRL---SRTSGQGLQEFKNEVNLIAKLQHKN 448
             KLG G FG V +G      GK +  AVK L     +  + + +F  EVN +  L H+N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ----LDWKRRQSIINGIARGIL 504
           L+RL G  L    + ++ E  P  SL   L              +         +A G+ 
Sbjct: 83  LIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV------QVAEGMG 135

Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT---YGY 561
           YL E  R   IHRDL A N+LL      KI DFGL R    N +             + +
Sbjct: 136 YL-ESKRF--IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ--EHRKVPFAW 190

Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRK 593
            APE      FS  SD + FGV L E+ + G++
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  162 bits (411), Expect = 3e-45
 Identities = 64/224 (28%), Positives = 91/224 (40%), Gaps = 38/224 (16%)

Query: 396 ENKLGQGGFGPVYKGTLADGKA------IAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHK 447
              LG G FG V + T            +AVK L         +   +E+ +++ L  H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSL---------------DVHLFDATRSVQLDWKRR 492
           N+V LLG C  G   L+I EY     L                         + LD +  
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQAN 551
            S    +A+G+ +L   +    IHRDL A NILL      KI DFGLAR I   +     
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204

Query: 552 TNIIAGTYG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
            N            +MAPE     +++ +SDV+S+G+ L E+ S
Sbjct: 205 GN------ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  162 bits (413), Expect = 3e-45
 Identities = 65/235 (27%), Positives = 100/235 (42%), Gaps = 55/235 (23%)

Query: 396 ENKLGQGGFGPVYKGTLADGK------AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKN 448
              +G+G FG V++              +AVK L    S     +F+ E  L+A+  + N
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHL---------------------FDATRSVQL 487
           +V+LLG C  G+ + L++EYM    L+  L                       +     L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 488 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
               +  I   +A G+ YL   S  K +HRDL   N L+ ++M  KI+DFGL+R      
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR------ 222

Query: 548 NQANTNIIAGTYGY------------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                NI +  Y Y            M PE      ++ +SDV+++GV+L EI S
Sbjct: 223 -----NIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  163 bits (415), Expect = 3e-45
 Identities = 66/210 (31%), Positives = 108/210 (51%), Gaps = 22/210 (10%)

Query: 396 ENKLGQGGFGPVYKGTL--ADGKAI--AVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLV 450
           +  +G G FG V  G L     K I  A+K L    + +  ++F  E +++ +  H N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
           RL G   + + ++++ EYM N SLD  L       Q    +   ++ GIA G+ YL   S
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---S 164

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG------YMAP 564
            +  +HRDL A NIL++ ++  K+SDFGL R+   +   A T     T G      + +P
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT-----TRGGKIPIRWTSP 219

Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIIS-GRK 593
           E      F+  SDV+S+G++L E++S G +
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  162 bits (412), Expect = 3e-45
 Identities = 70/221 (31%), Positives = 93/221 (42%), Gaps = 41/221 (18%)

Query: 396 ENKLGQGGFGPVYKGTLADGK------AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKN 448
              LG G FG VY+G ++          +AVK L    S Q   +F  E  +I+K  H+N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHL----FDATRSVQLDWKRRQSIINGIARGIL 504
           +VR +G  L+     ++ E M    L   L       ++   L       +   IA G  
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 505 YLHEDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           YL        IHRD+ A N LL         KI DFG+AR           +I   +Y Y
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----------DIYRASY-Y 199

Query: 562 ------------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                       M PE  M GIF+ K+D +SFGVLL EI S
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  164 bits (416), Expect = 3e-45
 Identities = 73/225 (32%), Positives = 107/225 (47%), Gaps = 40/225 (17%)

Query: 396 ENKLGQGGFGPVYKGTLADGK--------AIAVKRL-SRTSGQGLQEFKNEVNLIAKL-Q 445
              LG+G FG V                  +AVK L S  + + L +  +E+ ++  + +
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING------- 498
           HKN++ LLG C +   L +I EY    +L  +L  A R   L++    S           
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNPEEQLSSKD 192

Query: 499 -------IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGNQNQA 550
                  +ARG+ YL   +  K IHRDL A N+L+ +D   KI+DFGLAR I   +  + 
Sbjct: 193 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249

Query: 551 NTNIIAGTYG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
            TN      G     +MAPE     I++ +SDV+SFGVLL EI +
Sbjct: 250 TTN------GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  162 bits (412), Expect = 3e-45
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 21/209 (10%)

Query: 396 ENKLGQGGFGPVYKGTLADGK-----AIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNL 449
              LG G FG V+KG            + +K +   SG Q  Q   + +  I  L H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           VRLLG C     L L+ +Y+P  SL  H+        L  +   +    IA+G+ YL   
Sbjct: 78  VRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYL--- 131

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI----IAGTYGYMAPE 565
               ++HR+L A N+LL      +++DFG+A +   +  Q   +     I     +MA E
Sbjct: 132 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK----WMALE 187

Query: 566 YAMGGIFSIKSDVFSFGVLLLEIIS-GRK 593
               G ++ +SDV+S+GV + E+++ G +
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAE 216

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  160 bits (408), Expect = 8e-45
 Identities = 65/228 (28%), Positives = 95/228 (41%), Gaps = 49/228 (21%)

Query: 397 NKLGQGGFGPVYKGTLAD------GKAIAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHKN 448
             LG+G FG V +            + +AVK L    +    +   +E+ ++  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 449 LVRLLGCCL-EGQELLLIYEYMPNKSL-------------DVHLFDATRSVQLDWKRRQS 494
           +V LLG C   G  L++I E+    +L                  +      L  +    
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 495 IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
               +A+G+ +L   +  K IHRDL A NILL +    KI DFGLAR           +I
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----------DI 198

Query: 555 IAGTYGY------------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                 Y            MAPE     +++I+SDV+SFGVLL EI S
Sbjct: 199 YKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  160 bits (408), Expect = 1e-44
 Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 42/222 (18%)

Query: 396 ENKLGQGGFGPVYKGTLADGK----AIAVKRL--SRTSGQGLQEFKNEVNLIAKLQHKNL 449
              LG+G FG V +  L         +AVK L     +   ++EF  E   + +  H ++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 450 VRLLGCCLEGQ------ELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRRQSIINGIA 500
            +L+G  L  +        ++I  +M +  L   L           L  +     +  IA
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 560
            G+ YL   S    IHRDL A N +L +DM   ++DFGL+R            I +G Y 
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR-----------KIYSGDY- 192

Query: 561 Y------------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
           Y            +A E     ++++ SDV++FGV + EI++
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  159 bits (405), Expect = 1e-44
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 20/208 (9%)

Query: 396 ENKLGQGGFGPVYKGTL-ADGKAI--AVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
           + +LG G FG V +G      K I  A+K L   T     +E   E  ++ +L +  +VR
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
           L+G C   + L+L+ E      L   L    +  ++       +++ ++ G+ YL     
Sbjct: 75  LIGVCQA-EALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EE 128

Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-----YMAPEY 566
              +HRDL A N+LL +    KISDFGL++  G + +       A + G     + APE 
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY----YTARSAGKWPLKWYAPEC 184

Query: 567 AMGGIFSIKSDVFSFGVLLLEIIS-GRK 593
                FS +SDV+S+GV + E +S G+K
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQK 212

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  160 bits (407), Expect = 1e-44
 Identities = 62/209 (29%), Positives = 106/209 (50%), Gaps = 21/209 (10%)

Query: 396 ENKLGQGGFGPVYKGTLADGK-----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNL 449
              LG G FG VYKG            +A+K L   TS +  +E  +E  ++A + + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
            RLLG CL    + LI + MP   L  ++ +      +  +   +    IA+G+ YL   
Sbjct: 80  CRLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL--- 133

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI----IAGTYGYMAPE 565
              +++HRDL A N+L+    + KI+DFGLA++ G  + + +       I     +MA E
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALE 189

Query: 566 YAMGGIFSIKSDVFSFGVLLLEIIS-GRK 593
             +  I++ +SDV+S+GV + E+++ G K
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  159 bits (404), Expect = 2e-44
 Identities = 67/215 (31%), Positives = 97/215 (45%), Gaps = 37/215 (17%)

Query: 396 ENKLGQGGFGPVYKGTLADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLV 450
              +G+G FG VY GTL D        AVK L+R T    + +F  E  ++    H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 451 RLLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
            LLG CL  +   L++  YM +  L   +     +     K        +A+G+ YL   
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYLAS- 146

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY-------- 561
              K +HRDL A N +LD+    K++DFGLAR           ++    Y Y        
Sbjct: 147 --KKFVHRDLAARNCMLDEKFTVKVADFGLAR-----------DMYDKEY-YSVHNKTGA 192

Query: 562 ------MAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                 MA E      F+ KSDV+SFGVLL E+++
Sbjct: 193 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  158 bits (403), Expect = 3e-44
 Identities = 53/221 (23%), Positives = 91/221 (41%), Gaps = 39/221 (17%)

Query: 396 ENKLGQGGFGPVYKGTL--------ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK 447
              LGQG F  ++KG               + +K L +      + F    ++++KL HK
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
           +LV   G C+ G E +L+ E++   SLD +L      + + WK    +   +A  + +L 
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAAMHFL- 129

Query: 508 EDSRLKIIHRDLKASNILLDDDMNP--------KISDFGLARIFGGNQNQANTNIIAGTY 559
                 +IH ++ A NILL  + +         K+SD G++             ++    
Sbjct: 130 --EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-----------VLPKDI 176

Query: 560 GY-----MAPE-YAMGGIFSIKSDVFSFGVLLLEIIS-GRK 593
                  + PE        ++ +D +SFG  L EI S G K
Sbjct: 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  158 bits (402), Expect = 3e-44
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 23/209 (11%)

Query: 396 ENKLGQGGFGPVYKGTLADGK----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLV 450
              +G+G FG V++G     +    A+A+K   + TS    ++F  E   + +  H ++V
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
           +L+G   E   + +I E      L   L    R   LD          ++  + YL    
Sbjct: 80  KLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYL---E 133

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-----YMAPE 565
             + +HRD+ A N+L+  +   K+ DFGL+R         ++     + G     +MAPE
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM------EDSTYYKASKGKLPIKWMAPE 187

Query: 566 YAMGGIFSIKSDVFSFGVLLLEIIS-GRK 593
                 F+  SDV+ FGV + EI+  G K
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVK 216

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  160 bits (407), Expect = 4e-44
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 19/206 (9%)

Query: 396 ENKLGQGGFGPVYKGTLADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLV 450
              +G+G FG VY GTL D        AVK L+R T    + +F  E  ++    H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 451 RLLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
            LLG CL  +   L++  YM +  L   + +   +     K        +A+G+ +L   
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFL--- 208

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-----YMAP 564
           +  K +HRDL A N +LD+    K++DFGLAR      ++   ++   T       +MA 
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEFDSVHNKTGAKLPVKWMAL 265

Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIIS 590
           E      F+ KSDV+SFGVLL E+++
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMT 291

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  159 bits (405), Expect = 4e-44
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 43/229 (18%)

Query: 396 ENKLGQGGFGPVYKGTLADGKA------IAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHK 447
              LG G FG V   T            +AVK L  +      +   +E+ ++ +L  H+
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSL------------DVHLFDATRSVQLDWKRRQSI 495
           N+V LLG C     + LI+EY     L            +  +    +    + +    +
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 496 ING--------IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR-IFGGN 546
                      +A+G+ +L        +HRDL A N+L+      KI DFGLAR I   +
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226

Query: 547 QNQANTNIIAGTYG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                 N            +MAPE    GI++IKSDV+S+G+LL EI S
Sbjct: 227 NYVVRGN------ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  157 bits (399), Expect = 7e-44
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 23/209 (11%)

Query: 396 ENKLGQGGFGPVYKGTLADGKA----IAVKRLSR-TSGQGLQEFKNEVNLIAKLQHKNLV 450
              LG+G FG VY+G   + K     +AVK   +  +    ++F +E  ++  L H ++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
           +L+G   E +   +I E  P   L  +L     S+++           I + + YL    
Sbjct: 77  KLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYL---E 130

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-----YMAPE 565
            +  +HRD+   NIL+      K+ DFGL+R         + +    +       +M+PE
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYI------EDEDYYKASVTRLPIKWMSPE 184

Query: 566 YAMGGIFSIKSDVFSFGVLLLEIIS-GRK 593
                 F+  SDV+ F V + EI+S G++
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQ 213

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  157 bits (399), Expect = 8e-44
 Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 22/209 (10%)

Query: 396 ENKLGQGGFGPVYKGTLADGKA---IAVKRL--SRTSGQGLQEFKNEVNLIAKLQHKNLV 450
           + +LG G FG V KG     K    +AVK L           E   E N++ +L +  +V
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
           R++G C   +  +L+ E      L+ +L    ++  +  K    +++ ++ G+ YL    
Sbjct: 82  RMIGICE-AESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---E 134

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-----YMAPE 565
               +HRDL A N+LL      KISDFGL++    ++N       A T+G     + APE
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK----AQTHGKWPVKWYAPE 190

Query: 566 YAMGGIFSIKSDVFSFGVLLLEIIS-GRK 593
                 FS KSDV+SFGVL+ E  S G+K
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  157 bits (399), Expect = 3e-42
 Identities = 70/195 (35%), Positives = 107/195 (54%), Gaps = 7/195 (3%)

Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
           E KLGQG FG V+ GT      +A+K L +      + F  E  ++ KL+H+ LV+L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
             E + + ++ EYM   SL   L   T    L   +   +   IA G+ Y+    R+  +
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYV---ERMNYV 302

Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRDL+A+NIL+ +++  K++DFGLAR+   N+  A          + APE A+ G F+IK
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 361

Query: 576 SDVFSFGVLLLEIIS 590
           SDV+SFG+LL E+ +
Sbjct: 362 SDVWSFGILLTELTT 376

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  159 bits (403), Expect = 3e-42
 Identities = 70/195 (35%), Positives = 107/195 (54%), Gaps = 7/195 (3%)

Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
           E KLGQG FG V+ GT      +A+K L   +    + F  E  ++ KL+H+ LV+L   
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII 515
             E + + ++ EYM   SL   L   T    L   +   +   IA G+ Y+    R+  +
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYV---ERMNYV 385

Query: 516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIK 575
           HRDL+A+NIL+ +++  K++DFGLAR+   N+  A          + APE A+ G F+IK
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 444

Query: 576 SDVFSFGVLLLEIIS 590
           SDV+SFG+LL E+ +
Sbjct: 445 SDVWSFGILLTELTT 459

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  158 bits (400), Expect = 2e-41
 Identities = 63/220 (28%), Positives = 105/220 (47%), Gaps = 20/220 (9%)

Query: 384 RLALEATNHFSDENKLGQGGFGPVYKGTLADGKA---IAVKRL-SRTSGQGLQEFKNEVN 439
           +L L+  N    + +LG G FG V +G     K    +A+K L   T     +E   E  
Sbjct: 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 388

Query: 440 LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 499
           ++ +L +  +VRL+G C   + L+L+ E      L   L    +  ++       +++ +
Sbjct: 389 IMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQV 445

Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTY 559
           + G+ YL        +HR+L A N+LL +    KISDFGL++  G + +       A + 
Sbjct: 446 SMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY----YTARSA 498

Query: 560 G-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRK 593
           G     + APE      FS +SDV+S+GV + E +S G+K
Sbjct: 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  157 bits (398), Expect = 6e-41
 Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 22/205 (10%)

Query: 396 ENKLGQGGFGPVYKGTLADGK----AIAVKRL-SRTSGQGLQEFKNEVNLIAKLQHKNLV 450
              +G+G FG V++G     +    A+A+K   + TS    ++F  E   + +  H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
           +L+G   E   + +I E      L   L    R   LD          ++  + YL    
Sbjct: 455 KLIGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---E 508

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG-----YMAPE 565
             + +HRD+ A N+L+  +   K+ DFGL+R         ++     + G     +MAPE
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM------EDSTYYKASKGKLPIKWMAPE 562

Query: 566 YAMGGIFSIKSDVFSFGVLLLEIIS 590
                 F+  SDV+ FGV + EI+ 
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILM 587

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  148 bits (376), Expect = 1e-40
 Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 28/220 (12%)

Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
             F +   +G GGFG V+K     DGK   +KR+   +    ++ + EV  +AKL H N+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66

Query: 450 VRLLGC----------------CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ 493
           V   GC                  + + L +  E+    +L+    +  R  +LD     
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLE-QWIEKRRGEKLDKVLAL 125

Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
            +   I +G+ Y+H     K+I+RDLK SNI L D    KI DFGL      N  +   +
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-KNDGKRTRS 181

Query: 554 IIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRK 593
              GT  YM+PE      +  + D+++ G++L E++    
Sbjct: 182 K--GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  150 bits (381), Expect = 1e-40
 Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 9/198 (4%)

Query: 398 KLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
           K+G+G FG         DG+   +K   +SR S +  +E + EV ++A ++H N+V+   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
              E   L ++ +Y     L     +A + V     +       I   + ++H+    KI
Sbjct: 91  SFEENGSLYIVMDYCEGGDLF-KRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KI 146

Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           +HRD+K+ NI L  D   ++ DFG+AR+       A      GT  Y++PE      ++ 
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEICENKPYNN 204

Query: 575 KSDVFSFGVLLLEIISGR 592
           KSD+++ G +L E+ + +
Sbjct: 205 KSDIWALGCVLYELCTLK 222

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  148 bits (376), Expect = 1e-40
 Identities = 58/223 (26%), Positives = 90/223 (40%), Gaps = 27/223 (12%)

Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKN 448
             F     LG+GGFG V++     D    A+KR+         ++   EV  +AKL+H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 449 LVRLLGCCLEGQE------------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSII 496
           +VR     LE               L +  +    ++L   +       + +      I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 556
             IA  + +LH      ++HRDLK SNI    D   K+ DFGL      ++ +       
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 557 ----------GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEII 589
                     GT  YM+PE   G  +S K D+FS G++L E++
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  145 bits (368), Expect = 3e-39
 Identities = 50/207 (24%), Positives = 97/207 (46%), Gaps = 10/207 (4%)

Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRL---SRTSGQGLQEFKNEVNLIAKLQH 446
            +F  E K+G+G F  VY+   L DG  +A+K++        +   +   E++L+ +L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRS-VQLDWKRRQSIINGIARGILY 505
            N+++     +E  EL ++ E      L   +    +    +  +        +   + +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           +H     +++HRD+K +N+ +      K+ D GL R F      A++ +  GT  YM+PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPE 206

Query: 566 YAMGGIFSIKSDVFSFGVLLLEIISGR 592
                 ++ KSD++S G LL E+ + +
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQ 233

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  142 bits (359), Expect = 4e-38
 Identities = 68/248 (27%), Positives = 102/248 (41%), Gaps = 45/248 (18%)

Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
            + F +   LGQG FG V K     D +  A+K++  T  + L    +EV L+A L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63

Query: 449 LVRLLGCCLE-------------GQELLLIYEYMPNKSLDVHLFD--ATRSVQLDWKRRQ 493
           +VR     LE                L +  EY  N +L    +D   + ++        
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYW 119

Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF---------- 543
            +   I   + Y+H      IIHRDLK  NI +D+  N KI DFGLA+            
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 544 ----GGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFY 598
                G+ +   + I  GT  Y+A E   G G ++ K D++S G++  E+I         
Sbjct: 177 SQNLPGSSDNLTSAI--GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPF----ST 230

Query: 599 FSEHGQTL 606
             E    L
Sbjct: 231 GMERVNIL 238

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  141 bits (357), Expect = 5e-38
 Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 10/203 (4%)

Query: 398 KLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
            +G G +G   K    +DGK +  K       +    Q   +EVNL+ +L+H N+VR   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 455 CCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGILYLHE--D 509
             ++     L ++ EY     L   +   T+  Q LD +    ++  +   +   H   D
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 569
               ++HRDLK +N+ LD   N K+ DFGLARI   + + A T +  GT  YM+PE    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV--GTPYYMSPEQMNR 190

Query: 570 GIFSIKSDVFSFGVLLLEIISGR 592
             ++ KSD++S G LL E+ +  
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALM 213

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  140 bits (356), Expect = 9e-38
 Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 9/198 (4%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL 457
           LG+G +G VY G  L++   IA+K +     +  Q    E+ L   L+HKN+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 458 EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHR 517
           E   + +  E +P  SL   L      ++ + +        I  G+ YLH++   +I+HR
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 146

Query: 518 DLKASNILLDDDM-NPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI--FSI 574
           D+K  N+L++      KISDFG ++   G      T    GT  YMAPE    G   +  
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGYGK 204

Query: 575 KSDVFSFGVLLLEIISGR 592
            +D++S G  ++E+ +G+
Sbjct: 205 AADIWSLGCTIIEMATGK 222

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  140 bits (355), Expect = 9e-38
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 17/203 (8%)

Query: 398 KLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
           ++G+G F  VYKG        +A    +  + +    Q FK E  ++  LQH N+VR   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 455 CCLEGQE----LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                 +    ++L+ E M + +L  +L    R   +  K  +S    I +G+ +LH  +
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 149

Query: 511 RLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 569
              IIHRDLK  NI +     + KI D GLA +     + A   I  GT  +MAPE    
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVI--GTPEFMAPEMYEE 204

Query: 570 GIFSIKSDVFSFGVLLLEIISGR 592
             +    DV++FG+ +LE+ +  
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSE 226

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  139 bits (352), Expect = 6e-37
 Identities = 53/211 (25%), Positives = 87/211 (41%), Gaps = 23/211 (10%)

Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNL--VRL 452
            ++G GG   V++      +  A+K   L     Q L  ++NE+  + KLQ  +   +RL
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
               +  Q + ++ E   N  L+  L        +D   R+S    +   +  +H+    
Sbjct: 94  YDYEITDQYIYMVMECG-NIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ---H 146

Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE------- 565
            I+H DLK +N L+ D    K+ DFG+A     +      +   GT  YM PE       
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205

Query: 566 ----YAMGGIFSIKSDVFSFGVLLLEIISGR 592
                      S KSDV+S G +L  +  G+
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  138 bits (349), Expect = 8e-37
 Identities = 56/200 (28%), Positives = 105/200 (52%), Gaps = 10/200 (5%)

Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
           ++   K+GQG  G VY    +A G+ +A+++++       +   NE+ ++ + ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
            L   L G EL ++ EY+   SL     D      +D  +  ++     + + +LH +  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135

Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 571
            ++IHRD+K+ NILL  D + K++DFG        Q++ +T  + GT  +MAPE      
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 192

Query: 572 FSIKSDVFSFGVLLLEIISG 591
           +  K D++S G++ +E+I G
Sbjct: 193 YGPKVDIWSLGIMAIEMIEG 212

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  138 bits (349), Expect = 1e-36
 Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 19/217 (8%)

Query: 392 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
           H+    KLG+GGF  V     L DG   A+KR+     Q  +E + E ++     H N++
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 451 RLLGCCLE----GQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILY 505
           RL+  CL       E  L+  +    +L   +     +   L   +   ++ GI RG+  
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149

Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA-------GT 558
           +H        HRDLK +NILL D+  P + D G       +   +   +          T
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 559 YGYMAPE---YAMGGIFSIKSDVFSFGVLLLEIISGR 592
             Y APE        +   ++DV+S G +L  ++ G 
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  138 bits (349), Expect = 2e-36
 Identities = 54/200 (27%), Positives = 101/200 (50%), Gaps = 10/200 (5%)

Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
                K+G+G  G V        G+ +AVK +     Q  +   NEV ++   QH N+V 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
           +    L G+EL ++ E++   +L     D    V+L+ ++  ++   + + + YLH    
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQ-- 160

Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 571
             +IHRD+K+ +ILL  D   K+SDFG       +  +  +  + GT  +MAPE     +
Sbjct: 161 -GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSL 217

Query: 572 FSIKSDVFSFGVLLLEIISG 591
           ++ + D++S G++++E++ G
Sbjct: 218 YATEVDIWSLGIMVIEMVDG 237

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  137 bits (348), Expect = 2e-36
 Identities = 60/268 (22%), Positives = 92/268 (34%), Gaps = 20/268 (7%)

Query: 330 YRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLALEA 389
           +    H+   +    +    +     +++           +        P  P     + 
Sbjct: 2   HHHHHHSSGVDLGTENL---YFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQ- 57

Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKL-Q 445
              F   ++LG G +G V+K     DG+  AVK         +       EV    K+ Q
Sbjct: 58  --SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115

Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           H   VRL     EG  L L  E     SL  H         L   +    +      + +
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAH 172

Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           LH      ++H D+K +NI L      K+ DFGL     G           G   YMAPE
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEVQE--GDPRYMAPE 226

Query: 566 YAMGGIFSIKSDVFSFGVLLLEIISGRK 593
              G  +   +DVFS G+ +LE+    +
Sbjct: 227 LLQGS-YGTAADVFSLGLTILEVACNME 253

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  137 bits (347), Expect = 4e-36
 Identities = 53/211 (25%), Positives = 87/211 (41%), Gaps = 23/211 (10%)

Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNL--VRL 452
            ++G GG   V++      +  A+K   L     Q L  ++NE+  + KLQ  +   +RL
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
               +  Q + ++ E   N  L+  L        +D   R+S    +   +  +H+    
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ---H 127

Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE------- 565
            I+H DLK +N L+ D    K+ DFG+A     +      +   GT  YM PE       
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186

Query: 566 ----YAMGGIFSIKSDVFSFGVLLLEIISGR 592
                      S KSDV+S G +L  +  G+
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  138 bits (348), Expect = 7e-36
 Identities = 52/211 (24%), Positives = 86/211 (40%), Gaps = 23/211 (10%)

Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKLQHKNL--VRL 452
            ++G GG   V++      +  A+K   L     Q L  ++NE+  + KLQ  +   +RL
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
               +  Q + ++ E   N  L+  L        +D   R+S    +   +  +H+    
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ---H 174

Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE------- 565
            I+H DLK +N L+ D    K+ DFG+A     +      +   G   YM PE       
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233

Query: 566 ----YAMGGIFSIKSDVFSFGVLLLEIISGR 592
                      S KSDV+S G +L  +  G+
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  135 bits (342), Expect = 1e-35
 Identities = 59/202 (29%), Positives = 105/202 (51%), Gaps = 11/202 (5%)

Query: 392 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-LQEFKNEVNLIAKLQHKNL 449
            F+   K+G+G FG V+KG      K +A+K +     +  +++ + E+ ++++     +
Sbjct: 23  LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82

Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
            +  G  L+  +L +I EY+   S      D      LD  +  +I+  I +G+ YLH +
Sbjct: 83  TKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSE 138

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 569
              K IHRD+KA+N+LL +    K++DFG+A      Q + NT +  GT  +MAPE    
Sbjct: 139 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIKQ 193

Query: 570 GIFSIKSDVFSFGVLLLEIISG 591
             +  K+D++S G+  +E+  G
Sbjct: 194 SAYDSKADIWSLGITAIELARG 215

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  133 bits (337), Expect = 5e-35
 Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 12/201 (5%)

Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
           F    KLG+G +G VYK      G+ +A+K++       LQE   E++++ +    ++V+
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVK 88

Query: 452 LLGCCLEGQELLLIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
             G   +  +L ++ EY    S+ D+      R+  L      +I+    +G+ YLH   
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLHFM- 144

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
             + IHRD+KA NILL+ + + K++DFG+A        + NT I  GT  +MAPE     
Sbjct: 145 --RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI--GTPFWMAPEVIQEI 200

Query: 571 IFSIKSDVFSFGVLLLEIISG 591
            ++  +D++S G+  +E+  G
Sbjct: 201 GYNCVADIWSLGITAIEMAEG 221

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  134 bits (340), Expect = 5e-35
 Identities = 57/225 (25%), Positives = 105/225 (46%), Gaps = 11/225 (4%)

Query: 370 KQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG 428
           +Q+   + F     ++     + F   ++LG G  G V+K +    G  +A K +     
Sbjct: 12  QQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK 71

Query: 429 QGLQEF-KNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQL 487
             ++     E+ ++ +     +V   G      E+ +  E+M   SLD  +      +  
Sbjct: 72  PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIPE 130

Query: 488 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
               +  +   + +G+ YL E    KI+HRD+K SNIL++     K+ DFG++       
Sbjct: 131 QILGK--VSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--ID 184

Query: 548 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           + AN+ +  GT  YM+PE   G  +S++SD++S G+ L+E+  GR
Sbjct: 185 SMANSFV--GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  134 bits (338), Expect = 7e-35
 Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 18/211 (8%)

Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFK-NEVNLIAKLQ 445
           E  +  + + ++G+G FG V++      G   AVK++       L+ F+  E+   A L 
Sbjct: 55  EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLS 108

Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
              +V L G   EG  + +  E +   SL   +    +   L   R    +     G+ Y
Sbjct: 109 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEY 165

Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANT---NIIAGTYGY 561
           LH     +I+H D+KA N+LL  D +   + DFG A     +    +    + I GT  +
Sbjct: 166 LHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222

Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           MAPE  MG     K D++S   ++L +++G 
Sbjct: 223 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  135 bits (342), Expect = 9e-35
 Identities = 50/211 (23%), Positives = 87/211 (41%), Gaps = 23/211 (10%)

Query: 393 FSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVR 451
           F  ++ LG G  G +    + D + +AVKR+     +       EV L+ +  +H N++R
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVIR 82

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFD--ATRSVQLDWKRRQSIINGIARGILYLHED 509
                 + Q   +  E          L +    +          +++     G+ +LH  
Sbjct: 83  YFCTEKDRQFQYIAIELCAAT-----LQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS- 136

Query: 510 SRLKIIHRDLKASNILL-----DDDMNPKISDFGLARIFGGNQN-QANTNIIAGTYGYMA 563
             L I+HRDLK  NIL+        +   ISDFGL +     ++  +  + + GT G++A
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194

Query: 564 PEYAMGGIF---SIKSDVFSFGVLLLEIISG 591
           PE          +   D+FS G +   +IS 
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  132 bits (335), Expect = 9e-35
 Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 17/210 (8%)

Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
              +    +LG G FG VYK      G   A K +   S + L+++  E+ ++A   H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ--SIINGIARGILYL 506
           +V+LLG      +L ++ E+ P  ++D         +       Q   +   +   + +L
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVD----AIMLELDRGLTEPQIQVVCRQMLEALNFL 133

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H     +IIHRDLKA N+L+  + + +++DFG++        + ++ I  GT  +MAPE 
Sbjct: 134 HSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI--GTPYWMAPEV 188

Query: 567 AMGGIFS-----IKSDVFSFGVLLLEIISG 591
            M           K+D++S G+ L+E+   
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQI 218

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  132 bits (335), Expect = 1e-34
 Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 22/211 (10%)

Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLLGC 455
            LGQG    V++G     G   A+K  +  S     +    E  ++ KL HKN+V+L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 456 --CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
                 +  +LI E+ P  SL   L + + +  L       ++  +  G+ +L E     
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NG 132

Query: 514 IIHRDLKASNILL----DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE---- 565
           I+HR++K  NI+     D     K++DFG AR    ++ Q  +  + GT  Y+ P+    
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS--LYGTEEYLHPDMYER 189

Query: 566 ----YAMGGIFSIKSDVFSFGVLLLEIISGR 592
                     +    D++S GV      +G 
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  132 bits (333), Expect = 9e-34
 Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 22/211 (10%)

Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLLGC 455
            LGQG    V++G     G   A+K  +  S     +    E  ++ KL HKN+V+L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 456 --CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
                 +  +LI E+ P  SL   L + + +  L       ++  +  G+ +L E     
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NG 132

Query: 514 IIHRDLKASNILL----DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE---- 565
           I+HR++K  NI+     D     K++DFG AR    ++ Q  +  + GT  Y+ P+    
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS--LYGTEEYLHPDMYER 189

Query: 566 ----YAMGGIFSIKSDVFSFGVLLLEIISGR 592
                     +    D++S GV      +G 
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  129 bits (326), Expect = 2e-33
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 23/215 (10%)

Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHK 447
               D  ++G+G +G V K      G+ +AVKR+  T   +  ++   +++++ +     
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR--QSIINGIARGIL- 504
            +V+  G      +  +  E M + S D       + V         + I+  I    + 
Sbjct: 82  YIVQFYGALFREGDCWICMELM-STSFD----KFYKYVYSVLDDVIPEEILGKITLATVK 136

Query: 505 ---YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
              +L E+  LKIIHRD+K SNILLD   N K+ DFG++     +  +      AG   Y
Sbjct: 137 ALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGCRPY 191

Query: 562 MAPE----YAMGGIFSIKSDVFSFGVLLLEIISGR 592
           MAPE     A    + ++SDV+S G+ L E+ +GR
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  129 bits (327), Expect = 2e-33
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 19/209 (9%)

Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQ 445
              FSD  ++G G FG VY    + + + +A+K++S   + S +  Q+   EV  + KL+
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           H N ++  GC L      L+ EY    + D+          L      ++ +G  +G+ Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAY 169

Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           LH      +IHRD+KA NILL +    K+ DFG A         AN+ +  GT  +MAPE
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANSFV--GTPYWMAPE 220

Query: 566 YAMG---GIFSIKSDVFSFGVLLLEIISG 591
             +    G +  K DV+S G+  +E+   
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAER 249

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  128 bits (324), Expect = 5e-33
 Identities = 51/199 (25%), Positives = 93/199 (46%), Gaps = 14/199 (7%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTS--GQGLQE-FKNEVNLIAKLQHKNLVRLLG 454
           LG+GGF   ++ +     +  A K + ++       +E    E+++   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGILYLHEDSRLK 513
              +   + ++ E    +SL     +  +  + L     +  +  I  G  YLH   R +
Sbjct: 109 FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNR 161

Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 573
           +IHRDLK  N+ L++D+  KI DFGLA     +  +     + GT  Y+APE       S
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHS 219

Query: 574 IKSDVFSFGVLLLEIISGR 592
            + DV+S G ++  ++ G+
Sbjct: 220 FEVDVWSIGCIMYTLLVGK 238

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  130 bits (329), Expect = 5e-33
 Identities = 62/245 (25%), Positives = 90/245 (36%), Gaps = 36/245 (14%)

Query: 373 AESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQ 432
           +     P F   L     N    E  LG G  G V       G+ +AVKR+         
Sbjct: 1   SRIANIPNFEQSL----KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCD 53

Query: 433 EFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDV---HLFDATRSVQLD 488
               E+ L+ +   H N++R        + L +  E       D+               
Sbjct: 54  IALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQK 113

Query: 489 WKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-------------DDMNPKIS 535
                S++  IA G+ +LH    LKIIHRDLK  NIL+              +++   IS
Sbjct: 114 EYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170

Query: 536 DFGLARIFGGNQN--QANTNIIAGTYGYMAPEYAMGGIFSI-------KSDVFSFGVLLL 586
           DFGL +     Q+  + N N  +GT G+ APE                  D+FS G +  
Sbjct: 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY 230

Query: 587 EIISG 591
            I+S 
Sbjct: 231 YILSK 235

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  127 bits (321), Expect = 6e-33
 Identities = 51/199 (25%), Positives = 93/199 (46%), Gaps = 14/199 (7%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTS--GQGLQE-FKNEVNLIAKLQHKNLVRLLG 454
           LG+GGF   ++ +     +  A K + ++       +E    E+++   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGILYLHEDSRLK 513
              +   + ++ E    +SL     +  +  + L     +  +  I  G  YLH   R +
Sbjct: 83  FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNR 135

Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 573
           +IHRDLK  N+ L++D+  KI DFGLA     +  +     + GT  Y+APE       S
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHS 193

Query: 574 IKSDVFSFGVLLLEIISGR 592
            + DV+S G ++  ++ G+
Sbjct: 194 FEVDVWSIGCIMYTLLVGK 212

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  126 bits (320), Expect = 7e-33
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 22/214 (10%)

Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSG-QGLQEFKNEVN-LIAKLQHK 447
           +      +LG+G +G V K   +  G+ +AVKR+  T   Q  +    +++  +  +   
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR-RQSIINGIARGIL-- 504
             V   G      ++ +  E M + SLD       + V    +   + I+  IA  I+  
Sbjct: 67  FTVTFYGALFREGDVWICMELM-DTSLD----KFYKQVIDKGQTIPEDILGKIAVSIVKA 121

Query: 505 --YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYM 562
             +LH  S+L +IHRD+K SN+L++     K+ DFG++     +    + +   G   YM
Sbjct: 122 LEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDIDA--GCKPYM 176

Query: 563 APE----YAMGGIFSIKSDVFSFGVLLLEIISGR 592
           APE          +S+KSD++S G+ ++E+   R
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  125 bits (316), Expect = 2e-32
 Identities = 59/198 (29%), Positives = 102/198 (51%), Gaps = 11/198 (5%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTS--GQGLQE-FKNEVNLIAKLQHKNLVRLLG 454
           LG+G F  VY+   +  G  +A+K + + +    G+ +  +NEV +  +L+H +++ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
              +   + L+ E   N  ++ +L +  +    +  R    ++ I  G+LYLH      I
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH--FMHQIITGMLYLH---SHGI 133

Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           +HRDL  SN+LL  +MN KI+DFGLA        +  T  + GT  Y++PE A      +
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRSAHGL 191

Query: 575 KSDVFSFGVLLLEIISGR 592
           +SDV+S G +   ++ GR
Sbjct: 192 ESDVWSLGCMFYTLLIGR 209

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  130 bits (329), Expect = 5e-32
 Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 17/206 (8%)

Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLL-- 453
           +LG GGFG V +      G+ +A+K+  +      +E +  E+ ++ KL H N+V     
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 454 ----GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
                        LL  EY     L  +L        L     +++++ I+  + YLHE 
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE- 139

Query: 510 SRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
              +IIHRDLK  NI+L      +  KI D G A+     +         GT  Y+APE 
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTE--FVGTLQYLAPEL 194

Query: 567 AMGGIFSIKSDVFSFGVLLLEIISGR 592
                +++  D +SFG L  E I+G 
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGF 220

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  123 bits (312), Expect = 8e-32
 Identities = 51/228 (22%), Positives = 82/228 (35%), Gaps = 34/228 (14%)

Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKL-Q 445
           T  F +  K+G G FG V+K     DG   A+KR           Q    EV   A L Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGIL 504
           H ++VR      E   +L+  EY    SL   + +  R +        + ++  + RG+ 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNP-------------------KISDFGLARIFGG 545
           Y+H      ++H D+K SNI +     P                   KI D G       
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS- 185

Query: 546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
                +  +  G   ++A E          K+D+F+  + ++      
Sbjct: 186 -----SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  124 bits (314), Expect = 1e-31
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 20/215 (9%)

Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHK 447
              F     +G G +G VYKG  +  G+  A+K +   +G   +E K E+N++ K   H+
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHR 81

Query: 448 NLVRLLGCCLEG------QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR 501
           N+    G  ++        +L L+ E+    S+   L   T+   L  +    I   I R
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILR 140

Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ +LH+    K+IHRD+K  N+LL ++   K+ DFG++        + NT I  GT  +
Sbjct: 141 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI--GTPYW 195

Query: 562 MAPEYAMGGIFS-----IKSDVFSFGVLLLEIISG 591
           MAPE              KSD++S G+  +E+  G
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  124 bits (312), Expect = 2e-31
 Identities = 50/219 (22%), Positives = 78/219 (35%), Gaps = 23/219 (10%)

Query: 396 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLL 453
              L +GGF  VY+   +  G+  A+KRL     +  +    EV  + KL  H N+V+  
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92

Query: 454 GCCL-------EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
                       GQ   L+   +    L   L        L       I     R + ++
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA---------- 556
           H   +  IIHRDLK  N+LL +    K+ DFG A       + + +              
Sbjct: 153 H-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211

Query: 557 GTYGYMAPE---YAMGGIFSIKSDVFSFGVLLLEIISGR 592
            T  Y  PE            K D+++ G +L  +   +
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  122 bits (308), Expect = 3e-31
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 14/213 (6%)

Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKN 448
           + +  +  +G G    V         + +A+KR++    Q  + E   E+  +++  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSL-DVHLFDATRSVQLDWKRRQSIINGIARGIL--- 504
           +V      +   EL L+ + +   S+ D+      +         +S I  I R +L   
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 505 -YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL-ARIFGGNQNQANT--NIIAGTYG 560
            YLH++     IHRD+KA NILL +D + +I+DFG+ A +  G     N       GT  
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 561 YMAPEYAM-GGIFSIKSDVFSFGVLLLEIISGR 592
           +MAPE       +  K+D++SFG+  +E+ +G 
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  122 bits (308), Expect = 4e-31
 Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 11/199 (5%)

Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQHKNLVRLL 453
           KLG GG   VY          +A+K +    R   + L+ F+ EV+  ++L H+N+V ++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLK 513
               E     L+ EY+   +L  ++        L      +  N I  GI + H    ++
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH---DMR 131

Query: 514 IIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFS 573
           I+HRD+K  NIL+D +   KI DFG+A+      +   TN + GT  Y +PE A G    
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYFSPEQAKGEATD 190

Query: 574 IKSDVFSFGVLLLEIISGR 592
             +D++S G++L E++ G 
Sbjct: 191 ECTDIYSIGIVLYEMLVGE 209

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  122 bits (308), Expect = 6e-31
 Identities = 52/210 (24%), Positives = 95/210 (45%), Gaps = 16/210 (7%)

Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHK 447
           N   +  ++G G  G V+K      G  IAVK++ R+   +  +    +++++ K     
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
            +V+  G  +   ++ +  E M     +         +      +  +   I + + YL 
Sbjct: 85  YIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGK--MTVAIVKALYYLK 141

Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE-- 565
           E     +IHRD+K SNILLD+    K+ DFG++   G   +    +  AG   YMAPE  
Sbjct: 142 EK--HGVIHRDVKPSNILLDERGQIKLCDFGIS---GRLVDDKAKDRSAGCAAYMAPERI 196

Query: 566 ---YAMGGIFSIKSDVFSFGVLLLEIISGR 592
                    + I++DV+S G+ L+E+ +G+
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  123 bits (310), Expect = 6e-31
 Identities = 49/202 (24%), Positives = 81/202 (40%), Gaps = 23/202 (11%)

Query: 398 KLGQGGFGPVYKGT-LADGKAIAVK-----RLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
            +G+G F  V +      G+  AVK     + + + G   ++ K E ++   L+H ++V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFD-----ATRSVQLDWKRRQSIINGIARGILYL 506
           LL        L +++E+M        L       A              +  I   + Y 
Sbjct: 91  LLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146

Query: 507 HEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
           H+     IIHRD+K   +LL   ++    K+  FG+A   G +   A      GT  +MA
Sbjct: 147 HD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFMA 201

Query: 564 PEYAMGGIFSIKSDVFSFGVLL 585
           PE      +    DV+  GV+L
Sbjct: 202 PEVVKREPYGKPVDVWGCGVIL 223

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  125 bits (316), Expect = 7e-31
 Identities = 62/238 (26%), Positives = 96/238 (40%), Gaps = 26/238 (10%)

Query: 368 GGKQQAESQEFPLFPLRLALEATNHFSD----ENKLGQGGFGPVYKGT-LADGKAIAVKR 422
           G +      +    P         H S+      KLG G +G V            A+K 
Sbjct: 10  GRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKI 69

Query: 423 LSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD 480
           + +T  S     +   EV ++  L H N+++L     + +   L+ E          LFD
Sbjct: 70  IRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE----LFD 125

Query: 481 ATRSVQLDW---KRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKI 534
               +            II  +  G+ YLH+     I+HRDLK  N+LL   + D   KI
Sbjct: 126 --EIIHRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKI 180

Query: 535 SDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
            DFGL+ +F   +         GT  Y+APE  +   +  K DV+S GV+L  +++G 
Sbjct: 181 VDFGLSAVFENQKKM---KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  126 bits (318), Expect = 1e-30
 Identities = 41/203 (20%), Positives = 80/203 (39%), Gaps = 24/203 (11%)

Query: 398 KLGQGGFGPVYKG--TLADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLL- 453
            +  GG G +Y       +G+ + +K L  +     Q     E   +A++ H ++V++  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 454 -GCCLEGQELLLIY---EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
                +     + Y   EY+  +SL           +L      + +  I   + YLH  
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLH-- 199

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 569
             + +++ DLK  NI+L ++   K+ D G                + GT G+ APE    
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIVRT 251

Query: 570 GIFSIKSDVFSFGVLLLEIISGR 592
           G  ++ +D+++ G  L  +    
Sbjct: 252 GP-TVATDIYTVGRTLAALTLDL 273

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  124 bits (313), Expect = 2e-30
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 23/213 (10%)

Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQ 445
           ++ +  +  LG+G FG V        G+  AVK +S+         +    EV L+ +L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDW---KRRQSIINGIARG 502
           H N+++L     +     L+ E          LFD    +            II  +  G
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFD--EIISRKRFSEVDAARIIRQVLSG 138

Query: 503 ILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGTY 559
           I Y+H+    KI+HRDLK  N+LL     D N +I DFGL+  F  ++         GT 
Sbjct: 139 ITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTA 192

Query: 560 GYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
            Y+APE  + G +  K DV+S GV+L  ++SG 
Sbjct: 193 YYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  122 bits (307), Expect = 2e-30
 Identities = 39/215 (18%), Positives = 80/215 (37%), Gaps = 16/215 (7%)

Query: 390 TNHFSDENKLGQG--GFGPVYKGT-LADGKAIAVKR--LSRTSGQGLQEFKNEVNLIAKL 444
              +     +G+G      V        G+ + V+R  L   S + +   + E+++    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 445 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
            H N+V      +   EL ++  +M   S    L        ++      I+ G+ + + 
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSA-KDLICTHFMDGMNELAIAYILQGVLKALD 142

Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT-----NIIAGTY 559
           Y+H       +HR +KAS+IL+  D    +S          +  +               
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199

Query: 560 GYMAPEYAMGGI--FSIKSDVFSFGVLLLEIISGR 592
            +++PE     +  +  KSD++S G+   E+ +G 
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  119 bits (300), Expect = 4e-30
 Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 25/208 (12%)

Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-LQEFKNEVNLIAKLQHK 447
            + F  + KLG G FG V+     + G    +K +++   Q  +++ + E+ ++  L H 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ-------SIINGIA 500
           N++++     +   + ++ E      L     +  R V    + +         ++  + 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGEL----LE--RIVSAQARGKALSEGYVAELMKQMM 134

Query: 501 RGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAG 557
             + Y H      ++H+DLK  NIL          KI DFGLA +F  +++  N    AG
Sbjct: 135 NALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN---AAG 188

Query: 558 TYGYMAPEYAMGGIFSIKSDVFSFGVLL 585
           T  YMAPE       + K D++S GV++
Sbjct: 189 TALYMAPE-VFKRDVTFKCDIWSAGVVM 215

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  118 bits (299), Expect = 4e-30
 Identities = 61/203 (30%), Positives = 90/203 (44%), Gaps = 18/203 (8%)

Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQH 446
              ++    LG+G FG V K       +  AVK +++     +       EV L+ KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILY 505
            N+++L     +     ++ E          LFD   +  +        II  +  GI Y
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARIIKQVFSGITY 136

Query: 506 LHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYM 562
           +H+     I+HRDLK  NILL   + D + KI DFGL+  F  N          GT  Y+
Sbjct: 137 MHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYI 190

Query: 563 APEYAMGGIFSIKSDVFSFGVLL 585
           APE  + G +  K DV+S GV+L
Sbjct: 191 APE-VLRGTYDEKCDVWSAGVIL 212

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  120 bits (303), Expect = 4e-30
 Identities = 52/218 (23%), Positives = 86/218 (39%), Gaps = 29/218 (13%)

Query: 398 KLGQGGFGPVY---------------KGTLADGKAIAVKRLSRTSGQGLQE-FKNEVNLI 441
            L QG F  +                K  L   +        + S +   + FKNE+ +I
Sbjct: 38  TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 442 AKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-----FDATRSVQLDWKRRQSII 496
             ++++  +   G      E+ +IYEYM N S+          D   +  +  +  + II
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 556
             +     Y+H  +   I HRD+K SNIL+D +   K+SDFG +      +         
Sbjct: 158 KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK----IKGSR 211

Query: 557 GTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGR 592
           GTY +M PE+          K D++S G+ L  +    
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  122 bits (309), Expect = 5e-30
 Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 22/212 (10%)

Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQH 446
              ++    LG+G FG V K       +  AVK +++     +       EV L+ KL H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDW---KRRQSIINGIARGI 503
            N+++L     +     ++ E          LFD    ++           II  +  GI
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGE----LFD--EIIKRKRFSEHDAARIIKQVFSGI 134

Query: 504 LYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 560
            Y+H+     I+HRDLK  NILL   + D + KI DFGL+  F  N          GT  
Sbjct: 135 TYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAY 188

Query: 561 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           Y+APE  + G +  K DV+S GV+L  ++SG 
Sbjct: 189 YIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  118 bits (297), Expect = 7e-30
 Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 16/201 (7%)

Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRT----SGQGLQEFKNEVNLIAKLQHKNLVR 451
             LG+G FG VY          +A+K L +     +G   Q  + EV + + L+H N++R
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILR 73

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
           L G   +   + LI EY P  ++   L   ++    D +R  + I  +A  + Y H    
Sbjct: 74  LYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCH---S 127

Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 571
            ++IHRD+K  N+LL      KI+DFG +       ++     + GT  Y+ PE   G +
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTD--LCGTLDYLPPEMIEGRM 183

Query: 572 FSIKSDVFSFGVLLLEIISGR 592
              K D++S GVL  E + G+
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGK 204

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  120 bits (302), Expect = 8e-30
 Identities = 25/264 (9%), Positives = 54/264 (20%), Gaps = 43/264 (16%)

Query: 364 NILRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKR 422
            ++         Q        L  +          L  G    V+    +   +  A+K 
Sbjct: 35  AMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKV 94

Query: 423 L---SRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC----------------------- 456
               +  S   L+         A+L  ++                               
Sbjct: 95  FTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPG 154

Query: 457 ---LEGQELLLIYEYMPNKSLDV-HLFD--ATRSVQLDWKRRQSIINGIARGILYLHEDS 510
                    LL+          +    D                +   + R    L    
Sbjct: 155 QDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ--- 211

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
              ++H      N+ +  D    + D       G           +    Y   E+    
Sbjct: 212 SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNAS 266

Query: 571 --IFSIKSDVFSFGVLLLEIISGR 592
              F+   + +  G+ +  +    
Sbjct: 267 TATFTHALNAWQLGLSIYRVWCLF 290

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  117 bits (296), Expect = 1e-29
 Identities = 48/201 (23%), Positives = 86/201 (42%), Gaps = 16/201 (7%)

Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
             +++ EN +G+G +G V            A K++ +   + +  FK E+ ++  L H N
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLH 507
           ++RL     +  ++ L+ E          LF+               I+  +   + Y H
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCH 123

Query: 508 EDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           +   L + HRDLK  N L      D   K+ DFGLA  F   +         GT  Y++P
Sbjct: 124 K---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT---KVGTPYYVSP 177

Query: 565 EYAMGGIFSIKSDVFSFGVLL 585
           +  + G++  + D +S GV++
Sbjct: 178 Q-VLEGLYGPECDEWSAGVMM 197

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  119 bits (301), Expect = 1e-29
 Identities = 48/201 (23%), Positives = 87/201 (43%), Gaps = 15/201 (7%)

Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
            +++    +LG G FG V++    A G+    K ++          KNE++++ +L H  
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD--ATRSVQLDWKRRQSIINGIARGILYL 506
           L+ L     +  E++LI E++        LFD  A    ++      + +     G+ ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSG----GELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           HE     I+H D+K  NI+ +       KI DFGLA     ++      +   T  + AP
Sbjct: 166 HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAP 219

Query: 565 EYAMGGIFSIKSDVFSFGVLL 585
           E          +D+++ GVL 
Sbjct: 220 EIVDREPVGFYTDMWAIGVLG 240

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  119 bits (299), Expect = 2e-29
 Identities = 32/222 (14%), Positives = 67/222 (30%), Gaps = 22/222 (9%)

Query: 390 TNHFSDENKLGQGGFGPVYKGT------LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK 443
           +      + LG+G F  VY+ T        + +   +K     +          +  +  
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 444 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLD--VHLFDATRSVQLDWKRRQSIINGIAR 501
                 ++     L     +L+ E     +L   ++L+  T    +      S    +  
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183

Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNP-----------KISDFGLARIFGGNQNQA 550
            I  +H+    +IIH D+K  N +L +                + D G +          
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
                  T G+   E      ++ + D F     +  ++ G 
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  117 bits (295), Expect = 2e-29
 Identities = 61/220 (27%), Positives = 94/220 (42%), Gaps = 32/220 (14%)

Query: 388 EATNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGL---------QE 433
            +T+ F +       LG+G    V +       K  AVK +  T G            + 
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 434 FKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKR 491
              EV+++ K+  H N+++L           L+++ M    L    FD  T  V L  K 
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKE 125

Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
            + I+  +   I  LH+   L I+HRDLK  NILLDDDMN K++DFG +      +    
Sbjct: 126 TRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---K 179

Query: 552 TNIIAGTYGYMAPEYAMGGIFSIKS------DVFSFGVLL 585
              + GT  Y+APE     +           D++S GV++
Sbjct: 180 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  116 bits (294), Expect = 2e-29
 Identities = 57/207 (27%), Positives = 88/207 (42%), Gaps = 21/207 (10%)

Query: 390 TNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIA 442
           +  FSD      +LG+G F  V +      G   A K ++    S +  Q+ + E  +  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 443 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIAR 501
           KLQH N+VRL     E     L+++ +        LF+                I  I  
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILE 116

Query: 502 GILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
            I Y H      I+HR+LK  N+LL         K++DFGLA     ++     +  AGT
Sbjct: 117 SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGT 170

Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLL 585
            GY++PE      +S   D+++ GV+L
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVIL 197

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  120 bits (304), Expect = 3e-29
 Identities = 60/249 (24%), Positives = 103/249 (41%), Gaps = 37/249 (14%)

Query: 368 GGKQQAESQEFPLFPLRLALEATNHFSD----ENKLGQGGFGPVYKGT-LADGKAIAVKR 422
            G++    Q   + P     +      +      KLG G +G V            A+K 
Sbjct: 9   SGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKV 68

Query: 423 LSR-------------TSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM 469
           + +                +  +E  NE++L+  L H N+++L     + +   L+ E+ 
Sbjct: 69  IKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFY 128

Query: 470 PNKSLDVHLFDATRSVQLDW---KRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL 526
               L    F+  + +           +I+  I  GI YLH+     I+HRD+K  NILL
Sbjct: 129 EGGEL----FE--QIINRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILL 179

Query: 527 ---DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGV 583
              +  +N KI DFGL+  F  +    +     GT  Y+APE  +   ++ K DV+S GV
Sbjct: 180 ENKNSLLNIKIVDFGLSSFFSKDYKLRD---RLGTAYYIAPE-VLKKKYNEKCDVWSCGV 235

Query: 584 LLLEIISGR 592
           ++  ++ G 
Sbjct: 236 IMYILLCGY 244

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  116 bits (294), Expect = 3e-29
 Identities = 59/205 (28%), Positives = 90/205 (43%), Gaps = 17/205 (8%)

Query: 398 KLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLL 453
            LG GG   V+    L D + +AVK  R            F+ E    A L H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 454 --GCCLEGQELLLIY---EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
             G   E     L Y   EY+   +L   +        +  KR   +I    + + + H 
Sbjct: 79  DTGE-AETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH- 133

Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ-ANTNIIAGTYGYMAPEYA 567
             +  IIHRD+K +NI++      K+ DFG+AR    + N    T  + GT  Y++PE A
Sbjct: 134 --QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191

Query: 568 MGGIFSIKSDVFSFGVLLLEIISGR 592
            G     +SDV+S G +L E+++G 
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGE 216

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  118 bits (297), Expect = 4e-29
 Identities = 61/201 (30%), Positives = 92/201 (45%), Gaps = 21/201 (10%)

Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
            S    LG G FG V+K    A G  +A K +     +  +E KNE++++ +L H NL++
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVH---LFD--ATRSVQLDWKRRQSIINGIARGILYL 506
           L        +++L+ EY       V    LFD     S  L        +  I  GI ++
Sbjct: 151 LYDAFESKNDIVLVMEY-------VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203

Query: 507 HEDSRLKIIHRDLKASNILL--DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           H+   + I+H DLK  NIL    D    KI DFGLAR +   +      +  GT  ++AP
Sbjct: 204 HQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---KVNFGTPEFLAP 257

Query: 565 EYAMGGIFSIKSDVFSFGVLL 585
           E       S  +D++S GV+ 
Sbjct: 258 EVVNYDFVSFPTDMWSVGVIA 278

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  120 bits (303), Expect = 6e-29
 Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 15/201 (7%)

Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
            +H+    +LG G FG V++ T  A G   A K +        +  + E+  ++ L+H  
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD--ATRSVQLDWKRRQSIINGIARGILYL 506
           LV L     +  E+++IYE+M        LF+  A    ++        +  + +G+ ++
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMS----GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           HE      +H DLK  NI+     +   K+ DFGL       Q   +  +  GT  + AP
Sbjct: 272 HE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAP 325

Query: 565 EYAMGGIFSIKSDVFSFGVLL 585
           E A G      +D++S GVL 
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLS 346

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  116 bits (293), Expect = 7e-29
 Identities = 45/204 (22%), Positives = 89/204 (43%), Gaps = 22/204 (10%)

Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
              +     LG+G FG V++    +  K    K + +  G      K E++++   +H+N
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRN 62

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVH---LFD--ATRSVQLDWKRRQSIINGIARGI 503
           ++ L       +EL++I+E+       +    +F+   T + +L+ +   S ++ +   +
Sbjct: 63  ILHLHESFESMEELVMIFEF-------ISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115

Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNIIAGTYGY 561
            +LH      I H D++  NI+     +   KI +FG AR      N     ++     Y
Sbjct: 116 QFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEY 169

Query: 562 MAPEYAMGGIFSIKSDVFSFGVLL 585
            APE     + S  +D++S G L+
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLV 193

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  116 bits (293), Expect = 1e-28
 Identities = 58/215 (26%), Positives = 90/215 (41%), Gaps = 21/215 (9%)

Query: 382 PLRLALEATNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEF 434
                + A+  FSD      +LG+G F  V +      G   A K ++    S +  Q+ 
Sbjct: 16  GSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL 75

Query: 435 KNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQ 493
           + E  +  KLQH N+VRL     E     L+++ +        LF+              
Sbjct: 76  EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADAS 131

Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQA 550
             I  I   I Y H      I+HR+LK  N+LL         K++DFGLA     ++   
Sbjct: 132 HCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--- 185

Query: 551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 585
             +  AGT GY++PE      +S   D+++ GV+L
Sbjct: 186 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  115 bits (290), Expect = 1e-28
 Identities = 45/201 (22%), Positives = 78/201 (38%), Gaps = 11/201 (5%)

Query: 396 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSR--TSGQGLQE-FKNEVNLIAKLQHKNLVR 451
              +G+GG G VY+       + +A+K +S   +S    +   + E     +LQ  ++V 
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
           +        +L +    +    L   L        L   R  +I+  I   +   H    
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA-- 153

Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 571
               HRD+K  NIL+  D    + DFG+A                GT  YMAPE      
Sbjct: 154 -GATHRDVKPENILVSADDFAYLVDFGIASATTDE-KLTQLGNTVGTLYYMAPERFSESH 211

Query: 572 FSIKSDVFSFGVLLLEIISGR 592
            + ++D+++   +L E ++G 
Sbjct: 212 ATYRADIYALTCVLYECLTGS 232

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  116 bits (292), Expect = 2e-28
 Identities = 58/238 (24%), Positives = 100/238 (42%), Gaps = 31/238 (13%)

Query: 369 GKQQAESQEFPLFPLRLALEATNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRL 423
           G +    Q            A   F  +    + +G+G    V +    A G   AVK +
Sbjct: 68  GTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIM 127

Query: 424 SRTSGQGLQE--------FKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPNKSL 474
             T+ +   E         + E +++ ++  H +++ L+        + L+++ M    L
Sbjct: 128 EVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL 187

Query: 475 DVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPK 533
               FD  T  V L  K  +SI+  +   + +LH      I+HRDLK  NILLDD+M  +
Sbjct: 188 ----FDYLTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIR 240

Query: 534 ISDFGLARIFGGNQNQANTNIIAGTYGYMAPE------YAMGGIFSIKSDVFSFGVLL 585
           +SDFG +      +       + GT GY+APE            +  + D+++ GV+L
Sbjct: 241 LSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  114 bits (287), Expect = 3e-28
 Identities = 52/207 (25%), Positives = 103/207 (49%), Gaps = 24/207 (11%)

Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQHK 447
            K+G+G +G V+K       + +A+KR+       L +           E+ L+ +L+HK
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLLKELKHK 61

Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
           N+VRL       ++L L++E+      D+  +  + +  LD +  +S +  + +G+ + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFC---DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
                 ++HRDLK  N+L++ +   K+++FGLAR F G   +  +  +  T  Y  P+  
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWYRPPDVL 173

Query: 568 MGG-IFSIKSDVFSFGVLLLEIISGRK 593
            G  ++S   D++S G +  E+ +  +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGR 200

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  114 bits (287), Expect = 3e-28
 Identities = 60/205 (29%), Positives = 105/205 (51%), Gaps = 23/205 (11%)

Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQHKN 448
            K+G+G +G VYK   + G+ +A+KR+       L             E++L+ +L H N
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLKELHHPN 80

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
           +V L+      + L L++E+M     D+          L   + +  +  + RG+ + H+
Sbjct: 81  IVSLIDVIHSERCLTLVFEFME---KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ 137

Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
               +I+HRDLK  N+L++ D   K++DFGLAR F G   ++ T+ +  T  Y AP+  M
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYRAPDVLM 192

Query: 569 GG-IFSIKSDVFSFGVLLLEIISGR 592
           G   +S   D++S G +  E+I+G+
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  114 bits (287), Expect = 3e-28
 Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 30/202 (14%)

Query: 396 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
              LG G F  V+       GK  A+K + ++        +NE+ ++ K++H+N+V L  
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQS--------IINGIARGILYL 506
                    L+ + +    L    FD  R ++     R          +I  +   + YL
Sbjct: 74  IYESTTHYYLVMQLVSGGEL----FD--RILE-----RGVYTEKDASLVIQQVLSAVKYL 122

Query: 507 HEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
           HE     I+HRDLK  N+L    +++    I+DFGL+++          +   GT GY+A
Sbjct: 123 HE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTPGYVA 175

Query: 564 PEYAMGGIFSIKSDVFSFGVLL 585
           PE      +S   D +S GV+ 
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVIT 197

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  113 bits (285), Expect = 3e-28
 Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 14/198 (7%)

Query: 399 LGQGGFGPVYKG-TLADGKAIAVKRLSRT--SGQGLQE-FKNEVNLIAKLQHKNLVRLLG 454
           LG+G FG VY      +   +A+K L ++    +G++   + E+ + + L+H N++R+  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKI 514
              + + + L+ E+ P   L   L    R    D +R  + +  +A  + Y H     K+
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALHYCH---ERKV 135

Query: 515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
           IHRD+K  N+L+      KI+DFG +      +       + GT  Y+ PE   G     
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDE 191

Query: 575 KSDVFSFGVLLLEIISGR 592
           K D++  GVL  E + G 
Sbjct: 192 KVDLWCAGVLCYEFLVGM 209

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  114 bits (287), Expect = 4e-28
 Identities = 59/276 (21%), Positives = 94/276 (34%), Gaps = 52/276 (18%)

Query: 366 LRGGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVK--- 421
           +      +  +E   F     LE    +  +  +GQG +G V            A+K   
Sbjct: 1   MHHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60

Query: 422 --RLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP--------- 470
             ++ + + + ++  K EV L+ KL H N+ RL     + Q + L+ E            
Sbjct: 61  KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120

Query: 471 --NKSLDVHLFDATRSVQLDWKRRQ--------------------------SIINGIARG 502
                            Q+                                +I+  I   
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180

Query: 503 ILYLHEDSRLKIIHRDLKASNILL--DDDMNPKISDFGLARIFGGNQNQANTNI--IAGT 558
           + YLH      I HRD+K  N L   +     K+ DFGL++ F    N     +   AGT
Sbjct: 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237

Query: 559 YGYMAPEYAMGGIFSI--KSDVFSFGVLLLEIISGR 592
             ++APE       S   K D +S GVLL  ++ G 
Sbjct: 238 PYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  111 bits (281), Expect = 1e-27
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 23/205 (11%)

Query: 397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQHKN 448
            K+G+G +G VYK     G+  A+K++       L++           E++++ +L+H N
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILKELKHSN 61

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
           +V+L       + L+L++E++     D+          L+    +S +  +  GI Y H+
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHL---DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
               +++HRDLK  N+L++ +   KI+DFGLAR F G   +  T+ I  T  Y AP+  M
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYRAPDVLM 173

Query: 569 GG-IFSIKSDVFSFGVLLLEIISGR 592
           G   +S   D++S G +  E+++G 
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  113 bits (286), Expect = 2e-27
 Identities = 56/222 (25%), Positives = 104/222 (46%), Gaps = 36/222 (16%)

Query: 388 EATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQH 446
           +    +++   +G G FG V++  L +   +A+K++ +      + FKN E+ ++  ++H
Sbjct: 37  QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKH 91

Query: 447 KNLVRLLGCCLEGQE------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING-- 498
            N+V L        +      L L+ EY+P     V+     R+ +   K +Q++     
Sbjct: 92  PNVVDLKAFFYSNGDKKDEVFLNLVLEYVP---ETVY-----RASRHYAKLKQTMPMLLI 143

Query: 499 ------IARGILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQAN 551
                 + R + Y+H    + I HRD+K  N+LLD      K+ DFG A+I      + N
Sbjct: 144 KLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPN 198

Query: 552 TNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
            + I   Y Y APE   G   ++   D++S G ++ E++ G+
Sbjct: 199 VSYICSRY-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  111 bits (281), Expect = 2e-27
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 22/208 (10%)

Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVK------RLSRTSGQGLQEFKNEVNLIA 442
            + +    +LG G F  V K    + G   A K        +   G   +E + EV+++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 443 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIAR 501
           ++ H N++ L        +++LI E +        LFD   +   L  +   S I  I  
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSG----GELFDFLAQKESLSEEEATSFIKQILD 126

Query: 502 GILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLARIFGGNQNQANTNIIAG 557
           G+ YLH     KI H DLK  NI+L        + K+ DFGLA              I G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFG 180

Query: 558 TYGYMAPEYAMGGIFSIKSDVFSFGVLL 585
           T  ++APE        +++D++S GV+ 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  114 bits (287), Expect = 3e-27
 Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 20/212 (9%)

Query: 385 LALEATNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNE 437
           +A      F++E     +LG+G F  V +   +  G+  A   ++    S +  Q+ + E
Sbjct: 1   MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60

Query: 438 VNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSII 496
             +   L+H N+VRL     E     LI++ +    L    F+                I
Sbjct: 61  ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCI 116

Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTN 553
             I   +L+ H+   + ++HR+LK  N+LL         K++DFGLA    G Q      
Sbjct: 117 QQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG- 172

Query: 554 IIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 585
             AGT GY++PE      +    D+++ GV+L
Sbjct: 173 -FAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  112 bits (282), Expect = 3e-27
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 22/208 (10%)

Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVK------RLSRTSGQGLQEFKNEVNLIA 442
            + +    +LG G F  V K    + G   A K        +   G   +E + EV+++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 443 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIAR 501
           ++ H N++ L        +++LI E +        LFD   +   L  +   S I  I  
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSG----GELFDFLAQKESLSEEEATSFIKQILD 126

Query: 502 GILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLARIFGGNQNQANTNIIAG 557
           G+ YLH     KI H DLK  NI+L        + K+ DFGLA              I G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFG 180

Query: 558 TYGYMAPEYAMGGIFSIKSDVFSFGVLL 585
           T  ++APE        +++D++S GV+ 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  113 bits (283), Expect = 3e-27
 Identities = 31/238 (13%), Positives = 71/238 (29%), Gaps = 53/238 (22%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLS---RTSGQGLQEFKNEVNLIAKLQ--------- 445
           LGQ       + T    G++  V       R     +++ K EV  +  L+         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 446 -------------HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ------ 486
                             +++   L+ +++ ++  +     +  +L      +       
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 487 --LDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
             L    R  +   + R +  LH      ++H  L+  +I+LD      ++ F      G
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262

Query: 545 GNQNQANTNIIAGTYGYMAPEY----------AMGGIFSIKSDVFSFGVLLLEIISGR 592
                  + +     G+  PE               + +   D ++ G+ +  I    
Sbjct: 263 ------ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  111 bits (279), Expect = 5e-27
 Identities = 64/215 (29%), Positives = 109/215 (50%), Gaps = 18/215 (8%)

Query: 387 LEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-----LQEFKNEVNL 440
           + +++ F    KLG G +  VYKG     G  +A+K +   S +G     ++E    ++L
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISL 56

Query: 441 IAKLQHKNLVRLLGCCLEGQELLLIYEYMPN--KSLDVHLFDATRSVQLDWKRRQSIING 498
           + +L+H+N+VRL        +L L++E+M N  K              L+    +     
Sbjct: 57  MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116

Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           + +G+ + HE+   KI+HRDLK  N+L++     K+ DFGLAR F G      ++ +  T
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-T 171

Query: 559 YGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGR 592
             Y AP+  MG   +S   D++S G +L E+I+G+
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  110 bits (277), Expect = 8e-27
 Identities = 41/176 (23%), Positives = 67/176 (38%), Gaps = 13/176 (7%)

Query: 424 SRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATR 483
             +S   +     ++  +     KN V  L        L +  +    ++L   +     
Sbjct: 98  PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157

Query: 484 SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF 543
               +      I   IA  + +LH      ++HRDLK SNI    D   K+ DFGL    
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214

Query: 544 GGNQNQANTNIIA----------GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEII 589
             ++ +                 GT  YM+PE   G  +S K D+FS G++L E++
Sbjct: 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  109 bits (274), Expect = 9e-27
 Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 26/210 (12%)

Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVK------RLSRTSGQGLQEFKNEVNLIA 442
            +H+    +LG G F  V K      GK  A K        S   G   +E + EVN++ 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 443 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDW---KRRQSIINGI 499
           +++H N++ L        +++LI E +    L    FD     + +          +  I
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGEL----FD--FLAEKESLTEDEATQFLKQI 117

Query: 500 ARGILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLARIFGGNQNQANTNII 555
             G+ YLH     +I H DLK  NI+L      +   K+ DFG+A              I
Sbjct: 118 LDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNI 171

Query: 556 AGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 585
            GT  ++APE        +++D++S GV+ 
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  110 bits (276), Expect = 1e-26
 Identities = 52/217 (23%), Positives = 83/217 (38%), Gaps = 28/217 (12%)

Query: 390 TNHFSD-----ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK 443
           +  F D     E+ LG+G    V     L   +  AVK + +  G        EV ++ +
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66

Query: 444 LQ-HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIAR 501
            Q H+N++ L+    E     L++E M   S+         +    +      ++  +A 
Sbjct: 67  CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEASVVVQDVAS 122

Query: 502 GILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNI---- 554
            + +LH      I HRDLK  NIL    +     KI DF L      N + +  +     
Sbjct: 123 ALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179

Query: 555 -IAGTYGYMAPEYAMGGIFSIKS-----DVFSFGVLL 585
              G+  YMAPE                D++S GV+L
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  109 bits (275), Expect = 1e-26
 Identities = 53/207 (25%), Positives = 86/207 (41%), Gaps = 22/207 (10%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLVRLL 453
           LG+G +G V +          AVK L +        G    K E+ L+ +L+HKN+++L+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 454 G--CCLEGQELLLIYEYMPNKSLDVHLFD--ATRSVQLDWKRR--QSIINGIARGILYLH 507
                 E Q++ ++ EY      +  + D    +   +         +I+G+     YLH
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH 126

Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
                 I+H+D+K  N+LL      KIS  G+A                G+  +  PE A
Sbjct: 127 ---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183

Query: 568 MG--GIFSIKSDVFSFGVLLLEIISGR 592
            G       K D++S GV L  I +G 
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNITTGL 210

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  110 bits (276), Expect = 1e-26
 Identities = 56/211 (26%), Positives = 88/211 (41%), Gaps = 28/211 (13%)

Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRL------SRTSGQGLQEFKNEVNLIA 442
            +++    +LG G F  V K    + G   A K +      S   G   ++ + EV+++ 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 443 KLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVH---LFDA-TRSVQLDWKRRQSIING 498
           ++QH N++ L        +++LI E        V    LFD       L  +     +  
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILEL-------VAGGELFDFLAEKESLTEEEATEFLKQ 122

Query: 499 IARGILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLARIFGGNQNQANTNI 554
           I  G+ YLH    L+I H DLK  NI+L          KI DFGLA              
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKN 176

Query: 555 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 585
           I GT  ++APE        +++D++S GV+ 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  110 bits (278), Expect = 1e-26
 Identities = 58/206 (28%), Positives = 108/206 (52%), Gaps = 21/206 (10%)

Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQHK 447
           + LG+G F  VYK       + +A+K++ +   +   E K+        E+ L+ +L H 
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHR--SEAKDGINRTALREIKLLQELSHP 72

Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
           N++ LL        + L++++M     D+ +     S+ L     ++ +    +G+ YLH
Sbjct: 73  NIIGLLDAFGHKSNISLVFDFME---TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129

Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
           +     I+HRDLK +N+LLD++   K++DFGLA+ F G+ N+A T+ +  T  Y APE  
Sbjct: 130 QH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV-TRWYRAPELL 184

Query: 568 MGG-IFSIKSDVFSFGVLLLEIISGR 592
            G  ++ +  D+++ G +L E++   
Sbjct: 185 FGARMYGVGVDMWAVGCILAELLLRV 210

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  110 bits (276), Expect = 1e-26
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 27/204 (13%)

Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE--------FKNEVNLIAKLQHKN 448
            LG G  G V         K +A+K +S+                 + E+ ++ KL H  
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLH 507
           ++++     + ++  ++ E M    L    FD    + +L     +     +   + YLH
Sbjct: 77  IIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLH 131

Query: 508 EDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           E     IIHRDLK  N+LL   ++D   KI+DFG ++I G          + GT  Y+AP
Sbjct: 132 E---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAP 185

Query: 565 EYAMGGI---FSIKSDVFSFGVLL 585
           E  +      ++   D +S GV+L
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVIL 209

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  111 bits (280), Expect = 1e-26
 Identities = 51/204 (25%), Positives = 86/204 (42%), Gaps = 27/204 (13%)

Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSR--------TSGQGLQEFKNEVNLIAKLQHKN 448
            LG G  G V         K +A++ +S+                 + E+ ++ KL H  
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLH 507
           ++++     + ++  ++ E M    L    FD    + +L     +     +   + YLH
Sbjct: 202 IIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLH 256

Query: 508 EDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           E     IIHRDLK  N+LL   ++D   KI+DFG ++I G          + GT  Y+AP
Sbjct: 257 E---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAP 310

Query: 565 E---YAMGGIFSIKSDVFSFGVLL 585
           E         ++   D +S GV+L
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVIL 334

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  109 bits (275), Expect = 1e-26
 Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 24/206 (11%)

Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQHK 447
            K+G+G +G V+K      G+ +A+K+          E           E+ ++ +L+H 
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRMLKQLKHP 62

Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
           NLV LL      + L L++EY       V          +     +SI     + + + H
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYC---DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119

Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
              +   IHRD+K  NIL+      K+ DFG AR+  G  +    + +A T  Y +PE  
Sbjct: 120 ---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA-TRWYRSPELL 174

Query: 568 MGG-IFSIKSDVFSFGVLLLEIISGR 592
           +G   +    DV++ G +  E++SG 
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSGV 200

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  109 bits (275), Expect = 2e-26
 Identities = 47/196 (23%), Positives = 82/196 (41%), Gaps = 18/196 (9%)

Query: 396 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLL 453
           +  LG+G F    K       +A AVK +S+         + E+  +   + H N+V+L 
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLH 72

Query: 454 GCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
               +     L+ E +    L    F+   +           I+  +   + ++H+   +
Sbjct: 73  EVFHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHD---V 125

Query: 513 KIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 569
            ++HRDLK  N+L    +D++  KI DFG AR+   +     T     T  Y APE    
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLNQ 183

Query: 570 GIFSIKSDVFSFGVLL 585
             +    D++S GV+L
Sbjct: 184 NGYDESCDLWSLGVIL 199

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  109 bits (275), Expect = 2e-26
 Identities = 50/222 (22%), Positives = 87/222 (39%), Gaps = 25/222 (11%)

Query: 376 QEFPLFPLRLAL-EATNHFSDE----NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQ 429
           Q   +  +   L   +  F+D       +G G +    +    A     AVK + ++   
Sbjct: 2   QTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD 61

Query: 430 GLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA-TRSVQL 487
                  E+ ++ +  QH N++ L     +G+ + ++ E M    L     D   R    
Sbjct: 62  P----TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFF 113

Query: 488 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNP-KISDFGLARIF 543
             +   +++  I + + YLH      ++HRDLK SNIL      +    +I DFG A+  
Sbjct: 114 SEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170

Query: 544 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 585
                   T     T  ++APE      +    D++S GVLL
Sbjct: 171 RAENGLLMT--PCYTANFVAPEVLERQGYDAACDIWSLGVLL 210

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  109 bits (274), Expect = 2e-26
 Identities = 59/235 (25%), Positives = 99/235 (42%), Gaps = 24/235 (10%)

Query: 368 GGKQQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT 426
           G      S    L    L  ++   + +   +G+G +G V K      G+ +A+K+    
Sbjct: 2   GHHHHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL-- 59

Query: 427 SGQGLQEFKN--------EVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL 478
                 +           E+ L+ +L+H+NLV LL  C + +   L++E++      +  
Sbjct: 60  ----ESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV---DHTILD 112

Query: 479 FDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538
                   LD++  Q  +  I  GI + H      IIHRD+K  NIL+      K+ DFG
Sbjct: 113 DLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFG 169

Query: 539 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGR 592
            AR       +   + +A T  Y APE  +G   +    DV++ G L+ E+  G 
Sbjct: 170 FARTLAA-PGEVYDDEVA-TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  110 bits (275), Expect = 2e-26
 Identities = 34/239 (14%), Positives = 71/239 (29%), Gaps = 54/239 (22%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQ--------- 445
           LGQ       + T    G++  V     T       +++ K EV  +  L+         
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 446 ----------------HKNLVRLLGCC--LEGQELLLIYEYMPNKSLDV--HLFD-ATRS 484
                            K ++R+      +       +Y  M +        L   ++  
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 485 VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
             L    R  +   + R +  LH      ++H  L+  +I+LD      ++ F      G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257

Query: 545 GNQNQANTNIIAGTYGYMAPEY-----------AMGGIFSIKSDVFSFGVLLLEIISGR 592
                    + + + G+  PE                + +   D ++ G+++  I    
Sbjct: 258 ------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  106 bits (268), Expect = 5e-26
 Identities = 64/202 (31%), Positives = 93/202 (46%), Gaps = 19/202 (9%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLLGCC 456
           LG+G +G V         +A+AVK +         E  K E+ +   L H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 457 LEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRR--QSIINGIARGILYLHEDSR 511
            EG    L  EY     L    FD       +     +R    ++ G+     YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123

Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 571
           + I HRD+K  N+LLD+  N KISDFGLA +F  N  +   N + GT  Y+APE      
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 572 FS-IKSDVFSFGVLLLEIISGR 592
           F     DV+S G++L  +++G 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE 205

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  108 bits (271), Expect = 5e-26
 Identities = 53/237 (22%), Positives = 91/237 (38%), Gaps = 39/237 (16%)

Query: 371 QQAESQEFPLFPLRLALEATNHFSD-----ENKLGQGGFGPVYKGT-LADGKAIAVK--R 422
               S    L    L  ++  +F++       +LG+G F  V +    + G+  A K  +
Sbjct: 4   HHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK 63

Query: 423 LSRTSGQGLQEFKNEVNLIAKLQH-KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDA 481
             R       E  +E+ ++   +    ++ L        E++LI EY         +F  
Sbjct: 64  KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGE----IFS- 118

Query: 482 TRSVQLDWKR----------RQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DD 528
              +    +           +Q     I  G+ YLH+     I+H DLK  NILL     
Sbjct: 119 -LCLPELAEMVSENDVIRLIKQ-----ILEGVYYLHQ---NNIVHLDLKPQNILLSSIYP 169

Query: 529 DMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 585
             + KI DFG++R  G          I GT  Y+APE       +  +D+++ G++ 
Sbjct: 170 LGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  109 bits (275), Expect = 5e-26
 Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 37/221 (16%)

Query: 390 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHK 447
              ++D   +G G FG VY+  L D G+ +A+K++ +      + FKN E+ ++ KL H 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107

Query: 448 NLVRLLGCCLEGQE------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING--- 498
           N+VRL        E      L L+ +Y+P     V+     R  +   + +Q++      
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP---ETVY-----RVARHYSRAKQTLPVIYVK 159

Query: 499 -----IARGILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANT 552
                + R + Y+H      I HRD+K  N+LLD D    K+ DFG A+     + + N 
Sbjct: 160 LYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNV 214

Query: 553 NIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGR 592
           + I   Y Y APE   G    +   DV+S G +L E++ G+
Sbjct: 215 SYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  108 bits (271), Expect = 6e-26
 Identities = 54/209 (25%), Positives = 99/209 (47%), Gaps = 19/209 (9%)

Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-----LQEFKNEVNLIAKL 444
             +   +KLG+G +  VYKG        +A+K +     +G     ++E    V+L+  L
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDL 57

Query: 445 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +H N+V L       + L L++EY+     D+  +       ++    +  +  + RG+ 
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYL---DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114

Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           Y H     K++HRDLK  N+L+++    K++DFGLAR       +   N +  T  Y  P
Sbjct: 115 YCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYRPP 169

Query: 565 EYAMGG-IFSIKSDVFSFGVLLLEIISGR 592
           +  +G   +S + D++  G +  E+ +GR
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  108 bits (271), Expect = 9e-26
 Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 35/225 (15%)

Query: 388 EATNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRL-------SRTSGQGLQEFKNEVN 439
           +  + F  E   GQG FG V  G     G ++A+K++       +R     LQ  +    
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE----LQIMQ---- 71

Query: 440 LIAKLQHKNLVRLLGCCLEGQE-------LLLIYEYMPNKSLDVHLF---DATRSVQLDW 489
            +A L H N+V+L        E       L ++ EY+P     +H        R V    
Sbjct: 72  DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DTLHRCCRNYYRRQVAPPP 128

Query: 490 KRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQN 548
              +  +  + R I  LH  S + + HRD+K  N+L+++     K+ DFG A+    + +
Sbjct: 129 ILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SPS 185

Query: 549 QANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           + N   I   Y Y APE   G   ++   D++S G +  E++ G 
Sbjct: 186 EPNVAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  106 bits (266), Expect = 2e-25
 Identities = 64/202 (31%), Positives = 93/202 (46%), Gaps = 19/202 (9%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLLGCC 456
           LG+G +G V         +A+AVK +         E  K E+ +   L H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 457 LEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRR--QSIINGIARGILYLHEDSR 511
            EG    L  EY     L    FD       +     +R    ++ G+     YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123

Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 571
           + I HRD+K  N+LLD+  N KISDFGLA +F  N  +   N + GT  Y+APE      
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 572 FS-IKSDVFSFGVLLLEIISGR 592
           F     DV+S G++L  +++G 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE 205

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  106 bits (267), Expect = 2e-25
 Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 31/200 (15%)

Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
           +LG+G    VY+       K  A+K L +T  +  +  + E+ ++ +L H N+++L    
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIF 117

Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQS--------IINGIARGILYLHE 508
               E+ L+ E +    L    FD  R V+     +           +  I   + YLHE
Sbjct: 118 ETPTEISLVLELVTGGEL----FD--RIVE-----KGYYSERDAADAVKQILEAVAYLHE 166

Query: 509 DSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
                I+HRDLK  N+L      D   KI+DFGL++I            + GT GY APE
Sbjct: 167 ---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPE 220

Query: 566 YAMGGIFSIKSDVFSFGVLL 585
              G  +  + D++S G++ 
Sbjct: 221 ILRGCAYGPEVDMWSVGIIT 240

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  107 bits (269), Expect = 3e-25
 Identities = 57/211 (27%), Positives = 106/211 (50%), Gaps = 21/211 (9%)

Query: 398 KLGQGGFGPVYKG---TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
           K+G+G +G VYK       D K  A+K++   +G  +   + E+ L+ +L+H N++ L  
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQK 85

Query: 455 CCLEGQE--LLLIYEYMPN---KSLDVH--LFDATRSVQLDWKRRQSIINGIARGILYLH 507
             L   +  + L+++Y  +     +  H       + VQL     +S++  I  GI YLH
Sbjct: 86  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145

Query: 508 EDSRLKIIHRDLKASNILLDDDMNP----KISDFGLARIFGG-NQNQANTNIIAGTYGYM 562
            +    ++HRDLK +NIL+  +       KI+D G AR+F    +  A+ + +  T+ Y 
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 202

Query: 563 APEYAMGG-IFSIKSDVFSFGVLLLEIISGR 592
           APE  +G   ++   D+++ G +  E+++  
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  105 bits (265), Expect = 4e-25
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 32/212 (15%)

Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQHK 447
            KLG+G +G VYK       + +A+KR+       L+  +         EV+L+ +LQH+
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLLKELQHR 93

Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVH-LFDATRSVQLDWKRRQSIINGIARGILYL 506
           N++ L         L LI+EY      D+    D  ++  +  +  +S +  +  G+ + 
Sbjct: 94  NIIELKSVIHHNHRLHLIFEYA---ENDLKKYMD--KNPDVSMRVIKSFLYQLINGVNFC 148

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNP-----KISDFGLARIFGGNQNQANTNIIAGTYGY 561
           H     + +HRDLK  N+LL           KI DFGLAR F G   +  T+ I  T  Y
Sbjct: 149 HSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEII-TLWY 203

Query: 562 MAPEYAMGG-IFSIKSDVFSFGVLLLEIISGR 592
             PE  +G   +S   D++S   +  E++   
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  103 bits (260), Expect = 8e-25
 Identities = 57/231 (24%), Positives = 94/231 (40%), Gaps = 51/231 (22%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT--------------------------SGQGL 431
           +G+G +G V       D    A+K LS+                               +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 432 QEFKNEVNLIAKLQHKNLVRLLGCCLEG---QELLLIYEYMPNKSLDVHLFDATRSVQLD 488
           ++   E+ ++ KL H N+V+L+   L+      L +++E +    +     +      L 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135

Query: 489 ----WKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
                   Q +I GI     YLH     KIIHRD+K SN+L+ +D + KI+DFG++  F 
Sbjct: 136 EDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188

Query: 545 GNQNQANTNIIAGTYGYMAPEYAMGGIFSI---KSDVFSFGVLLLEIISGR 592
           G+    +     GT  +MAPE              DV++ GV L   + G+
Sbjct: 189 GSDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  104 bits (261), Expect = 9e-25
 Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 32/209 (15%)

Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEF---KNEVNLIAKLQHKNLVR 451
           LG+G F  V       T    +  A+K L +       +      E +++++L H   V+
Sbjct: 38  LGEGSFSTVVLARELAT---SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR--------GI 503
           L     + ++L     Y  N  L  ++           ++  S      R         +
Sbjct: 95  LYFTFQDDEKLYFGLSYAKNGELLKYI-----------RKIGSFDETCTRFYTAEIVSAL 143

Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  N   GT  Y++
Sbjct: 144 EYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200

Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           PE          SD+++ G ++ ++++G 
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGL 229

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  103 bits (260), Expect = 1e-24
 Identities = 54/215 (25%), Positives = 101/215 (46%), Gaps = 34/215 (15%)

Query: 397 NKLGQGGFGPVYKG--TLADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQ- 445
            ++G+G +G V+K       G+ +A+KR+       +Q  +         EV ++  L+ 
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAVLRHLET 70

Query: 446 --HKNLVRLLGCCLEGQE-----LLLIYEYMPNKSLDV-HLFDATRSVQLDWKRRQSIIN 497
             H N+VRL   C   +      L L++E++     D+    D      +  +  + ++ 
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV---DQDLTTYLDKVPEPGVPTETIKDMMF 127

Query: 498 GIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAG 557
            + RG+ +LH     +++HRDLK  NIL+      K++DFGLARI+        T+++  
Sbjct: 128 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVV- 181

Query: 558 TYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           T  Y APE  +   ++   D++S G +  E+   +
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  103 bits (259), Expect = 2e-24
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 24/211 (11%)

Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLS-RTSGQGLQEFKN----EVNLIAKLQ---HK 447
            ++G G +G VYK      G  +A+K +     G G          EV L+ +L+   H 
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74

Query: 448 NLVRLLGCCLEGQE-----LLLIYEYMPNKSLDV-HLFDATRSVQLDWKRRQSIINGIAR 501
           N+VRL+  C   +      + L++E++     D+    D      L  +  + ++    R
Sbjct: 75  NVVRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLMRQFLR 131

Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           G+ +LH +    I+HRDLK  NIL+      K++DFGLARI+      A T ++  T  Y
Sbjct: 132 GLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYS--YQMALTPVVV-TLWY 185

Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
            APE  +   ++   D++S G +  E+   +
Sbjct: 186 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  103 bits (259), Expect = 3e-24
 Identities = 54/217 (24%), Positives = 102/217 (47%), Gaps = 34/217 (15%)

Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN--------EVNLIAKLQHK 447
            K+GQG FG V+K      G+ +A+K++       ++  K         E+ ++  L+H+
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKILQLLKHE 76

Query: 448 NLVRLLGCCLEGQE--------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 499
           N+V L+  C             + L++++      D+    +   V+      + ++  +
Sbjct: 77  NVVNLIEICRTKASPYNRCKGSIYLVFDFC---EHDLAGLLSNVLVKFTLSEIKRVMQML 133

Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN---TNIIA 556
             G+ Y+H +   KI+HRD+KA+N+L+  D   K++DFGLAR F   +N      TN + 
Sbjct: 134 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 190

Query: 557 GTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGR 592
            T  Y  PE  +G   +    D++  G ++ E+ +  
Sbjct: 191 -TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  103 bits (258), Expect = 3e-24
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 23/203 (11%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
           +G+G F  V     +  G+ +A+K + +T  +   LQ+   EV ++  L H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 456 CLEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRR--QSIINGIARGILYLHEDS 510
               + L LI EY     +    FD   A   ++    R   + I++ +     Y H   
Sbjct: 83  IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQ----YCH--- 131

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
           + +I+HRDLKA N+LLD DMN KI+DFG +  F     + +     G   Y APE   G 
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAF--CGAPPYAAPELFQGK 188

Query: 571 IFS-IKSDVFSFGVLLLEIISGR 592
            +   + DV+S GV+L  ++SG 
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGS 211

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  105 bits (264), Expect = 4e-24
 Identities = 77/266 (28%), Positives = 116/266 (43%), Gaps = 23/266 (8%)

Query: 339 QEEKRNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLFPLRLALEAT----NHFS 394
              +  + +  F      +  H         ++  +S  F  F     LEA     + F 
Sbjct: 132 ARARAGAGDGLFQPLLRAVLAHLGQAPF---QEFLDSLYFLRFLQWKWLEAQPMGEDWFL 188

Query: 395 DENKLGQGGFGPVY----KGTLADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQHK 447
           D   LG+GGFG V+    K T   GK  A K+L++      +G Q    E  ++AK+  +
Sbjct: 189 DFRVLGRGGFGEVFACQMKAT---GKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR 245

Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYL 506
            +V L        +L L+   M    +  H+++    +      R       I  G+ +L
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H+     II+RDLK  N+LLDDD N +ISD GLA      Q +      AGT G+MAPE 
Sbjct: 306 HQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGTPGFMAPEL 360

Query: 567 AMGGIFSIKSDVFSFGVLLLEIISGR 592
            +G  +    D F+ GV L E+I+ R
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAAR 386

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  102 bits (255), Expect = 8e-24
 Identities = 48/211 (22%), Positives = 80/211 (37%), Gaps = 44/211 (20%)

Query: 395 DENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRL 452
            +  LG G  G V +      G+  A+K L  +      + + EV+   +     ++V +
Sbjct: 33  SKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCI 87

Query: 453 LGCCLEGQELLLIYEYMPNKSLDVH----------LFDATRSVQLDWKR---RQ--SIIN 497
           L           +YE M +    +           LF   R  +   +    R+   I+ 
Sbjct: 88  LD----------VYENMHHGKRCLLIIMECMEGGELFS--RIQERGDQAFTEREAAEIMR 135

Query: 498 GIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNI 554
            I   I +LH      I HRD+K  N+L    + D   K++DFG A+    N        
Sbjct: 136 DIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQT 188

Query: 555 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 585
              T  Y+APE      +    D++S GV++
Sbjct: 189 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  104 bits (262), Expect = 8e-24
 Identities = 62/201 (30%), Positives = 90/201 (44%), Gaps = 17/201 (8%)

Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQHKNLVR 451
           LG+GGFG V     + T   GK  A K+L +      +G     NE  ++ K+  + +V 
Sbjct: 192 LGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
           L         L L+   M    L  H++   ++      R       I  G+  LH    
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG-FPEARAVFYAAEICCGLEDLHR--- 304

Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 571
            +I++RDLK  NILLDD  + +ISD GLA      Q         GT GYMAPE      
Sbjct: 305 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNER 361

Query: 572 FSIKSDVFSFGVLLLEIISGR 592
           ++   D ++ G LL E+I+G+
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQ 382

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  100 bits (251), Expect = 2e-23
 Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 22/206 (10%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN------EVNLIAKLQHK--NL 449
           LG GGFG VY G  ++D   +A+K + +       E  N      EV L+ K+      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIARGILYLHE 508
           +RLL         +LI E  P    D  LFD  T    L  +  +S    +   + + H 
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELARSFFWQVLEAVRHCH- 166

Query: 509 DSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
                ++HRD+K  NIL+D +    K+ DFG   +              GT  Y  PE+ 
Sbjct: 167 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTD--FDGTRVYSPPEWI 220

Query: 568 MGGIFS-IKSDVFSFGVLLLEIISGR 592
               +    + V+S G+LL +++ G 
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGD 246

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  100 bits (251), Expect = 2e-23
 Identities = 49/215 (22%), Positives = 85/215 (39%), Gaps = 40/215 (18%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT--------SGQGLQEFKNEVNLIAKLQHKNL 449
           LG G FG V+        K + VK + +             L +   E+ ++++++H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 450 VRLLGCCLEGQELLLIYEYMPNKS-----LDVH-----LFD-ATRSVQLDWKRRQSIING 498
           +++              +   N+      ++ H     LF    R  +LD      I   
Sbjct: 92  IKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138

Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +   + YL       IIHRD+K  NI++ +D   K+ DFG A      +         GT
Sbjct: 139 LVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYTFCGT 192

Query: 559 YGYMAPEYAMGGIFS-IKSDVFSFGVLLLEIISGR 592
             Y APE  MG  +   + +++S GV L  ++   
Sbjct: 193 IEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  101 bits (253), Expect = 3e-23
 Identities = 56/238 (23%), Positives = 92/238 (38%), Gaps = 37/238 (15%)

Query: 368 GGKQQAESQEFPLFPLRLALEA-TNHFSDE-----NKLGQGGFGPVYKGT-LADGKAIAV 420
                   Q+FP F ++  L+   N   D+       LG G  G V +       +  A+
Sbjct: 33  AQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFAL 92

Query: 421 KRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLG----CCLEGQELLLIYEYMPNKSLD 475
           K L         + + EV L  +     ++VR++          + LL++ E +    L 
Sbjct: 93  KMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL- 146

Query: 476 VHLFDATRSVQLDWKR---RQ--SIINGIARGILYLHEDSRLKIIHRDLKASNILL---D 527
              F   R      +    R+   I+  I   I YLH    + I HRD+K  N+L     
Sbjct: 147 ---FS--RIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKR 198

Query: 528 DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 585
            +   K++DFG A+    + N   T     T  Y+APE      +    D++S GV++
Sbjct: 199 PNAILKLTDFGFAKETTSH-NSLTT--PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 98.9 bits (247), Expect = 5e-23
 Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 24/208 (11%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT------SGQGLQEFKNEVNLIAKL----QHK 447
           LG+GGFG V+ G  L D   +A+K + R                 EV L+ K+     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIARGILYL 506
            ++RLL      +  +L+ E  P  + D  LFD  T    L     +     +   I + 
Sbjct: 99  GVIRLLDWFETQEGFMLVLER-PLPAQD--LFDYITEKGPLGEGPSRCFFGQVVAAIQHC 155

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNP-KISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           H      ++HRD+K  NIL+D      K+ DFG   +              GT  Y  PE
Sbjct: 156 H---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE----PYTDFDGTRVYSPPE 208

Query: 566 YAMGGIFS-IKSDVFSFGVLLLEIISGR 592
           +     +  + + V+S G+LL +++ G 
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGD 236

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  101 bits (254), Expect = 1e-22
 Identities = 65/235 (27%), Positives = 103/235 (43%), Gaps = 29/235 (12%)

Query: 374 ESQEFPLFPLRLALEATNHFSDEN-----KLGQGGFGPVY----KGTLADGKAIAVKRLS 424
           ES +F  F     +E   H +  +      +G+GGFG VY      T   GK  A+K L 
Sbjct: 167 ESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADT---GKMYAMKCLD 223

Query: 425 RT---SGQGLQEFKNEVNLIAKLQHKN---LVRLLGCCLEGQELLLIYEYMPNKSLDVHL 478
           +      QG     NE  +++ +   +   +V +        +L  I + M    L  HL
Sbjct: 224 KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL 283

Query: 479 FDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG 538
              ++         +     I  G+ ++H      +++RDLK +NILLD+  + +ISD G
Sbjct: 284 ---SQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLG 337

Query: 539 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKS-DVFSFGVLLLEIISGR 592
           LA  F   +     +   GT+GYMAPE    G+    S D FS G +L +++ G 
Sbjct: 338 LACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 98.9 bits (247), Expect = 1e-22
 Identities = 53/222 (23%), Positives = 95/222 (42%), Gaps = 26/222 (11%)

Query: 388 EATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQE--FKN--------- 436
              + ++ +  +  G +G V  G  ++G  +A+KR+  T   G       +         
Sbjct: 19  AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78

Query: 437 EVNLIAKLQHKNLVRLLGCCL-----EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 491
           E+ L+    H N++ L    +        +L L+ E M     D+      + + +  + 
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT---DLAQVIHDQRIVISPQH 135

Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
            Q  +  I  G+  LHE     ++HRDL   NILL D+ +  I DF LAR    + N+  
Sbjct: 136 IQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANK-- 190

Query: 552 TNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGR 592
           T+ +     Y APE  M    F+   D++S G ++ E+ + +
Sbjct: 191 THYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 96.1 bits (240), Expect = 3e-22
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 24/204 (11%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
           LG G FG V  G     G  +AVK L+R    S   + + K E+  +   +H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRR--QSIINGIARGILYLHED 509
                 +  ++ EY+    L    FD       V+    RR  Q I++ +     Y H  
Sbjct: 79  VISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVD----YCH-- 128

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 569
            R  ++HRDLK  N+LLD  MN KI+DFGL+ +         T+   G+  Y APE   G
Sbjct: 129 -RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTS--CGSPNYAAPEVISG 184

Query: 570 GIFS-IKSDVFSFGVLLLEIISGR 592
            +++  + D++S GV+L  ++ G 
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGT 208

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 97.8 bits (244), Expect = 3e-22
 Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 35/221 (15%)

Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 437
                + +   +G G  G V         + +A+K+LSR        F+N         E
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRE 74

Query: 438 VNLIAKLQHKNLVRLL------GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 491
           + L+  + HKN++ LL          E Q++ ++ E M     D +L    +  +LD +R
Sbjct: 75  LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQM-ELDHER 128

Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
              ++  +  GI +LH      IIHRDLK SNI++  D   KI DFGLAR  G   +   
Sbjct: 129 MSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMM 183

Query: 552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           T  +  T  Y APE  +G  +    D++S G ++ E+I G 
Sbjct: 184 TPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 95.0 bits (237), Expect = 2e-21
 Identities = 65/204 (31%), Positives = 105/204 (51%), Gaps = 25/204 (12%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQE-FKNEVNLIAKLQHKNLVRLLG 454
           LG+G FG V   T     + +A+K +SR       +    + E++ +  L+H ++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRR--QSIINGIARGILYLHED 509
                 +++++ EY   +     LFD     + +  D  RR  Q II  I     Y H  
Sbjct: 77  VITTPTDIVMVIEYAGGE-----LFDYIVEKKRMTEDEGRRFFQQIICAIE----YCH-- 125

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 569
            R KI+HRDLK  N+LLDD++N KI+DFGL+ I     N   T+   G+  Y APE   G
Sbjct: 126 -RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTS--CGSPNYAAPEVING 181

Query: 570 GIFS-IKSDVFSFGVLLLEIISGR 592
            +++  + DV+S G++L  ++ GR
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGR 205

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 95.1 bits (237), Expect = 3e-21
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 37/222 (16%)

Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 437
           E    + D   +G G +G V        G  +A+K+L R        F++         E
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRE 74

Query: 438 VNLIAKLQHKNLVRLL------GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 491
           + L+  ++H+N++ LL          +  +  L+  +M        L    +  +L   R
Sbjct: 75  LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDR 129

Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
            Q ++  + +G+ Y+H      IIHRDLK  N+ +++D   KI DFGLAR          
Sbjct: 130 IQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---- 182

Query: 552 TNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGR 592
           T  +  T  Y APE  +    ++   D++S G ++ E+I+G+
Sbjct: 183 TGYVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 96.4 bits (240), Expect = 3e-21
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 24/204 (11%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
           LG G FG V  G     G  +AVK L+R    S   + + + E+  +   +H ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 455 CCLEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRR--QSIINGIARGILYLHED 509
                 ++ ++ EY+        LFD       +     RR  Q I++G+     Y H  
Sbjct: 84  VISTPSDIFMVMEYVSGG----ELFDYICKNGRLDEKESRRLFQQILSGVD----YCH-- 133

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 569
            R  ++HRDLK  N+LLD  MN KI+DFGL+ +         T+   G+  Y APE   G
Sbjct: 134 -RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTS--CGSPNYAAPEVISG 189

Query: 570 GIFS-IKSDVFSFGVLLLEIISGR 592
            +++  + D++S GV+L  ++ G 
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGT 213

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 96.1 bits (239), Expect = 3e-21
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 35/221 (15%)

Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 437
                + +   +G G  G V         + +A+K+LSR        F+N         E
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRE 111

Query: 438 VNLIAKLQHKNLVRLL------GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 491
           + L+  + HKN++ LL          E Q++ L+ E M     ++        ++LD +R
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA---NLC---QVIQMELDHER 165

Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
              ++  +  GI +LH      IIHRDLK SNI++  D   KI DFGLAR  G   +   
Sbjct: 166 MSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMM 220

Query: 552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           T  +  T  Y APE  +G  +    D++S G ++ E++  +
Sbjct: 221 TPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 94.0 bits (234), Expect = 6e-21
 Identities = 54/253 (21%), Positives = 103/253 (40%), Gaps = 69/253 (27%)

Query: 390 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKN-EVNLIAKLQHK 447
           +  +S    LG G FG V +    + GK  A+K++ +        +KN E++++  L H 
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVLDHV 60

Query: 448 NLVRLLGC--------------------------------------CLEGQELLLIYEYM 469
           N+++L+                                          + + L +I EY+
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 470 PNKSLDVHLFDATRSVQLDWKRRQSIING--------IARGILYLHEDSRLKIIHRDLKA 521
           P     +H     + ++   +  +SI           + R + ++H    L I HRD+K 
Sbjct: 121 P---DTLH-----KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKP 169

Query: 522 SNILLD-DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVF 579
            N+L++  D   K+ DFG A+      ++ +   I   + Y APE  +G   ++   D++
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEYTPSIDLW 226

Query: 580 SFGVLLLEIISGR 592
           S G +  E+I G+
Sbjct: 227 SIGCVFGELILGK 239

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 93.1 bits (232), Expect = 1e-20
 Identities = 50/223 (22%), Positives = 106/223 (47%), Gaps = 35/223 (15%)

Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 437
           +    +++ + +G+G +G V       +   +A+K++S         F++         E
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLRE 75

Query: 438 VNLIAKLQHKNLVRLLGCCL-----EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR 492
           + ++ + +H+N++ +          + +++ ++ + M     +  L+   ++  L     
Sbjct: 76  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHI 130

Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN- 551
              +  I RG+ Y+H  +   ++HRDLK SN+LL+   + KI DFGLAR+   + +    
Sbjct: 131 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187

Query: 552 -TNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGR 592
            T  +A T  Y APE  +    ++   D++S G +L E++S R
Sbjct: 188 LTEYVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 93.1 bits (231), Expect = 1e-20
 Identities = 39/97 (40%), Positives = 54/97 (55%), Gaps = 13/97 (13%)

Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           +A+G+ +L   +  K IHRDL A NILL +    KI DFGLAR         + + +   
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPDYVRKG 253

Query: 559 YG-----YMAPEYAMGGIFSIKSDVFSFGVLLLEIIS 590
                  +MAPE     +++I+SDV+SFGVLL EI S
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 71.1 bits (174), Expect = 2e-13
 Identities = 33/163 (20%), Positives = 60/163 (36%), Gaps = 19/163 (11%)

Query: 396 ENKLGQGGFGPVYKGTL------ADGKAIAVKRL-SRTSGQGLQEFKNEVNLIAKL-QHK 447
              LG+G FG V +         A  + +AVK L    +    +   +E+ ++  +  H 
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86

Query: 448 NLVRLLGCCL-EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
           N+V LLG C   G  L++I E+    +L  +L            +R   +    +G  + 
Sbjct: 87  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFR 136

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ 549
                +  I  DLK     +    +   S F   +     + +
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 52/222 (23%), Positives = 97/222 (43%), Gaps = 38/222 (17%)

Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 437
           E    +     +G G +G V        G+ +A+K+LSR        F++         E
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRE 73

Query: 438 VNLIAKLQHKNLVRLL------GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 491
           + L+  +QH+N++ LL             +  L+  +M        L       +   ++
Sbjct: 74  LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGL-KFSEEK 127

Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
            Q ++  + +G+ Y+H      ++HRDLK  N+ +++D   KI DFGLAR          
Sbjct: 128 IQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM---- 180

Query: 552 TNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGR 592
           T  +  T  Y APE  +    ++   D++S G ++ E+++G+
Sbjct: 181 TGYVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 91.9 bits (229), Expect = 2e-20
 Identities = 50/233 (21%), Positives = 101/233 (43%), Gaps = 46/233 (19%)

Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 437
           +  + + D   LG GG G V+        K +A+K++            +         E
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALRE 58

Query: 438 VNLIAKLQHKNLVRLL--------------GCCLEGQELLLIYEYMPNKSLDVHLFDATR 483
           + +I +L H N+V++               G   E   + ++ EYM     +  L +   
Sbjct: 59  IKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLE 113

Query: 484 SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARI 542
              L  +  +  +  + RG+ Y+H  +   ++HRDLK +N+ ++ +D+  KI DFGLARI
Sbjct: 114 QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARI 170

Query: 543 FGGNQNQAN--TNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
              + +     +  +  T  Y +P   +    ++   D+++ G +  E+++G+
Sbjct: 171 MDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 92.0 bits (229), Expect = 3e-20
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 20/201 (9%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKNLVRLLGCC 456
           +G G FG           + +AVK + R  G  + E  + E+     L+H N+VR     
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85

Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR--QSIINGIARGILYLHEDSRLKI 514
           L    L +I EY     L   + +A R    D  R   Q +++G++    Y H    ++I
Sbjct: 86  LTPTHLAIIMEYASGGELYERICNAGR-FSEDEARFFFQQLLSGVS----YCH---SMQI 137

Query: 515 IHRDLKASNILLDDD--MNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
            HRDLK  N LLD       KI DFG ++    + +Q  + +  GT  Y+APE  +   +
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV--GTPAYIAPEVLLRQEY 194

Query: 573 S-IKSDVFSFGVLLLEIISGR 592
               +DV+S GV L  ++ G 
Sbjct: 195 DGKIADVWSCGVTLYVMLVGA 215

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 91.6 bits (228), Expect = 4e-20
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 32/217 (14%)

Query: 391 NHFSDENKLGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEFKN---EVNLIAK 443
           +HF     +G+G FG V       T    K  A+K +++       E +N   E+ ++  
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71

Query: 444 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
           L+H  LV L     + +++ ++ + +    L  HL    ++V    +  +  I  +   +
Sbjct: 72  LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFKEETVKLFICELVMAL 128

Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            YL      +IIHRD+K  NILLD+  +  I+DF +A +      Q  T  +AGT  YMA
Sbjct: 129 DYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITT--MAGTKPYMA 182

Query: 564 PEYAMGGIFSIKS--------DVFSFGVLLLEIISGR 592
           PE     +FS +         D +S GV   E++ GR
Sbjct: 183 PE-----MFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 90.5 bits (225), Expect = 9e-20
 Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 37/222 (16%)

Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 437
           E    + + + +G G +G V        G  +AVK+LSR        F++         E
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRE 78

Query: 438 VNLIAKLQHKNLVRLL------GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 491
           + L+  ++H+N++ LL          E  ++ L+   M        L +  +  +L    
Sbjct: 79  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDH 133

Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
            Q +I  I RG+ Y+H      IIHRDLK SN+ +++D   KI DFGLAR          
Sbjct: 134 VQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEM---- 186

Query: 552 TNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGR 592
           T  +A T  Y APE  +    ++   D++S G ++ E+++GR
Sbjct: 187 TGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 91.0 bits (226), Expect = 1e-19
 Identities = 43/196 (21%), Positives = 85/196 (43%), Gaps = 31/196 (15%)

Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 437
           +  + +   + +G G +G V +     + + +A+K++ R        F++         E
Sbjct: 50  QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILRE 102

Query: 438 VNLIAKLQHKNLVRLL-----GCCLEGQELLLIYEYMPNKSLDVH-LFDATRSVQLDWKR 491
           + ++ +L H ++V++L         +  EL ++ E       D   LF     V L    
Sbjct: 103 IAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD---SDFKKLFRT--PVYLTELH 157

Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
            ++++  +  G+ Y+H      I+HRDLK +N L++ D + K+ DFGLAR     +N  +
Sbjct: 158 IKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS 214

Query: 552 TNIIAGTYGYMAPEYA 567
              I+     M     
Sbjct: 215 QLPISPREDDMNLVTF 230

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 88.5 bits (220), Expect = 3e-19
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 44/231 (19%)

Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLS---------RTSGQGLQEFKNE 437
             ++ F  ++ LG+G +G V   T    G+ +A+K++          RT    L+E K  
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT----LREIK-- 61

Query: 438 VNLIAKLQHKNLVRLL-----GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR 492
             ++   +H+N++ +             E+ +I E M        L     +  L     
Sbjct: 62  --ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDHI 114

Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
           Q  I    R +  LH  +   +IHRDLK SN+L++ + + K+ DFGLARI   +++ A+ 
Sbjct: 115 QYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADN 169

Query: 553 NIIAGTYGYM----------APEYAMG-GIFSIKSDVFSFGVLLLEIISGR 592
           +   G    M          APE  +    +S   DV+S G +L E+   R
Sbjct: 170 SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 87.5 bits (217), Expect = 2e-18
 Identities = 42/199 (21%), Positives = 87/199 (43%), Gaps = 31/199 (15%)

Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 437
              +++  ++ +G+G +G VY        K +A+K+++R        F++         E
Sbjct: 23  HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FEDLIDCKRILRE 75

Query: 438 VNLIAKLQHKNLVRLLGCCL-----EGQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKR 491
           + ++ +L+   ++RL    +     +  EL ++ E   +   D+      ++   L  + 
Sbjct: 76  ITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS---DLK--KLFKTPIFLTEEH 130

Query: 492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN 551
            ++I+  +  G  ++HE     IIHRDLK +N LL+ D + K+ DFGLAR     ++   
Sbjct: 131 IKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187

Query: 552 TNIIAGTYGYMAPEYAMGG 570
            N +            +  
Sbjct: 188 VNDLEENEEPGPHNKNLKK 206

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 54/209 (25%), Positives = 87/209 (41%), Gaps = 37/209 (17%)

Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEF---KNEVNLIAKLQHKNLVR 451
           LG G FG V     K +   G   A+K L +     L++     NE  ++  +    LV+
Sbjct: 49  LGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR--------GI 503
           L     +   L ++ EY+    +  HL           +R        AR          
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL-----------RRIGRFSEPHARFYAAQIVLTF 154

Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            YLH    L +I+RDLK  N+L+D     +++DFG A+   G      T  + GT   +A
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALA 206

Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           PE  +   ++   D ++ GVL+ E+ +G 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGY 235

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 84.3 bits (209), Expect = 5e-18
 Identities = 43/215 (20%), Positives = 72/215 (33%), Gaps = 64/215 (29%)

Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKN 448
           ++      LG G  G V +       +  A+K L         + + EV L  +  Q  +
Sbjct: 18  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPH 72

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVH----------LFDATRSVQLDWKR---RQ-- 493
           +VR++           +YE +      +           LF   R      +    R+  
Sbjct: 73  IVRIVD----------VYENLYAGRKCLLIVMECLDGGELFS--RIQDRGDQAFTEREAS 120

Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQA 550
            I+  I   I YLH    + I HRD+K  N+L      +   K++DFG A+         
Sbjct: 121 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-------- 169

Query: 551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLL 585
                   Y                 D++S GV++
Sbjct: 170 ---TTGEKYDK-------------SCDMWSLGVIM 188

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 84.7 bits (210), Expect = 8e-18
 Identities = 61/238 (25%), Positives = 110/238 (46%), Gaps = 48/238 (20%)

Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKN---------E 437
                +    KLG+G +G V+K      G+ +AVK++          F+N         E
Sbjct: 6   HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFRE 58

Query: 438 VNLIAKLQ-HKNLVRLLGCCL--EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQS 494
           + ++ +L  H+N+V LL        +++ L+++YM     +  L    R+  L+   +Q 
Sbjct: 59  IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQY 113

Query: 495 IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI 554
           ++  + + I YLH  S   ++HRD+K SNILL+ + + K++DFGL+R F   +   N   
Sbjct: 114 VVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170

Query: 555 IAGTYG-------------------YMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           ++                       Y APE  +G   ++   D++S G +L EI+ G+
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 84.4 bits (209), Expect = 2e-17
 Identities = 57/201 (28%), Positives = 84/201 (41%), Gaps = 17/201 (8%)

Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEF---KNEVNLIAKLQHKNLVR 451
           LG+G FG V     K T   G+  A+K L +       E      E  ++   +H  L  
Sbjct: 156 LGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
           L         L  + EY     L  HL   +R       R +     I   + YLH  S 
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLH--SE 267

Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 571
             +++RDLK  N++LD D + KI+DFGL +    +     T    GT  Y+APE      
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLEDND 325

Query: 572 FSIKSDVFSFGVLLLEIISGR 592
           +    D +  GV++ E++ GR
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGR 346

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 82.2 bits (204), Expect = 3e-17
 Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 37/209 (17%)

Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEF---KNEVNLIAKLQHKNLVR 451
           LG G FG V+    +     G+  A+K L +     L++     +E  +++ + H  ++R
Sbjct: 14  LGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR--------GI 503
           + G   + Q++ +I +Y+    L   L           ++ Q   N +A+         +
Sbjct: 71  MWGTFQDAQQIFMIMDYIEGGELFSLL-----------RKSQRFPNPVAKFYAAEVCLAL 119

Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            YLH      II+RDLK  NILLD + + KI+DFG A+          T  + GT  Y+A
Sbjct: 120 EYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIA 171

Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           PE      ++   D +SFG+L+ E+++G 
Sbjct: 172 PEVVSTKPYNKSIDWWSFGILIYEMLAGY 200

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 81.1 bits (201), Expect = 7e-17
 Identities = 59/200 (29%), Positives = 106/200 (53%), Gaps = 14/200 (7%)

Query: 399 LGQGGFGPVY---KGTLADGKAI-AVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRL 452
           LGQG FG V+   K + +D + + A+K L + +   +     K E +++ ++ H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 453 LGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRL 512
                   +L LI +++    L   L   ++ V    +  +  +  +A  + +LH    L
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLHS---L 145

Query: 513 KIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF 572
            II+RDLK  NILLD++ + K++DFGL++    ++ +A +    GT  YMAPE       
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRGH 203

Query: 573 SIKSDVFSFGVLLLEIISGR 592
           +  +D +SFGVL+ E+++G 
Sbjct: 204 TQSADWWSFGVLMFEMLTGT 223

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 81.2 bits (201), Expect = 7e-17
 Identities = 45/213 (21%), Positives = 92/213 (43%), Gaps = 23/213 (10%)

Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ- 445
              + +    KLG+G +  V++   + + + + VK L        ++ K E+ ++  L+ 
Sbjct: 33  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRG 89

Query: 446 HKNLVRLLGCCLEGQE--LLLIYEYMPNKSLDVH-LFDATRSVQLDWKRRQSIINGIARG 502
             N++ L     +       L++E++ N   D   L+       L     +  +  I + 
Sbjct: 90  GPNIITLADIVKDPVSRTPALVFEHVNN--TDFKQLYQT-----LTDYDIRFYMYEILKA 142

Query: 503 ILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           + Y H  S   I+HRD+K  N+++D +    ++ D+GLA     +  Q     +A  Y +
Sbjct: 143 LDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-F 196

Query: 562 MAPEYAMGGIFSIKS-DVFSFGVLLLEIISGRK 593
             PE  +       S D++S G +L  +I  ++
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 82.1 bits (203), Expect = 8e-17
 Identities = 48/214 (22%), Positives = 83/214 (38%), Gaps = 37/214 (17%)

Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVR 451
           +G+G FG V     K      K  A+K L++       E   F+ E +++     K +  
Sbjct: 82  IGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT 138

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR--------GI 503
           L     +   L L+ +Y     L   L           K    +   +AR         I
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLS----------KFEDRLPEEMARFYLAEMVIAI 188

Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
             +H+   L  +HRD+K  NIL+D + + +++DFG       +     +++  GT  Y++
Sbjct: 189 DSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQSSVAVGTPDYIS 244

Query: 564 PEYAMGGIFSIKS-----DVFSFGVLLLEIISGR 592
           PE                D +S GV + E++ G 
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 81.0 bits (201), Expect = 8e-17
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 22/205 (10%)

Query: 399 LGQGGFGPVY---KGTLADGKAI-AVKRLSRTSGQGLQEFKNEV-------NLIAKLQHK 447
           LG+GG+G V+   K T A+   I A+K L +     +     +        N++ +++H 
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAM---IVRNAKDTAHTKAERNILEEVKHP 81

Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
            +V L+     G +L LI EY+    L + L    R            +  I+  + +LH
Sbjct: 82  FIVDLIYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAEISMALGHLH 138

Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
           +     II+RDLK  NI+L+   + K++DFGL +    +    +T    GT  YMAPE  
Sbjct: 139 Q---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAPEIL 193

Query: 568 MGGIFSIKSDVFSFGVLLLEIISGR 592
           M    +   D +S G L+ ++++G 
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGA 218

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 81.7 bits (202), Expect = 1e-16
 Identities = 50/208 (24%), Positives = 86/208 (41%), Gaps = 23/208 (11%)

Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVR 451
           +G+G F  V     K T   G+  A+K +++       E   F+ E +++     + + +
Sbjct: 69  IGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
           L     +   L L+ EY     L   L      +  +  R    +  I   I  +H    
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMAR--FYLAEIVMAIDSVHR--- 180

Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE--YAMG 569
           L  +HRD+K  NILLD   + +++DFG       +     + +  GT  Y++PE   A+G
Sbjct: 181 LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVG 239

Query: 570 GIFSIKS-----DVFSFGVLLLEIISGR 592
           G     S     D ++ GV   E+  G+
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 81.7 bits (202), Expect = 1e-16
 Identities = 52/213 (24%), Positives = 84/213 (39%), Gaps = 38/213 (17%)

Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQE---FKNEVNLIAKLQHKNLVR 451
           +G+G FG V     K T    K  A+K LS+       +   F  E +++A      +V+
Sbjct: 77  IGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR--------GI 503
           L     + + L ++ EYMP   L   +                +    AR         +
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLM------------SNYDVPEKWARFYTAEVVLAL 181

Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
             +H    +  IHRD+K  N+LLD   + K++DFG              +   GT  Y++
Sbjct: 182 DAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYIS 237

Query: 564 PE--YAMGGIFSIKSDV--FSFGVLLLEIISGR 592
           PE   + GG      +   +S GV L E++ G 
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 80.3 bits (199), Expect = 1e-16
 Identities = 55/201 (27%), Positives = 84/201 (41%), Gaps = 18/201 (8%)

Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEF---KNEVNLIAKLQHKNLVR 451
           LG+G FG V     K T   G+  A+K L +       E      E  ++   +H  L  
Sbjct: 13  LGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
           L         L  + EY     L  HL   +R      +R +     I   + YLH    
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHS--- 123

Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 571
             +++RD+K  N++LD D + KI+DFGL +    +     T    GT  Y+APE      
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDND 181

Query: 572 FSIKSDVFSFGVLLLEIISGR 592
           +    D +  GV++ E++ GR
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGR 202

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 22/201 (10%), Positives = 53/201 (26%), Gaps = 45/201 (22%)

Query: 398 KLGQGGFGPVYKGTLAD---GKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVR 451
             G       ++    D    + +A+  +          LQE  +    ++++    + R
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSR 511
           +L         L++ E++   SL      +              +  +A      H   R
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAH---R 147

Query: 512 LKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI 571
             +       S + +  D +  ++                          M         
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPDA------ 179

Query: 572 FSIKSDVFSFGVLLLEIISGR 592
            + + D+   G  L  ++  R
Sbjct: 180 -NPQDDIRGIGASLYALLVNR 199

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 27/206 (13%)

Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEFKNEVN--------LIAKLQH 446
           LG+G FG V     K T   G   AVK L +     + +  ++V         L     H
Sbjct: 31  LGKGSFGKVMLARVKET---GDLYAVKVLKK---DVILQ-DDDVECTMTEKRILSLARNH 83

Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             L +L  C      L  + E++    L  H+    +S + D  R +     I   +++L
Sbjct: 84  PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI---QKSRRFDEARARFYAAEIISALMFL 140

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H+     II+RDLK  N+LLD + + K++DFG+ +    N     T    GT  Y+APE 
Sbjct: 141 HD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDYIAPEI 195

Query: 567 AMGGIFSIKSDVFSFGVLLLEIISGR 592
               ++    D ++ GVLL E++ G 
Sbjct: 196 LQEMLYGPAVDWWAMGVLLYEMLCGH 221

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 79.6 bits (197), Expect = 3e-16
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 27/206 (13%)

Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVN--------LIAKLQH 446
           LG+G FG V    +K T    +  A+K L +     +    ++V         L    +H
Sbjct: 25  LGKGSFGKVFLAEFKKT---NQFFAIKALKK----DVVLMDDDVECTMVEKRVLSLAWEH 77

Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             L  +       + L  + EY+    L  H+       + D  R       I  G+ +L
Sbjct: 78  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQFL 134

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H      I++RDLK  NILLD D + KI+DFG+ +       + NT    GT  Y+APE 
Sbjct: 135 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEI 189

Query: 567 AMGGIFSIKSDVFSFGVLLLEIISGR 592
            +G  ++   D +SFGVLL E++ G+
Sbjct: 190 LLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 80.8 bits (199), Expect = 4e-16
 Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 27/206 (13%)

Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVN--------LIAKLQH 446
           LG+G FG V     KGT    +  AVK L +     +    ++V         L    + 
Sbjct: 349 LGKGSFGKVMLSERKGT---DELYAVKILKK----DVVIQDDDVECTMVEKRVLALPGKP 401

Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             L +L  C      L  + EY+    L  H+    +  +            IA G+ +L
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI---QQVGRFKEPHAVFYAAEIAIGLFFL 458

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
                  II+RDLK  N++LD + + KI+DFG+ +    +     T    GT  Y+APE 
Sbjct: 459 QS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIAPEI 513

Query: 567 AMGGIFSIKSDVFSFGVLLLEIISGR 592
                +    D ++FGVLL E+++G+
Sbjct: 514 IAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 78.0 bits (193), Expect = 1e-15
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 31/208 (14%)

Query: 399 LGQGGFGPV----YKGTLADGKAIAVKRLSRTSGQGLQEFKNEVN--------LIAKLQH 446
           LG+G FG V     KGT    +  AVK L +     + +  ++V         L    + 
Sbjct: 28  LGKGSFGKVMLSERKGT---DELYAVKILKKDV---VIQ-DDDVECTMVEKRVLALPGKP 80

Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             L +L  C      L  + EY+    L  H+    +  +            IA G+ +L
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI---QQVGRFKEPHAVFYAAEIAIGLFFL 137

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR--IFGGNQNQANTNIIAGTYGYMAP 564
                  II+RDLK  N++LD + + KI+DFG+ +  I+ G      T    GT  Y+AP
Sbjct: 138 QS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT----TKTFCGTPDYIAP 190

Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E      +    D ++FGVLL E+++G+
Sbjct: 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 76.1 bits (188), Expect = 5e-15
 Identities = 57/206 (27%), Positives = 85/206 (41%), Gaps = 27/206 (13%)

Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEFKNEVN--------LIAKLQH 446
           +G+G FG V     K         AVK L +     L+  K E          L+  ++H
Sbjct: 46  IGKGSFGKVLLARHKAE---EVFYAVKVLQK--KAILK--KKEEKHIMSERNVLLKNVKH 98

Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV L        +L  + +Y+    L  HL    R       R +     IA  + YL
Sbjct: 99  PFLVGLHFSFQTADKLYFVLDYINGGELFYHL---QRERCFLEPRARFYAAEIASALGYL 155

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L I++RDLK  NILLD   +  ++DFGL +    + +  +T    GT  Y+APE 
Sbjct: 156 HS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEYLAPEV 210

Query: 567 AMGGIFSIKSDVFSFGVLLLEIISGR 592
                +    D +  G +L E++ G 
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGL 236

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 75.7 bits (187), Expect = 6e-15
 Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 27/206 (13%)

Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEFKNEVN--------LIAKLQH 446
           +G+G +  V     K T    +  A+K + +     L     +++              H
Sbjct: 17  IGRGSYAKVLLVRLKKT---DRIYAMKVVKK----ELVNDDEDIDWVQTEKHVFEQASNH 69

Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV L  C      L  + EY+    L  H+    R  +L  +  +     I+  + YL
Sbjct: 70  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEISLALNYL 126

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           HE     II+RDLK  N+LLD + + K++D+G+ +      +  +T    GT  Y+APE 
Sbjct: 127 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPEI 181

Query: 567 AMGGIFSIKSDVFSFGVLLLEIISGR 592
             G  +    D ++ GVL+ E+++GR
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGR 207

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 75.5 bits (186), Expect = 8e-15
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 27/206 (13%)

Query: 399 LGQGGFGPVY----KGTLADGKAIAVKRLSRTSGQGLQEFKNEVN--------LIAKLQH 446
           +G+G +  V     K T    +  A++ + +     L     +++              H
Sbjct: 60  IGRGSYAKVLLVRLKKT---DRIYAMRVVKK----ELVNDDEDIDWVQTEKHVFEQASNH 112

Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV L  C      L  + EY+    L  H+    R  +L  +  +     I+  + YL
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEISLALNYL 169

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           HE     II+RDLK  N+LLD + + K++D+G+ +      +  +T    GT  Y+APE 
Sbjct: 170 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPEI 224

Query: 567 AMGGIFSIKSDVFSFGVLLLEIISGR 592
             G  +    D ++ GVL+ E+++GR
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGR 250

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 73.9 bits (182), Expect = 3e-14
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 22/207 (10%)

Query: 399 LGQGGFGPVY---KGTLADGKAI-AVKRLSRTS----GQGLQEFKNEVNLIAKLQHKN-L 449
           LG G +G V+   K +  D   + A+K L + +     +  +  + E  ++  ++    L
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121

Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           V L        +L LI +Y+    L  HL   ++  +      Q  +  I   + +LH+ 
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHL---SQRERFTEHEVQIYVGEIVLALEHLHK- 177

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE---- 565
             L II+RD+K  NILLD + +  ++DFGL++ F  ++ +       GT  YMAP+    
Sbjct: 178 --LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRG 234

Query: 566 YAMGGIFSIKSDVFSFGVLLLEIISGR 592
              G   ++  D +S GVL+ E+++G 
Sbjct: 235 GDSGHDKAV--DWWSLGVLMYELLTGA 259

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 69.5 bits (169), Expect = 5e-13
 Identities = 31/217 (14%), Positives = 61/217 (28%), Gaps = 52/217 (23%)

Query: 371 QQAESQEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--- 427
            Q     F           T       K+G+G FG V++   AD   +A+K ++      
Sbjct: 6   SQKGPVPFSHCL------PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDL 58

Query: 428 -----GQGLQEFKNEVNLIAKLQ---------HKNLVRLLGCCL----EGQELLLIYEYM 469
                 +  +E   E+ +  +L           +  + L             LL  +++ 
Sbjct: 59  VNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHY 118

Query: 470 PNK----------------------SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
            +                              +  R+        +SI++ +   +    
Sbjct: 119 NSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE 178

Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG 544
               L+  HRDL   N+LL      K+      +   
Sbjct: 179 A--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSST 213

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 69.3 bits (170), Expect = 8e-13
 Identities = 49/220 (22%), Positives = 94/220 (42%), Gaps = 38/220 (17%)

Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ----------- 445
           KLG G F  V+    + +   +A+K + R      +  ++E+ L+ ++            
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 446 HKNLVRLLGC----CLEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRRQSIING 498
             ++++LL         G  +++++E      L  +L           +     + I   
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHRGIPLIYVKQISKQ 139

Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNP------KISDFGLARIFGGNQNQANT 552
           +  G+ Y+H   R  IIH D+K  N+L++   +P      KI+D G A       ++  T
Sbjct: 140 LLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW----YDEHYT 193

Query: 553 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           N I  T  Y +PE  +G  +   +D++S   L+ E+I+G 
Sbjct: 194 NSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 51/218 (23%), Positives = 88/218 (40%), Gaps = 30/218 (13%)

Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVK---RLSRTSGQGLQEFKNEVNLIAKLQ 445
            + +  ++ +G+G FG V K     + + +A+K          Q       EV L+  + 
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMN 108

Query: 446 H------KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ---LDWKRRQSII 496
                    +V L    +    L L++E      L  +L+D  R+     +     +   
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFA 163

Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNI 554
             +   +L+L     L IIH DLK  NILL +      KI DFG +        Q     
Sbjct: 164 QQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ----LGQRIYQY 218

Query: 555 IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           I   + Y +PE  +G  + +  D++S G +L+E+ +G 
Sbjct: 219 IQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 64.4 bits (157), Expect = 4e-11
 Identities = 47/209 (22%), Positives = 89/209 (42%), Gaps = 32/209 (15%)

Query: 399 LGQGGFGPVYKGT-LADGKAIAVKRL---SRTSGQGLQEFKNEVNLIAKLQHK------N 448
           +G+G FG V K       + +A+K +    R   Q       E+ ++  L+ +      N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA----EEIRILEHLRKQDKDNTMN 160

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRRQSIINGIARGILY 505
           ++ +L        + + +E      L ++L++     +         +   + I + +  
Sbjct: 161 VIHMLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDA 215

Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
           LH   + +IIH DLK  NILL        K+ DFG +      ++Q     I   + Y A
Sbjct: 216 LH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY----EHQRVYTYIQSRF-YRA 267

Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           PE  +G  + +  D++S G +L E+++G 
Sbjct: 268 PEVILGARYGMPIDMWSLGCILAELLTGY 296

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 41/158 (25%), Positives = 70/158 (44%), Gaps = 13/158 (8%)

Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
           N +    K+G G FG +Y GT +A G+ +A+K     +     +   E  +   +Q    
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 66

Query: 450 V-RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
           +  +  C  EG   +++ E +   SL+  LF+   S +   K    + + +   I Y+H 
Sbjct: 67  IPTIRWCGAEGDYNVMVMELL-GPSLE-DLFNFC-SRKFSLKTVLLLADQMISRIEYIHS 123

Query: 509 DSRLKIIHRDLKASNILLDDDMNPK---ISDFGLARIF 543
            +    IHRD+K  N L+          I DFGLA+ +
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 54.5 bits (131), Expect = 5e-08
 Identities = 50/268 (18%), Positives = 93/268 (34%), Gaps = 94/268 (35%)

Query: 398 KLGQGGFGPVYKG-TLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ--------HKN 448
           KLG G F  V+    +   K +A+K + +++    +   +E+ L+  ++         + 
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102

Query: 449 LVRLLGC-----------CL--E--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ 493
           +V+LL             C+  E  G  LL        + L +                +
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCV-------------K 149

Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNILL--------------------------- 526
            II  + +G+ YLH  ++ +IIH D+K  NILL                           
Sbjct: 150 KIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207

Query: 527 ----------------------DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
                                  + +  KI+D G A       ++  T  I  T  Y + 
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV----HKHFTEDI-QTRQYRSL 262

Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E  +G  ++  +D++S   +  E+ +G 
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGD 290

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 53.5 bits (129), Expect = 7e-08
 Identities = 36/166 (21%), Positives = 73/166 (43%), Gaps = 27/166 (16%)

Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
            H+    ++G+G FG +++GT L + + +A+K   R S     + ++E      L     
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 67

Query: 450 V-RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI--INGIARGIL-- 504
           +  +     EG   +L+ + +   SL+  L D          R+ S+  +   A+ +L  
Sbjct: 68  IPNVYYFGQEGLHNVLVIDLLG-PSLE-DLLDLC-------GRKFSVKTVAMAAKQMLAR 118

Query: 505 --YLHEDSRLKIIHRDLKASNILLDDDMNPK-----ISDFGLARIF 543
              +HE S   +++RD+K  N L+    +       + DFG+ + +
Sbjct: 119 VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 38/166 (22%), Positives = 66/166 (39%), Gaps = 27/166 (16%)

Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH-KN 448
            +F    K+G G FG +  G  L   + +A+K     S     +   E     +L     
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDG 66

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI--INGIARGIL-- 504
           + ++      G+   ++ E +   SL+  LFD          R  S+  +  IA  ++  
Sbjct: 67  IPQVYYFGPCGKYNAMVLELL-GPSLE-DLFDLC-------DRTFSLKTVLMIAIQLISR 117

Query: 505 --YLHEDSRLKIIHRDLKASNILLDDDMNPK-----ISDFGLARIF 543
             Y+H  +   +I+RD+K  N L+    N       I DF LA+ +
Sbjct: 118 MEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 40/165 (24%), Positives = 69/165 (41%), Gaps = 27/165 (16%)

Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
           N F    K+G G FG +Y GT +   + +A+K  +  +     +   E  +   LQ    
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTG 64

Query: 450 V-RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSI-------INGIAR 501
           +  +    +EG   +L+ + +   SL+  LF+          R+ S+          I R
Sbjct: 65  IPNVRWFGVEGDYNVLVMDLL-GPSLE-DLFNFC-------SRKLSLKTVLMLADQMINR 115

Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPK---ISDFGLARIF 543
            + ++H  S    +HRD+K  N L+          I DFGLA+ +
Sbjct: 116 -VEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 40/181 (22%), Positives = 67/181 (37%), Gaps = 39/181 (21%)

Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAI------AVKRLSRTSGQGLQEFK-----NEVN 439
             +     +GQGGFG +Y   +   +++       VK     +G    E K      +  
Sbjct: 35  AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94

Query: 440 LIAKLQHKNLVRLLGCCL---EGQELLLIYEY----MP--NKSLDVHLFDATRSVQLDWK 490
            I K      ++ LG       G        Y    M      L   +++A         
Sbjct: 95  QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQ-KIYEAN-------A 146

Query: 491 RRQSI--INGIARGIL----YLHEDSRLKIIHRDLKASNILLDDDMNPKI--SDFGLARI 542
           +R S   +  ++  IL    Y+HE      +H D+KASN+LL+     ++   D+GLA  
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203

Query: 543 F 543
           +
Sbjct: 204 Y 204

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 50.8 bits (122), Expect = 6e-07
 Identities = 44/227 (19%), Positives = 82/227 (36%), Gaps = 50/227 (22%)

Query: 398 KLGQGGFGPVYKG--TLADGKAIAVK---RLSRTSGQGLQEFKNEVNLIAKLQHK----- 447
            LG+G FG V +          +A+K    + +       E    +N++ K++ K     
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----INVLKKIKEKDKENK 81

Query: 448 -NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRRQSIINGIARGI 503
              V +         + + +E      L  + F+               + +   +   +
Sbjct: 82  FLCVLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL 136

Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNP-------------------KISDFGLARIFG 544
            +LHE    ++ H DLK  NIL  +                       +++DFG A  F 
Sbjct: 137 RFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA-TF- 191

Query: 545 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
              ++ +T I+A  + Y  PE  +   ++   DV+S G +L E   G
Sbjct: 192 --DHEHHTTIVATRH-YRPPEVILELGWAQPCDVWSIGCILFEYYRG 235

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 50.9 bits (122), Expect = 6e-07
 Identities = 30/180 (16%), Positives = 66/180 (36%), Gaps = 37/180 (20%)

Query: 391 NHFSDENKLGQGGFGPVYKGT---------LADGKAIAVKRLSRTSGQGLQEFK------ 435
             +  ++   +   G +Y+               +  ++K L    G+   E        
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100

Query: 436 --NEVNLIAKLQHKNLV---RLLGCCLEGQEL-LLIYEYMPNKSLDVHLFDATRSVQLDW 489
              +VN   KL    L+     +G  +   +   L+   +  +SL     D +    L  
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQ-SALDVSPKHVLSE 158

Query: 490 KRRQSIINGIARGIL----YLHEDSRLKIIHRDLKASNILLDDDMNPKI--SDFGLARIF 543
           +   S++  +A  +L    +LHE+     +H ++ A NI +D +   ++  + +G A  +
Sbjct: 159 R---SVLQ-VACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 50.8 bits (122), Expect = 7e-07
 Identities = 55/231 (23%), Positives = 93/231 (40%), Gaps = 54/231 (23%)

Query: 398 KLGQGGFGPVYKGT-LADGKAIAVK---RLSRTSGQGLQEFKNEVNLIAKLQH-----KN 448
           K+G G FG V     + + K  AVK    + + +       K E +++ K+Q+      N
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQ---LDWKRRQSIINGIARGILY 505
           +V+  G  +    + LI+E      L   L++            +  +     I + + Y
Sbjct: 98  IVKYHGKFMYYDHMCLIFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152

Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNP-------------------------KISDFGLA 540
           L +   + + H DLK  NILLDD                             K+ DFG A
Sbjct: 153 LRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209

Query: 541 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
             F   ++  + +II     Y APE  +   + + SD++SFG +L E+ +G
Sbjct: 210 -TF---KSDYHGSIINTRQ-YRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 49.0 bits (117), Expect = 3e-06
 Identities = 33/180 (18%), Positives = 61/180 (33%), Gaps = 40/180 (22%)

Query: 391 NHFSDENKLGQGGFGPVYKG----TLADGKAIAVKRLSRTSGQGLQEFK-----NEVNLI 441
           N +    K+G GGFG +Y               VK   + +G    E K      + + I
Sbjct: 37  NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96

Query: 442 AKLQHKNLVRLLG----------CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKR 491
            K   +  +  LG                   ++ E +    L   +             
Sbjct: 97  KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQ-KISG--------QNG 146

Query: 492 RQSI--INGIARGIL----YLHEDSRLKIIHRDLKASNILLDDDMNPKI--SDFGLARIF 543
                 +  +   +L    Y+HE+     +H D+KA+N+LL      ++  +D+GL+  +
Sbjct: 147 TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.5 bits (117), Expect = 3e-06
 Identities = 66/473 (13%), Positives = 127/473 (26%), Gaps = 115/473 (24%)

Query: 119 PDSVYGLYLCKFNVSFQSCQNCIVAAVNSVLQKCSGTKEAFIWYQVQ-ECMVRFSDHSSS 177
            D+V G     F       +  +   V  VL+        F+   ++ E           
Sbjct: 58  KDAVSGTLRL-FWTLLSKQEEMVQKFVEEVLRINYK----FLMSPIKTEQR--------- 103

Query: 178 IMDTSAPLCMKIFQNTYNVTKSLAQSFN--DVIAMPSLSSFRNATKRTNISNIIRLET-- 233
               S     +++    +   +  Q F   +V  +      R A      +  + ++   
Sbjct: 104 --QPSMM--TRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVL 159

Query: 234 -FGQCIPVLSVDDCRD-----CLNNTIRWIQRCFDPPGMGFGRILFPSCIMGFELYRYSK 287
             G+    +++D C        ++  I W+                P  ++        +
Sbjct: 160 GSGK--TWVALDVCLSYKVQCKMDFKIFWL---------NLKNCNSPETVLEMLQKLLYQ 208

Query: 288 V-PAVGALAPSSAPGGKRGRAISIAIGTTLS------ALIV---VLFGSFLWYRRRRHAR 337
           + P   + +  S+    R  +I   +   L        L+V   V         +  +A 
Sbjct: 209 IDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNV------QNAKAWNAF 262

Query: 338 DQEEK-----RNSQEVQFLHWEGRIRNHYAYNILRGGKQQAESQEFPLF-------PLRL 385
           +   K     R  Q   FL        H + +         E +   L        P  L
Sbjct: 263 NLSCKILLTTRFKQVTDFL--SAATTTHISLDHHSMTLTPDEVKS--LLLKYLDCRPQDL 318

Query: 386 ALEATNHFSDENKLGQGGFGPVYKGTLA--DG-KAIAVKRLSRTSGQGLQE--------- 433
             E        N           +  LA  D  K +   +L+      L           
Sbjct: 319 PREVLTT----NPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM 374

Query: 434 ------FKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQL 487
                 F    ++   L    L  L+   +   +++++   +   SL          V+ 
Sbjct: 375 FDRLSVFPPSAHIPTIL----LS-LIWFDVIKSDVMVVVNKLHKYSL----------VEK 419

Query: 488 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKAS-NILLD---DDMNPKISD 536
             K     I  I   +    +      +HR +    NI      DD+ P   D
Sbjct: 420 QPKESTISIPSIY--LELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLD 470

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.5 bits (117), Expect = 3e-06
 Identities = 44/329 (13%), Positives = 94/329 (28%), Gaps = 91/329 (27%)

Query: 326 SFLW--YRRRRHARDQEEKRNSQEVQFLHWEGRIRNHYA-YNILRGGKQQAESQEFPLFP 382
            FL    +  +       +   ++   L+ + ++   +A YN+ R           P   
Sbjct: 92  KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQV---FAKYNVSR---------LQPYLK 139

Query: 383 LRLALEATNHFSDENKL---GQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVN 439
           LR AL           +   G  G G   K  +A    + V    +       +   ++ 
Sbjct: 140 LRQALL---ELRPAKNVLIDGVLGSG---KTWVA----LDVCLSYKV----QCKMDFKIF 185

Query: 440 LIAKLQHKNLVRLLGCCLEGQELL-----LIYEYMPNKSLDVHLFDATRSVQLDWKRRQS 494
            +           L  C   + +L     L+Y+  PN +         +      +    
Sbjct: 186 WLN----------LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAE-- 233

Query: 495 IINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISD-FGL-ARIFGGNQNQANT 552
                           RL +  +  +   ++L +  N K  + F L  +I    + +  T
Sbjct: 234 --------------LRRL-LKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVT 278

Query: 553 NIIAGTYGY----------MAPEYAMGGIFS---------IKSDVFSFGVLLLEIISGRK 593
           + ++               + P+     +           +  +V +     L II+   
Sbjct: 279 DFLSAATTTHISLDHHSMTLTPDEVK-SLLLKYLDCRPQDLPREVLTTNPRRLSIIAESI 337

Query: 594 NNGFYFSEHGQTLLTYVCNSLS--LSLSL 620
            +G              C+ L+  +  SL
Sbjct: 338 RDGL---ATWDNWKHVNCDKLTTIIESSL 363

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 47.7 bits (114), Expect = 7e-06
 Identities = 47/227 (20%), Positives = 87/227 (38%), Gaps = 50/227 (22%)

Query: 398 KLGQGGFGPVYKG--TLADGKAIAVK---RLSRTSGQGLQEFKNEVNLIAKLQHK----- 447
            LG+G FG V +     A G+ +AVK    + R         ++E+ ++  L        
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNST 76

Query: 448 -NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD---ATRSVQLDWKRRQSIINGIARGI 503
              V++L        + +++E      L +  +D       +       + +   I + +
Sbjct: 77  FRCVQMLEWFEHHGHICIVFE-----LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131

Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNP-------------------KISDFGLARIFG 544
            +LH     K+ H DLK  NIL                          K+ DFG A  + 
Sbjct: 132 NFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA-TY- 186

Query: 545 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG 591
              ++ ++ +++  + Y APE  +   +S   DV+S G +L+E   G
Sbjct: 187 --DDEHHSTLVSTRH-YRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	621
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.98
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.98
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.98
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.98
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.98
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.98
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.98
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.97
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.97
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.97
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.97
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.97
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.97
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.97
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.97
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.97
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.97
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.97
3uqc_A	286	Probable conserved transmembrane protein; structur	99.97
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.96
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.96
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.93
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.78
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.77
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.75
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.61
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.3
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.12
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.97
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.91
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.56
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.48
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.39
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.38
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.29
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.26
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.0
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.89
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.82
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.81
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.51
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.34
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.25
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.21
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.18
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.13
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.07
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.77
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.75
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.73
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.41
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.42
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.21
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	92.01
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	85.76
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	84.83
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	82.52
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	80.5

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.7e-46  Score=384.92  Aligned_cols=205  Identities=31%  Similarity=0.519  Sum_probs=179.9

Q ss_pred             CCCCccceeccCCceeEEEEEec------CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      ++|.+.++||+|+||.||+|++.      ++..||||+++..+....++|.+|+++|++++|||||+++|++.+++..++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            46788899999999999999863      478899999987777777889999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhhcc----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEE
Q 007006          465 IYEYMPNKSLDVHLFDAT----------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI  534 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL  534 (621)
                      ||||+++|+|.++|+...          ....++|.++++|+.||++||.|||+++   |+||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            999999999999996532          2356999999999999999999999986   999999999999999999999


Q ss_pred             eeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          535 SDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       535 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      +|||+++...............||+.|||||++.+..++.++|||||||++|||+| |+.||...
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~  234 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL  234 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            99999987654433333344578999999999999999999999999999999999 89998643

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=7.6e-46  Score=385.27  Aligned_cols=204  Identities=31%  Similarity=0.503  Sum_probs=172.6

Q ss_pred             CCCCccceeccCCceeEEEEEec------CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      ++|.+.++||+|+||.||+|++.      +++.||||+++..+....++|.+|+++|++++|||||+++|+|.+++.++|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            46777889999999999999864      478999999988777777889999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhhccC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCe
Q 007006          465 IYEYMPNKSLDVHLFDATR------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP  532 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~v  532 (621)
                      ||||+++|+|.++++....            ..+++|.++++|+.||++||.|||+.+   |+||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            9999999999999965322            346999999999999999999999985   9999999999999999999


Q ss_pred             EEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          533 KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       533 kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      ||+|||+++...............||+.|||||++.+..++.++|||||||+||||+| |+.||..
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~  263 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ  263 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC
Confidence            9999999987655444444445678999999999999999999999999999999999 8999864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.4e-45  Score=379.73  Aligned_cols=204  Identities=35%  Similarity=0.501  Sum_probs=177.2

Q ss_pred             CCCccceeccCCceeEEEEEec------CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      ++...++||+|+||+||+|++.      +++.||||+++... ....++|.+|+.+|++++|||||+++|+|.+++.+++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            4566789999999999999863      46889999997543 3456789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhhccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCC
Q 007006          465 IYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN  531 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~  531 (621)
                      ||||+++|+|.++|.....             ...++|.++++|+.||++||+|||+.+   |+||||||+||||++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence            9999999999999964321             246999999999999999999999986   999999999999999999


Q ss_pred             eEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          532 PKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       532 vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      +||+|||+++...............||+.|||||++.++.++.++|||||||+||||+| |+.||...
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~  251 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY  251 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Confidence            99999999987654443334445678999999999999999999999999999999999 89998643

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.4e-45  Score=377.84  Aligned_cols=201  Identities=27%  Similarity=0.410  Sum_probs=182.8

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|++.+.||+|+||+||+++. .+|+.||||++.+.   .....+.+.+|+++|++++|||||++++++.+++.+++||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5799999999999999999996 46999999999754   2345678999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            99999999999954   346999999999999999999999986   999999999999999999999999999987655


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .........+||+.|||||++.+..++.++||||+||++|||+||++||..
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~  236 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA  236 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            555555667899999999999999999999999999999999999999964

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=5.2e-45  Score=374.26  Aligned_cols=200  Identities=32%  Similarity=0.534  Sum_probs=168.0

Q ss_pred             hCCCCccceeccCCceeEEEEEecCCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      .+++.+.++||+|+||+||+|+++  ..||||+++..  +.+..+.|.+|+++|++++|||||+++|++.+ +.++||||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            356788899999999999999875  36999998754  34456789999999999999999999998865 56899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |+++|+|.++|..  ....+++.++.+|+.||+.||.|||+++   |+||||||+||||++++.+||+|||+++......
T Consensus       112 y~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          112 WCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             CCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             cCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            9999999999964  3356999999999999999999999985   9999999999999999999999999998765444


Q ss_pred             CCcccccccccCCccChhcccC---CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .........||+.|||||++.+   +.++.++|||||||+||||+||+.||..
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~  239 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSH  239 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCC
Confidence            3344455689999999999864   4589999999999999999999999964

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.7e-45  Score=380.22  Aligned_cols=198  Identities=26%  Similarity=0.431  Sum_probs=179.6

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      +.|+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++.++|||||+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46889999999999999999964 69999999998766666677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++|+|.+++..    ..+++.++..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.+..... 
T Consensus       154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-  225 (346)
T 4fih_A          154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  225 (346)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred             CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence            99999998853    35999999999999999999999986   99999999999999999999999999997654322 


Q ss_pred             cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                       .....+||+.|||||++.+..|+.++|||||||++|||++|++||..
T Consensus       226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~  272 (346)
T 4fih_A          226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN  272 (346)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence             23346899999999999999999999999999999999999999853

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.6e-45  Score=380.10  Aligned_cols=201  Identities=23%  Similarity=0.408  Sum_probs=172.8

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      ++|++.++||+|+||+||+++. .+|+.||||++.+..  ....+.+.+|+++|++++|||||++++++.+++.+++|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            5899999999999999999996 469999999997543  3445779999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |+++|+|.+++.. .+...+++.+++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++..... 
T Consensus       104 y~~gg~L~~~i~~-~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-  178 (350)
T 4b9d_A          104 YCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-  178 (350)
T ss_dssp             CCTTCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred             CCCCCcHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence            9999999999954 23456899999999999999999999986   999999999999999999999999999865321 


Q ss_pred             CCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                       .......+||+.|||||++.+..|+.++|||||||++|||+||++||..
T Consensus       179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~  227 (350)
T 4b9d_A          179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA  227 (350)
T ss_dssp             -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence             1122346799999999999999999999999999999999999999964

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4e-44  Score=381.49  Aligned_cols=197  Identities=26%  Similarity=0.439  Sum_probs=179.6

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      +.|+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++.++||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56999999999999999999964 69999999998776666778999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++|+|.+++..    ..+++.++..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.+..... 
T Consensus       231 ~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-  302 (423)
T 4fie_A          231 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  302 (423)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-
T ss_pred             CCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc-
Confidence            99999998843    35999999999999999999999986   99999999999999999999999999997654322 


Q ss_pred             cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                       .....+||+.|||||++.+..|+.++|||||||++|||++|++||.
T Consensus       303 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~  348 (423)
T 4fie_A          303 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF  348 (423)
T ss_dssp             -CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence             2344689999999999999999999999999999999999999985

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-43  Score=361.15  Aligned_cols=194  Identities=29%  Similarity=0.434  Sum_probs=168.2

Q ss_pred             CccceeccCCceeEEEEEec-CCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEee----CceEEEEE
Q 007006          394 SDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELLLIY  466 (621)
Q Consensus       394 ~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~----~~~~~lV~  466 (621)
                      ...++||+|+||.||+|.+. ++..||+|++...  .....+.|.+|+++|++++|||||++++++.+    ++.+++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            55678999999999999864 6899999999754  33445779999999999999999999999875    34689999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc-CCCCeEEeeecCceecCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGG  545 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~vkL~Dfgla~~~~~  545 (621)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+++ ++|+||||||+||||+ .++.+||+|||+++....
T Consensus       109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            99999999999954   346999999999999999999999874 4699999999999998 479999999999975432


Q ss_pred             CCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                          ......+||+.|||||++.+ .++.++|||||||++|||+||+.||.
T Consensus       185 ----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~  230 (290)
T 3fpq_A          185 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS  230 (290)
T ss_dssp             ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             ----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence                22345689999999998865 69999999999999999999999995

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.6e-44  Score=369.72  Aligned_cols=197  Identities=27%  Similarity=0.355  Sum_probs=171.1

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      +.|...++||+|+||.||+++.. +|+.||||+++....     ..+|+.+|++++|||||++++++.+++.++|||||+
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            56788899999999999999964 699999999976432     247999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC-CeEEeeecCceecCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIFGGNQN  548 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~vkL~Dfgla~~~~~~~~  548 (621)
                      ++|+|.+++..   ...+++.++..++.||+.||+|||+++   |+||||||+||||+.++ .+||+|||+++.+.....
T Consensus       133 ~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          133 EGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             TTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            99999999954   346999999999999999999999986   99999999999999987 699999999998754322


Q ss_pred             Cc---ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          549 QA---NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       549 ~~---~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ..   .....+||+.|||||++.+..++.++|||||||++|||+||++||...
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~  259 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY  259 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred             ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence            21   223467999999999999999999999999999999999999999643

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.3e-43  Score=356.45  Aligned_cols=197  Identities=26%  Similarity=0.464  Sum_probs=162.1

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|++.+.||+|+||+||+++. .+|+.||||++++..   ....+.+.+|+++|++++|||||++++++.+++..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            5899999999999999999995 469999999997542   344567999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+ +|+|.+++..   ...+++.++..++.||+.||+|||+++   |+||||||+|||++.++++||+|||+++.....
T Consensus        93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 6889888854   346999999999999999999999986   999999999999999999999999999875432


Q ss_pred             CCCcccccccccCCccChhcccCCCC-ChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .   .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||..
T Consensus       166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~  214 (275)
T 3hyh_A          166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD  214 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC
Confidence            2   2234689999999999988876 6899999999999999999999963

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.8e-44  Score=368.00  Aligned_cols=199  Identities=28%  Similarity=0.375  Sum_probs=169.1

Q ss_pred             CCCCccceeccCCceeEEEEEec----CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      ++|++.+.||+|+||+||+++..    .++.||||++++..  ......+.+|+++|++++|||||++++++.+++.+++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            46999999999999999999852    47899999997542  2334568899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      ||||+++|+|.+++..   ...+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            9999999999999954   346999999999999999999999986   9999999999999999999999999998654


Q ss_pred             CCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ....  .....+||+.|||||++.+..++.++||||+||++|||+||++||..
T Consensus       178 ~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~  228 (304)
T 3ubd_A          178 DHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG  228 (304)
T ss_dssp             ---C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC
Confidence            3222  22346899999999999999999999999999999999999999964

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.5e-43  Score=367.43  Aligned_cols=207  Identities=30%  Similarity=0.434  Sum_probs=179.0

Q ss_pred             HHhCCCCccceeccCCceeEEEEEecC------CcEEEEEEeccCCc-ccHHHHHHHHHHHHhccc-CCceeEeeEEeeC
Q 007006          388 EATNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQH-KNLVRLLGCCLEG  459 (621)
Q Consensus       388 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~h-~nIv~l~g~~~~~  459 (621)
                      ...++|++.++||+|+||.||+|.+..      ++.||||++..... ...+.|.+|+++|.+++| ||||+++|+|.++
T Consensus        61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~  140 (353)
T 4ase_A           61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP  140 (353)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence            345789999999999999999998542      46899999976543 345679999999999965 8999999999765


Q ss_pred             -ceEEEEEEecCCCChhhhhhhccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEE
Q 007006          460 -QELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNIL  525 (621)
Q Consensus       460 -~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NIL  525 (621)
                       +.+++|||||++|+|.++|+....             ...+++.++..++.||++||.|||+++   |+||||||+|||
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NIL  217 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL  217 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCcccee
Confidence             568999999999999999975322             345899999999999999999999986   999999999999


Q ss_pred             EcCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          526 LDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       526 l~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      +++++.+||+|||+++....+..........||+.|||||++.+..++.++|||||||+||||+| |+.||..
T Consensus       218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            99999999999999997755544444455678999999999999999999999999999999998 9999864

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=8.1e-43  Score=359.36  Aligned_cols=201  Identities=26%  Similarity=0.366  Sum_probs=164.4

Q ss_pred             CCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCc----eEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----ELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~----~~~lV~  466 (621)
                      ++|.+.++||+|+||+||+|++ +|+.||||+++..... ...+..|+..+.+++|||||+++|++.+++    .++|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            3577789999999999999998 5899999999754321 122345666667889999999999998753    679999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEeccCCCCCEEEcCCCCeEEeeecCce
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-----SRLKIIHRDLKASNILLDDDMNPKISDFGLAR  541 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~  541 (621)
                      ||+++|+|.++++.    ..++|..+.+++.|+++||+|||++     ..++|+||||||+||||+.++++||+|||+++
T Consensus        81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            99999999999954    3589999999999999999999986     23469999999999999999999999999998


Q ss_pred             ecCCCCCC--cccccccccCCccChhcccCC------CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          542 IFGGNQNQ--ANTNIIAGTYGYMAPEYAMGG------IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       542 ~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~------~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ........  .......||+.|||||++.+.      .++.++|||||||+||||+||++|+..
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~  220 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  220 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence            77544322  222345799999999998764      367899999999999999999887653

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3e-42  Score=353.81  Aligned_cols=200  Identities=29%  Similarity=0.449  Sum_probs=162.7

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCc-ccHHHHHHHHHHHHhcccCCceeEeeEEeeCc--------
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ--------  460 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~--------  460 (621)
                      ++|++.+.||+|+||+||+++. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            3588999999999999999996 4699999999976543 34567899999999999999999999987644        


Q ss_pred             ----eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEee
Q 007006          461 ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISD  536 (621)
Q Consensus       461 ----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~D  536 (621)
                          .+++||||+++|+|.+++.........++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence                36899999999999999976544455677889999999999999999986   99999999999999999999999


Q ss_pred             ecCceecCCCCCCc----------ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          537 FGLARIFGGNQNQA----------NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       537 fgla~~~~~~~~~~----------~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      ||+++.+.......          .....+||+.|||||++.+..++.++|||||||++|||++   ||.
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~  228 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS  228 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCC
Confidence            99998775433221          1223579999999999999999999999999999999997   654

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.9e-40  Score=349.56  Aligned_cols=201  Identities=22%  Similarity=0.393  Sum_probs=171.3

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeC------c
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------Q  460 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~------~  460 (621)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++++..  ....+.+.+|+++|+.++|||||++++++...      +
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            35799999999999999999996 479999999997543  23456788999999999999999999997643      5


Q ss_pred             eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCc
Q 007006          461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA  540 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla  540 (621)
                      .+++||||++ |+|..++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence            7899999996 678888843   457999999999999999999999986   999999999999999999999999999


Q ss_pred             eecCCCC--CCcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          541 RIFGGNQ--NQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       541 ~~~~~~~--~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      +.+....  ........+||+.|||||++.+. .++.++||||+||++|||++|++||..
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g  265 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG  265 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC
Confidence            8764322  12233456899999999998775 469999999999999999999999964

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.6e-39  Score=342.44  Aligned_cols=198  Identities=26%  Similarity=0.369  Sum_probs=170.1

Q ss_pred             HhCCCCccceeccCCceeEEEEEec----CCcEEEEEEeccCCcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEE
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELL  463 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~  463 (621)
                      ..++|++.++||+|+||+||+|+.+    .++.||+|++.+..  ...++.+|+++|..+ +||||+++++++.+++..+
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            3578999999999999999999753    47889999987543  346678999999998 6999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC-CCeEEeeecCcee
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGLARI  542 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~vkL~Dfgla~~  542 (621)
                      +||||+++|+|.+++.      .+++.++..++.||+.||+|||+++   |+||||||+|||++.+ +.+||+|||+|+.
T Consensus        97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            9999999999999882      3899999999999999999999986   9999999999999876 7999999999986


Q ss_pred             cCCCCCC--------------------------cccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCC
Q 007006          543 FGGNQNQ--------------------------ANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNN  595 (621)
Q Consensus       543 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~  595 (621)
                      .......                          ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            5432211                          111234799999999999776 4899999999999999999999998


Q ss_pred             CC
Q 007006          596 GF  597 (621)
Q Consensus       596 ~~  597 (621)
                      ..
T Consensus       248 ~~  249 (361)
T 4f9c_A          248 YK  249 (361)
T ss_dssp             SC
T ss_pred             CC
Confidence            54

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=7.6e-40  Score=363.92  Aligned_cols=199  Identities=31%  Similarity=0.408  Sum_probs=171.9

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHH---HHHHHhcccCCceeEeeEEeeCceEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNE---VNLIAKLQHKNLVRLLGCCLEGQELL  463 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E---i~~l~~l~h~nIv~l~g~~~~~~~~~  463 (621)
                      ++|++.+.||+|+||.||+++.. +|+.||||++.+..   ......+.+|   +.+++.++|||||++++++.+++.++
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            57999999999999999999964 69999999997532   2223334444   56666779999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceec
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF  543 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~  543 (621)
                      +||||++||+|..+|..   ...+++..+..++.||+.||.|||+++   |+||||||+||||+.+|++||+|||+++.+
T Consensus       269 lVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence            99999999999999954   346999999999999999999999986   999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          544 GGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       544 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      ....    ....+||+.|||||++.+ ..|+.++|||||||++|||++|++||....
T Consensus       343 ~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~  395 (689)
T 3v5w_A          343 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK  395 (689)
T ss_dssp             SSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG
T ss_pred             CCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            5432    234689999999999975 579999999999999999999999996443

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=7.4e-39  Score=357.17  Aligned_cols=199  Identities=27%  Similarity=0.448  Sum_probs=179.4

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      ++|++.+.||+|+||.||+++.+ +|+.||+|++........+.+.+|+.+|+.++|||||++++++.+++.+++||||+
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            68999999999999999999964 69999999998766666678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC--CCeEEeeecCceecCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD--MNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~--~~vkL~Dfgla~~~~~~~  547 (621)
                      ++|+|.+++..  +...+++.++..++.||+.||.|||+++   |+||||||+|||++.+  +.+||+|||+++.+....
T Consensus       237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~  311 (573)
T 3uto_A          237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  311 (573)
T ss_dssp             CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred             CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence            99999998843  3456999999999999999999999986   9999999999999854  889999999999875432


Q ss_pred             CCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                         .....+||+.|||||++.+..++.++||||+||++|||++|++||..
T Consensus       312 ---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~  358 (573)
T 3uto_A          312 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG  358 (573)
T ss_dssp             ---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             ---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence               23346899999999999999999999999999999999999999863

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7.6e-38  Score=324.93  Aligned_cols=223  Identities=40%  Similarity=0.712  Sum_probs=193.7

Q ss_pred             HHHHhCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          386 ALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       386 ~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      +...+++|...+.||+|+||.||+|++++++.||+|++........+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  113 (321)
T 2qkw_B           34 LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI  113 (321)
T ss_dssp             CCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred             HHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence            34567899999999999999999999888999999999877667778899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          466 YEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      |||+++++|.+++..... ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  190 (321)
T 2qkw_B          114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGT  190 (321)
T ss_dssp             EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred             EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            999999999999864322 235899999999999999999999986   9999999999999999999999999998765


Q ss_pred             CCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCcCCCCCChHHHHH
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVC  611 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~v~  611 (621)
                      ............||+.|+|||.+.+..++.++||||||+++|||++|+.||....+.+...+..+..
T Consensus       191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~  257 (321)
T 2qkw_B          191 ELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV  257 (321)
T ss_dssp             SSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTH
T ss_pred             cccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhh
Confidence            4333333344568999999999998899999999999999999999999997666555555555443

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.5e-36  Score=311.88  Aligned_cols=199  Identities=27%  Similarity=0.463  Sum_probs=179.4

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      .++|.+.+.||+|+||.||++.. .+++.||+|++........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            35799999999999999999985 57999999999876666678899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++++|.+++..    ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            999999999854    25899999999999999999999986   99999999999999999999999999987654332


Q ss_pred             CcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                        ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       172 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  218 (297)
T 3fxz_A          172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN  218 (297)
T ss_dssp             --CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             --ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence              22345789999999999999999999999999999999999999864

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.7e-36  Score=310.57  Aligned_cols=206  Identities=33%  Similarity=0.543  Sum_probs=180.0

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      .++|.+.++||+|+||.||++... +++.||+|++...+....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            357888999999999999999964 6899999999777777778899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++++|.+++...  ...+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            9999999999642  356999999999999999999999986   99999999999999999999999999987644322


Q ss_pred             Ccc------------cccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCcC
Q 007006          549 QAN------------TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFS  600 (621)
Q Consensus       549 ~~~------------~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~  600 (621)
                      ...            .....||+.|+|||.+.+..++.++||||||+++|||++|..|+.....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~  227 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP  227 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSC
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhh
Confidence            111            1135689999999999999999999999999999999999999865443

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=7.7e-37  Score=330.28  Aligned_cols=205  Identities=22%  Similarity=0.308  Sum_probs=177.1

Q ss_pred             HHHhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceE
Q 007006          387 LEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL  462 (621)
Q Consensus       387 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~  462 (621)
                      ....++|++.++||+|+||.||+++.. +++.||+|++.+..   ......+.+|+.++..++||||+++++++.+++..
T Consensus        70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  149 (437)
T 4aw2_A           70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL  149 (437)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence            344678999999999999999999976 47899999997532   22234488999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      ++||||+++|+|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       150 ~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~  224 (437)
T 4aw2_A          150 YLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLK  224 (437)
T ss_dssp             EEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence            999999999999999954  2346999999999999999999999986   99999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccCCccChhccc-----CCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          543 FGGNQNQANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       543 ~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ...... ......+||+.|+|||++.     ...++.++|||||||++|||++|++||..
T Consensus       225 ~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~  283 (437)
T 4aw2_A          225 LMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA  283 (437)
T ss_dssp             CCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             cccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC
Confidence            644322 1223357999999999987     56689999999999999999999999864

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=6.7e-36  Score=310.60  Aligned_cols=196  Identities=27%  Similarity=0.460  Sum_probs=176.9

Q ss_pred             CCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCC
Q 007006          393 FSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN  471 (621)
Q Consensus       393 f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  471 (621)
                      |...++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  126 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG  126 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence            667789999999999999975 7999999999877767778899999999999999999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcc
Q 007006          472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN  551 (621)
Q Consensus       472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~  551 (621)
                      ++|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++........  .
T Consensus       127 ~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~  197 (321)
T 2c30_A          127 GALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K  197 (321)
T ss_dssp             CBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred             CCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--c
Confidence            999998842    35999999999999999999999986   99999999999999999999999999987654322  2


Q ss_pred             cccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       552 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~  243 (321)
T 2c30_A          198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS  243 (321)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            2345789999999999999999999999999999999999999864

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.8e-36  Score=318.74  Aligned_cols=206  Identities=32%  Similarity=0.481  Sum_probs=178.6

Q ss_pred             hCCCCccceeccCCceeEEEEEec--------CCcEEEEEEeccCC-cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeC
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG  459 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~  459 (621)
                      .++|.+.+.||+|+||.||++...        ++..||||+++... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            367889999999999999999852        35679999997653 34456789999999999 899999999999999


Q ss_pred             ceEEEEEEecCCCChhhhhhhccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE
Q 007006          460 QELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL  526 (621)
Q Consensus       460 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl  526 (621)
                      +..++||||+++|+|.+++.....             ...+++.+++.++.||+.||.|||+.+   |+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            999999999999999999965331             245899999999999999999999986   9999999999999


Q ss_pred             cCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          527 DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       527 ~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~  309 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  309 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999999997755443333344567889999999999999999999999999999999 99998643

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.1e-36  Score=316.78  Aligned_cols=221  Identities=45%  Similarity=0.757  Sum_probs=190.2

Q ss_pred             CCccccchHHHHHHhCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCc-ccHHHHHHHHHHHHhcccCCceeEee
Q 007006          376 QEFPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLG  454 (621)
Q Consensus       376 ~~~~~~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g  454 (621)
                      .....++........++|.+.+.||+|+||.||++...+++.||||++..... .....+.+|++++++++||||+++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            34556778888899999999999999999999999988899999999976532 23346899999999999999999999


Q ss_pred             EEeeCceEEEEEEecCCCChhhhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeE
Q 007006          455 CCLEGQELLLIYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPK  533 (621)
Q Consensus       455 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vk  533 (621)
                      ++.+.+..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+....+|+||||||+|||++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            9999999999999999999999996543 234599999999999999999999998333499999999999999999999


Q ss_pred             EeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          534 ISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       534 L~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      |+|||++......... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       175 l~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  237 (326)
T 3uim_A          175 VGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL  237 (326)
T ss_dssp             ECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCH
T ss_pred             eccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccc
Confidence            9999999876543222 22334689999999999888899999999999999999999999963

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.6e-36  Score=315.72  Aligned_cols=199  Identities=27%  Similarity=0.354  Sum_probs=176.6

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|++.+.||+|+||.||+++.. +|+.||+|++++.   .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            57899999999999999999965 6999999999754   2345677899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++|+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        85 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            99999999988854   345899999999999999999999986   999999999999999999999999999864322


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .  .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       159 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  207 (337)
T 1o6l_A          159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  207 (337)
T ss_dssp             T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             C--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC
Confidence            2  223346789999999999999999999999999999999999999864

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.7e-36  Score=314.60  Aligned_cols=199  Identities=31%  Similarity=0.478  Sum_probs=176.5

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      .++|.+.+.||+|+||.||++.+ .+|+.||||++...  .....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            35799999999999999999996 57999999999754  3344567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++++|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++++||+|||++......
T Consensus        94 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             ECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            999999999998543   45899999999999999999999986   999999999999999999999999999865432


Q ss_pred             CCCcccccccccCCccChhcccCCCC-ChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .   ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||..
T Consensus       168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  216 (328)
T 3fe3_A          168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG  216 (328)
T ss_dssp             C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence            2   2334578999999999988876 4899999999999999999999864

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.3e-35  Score=305.74  Aligned_cols=220  Identities=44%  Similarity=0.670  Sum_probs=190.2

Q ss_pred             CCccccchHHHHHHhCCCCcc------ceeccCCceeEEEEEecCCcEEEEEEeccCC----cccHHHHHHHHHHHHhcc
Q 007006          376 QEFPLFPLRLALEATNHFSDE------NKLGQGGFGPVYKGTLADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQ  445 (621)
Q Consensus       376 ~~~~~~~~~~~~~~~~~f~~~------~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~  445 (621)
                      .....+....+..++++|...      ++||+|+||.||+|.. +++.||+|++....    ....+.+.+|+.++++++
T Consensus        10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~   88 (307)
T 2nru_A           10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ   88 (307)
T ss_dssp             -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred             CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence            345667888888999888877      8999999999999987 68899999987532    334577899999999999


Q ss_pred             cCCceeEeeEEeeCceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEE
Q 007006          446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNIL  525 (621)
Q Consensus       446 h~nIv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NIL  525 (621)
                      ||||+++++++.+.+..++||||+++++|.+++........+++..++.++.||+.||.|||+.+   |+||||||+||+
T Consensus        89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil  165 (307)
T 2nru_A           89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL  165 (307)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred             CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence            99999999999999999999999999999999976555567999999999999999999999986   999999999999


Q ss_pred             EcCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCcC
Q 007006          526 LDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFS  600 (621)
Q Consensus       526 l~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~  600 (621)
                      ++.++.+||+|||++................|++.|+|||.+.+ .++.++||||||+++|||++|++||.....
T Consensus       166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  239 (307)
T 2nru_A          166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE  239 (307)
T ss_dssp             ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred             EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence            99999999999999987654433333344578999999998765 578999999999999999999999975443

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.6e-36  Score=312.14  Aligned_cols=204  Identities=30%  Similarity=0.429  Sum_probs=175.7

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      .++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            368999999999999999999865 78999999987543 2334668899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |+++++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+....
T Consensus        86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            999999999884   3346999999999999999999999986   9999999999999999999999999998765433


Q ss_pred             CCcccccccccCCccChhcccCCCC-ChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      .........||+.|+|||++.+..+ +.++||||||+++|||++|+.||....
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  212 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS  212 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence            3333345678999999999987775 789999999999999999999996543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.8e-36  Score=319.04  Aligned_cols=203  Identities=17%  Similarity=0.162  Sum_probs=175.7

Q ss_pred             HhCCCCccceeccCCceeEEEEE------ecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcc---cCCceeEeeEEeeC
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGT------LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLEG  459 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~------~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---h~nIv~l~g~~~~~  459 (621)
                      ..++|.+.++||+|+||.||+|.      ..+++.||+|+++..   ...++..|+++++.++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            35679999999999999999994      456889999999754   3456788888888886   99999999999999


Q ss_pred             ceEEEEEEecCCCChhhhhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC---------
Q 007006          460 QELLLIYEYMPNKSLDVHLFDAT--RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---------  528 (621)
Q Consensus       460 ~~~~lV~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---------  528 (621)
                      +..++||||+++|+|.+++....  ....+++..++.++.||+.||+|||+.+   |+||||||+|||++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence            99999999999999999996432  3456999999999999999999999986   999999999999998         


Q ss_pred             --CCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          529 --DMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       529 --~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                        ++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  287 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK  287 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence              899999999999876433333333456799999999999999999999999999999999999999853

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.5e-36  Score=320.18  Aligned_cols=201  Identities=25%  Similarity=0.414  Sum_probs=175.1

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~l  464 (621)
                      .++|++.++||+|+||.||+++.+ +++.||+|++++..   ....+.+..|..++.++ +||||+++++++.+++..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            367999999999999999999965 58899999997642   23345678899999887 89999999999999999999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      ||||+++|+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            9999999999988854   345999999999999999999999986   9999999999999999999999999998532


Q ss_pred             CCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ..  .......+||+.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus       205 ~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~  256 (396)
T 4dc2_A          205 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV  256 (396)
T ss_dssp             CT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred             cC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence            22  12234468999999999999999999999999999999999999999643

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.5e-36  Score=317.93  Aligned_cols=201  Identities=27%  Similarity=0.434  Sum_probs=172.9

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC---CcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~l  464 (621)
                      .++|++.+.||+|+||.||+++.. +++.||||++++.   .....+.+.+|..++..+ +||||+++++++.+.+..++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            468999999999999999999965 6899999999754   234456788999999998 79999999999999999999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      ||||+++|+|..++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       102 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            99999999999998543   45999999999999999999999986   9999999999999999999999999998543


Q ss_pred             CCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ..  .......+||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       176 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~  227 (353)
T 3txo_A          176 CN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE  227 (353)
T ss_dssp             C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC
Confidence            22  12233457999999999999888999999999999999999999999643

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-36  Score=309.04  Aligned_cols=196  Identities=28%  Similarity=0.415  Sum_probs=175.8

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|++.+.||+|+||.||+++.. +|+.||+|++++..   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            57889999999999999999965 69999999997542   244577889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        86 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           86 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            99999999999954   345899999999999999999999886   999999999999999999999999999875432


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                           .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       160 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  205 (318)
T 1fot_A          160 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD  205 (318)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             -----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence                 2345789999999999999999999999999999999999999854

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=9.8e-36  Score=316.43  Aligned_cols=200  Identities=27%  Similarity=0.441  Sum_probs=176.2

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|.+.+.||+|+||.||++... +++.||+|++.+.   .....+.+.+|+.+|+.++||||+++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            57899999999999999999864 5889999998754   2345677899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++|+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            99999999999853   346999999999999999999999986   999999999999999999999999999876433


Q ss_pred             CCCcccccccccCCccChhcccC---CCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      .   ......||+.|+|||++..   ..++.++||||||+++|||++|+.||....
T Consensus       169 ~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~  221 (384)
T 4fr4_A          169 T---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS  221 (384)
T ss_dssp             C---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT
T ss_pred             C---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCC
Confidence            2   2234579999999999864   458999999999999999999999997543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.2e-35  Score=311.61  Aligned_cols=199  Identities=28%  Similarity=0.371  Sum_probs=176.7

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc------ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL  462 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~  462 (621)
                      .++|.+.+.||+|+||.||+++.. +|+.||+|++.+...      ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467999999999999999999965 699999999976532      2357899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC----CeEEeeec
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM----NPKISDFG  538 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~vkL~Dfg  538 (621)
                      ++||||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            999999999999999843   346999999999999999999999986   99999999999998877    79999999


Q ss_pred             CceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          539 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       539 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ++........   .....||+.|+|||++.+..++.++||||||+++|||++|++||..
T Consensus       165 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~  220 (361)
T 2yab_A          165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG  220 (361)
T ss_dssp             SCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             CceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence            9987654322   2335789999999999999999999999999999999999999864

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6.6e-36  Score=309.02  Aligned_cols=205  Identities=34%  Similarity=0.530  Sum_probs=170.3

Q ss_pred             hCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      .++|.+.+.||+|+||.||+++. +|+.||||++....  ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            45789999999999999999987 58899999987653  3345678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |+++++|.+++........+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~  193 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF  193 (309)
T ss_dssp             CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred             cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence            9999999999965443445999999999999999999999874 349999999999999999999999999997643322


Q ss_pred             CCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                        .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       194 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~  242 (309)
T 3p86_A          194 --LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL  242 (309)
T ss_dssp             ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred             --cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence              1223457899999999999999999999999999999999999998643

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=8.1e-36  Score=305.95  Aligned_cols=202  Identities=29%  Similarity=0.437  Sum_probs=172.3

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      .++|++.+.||+|+||.||++... +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            467999999999999999999854 68999999986543   23356789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      |||+++++|.+++...   .++++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            9999999999999543   46999999999999999999999986   99999999999999999999999999986543


Q ss_pred             CCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  215 (294)
T 4eqm_A          164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE  215 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            322 2223456899999999999999999999999999999999999999643

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.6e-36  Score=323.69  Aligned_cols=203  Identities=24%  Similarity=0.312  Sum_probs=176.1

Q ss_pred             HHHhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceE
Q 007006          387 LEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL  462 (621)
Q Consensus       387 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~  462 (621)
                      ....++|.+.++||+|+||.||+++.. +++.||+|++++..   ....+.+.+|+.+++.++||||+++++++.+++..
T Consensus        65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~  144 (410)
T 3v8s_A           65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  144 (410)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            344578999999999999999999975 58999999997531   22334578999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      ++||||+++|+|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       145 ~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~  217 (410)
T 3v8s_A          145 YMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK  217 (410)
T ss_dssp             EEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEe
Confidence            999999999999998853    35899999999999999999999986   99999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccCCccChhcccCCC----CChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          543 FGGNQNQANTNIIAGTYGYMAPEYAMGGI----FSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       543 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ...... ......+||+.|+|||++.+..    ++.++|||||||++|||++|++||..
T Consensus       218 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~  275 (410)
T 3v8s_A          218 MNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA  275 (410)
T ss_dssp             CCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             eccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC
Confidence            654321 1223457999999999997665    78999999999999999999999863

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.1e-35  Score=312.07  Aligned_cols=201  Identities=29%  Similarity=0.456  Sum_probs=176.7

Q ss_pred             HhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEE
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELL  463 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~  463 (621)
                      ..++|.+.+.||+|+||.||+++.+ +|+.||+|++++..   ....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            4578999999999999999999975 68999999997642   34456788899999887 9999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceec
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF  543 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~  543 (621)
                      +||||+++|+|..++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        95 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             EEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            999999999999998542   45899999999999999999999986   999999999999999999999999999854


Q ss_pred             CCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          544 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       544 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ....  .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       169 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  220 (345)
T 1xjd_A          169 MLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG  220 (345)
T ss_dssp             CCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC
Confidence            3221  223446799999999999999999999999999999999999999864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.5e-35  Score=304.84  Aligned_cols=202  Identities=29%  Similarity=0.463  Sum_probs=172.3

Q ss_pred             hCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      .++|++.++||+|+||.||+++..+|+.||+|++....  ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            36799999999999999999999889999999997543  2334678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |+++ +|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus       100 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A          100 FMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             CCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             CCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            9985 77777743  3345899999999999999999999986   9999999999999999999999999998764332


Q ss_pred             CCcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          548 NQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      ..  .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus       174 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  224 (311)
T 3niz_A          174 RS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT  224 (311)
T ss_dssp             C-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC
Confidence            22  223467999999999876 568999999999999999999999996443

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.1e-35  Score=312.05  Aligned_cols=199  Identities=26%  Similarity=0.422  Sum_probs=175.4

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      ++|.+.+.||+|+||.||+++.+ +++.||+|++.+..   ....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            57889999999999999999965 58999999997653   23445688999999988 899999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      |||+++|+|..++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            9999999999988542   45899999999999999999999986   99999999999999999999999999985432


Q ss_pred             CCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ..  .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       163 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  212 (345)
T 3a8x_A          163 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  212 (345)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence            21  223345789999999999999999999999999999999999999964

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.7e-35  Score=307.58  Aligned_cols=202  Identities=29%  Similarity=0.444  Sum_probs=173.0

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCc--------
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ--------  460 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~--------  460 (621)
                      ++|++.+.||+|+||.||+++.. +|+.||||+++... ....+.+.+|++++++++||||+++++++.+..        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            56889999999999999999975 79999999997543 344577999999999999999999999986643        


Q ss_pred             -------------------------------------------------eEEEEEEecCCCChhhhhhhccCCCCCCHHH
Q 007006          461 -------------------------------------------------ELLLIYEYMPNKSLDVHLFDATRSVQLDWKR  491 (621)
Q Consensus       461 -------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~  491 (621)
                                                                       ..++||||+++++|.+++.........++..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  165 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV  165 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence                                                             2799999999999999997665556678888


Q ss_pred             HHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC----------cccccccccCCc
Q 007006          492 RQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ----------ANTNIIAGTYGY  561 (621)
Q Consensus       492 ~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~----------~~~~~~~gt~~y  561 (621)
                      ++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.........          .......||+.|
T Consensus       166 ~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             HHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            9999999999999999986   999999999999999999999999999987554221          112334689999


Q ss_pred             cChhcccCCCCChhhhHHHHHHHHHHHHcCCCCC
Q 007006          562 MAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNN  595 (621)
Q Consensus       562 ~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~  595 (621)
                      +|||.+.+..++.++||||||+++|||++|..|+
T Consensus       243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~  276 (332)
T 3qd2_B          243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ  276 (332)
T ss_dssp             SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred             cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence            9999999999999999999999999999998774

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=5.9e-36  Score=311.06  Aligned_cols=204  Identities=29%  Similarity=0.447  Sum_probs=172.9

Q ss_pred             hCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCc----eEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----ELLLI  465 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~----~~~lV  465 (621)
                      .++|++.++||+|+||.||+|+.. ++.||||++..... ....+..|+.++++++||||+++++++.+..    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            357899999999999999999875 89999999975432 2345567899999999999999999998754    47999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCCeEeccCCCCCEEEcCCCCeEEeeec
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-------SRLKIIHRDLKASNILLDDDMNPKISDFG  538 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-------~~~~iiH~Dlkp~NILl~~~~~vkL~Dfg  538 (621)
                      |||+++|+|.+++..    ..+++..++.++.|++.||.|||+.       ...+|+||||||+|||++.++.+||+|||
T Consensus       101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg  176 (322)
T 3soc_A          101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG  176 (322)
T ss_dssp             EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence            999999999999954    3489999999999999999999987       01139999999999999999999999999


Q ss_pred             CceecCCCCCCcccccccccCCccChhcccCC-----CCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          539 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-----IFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       539 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      +++...............||+.|+|||++.+.     .++.++||||||+++|||+||+.||....
T Consensus       177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~  242 (322)
T 3soc_A          177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV  242 (322)
T ss_dssp             TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred             cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence            99887655444444446789999999998763     45678999999999999999999986543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.4e-36  Score=322.05  Aligned_cols=205  Identities=21%  Similarity=0.302  Sum_probs=177.4

Q ss_pred             HHHhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceE
Q 007006          387 LEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL  462 (621)
Q Consensus       387 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~  462 (621)
                      ....++|++.+.||+|+||.||+++.+ +|+.||+|++++..   ....+.+.+|..++..++||||+++++++.+.+..
T Consensus        57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  136 (412)
T 2vd5_A           57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL  136 (412)
T ss_dssp             SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            344578999999999999999999974 69999999997532   22334578999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      ++||||+++|+|..++...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++++||+|||+++.
T Consensus       137 ~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~  211 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLK  211 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhhee
Confidence            9999999999999999643  236899999999999999999999986   99999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccCCccChhccc-------CCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          543 FGGNQNQANTNIIAGTYGYMAPEYAM-------GGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       543 ~~~~~~~~~~~~~~gt~~y~aPE~l~-------~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ...... ......+||+.|+|||++.       ...++.++|||||||++|||++|+.||..
T Consensus       212 ~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~  272 (412)
T 2vd5_A          212 LRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA  272 (412)
T ss_dssp             CCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC
Confidence            654322 1223457999999999987       45689999999999999999999999864

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-35  Score=305.64  Aligned_cols=203  Identities=26%  Similarity=0.377  Sum_probs=176.7

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCc--eEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ--ELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~--~~~lV~  466 (621)
                      ++|.+.++||+|+||.||++... +++.||||++.... ....+.+.+|++++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            57899999999999999999965 58999999997543 344677889999999999999999999998765  789999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE----cCCCCeEEeeecCcee
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLARI  542 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~vkL~Dfgla~~  542 (621)
                      ||+++++|.+++........+++..++.++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            99999999999976555556999999999999999999999986   9999999999999    7788899999999987


Q ss_pred             cCCCCCCcccccccccCCccChhccc--------CCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          543 FGGNQNQANTNIIAGTYGYMAPEYAM--------GGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       543 ~~~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      ......   .....||+.|+|||++.        +..++.++||||||+++|||++|+.||....
T Consensus       166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  227 (319)
T 4euu_A          166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE  227 (319)
T ss_dssp             CCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred             cCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            654322   22346899999999886        5778999999999999999999999996543

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.9e-35  Score=306.83  Aligned_cols=203  Identities=20%  Similarity=0.253  Sum_probs=176.7

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      .++|.+.+.||+|+||.||+++. .+++.||||++.....  .+.+.+|+++++++ +||||+++++++.+.+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            36799999999999999999995 5799999999875432  24578999999999 99999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCC-----eEEeeecCcee
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN-----PKISDFGLARI  542 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----vkL~Dfgla~~  542 (621)
                      |+ +++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.     +||+|||++..
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            99 99999998643  356999999999999999999999986   999999999999998887     99999999997


Q ss_pred             cCCCCCCc-----ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCcC
Q 007006          543 FGGNQNQA-----NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFS  600 (621)
Q Consensus       543 ~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~  600 (621)
                      +.......     ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~  222 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA  222 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc
Confidence            65433221     12346789999999999999999999999999999999999999976543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.7e-35  Score=308.30  Aligned_cols=200  Identities=29%  Similarity=0.398  Sum_probs=166.5

Q ss_pred             hCCCCccceeccCCceeEEEEEe----cCCcEEEEEEeccCC----cccHHHHHHHHHHHHhcccCCceeEeeEEeeCce
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE  461 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~  461 (621)
                      .++|++.+.||+|+||.||+++.    .+++.||+|++++..    ......+.+|++++++++||||+++++++.+.+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            35799999999999999999986    478999999997642    2334567899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCce
Q 007006          462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR  541 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~  541 (621)
                      .++||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            9999999999999998854   345899999999999999999999986   9999999999999999999999999987


Q ss_pred             ecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          542 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       542 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ......  .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  223 (327)
T 3a62_A          170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG  223 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC
Confidence            543221  122345789999999999999999999999999999999999999864

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.6e-35  Score=304.33  Aligned_cols=199  Identities=27%  Similarity=0.374  Sum_probs=176.1

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc------ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL  462 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~  462 (621)
                      .++|.+.+.||+|+||.||++... +|+.||+|++.....      ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            356889999999999999999965 689999999875432      2467899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC----CeEEeeec
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM----NPKISDFG  538 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~vkL~Dfg  538 (621)
                      ++||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            999999999999999843   356999999999999999999999986   99999999999999887    79999999


Q ss_pred             CceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          539 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       539 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ++........   .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       164 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  219 (326)
T 2y0a_A          164 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG  219 (326)
T ss_dssp             TCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             CCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCC
Confidence            9987653322   2235689999999999999999999999999999999999999854

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.1e-35  Score=310.49  Aligned_cols=196  Identities=26%  Similarity=0.360  Sum_probs=176.3

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|.+.+.||+|+||.||+++.. +|+.||+|++.+..   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57899999999999999999965 69999999997542   345677899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++|+|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       121 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence            999999999999643   35899999999999999999999986   999999999999999999999999999876432


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                           .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  240 (350)
T 1rdq_E          195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA  240 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC
Confidence                 2335789999999999999999999999999999999999999864

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.9e-35  Score=311.07  Aligned_cols=200  Identities=27%  Similarity=0.369  Sum_probs=176.4

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC---CcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~l  464 (621)
                      .++|.+.+.||+|+||.||+++.. +++.||+|++++.   .....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            468999999999999999999975 4889999999754   234456788999999988 89999999999999999999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      ||||+++|+|..++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        99 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            99999999999998543   35899999999999999999999986   9999999999999999999999999998543


Q ss_pred             CCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ...  .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       173 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~  223 (353)
T 2i0e_A          173 WDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG  223 (353)
T ss_dssp             CTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC
Confidence            221  223346799999999999999999999999999999999999999864

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-35  Score=305.39  Aligned_cols=200  Identities=22%  Similarity=0.351  Sum_probs=176.5

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      .++|.+.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            468999999999999999999965 58899999987543 3456688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC--CCCeEEeeecCceecCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD--DMNPKISDFGLARIFGGN  546 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~--~~~vkL~Dfgla~~~~~~  546 (621)
                      +++++|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||++......
T Consensus        83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            999999998843  3346999999999999999999999986   999999999999987  789999999999876533


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      .   ......+|+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  206 (321)
T 1tki_A          158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE  206 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC
Confidence            2   223457899999999999888999999999999999999999998643

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.5e-35  Score=306.84  Aligned_cols=203  Identities=31%  Similarity=0.498  Sum_probs=173.4

Q ss_pred             hCCCCccceeccCCceeEEEEEec----CCcEEEEEEeccC-CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      .++|.+.+.||+|+||.||+|.+.    .+..||||+++.. .....+.+.+|++++++++||||+++++++.+++..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            357889999999999999999974    3556999999765 33445679999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      ||||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999999953  3346999999999999999999999986   9999999999999999999999999998765


Q ss_pred             CCCCCc-ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          545 GNQNQA-NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       545 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      ...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~  257 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN  257 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCccc
Confidence            432221 2222345778999999998899999999999999999999 9999854

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.6e-35  Score=310.07  Aligned_cols=202  Identities=25%  Similarity=0.368  Sum_probs=175.6

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC-----CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT-----SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      ++|++.+.||+|+||.||++... +++.||||++...     .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            56899999999999999999864 6899999998642     12346789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCC---eEEeeecCc
Q 007006          465 IYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN---PKISDFGLA  540 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---vkL~Dfgla  540 (621)
                      ||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.   +||+|||++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            999999999988775432 3345899999999999999999999986   999999999999987655   999999999


Q ss_pred             eecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          541 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       541 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ........  ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       181 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  235 (351)
T 3c0i_A          181 IQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG  235 (351)
T ss_dssp             EECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             eEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC
Confidence            87654322  12335789999999999999999999999999999999999999864

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.3e-35  Score=309.01  Aligned_cols=199  Identities=27%  Similarity=0.408  Sum_probs=175.0

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      .++|.+.+.||+|+||.||++... +++.||+|++....  ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            467999999999999999999864 68999999997543  334567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC---CeEEeeecCceec
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM---NPKISDFGLARIF  543 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~vkL~Dfgla~~~  543 (621)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++   .+||+|||++...
T Consensus       108 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          108 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             CCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            99999999988843   346899999999999999999999986   99999999999998654   5999999999876


Q ss_pred             CCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          544 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       544 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .....   .....||+.|+|||++.+..++.++||||||+++|||++|++||..
T Consensus       182 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~  232 (362)
T 2bdw_A          182 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD  232 (362)
T ss_dssp             TTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            53322   2235789999999999999999999999999999999999999853

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=6.8e-36  Score=317.67  Aligned_cols=204  Identities=30%  Similarity=0.458  Sum_probs=175.6

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      .++|.+.+.||+|+||.||+|... +++.||||+++... ....+.+.+|+++|++++||||+++++++.+++..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            457888999999999999999975 78999999987543 2334568899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |+++|+|.+++...  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       193 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          193 LVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             CCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            99999999999642  345899999999999999999999986   9999999999999999999999999998654332


Q ss_pred             CCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      .........+++.|+|||.+..+.++.++||||||+++|||++ |+.||...
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~  319 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL  319 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred             eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            2222222335678999999998899999999999999999998 99998643

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.8e-35  Score=299.82  Aligned_cols=198  Identities=27%  Similarity=0.405  Sum_probs=167.4

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCc--------------------------ccHHHHHHHHHHHHh
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG--------------------------QGLQEFKNEVNLIAK  443 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~--------------------------~~~~~~~~Ei~~l~~  443 (621)
                      ++|.+.+.||+|+||.||+++. .+++.||||++.....                          ...+.+.+|++++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            6799999999999999999986 4689999999875421                          123568899999999


Q ss_pred             cccCCceeEeeEEee--CceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCC
Q 007006          444 LQHKNLVRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKA  521 (621)
Q Consensus       444 l~h~nIv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp  521 (621)
                      ++||||+++++++.+  .+..++||||+++++|.+++    ....+++..+..++.||+.||.|||+.+   |+||||||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp  165 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKP  165 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCH
Confidence            999999999999987  56889999999999998765    2346999999999999999999999986   99999999


Q ss_pred             CCEEEcCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCC---CChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          522 SNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI---FSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       522 ~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      +|||++.++.+||+|||++........  ......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||..
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            999999999999999999987654322  122346899999999997765   47899999999999999999999863

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5.7e-35  Score=311.22  Aligned_cols=200  Identities=24%  Similarity=0.359  Sum_probs=177.4

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      .++|.+.+.||+|+||.||++... +++.||+|++..........+.+|+++|++++||||+++++++.+.+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            467999999999999999999865 6899999999876555567789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC--CCCeEEeeecCceecCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD--DMNPKISDFGLARIFGGN  546 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~--~~~vkL~Dfgla~~~~~~  546 (621)
                      +++++|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||++......
T Consensus       130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            999999998853  2346899999999999999999999986   999999999999974  477999999999876543


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .   ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~  252 (387)
T 1kob_A          205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG  252 (387)
T ss_dssp             S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC
Confidence            2   22334789999999999999999999999999999999999999864

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.4e-35  Score=312.37  Aligned_cols=211  Identities=30%  Similarity=0.421  Sum_probs=178.2

Q ss_pred             HHHHHhCCCCccceeccCCceeEEEEEe------cCCcEEEEEEeccCC-cccHHHHHHHHHHHHhc-ccCCceeEeeEE
Q 007006          385 LALEATNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCC  456 (621)
Q Consensus       385 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~  456 (621)
                      ......++|.+.+.||+|+||.||++++      .+++.||||+++... ....+.+.+|++++.++ +||||+++++++
T Consensus        16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~   95 (359)
T 3vhe_A           16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC   95 (359)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence            3334567899999999999999999973      246899999997653 33456789999999999 789999999999


Q ss_pred             eeCc-eEEEEEEecCCCChhhhhhhccC----------------------------------------------------
Q 007006          457 LEGQ-ELLLIYEYMPNKSLDVHLFDATR----------------------------------------------------  483 (621)
Q Consensus       457 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~----------------------------------------------------  483 (621)
                      .+.+ ..++||||+++|+|.+++.....                                                    
T Consensus        96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (359)
T 3vhe_A           96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD  175 (359)
T ss_dssp             CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred             ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence            8865 48999999999999999965432                                                    


Q ss_pred             -----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCccc
Q 007006          484 -----------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT  552 (621)
Q Consensus       484 -----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~  552 (621)
                                 ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++............
T Consensus       176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (359)
T 3vhe_A          176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK  252 (359)
T ss_dssp             --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred             hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhc
Confidence                       122899999999999999999999986   999999999999999999999999999876544333334


Q ss_pred             ccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          553 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       553 ~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      ....+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus       253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  299 (359)
T 3vhe_A          253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  299 (359)
T ss_dssp             --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCcc
Confidence            44567889999999999999999999999999999998 99998643

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.3e-34  Score=300.33  Aligned_cols=203  Identities=31%  Similarity=0.479  Sum_probs=161.2

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      .++|++.++||+|+||.||++... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467999999999999999999864 68999999997543 3345678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          468 YMPNKSLDVHLFDAT---RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      |++ ++|.+++....   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 58988886432   1245899999999999999999999986   9999999999999999999999999998765


Q ss_pred             CCCCCcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      .....  .....+|+.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus       160 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  212 (317)
T 2pmi_A          160 IPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT  212 (317)
T ss_dssp             SCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            33221  2234679999999998764 6899999999999999999999998643

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.6e-35  Score=306.93  Aligned_cols=198  Identities=27%  Similarity=0.456  Sum_probs=173.5

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|.+.+.||+|+||.||++.. .+++.||+|++...   .......+.+|+.+++.++||||+++++++.+++..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            6799999999999999999996 57899999998653   2233467899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+ +|+|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||++......
T Consensus        89 E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           89 EYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             CCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             ECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            999 68888888543   45999999999999999999999986   999999999999999999999999999865433


Q ss_pred             CCCcccccccccCCccChhcccCCCC-ChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ..   .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...
T Consensus       162 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~  211 (336)
T 3h4j_B          162 NF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE  211 (336)
T ss_dssp             BT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred             cc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence            22   233578999999999988776 78999999999999999999998643

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.9e-35  Score=299.73  Aligned_cols=199  Identities=28%  Similarity=0.449  Sum_probs=170.0

Q ss_pred             CCCCccceeccCCceeEEEEEecCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      ++|.+.+.||+|+||.||+++..+++.||+|++....  ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            4788999999999999999999889999999997543  23346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++ +|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence            985 88888753  2356899999999999999999999986   99999999999999999999999999987643221


Q ss_pred             CcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                        ......+|+.|+|||++.+. .++.++||||||+++|||++|+.||..
T Consensus       156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  203 (288)
T 1ob3_A          156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG  203 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence              12234679999999998764 589999999999999999999999864

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3e-35  Score=312.23  Aligned_cols=202  Identities=31%  Similarity=0.517  Sum_probs=163.7

Q ss_pred             CCCCccceeccCCceeEEEEEec----CCcEEEEEEeccC-CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      ++|.+.+.||+|+||.||+|++.    ++..||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            57999999999999999999864    5778999999765 334456799999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      |||+++++|.+++..  ....+++.+++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       125 ~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          125 TEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             EECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            999999999999954  3346999999999999999999999986   99999999999999999999999999987654


Q ss_pred             CCCCc-ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          546 NQNQA-NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       546 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      ..... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~  253 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE  253 (373)
T ss_dssp             --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTT
T ss_pred             CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence            32211 1222345678999999999999999999999999999998 9999853

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.2e-35  Score=297.04  Aligned_cols=200  Identities=30%  Similarity=0.466  Sum_probs=175.6

Q ss_pred             CCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecC
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP  470 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  470 (621)
                      ++|.+.+.||+|+||.||++...+++.||+|++.... ...+++.+|++++++++||||+++++++.+++..++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            5788899999999999999998889999999997653 335778999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc
Q 007006          471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA  550 (621)
Q Consensus       471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~  550 (621)
                      +++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++........ .
T Consensus        89 ~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  162 (269)
T 4hcu_A           89 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T  162 (269)
T ss_dssp             TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred             CCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-c
Confidence            9999999954  3346899999999999999999999986   99999999999999999999999999986543211 1


Q ss_pred             ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~  210 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN  210 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC
Confidence            1222345778999999998999999999999999999999 9999864

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-35  Score=307.84  Aligned_cols=206  Identities=30%  Similarity=0.487  Sum_probs=177.1

Q ss_pred             HhCCCCccceeccCCceeEEEEEec------CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCce
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE  461 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~  461 (621)
                      ..++|.+.+.||+|+||.||+++..      +++.||+|+++... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            3578999999999999999999874      34889999998653 3345678999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhhccC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCC
Q 007006          462 LLLIYEYMPNKSLDVHLFDATR---------------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLK  520 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlk  520 (621)
                      .++||||+++++|.+++.....                     ...+++.+++.++.||+.||.|||+.+   |+|||||
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk  201 (343)
T 1luf_A          125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA  201 (343)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence            9999999999999999965321                     256999999999999999999999986   9999999


Q ss_pred             CCCEEEcCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          521 ASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       521 p~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      |+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            9999999999999999999987644332223334467889999999998899999999999999999999 9999864

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.6e-35  Score=309.04  Aligned_cols=195  Identities=31%  Similarity=0.428  Sum_probs=168.0

Q ss_pred             ccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCCCC
Q 007006          395 DENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKS  473 (621)
Q Consensus       395 ~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~gs  473 (621)
                      ..+.||+|+||.||++.. .+|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            357899999999999986 4699999999987665667789999999999999999999999999999999999999999


Q ss_pred             hhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE--cCCCCeEEeeecCceecCCCCCCcc
Q 007006          474 LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL--DDDMNPKISDFGLARIFGGNQNQAN  551 (621)
Q Consensus       474 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl--~~~~~vkL~Dfgla~~~~~~~~~~~  551 (621)
                      |.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||+  +.++.+||+|||+++.......   
T Consensus       173 L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---  244 (373)
T 2x4f_A          173 LFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---  244 (373)
T ss_dssp             EHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---
T ss_pred             HHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---
Confidence            9988854  2346899999999999999999999986   9999999999999  5678899999999987654322   


Q ss_pred             cccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          552 TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       552 ~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  290 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG  290 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence            2234689999999999999999999999999999999999999864

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.4e-35  Score=306.51  Aligned_cols=203  Identities=27%  Similarity=0.399  Sum_probs=168.0

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCc----e
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----E  461 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~----~  461 (621)
                      .++|++.+.||+|+||.||+++. .+++.||||++....   ......+.+|++++++++||||+++++++....    .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46899999999999999999995 578999999997653   233457889999999999999999999987654    3


Q ss_pred             EEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCce
Q 007006          462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR  541 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~  541 (621)
                      .++||||+++++|.+++...   ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            49999999999999999543   46899999999999999999999986   9999999999999999999999999998


Q ss_pred             ecCCCCCC-cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          542 IFGGNQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       542 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ........ .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  222 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD  222 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            76443222 2223456899999999999999999999999999999999999998643

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2e-35  Score=302.63  Aligned_cols=203  Identities=32%  Similarity=0.530  Sum_probs=171.9

Q ss_pred             hCCCCccceeccCCceeEEEEEe-----cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeC--ceE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QEL  462 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~  462 (621)
                      .++|++.++||+|+||.||++++     .+++.||||++........+.+.+|++++++++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            35788999999999999999984     36889999999877766678899999999999999999999998654  458


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      ++||||+++++|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            9999999999999999643  335899999999999999999999986   99999999999999999999999999987


Q ss_pred             cCCCCCC-cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          543 FGGNQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       543 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~  219 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS  219 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence            6543221 122234567789999999999999999999999999999999998764

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.3e-35  Score=295.14  Aligned_cols=202  Identities=30%  Similarity=0.443  Sum_probs=176.9

Q ss_pred             hCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      .++|.+.+.||+|+||.||++..+++..||+|++.... ...+++.+|++++.+++||||+++++++.+++..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            35788999999999999999999888899999997654 33577899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++++|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.........
T Consensus        86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            999999999643  345899999999999999999999986   999999999999999999999999999876443222


Q ss_pred             cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      . .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  209 (268)
T 3sxs_A          161 S-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY  209 (268)
T ss_dssp             E-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             c-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc
Confidence            1 122345678999999998889999999999999999999 99998643

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.9e-35  Score=309.95  Aligned_cols=205  Identities=34%  Similarity=0.466  Sum_probs=178.3

Q ss_pred             hCCCCccceeccCCceeEEEEEec--------CCcEEEEEEeccCC-cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeC
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG  459 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~  459 (621)
                      .++|.+.++||+|+||.||+++..        .+..||+|++.... ....+.+.+|+++++++ +||||+++++++.++
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            467899999999999999999852        24579999997653 34457789999999999 999999999999999


Q ss_pred             ceEEEEEEecCCCChhhhhhhccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE
Q 007006          460 QELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL  526 (621)
Q Consensus       460 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl  526 (621)
                      +..++||||+++++|.+++.....             ...+++..++.++.||+.||.|||+.+   |+||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence            999999999999999999965431             245999999999999999999999986   9999999999999


Q ss_pred             cCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          527 DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       527 ~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~  296 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG  296 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999987655443333444567889999999999999999999999999999999 9999864

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=8.6e-35  Score=321.35  Aligned_cols=203  Identities=33%  Similarity=0.496  Sum_probs=179.5

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|.+.+.||+|+||.||+++.. +|+.||+|++.+..   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            67889999999999999999975 69999999997542   344577899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          467 EYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      ||+++|+|..++..... ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            99999999999865332 446999999999999999999999986   99999999999999999999999999987654


Q ss_pred             CCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       342 ~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~  392 (543)
T 3c4z_A          342 GQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR  392 (543)
T ss_dssp             TCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred             CCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence            322  223357999999999999999999999999999999999999999754

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.8e-35  Score=302.94  Aligned_cols=206  Identities=33%  Similarity=0.469  Sum_probs=178.2

Q ss_pred             hCCCCccceeccCCceeEEEEEe------cCCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL  462 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~  462 (621)
                      .++|.+.+.||+|+||.||++..      .++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            46788999999999999999985      245789999997643 34457789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCC
Q 007006          463 LLIYEYMPNKSLDVHLFDATR---------------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKA  521 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp  521 (621)
                      ++||||+++++|.+++.....                     ...+++..++.++.||+.||.|||+.+   |+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence            999999999999999975432                     234899999999999999999999986   99999999


Q ss_pred             CCEEEcCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          522 SNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       522 ~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      +|||++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  256 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  256 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999987654433333334456788999999998889999999999999999999 99998643

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1e-34  Score=297.17  Aligned_cols=197  Identities=26%  Similarity=0.432  Sum_probs=169.3

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      ++|++.++||+|+||.||++... +++.||+|++....  ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            47889999999999999999965 68999999997543  3334678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |+++ ++..++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            9986 45444432  2356999999999999999999999986   9999999999999999999999999998764332


Q ss_pred             CCcccccccccCCccChhcccCCC-CChhhhHHHHHHHHHHHHcCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNN  595 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~~-~s~~sDVwS~Gvll~elltG~~p~  595 (621)
                      ..  .....+|+.|+|||++.+.. ++.++||||||+++|||++|+.|+
T Consensus       156 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~  202 (292)
T 3o0g_A          156 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL  202 (292)
T ss_dssp             SC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred             cc--ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC
Confidence            22  22346799999999997766 799999999999999999998885

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=7.8e-35  Score=322.64  Aligned_cols=203  Identities=31%  Similarity=0.434  Sum_probs=178.8

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      .++|.+.+.||+|+||.||+++.. +|+.||+|++.+.   .......+.+|+.+|++++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            357899999999999999999964 6999999999754   234456788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      |||+++|+|..++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       263 mEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            9999999999988543 2345999999999999999999999986   99999999999999999999999999987643


Q ss_pred             CCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      ..   ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~  389 (576)
T 2acx_A          339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK  389 (576)
T ss_dssp             TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred             Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence            32   2223479999999999999899999999999999999999999997543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-35  Score=311.97  Aligned_cols=205  Identities=34%  Similarity=0.470  Sum_probs=175.3

Q ss_pred             hCCCCccceeccCCceeEEEEEec------CCcEEEEEEeccC-CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL  462 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~  462 (621)
                      .++|.+.+.||+|+||.||+|++.      +++.||||++... .......+.+|+.++++++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            357889999999999999999843      4678999999754 344456789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC---CeEEe
Q 007006          463 LLIYEYMPNKSLDVHLFDAT----RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM---NPKIS  535 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~vkL~  535 (621)
                      ++||||+++|+|.+++....    ....+++.+++.++.||+.||.|||+.+   |+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999997543    2245899999999999999999999986   99999999999999555   59999


Q ss_pred             eecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          536 DFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       536 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      |||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~  289 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS  289 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999986543322233334567889999999999999999999999999999998 9999864

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.8e-35  Score=311.03  Aligned_cols=200  Identities=27%  Similarity=0.341  Sum_probs=166.5

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHH-HHhcccCCceeEeeEEeeCceEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNL-IAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~-l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      .++|.+.+.||+|+||.||+++.+ +++.||+|++++..   ......+..|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            357999999999999999999965 58899999997653   2233456667766 567899999999999999999999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      ||||+++|+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++++||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            9999999999998854   345899999999999999999999986   9999999999999999999999999998643


Q ss_pred             CCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ...  ......+||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~  241 (373)
T 2r5t_A          191 EHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS  241 (373)
T ss_dssp             CCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             cCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence            221  223346799999999999999999999999999999999999999864

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6e-35  Score=305.89  Aligned_cols=206  Identities=32%  Similarity=0.463  Sum_probs=175.5

Q ss_pred             hCCCCccceeccCCceeEEEEEe------cCCcEEEEEEeccC-CcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCce
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE  461 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~  461 (621)
                      .++|.+.+.||+|+||.||++..      .++..||+|++... .....+.+.+|+.++.++ +||||+++++++.+.+.
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  123 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  123 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence            46889999999999999999985      24668999999754 234457789999999999 89999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhhccCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCC
Q 007006          462 LLLIYEYMPNKSLDVHLFDATRS--------------------VQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKA  521 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp  521 (621)
                      .++||||+++|+|.+++......                    ..+++..++.++.||+.||.|||+.+   |+||||||
T Consensus       124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp  200 (344)
T 1rjb_A          124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  200 (344)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCh
Confidence            99999999999999999653321                    34899999999999999999999986   99999999


Q ss_pred             CCEEEcCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          522 SNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       522 ~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      +|||++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus       201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            999999999999999999987654433333334567889999999999999999999999999999998 99998643

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.6e-35  Score=305.85  Aligned_cols=202  Identities=31%  Similarity=0.507  Sum_probs=167.6

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCc----EEEEEEeccC-CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      ++|.+.++||+|+||.||+|++. +++    .||+|.+... .....+.+.+|+.++++++||||+++++++.++. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            57889999999999999999853 444    4688888644 3455678999999999999999999999998764 788


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      |+||+++|+|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        94 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            99999999999999653  346999999999999999999999986   9999999999999999999999999998876


Q ss_pred             CCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      ............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  223 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI  223 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC
Confidence            5544444444566889999999999999999999999999999999 99998653

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4.9e-35  Score=303.81  Aligned_cols=206  Identities=27%  Similarity=0.455  Sum_probs=161.0

Q ss_pred             hCCCCccceeccCCceeEEEEEecC-C---cEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceE-
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLAD-G---KAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL-  462 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g---~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~-  462 (621)
                      .++|.+.+.||+|+||.||++.... +   ..||||+++..  .....+.+.+|++++++++||||+++++++...... 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            4689999999999999999998654 3   27999999764  344567899999999999999999999999877654 


Q ss_pred             -----EEEEEecCCCChhhhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEE
Q 007006          463 -----LLIYEYMPNKSLDVHLFDATR---SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI  534 (621)
Q Consensus       463 -----~lV~e~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL  534 (621)
                           ++||||+++++|.+++.....   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence                 999999999999999864322   235899999999999999999999986   999999999999999999999


Q ss_pred             eeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          535 SDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       535 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      +|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~  243 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI  243 (323)
T ss_dssp             CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc
Confidence            99999987654433333333456788999999999999999999999999999999 99998643

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.1e-34  Score=305.89  Aligned_cols=210  Identities=28%  Similarity=0.343  Sum_probs=179.8

Q ss_pred             ccccchHHHHHHhCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcc-----cCCcee
Q 007006          378 FPLFPLRLALEATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-----HKNLVR  451 (621)
Q Consensus       378 ~~~~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----h~nIv~  451 (621)
                      ...+.++......++|.+.++||+|+||.||+++. .+++.||||++... ....+.+..|+++++.++     ||||++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            33444444445678999999999999999999996 46899999999743 334466788999999996     999999


Q ss_pred             EeeEEeeCceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC---
Q 007006          452 LLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---  528 (621)
Q Consensus       452 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---  528 (621)
                      +++++...+..++||||+ +++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.   
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~  175 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF  175 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence            999999999999999999 99999998643 2345899999999999999999999986   999999999999975   


Q ss_pred             ----------------------CCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHH
Q 007006          529 ----------------------DMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLL  586 (621)
Q Consensus       529 ----------------------~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~  586 (621)
                                            ++.+||+|||++.......     ....||+.|+|||++.+..++.++||||||+++|
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  250 (360)
T 3llt_A          176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA  250 (360)
T ss_dssp             CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred             cccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence                                  7889999999998644322     2346899999999999999999999999999999


Q ss_pred             HHHcCCCCCCCC
Q 007006          587 EIISGRKNNGFY  598 (621)
Q Consensus       587 elltG~~p~~~~  598 (621)
                      ||++|+.||...
T Consensus       251 ell~g~~pf~~~  262 (360)
T 3llt_A          251 ELYTGSLLFRTH  262 (360)
T ss_dssp             HHHHSSCSCCCS
T ss_pred             HHHHCCCCCCCC
Confidence            999999999643

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=8.8e-35  Score=315.13  Aligned_cols=200  Identities=26%  Similarity=0.358  Sum_probs=173.8

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      .++|++.+.||+|+||.||++.. .+|+.+|+|++....  ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            46799999999999999999985 478999999997653  234567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc---CCCCeEEeeecCceec
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIF  543 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~---~~~~vkL~Dfgla~~~  543 (621)
                      ||+++|+|.+.+..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++   .++.+||+|||++...
T Consensus        90 E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           90 DLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             CCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            99999999988854   345999999999999999999999986   99999999999998   4678999999999876


Q ss_pred             CCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          544 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       544 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ......  .....||+.|+|||++.+..++.++||||+|+++|||++|++||..
T Consensus       164 ~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~  215 (444)
T 3soa_A          164 EGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD  215 (444)
T ss_dssp             CTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence            543221  2235789999999999999999999999999999999999999853

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.7e-34  Score=307.95  Aligned_cols=205  Identities=18%  Similarity=0.248  Sum_probs=176.8

Q ss_pred             hCCCCccceeccC--CceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          390 TNHFSDENKLGQG--GFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       390 ~~~f~~~~~LG~G--~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      .++|++.++||+|  +||.||+++.. +++.||||++....  ....+.+.+|+++++.++||||+++++++.+++..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4679999999999  99999999975 69999999997543  3445678889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      ||||+++++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||.+....
T Consensus       104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            99999999999998643 2345999999999999999999999986   9999999999999999999999999987542


Q ss_pred             CCC-----CCcccccccccCCccChhcccC--CCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          545 GNQ-----NQANTNIIAGTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       545 ~~~-----~~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ...     .........||+.|+|||++.+  ..++.++||||||+++|||++|+.||...
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  240 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  240 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence            211     1112233468899999999987  57899999999999999999999999643

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.4e-34  Score=301.24  Aligned_cols=194  Identities=24%  Similarity=0.347  Sum_probs=151.4

Q ss_pred             cceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcc-cCCceeEeeEEeeCceEEEEEEecCCCC
Q 007006          396 ENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEYMPNKS  473 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV~e~~~~gs  473 (621)
                      .++||+|+||.||++... +++.||||++.+.   ....+.+|+.++..+. ||||+++++++.++...++||||+++++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999965 6899999999653   3466789999999997 9999999999999999999999999999


Q ss_pred             hhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC---CeEEeeecCceecCCCCCCc
Q 007006          474 LDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM---NPKISDFGLARIFGGNQNQA  550 (621)
Q Consensus       474 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~vkL~Dfgla~~~~~~~~~~  550 (621)
                      |.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++   .+||+|||++........  
T Consensus        93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--  164 (325)
T 3kn6_A           93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--  164 (325)
T ss_dssp             HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--
Confidence            9999954   346999999999999999999999986   99999999999998765   799999999987543322  


Q ss_pred             ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCcC
Q 007006          551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFS  600 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~  600 (621)
                      ......+|+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  214 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDR  214 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC----
T ss_pred             cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcc
Confidence            22234679999999999999999999999999999999999999975443

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=7.9e-35  Score=296.27  Aligned_cols=202  Identities=30%  Similarity=0.457  Sum_probs=173.5

Q ss_pred             hCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      .++|.+.+.||+|+||.||++...++..||+|++.... ...+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            45788999999999999999999888899999997653 33577899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++++|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++........ 
T Consensus       102 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  175 (283)
T 3gen_A          102 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-  175 (283)
T ss_dssp             TTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-
T ss_pred             CCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc-
Confidence            999999999542  345999999999999999999999986   99999999999999999999999999986543211 


Q ss_pred             cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~  225 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF  225 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            11122345778999999998899999999999999999998 99998643

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.6e-35  Score=320.26  Aligned_cols=201  Identities=27%  Similarity=0.346  Sum_probs=166.2

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      .++|++.++||+|+||.||++.. .+|+.||||++...   .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            36799999999999999999985 46899999999753   334456678899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE-DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      |||+++++|..++..   ...+++..+..++.||+.||.|||+ .+   |+||||||+|||++.++.+||+|||+++...
T Consensus       227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            999999999998854   3468999999999999999999998 65   9999999999999999999999999997543


Q ss_pred             CCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ...  .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  352 (446)
T 4ejn_A          301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  352 (446)
T ss_dssp             C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence            221  2223467899999999999999999999999999999999999998643

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.2e-34  Score=292.06  Aligned_cols=199  Identities=24%  Similarity=0.383  Sum_probs=176.3

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      .++|.+.+.||+|+||.||++... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            457899999999999999999965 5789999999877666778899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE---cCCCCeEEeeecCceecCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~vkL~Dfgla~~~~~  545 (621)
                      +++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||+   +.++.+||+|||++.....
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           88 CTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             CCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            999999988854   345899999999999999999999986   9999999999999   7889999999999987654


Q ss_pred             CCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ...   .....+|+.|+|||.+.+. ++.++||||||+++|||++|+.||...
T Consensus       162 ~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~  210 (277)
T 3f3z_A          162 GKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAP  210 (277)
T ss_dssp             TSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCC
Confidence            322   2234689999999988654 899999999999999999999998643

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.7e-34  Score=293.25  Aligned_cols=202  Identities=20%  Similarity=0.313  Sum_probs=175.8

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      .++|.+.+.||+|+||.||++.. .+++.||+|++.....  .+.+.+|+.+++.+ +|+|++++++++.+....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            46799999999999999999995 5799999999865432  34578899999999 79999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCC-----eEEeeecCcee
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN-----PKISDFGLARI  542 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----vkL~Dfgla~~  542 (621)
                      |+ +++|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.     +||+|||++..
T Consensus        87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            99 99999999643  345999999999999999999999886   999999999999987776     99999999997


Q ss_pred             cCCCCCC-----cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          543 FGGNQNQ-----ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       543 ~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      .......     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  222 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  222 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence            7544322     12234578999999999999999999999999999999999999997644

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.2e-34  Score=299.17  Aligned_cols=206  Identities=33%  Similarity=0.467  Sum_probs=178.3

Q ss_pred             hCCCCccceeccCCceeEEEEEe------cCCcEEEEEEeccCCc-ccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCce
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE  461 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~  461 (621)
                      .++|.+.+.||+|+||.||++..      .+++.||+|++..... ...+.+.+|+.+++++ +||||+++++++.+++.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            35788999999999999999984      3468899999976533 3457789999999999 99999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhhccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE
Q 007006          462 LLLIYEYMPNKSLDVHLFDATR---------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL  526 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl  526 (621)
                      .++||||+++++|.+++.....               ...+++..++.++.||+.||.|||+.+   |+||||||+|||+
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence            9999999999999999965432               225899999999999999999999986   9999999999999


Q ss_pred             cCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          527 DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       527 ~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      +.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  251 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence            9999999999999987655443333334456788999999999999999999999999999999 99998643

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-34  Score=303.91  Aligned_cols=208  Identities=28%  Similarity=0.355  Sum_probs=172.6

Q ss_pred             HHHhCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC-----CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCc
Q 007006          387 LEATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT-----SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ  460 (621)
Q Consensus       387 ~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~  460 (621)
                      ....++|.+.+.||+|+||.||++.. .++..||+|++...     .....+.+.+|++++++++||||+++++++.+.+
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            35567899999999999999999986 46889999998653     3455678999999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhhcc-------------------------------------CCCCCCHHHHHHHHHHHHHHH
Q 007006          461 ELLLIYEYMPNKSLDVHLFDAT-------------------------------------RSVQLDWKRRQSIINGIARGI  503 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~~L  503 (621)
                      ..++||||+++++|.+++....                                     ....+++..+..++.||+.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            9999999999999999884210                                     022346778889999999999


Q ss_pred             HHHHhCCCCCeEeccCCCCCEEEcCCC--CeEEeeecCceecCCCCCCc--ccccccccCCccChhcccC--CCCChhhh
Q 007006          504 LYLHEDSRLKIIHRDLKASNILLDDDM--NPKISDFGLARIFGGNQNQA--NTNIIAGTYGYMAPEYAMG--GIFSIKSD  577 (621)
Q Consensus       504 ~yLH~~~~~~iiH~Dlkp~NILl~~~~--~vkL~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~--~~~s~~sD  577 (621)
                      .|||+.+   |+||||||+|||++.++  .+||+|||++..+.......  ......||+.|+|||.+.+  ..++.++|
T Consensus       182 ~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          182 HYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            9999986   99999999999998776  89999999998764322211  2234568999999999865  67899999


Q ss_pred             HHHHHHHHHHHHcCCCCCCC
Q 007006          578 VFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       578 VwS~Gvll~elltG~~p~~~  597 (621)
                      |||||+++|||++|+.||..
T Consensus       259 iwslG~il~el~~g~~pf~~  278 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPG  278 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHHHHHHHHHHHCCCCCCC
Confidence            99999999999999999854

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.4e-35  Score=305.09  Aligned_cols=200  Identities=27%  Similarity=0.393  Sum_probs=167.6

Q ss_pred             hCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCC--cccHHHHHHHHHHHHhccc--CCceeEeeEEeeCceEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQH--KNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h--~nIv~l~g~~~~~~~~~lV  465 (621)
                      .++|++.+.||+|+||.||++...+++.||||++....  ....+.+.+|+.++.+++|  |||+++++++.+++..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            35789999999999999999998889999999987543  3445778999999999976  9999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      || +.+++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||++.....
T Consensus        88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            99 578899999954   346899999999999999999999986   99999999999997 57899999999987654


Q ss_pred             CCCCcccccccccCCccChhcccC-----------CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMG-----------GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ...........||+.|+|||++.+           ..++.++||||||+++|||++|+.||..
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  222 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  222 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence            433333345579999999999864           6789999999999999999999999864

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.3e-34  Score=304.41  Aligned_cols=198  Identities=27%  Similarity=0.437  Sum_probs=159.9

Q ss_pred             HhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      ..++|.+.+.||+|+||.||+++.. +++.||||+++...  ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            3467999999999999999999975 58899999997643  34568899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC---CCCeEEeeecCceecC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGLARIFG  544 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~vkL~Dfgla~~~~  544 (621)
                      |+++++|.+++..   ...+++.++..++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||++....
T Consensus       129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            9999999998853   345899999999999999999999986   999999999999975   8899999999998654


Q ss_pred             CCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ...   ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  252 (349)
T 2w4o_A          203 HQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYD  252 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence            322   12335689999999999999999999999999999999999999854

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=8.9e-35  Score=302.52  Aligned_cols=202  Identities=30%  Similarity=0.472  Sum_probs=170.7

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcE----EEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKA----IAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~----vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      ++|.+.+.||+|+||.||+|.+. +++.    |++|.+.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            57889999999999999999854 4443    7888875443 334456788999999999999999999986 456889


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      |+||+++|+|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence            99999999999998542  346899999999999999999999986   9999999999999999999999999999876


Q ss_pred             CCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  221 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL  221 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc
Confidence            5544444445677889999999999999999999999999999999 99998753

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.2e-34  Score=304.17  Aligned_cols=199  Identities=27%  Similarity=0.349  Sum_probs=165.5

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      .++|.+.+.||+|+||.||+++.. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            468999999999999999999965 789999999976433 336688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCC--eEEeeecCceecCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN--PKISDFGLARIFGGN  546 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--vkL~Dfgla~~~~~~  546 (621)
                      +++|+|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.  +||+|||+++.....
T Consensus        98 ~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           98 ASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            9999999988542   35999999999999999999999986   999999999999987765  999999998743222


Q ss_pred             CCCcccccccccCCccChhcccCCCCChh-hhHHHHHHHHHHHHcCCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIK-SDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~-sDVwS~Gvll~elltG~~p~~~~  598 (621)
                         .......||+.|+|||++.+..++.+ +||||||+++|||++|+.||...
T Consensus       172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  221 (361)
T 3uc3_A          172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP  221 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--
T ss_pred             ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCC
Confidence               12233468999999999988887665 89999999999999999998643

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.5e-34  Score=291.16  Aligned_cols=204  Identities=30%  Similarity=0.429  Sum_probs=177.2

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      .++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++|+|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            357899999999999999999965 68999999987543 3445778999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            9999999998843   346899999999999999999999986   9999999999999999999999999998764333


Q ss_pred             CCcccccccccCCccChhcccCCCC-ChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      .........+++.|+|||.+.+..+ +.++||||||+++|||++|+.||....
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  212 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS  212 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Confidence            2222334578999999999987765 789999999999999999999996543

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.2e-34  Score=311.87  Aligned_cols=197  Identities=34%  Similarity=0.472  Sum_probs=171.6

Q ss_pred             hCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCc-eEEEEEEe
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ-ELLLIYEY  468 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~-~~~lV~e~  468 (621)
                      .++|.+.+.||+|+||.||+|... ++.||||+++...  ..+.|.+|+++|++++||||+++++++.+.+ ..++||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            357888999999999999999985 7899999997653  4578999999999999999999999987765 78999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++|+|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus       269 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  343 (450)
T 1k9a_A          269 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  343 (450)
T ss_dssp             CTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence            9999999999653 2334799999999999999999999986   9999999999999999999999999998643221 


Q ss_pred             CcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                          ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       344 ----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~  390 (450)
T 1k9a_A          344 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI  390 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTS
T ss_pred             ----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                12356789999999999999999999999999999998 99998654

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.5e-34  Score=313.75  Aligned_cols=198  Identities=28%  Similarity=0.497  Sum_probs=175.8

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|.+.+.||+|+||.||+|+.. +|+.||||++....   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            57899999999999999999965 79999999997542   234567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        96 E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           96 EYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             ECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            99999999999843   456999999999999999999999986   999999999999999999999999999876543


Q ss_pred             CCCcccccccccCCccChhcccCCCC-ChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .   ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||..
T Consensus       170 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~  218 (476)
T 2y94_A          170 E---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD  218 (476)
T ss_dssp             C---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             c---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC
Confidence            2   2234578999999999988775 7899999999999999999999864

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.9e-34  Score=291.48  Aligned_cols=199  Identities=37%  Similarity=0.570  Sum_probs=164.1

Q ss_pred             hCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCC----cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      .++|.+.+.||+|+||.||++... ++.||+|++....    ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            357889999999999999999974 8999999987543    23357789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC--------CCCeEEeee
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD--------DMNPKISDF  537 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~--------~~~vkL~Df  537 (621)
                      |||+++++|.+++.    ...+++..++.++.|++.||.|||+.+..+|+||||||+|||++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999883    346899999999999999999999986455999999999999986        678999999


Q ss_pred             cCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          538 GLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       538 gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      |++........    ....+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       161 g~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  216 (271)
T 3dtc_A          161 GLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG  216 (271)
T ss_dssp             CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTT
T ss_pred             Ccccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99986543222    234689999999999999999999999999999999999999864

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.9e-34  Score=301.19  Aligned_cols=205  Identities=32%  Similarity=0.489  Sum_probs=176.2

Q ss_pred             hCCCCccceeccCCceeEEEEEec--------CCcEEEEEEeccCC-cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeC
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG  459 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~  459 (621)
                      .++|.+.+.||+|+||.||++...        ++..||+|++.... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            467999999999999999999863        46789999997653 34456789999999999 899999999999999


Q ss_pred             ceEEEEEEecCCCChhhhhhhccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE
Q 007006          460 QELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL  526 (621)
Q Consensus       460 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl  526 (621)
                      +..++||||+++++|.+++.....             ...+++..++.++.||+.||.|||+.+   |+||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence            999999999999999999965332             234899999999999999999999986   9999999999999


Q ss_pred             cCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          527 DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       527 ~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      +.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~  262 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG  262 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc
Confidence            9999999999999987655433333334456788999999988889999999999999999999 9999864

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.5e-34  Score=291.79  Aligned_cols=202  Identities=30%  Similarity=0.502  Sum_probs=157.1

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|.+.+.||+|+||.||+++. .+|+.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            5788999999999999999986 579999999996542   234577899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++++|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus        91 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           91 EMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             ECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             ecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            99999999999854  3356899999999999999999999986   999999999999999999999999999876433


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      ...  .....+++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       166 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  216 (278)
T 3cok_A          166 HEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT  216 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred             CCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChh
Confidence            221  223468999999999998889999999999999999999999986543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.7e-34  Score=297.07  Aligned_cols=196  Identities=30%  Similarity=0.383  Sum_probs=164.6

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc--ccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      .++|++.++||+|+||+||+|+.. +|+.||||++.....  .....+..|+..+.++ +||||+++++++.+++..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            357999999999999999999975 799999999865432  2334455666666666 899999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      |||+ +++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       136 ~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             Eecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            9999 67888888543  346999999999999999999999986   99999999999999999999999999987643


Q ss_pred             CCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNN  595 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~  595 (621)
                      ..   ......||+.|+|||++.+ .++.++||||||+++|||++|+.|+
T Consensus       210 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~  255 (311)
T 3p1a_A          210 AG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELP  255 (311)
T ss_dssp             --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCC
T ss_pred             CC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence            32   2233468999999998876 7899999999999999999997665

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4.3e-34  Score=296.75  Aligned_cols=199  Identities=28%  Similarity=0.375  Sum_probs=176.2

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc------ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL  462 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~  462 (621)
                      .++|.+.+.||+|+||.||++... +|+.||+|++.....      ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            457899999999999999999965 689999999976432      1367899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC----CeEEeeec
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM----NPKISDFG  538 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~vkL~Dfg  538 (621)
                      ++||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            999999999999999953   346899999999999999999999986   99999999999999888    79999999


Q ss_pred             CceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          539 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       539 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ++........   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       165 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  220 (321)
T 2a2a_A          165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG  220 (321)
T ss_dssp             TCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             cceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC
Confidence            9987654322   2234689999999999999999999999999999999999999864

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=6.4e-35  Score=304.24  Aligned_cols=206  Identities=32%  Similarity=0.474  Sum_probs=176.7

Q ss_pred             HhCCCCccceeccCCceeEEEEEecC------CcEEEEEEeccCC-cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCc
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ  460 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~  460 (621)
                      ..++|.+.+.||+|+||.||++....      ...||+|++.... ....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            34789999999999999999998642      2479999997653 33456789999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhhccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC
Q 007006          461 ELLLIYEYMPNKSLDVHLFDATR-----------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD  529 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~  529 (621)
                      ..++||||+++|+|.+++.....           ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence            99999999999999999864321           345899999999999999999999986   9999999999999999


Q ss_pred             CCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          530 MNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       530 ~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      +.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  269 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG  269 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcc
Confidence            9999999999987654433323333456788999999999999999999999999999999 9999864

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.7e-34  Score=305.36  Aligned_cols=202  Identities=20%  Similarity=0.246  Sum_probs=167.0

Q ss_pred             hCCCCccceeccCCceeEEEEEecC------CcEEEEEEeccCCccc-----------HHHHHHHHHHHHhcccCCceeE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLAD------GKAIAVKRLSRTSGQG-----------LQEFKNEVNLIAKLQHKNLVRL  452 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vavK~l~~~~~~~-----------~~~~~~Ei~~l~~l~h~nIv~l  452 (621)
                      .++|.+.++||+|+||.||+|.+..      ++.||||++.......           ...+..|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4689999999999999999998754      4789999987653211           1123345556677789999999


Q ss_pred             eeEEeeC----ceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc-
Q 007006          453 LGCCLEG----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-  527 (621)
Q Consensus       453 ~g~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-  527 (621)
                      ++++...    ...++||||+ +++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++ 
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~  187 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence            9999875    4589999999 9999999854  3356999999999999999999999986   99999999999999 


Q ss_pred             -CCCCeEEeeecCceecCCCCCCc-----ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          528 -DDMNPKISDFGLARIFGGNQNQA-----NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       528 -~~~~vkL~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                       .++.+||+|||+++.+.......     ......||+.|+|||++.+..++.++||||||+++|||+||+.||..
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~  263 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED  263 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence             88999999999998765332211     11334589999999999999999999999999999999999999974

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.6e-34  Score=297.24  Aligned_cols=203  Identities=25%  Similarity=0.376  Sum_probs=169.8

Q ss_pred             CCCCcc-ceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEEEE
Q 007006          391 NHFSDE-NKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       391 ~~f~~~-~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      +.|.+. +.||+|+||.||++.. .+++.||||++........+.+.+|++++.++ +||||+++++++.+++..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            567774 7899999999999985 47999999999877666678899999999995 79999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCC---eEEeeecCceecC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN---PKISDFGLARIFG  544 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---vkL~Dfgla~~~~  544 (621)
                      |+++++|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.   +||+|||++....
T Consensus        92 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           92 KMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             cCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            99999999999643   45899999999999999999999986   999999999999998776   9999999987654


Q ss_pred             CCCC-----CcccccccccCCccChhcccC-----CCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          545 GNQN-----QANTNIIAGTYGYMAPEYAMG-----GIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       545 ~~~~-----~~~~~~~~gt~~y~aPE~l~~-----~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      ....     ........||+.|+|||++.+     ..++.++||||||+++|||++|+.||....
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  230 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC  230 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence            2211     111223458999999999865     457899999999999999999999997543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=9.6e-35  Score=316.43  Aligned_cols=202  Identities=34%  Similarity=0.496  Sum_probs=174.7

Q ss_pred             HhCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      ..++|.+.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+.+|++++||||+++++++. .+..++||||
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~  263 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF  263 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence            346788899999999999999999889999999997644 45688999999999999999999999986 5678999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++|+|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       264 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~  339 (454)
T 1qcf_A          264 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  339 (454)
T ss_dssp             CTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred             cCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence            9999999999642 2235889999999999999999999986   99999999999999999999999999987543211


Q ss_pred             CcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      . ......+++.|+|||++....++.++||||||+++|||+| |+.||..
T Consensus       340 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~  388 (454)
T 1qcf_A          340 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG  388 (454)
T ss_dssp             H-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             e-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC
Confidence            1 1112345778999999998999999999999999999999 9999864

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.9e-34  Score=307.87  Aligned_cols=199  Identities=26%  Similarity=0.390  Sum_probs=168.0

Q ss_pred             CCCCccceeccCCceeEEEEEecCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcc--cCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQ--HKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~--h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|.+.+.||+|+||.||++...+++.||||++....  ....+.+.+|+.+|.+++  ||||+++++++..++..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            4699999999999999999998889999999987543  344577899999999996  599999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      | +.+++|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||++..+...
T Consensus       136 E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             E-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             e-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            9 6789999998643   36899999999999999999999986   99999999999995 578999999999876544


Q ss_pred             CCCcccccccccCCccChhcccC-----------CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMG-----------GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~-----------~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ..........||+.|+|||++.+           ..++.++|||||||++|||++|+.||..
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~  269 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  269 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchh
Confidence            33333344579999999999865           4689999999999999999999999964

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.4e-34  Score=294.16  Aligned_cols=200  Identities=26%  Similarity=0.383  Sum_probs=169.4

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc--ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      ++|.+.++||+|+||.||++... +|+.||+|++.....  ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57899999999999999999975 589999999865532  234668899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |+++++|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            9999999888743   345899999999999999999999986   9999999999999999999999999998765332


Q ss_pred             CCcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ..  .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       157 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  206 (311)
T 4agu_A          157 DY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK  206 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            21  223467899999999876 56899999999999999999999998644

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.6e-34  Score=305.45  Aligned_cols=203  Identities=29%  Similarity=0.473  Sum_probs=163.3

Q ss_pred             HHhCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC--CcccHHHHHHHHHHHHhcc-cCCceeEeeEEeeCc--e
Q 007006          388 EATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQ--E  461 (621)
Q Consensus       388 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~--~  461 (621)
                      ...++|.+.+.||+|+||.||++.. .+|+.||||++...  .....+.+.+|+.++.++. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3457899999999999999999985 46999999998654  2344567889999999997 999999999997544  7


Q ss_pred             EEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCce
Q 007006          462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR  541 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~  541 (621)
                      .++||||++ ++|..++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            899999998 688888843    36899999999999999999999986   9999999999999999999999999998


Q ss_pred             ecCCCCC-------------------CcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          542 IFGGNQN-------------------QANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       542 ~~~~~~~-------------------~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      .+.....                   ........||+.|+|||++.+ ..++.++|||||||++|||++|++||...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  234 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS  234 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence            7643111                   111233578999999999876 67899999999999999999999999643

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=7.9e-34  Score=292.79  Aligned_cols=201  Identities=29%  Similarity=0.470  Sum_probs=169.3

Q ss_pred             HhCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC-----cccHHHHHHHHHHHHhcc---cCCceeEeeEEeeC
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS-----GQGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLEG  459 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~---h~nIv~l~g~~~~~  459 (621)
                      ..++|++.++||+|+||.||+++. .+++.||+|++....     ......+.+|++++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            457899999999999999999995 578999999987432     122356678888877775   99999999999875


Q ss_pred             c-----eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEE
Q 007006          460 Q-----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI  534 (621)
Q Consensus       460 ~-----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL  534 (621)
                      .     ..++||||+. ++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence            5     5799999997 5999988543 2334999999999999999999999986   999999999999999999999


Q ss_pred             eeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          535 SDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       535 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      +|||++.......   ......+|+.|+|||++.+..++.++||||||+++|||++|++||..
T Consensus       162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  221 (308)
T 3g33_A          162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG  221 (308)
T ss_dssp             CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCC
T ss_pred             eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999998654322   22345789999999999999999999999999999999999999854

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.8e-34  Score=317.58  Aligned_cols=203  Identities=31%  Similarity=0.480  Sum_probs=176.8

Q ss_pred             hCCCCccceeccCCceeEEEEEecC-CcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      .++|.+.++||+|+||.||+|.+.. +..||||+++... ...++|.+|+.+|++++||||+++++++.+.+..++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            3568889999999999999999764 8899999997653 3467899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++|+|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus       298 ~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          298 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred             cCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence            9999999999653 2346899999999999999999999986   99999999999999999999999999987643322


Q ss_pred             CcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      . ......++..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus       374 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~  423 (495)
T 1opk_A          374 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI  423 (495)
T ss_dssp             E-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             e-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC
Confidence            1 1122345678999999998899999999999999999999 99998643

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-34  Score=295.84  Aligned_cols=197  Identities=32%  Similarity=0.470  Sum_probs=165.3

Q ss_pred             CCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecC
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP  470 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  470 (621)
                      ++|++.+.||+|+||.||+++.. ++.||+|++...  ...+.+.+|++++++++||||+++++++.+  ..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            56888999999999999999874 789999998643  345778999999999999999999998874  4789999999


Q ss_pred             CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCC-eEEeeecCceecCCCCCC
Q 007006          471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN-PKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-vkL~Dfgla~~~~~~~~~  549 (621)
                      +++|.+++........+++..++.++.|+++||.|||+.+..+|+||||||+|||++.++. +||+|||++......   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999999975544446889999999999999999999943335999999999999998887 799999999765322   


Q ss_pred             cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                        .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  205 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE  205 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTT
T ss_pred             --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchh
Confidence              1223589999999999999999999999999999999999999864

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.8e-34  Score=293.58  Aligned_cols=197  Identities=30%  Similarity=0.408  Sum_probs=165.8

Q ss_pred             hCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHh--cccCCceeEeeEEeeC----ceEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK--LQHKNLVRLLGCCLEG----QELL  463 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~h~nIv~l~g~~~~~----~~~~  463 (621)
                      .++|.+.+.||+|+||.||+|+. +++.||||++...   ....+..|.+++..  ++||||+++++++.+.    ...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46899999999999999999988 6899999998653   33556677777776  7999999999997653    4689


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeccCCCCCEEEcCCCCeEEe
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH--------EDSRLKIIHRDLKASNILLDDDMNPKIS  535 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~iiH~Dlkp~NILl~~~~~vkL~  535 (621)
                      +||||+++|+|.+++.    ...+++..+++++.||+.||.|||        +.   +|+||||||+|||++.++.+||+
T Consensus        83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEEC
T ss_pred             EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEe
Confidence            9999999999999993    346999999999999999999999        65   49999999999999999999999


Q ss_pred             eecCceecCCCCCCc--ccccccccCCccChhcccCC------CCChhhhHHHHHHHHHHHHcC----------CCCCCC
Q 007006          536 DFGLARIFGGNQNQA--NTNIIAGTYGYMAPEYAMGG------IFSIKSDVFSFGVLLLEIISG----------RKNNGF  597 (621)
Q Consensus       536 Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~------~~s~~sDVwS~Gvll~elltG----------~~p~~~  597 (621)
                      |||++..........  ......||+.|+|||++.+.      .++.++||||||+++|||++|          +.||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            999998765433221  12334789999999999876      455799999999999999999          777753

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.5e-34  Score=302.22  Aligned_cols=200  Identities=25%  Similarity=0.376  Sum_probs=174.2

Q ss_pred             HhCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCc--------ccHHHHHHHHHHHHhcccCCceeEeeEEeeC
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG--------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG  459 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~--------~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~  459 (621)
                      ..++|.+.+.||+|+||.||++.. .+++.||||++.....        ...+.+.+|++++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            346899999999999999999985 5689999999976531        1234577899999999999999999999999


Q ss_pred             ceEEEEEEecCCC-ChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeec
Q 007006          460 QELLLIYEYMPNK-SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG  538 (621)
Q Consensus       460 ~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfg  538 (621)
                      +..++||||+.+| +|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999777 99888853   345999999999999999999999986   9999999999999999999999999


Q ss_pred             CceecCCCCCCcccccccccCCccChhcccCCCC-ChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          539 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       539 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ++........   .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..
T Consensus       176 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  232 (335)
T 3dls_A          176 SAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE  232 (335)
T ss_dssp             TCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred             cceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence            9987654322   223568999999999988876 8999999999999999999999864

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.3e-34  Score=325.29  Aligned_cols=200  Identities=27%  Similarity=0.369  Sum_probs=176.8

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC---CcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~l  464 (621)
                      .++|++.+.||+|+||.||+++.. +++.||||++++.   .....+.+..|..++..+ +||||+++++++.+.+.+++
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            468999999999999999999964 6889999999753   234456788899999988 79999999999999999999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      ||||+++|+|..++...   ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus       420 V~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            99999999999999643   45999999999999999999999986   9999999999999999999999999998643


Q ss_pred             CCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ...  .......||+.|+|||++.+..++.++||||||+++|||++|++||..
T Consensus       494 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~  544 (674)
T 3pfq_A          494 WDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG  544 (674)
T ss_dssp             CTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC
Confidence            322  223456899999999999999999999999999999999999999964

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=7.6e-34  Score=289.02  Aligned_cols=199  Identities=27%  Similarity=0.409  Sum_probs=174.6

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      .++|.+.+.||+|+||.||++... +++.||+|++....  ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            468999999999999999999864 58999999987543  334567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCC---eEEeeecCceec
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN---PKISDFGLARIF  543 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---vkL~Dfgla~~~  543 (621)
                      ||+++++|.+++...   ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.   +||+|||++...
T Consensus        85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            999999998888543   45899999999999999999999986   999999999999987655   999999999876


Q ss_pred             CCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          544 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       544 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .....   .....+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  209 (284)
T 3kk8_A          159 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD  209 (284)
T ss_dssp             CSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC
Confidence            43322   2234689999999999999999999999999999999999999853

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-34  Score=309.05  Aligned_cols=204  Identities=25%  Similarity=0.376  Sum_probs=175.9

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCc--eEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ--ELLLI  465 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~--~~~lV  465 (621)
                      .++|.+.++||+|+||.||++... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            357899999999999999999965 58999999997543 344677889999999999999999999998765  78999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE----cCCCCeEEeeecCce
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL----DDDMNPKISDFGLAR  541 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~vkL~Dfgla~  541 (621)
                      |||+++++|.+++........+++..++.++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999976555555999999999999999999999986   9999999999999    777889999999998


Q ss_pred             ecCCCCCCcccccccccCCccChhcccC--------CCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          542 IFGGNQNQANTNIIAGTYGYMAPEYAMG--------GIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       542 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      .......   .....||+.|+|||++.+        ..++.++||||||+++|||++|+.||....
T Consensus       165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~  227 (396)
T 4eut_A          165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE  227 (396)
T ss_dssp             ECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred             EccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            7644322   223468999999998865        457889999999999999999999997544

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.1e-34  Score=300.77  Aligned_cols=196  Identities=23%  Similarity=0.390  Sum_probs=169.7

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      .++|++.+.||+|+||.||++..+ +++.||+|++.+....    ..+|++++.++ +||||+++++++.+++..++|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            467999999999999999999965 6899999999765432    35688888888 79999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC----CCeEEeeecCceec
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD----MNPKISDFGLARIF  543 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~----~~vkL~Dfgla~~~  543 (621)
                      |+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+.++    +.+||+|||++...
T Consensus        97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            9999999998853   346999999999999999999999986   9999999999998543    34999999999876


Q ss_pred             CCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          544 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       544 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .....  ......+|+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       171 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  222 (342)
T 2qr7_A          171 RAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFAN  222 (342)
T ss_dssp             BCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             cCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCC
Confidence            54322  22335789999999999888889999999999999999999999974

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.7e-34  Score=299.50  Aligned_cols=207  Identities=30%  Similarity=0.457  Sum_probs=177.1

Q ss_pred             HhCCCCccceeccCCceeEEEEEec------CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCce
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE  461 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~  461 (621)
                      ..++|.+.+.||+|+||.||+|...      +++.||+|++.... ......+.+|++++++++||||+++++++.+.+.
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~  102 (322)
T 1p4o_A           23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP  102 (322)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence            4568999999999999999999854      37889999997553 2345578999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhhccC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEE
Q 007006          462 LLLIYEYMPNKSLDVHLFDATR-------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI  534 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL  534 (621)
                      .++||||+++++|.+++.....       ...+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||
T Consensus       103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl  179 (322)
T 1p4o_A          103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  179 (322)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred             cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEE
Confidence            9999999999999999864321       245799999999999999999999986   999999999999999999999


Q ss_pred             eeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          535 SDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       535 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      +|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  244 (322)
T 1p4o_A          180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL  244 (322)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred             CcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence            99999986543332222333456888999999999999999999999999999999 89998643

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.4e-34  Score=292.85  Aligned_cols=200  Identities=36%  Similarity=0.579  Sum_probs=160.0

Q ss_pred             hCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      .++|.+.++||+|+||.||+++..  ..||+|+++...  ....+.+.+|++++++++||||++++++. ..+..++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            467999999999999999999864  359999987543  34457799999999999999999999965 4556899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus       100 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A          100 WCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             CCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             ecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence            9999999998853  3456999999999999999999999986   9999999999999999999999999998665433


Q ss_pred             CCcccccccccCCccChhccc---CCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .........||+.|+|||.+.   +..++.++||||||+++|||++|+.||..
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  227 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN  227 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccc
Confidence            333334457899999999986   66789999999999999999999999864

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.1e-33  Score=287.78  Aligned_cols=199  Identities=28%  Similarity=0.393  Sum_probs=172.9

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc------ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL  463 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~  463 (621)
                      ++|.+.+.||+|+||.||++... +++.||+|++.....      ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            46889999999999999999975 689999999875421      24678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC----CeEEeeecC
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM----NPKISDFGL  539 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~vkL~Dfgl  539 (621)
                      +||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   ++||||||+||+++.++    .+||+|||+
T Consensus        85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            99999999999999854   346899999999999999999999986   99999999999998877    799999999


Q ss_pred             ceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          540 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       540 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      +........   .....+++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       159 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  214 (283)
T 3bhy_A          159 AHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE  214 (283)
T ss_dssp             CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             ceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc
Confidence            987643321   22346889999999999999999999999999999999999998643

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=9e-34  Score=289.95  Aligned_cols=201  Identities=30%  Similarity=0.466  Sum_probs=172.2

Q ss_pred             CCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecC
Q 007006          392 HFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP  470 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  470 (621)
                      +|.....||+|+||.||+|.. .+++.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            455566999999999999995 5688999999987766667889999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC-CCCeEEeeecCceecCCCCCC
Q 007006          471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      +++|.+++........+++..+..++.||+.||.|||+.+   |+||||||+||+++. ++.+||+|||++........ 
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-  178 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-  178 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence            9999999976544556789999999999999999999986   999999999999987 89999999999987643221 


Q ss_pred             cccccccccCCccChhcccCCC--CChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGGI--FSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~~--~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                       ......+++.|+|||++.+..  ++.++||||||+++|||++|+.||..
T Consensus       179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  227 (295)
T 2clq_A          179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE  227 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred             -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence             122346889999999987654  89999999999999999999999853

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4e-34  Score=300.64  Aligned_cols=195  Identities=32%  Similarity=0.499  Sum_probs=170.0

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      +.|...+.||+|+||.||+++. .+++.||||++....   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588899999999999999985 579999999997543   233467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+. |+|.+++...  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus       134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            9997 6777777432  356899999999999999999999986   999999999999999999999999999765321


Q ss_pred             CCCcccccccccCCccChhccc---CCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                            ....||+.|+|||++.   ...++.++||||||+++|||++|+.||..
T Consensus       208 ------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  255 (348)
T 1u5q_A          208 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  255 (348)
T ss_dssp             ------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                  2346899999999984   56789999999999999999999999853

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=5.8e-34  Score=290.65  Aligned_cols=201  Identities=25%  Similarity=0.417  Sum_probs=170.7

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      .++|.+.++||+|+||.||++.. .++..+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            35789999999999999999986 468999999987653 3456789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE---cCCCCeEEeeecCceec
Q 007006          468 YMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIF  543 (621)
Q Consensus       468 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~vkL~Dfgla~~~  543 (621)
                      |+++++|.+++... .....+++..+..++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||++...
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999988643 23456999999999999999999999986   9999999999999   45678999999999865


Q ss_pred             CCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          544 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       544 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .....   .....+++.|+|||.+. ..++.++||||||+++|||++|+.||..
T Consensus       178 ~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~  227 (285)
T 3is5_A          178 KSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTG  227 (285)
T ss_dssp             ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCC
Confidence            43322   23356899999999875 5689999999999999999999999864

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1e-33  Score=289.90  Aligned_cols=201  Identities=25%  Similarity=0.397  Sum_probs=176.5

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      .++|.+.+.||+|+||.||++... +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            357889999999999999999975 58899999987542   33456788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      |||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            999999999998854   246899999999999999999999986   99999999999999999999999999987643


Q ss_pred             CCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ...  ......+++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  218 (294)
T 2rku_A          168 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS  218 (294)
T ss_dssp             TTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             Ccc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            222  223356899999999999988999999999999999999999998643

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-34  Score=303.65  Aligned_cols=201  Identities=28%  Similarity=0.410  Sum_probs=172.6

Q ss_pred             CCCCccceeccCCceeEEEEEe----cCCcEEEEEEeccCC----cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCce
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL----ADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE  461 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~  461 (621)
                      ++|.+.+.||+|+||.||+++.    .+++.||||+++...    ....+.+.+|++++.++ +||||+++++++.+.+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5799999999999999999986    368999999987542    23345677899999999 69999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCce
Q 007006          462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR  541 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~  541 (621)
                      .++||||+++++|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             EEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            99999999999999999643   35899999999999999999999986   9999999999999999999999999998


Q ss_pred             ecCCCCCCcccccccccCCccChhcccCC--CCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          542 IFGGNQNQANTNIIAGTYGYMAPEYAMGG--IFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       542 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      .+..... .......||+.|+|||++.+.  .++.++||||||+++|||++|+.||...
T Consensus       208 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~  265 (355)
T 1vzo_A          208 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD  265 (355)
T ss_dssp             ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred             ecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence            7543222 122345789999999999863  4789999999999999999999999643

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=8e-34  Score=304.00  Aligned_cols=197  Identities=24%  Similarity=0.316  Sum_probs=161.9

Q ss_pred             CCCCcc-ceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhc-ccCCceeEeeEEee----CceEE
Q 007006          391 NHFSDE-NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLE----GQELL  463 (621)
Q Consensus       391 ~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~----~~~~~  463 (621)
                      ++|.+. +.||+|+||.||++... +++.||||+++..     ..+.+|++++.++ +||||+++++++..    ....+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456665 68999999999999865 6899999999642     4567888887554 89999999999876    56789


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC---CCCeEEeeecCc
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGLA  540 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~vkL~Dfgla  540 (621)
                      +||||+++|+|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||++
T Consensus       136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence            999999999999999642 2346999999999999999999999986   999999999999997   788999999999


Q ss_pred             eecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          541 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       541 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      +......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  267 (400)
T 1nxk_A          212 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH  267 (400)
T ss_dssp             EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred             cccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence            8754322   1234578999999999999999999999999999999999999996543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.8e-34  Score=312.22  Aligned_cols=196  Identities=30%  Similarity=0.401  Sum_probs=164.5

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeC------c
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------Q  460 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~------~  460 (621)
                      .++|++.++||+|+||.||++... +++.||||++...  .....+.+.+|+.+|+.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            468999999999999999999854 6899999999754  334456788999999999999999999999754      3


Q ss_pred             eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCc
Q 007006          461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA  540 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla  540 (621)
                      ..++||||++++ |...+.     ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            579999999865 545442     24899999999999999999999986   999999999999999999999999999


Q ss_pred             eecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          541 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       541 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      +......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g  265 (464)
T 3ttj_A          212 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG  265 (464)
T ss_dssp             -----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCC
Confidence            8764322   22345789999999999999999999999999999999999999964

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.2e-34  Score=296.31  Aligned_cols=208  Identities=31%  Similarity=0.441  Sum_probs=177.3

Q ss_pred             HHhCCCCccceeccCCceeEEEEEe------cCCcEEEEEEeccCCc-ccHHHHHHHHHHHHhc-ccCCceeEeeEEeeC
Q 007006          388 EATNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG  459 (621)
Q Consensus       388 ~~~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~  459 (621)
                      ...++|.+.+.||+|+||.||++..      .+++.||||++..... ...+.+.+|++++.++ +||||+++++++.+.
T Consensus        24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  103 (316)
T 2xir_A           24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP  103 (316)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence            3457899999999999999999974      3468999999976533 3446789999999999 799999999998876


Q ss_pred             c-eEEEEEEecCCCChhhhhhhccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEE
Q 007006          460 Q-ELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNIL  525 (621)
Q Consensus       460 ~-~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NIL  525 (621)
                      + ..++||||+++++|.+++.....             ...+++..++.++.||+.||.|||+.+   |+||||||+||+
T Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil  180 (316)
T 2xir_A          104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL  180 (316)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEE
Confidence            5 58999999999999999965332             123899999999999999999999986   999999999999


Q ss_pred             EcCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          526 LDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       526 l~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      ++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999987654433333344567889999999999999999999999999999998 99998643

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.8e-33  Score=289.31  Aligned_cols=199  Identities=29%  Similarity=0.491  Sum_probs=177.0

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      .+.|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            35688999999999999999985 468999999997553 3456789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |+++++|.+++.    ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus       101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            999999999884    246899999999999999999999986   9999999999999999999999999998765432


Q ss_pred             CCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .  ......+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  221 (303)
T 3a7i_A          174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE  221 (303)
T ss_dssp             C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCC
Confidence            2  22335688999999999999999999999999999999999999864

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.3e-34  Score=291.64  Aligned_cols=202  Identities=25%  Similarity=0.345  Sum_probs=161.9

Q ss_pred             hCCCCccceeccCCceeEEEEEecC----CcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      .++|.+.+.||+|+||.||+|....    +..||+|++.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            3578899999999999999998642    4579999987643 344567899999999999999999999985 457889


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      ||||+++++|.+++...  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence            99999999999999542  346899999999999999999999986   9999999999999999999999999998764


Q ss_pred             CCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      ..... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~  221 (281)
T 1mp8_A          168 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV  221 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             ccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC
Confidence            43221 1223356778999999998999999999999999999997 99998643

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.8e-34  Score=312.59  Aligned_cols=201  Identities=34%  Similarity=0.514  Sum_probs=169.7

Q ss_pred             hCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      .++|.+.++||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++||||+++++++.+ +..++||||+
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~  260 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  260 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence            45788899999999999999999888889999997654 345789999999999999999999999876 6789999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++|+|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++........
T Consensus       261 ~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  336 (452)
T 1fmk_A          261 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  336 (452)
T ss_dssp             TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             cCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence            999999999542 2345899999999999999999999986   999999999999999999999999999876433221


Q ss_pred             cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                       ......++..|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus       337 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~  384 (452)
T 1fmk_A          337 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG  384 (452)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             -cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC
Confidence             1122346788999999999999999999999999999999 9999864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.6e-34  Score=292.16  Aligned_cols=196  Identities=27%  Similarity=0.433  Sum_probs=170.7

Q ss_pred             hCCCCccceeccCCceeEEEEEecC-C-------cEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCce
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLAD-G-------KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE  461 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g-------~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~  461 (621)
                      .++|.+.+.||+|+||.||++.... +       ..||+|++........+.+.+|++++++++||||+++++++.+++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3578899999999999999998543 3       5799999987766777889999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCC--------eE
Q 007006          462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN--------PK  533 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--------vk  533 (621)
                      .++||||+++++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.        +|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence            99999999999999999643  334899999999999999999999986   999999999999998887        99


Q ss_pred             EeeecCceecCCCCCCcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCC-CCC
Q 007006          534 ISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRK-NNG  596 (621)
Q Consensus       534 L~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~-p~~  596 (621)
                      |+|||++.....      .....+++.|+|||.+.+ ..++.++||||||+++|||++|.. |+.
T Consensus       162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~  220 (289)
T 4fvq_A          162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS  220 (289)
T ss_dssp             ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcc
Confidence            999999864321      223457889999999987 678999999999999999999644 443

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3e-34  Score=289.08  Aligned_cols=200  Identities=30%  Similarity=0.447  Sum_probs=175.2

Q ss_pred             CCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecC
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP  470 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  470 (621)
                      ++|.+.+.||+|+||.||++...+++.||+|++..... ..+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            57888999999999999999988899999999986543 34778999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc
Q 007006          471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA  550 (621)
Q Consensus       471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~  550 (621)
                      +++|.+++...  ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........ .
T Consensus        87 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~  160 (267)
T 3t9t_A           87 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T  160 (267)
T ss_dssp             TCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred             CCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-c
Confidence            99999999542  346899999999999999999999986   99999999999999999999999999886533211 1


Q ss_pred             ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~  208 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN  208 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC
Confidence            1122346778999999998899999999999999999999 8999864

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=9.9e-34  Score=295.94  Aligned_cols=201  Identities=25%  Similarity=0.397  Sum_probs=176.9

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      .++|.+.+.||+|+||.||++... +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            357889999999999999999965 58899999987542   34456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      |||+++++|.+++..   ...+++.+++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       120 ~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            999999999998854   246899999999999999999999986   99999999999999999999999999987643


Q ss_pred             CCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ...  ......+++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       194 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  244 (335)
T 2owb_A          194 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS  244 (335)
T ss_dssp             TTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             Ccc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC
Confidence            222  223456899999999999999999999999999999999999998643

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.3e-34  Score=293.50  Aligned_cols=201  Identities=30%  Similarity=0.511  Sum_probs=171.9

Q ss_pred             CCCCccceeccCCceeEEEEEe-----cCCcEEEEEEeccC-CcccHHHHHHHHHHHHhcccCCceeEeeEEeeC--ceE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QEL  462 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~  462 (621)
                      +.|++.++||+|+||.||++++     .+++.||+|++... .....+.+.+|++++++++||||+++++++.+.  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4588899999999999999983     46899999999754 344567899999999999999999999999876  568


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      ++||||+++++|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       101 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence            9999999999999999543  345899999999999999999999986   99999999999999999999999999987


Q ss_pred             cCCCCCC-cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          543 FGGNQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       543 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      ....... .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+.
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  230 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS  230 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence            6543321 12233467888999999999999999999999999999999999854

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.9e-34  Score=289.34  Aligned_cols=199  Identities=29%  Similarity=0.468  Sum_probs=171.9

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      .++|.+.+.||+|+||.||++... ++..||+|++....   ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            367899999999999999999865 57899999986532   23356789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      |||+++++|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            9999999999988543   45899999999999999999999886   99999999999999999999999998865432


Q ss_pred             CCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      .    ......+++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  210 (279)
T 3fdn_A          162 S----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN  210 (279)
T ss_dssp             ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             c----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC
Confidence            2    122346899999999999999999999999999999999999998643

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.7e-34  Score=295.80  Aligned_cols=207  Identities=29%  Similarity=0.459  Sum_probs=164.5

Q ss_pred             HhCCCCccceeccCCceeEEEEEec----CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCc--
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ--  460 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~--  460 (621)
                      ..++|.+.+.||+|+||.||++...    .+..||+|+++...  ....+.+.+|+.++++++||||+++++++.+.+  
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            4567999999999999999999854    34589999987543  334567899999999999999999999998765  


Q ss_pred             ---eEEEEEEecCCCChhhhhhhc---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEE
Q 007006          461 ---ELLLIYEYMPNKSLDVHLFDA---TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKI  534 (621)
Q Consensus       461 ---~~~lV~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL  534 (621)
                         ..++||||+++++|.+++...   .....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence               359999999999999998532   23456999999999999999999999986   999999999999999999999


Q ss_pred             eeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          535 SDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       535 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      +|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  253 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV  253 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC
Confidence            99999987654433333334457889999999999999999999999999999999 88998643

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.2e-34  Score=297.87  Aligned_cols=203  Identities=31%  Similarity=0.504  Sum_probs=166.0

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCc----EEEEEEeccC-CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL  463 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~  463 (621)
                      .++|.+.++||+|+||.||++... +++    .|++|.+... .....+.+.+|+.++++++||||+++++++.++. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            367999999999999999999854 444    3577877544 3456688999999999999999999999998765 78


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceec
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF  543 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~  543 (621)
                      +|+||+++++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            899999999999998643  346899999999999999999999986   999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          544 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       544 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      .............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~  223 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI  223 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            54443333334456788999999999999999999999999999999 99998753

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=6.7e-34  Score=292.76  Aligned_cols=198  Identities=26%  Similarity=0.402  Sum_probs=172.3

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      .++|.+.+.||+|+||.||+++.. +|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            357889999999999999999965 6999999999876555556789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE---cCCCCeEEeeecCceecCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~vkL~Dfgla~~~~~  545 (621)
                      +++++|.+++...   ..+++..+..++.|++.||.|||+.+   |+||||||+||++   +.++.+||+|||++.....
T Consensus        88 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           88 VSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             CCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            9999999988542   35899999999999999999999986   9999999999999   7889999999999875432


Q ss_pred             CCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .    ......+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  209 (304)
T 2jam_A          162 G----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE  209 (304)
T ss_dssp             B----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             C----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            1    22334689999999999999999999999999999999999999854

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=9.2e-34  Score=306.70  Aligned_cols=200  Identities=25%  Similarity=0.422  Sum_probs=167.0

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeC-----ce
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QE  461 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~-----~~  461 (621)
                      .++|.+.+.||+|+||.||++... +++.||||++...  .....+.+.+|+++|++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468999999999999999999864 6889999999754  233456789999999999999999999999876     57


Q ss_pred             EEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCce
Q 007006          462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR  541 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~  541 (621)
                      .++||||++ ++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999986 599888843   356999999999999999999999986   9999999999999999999999999999


Q ss_pred             ecCCCCCC--------------------cccccccccCCccChhcc-cCCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          542 IFGGNQNQ--------------------ANTNIIAGTYGYMAPEYA-MGGIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       542 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~l-~~~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      ........                    .......||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            76543221                    112445789999999986 55669999999999999999998766553

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=9.4e-34  Score=287.73  Aligned_cols=200  Identities=37%  Similarity=0.553  Sum_probs=173.2

Q ss_pred             CCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecC
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP  470 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  470 (621)
                      ++|.+.+.||+|+||.||++...++..||+|++.... ...+.+.+|++++++++||||+++++++.+ +..++||||++
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   90 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCC
Confidence            5788899999999999999998888899999997643 346789999999999999999999999864 46899999999


Q ss_pred             CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc
Q 007006          471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA  550 (621)
Q Consensus       471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~  550 (621)
                      +++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++......... 
T Consensus        91 ~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  165 (279)
T 1qpc_A           91 NGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-  165 (279)
T ss_dssp             TCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-
T ss_pred             CCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc-
Confidence            99999998532 1235899999999999999999999986   999999999999999999999999999876543221 


Q ss_pred             ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  213 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG  213 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc
Confidence            1223346778999999988889999999999999999999 9999864

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.1e-33  Score=285.92  Aligned_cols=206  Identities=24%  Similarity=0.337  Sum_probs=169.9

Q ss_pred             HHhCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEE-eeCceEEEE
Q 007006          388 EATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC-LEGQELLLI  465 (621)
Q Consensus       388 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~-~~~~~~~lV  465 (621)
                      ...++|.+.+.||+|+||.||+++. .+++.||+|++......  +.+.+|+++++.++|++++..+..+ .+.+..++|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            3457899999999999999999995 57899999987654322  3578899999999988877766665 566788999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE---cCCCCeEEeeecCcee
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARI  542 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~vkL~Dfgla~~  542 (621)
                      |||+ +++|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||++..
T Consensus        84 ~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEcc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            9999 99999998532  345999999999999999999999986   9999999999999   7889999999999998


Q ss_pred             cCCCCCCc-----ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCcCC
Q 007006          543 FGGNQNQA-----NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE  601 (621)
Q Consensus       543 ~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~~  601 (621)
                      ........     ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  221 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA  221 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchh
Confidence            75543221     223457899999999999999999999999999999999999999765544

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.7e-34  Score=297.96  Aligned_cols=202  Identities=31%  Similarity=0.475  Sum_probs=176.0

Q ss_pred             CCCCccceeccCCceeEEEEEe-----cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEe--eCceEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL--EGQELL  463 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~--~~~~~~  463 (621)
                      ++|++.+.||+|+||.||++++     .+++.||||++........+.+.+|++++++++||||+++++++.  +....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5788999999999999999984     368899999998776666778999999999999999999999987  445689


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceec
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF  543 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~  543 (621)
                      +||||+++++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence            999999999999999643  235899999999999999999999986   999999999999999999999999999876


Q ss_pred             CCCCCC-cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          544 GGNQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       544 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ...... .......+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~  232 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS  232 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence            543221 122334578889999999988899999999999999999999999753

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.6e-33  Score=298.05  Aligned_cols=205  Identities=26%  Similarity=0.438  Sum_probs=176.7

Q ss_pred             HHHHHHhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc--------ccHHHHHHHHHHHHhc-ccCCceeEe
Q 007006          384 RLALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--------QGLQEFKNEVNLIAKL-QHKNLVRLL  453 (621)
Q Consensus       384 ~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--------~~~~~~~~Ei~~l~~l-~h~nIv~l~  453 (621)
                      .......++|.+.+.||+|+||.||++++. +|+.||||+++....        ...+.+.+|+.++.++ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            334445578999999999999999999975 799999999875432        1245678999999999 899999999


Q ss_pred             eEEeeCceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeE
Q 007006          454 GCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPK  533 (621)
Q Consensus       454 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vk  533 (621)
                      +++...+..++||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+|
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik  240 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR  240 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence            999999999999999999999999854   245899999999999999999999986   99999999999999999999


Q ss_pred             EeeecCceecCCCCCCcccccccccCCccChhcccC------CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          534 ISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG------GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       534 L~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      |+|||++........   .....||+.|+|||++.+      ..++.++||||||+++|||++|+.||..
T Consensus       241 l~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  307 (365)
T 2y7j_A          241 LSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH  307 (365)
T ss_dssp             ECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC
Confidence            999999987654322   233578999999998853      3588999999999999999999999854

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4.8e-33  Score=284.69  Aligned_cols=204  Identities=24%  Similarity=0.335  Sum_probs=173.2

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEE-eeCceEEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC-LEGQELLLIYE  467 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~-~~~~~~~lV~e  467 (621)
                      .++|.+.+.||+|+||.||+++. .+++.||+|++.....  .+.+.+|+.+++.++|+++++.+..+ .+.+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            57899999999999999999996 5799999999875533  24688999999999988876666555 55678899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE---cCCCCeEEeeecCceecC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFG  544 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~vkL~Dfgla~~~~  544 (621)
                      |+ +++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||++....
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99 99999998532  346999999999999999999999986   9999999999999   488899999999998775


Q ss_pred             CCCCCc-----ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCcCC
Q 007006          545 GNQNQA-----NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE  601 (621)
Q Consensus       545 ~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~~  601 (621)
                      ......     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  221 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA  221 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCch
Confidence            543211     123457899999999999999999999999999999999999999865443

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-33  Score=288.40  Aligned_cols=202  Identities=29%  Similarity=0.489  Sum_probs=172.1

Q ss_pred             CCCCccc-eeccCCceeEEEEEec---CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          391 NHFSDEN-KLGQGGFGPVYKGTLA---DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       391 ~~f~~~~-~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      ++|.+.+ .||+|+||.||+|...   ++..||+|+++... ....+.+.+|++++++++||||+++++++ +.+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4455555 9999999999999853   57889999998653 34567789999999999999999999999 55678999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      |||+++++|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            999999999999853  3456999999999999999999999986   99999999999999999999999999987754


Q ss_pred             CCCCc-ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          546 NQNQA-NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       546 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      ..... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  217 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM  217 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence            32221 1223346788999999988889999999999999999999 99998643

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7.1e-34  Score=298.30  Aligned_cols=201  Identities=20%  Similarity=0.245  Sum_probs=165.5

Q ss_pred             hCCCCccceeccCCceeEEEEEec----CCcEEEEEEeccCCcc-----------cHHHHHHHHHHHHhcccCCceeEee
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTSGQ-----------GLQEFKNEVNLIAKLQHKNLVRLLG  454 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~~~-----------~~~~~~~Ei~~l~~l~h~nIv~l~g  454 (621)
                      .++|.+.+.||+|+||.||++...    ++..+|+|++......           ....+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            367999999999999999999975    5788999998765321           1234667888899999999999999


Q ss_pred             EEee----CceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC
Q 007006          455 CCLE----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM  530 (621)
Q Consensus       455 ~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~  530 (621)
                      ++.+    ....++||||+ +++|.+++...   ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence            9988    67899999999 99999998543   27999999999999999999999986   99999999999999887


Q ss_pred             --CeEEeeecCceecCCCCCC-----cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          531 --NPKISDFGLARIFGGNQNQ-----ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       531 --~vkL~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                        .+||+|||+++.+......     .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence              9999999999876432211     112345789999999999999999999999999999999999999953

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.7e-33  Score=294.35  Aligned_cols=202  Identities=25%  Similarity=0.436  Sum_probs=170.8

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeC--------
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--------  459 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--------  459 (621)
                      ++|.+.++||+|+||.||+++. .+|+.||+|++....  ......+.+|+++++.++||||+++++++.+.        
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            5799999999999999999996 579999999986543  23346788999999999999999999999873        


Q ss_pred             ceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecC
Q 007006          460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL  539 (621)
Q Consensus       460 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgl  539 (621)
                      +..++||||+++ +|...+..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence            468999999985 66666643  2345999999999999999999999986   99999999999999999999999999


Q ss_pred             ceecCCCCCC--cccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          540 ARIFGGNQNQ--ANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       540 a~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      +..+......  .......||+.|+|||++.+ ..++.++||||||+++|||++|++||...
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  232 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN  232 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC
Confidence            9876533222  22234568999999998876 45899999999999999999999998643

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=9.8e-34  Score=305.23  Aligned_cols=201  Identities=25%  Similarity=0.396  Sum_probs=163.2

Q ss_pred             HHhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--------cccHHHHHHHHHHHHhcccCCceeEeeEEee
Q 007006          388 EATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--------GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE  458 (621)
Q Consensus       388 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~  458 (621)
                      ...++|.+.+.||+|+||.||++... +++.||+|++....        ......+.+|+++|++++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            34678999999999999999999864 68999999987532        112234789999999999999999999975 


Q ss_pred             CceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC---CeEEe
Q 007006          459 GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM---NPKIS  535 (621)
Q Consensus       459 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~vkL~  535 (621)
                      .+..++||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++   .+||+
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             cCceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence            4568999999999999988843   456999999999999999999999986   99999999999997544   59999


Q ss_pred             eecCceecCCCCCCcccccccccCCccChhcccC---CCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          536 DFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       536 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      |||+++......   ......||+.|+|||++.+   ..++.++||||||+++|||++|++||...
T Consensus       285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~  347 (419)
T 3i6u_A          285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH  347 (419)
T ss_dssp             CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred             ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence            999998764322   2234578999999999853   66889999999999999999999999643

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.5e-33  Score=294.02  Aligned_cols=200  Identities=28%  Similarity=0.438  Sum_probs=168.9

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc--ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      ++|++.+.||+|+||.||+++.. +|+.||+|++.....  ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            57899999999999999999965 589999999865432  234567899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |+++++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus       105 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          105 FVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             CCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             cCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            9999999887642   345999999999999999999999986   9999999999999999999999999998654322


Q ss_pred             CCcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      .  ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus       179 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  228 (331)
T 4aaa_A          179 E--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD  228 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             c--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            2  12234689999999999775 6899999999999999999999998654

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.9e-34  Score=297.58  Aligned_cols=200  Identities=27%  Similarity=0.438  Sum_probs=164.5

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcc-cHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ-GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      ++|.+.++||+|+||.||+++.. +++.||+|++...... ....+.+|++++++++||||+++++++.+++..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            47889999999999999999965 7899999999754322 122456799999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      ++ ++|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            97 5888888543  346899999999999999999999986   99999999999999999999999999986543221


Q ss_pred             CcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                        ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus       156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  204 (324)
T 3mtl_A          156 --TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS  204 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             --ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence              1223467999999999876 56899999999999999999999999643

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.5e-33  Score=287.35  Aligned_cols=200  Identities=32%  Similarity=0.578  Sum_probs=169.7

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCccc-------HHHHHHHHHHHHhcccCCceeEeeEEeeCce
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQG-------LQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE  461 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~-------~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~  461 (621)
                      .++|.+.+.||+|+||.||+++. .+++.||+|++.......       .+.+.+|++++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            46899999999999999999996 478999999986543221       267899999999999999999999987665 


Q ss_pred             EEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCC-----eEEee
Q 007006          462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN-----PKISD  536 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----vkL~D  536 (621)
                       ++||||+++++|.+++..  +...+++..++.++.|++.||.|||+.+ .+|+||||||+|||++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             699999999999888854  3456999999999999999999999874 34999999999999988776     99999


Q ss_pred             ecCceecCCCCCCcccccccccCCccChhcc--cCCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          537 FGLARIFGGNQNQANTNIIAGTYGYMAPEYA--MGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       537 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~l--~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      ||++.....     ......+|+.|+|||.+  ....++.++||||||+++|||++|+.||....
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  232 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS  232 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence            999975322     22335689999999998  34557899999999999999999999996543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=9.3e-34  Score=309.03  Aligned_cols=196  Identities=24%  Similarity=0.422  Sum_probs=154.5

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeC-----ce
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QE  461 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~-----~~  461 (621)
                      .++|.+.+.||+|+||.||+++.. +++.||||++...  .....+.+.+|+++|++++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            368999999999999999999854 6899999999754  233456789999999999999999999999543     57


Q ss_pred             EEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCce
Q 007006          462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR  541 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~  541 (621)
                      .++||||+ +++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       132 ~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence            89999987 5788888843   356999999999999999999999986   9999999999999999999999999998


Q ss_pred             ecCCCCCC-------------------------cccccccccCCccChhcc-cCCCCChhhhHHHHHHHHHHHHcCC
Q 007006          542 IFGGNQNQ-------------------------ANTNIIAGTYGYMAPEYA-MGGIFSIKSDVFSFGVLLLEIISGR  592 (621)
Q Consensus       542 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~l-~~~~~s~~sDVwS~Gvll~elltG~  592 (621)
                      ........                         ......+||+.|+|||++ ....++.++|||||||++|||++|.
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~  281 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI  281 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence            76432211                         112334689999999976 5567999999999999999999943

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9.7e-34  Score=292.53  Aligned_cols=202  Identities=22%  Similarity=0.279  Sum_probs=166.1

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc---ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      -++|.+.+.||+|+||.||++... +++.||+|++.....   ...+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            468999999999999999999965 688999999976532   2346789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      +||+++++|.+++...   ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       113 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            9999999999999643   45899999999999999999999986   99999999999999999999999999886543


Q ss_pred             CCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      .... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       187 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  238 (309)
T 2h34_A          187 EKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD  238 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred             cccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence            3221 122346889999999999999999999999999999999999998643

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.3e-33  Score=287.63  Aligned_cols=198  Identities=26%  Similarity=0.435  Sum_probs=174.9

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|.+.+.||+|+||.||++... +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57899999999999999999965 57899999986532   234567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++++|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus        94 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           94 EFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            999999999988543   35899999999999999999999886   999999999999999999999999998765432


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                          ......+++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       168 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  215 (284)
T 2vgo_A          168 ----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP  215 (284)
T ss_dssp             ----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             ----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC
Confidence                122356899999999999999999999999999999999999998643

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.4e-33  Score=286.80  Aligned_cols=195  Identities=30%  Similarity=0.520  Sum_probs=171.1

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEee----------
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE----------  458 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~----------  458 (621)
                      .++|++.+.||+|+||.||++... +++.||+|++....    +.+.+|++++++++||||+++++++..          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            457899999999999999999975 79999999997653    346789999999999999999998864          


Q ss_pred             ------CceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCe
Q 007006          459 ------GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP  532 (621)
Q Consensus       459 ------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~v  532 (621)
                            ....++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence                  34579999999999999999643 2356999999999999999999999986   9999999999999999999


Q ss_pred             EEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCC
Q 007006          533 KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNN  595 (621)
Q Consensus       533 kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~  595 (621)
                      ||+|||++........   .....+++.|+|||.+.+..++.++||||||+++|||++|..|+
T Consensus       162 kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~  221 (284)
T 2a19_B          162 KIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA  221 (284)
T ss_dssp             EECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSH
T ss_pred             EECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcc
Confidence            9999999987654322   22346899999999999999999999999999999999999886

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.7e-33  Score=286.21  Aligned_cols=198  Identities=26%  Similarity=0.381  Sum_probs=170.7

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      .++|.+.+.||+|+||.||++... +++.||+|++....  ......+.+|+..+..+ +||||+++++++.+++..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            467899999999999999999975 79999999997642  34456788999999999 999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC---------------
Q 007006          466 YEYMPNKSLDVHLFDATR-SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD---------------  529 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---------------  529 (621)
                      |||+++++|.+++..... ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.+               
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            999999999999965322 256899999999999999999999986   9999999999999844               


Q ss_pred             ----CCeEEeeecCceecCCCCCCcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          530 ----MNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       530 ----~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                          ..+||+|||++.......      ...+|+.|+|||.+.+. .++.++||||||+++|||++|++|+.
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~  232 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR  232 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred             cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence                479999999998765432      23478999999999776 56789999999999999999998753

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=7.5e-34  Score=289.68  Aligned_cols=204  Identities=31%  Similarity=0.470  Sum_probs=177.7

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      .++|.+.+.||+|+||.||++... ++..||+|++.... ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus        12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   90 (288)
T 3kfa_A           12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   90 (288)
T ss_dssp             GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence            467889999999999999999975 48899999997543 3467889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++........
T Consensus        91 ~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  166 (288)
T 3kfa_A           91 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  166 (288)
T ss_dssp             CTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred             CCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence            9999999999653 3456999999999999999999999986   99999999999999999999999999987643322


Q ss_pred             CcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCCc
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYF  599 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~~  599 (621)
                       .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       167 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~  217 (288)
T 3kfa_A          167 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID  217 (288)
T ss_dssp             -EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             -ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence             22223456788999999999999999999999999999999 999986533

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.8e-33  Score=288.25  Aligned_cols=200  Identities=29%  Similarity=0.472  Sum_probs=171.8

Q ss_pred             HhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      ..++|++.+.||+|+||.||++... +|+.||+|++....  ..+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            4568999999999999999999865 58999999997643  34778999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |+++++|.+++..  ....+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||++.......
T Consensus       105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            9999999999853  2356899999999999999999999986   9999999999999999999999999998765432


Q ss_pred             CCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .  ......+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       180 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  227 (314)
T 3com_A          180 A--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD  227 (314)
T ss_dssp             S--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             c--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence            2  22334688999999999998999999999999999999999999864

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.5e-34  Score=300.14  Aligned_cols=200  Identities=28%  Similarity=0.388  Sum_probs=174.8

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      .++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            357899999999999999999965 68999999997653 3445678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      |+++++|.+++...   ..+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||++......
T Consensus       112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            99999999999543   3589999999999999999999985 5   999999999999999999999999998754321


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                          ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus       186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  234 (360)
T 3eqc_A          186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  234 (360)
T ss_dssp             ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred             ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                1223468999999999999999999999999999999999999986543

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-33  Score=293.82  Aligned_cols=202  Identities=30%  Similarity=0.510  Sum_probs=166.9

Q ss_pred             CCCCccceeccCCceeEEEEEecC-----CcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLAD-----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~-----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      ++|...+.||+|+||.||+|....     +..||+|+++... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            567888999999999999998643     2469999997643 3345678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      ||||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       124 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          124 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            9999999999999954  2356999999999999999999999986   9999999999999999999999999998765


Q ss_pred             CCCCCc-ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          545 GNQNQA-NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       545 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      ...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~  253 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE  253 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc
Confidence            432211 1222345778999999999999999999999999999999 9999853

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.4e-33  Score=289.30  Aligned_cols=203  Identities=24%  Similarity=0.410  Sum_probs=165.7

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      .++|.+.+.||+|+||.||++.. .+|+.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            35799999999999999999985 579999999997532   33456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          466 YEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      |||+++++|.+++.... ....+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            99999999999986422 3456899999999999999999999986   9999999999999999999999999988654


Q ss_pred             CCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ....  ......+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  238 (310)
T 2wqm_A          188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG  238 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred             CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence            3322  12234688999999999999999999999999999999999999853

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-33  Score=297.97  Aligned_cols=196  Identities=27%  Similarity=0.435  Sum_probs=164.9

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCc------
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------  460 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~------  460 (621)
                      .++|.+.+.||+|+||.||++.. .+|+.||||++....  ....+.+.+|+++++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46799999999999999999996 469999999996542  333567889999999999999999999998653      


Q ss_pred             eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCc
Q 007006          461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA  540 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla  540 (621)
                      ..++||||+ +++|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            469999999 8899998853    35899999999999999999999986   999999999999999999999999999


Q ss_pred             eecCCCCCCcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          541 RIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       541 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      +.....     .....+|+.|+|||++.+ ..++.++||||+|+++|||++|+.||...
T Consensus       176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  229 (367)
T 1cm8_A          176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS  229 (367)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence            875432     223467999999999877 67899999999999999999999998643

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.1e-33  Score=294.31  Aligned_cols=206  Identities=33%  Similarity=0.465  Sum_probs=171.2

Q ss_pred             hCCCCccceeccCCceeEEEEEe------cCCcEEEEEEeccC-CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL  462 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~  462 (621)
                      .++|.+.+.||+|+||.||+++.      .++..||||++... .......+.+|+.++++++||||+++++++.+.+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            46799999999999999999984      24778999999754 334456789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC---CCCeEEe
Q 007006          463 LLIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKIS  535 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~vkL~  535 (621)
                      ++||||+++++|.+++.....    ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999975432    245899999999999999999999986   999999999999994   4469999


Q ss_pred             eecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          536 DFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       536 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      |||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  249 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK  249 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Confidence            9999986544333333334567889999999999999999999999999999998 99998643

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.6e-34  Score=307.00  Aligned_cols=200  Identities=17%  Similarity=0.195  Sum_probs=163.2

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC---CcccHHHHHHHH---HHHHhcccCCceeEe-------eE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEV---NLIAKLQHKNLVRLL-------GC  455 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei---~~l~~l~h~nIv~l~-------g~  455 (621)
                      .++|.+.+.||+|+||.||+|+. .+|+.||||++...   .....+.+.+|+   +.+++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            45788899999999999999995 56999999999743   334567789999   455556899999998       66


Q ss_pred             EeeCc-----------------eEEEEEEecCCCChhhhhhhccC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 007006          456 CLEGQ-----------------ELLLIYEYMPNKSLDVHLFDATR----SVQLDWKRRQSIINGIARGILYLHEDSRLKI  514 (621)
Q Consensus       456 ~~~~~-----------------~~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i  514 (621)
                      +.+++                 ..++||||+ +|+|.+++.....    ...+++..++.|+.||+.||.|||+.+   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            65543                 278999999 6899999964321    123456888999999999999999986   9


Q ss_pred             EeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCC-----------CCChhhhHHHHHH
Q 007006          515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-----------IFSIKSDVFSFGV  583 (621)
Q Consensus       515 iH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~s~~sDVwS~Gv  583 (621)
                      +||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++||||||+
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999986332     2233466 899999999887           8999999999999


Q ss_pred             HHHHHHcCCCCCCCCc
Q 007006          584 LLLEIISGRKNNGFYF  599 (621)
Q Consensus       584 ll~elltG~~p~~~~~  599 (621)
                      ++|||++|+.||....
T Consensus       302 il~elltg~~Pf~~~~  317 (377)
T 3byv_A          302 VIYWIWCADLPITKDA  317 (377)
T ss_dssp             HHHHHHHSSCCC----
T ss_pred             HHHHHHHCCCCCcccc
Confidence            9999999999986433

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=7e-34  Score=296.34  Aligned_cols=200  Identities=28%  Similarity=0.421  Sum_probs=163.7

Q ss_pred             HhCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCc--ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      ..++|.+.++||+|+||.||++.. .+++.||||+++....  ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            346899999999999999999985 4789999999975432  2345678999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc-----CCCCeEEeeecCc
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-----DDMNPKISDFGLA  540 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-----~~~~vkL~Dfgla  540 (621)
                      |||++ ++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++     .++.+||+|||++
T Consensus       112 ~e~~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EECCS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EecCC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            99998 589888854   335899999999999999999999986   99999999999994     4556999999999


Q ss_pred             eecCCCCCCcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          541 RIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       541 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .........  .....+|+.|+|||++.+. .++.++||||||+++|||++|+.||..
T Consensus       185 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  240 (329)
T 3gbz_A          185 RAFGIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPG  240 (329)
T ss_dssp             HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cccCCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence            876433221  2234679999999999875 489999999999999999999999864

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.7e-33  Score=291.68  Aligned_cols=205  Identities=24%  Similarity=0.336  Sum_probs=173.8

Q ss_pred             HHHHhCCCCcc-ceeccCCceeEEEEEec-CCcEEEEEEeccC--CcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCc
Q 007006          386 ALEATNHFSDE-NKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQ  460 (621)
Q Consensus       386 ~~~~~~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~  460 (621)
                      .....+.|.+. +.||+|+||.||++... +++.||+|++...  .......+.+|+.++.++ +||||+++++++.+.+
T Consensus        23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~  102 (327)
T 3lm5_A           23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS  102 (327)
T ss_dssp             HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence            33445667776 88999999999999865 6999999998754  234467889999999999 5699999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC---CCCeEEeee
Q 007006          461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDF  537 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~vkL~Df  537 (621)
                      ..++||||+++++|.+++.. .....+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+||
T Consensus       103 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Df  178 (327)
T 3lm5_A          103 EIILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDF  178 (327)
T ss_dssp             EEEEEEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred             eEEEEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeC
Confidence            99999999999999998843 23456999999999999999999999986   999999999999998   789999999


Q ss_pred             cCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          538 GLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       538 gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      |++........   .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       179 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  235 (327)
T 3lm5_A          179 GMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG  235 (327)
T ss_dssp             GGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99987643322   2235689999999999999999999999999999999999999854

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=9.1e-34  Score=285.86  Aligned_cols=197  Identities=24%  Similarity=0.338  Sum_probs=169.6

Q ss_pred             CCCCccceeccCCceeEEEEEecCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeC--ceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~~lV~  466 (621)
                      ++|.+.+.||+|+||.||+++.+ ++.||+|++....  ....+.+.+|+.++++++||||+++++++.+.  +..++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            57889999999999999999985 8899999997653  34456799999999999999999999999887  7889999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++++|.+++... ....+++..++.++.||+.||.|||+.+ .+++||||||+||+++.++.++|.|||+...... 
T Consensus        89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-  165 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-  165 (271)
T ss_dssp             ECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred             cccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence            999999999999642 2336899999999999999999999874 3599999999999999999999999988654221 


Q ss_pred             CCCcccccccccCCccChhcccCCCCC---hhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFS---IKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s---~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                            ....+|+.|+|||.+.+..++   .++||||||+++|||++|+.||..
T Consensus       166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  213 (271)
T 3kmu_A          166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD  213 (271)
T ss_dssp             ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTT
T ss_pred             ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence                  123678999999999876543   489999999999999999999864

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.1e-33  Score=296.33  Aligned_cols=207  Identities=25%  Similarity=0.362  Sum_probs=168.6

Q ss_pred             hHHHHHHhCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcc-----------cHHHHHHHHHHHHhcccCCcee
Q 007006          383 LRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQ-----------GLQEFKNEVNLIAKLQHKNLVR  451 (621)
Q Consensus       383 ~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~-----------~~~~~~~Ei~~l~~l~h~nIv~  451 (621)
                      ........++|.+.+.||+|+||.||++...+|..||||++......           ..+.+.+|++++++++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            34556677899999999999999999999888999999998653221           1377899999999999999999


Q ss_pred             EeeEEee-----CceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE
Q 007006          452 LLGCCLE-----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL  526 (621)
Q Consensus       452 l~g~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl  526 (621)
                      +++++..     ....++||||++ ++|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||+
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL  167 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence            9999854     336899999998 677777753  3446999999999999999999999986   9999999999999


Q ss_pred             cCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          527 DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       527 ~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      +.++.+||+|||++.......   ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  237 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS  237 (362)
T ss_dssp             CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence            999999999999997543322   2233467899999999877 67899999999999999999999998643

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.9e-33  Score=291.64  Aligned_cols=198  Identities=32%  Similarity=0.475  Sum_probs=170.8

Q ss_pred             CCccceeccCCceeEEEEEec-----CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeC--ceEEE
Q 007006          393 FSDENKLGQGGFGPVYKGTLA-----DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG--QELLL  464 (621)
Q Consensus       393 f~~~~~LG~G~fG~Vy~~~~~-----~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~--~~~~l  464 (621)
                      |.+.++||+|+||.||++...     +++.||||++.... ....+.+.+|++++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            488999999999999988642     68899999998653 34456789999999999999999999999884  57899


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      ||||+++++|.+++..    ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            9999999999999943    34899999999999999999999986   9999999999999999999999999998875


Q ss_pred             CCCCC-cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          545 GNQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       545 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ..... .......++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~  239 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS  239 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence            43221 122334577889999999998999999999999999999999999864

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.2e-33  Score=294.21  Aligned_cols=206  Identities=25%  Similarity=0.307  Sum_probs=161.4

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcc-cCCceeEeeEEe--------eC
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCL--------EG  459 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~--------~~  459 (621)
                      ..+|.+.++||+|+||.||+++. .+++.||+|++........+.+.+|+.++.++. ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            35789999999999999999996 478999999997776666778899999999996 999999999994        34


Q ss_pred             ceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecC
Q 007006          460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL  539 (621)
Q Consensus       460 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgl  539 (621)
                      ...++|+||+. |+|.+++........+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+|||+
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  184 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS  184 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence            46899999996 789888876555667999999999999999999999874 3499999999999999999999999999


Q ss_pred             ceecCCCCCCc----------ccccccccCCccChhcc---cCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          540 ARIFGGNQNQA----------NTNIIAGTYGYMAPEYA---MGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       540 a~~~~~~~~~~----------~~~~~~gt~~y~aPE~l---~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      +..........          ......+|+.|+|||++   .+..++.++||||||+++|||++|+.||..
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  255 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED  255 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence            98765432211          11134589999999998   566789999999999999999999999854

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=8.8e-34  Score=291.17  Aligned_cols=203  Identities=26%  Similarity=0.446  Sum_probs=171.1

Q ss_pred             HhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      ..++|++.+.||+|+||.||++... +++.||+|++........+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            3468999999999999999999975 589999999987776777889999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |+++++|..++...  ...+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (302)
T 2j7t_A           97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL  171 (302)
T ss_dssp             CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred             eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence            99999999988542  345899999999999999999999986   9999999999999999999999999875432110


Q ss_pred             CCcccccccccCCccChhcc-----cCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYA-----MGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l-----~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                        .......+++.|+|||.+     ....++.++||||||+++|||++|+.||...
T Consensus       172 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  225 (302)
T 2j7t_A          172 --QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL  225 (302)
T ss_dssp             --HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             --cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC
Confidence              111234678999999988     4667899999999999999999999998653

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.9e-33  Score=284.81  Aligned_cols=198  Identities=27%  Similarity=0.474  Sum_probs=167.3

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|.+.+.||+|+||.||++... +|+.||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            67899999999999999999975 7999999998654   2344567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++++|.+++...   ..+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||++......
T Consensus        91 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           91 EYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             ECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             eccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            999999999998543   35899999999999999999999986   999999999999999999999999999865433


Q ss_pred             CCCcccccccccCCccChhcccCCCC-ChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ..   .....+++.|+|||.+.+..+ +.++||||||+++|||++|+.||..
T Consensus       165 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  213 (276)
T 2h6d_A          165 EF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD  213 (276)
T ss_dssp             ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence            21   223467899999999988765 6899999999999999999999864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4.2e-33  Score=286.52  Aligned_cols=203  Identities=26%  Similarity=0.360  Sum_probs=170.8

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC----cccHHHHHHHHHHHHhcccCCceeEeeEEe--eCceE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQHKNLVRLLGCCL--EGQEL  462 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~--~~~~~  462 (621)
                      .++|.+.+.||+|+||.||++.. .+++.||+|++....    ....+.+.+|++++++++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            36899999999999999999996 468999999997542    344577999999999999999999999984  44578


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      ++||||++++ |.+++.. .....+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDS-VPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHH-STTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHh-CcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999877 6666643 23456999999999999999999999986   99999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccCCccChhcccCCC--CChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          543 FGGNQNQANTNIIAGTYGYMAPEYAMGGI--FSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       543 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ..............+++.|+|||.+.+..  .+.++||||||+++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  215 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG  215 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence            65433333334456899999999987654  48899999999999999999999864

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.4e-33  Score=291.98  Aligned_cols=205  Identities=27%  Similarity=0.371  Sum_probs=172.6

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEee----CceEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELLL  464 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~----~~~~~l  464 (621)
                      .++|.+.+.||+|+||.||+++. .+++.||+|++........+.+.+|++++++++||||+++++++..    ....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            46799999999999999999996 5799999999977666667889999999999999999999999873    347899


Q ss_pred             EEEecCCCChhhhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceec
Q 007006          465 IYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF  543 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~  543 (621)
                      |+||+++++|.+++.... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            999999999999986532 3456999999999999999999999986   999999999999999999999999998764


Q ss_pred             CCCCCCc-------ccccccccCCccChhcccCCC---CChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          544 GGNQNQA-------NTNIIAGTYGYMAPEYAMGGI---FSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       544 ~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~---~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .......       ......||+.|+|||.+....   ++.++||||||+++|||++|+.||..
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  248 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM  248 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence            3211110       011235689999999987654   68999999999999999999999853

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-33  Score=294.93  Aligned_cols=201  Identities=27%  Similarity=0.449  Sum_probs=166.0

Q ss_pred             HhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcc-----cHHHHHHHHHHHHhcccCCceeEeeEEeeCceE
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQ-----GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL  462 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~  462 (621)
                      ..++|.+.+.||+|+||.||++... +|+.||+|++......     ..+.+.+|++++++++||||+++++++.+.+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            3468999999999999999999964 6899999999753221     124678999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      ++||||+++ +|..++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        88 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             EEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             EEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            999999986 78877743  3346889999999999999999999986   99999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          543 FGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       543 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ......  ......+|+.|+|||.+.+. .++.++||||||+++|||++|++||..
T Consensus       162 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~  215 (346)
T 1ua2_A          162 FGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG  215 (346)
T ss_dssp             TTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            643322  22234689999999998764 589999999999999999999999864

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.8e-33  Score=286.07  Aligned_cols=201  Identities=26%  Similarity=0.378  Sum_probs=168.9

Q ss_pred             hCCCCccceeccCCceeEEEEEecC----CcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      .++|.+.+.||+|+||.||++...+    +..||+|++.... ....+.+.+|+.++++++||||+++++++.++ ..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            4678899999999999999998543    3469999997653 34567789999999999999999999998754 5689


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      ||||+++++|.+++...  ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus        90 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           90 IMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            99999999999999542  345899999999999999999999986   9999999999999999999999999998664


Q ss_pred             CCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      ..... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       165 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~  217 (281)
T 3cc6_A          165 DEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW  217 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             ccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCccc
Confidence            33221 1223456788999999998999999999999999999998 9999864

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.1e-33  Score=294.41  Aligned_cols=201  Identities=27%  Similarity=0.420  Sum_probs=175.2

Q ss_pred             hCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCccc-----------------HHHHHHHHHHHHhcccCCceeE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQG-----------------LQEFKNEVNLIAKLQHKNLVRL  452 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~-----------------~~~~~~Ei~~l~~l~h~nIv~l  452 (621)
                      .++|.+.+.||+|+||.||++.. +++.||+|++.......                 .+.+.+|++++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            36899999999999999999999 89999999987542111                 1789999999999999999999


Q ss_pred             eeEEeeCceEEEEEEecCCCChhhh------hhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCEE
Q 007006          453 LGCCLEGQELLLIYEYMPNKSLDVH------LFDATRSVQLDWKRRQSIINGIARGILYLHE-DSRLKIIHRDLKASNIL  525 (621)
Q Consensus       453 ~g~~~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiH~Dlkp~NIL  525 (621)
                      ++++.+.+..++||||+++++|.++      +.. .....+++..++.++.||+.||.|||+ .+   |+||||||+||+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence            9999999999999999999999998      432 224679999999999999999999998 75   999999999999


Q ss_pred             EcCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCC-CCCh-hhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          526 LDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSI-KSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       526 l~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~-~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      ++.++.+||+|||++......    ......+++.|+|||.+.+. .++. ++||||||+++|||++|+.||....
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  256 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI  256 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999876433    22335688999999999887 5666 9999999999999999999997543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.1e-33  Score=307.88  Aligned_cols=198  Identities=28%  Similarity=0.447  Sum_probs=168.8

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      .++|.+.++||+|+||.||+++.. ++..||+|++.+..  ......+.+|+.+++.++||||+++++++.+....++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            356999999999999999999965 68999999997653  344577899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC---CCeEEeeecCceec
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD---MNPKISDFGLARIF  543 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~vkL~Dfgla~~~  543 (621)
                      ||+++|+|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.+   +.+||+|||++...
T Consensus       116 e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          116 ECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            999999998888543   45899999999999999999999986   9999999999999764   45999999999876


Q ss_pred             CCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          544 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       544 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ....   ......||+.|+|||++. ..++.++||||||+++|||++|++||..
T Consensus       190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~  239 (494)
T 3lij_A          190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGG  239 (494)
T ss_dssp             BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence            5432   223357899999999876 5689999999999999999999999864

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-33  Score=293.91  Aligned_cols=203  Identities=32%  Similarity=0.524  Sum_probs=174.9

Q ss_pred             hCCCCccceeccCCceeEEEEEe-----cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCc--eE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-----ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ--EL  462 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~--~~  462 (621)
                      .++|.+.+.||+|+||.||+++.     .+++.||+|++........+.+.+|++++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35688899999999999999983     368999999998776666788999999999999999999999987654  67


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      ++||||+++++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            9999999999999999643  345899999999999999999999986   99999999999999999999999999987


Q ss_pred             cCCCCCCc-ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          543 FGGNQNQA-NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       543 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ........ ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~  250 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS  250 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence            65432211 12233567789999999988899999999999999999999998753

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.3e-33  Score=308.25  Aligned_cols=198  Identities=31%  Similarity=0.461  Sum_probs=171.9

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      .++|.+.++||+|+||.||++... +++.||||++...  .......+.+|++++++++||||+++++++.+....++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            457999999999999999999965 7899999998643  2345678899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc---CCCCeEEeeecCceec
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIF  543 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~---~~~~vkL~Dfgla~~~  543 (621)
                      ||+++++|.+.+...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++   .++.+||+|||++...
T Consensus       101 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          101 ELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            999999998888543   45899999999999999999999986   99999999999995   4567999999999865


Q ss_pred             CCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          544 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       544 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .....   .....||+.|+|||++.+ .++.++||||||+++|||++|++||..
T Consensus       175 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~  224 (486)
T 3mwu_A          175 QQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG  224 (486)
T ss_dssp             CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            43321   223468999999999875 589999999999999999999999853

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=7.1e-33  Score=288.25  Aligned_cols=192  Identities=21%  Similarity=0.389  Sum_probs=169.0

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcc-cCCceeEeeEEee--CceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLE--GQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~--~~~~~lV~  466 (621)
                      ++|++.++||+|+||.||++.. .+++.||+|+++..   ..+.+.+|++++++++ ||||+++++++.+  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            6799999999999999999985 57899999998743   3467899999999997 9999999999988  56789999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC-CeEEeeecCceecCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIFGG  545 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~vkL~Dfgla~~~~~  545 (621)
                      ||+++++|..++.      .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++ .+||+|||++.....
T Consensus       113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            9999999998873      3889999999999999999999986   99999999999999776 899999999987654


Q ss_pred             CCCCcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ...   .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       184 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~  233 (330)
T 3nsz_A          184 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH  233 (330)
T ss_dssp             TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             CCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            322   223467889999999877 6689999999999999999999999843

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-33  Score=299.75  Aligned_cols=202  Identities=32%  Similarity=0.464  Sum_probs=160.1

Q ss_pred             CCCccceeccCCceeEEEEEec--CC--cEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEee-CceEEEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA--DG--KAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-GQELLLI  465 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~--~g--~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~-~~~~~lV  465 (621)
                      .|...+.||+|+||.||+|.+.  ++  ..||+|.++... ....+.+.+|+.++++++||||+++++++.+ ++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4667789999999999999853  22  468999987543 3456789999999999999999999998765 4578999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      |||+++++|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence            999999999999953  3345889999999999999999999986   99999999999999999999999999986543


Q ss_pred             CCCCc--ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          546 NQNQA--NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       546 ~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      .....  ......+++.|+|||.+.+..++.++||||||+++|||++ |.+||...
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~  300 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV  300 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC
Confidence            32211  1223456788999999999999999999999999999999 67777543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.2e-33  Score=288.08  Aligned_cols=201  Identities=26%  Similarity=0.425  Sum_probs=165.2

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEe-----------
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCL-----------  457 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~-----------  457 (621)
                      .++|.+.+.||+|+||.||++... +++.||+|++........+.+.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            367999999999999999999975 48999999998776666788999999999999999999999874           


Q ss_pred             ---eCceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc-CCCCeE
Q 007006          458 ---EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPK  533 (621)
Q Consensus       458 ---~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~vk  533 (621)
                         +....++||||++ ++|.+++.    ...+++..+..++.||+.||.|||+.+   |+||||||+|||++ +++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence               3467899999998 69988884    346899999999999999999999986   99999999999997 567999


Q ss_pred             EeeecCceecCCCCC-CcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          534 ISDFGLARIFGGNQN-QANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       534 L~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      |+|||++........ ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  228 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA  228 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCC
Confidence            999999987643221 112233457889999998865 67899999999999999999999998754

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5e-33  Score=306.92  Aligned_cols=200  Identities=29%  Similarity=0.450  Sum_probs=171.7

Q ss_pred             HhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc-------------ccHHHHHHHHHHHHhcccCCceeEee
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-------------QGLQEFKNEVNLIAKLQHKNLVRLLG  454 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-------------~~~~~~~~Ei~~l~~l~h~nIv~l~g  454 (621)
                      ..++|.+.++||+|+||.||++... +++.||+|++.....             ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3578999999999999999999965 588999999875421             33567899999999999999999999


Q ss_pred             EEeeCceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC---C
Q 007006          455 CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM---N  531 (621)
Q Consensus       455 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~---~  531 (621)
                      ++.+....++||||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++   .
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence            99999999999999999999988854   245999999999999999999999986   99999999999998776   6


Q ss_pred             eEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          532 PKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       532 vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      +||+|||++........   .....||+.|+|||++. +.++.++||||+|+++|||++|++||...
T Consensus       188 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~  250 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ  250 (504)
T ss_dssp             EEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999987654322   23356899999999886 46899999999999999999999999643

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.5e-33  Score=299.61  Aligned_cols=198  Identities=24%  Similarity=0.378  Sum_probs=165.6

Q ss_pred             CCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCc------eEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------ELLL  464 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~------~~~l  464 (621)
                      .+|.+.+.||+|+||.||+++...+..||+|++......    ..+|+++++.++||||+++++++...+      ..++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            468999999999999999999877777999988654322    246999999999999999999996543      3789


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc-CCCCeEEeeecCceec
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIF  543 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~vkL~Dfgla~~~  543 (621)
                      ||||++++.+............+++..+..++.||+.||.|||+.+   |+||||||+|||++ .++.+||+|||+++..
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            9999987655544433334567999999999999999999999986   99999999999999 7999999999999876


Q ss_pred             CCCCCCcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          544 GGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       544 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ......   ....+|+.|+|||++.+. .++.++||||||+++|||++|++||...
T Consensus       193 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  245 (394)
T 4e7w_A          193 IAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE  245 (394)
T ss_dssp             CTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            433222   234678999999998765 5899999999999999999999998643

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-33  Score=316.48  Aligned_cols=201  Identities=28%  Similarity=0.478  Sum_probs=166.9

Q ss_pred             CCCccc-eeccCCceeEEEEEec---CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          392 HFSDEN-KLGQGGFGPVYKGTLA---DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       392 ~f~~~~-~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++.+.+ .||+|+||.||+|.+.   ++..||||+++... ....+++.+|+++|++++||||+++++++.+ +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            344444 7999999999999864   46789999998653 3456889999999999999999999999976 5689999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++|+|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       415 E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          415 EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             ECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             EeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence            99999999999954  3456999999999999999999999986   999999999999999999999999999876433


Q ss_pred             CCCc-ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          547 QNQA-NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       547 ~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      .... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus       490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~  543 (613)
T 2ozo_A          490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM  543 (613)
T ss_dssp             ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            2211 1122345688999999999999999999999999999998 99998654

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7.9e-34  Score=291.36  Aligned_cols=207  Identities=25%  Similarity=0.424  Sum_probs=158.2

Q ss_pred             HhCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ..++|.+.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            357899999999999999999985 468999999986543 334567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhc-----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCce
Q 007006          467 EYMPNKSLDVHLFDA-----TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR  541 (621)
Q Consensus       467 e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~  541 (621)
                      ||+++++|.+++...     .....+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            999999999988642     12456899999999999999999999986   9999999999999999999999999987


Q ss_pred             ecCCCCC---CcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          542 IFGGNQN---QANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       542 ~~~~~~~---~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      .......   ........+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  230 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY  230 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccC
Confidence            6543211   111234568999999999865 56899999999999999999999998653

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=7e-33  Score=283.92  Aligned_cols=199  Identities=29%  Similarity=0.417  Sum_probs=173.4

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc---------ccHHHHHHHHHHHHhcc-cCCceeEeeEEee
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---------QGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLE  458 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---------~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~  458 (621)
                      .++|.+.+.||+|+||.||++... +++.||||++.....         ...+.+.+|+++++++. ||||+++++++.+
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            468999999999999999999975 689999999975431         22456789999999995 9999999999999


Q ss_pred             CceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeec
Q 007006          459 GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFG  538 (621)
Q Consensus       459 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfg  538 (621)
                      ++..++||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEeccc
Confidence            9999999999999999999954   346899999999999999999999986   9999999999999999999999999


Q ss_pred             CceecCCCCCCcccccccccCCccChhccc------CCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          539 LARIFGGNQNQANTNIIAGTYGYMAPEYAM------GGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       539 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ++........   .....+++.|+|||.+.      ...++.++||||||+++|||++|+.||..
T Consensus       170 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  231 (298)
T 1phk_A          170 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH  231 (298)
T ss_dssp             TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             chhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC
Confidence            9987654322   22346889999999885      45689999999999999999999999854

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.9e-33  Score=286.93  Aligned_cols=202  Identities=32%  Similarity=0.448  Sum_probs=167.7

Q ss_pred             CCCCccceeccCCceeEEEEEecC----CcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEee-CceEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE-GQELLL  464 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~-~~~~~l  464 (621)
                      .+|.+.+.||+|+||.||+|...+    ...+|+|.+.... ....+.+.+|+.++++++||||+++++++.+ ++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            468888999999999999998542    2368999987643 3445778999999999999999999998654 557899


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      ||||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       105 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             EEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             EEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence            9999999999999954  3456899999999999999999999986   9999999999999999999999999998764


Q ss_pred             CCCCC--cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          545 GNQNQ--ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       545 ~~~~~--~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      .....  .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||..
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~  235 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD  235 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc
Confidence            33211  12223456788999999999999999999999999999999 5555543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.7e-33  Score=309.09  Aligned_cols=198  Identities=30%  Similarity=0.466  Sum_probs=174.4

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      .++|.+.+.||+|+||.||+++.. +++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            357899999999999999999965 79999999986542   34567899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE---cCCCCeEEeeecCcee
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARI  542 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~vkL~Dfgla~~  542 (621)
                      |||+.+++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||++..
T Consensus       105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            999999999988853   346999999999999999999999986   9999999999999   5678999999999987


Q ss_pred             cCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          543 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       543 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      +....   ......||+.|+|||++.+ .++.++||||||+++|||++|++||..
T Consensus       179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~  229 (484)
T 3nyv_A          179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNG  229 (484)
T ss_dssp             BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCC
Confidence            64332   2234568999999999876 689999999999999999999999864

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=7.1e-34  Score=315.73  Aligned_cols=201  Identities=34%  Similarity=0.514  Sum_probs=173.6

Q ss_pred             hCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      .++|.+.++||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++||||+++++++.+ +..++||||+
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~  343 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  343 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence            45788899999999999999999888899999997654 345789999999999999999999999876 6789999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++|+|.+++... ....+++.+++.++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++........
T Consensus       344 ~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  419 (535)
T 2h8h_A          344 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  419 (535)
T ss_dssp             TTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred             cCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence            999999999542 2245899999999999999999999986   999999999999999999999999999865432111


Q ss_pred             cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                       ......++..|+|||++....++.++||||||+++|||++ |+.||..
T Consensus       420 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~  467 (535)
T 2h8h_A          420 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG  467 (535)
T ss_dssp             -TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT
T ss_pred             -cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence             1112345778999999999999999999999999999999 9999864

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=6e-33  Score=283.56  Aligned_cols=198  Identities=29%  Similarity=0.422  Sum_probs=169.2

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEee----CceEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELL  463 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~----~~~~~  463 (621)
                      ..|.+.+.||+|+||.||+|.. .++..||+|++...  .....+.+.+|+.++++++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            3477788999999999999986 46889999998754  33445778999999999999999999999875    35689


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc-CCCCeEEeeecCcee
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARI  542 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~vkL~Dfgla~~  542 (621)
                      +||||+++++|.+++...   ..+++..++.++.||+.||.|||+.+ .+|+||||||+|||++ +++.+||+|||++..
T Consensus       106 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            999999999999999542   45899999999999999999999874 3599999999999998 789999999999975


Q ss_pred             cCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          543 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       543 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ....    ......+++.|+|||.+. +.++.++||||||+++|||++|+.||..
T Consensus       182 ~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~  231 (290)
T 1t4h_A          182 KRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSE  231 (290)
T ss_dssp             CCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence            4322    223356899999999876 4589999999999999999999999864

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.6e-33  Score=295.93  Aligned_cols=197  Identities=30%  Similarity=0.399  Sum_probs=162.1

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCc------
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------  460 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~------  460 (621)
                      .++|.+.+.||+|+||.||++... +++.||||++...  .....+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            368999999999999999999854 6899999999754  2334567889999999999999999999998664      


Q ss_pred             eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCc
Q 007006          461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA  540 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla  540 (621)
                      ..++||||+++ +|.+++.     ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence            78999999975 6777663     24899999999999999999999986   999999999999999999999999999


Q ss_pred             eecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          541 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       541 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      .......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  229 (371)
T 2xrw_A          175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT  229 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            8654321   122356899999999999999999999999999999999999998643

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.4e-33  Score=301.15  Aligned_cols=196  Identities=28%  Similarity=0.411  Sum_probs=162.2

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeC------ceEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------QELL  463 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~------~~~~  463 (621)
                      .+|.+.+.||+|+||.||++++. +|+.||||++.....    ...+|+++|++++||||+++++++...      ..++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46888999999999999999975 699999999865432    234799999999999999999998642      2367


Q ss_pred             EEEEecCCCChhhhhhh-ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC-CCeEEeeecCce
Q 007006          464 LIYEYMPNKSLDVHLFD-ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGLAR  541 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-~~vkL~Dfgla~  541 (621)
                      +||||+++ +|...+.. ......+++..+..++.||++||.|||+.+   |+||||||+|||++.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999986 55555432 233457999999999999999999999886   9999999999999965 568999999998


Q ss_pred             ecCCCCCCcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          542 IFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       542 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .......   .....+|+.|+|||++.+. .++.++|||||||++|||++|++||..
T Consensus       206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~  259 (420)
T 1j1b_A          206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG  259 (420)
T ss_dssp             ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            7643322   1234689999999998765 689999999999999999999999864

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.2e-33  Score=288.37  Aligned_cols=202  Identities=29%  Similarity=0.454  Sum_probs=164.3

Q ss_pred             chHHHHHHhCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhc--ccCCceeEeeEEeeC
Q 007006          382 PLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL--QHKNLVRLLGCCLEG  459 (621)
Q Consensus       382 ~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l--~h~nIv~l~g~~~~~  459 (621)
                      +........++|.+.+.||+|+||.||+++.. ++.||||++....   ...+..|.+++...  +||||+++++++.+.
T Consensus        28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             CcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            34444455678999999999999999999985 8999999986432   23445566665554  899999999999887


Q ss_pred             ----ceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEeccCCCCCEEEcCCC
Q 007006          460 ----QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS-----RLKIIHRDLKASNILLDDDM  530 (621)
Q Consensus       460 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~iiH~Dlkp~NILl~~~~  530 (621)
                          ...++||||+++++|.+++..    ..+++..++.++.|++.||.|||+..     +.+|+||||||+|||++.++
T Consensus       104 ~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~  179 (337)
T 3mdy_A          104 TGSWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG  179 (337)
T ss_dssp             CGGGCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred             CCCCCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence                688999999999999999953    35899999999999999999999871     12499999999999999999


Q ss_pred             CeEEeeecCceecCCCCCCc--ccccccccCCccChhcccCCCCChh------hhHHHHHHHHHHHHcC
Q 007006          531 NPKISDFGLARIFGGNQNQA--NTNIIAGTYGYMAPEYAMGGIFSIK------SDVFSFGVLLLEIISG  591 (621)
Q Consensus       531 ~vkL~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~s~~------sDVwS~Gvll~elltG  591 (621)
                      .+||+|||++..+.......  ......||+.|+|||++.+.....+      +||||||+++|||++|
T Consensus       180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg  248 (337)
T 3mdy_A          180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR  248 (337)
T ss_dssp             CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence            99999999998764432221  1223578999999999987766554      9999999999999999

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.5e-33  Score=286.02  Aligned_cols=207  Identities=29%  Similarity=0.420  Sum_probs=173.0

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEee--CceEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLL  464 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~--~~~~~l  464 (621)
                      .++|.+.+.||+|+||.||++... +++.||+|++....  ....+.+.+|++++++++||||+++++++.+  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            367899999999999999999965 68999999997543  3445678999999999999999999998854  568899


Q ss_pred             EEEecCCCChhhhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeccCCCCCEEEcCCCCeEEeeecCce
Q 007006          465 IYEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDS--RLKIIHRDLKASNILLDDDMNPKISDFGLAR  541 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~  541 (621)
                      ||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+  ..+|+||||||+||+++.++.+||+|||++.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999996532 2345999999999999999999999875  1239999999999999999999999999998


Q ss_pred             ecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          542 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       542 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ......  .......+++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  219 (279)
T 2w5a_A          165 ILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF  219 (279)
T ss_dssp             HC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc
Confidence            654321  1122346899999999999999999999999999999999999998754

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.3e-33  Score=297.01  Aligned_cols=196  Identities=30%  Similarity=0.440  Sum_probs=154.2

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeC------c
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------Q  460 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~------~  460 (621)
                      .++|.+.+.||+|+||.||++.. .+|+.||||++...  .....+.+.+|+++++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            46899999999999999999985 56899999999754  233456788999999999999999999998754      4


Q ss_pred             eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCc
Q 007006          461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA  540 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla  540 (621)
                      ..++|+|++ +++|..++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence            679999998 6899888743    46999999999999999999999986   999999999999999999999999999


Q ss_pred             eecCCCCCCcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          541 RIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       541 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      +.....     .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus       180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  233 (367)
T 2fst_X          180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT  233 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            865332     223578999999999877 67899999999999999999999998643

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.7e-33  Score=295.68  Aligned_cols=200  Identities=25%  Similarity=0.378  Sum_probs=166.0

Q ss_pred             HHhCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeC-------
Q 007006          388 EATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-------  459 (621)
Q Consensus       388 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~-------  459 (621)
                      ...++|.+.+.||+|+||.||++.. .+|+.||||++......    ..+|+++++.++||||+++++++...       
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            3457899999999999999999985 57999999998754322    24799999999999999999998543       


Q ss_pred             -------------------------------ceEEEEEEecCCCChhhhhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHH
Q 007006          460 -------------------------------QELLLIYEYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLH  507 (621)
Q Consensus       460 -------------------------------~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH  507 (621)
                                                     ...++||||++ ++|.+.+... .....+++..+..++.||+.||.|||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                           34789999998 5877777542 33456999999999999999999999


Q ss_pred             hCCCCCeEeccCCCCCEEEc-CCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCC-CChhhhHHHHHHHH
Q 007006          508 EDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLL  585 (621)
Q Consensus       508 ~~~~~~iiH~Dlkp~NILl~-~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~~sDVwS~Gvll  585 (621)
                      +.+   |+||||||+|||++ .++.+||+|||+++........   ....+|+.|+|||.+.+.. ++.++||||+|+++
T Consensus       159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  232 (383)
T 3eb0_A          159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF  232 (383)
T ss_dssp             TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred             HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence            886   99999999999998 6889999999999876443222   2346789999999987754 89999999999999


Q ss_pred             HHHHcCCCCCCCC
Q 007006          586 LEIISGRKNNGFY  598 (621)
Q Consensus       586 ~elltG~~p~~~~  598 (621)
                      |||++|++||...
T Consensus       233 ~ell~g~~pf~~~  245 (383)
T 3eb0_A          233 GELILGKPLFSGE  245 (383)
T ss_dssp             HHHHHSSCSSCCS
T ss_pred             HHHHhCCCCCCCC
Confidence            9999999998743

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.5e-33  Score=290.57  Aligned_cols=202  Identities=33%  Similarity=0.506  Sum_probs=169.2

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcE--EEEEEeccC-CcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKA--IAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~--vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      ++|.+.+.||+|+||.||+++.. ++..  +++|++... .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            57999999999999999999864 5664  499988753 334456789999999999 899999999999999999999


Q ss_pred             EEecCCCChhhhhhhcc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCe
Q 007006          466 YEYMPNKSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP  532 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~v  532 (621)
                      |||+++++|.+++....             ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999996432             2346999999999999999999999986   9999999999999999999


Q ss_pred             EEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          533 KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       533 kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      ||+|||++......   .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~  245 (327)
T 1fvr_A          182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM  245 (327)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC
Confidence            99999998743211   11223356788999999988889999999999999999998 99998543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-33  Score=284.73  Aligned_cols=199  Identities=32%  Similarity=0.421  Sum_probs=167.8

Q ss_pred             CCCccceeccCCceeEEEEEec-C---CcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceE-EEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-D---GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL-LLI  465 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~---g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~-~lV  465 (621)
                      .|...++||+|+||.||+|... +   +..+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            4556789999999999999853 2   2379999997643 34457789999999999999999999999876655 999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      +||+.+++|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            999999999999954  3456899999999999999999999986   99999999999999999999999999986543


Q ss_pred             CC--CCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCC
Q 007006          546 NQ--NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNN  595 (621)
Q Consensus       546 ~~--~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~  595 (621)
                      ..  .........+++.|+|||.+.+..++.++||||||+++|||++|..|+
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~  228 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP  228 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence            22  112223346788999999999999999999999999999999965553

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5e-33  Score=294.02  Aligned_cols=201  Identities=24%  Similarity=0.389  Sum_probs=171.1

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeC-----ceE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QEL  462 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~-----~~~  462 (621)
                      .++|.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++.+++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            468999999999999999999864 68899999997543 33346789999999999999999999999765     368


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      ++|+||++ ++|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            99999997 588888843    35899999999999999999999986   99999999999999999999999999987


Q ss_pred             cCCCCCCc-ccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          543 FGGNQNQA-NTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       543 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ........ ......||+.|+|||++.+ ..++.++||||||+++|||++|++||...
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  235 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK  235 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCC
Confidence            65332211 1234578999999998754 45899999999999999999999998644

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.7e-33  Score=288.98  Aligned_cols=199  Identities=26%  Similarity=0.400  Sum_probs=167.0

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--------cccHHHHHHHHHHHHhcccCCceeEeeEEeeCc
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--------GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ  460 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~  460 (621)
                      .++|.+.+.||+|+||.||++... +++.||||++....        ......+.+|++++++++||||+++++++..+.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            467999999999999999999864 58999999986532        122345889999999999999999999987654


Q ss_pred             eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCC---eEEeee
Q 007006          461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN---PKISDF  537 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---vkL~Df  537 (621)
                       .++||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.   +||+||
T Consensus        89 -~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             -EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             -eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence             8999999999999988843   356899999999999999999999986   999999999999987664   999999


Q ss_pred             cCceecCCCCCCcccccccccCCccChhccc---CCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          538 GLARIFGGNQNQANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       538 gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      |++......   .......||+.|+|||++.   ...++.++||||||+++|||++|+.||...
T Consensus       162 g~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  222 (322)
T 2ycf_A          162 GHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH  222 (322)
T ss_dssp             TTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCST
T ss_pred             ccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            999876432   1123356899999999874   567899999999999999999999998643

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.3e-33  Score=284.80  Aligned_cols=197  Identities=34%  Similarity=0.467  Sum_probs=164.5

Q ss_pred             hCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeC-ceEEEEEEe
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-QELLLIYEY  468 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~-~~~~lV~e~  468 (621)
                      .++|.+.+.||+|+||.||++... |+.||+|+++...  ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            357899999999999999999874 8899999997543  457789999999999999999999997655 478999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++....... 
T Consensus        97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  171 (278)
T 1byg_A           97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  171 (278)
T ss_dssp             CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence            99999999985432 234889999999999999999999986   9999999999999999999999999987653321 


Q ss_pred             CcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                          ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  218 (278)
T 1byg_A          172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI  218 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred             ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence                12356789999999999999999999999999999998 99998653

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=9.9e-33  Score=288.51  Aligned_cols=208  Identities=26%  Similarity=0.371  Sum_probs=175.2

Q ss_pred             ccchHHHHHHhCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHh--cccCCceeEeeEEe
Q 007006          380 LFPLRLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAK--LQHKNLVRLLGCCL  457 (621)
Q Consensus       380 ~~~~~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~h~nIv~l~g~~~  457 (621)
                      ..+........++|.+.+.||+|+||.||+++. +++.||||++...   ....+.+|++++..  ++||||+++++++.
T Consensus        31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~  106 (342)
T 1b6c_B           31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN  106 (342)
T ss_dssp             SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred             CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence            445555566678999999999999999999998 5899999999643   34667889999888  78999999999998


Q ss_pred             eCc----eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeccCCCCCEE
Q 007006          458 EGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH--------EDSRLKIIHRDLKASNIL  525 (621)
Q Consensus       458 ~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~iiH~Dlkp~NIL  525 (621)
                      ...    ..++||||+++++|.+++..    ..+++..++.++.|++.||.|||        +.   +|+||||||+|||
T Consensus       107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIl  179 (342)
T 1b6c_B          107 KDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNIL  179 (342)
T ss_dssp             CCCSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEE
T ss_pred             ccCCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEE
Confidence            876    78999999999999999953    35899999999999999999999        55   4999999999999


Q ss_pred             EcCCCCeEEeeecCceecCCCCCCc--ccccccccCCccChhcccCCC------CChhhhHHHHHHHHHHHHcC------
Q 007006          526 LDDDMNPKISDFGLARIFGGNQNQA--NTNIIAGTYGYMAPEYAMGGI------FSIKSDVFSFGVLLLEIISG------  591 (621)
Q Consensus       526 l~~~~~vkL~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~------~s~~sDVwS~Gvll~elltG------  591 (621)
                      ++.++.+||+|||++..........  ......||+.|+|||.+.+..      ++.++||||||+++|||++|      
T Consensus       180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~  259 (342)
T 1b6c_B          180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  259 (342)
T ss_dssp             ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred             ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence            9999999999999998765433221  223456899999999987763      34789999999999999999      


Q ss_pred             ----CCCCCCC
Q 007006          592 ----RKNNGFY  598 (621)
Q Consensus       592 ----~~p~~~~  598 (621)
                          +.||...
T Consensus       260 ~~~~~~p~~~~  270 (342)
T 1b6c_B          260 HEDYQLPYYDL  270 (342)
T ss_dssp             CCCCCCTTTTT
T ss_pred             ccccccCcccc
Confidence                6777543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.3e-33  Score=294.52  Aligned_cols=199  Identities=33%  Similarity=0.510  Sum_probs=160.0

Q ss_pred             hCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHH--HHhcccCCceeEeeEEee-----CceE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNL--IAKLQHKNLVRLLGCCLE-----GQEL  462 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~--l~~l~h~nIv~l~g~~~~-----~~~~  462 (621)
                      .++|.+.+.||+|+||.||+|+. +++.||||++....   ...+..|.++  +..++||||+++++.+..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            36799999999999999999987 68999999997543   3344445444  445899999999986543     3367


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEeccCCCCCEEEcCCCCeEEee
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS------RLKIIHRDLKASNILLDDDMNPKISD  536 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~iiH~Dlkp~NILl~~~~~vkL~D  536 (621)
                      ++||||+++|+|.+++..    ...++..+.+++.||+.||.|||+..      +.+|+||||||+|||++.++.+||+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D  163 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD  163 (336)
T ss_dssp             EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred             EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence            899999999999999953    23589999999999999999999871      11499999999999999999999999


Q ss_pred             ecCceecCCCCC------CcccccccccCCccChhcccC-------CCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          537 FGLARIFGGNQN------QANTNIIAGTYGYMAPEYAMG-------GIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       537 fgla~~~~~~~~------~~~~~~~~gt~~y~aPE~l~~-------~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      ||++..+.....      ........||+.|+|||++.+       ..++.++||||||+++|||++|+.|+-
T Consensus       164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~  236 (336)
T 3g2f_A          164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF  236 (336)
T ss_dssp             CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred             ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence            999987654321      111223468999999999876       356778999999999999999987764

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.1e-33  Score=297.77  Aligned_cols=197  Identities=12%  Similarity=0.131  Sum_probs=153.0

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc---ccHHHHHHHHHHHHhc--ccCCceeEe-------eEEe
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKL--QHKNLVRLL-------GCCL  457 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l--~h~nIv~l~-------g~~~  457 (621)
                      .+|.+.+.||+|+||.||++... +|+.||||++.....   ...+.+.+|+.+++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45888999999999999999964 789999999987542   3345677886655555  599988755       4443


Q ss_pred             eC-----------------ceEEEEEEecCCCChhhhhhhccCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCCe
Q 007006          458 EG-----------------QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRR------QSIINGIARGILYLHEDSRLKI  514 (621)
Q Consensus       458 ~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~~L~yLH~~~~~~i  514 (621)
                      .+                 ...++||||++ ++|.+++....  ..+.+..+      ..++.||+.||.|||+++   |
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i  215 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG---L  215 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence            32                 34799999999 89999996532  23455555      778899999999999986   9


Q ss_pred             EeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccC--CCCChhhhHHHHHHHHHHHHcCC
Q 007006          515 IHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGR  592 (621)
Q Consensus       515 iH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwS~Gvll~elltG~  592 (621)
                      +||||||+|||++.++.+||+|||+++.....     .....+++.|+|||++.+  ..++.++||||||+++|||++|+
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~  290 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF  290 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence            99999999999999999999999999875322     113456799999999987  67999999999999999999999


Q ss_pred             CCCCCC
Q 007006          593 KNNGFY  598 (621)
Q Consensus       593 ~p~~~~  598 (621)
                      .||...
T Consensus       291 ~Pf~~~  296 (371)
T 3q60_A          291 LPFGLV  296 (371)
T ss_dssp             CSTTBC
T ss_pred             CCCCCc
Confidence            999755

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=8.5e-33  Score=294.79  Aligned_cols=202  Identities=23%  Similarity=0.311  Sum_probs=170.8

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcc--------cCCceeEeeEEe---
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ--------HKNLVRLLGCCL---  457 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~--------h~nIv~l~g~~~---  457 (621)
                      .++|.+.++||+|+||.||+++. .+++.||||++... ....+.+.+|+++++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            47899999999999999999985 46889999999753 334567889999999996        788999999988   


Q ss_pred             -eCceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCEEEcCCC-----
Q 007006          458 -EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-SRLKIIHRDLKASNILLDDDM-----  530 (621)
Q Consensus       458 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~-----  530 (621)
                       +....++||||+ +++|.+++... ....+++..++.++.||+.||.|||++ +   |+||||||+|||++.++     
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence             456889999999 55565555432 235699999999999999999999997 5   99999999999999775     


Q ss_pred             --------------------------------------------CeEEeeecCceecCCCCCCcccccccccCCccChhc
Q 007006          531 --------------------------------------------NPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY  566 (621)
Q Consensus       531 --------------------------------------------~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~  566 (621)
                                                                  .+||+|||++......     .....||+.|+|||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence                                                        7999999999876432     223468999999999


Q ss_pred             ccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCcCCC
Q 007006          567 AMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH  602 (621)
Q Consensus       567 l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~~~  602 (621)
                      +.+..++.++||||||+++|||++|+.||.......
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  300 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEE  300 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSS
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccc
Confidence            999999999999999999999999999997655443

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-33  Score=290.14  Aligned_cols=203  Identities=28%  Similarity=0.481  Sum_probs=168.3

Q ss_pred             HHhCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhc-ccCCceeEeeEEee------C
Q 007006          388 EATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLE------G  459 (621)
Q Consensus       388 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~------~  459 (621)
                      ...++|.+.+.||+|+||.||+++. .+++.||+|++.... ...+.+.+|+.+++++ +||||+++++++..      .
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   99 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   99 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence            3467899999999999999999996 478999999987543 3357789999999999 89999999999987      4


Q ss_pred             ceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecC
Q 007006          460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL  539 (621)
Q Consensus       460 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgl  539 (621)
                      +..++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~  175 (326)
T 2x7f_A          100 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  175 (326)
T ss_dssp             CEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcC
Confidence            5789999999999999998643 2356899999999999999999999986   99999999999999999999999999


Q ss_pred             ceecCCCCCCcccccccccCCccChhccc-----CCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          540 ARIFGGNQNQANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       540 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      +........  ......+++.|+|||.+.     +..++.++||||||+++|||++|+.||..
T Consensus       176 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  236 (326)
T 2x7f_A          176 SAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD  236 (326)
T ss_dssp             TC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence            886543221  122346899999999986     56689999999999999999999999854

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-33  Score=296.60  Aligned_cols=200  Identities=16%  Similarity=0.224  Sum_probs=170.3

Q ss_pred             hCCCCccceeccCCceeEEEEEecC---------CcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCcee---------
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLAD---------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR---------  451 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~---------  451 (621)
                      .++|.+.+.||+|+||.||+++...         ++.||+|++...     +.+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3679999999999999999999753         789999998754     35789999999999999987         


Q ss_pred             ------EeeEEee-CceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCE
Q 007006          452 ------LLGCCLE-GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNI  524 (621)
Q Consensus       452 ------l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NI  524 (621)
                            +++++.. ++..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                  6777776 67889999999 99999999643 2356999999999999999999999986   99999999999


Q ss_pred             EEcCCC--CeEEeeecCceecCCCCCC-----cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          525 LLDDDM--NPKISDFGLARIFGGNQNQ-----ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       525 Ll~~~~--~vkL~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      |++.++  .+||+|||+++.+......     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  8999999999876432211     112334789999999999999999999999999999999999999975


Q ss_pred             Cc
Q 007006          598 YF  599 (621)
Q Consensus       598 ~~  599 (621)
                      ..
T Consensus       271 ~~  272 (352)
T 2jii_A          271 CL  272 (352)
T ss_dssp             GT
T ss_pred             CC
Confidence            43

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.1e-32  Score=297.78  Aligned_cols=198  Identities=21%  Similarity=0.292  Sum_probs=170.9

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhc------ccCCceeEeeEEeeCceE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL------QHKNLVRLLGCCLEGQEL  462 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l------~h~nIv~l~g~~~~~~~~  462 (621)
                      ..+|++.+.||+|+||.||++... +++.||||+++.. ....+.+.+|+++++.+      +|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            467999999999999999999864 5899999999753 23345678899988888      467999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCC--eEEeeecCc
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN--PKISDFGLA  540 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~--vkL~Dfgla  540 (621)
                      ++||||+. ++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.  +||+|||++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence            99999996 6888888543 2345899999999999999999999986   999999999999999887  999999999


Q ss_pred             eecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          541 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       541 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ......     .....+|+.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus       250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            764332     22346899999999999999999999999999999999999998643

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=8.2e-33  Score=291.36  Aligned_cols=206  Identities=25%  Similarity=0.335  Sum_probs=159.4

Q ss_pred             HHHHHhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCce--
Q 007006          385 LALEATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE--  461 (621)
Q Consensus       385 ~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~--  461 (621)
                      ......++|.+.+.||+|+||.||+++.. +|+.||||++..... ....+.+|++.+..++||||+++++++...+.  
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            34456689999999999999999999964 689999999865432 23456788888999999999999999976433  


Q ss_pred             -----EEEEEEecCCCChhhhhh-hccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEeccCCCCCEEEcC-CCCe
Q 007006          462 -----LLLIYEYMPNKSLDVHLF-DATRSVQLDWKRRQSIINGIARGILYLH--EDSRLKIIHRDLKASNILLDD-DMNP  532 (621)
Q Consensus       462 -----~~lV~e~~~~gsL~~~l~-~~~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~~~iiH~Dlkp~NILl~~-~~~v  532 (621)
                           .++||||++++ |...+. .......+++..+..++.|++.||.|||  +.+   |+||||||+|||++. ++.+
T Consensus        96 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             TTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred             ccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence                 78999999865 443332 2344567899999999999999999999  665   999999999999997 8999


Q ss_pred             EEeeecCceecCCCCCCcccccccccCCccChhcccCCC-CChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          533 KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       533 kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ||+|||++........   .....+|+.|+|||++.+.. ++.++||||||+++|||++|+.||...
T Consensus       172 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~  235 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD  235 (360)
T ss_dssp             EECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence            9999999987654322   22346799999999986654 899999999999999999999998653

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.4e-33  Score=284.82  Aligned_cols=201  Identities=33%  Similarity=0.461  Sum_probs=168.8

Q ss_pred             CCCCccc-eeccCCceeEEEEEe---cCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          391 NHFSDEN-KLGQGGFGPVYKGTL---ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       391 ~~f~~~~-~LG~G~fG~Vy~~~~---~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      ++|.+.+ .||+|+||.||++..   .+++.||||+++...  ....+.+.+|+++++.++||||+++++++ +.+..++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            4677777 999999999999964   347889999997653  23357799999999999999999999999 5667899


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      ||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus        95 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            9999999999999954   345899999999999999999999986   9999999999999999999999999998765


Q ss_pred             CCCCCc-ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          545 GNQNQA-NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       545 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      ...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  224 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM  224 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence            433221 1222345688999999988889999999999999999999 99998643

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4e-33  Score=284.38  Aligned_cols=201  Identities=26%  Similarity=0.357  Sum_probs=157.8

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCc--ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG--QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      .++|++.+.||+|+||.||++.. .+|+.||+|++.....  ...+.+.++...++.++||||+++++++.+++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            46789999999999999999996 5789999999976532  22233445555678889999999999999999999999


Q ss_pred             EecCCCChhhhhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          467 EYMPNKSLDVHLFDA-TRSVQLDWKRRQSIINGIARGILYLHED-SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       467 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      ||++ ++|.+++... .....+++..++.++.|++.||.|||+. +   |+||||||+||+++.++.+||+|||++....
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9997 5887777542 2345799999999999999999999997 6   9999999999999999999999999998764


Q ss_pred             CCCCCcccccccccCCccChhcc----cCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYA----MGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l----~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ....   .....+|+.|+|||.+    .+..++.++||||||+++|||++|+.||..
T Consensus       162 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  215 (290)
T 3fme_A          162 DDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS  215 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             cccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence            3322   2234689999999996    566789999999999999999999999864

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1e-32  Score=286.46  Aligned_cols=202  Identities=26%  Similarity=0.434  Sum_probs=170.3

Q ss_pred             HhCCCCccceeccCCceeEEEEEe--cCCcEEEEEEeccCC--cccHHHHHHHHHHHHhc---ccCCceeEeeEEe----
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTL--ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKL---QHKNLVRLLGCCL----  457 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~--~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l---~h~nIv~l~g~~~----  457 (621)
                      ..++|.+.+.||+|+||.||++..  .+++.||+|++....  ......+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            357899999999999999999997  468899999987542  22234566788877776   8999999999987    


Q ss_pred             -eCceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEee
Q 007006          458 -EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISD  536 (621)
Q Consensus       458 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~D  536 (621)
                       .....++||||++ ++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence             4567899999998 6999988543 2345899999999999999999999986   99999999999999999999999


Q ss_pred             ecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          537 FGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       537 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ||++.......   ......+++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  222 (326)
T 1blx_A          164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS  222 (326)
T ss_dssp             CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence            99998654221   223356899999999999999999999999999999999999998643

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=7.4e-33  Score=290.91  Aligned_cols=201  Identities=27%  Similarity=0.392  Sum_probs=169.5

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeC-----ceE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QEL  462 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~-----~~~  462 (621)
                      .++|.+.+.||+|+||.||++... +|+.||||++.... ......+.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468999999999999999999965 68999999997543 33456788999999999999999999998764     678


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      ++||||+. ++|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            99999997 688888853    35899999999999999999999986   99999999999999999999999999987


Q ss_pred             cCCCCCCc--------ccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          543 FGGNQNQA--------NTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       543 ~~~~~~~~--------~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ........        ......||+.|+|||++.+ ..++.++||||||+++|||++|++||...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  226 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR  226 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            65332211        1123468999999998765 67899999999999999999999998643

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=7.5e-33  Score=286.14  Aligned_cols=200  Identities=27%  Similarity=0.391  Sum_probs=166.7

Q ss_pred             hCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcc--cCCceeEeeEEeeCceEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQ--HKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~--h~nIv~l~g~~~~~~~~~lV  465 (621)
                      .++|.+.+.||+|+||.||++...+++.||+|++....  ....+.+.+|++++.+++  ||||+++++++.+++..++|
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  106 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  106 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred             cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence            46799999999999999999998889999999997543  344577899999999997  49999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      || +.+++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++ +.+||+|||++.....
T Consensus       107 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          107 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQP  178 (313)
T ss_dssp             EC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred             Ee-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence            99 678999999854   346899999999999999999999986   999999999999965 7999999999987654


Q ss_pred             CCCCcccccccccCCccChhcccC-----------CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMG-----------GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ...........|++.|+|||.+.+           ..++.++||||||+++|||++|+.||..
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  241 (313)
T 3cek_A          179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  241 (313)
T ss_dssp             -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence            433333334568999999999865           4689999999999999999999999864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.3e-33  Score=296.66  Aligned_cols=202  Identities=29%  Similarity=0.463  Sum_probs=154.1

Q ss_pred             CCCc-cceeccCCceeEEEEEec---CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEee--CceEEEE
Q 007006          392 HFSD-ENKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLLI  465 (621)
Q Consensus       392 ~f~~-~~~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~--~~~~~lV  465 (621)
                      .|.+ .++||+|+||.||+++..   +++.||||++.....  ...+.+|+++|++++||||+++++++..  ....++|
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            4554 458999999999999965   578999999975432  3568899999999999999999999954  6689999


Q ss_pred             EEecCCCChhhhhhhcc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE----cCCCCeEEe
Q 007006          466 YEYMPNKSLDVHLFDAT------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL----DDDMNPKIS  535 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl----~~~~~vkL~  535 (621)
                      |||++ ++|.+++....      ....+++..++.++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+
T Consensus        99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            99997 47776664221      2235999999999999999999999986   9999999999999    677899999


Q ss_pred             eecCceecCCCCCC-cccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          536 DFGLARIFGGNQNQ-ANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       536 Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      |||+++........ .......||+.|+|||++.+. .++.++|||||||++|||++|++||....
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            99999876543211 223345789999999999874 58999999999999999999999996443

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.3e-32  Score=284.67  Aligned_cols=199  Identities=23%  Similarity=0.341  Sum_probs=172.5

Q ss_pred             hCCCCccceeccCCceeEEEEEe--cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCC------ceeEeeEEeeCce
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL--ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN------LVRLLGCCLEGQE  461 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~--~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~n------Iv~l~g~~~~~~~  461 (621)
                      .++|.+.+.||+|+||.||++..  .+++.||+|+++.. ....+.+.+|+++++.++|++      ++++++++.+.+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            36899999999999999999986  36889999999754 234567889999999998765      9999999999999


Q ss_pred             EEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC-------------
Q 007006          462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-------------  528 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-------------  528 (621)
                      .++||||+ +++|.+++... ...++++..+..++.||+.||.|||+.+   |+||||||+|||++.             
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence            99999999 89999988543 2346899999999999999999999986   999999999999987             


Q ss_pred             ------CCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          529 ------DMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       529 ------~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                            ++.+||+|||++......     .....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  238 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD  238 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred             ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence                  678999999999864332     223468999999999999999999999999999999999999997543

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.2e-32  Score=298.93  Aligned_cols=203  Identities=23%  Similarity=0.335  Sum_probs=172.6

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhccc-CCceeEeeEEeeCceEEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH-KNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h-~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      .++|.+.++||+|+||.||+++. .+++.||||++......  .++..|+++++.++| ++++.+..++.+.+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46899999999999999999995 57999999988754332  357899999999987 556666667777888999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE---cCCCCeEEeeecCceecC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFG  544 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl---~~~~~vkL~Dfgla~~~~  544 (621)
                      |+ +++|.+++...  ...+++..++.|+.||+.||.|||+.+   |+||||||+||||   +.++.+||+|||+++.+.
T Consensus        84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 99999998542  346999999999999999999999986   9999999999999   688999999999999875


Q ss_pred             CCCCCc-----ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCcC
Q 007006          545 GNQNQA-----NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFS  600 (621)
Q Consensus       545 ~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~  600 (621)
                      ......     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~  218 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA  218 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence            543221     12246789999999999999999999999999999999999999976443

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.6e-33  Score=314.01  Aligned_cols=195  Identities=33%  Similarity=0.461  Sum_probs=163.9

Q ss_pred             ceeccCCceeEEEEEec---CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCC
Q 007006          397 NKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN  471 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  471 (621)
                      ++||+|+||.||+|.+.   .++.||||+++...  ....+++.+|+++|++++|||||++++++.+ +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999653   46789999997643  3446789999999999999999999999964 468899999999


Q ss_pred             CChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC-c
Q 007006          472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ-A  550 (621)
Q Consensus       472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~-~  550 (621)
                      |+|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...... .
T Consensus       454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            999999953   346899999999999999999999986   999999999999999999999999999876543221 1


Q ss_pred             ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~  576 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM  576 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            2223356788999999999999999999999999999998 99999653

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.2e-33  Score=283.68  Aligned_cols=202  Identities=32%  Similarity=0.442  Sum_probs=163.2

Q ss_pred             hCCCCccceeccCCceeEEEEEec--CCc--EEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA--DGK--AIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL  462 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~--~g~--~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~  462 (621)
                      .++|++.+.||+|+||.||++++.  ++.  .||+|+++..   .....+.+.+|++++++++||||+++++++.++. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            357899999999999999999853  333  6899998754   2345678899999999999999999999998765 8


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      ++|+||+++++|.+++...  ...+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence            8999999999999998643  345899999999999999999999986   99999999999999999999999999987


Q ss_pred             cCCCCCCc-ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          543 FGGNQNQA-NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       543 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      ........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~  227 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG  227 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            65432211 1223456778999999988889999999999999999999 9999864

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.7e-32  Score=290.74  Aligned_cols=195  Identities=26%  Similarity=0.435  Sum_probs=165.8

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceE----
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL----  462 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~----  462 (621)
                      .++|.+.+.||+|+||.||++... +|+.||||++....  ....+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468999999999999999999864 68999999997643  33356788999999999999999999999877654    


Q ss_pred             --EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCc
Q 007006          463 --LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA  540 (621)
Q Consensus       463 --~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla  540 (621)
                        ++||||+. ++|..++.     ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999997 67777662     34899999999999999999999986   999999999999999999999999999


Q ss_pred             eecCCCCCCcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          541 RIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       541 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ......     .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus       192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  245 (371)
T 4exu_A          192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK  245 (371)
T ss_dssp             -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence            865432     223467999999999877 67899999999999999999999999643

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.98  E-value=2.5e-32  Score=278.66  Aligned_cols=199  Identities=30%  Similarity=0.448  Sum_probs=172.4

Q ss_pred             HhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      ..++|.+.+.||+|+||.||+++.. +++.||+|++...  .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            3468999999999999999999975 6899999998654  234567899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC---CCeEEeeecCcee
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD---MNPKISDFGLARI  542 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~---~~vkL~Dfgla~~  542 (621)
                      +||+++++|.+++...   ..+++..++.++.||+.||.|||+.+   ++||||||+||+++.+   +.+||+|||++..
T Consensus       100 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A          100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             EEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            9999999998888543   35899999999999999999999986   9999999999999764   4699999999986


Q ss_pred             cCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          543 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       543 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ......   .....+++.|+|||.+.+ .++.++||||||+++|||++|+.||..
T Consensus       174 ~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~  224 (287)
T 2wei_A          174 FQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG  224 (287)
T ss_dssp             BCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCC
Confidence            543322   123357889999998865 489999999999999999999999864

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.98  E-value=3.4e-32  Score=286.29  Aligned_cols=195  Identities=25%  Similarity=0.432  Sum_probs=165.4

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCce-----
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE-----  461 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~-----  461 (621)
                      .++|.+.+.||+|+||.||++... +|+.||||++....  ....+.+.+|+.++++++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            367899999999999999999964 69999999997542  2335678899999999999999999999987653     


Q ss_pred             -EEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCc
Q 007006          462 -LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA  540 (621)
Q Consensus       462 -~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla  540 (621)
                       .++||||++ ++|..++.     ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999997 68877762     24899999999999999999999986   999999999999999999999999999


Q ss_pred             eecCCCCCCcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          541 RIFGGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       541 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ......     .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  227 (353)
T 3coi_A          174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK  227 (353)
T ss_dssp             TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS
T ss_pred             cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            764322     223467999999999877 67899999999999999999999998643

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.98  E-value=3.9e-32  Score=278.29  Aligned_cols=195  Identities=32%  Similarity=0.508  Sum_probs=161.7

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEee----------
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE----------  458 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~----------  458 (621)
                      .++|++.+.||+|+||.||+++. .+++.||+|++... ....+.+.+|+.++++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            45789999999999999999996 47999999999653 3445778999999999999999999998865          


Q ss_pred             ---CceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEe
Q 007006          459 ---GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS  535 (621)
Q Consensus       459 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~  535 (621)
                         .+..++||||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence               3568999999999999999964  2346788999999999999999999986   9999999999999999999999


Q ss_pred             eecCceecCCCCC------------CcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHc
Q 007006          536 DFGLARIFGGNQN------------QANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIIS  590 (621)
Q Consensus       536 Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~ellt  590 (621)
                      |||++........            ........+++.|+|||.+.+. .++.++||||||+++|||++
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  226 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY  226 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence            9999986543211            1112334688999999998764 68999999999999999998

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.98  E-value=5e-32  Score=286.64  Aligned_cols=200  Identities=21%  Similarity=0.327  Sum_probs=168.1

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcc-----------cCCceeEeeEEe
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-----------HKNLVRLLGCCL  457 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----------h~nIv~l~g~~~  457 (621)
                      .++|.+.+.||+|+||.||+++. .+++.||||++... ....+.+.+|++++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            35799999999999999999996 57899999999743 234567889999999886           899999999998


Q ss_pred             eCc----eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCEEEc-----
Q 007006          458 EGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-SRLKIIHRDLKASNILLD-----  527 (621)
Q Consensus       458 ~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dlkp~NILl~-----  527 (621)
                      ..+    ..++|||++ +++|.+++... ....+++..+..++.||+.||.|||++ +   |+||||||+|||++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence            654    789999999 89999988643 234589999999999999999999997 6   99999999999994     


Q ss_pred             -CCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCcC
Q 007006          528 -DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFS  600 (621)
Q Consensus       528 -~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~  600 (621)
                       ..+.+||+|||++......     .....+|+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  240 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG  240 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcc
Confidence             4447999999999876432     2234689999999999999999999999999999999999999976543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.98  E-value=3.2e-32  Score=283.20  Aligned_cols=201  Identities=27%  Similarity=0.392  Sum_probs=150.9

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHH-HHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVN-LIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~-~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      .++|.+.+.||+|+||.||++... +|+.||||++.... .....++..|+. +++.++||||+++++++.+++..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            367889999999999999999974 68999999997653 233345566665 677789999999999999999999999


Q ss_pred             EecCCCChhhhhhh--ccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCEEEcCCCCeEEeeecCceec
Q 007006          467 EYMPNKSLDVHLFD--ATRSVQLDWKRRQSIINGIARGILYLHED-SRLKIIHRDLKASNILLDDDMNPKISDFGLARIF  543 (621)
Q Consensus       467 e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~  543 (621)
                      ||+++ +|.+++..  ......+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||++...
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99985 77777643  12245689999999999999999999997 6   999999999999999999999999999865


Q ss_pred             CCCCCCcccccccccCCccChhcc----cCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          544 GGNQNQANTNIIAGTYGYMAPEYA----MGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       544 ~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .....   .....|++.|+|||.+    .+..++.++||||||+++|||++|+.||..
T Consensus       177 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  231 (327)
T 3aln_A          177 VDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK  231 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred             ccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            43221   2223689999999998    456689999999999999999999999864

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.98  E-value=1.2e-31  Score=285.46  Aligned_cols=201  Identities=24%  Similarity=0.343  Sum_probs=170.4

Q ss_pred             HhCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcc-cC-----CceeEeeEEeeCce
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HK-----NLVRLLGCCLEGQE  461 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-h~-----nIv~l~g~~~~~~~  461 (621)
                      ..++|.+.+.||+|+||.||+|... +++.||||+++.. ......+..|+.+++.++ |+     +|+++++++...+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            4578999999999999999999865 6889999999753 233566788999998885 44     49999999999999


Q ss_pred             EEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc--CCCCeEEeeecC
Q 007006          462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD--DDMNPKISDFGL  539 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~--~~~~vkL~Dfgl  539 (621)
                      .++||||++ ++|.+++... ....+++..+..++.||+.||.|||++ ..+|+||||||+|||++  .++.+||+|||+
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             eEEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            999999996 5999888643 234589999999999999999999963 23599999999999995  477899999999


Q ss_pred             ceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          540 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       540 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      +......     .....+|+.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus       208 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          208 SCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             CEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9876432     22346889999999999999999999999999999999999999743

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.97  E-value=1.6e-32  Score=284.96  Aligned_cols=202  Identities=24%  Similarity=0.364  Sum_probs=171.9

Q ss_pred             HHHHhCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcc------cHHHHHHHHHHHHhcc--cCCceeEeeEE
Q 007006          386 ALEATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQ------GLQEFKNEVNLIAKLQ--HKNLVRLLGCC  456 (621)
Q Consensus       386 ~~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~------~~~~~~~Ei~~l~~l~--h~nIv~l~g~~  456 (621)
                      .....++|.+.+.||+|+||.||+++. .+++.||||++......      ..+.+.+|+.++++++  ||||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            334457899999999999999999985 57899999999754321      2245678999999996  59999999999


Q ss_pred             eeCceEEEEEEecCC-CChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc-CCCCeEE
Q 007006          457 LEGQELLLIYEYMPN-KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKI  534 (621)
Q Consensus       457 ~~~~~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~vkL  534 (621)
                      .+++..++|+|++.+ ++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++ +++.+||
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL  191 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL  191 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEE
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEE
Confidence            999999999999986 899998854   346899999999999999999999986   99999999999999 7899999


Q ss_pred             eeecCceecCCCCCCcccccccccCCccChhcccCCCC-ChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          535 SDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       535 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      +|||++.......    .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..
T Consensus       192 ~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  251 (320)
T 3a99_A          192 IDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH  251 (320)
T ss_dssp             CCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             eeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence            9999998765322    223468999999999877665 7889999999999999999999864

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.97  E-value=1.4e-31  Score=280.79  Aligned_cols=199  Identities=22%  Similarity=0.315  Sum_probs=169.5

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CC-cEEEEEEeccCCcccHHHHHHHHHHHHhcccCC------ceeEeeEEeeCce
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DG-KAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN------LVRLLGCCLEGQE  461 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g-~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~n------Iv~l~g~~~~~~~  461 (621)
                      .++|.+.+.||+|+||.||++... ++ +.||+|+++.. ....+.+.+|+.++++++|++      ++.+.+++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            468999999999999999999864 34 78999999753 234567889999999998766      8999999999999


Q ss_pred             EEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE---------------
Q 007006          462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL---------------  526 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl---------------  526 (621)
                      .++||||+ +++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||+               
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence            99999999 56666666432 2346999999999999999999999886   9999999999999               


Q ss_pred             ----cCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          527 ----DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       527 ----~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                          +.++.+||+|||++.......     ....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE  243 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence                567899999999998643321     23468999999999999999999999999999999999999997543

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.97  E-value=1.6e-32  Score=284.06  Aligned_cols=201  Identities=29%  Similarity=0.457  Sum_probs=166.3

Q ss_pred             HhCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ..++|.+.+.||+|+||.||+|....  .+|+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++|+
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  108 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT  108 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence            34689999999999999999998753  48999987542  333456788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||++......
T Consensus       109 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          109 SLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             BCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             ecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            99999999999954  2346899999999999999999999986   99999999999998 679999999998765321


Q ss_pred             C---CCcccccccccCCccChhcccC---------CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          547 Q---NQANTNIIAGTYGYMAPEYAMG---------GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       547 ~---~~~~~~~~~gt~~y~aPE~l~~---------~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .   .........|++.|+|||.+..         ..++.++||||||+++|||++|+.||..
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  245 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT  245 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            1   1122233468899999999864         4579999999999999999999999864

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.97  E-value=2.4e-32  Score=282.03  Aligned_cols=200  Identities=25%  Similarity=0.398  Sum_probs=163.8

Q ss_pred             HHhCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcc------cHHHHHHHHHHHHhc----ccCCceeEeeEE
Q 007006          388 EATNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQ------GLQEFKNEVNLIAKL----QHKNLVRLLGCC  456 (621)
Q Consensus       388 ~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~------~~~~~~~Ei~~l~~l----~h~nIv~l~g~~  456 (621)
                      ...++|.+.+.||+|+||.||+++. .+++.||+|++......      ....+.+|+.++.++    +||||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            3457899999999999999999985 46899999999765321      223456799999999    899999999999


Q ss_pred             eeCceEEEEEEe-cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc-CCCCeEE
Q 007006          457 LEGQELLLIYEY-MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKI  534 (621)
Q Consensus       457 ~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~vkL  534 (621)
                      .+.+..++|+|+ +.+++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+||+++ .++.+||
T Consensus       108 ~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          108 ETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred             ecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence            999999999999 789999999964   335899999999999999999999986   99999999999999 8899999


Q ss_pred             eeecCceecCCCCCCcccccccccCCccChhcccCCCC-ChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          535 SDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       535 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      +|||++.......    .....++..|+|||++.+..+ +.++||||||+++|||++|+.||..
T Consensus       182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  241 (312)
T 2iwi_A          182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER  241 (312)
T ss_dssp             CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence            9999998765432    223468999999999877666 4589999999999999999999863

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.97  E-value=7.2e-32  Score=291.98  Aligned_cols=200  Identities=30%  Similarity=0.357  Sum_probs=157.1

Q ss_pred             CCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEEEEec
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      +.|...+.||+|+||+||.....+|+.||||++...   ..+.+.+|++++.++ +||||+++++++.+++..++||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            445667889999999998776678999999998653   235678999999987 8999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC-------------CCe
Q 007006          470 PNKSLDVHLFDATRSV----QLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD-------------MNP  532 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~-------------~~v  532 (621)
                      . |+|.+++.......    ..++..++.++.||+.||.|||+.+   |+||||||+|||++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence            6 69999986432211    1133456789999999999999986   9999999999999754             479


Q ss_pred             EEeeecCceecCCCCCCc--ccccccccCCccChhcccC-------CCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          533 KISDFGLARIFGGNQNQA--NTNIIAGTYGYMAPEYAMG-------GIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       533 kL~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~-------~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      ||+|||++..........  ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||..
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~  242 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD  242 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence            999999999875433221  1234578999999999865       668999999999999999999 9999864

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.97  E-value=7e-32  Score=306.15  Aligned_cols=202  Identities=26%  Similarity=0.363  Sum_probs=169.2

Q ss_pred             HhCCCCccceeccCCceeEEEEEec----CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEE
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL  463 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~  463 (621)
                      ..++|.+.+.||+|+||.||+|.+.    .+..||+|++.... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence            3467889999999999999999864    25679999987543 3345678999999999999999999999854 5689


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceec
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF  543 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~  543 (621)
                      +||||+++|+|.+++..  +...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       467 lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             EEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             EEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence            99999999999999954  2346899999999999999999999986   999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          544 GGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       544 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      ...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       542 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~  595 (656)
T 2j0j_A          542 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG  595 (656)
T ss_dssp             CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             CCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC
Confidence            433221 1223456788999999998999999999999999999997 9999864

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.97  E-value=1.1e-31  Score=280.55  Aligned_cols=198  Identities=24%  Similarity=0.292  Sum_probs=146.6

Q ss_pred             HhCCCCccc-eeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEee----CceE
Q 007006          389 ATNHFSDEN-KLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQEL  462 (621)
Q Consensus       389 ~~~~f~~~~-~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~----~~~~  462 (621)
                      ..++|.+.+ .||+|+||.||++... +++.||||++....    ....+....++.++||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            346788855 6999999999999975 69999999986532    222233334667799999999999976    4458


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC---CCCeEEeeecC
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGL  539 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~vkL~Dfgl  539 (621)
                      ++||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus       102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence            9999999999999999643 2346999999999999999999999986   999999999999986   45599999999


Q ss_pred             ceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          540 ARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       540 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      +.......    .....+|+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       178 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  232 (336)
T 3fhr_A          178 AKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN  232 (336)
T ss_dssp             CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             ceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            98654321    22346799999999998888999999999999999999999998543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.97  E-value=5.8e-32  Score=309.06  Aligned_cols=192  Identities=20%  Similarity=0.353  Sum_probs=165.9

Q ss_pred             hCCCCccceeccCCceeEEEEEec--CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCce-----
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA--DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQE-----  461 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~-----  461 (621)
                      .++|.+.+.||+|+||.||++.+.  +++.||||++.... ......+.+|++++.+++||||+++++++.+.+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            478999999999999999999975  68999999987543 3445678899999999999999999999987655     


Q ss_pred             EEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCce
Q 007006          462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR  541 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~  541 (621)
                      .++||||+++++|.+++..     .+++.+++.++.||+.||.|||+++   |+||||||+|||++.+ .+||+|||+++
T Consensus       159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence            7999999999999887632     6999999999999999999999986   9999999999999986 89999999998


Q ss_pred             ecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          542 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       542 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .....      ....||+.|+|||++.+.. +.++||||||+++|||++|.+|+..
T Consensus       230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~  278 (681)
T 2pzi_A          230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG  278 (681)
T ss_dssp             ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred             hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcc
Confidence            76433      2356899999999987654 8999999999999999999998754

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=9.2e-33  Score=288.60  Aligned_cols=191  Identities=17%  Similarity=0.218  Sum_probs=161.4

Q ss_pred             hCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCC--------cccHHHHHHHHHHHHhcc---------cCCceeE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--------GQGLQEFKNEVNLIAKLQ---------HKNLVRL  452 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~---------h~nIv~l  452 (621)
                      .++|.+.++||+|+||.||+++. +|+.||||++....        ....+.+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35688899999999999999998 68999999997652        233478899999999986         7777777


Q ss_pred             eeEEe-----------------e-------------CceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHH
Q 007006          453 LGCCL-----------------E-------------GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARG  502 (621)
Q Consensus       453 ~g~~~-----------------~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~  502 (621)
                      .+++.                 +             .+..++||||+++|++.+.+..    ..+++..+..++.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence            76643                 2             6789999999999976665522    458999999999999999


Q ss_pred             HHHHH-hCCCCCeEeccCCCCCEEEcCCC--------------------CeEEeeecCceecCCCCCCcccccccccCCc
Q 007006          503 ILYLH-EDSRLKIIHRDLKASNILLDDDM--------------------NPKISDFGLARIFGGNQNQANTNIIAGTYGY  561 (621)
Q Consensus       503 L~yLH-~~~~~~iiH~Dlkp~NILl~~~~--------------------~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y  561 (621)
                      |.||| +.+   |+||||||+|||++.++                    .+||+|||+++.....       ...||+.|
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y  243 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS  243 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence            99999 876   99999999999999887                    8999999999876432       34789999


Q ss_pred             cChhcccCCCCChhhhHHHHHHH-HHHHHcCCCCCC
Q 007006          562 MAPEYAMGGIFSIKSDVFSFGVL-LLEIISGRKNNG  596 (621)
Q Consensus       562 ~aPE~l~~~~~s~~sDVwS~Gvl-l~elltG~~p~~  596 (621)
                      +|||++.+.. +.++||||++++ .+++++|..||.
T Consensus       244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~  278 (336)
T 2vuw_A          244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS  278 (336)
T ss_dssp             TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred             cChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence            9999998766 999999998776 888999999974

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.97  E-value=4.4e-32  Score=303.76  Aligned_cols=202  Identities=29%  Similarity=0.418  Sum_probs=173.7

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC-CcccHHHHHHHHHHHHhcccCCceeEeeEEee------Cce
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE------GQE  461 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~------~~~  461 (621)
                      .++|.+.+.||+|+||.||++.. .+|+.||||++... .....+.+.+|++++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            36899999999999999999986 46899999998754 34445678999999999999999999999765      667


Q ss_pred             EEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCC---eEEeeec
Q 007006          462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN---PKISDFG  538 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~---vkL~Dfg  538 (621)
                      .++||||+++++|.+++........+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence            8999999999999999976555557999999999999999999999986   999999999999997765   9999999


Q ss_pred             CceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          539 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       539 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ++........   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       170 ~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~  225 (676)
T 3qa8_A          170 YAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP  225 (676)
T ss_dssp             CCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence            9987644322   2335789999999999999999999999999999999999999853

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.97  E-value=1.3e-31  Score=276.94  Aligned_cols=199  Identities=25%  Similarity=0.410  Sum_probs=150.2

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc-cc-HHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-QG-LQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-~~-~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      .++|++.+.||+|+||.||++... +|+.||||++..... .. .+.+.++..+++.++||||+++++++.+++..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            357888999999999999999975 689999999976532 22 233445555778889999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      ||+ ++.+..+...  ....+++..+..++.||+.||.|||+. +   |+||||||+||+++.++.+||+|||++.....
T Consensus       104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999 4555444422  235689999999999999999999984 5   99999999999999999999999999976543


Q ss_pred             CCCCcccccccccCCccChhccc-----CCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ...   .....+++.|+|||.+.     ...++.++||||||+++|||++|+.||..
T Consensus       178 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  231 (318)
T 2dyl_A          178 DKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN  231 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             Ccc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence            221   22346899999999984     55689999999999999999999999864

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.97  E-value=1.8e-31  Score=288.41  Aligned_cols=198  Identities=26%  Similarity=0.361  Sum_probs=157.7

Q ss_pred             CCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEEEEec
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      .+|...+.||+|+||+|+.....+++.||||++......   .+.+|+++|+++ +||||+++++++.+....++||||+
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~  100 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC  100 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence            468888999999999976555668999999999754322   346899999999 7999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC-----CCCeEEeeecCceecC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-----DMNPKISDFGLARIFG  544 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-----~~~vkL~Dfgla~~~~  544 (621)
                      + |+|.+++...  ...+.+..+..++.||+.||.|||+.+   |+||||||+|||++.     ...+||+|||+++...
T Consensus       101 ~-g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A          101 A-ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             S-EEHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             C-CCHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            6 6999988543  233455567789999999999999986   999999999999953     2358899999998765


Q ss_pred             CCCCC-cccccccccCCccChhccc---CCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          545 GNQNQ-ANTNIIAGTYGYMAPEYAM---GGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       545 ~~~~~-~~~~~~~gt~~y~aPE~l~---~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      ..... .......||+.|+|||++.   ...++.++|||||||++|||++ |+.||+.
T Consensus       175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~  232 (432)
T 3p23_A          175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK  232 (432)
T ss_dssp             -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBS
T ss_pred             CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcch
Confidence            33211 2233457899999999997   4567889999999999999999 9999853

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.97  E-value=2.8e-30  Score=263.75  Aligned_cols=173  Identities=12%  Similarity=0.012  Sum_probs=151.3

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCc---ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG---QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      .++|.+.+.||+|+||.||++... +++.||||++.....   ...+.+.+|+..+.+++||||+++++++.+++..++|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            367999999999999999999975 589999999976532   3347789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      |||+++++|.+++..     .....++.+++.||+.||.|||+++   |+||||||+|||++.++.+||++++       
T Consensus       110 ~e~~~g~~L~~~l~~-----~~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             EECCCEEEHHHHHTT-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             EEecCCCCHHHHHhc-----CCChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence            999999999999832     1356678899999999999999986   9999999999999999999998443       


Q ss_pred             CCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                                     |++|       ++.++||||||+++|||+||+.||....
T Consensus       175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~  206 (286)
T 3uqc_A          175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAG  206 (286)
T ss_dssp             ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred             ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                           3443       6889999999999999999999997544

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.96  E-value=2.1e-30  Score=278.70  Aligned_cols=199  Identities=18%  Similarity=0.186  Sum_probs=153.6

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC---cccHHHHHHHHHHHHhccc-CCce---------e-----
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQH-KNLV---------R-----  451 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h-~nIv---------~-----  451 (621)
                      ..|...+.||+|+||.||++.+ .+|+.||||++....   ....+.+.+|+.+++.++| +|..         .     
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            3477788999999999999994 579999999987443   2336789999999999977 2211         1     


Q ss_pred             -------EeeEEee-----CceEEEEEEecCCCChhhhhhh----ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 007006          452 -------LLGCCLE-----GQELLLIYEYMPNKSLDVHLFD----ATRSVQLDWKRRQSIINGIARGILYLHEDSRLKII  515 (621)
Q Consensus       452 -------l~g~~~~-----~~~~~lV~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ii  515 (621)
                             +..+...     ....+++|++ .+++|.+++..    ......+++..++.++.||+.||.|||+.+   |+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             ccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence                   1111111     1234666665 46899888842    123456889999999999999999999986   99


Q ss_pred             eccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcc----------cCCCCChhhhHHHHHHHH
Q 007006          516 HRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA----------MGGIFSIKSDVFSFGVLL  585 (621)
Q Consensus       516 H~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l----------~~~~~s~~sDVwS~Gvll  585 (621)
                      ||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          .+..++.++|||||||++
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            9999999999999999999999998865432     233466 899999999          555689999999999999


Q ss_pred             HHHHcCCCCCCCCc
Q 007006          586 LEIISGRKNNGFYF  599 (621)
Q Consensus       586 ~elltG~~p~~~~~  599 (621)
                      |||++|+.||....
T Consensus       308 ~elltg~~Pf~~~~  321 (413)
T 3dzo_A          308 YWIWCADLPNTDDA  321 (413)
T ss_dssp             HHHHHSSCCCCTTG
T ss_pred             HHHHHCCCCCCCcc
Confidence            99999999997543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.96  E-value=2.3e-29  Score=258.33  Aligned_cols=174  Identities=25%  Similarity=0.358  Sum_probs=150.2

Q ss_pred             CCCCcc-ceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHH-HhcccCCceeEeeEEee----CceEE
Q 007006          391 NHFSDE-NKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLI-AKLQHKNLVRLLGCCLE----GQELL  463 (621)
Q Consensus       391 ~~f~~~-~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l-~~l~h~nIv~l~g~~~~----~~~~~  463 (621)
                      ++|.+. +.||+|+||.||++.. .+++.||+|++...     ..+.+|++++ +..+||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            456666 7799999999999986 56899999998643     4567889888 55599999999999987    66789


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC---CCCeEEeeecCc
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGLA  540 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~vkL~Dfgla  540 (621)
                      +||||+++++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||++
T Consensus        92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            999999999999999653 2346999999999999999999999986   999999999999998   788999999998


Q ss_pred             eecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          541 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       541 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ....                        +..++.++||||||+++|||++|+.||..
T Consensus       168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~  200 (299)
T 3m2w_A          168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYS  200 (299)
T ss_dssp             EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            7532                        13357799999999999999999999854

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=1.3e-28  Score=274.44  Aligned_cols=184  Identities=16%  Similarity=0.139  Sum_probs=129.6

Q ss_pred             eccCCceeEEEEE-ecCCcEEEEEEeccCC----------cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEEE
Q 007006          399 LGQGGFGPVYKGT-LADGKAIAVKRLSRTS----------GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       399 LG~G~fG~Vy~~~-~~~g~~vavK~l~~~~----------~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++.|.+|.+..++ ...|+.+++|.+.+..          ....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            4556666665544 3358899999997542          23346799999999999 7999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||++|++|.+.|..   ..+++..   +|+.||+.||+|||++|   |+||||||+||||++++++||+|||+++....+
T Consensus       322 Eyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          322 EKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             ECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             ecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            99999999999954   3456654   48899999999999997   999999999999999999999999999876543


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKN  594 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p  594 (621)
                      ..  .....+||+.|||||++.+. +..++|+|++|+++++|.++..|
T Consensus       393 ~~--~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 CS--WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             Cc--cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence            22  23346799999999988654 56789999999998887665444

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.93  E-value=4.2e-26  Score=195.81  Aligned_cols=103  Identities=18%  Similarity=0.365  Sum_probs=92.7

Q ss_pred             CCcccccCCCCccCCCChHHHHHHHHHhhcccccccc--cCceecccC-CCCCcEEEEEeccCCCCccchHHHHHHHHHH
Q 007006           71 EEDMVLSCAVSNNTASNTFTSNLNILFNQKLHSEAGK--SLYYNASEG-EFPDSVYGLYLCKFNVSFQSCQNCIVAAVNS  147 (621)
Q Consensus        71 ~~~~~~~C~~~~~~~~s~~~~nl~~ll~~l~~~~~~~--~~f~~~~~g-~~~~~vygl~qC~~D~~~~~C~~Cl~~a~~~  147 (621)
                      +..+++.|++++|+++++|++||+.||++|+ ++++.  .+|+++..| .++++|||++|||||+++++|..||+.|+.+
T Consensus         3 t~~v~~~Cn~~~~t~~s~f~~nl~~ll~~L~-~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~   81 (108)
T 3a2e_A            3 TAFVSSACNTQKIPSGSPFNRNLRAMLADLR-QNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNR   81 (108)
T ss_dssp             CCEEEEEECSSBCCTTCTHHHHHHHHHHHHH-HHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTT
T ss_pred             cceeeeecCCCccCCCChHHHHHHHHHHHHH-hhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHH
Confidence            4568888999999999999999999999999 66655  456666655 4568999999999999999999999999999


Q ss_pred             HHhcCCCCCceEEEeecCceEEeecCCCC
Q 007006          148 VLQKCSGTKEAFIWYQVQECMVRFSDHSS  176 (621)
Q Consensus       148 ~~~~C~~~~~a~~~~~~~~C~lry~~~~f  176 (621)
                      +.+.||++++|+||+++  |+||||+++|
T Consensus        82 ~~~~C~~~~g~~i~~~~--C~lRY~~~~F  108 (108)
T 3a2e_A           82 IFSICNNAIGARVQLVD--CFIQYEQRSF  108 (108)
T ss_dssp             HHHHTTSBSSEEEEETT--EEEEEESSCC
T ss_pred             HHHHCCCCceEEEECCC--EEEEEeCCcC
Confidence            99999999999999999  9999999998

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=1e-25  Score=249.78  Aligned_cols=186  Identities=17%  Similarity=0.169  Sum_probs=146.4

Q ss_pred             CccceeccCCceeEEEEEecCCcEEEEEEeccCCc--------ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          394 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG--------QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       394 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~--------~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      ...+.||+|+||.||++.. .+..+++|+......        ...+.+.+|++++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4467899999999999954 578889998654321        1134589999999999999999766666677788999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      |||+++++|.+++..           +..++.|+++||.|||+++   |+||||||+|||++.  ++||+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999843           5689999999999999986   999999999999999  999999999998654


Q ss_pred             CCCCc-----ccccccccCCccChhcccC--CCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          546 NQNQA-----NTNIIAGTYGYMAPEYAMG--GIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       546 ~~~~~-----~~~~~~gt~~y~aPE~l~~--~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      .....     ......||+.|||||++..  ..|+...|+|+..+-.++-+.++.+|.
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            32211     1234679999999999976  567888999999999999998888763

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=2.7e-22  Score=203.94  Aligned_cols=152  Identities=16%  Similarity=0.100  Sum_probs=120.9

Q ss_pred             HHHHHHhCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCc------------------ccHHHHHHHHHHHHhcc
Q 007006          384 RLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG------------------QGLQEFKNEVNLIAKLQ  445 (621)
Q Consensus       384 ~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~------------------~~~~~~~~Ei~~l~~l~  445 (621)
                      .........|.+.+.||+|+||.||++...+|+.||+|+++....                  .....+.+|++++++++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            344445567778899999999999999997799999999964321                  12456899999999999


Q ss_pred             cCCceeEeeEEeeCceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEE
Q 007006          446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNIL  525 (621)
Q Consensus       446 h~nIv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NIL  525 (621)
                        | +++.+++.. +..++||||+++++|.+ +..         .....++.|++.||.|||+.+   |+||||||+|||
T Consensus       163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL  225 (282)
T 1zar_A          163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL  225 (282)
T ss_dssp             --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred             --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence              4 555554433 55699999999999987 411         224469999999999999986   999999999999


Q ss_pred             EcCCCCeEEeeecCceecCCCCCCcccccccccCCccChhccc
Q 007006          526 LDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM  568 (621)
Q Consensus       526 l~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~  568 (621)
                      ++ ++.+||+|||++..               +..++|||++.
T Consensus       226 l~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          226 VS-EEGIWIIDFPQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             EE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred             EE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence            99 99999999999874               34578999874

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.78  E-value=2e-19  Score=154.22  Aligned_cols=92  Identities=16%  Similarity=0.252  Sum_probs=82.6

Q ss_pred             chhcHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccCccceeEEeeecCCCCccchhhHHHHHHHhhhhccCCCCCcc
Q 007006          189 IFQNTYNVTKSLAQSFNDVIAMPSLSSFRNATKRTNISNIIRLETFGQCIPVLSVDDCRDCLNNTIRWIQRCFDPPGMGF  268 (621)
Q Consensus       189 ~~~~~~~~~~~l~~~l~~~a~~~~~~~~~~a~~~~~~~~~~~vy~laQCt~DLs~~~C~~CL~~~~~~~~~~c~~~~~~~  268 (621)
                      ..+.|+..++.|+..|...++   .+..+|+++.....+..+||||+||+|||++++|+.||+.++.+++++|+++  +|
T Consensus        17 ~~s~f~~nl~~ll~~L~~~a~---~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~~~~C~~~--~g   91 (108)
T 3a2e_A           17 SGSPFNRNLRAMLADLRQNTA---FSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRIFSICNNA--IG   91 (108)
T ss_dssp             TTCTHHHHHHHHHHHHHHHGG---GTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTHHHHTTSB--SS
T ss_pred             CCChHHHHHHHHHHHHHhhCc---cccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHHHHHCCCC--ce
Confidence            345799999999999998886   4567888877766677899999999999999999999999999999999977  89


Q ss_pred             eEEEccccccceeeccc
Q 007006          269 GRILFPSCIMGFELYRY  285 (621)
Q Consensus       269 g~v~~~~C~lry~~~~f  285 (621)
                      |+|++++|++|||.++|
T Consensus        92 ~~i~~~~C~lRY~~~~F  108 (108)
T 3a2e_A           92 ARVQLVDCFIQYEQRSF  108 (108)
T ss_dssp             EEEEETTEEEEEESSCC
T ss_pred             EEEECCCEEEEEeCCcC
Confidence            99999999999999987

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.75  E-value=3.3e-18  Score=171.48  Aligned_cols=138  Identities=19%  Similarity=0.200  Sum_probs=107.0

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcE--EEEEEeccCCcc------------------------cHHHHHHHHHHHHh
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKA--IAVKRLSRTSGQ------------------------GLQEFKNEVNLIAK  443 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~--vavK~l~~~~~~------------------------~~~~~~~Ei~~l~~  443 (621)
                      ..|.+.+.||+|+||.||+|.. .+|+.  ||||+++.....                        ....+.+|+..|.+
T Consensus        47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  126 (258)
T 1zth_A           47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER  126 (258)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred             CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence            3467789999999999999997 68989  999987543111                        01357899999999


Q ss_pred             cccCCc--eeEeeEEeeCceEEEEEEecCC-C----ChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeE
Q 007006          444 LQHKNL--VRLLGCCLEGQELLLIYEYMPN-K----SLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH-EDSRLKII  515 (621)
Q Consensus       444 l~h~nI--v~l~g~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ii  515 (621)
                      +.|+++  +.++..    +..+|||||+.+ |    +|.++...      .++..+..++.|++.+|.||| +.+   |+
T Consensus       127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---iv  193 (258)
T 1zth_A          127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LV  193 (258)
T ss_dssp             HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred             HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence            998864  444442    356899999952 4    55554421      234567789999999999999 775   99


Q ss_pred             eccCCCCCEEEcCCCCeEEeeecCceec
Q 007006          516 HRDLKASNILLDDDMNPKISDFGLARIF  543 (621)
Q Consensus       516 H~Dlkp~NILl~~~~~vkL~Dfgla~~~  543 (621)
                      ||||||+|||+++  .++|+|||++...
T Consensus       194 HrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          194 HADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             eCCCCHHHEEEcC--cEEEEECcccccC
Confidence            9999999999998  9999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.61  E-value=4.6e-16  Score=162.92  Aligned_cols=144  Identities=15%  Similarity=0.153  Sum_probs=104.3

Q ss_pred             HHHHHHhCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCc--------------ccHHH--------HHHHHHHH
Q 007006          384 RLALEATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG--------------QGLQE--------FKNEVNLI  441 (621)
Q Consensus       384 ~~~~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~--------------~~~~~--------~~~Ei~~l  441 (621)
                      ..+.....-|++.++||+|++|.||+|...+|+.||||+++....              .....        ...|...|
T Consensus        88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL  167 (397)
T 4gyi_A           88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM  167 (397)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence            444444456999999999999999999998999999998753210              01111        23466666


Q ss_pred             HhcccCCce--eEeeEEeeCceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 007006          442 AKLQHKNLV--RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDL  519 (621)
Q Consensus       442 ~~l~h~nIv--~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dl  519 (621)
                      .++.+.++.  ..++.  .  ..+|||||+++++|..+..         ......++.||+.+|.+||+.+   ||||||
T Consensus       168 ~rL~~~gv~vp~p~~~--~--~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDL  231 (397)
T 4gyi_A          168 KALYEEGFPVPEPIAQ--S--RHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDF  231 (397)
T ss_dssp             HHHHHTTCSCCCEEEE--E--TTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred             HHHHhcCCCCCeeeec--c--CceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCC
Confidence            777554432  22322  1  2379999999988865441         1123567899999999999986   999999


Q ss_pred             CCCCEEEcCCCC----------eEEeeecCceec
Q 007006          520 KASNILLDDDMN----------PKISDFGLARIF  543 (621)
Q Consensus       520 kp~NILl~~~~~----------vkL~Dfgla~~~  543 (621)
                      ||.|||+++++.          +.|+||+-+-..
T Consensus       232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             STTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence            999999988773          899999977653

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.30  E-value=1.5e-11  Score=122.87  Aligned_cols=145  Identities=17%  Similarity=0.093  Sum_probs=113.8

Q ss_pred             HhCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcc-cCCceeEeeEEeeCceEEEEEE
Q 007006          389 ATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       389 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      .-+.|.....++.|+.+.||+.... +..+++|+...........+.+|+++++.+. +..+++++++..+.+..++|||
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e   90 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS   90 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence            3457888888898999999999754 7899999987532222346889999999994 6788899999998889999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS-------------------------------------  510 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------------------------------------  510 (621)
                      |++|.+|...+.        +......++.+++++|..||+..                                     
T Consensus        91 ~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           91 EADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             CCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             ecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            999999876531        11223467889999999999821                                     


Q ss_pred             -------------------CCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          511 -------------------RLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       511 -------------------~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                                         +..++|||++|.|||++++..+.|+||+.+..
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                               13489999999999998765667999998753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.12  E-value=1.4e-10  Score=115.23  Aligned_cols=137  Identities=17%  Similarity=0.162  Sum_probs=101.2

Q ss_pred             CCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCC--ceeEeeEEeeCceEEEEEEec
Q 007006          392 HFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN--LVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~n--Iv~l~g~~~~~~~~~lV~e~~  469 (621)
                      .+.+....+.|..+.||+....+|..+++|+....   ....+..|+++++.+.+.+  +++++++...++..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            34443333456669999998777888999997653   2245788999999996544  566888888877889999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS---------------------------------------  510 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------------  510 (621)
                      +|.+|.  ...      .+   ...++.++++.|..||+..                                       
T Consensus        98 ~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           98 PGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             SSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             CCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence            998884  211      11   1256777888888888643                                       


Q ss_pred             ----------------CCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          511 ----------------RLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       511 ----------------~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                                      +..++|+|++|.|||++++..+.|+||+.+..
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                            12399999999999998876677999998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.97  E-value=2.7e-09  Score=111.65  Aligned_cols=142  Identities=15%  Similarity=0.273  Sum_probs=107.9

Q ss_pred             ccceeccCCceeEEEEEecCCcEEEEEEec--cCC-cccHHHHHHHHHHHHhcc--cCCceeEeeEEeeC---ceEEEEE
Q 007006          395 DENKLGQGGFGPVYKGTLADGKAIAVKRLS--RTS-GQGLQEFKNEVNLIAKLQ--HKNLVRLLGCCLEG---QELLLIY  466 (621)
Q Consensus       395 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~--~~~-~~~~~~~~~Ei~~l~~l~--h~nIv~l~g~~~~~---~~~~lV~  466 (621)
                      ..+.|+.|.++.||+.... +..+++|+..  ... ......+.+|+.+++.+.  +..+++++.++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            4678999999999998875 4678888775  322 122356788999999997  45688999988776   4579999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS------------------------------------  510 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------  510 (621)
                      ||++|..+.+..     ...++..++..++.++++.|..||+..                                    
T Consensus       121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999998874322     123678888899999999999999831                                    


Q ss_pred             -------------------CCCeEeccCCCCCEEEcCCCC--eEEeeecCcee
Q 007006          511 -------------------RLKIIHRDLKASNILLDDDMN--PKISDFGLARI  542 (621)
Q Consensus       511 -------------------~~~iiH~Dlkp~NILl~~~~~--vkL~Dfgla~~  542 (621)
                                         +..++|||+++.|||++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               246999999999999997753  68999999875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.91  E-value=1.4e-09  Score=111.18  Aligned_cols=187  Identities=19%  Similarity=0.202  Sum_probs=123.6

Q ss_pred             cceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcc-cCC--ceeEeeEEeeCc---eEEEEEEec
Q 007006          396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKN--LVRLLGCCLEGQ---ELLLIYEYM  469 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-h~n--Iv~l~g~~~~~~---~~~lV~e~~  469 (621)
                      .+.++.|....||+..    ..+++|+....  .....+.+|.++|+.+. +..  +++++......+   ..++|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999863    56888886432  33567889999999883 333  455555544333   348899999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS---------------------------------------  510 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------------  510 (621)
                      +|.+|.....     ..++..++..++.+++..|..||+..                                       
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9988865432     23677788888888888888888621                                       


Q ss_pred             ----------------CCCeEeccCCCCCEEEcC--CCCeEEeeecCceecCCCCCCcccc------------cccccCC
Q 007006          511 ----------------RLKIIHRDLKASNILLDD--DMNPKISDFGLARIFGGNQNQANTN------------IIAGTYG  560 (621)
Q Consensus       511 ----------------~~~iiH~Dlkp~NILl~~--~~~vkL~Dfgla~~~~~~~~~~~~~------------~~~gt~~  560 (621)
                                      +..++|+|++|.||++++  +..+.|+||+.+...+.........            ......+
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                            235899999999999998  4567899999987643211000000            0000001


Q ss_pred             ccC-hhcccCCCCChhhhHHHHHHHHHHHHcCCCCC
Q 007006          561 YMA-PEYAMGGIFSIKSDVFSFGVLLLEIISGRKNN  595 (621)
Q Consensus       561 y~a-PE~l~~~~~s~~sDVwS~Gvll~elltG~~p~  595 (621)
                      ... |+.....  ....+.|+++.++|++.+|+.++
T Consensus       254 ~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          254 HKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence            112 2221111  12368999999999999999875

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.39  E-value=1.9e-06  Score=85.78  Aligned_cols=135  Identities=16%  Similarity=0.155  Sum_probs=98.0

Q ss_pred             eeccCCce-eEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcc-cCCceeEeeEEeeCceEEEEEEecCCCCh
Q 007006          398 KLGQGGFG-PVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIYEYMPNKSL  474 (621)
Q Consensus       398 ~LG~G~fG-~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV~e~~~~gsL  474 (621)
                      .+..|..+ .||+.... ++..+++|+-..   .....+..|...|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            45556555 58988754 466788887643   23456888999999884 44478899999999999999999999887


Q ss_pred             hhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 007006          475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLHED---------------------------------------------  509 (621)
Q Consensus       475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~---------------------------------------------  509 (621)
                      .+.....       ......+..+++..|..||..                                             
T Consensus       108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            7654221       122334566677777777742                                             


Q ss_pred             ----------CCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          510 ----------SRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       510 ----------~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                                .+..++|+|+.+.|||+++++.+-|+||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                      012379999999999999887778999998764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.38  E-value=2.5e-06  Score=86.94  Aligned_cols=137  Identities=19%  Similarity=0.147  Sum_probs=96.1

Q ss_pred             cceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccC---CceeEeeEEe-eCceEEEEEEecCC
Q 007006          396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK---NLVRLLGCCL-EGQELLLIYEYMPN  471 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~---nIv~l~g~~~-~~~~~~lV~e~~~~  471 (621)
                      .+.++.|....||+.    |..+++|+...  ......+..|.++|+.+.+.   .+.+++.+.. ..+..++|||+++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            456888888899987    56788888532  23356789999999999652   3667777764 34567899999999


Q ss_pred             CChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 007006          472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED------------------------------------------  509 (621)
Q Consensus       472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------------  509 (621)
                      .++......     .++..+...++.++.+.|..||+.                                          
T Consensus        98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            888653211     234445555555555555555543                                          


Q ss_pred             ---------------CCCCeEeccCCCCCEEEcC---CCC-eEEeeecCceec
Q 007006          510 ---------------SRLKIIHRDLKASNILLDD---DMN-PKISDFGLARIF  543 (621)
Q Consensus       510 ---------------~~~~iiH~Dlkp~NILl~~---~~~-vkL~Dfgla~~~  543 (621)
                                     .+..++|+|+++.|||++.   ++. +.|+||+.+..-
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                           2235799999999999997   455 489999988754

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.29  E-value=2e-06  Score=89.44  Aligned_cols=81  Identities=9%  Similarity=0.012  Sum_probs=57.8

Q ss_pred             ccee-ccCCceeEEEEEec-------CCcEEEEEEeccCC---cccHHHHHHHHHHHHhcc-c--CCceeEeeEEeeC--
Q 007006          396 ENKL-GQGGFGPVYKGTLA-------DGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQ-H--KNLVRLLGCCLEG--  459 (621)
Q Consensus       396 ~~~L-G~G~fG~Vy~~~~~-------~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~-h--~nIv~l~g~~~~~--  459 (621)
                      .+.| +.|....+|+....       ++..+++|+.....   ......+..|+.+++.+. +  ..+++++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4567 88889999998764       26788888765432   111245788999999884 3  3577888887665  


Q ss_pred             -ceEEEEEEecCCCChhh
Q 007006          460 -QELLLIYEYMPNKSLDV  476 (621)
Q Consensus       460 -~~~~lV~e~~~~gsL~~  476 (621)
                       +..++||||++|..+..
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             35689999999877653

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.00  E-value=2.8e-05  Score=79.94  Aligned_cols=142  Identities=17%  Similarity=0.251  Sum_probs=83.2

Q ss_pred             cceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhccc--CCceeEee------EEeeCceEEEEEE
Q 007006          396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH--KNLVRLLG------CCLEGQELLLIYE  467 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h--~nIv~l~g------~~~~~~~~~lV~e  467 (621)
                      .+.|+.|..+.||+....+| .+++|+....    ...+..|..+++.+..  -.+++++.      +....+..++++|
T Consensus        37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EEECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            34566677889999987655 5889988652    2344556666666632  23444443      1234567899999


Q ss_pred             ecCCCChh--------------hhhhhccCC-----------CCCCHHHH------------------------------
Q 007006          468 YMPNKSLD--------------VHLFDATRS-----------VQLDWKRR------------------------------  492 (621)
Q Consensus       468 ~~~~gsL~--------------~~l~~~~~~-----------~~l~~~~~------------------------------  492 (621)
                      |++|..+.              .-++.....           ....|...                              
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986553              011111110           01123211                              


Q ss_pred             -HHHHHHHHHHHHHHHh----------CCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          493 -QSIINGIARGILYLHE----------DSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       493 -~~i~~~ia~~L~yLH~----------~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                       ..+...+..++.+|+.          ..+..++|||+.+.|||++.++.+.|+||+.+..
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence             0111223445666763          1245699999999999998888999999998764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.89  E-value=6.5e-05  Score=79.27  Aligned_cols=75  Identities=11%  Similarity=0.161  Sum_probs=50.6

Q ss_pred             cceeccCCceeEEEEEec-CCcEEEEEEeccCCc-------ccHHHHHHHHHHHHhccc--C-CceeEeeEEeeCceEEE
Q 007006          396 ENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSG-------QGLQEFKNEVNLIAKLQH--K-NLVRLLGCCLEGQELLL  464 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~-------~~~~~~~~Ei~~l~~l~h--~-nIv~l~g~~~~~~~~~l  464 (621)
                      .+.||.|..+.||++... +++.+++|.......       .....+..|.++++.+..  | .+++++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            568999999999999754 468899997653211       123456789999988843  3 34556654  3445689


Q ss_pred             EEEecCCC
Q 007006          465 IYEYMPNK  472 (621)
Q Consensus       465 V~e~~~~g  472 (621)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999863

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.82  E-value=0.00017  Score=73.36  Aligned_cols=139  Identities=19%  Similarity=0.167  Sum_probs=94.2

Q ss_pred             ccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcc---cCCceeEeeEEeeCceEEEEEEecCC
Q 007006          395 DENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ---HKNLVRLLGCCLEGQELLLIYEYMPN  471 (621)
Q Consensus       395 ~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---h~nIv~l~g~~~~~~~~~lV~e~~~~  471 (621)
                      ..+.|+.|....+|+... ++..+++|+....   ....+..|.+.|+.+.   ...+++++.+....+..++||||+++
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            356799999999999886 4678889987542   3567889999999984   35688999988888889999999998


Q ss_pred             CChhh-----------hhhhccC--CC-----------------CCCHHHHH---HHHH----------------HHHHH
Q 007006          472 KSLDV-----------HLFDATR--SV-----------------QLDWKRRQ---SIIN----------------GIARG  502 (621)
Q Consensus       472 gsL~~-----------~l~~~~~--~~-----------------~l~~~~~~---~i~~----------------~ia~~  502 (621)
                      ..+..           -|+....  ..                 .-+|....   ++..                .+..-
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            76521           1222111  00                 12454332   1111                11111


Q ss_pred             -HHHHHh-CCCCCeEeccCCCCCEEEcCCCCeEEeeec
Q 007006          503 -ILYLHE-DSRLKIIHRDLKASNILLDDDMNPKISDFG  538 (621)
Q Consensus       503 -L~yLH~-~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfg  538 (621)
                       ...|.. ..++.++|+|+.+.|++++.++ +.|.|+.
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             223422 2346799999999999999887 8999984

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.81  E-value=0.00011  Score=73.90  Aligned_cols=80  Identities=19%  Similarity=0.194  Sum_probs=60.2

Q ss_pred             CCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhccc---CCceeEeeEEeeCceEEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH---KNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h---~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      ......+.+|.|..+.||+.++.+|+.+++|+...........|..|.+.|+.+..   --+++++++.    .-++|||
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e   90 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME   90 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence            34555678999999999999999999999998765544444568899999999843   2355666542    2378999


Q ss_pred             ecCCCCh
Q 007006          468 YMPNKSL  474 (621)
Q Consensus       468 ~~~~gsL  474 (621)
                      |++++..
T Consensus        91 ~l~~~~~   97 (288)
T 3f7w_A           91 WVDERPP   97 (288)
T ss_dssp             CCCCCCC
T ss_pred             eecccCC
Confidence            9987654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.51  E-value=0.00056  Score=72.68  Aligned_cols=80  Identities=11%  Similarity=0.052  Sum_probs=47.2

Q ss_pred             CCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCC---CCChhhhHHHHHHHHHH
Q 007006          511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG---IFSIKSDVFSFGVLLLE  587 (621)
Q Consensus       511 ~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~s~~sDVwS~Gvll~e  587 (621)
                      +..++|||+++.|||++.++ ++|+||+.+..-......... ...-...|.+|+.....   ......++......+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAY-LGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHH-HHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHH-HHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            45699999999999999876 999999988753211000000 00001235555544311   11223555677777887


Q ss_pred             HHcCC
Q 007006          588 IISGR  592 (621)
Q Consensus       588 lltG~  592 (621)
                      .++++
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77664

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.34  E-value=0.00097  Score=67.80  Aligned_cols=144  Identities=15%  Similarity=0.113  Sum_probs=82.2

Q ss_pred             cceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCC--ceeEeeE------EeeCceEEEEEE
Q 007006          396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN--LVRLLGC------CLEGQELLLIYE  467 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~n--Iv~l~g~------~~~~~~~~lV~e  467 (621)
                      .+.|+.|....+|+....+| .+++|+.....  ....+..|+.++..+....  +++++..      ....+..+++++
T Consensus        27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             eeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            35677788899999987656 67889886521  1234567888888774322  3444421      122356789999


Q ss_pred             ecCCCChhh--------------hhhhccCC------CC---CCHHHHHH------------HHHHHHHHHHHHHhC---
Q 007006          468 YMPNKSLDV--------------HLFDATRS------VQ---LDWKRRQS------------IINGIARGILYLHED---  509 (621)
Q Consensus       468 ~~~~gsL~~--------------~l~~~~~~------~~---l~~~~~~~------------i~~~ia~~L~yLH~~---  509 (621)
                      |++|..+..              -++.....      ..   ..|...+.            +...+...+..++..   
T Consensus       104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~  183 (322)
T 2ppq_A          104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK  183 (322)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred             eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence            999865421              01111000      00   11222110            011234455555532   


Q ss_pred             -CCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          510 -SRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       510 -~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                       .+..++|+|+.+.|||++++..+.|+||+.+..
T Consensus       184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence             234689999999999999876568999998764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.25  E-value=0.0012  Score=66.62  Aligned_cols=138  Identities=12%  Similarity=0.107  Sum_probs=76.8

Q ss_pred             cceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCc-eeEeeEEeeCceEEEEEEec-CCCC
Q 007006          396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEYM-PNKS  473 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nI-v~l~g~~~~~~~~~lV~e~~-~~gs  473 (621)
                      .+.|+.|....+|+.     ..+++|+........ .+..+|+.+++.+....+ .++++..  .+.-++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence            678989999999998     568888876432211 123568888888753333 4666543  33347899999 6655


Q ss_pred             hhhhh------------------hhccC--CCCCCH-HHHHHHHH--------------HHHHHHH----HHHh-CCCCC
Q 007006          474 LDVHL------------------FDATR--SVQLDW-KRRQSIIN--------------GIARGIL----YLHE-DSRLK  513 (621)
Q Consensus       474 L~~~l------------------~~~~~--~~~l~~-~~~~~i~~--------------~ia~~L~----yLH~-~~~~~  513 (621)
                      +....                  |....  ....+. .....+..              .+...+.    .|.. ..+..
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            53210                  00000  000111 11111100              0111111    1111 12345


Q ss_pred             eEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          514 IIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       514 iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      ++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            899999999999 5667889999998775

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.21  E-value=0.00082  Score=71.61  Aligned_cols=73  Identities=15%  Similarity=0.250  Sum_probs=51.3

Q ss_pred             cceeccCCceeEEEEEecC--------CcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCc-eeEeeEEeeCceEEEEE
Q 007006          396 ENKLGQGGFGPVYKGTLAD--------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIY  466 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nI-v~l~g~~~~~~~~~lV~  466 (621)
                      .+.|+.|....+|+....+        +..+++|+....  .....+..|..+++.+...++ +++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            4578888889999998653        578999988432  112556689999998854444 667776542    3899


Q ss_pred             EecCCCCh
Q 007006          467 EYMPNKSL  474 (621)
Q Consensus       467 e~~~~gsL  474 (621)
                      ||++|.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987454

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.18  E-value=0.0017  Score=67.91  Aligned_cols=142  Identities=18%  Similarity=0.242  Sum_probs=85.1

Q ss_pred             cceeccCCceeEEEEEec--------CCcEEEEEEeccCCcccHHHHHHHHHHHHhccc-CCceeEeeEEeeCceEEEEE
Q 007006          396 ENKLGQGGFGPVYKGTLA--------DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH-KNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h-~nIv~l~g~~~~~~~~~lV~  466 (621)
                      .+.|..|-...+|+....        ++..+++|+.... ......+.+|..+++.+.. .-..++++.+.+    .+|+
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            356777888889998864        2578999986432 2345667799999998853 334667766543    2899


Q ss_pred             EecCCCChhhh-h----------------hhcc--CCCCCC--HHHHHHHHHHHHH-------------------HHHH-
Q 007006          467 EYMPNKSLDVH-L----------------FDAT--RSVQLD--WKRRQSIINGIAR-------------------GILY-  505 (621)
Q Consensus       467 e~~~~gsL~~~-l----------------~~~~--~~~~l~--~~~~~~i~~~ia~-------------------~L~y-  505 (621)
                      ||++|.+|..- +                +...  -.....  +.++.++..++..                   .+.. 
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998665321 0                1100  011122  3445555443321                   2233 


Q ss_pred             ---HHhC-CCCCeEeccCCCCCEEEcCC----CCeEEeeecCcee
Q 007006          506 ---LHED-SRLKIIHRDLKASNILLDDD----MNPKISDFGLARI  542 (621)
Q Consensus       506 ---LH~~-~~~~iiH~Dlkp~NILl~~~----~~vkL~Dfgla~~  542 (621)
                         |... .+..++|+|+.+.|||++++    +.+.|+||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence               3222 23468999999999999876    7899999998874

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.13  E-value=0.0034  Score=64.13  Aligned_cols=142  Identities=15%  Similarity=0.135  Sum_probs=75.1

Q ss_pred             ceeccCCcee-EEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhccc--CCceeEeeEEeeCceEEEEEEecCCCC
Q 007006          397 NKLGQGGFGP-VYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH--KNLVRLLGCCLEGQELLLIYEYMPNKS  473 (621)
Q Consensus       397 ~~LG~G~fG~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h--~nIv~l~g~~~~~~~~~lV~e~~~~gs  473 (621)
                      +.|+.|.... +|+....++..+++|.......   ..+..|+.+++.+..  -.+++++.+..+.+  +++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            4565554444 6677654467777776543221   234567777777743  23567777644433  68999998766


Q ss_pred             hhhhhhhcc---------------------C--CCCCCHHHHH-------H-------------HHHHHHHHHHHHH---
Q 007006          474 LDVHLFDAT---------------------R--SVQLDWKRRQ-------S-------------IINGIARGILYLH---  507 (621)
Q Consensus       474 L~~~l~~~~---------------------~--~~~l~~~~~~-------~-------------i~~~ia~~L~yLH---  507 (621)
                      +..++....                     .  ...++.....       .             ....+...+..|.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            654332100                     0  0011111100       0             0011112222221   


Q ss_pred             hCCCCCeEeccCCCCCEEEcCC----CCeEEeeecCceec
Q 007006          508 EDSRLKIIHRDLKASNILLDDD----MNPKISDFGLARIF  543 (621)
Q Consensus       508 ~~~~~~iiH~Dlkp~NILl~~~----~~vkL~Dfgla~~~  543 (621)
                      ...+..++|||+.+.|||++.+    +.+.|+||+.+..-
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            1124569999999999999875    67999999988753

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.07  E-value=0.0053  Score=62.44  Aligned_cols=142  Identities=14%  Similarity=0.159  Sum_probs=83.7

Q ss_pred             ceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccC--CceeEeeE-----EeeCceEEEEEEec
Q 007006          397 NKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHK--NLVRLLGC-----CLEGQELLLIYEYM  469 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~--nIv~l~g~-----~~~~~~~~lV~e~~  469 (621)
                      ..|+ |....||+....+|+.+++|+..... .....+..|..+++.+...  .+++++..     ....+..++++|++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4566 77889999887778789999986331 2345677788888888532  24455543     11244567899999


Q ss_pred             CCCChhh----h----------hhhcc------CCCCCCHHHH----HHH---------------HHHHHHHHHHHHhC-
Q 007006          470 PNKSLDV----H----------LFDAT------RSVQLDWKRR----QSI---------------INGIARGILYLHED-  509 (621)
Q Consensus       470 ~~gsL~~----~----------l~~~~------~~~~l~~~~~----~~i---------------~~~ia~~L~yLH~~-  509 (621)
                      +|..+..    .          ++...      ....+++...    ..+               ...+...+..+... 
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            9855421    0          11100      0111222211    001               11111223333221 


Q ss_pred             ---CCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          510 ---SRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       510 ---~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                         .+..++|||+++.|||++ + .+.|+||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence               234589999999999999 4 899999988764

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.77  E-value=0.0084  Score=61.55  Aligned_cols=66  Identities=9%  Similarity=0.071  Sum_probs=44.0

Q ss_pred             CCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhccc---CCceeEeeE------EeeCceEEEEEEecCCC
Q 007006          402 GGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH---KNLVRLLGC------CLEGQELLLIYEYMPNK  472 (621)
Q Consensus       402 G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h---~nIv~l~g~------~~~~~~~~lV~e~~~~g  472 (621)
                      |....||+....+| .+++|+......      ..|+.+++.|..   |++++++..      ....+..+++|+|++|.
T Consensus        34 g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~  106 (339)
T 3i1a_A           34 DTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP  106 (339)
T ss_dssp             CSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred             ccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence            33678999987777 899998765432      356666666632   225555532      22346779999999987


Q ss_pred             Ch
Q 007006          473 SL  474 (621)
Q Consensus       473 sL  474 (621)
                      .+
T Consensus       107 ~~  108 (339)
T 3i1a_A          107 NG  108 (339)
T ss_dssp             BT
T ss_pred             cC
Confidence            65

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.75  E-value=0.0063  Score=65.19  Aligned_cols=74  Identities=14%  Similarity=0.074  Sum_probs=49.1

Q ss_pred             cceeccCCceeEEEEEecC-CcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCc-eeEeeEEeeCceEEEEEEecCCCC
Q 007006          396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL-VRLLGCCLEGQELLLIYEYMPNKS  473 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nI-v~l~g~~~~~~~~~lV~e~~~~gs  473 (621)
                      .+.|+.|-...+|+....+ +..+++|+......... +...|..+++.+...++ +++++.+.  +  .+|+||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            4678888889999998765 47888888754322211 12578999999965444 56777763  2  25999999755


Q ss_pred             h
Q 007006          474 L  474 (621)
Q Consensus       474 L  474 (621)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            5

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.73  E-value=0.0035  Score=65.11  Aligned_cols=74  Identities=12%  Similarity=0.138  Sum_probs=45.9

Q ss_pred             cceeccCCceeEEEEEecC---------CcEEEEEEeccCCcccHHHHHHHHHHHHhcccCC-ceeEeeEEeeCceEEEE
Q 007006          396 ENKLGQGGFGPVYKGTLAD---------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN-LVRLLGCCLEGQELLLI  465 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~n-Iv~l~g~~~~~~~~~lV  465 (621)
                      .+.|+.|....+|+....+         +..+++|+....... ..+...|.++++.+...+ ++++++..  .  -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            3567788888999988654         268888887543221 122467888888885444 45676554  2  2689


Q ss_pred             EEecCCCCh
Q 007006          466 YEYMPNKSL  474 (621)
Q Consensus       466 ~e~~~~gsL  474 (621)
                      +||++|..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999997554

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.42  E-value=0.11  Score=54.78  Aligned_cols=141  Identities=18%  Similarity=0.202  Sum_probs=85.3

Q ss_pred             cceeccCCceeEEEEEecC--------CcEEEEEEeccCCcccHHHHHHHHHHHHhcccCC-ceeEeeEEeeCceEEEEE
Q 007006          396 ENKLGQGGFGPVYKGTLAD--------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN-LVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~n-Iv~l~g~~~~~~~~~lV~  466 (621)
                      .+.|..|-...+|+....+        +..+++|+....... .-+..+|..+++.+...+ .+++++.+.    -++|+
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            4567778888999998753        578899886543222 122367888888885333 456665432    27899


Q ss_pred             EecCCCChhh--h---------------hhh--c-----c---CCCCCCHHHHHHHHHHH-------------------H
Q 007006          467 EYMPNKSLDV--H---------------LFD--A-----T---RSVQLDWKRRQSIINGI-------------------A  500 (621)
Q Consensus       467 e~~~~gsL~~--~---------------l~~--~-----~---~~~~l~~~~~~~i~~~i-------------------a  500 (621)
                      ||++|..|..  +               +|.  .     .   ...+.-+.++.++..++                   .
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            9999866421  0               010  0     0   11111244433333222                   1


Q ss_pred             HHHHHHHh---------------------CCCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          501 RGILYLHE---------------------DSRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       501 ~~L~yLH~---------------------~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      ..+.+|.+                     ..+..++|+|+.+.||+ +.++.+.|+||..+..
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            22333321                     12346899999999999 7888999999998874

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.21  E-value=0.48  Score=49.49  Aligned_cols=30  Identities=27%  Similarity=0.416  Sum_probs=25.4

Q ss_pred             CeEeccCCCCCEEE------cCCCCeEEeeecCcee
Q 007006          513 KIIHRDLKASNILL------DDDMNPKISDFGLARI  542 (621)
Q Consensus       513 ~iiH~Dlkp~NILl------~~~~~vkL~Dfgla~~  542 (621)
                      -++|+|+.+.|||+      +++..+.++||..+..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4566799999998875

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=92.01  E-value=0.51  Score=44.66  Aligned_cols=100  Identities=13%  Similarity=0.054  Sum_probs=64.6

Q ss_pred             CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc
Q 007006          471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA  550 (621)
Q Consensus       471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~  550 (621)
                      .-+|.++|..  ...+++++++|.++.|.+..|.-+-... .+ ..+=+.|..|++..+|+|...+ ..+.         
T Consensus        32 ~vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------   97 (229)
T 2yle_A           32 ALSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD---------   97 (229)
T ss_dssp             EEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             cccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc---------
Confidence            3468888843  4568999999999999999987762211 11 1233457889999999987764 1110         


Q ss_pred             ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc
Q 007006          551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS  590 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt  590 (621)
                           .....+.+||... ...+.+.=|||+|+++|.-+-
T Consensus        98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             --------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence                 1122467888653 345789999999999999775

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=85.76  E-value=0.067  Score=36.61  Aligned_cols=14  Identities=43%  Similarity=0.565  Sum_probs=5.8

Q ss_pred             HHHhhheeEEeecc
Q 007006          322 VLFGSFLWYRRRRH  335 (621)
Q Consensus       322 ~~~~~~~~~~~rr~  335 (621)
                      ++++.++++|||+.
T Consensus        27 i~~~~~~~~RRr~~   40 (44)
T 2ks1_B           27 VALGIGLFMRRRHI   40 (44)
T ss_dssp             HHHHHHHHHHTTTC
T ss_pred             HHHHHHHHhhhhHh
Confidence            33333444444433

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=84.83  E-value=3.6  Score=38.68  Aligned_cols=116  Identities=9%  Similarity=0.027  Sum_probs=78.3

Q ss_pred             ccCCceeEeeEEeeCceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCE
Q 007006          445 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNI  524 (621)
Q Consensus       445 ~h~nIv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NI  524 (621)
                      .||++++. .+-.+.+.+.+.++.-+  +...|-    .-..++...+++++.+|+....+++.     -+|--|.|+||
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCc--ccCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence            58888877 45566666666555433  222222    12347889999999999888766654     46778999999


Q ss_pred             EEcCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          525 LLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       525 Ll~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      +++.++.+++.=.|+-..                   ++|.     ..+...=.-.+=+++..+++++.+|.
T Consensus       111 ~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999987776332                   1221     11222333477888999999998874

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=82.52  E-value=0.087  Score=35.97  Aligned_cols=14  Identities=21%  Similarity=0.223  Sum_probs=5.7

Q ss_pred             HHHhhheeEEeecc
Q 007006          322 VLFGSFLWYRRRRH  335 (621)
Q Consensus       322 ~~~~~~~~~~~rr~  335 (621)
                      ++++.++++|||+.
T Consensus        26 i~~~~~~~~RRRr~   39 (44)
T 2l2t_A           26 VGLTFAVYVRRKSI   39 (44)
T ss_dssp             HHHHHHHHHHTTCS
T ss_pred             HHHHHHHHhhhhhh
Confidence            33333444444433

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=80.50  E-value=8.3  Score=36.31  Aligned_cols=115  Identities=7%  Similarity=0.045  Sum_probs=74.8

Q ss_pred             ccCCceeEeeEEeeCceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEeccCCCCC
Q 007006          445 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL-YLHEDSRLKIIHRDLKASN  523 (621)
Q Consensus       445 ~h~nIv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~-yLH~~~~~~iiH~Dlkp~N  523 (621)
                      .||++  -..+-.+++.+.+.++.-+++.=...+      ..++...+++++.+|+.... +++.     -+|--|.|+|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence            57888  344446667777776654332222222      24788899999998887666 5543     5677899999


Q ss_pred             EEEcCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          524 ILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       524 ILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      |+++.++.+++.-.|+-..                   ++|.-     .+...=.-++=+++..++.++..|.
T Consensus       115 L~f~~~~~p~i~hRGi~~~-------------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVKES-------------------LPPDE-----WDDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             EEECTTCCEEESCCEETTT-------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             EEEeCCCcEEEEEcCCccc-------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999988776332                   22321     1222223367778888888887763

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	621
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-68
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-65
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-62
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-59
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-59
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-59
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-58
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-58
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-57
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-57
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-57
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	9e-57
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-56
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-56
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-56
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-56
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-56
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-55
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	7e-55
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	9e-55
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-54
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-54
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-54
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-53
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-52
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-52
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-52
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-52
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-50
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-49
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-49
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-48
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-47
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-47
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-46
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-46
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-46
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-45
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-45
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-44
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-44
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-43
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-42
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-42
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-42
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-41
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-41
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-40
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-40
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	6e-40
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	7e-40
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-39
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	8e-39
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-37
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-36
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-36
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-36
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-33
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-33
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-33
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-31
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-29
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	5e-23

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (563), Expect = 4e-68
 Identities = 65/206 (31%), Positives = 107/206 (51%), Gaps = 9/206 (4%)

Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
              +   ++G G FG VYKG      A+ +  ++  + Q LQ FKNEV ++ K +H N++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
             +G     Q L ++ ++    SL  HL       + +  +   I    A+G+ YLH   
Sbjct: 68  LFMGYSTAPQ-LAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAK- 123

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG- 569
              IIHRDLK++NI L +D+  KI DFGLA +            ++G+  +MAPE     
Sbjct: 124 --SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 570 --GIFSIKSDVFSFGVLLLEIISGRK 593
               +S +SDV++FG++L E+++G+ 
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQL 207

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (547), Expect = 3e-65
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 11/206 (5%)

Query: 389 ATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGL-QEFKNEVNLIAKLQH 446
             + F   ++LG G  G V+K +    G  +A K +       +  +   E+ ++ +   
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             +V   G      E+ +  E+M   SLD  L  A R   +  +    +   + +G+ YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
               + KI+HRD+K SNIL++     K+ DFG++     +      N   GT  YM+PE 
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPER 174

Query: 567 AMGGIFSIKSDVFSFGVLLLEIISGR 592
             G  +S++SD++S G+ L+E+  GR
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 2e-62
 Identities = 74/226 (32%), Positives = 110/226 (48%), Gaps = 9/226 (3%)

Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
                  +LG G FG V+ G       +AVK L + S      F  E NL+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
           RL     +   + +I EYM N SL   L      ++L   +   +   IA G+ ++ E  
Sbjct: 72  RLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEE-- 127

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
               IHRDL+A+NIL+ D ++ KI+DFGLAR+   N+  A          + APE    G
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAINYG 185

Query: 571 IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLSL 616
            F+IKSDV+SFG+LL EI++  +    Y       ++  +     +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI--PYPGMTNPEVIQNLERGYRM 229

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (503), Expect = 1e-59
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 7/203 (3%)

Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
           +  +   ++G G FG V+ G   +   +A+K + R      ++F  E  ++ KL H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
           +L G CLE   + L++E+M +  L  +L    +      +    +   +  G   +    
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEG---MAYLE 118

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
              +IHRDL A N L+ ++   K+SDFG+ R    +Q   ++        + +PE     
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177

Query: 571 IFSIKSDVFSFGVLLLEIISGRK 593
            +S KSDV+SFGVL+ E+ S  K
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGK 200

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  199 bits (507), Expect = 2e-59
 Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 19/210 (9%)

Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG---LQEFKNEVNLIAKLQ 445
              FSD  ++G G FG VY    + + + +A+K++S +  Q     Q+   EV  + KL+
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           H N ++  GC L      L+ EY    + D+          L      ++ +G  +G+ Y
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAY 130

Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           LH      +IHRD+KA NILL +    K+ DFG A I       A  N   GT  +MAPE
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPE 181

Query: 566 YAMG---GIFSIKSDVFSFGVLLLEIISGR 592
             +    G +  K DV+S G+  +E+   +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERK 211

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 7e-59
 Identities = 62/236 (26%), Positives = 108/236 (45%), Gaps = 16/236 (6%)

Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
            + +    +LG G FG VYK          A K +   S + L+++  E++++A   H N
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
           +V+LL        L ++ E+    ++D  + +  R   L   + Q +       + YLH+
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHD 128

Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
               KIIHRDLKA NIL   D + K++DFG++        + ++    GT  +MAPE  M
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVM 183

Query: 569 G-----GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLSLSLS 619
                   +  K+DV+S G+ L+E+         +   +   +L  +  S   +L+
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEP---PHHELNPMRVLLKIAKSEPPTLA 236

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 4e-58
 Identities = 71/228 (31%), Positives = 112/228 (49%), Gaps = 9/228 (3%)

Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
                E KLGQG FG V+ GT      +A+K L   +    + F  E  ++ KL+H+ LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
           +L       + + ++ EYM   SL   L   T        +   +   IA G+ Y+    
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVE--- 130

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
           R+  +HRDL+A+NIL+ +++  K++DFGLAR+   N+  A          + APE A+ G
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYG 189

Query: 571 IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLSLSL 618
            F+IKSDV+SFG+LL E+ +  +    Y     + +L  V     +  
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV--PYPGMVNREVLDQVERGYRMPC 235

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 5e-58
 Identities = 63/226 (27%), Positives = 101/226 (44%), Gaps = 9/226 (3%)

Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
              +   +LG G FG V  G       +A+K +   S     EF  E  ++  L H+ LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
           +L G C + + + +I EYM N  L  +L +     +   ++   +   +   + YL    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK- 119

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGG 570
             + +HRDL A N L++D    K+SDFGL+R    ++  ++         +  PE  M  
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK-FPVRWSPPEVLMYS 176

Query: 571 IFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLSL 616
            FS KSD+++FGVL+ EI S  K    Y          ++   L L
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKM--PYERFTNSETAEHIAQGLRL 220

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 2e-57
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 10/208 (4%)

Query: 393 FSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNL 449
           +     +G G +G   K    +DGK +  K L   S      Q   +EVNL+ +L+H N+
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 450 VRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQ-LDWKRRQSIINGIARGILYL 506
           VR     ++     L ++ EY     L   +   T+  Q LD +    ++  +   +   
Sbjct: 66  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125

Query: 507 HE--DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           H   D    ++HRDLK +N+ LD   N K+ DFGLARI   + + A      GT  YM+P
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMSP 183

Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E      ++ KSD++S G LL E+ +  
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALM 211

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 4e-57
 Identities = 69/229 (30%), Positives = 102/229 (44%), Gaps = 15/229 (6%)

Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV 450
                   +G+G FG V  G    G  +AVK +   +    Q F  E +++ +L+H NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63

Query: 451 RLLGCCLEGQE-LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +LLG  +E +  L ++ EYM   SL  +L    RSV L           +   + YL   
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLE-- 120

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 569
                +HRDL A N+L+ +D   K+SDFGL +     Q+            + APE    
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEALRE 174

Query: 570 GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLSLSL 618
             FS KSDV+SFG+LL EI S  +    Y     + ++  V     +  
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV--PYPRIPLKDVVPRVEKGYKMDA 221

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 9e-57
 Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 15/230 (6%)

Query: 395 DENKLGQGGFGPVYKGTLAD---GKAIAVKRLSRTSGQG--LQEFKNEVNLIAKLQHKNL 449
           ++ +LG G FG V KG        K +AVK L   +       E   E N++ +L +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           VR++G C E +  +L+ E      L+ +L        +  K    +++ ++ G+ YL   
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE-- 124

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI-IAGTYGYMAPEYAM 568
                +HRDL A N+LL      KISDFGL++    ++N             + APE   
Sbjct: 125 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183

Query: 569 GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLSLSL 618
              FS KSDV+SFGVL+ E  S  +    Y    G  +   +     +  
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQK--PYRGMKGSEVTAMLEKGERMGC 231

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 9e-57
 Identities = 60/240 (25%), Positives = 110/240 (45%), Gaps = 13/240 (5%)

Query: 384 RLALEATNHFSDENKLGQGGFGPVYKGTLA---DGKAIAVKRLSRTSGQG-LQEFKNEVN 439
           +L L+  N    + +LG G FG V +G          +A+K L + + +   +E   E  
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 440 LIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 499
           ++ +L +  +VRL+G C + + L+L+ E      L   L    +  ++       +++ +
Sbjct: 62  IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQV 118

Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQAN-TNIIAGT 558
           + G+ YL        +HRDL A N+LL +    KISDFGL++  G + +     +     
Sbjct: 119 SMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175

Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLSLSL 618
             + APE      FS +SDV+S+GV + E +S  +    Y    G  ++ ++     +  
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK--PYKKMKGPEVMAFIEQGKRMEC 233

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  191 bits (485), Expect = 1e-56
 Identities = 66/229 (28%), Positives = 110/229 (48%), Gaps = 9/229 (3%)

Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
              + ++KLG G +G VY+G        +AVK L   + + ++EF  E  ++ +++H NL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75

Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           V+LLG C       +I E+M   +L  +L +  R  ++       +   I+  + YL   
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE-- 132

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG 569
            +   IHRDL A N L+ ++   K++DFGL+R+  G+   A+         + APE    
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAY 190

Query: 570 GIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLSLSL 618
             FSIKSDV++FGVLL EI +   +   Y       +   +     +  
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMS--PYPGIDLSQVYELLEKDYRMER 237

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 1e-56
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 17/206 (8%)

Query: 396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLS--RTSGQGLQEFKNEVNLIAKLQHKNLVRL 452
           + ++G+G F  VYKG   +    +A   L   + +    Q FK E  ++  LQH N+VR 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 453 LGCCLE----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
                      + ++L+ E M + +L  +L    R   +  K  +S    I +G+ +LH 
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 509 DSRLKIIHRDLKASNILLDD-DMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
            +   IIHRDLK  NI +     + KI D GLA +   +        + GT  +MAPE  
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMY 185

Query: 568 MGGIFSIKSDVFSFGVLLLEIISGRK 593
               +    DV++FG+ +LE+ +   
Sbjct: 186 EEK-YDESVDVYAFGMCMLEMATSEY 210

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 3e-56
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 9/205 (4%)

Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHKN 448
             +     LG+G +G V         +A+AVK +         E  K E+ +   L H+N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
           +V+  G   EG    L  EY     L   +      + +     Q   + +  G++YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
              + I HRD+K  N+LLD+  N KISDFGLA +F  N  +   N + GT  Y+APE   
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 569 GGIF-SIKSDVFSFGVLLLEIISGR 592
              F +   DV+S G++L  +++G 
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGE 203

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 3e-56
 Identities = 55/204 (26%), Positives = 104/204 (50%), Gaps = 10/204 (4%)

Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN 448
              ++   K+GQG  G VY    +A G+ +A+++++       +   NE+ ++ + ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
           +V  L   L G EL ++ EY+   SL   + +       D  +  ++     + + +LH 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHS 134

Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
               ++IHRD+K+ NILL  D + K++DFG        Q++ +T +  GT  +MAPE   
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--GTPYWMAPEVVT 189

Query: 569 GGIFSIKSDVFSFGVLLLEIISGR 592
              +  K D++S G++ +E+I G 
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGE 213

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  189 bits (481), Expect = 6e-56
 Identities = 65/246 (26%), Positives = 113/246 (45%), Gaps = 24/246 (9%)

Query: 388 EATNHFSDE---------NKLGQGGFGPVYKGTLA----DGKAIAVKRL-SRTSGQGLQE 433
           EA   F+ E           +G G FG V  G L         +A+K L S  + +  ++
Sbjct: 14  EAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRD 73

Query: 434 FKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQ 493
           F +E +++ +  H N++ L G   +   +++I E+M N SLD  L       Q    +  
Sbjct: 74  FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQFTVIQLV 131

Query: 494 SIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTN 553
            ++ GIA G+ YL     +  +HRDL A NIL++ ++  K+SDFGL+R    + +     
Sbjct: 132 GMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT 188

Query: 554 I---IAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYV 610
                     + APE      F+  SDV+S+G+++ E++S  +    Y+    Q ++  +
Sbjct: 189 SALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER--PYWDMTNQDVINAI 246

Query: 611 CNSLSL 616
                L
Sbjct: 247 EQDYRL 252

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  187 bits (476), Expect = 3e-55
 Identities = 67/256 (26%), Positives = 111/256 (43%), Gaps = 33/256 (12%)

Query: 391 NHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSGQGLQ-EFKNEVNLIAK 443
           N+      +G+G FG V++              +AVK L   +   +Q +F+ E  L+A+
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 444 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATR-------------------- 483
             + N+V+LLG C  G+ + L++EYM    L+  L   +                     
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 484 -SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
               L    +  I   +A G+ YL E    K +HRDL   N L+ ++M  KI+DFGL+R 
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 543 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEH 602
                        A    +M PE      ++ +SDV+++GV+L EI S       Y+   
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ--PYYGMA 247

Query: 603 GQTLLTYVCNSLSLSL 618
            + ++ YV +   L+ 
Sbjct: 248 HEEVIYYVRDGNILAC 263

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 7e-55
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 14/206 (6%)

Query: 391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQH 446
             F     LG+G FG VY          +A+K L +          + + EV + + L+H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
            N++RL G   +   + LI EY P  ++   L   ++    D +R  + I  +A  + Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H     ++IHRD+K  N+LL      KI+DFG +     ++       + GT  Y+ PE 
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175

Query: 567 AMGGIFSIKSDVFSFGVLLLEIISGR 592
             G +   K D++S GVL  E + G+
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGK 201

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 9e-55
 Identities = 67/233 (28%), Positives = 104/233 (44%), Gaps = 17/233 (7%)

Query: 392 HFSDENKLGQGGFGPVYKGTLADGK----AIAVKRLSRTSGQG-LQEFKNEVNLIAKLQH 446
           HF     +G+G FG VY GTL D        AVK L+R +  G + +F  E  ++    H
Sbjct: 30  HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 447 KNLVRLLGCCLEGQ-ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
            N++ LLG CL  +   L++  YM +  L   + + T +  +       +          
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG----- 142

Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI--IAGTYGYMA 563
           +   +  K +HRDL A N +LD+    K++DFGLAR     +  +  N         +MA
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202

Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLSL 616
            E      F+ KSDV+SFGVLL E+++       Y   +   +  Y+     L
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQGRRL 253

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 3e-54
 Identities = 66/237 (27%), Positives = 96/237 (40%), Gaps = 26/237 (10%)

Query: 391 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSGQG-LQEFKNEVNLIAK 443
           N  S    LG G FG V + T            +AVK L  ++     +   +E+ +++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 444 L-QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD---------------ATRSVQL 487
           L  H N+V LLG C  G   L+I EY     L   L                     + L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 488 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
           D +   S    +A+G+ +L        IHRDL A NILL      KI DFGLAR    + 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 548 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQ 604
           N            +MAPE     +++ +SDV+S+G+ L E+ S   +         +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 6e-54
 Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 23/219 (10%)

Query: 396 ENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGC 455
           +  +G+G FG V++G    G+ +AVK  S    +     + E+     L+H+N++  +  
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAA 65

Query: 456 CLEGQ----ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-- 509
             +      +L L+ +Y  + SL  +L        +  +    +    A G+ +LH +  
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 510 ---SRLKIIHRDLKASNILLDDDMNPKISDFGLARIF--GGNQNQANTNIIAGTYGYMAP 564
               +  I HRDLK+ NIL+  +    I+D GLA       +      N   GT  YMAP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 565 EYAMGGI------FSIKSDVFSFGVLLLEIISGRKNNGF 597
           E     I         ++D+++ G++  EI       G 
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 7e-54
 Identities = 62/233 (26%), Positives = 113/233 (48%), Gaps = 14/233 (6%)

Query: 391 NHFSDENKLGQGGFGPVYKGTLADG-----KAIAVKRLSRTSGQG-LQEFKNEVNLIAKL 444
           +  + +  +G G FG VYKG L          +A+K L     +    +F  E  ++ + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 445 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
            H N++RL G   + + +++I EYM N +LD  L +  +  +    +   ++ GIA G+ 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124

Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI-IAGTYGYMA 563
           YL     +  +HRDL A NIL++ ++  K+SDFGL+R+   +     T         + A
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 564 PEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLSL 616
           PE      F+  SDV+SFG+++ E+++  +    Y+      ++  + +   L
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGER--PYWELSNHEVMKAINDGFRL 232

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 2e-53
 Identities = 64/231 (27%), Positives = 94/231 (40%), Gaps = 31/231 (13%)

Query: 391 NHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTSGQG-LQEFKNEVNLIAK 443
            +      LG G FG V   T            +AVK L   +     +   +E+ ++ +
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 444 L-QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFD--------------------AT 482
           L  H+N+V LLG C     + LI+EY     L  +L                        
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 483 RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARI 542
               L ++        +A+G+ +L        +HRDL A N+L+      KI DFGLAR 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 543 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRK 593
              + N            +MAPE    GI++IKSDV+S+G+LL EI S   
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 2e-52
 Identities = 63/232 (27%), Positives = 113/232 (48%), Gaps = 14/232 (6%)

Query: 393 FSDENKLGQGGFGPVYKGT-LADGK----AIAVKRLSR-TSGQGLQEFKNEVNLIAKLQH 446
           F     LG G FG VYKG  + +G+     +A+K L   TS +  +E  +E  ++A + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
            ++ RLLG CL    + LI + MP   L  ++ +      +  +   +    IA+G+ YL
Sbjct: 71  PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 127

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
                 +++HRDL A N+L+    + KI+DFGLA++ G  + + +         +MA E 
Sbjct: 128 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 567 AMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLSLSL 618
            +  I++ +SDV+S+GV + E+++       Y       + + +     L  
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSK--PYDGIPASEISSILEKGERLPQ 234

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 3e-52
 Identities = 68/246 (27%), Positives = 107/246 (43%), Gaps = 26/246 (10%)

Query: 391 NHFSDENKLGQGGFGPVYKGTLADG---KAIAVKRLSRT-SGQGLQEFKNEVNLIAKL-Q 445
           N    ++ +G+G FG V K  +         A+KR+    S    ++F  E+ ++ KL  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHL-------------FDATRSVQLDWKRR 492
           H N++ LLG C     L L  EY P+ +L   L                + +  L  ++ 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 493 QSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT 552
                 +ARG+ YL +    + IHRDL A NIL+ ++   KI+DFGL+R   G +     
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183

Query: 553 NIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCN 612
            +      +MA E     +++  SDV+S+GVLL EI+S       Y       L   +  
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMTCAELYEKLPQ 241

Query: 613 SLSLSL 618
              L  
Sbjct: 242 GYRLEK 247

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 7e-52
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 10/205 (4%)

Query: 392 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQHK 447
            F     LG+G F  V     LA  +  A+K L +        +     E +++++L H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
             V+L     + ++L     Y  N  L  ++         D    +     I   + YLH
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH 125

Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
                 IIHRDLK  NILL++DM+ +I+DFG A++      QA  N   GT  Y++PE  
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182

Query: 568 MGGIFSIKSDVFSFGVLLLEIISGR 592
                   SD+++ G ++ ++++G 
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGL 207

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  179 bits (456), Expect = 9e-52
 Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 11/205 (5%)

Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
           +H+    +LG G FG V++ T  A G   A K +        +  + E+  ++ L+H  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           V L     +  E+++IYE+M    L   + D     ++        +  + +G+ ++HE 
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE- 142

Query: 510 SRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
                +H DLK  NI+     +   K+ DFGL       Q+   T    GT  + APE A
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVA 197

Query: 568 MGGIFSIKSDVFSFGVLLLEIISGR 592
            G      +D++S GVL   ++SG 
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL 222

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 2e-50
 Identities = 64/225 (28%), Positives = 92/225 (40%), Gaps = 16/225 (7%)

Query: 397 NKLGQGGFGPVYKGTL----ADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQHKNL 449
            KLG G FG V +G          ++AVK L     +  + + +F  EVN +  L H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           +RL G  L    + ++ E  P  SL   L                    +A G+ YL   
Sbjct: 74  IRLYGVVLTP-PMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLES- 129

Query: 510 SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ-ANTNIIAGTYGYMAPEYAM 568
              + IHRDL A N+LL      KI DFGL R    N +           + + APE   
Sbjct: 130 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187

Query: 569 GGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNS 613
              FS  SD + FGV L E+ +  +    +   +G  +L  +   
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQE--PWIGLNGSQILHKIDKE 230

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 1e-49
 Identities = 66/236 (27%), Positives = 105/236 (44%), Gaps = 19/236 (8%)

Query: 391 NHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSR-TSGQGLQEFKNEVNLIAK 443
              +   +LGQG FG VY+G             +A+K ++   S +   EF NE +++ +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 444 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF-------DATRSVQLDWKRRQSII 496
               ++VRLLG   +GQ  L+I E M    L  +L        +          +   + 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 497 NGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIA 556
             IA G+ YL+ +   K +HRDL A N ++ +D   KI DFG+ R               
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 557 GTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCN 612
               +M+PE    G+F+  SDV+SFGV+L EI +  +    Y     + +L +V  
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGLSNEQVLRFVME 250

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  173 bits (440), Expect = 2e-49
 Identities = 48/205 (23%), Positives = 90/205 (43%), Gaps = 11/205 (5%)

Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
           +++    +LG G FG V++    A G+    K ++          KNE++++ +L H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 450 VRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
           + L     +  E++LI E++    L   +  A    ++      + +     G+ ++HE 
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHE- 145

Query: 510 SRLKIIHRDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
               I+H D+K  NI+ +       KI DFGLA     ++      +   T  + APE  
Sbjct: 146 --HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIV 200

Query: 568 MGGIFSIKSDVFSFGVLLLEIISGR 592
                   +D+++ GVL   ++SG 
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGL 225

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 2e-48
 Identities = 53/233 (22%), Positives = 93/233 (39%), Gaps = 14/233 (6%)

Query: 391 NHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQ 445
                   +G+G FG V++G          A+A+K     +   ++E F  E   + +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           H ++V+L+G   E   + +I E      L   L     S  LD          ++  + Y
Sbjct: 67  HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123

Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           L      + +HRD+ A N+L+  +   K+ DFGL+R    +     +        +MAPE
Sbjct: 124 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK-GKLPIKWMAPE 179

Query: 566 YAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLLTYVCNSLSLSL 618
                 F+  SDV+ FGV + EI+        +       ++  + N   L +
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVK--PFQGVKNNDVIGRIENGERLPM 230

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 2e-47
 Identities = 51/210 (24%), Positives = 96/210 (45%), Gaps = 7/210 (3%)

Query: 387 LEATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG-LQEFKNEVNLIAKL 444
            +    +++ + +G+G +G V       +   +A+K++S    Q   Q    E+ ++ + 
Sbjct: 4   FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 63

Query: 445 QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGIL 504
           +H+N++ +           +   Y+    +   L+   ++  L        +  I RG+ 
Sbjct: 64  RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLK 123

Query: 505 YLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANT-NIIAGTYGYMA 563
           Y+H      ++HRDLK SN+LL+   + KI DFGLAR+   + +          T  Y A
Sbjct: 124 YIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180

Query: 564 PEYAMGGIFSIKS-DVFSFGVLLLEIISGR 592
           PE  +      KS D++S G +L E++S R
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 3e-47
 Identities = 71/251 (28%), Positives = 105/251 (41%), Gaps = 28/251 (11%)

Query: 391 NHFSDENKLGQGGFGPVYKGTL--------ADGKAIAVKRLSR-TSGQGLQEFKNEVNLI 441
           +       LG+G FG V                  +AVK L    + + L +  +E+ ++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 442 AKL-QHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLF-------------DATRSVQL 487
             + +HKN++ LLG C +   L +I EY    +L  +L                    QL
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 488 DWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ 547
             K   S    +ARG+ YL      K IHRDL A N+L+ +D   KI+DFGLAR      
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 548 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSEHGQTLL 607
               T        +MAPE     I++ +SDV+SFGVLL EI +   +   Y     + L 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVPVEELF 247

Query: 608 TYVCNSLSLSL 618
             +     +  
Sbjct: 248 KLLKEGHRMDK 258

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  165 bits (419), Expect = 2e-46
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 18/210 (8%)

Query: 391 NHFSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQ- 445
           N FS    +G+GGFG VY    AD GK  A+K L +      QG     NE  +++ +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 446 --HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
                +V +        +L  I + M    L  HL    +         +     I  G+
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120

Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            ++H      +++RDLK +NILLD+  + +ISD GLA  F   +     +   GT+GYMA
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173

Query: 564 PEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           PE    G+ +   +D FS G +L +++ G 
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 3e-46
 Identities = 65/225 (28%), Positives = 98/225 (43%), Gaps = 25/225 (11%)

Query: 391 NHFSDENKLGQGGFGPVYKGT------LADGKAIAVKRLSRTSGQG-LQEFKNEVNLIAK 443
           +       LG+G FG V +         A  + +AVK L   +     +   +E+ ++  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 444 -LQHKNLVRLLGCCLE-GQELLLIYEYMPNKSLDVHLF-------------DATRSVQLD 488
              H N+V LLG C + G  L++I E+    +L  +L              +      L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 489 WKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN 548
            +        +A+G+ +L      K IHRDL A NILL +    KI DFGLAR    + +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 549 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRK 593
                       +MAPE     +++I+SDV+SFGVLL EI S   
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 234

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 3e-46
 Identities = 46/198 (23%), Positives = 91/198 (45%), Gaps = 12/198 (6%)

Query: 398 KLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCC 456
            LG+G FG V++    +  K    K + +  G      K E++++   +H+N++ L    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 457 LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIH 516
              +EL++I+E++    +   +   T + +L+ +   S ++ +   + +LH      I H
Sbjct: 71  ESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125

Query: 517 RDLKASNILLDDDMNP--KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSI 574
            D++  NI+     +   KI +FG AR         N  ++     Y APE     + S 
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVST 182

Query: 575 KSDVFSFGVLLLEIISGR 592
            +D++S G L+  ++SG 
Sbjct: 183 ATDMWSLGTLVYVLLSGI 200

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  160 bits (406), Expect = 1e-45
 Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 15/212 (7%)

Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG---LQEFKNEVNLIAKLQ 445
           ++ +     LG GG   V+    L   + +AVK L     +       F+ E    A L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 446 HKNLVRLLGCCLE----GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR 501
           H  +V +          G    ++ EY+   +L   +        +  KR   +I    +
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122

Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ-ANTNIIAGTYG 560
            + + H+     IIHRD+K +NI++      K+ DFG+AR    + N    T  + GT  
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 561 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           Y++PE A G     +SDV+S G +L E+++G 
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  161 bits (409), Expect = 2e-45
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 15/207 (7%)

Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQH 446
             F     LG G FG V+      +G+  A+K L +      + ++   +E  +++ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             ++R+ G   + Q++ +I +Y+    L   L  + R      K   + +       L L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
                  II+RDLK  NILLD + + KI+DFG A+             + GT  Y+APE 
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPDYIAPEV 172

Query: 567 AMGGIFSIKSDVFSFGVLLLEIISGRK 593
                ++   D +SFG+L+ E+++G  
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  157 bits (398), Expect = 2e-44
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 26/218 (11%)

Query: 392 HFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGL---------QEFKNEVNLI 441
           ++  +  LG+G    V +       K  AVK +  T G            +    EV+++
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 442 AKLQ-HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIA 500
            K+  H N+++L           L+++ M    L  +L   T  V L  K  + I+  + 
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120

Query: 501 RGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 560
             I  LH+   L I+HRDLK  NILLDDDMN K++DFG +      +       + GT  
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPS 174

Query: 561 YMAPEYAMGGI------FSIKSDVFSFGVLLLEIISGR 592
           Y+APE     +      +  + D++S GV++  +++G 
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  157 bits (399), Expect = 3e-44
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 14/208 (6%)

Query: 390 TNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-FKNEVNLIAKLQHK 447
            + +   + LG G F  V         K +A+K +++ + +G +   +NE+ ++ K++H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
           N+V L      G  L LI + +    L   + +         +    +I  +   + YLH
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLH 124

Query: 508 EDSRLKIIHRDLKASNILL---DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           +     I+HRDLK  N+L    D+D    ISDFGL+++          +   GT GY+AP
Sbjct: 125 DL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAP 178

Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           E      +S   D +S GV+   ++ G 
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGY 206

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 1e-43
 Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 13/207 (6%)

Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAK-LQ 445
             F     LG+G FG V+        +  A+K L +        ++    E  +++   +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 446 HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           H  L  +       + L  + EY+    L  H+    +    D  R       I  G+ +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118

Query: 506 LHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           LH      I++RDLK  NILLD D + KI+DFG+ +       + NT    GT  Y+APE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173

Query: 566 YAMGGIFSIKSDVFSFGVLLLEIISGR 592
             +G  ++   D +SFGVLL E++ G+
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ 200

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 2e-42
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 17/208 (8%)

Query: 393 FSDENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVR 451
           ++D   +G G FG VY+  L D G+ +A+K++ +      +    E+ ++ KL H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77

Query: 452 LLGCCLEGQE------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILY 505
           L        E      L L+ +Y+P     V    +     L     +  +  + R + Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 506 LHEDSRLKIIHRDLKASNILLDDD-MNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAP 564
           +H      I HRD+K  N+LLD D    K+ DFG A+     + + N + I   Y     
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPE 192

Query: 565 EYAMGGIFSIKSDVFSFGVLLLEIISGR 592
                  ++   DV+S G +L E++ G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 2e-42
 Identities = 52/203 (25%), Positives = 97/203 (47%), Gaps = 15/203 (7%)

Query: 397 NKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE-----FKNEVNLIAKLQHKNLV 450
           + LG+G F  VYK       + +A+K++        ++        E+ L+ +L H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 451 RLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS 510
            LL        + L++++M      +       S+ L     ++ +    +G+ YLH+  
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 511 RLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMG- 569
              I+HRDLK +N+LLD++   K++DFGLA+ FG         +   T  Y APE   G 
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV--VTRWYRAPELLFGA 175

Query: 570 GIFSIKSDVFSFGVLLLEIISGR 592
            ++ +  D+++ G +L E++   
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRV 198

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 7e-42
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 11/205 (5%)

Query: 392 HFSDENKLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKN 448
           +F    K+G+G +G VYK      G+ +A+K  RL   +         E++L+ +L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
           +V+LL       +L L++E++          DA+    +     +S +  + +G+ + H 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE-YA 567
               +++HRDLK  N+L++ +   K++DFGLAR FG         +   T  Y APE   
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV--VTLWYRAPEILL 175

Query: 568 MGGIFSIKSDVFSFGVLLLEIISGR 592
               +S   D++S G +  E+++ R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  149 bits (377), Expect = 2e-41
 Identities = 57/205 (27%), Positives = 102/205 (49%), Gaps = 11/205 (5%)

Query: 391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHKN 448
             +    K+G+G +G VYK     G+  A+K  RL +           E++++ +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
           +V+L       + L+L++E++      +          L+    +S +  +  GI Y H+
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 509 DSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAM 568
               +++HRDLK  N+L++ +   KI+DFGLAR FG    +    I+  T  Y AP+  M
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDVLM 173

Query: 569 G-GIFSIKSDVFSFGVLLLEIISGR 592
           G   +S   D++S G +  E+++G 
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 4e-41
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 16/214 (7%)

Query: 389 ATNHFSDENKLGQGGFGPVYKGT--LADGKAIAVKRLSRTSGQG--LQEFKNEVNLIAKL 444
           A   +    ++G+G +G V+K       G+ +A+KR+   +G+         EV ++  L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 445 ---QHKNLVRLLGCCLEGQELLLIYEYMPNKSLD---VHLFDATRSVQLDWKRRQSIING 498
              +H N+VRL   C   +        +  + +D       D      +  +  + ++  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           + RG+ +LH     +++HRDLK  NIL+      K++DFGLARI+           +  T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVT 178

Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
             Y APE  +   ++   D++S G +  E+   +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 2e-40
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 20/213 (9%)

Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTS------GQGLQEFKNEVNLIAK 443
           +++    +LG G F  V K    + G   A K + +        G   ++ + EV+++ +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 444 LQHKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
           +QH N++ L        +++LI E +    L   L +      L  +     +  I  G 
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNG- 125

Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNP----KISDFGLARIFGGNQNQANTNIIAGTY 559
             ++    L+I H DLK  NI+L D   P    KI DFGLA              I GT 
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTP 180

Query: 560 GYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
            ++APE        +++D++S GV+   ++SG 
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  146 bits (369), Expect = 4e-40
 Identities = 48/212 (22%), Positives = 84/212 (39%), Gaps = 18/212 (8%)

Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL 449
           N +    K+G G FG +Y GT +A G+ +A+K     +     +   E  +   +Q    
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64

Query: 450 VRLLG-CCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
           +  +  C  EG   +++ E +     D+  F + +      K    + + +   I Y+H 
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHS 121

Query: 509 DSRLKIIHRDLKASNIL---LDDDMNPKISDFGLARIFGGNQNQAN-----TNIIAGTYG 560
                 IHRD+K  N L           I DFGLA+ +   +   +        + GT  
Sbjct: 122 ---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178

Query: 561 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           Y +    +G   S + D+ S G +L+    G 
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGS 210

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  145 bits (367), Expect = 6e-40
 Identities = 38/214 (17%), Positives = 84/214 (39%), Gaps = 20/214 (9%)

Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH-KN 448
            H+    ++G+G FG +++GT L + + +A+K   R S     + ++E      L     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62

Query: 449 LVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHE 508
           +  +     EG   +L+ + +     D+         +   K        +   +  +HE
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSIHE 119

Query: 509 DSRLKIIHRDLKASNILLDDDMNP-----KISDFGLARIF-----GGNQNQANTNIIAGT 558
                +++RD+K  N L+    +       + DFG+ + +       +        ++GT
Sbjct: 120 ---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176

Query: 559 YGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
             YM+    +G   S + D+ + G + +  + G 
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 210

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 7e-40
 Identities = 50/213 (23%), Positives = 82/213 (38%), Gaps = 20/213 (9%)

Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQE------FKNEVNLIAK 443
           + +     LG GGFG VY G  ++D   +A+K + +       E         EV L+ K
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 444 LQ--HKNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR 501
           +      ++RLL         +LI E              T    L  +  +S    +  
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLE 121

Query: 502 GILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 560
            + + H      ++HRD+K  NIL+D +    K+ DFG   +              GT  
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRV 174

Query: 561 YMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGR 592
           Y  PE+          + V+S G+LL +++ G 
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 3e-39
 Identities = 54/206 (26%), Positives = 84/206 (40%), Gaps = 12/206 (5%)

Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQH 446
           N F     LG+G FG V      A G+  A+K L +    +   +     E  ++   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             L  L         L  + EY     L  HL   +R      +R +     I      L
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSA---L 118

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
                  +++RD+K  N++LD D + KI+DFGL +   G  + A      GT  Y+APE 
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEV 176

Query: 567 AMGGIFSIKSDVFSFGVLLLEIISGR 592
                +    D +  GV++ E++ GR
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 8e-39
 Identities = 50/216 (23%), Positives = 97/216 (44%), Gaps = 20/216 (9%)

Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQG--LQEFKNEVNLIAKLQHK 447
           + +    K+GQG FG V+K      G+ +A+K++   + +         E+ ++  L+H+
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 448 NLVRLLGCCLEGQE--------LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGI 499
           N+V L+  C             + L++++  +    +        V+      + ++  +
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQML 126

Query: 500 ARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNI--IAG 557
             G   L+   R KI+HRD+KA+N+L+  D   K++DFGLAR F   +N           
Sbjct: 127 LNG---LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 558 TYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           T  Y  PE  +G   +    D++  G ++ E+ +  
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 2e-37
 Identities = 47/206 (22%), Positives = 80/206 (38%), Gaps = 21/206 (10%)

Query: 396 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLL 453
              LG G  G V +       +  A+K L         + + EV L  +  Q  ++VR++
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIV 71

Query: 454 GCC----LEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED 509
                     + LL++ E +    L   + D         +    I+  I   I YLH  
Sbjct: 72  DVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHS- 129

Query: 510 SRLKIIHRDLKASNILLDDDMNP---KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
             + I HRD+K  N+L          K++DFG A+    + +         T  Y+APE 
Sbjct: 130 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEV 184

Query: 567 AMGGIFSIKSDVFSFGVLLLEIISGR 592
                +    D++S GV++  ++ G 
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGY 210

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 1e-36
 Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 23/215 (10%)

Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKL 444
           E    + D   +G G +G V        G  +A+K+L R   S    +    E+ L+  +
Sbjct: 15  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74

Query: 445 QHKNLVRLLGCCLEGQ------ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIING 498
           +H+N++ LL      +      +  L+  +M      +      +  +L   R Q ++  
Sbjct: 75  RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQ 129

Query: 499 IARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGT 558
           + +G+ Y+H      IIHRDLK  N+ +++D   KI DFGLAR                T
Sbjct: 130 MLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG-----YVVT 181

Query: 559 YGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
             Y APE  +  + ++   D++S G ++ E+I+G+
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  138 bits (348), Expect = 1e-36
 Identities = 51/206 (24%), Positives = 85/206 (41%), Gaps = 15/206 (7%)

Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSR---TSGQGLQEFKNEVNLIAKLQH 446
           + F     LG G FG V        G   A+K L +      + ++   NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
             LV+L     +   L ++ EY+    +  HL    R         +     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYL 157

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEY 566
           H    L +I+RDLK  N+L+D     +++DFG A+   G         + GT   +APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEI 209

Query: 567 AMGGIFSIKSDVFSFGVLLLEIISGR 592
            +   ++   D ++ GVL+ E+ +G 
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGY 235

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (339), Expect = 5e-36
 Identities = 43/206 (20%), Positives = 88/206 (42%), Gaps = 10/206 (4%)

Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVK--RLSRTSGQGLQEFKNEVNLIAKLQHK 447
             +    K+G+G +G V+K       + +A+K  RL             E+ L+ +L+HK
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 448 NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLH 507
           N+VRL       ++L L++E+                        + + + + + +  L 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115

Query: 508 EDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYA 567
                 ++HRDLK  N+L++ +   K+++FGLAR FG    +  +  +   +        
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLF 174

Query: 568 MGGIFSIKSDVFSFGVLLLEIISGRK 593
              ++S   D++S G +  E+ +  +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 1e-33
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 18/213 (8%)

Query: 391 NHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTS----GQGLQEFKNEVNLIA 442
            +F     LG G +G V+          GK  A+K L + +     +  +  + E  ++ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 443 KLQHK-NLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR 501
            ++    LV L        +L LI +Y+    L  HL    R  + + +        +  
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY------VGE 137

Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
            +L L    +L II+RD+K  NILLD + +  ++DFGL++ F  ++ +       GT  Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196

Query: 562 MAPEYAMGGI--FSIKSDVFSFGVLLLEIISGR 592
           MAP+   GG        D +S GVL+ E+++G 
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 2e-33
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 21/211 (9%)

Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHK 447
             + +   +G G  G V         + +A+K+LSR   +    +    E+ L+  + HK
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 448 NLVRLLGCCL------EGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIAR 501
           N++ LL          E Q++ L+ E M      V         +LD +R   ++  +  
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLC 130

Query: 502 GILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGY 561
           GI +LH      IIHRDLK SNI++  D   KI DFGLAR  G +           T  Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYY 184

Query: 562 MAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
            APE  +G  +    D++S G ++ E++  +
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  127 bits (319), Expect = 5e-33
 Identities = 40/208 (19%), Positives = 90/208 (43%), Gaps = 21/208 (10%)

Query: 391 NHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKN 448
           + +    KLG+G +  V++   + + + + VK L        ++ K E+ ++  L+   N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91

Query: 449 LVRLLGCCLE--GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
           ++ L     +   +   L++E++ N               L     +  +  I + + Y 
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYC 145

Query: 507 HEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPE 565
           H    + I+HRD+K  N+++D +    ++ D+GLA  +   Q     N+   +  +  PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPE 199

Query: 566 YAMG-GIFSIKSDVFSFGVLLLEIISGR 592
             +   ++    D++S G +L  +I  +
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRK 227

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 2e-31
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 13/210 (6%)

Query: 388 EATNHFSDENKLGQGGFGPVYKGT-LADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKL 444
           E    + + + +G G +G V        G  +AVK+LSR   S    +    E+ L+  +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74

Query: 445 QHKNLVRLLGCCLEGQELLLI-YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGI 503
           +H+N++ LL      + L      Y+    +   L +  +  +L     Q +I  I RG+
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134

Query: 504 LYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMA 563
            Y+H      IIHRDLK SN+ +++D   KI DFGLAR                T  Y A
Sbjct: 135 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRA 186

Query: 564 PEYAMGGI-FSIKSDVFSFGVLLLEIISGR 592
           PE  +  + ++   D++S G ++ E+++GR
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  117 bits (292), Expect = 3e-29
 Identities = 38/212 (17%), Positives = 77/212 (36%), Gaps = 18/212 (8%)

Query: 396 ENKLGQGGFGPVYKGT-LADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLG 454
             KLG G F  V+    + +   +A+K +        +  ++E+ L+ ++   +  +   
Sbjct: 18  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDS 76

Query: 455 CCLEGQELLLIYEYMPNKSLDV-------------HLFDATRSVQLDWKRRQSIINGIAR 501
                   LL +      +                 L        +     + I   +  
Sbjct: 77  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136

Query: 502 GILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGGNQNQANTNIIAGTYG 560
           G+ Y+H   R  IIH D+K  N+L++  D    +    +A +        +      T  
Sbjct: 137 GLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 561 YMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR 592
           Y +PE  +G  +   +D++S   L+ E+I+G 
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 94.8 bits (235), Expect = 5e-23
 Identities = 28/155 (18%), Positives = 56/155 (36%), Gaps = 20/155 (12%)

Query: 397 NKLGQGGFGPVYKGTLADGKAIAVK--RLSRTSGQ--------GLQEFKNEVNLIAKLQH 446
             +G+G    V+           VK  ++  TS +        G   F       A+ + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 447 KNLVRLLGCCLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYL 506
           + L +L G  +        Y +  N ++ + L DA    ++  +    +++ I   +   
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGN-AVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119

Query: 507 HEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR 541
           +      I+H DL   N+L+  +    I DF  + 
Sbjct: 120 YHR---GIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	621
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.97
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.86
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.54
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.0
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.56
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.84
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.67
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.69

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-44  Score=361.58  Aligned_cols=202  Identities=30%  Similarity=0.438  Sum_probs=176.4

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++... .+..+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            57999999999999999999964 69999999997653 33446789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++|+|.+++.   +...+++.++..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.......
T Consensus        85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            99999999984   3456999999999999999999999986   99999999999999999999999999998754443


Q ss_pred             CcccccccccCCccChhcccCCCC-ChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      .......+||+.|||||++.+..+ +.++|||||||++|||++|++||...
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~  209 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP  209 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred             cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCC
Confidence            334445689999999999988876 67899999999999999999999643

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-43  Score=358.95  Aligned_cols=198  Identities=27%  Similarity=0.465  Sum_probs=179.1

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      ++|++.++||+|+||+||+|+. .+|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            4799999999999999999985 569999999998766666788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++|+|.+++.+    ..+++.++..++.||+.||.|||+++   |+||||||+|||++.++++||+|||+++.+..... 
T Consensus       100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-  171 (293)
T d1yhwa1         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (293)
T ss_dssp             TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence            99999987743    35999999999999999999999986   99999999999999999999999999997654322 


Q ss_pred             cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                       ......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus       172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~  218 (293)
T d1yhwa1         172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN  218 (293)
T ss_dssp             -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCC
Confidence             23345799999999999999999999999999999999999999853

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-43  Score=354.60  Aligned_cols=200  Identities=35%  Similarity=0.564  Sum_probs=168.0

Q ss_pred             hCCCCccceeccCCceeEEEEEecCCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      .++|.+.++||+|+||+||+|+++  ..||||+++..  +....+.|.+|+++|++++|||||++++++.+ +.+++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            367889999999999999999864  36999998754  34556789999999999999999999998765 56899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |+++|+|.+++..  ....+++..+..++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++......
T Consensus        84 y~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          84 WCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             cCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            9999999999954  3346999999999999999999999986   9999999999999999999999999998765444


Q ss_pred             CCcccccccccCCccChhcccC---CCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .........||+.|||||++.+   ..++.++|||||||++|||+||+.||..
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~  211 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN  211 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCC
Confidence            4444455679999999999864   4589999999999999999999999864

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-43  Score=356.94  Aligned_cols=201  Identities=27%  Similarity=0.410  Sum_probs=176.0

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++.+.   .....+.+.+|+++|++++||||+++++++.+++..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5699999999999999999996 46999999998753   2345677999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.+...
T Consensus        88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            99999999998854   346999999999999999999999986   999999999999999999999999999987654


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ..........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~  212 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA  212 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC
Confidence            444444456799999999999999999999999999999999999999964

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-43  Score=350.95  Aligned_cols=197  Identities=29%  Similarity=0.481  Sum_probs=176.5

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|++.+.||+|+||.||+++.+ +++.||+|++.+.   .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46889999999999999999974 6899999998643   2344677899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            99999999999854   345999999999999999999999986   999999999999999999999999999765432


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                          ......||+.|||||++.+..++.++|||||||++|||++|+.||..
T Consensus       160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~  206 (263)
T d2j4za1         160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA  206 (263)
T ss_dssp             ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC
Confidence                23345799999999999999999999999999999999999999864

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-42  Score=349.08  Aligned_cols=199  Identities=29%  Similarity=0.459  Sum_probs=166.4

Q ss_pred             CCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecC
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP  470 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  470 (621)
                      ++|+..+.||+|+||.||+|++.+++.||||+++.. ....++|.+|++++++++|||||+++|++.+++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            578889999999999999999988999999999764 3445789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc
Q 007006          471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA  550 (621)
Q Consensus       471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~  550 (621)
                      +|+|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++........ 
T Consensus        84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-  157 (263)
T d1sm2a_          84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-  157 (263)
T ss_dssp             TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence            9999998854  3456899999999999999999999986   999999999999999999999999999876543222 


Q ss_pred             ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcC-CCCCC
Q 007006          551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG-RKNNG  596 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG-~~p~~  596 (621)
                      ......||+.|+|||++.+..++.++|||||||++|||+|+ ++|+.
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~  204 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE  204 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCC
Confidence            22235689999999999999999999999999999999995 55544

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-43  Score=356.66  Aligned_cols=201  Identities=28%  Similarity=0.454  Sum_probs=177.3

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      +.|++.+.||+|+||.||+|+. .+|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            5688999999999999999996 468999999998777777788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++|+|..++.+.  ...+++.++..++.||+.||.|||+++   |+||||||+|||++.++++||+|||++.......  
T Consensus        92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--  164 (288)
T d2jfla1          92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--  164 (288)
T ss_dssp             TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred             CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence            999999987543  346999999999999999999999986   9999999999999999999999999997643211  


Q ss_pred             cccccccccCCccChhccc-----CCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          550 ANTNIIAGTYGYMAPEYAM-----GGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~-----~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      .......||+.|+|||++.     +..++.++|||||||++|||+||+.||...
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~  218 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL  218 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC
Confidence            1122457899999999984     456899999999999999999999998643

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-43  Score=353.43  Aligned_cols=205  Identities=29%  Similarity=0.416  Sum_probs=166.5

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEee--CceEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--GQELLLI  465 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~--~~~~~lV  465 (621)
                      ++|++.+.||+|+||+||+++. .+|+.||+|++....  ....+.+.+|+++|++++|||||++++++.+  ++.+++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5799999999999999999986 468999999997653  3345678999999999999999999999875  4568999


Q ss_pred             EEecCCCChhhhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          466 YEYMPNKSLDVHLFDAT-RSVQLDWKRRQSIINGIARGILYLHEDS--RLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      |||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+  ..+|+||||||+||||+.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            99999999999986432 3457999999999999999999999864  23599999999999999999999999999987


Q ss_pred             cCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          543 FGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       543 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      +.....  ......||+.|||||++.+..++.++|||||||++|||+||++||..
T Consensus       164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~  216 (269)
T d2java1         164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA  216 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC
Confidence            654322  22346789999999999999999999999999999999999999864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-43  Score=362.00  Aligned_cols=200  Identities=28%  Similarity=0.389  Sum_probs=176.9

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      .++|++.++||+|+||+||+|+. .+|+.||+|+++... ....+.+.+|+.+|++++|||||++++++.+++..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            56899999999999999999996 468999999997653 3445678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHED-SRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      |+++|+|.+++.+.   ..+++..+..++.||+.||.|||+. +   |+||||||+|||++.++++||+|||+|+.....
T Consensus        85 y~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence            99999999999643   4599999999999999999999974 5   999999999999999999999999999865332


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                          .....+||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus       159 ----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~  207 (322)
T d1s9ja_         159 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  207 (322)
T ss_dssp             ----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred             ----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence                1234589999999999999999999999999999999999999996543

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-42  Score=346.83  Aligned_cols=198  Identities=36%  Similarity=0.553  Sum_probs=172.2

Q ss_pred             CCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecC
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP  470 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  470 (621)
                      ++|++.++||+|+||.||+|.++++..||||+++... ...+.|.+|+++|++++|||||+++|++.+ +..++||||++
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~   90 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence            5688899999999999999999888999999997643 445789999999999999999999998865 56789999999


Q ss_pred             CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc
Q 007006          471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA  550 (621)
Q Consensus       471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~  550 (621)
                      +|+|.+++... ....+++..+++|+.||++||.|||+.+   |+||||||+||||++++.+||+|||+++........ 
T Consensus        91 ~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~-  165 (272)
T d1qpca_          91 NGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-  165 (272)
T ss_dssp             TCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-
T ss_pred             CCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc-
Confidence            99999887542 2345999999999999999999999986   999999999999999999999999999987543222 


Q ss_pred             ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCC
Q 007006          551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNN  595 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~  595 (621)
                      ......||+.|+|||++.++.++.++|||||||++|||+||..|+
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~  210 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP  210 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCC
Confidence            223346889999999999999999999999999999999965553

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-41  Score=339.44  Aligned_cols=202  Identities=30%  Similarity=0.451  Sum_probs=179.4

Q ss_pred             CCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecC
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP  470 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  470 (621)
                      ++|+..++||+|+||+||+|++++++.||||++++.. ...++|.+|+.++++++||||++++|++.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            6789999999999999999999889999999998653 345789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc
Q 007006          471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA  550 (621)
Q Consensus       471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~  550 (621)
                      +|+|..++..  ....+++..+.+++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++........ 
T Consensus        83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-  156 (258)
T d1k2pa_          83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-  156 (258)
T ss_dssp             TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred             CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence            9999988754  3446899999999999999999999986   999999999999999999999999999876543322 


Q ss_pred             ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCCc
Q 007006          551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYF  599 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~~  599 (621)
                      ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||+...
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~  206 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT  206 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC
Confidence            2223568899999999999999999999999999999998 899987543

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.1e-42  Score=349.81  Aligned_cols=200  Identities=32%  Similarity=0.483  Sum_probs=175.9

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      .++|++.++||+|+||+||+|++. +++.||||+++... ...++|.+|+++|++++|||||++++++.+++..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            357888899999999999999975 58899999997543 4467899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +++|+|..++... ....+++..+..++.||++||.|||+++   |+||||||+||||++++.+||+|||+++.......
T Consensus        95 ~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          95 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             ccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence            9999999998643 3457999999999999999999999986   99999999999999999999999999987654322


Q ss_pred             CcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNN  595 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~  595 (621)
                      . ......|++.|+|||++.++.++.++|||||||++|||++|+.|+
T Consensus       171 ~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~  216 (287)
T d1opja_         171 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP  216 (287)
T ss_dssp             E-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             e-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCC
Confidence            2 222345788999999999999999999999999999999987765

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.4e-42  Score=350.78  Aligned_cols=202  Identities=30%  Similarity=0.479  Sum_probs=163.9

Q ss_pred             CCCCccceeccCCceeEEEEEecC-C---cEEEEEEeccC-CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLAD-G---KAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~-g---~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      ++|.+.+.||+|+||+||+|+++. +   ..||||++... .....++|.+|+++|++++|||||+++|++.+++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            457788999999999999998642 3   36899998754 344567899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      |||+++|+|.+++..  ....+++.++++++.||++||.|||+.+   |+||||||+||||+.++.+||+|||+++....
T Consensus       106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence            999999999998853  3446999999999999999999999986   99999999999999999999999999987654


Q ss_pred             CCCCcc---cccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          546 NQNQAN---TNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       546 ~~~~~~---~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      ......   .....+|+.|||||.+.++.++.++|||||||++|||+| |++||..
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~  236 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD  236 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC
Confidence            332221   122357889999999999999999999999999999998 8999864

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-41  Score=341.49  Aligned_cols=195  Identities=29%  Similarity=0.425  Sum_probs=167.7

Q ss_pred             CccceeccCCceeEEEEEec-CCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEee----CceEEEEE
Q 007006          394 SDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE----GQELLLIY  466 (621)
Q Consensus       394 ~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~----~~~~~lV~  466 (621)
                      +..++||+|+||+||+|+.. +++.||+|++...  .....+.+.+|+++|++++|||||++++++.+    +..+++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            55678999999999999964 6889999998754  33445678999999999999999999999875    34679999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc-CCCCeEEeeecCceecCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD-DDMNPKISDFGLARIFGG  545 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~-~~~~vkL~Dfgla~~~~~  545 (621)
                      ||+++|+|.+++..   ...+++..+..++.||++||+|||+++ .+|+||||||+|||++ +++.+||+|||+++....
T Consensus        92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            99999999999954   346999999999999999999999874 4599999999999996 578999999999975432


Q ss_pred             CCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .    ......||+.|||||++.+ .++.++|||||||++|||++|+.||..
T Consensus       168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~  214 (270)
T d1t4ha_         168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE  214 (270)
T ss_dssp             T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCC
Confidence            2    2334679999999998865 599999999999999999999999863

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.9e-41  Score=353.19  Aligned_cols=199  Identities=28%  Similarity=0.453  Sum_probs=178.7

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      ++|++.+.||+|+||.||+++. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+++..++||||+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            5799999999999999999996 469999999998776666678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC--CCCeEEeeecCceecCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD--DMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~--~~~vkL~Dfgla~~~~~~~  547 (621)
                      ++|+|.+++..  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.  ++.+||+|||+++.+....
T Consensus       106 ~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         106 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             CSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             CCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            99999998843  3446999999999999999999999986   999999999999964  5789999999998765432


Q ss_pred             CCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                         ......||+.|||||++.+..++.++|||||||++|||++|+.||..
T Consensus       181 ---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~  227 (350)
T d1koaa2         181 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG  227 (350)
T ss_dssp             ---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC
Confidence               23346789999999999999999999999999999999999999863

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-41  Score=351.79  Aligned_cols=200  Identities=27%  Similarity=0.354  Sum_probs=178.8

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|++.+.||+|+||.||+++. .+|+.||||++++.   .....+.+.+|+.+|++++||||+++++++.+++.+++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            5799999999999999999996 57999999999754   2345677899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++|+|..++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.+|.+||+|||+++.....
T Consensus        85 ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            99999999998854   346899999999999999999999986   999999999999999999999999999865432


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      .  ......+||+.|+|||++.+..++.++||||+||++|||++|++||...
T Consensus       159 ~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~  208 (337)
T d1o6la_         159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  208 (337)
T ss_dssp             T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             C--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc
Confidence            2  2233468999999999999999999999999999999999999998643

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-41  Score=343.93  Aligned_cols=202  Identities=29%  Similarity=0.488  Sum_probs=172.8

Q ss_pred             CCCCccc-eeccCCceeEEEEEec---CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          391 NHFSDEN-KLGQGGFGPVYKGTLA---DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       391 ~~f~~~~-~LG~G~fG~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      ++|.+.+ +||+|+||.||+|.++   ++..||||+++... ....++|.+|+++|++++|||||+++|++.+ +.+++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            4566666 4999999999999753   35689999997653 3456789999999999999999999999865 468999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      |||+++|+|.+++..  ....+++..+.+++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence            999999999998743  3356999999999999999999999986   99999999999999999999999999998755


Q ss_pred             CCCC-cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          546 NQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       546 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      .... .......||+.|+|||++.++.++.++|||||||++|||+| |+.||...
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~  216 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM  216 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC
Confidence            4322 22234568899999999999999999999999999999998 99998643

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.6e-41  Score=347.42  Aligned_cols=196  Identities=28%  Similarity=0.418  Sum_probs=176.1

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|++.+.||+|+||+||+++. .+|+.||||++++.   .....+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            4689999999999999999996 46999999999753   2345678999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++|+|..++..   ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus        84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            99999999888853   345889999999999999999999886   999999999999999999999999999876432


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                           .....||+.|||||++.+..++.++|||||||++|||++|+.||..
T Consensus       158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~  203 (316)
T d1fota_         158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD  203 (316)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC
Confidence                 2245799999999999999999999999999999999999999864

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-41  Score=348.78  Aligned_cols=199  Identities=26%  Similarity=0.378  Sum_probs=160.7

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      .+.|++.+.||+|+||+||+++.. +|+.||||++.+.. ....+.+.+|+++|++++|||||++++++.+++..++|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            457999999999999999999964 68999999997653 2334568899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc---CCCCeEEeeecCceecC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD---DDMNPKISDFGLARIFG  544 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~---~~~~vkL~Dfgla~~~~  544 (621)
                      |+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||+.   +++.+||+|||+++...
T Consensus        88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            9999999999953   456999999999999999999999986   99999999999995   57899999999998654


Q ss_pred             CCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ....   .....||+.|||||++.+..++.++|||||||++|||++|++||..
T Consensus       162 ~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~  211 (307)
T d1a06a_         162 PGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD  211 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC
Confidence            3322   2345799999999999999999999999999999999999999863

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3e-41  Score=351.88  Aligned_cols=199  Identities=24%  Similarity=0.369  Sum_probs=178.3

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEec
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYM  469 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~  469 (621)
                      ++|++.+.||+|+||.||+|+. .+|+.||||+++.......+.+.+|+++|++++|||||++++++.+++.+++||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            5799999999999999999996 479999999998766555677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc--CCCCeEEeeecCceecCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD--DDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~--~~~~vkL~Dfgla~~~~~~~  547 (621)
                      ++|+|.+++..  ....+++.++..|+.||+.||.|||+.+   |+||||||+||||+  .++.+||+|||++.......
T Consensus       109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            99999887743  3446999999999999999999999986   99999999999998  67899999999999875432


Q ss_pred             CCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                         ......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus       184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~  230 (352)
T d1koba_         184 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG  230 (352)
T ss_dssp             ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             ---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence               23345789999999999999999999999999999999999999863

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-41  Score=350.40  Aligned_cols=204  Identities=32%  Similarity=0.466  Sum_probs=173.8

Q ss_pred             CCCCccceeccCCceeEEEEEecC-C-----cEEEEEEeccC-CcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLAD-G-----KAIAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQEL  462 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~-g-----~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~  462 (621)
                      ++|++.++||+|+||+||+|+... +     ..||+|++... .......+.+|+.+|.++ +|||||++++++.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            578899999999999999998642 2     36999998654 334456789999999998 899999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCC
Q 007006          463 LLIYEYMPNKSLDVHLFDATR--------------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKAS  522 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~  522 (621)
                      ++||||+++|+|.+++.....                    ...+++..++.++.||++||.|||+++   |+||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence            999999999999999964321                    235899999999999999999999986   999999999


Q ss_pred             CEEEcCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          523 NILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       523 NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      |||++.++.+||+|||+++...............||+.|||||++.++.++.++|||||||++|||+| |++||..
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence            99999999999999999987655444333344568999999999999999999999999999999998 8999864

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-41  Score=348.67  Aligned_cols=194  Identities=32%  Similarity=0.527  Sum_probs=171.2

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      +.|+..++||+|+||+||+|+. .+|+.||||+++...   ....+.+.+|+++|++++|||||++++++.+++..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            3588999999999999999985 578999999997653   233467899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+++|+|..++..   ...+++.++..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++..... 
T Consensus        95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            99999999766633   356999999999999999999999986   99999999999999999999999999986432 


Q ss_pred             CCCcccccccccCCccChhcccC---CCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMG---GIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~---~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                           .....||+.|||||++.+   +.++.++|||||||++|||++|+.||.
T Consensus       168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~  215 (309)
T d1u5ra_         168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  215 (309)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCC
Confidence                 223579999999999864   458999999999999999999999985

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-40  Score=339.61  Aligned_cols=199  Identities=28%  Similarity=0.388  Sum_probs=176.4

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC------cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS------GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL  462 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~------~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~  462 (621)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++++..      ....+.+.+|+.+|++++|||||++++++.+++..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            36799999999999999999996 479999999986542      23467899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC----CeEEeeec
Q 007006          463 LLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM----NPKISDFG  538 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~----~vkL~Dfg  538 (621)
                      ++||||+++|+|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence            9999999999999998543   46999999999999999999999986   99999999999998776    49999999


Q ss_pred             CceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          539 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       539 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ++........   .....+|+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       163 ~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~  218 (293)
T d1jksa_         163 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG  218 (293)
T ss_dssp             TCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             hhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC
Confidence            9987654322   2234689999999999999999999999999999999999999864

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-41  Score=340.91  Aligned_cols=194  Identities=33%  Similarity=0.460  Sum_probs=165.2

Q ss_pred             ceeccCCceeEEEEEecC---CcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecCC
Q 007006          397 NKLGQGGFGPVYKGTLAD---GKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMPN  471 (621)
Q Consensus       397 ~~LG~G~fG~Vy~~~~~~---g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~~  471 (621)
                      ++||+|+||.||+|.+++   ++.||||+++..  +....++|.+|+++|++++|||||+++|++.+ +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            579999999999998643   568999999754  23345679999999999999999999999865 467899999999


Q ss_pred             CChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc-
Q 007006          472 KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA-  550 (621)
Q Consensus       472 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~-  550 (621)
                      |+|.+++..   ...+++..+++++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......... 
T Consensus        92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            999999854   346999999999999999999999986   9999999999999999999999999999765443322 


Q ss_pred             ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      ......||+.|+|||.+.+..++.++|||||||++|||+| |++||..
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~  213 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG  213 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCC
Confidence            2234568999999999999999999999999999999998 8999864

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-41  Score=338.79  Aligned_cols=201  Identities=30%  Similarity=0.497  Sum_probs=165.3

Q ss_pred             CCCCccceeccCCceeEEEEEecCC-----cEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADG-----KAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g-----~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      +.|+..+.||+|+||.||+|.++..     ..||||+++... .....+|.+|+++|++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4577889999999999999986532     479999997543 3345678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      ||||+.++++..++..  ....+++.++.+++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus        87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999887754  3356999999999999999999999986   9999999999999999999999999998765


Q ss_pred             CCCCC-cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          545 GNQNQ-ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       545 ~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      ..... .......||+.|||||++.++.++.++|||||||++|||++|..|+.
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~  214 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY  214 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcc
Confidence            43222 22233467899999999999999999999999999999999766643

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-40  Score=346.93  Aligned_cols=196  Identities=26%  Similarity=0.361  Sum_probs=176.8

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ++|++.+.||+|+||.||+++. .+|+.||||++.+.   .....+.+.+|+++|+.++|||||++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            4799999999999999999996 47999999998643   2345677899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGN  546 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~  546 (621)
                      ||+.+|+|..++...   ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            999999999988543   46999999999999999999999986   999999999999999999999999999976432


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                           .....||+.|||||++.+..++.++|||||||++|||+||++||..
T Consensus       195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~  240 (350)
T d1rdqe_         195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA  240 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC
Confidence                 2235799999999999999999999999999999999999999863

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-40  Score=337.84  Aligned_cols=199  Identities=34%  Similarity=0.503  Sum_probs=167.9

Q ss_pred             CCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEecC
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEYMP  470 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~~~  470 (621)
                      ++|++.+.||+|+||.||+|+++++..||||+++.. ....+.|.+|+.+|++++|||||+++|++.+ +..++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            578999999999999999999988889999999754 3445789999999999999999999999855 56789999999


Q ss_pred             CCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCCc
Q 007006          471 NKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQA  550 (621)
Q Consensus       471 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~~  550 (621)
                      +|+|..++... ....++|.+++.++.||+.||+|||+.+   |+||||||+||||+.++++||+|||+++........ 
T Consensus        95 ~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~-  169 (285)
T d1fmka3          95 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-  169 (285)
T ss_dssp             TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce-
Confidence            99999888643 2345999999999999999999999986   999999999999999999999999999876443222 


Q ss_pred             ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          551 NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       551 ~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      ......+|+.|+|||++..+.++.++||||||+++|||+||..|+.
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~  215 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY  215 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCC
Confidence            2233468999999999999999999999999999999999766653

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-40  Score=340.43  Aligned_cols=202  Identities=31%  Similarity=0.509  Sum_probs=169.1

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCc----EEEEEEeccC-CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGK----AIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~l  464 (621)
                      ++|++.++||+|+||+||+|.+. +|+    .||+|+++.. +....++|.+|++++++++|||||+++|++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46999999999999999999864 444    6899988754 345678899999999999999999999999875 5678


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFG  544 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~  544 (621)
                      ++||+.+++|.+++..  +...+++..+++++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            8899999999988754  3456999999999999999999999986   9999999999999999999999999999876


Q ss_pred             CCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCC
Q 007006          545 GNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFY  598 (621)
Q Consensus       545 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~  598 (621)
                      ............||+.|+|||++.++.++.++|||||||++|||+| |++||...
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~  217 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI  217 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC
Confidence            5544444445578999999999999999999999999999999999 78888643

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-40  Score=338.53  Aligned_cols=199  Identities=30%  Similarity=0.464  Sum_probs=174.9

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccC---CcccHHHHHHHHHHHH-hcccCCceeEeeEEeeCceEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRT---SGQGLQEFKNEVNLIA-KLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~~l~-~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++++.   .....+.+..|..++. .++|||||++++++.+++..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57899999999999999999964 6999999999753   2344566777777765 68999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      |||+++|+|..++..   ...+++.++..++.||+.||+|||+++   |+||||||+|||+++++++||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            999999999999954   345899999999999999999999986   99999999999999999999999999986543


Q ss_pred             CCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~  205 (320)
T d1xjda_         156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG  205 (320)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC
Confidence            32  223345799999999999999999999999999999999999999964

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.7e-40  Score=333.08  Aligned_cols=202  Identities=26%  Similarity=0.384  Sum_probs=168.5

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC---cccHHHHHHHHHHHHhcccCCceeEeeEEeeCc----e
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS---GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----E  461 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~----~  461 (621)
                      .++|++.+.||+|+||.||+++. .+|+.||||+++...   ....+.+.+|+++++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46799999999999999999985 579999999997643   233567899999999999999999999998654    4


Q ss_pred             EEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCce
Q 007006          462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR  541 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~  541 (621)
                      .++||||+++++|..++..   ...+++.++..++.||+.||.|||+++   |+||||||+|||++.++..+|+|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence            7999999999999988854   346999999999999999999999986   9999999999999999999999999987


Q ss_pred             ecCCCC-CCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          542 IFGGNQ-NQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       542 ~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ...... .........||+.|+|||++.+..++.++|||||||++|||+||++||..
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~  216 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG  216 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCC
Confidence            654322 22233446799999999999999999999999999999999999999863

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.1e-40  Score=344.95  Aligned_cols=199  Identities=31%  Similarity=0.408  Sum_probs=170.8

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC---cccHHHHHHH---HHHHHhcccCCceeEeeEEeeCceEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS---GQGLQEFKNE---VNLIAKLQHKNLVRLLGCCLEGQELL  463 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E---i~~l~~l~h~nIv~l~g~~~~~~~~~  463 (621)
                      ++|++.+.||+|+||.||+|+.. +|+.||||++.+..   ......+.+|   +.+++.++|||||++++++.+++..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57999999999999999999964 69999999986432   2223334444   56667778999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceec
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF  543 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~  543 (621)
                      +||||+++|+|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            99999999999999954   345899999999999999999999986   999999999999999999999999999976


Q ss_pred             CCCCCCcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          544 GGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       544 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      ....    .....||+.|+|||++.. ..++.++|||||||++|||+||+.||....
T Consensus       158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~  210 (364)
T d1omwa3         158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK  210 (364)
T ss_dssp             SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred             CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC
Confidence            5432    234579999999999875 468999999999999999999999996543

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.3e-39  Score=328.41  Aligned_cols=199  Identities=29%  Similarity=0.414  Sum_probs=174.2

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcc---------cHHHHHHHHHHHHhcc-cCCceeEeeEEeeC
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQ---------GLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEG  459 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~---------~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~  459 (621)
                      ++|++.+.||+|+||+||+++. .+|+.||||++++....         ..+.+.+|+.+|++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            5799999999999999999996 57999999999765321         2245889999999997 99999999999999


Q ss_pred             ceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecC
Q 007006          460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL  539 (621)
Q Consensus       460 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgl  539 (621)
                      +..++||||+++|+|.+++..   ...+++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence            999999999999999999954   346999999999999999999999986   99999999999999999999999999


Q ss_pred             ceecCCCCCCcccccccccCCccChhccc------CCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          540 ARIFGGNQNQANTNIIAGTYGYMAPEYAM------GGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       540 a~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ++.......   .....||+.|+|||.+.      ...++.++||||+||++|||++|+.||...
T Consensus       157 a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~  218 (277)
T d1phka_         157 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR  218 (277)
T ss_dssp             CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC
Confidence            998754322   23357899999999885      334788999999999999999999999643

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.8e-40  Score=336.25  Aligned_cols=205  Identities=30%  Similarity=0.473  Sum_probs=175.5

Q ss_pred             hCCCCccceeccCCceeEEEEEec------CCcEEEEEEeccCCc-ccHHHHHHHHHHHHhcccCCceeEeeEEeeCceE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTSG-QGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQEL  462 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~  462 (621)
                      .++|++.+.||+|+||.||+|+.+      +++.||||+++.... +..++|.+|+++|++++||||+++++++.+.+..
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~   91 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM   91 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence            467999999999999999999863      357899999976533 3456799999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhcc---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCC
Q 007006          463 LLIYEYMPNKSLDVHLFDAT---------------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKA  521 (621)
Q Consensus       463 ~lV~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp  521 (621)
                      ++||||+++|+|.+++....                     ....+++..+++|+.||+.||+|||+.+   |+||||||
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp  168 (301)
T d1lufa_          92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT  168 (301)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred             EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcc
Confidence            99999999999999986422                     1235899999999999999999999986   99999999


Q ss_pred             CCEEEcCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCC-CCCCC
Q 007006          522 SNILLDDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR-KNNGF  597 (621)
Q Consensus       522 ~NILl~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~-~p~~~  597 (621)
                      +|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++|. +||..
T Consensus       169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence            99999999999999999998765444334444567889999999999999999999999999999999996 56653

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-39  Score=333.22  Aligned_cols=200  Identities=22%  Similarity=0.347  Sum_probs=175.6

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      .++|++.+.||+|+||+||+|... +|+.||||+++.... ....+.+|+++|+.++|||||++++++.+++.+++||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            367999999999999999999964 688999999976543 345688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCC--CCeEEeeecCceecCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDD--MNPKISDFGLARIFGGN  546 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~--~~vkL~Dfgla~~~~~~  546 (621)
                      +++|+|.+++..  ....+++.++..++.||+.||.|||+.+   |+||||||+|||++.+  ..+||+|||++......
T Consensus        83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            999999999843  2346999999999999999999999986   9999999999999854  57999999999876432


Q ss_pred             CCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          547 QNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       547 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      .   ......+++.|+|||.+.+..++.++||||+||++|||++|+.||...
T Consensus       158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~  206 (321)
T d1tkia_         158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE  206 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC
Confidence            2   223457899999999999999999999999999999999999998643

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-40  Score=327.45  Aligned_cols=197  Identities=33%  Similarity=0.455  Sum_probs=164.3

Q ss_pred             CCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeC-ceEEEEEEec
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-QELLLIYEYM  469 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~-~~~~lV~e~~  469 (621)
                      ++|+..++||+|+||.||+|+++ |..||||+++..  ...+.|.+|++++++++||||++++|++.++ +.+++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            46778899999999999999984 789999999754  3457899999999999999999999998654 5689999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++|+|.+++... ....+++..+++++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....   
T Consensus        84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---  156 (262)
T d1byga_          84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  156 (262)
T ss_dssp             TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence            999999999643 2345899999999999999999999985   999999999999999999999999999865332   


Q ss_pred             cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCCc
Q 007006          550 ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYF  599 (621)
Q Consensus       550 ~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~~  599 (621)
                        .....++..|+|||++.++.++.++||||||+++|||+| |++||....
T Consensus       157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~  205 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP  205 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred             --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC
Confidence              223457889999999999999999999999999999998 688876543

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-39  Score=328.83  Aligned_cols=202  Identities=25%  Similarity=0.348  Sum_probs=162.8

Q ss_pred             CCCCccceeccCCceeEEEEEecC----CcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLAD----GKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      ++|++.+.||+|+||.||+|++..    +..||||+++... ....+.|.+|+++|++++|||||++++++. ++..++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            578889999999999999998642    4578999987543 334567999999999999999999999986 4678999


Q ss_pred             EEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCC
Q 007006          466 YEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGG  545 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~  545 (621)
                      |||+++|+|..++..  ....+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus        86 ~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          86 MELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             EECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccC
Confidence            999999999988753  3456999999999999999999999986   99999999999999999999999999987654


Q ss_pred             CCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCCCc
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGFYF  599 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~~~  599 (621)
                      .... ......||+.|+|||++.+..++.++|||||||++|||+| |++||....
T Consensus       161 ~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~  214 (273)
T d1mp8a_         161 STYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK  214 (273)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             Ccce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC
Confidence            3222 2234567899999999999999999999999999999998 899986543

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-39  Score=326.20  Aligned_cols=200  Identities=32%  Similarity=0.449  Sum_probs=162.7

Q ss_pred             CCCCccceeccCCceeEEEEEec--CC--cEEEEEEeccC---CcccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA--DG--KAIAVKRLSRT---SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL  463 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~--~g--~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~  463 (621)
                      ++|++.+.||+|+||.||+|++.  ++  ..||||++.+.   ..+..++|.+|+++|++++||||++++|++.++ ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            56889999999999999999853  22  47899998754   334457899999999999999999999999764 678


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceec
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF  543 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~  543 (621)
                      +||||+++|++.+++..  +...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence            99999999999988754  3346999999999999999999999986   999999999999999999999999999987


Q ss_pred             CCCCCCc-ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCC
Q 007006          544 GGNQNQA-NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNG  596 (621)
Q Consensus       544 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~  596 (621)
                      ....... ......++..|+|||.+.+..++.++||||||+++|||+| |+.||.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~  216 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI  216 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCC
Confidence            5443322 2334567889999999999999999999999999999998 899985

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-39  Score=330.06  Aligned_cols=205  Identities=30%  Similarity=0.428  Sum_probs=165.6

Q ss_pred             hCCCCccceeccCCceeEEEEEec------CCcEEEEEEeccCC-cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeC-c
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG-Q  460 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~-~  460 (621)
                      .++|++.++||+|+||.||+|...      +++.||||+++... ....+.+.+|+..+.++ +|+||+.+++++.++ .
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            357899999999999999999853      34689999997543 33456688888888887 689999999998765 4


Q ss_pred             eEEEEEEecCCCChhhhhhhccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEc
Q 007006          461 ELLLIYEYMPNKSLDVHLFDATR-------------SVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLD  527 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~  527 (621)
                      ..++||||+++|+|.+++.....             ...+++.++..++.||++||.|||+++   |+||||||+||||+
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence            68999999999999999965322             345899999999999999999999986   99999999999999


Q ss_pred             CCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCC-CCCCC
Q 007006          528 DDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR-KNNGF  597 (621)
Q Consensus       528 ~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~-~p~~~  597 (621)
                      +++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+||. +||..
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~  239 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  239 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence            99999999999998765554444445567999999999999999999999999999999999975 56653

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-39  Score=333.18  Aligned_cols=195  Identities=24%  Similarity=0.322  Sum_probs=168.3

Q ss_pred             CCCCccc-eeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhc-ccCCceeEeeEEee----CceEE
Q 007006          391 NHFSDEN-KLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLE----GQELL  463 (621)
Q Consensus       391 ~~f~~~~-~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~----~~~~~  463 (621)
                      ++|.+.+ .||+|+||.||+|+. .+++.||||++++.     ..+.+|++++.++ +|||||++++++.+    +..++
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            5788775 599999999999986 57999999998643     4578899987665 89999999999875    45789


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC---CCCeEEeeecCc
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGLA  540 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~vkL~Dfgla  540 (621)
                      +||||+++|+|.+++... ....+++.++..++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||++
T Consensus        86 ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence            999999999999999642 2346999999999999999999999986   999999999999985   567999999999


Q ss_pred             eecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          541 RIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       541 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      +.......   .....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus       162 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~  215 (335)
T d2ozaa1         162 KETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS  215 (335)
T ss_dssp             EECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEE
T ss_pred             eeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCC
Confidence            87654332   2345799999999999999999999999999999999999999953

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-39  Score=329.04  Aligned_cols=195  Identities=27%  Similarity=0.416  Sum_probs=164.7

Q ss_pred             ccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcc-----cHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          395 DENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQ-----GLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       395 ~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~-----~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      .+++||+|+||+||+|+. .+|+.||||+++.....     ..+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            357899999999999996 46999999998754321     234688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +.++++..+.   .....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            9988776555   23456899999999999999999999986   99999999999999999999999999986644322


Q ss_pred             CcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .  .....||+.|+|||++... .++.++|||||||++|||+||++||..
T Consensus       156 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~  203 (299)
T d1ua2a_         156 A--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG  203 (299)
T ss_dssp             C--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             c--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCC
Confidence            2  2235789999999998654 579999999999999999999999864

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-39  Score=326.15  Aligned_cols=200  Identities=27%  Similarity=0.456  Sum_probs=169.9

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      ++|++.++||+|+||+||+|+. .+|+.||||+++...  ....+.+.+|+++|++++|||||++++++.+++..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5799999999999999999996 579999999996543  2345788999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      |+.++.+. ++.. .....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~~~~-~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKK-FMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHH-HHHH-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCchhh-hhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence            99765444 3322 23456999999999999999999999986   9999999999999999999999999998765432


Q ss_pred             CCcccccccccCCccChhcccCCC-CChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~~-~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .  ......||+.|+|||.+.... ++.++||||+||++|||++|+.||..
T Consensus       157 ~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~  205 (298)
T d1gz8a_         157 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG  205 (298)
T ss_dssp             B--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             c--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCC
Confidence            2  233457899999999877665 58999999999999999999999863

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-39  Score=326.80  Aligned_cols=205  Identities=34%  Similarity=0.466  Sum_probs=173.3

Q ss_pred             hCCCCccceeccCCceeEEEEEecC--------CcEEEEEEeccCCc-ccHHHHHHHHHHHHhc-ccCCceeEeeEEeeC
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLAD--------GKAIAVKRLSRTSG-QGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEG  459 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~~--------g~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~  459 (621)
                      .++|++.+.||+|+||.||+|+...        +..||||++++... ....++.+|...+.++ +|||||++++++.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            3578889999999999999998532        34799999976543 4457788999999998 899999999999999


Q ss_pred             ceEEEEEEecCCCChhhhhhhcc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE
Q 007006          460 QELLLIYEYMPNKSLDVHLFDAT-------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL  526 (621)
Q Consensus       460 ~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl  526 (621)
                      +..++||||+++|+|.+++....             ....+++.++++++.||+.||+|||+.+   |+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence            99999999999999999996432             1246899999999999999999999986   9999999999999


Q ss_pred             cCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHc-CCCCCCC
Q 007006          527 DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIIS-GRKNNGF  597 (621)
Q Consensus       527 ~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~ellt-G~~p~~~  597 (621)
                      +.++.+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |++||..
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~  240 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG  240 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC
Confidence            9999999999999998765555445555678999999999999999999999999999999998 6888753

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-39  Score=327.38  Aligned_cols=199  Identities=27%  Similarity=0.394  Sum_probs=163.4

Q ss_pred             CCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHH--HHHHHHhcccCCceeEeeEEeeCc----eEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKN--EVNLIAKLQHKNLVRLLGCCLEGQ----ELLL  464 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~--Ei~~l~~l~h~nIv~l~g~~~~~~----~~~l  464 (621)
                      .+|...+.||+|+||.||+|++ +|+.||||+++...   .+++..  |+..+.+++|||||++++++.+++    .+++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            4567788999999999999997 68999999996542   233344  455556789999999999998654    6899


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEeccCCCCCEEEcCCCCeEEeeecC
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS-----RLKIIHRDLKASNILLDDDMNPKISDFGL  539 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~iiH~Dlkp~NILl~~~~~vkL~Dfgl  539 (621)
                      ||||+++|+|..++..    ..++|..+++++.|++.||.|||+..     ..+|+||||||+||||+.++.+||+|||+
T Consensus        79 v~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl  154 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence            9999999999999954    35899999999999999999999741     24699999999999999999999999999


Q ss_pred             ceecCCCCCC--cccccccccCCccChhcccCCC------CChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          540 ARIFGGNQNQ--ANTNIIAGTYGYMAPEYAMGGI------FSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       540 a~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~------~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ++........  .......||+.|+|||++.+..      ++.++|||||||++|||+||..|++.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~  220 (303)
T d1vjya_         155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  220 (303)
T ss_dssp             CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred             cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence            9987543322  2233467999999999987643      57799999999999999999988754

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-38  Score=325.86  Aligned_cols=204  Identities=32%  Similarity=0.457  Sum_probs=176.5

Q ss_pred             hCCCCccceeccCCceeEEEEEe------cCCcEEEEEEeccCC-cccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCce
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL------ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQE  461 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~  461 (621)
                      .++|++.++||+|+||.||+|++      .+++.||||+++... ......|.+|+.+++++ +|||||++++++.+++.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            36788899999999999999985      246789999997653 33456789999999999 69999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhhcc---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEE
Q 007006          462 LLLIYEYMPNKSLDVHLFDAT---------------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILL  526 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl  526 (621)
                      .++||||+++|+|.+++....               ....+++..+..++.||++||+|||+++   ++||||||+|||+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence            999999999999999986532               2236899999999999999999999986   9999999999999


Q ss_pred             cCCCCeEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcC-CCCCC
Q 007006          527 DDDMNPKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISG-RKNNG  596 (621)
Q Consensus       527 ~~~~~vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG-~~p~~  596 (621)
                      +.++.+||+|||+++...............||+.|+|||.+.++.++.++||||||+++|||+|+ ++|+.
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~  249 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP  249 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence            99999999999999977654444444556789999999999999999999999999999999995 55543

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-38  Score=323.10  Aligned_cols=197  Identities=32%  Similarity=0.464  Sum_probs=168.3

Q ss_pred             cceeccCCceeEEEEEecCC----cEEEEEEeccC-CcccHHHHHHHHHHHHhcccCCceeEeeEEeeC-ceEEEEEEec
Q 007006          396 ENKLGQGGFGPVYKGTLADG----KAIAVKRLSRT-SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-QELLLIYEYM  469 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~g----~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~-~~~~lV~e~~  469 (621)
                      .++||+|+||+||+|++.++    ..||||+++.. +....++|.+|+++|++++||||++++|++.+. ...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999986432    36899999754 445567899999999999999999999998764 5889999999


Q ss_pred             CCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCCC
Q 007006          470 PNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQNQ  549 (621)
Q Consensus       470 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~~  549 (621)
                      ++|+|.+++..  ....+++..+++++.|+++||.|||+.+   |+||||||+||||++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999998854  3446788999999999999999999986   999999999999999999999999999876543322


Q ss_pred             c--ccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          550 A--NTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       550 ~--~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      .  ......||+.|+|||.+....++.++||||||+++|||+||+.||..
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~  236 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP  236 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence            2  22234689999999999999999999999999999999998888653

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.1e-38  Score=321.69  Aligned_cols=199  Identities=27%  Similarity=0.440  Sum_probs=171.2

Q ss_pred             CCCCccceeccCCceeEEEEEecCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEEe
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYEY  468 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e~  468 (621)
                      ++|.+.++||+|+||+||+|+.++|+.||||+++...  ....+.+.+|+.+|++++||||+++++++.+++..++++|+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5789999999999999999999999999999997543  33457899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCCC
Q 007006          469 MPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQN  548 (621)
Q Consensus       469 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~~  548 (621)
                      +.++.+..+..   ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            98877766652   3456999999999999999999999986   99999999999999999999999999987654322


Q ss_pred             CcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          549 QANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       549 ~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                        ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus       156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~  203 (286)
T d1ob3a_         156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG  203 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCC
Confidence              22334678999999998754 569999999999999999999999864

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-38  Score=326.69  Aligned_cols=200  Identities=33%  Similarity=0.500  Sum_probs=168.3

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCc--EEEEEEeccC-CcccHHHHHHHHHHHHhc-ccCCceeEeeEEeeCceEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGK--AIAVKRLSRT-SGQGLQEFKNEVNLIAKL-QHKNLVRLLGCCLEGQELLLI  465 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~--~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~nIv~l~g~~~~~~~~~lV  465 (621)
                      ++|++.++||+|+||.||+|+++ +|.  .||||+++.. .....+.|.+|+++|.++ +|||||+++|++.+++.+++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            57888999999999999999865 344  5788888644 344567899999999999 799999999999999999999


Q ss_pred             EEecCCCChhhhhhhc-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCe
Q 007006          466 YEYMPNKSLDVHLFDA-------------TRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNP  532 (621)
Q Consensus       466 ~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~v  532 (621)
                      |||+++|+|.+++...             .....+++..+.+++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999998643             23457999999999999999999999986   9999999999999999999


Q ss_pred             EEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCC-CCC
Q 007006          533 KISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRK-NNG  596 (621)
Q Consensus       533 kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~-p~~  596 (621)
                      ||+|||+++......   ......+|..|+|||.+.++.++.++|||||||++|||++|.. ||.
T Consensus       167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~  228 (309)
T d1fvra_         167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC  228 (309)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC
Confidence            999999998643221   1223468899999999999999999999999999999999765 564

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-38  Score=325.81  Aligned_cols=203  Identities=30%  Similarity=0.459  Sum_probs=176.2

Q ss_pred             CCCCccceeccCCceeEEEEEec------CCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA------DGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELL  463 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~  463 (621)
                      ++|.+.++||+|+||.||+|.+.      ++..||||+++... ......|.+|++++++++||||+++++++..++..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            57888999999999999999863      35789999997643 334456899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhcc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEee
Q 007006          464 LIYEYMPNKSLDVHLFDAT-------RSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISD  536 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~D  536 (621)
                      +||||+++|+|.+++....       ....+++..+.+++.|+++||.|||+.+   |+||||||+|||+++++++||+|
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D  176 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD  176 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence            9999999999999886421       2245799999999999999999999985   99999999999999999999999


Q ss_pred             ecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCC-CCCC
Q 007006          537 FGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGR-KNNG  596 (621)
Q Consensus       537 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~-~p~~  596 (621)
                      ||+++...............+|+.|+|||.+.++.++.++||||||+++|||+||+ +||.
T Consensus       177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~  237 (308)
T d1p4oa_         177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ  237 (308)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred             cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCC
Confidence            99998765544444444557899999999999999999999999999999999985 6664

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-38  Score=321.67  Aligned_cols=198  Identities=25%  Similarity=0.367  Sum_probs=168.1

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCc------ccHHHHHHHHHHHHhcc--cCCceeEeeEEeeCc
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSG------QGLQEFKNEVNLIAKLQ--HKNLVRLLGCCLEGQ  460 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~--h~nIv~l~g~~~~~~  460 (621)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++.+...      .....+.+|+.+|++++  |||||++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            35799999999999999999996 4799999999875421      11234678999999996  899999999999999


Q ss_pred             eEEEEEEecCC-CChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC-CCCeEEeeec
Q 007006          461 ELLLIYEYMPN-KSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-DMNPKISDFG  538 (621)
Q Consensus       461 ~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-~~~vkL~Dfg  538 (621)
                      ..++||||+.+ +++..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++. ++.+||+|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence            99999999976 567666643   346999999999999999999999986   999999999999985 4789999999


Q ss_pred             CceecCCCCCCcccccccccCCccChhcccCCCC-ChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          539 LARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIF-SIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       539 la~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ++......    ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..
T Consensus       157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~  212 (273)
T d1xwsa_         157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH  212 (273)
T ss_dssp             TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             cceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence            99875432    2234579999999999987765 6779999999999999999999864

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-38  Score=320.83  Aligned_cols=201  Identities=25%  Similarity=0.405  Sum_probs=167.6

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cC-CcEEEEEEeccCC--cccHHHHHHHHHHHHhc---ccCCceeEeeEEee----
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-AD-GKAIAVKRLSRTS--GQGLQEFKNEVNLIAKL---QHKNLVRLLGCCLE----  458 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~-g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l---~h~nIv~l~g~~~~----  458 (621)
                      .++|++.++||+|+||+||+|+. ++ ++.||||+++...  ......+.+|+.+|+.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999986 34 6679999986542  22234566788877766   79999999999863    


Q ss_pred             -CceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeee
Q 007006          459 -GQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDF  537 (621)
Q Consensus       459 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Df  537 (621)
                       ....++++||++++++.....  .....+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence             346899999999887754442  34456899999999999999999999986   999999999999999999999999


Q ss_pred             cCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          538 GLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       538 gla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      |++......   .......||+.|+|||++.+..++.++||||+||++|||++|++||...
T Consensus       161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~  218 (305)
T d1blxa_         161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS  218 (305)
T ss_dssp             CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC
Confidence            998764322   2234467999999999999999999999999999999999999999643

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=6e-37  Score=311.83  Aligned_cols=203  Identities=20%  Similarity=0.305  Sum_probs=173.1

Q ss_pred             hCCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhccc-CCceeEeeEEeeCceEEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH-KNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h-~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      .++|++.++||+|+||+||+|+.. +|+.||||++.....  ...+.+|++.++.++| +|++.+++++.++...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            368999999999999999999964 689999999865432  2456789999999965 899999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC-----CCCeEEeeecCcee
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD-----DMNPKISDFGLARI  542 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~-----~~~vkL~Dfgla~~  542 (621)
                      |+ +++|..++..  ....+++.++..++.|++.||+|||+.+   |+||||||+|||++.     ++.+||+|||+++.
T Consensus        82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            98 6899888754  2346899999999999999999999986   999999999999974     56799999999998


Q ss_pred             cCCCCCC-----cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCcC
Q 007006          543 FGGNQNQ-----ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFS  600 (621)
Q Consensus       543 ~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~  600 (621)
                      +......     .......||+.|||||.+.+..++.++||||||+++|||+||+.||.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~  218 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA  218 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc
Confidence            7543221     123345799999999999999999999999999999999999999975443

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-37  Score=319.41  Aligned_cols=197  Identities=28%  Similarity=0.414  Sum_probs=165.3

Q ss_pred             CCCccceeccCCceeEEEEEec-CCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCceeEeeEEeeC------ceEEE
Q 007006          392 HFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------QELLL  464 (621)
Q Consensus       392 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~------~~~~l  464 (621)
                      +|...++||+|+||+||+|+.. +|+.||||++......    ..+|+++|++++||||+++++++...      ..+++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5788899999999999999964 6999999999765432    24799999999999999999998643      34789


Q ss_pred             EEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC-CeEEeeecCceec
Q 007006          465 IYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIF  543 (621)
Q Consensus       465 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~vkL~Dfgla~~~  543 (621)
                      ||||++++.+..+.........+++.++..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||++...
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987765554443345567999999999999999999999886   99999999999999775 8999999999876


Q ss_pred             CCCCCCcccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          544 GGNQNQANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       544 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ......   ....|++.|+|||.+.+ ..++.++||||+||++|||++|++||...
T Consensus       174 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~  226 (350)
T d1q5ka_         174 VRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD  226 (350)
T ss_dssp             CTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred             cCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC
Confidence            543322   23478999999998765 46899999999999999999999998643

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-37  Score=314.43  Aligned_cols=201  Identities=24%  Similarity=0.428  Sum_probs=167.4

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccC--CcccHHHHHHHHHHHHhcccCCceeEeeEEee--------C
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRT--SGQGLQEFKNEVNLIAKLQHKNLVRLLGCCLE--------G  459 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~--------~  459 (621)
                      ++|++.++||+|+||+||+|+. .+|+.||||++...  .....+.+.+|+++|++++||||+++++++..        +
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            6899999999999999999996 57999999998644  33445778999999999999999999999865        3


Q ss_pred             ceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecC
Q 007006          460 QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGL  539 (621)
Q Consensus       460 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgl  539 (621)
                      ...++||||+.++.+..+.   .....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence            4579999999888776544   23456899999999999999999999986   99999999999999999999999999


Q ss_pred             ceecCCCCCC--cccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          540 ARIFGGNQNQ--ANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       540 a~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      +..+......  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~  224 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG  224 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence            9876543222  222335789999999998765 689999999999999999999999863

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-36  Score=317.50  Aligned_cols=202  Identities=24%  Similarity=0.358  Sum_probs=167.6

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC-cccHHHHHHHHHHHHhcccCCceeEeeEEeeCc----eEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS-GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ----ELL  463 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~----~~~  463 (621)
                      +++|++.++||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|+++|+.++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            46799999999999999999985 579999999997643 334567899999999999999999999997653    234


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceec
Q 007006          464 LIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIF  543 (621)
Q Consensus       464 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~  543 (621)
                      ++++++.+|+|.+++..    ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus        87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            55566789999999843    35999999999999999999999986   999999999999999999999999999876


Q ss_pred             CCCCCC-cccccccccCCccChhcccC-CCCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          544 GGNQNQ-ANTNIIAGTYGYMAPEYAMG-GIFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       544 ~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      ...... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~  216 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK  216 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCC
Confidence            443222 22344578999999999854 45799999999999999999999998643

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-36  Score=316.68  Aligned_cols=196  Identities=27%  Similarity=0.432  Sum_probs=163.1

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCc------
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQ------  460 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~------  460 (621)
                      .++|++.++||+|+||+||+|.. .+|+.||||+++...  ....+.+.+|+++|+.++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            36899999999999999999996 469999999997542  334567889999999999999999999998654      


Q ss_pred             eEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCc
Q 007006          461 ELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLA  540 (621)
Q Consensus       461 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla  540 (621)
                      .+++||||+ +.+|..++.    ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence            579999999 566766653    345999999999999999999999986   999999999999999999999999999


Q ss_pred             eecCCCCCCcccccccccCCccChhcccCC-CCChhhhHHHHHHHHHHHHcCCCCCCCC
Q 007006          541 RIFGGNQNQANTNIIAGTYGYMAPEYAMGG-IFSIKSDVFSFGVLLLEIISGRKNNGFY  598 (621)
Q Consensus       541 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~~sDVwS~Gvll~elltG~~p~~~~  598 (621)
                      +......     ....+|+.|+|||.+.+. .++.++||||+||++|||++|++||...
T Consensus       169 ~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~  222 (346)
T d1cm8a_         169 RQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS  222 (346)
T ss_dssp             EECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence            8764332     234689999999998764 5699999999999999999999998654

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.8e-36  Score=306.90  Aligned_cols=204  Identities=24%  Similarity=0.317  Sum_probs=166.6

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCce-eEeeEEeeCceEEEEEE
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNLV-RLLGCCLEGQELLLIYE  467 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nIv-~l~g~~~~~~~~~lV~e  467 (621)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++......  +++..|+++++.++|+|++ .+.++..+.+..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            35799999999999999999986 56899999998765332  4578899999999877655 55566677788899999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcC---CCCeEEeeecCceecC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDD---DMNPKISDFGLARIFG  544 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~---~~~vkL~Dfgla~~~~  544 (621)
                      |+. ++|...+..  ....+++..+..++.|++.||+|||+++   |+||||||+|||++.   +..+||+|||+++.+.
T Consensus        84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          84 LLG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             CCC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             EcC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            984 556555533  3346999999999999999999999986   999999999999863   5579999999999875


Q ss_pred             CCCCC-----cccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCcCC
Q 007006          545 GNQNQ-----ANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFSE  601 (621)
Q Consensus       545 ~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~~  601 (621)
                      .....     .......||+.|||||.+.+..++.++|||||||++|||+||+.||......
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~  219 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA  219 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchH
Confidence            43322     1223457999999999999999999999999999999999999999765443

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-36  Score=313.17  Aligned_cols=202  Identities=28%  Similarity=0.402  Sum_probs=171.8

Q ss_pred             CCCCccceeccCCceeEEEEEec----CCcEEEEEEeccCC----cccHHHHHHHHHHHHhccc-CCceeEeeEEeeCce
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA----DGKAIAVKRLSRTS----GQGLQEFKNEVNLIAKLQH-KNLVRLLGCCLEGQE  461 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~h-~nIv~l~g~~~~~~~  461 (621)
                      ++|++.++||+|+||+||+++..    +|+.||||++++..    ....+.+.+|+++|++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            56999999999999999999842    48899999986532    2335668899999999977 899999999999999


Q ss_pred             EEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCce
Q 007006          462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR  541 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~  541 (621)
                      .+++|||+.+|+|..++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            99999999999999998543   35788999999999999999999986   9999999999999999999999999998


Q ss_pred             ecCCCCCCcccccccccCCccChhcccCC--CCChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          542 IFGGNQNQANTNIIAGTYGYMAPEYAMGG--IFSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       542 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      .+...... ......|++.|++||.+.+.  .++.++|||||||+||||++|+.||....
T Consensus       178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~  236 (322)
T d1vzoa_         178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG  236 (322)
T ss_dssp             ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred             hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            76433222 22345789999999998765  36889999999999999999999986543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-36  Score=303.82  Aligned_cols=198  Identities=25%  Similarity=0.405  Sum_probs=172.4

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeCceEEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEGQELLLIYE  467 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~~~~~lV~e  467 (621)
                      ++|++.++||+|+||+||+|+. .+++.||||+++...  ....+.+.+|+.+|+.++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5799999999999999999996 578999999986543  3446788999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCceecCCCC
Q 007006          468 YMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLARIFGGNQ  547 (621)
Q Consensus       468 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~~~~~~  547 (621)
                      ++.+++|..++.   ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++......
T Consensus        82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            999998887764   3456899999999999999999999986   9999999999999999999999999998765433


Q ss_pred             CCcccccccccCCccChhcccCCC-CChhhhHHHHHHHHHHHHcCCCCCC
Q 007006          548 NQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNG  596 (621)
Q Consensus       548 ~~~~~~~~~gt~~y~aPE~l~~~~-~s~~sDVwS~Gvll~elltG~~p~~  596 (621)
                      ..  .....+++.|+|||.+.... ++.++|||||||++|||++|+.||.
T Consensus       156 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  203 (292)
T d1unla_         156 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  203 (292)
T ss_dssp             SC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred             cc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence            22  22235678899999887665 6999999999999999999999974

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.1e-35  Score=307.62  Aligned_cols=194  Identities=21%  Similarity=0.363  Sum_probs=167.6

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcc-cCCceeEeeEEeeC--ceEEEEE
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEG--QELLLIY  466 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~--~~~~lV~  466 (621)
                      ++|++.++||+|+||+||+|+. .+|+.||||+++..   ..+++.+|+++|++++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            5799999999999999999996 57999999998753   3467889999999995 99999999999754  4689999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCC-CeEEeeecCceecCC
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDM-NPKISDFGLARIFGG  545 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~-~vkL~Dfgla~~~~~  545 (621)
                      ||+++++|..+.      ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++ .+||+|||++.....
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999987654      35899999999999999999999986   99999999999998655 699999999987654


Q ss_pred             CCCCcccccccccCCccChhcccCCC-CChhhhHHHHHHHHHHHHcCCCCCCCCc
Q 007006          546 NQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGFYF  599 (621)
Q Consensus       546 ~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~~sDVwS~Gvll~elltG~~p~~~~~  599 (621)
                      ...   .....+|+.|+|||.+.+.. ++.++||||+|++++||++|+.||....
T Consensus       183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~  234 (328)
T d3bqca1         183 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH  234 (328)
T ss_dssp             TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             CCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence            332   23456899999999987654 7999999999999999999999986543

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-35  Score=307.10  Aligned_cols=195  Identities=30%  Similarity=0.405  Sum_probs=159.2

Q ss_pred             CCCCccceeccCCceeEEEEEec-CCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeC------ce
Q 007006          391 NHFSDENKLGQGGFGPVYKGTLA-DGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG------QE  461 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~------~~  461 (621)
                      ++|++.++||+|+||+||+|++. +|+.||||++....  ....+.+.+|+.++++++|||||++++++...      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            67999999999999999999965 69999999997543  34456788999999999999999999999643      57


Q ss_pred             EEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCce
Q 007006          462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR  541 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~  541 (621)
                      +++||||+.++.+.. +.     ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~iv~Ey~~~~l~~~-~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLCQV-IQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHHHH-HT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHHHh-hh-----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence            899999997765543 31     34899999999999999999999986   9999999999999999999999999988


Q ss_pred             ecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          542 IFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       542 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ......   ......+|+.|+|||++.+..++.++||||+||+++||++|+.||..
T Consensus       168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~  220 (355)
T d2b1pa1         168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG  220 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCC
Confidence            654322   23345789999999999999999999999999999999999999863

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-35  Score=306.96  Aligned_cols=196  Identities=28%  Similarity=0.409  Sum_probs=164.5

Q ss_pred             hCCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCC--cccHHHHHHHHHHHHhcccCCceeEeeEEeeC-----ce
Q 007006          390 TNHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTS--GQGLQEFKNEVNLIAKLQHKNLVRLLGCCLEG-----QE  461 (621)
Q Consensus       390 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~nIv~l~g~~~~~-----~~  461 (621)
                      .++|++.++||+|+||+||+|+. .+|+.||||++++..  ....+.+.+|+++|++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            46799999999999999999985 579999999997653  23446788999999999999999999998643     34


Q ss_pred             EEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEeeecCce
Q 007006          462 LLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKISDFGLAR  541 (621)
Q Consensus       462 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~  541 (621)
                      .+++++++.+|+|.+++..    ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            4667788899999998842    35999999999999999999999986   9999999999999999999999999987


Q ss_pred             ecCCCCCCcccccccccCCccChhcccCCC-CChhhhHHHHHHHHHHHHcCCCCCCC
Q 007006          542 IFGGNQNQANTNIIAGTYGYMAPEYAMGGI-FSIKSDVFSFGVLLLEIISGRKNNGF  597 (621)
Q Consensus       542 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~s~~sDVwS~Gvll~elltG~~p~~~  597 (621)
                      ....     ......|++.|+|||.+.+.. ++.++|||||||++|||++|+.||..
T Consensus       170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~  221 (348)
T d2gfsa1         170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG  221 (348)
T ss_dssp             CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCC
Confidence            5432     223346888999999876654 68999999999999999999999864

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.97  E-value=3.6e-31  Score=277.02  Aligned_cols=202  Identities=20%  Similarity=0.273  Sum_probs=161.9

Q ss_pred             CCCCccceeccCCceeEEEEEe-cCCcEEEEEEeccCCcccHHHHHHHHHHHHhcc-----------cCCceeEeeEEee
Q 007006          391 NHFSDENKLGQGGFGPVYKGTL-ADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-----------HKNLVRLLGCCLE  458 (621)
Q Consensus       391 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----------h~nIv~l~g~~~~  458 (621)
                      ++|++.++||+|+||+||+|+. .+|+.||||++++.. ...+.+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            3599999999999999999996 579999999997543 23466788999988875           5789999988865


Q ss_pred             C--ceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCC-----
Q 007006          459 G--QELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMN-----  531 (621)
Q Consensus       459 ~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~-----  531 (621)
                      .  ...+++++++..+..............+++..+..++.||+.||.|||+..  +|+||||||+||||+.++.     
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccc
Confidence            3  456777777766554444434455667899999999999999999999832  5999999999999986653     


Q ss_pred             -eEEeeecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHHHHHcCCCCCCCCcC
Q 007006          532 -PKISDFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLLEIISGRKNNGFYFS  600 (621)
Q Consensus       532 -vkL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~elltG~~p~~~~~~  600 (621)
                       ++++|||.+......     .....||+.|+|||.+....++.++||||+||+++||++|+.||.....
T Consensus       170 ~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~  234 (362)
T d1q8ya_         170 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG  234 (362)
T ss_dssp             EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             eeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence             999999999865322     2335789999999999999999999999999999999999999875544

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.86  E-value=2.4e-22  Score=189.99  Aligned_cols=170  Identities=16%  Similarity=0.166  Sum_probs=119.8

Q ss_pred             CccceeccCCceeEEEEEecCCcEEEEEEeccCCc------------------ccHHHHHHHHHHHHhcccCCceeEeeE
Q 007006          394 SDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSG------------------QGLQEFKNEVNLIAKLQHKNLVRLLGC  455 (621)
Q Consensus       394 ~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~------------------~~~~~~~~Ei~~l~~l~h~nIv~l~g~  455 (621)
                      .+.++||+|+||+||+|...+|+.||||+++....                  ........|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            45689999999999999988999999998753210                  011234568889999999999998865


Q ss_pred             EeeCceEEEEEEecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCEEEcCCCCeEEe
Q 007006          456 CLEGQELLLIYEYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDSRLKIIHRDLKASNILLDDDMNPKIS  535 (621)
Q Consensus       456 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~Dlkp~NILl~~~~~vkL~  535 (621)
                      ..    .+++|||+++..+..          ++......++.|++.+|.|||+.+   |+||||||+|||++++ .++|+
T Consensus        83 ~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred             cC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence            32    379999998765432          334445678999999999999986   9999999999999976 48999


Q ss_pred             eecCceecCCCCCCcccccccccCCccChhcccCCCCChhhhHHHHHHHHH
Q 007006          536 DFGLARIFGGNQNQANTNIIAGTYGYMAPEYAMGGIFSIKSDVFSFGVLLL  586 (621)
Q Consensus       536 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~~sDVwS~Gvll~  586 (621)
                      |||++.....+.....   ....... -.|. ..+.|+.++|+||..--++
T Consensus       145 DFG~a~~~~~~~~~~~---l~rd~~~-~~~~-f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         145 DFPQSVEVGEEGWREI---LERDVRN-IITY-FSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CCTTCEETTSTTHHHH---HHHHHHH-HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred             ECCCcccCCCCCcHHH---HHHHHHH-HHHH-HcCCCCCcccHHHHHHHHh
Confidence            9999976532211100   0000000 0111 1345678899999765443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.54  E-value=2.6e-07  Score=89.35  Aligned_cols=146  Identities=16%  Similarity=0.111  Sum_probs=100.9

Q ss_pred             HHhCCCCccceeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcc-cCCceeEeeEEeeCceEEEEE
Q 007006          388 EATNHFSDENKLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQ-HKNLVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       388 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-h~nIv~l~g~~~~~~~~~lV~  466 (621)
                      ..-..|...+..+.++...||+... ++..+++|+...........+.+|...+..+. +--+.+++.+..+++..++||
T Consensus        11 ~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~   89 (263)
T d1j7la_          11 KLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             HHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             HhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEE
Confidence            3345666655544444568998865 56677888887654444456788999888874 444788888888888899999


Q ss_pred             EecCCCChhhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 007006          467 EYMPNKSLDVHLFDATRSVQLDWKRRQSIINGIARGILYLHEDS------------------------------------  510 (621)
Q Consensus       467 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------  510 (621)
                      +++++.++.......        .....++.++++.+..||+..                                    
T Consensus        90 ~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T d1j7la_          90 SEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             ECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred             Eeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence            999998875544211        112334555666666666420                                    


Q ss_pred             --------------------CCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          511 --------------------RLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       511 --------------------~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                                          +..++|+|+.|.|||+++++.+.|+||+.+..
T Consensus       162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                12379999999999999876677999998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.00  E-value=1.7e-05  Score=75.66  Aligned_cols=131  Identities=18%  Similarity=0.170  Sum_probs=87.4

Q ss_pred             eeccCCc-eeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhccc--CCceeEeeEEeeCceEEEEEEecCCCCh
Q 007006          398 KLGQGGF-GPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQH--KNLVRLLGCCLEGQELLLIYEYMPNKSL  474 (621)
Q Consensus       398 ~LG~G~f-G~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h--~nIv~l~g~~~~~~~~~lV~e~~~~gsL  474 (621)
                      .+..|.. ..||+...+++..+++|.......   ..+..|...++.+..  -.+++++.+..+++..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4455554 678999888888889997654432   346778888887743  3467788888888889999999998766


Q ss_pred             hhhhhhccCCCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q 007006          475 DVHLFDATRSVQLDWKRRQSIINGIARGILYLH-----------------------------------------------  507 (621)
Q Consensus       475 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-----------------------------------------------  507 (621)
                      ....        ++..   .++.++...|.-||                                               
T Consensus        94 ~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          94 LSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             cccc--------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            4311        1111   11122333333333                                               


Q ss_pred             ----hC----CCCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          508 ----ED----SRLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       508 ----~~----~~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                          ..    .+..++|+|+.|.|||++++..+-|+||+.+..
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                21    122379999999999999876678999998763

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.56  E-value=0.00028  Score=71.81  Aligned_cols=76  Identities=12%  Similarity=0.178  Sum_probs=49.5

Q ss_pred             cceeccCCceeEEEEEecC-CcEEEEEEeccC-------CcccHHHHHHHHHHHHhcc-c--CCceeEeeEEeeCceEEE
Q 007006          396 ENKLGQGGFGPVYKGTLAD-GKAIAVKRLSRT-------SGQGLQEFKNEVNLIAKLQ-H--KNLVRLLGCCLEGQELLL  464 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~-g~~vavK~l~~~-------~~~~~~~~~~Ei~~l~~l~-h--~nIv~l~g~~~~~~~~~l  464 (621)
                      .+.||.|....||+....+ ++.++||.-...       -.....+...|.+.|+.+. +  ..+++++.+  +++..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            4578999999999998654 678999964321       1112344567888887773 2  346666654  4455688


Q ss_pred             EEEecCCCC
Q 007006          465 IYEYMPNKS  473 (621)
Q Consensus       465 V~e~~~~gs  473 (621)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999998654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.84  E-value=0.0023  Score=62.87  Aligned_cols=136  Identities=15%  Similarity=0.161  Sum_probs=79.3

Q ss_pred             ceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCc--eeEee-----EEeeCceEEEEEEecCCCChhh
Q 007006          404 FGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL--VRLLG-----CCLEGQELLLIYEYMPNKSLDV  476 (621)
Q Consensus       404 fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nI--v~l~g-----~~~~~~~~~lV~e~~~~gsL~~  476 (621)
                      --.||+...++|..+++|+.+.. ....+++..|...+..|....+  +..+.     .....+..+.++++++|..++.
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            35799999999999999987643 2345678889999988854332  22211     1123456788999998744321


Q ss_pred             -----h---------hhh------ccCCCCCCHH-------------------HHHHHHHHHHHHHHHHHh----CCCCC
Q 007006          477 -----H---------LFD------ATRSVQLDWK-------------------RRQSIINGIARGILYLHE----DSRLK  513 (621)
Q Consensus       477 -----~---------l~~------~~~~~~l~~~-------------------~~~~i~~~ia~~L~yLH~----~~~~~  513 (621)
                           +         ++.      ...+..+++.                   ....+...+...+..+..    ..+..
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence                 0         010      0011112211                   111122222233333322    22456


Q ss_pred             eEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          514 IIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       514 iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      ++|+|+.+.|||++++  ..++||+-+..
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eecCCCCcccEEEeCC--ceEEechhccc
Confidence            8999999999999754  45899998764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.67  E-value=0.0039  Score=62.99  Aligned_cols=73  Identities=14%  Similarity=0.204  Sum_probs=50.7

Q ss_pred             cceeccCCceeEEEEEecC--------CcEEEEEEeccCCcccHHHHHHHHHHHHhcccCC-ceeEeeEEeeCceEEEEE
Q 007006          396 ENKLGQGGFGPVYKGTLAD--------GKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKN-LVRLLGCCLEGQELLLIY  466 (621)
Q Consensus       396 ~~~LG~G~fG~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~n-Iv~l~g~~~~~~~~~lV~  466 (621)
                      .+.|+.|-.-.+|+...++        .+.|.+++.-.  .....+..+|..+++.+.-.+ .+++++++.+    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            4578888889999998654        34567776653  223345678999999885434 4577877653    6889


Q ss_pred             EecCCCCh
Q 007006          467 EYMPNKSL  474 (621)
Q Consensus       467 e~~~~gsL  474 (621)
                      ||+++..+
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987554

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.69  E-value=0.027  Score=54.34  Aligned_cols=142  Identities=15%  Similarity=0.041  Sum_probs=73.1

Q ss_pred             eeccCCceeEEEEEecCCcEEEEEEeccCCcccHHHHHHHHHHHHhcccCCc--eeEeeE------EeeCceEEEEEEec
Q 007006          398 KLGQGGFGPVYKGTLADGKAIAVKRLSRTSGQGLQEFKNEVNLIAKLQHKNL--VRLLGC------CLEGQELLLIYEYM  469 (621)
Q Consensus       398 ~LG~G~fG~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~nI--v~l~g~------~~~~~~~~lV~e~~  469 (621)
                      .|..|---+.|+.+..+|+ +++|+.....  ..+++..|++++..+...++  +..+-.      .........++.++
T Consensus        25 ~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~  101 (316)
T d2ppqa1          25 GIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL  101 (316)
T ss_dssp             EECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred             cCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeec
Confidence            4556767888998876664 8999886432  22445567777777753322  211111      11234556677777


Q ss_pred             CCCChhhhh--------------hhc------cCCC------------------CCCHHHHHHHHHHHHHHHHHHHh-CC
Q 007006          470 PNKSLDVHL--------------FDA------TRSV------------------QLDWKRRQSIINGIARGILYLHE-DS  510 (621)
Q Consensus       470 ~~gsL~~~l--------------~~~------~~~~------------------~l~~~~~~~i~~~ia~~L~yLH~-~~  510 (621)
                      .+.......              +..      ....                  ..........+..+...+.-.+. .-
T Consensus       102 ~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L  181 (316)
T d2ppqa1         102 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL  181 (316)
T ss_dssp             CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred             ccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCcccc
Confidence            654332100              000      0000                  00001111122222222222221 11


Q ss_pred             CCCeEeccCCCCCEEEcCCCCeEEeeecCcee
Q 007006          511 RLKIIHRDLKASNILLDDDMNPKISDFGLARI  542 (621)
Q Consensus       511 ~~~iiH~Dlkp~NILl~~~~~vkL~Dfgla~~  542 (621)
                      +.++||+|+.++||+++.+...-|+||+.+..
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccccccCCcchhhhhcccccceeEeccccccc
Confidence            34699999999999999887778999998864